data_5tvz_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5tvz _Structure_validation_residue.Date_analyzed 2017-03-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 720' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp . . . . . 0 N--CA 1.446 -0.657 0 N-CA-C 109.373 -0.602 . . . . 99.989999999999995 109.373 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 721' ' ' PRO . . . . . 0.436 ' HG3' ' CE2' ' A' ' 751' ' ' PHE . 62.7 Cg_endo -87.62 155.97 7.67 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 122.948 2.432 . . . . 99.989999999999995 112.071 -174.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 722' ' ' SER . . . . . 0.505 ' HA ' ' CD2' ' A' ' 808' ' ' LEU . 12.7 t -176.77 -146.42 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.567 -0.531 . . . . 99.989999999999995 109.567 -174.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 723' ' ' ALA . . . . . 0.475 ' HA ' ' HA ' ' A' ' 745' ' ' LEU . . . -153.24 149.31 27.82 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.658 0.266 . . . . 99.989999999999995 110.621 177.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 70.6 m -135.11 98.42 3.99 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.588 -0.893 . . . . 99.989999999999995 108.588 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 725' ' ' LEU . . . . . 0.628 HD21 ' CG2' ' A' ' 743' ' ' VAL . 2.3 mt -64.67 141.91 58.61 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 115.867 -0.606 . . . . 99.989999999999995 110.571 -171.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 33.3 mtpt -93.47 -22.51 18.83 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.396 -0.82 . . . . 99.989999999999995 110.043 -176.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 727' ' ' LEU . . . . . 0.467 ' HB2' ' HD2' ' A' ' 742' ' ' PRO . 0.2 OUTLIER -70.24 108.7 4.29 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 107.733 -1.21 . . . . 99.989999999999995 107.733 173.771 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 34.2 m170 -104.78 42.93 1.15 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.508 0.559 . . . . 99.989999999999995 112.508 -169.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -179.45 -177.21 0.42 Allowed 'General case' 0 C--N 1.327 -0.402 0 O-C-N 123.238 0.336 . . . . 99.989999999999995 110.279 176.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 730' ' ' ASP . . . . . 0.446 ' HB3' ' HE2' ' A' ' 814' ' ' LYS . 5.0 p-10 -78.47 153.96 30.96 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.075 0.464 . . . . 99.989999999999995 110.86 179.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 731' ' ' LEU . . . . . 0.554 ' HB2' ' HA ' ' A' ' 815' ' ' ILE . 49.1 mt -102.53 137.35 40.88 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.505 -0.77 . . . . 99.989999999999995 110.672 178.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 732' ' ' LYS . . . . . . . . . . . . . 35.2 mmtm -104.12 103.83 13.67 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.155 0.503 . . . . 99.989999999999995 110.901 177.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 733' ' ' LEU . . . . . 0.492 ' HG ' ' HB3' ' A' ' 737' ' ' ASP . 0.8 OUTLIER -112.01 164.17 13.44 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.625 -0.716 . . . . 99.989999999999995 110.725 -178.972 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 734' ' ' CYS . . . . . 0.62 ' O ' ' HB2' ' A' ' 737' ' ' ASP . 56.6 m -104.65 -176.8 3.18 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.089 -1.078 . . . . 99.989999999999995 108.089 171.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 735' ' ' LEU . . . . . . . . . . . . . 10.3 tt -84.28 137.23 33.57 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 119.767 -0.773 . . . . 99.989999999999995 109.639 -175.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 82.97 8.02 86.36 Favored Glycine 0 N--CA 1.441 -0.989 0 CA-C-N 114.947 -1.024 . . . . 99.989999999999995 110.845 -171.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 737' ' ' ASP . . . . . 0.62 ' HB2' ' O ' ' A' ' 734' ' ' CYS . 0.5 OUTLIER -93.27 145.9 24.1 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.13 0.49 . . . . 99.989999999999995 111.546 177.262 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 738' ' ' HIS . . . . . 0.522 ' HB2' ' O ' ' A' ' 782' ' ' THR . 40.8 p-80 -110.76 175.82 5.28 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 107.353 -1.351 . . . . 99.989999999999995 107.353 170.173 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 739' ' ' SER . . . . . 0.405 ' CB ' HD23 ' A' ' 733' ' ' LEU . 0.0 OUTLIER -132.19 173.02 11.68 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 120.019 -0.672 . . . . 99.989999999999995 111.883 -177.344 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 36.8 m -143.03 106.82 4.65 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.032 -0.986 . . . . 99.989999999999995 109.702 178.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 741' ' ' VAL . . . . . 0.481 HG13 HD23 ' A' ' 793' ' ' LEU . 0.8 OUTLIER -110.32 111.92 57.41 Favored Pre-proline 0 C--N 1.318 -0.771 0 CA-C-N 115.931 -0.577 . . . . 99.989999999999995 110.177 -176.871 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 742' ' ' PRO . . . . . 0.704 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 4.0 Cg_exo -72.16 131.29 17.69 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 122.434 2.089 . . . . 99.989999999999995 111.249 -179.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 743' ' ' VAL . . . . . 0.628 ' CG2' HD21 ' A' ' 725' ' ' LEU . 41.2 t -131.3 118.05 38.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.503 0.668 . . . . 99.989999999999995 112.742 -179.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 744' ' ' ALA . . . . . 0.587 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -82.75 97.42 8.57 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 122.009 0.909 . . . . 99.989999999999995 108.621 170.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 745' ' ' LEU . . . . . 0.497 HD13 ' CD1' ' A' ' 773' ' ' ILE . 2.5 mt -76.72 159.72 29.93 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 113.972 -1.467 . . . . 99.989999999999995 111.86 -168.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -111.61 146.78 36.8 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.416 -0.811 . . . . 99.989999999999995 110.08 -178.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 747' ' ' GLY . . . . . 0.409 ' HA3' ' HB3' ' A' ' 721' ' ' PRO . . . 103.24 119.87 4.68 Favored Glycine 0 C--N 1.304 -1.204 0 CA-C-N 115.111 -0.95 . . . . 99.989999999999995 111.622 -178.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 748' ' ' GLN . . . . . 0.429 ' C ' ' HE1' ' A' ' 751' ' ' PHE . 0.0 OUTLIER -105.43 110.01 22.2 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.138 0.494 . . . . 99.989999999999995 111.2 -173.415 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 136.23 -175.68 20.76 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 115.207 -0.906 . . . . 99.989999999999995 110.877 -176.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -71.04 94.1 0.64 Allowed 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.397 2.064 . . . . 99.989999999999995 111.865 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 751' ' ' PHE . . . . . 0.566 ' HA ' ' O ' ' A' ' 799' ' ' LYS . 88.1 m-85 -113.2 140.46 47.92 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.327 -0.397 . . . . 99.989999999999995 111.368 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 752' ' ' THR . . . . . 0.652 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 98.0 m -89.92 104.99 17.5 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 121.556 0.693 . . . . 99.989999999999995 109.243 178.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 753' ' ' LEU . . . . . . . . . . . . . 21.3 tp -92.24 116.96 29.41 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 114.374 -1.285 . . . . 99.989999999999995 110.532 -172.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 754' ' ' THR . . . . . 0.471 HG23 ' HB2' ' A' ' 769' ' ' GLU . 0.9 OUTLIER -117.88 130.18 56.09 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.458 -0.337 . . . . 99.989999999999995 110.21 179.241 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 755' ' ' TYR . . . . . 0.539 ' CE1' ' HB3' ' A' ' 768' ' ' PHE . 20.8 p90 -139.43 153.8 47.66 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 120.741 -0.384 . . . . 99.989999999999995 111.582 -179.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 756' ' ' ASP . . . . . 0.435 ' HB2' HG23 ' A' ' 758' ' ' ILE . 7.6 p-10 -114.93 118.85 34.62 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 115.769 -0.651 . . . . 99.989999999999995 111.823 -176.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 757' ' ' ILE . . . . . 0.553 ' CD1' HD13 ' A' ' 793' ' ' LEU . 3.6 mp -91.68 95.36 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 N-CA-C 107.522 -1.288 . . . . 99.989999999999995 107.522 167.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 758' ' ' ILE . . . . . 0.51 HG13 ' O ' ' A' ' 792' ' ' ILE . 2.3 pp -103.93 149.67 7.62 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 115.413 -0.812 . . . . 99.989999999999995 111.061 -170.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -96.89 135.28 39.1 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 120.283 -0.567 . . . . 99.989999999999995 110.364 177.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 760' ' ' THR . . . . . 0.491 ' OG1' ' HB3' ' A' ' 790' ' ' ASP . 38.7 p . . . . . 0 N--CA 1.44 -0.938 0 CA-C-O 121.904 0.859 . . . . 99.989999999999995 108.684 174.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 765' ' ' ARG . . . . . 0.444 ' HG3' HG21 ' A' ' 758' ' ' ILE . 15.2 ttp180 . . . . . 0 N--CA 1.445 -0.688 0 CA-C-O 121.252 0.548 . . . . 99.989999999999995 111.88 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 766' ' ' LYS . . . . . 0.583 ' HD3' ' N ' ' A' ' 767' ' ' THR . 9.3 tmtm? -97.99 144.11 27.85 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 108.406 -0.961 . . . . 99.989999999999995 108.406 177.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 767' ' ' THR . . . . . 0.583 ' N ' ' HD3' ' A' ' 766' ' ' LYS . 60.0 m -132.3 132.61 43.16 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 116.197 -0.456 . . . . 99.989999999999995 110.603 -178.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 768' ' ' PHE . . . . . 0.539 ' HB3' ' CE1' ' A' ' 755' ' ' TYR . 1.7 t80 -130.83 136.25 48.49 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.927 -0.768 . . . . 99.989999999999995 108.927 178.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 769' ' ' GLU . . . . . 0.471 ' HB2' HG23 ' A' ' 754' ' ' THR . 35.1 tt0 -128.83 118.71 23.19 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.073 -0.512 . . . . 99.989999999999995 110.954 -177.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 7.7 mt -115.68 112.26 39.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.222 -0.659 . . . . 99.989999999999995 109.222 178.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 771' ' ' LYS . . . . . 0.58 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 3.1 mtpt -82.25 150.61 27.21 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 121.431 0.634 . . . . 99.989999999999995 111.528 -176.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 772' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 56.21 48.32 17.6 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 113.985 -1.462 . . . . 99.989999999999995 112.549 176.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 773' ' ' ILE . . . . . 0.497 ' CD1' HD13 ' A' ' 745' ' ' LEU . 0.5 OUTLIER -74.58 119.09 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 N-CA-C 107.722 -1.214 . . . . 99.989999999999995 107.722 173.215 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 76.2 mttt -117.91 31.32 6.76 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 108.16 -1.052 . . . . 99.989999999999995 108.16 -178.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 775' ' ' THR . . . . . 0.577 ' O ' ' HB2' ' A' ' 776' ' ' ASN . 2.1 m -95.74 -69.99 0.73 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.388 -1.278 . . . . 99.989999999999995 112.55 -172.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 776' ' ' ASN . . . . . 0.577 ' HB2' ' O ' ' A' ' 775' ' ' THR . 0.9 OUTLIER 82.78 4.43 1.0 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.825 0.85 . . . . 99.989999999999995 110.547 -177.092 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 777' ' ' GLU . . . . . 0.587 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 9.4 mt-10 -160.88 85.8 0.7 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.046 -0.979 . . . . 99.989999999999995 109.344 175.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 778' ' ' TYR . . . . . 0.485 ' HB3' HD12 ' A' ' 745' ' ' LEU . 75.6 t80 -136.26 126.97 27.24 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.196 -0.456 . . . . 99.989999999999995 110.258 -172.09 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 779' ' ' VAL . . . . . 0.704 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 1.6 m -91.52 126.4 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 CA-C-O 122.435 1.112 . . . . 99.989999999999995 110.612 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 780' ' ' ILE . . . . . . . . . . . . . 71.0 mt -89.22 145.32 7.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 113.543 -1.662 . . . . 99.989999999999995 110.954 -172.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -112.75 115.45 28.54 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.009 -0.738 . . . . 99.989999999999995 109.009 175.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 782' ' ' THR . . . . . 0.522 ' O ' ' HB2' ' A' ' 738' ' ' HIS . 22.9 p -89.43 140.48 28.45 Favored Pre-proline 0 C--N 1.309 -1.158 0 CA-C-N 115.252 -0.886 . . . . 99.989999999999995 110.674 -178.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 783' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.02 156.56 28.5 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.641 2.894 . . . . 99.989999999999995 112.655 -174.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 784' ' ' VAL . . . . . . . . . . . . . 15.0 p -62.9 135.31 27.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.761 -0.654 . . . . 99.989999999999995 111.126 -176.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 785' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -105.04 102.72 12.21 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.895 -0.593 . . . . 99.989999999999995 109.744 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 81.4 p -84.54 19.35 1.99 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.96 -0.564 . . . . 99.989999999999995 111.386 -174.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -159.42 119.05 2.98 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.364 -0.835 . . . . 99.989999999999995 111.211 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 788' ' ' GLY . . . . . 0.46 ' HA2' HG12 ' A' ' 817' ' ' VAL . . . -46.08 116.29 2.11 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.431 -0.804 . . . . 99.989999999999995 113.571 170.233 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 789' ' ' GLY . . . . . 0.455 ' H ' ' HB ' ' A' ' 817' ' ' VAL . . . -156.8 -162.31 11.4 Favored Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 111.132 -0.787 . . . . 99.989999999999995 111.132 177.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 790' ' ' ASP . . . . . 0.491 ' HB3' ' OG1' ' A' ' 760' ' ' THR . 16.5 t70 -130.54 122.09 26.92 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.096 -0.705 . . . . 99.989999999999995 109.096 179.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 791' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -127.55 153.39 46.42 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 116.443 -0.344 . . . . 99.989999999999995 110.379 -174.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 792' ' ' ILE . . . . . 0.51 ' O ' HG13 ' A' ' 758' ' ' ILE . 19.2 mt -127.85 124.74 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 109.606 -0.516 . . . . 99.989999999999995 109.606 176.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 793' ' ' LEU . . . . . 0.553 HD13 ' CD1' ' A' ' 757' ' ' ILE . 1.2 tp -90.67 112.25 23.92 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 108.827 -0.805 . . . . 99.989999999999995 108.827 173.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 794' ' ' SER . . . . . 0.538 ' N ' HD11 ' A' ' 793' ' ' LEU . 9.4 t -118.79 175.16 5.88 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 114.451 -1.25 . . . . 99.989999999999995 108.492 -176.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 795' ' ' LEU . . . . . . . . . . . . . 21.5 mt -103.74 127.88 51.16 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 110.146 -0.316 . . . . 99.989999999999995 110.146 -178.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 796' ' ' VAL . . . . . . . . . . . . . 55.6 t -86.71 -57.6 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 CA-C-O 120.865 0.364 . . . . 99.989999999999995 110.773 -177.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 797' ' ' SER . . . . . 0.578 ' HA ' ' HG ' ' A' ' 808' ' ' LEU . 27.3 m -174.64 156.23 2.33 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.574 -0.739 . . . . 99.989999999999995 109.61 -173.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 798' ' ' ILE . . . . . 0.572 ' HA ' ' O ' ' A' ' 752' ' ' THR . 11.8 tt -128.8 168.06 22.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 N-CA-C 108.732 -0.84 . . . . 99.989999999999995 108.732 176.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 799' ' ' LYS . . . . . 0.652 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 42.9 tttp -139.62 121.89 15.95 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 120.739 -0.384 . . . . 99.989999999999995 111.312 -174.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 800' ' ' ASP . . . . . 0.544 ' HA ' ' CD2' ' A' ' 751' ' ' PHE . 12.6 t70 -69.22 156.94 37.9 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.429 -0.805 . . . . 99.989999999999995 109.236 176.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 27.4 t -64.6 -10.9 29.7 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 123.759 0.662 . . . . 99.989999999999995 112.208 -174.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 13.9 t -90.95 2.26 56.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.991 0.9 . . . . 99.989999999999995 109.137 175.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 803' ' ' GLY . . . . . 0.43 ' HA2' ' HE3' ' A' ' 799' ' ' LYS . . . 81.71 46.79 6.6 Favored Glycine 0 N--CA 1.44 -1.061 0 CA-C-N 114.764 -1.107 . . . . 99.989999999999995 111.781 -178.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 804' ' ' CYS . . . . . 0.41 ' HB3' ' HB3' ' A' ' 800' ' ' ASP . 42.7 t -114.12 113.23 24.42 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.927 -0.309 . . . . 99.989999999999995 110.39 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 805' ' ' VAL . . . . . 0.526 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 8.4 p -85.03 129.93 36.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.346 0.593 . . . . 99.989999999999995 110.549 -177.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 806' ' ' VAL . . . . . 0.437 ' HB ' HG22 ' A' ' 798' ' ' ILE . 74.0 t -112.97 133.61 58.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.346 -0.843 . . . . 99.989999999999995 110.022 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -69.87 113.34 4.94 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.772 -0.649 . . . . 99.989999999999995 111.755 178.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 808' ' ' LEU . . . . . 0.578 ' HG ' ' HA ' ' A' ' 797' ' ' SER . 38.0 mt -84.55 125.05 32.08 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 112.34 0.496 . . . . 99.989999999999995 112.34 -175.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 23.2 t -144.51 87.14 1.85 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.422 -0.808 . . . . 99.989999999999995 109.169 172.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 810' ' ' GLN . . . . . 0.486 ' HB3' ' HD2' ' A' ' 811' ' ' PRO . 10.6 mt-30 -143.88 171.22 7.11 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.434 -0.803 . . . . 99.989999999999995 109.132 178.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 811' ' ' PRO . . . . . 0.537 ' O ' ' HG ' ' A' ' 725' ' ' LEU . 79.2 Cg_exo -42.73 139.68 3.16 Favored 'Trans proline' 0 C--N 1.356 0.925 0 C-N-CA 123.045 2.497 . . . . 99.989999999999995 114.826 -171.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 812' ' ' ASP . . . . . 0.453 ' C ' HD12 ' A' ' 725' ' ' LEU . 9.3 p-10 -112.19 167.71 10.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.51 -1.223 . . . . 99.989999999999995 110.642 -177.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 813' ' ' ALA . . . . . 0.509 ' N ' HD12 ' A' ' 725' ' ' LEU . . . -118.19 155.85 29.78 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.96 -0.564 . . . . 99.989999999999995 109.604 179.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 814' ' ' LYS . . . . . 0.456 ' HG3' ' CG1' ' A' ' 792' ' ' ILE . 12.0 ttpt -121.24 134.42 55.18 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.137 -0.625 . . . . 99.989999999999995 110.528 176.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 815' ' ' ILE . . . . . 0.554 ' HA ' ' HB2' ' A' ' 731' ' ' LEU . 4.6 mp -116.38 108.15 24.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-N 115.21 -0.905 . . . . 99.989999999999995 108.68 177.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 816' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -103.05 108.43 19.6 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.545 0.688 . . . . 99.989999999999995 109.629 -178.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 817' ' ' VAL . . . . . 0.46 HG12 ' HA2' ' A' ' 788' ' ' GLY . 90.4 t -98.36 139.5 20.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-N 115.295 -0.866 . . . . 99.989999999999995 110.168 -177.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 818' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 . . . . . 0 C--N 1.312 -1.028 0 N-CA-C 110.168 -0.308 . . . . 99.989999999999995 110.168 178.371 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 720' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp . . . . . 0 N--CA 1.45 -0.443 0 N-CA-C 109.545 -0.539 . . . . 99.989999999999995 109.545 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 721' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -87.62 152.41 7.57 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 122.977 2.451 . . . . 99.989999999999995 112.401 -172.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 722' ' ' SER . . . . . 0.429 ' OG ' ' HG ' ' A' ' 808' ' ' LEU . 15.0 t -176.66 -148.5 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.168 -0.679 . . . . 99.989999999999995 109.168 -174.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 723' ' ' ALA . . . . . 0.524 ' HA ' ' HA ' ' A' ' 745' ' ' LEU . . . -157.18 155.41 30.88 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.264 -0.643 . . . . 99.989999999999995 109.264 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 20.8 p -147.47 107.53 4.02 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.969 0.414 . . . . 99.989999999999995 109.894 174.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 725' ' ' LEU . . . . . 0.573 ' CD2' ' HB ' ' A' ' 743' ' ' VAL . 14.6 mt -62.96 145.62 54.91 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 121.591 0.71 . . . . 99.989999999999995 111.683 -175.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 29.9 mtpt -95.85 -17.63 20.98 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 114.707 -1.133 . . . . 99.989999999999995 110.13 -177.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 727' ' ' LEU . . . . . 0.429 HD23 ' HG ' ' A' ' 731' ' ' LEU . 37.1 tp -67.15 115.14 6.5 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.607 -0.724 . . . . 99.989999999999995 110.213 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 34.5 m80 -109.48 30.02 7.02 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.968 0.413 . . . . 99.989999999999995 111.742 -176.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -162.23 179.9 7.54 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.043 -0.725 . . . . 99.989999999999995 109.043 175.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 730' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -91.72 143.47 26.51 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.023 0.439 . . . . 99.989999999999995 110.315 -178.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 731' ' ' LEU . . . . . 0.573 ' HB2' ' HA ' ' A' ' 815' ' ' ILE . 16.0 mt -78.48 108.44 11.85 Favored 'General case' 0 C--O 1.217 -0.629 0 CA-C-N 115.832 -0.622 . . . . 99.989999999999995 111.771 -177.254 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 732' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -77.5 103.91 7.72 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.718 0.294 . . . . 99.989999999999995 111.022 178.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 733' ' ' LEU . . . . . 0.598 ' HB2' ' HB ' ' A' ' 817' ' ' VAL . 30.9 mt -118.06 164.78 14.6 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.183 0.516 . . . . 99.989999999999995 111.794 -177.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 734' ' ' CYS . . . . . . . . . . . . . 11.2 t -120.77 -174.41 2.81 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.159 -0.928 . . . . 99.989999999999995 109.039 179.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 735' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.39 119.29 16.39 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.064 0.459 . . . . 99.989999999999995 110.858 -171.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 86.66 10.93 72.09 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.449 -0.796 . . . . 99.989999999999995 111.893 -179.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 737' ' ' ASP . . . . . 0.499 ' HB3' ' HB3' ' A' ' 733' ' ' LEU . 5.8 t0 -75.43 168.78 19.36 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.084 0.469 . . . . 99.989999999999995 110.417 177.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 47.7 p-80 -126.21 153.72 44.29 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.848 -1.167 . . . . 99.989999999999995 107.848 175.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 739' ' ' SER . . . . . 0.592 ' HB2' ' OG1' ' A' ' 782' ' ' THR . 1.4 m -101.96 152.69 20.64 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 119.817 -0.753 . . . . 99.989999999999995 111.07 -173.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 740' ' ' SER . . . . . 0.441 ' HA ' ' O ' ' A' ' 780' ' ' ILE . 54.6 p -140.97 104.91 4.76 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.494 0.664 . . . . 99.989999999999995 110.055 179.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 741' ' ' VAL . . . . . 0.45 HG13 HD13 ' A' ' 793' ' ' LEU . 1.5 p -118.67 114.94 35.6 Favored Pre-proline 0 C--N 1.317 -0.838 0 CA-C-N 115.605 -0.725 . . . . 99.989999999999995 109.918 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 742' ' ' PRO . . . . . 0.635 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 1.8 Cg_endo -75.86 130.37 12.37 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 122.431 2.087 . . . . 99.989999999999995 111.082 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 743' ' ' VAL . . . . . 0.573 ' HB ' ' CD2' ' A' ' 725' ' ' LEU . 1.6 p -126.7 121.29 58.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.547 0.689 . . . . 99.989999999999995 112.61 175.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 744' ' ' ALA . . . . . 0.474 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -82.67 102.23 11.35 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.203 -1.036 . . . . 99.989999999999995 108.203 168.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 745' ' ' LEU . . . . . 0.524 ' HA ' ' HA ' ' A' ' 723' ' ' ALA . 1.0 OUTLIER -81.11 168.63 18.39 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 114.282 -1.327 . . . . 99.989999999999995 111.258 -168.569 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 28.0 ttmt -123.02 154.82 37.97 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.307 0.575 . . . . 99.989999999999995 110.717 -177.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 747' ' ' GLY . . . . . . . . . . . . . . . 92.05 133.11 5.98 Favored Glycine 0 C--N 1.309 -0.926 0 CA-C-N 114.919 -1.037 . . . . 99.989999999999995 111.001 -174.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 748' ' ' GLN . . . . . 0.41 ' C ' ' HE1' ' A' ' 751' ' ' PHE . 65.7 mm-40 -101.89 123.03 45.13 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 112.505 0.557 . . . . 99.989999999999995 112.505 -170.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 107.98 -169.54 14.53 Favored Glycine 0 C--O 1.219 -0.815 0 CA-C-N 115.408 -0.814 . . . . 99.989999999999995 111.896 179.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -67.23 99.86 0.51 Allowed 'Trans proline' 0 CA--C 1.531 0.356 0 C-N-CA 123.561 2.84 . . . . 99.989999999999995 113.542 -178.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 751' ' ' PHE . . . . . 0.615 ' CE2' ' HA ' ' A' ' 800' ' ' ASP . 60.9 m-85 -115.29 142.8 46.18 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.894 -0.594 . . . . 99.989999999999995 111.384 178.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 752' ' ' THR . . . . . 0.725 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 91.0 m -87.91 102.84 15.1 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.575 0.702 . . . . 99.989999999999995 109.867 178.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 753' ' ' LEU . . . . . . . . . . . . . 17.4 tp -92.08 130.71 37.75 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.537 -1.211 . . . . 99.989999999999995 110.538 -170.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 754' ' ' THR . . . . . 0.483 HG23 ' HB2' ' A' ' 769' ' ' GLU . 0.6 OUTLIER -125.98 134.84 51.37 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.607 0.241 . . . . 99.989999999999995 111.327 179.813 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 755' ' ' TYR . . . . . 0.454 ' HH ' HD12 ' A' ' 770' ' ' ILE . 26.1 p90 -145.93 154.66 42.18 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.436 -0.347 . . . . 99.989999999999995 111.14 177.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 756' ' ' ASP . . . . . 0.46 ' OD2' ' HD2' ' A' ' 765' ' ' ARG . 49.8 m-20 -116.9 122.76 45.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.703 -0.68 . . . . 99.989999999999995 110.868 -179.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 757' ' ' ILE . . . . . 0.411 ' N ' HD13 ' A' ' 757' ' ' ILE . 4.2 mp -89.88 97.31 6.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 108.258 -1.015 . . . . 99.989999999999995 108.258 170.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 758' ' ' ILE . . . . . 0.491 ' HA ' ' HA ' ' A' ' 765' ' ' ARG . 2.1 pp -96.5 149.62 4.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.953 -0.567 . . . . 99.989999999999995 112.042 -169.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -93.79 112.52 24.39 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.875 -0.602 . . . . 99.989999999999995 110.839 -176.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 760' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.32 -0.704 0 CA-C-O 121.843 0.83 . . . . 99.989999999999995 109.252 179.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 765' ' ' ARG . . . . . 0.491 ' HA ' ' HA ' ' A' ' 758' ' ' ILE . 3.8 ttp180 . . . . . 0 N--CA 1.441 -0.908 0 CA-C-O 120.641 0.258 . . . . 99.989999999999995 110.341 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 766' ' ' LYS . . . . . 0.466 ' HD3' ' N ' ' A' ' 767' ' ' THR . 1.3 tmtp? -109.78 146.12 35.51 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 108.916 -0.772 . . . . 99.989999999999995 108.916 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 767' ' ' THR . . . . . 0.466 ' N ' ' HD3' ' A' ' 766' ' ' LYS . 77.6 m -121.05 134.14 55.27 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 116.532 -0.304 . . . . 99.989999999999995 111.244 -176.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 768' ' ' PHE . . . . . 0.401 ' HB3' ' CE1' ' A' ' 755' ' ' TYR . 0.7 OUTLIER -133.66 131.48 39.58 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.995 0.426 . . . . 99.989999999999995 110.498 175.101 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 769' ' ' GLU . . . . . 0.483 ' HB2' HG23 ' A' ' 754' ' ' THR . 36.5 tt0 -127.25 117.23 21.89 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.526 -0.761 . . . . 99.989999999999995 110.681 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 770' ' ' ILE . . . . . 0.454 HD12 ' HH ' ' A' ' 755' ' ' TYR . 12.1 mt -111.43 112.02 38.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 108.99 -0.745 . . . . 99.989999999999995 108.99 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 771' ' ' LYS . . . . . 0.584 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 12.4 mtpt -83.79 153.03 24.32 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-O 121.496 0.665 . . . . 99.989999999999995 111.609 -175.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 772' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 56.64 46.16 20.79 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 113.979 -1.464 . . . . 99.989999999999995 112.558 177.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 773' ' ' ILE . . . . . 0.427 HD12 ' H ' ' A' ' 775' ' ' THR . 0.6 OUTLIER -74.29 113.84 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 107.588 -1.264 . . . . 99.989999999999995 107.588 171.949 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 53.6 mttt -107.31 29.65 6.95 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.31 -0.996 . . . . 99.989999999999995 108.31 -177.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 775' ' ' THR . . . . . 0.655 ' O ' ' HB2' ' A' ' 776' ' ' ASN . 0.2 OUTLIER -95.85 -82.32 0.39 Allowed 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 113.695 0.998 . . . . 99.989999999999995 113.695 -167.785 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 776' ' ' ASN . . . . . 0.655 ' HB2' ' O ' ' A' ' 775' ' ' THR . 0.8 OUTLIER 89.08 3.64 0.21 Allowed 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 124.521 1.129 . . . . 99.989999999999995 111.281 -171.741 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 777' ' ' GLU . . . . . 0.474 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 12.5 mt-10 -160.88 82.94 0.66 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.003 -0.74 . . . . 99.989999999999995 109.003 175.236 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 778' ' ' TYR . . . . . 0.478 ' HB3' HD11 ' A' ' 745' ' ' LEU . 87.9 t80 -127.33 127.68 44.68 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.772 -0.371 . . . . 99.989999999999995 111.128 -171.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 779' ' ' VAL . . . . . 0.635 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 20.8 t -87.25 116.44 29.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.111 0.481 . . . . 99.989999999999995 110.4 177.054 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 780' ' ' ILE . . . . . 0.441 ' O ' ' HA ' ' A' ' 740' ' ' SER . 75.9 mt -86.35 139.6 17.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.46 -0.791 . . . . 99.989999999999995 110.405 -178.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 781' ' ' LYS . . . . . 0.416 ' HA ' ' O ' ' A' ' 739' ' ' SER . 3.6 mppt? -125.33 104.11 8.29 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.139 -0.689 . . . . 99.989999999999995 109.139 176.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 782' ' ' THR . . . . . 0.592 ' OG1' ' HB2' ' A' ' 739' ' ' SER . 44.3 p -77.42 145.5 72.18 Favored Pre-proline 0 N--CA 1.443 -0.79 0 N-CA-C 109.728 -0.471 . . . . 99.989999999999995 109.728 -177.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 783' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_exo -50.69 158.92 2.55 Favored 'Trans proline' 0 CA--C 1.529 0.271 0 C-N-CA 123.711 2.94 . . . . 99.989999999999995 113.57 -177.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 784' ' ' VAL . . . . . 0.516 HG12 HG21 ' A' ' 786' ' ' THR . 54.7 t -58.65 127.26 17.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.238 -0.892 . . . . 99.989999999999995 112.308 -177.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 785' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -102.45 103.25 13.63 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.516 -0.765 . . . . 99.989999999999995 110.294 177.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 786' ' ' THR . . . . . 0.516 HG21 HG12 ' A' ' 784' ' ' VAL . 38.9 p -90.59 30.65 1.13 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.939 0.876 . . . . 99.989999999999995 110.846 -178.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 27.6 m -152.34 107.42 3.25 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.709 -1.132 . . . . 99.989999999999995 110.347 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 788' ' ' GLY . . . . . 0.692 ' HA2' ' CG2' ' A' ' 817' ' ' VAL . . . -51.24 107.96 0.49 Allowed Glycine 0 CA--C 1.525 0.676 0 C-N-CA 121.065 -0.588 . . . . 99.989999999999995 113.128 174.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 789' ' ' GLY . . . . . 0.511 ' H ' HG22 ' A' ' 817' ' ' VAL . . . -152.22 -173.33 21.7 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 110.709 -0.956 . . . . 99.989999999999995 110.709 -179.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -121.5 129.95 53.25 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.023 -0.732 . . . . 99.989999999999995 109.023 -177.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 791' ' ' TYR . . . . . 0.4 ' HA ' ' O ' ' A' ' 758' ' ' ILE . 61.6 m-85 -134.12 161.31 35.22 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.085 -0.507 . . . . 99.989999999999995 110.077 -176.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 792' ' ' ILE . . . . . . . . . . . . . 9.9 mt -137.94 121.64 21.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-O 120.845 0.355 . . . . 99.989999999999995 110.087 176.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 793' ' ' LEU . . . . . 0.45 HD13 HG13 ' A' ' 741' ' ' VAL . 9.6 tt -84.76 107.77 17.11 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.953 -0.758 . . . . 99.989999999999995 108.953 178.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 794' ' ' SER . . . . . . . . . . . . . 21.7 m -112.6 150.63 31.12 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.783 -0.644 . . . . 99.989999999999995 110.297 -178.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 795' ' ' LEU . . . . . . . . . . . . . 34.6 mt -83.55 132.42 34.92 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.259 -0.428 . . . . 99.989999999999995 110.359 -178.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 796' ' ' VAL . . . . . . . . . . . . . 71.7 t -99.39 -57.88 4.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.926 -0.309 . . . . 99.989999999999995 111.794 -175.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 797' ' ' SER . . . . . 0.486 ' C ' HD13 ' A' ' 808' ' ' LEU . 22.9 m -172.32 177.28 3.14 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.075 -0.511 . . . . 99.989999999999995 110.379 -173.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 798' ' ' ILE . . . . . 0.639 ' HA ' ' O ' ' A' ' 752' ' ' THR . 8.4 tt -150.92 156.73 6.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 108.598 -0.89 . . . . 99.989999999999995 108.598 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 799' ' ' LYS . . . . . 0.725 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 8.9 tmtt? -124.81 119.25 28.33 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.749 -0.463 . . . . 99.989999999999995 109.749 177.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 800' ' ' ASP . . . . . 0.615 ' HA ' ' CE2' ' A' ' 751' ' ' PHE . 11.4 t70 -63.88 154.1 34.77 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.902 -1.045 . . . . 99.989999999999995 109.487 175.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 10.6 t -60.95 -12.04 9.98 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 123.94 0.775 . . . . 99.989999999999995 112.171 -171.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 39.9 p -91.35 1.0 57.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.485 0.66 . . . . 99.989999999999995 110.45 177.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 803' ' ' GLY . . . . . 0.435 ' HA2' ' HE2' ' A' ' 799' ' ' LYS . . . 81.5 39.01 12.92 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.015 -0.993 . . . . 99.989999999999995 111.713 -176.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 804' ' ' CYS . . . . . 0.414 ' HB3' ' HB3' ' A' ' 800' ' ' ASP . 49.4 t -111.77 110.71 21.21 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.643 -0.503 . . . . 99.989999999999995 109.643 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 805' ' ' VAL . . . . . . . . . . . . . 7.5 p -86.25 127.49 40.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.671 0.748 . . . . 99.989999999999995 111.377 -173.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 806' ' ' VAL . . . . . . . . . . . . . 81.1 t -112.42 139.0 39.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 114.94 -1.027 . . . . 99.989999999999995 109.851 -178.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -83.96 109.53 3.21 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.706 -0.759 . . . . 99.989999999999995 112.756 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 808' ' ' LEU . . . . . 0.486 HD13 ' C ' ' A' ' 797' ' ' SER . 10.4 mp -74.58 133.43 42.22 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 113.167 0.803 . . . . 99.989999999999995 113.167 178.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 38.3 m -148.28 85.64 1.53 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.911 -1.04 . . . . 99.989999999999995 109.166 170.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 810' ' ' GLN . . . . . 0.502 ' HB3' ' HD2' ' A' ' 811' ' ' PRO . 12.0 mt-30 -138.86 173.66 4.99 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.458 -0.792 . . . . 99.989999999999995 109.527 178.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 811' ' ' PRO . . . . . 0.502 ' HD2' ' HB3' ' A' ' 810' ' ' GLN . 86.9 Cg_exo -44.39 140.76 5.67 Favored 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 123.153 2.568 . . . . 99.989999999999995 115.273 -175.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -113.25 166.61 11.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.474 -1.239 . . . . 99.989999999999995 109.727 176.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 813' ' ' ALA . . . . . 0.414 ' HB3' HD21 ' A' ' 727' ' ' LEU . . . -124.45 143.79 50.44 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.456 -0.338 . . . . 99.989999999999995 110.909 -177.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 814' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -97.53 130.18 44.62 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.589 0.709 . . . . 99.989999999999995 110.952 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 815' ' ' ILE . . . . . 0.573 ' HA ' ' HB2' ' A' ' 731' ' ' LEU . 5.0 mp -107.28 119.64 57.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 114.833 -1.076 . . . . 99.989999999999995 108.824 176.238 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 816' ' ' GLN . . . . . 0.729 ' NE2' ' HG2' ' A' ' 818' ' ' ARG . 0.9 OUTLIER -117.02 106.66 13.63 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.272 0.558 . . . . 99.989999999999995 110.648 -177.842 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 817' ' ' VAL . . . . . 0.692 ' CG2' ' HA2' ' A' ' 788' ' ' GLY . 0.7 OUTLIER -111.29 143.97 20.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-O 121.113 0.482 . . . . 99.989999999999995 110.201 -179.167 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 818' ' ' ARG . . . . . 0.729 ' HG2' ' NE2' ' A' ' 816' ' ' GLN . 29.1 mmt180 . . . . . 0 C--N 1.315 -0.907 0 CA-C-N 115.792 -0.64 . . . . 99.989999999999995 110.502 -179.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 720' ' ' LYS . . . . . . . . . . . . . 49.5 mtpt . . . . . 0 N--CA 1.455 -0.199 0 N-CA-C 110.557 -0.164 . . . . 99.989999999999995 110.557 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 721' ' ' PRO . . . . . 0.452 ' HD2' HG22 ' A' ' 806' ' ' VAL . 38.7 Cg_endo -87.47 164.18 8.06 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.826 2.351 . . . . 99.989999999999995 111.291 179.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 722' ' ' SER . . . . . 0.584 ' HA ' ' CD2' ' A' ' 808' ' ' LEU . 8.8 t -174.76 -154.37 0.05 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.892 0.377 . . . . 99.989999999999995 110.521 -173.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 723' ' ' ALA . . . . . 0.527 ' HB1' HG23 ' A' ' 743' ' ' VAL . . . -151.73 143.03 23.38 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.771 -0.455 . . . . 99.989999999999995 109.771 178.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 14.9 t -134.57 98.97 4.21 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.51 -0.552 . . . . 99.989999999999995 109.51 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 725' ' ' LEU . . . . . 0.621 HD11 ' N ' ' A' ' 725' ' ' LEU . 5.7 mp -59.7 144.28 48.47 Favored 'General case' 0 N--CA 1.427 -1.589 0 CA-C-O 122.476 1.131 . . . . 99.989999999999995 112.752 -175.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 32.4 mtpt -93.23 -19.66 21.2 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 113.038 -1.892 . . . . 99.989999999999995 109.461 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 727' ' ' LEU . . . . . 0.465 ' HB2' ' HD2' ' A' ' 742' ' ' PRO . 0.6 OUTLIER -72.0 108.64 5.33 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.551 -0.907 . . . . 99.989999999999995 108.551 177.588 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 31.2 t-80 -115.56 52.32 0.89 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.705 0.288 . . . . 99.989999999999995 111.401 -172.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 7.8 p80 -175.92 -177.91 0.98 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.522 -0.308 . . . . 99.989999999999995 110.49 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 730' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -77.78 131.76 37.76 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.878 -0.786 . . . . 99.989999999999995 108.878 173.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 731' ' ' LEU . . . . . 0.546 ' HB3' ' HA ' ' A' ' 815' ' ' ILE . 9.8 tp -96.35 100.81 12.39 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 120.979 0.419 . . . . 99.989999999999995 110.053 -176.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 732' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -80.52 112.36 17.8 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.749 -0.659 . . . . 99.989999999999995 112.087 -171.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 733' ' ' LEU . . . . . 0.591 ' HG ' ' HB3' ' A' ' 737' ' ' ASP . 7.3 mp -113.58 163.26 15.18 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.605 -0.725 . . . . 99.989999999999995 110.88 177.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 734' ' ' CYS . . . . . 0.563 ' O ' ' HB2' ' A' ' 737' ' ' ASP . 51.6 t -104.69 -174.96 2.66 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.886 -1.052 . . . . 99.989999999999995 108.501 173.29 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 735' ' ' LEU . . . . . 0.478 ' N ' ' SG ' ' A' ' 734' ' ' CYS . 40.0 tp -72.47 130.14 39.96 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.195 0.522 . . . . 99.989999999999995 111.293 -178.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 78.92 4.17 88.36 Favored Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.314 -0.857 . . . . 99.989999999999995 111.608 -177.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 737' ' ' ASP . . . . . 0.591 ' HB3' ' HG ' ' A' ' 733' ' ' LEU . 0.3 OUTLIER -77.87 151.71 33.72 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.096 0.474 . . . . 99.989999999999995 111.687 179.327 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 738' ' ' HIS . . . . . 0.434 ' HB2' ' O ' ' A' ' 782' ' ' THR . 34.6 p-80 -114.95 161.7 17.94 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 106.89 -1.522 . . . . 99.989999999999995 106.89 170.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 739' ' ' SER . . . . . 0.432 ' HB2' ' CD2' ' A' ' 731' ' ' LEU . 8.0 p -120.36 171.78 8.27 Favored 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 119.159 -1.016 . . . . 99.989999999999995 111.522 -173.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 7.0 p -137.85 100.74 4.26 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 115.115 -0.948 . . . . 99.989999999999995 109.649 177.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 741' ' ' VAL . . . . . 0.436 HG13 HD13 ' A' ' 793' ' ' LEU . 0.7 OUTLIER -109.86 107.74 59.11 Favored Pre-proline 0 C--N 1.318 -0.775 0 CA-C-N 115.002 -0.999 . . . . 99.989999999999995 109.618 -179.119 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 742' ' ' PRO . . . . . 0.635 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 3.1 Cg_endo -76.84 137.83 18.15 Favored 'Trans proline' 0 N--CA 1.448 -1.183 0 C-N-CA 122.478 2.119 . . . . 99.989999999999995 111.545 -177.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 743' ' ' VAL . . . . . 0.591 ' HA ' ' HA ' ' A' ' 725' ' ' LEU . 1.7 p -131.01 118.58 42.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.697 0.76 . . . . 99.989999999999995 112.121 175.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 744' ' ' ALA . . . . . 0.582 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -80.62 95.61 6.6 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 108.237 -1.023 . . . . 99.989999999999995 108.237 169.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 745' ' ' LEU . . . . . 0.517 ' HA ' ' HA ' ' A' ' 723' ' ' ALA . 0.7 OUTLIER -73.31 159.23 33.68 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 113.901 -1.499 . . . . 99.989999999999995 111.472 -168.545 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -114.39 147.67 38.86 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.455 -0.793 . . . . 99.989999999999995 110.025 -174.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 747' ' ' GLY . . . . . . . . . . . . . . . 92.81 127.84 4.52 Favored Glycine 0 N--CA 1.442 -0.935 0 C-N-CA 120.166 -1.016 . . . . 99.989999999999995 110.625 -174.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 25.0 mp0 -101.68 127.07 48.6 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 121.194 0.521 . . . . 99.989999999999995 112.036 -171.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 112.88 -177.12 18.09 Favored Glycine 0 CA--C 1.5 -0.853 0 CA-C-N 115.169 -0.923 . . . . 99.989999999999995 111.936 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 750' ' ' PRO . . . . . 0.454 ' HB3' ' HE2' ' A' ' 774' ' ' LYS . 74.4 Cg_endo -65.87 94.91 0.28 Allowed 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 123.838 3.025 . . . . 99.989999999999995 113.71 -177.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 751' ' ' PHE . . . . . 0.515 ' CE2' ' HA ' ' A' ' 800' ' ' ASP . 68.6 m-85 -113.91 144.06 43.67 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.94 -0.573 . . . . 99.989999999999995 110.997 178.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 752' ' ' THR . . . . . 0.699 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 63.8 m -89.41 107.93 19.35 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 109.062 -0.718 . . . . 99.989999999999995 109.062 177.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 753' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.73 112.16 24.32 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 115.411 -0.813 . . . . 99.989999999999995 110.285 -171.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 754' ' ' THR . . . . . 0.491 HG23 ' HB2' ' A' ' 769' ' ' GLU . 2.2 m -109.74 135.32 50.85 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 116.092 -0.503 . . . . 99.989999999999995 111.41 -179.144 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 755' ' ' TYR . . . . . 0.501 ' CE1' ' HB3' ' A' ' 768' ' ' PHE . 29.2 p90 -143.43 157.01 44.8 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 120.968 0.413 . . . . 99.989999999999995 111.208 177.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 756' ' ' ASP . . . . . 0.411 ' OD2' ' HD2' ' A' ' 765' ' ' ARG . 41.2 m-20 -115.57 120.29 38.98 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.598 -0.728 . . . . 99.989999999999995 110.694 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 757' ' ' ILE . . . . . . . . . . . . . 3.3 mp -84.71 94.73 3.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 107.621 -1.252 . . . . 99.989999999999995 107.621 167.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 758' ' ' ILE . . . . . 0.453 ' HA ' ' HA ' ' A' ' 765' ' ' ARG . 2.2 pp -91.75 140.7 15.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 C-N-CA 120.258 -0.577 . . . . 99.989999999999995 111.429 -171.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -93.19 99.88 12.36 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.304 -0.862 . . . . 99.989999999999995 110.06 -174.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 760' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.321 -0.642 0 CA-C-O 121.819 0.819 . . . . 99.989999999999995 109.358 -175.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 765' ' ' ARG . . . . . 0.453 ' HA ' ' HA ' ' A' ' 758' ' ' ILE . 6.7 ttp180 . . . . . 0 N--CA 1.443 -0.813 0 CA-C-O 121.247 0.546 . . . . 99.989999999999995 111.417 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 766' ' ' LYS . . . . . 0.521 ' HD3' ' N ' ' A' ' 767' ' ' THR . 9.8 tmtm? -111.89 146.02 38.48 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 108.45 -0.944 . . . . 99.989999999999995 108.45 178.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 767' ' ' THR . . . . . 0.521 ' N ' ' HD3' ' A' ' 766' ' ' LYS . 88.4 m -123.76 135.14 53.65 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 116.471 -0.331 . . . . 99.989999999999995 110.9 -178.17 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 768' ' ' PHE . . . . . 0.501 ' HB3' ' CE1' ' A' ' 755' ' ' TYR . 3.0 t80 -139.73 137.53 35.2 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 109.678 -0.49 . . . . 99.989999999999995 109.678 177.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 769' ' ' GLU . . . . . 0.491 ' HB2' HG23 ' A' ' 754' ' ' THR . 31.8 tt0 -131.2 132.8 44.95 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.054 -0.521 . . . . 99.989999999999995 111.003 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 770' ' ' ILE . . . . . 0.452 HG21 HG22 ' A' ' 773' ' ' ILE . 4.1 mt -121.99 111.57 31.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 108.975 -0.75 . . . . 99.989999999999995 108.975 177.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 771' ' ' LYS . . . . . 0.509 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 5.2 mtpt -85.15 157.31 20.7 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.176 0.512 . . . . 99.989999999999995 111.349 -175.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 772' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 53.71 44.29 29.88 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.546 -1.206 . . . . 99.989999999999995 112.19 177.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 773' ' ' ILE . . . . . 0.452 HG22 HG21 ' A' ' 770' ' ' ILE . 0.5 OUTLIER -75.15 111.36 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 107.373 -1.343 . . . . 99.989999999999995 107.373 173.342 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 774' ' ' LYS . . . . . 0.454 ' HE2' ' HB3' ' A' ' 750' ' ' PRO . 56.9 mttt -108.36 29.87 6.96 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 107.743 -1.206 . . . . 99.989999999999995 107.743 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 775' ' ' THR . . . . . 0.485 ' O ' ' HB2' ' A' ' 776' ' ' ASN . 2.1 m -96.11 -81.39 0.41 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.913 -1.039 . . . . 99.989999999999995 113.392 -166.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 776' ' ' ASN . . . . . 0.485 ' HB2' ' O ' ' A' ' 775' ' ' THR . 10.3 m120 93.79 4.18 0.05 OUTLIER 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.268 1.427 . . . . 99.989999999999995 110.971 -176.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 777' ' ' GLU . . . . . 0.582 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 4.9 mt-10 -161.11 87.96 0.73 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.66 -0.7 . . . . 99.989999999999995 109.364 171.041 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 778' ' ' TYR . . . . . 0.502 ' HB3' HD11 ' A' ' 745' ' ' LEU . 73.7 t80 -125.92 128.29 47.31 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.036 -0.529 . . . . 99.989999999999995 110.418 -172.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 779' ' ' VAL . . . . . 0.635 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 21.2 t -86.33 113.27 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 CA-C-O 121.14 0.495 . . . . 99.989999999999995 110.46 179.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 780' ' ' ILE . . . . . 0.436 HD13 ' CE2' ' A' ' 755' ' ' TYR . 76.2 mt -82.39 143.69 11.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.525 -0.761 . . . . 99.989999999999995 109.958 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 781' ' ' LYS . . . . . 0.417 ' N ' HG23 ' A' ' 780' ' ' ILE . 3.9 mppt? -123.8 112.77 17.7 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.166 -0.679 . . . . 99.989999999999995 109.166 175.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 782' ' ' THR . . . . . 0.434 ' O ' ' HB2' ' A' ' 738' ' ' HIS . 44.2 p -77.01 142.19 68.69 Favored Pre-proline 0 C--N 1.318 -0.77 0 CA-C-N 116.097 -0.501 . . . . 99.989999999999995 109.75 -179.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 783' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 782' ' ' THR . 51.2 Cg_exo -55.3 161.5 7.03 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 123.509 2.806 . . . . 99.989999999999995 112.899 -178.307 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 784' ' ' VAL . . . . . 0.528 HG12 HG21 ' A' ' 786' ' ' THR . 46.5 t -58.39 124.21 11.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.423 -0.808 . . . . 99.989999999999995 112.094 -179.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 785' ' ' PHE . . . . . 0.433 ' HE1' ' OG1' ' A' ' 782' ' ' THR . 99.5 m-85 -99.44 95.53 7.08 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.037 -0.529 . . . . 99.989999999999995 110.741 178.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 786' ' ' THR . . . . . 0.528 HG21 HG12 ' A' ' 784' ' ' VAL . 59.9 p -84.71 28.97 0.64 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.526 0.679 . . . . 99.989999999999995 110.912 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.05 108.92 3.68 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.103 -0.953 . . . . 99.989999999999995 110.56 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 788' ' ' GLY . . . . . . . . . . . . . . . -52.44 107.46 0.51 Allowed Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.951 -0.642 . . . . 99.989999999999995 112.465 171.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 789' ' ' GLY . . . . . 0.464 ' H ' ' HB ' ' A' ' 817' ' ' VAL . . . -152.22 -151.58 5.69 Favored Glycine 0 N--CA 1.444 -0.803 0 N-CA-C 111.105 -0.798 . . . . 99.989999999999995 111.105 -179.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -141.07 133.16 27.85 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.381 -0.97 . . . . 99.989999999999995 108.381 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 791' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -135.0 149.06 50.12 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.49 -0.323 . . . . 99.989999999999995 110.382 -174.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 792' ' ' ILE . . . . . . . . . . . . . 13.8 mt -127.61 116.32 42.96 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-O 121.091 0.472 . . . . 99.989999999999995 110.046 178.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 793' ' ' LEU . . . . . 0.436 HD13 HG13 ' A' ' 741' ' ' VAL . 10.3 tt -84.15 106.79 16.06 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.716 -0.846 . . . . 99.989999999999995 108.716 178.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 794' ' ' SER . . . . . . . . . . . . . 19.3 m -116.33 150.92 36.89 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.332 -0.849 . . . . 99.989999999999995 109.861 -177.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 795' ' ' LEU . . . . . . . . . . . . . 52.9 mt -83.0 136.55 34.47 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.495 -0.321 . . . . 99.989999999999995 110.861 -178.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 796' ' ' VAL . . . . . . . . . . . . . 77.2 t -100.35 -57.44 4.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.317 -0.401 . . . . 99.989999999999995 111.642 -176.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 797' ' ' SER . . . . . 0.545 ' HA ' ' HG ' ' A' ' 808' ' ' LEU . 25.9 m -170.86 153.54 3.97 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.017 -0.538 . . . . 99.989999999999995 110.305 -173.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 798' ' ' ILE . . . . . 0.606 ' HA ' ' O ' ' A' ' 752' ' ' THR . 9.1 tt -125.41 166.45 21.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 108.989 -0.745 . . . . 99.989999999999995 108.989 176.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 799' ' ' LYS . . . . . 0.699 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 87.7 tttt -137.53 123.09 19.71 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 120.74 -0.384 . . . . 99.989999999999995 111.407 -173.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 800' ' ' ASP . . . . . 0.563 ' HB3' ' HB3' ' A' ' 804' ' ' CYS . 13.4 t70 -70.93 157.64 37.83 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.978 -1.01 . . . . 99.989999999999995 109.469 175.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 10.4 p -60.68 -9.62 4.17 Favored 'General case' 0 CA--C 1.532 0.251 0 O-C-N 124.007 0.817 . . . . 99.989999999999995 112.799 -174.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 42.8 p -97.38 7.38 46.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.577 0.703 . . . . 99.989999999999995 110.308 176.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 803' ' ' GLY . . . . . 0.489 ' HA2' ' CE ' ' A' ' 799' ' ' LYS . . . 76.68 31.41 54.02 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.072 -0.967 . . . . 99.989999999999995 111.841 -176.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 804' ' ' CYS . . . . . 0.563 ' HB3' ' HB3' ' A' ' 800' ' ' ASP . 35.5 t -96.41 103.43 15.34 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.225 -0.657 . . . . 99.989999999999995 109.225 -179.089 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 805' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 3.2 t -86.17 119.9 35.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.165 0.507 . . . . 99.989999999999995 110.889 -173.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 806' ' ' VAL . . . . . 0.452 HG22 ' HD2' ' A' ' 721' ' ' PRO . 73.0 t -103.56 133.6 47.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.291 -0.868 . . . . 99.989999999999995 110.245 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -67.14 134.09 31.35 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 121.077 -0.582 . . . . 99.989999999999995 111.664 178.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 808' ' ' LEU . . . . . 0.584 ' CD2' ' HA ' ' A' ' 722' ' ' SER . 69.2 mt -100.73 132.82 45.93 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.565 0.58 . . . . 99.989999999999995 112.565 -176.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 22.0 t -146.77 87.18 1.68 Allowed 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.377 -0.829 . . . . 99.989999999999995 109.921 171.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 810' ' ' GLN . . . . . 0.464 ' HB3' ' HD2' ' A' ' 811' ' ' PRO . 8.7 mt-30 -139.83 173.76 4.74 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.553 -0.748 . . . . 99.989999999999995 109.678 173.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 811' ' ' PRO . . . . . 0.464 ' HD2' ' HB3' ' A' ' 810' ' ' GLN . 78.9 Cg_exo -44.58 141.1 5.77 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 122.971 2.447 . . . . 99.989999999999995 115.209 -176.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -108.36 168.05 9.59 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.285 -1.325 . . . . 99.989999999999995 109.495 176.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 813' ' ' ALA . . . . . 0.453 ' HB2' HD21 ' A' ' 725' ' ' LEU . . . -126.03 137.26 53.63 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.403 -0.362 . . . . 99.989999999999995 110.36 176.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 814' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -103.14 114.83 29.44 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 120.911 0.386 . . . . 99.989999999999995 110.441 -177.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 815' ' ' ILE . . . . . 0.546 ' HA ' ' HB3' ' A' ' 731' ' ' LEU . 5.2 mp -97.81 109.39 23.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.704 -0.68 . . . . 99.989999999999995 109.493 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 816' ' ' GLN . . . . . 0.687 ' NE2' ' HG2' ' A' ' 818' ' ' ARG . 0.8 OUTLIER -95.32 124.17 39.22 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.848 -0.615 . . . . 99.989999999999995 109.871 -178.592 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 817' ' ' VAL . . . . . 0.464 ' HB ' ' H ' ' A' ' 789' ' ' GLY . 59.7 t -117.09 135.17 58.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 109.958 -0.386 . . . . 99.989999999999995 109.958 -177.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 818' ' ' ARG . . . . . 0.687 ' HG2' ' NE2' ' A' ' 816' ' ' GLN . 35.2 mmt180 . . . . . 0 C--N 1.327 -0.384 0 O-C-N 121.841 -0.537 . . . . 99.989999999999995 111.372 176.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 720' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp . . . . . 0 N--CA 1.447 -0.597 0 N-CA-C 109.601 -0.518 . . . . 99.989999999999995 109.601 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 721' ' ' PRO . . . . . 0.418 ' HB3' ' HA3' ' A' ' 747' ' ' GLY . 57.1 Cg_endo -87.48 150.03 7.66 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 122.82 2.346 . . . . 99.989999999999995 111.869 -177.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 16.1 t -176.71 -150.15 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.186 -0.672 . . . . 99.989999999999995 109.186 -172.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 723' ' ' ALA . . . . . 0.515 ' HB1' HG23 ' A' ' 743' ' ' VAL . . . -153.95 143.41 21.56 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 110.449 -0.204 . . . . 99.989999999999995 110.449 178.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 4.2 p -134.36 105.44 6.6 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.494 -0.558 . . . . 99.989999999999995 109.494 178.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 725' ' ' LEU . . . . . 0.489 ' CD2' ' HB ' ' A' ' 743' ' ' VAL . 14.4 mt -65.4 148.95 50.83 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-N 115.391 -0.822 . . . . 99.989999999999995 111.728 -173.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 32.1 mtpt -105.75 -0.45 25.4 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.471 -1.241 . . . . 99.989999999999995 109.408 -177.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 727' ' ' LEU . . . . . 0.418 ' HB2' ' HD2' ' A' ' 742' ' ' PRO . 2.6 tm? -81.78 124.74 29.9 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.818 -1.083 . . . . 99.989999999999995 108.953 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 48.6 m80 -86.08 -85.14 0.16 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.291 0.478 . . . . 99.989999999999995 112.291 -173.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 10.7 p80 -92.56 174.83 7.07 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 120.587 -0.445 . . . . 99.989999999999995 111.235 -176.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 730' ' ' ASP . . . . . 0.401 ' HA ' ' O ' ' A' ' 814' ' ' LYS . 4.0 p30 -53.11 144.3 15.81 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.638 0.732 . . . . 99.989999999999995 111.898 -177.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 731' ' ' LEU . . . . . 0.543 ' HB2' ' HA ' ' A' ' 815' ' ' ILE . 15.8 mt -83.27 118.85 23.93 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.972 -1.013 . . . . 99.989999999999995 111.272 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 732' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -85.18 117.94 24.43 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.405 -0.361 . . . . 99.989999999999995 110.457 179.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 733' ' ' LEU . . . . . 0.46 HD11 ' OD2' ' A' ' 737' ' ' ASP . 4.6 mt -142.48 164.64 29.57 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.913 0.387 . . . . 99.989999999999995 111.488 -173.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 734' ' ' CYS . . . . . 0.684 ' HA ' ' O ' ' A' ' 818' ' ' ARG . 18.5 p -117.78 -174.15 2.58 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.961 -0.563 . . . . 99.989999999999995 111.129 -177.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 735' ' ' LEU . . . . . . . . . . . . . 1.4 tt -61.0 127.84 33.54 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.444 -0.343 . . . . 99.989999999999995 110.552 -177.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 78.52 16.48 79.29 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.377 -0.916 . . . . 99.989999999999995 112.033 174.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 737' ' ' ASP . . . . . 0.46 ' OD2' HD11 ' A' ' 733' ' ' LEU . 0.9 OUTLIER -64.99 165.72 10.47 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.377 0.608 . . . . 99.989999999999995 111.096 176.995 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 22.0 p-80 -137.52 129.33 28.7 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 106.108 -1.812 . . . . 99.989999999999995 106.108 162.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 739' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -97.86 171.76 8.09 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 119.674 -0.81 . . . . 99.989999999999995 111.165 -165.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 740' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 780' ' ' ILE . 50.2 m -142.45 107.68 4.99 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.833 -0.622 . . . . 99.989999999999995 110.16 -178.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 741' ' ' VAL . . . . . 0.442 HG13 HD13 ' A' ' 793' ' ' LEU . 1.0 OUTLIER -114.51 105.67 53.39 Favored Pre-proline 0 C--N 1.315 -0.924 0 CA-C-N 115.31 -0.859 . . . . 99.989999999999995 109.075 179.672 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 742' ' ' PRO . . . . . 0.696 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 5.9 Cg_exo -73.76 135.5 21.72 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 122.248 1.965 . . . . 99.989999999999995 111.441 -176.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 743' ' ' VAL . . . . . 0.515 HG23 ' HB1' ' A' ' 723' ' ' ALA . 2.1 p -133.54 122.76 44.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 113.126 0.787 . . . . 99.989999999999995 113.126 178.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 744' ' ' ALA . . . . . 0.575 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -82.77 98.6 9.19 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.381 -0.97 . . . . 99.989999999999995 108.381 167.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 745' ' ' LEU . . . . . 0.492 HD11 ' HB3' ' A' ' 778' ' ' TYR . 1.8 mt -77.53 157.69 30.26 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.262 -1.335 . . . . 99.989999999999995 111.471 -170.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 22.2 ttmm -112.56 155.48 24.28 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 115.539 -0.755 . . . . 99.989999999999995 110.284 -176.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 747' ' ' GLY . . . . . 0.418 ' HA3' ' HB3' ' A' ' 721' ' ' PRO . . . 100.19 120.43 4.52 Favored Glycine 0 C--N 1.305 -1.161 0 CA-C-N 115.131 -0.941 . . . . 99.989999999999995 111.62 -175.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 20.2 mm-40 -100.34 106.35 17.95 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 120.942 -0.303 . . . . 99.989999999999995 111.003 -174.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 136.14 -174.52 21.4 Favored Glycine 0 N--CA 1.448 -0.546 0 N-CA-C 111.64 -0.584 . . . . 99.989999999999995 111.64 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -68.47 94.41 0.43 Allowed 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 122.642 2.228 . . . . 99.989999999999995 111.983 178.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 751' ' ' PHE . . . . . 0.554 ' CE2' ' HA ' ' A' ' 800' ' ' ASP . 73.8 m-85 -113.35 136.53 52.67 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.937 -0.574 . . . . 99.989999999999995 111.391 -179.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 752' ' ' THR . . . . . 0.757 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 59.8 m -90.44 102.46 15.19 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 121.961 0.886 . . . . 99.989999999999995 109.287 178.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 753' ' ' LEU . . . . . . . . . . . . . 16.4 tp -89.0 131.71 35.06 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 113.803 -1.544 . . . . 99.989999999999995 110.48 -170.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 754' ' ' THR . . . . . 0.451 HG23 ' HB2' ' A' ' 769' ' ' GLU . 1.2 m -131.61 132.89 44.41 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 121.012 -0.275 . . . . 99.989999999999995 111.17 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 755' ' ' TYR . . . . . 0.455 ' CE2' HD13 ' A' ' 780' ' ' ILE . 22.4 p90 -141.52 153.93 45.18 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.072 0.463 . . . . 99.989999999999995 111.758 179.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 756' ' ' ASP . . . . . 0.431 ' CG ' ' HD2' ' A' ' 765' ' ' ARG . 5.5 m-20 -115.13 119.63 37.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.273 -0.876 . . . . 99.989999999999995 110.451 -179.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 757' ' ' ILE . . . . . 0.445 HG12 HG22 ' A' ' 782' ' ' THR . 4.8 mp -90.88 95.56 5.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 107.5 -1.296 . . . . 99.989999999999995 107.5 168.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 758' ' ' ILE . . . . . 0.474 ' HA ' ' HA ' ' A' ' 765' ' ' ARG . 2.2 pp -90.21 140.06 16.54 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-O 121.413 0.625 . . . . 99.989999999999995 111.188 -170.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -92.73 98.72 11.59 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.346 -0.843 . . . . 99.989999999999995 109.724 -174.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 760' ' ' THR . . . . . . . . . . . . . 1.4 t . . . . . 0 C--N 1.321 -0.647 0 CA-C-N 115.45 -0.795 . . . . 99.989999999999995 109.663 -172.902 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 765' ' ' ARG . . . . . 0.474 ' HA ' ' HA ' ' A' ' 758' ' ' ILE . 16.7 ttp180 . . . . . 0 N--CA 1.445 -0.715 0 N-CA-C 110.155 -0.313 . . . . 99.989999999999995 110.155 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 766' ' ' LYS . . . . . 0.585 ' HD3' ' N ' ' A' ' 767' ' ' THR . 10.3 tmtt? -120.89 146.5 46.54 Favored 'General case' 0 C--O 1.218 -0.579 0 N-CA-C 109.138 -0.69 . . . . 99.989999999999995 109.138 -179.038 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 767' ' ' THR . . . . . 0.585 ' N ' ' HD3' ' A' ' 766' ' ' LYS . 31.1 m -123.67 143.24 50.38 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 116.725 -0.216 . . . . 99.989999999999995 111.13 -176.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 768' ' ' PHE . . . . . 0.428 ' HB3' ' CE1' ' A' ' 755' ' ' TYR . 4.5 t80 -142.34 137.32 30.46 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 120.995 0.426 . . . . 99.989999999999995 110.485 172.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 769' ' ' GLU . . . . . 0.451 ' HB2' HG23 ' A' ' 754' ' ' THR . 26.5 tt0 -128.33 123.67 34.55 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.667 -0.697 . . . . 99.989999999999995 110.951 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 770' ' ' ILE . . . . . 0.46 HG21 HG22 ' A' ' 773' ' ' ILE . 7.4 mt -116.56 112.69 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 108.773 -0.825 . . . . 99.989999999999995 108.773 178.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 771' ' ' LYS . . . . . 0.534 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 4.1 mtpt -84.61 150.39 25.21 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.31 0.576 . . . . 99.989999999999995 111.777 -173.043 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 772' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 51.69 52.89 13.67 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.315 -1.311 . . . . 99.989999999999995 111.943 178.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 773' ' ' ILE . . . . . 0.46 HG22 HG21 ' A' ' 770' ' ' ILE . 0.5 OUTLIER -76.81 117.82 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 107.891 -1.152 . . . . 99.989999999999995 107.891 173.437 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -116.29 30.62 7.23 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 107.912 -1.144 . . . . 99.989999999999995 107.912 -178.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 775' ' ' THR . . . . . 0.446 ' O ' ' HB2' ' A' ' 776' ' ' ASN . 1.6 m -96.62 -72.25 0.64 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 113.76 -1.563 . . . . 99.989999999999995 112.215 -171.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 776' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 775' ' ' THR . 11.7 m120 85.43 6.37 0.45 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.349 1.06 . . . . 99.989999999999995 110.238 178.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 777' ' ' GLU . . . . . 0.575 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 2.3 tm-20 -162.1 93.46 0.88 Allowed 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 114.374 -1.285 . . . . 99.989999999999995 107.702 176.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 778' ' ' TYR . . . . . 0.492 ' HB3' HD11 ' A' ' 745' ' ' LEU . 52.8 t80 -144.57 128.68 17.62 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.22 -0.9 . . . . 99.989999999999995 109.666 -169.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 779' ' ' VAL . . . . . 0.696 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 1.3 m -94.52 129.09 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.082 0 C-N-CA 118.861 -1.136 . . . . 99.989999999999995 110.506 179.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 780' ' ' ILE . . . . . 0.455 HD13 ' CE2' ' A' ' 755' ' ' TYR . 83.0 mt -89.43 142.94 12.18 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-N 114.072 -1.422 . . . . 99.989999999999995 110.828 -174.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -118.38 107.52 13.95 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.854 -0.612 . . . . 99.989999999999995 109.942 178.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 782' ' ' THR . . . . . 0.445 HG22 HG12 ' A' ' 757' ' ' ILE . 25.1 p -76.91 141.13 67.61 Favored Pre-proline 0 C--N 1.315 -0.902 0 CA-C-N 115.526 -0.761 . . . . 99.989999999999995 110.376 -177.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 783' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 782' ' ' THR . 50.2 Cg_exo -55.07 161.4 6.7 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.719 2.946 . . . . 99.989999999999995 112.837 -174.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 784' ' ' VAL . . . . . 0.552 HG22 HG21 ' A' ' 786' ' ' THR . 7.4 p -58.83 131.46 23.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.572 -0.74 . . . . 99.989999999999995 111.107 -178.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 785' ' ' PHE . . . . . 0.458 ' C ' ' H ' ' A' ' 787' ' ' THR . 32.0 m-85 -112.14 88.59 2.85 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.367 -0.833 . . . . 99.989999999999995 109.716 177.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 786' ' ' THR . . . . . 0.552 HG21 HG22 ' A' ' 784' ' ' VAL . 44.8 p -82.23 31.71 0.39 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.796 0.808 . . . . 99.989999999999995 110.918 -178.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 787' ' ' THR . . . . . 0.458 ' H ' ' C ' ' A' ' 785' ' ' PHE . 12.4 m -157.38 107.46 2.22 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.721 -1.127 . . . . 99.989999999999995 110.282 -179.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 788' ' ' GLY . . . . . 0.406 ' HA2' HG12 ' A' ' 817' ' ' VAL . . . -45.66 124.39 6.9 Favored Glycine 0 C--N 1.334 0.471 0 CA-C-N 116.174 -0.466 . . . . 99.989999999999995 113.243 174.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 789' ' ' GLY . . . . . 0.504 ' H ' ' HB ' ' A' ' 817' ' ' VAL . . . -165.88 -151.24 6.62 Favored Glycine 0 N--CA 1.443 -0.861 0 N-CA-C 110.952 -0.859 . . . . 99.989999999999995 110.952 179.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -147.15 133.43 19.5 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.429 -0.952 . . . . 99.989999999999995 108.429 -178.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 791' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -132.73 154.66 49.99 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.969 -0.559 . . . . 99.989999999999995 109.777 -174.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 792' ' ' ILE . . . . . 0.426 ' CG1' ' HG3' ' A' ' 814' ' ' LYS . 12.6 mt -131.2 116.79 34.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 109.914 -0.402 . . . . 99.989999999999995 109.914 176.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 793' ' ' LEU . . . . . 0.442 HD13 HG13 ' A' ' 741' ' ' VAL . 10.1 tt -84.72 107.29 16.84 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.949 -0.76 . . . . 99.989999999999995 108.949 178.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 794' ' ' SER . . . . . . . . . . . . . 19.3 m -114.18 164.96 13.17 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.176 -0.92 . . . . 99.989999999999995 109.319 179.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 795' ' ' LEU . . . . . . . . . . . . . 48.9 mt -94.89 132.61 39.52 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 120.71 0.29 . . . . 99.989999999999995 110.905 -175.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 796' ' ' VAL . . . . . . . . . . . . . 85.4 t -88.95 -56.99 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.386 0 CA-C-N 116.262 -0.426 . . . . 99.989999999999995 110.705 -178.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 797' ' ' SER . . . . . 0.477 ' C ' HD13 ' A' ' 808' ' ' LEU . 7.1 m 178.46 177.26 0.45 Allowed 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.013 0.821 . . . . 99.989999999999995 109.583 -175.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 798' ' ' ILE . . . . . 0.527 ' O ' ' HA ' ' A' ' 805' ' ' VAL . 11.4 tt -146.31 164.67 9.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 108.183 -1.043 . . . . 99.989999999999995 108.183 177.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 799' ' ' LYS . . . . . 0.757 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 7.4 tttm -135.08 120.02 18.58 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.045 0.45 . . . . 99.989999999999995 111.142 -176.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 800' ' ' ASP . . . . . 0.554 ' HA ' ' CE2' ' A' ' 751' ' ' PHE . 19.3 t70 -63.65 159.36 19.18 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.085 -0.961 . . . . 99.989999999999995 109.877 176.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 24.9 t -61.19 -20.91 63.3 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 123.902 0.751 . . . . 99.989999999999995 111.422 -175.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 39.7 p -83.8 -5.29 59.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.698 0.761 . . . . 99.989999999999995 109.676 178.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 803' ' ' GLY . . . . . . . . . . . . . . . 87.88 43.86 5.59 Favored Glycine 0 N--CA 1.439 -1.14 0 CA-C-N 114.435 -1.257 . . . . 99.989999999999995 111.258 -177.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 804' ' ' CYS . . . . . 0.474 ' HB3' ' HB3' ' A' ' 800' ' ' ASP . 30.6 t -107.99 108.69 19.92 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.926 -0.398 . . . . 99.989999999999995 109.926 -179.027 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 805' ' ' VAL . . . . . 0.527 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 4.8 t -85.75 110.53 19.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 121.178 0.514 . . . . 99.989999999999995 110.616 -175.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 806' ' ' VAL . . . . . . . . . . . . . 94.1 t -94.69 141.12 15.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.258 -0.883 . . . . 99.989999999999995 110.233 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -80.89 109.83 3.03 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.803 -0.713 . . . . 99.989999999999995 112.146 178.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 808' ' ' LEU . . . . . 0.477 HD13 ' C ' ' A' ' 797' ' ' SER . 10.5 mp -73.61 126.85 31.21 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 113.24 0.83 . . . . 99.989999999999995 113.24 178.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 20.5 m -141.59 85.7 1.96 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.448 -0.796 . . . . 99.989999999999995 109.171 170.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 810' ' ' GLN . . . . . 0.479 ' HB3' ' HD2' ' A' ' 811' ' ' PRO . 11.0 mt-30 -145.56 169.36 9.89 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 115.305 -0.861 . . . . 99.989999999999995 109.303 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 811' ' ' PRO . . . . . 0.479 ' HD2' ' HB3' ' A' ' 810' ' ' GLN . 88.1 Cg_exo -43.94 139.19 5.86 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 123.336 2.69 . . . . 99.989999999999995 115.714 -171.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -107.78 167.94 9.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.355 -1.293 . . . . 99.989999999999995 109.763 175.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 813' ' ' ALA . . . . . . . . . . . . . . . -127.36 151.9 48.19 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.099 -0.5 . . . . 99.989999999999995 110.304 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 814' ' ' LYS . . . . . 0.426 ' HG3' ' CG1' ' A' ' 792' ' ' ILE . 13.9 ttpp -113.54 127.86 56.23 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 121.709 0.766 . . . . 99.989999999999995 111.265 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 815' ' ' ILE . . . . . 0.543 ' HA ' ' HB2' ' A' ' 731' ' ' LEU . 4.3 mp -106.01 125.09 61.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 114.712 -1.131 . . . . 99.989999999999995 109.386 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 816' ' ' GLN . . . . . 0.637 ' NE2' ' HG2' ' A' ' 818' ' ' ARG . 0.8 OUTLIER -115.19 116.65 28.71 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.275 0.56 . . . . 99.989999999999995 111.027 -178.291 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 817' ' ' VAL . . . . . 0.504 ' HB ' ' H ' ' A' ' 789' ' ' GLY . 58.7 t -109.94 133.22 55.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 116.133 -0.485 . . . . 99.989999999999995 109.882 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 818' ' ' ARG . . . . . 0.684 ' O ' ' HA ' ' A' ' 734' ' ' CYS . 85.4 mmt-85 . . . . . 0 C--N 1.324 -0.519 0 CA-C-O 120.914 0.388 . . . . 99.989999999999995 110.395 175.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 720' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt . . . . . 0 N--CA 1.446 -0.63 0 CA-C-O 120.695 0.283 . . . . 99.989999999999995 110.402 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 721' ' ' PRO . . . . . 0.451 ' HD2' HG11 ' A' ' 806' ' ' VAL . 60.7 Cg_endo -88.6 145.16 5.71 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 122.897 2.398 . . . . 99.989999999999995 111.429 177.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 722' ' ' SER . . . . . 0.575 ' HA ' ' CD2' ' A' ' 808' ' ' LEU . 10.7 t -175.9 -153.04 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.82 0.343 . . . . 99.989999999999995 110.524 -175.197 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 723' ' ' ALA . . . . . 0.498 ' HB1' HG23 ' A' ' 743' ' ' VAL . . . -149.49 143.19 25.49 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.361 -0.381 . . . . 99.989999999999995 109.99 179.044 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 9.4 m -131.37 98.61 4.58 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.281 -0.637 . . . . 99.989999999999995 109.281 178.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 725' ' ' LEU . . . . . 0.467 HD21 ' CG2' ' A' ' 743' ' ' VAL . 12.7 mt -64.42 143.49 57.87 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-O 121.695 0.759 . . . . 99.989999999999995 111.557 -175.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 34.2 mtpt -96.77 -18.75 19.4 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 114.6 -1.182 . . . . 99.989999999999995 109.866 -176.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 727' ' ' LEU . . . . . 0.421 HD21 ' HB3' ' A' ' 813' ' ' ALA . 33.7 tp -69.66 112.67 6.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.682 -0.69 . . . . 99.989999999999995 109.854 175.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 31.3 t-80 -112.78 45.83 1.28 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.695 0.283 . . . . 99.989999999999995 111.573 -174.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -177.77 -177.91 0.68 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.698 -0.228 . . . . 99.989999999999995 110.643 177.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 730' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -76.42 137.6 39.83 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.194 0.521 . . . . 99.989999999999995 109.71 175.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 731' ' ' LEU . . . . . 0.521 ' CD2' ' HB2' ' A' ' 739' ' ' SER . 25.9 tp -100.42 113.05 25.5 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.363 -0.835 . . . . 99.989999999999995 110.865 -176.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 732' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -78.29 110.8 13.63 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.746 -0.661 . . . . 99.989999999999995 112.047 -173.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 733' ' ' LEU . . . . . 0.613 ' HG ' ' HB3' ' A' ' 737' ' ' ASP . 8.5 mp -117.5 163.75 15.94 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.233 -0.44 . . . . 99.989999999999995 110.489 175.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 734' ' ' CYS . . . . . 0.526 ' HA ' ' O ' ' A' ' 818' ' ' ARG . 74.5 m -115.82 -173.85 2.42 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.721 -0.672 . . . . 99.989999999999995 109.826 175.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 735' ' ' LEU . . . . . 0.41 ' HA ' HD11 ' A' ' 735' ' ' LEU . 16.7 tp -65.92 123.71 20.54 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.794 0.33 . . . . 99.989999999999995 110.531 -177.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 79.64 13.29 82.65 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.472 -0.87 . . . . 99.989999999999995 112.312 179.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 737' ' ' ASP . . . . . 0.613 ' HB3' ' HG ' ' A' ' 733' ' ' LEU . 0.3 OUTLIER -80.72 151.99 28.59 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.03 0.443 . . . . 99.989999999999995 111.057 175.987 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 738' ' ' HIS . . . . . 0.47 ' HB2' ' O ' ' A' ' 782' ' ' THR . 38.6 p-80 -117.08 149.22 40.67 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.087 -1.449 . . . . 99.989999999999995 107.087 170.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 739' ' ' SER . . . . . 0.521 ' HB2' ' CD2' ' A' ' 731' ' ' LEU . 5.3 p -103.95 167.63 9.65 Favored 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 119.387 -0.925 . . . . 99.989999999999995 111.549 -169.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 740' ' ' SER . . . . . 0.458 ' HA ' ' O ' ' A' ' 780' ' ' ILE . 40.4 m -139.07 100.41 4.02 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.251 -0.886 . . . . 99.989999999999995 109.327 176.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 741' ' ' VAL . . . . . 0.443 HG13 HD23 ' A' ' 793' ' ' LEU . 0.9 OUTLIER -111.86 113.87 52.22 Favored Pre-proline 0 C--N 1.317 -0.831 0 CA-C-N 115.305 -0.861 . . . . 99.989999999999995 109.873 -179.434 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 742' ' ' PRO . . . . . 0.648 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 1.0 OUTLIER -74.98 132.95 16.03 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 122.278 1.985 . . . . 99.989999999999995 111.454 -179.093 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 743' ' ' VAL . . . . . 0.498 HG23 ' HB1' ' A' ' 723' ' ' ALA . 2.0 p -130.21 120.35 48.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.405 0.622 . . . . 99.989999999999995 112.316 175.037 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 744' ' ' ALA . . . . . 0.616 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -80.72 95.26 6.56 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 122.098 0.951 . . . . 99.989999999999995 108.697 168.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 745' ' ' LEU . . . . . 0.485 ' HA ' ' HA ' ' A' ' 723' ' ' ALA . 3.0 mt -74.92 151.62 38.89 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.165 -1.38 . . . . 99.989999999999995 111.477 -170.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 19.8 ttmm -106.36 162.26 13.84 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.873 -0.603 . . . . 99.989999999999995 110.001 -178.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 747' ' ' GLY . . . . . . . . . . . . . . . 99.74 129.87 6.76 Favored Glycine 0 C--N 1.308 -0.975 0 CA-C-N 115.738 -0.665 . . . . 99.989999999999995 111.458 -175.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 40.1 mm-40 -107.43 107.8 18.85 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.895 -0.322 . . . . 99.989999999999995 110.856 -174.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 125.89 -171.43 17.72 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.848 -0.691 . . . . 99.989999999999995 111.927 -179.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -70.2 95.11 0.58 Allowed 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.953 2.435 . . . . 99.989999999999995 112.177 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 751' ' ' PHE . . . . . 0.526 ' HA ' ' O ' ' A' ' 799' ' ' LYS . 76.2 m-85 -117.25 135.39 53.85 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.98 -0.554 . . . . 99.989999999999995 111.239 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 752' ' ' THR . . . . . 0.704 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 89.8 m -85.95 107.65 17.83 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 109.398 -0.593 . . . . 99.989999999999995 109.398 178.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 753' ' ' LEU . . . . . 0.448 ' HG ' HD22 ' A' ' 745' ' ' LEU . 0.6 OUTLIER -97.93 117.73 32.9 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 114.992 -1.004 . . . . 99.989999999999995 110.322 -171.944 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 754' ' ' THR . . . . . 0.436 HG23 ' HB2' ' A' ' 769' ' ' GLU . 1.0 OUTLIER -118.17 139.28 51.5 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.913 -0.585 . . . . 99.989999999999995 111.056 -177.002 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 755' ' ' TYR . . . . . 0.675 ' CE1' ' HB3' ' A' ' 768' ' ' PHE . 22.5 p90 -147.1 158.81 44.06 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.018 0.377 . . . . 99.989999999999995 112.018 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 756' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -122.77 120.5 33.76 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 115.675 -0.693 . . . . 99.989999999999995 110.833 -178.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 757' ' ' ILE . . . . . 0.586 ' CD1' HD13 ' A' ' 793' ' ' LEU . 3.8 mp -89.3 96.51 6.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 N-CA-C 108.01 -1.107 . . . . 99.989999999999995 108.01 170.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 758' ' ' ILE . . . . . 0.528 HG13 ' O ' ' A' ' 792' ' ' ILE . 2.5 pp -98.65 152.01 4.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 121.52 0.676 . . . . 99.989999999999995 112.593 -168.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 759' ' ' GLU . . . . . 0.59 ' HG2' ' CE2' ' A' ' 791' ' ' TYR . 2.6 mt-10 -91.15 120.08 31.8 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.181 -0.918 . . . . 99.989999999999995 112.422 -179.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 760' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.312 -1.028 0 CA-C-N 115.372 -0.831 . . . . 99.989999999999995 109.725 172.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 68.8 mtm180 . . . . . 0 N--CA 1.464 0.24 0 N-CA-C 109.907 -0.405 . . . . 99.989999999999995 109.907 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 766' ' ' LYS . . . . . 0.627 ' HD3' ' N ' ' A' ' 767' ' ' THR . 8.1 tmtt? -145.11 136.93 25.57 Favored 'General case' 0 C--O 1.216 -0.686 0 CA-C-O 120.971 0.415 . . . . 99.989999999999995 110.423 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 767' ' ' THR . . . . . 0.627 ' N ' ' HD3' ' A' ' 766' ' ' LYS . 84.8 m -114.0 128.14 56.26 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 116.333 -0.394 . . . . 99.989999999999995 110.544 -176.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 768' ' ' PHE . . . . . 0.675 ' HB3' ' CE1' ' A' ' 755' ' ' TYR . 2.9 t80 -128.62 137.24 51.57 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 109.166 -0.679 . . . . 99.989999999999995 109.166 178.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 769' ' ' GLU . . . . . 0.436 ' HB2' HG23 ' A' ' 754' ' ' THR . 34.7 tt0 -130.58 122.38 27.4 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.736 -0.665 . . . . 99.989999999999995 110.706 -175.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 770' ' ' ILE . . . . . 0.462 HG21 HG22 ' A' ' 773' ' ' ILE . 6.0 mt -117.14 111.15 33.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 108.463 -0.94 . . . . 99.989999999999995 108.463 177.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 771' ' ' LYS . . . . . 0.571 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 13.4 mtpt -85.03 150.2 25.05 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-O 121.547 0.689 . . . . 99.989999999999995 112.065 -173.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 772' ' ' GLU . . . . . 0.416 ' O ' ' HG3' ' A' ' 774' ' ' LYS . 3.6 mt-10 52.1 49.63 20.22 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 113.897 -1.501 . . . . 99.989999999999995 111.865 177.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 773' ' ' ILE . . . . . 0.462 HG22 HG21 ' A' ' 770' ' ' ILE . 0.5 OUTLIER -73.75 118.6 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 108.255 -1.017 . . . . 99.989999999999995 108.255 176.266 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 774' ' ' LYS . . . . . 0.416 ' HG3' ' O ' ' A' ' 772' ' ' GLU . 73.9 mttt -116.23 30.16 7.51 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 107.92 -1.141 . . . . 99.989999999999995 107.92 -178.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 775' ' ' THR . . . . . 0.487 ' O ' ' HB2' ' A' ' 776' ' ' ASN . 1.6 m -95.9 -73.25 0.6 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 113.79 -1.55 . . . . 99.989999999999995 112.238 -171.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 776' ' ' ASN . . . . . 0.487 ' HB2' ' O ' ' A' ' 775' ' ' THR . 11.6 m120 88.14 5.59 0.23 Allowed 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.622 1.169 . . . . 99.989999999999995 110.62 179.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 777' ' ' GLU . . . . . 0.616 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 30.7 tt0 -161.94 100.47 1.12 Allowed 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 114.989 -1.005 . . . . 99.989999999999995 108.875 171.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 778' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -141.92 129.98 22.02 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.794 -0.639 . . . . 99.989999999999995 110.63 -170.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 779' ' ' VAL . . . . . 0.648 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 14.4 t -89.22 114.11 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 CA-C-O 121.259 0.552 . . . . 99.989999999999995 110.094 -179.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 780' ' ' ILE . . . . . 0.458 ' O ' ' HA ' ' A' ' 740' ' ' SER . 77.7 mt -81.17 141.72 14.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.004 -0.998 . . . . 99.989999999999995 110.604 -178.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 781' ' ' LYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 739' ' ' SER . 0.0 OUTLIER -121.54 109.4 14.77 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.324 -0.621 . . . . 99.989999999999995 109.324 176.288 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 782' ' ' THR . . . . . 0.47 ' O ' ' HB2' ' A' ' 738' ' ' HIS . 38.7 p -79.08 143.51 61.33 Favored Pre-proline 0 C--N 1.32 -0.705 0 N-CA-C 109.705 -0.48 . . . . 99.989999999999995 109.705 -178.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 783' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.17 158.19 7.41 Favored 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 123.546 2.83 . . . . 99.989999999999995 113.179 -177.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 784' ' ' VAL . . . . . 0.53 HG12 HG21 ' A' ' 786' ' ' THR . 53.5 t -58.93 118.69 2.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.11 -0.95 . . . . 99.989999999999995 112.157 -179.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 785' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -98.43 97.19 8.56 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.374 -0.83 . . . . 99.989999999999995 109.913 178.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 786' ' ' THR . . . . . 0.53 HG21 HG12 ' A' ' 784' ' ' VAL . 38.4 p -84.71 31.49 0.53 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.711 0.767 . . . . 99.989999999999995 111.201 -178.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 77.6 m -152.27 112.59 4.08 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.847 -1.07 . . . . 99.989999999999995 110.829 179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 788' ' ' GLY . . . . . . . . . . . . . . . -51.57 114.13 2.84 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 116.069 -0.514 . . . . 99.989999999999995 112.648 171.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 789' ' ' GLY . . . . . 0.495 ' H ' ' HB ' ' A' ' 817' ' ' VAL . . . -158.52 -167.26 19.08 Favored Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 110.391 -1.083 . . . . 99.989999999999995 110.391 -178.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -128.3 124.75 37.3 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 117.629 0.715 . . . . 99.989999999999995 109.864 -178.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 791' ' ' TYR . . . . . 0.59 ' CE2' ' HG2' ' A' ' 759' ' ' GLU . 97.7 m-85 -120.67 149.48 42.43 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.737 -0.665 . . . . 99.989999999999995 111.32 -176.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 792' ' ' ILE . . . . . 0.528 ' O ' HG13 ' A' ' 758' ' ' ILE . 12.5 mt -126.88 116.46 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 109.042 -0.725 . . . . 99.989999999999995 109.042 171.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 793' ' ' LEU . . . . . 0.586 HD13 ' CD1' ' A' ' 757' ' ' ILE . 0.9 OUTLIER -84.95 113.14 21.19 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 109.134 -0.691 . . . . 99.989999999999995 109.134 178.211 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 794' ' ' SER . . . . . 0.546 ' N ' HD11 ' A' ' 793' ' ' LEU . 21.6 t -122.76 164.6 18.03 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.864 -1.062 . . . . 99.989999999999995 108.997 -176.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 795' ' ' LEU . . . . . . . . . . . . . 21.6 mt -94.49 134.11 37.37 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.525 -0.307 . . . . 99.989999999999995 110.992 -173.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 796' ' ' VAL . . . . . . . . . . . . . 67.8 t -95.51 -55.79 5.79 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 CA-C-N 116.302 -0.408 . . . . 99.989999999999995 111.767 -176.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 797' ' ' SER . . . . . 0.56 ' HA ' ' HG ' ' A' ' 808' ' ' LEU . 87.5 p -177.33 160.22 1.65 Allowed 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.785 -0.366 . . . . 99.989999999999995 110.755 -174.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 798' ' ' ILE . . . . . 0.673 ' HA ' ' O ' ' A' ' 752' ' ' THR . 9.4 tt -131.35 166.95 27.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 109.273 -0.64 . . . . 99.989999999999995 109.273 177.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 799' ' ' LYS . . . . . 0.704 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 15.6 tttm -136.62 117.25 13.91 Favored 'General case' 0 C--N 1.322 -0.623 0 O-C-N 122.26 -0.275 . . . . 99.989999999999995 111.65 -174.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 800' ' ' ASP . . . . . 0.454 ' HB3' ' HB3' ' A' ' 804' ' ' CYS . 24.2 t70 -69.9 157.14 37.98 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.306 -0.627 . . . . 99.989999999999995 109.306 170.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 58.0 p -63.09 -8.92 8.67 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 112.755 0.65 . . . . 99.989999999999995 112.755 -170.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 26.6 p -89.0 -1.75 58.26 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.636 0.731 . . . . 99.989999999999995 109.875 176.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 803' ' ' GLY . . . . . 0.463 ' HA2' ' HZ1' ' A' ' 799' ' ' LYS . . . 84.59 27.14 36.39 Favored Glycine 0 N--CA 1.439 -1.111 0 CA-C-N 114.907 -1.042 . . . . 99.989999999999995 111.028 -176.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 804' ' ' CYS . . . . . 0.454 ' HB3' ' HB3' ' A' ' 800' ' ' ASP . 46.1 t -94.43 108.94 20.84 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.429 -0.582 . . . . 99.989999999999995 109.429 -178.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 805' ' ' VAL . . . . . 0.524 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 4.2 p -85.58 119.6 34.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.875 0.845 . . . . 99.989999999999995 110.626 -176.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 806' ' ' VAL . . . . . 0.451 HG11 ' HD2' ' A' ' 721' ' ' PRO . 21.4 t -102.03 135.36 39.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 114.588 -1.187 . . . . 99.989999999999995 110.106 -178.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -73.12 125.24 9.5 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.425 -0.807 . . . . 99.989999999999995 111.997 -177.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 808' ' ' LEU . . . . . 0.575 ' CD2' ' HA ' ' A' ' 722' ' ' SER . 49.3 mt -89.91 123.36 33.78 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.162 0.506 . . . . 99.989999999999995 112.225 -177.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 22.5 m -142.12 86.61 1.98 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.648 -0.706 . . . . 99.989999999999995 110.101 175.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 810' ' ' GLN . . . . . 0.439 ' HB3' ' HD2' ' A' ' 811' ' ' PRO . 8.1 mt-30 -144.54 173.58 4.24 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.645 -0.707 . . . . 99.989999999999995 110.23 175.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 811' ' ' PRO . . . . . 0.439 ' HD2' ' HB3' ' A' ' 810' ' ' GLN . 82.5 Cg_exo -45.0 140.86 6.75 Favored 'Trans proline' 0 C--N 1.358 1.05 0 C-N-CA 123.102 2.534 . . . . 99.989999999999995 114.716 -177.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -109.09 167.21 10.27 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.653 -1.158 . . . . 99.989999999999995 110.418 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 813' ' ' ALA . . . . . 0.421 ' HB3' HD21 ' A' ' 727' ' ' LEU . . . -116.25 156.82 25.92 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.03 -0.532 . . . . 99.989999999999995 110.687 -179.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 814' ' ' LYS . . . . . 0.403 ' HG2' HG12 ' A' ' 792' ' ' ILE . 49.2 mttp -118.76 125.04 48.74 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.121 0.486 . . . . 99.989999999999995 110.821 177.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 815' ' ' ILE . . . . . 0.511 ' HA ' ' HB3' ' A' ' 731' ' ' LEU . 5.3 mp -113.02 117.4 55.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 115.311 -0.859 . . . . 99.989999999999995 108.888 178.008 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 816' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -103.71 113.36 26.82 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.445 -0.343 . . . . 99.989999999999995 110.195 -177.243 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 817' ' ' VAL . . . . . 0.495 ' HB ' ' H ' ' A' ' 789' ' ' GLY . 43.8 t -106.02 137.28 36.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.665 -0.495 . . . . 99.989999999999995 109.665 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 818' ' ' ARG . . . . . 0.526 ' O ' ' HA ' ' A' ' 734' ' ' CYS . 22.4 tpt180 . . . . . 0 C--N 1.322 -0.595 0 N-CA-C 109.725 -0.472 . . . . 99.989999999999995 109.725 -178.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 720' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt . . . . . 0 N--CA 1.444 -0.734 0 CA-C-O 120.772 0.32 . . . . 99.989999999999995 110.17 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 721' ' ' PRO . . . . . 0.527 ' HD2' HG13 ' A' ' 806' ' ' VAL . 36.4 Cg_endo -83.95 137.92 7.75 Favored 'Trans proline' 0 N--CA 1.447 -1.227 0 C-N-CA 122.597 2.198 . . . . 99.989999999999995 110.601 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 32.4 p -176.25 -150.58 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.361 -0.381 . . . . 99.989999999999995 110.205 -167.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 723' ' ' ALA . . . . . 0.545 ' HA ' ' HA ' ' A' ' 745' ' ' LEU . . . -155.09 149.4 26.08 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 110.428 -0.212 . . . . 99.989999999999995 110.428 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 15.9 m -139.89 98.78 3.54 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.172 -0.677 . . . . 99.989999999999995 109.172 178.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 725' ' ' LEU . . . . . 0.628 HD11 ' N ' ' A' ' 725' ' ' LEU . 6.2 mp -59.84 142.19 53.95 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 122.328 1.061 . . . . 99.989999999999995 112.551 -175.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 36.9 mtpt -91.41 -16.7 26.96 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 113.269 -1.787 . . . . 99.989999999999995 110.309 -176.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 727' ' ' LEU . . . . . 0.434 HD21 ' HB3' ' A' ' 813' ' ' ALA . 51.1 tp -70.24 126.93 31.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.935 -0.575 . . . . 99.989999999999995 110.016 178.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -119.26 29.93 7.39 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.427 0.529 . . . . 99.989999999999995 112.427 -174.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 9.7 p80 -166.94 170.78 11.81 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.73 0.3 . . . . 99.989999999999995 110.434 177.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 730' ' ' ASP . . . . . 0.509 ' HA ' ' O ' ' A' ' 814' ' ' LYS . 10.3 p-10 -79.44 138.57 37.64 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.759 -0.655 . . . . 99.989999999999995 110.69 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 731' ' ' LEU . . . . . 0.518 ' HB2' ' HA ' ' A' ' 815' ' ' ILE . 35.1 mt -87.23 107.76 18.63 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.473 -0.785 . . . . 99.989999999999995 111.485 -177.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 732' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt -81.59 96.71 7.56 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.203 -0.453 . . . . 99.989999999999995 111.013 -176.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 733' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.95 163.97 14.01 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.328 0.585 . . . . 99.989999999999995 111.904 -178.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 734' ' ' CYS . . . . . 0.587 ' O ' ' HB2' ' A' ' 737' ' ' ASP . 72.5 m -105.39 -172.98 2.19 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.032 -0.986 . . . . 99.989999999999995 109.66 176.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 735' ' ' LEU . . . . . . . . . . . . . 13.4 tp -73.83 138.68 44.59 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.444 0.64 . . . . 99.989999999999995 112.03 -172.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 74.38 14.8 80.59 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 114.756 -1.111 . . . . 99.989999999999995 111.286 -177.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 737' ' ' ASP . . . . . 0.587 ' HB2' ' O ' ' A' ' 734' ' ' CYS . 1.0 OUTLIER -89.34 147.09 24.27 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.394 0.616 . . . . 99.989999999999995 112.036 177.61 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 738' ' ' HIS . . . . . 0.63 ' HB2' ' O ' ' A' ' 782' ' ' THR . 46.5 p-80 -110.31 177.49 4.68 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 106.511 -1.663 . . . . 99.989999999999995 106.511 167.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 739' ' ' SER . . . . . 0.508 ' HB2' HD11 ' A' ' 731' ' ' LEU . 16.5 p -138.36 171.08 14.9 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 118.519 -1.272 . . . . 99.989999999999995 112.503 -174.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 12.4 p -133.44 110.86 10.28 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.093 -0.958 . . . . 99.989999999999995 110.314 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 741' ' ' VAL . . . . . 0.464 HG13 HD23 ' A' ' 793' ' ' LEU . 1.5 p -119.31 113.9 35.04 Favored Pre-proline 0 C--N 1.319 -0.745 0 CA-C-N 115.62 -0.718 . . . . 99.989999999999995 110.031 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 742' ' ' PRO . . . . . 0.634 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 2.2 Cg_endo -77.9 136.35 14.86 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.389 2.059 . . . . 99.989999999999995 111.641 -178.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 743' ' ' VAL . . . . . 0.558 ' HA ' ' HA ' ' A' ' 725' ' ' LEU . 2.1 p -132.45 121.52 45.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.602 0.715 . . . . 99.989999999999995 112.466 177.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 744' ' ' ALA . . . . . 0.597 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -79.46 95.69 5.87 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 122.17 0.985 . . . . 99.989999999999995 108.769 168.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 745' ' ' LEU . . . . . 0.545 ' HA ' ' HA ' ' A' ' 723' ' ' ALA . 2.0 mt -77.68 160.18 28.65 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 114.074 -1.421 . . . . 99.989999999999995 111.137 -172.111 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 31.8 ttmt -116.29 167.15 11.27 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.992 -0.549 . . . . 99.989999999999995 109.793 -178.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 747' ' ' GLY . . . . . . . . . . . . . . . 93.78 125.0 3.99 Favored Glycine 0 C--N 1.309 -0.921 0 CA-C-N 115.562 -0.744 . . . . 99.989999999999995 111.384 -173.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 67.0 mm-40 -100.24 114.29 27.61 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.877 0.37 . . . . 99.989999999999995 111.532 -175.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 119.98 -175.92 16.02 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.926 -0.654 . . . . 99.989999999999995 111.923 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -67.95 94.39 0.4 Allowed 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.929 2.419 . . . . 99.989999999999995 112.259 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 751' ' ' PHE . . . . . 0.422 ' HB3' HG12 ' A' ' 798' ' ' ILE . 53.7 m-85 -108.98 141.62 40.81 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.086 -0.506 . . . . 99.989999999999995 111.313 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 752' ' ' THR . . . . . 0.724 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 99.2 m -88.39 101.77 14.22 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 121.737 0.779 . . . . 99.989999999999995 109.645 177.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 753' ' ' LEU . . . . . . . . . . . . . 16.9 tp -90.19 125.2 35.39 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 114.409 -1.269 . . . . 99.989999999999995 110.511 -171.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 754' ' ' THR . . . . . 0.418 HG23 ' HB2' ' A' ' 769' ' ' GLU . 0.6 OUTLIER -123.48 131.24 53.58 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.428 -0.351 . . . . 99.989999999999995 111.159 -179.866 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 755' ' ' TYR . . . . . 0.564 ' CE1' ' HB3' ' A' ' 768' ' ' PHE . 22.3 p90 -141.39 157.34 45.31 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.801 0.334 . . . . 99.989999999999995 111.207 178.167 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 756' ' ' ASP . . . . . 0.469 ' HA ' ' O ' ' A' ' 766' ' ' LYS . 0.5 OUTLIER -119.82 118.48 30.92 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 115.64 -0.709 . . . . 99.989999999999995 110.256 -176.386 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 757' ' ' ILE . . . . . 0.522 ' CD1' HD13 ' A' ' 793' ' ' LEU . 3.5 mp -87.93 95.91 5.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 N-CA-C 107.075 -1.454 . . . . 99.989999999999995 107.075 168.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 758' ' ' ILE . . . . . 0.592 HG13 ' O ' ' A' ' 792' ' ' ILE . 2.3 pp -94.68 149.62 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 CA-C-N 115.637 -0.711 . . . . 99.989999999999995 110.256 -173.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 759' ' ' GLU . . . . . 0.643 ' HB3' ' CE2' ' A' ' 791' ' ' TYR . 8.7 pt-20 -107.09 129.36 54.83 Favored 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 120.148 -0.621 . . . . 99.989999999999995 111.132 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 760' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.319 -0.754 0 N-CA-C 108.757 -0.831 . . . . 99.989999999999995 108.757 176.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 765' ' ' ARG . . . . . 0.428 ' HA ' ' HA ' ' A' ' 758' ' ' ILE . 48.7 mtm180 . . . . . 0 C--O 1.232 0.183 0 CA-C-O 120.882 0.373 . . . . 99.989999999999995 110.707 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 766' ' ' LYS . . . . . 0.469 ' O ' ' HA ' ' A' ' 756' ' ' ASP . 0.7 OUTLIER -120.5 143.12 48.72 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 109.627 -0.508 . . . . 99.989999999999995 109.627 -179.887 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 767' ' ' THR . . . . . . . . . . . . . 87.6 m -119.32 130.71 55.51 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 116.229 -0.441 . . . . 99.989999999999995 110.949 -176.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 768' ' ' PHE . . . . . 0.564 ' HB3' ' CE1' ' A' ' 755' ' ' TYR . 1.8 t80 -127.09 128.67 46.61 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.477 -0.564 . . . . 99.989999999999995 109.477 174.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 769' ' ' GLU . . . . . 0.418 ' HB2' HG23 ' A' ' 754' ' ' THR . 40.0 tt0 -126.22 118.27 24.82 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.275 -0.875 . . . . 99.989999999999995 110.782 -175.062 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 770' ' ' ILE . . . . . 0.453 HD12 ' HH ' ' A' ' 755' ' ' TYR . 9.0 mt -116.12 113.29 42.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.021 -0.536 . . . . 99.989999999999995 109.557 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 771' ' ' LYS . . . . . 0.603 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 6.1 mtpt -82.56 151.98 26.17 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-O 121.394 0.616 . . . . 99.989999999999995 111.079 -178.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 772' ' ' GLU . . . . . 0.409 ' O ' ' HG3' ' A' ' 774' ' ' LYS . 8.0 mt-10 57.75 46.92 16.38 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.169 -1.378 . . . . 99.989999999999995 112.28 176.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 773' ' ' ILE . . . . . 0.429 HD11 HD13 ' A' ' 745' ' ' LEU . 0.5 OUTLIER -73.85 119.46 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 107.711 -1.218 . . . . 99.989999999999995 107.711 172.969 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 774' ' ' LYS . . . . . 0.409 ' HG3' ' O ' ' A' ' 772' ' ' GLU . 74.0 mttt -118.21 30.53 7.18 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 107.842 -1.17 . . . . 99.989999999999995 107.842 -177.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 775' ' ' THR . . . . . 0.452 ' O ' ' HB2' ' A' ' 776' ' ' ASN . 0.2 OUTLIER -96.06 -73.57 0.59 Allowed 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 113.988 -1.46 . . . . 99.989999999999995 112.498 -171.43 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 776' ' ' ASN . . . . . 0.452 ' HB2' ' O ' ' A' ' 775' ' ' THR . 11.7 m120 83.48 4.3 0.86 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.504 1.121 . . . . 99.989999999999995 110.431 -176.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 777' ' ' GLU . . . . . 0.597 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 22.5 mt-10 -161.56 88.41 0.71 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.998 -1.001 . . . . 99.989999999999995 108.643 173.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 778' ' ' TYR . . . . . 0.501 ' HB3' ' CD1' ' A' ' 745' ' ' LEU . 50.2 t80 -130.88 132.41 45.13 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.252 -0.431 . . . . 99.989999999999995 110.644 -169.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 779' ' ' VAL . . . . . 0.634 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 20.1 t -87.07 113.78 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 CA-C-O 121.209 0.528 . . . . 99.989999999999995 110.396 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 780' ' ' ILE . . . . . 0.472 HG23 ' N ' ' A' ' 781' ' ' LYS . 66.0 mt -82.79 143.41 12.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.343 -0.844 . . . . 99.989999999999995 110.577 -178.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 781' ' ' LYS . . . . . 0.472 ' N ' HG23 ' A' ' 780' ' ' ILE . 0.0 OUTLIER -117.73 110.55 17.97 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.188 -0.671 . . . . 99.989999999999995 109.188 176.042 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 782' ' ' THR . . . . . 0.63 ' O ' ' HB2' ' A' ' 738' ' ' HIS . 29.8 p -77.56 142.07 66.02 Favored Pre-proline 0 C--N 1.317 -0.834 0 N-CA-C 109.49 -0.559 . . . . 99.989999999999995 109.49 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 783' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 782' ' ' THR . 38.0 Cg_exo -57.46 166.02 5.2 Favored 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 123.364 2.709 . . . . 99.989999999999995 112.229 -179.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 784' ' ' VAL . . . . . . . . . . . . . 14.1 p -67.53 135.26 28.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.291 0.567 . . . . 99.989999999999995 111.065 -175.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 785' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -104.77 103.64 13.29 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.612 -0.722 . . . . 99.989999999999995 109.539 178.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 82.3 p -86.21 18.54 3.09 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.546 -0.752 . . . . 99.989999999999995 111.463 -172.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 29.9 m -158.11 121.77 4.01 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.457 -0.792 . . . . 99.989999999999995 110.66 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 788' ' ' GLY . . . . . . . . . . . . . . . -48.85 118.22 4.77 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.888 -0.596 . . . . 99.989999999999995 112.791 171.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 789' ' ' GLY . . . . . 0.474 ' H ' ' HB ' ' A' ' 817' ' ' VAL . . . -174.88 168.39 40.99 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 110.058 -1.217 . . . . 99.989999999999995 110.058 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -97.32 135.93 38.52 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 118.066 0.933 . . . . 99.989999999999995 110.692 -178.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 791' ' ' TYR . . . . . 0.643 ' CE2' ' HB3' ' A' ' 759' ' ' GLU . 70.3 m-85 -123.18 150.21 43.63 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.504 -0.771 . . . . 99.989999999999995 109.671 176.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 792' ' ' ILE . . . . . 0.592 ' O ' HG13 ' A' ' 758' ' ' ILE . 11.3 mt -128.7 110.38 21.0 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 N-CA-C 108.901 -0.777 . . . . 99.989999999999995 108.901 177.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 793' ' ' LEU . . . . . 0.538 HD11 ' N ' ' A' ' 794' ' ' SER . 1.1 tp -84.2 111.75 19.65 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.96 -0.756 . . . . 99.989999999999995 108.96 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 794' ' ' SER . . . . . 0.538 ' N ' HD11 ' A' ' 793' ' ' LEU . 40.5 t -122.48 161.07 24.26 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.322 -1.308 . . . . 99.989999999999995 108.875 -175.024 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 795' ' ' LEU . . . . . . . . . . . . . 39.9 mt -88.71 142.67 27.48 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.658 -0.247 . . . . 99.989999999999995 110.738 -176.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 796' ' ' VAL . . . . . . . . . . . . . 73.4 t -102.73 -55.18 6.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.198 -0.455 . . . . 99.989999999999995 111.186 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 797' ' ' SER . . . . . 0.47 ' C ' HD13 ' A' ' 808' ' ' LEU . 7.4 t -178.03 177.78 1.0 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.429 -0.35 . . . . 99.989999999999995 110.475 -173.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 798' ' ' ILE . . . . . 0.634 ' HA ' ' O ' ' A' ' 752' ' ' THR . 9.2 tt -150.15 163.12 3.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 108.527 -0.916 . . . . 99.989999999999995 108.527 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 799' ' ' LYS . . . . . 0.724 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 9.6 tmtt? -138.71 119.53 14.22 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.895 0.379 . . . . 99.989999999999995 111.0 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 800' ' ' ASP . . . . . 0.538 ' HB3' ' HB3' ' A' ' 804' ' ' CYS . 14.1 t70 -64.12 155.72 30.62 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.244 -0.889 . . . . 99.989999999999995 109.729 174.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 3.5 m -60.01 -17.22 37.15 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 124.071 0.857 . . . . 99.989999999999995 112.596 -173.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 802' ' ' THR . . . . . 0.417 HG21 ' OD1' ' A' ' 800' ' ' ASP . 13.0 t -89.86 -0.55 57.63 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 121.836 0.827 . . . . 99.989999999999995 109.636 177.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 803' ' ' GLY . . . . . 0.432 ' HA2' ' HE2' ' A' ' 799' ' ' LYS . . . 86.68 38.23 8.24 Favored Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 115.001 -1.0 . . . . 99.989999999999995 111.846 -178.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 804' ' ' CYS . . . . . 0.538 ' HB3' ' HB3' ' A' ' 800' ' ' ASP . 46.5 t -99.73 105.15 16.92 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.206 -0.664 . . . . 99.989999999999995 109.206 178.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 805' ' ' VAL . . . . . . . . . . . . . 5.9 t -85.51 122.87 38.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.246 0.546 . . . . 99.989999999999995 110.143 -176.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 806' ' ' VAL . . . . . 0.527 HG13 ' HD2' ' A' ' 721' ' ' PRO . 32.4 t -114.43 136.99 49.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.154 -0.93 . . . . 99.989999999999995 110.552 -174.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -81.89 110.31 3.16 Favored Glycine 0 C--N 1.322 -0.207 0 C-N-CA 120.76 -0.733 . . . . 99.989999999999995 113.279 -176.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 808' ' ' LEU . . . . . 0.47 HD13 ' C ' ' A' ' 797' ' ' SER . 10.9 mp -81.36 123.58 28.66 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 113.502 0.927 . . . . 99.989999999999995 113.502 178.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 9.7 t -141.91 86.78 2.0 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.765 -1.198 . . . . 99.989999999999995 107.765 168.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 810' ' ' GLN . . . . . 0.446 ' HB3' ' O ' ' A' ' 723' ' ' ALA . 0.9 OUTLIER -146.07 176.07 2.4 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 115.261 -0.881 . . . . 99.989999999999995 109.879 -171.238 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 811' ' ' PRO . . . . . 0.403 ' O ' HD13 ' A' ' 725' ' ' LEU . 70.7 Cg_exo -41.61 142.91 1.11 Allowed 'Trans proline' 0 C--N 1.362 1.258 0 C-N-CA 123.559 2.839 . . . . 99.989999999999995 115.495 -171.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -125.37 167.57 14.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.348 -1.296 . . . . 99.989999999999995 110.577 -176.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 813' ' ' ALA . . . . . 0.47 ' HB2' HD21 ' A' ' 725' ' ' LEU . . . -122.31 158.56 29.29 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.939 -0.573 . . . . 99.989999999999995 110.714 178.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 814' ' ' LYS . . . . . 0.509 ' O ' ' HA ' ' A' ' 730' ' ' ASP . 21.5 ttpp -123.55 111.42 16.25 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.381 0.61 . . . . 99.989999999999995 110.521 175.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 815' ' ' ILE . . . . . 0.518 ' HA ' ' HB2' ' A' ' 731' ' ' LEU . 5.4 mp -92.54 113.67 28.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 115.364 -0.834 . . . . 99.989999999999995 108.837 177.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 816' ' ' GLN . . . . . 0.46 HE22 ' HB2' ' A' ' 818' ' ' ARG . 1.1 tm0? -99.55 108.38 20.78 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.258 0.551 . . . . 99.989999999999995 110.119 -177.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 817' ' ' VAL . . . . . 0.474 ' HB ' ' H ' ' A' ' 789' ' ' GLY . 42.0 t -99.08 143.66 13.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.948 -0.569 . . . . 99.989999999999995 109.81 -179.156 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 818' ' ' ARG . . . . . 0.46 ' HB2' HE22 ' A' ' 816' ' ' GLN . 30.1 tpt180 . . . . . 0 C--N 1.318 -0.761 0 N-CA-C 108.921 -0.77 . . . . 99.989999999999995 108.921 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 720' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp . . . . . 0 N--CA 1.447 -0.585 0 N-CA-C 108.609 -0.886 . . . . 99.989999999999995 108.609 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 721' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -84.79 146.65 10.55 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 122.106 1.871 . . . . 99.989999999999995 112.042 -172.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 722' ' ' SER . . . . . 0.454 ' CB ' HE21 ' A' ' 810' ' ' GLN . 22.7 t -177.39 -157.29 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.911 -0.586 . . . . 99.989999999999995 109.597 -171.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 723' ' ' ALA . . . . . 0.519 ' HA ' ' HA ' ' A' ' 745' ' ' LEU . . . -148.97 142.07 24.91 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 110.289 -0.263 . . . . 99.989999999999995 110.289 176.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 724' ' ' SER . . . . . 0.444 ' HB2' ' OE1' ' A' ' 810' ' ' GLN . 23.0 t -130.98 105.04 7.48 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 109.488 -0.56 . . . . 99.989999999999995 109.488 -178.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 725' ' ' LEU . . . . . 0.479 ' CD2' ' HB ' ' A' ' 743' ' ' VAL . 14.0 mt -65.31 149.17 50.42 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-O 121.854 0.835 . . . . 99.989999999999995 112.31 -173.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 40.0 mtpt -100.32 -17.05 17.46 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 114.072 -1.422 . . . . 99.989999999999995 109.547 -177.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 727' ' ' LEU . . . . . . . . . . . . . 23.6 tp -66.13 117.24 8.16 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.248 -0.887 . . . . 99.989999999999995 109.845 177.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 9.8 t-80 -111.85 33.34 4.85 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 111.898 0.333 . . . . 99.989999999999995 111.898 -170.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -172.62 168.73 5.2 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.543 0.211 . . . . 99.989999999999995 110.546 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 730' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -73.25 126.63 30.53 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.479 0.657 . . . . 99.989999999999995 110.042 176.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 731' ' ' LEU . . . . . 0.52 ' HB3' ' HA ' ' A' ' 815' ' ' ILE . 16.2 tp -85.94 101.29 12.76 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.01 -0.995 . . . . 99.989999999999995 111.473 -173.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 732' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -77.72 115.79 17.75 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.679 -0.691 . . . . 99.989999999999995 110.876 -177.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 733' ' ' LEU . . . . . 0.463 ' HB3' ' HB3' ' A' ' 737' ' ' ASP . 23.9 mt -118.77 165.41 14.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 99.989999999999995 111.414 -178.036 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 734' ' ' CYS . . . . . . . . . . . . . 69.4 m -106.18 -176.79 3.18 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.797 -0.638 . . . . 99.989999999999995 110.413 174.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 735' ' ' LEU . . . . . 0.403 HD21 ' N ' ' A' ' 736' ' ' GLY . 2.4 tt -63.75 130.49 44.42 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.195 -0.457 . . . . 99.989999999999995 110.425 -175.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 736' ' ' GLY . . . . . 0.403 ' N ' HD21 ' A' ' 735' ' ' LEU . . . 72.05 15.76 76.53 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.733 -0.746 . . . . 99.989999999999995 112.212 175.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 737' ' ' ASP . . . . . 0.463 ' HB3' ' HB3' ' A' ' 733' ' ' LEU . 20.6 t0 -80.59 161.4 24.75 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.18 0.514 . . . . 99.989999999999995 110.102 178.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 50.3 p-80 -120.72 153.18 37.3 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 106.658 -1.608 . . . . 99.989999999999995 106.658 173.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 739' ' ' SER . . . . . 0.478 ' HB2' HD21 ' A' ' 731' ' ' LEU . 1.4 p -101.56 160.64 14.27 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 118.954 -1.099 . . . . 99.989999999999995 111.383 -171.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 39.3 t -132.73 100.41 4.92 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 114.822 -1.081 . . . . 99.989999999999995 108.703 179.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 741' ' ' VAL . . . . . 0.434 HG13 HD13 ' A' ' 793' ' ' LEU . 1.3 p -120.05 108.59 38.32 Favored Pre-proline 0 C--N 1.316 -0.883 0 CA-C-N 115.57 -0.741 . . . . 99.989999999999995 109.884 -177.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 742' ' ' PRO . . . . . 0.643 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 2.5 Cg_endo -74.36 137.26 23.03 Favored 'Trans proline' 0 N--CA 1.448 -1.179 0 C-N-CA 122.316 2.011 . . . . 99.989999999999995 110.895 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 743' ' ' VAL . . . . . 0.48 HG23 ' HB1' ' A' ' 723' ' ' ALA . 1.6 p -135.64 120.38 27.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.49 0.662 . . . . 99.989999999999995 112.267 177.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 744' ' ' ALA . . . . . 0.481 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -83.4 100.91 10.99 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.086 -1.079 . . . . 99.989999999999995 108.086 168.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 745' ' ' LEU . . . . . 0.543 HD11 ' HB3' ' A' ' 778' ' ' TYR . 0.2 OUTLIER -82.47 168.64 17.23 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 113.936 -1.483 . . . . 99.989999999999995 111.073 -167.222 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -123.39 146.19 48.17 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 115.805 -0.634 . . . . 99.989999999999995 110.675 -175.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 747' ' ' GLY . . . . . . . . . . . . . . . 101.86 123.38 5.21 Favored Glycine 0 C--N 1.312 -0.782 0 CA-C-N 115.769 -0.65 . . . . 99.989999999999995 111.869 -178.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -103.6 120.81 41.63 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.793 0.33 . . . . 99.989999999999995 110.851 -174.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 127.31 179.83 16.01 Favored Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 115.812 -0.631 . . . . 99.989999999999995 111.74 -178.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -70.56 93.53 0.59 Allowed 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.339 2.026 . . . . 99.989999999999995 111.936 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 751' ' ' PHE . . . . . 0.487 ' CD2' ' HA ' ' A' ' 800' ' ' ASP . 82.9 m-85 -112.19 142.09 45.08 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.781 -0.645 . . . . 99.989999999999995 110.901 179.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 752' ' ' THR . . . . . 0.686 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 85.0 m -92.18 106.01 18.11 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.374 -0.602 . . . . 99.989999999999995 109.374 177.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 753' ' ' LEU . . . . . 0.509 ' CD2' HD22 ' A' ' 745' ' ' LEU . 59.2 tp -94.6 114.69 26.69 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.949 -1.023 . . . . 99.989999999999995 110.924 -172.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 754' ' ' THR . . . . . 0.462 HG23 ' HB2' ' A' ' 769' ' ' GLU . 1.5 m -113.92 134.59 54.72 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.987 -0.551 . . . . 99.989999999999995 110.683 179.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 755' ' ' TYR . . . . . 0.62 ' CE1' ' HB3' ' A' ' 768' ' ' PHE . 25.6 p90 -143.2 156.79 44.84 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.088 0.471 . . . . 99.989999999999995 111.177 178.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 756' ' ' ASP . . . . . 0.519 ' OD2' HG23 ' A' ' 758' ' ' ILE . 2.2 p30 -106.41 125.76 51.41 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.508 -0.769 . . . . 99.989999999999995 111.211 -178.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 757' ' ' ILE . . . . . 0.427 ' HB ' ' HB3' ' A' ' 766' ' ' LYS . 3.5 mp -94.47 93.23 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 N-CA-C 106.761 -1.57 . . . . 99.989999999999995 106.761 163.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 758' ' ' ILE . . . . . 0.519 HG23 ' OD2' ' A' ' 756' ' ' ASP . 2.3 pp -95.12 143.46 11.81 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-O 121.12 0.486 . . . . 99.989999999999995 111.6 -170.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -91.16 101.46 14.19 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 115.703 -0.681 . . . . 99.989999999999995 110.226 -176.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 760' ' ' THR . . . . . 0.45 HG23 ' CB ' ' A' ' 790' ' ' ASP . 0.5 OUTLIER . . . . . 0 C--N 1.317 -0.823 0 CA-C-O 121.869 0.842 . . . . 99.989999999999995 108.939 -178.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 765' ' ' ARG . . . . . 0.463 ' HA ' ' HA ' ' A' ' 758' ' ' ILE . 21.6 ttp180 . . . . . 0 N--CA 1.439 -0.983 0 CA-C-O 121.004 0.431 . . . . 99.989999999999995 111.001 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 766' ' ' LYS . . . . . 0.665 ' HD3' ' N ' ' A' ' 767' ' ' THR . 8.4 tmtm? -118.2 146.36 44.29 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 108.144 -1.058 . . . . 99.989999999999995 108.144 175.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 767' ' ' THR . . . . . 0.665 ' N ' ' HD3' ' A' ' 766' ' ' LYS . 32.3 m -124.41 125.19 43.88 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 110.048 -0.352 . . . . 99.989999999999995 110.048 178.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 768' ' ' PHE . . . . . 0.62 ' HB3' ' CE1' ' A' ' 755' ' ' TYR . 3.4 t80 -122.5 137.73 54.79 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 108.828 -0.805 . . . . 99.989999999999995 108.828 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 769' ' ' GLU . . . . . 0.462 ' HB2' HG23 ' A' ' 754' ' ' THR . 38.3 tt0 -133.23 130.37 38.96 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 116.122 -0.49 . . . . 99.989999999999995 111.397 -175.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 770' ' ' ILE . . . . . 0.449 HG21 HG22 ' A' ' 773' ' ' ILE . 3.7 mt -121.91 110.61 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 108.318 -0.993 . . . . 99.989999999999995 108.318 177.142 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 771' ' ' LYS . . . . . 0.584 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 11.4 mtpt -83.87 150.79 25.5 Favored 'General case' 0 N--CA 1.436 -1.175 0 CA-C-O 121.243 0.544 . . . . 99.989999999999995 110.889 -175.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 772' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 55.53 50.82 13.78 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.39 -1.277 . . . . 99.989999999999995 111.998 177.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 773' ' ' ILE . . . . . 0.451 ' O ' HG13 ' A' ' 773' ' ' ILE . 0.5 OUTLIER -77.86 116.88 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 107.949 -1.13 . . . . 99.989999999999995 107.949 173.377 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 70.0 mttt -117.61 29.5 7.82 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.356 -0.979 . . . . 99.989999999999995 108.356 -177.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 775' ' ' THR . . . . . 0.619 ' O ' ' HB2' ' A' ' 776' ' ' ASN . 1.8 m -97.2 -72.58 0.64 Allowed 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 114.748 -1.115 . . . . 99.989999999999995 112.868 -172.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 776' ' ' ASN . . . . . 0.619 ' HB2' ' O ' ' A' ' 775' ' ' THR . 0.9 OUTLIER 87.26 6.18 0.27 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.512 1.125 . . . . 99.989999999999995 109.915 -178.074 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 777' ' ' GLU . . . . . 0.481 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 1.4 tm-20 -161.91 86.16 0.63 Allowed 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 114.846 -1.07 . . . . 99.989999999999995 108.333 179.001 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 778' ' ' TYR . . . . . 0.543 ' HB3' HD11 ' A' ' 745' ' ' LEU . 87.3 t80 -137.28 134.36 36.03 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 116.244 -0.435 . . . . 99.989999999999995 111.686 -170.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 779' ' ' VAL . . . . . 0.643 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 23.5 t -89.94 117.96 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 CA-C-O 121.022 0.439 . . . . 99.989999999999995 110.529 177.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 780' ' ' ILE . . . . . 0.486 HG23 ' N ' ' A' ' 781' ' ' LYS . 68.3 mt -88.47 143.26 11.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.621 -0.718 . . . . 99.989999999999995 110.782 -178.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 781' ' ' LYS . . . . . 0.486 ' N ' HG23 ' A' ' 780' ' ' ILE . 3.8 mppt? -124.21 109.39 13.36 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.849 -0.797 . . . . 99.989999999999995 108.849 175.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 782' ' ' THR . . . . . . . . . . . . . 42.9 p -78.06 144.92 68.45 Favored Pre-proline 0 C--N 1.321 -0.653 0 N-CA-C 109.987 -0.375 . . . . 99.989999999999995 109.987 -177.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 783' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -51.32 158.33 3.82 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 123.465 2.777 . . . . 99.989999999999995 113.193 -178.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 784' ' ' VAL . . . . . 0.518 HG12 HG21 ' A' ' 786' ' ' THR . 53.4 t -58.81 126.71 16.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.066 -0.97 . . . . 99.989999999999995 112.208 -176.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 785' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -103.85 98.2 8.08 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.576 -0.738 . . . . 99.989999999999995 109.883 176.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 786' ' ' THR . . . . . 0.518 HG21 HG12 ' A' ' 784' ' ' VAL . 37.1 p -87.22 32.48 0.69 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.704 0.764 . . . . 99.989999999999995 110.989 -178.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.45 110.97 3.51 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.533 -1.212 . . . . 99.989999999999995 110.59 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 788' ' ' GLY . . . . . . . . . . . . . . . -53.1 112.62 2.35 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.623 -0.799 . . . . 99.989999999999995 112.253 171.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 789' ' ' GLY . . . . . 0.446 ' H ' ' HB ' ' A' ' 817' ' ' VAL . . . -154.5 -151.55 5.84 Favored Glycine 0 N--CA 1.443 -0.893 0 N-CA-C 110.806 -0.917 . . . . 99.989999999999995 110.806 -178.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 790' ' ' ASP . . . . . 0.45 ' CB ' HG23 ' A' ' 760' ' ' THR . 4.3 m-20 -137.57 124.01 20.77 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.301 -0.629 . . . . 99.989999999999995 109.301 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 791' ' ' TYR . . . . . 0.485 ' HA ' ' O ' ' A' ' 758' ' ' ILE . 80.9 m-85 -124.64 152.91 43.05 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.294 -0.412 . . . . 99.989999999999995 109.99 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 792' ' ' ILE . . . . . 0.514 ' HB ' HD12 ' A' ' 758' ' ' ILE . 14.4 mt -133.39 122.84 45.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 109.664 -0.495 . . . . 99.989999999999995 109.664 171.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 793' ' ' LEU . . . . . 0.446 ' HA ' ' O ' ' A' ' 756' ' ' ASP . 10.4 tt -87.71 108.01 18.91 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.253 -0.647 . . . . 99.989999999999995 109.253 178.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 794' ' ' SER . . . . . 0.436 ' HB3' ' OD2' ' A' ' 756' ' ' ASP . 31.3 t -121.54 146.06 47.33 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.53 -0.759 . . . . 99.989999999999995 109.166 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 795' ' ' LEU . . . . . 0.483 ' H ' HD22 ' A' ' 795' ' ' LEU . 1.4 mm? -72.98 135.15 44.94 Favored 'General case' 0 N--CA 1.448 -0.569 0 O-C-N 122.062 -0.399 . . . . 99.989999999999995 111.481 -179.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 796' ' ' VAL . . . . . . . . . . . . . 66.7 t -95.91 -57.46 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 CA-C-N 116.207 -0.451 . . . . 99.989999999999995 111.207 -177.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 797' ' ' SER . . . . . 0.58 ' HA ' ' HG ' ' A' ' 808' ' ' LEU . 35.7 m -171.38 157.02 4.77 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.779 -0.646 . . . . 99.989999999999995 109.719 -173.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 798' ' ' ILE . . . . . 0.556 ' HA ' ' O ' ' A' ' 752' ' ' THR . 13.2 tt -132.22 162.07 40.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 109.016 -0.735 . . . . 99.989999999999995 109.016 177.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 799' ' ' LYS . . . . . 0.686 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 22.1 tttt -129.83 118.19 21.37 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 120.967 0.413 . . . . 99.989999999999995 110.993 -174.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 800' ' ' ASP . . . . . 0.487 ' HA ' ' CD2' ' A' ' 751' ' ' PHE . 21.6 t70 -65.3 152.89 42.65 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.259 -0.882 . . . . 99.989999999999995 108.854 173.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 4.4 m -62.62 -8.56 6.71 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 123.768 0.667 . . . . 99.989999999999995 112.503 -171.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 40.1 p -96.67 5.62 50.32 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.426 0.631 . . . . 99.989999999999995 110.191 176.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 803' ' ' GLY . . . . . 0.486 ' HA2' ' HE2' ' A' ' 799' ' ' LYS . . . 77.98 42.25 16.6 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.202 -0.908 . . . . 99.989999999999995 112.029 -177.014 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 804' ' ' CYS . . . . . 0.48 ' HB2' ' HB3' ' A' ' 800' ' ' ASP . 69.4 m -110.24 106.87 16.45 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.574 -0.528 . . . . 99.989999999999995 109.574 176.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 805' ' ' VAL . . . . . 0.524 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 3.5 t -86.24 112.36 22.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.279 0.561 . . . . 99.989999999999995 111.071 -173.094 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 806' ' ' VAL . . . . . 0.41 ' HB ' HG22 ' A' ' 798' ' ' ILE . 73.4 t -90.0 135.14 27.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.349 -0.842 . . . . 99.989999999999995 110.152 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -73.7 120.57 6.95 Favored Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 111.601 -0.599 . . . . 99.989999999999995 111.601 178.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 808' ' ' LEU . . . . . 0.58 ' HG ' ' HA ' ' A' ' 797' ' ' SER . 45.4 mt -88.71 132.96 34.37 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 112.747 0.647 . . . . 99.989999999999995 112.747 -175.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 44.7 m -149.86 87.2 1.47 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.023 -0.989 . . . . 99.989999999999995 109.633 172.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 810' ' ' GLN . . . . . 0.455 ' HB3' ' HD2' ' A' ' 811' ' ' PRO . 11.3 mt-30 -135.34 171.84 8.23 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.82 -0.627 . . . . 99.989999999999995 110.336 174.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 811' ' ' PRO . . . . . 0.455 ' HD2' ' HB3' ' A' ' 810' ' ' GLN . 97.0 Cg_exo -45.81 137.82 12.18 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 122.999 2.466 . . . . 99.989999999999995 114.328 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -109.1 167.29 10.21 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.623 -1.171 . . . . 99.989999999999995 110.217 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 813' ' ' ALA . . . . . 0.419 ' HB2' HD11 ' A' ' 725' ' ' LEU . . . -126.7 141.17 51.92 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.892 -0.594 . . . . 99.989999999999995 110.571 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 814' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -100.24 129.56 46.26 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.143 0.497 . . . . 99.989999999999995 110.555 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 815' ' ' ILE . . . . . 0.52 ' HA ' ' HB3' ' A' ' 731' ' ' LEU . 5.3 mp -112.55 109.75 29.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 N-CA-C 108.699 -0.852 . . . . 99.989999999999995 108.699 176.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 816' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -106.08 109.05 20.86 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.061 0.457 . . . . 99.989999999999995 109.991 -175.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 817' ' ' VAL . . . . . 0.446 ' HB ' ' H ' ' A' ' 789' ' ' GLY . 4.7 t -99.74 141.27 17.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 116.02 -0.536 . . . . 99.989999999999995 110.513 -174.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 818' ' ' ARG . . . . . . . . . . . . . 39.9 mmt180 . . . . . 0 C--N 1.319 -0.724 0 N-CA-C 108.975 -0.75 . . . . 99.989999999999995 108.975 177.521 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 720' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt . . . . . 0 N--CA 1.442 -0.828 0 N-CA-C 109.652 -0.499 . . . . 99.989999999999995 109.652 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 721' ' ' PRO . . . . . 0.421 ' C ' ' HG ' ' A' ' 722' ' ' SER . 47.2 Cg_endo -86.46 140.34 6.26 Favored 'Trans proline' 0 N--CA 1.445 -1.353 0 C-N-CA 122.233 1.955 . . . . 99.989999999999995 111.204 178.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 722' ' ' SER . . . . . 0.436 ' HA ' ' CD2' ' A' ' 808' ' ' LEU . 50.2 m -167.42 -157.19 0.23 Allowed 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.353 -0.61 . . . . 99.989999999999995 109.353 -172.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 723' ' ' ALA . . . . . 0.51 ' HB1' HG23 ' A' ' 743' ' ' VAL . . . -145.77 142.62 29.08 Favored 'General case' 0 N--CA 1.449 -0.521 0 O-C-N 122.093 -0.38 . . . . 99.989999999999995 110.27 175.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -129.72 100.4 5.49 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.36 -0.607 . . . . 99.989999999999995 109.36 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 725' ' ' LEU . . . . . 0.481 ' CD2' ' HB ' ' A' ' 743' ' ' VAL . 13.2 mt -62.65 144.09 56.65 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 121.765 0.793 . . . . 99.989999999999995 111.869 -173.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 33.4 mtpt -95.22 -18.92 20.47 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.544 -1.207 . . . . 99.989999999999995 109.366 -178.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 727' ' ' LEU . . . . . 0.512 ' HB2' ' HD2' ' A' ' 742' ' ' PRO . 0.7 OUTLIER -76.67 109.97 10.87 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.755 -0.832 . . . . 99.989999999999995 108.755 177.304 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 33.4 m80 -115.83 46.19 1.58 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.02 0.438 . . . . 99.989999999999995 110.532 -176.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -148.31 174.33 12.13 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.873 -0.603 . . . . 99.989999999999995 110.92 -176.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 730' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -100.5 108.78 20.82 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.773 -0.825 . . . . 99.989999999999995 108.773 175.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 731' ' ' LEU . . . . . 0.569 ' HB2' ' HA ' ' A' ' 815' ' ' ILE . 53.9 mt -72.03 100.82 2.58 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.236 -0.438 . . . . 99.989999999999995 111.984 -173.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 732' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -79.43 121.6 25.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.36 -0.382 . . . . 99.989999999999995 110.681 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 733' ' ' LEU . . . . . 0.674 ' HB2' ' HB ' ' A' ' 817' ' ' VAL . 25.6 mt -126.41 169.52 12.9 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.372 0.606 . . . . 99.989999999999995 111.835 -174.154 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 734' ' ' CYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 818' ' ' ARG . 13.2 p -105.39 -176.97 3.23 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.8 -1.091 . . . . 99.989999999999995 109.107 176.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 735' ' ' LEU . . . . . . . . . . . . . 36.2 tp -71.41 122.54 20.56 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.536 -0.302 . . . . 99.989999999999995 110.569 -178.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 79.94 16.46 76.92 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.191 -1.004 . . . . 99.989999999999995 112.317 178.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 737' ' ' ASP . . . . . 0.519 ' HB3' ' HB3' ' A' ' 733' ' ' LEU . 25.3 t0 -86.22 157.63 19.91 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.769 0.318 . . . . 99.989999999999995 110.713 174.217 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 27.1 p-80 -117.16 -177.86 3.31 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.375 -0.972 . . . . 99.989999999999995 108.375 174.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 739' ' ' SER . . . . . 0.56 ' HB2' ' OG1' ' A' ' 782' ' ' THR . 29.8 m -142.22 169.43 17.6 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 119.777 -0.769 . . . . 99.989999999999995 112.894 179.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 5.7 p -138.07 109.66 7.04 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 114.433 -1.258 . . . . 99.989999999999995 109.4 177.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 741' ' ' VAL . . . . . 0.431 HG13 HD13 ' A' ' 793' ' ' LEU . 0.6 OUTLIER -113.1 112.44 49.86 Favored Pre-proline 0 C--N 1.316 -0.877 0 CA-C-N 115.671 -0.695 . . . . 99.989999999999995 110.226 -177.912 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 742' ' ' PRO . . . . . 0.638 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 4.1 Cg_endo -75.48 135.38 18.15 Favored 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 122.422 2.081 . . . . 99.989999999999995 111.652 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 743' ' ' VAL . . . . . 0.51 HG23 ' HB1' ' A' ' 723' ' ' ALA . 1.7 p -131.05 119.31 44.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.564 0.697 . . . . 99.989999999999995 111.981 176.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 744' ' ' ALA . . . . . 0.436 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -83.89 101.47 11.69 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 107.791 -1.188 . . . . 99.989999999999995 107.791 169.102 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 745' ' ' LEU . . . . . 0.511 HD11 ' HB3' ' A' ' 778' ' ' TYR . 0.3 OUTLIER -80.4 161.37 25.0 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 114.26 -1.336 . . . . 99.989999999999995 111.2 -166.752 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -110.91 146.31 36.79 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.686 -0.688 . . . . 99.989999999999995 109.628 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 747' ' ' GLY . . . . . . . . . . . . . . . 98.87 122.92 4.79 Favored Glycine 0 C--N 1.305 -1.168 0 N-CA-C 110.54 -1.024 . . . . 99.989999999999995 110.54 -176.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.95 128.68 53.96 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.321 0.581 . . . . 99.989999999999995 111.811 -169.22 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 109.44 -178.7 20.64 Favored Glycine 0 C--O 1.22 -0.724 0 CA-C-N 114.902 -1.044 . . . . 99.989999999999995 111.044 -175.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 750' ' ' PRO . . . . . 0.478 ' HB3' ' HE2' ' A' ' 774' ' ' LYS . 73.3 Cg_endo -65.51 100.96 0.42 Allowed 'Trans proline' 0 C--O 1.235 0.363 0 C-N-CA 123.37 2.714 . . . . 99.989999999999995 113.821 -178.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 751' ' ' PHE . . . . . 0.582 ' CE2' ' HA ' ' A' ' 800' ' ' ASP . 75.6 m-85 -117.0 146.86 42.78 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.643 -0.708 . . . . 99.989999999999995 110.743 176.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 752' ' ' THR . . . . . 0.653 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 33.4 m -89.64 106.64 18.59 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 109.07 -0.715 . . . . 99.989999999999995 109.07 176.04 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 753' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -96.72 111.26 23.49 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.713 -0.676 . . . . 99.989999999999995 110.338 -172.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 754' ' ' THR . . . . . 0.486 HG23 ' HB2' ' A' ' 769' ' ' GLU . 1.6 m -108.81 137.26 47.03 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.558 -0.747 . . . . 99.989999999999995 111.269 -178.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 755' ' ' TYR . . . . . 0.448 ' HH ' ' CD1' ' A' ' 770' ' ' ILE . 29.9 p90 -148.16 156.89 43.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.88 0.371 . . . . 99.989999999999995 110.953 176.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 756' ' ' ASP . . . . . 0.631 ' OD2' HG23 ' A' ' 796' ' ' VAL . 0.7 OUTLIER -125.18 121.76 35.11 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.782 -0.644 . . . . 99.989999999999995 110.513 178.667 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 757' ' ' ILE . . . . . 0.442 ' N ' HD13 ' A' ' 757' ' ' ILE . 4.2 mp -83.72 96.59 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 N-CA-C 107.728 -1.212 . . . . 99.989999999999995 107.728 172.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 758' ' ' ILE . . . . . 0.53 HG13 ' O ' ' A' ' 792' ' ' ILE . 2.4 pp -93.92 148.25 5.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 115.682 -0.69 . . . . 99.989999999999995 112.248 -167.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 759' ' ' GLU . . . . . 0.619 ' HG2' ' CE2' ' A' ' 791' ' ' TYR . 23.9 mt-10 -88.68 117.82 27.92 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.425 -0.807 . . . . 99.989999999999995 109.921 176.097 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 760' ' ' THR . . . . . . . . . . . . . 1.2 t . . . . . 0 C--N 1.313 -1.016 0 CA-C-O 121.512 0.672 . . . . 99.989999999999995 109.227 176.501 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 765' ' ' ARG . . . . . 0.445 ' HD2' ' CG2' ' A' ' 758' ' ' ILE . 19.0 ttt180 . . . . . 0 N--CA 1.453 -0.29 0 CA-C-O 120.952 0.406 . . . . 99.989999999999995 110.8 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 766' ' ' LYS . . . . . 0.402 ' HD3' ' N ' ' A' ' 767' ' ' THR . 9.7 tmtm? -106.78 140.47 39.57 Favored 'General case' 0 C--O 1.216 -0.674 0 CA-C-N 115.994 -0.548 . . . . 99.989999999999995 109.794 -175.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 767' ' ' THR . . . . . 0.402 ' N ' ' HD3' ' A' ' 766' ' ' LYS . 21.1 m -111.39 134.83 52.69 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 116.046 -0.525 . . . . 99.989999999999995 111.016 -176.015 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 768' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -140.46 137.89 34.26 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.01 0.433 . . . . 99.989999999999995 110.742 173.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 769' ' ' GLU . . . . . 0.486 ' HB2' HG23 ' A' ' 754' ' ' THR . 27.7 tt0 -131.86 123.17 26.97 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.738 -0.664 . . . . 99.989999999999995 110.558 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 770' ' ' ILE . . . . . 0.448 ' CD1' ' HH ' ' A' ' 755' ' ' TYR . 6.5 mt -114.45 112.23 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 109.065 -0.717 . . . . 99.989999999999995 109.065 178.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 771' ' ' LYS . . . . . 0.534 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 9.7 mtpt -85.88 154.64 21.38 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.927 -0.579 . . . . 99.989999999999995 111.52 -173.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 772' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 54.6 44.06 29.25 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.388 -1.278 . . . . 99.989999999999995 111.984 175.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 773' ' ' ILE . . . . . 0.448 HG22 HG21 ' A' ' 770' ' ' ILE . 0.5 OUTLIER -73.95 116.21 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 N-CA-C 106.977 -1.49 . . . . 99.989999999999995 106.977 172.142 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 774' ' ' LYS . . . . . 0.478 ' HE2' ' HB3' ' A' ' 750' ' ' PRO . 58.0 mttt -111.88 26.36 10.69 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 108.093 -1.077 . . . . 99.989999999999995 108.093 -178.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 775' ' ' THR . . . . . 0.67 ' O ' ' HB2' ' A' ' 776' ' ' ASN . 0.2 OUTLIER -96.22 -75.86 0.52 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 114.767 -1.106 . . . . 99.989999999999995 113.676 -166.333 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 776' ' ' ASN . . . . . 0.67 ' HB2' ' O ' ' A' ' 775' ' ' THR . 0.8 OUTLIER 89.98 2.52 0.19 Allowed 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.892 1.277 . . . . 99.989999999999995 110.565 -172.897 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 777' ' ' GLU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 9.4 mp0 -154.6 90.65 1.33 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.757 -0.831 . . . . 99.989999999999995 108.757 175.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 778' ' ' TYR . . . . . 0.511 ' HB3' HD11 ' A' ' 745' ' ' LEU . 81.7 t80 -132.12 128.8 38.89 Favored 'General case' 0 C--N 1.315 -0.932 0 C-N-CA 120.249 -0.58 . . . . 99.989999999999995 111.212 -172.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 779' ' ' VAL . . . . . 0.638 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 17.3 t -89.18 112.82 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-O 121.308 0.575 . . . . 99.989999999999995 110.4 178.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 780' ' ' ILE . . . . . 0.528 HG23 ' N ' ' A' ' 781' ' ' LYS . 77.8 mt -81.29 147.05 6.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.179 -0.919 . . . . 99.989999999999995 110.549 -178.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 781' ' ' LYS . . . . . 0.528 ' N ' HG23 ' A' ' 780' ' ' ILE . 3.8 mppt? -120.1 108.23 14.01 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.5 -0.555 . . . . 99.989999999999995 109.5 175.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 782' ' ' THR . . . . . 0.56 ' OG1' ' HB2' ' A' ' 739' ' ' SER . 54.6 p -77.51 141.41 65.35 Favored Pre-proline 0 C--N 1.319 -0.758 0 CA-C-N 116.084 -0.507 . . . . 99.989999999999995 110.359 -178.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 783' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 782' ' ' THR . 52.3 Cg_exo -53.91 158.57 8.54 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 123.758 2.972 . . . . 99.989999999999995 112.515 -175.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 784' ' ' VAL . . . . . 0.436 ' O ' HG11 ' A' ' 784' ' ' VAL . 12.9 p -65.7 128.93 29.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.33 0.586 . . . . 99.989999999999995 109.974 -178.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 785' ' ' PHE . . . . . 0.404 ' CG ' HG12 ' A' ' 817' ' ' VAL . 89.8 m-85 -97.48 96.61 8.45 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.965 -0.561 . . . . 99.989999999999995 110.321 -176.164 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 69.8 p -84.32 18.63 2.13 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.395 0.616 . . . . 99.989999999999995 111.473 -174.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 3.0 m -155.72 124.22 5.93 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.622 -0.717 . . . . 99.989999999999995 110.629 177.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 788' ' ' GLY . . . . . 0.684 ' HA2' ' CG2' ' A' ' 817' ' ' VAL . . . -50.89 123.69 17.8 Favored Glycine 0 CA--C 1.524 0.645 0 O-C-N 123.522 0.513 . . . . 99.989999999999995 112.336 172.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 789' ' ' GLY . . . . . . . . . . . . . . . -164.03 -165.76 21.77 Favored Glycine 0 N--CA 1.442 -0.964 0 N-CA-C 110.981 -0.848 . . . . 99.989999999999995 110.981 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -133.41 124.18 26.66 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.577 -0.897 . . . . 99.989999999999995 108.577 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 791' ' ' TYR . . . . . 0.619 ' CE2' ' HG2' ' A' ' 759' ' ' GLU . 81.5 m-85 -124.78 148.68 48.0 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.106 0.479 . . . . 99.989999999999995 111.286 -173.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 792' ' ' ILE . . . . . 0.53 ' O ' HG13 ' A' ' 758' ' ' ILE . 13.2 mt -126.07 116.36 45.56 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-N 115.612 -0.722 . . . . 99.989999999999995 109.656 175.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 793' ' ' LEU . . . . . 0.46 ' C ' HD21 ' A' ' 793' ' ' LEU . 9.3 tt -84.25 111.23 19.2 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.634 -0.876 . . . . 99.989999999999995 108.634 178.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 794' ' ' SER . . . . . . . . . . . . . 17.8 m -120.65 139.66 52.69 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.912 -0.585 . . . . 99.989999999999995 110.389 -178.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 795' ' ' LEU . . . . . 0.494 ' H ' HD22 ' A' ' 795' ' ' LEU . 1.6 mm? -69.25 132.07 45.9 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 116.533 -0.303 . . . . 99.989999999999995 110.619 176.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 796' ' ' VAL . . . . . 0.631 HG23 ' OD2' ' A' ' 756' ' ' ASP . 53.4 t -97.61 -51.71 10.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-O 120.993 0.425 . . . . 99.989999999999995 111.272 -178.063 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 797' ' ' SER . . . . . 0.541 ' HA ' ' HG ' ' A' ' 808' ' ' LEU . 81.1 p -168.42 155.62 7.75 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 116.032 -0.531 . . . . 99.989999999999995 110.391 -172.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 798' ' ' ILE . . . . . 0.633 ' HA ' ' O ' ' A' ' 752' ' ' THR . 8.7 tt -130.15 167.2 25.88 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 108.862 -0.792 . . . . 99.989999999999995 108.862 177.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 799' ' ' LYS . . . . . 0.653 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 2.7 ttmp? -135.74 118.32 15.93 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 120.732 -0.387 . . . . 99.989999999999995 111.626 -176.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 800' ' ' ASP . . . . . 0.582 ' HA ' ' CE2' ' A' ' 751' ' ' PHE . 12.0 m-20 -58.88 154.91 14.15 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.192 -0.913 . . . . 99.989999999999995 109.805 171.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 5.8 m -62.06 -10.21 9.43 Favored 'General case' 0 C--N 1.326 -0.415 0 O-C-N 124.14 0.9 . . . . 99.989999999999995 112.505 -172.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 14.0 t -96.24 4.99 51.98 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.559 0.695 . . . . 99.989999999999995 109.636 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 803' ' ' GLY . . . . . . . . . . . . . . . 81.19 43.36 8.73 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 115.316 -0.857 . . . . 99.989999999999995 112.135 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 804' ' ' CYS . . . . . . . . . . . . . 46.4 t -114.71 119.75 37.74 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.765 -0.457 . . . . 99.989999999999995 109.765 178.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 805' ' ' VAL . . . . . 0.537 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 3.0 t -94.22 124.79 46.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.327 0.584 . . . . 99.989999999999995 111.562 -172.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 806' ' ' VAL . . . . . . . . . . . . . 39.5 t -104.72 135.64 41.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.197 -0.91 . . . . 99.989999999999995 110.299 177.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -74.16 127.91 10.41 Favored Glycine 0 C--N 1.323 -0.177 0 CA-C-N 115.673 -0.694 . . . . 99.989999999999995 111.47 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 808' ' ' LEU . . . . . 0.541 ' HG ' ' HA ' ' A' ' 797' ' ' SER . 64.2 mt -98.05 136.96 37.55 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 113.054 0.761 . . . . 99.989999999999995 113.054 -172.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 43.0 m -148.71 86.39 1.52 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.822 -1.081 . . . . 99.989999999999995 109.173 170.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 810' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -139.79 172.92 5.65 Favored Pre-proline 0 CA--C 1.539 0.539 0 CA-C-N 115.194 -0.912 . . . . 99.989999999999995 109.132 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 811' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -44.4 138.77 7.21 Favored 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 123.059 2.506 . . . . 99.989999999999995 115.159 -173.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 812' ' ' ASP . . . . . 0.4 ' C ' HD12 ' A' ' 725' ' ' LEU . 7.8 p-10 -104.47 167.46 9.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.541 -1.209 . . . . 99.989999999999995 110.327 178.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 813' ' ' ALA . . . . . . . . . . . . . . . -123.88 152.01 42.84 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.314 -0.857 . . . . 99.989999999999995 109.437 175.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 814' ' ' LYS . . . . . 0.475 ' HG2' HG12 ' A' ' 792' ' ' ILE . 48.8 mttp -118.18 127.7 54.0 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.718 0.771 . . . . 99.989999999999995 111.241 -178.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 815' ' ' ILE . . . . . 0.597 ' CG2' HD13 ' A' ' 733' ' ' LEU . 5.3 mp -116.44 107.29 22.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 114.552 -1.204 . . . . 99.989999999999995 108.797 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 816' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -108.68 107.24 17.62 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.313 0.578 . . . . 99.989999999999995 110.024 -177.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 817' ' ' VAL . . . . . 0.684 ' CG2' ' HA2' ' A' ' 788' ' ' GLY . 1.9 m -102.21 147.46 8.87 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 N-CA-C 109.169 -0.678 . . . . 99.989999999999995 109.169 -178.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 818' ' ' ARG . . . . . 0.473 ' O ' ' HA ' ' A' ' 734' ' ' CYS . 16.1 tpt180 . . . . . 0 C--N 1.313 -1.019 0 N-CA-C 109.587 -0.523 . . . . 99.989999999999995 109.587 -172.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 720' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm . . . . . 0 N--CA 1.45 -0.45 0 CA-C-O 120.926 0.393 . . . . 99.989999999999995 111.119 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 721' ' ' PRO . . . . . 0.494 ' HD2' HG11 ' A' ' 806' ' ' VAL . 74.1 Cg_endo -88.35 148.3 6.44 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 123.279 2.653 . . . . 99.989999999999995 111.249 177.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 722' ' ' SER . . . . . 0.524 ' HA ' ' CD2' ' A' ' 808' ' ' LEU . 11.6 p 179.44 -158.25 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.982 -0.554 . . . . 99.989999999999995 109.802 -171.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 723' ' ' ALA . . . . . 0.528 ' HB1' HG23 ' A' ' 743' ' ' VAL . . . -144.15 142.03 30.32 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 110.168 -0.308 . . . . 99.989999999999995 110.168 177.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 11.7 m -129.31 99.0 5.05 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.245 -0.65 . . . . 99.989999999999995 109.245 -178.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 725' ' ' LEU . . . . . 0.462 HD11 ' HB2' ' A' ' 813' ' ' ALA . 8.3 mt -64.22 143.63 57.74 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-O 121.811 0.815 . . . . 99.989999999999995 112.366 -172.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 29.1 mtpt -93.67 -18.91 21.62 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.216 -1.356 . . . . 99.989999999999995 108.583 177.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 727' ' ' LEU . . . . . 0.431 HD11 ' C ' ' A' ' 727' ' ' LEU . 3.0 tm? -60.43 119.2 7.55 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 114.905 -1.043 . . . . 99.989999999999995 108.569 173.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -88.93 -48.26 7.57 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.234 0.457 . . . . 99.989999999999995 112.234 -170.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 729' ' ' HIS . . . . . 0.43 ' O ' HD13 ' A' ' 727' ' ' LEU . 8.8 p80 -136.11 -175.7 4.07 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.798 -0.361 . . . . 99.989999999999995 111.224 -177.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 730' ' ' ASP . . . . . 0.45 ' HA ' ' O ' ' A' ' 814' ' ' LYS . 9.1 p-10 -40.65 133.98 1.9 Allowed 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.66 0.743 . . . . 99.989999999999995 112.098 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 731' ' ' LEU . . . . . 0.546 ' HB3' ' HA ' ' A' ' 815' ' ' ILE . 22.1 tp -104.26 104.68 14.62 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.225 -0.898 . . . . 99.989999999999995 110.258 -177.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 732' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -74.19 112.74 10.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.611 -0.722 . . . . 99.989999999999995 112.481 -171.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 733' ' ' LEU . . . . . 0.612 ' HG ' ' HB3' ' A' ' 737' ' ' ASP . 9.2 mp -120.01 164.97 15.31 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.679 -0.691 . . . . 99.989999999999995 109.73 173.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 734' ' ' CYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 818' ' ' ARG . 2.1 p -124.4 -173.62 2.82 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.266 -0.425 . . . . 99.989999999999995 110.486 173.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 735' ' ' LEU . . . . . . . . . . . . . 2.6 tt -53.64 115.65 2.08 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.088 0.471 . . . . 99.989999999999995 111.284 -174.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 87.88 3.27 80.27 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.592 -0.814 . . . . 99.989999999999995 112.965 173.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 737' ' ' ASP . . . . . 0.612 ' HB3' ' HG ' ' A' ' 733' ' ' LEU . 0.3 OUTLIER -76.99 148.98 35.95 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.253 0.549 . . . . 99.989999999999995 111.684 178.076 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 738' ' ' HIS . . . . . 0.483 ' HB2' ' O ' ' A' ' 782' ' ' THR . 36.1 p-80 -113.1 151.05 31.26 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 106.751 -1.574 . . . . 99.989999999999995 106.751 170.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 739' ' ' SER . . . . . 0.515 ' O ' ' HA ' ' A' ' 781' ' ' LYS . 17.3 p -108.6 167.56 9.96 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 119.219 -0.992 . . . . 99.989999999999995 111.803 -170.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 740' ' ' SER . . . . . 0.418 ' HA ' ' O ' ' A' ' 780' ' ' ILE . 12.9 p -132.7 99.62 4.68 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 114.924 -1.035 . . . . 99.989999999999995 109.301 175.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 741' ' ' VAL . . . . . 0.452 HG13 HD13 ' A' ' 793' ' ' LEU . 0.5 OUTLIER -104.98 105.04 49.85 Favored Pre-proline 0 C--N 1.316 -0.877 0 CA-C-N 115.037 -0.983 . . . . 99.989999999999995 108.799 179.02 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 742' ' ' PRO . . . . . 0.682 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 2.1 Cg_endo -74.97 131.91 14.85 Favored 'Trans proline' 0 N--CA 1.441 -1.589 0 C-N-CA 122.097 1.865 . . . . 99.989999999999995 110.777 -177.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 743' ' ' VAL . . . . . 0.528 HG23 ' HB1' ' A' ' 723' ' ' ALA . 1.4 p -131.99 120.88 45.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.769 0.795 . . . . 99.989999999999995 112.788 177.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 744' ' ' ALA . . . . . 0.514 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -81.02 99.88 8.68 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.134 -1.062 . . . . 99.989999999999995 108.134 168.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 745' ' ' LEU . . . . . 0.592 HD22 ' CD1' ' A' ' 753' ' ' LEU . 0.2 OUTLIER -83.59 165.33 19.13 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 114.536 -1.211 . . . . 99.989999999999995 111.28 -167.475 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 34.9 tptt -114.51 165.0 13.21 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.664 -0.698 . . . . 99.989999999999995 109.699 -178.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 747' ' ' GLY . . . . . . . . . . . . . . . 90.16 129.61 4.04 Favored Glycine 0 C--N 1.306 -1.089 0 CA-C-N 115.276 -0.874 . . . . 99.989999999999995 111.538 -175.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 748' ' ' GLN . . . . . 0.419 ' C ' ' HE1' ' A' ' 751' ' ' PHE . 0.0 OUTLIER -112.34 113.82 26.23 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.201 0.524 . . . . 99.989999999999995 111.636 -173.89 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 123.77 -174.88 16.81 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.371 -0.832 . . . . 99.989999999999995 111.045 -177.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 750' ' ' PRO . . . . . 0.409 ' HD2' ' OG ' ' A' ' 801' ' ' SER . 14.0 Cg_exo -69.69 93.89 0.52 Allowed 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.552 2.168 . . . . 99.989999999999995 112.317 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 751' ' ' PHE . . . . . 0.564 ' HA ' ' O ' ' A' ' 799' ' ' LYS . 75.6 m-85 -109.84 139.97 44.31 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.741 -0.663 . . . . 99.989999999999995 110.45 177.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 752' ' ' THR . . . . . 0.659 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 92.6 m -91.04 108.22 19.72 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 109.505 -0.554 . . . . 99.989999999999995 109.505 176.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 753' ' ' LEU . . . . . 0.592 ' CD1' HD22 ' A' ' 745' ' ' LEU . 3.7 tt -100.46 118.41 36.61 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.517 -0.765 . . . . 99.989999999999995 110.094 -171.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 754' ' ' THR . . . . . 0.433 HG23 ' HB2' ' A' ' 769' ' ' GLU . 1.6 m -114.66 138.25 50.92 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.936 -0.575 . . . . 99.989999999999995 110.967 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 755' ' ' TYR . . . . . 0.619 ' CE1' ' HB3' ' A' ' 768' ' ' PHE . 28.9 p90 -146.47 153.91 40.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.998 0.428 . . . . 99.989999999999995 111.392 178.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 756' ' ' ASP . . . . . 0.423 ' CG ' ' HD2' ' A' ' 765' ' ' ARG . 39.3 m-20 -112.04 120.85 43.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.555 -0.748 . . . . 99.989999999999995 110.818 -178.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 757' ' ' ILE . . . . . . . . . . . . . 3.3 mp -88.02 95.77 5.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 107.887 -1.153 . . . . 99.989999999999995 107.887 168.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 758' ' ' ILE . . . . . 0.442 HG21 ' HD3' ' A' ' 765' ' ' ARG . 2.3 pp -96.09 140.58 16.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-O 121.595 0.712 . . . . 99.989999999999995 112.056 -170.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -95.64 103.32 15.19 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.839 -1.073 . . . . 99.989999999999995 109.336 -176.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 760' ' ' THR . . . . . 0.447 HG23 ' HB3' ' A' ' 790' ' ' ASP . 0.5 OUTLIER . . . . . 0 C--N 1.315 -0.918 0 CA-C-N 115.627 -0.715 . . . . 99.989999999999995 111.132 -168.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 765' ' ' ARG . . . . . 0.442 ' HD3' HG21 ' A' ' 758' ' ' ILE . 5.4 ttp180 . . . . . 0 N--CA 1.443 -0.788 0 CA-C-O 120.958 0.408 . . . . 99.989999999999995 111.531 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 766' ' ' LYS . . . . . 0.462 ' HD3' ' N ' ' A' ' 767' ' ' THR . 9.6 tmtm? -117.91 146.42 43.96 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.691 -0.855 . . . . 99.989999999999995 108.691 177.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 767' ' ' THR . . . . . 0.462 ' N ' ' HD3' ' A' ' 766' ' ' LYS . 90.0 m -121.09 133.9 55.24 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 116.629 -0.26 . . . . 99.989999999999995 110.473 178.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 768' ' ' PHE . . . . . 0.619 ' HB3' ' CE1' ' A' ' 755' ' ' TYR . 1.2 t80 -134.74 135.93 42.29 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.152 -0.685 . . . . 99.989999999999995 109.152 177.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 769' ' ' GLU . . . . . 0.433 ' HB2' HG23 ' A' ' 754' ' ' THR . 42.8 tt0 -131.94 135.25 46.46 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.005 -0.543 . . . . 99.989999999999995 111.054 -178.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 770' ' ' ILE . . . . . 0.403 HG21 HG22 ' A' ' 773' ' ' ILE . 3.8 mt -126.81 112.0 27.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 108.637 -0.875 . . . . 99.989999999999995 108.637 176.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 771' ' ' LYS . . . . . 0.584 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 11.3 mtpt -83.49 154.96 23.62 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-O 121.035 0.445 . . . . 99.989999999999995 110.897 -177.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 772' ' ' GLU . . . . . 0.406 ' O ' ' HG3' ' A' ' 774' ' ' LYS . 5.2 mt-10 53.58 48.45 21.65 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.674 -1.148 . . . . 99.989999999999995 111.932 177.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 773' ' ' ILE . . . . . 0.425 ' O ' HG13 ' A' ' 773' ' ' ILE . 0.5 OUTLIER -74.77 115.34 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 107.965 -1.124 . . . . 99.989999999999995 107.965 174.278 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 774' ' ' LYS . . . . . 0.406 ' HG3' ' O ' ' A' ' 772' ' ' GLU . 72.0 mttt -116.33 32.28 6.22 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 107.894 -1.15 . . . . 99.989999999999995 107.894 -178.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 775' ' ' THR . . . . . 0.467 HG22 ' HB2' ' A' ' 778' ' ' TYR . 0.2 OUTLIER -96.56 -72.37 0.64 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.212 -1.358 . . . . 99.989999999999995 112.522 -171.598 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 776' ' ' ASN . . . . . 0.45 ' H ' HD13 ' A' ' 745' ' ' LEU . 11.5 m120 79.36 5.35 2.15 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.035 0.934 . . . . 99.989999999999995 110.506 -176.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 777' ' ' GLU . . . . . 0.514 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 21.8 mt-10 -160.36 79.45 0.66 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.7 -1.136 . . . . 99.989999999999995 108.826 176.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 778' ' ' TYR . . . . . 0.531 ' HB3' HD11 ' A' ' 745' ' ' LEU . 91.4 t80 -132.61 130.72 40.59 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.904 -0.589 . . . . 99.989999999999995 109.964 -171.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 779' ' ' VAL . . . . . 0.682 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 2.0 m -95.73 126.16 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 CA-C-O 122.331 1.062 . . . . 99.989999999999995 110.575 176.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 780' ' ' ILE . . . . . 0.435 HG23 ' N ' ' A' ' 781' ' ' LYS . 79.6 mt -89.04 145.57 7.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 113.542 -1.663 . . . . 99.989999999999995 110.465 -174.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 781' ' ' LYS . . . . . 0.515 ' HA ' ' O ' ' A' ' 739' ' ' SER . 3.9 mppt? -118.07 111.91 19.53 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.389 -0.597 . . . . 99.989999999999995 109.389 177.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 782' ' ' THR . . . . . 0.483 ' O ' ' HB2' ' A' ' 738' ' ' HIS . 30.8 p -74.75 142.87 77.58 Favored Pre-proline 0 C--N 1.319 -0.727 0 N-CA-C 109.037 -0.727 . . . . 99.989999999999995 109.037 177.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 783' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_exo -52.03 161.52 2.39 Favored 'Trans proline' 0 N--CA 1.472 0.22 0 C-N-CA 123.681 2.921 . . . . 99.989999999999995 113.171 -177.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 784' ' ' VAL . . . . . 0.433 HG21 ' HB3' ' A' ' 738' ' ' HIS . 51.1 t -63.4 113.7 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 115.653 -0.703 . . . . 99.989999999999995 111.046 177.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 785' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -104.16 102.3 12.03 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.802 -0.635 . . . . 99.989999999999995 110.351 178.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 77.2 p -85.94 26.64 0.97 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.781 0.8 . . . . 99.989999999999995 111.058 -176.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 92.4 m -144.74 111.47 5.77 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.735 -1.12 . . . . 99.989999999999995 110.173 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 788' ' ' GLY . . . . . 0.424 ' HA2' HG12 ' A' ' 817' ' ' VAL . . . -49.65 121.4 9.11 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.971 -0.633 . . . . 99.989999999999995 113.201 171.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 789' ' ' GLY . . . . . 0.459 ' H ' ' HB ' ' A' ' 817' ' ' VAL . . . -175.19 173.94 46.51 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 110.041 -1.224 . . . . 99.989999999999995 110.041 178.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 790' ' ' ASP . . . . . 0.447 ' HB3' HG23 ' A' ' 760' ' ' THR . 13.2 t70 -100.19 133.98 43.79 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 117.819 0.809 . . . . 99.989999999999995 109.606 -179.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 791' ' ' TYR . . . . . 0.442 ' HA ' ' O ' ' A' ' 758' ' ' ILE . 68.1 m-85 -129.63 118.62 22.26 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.063 0.459 . . . . 99.989999999999995 110.702 -177.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 792' ' ' ILE . . . . . 0.514 HG12 ' HG2' ' A' ' 814' ' ' LYS . 17.8 mt -97.01 116.09 38.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 115.979 -0.555 . . . . 99.989999999999995 110.066 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 793' ' ' LEU . . . . . 0.452 HD13 HG13 ' A' ' 741' ' ' VAL . 10.1 tt -84.45 106.49 16.07 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 108.312 -0.995 . . . . 99.989999999999995 108.312 175.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 794' ' ' SER . . . . . . . . . . . . . 23.0 t -115.88 148.42 40.0 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.242 -0.89 . . . . 99.989999999999995 109.397 -177.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 795' ' ' LEU . . . . . . . . . . . . . 44.9 mt -82.39 134.23 35.24 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.829 0.347 . . . . 99.989999999999995 110.681 -176.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 796' ' ' VAL . . . . . . . . . . . . . 77.6 t -95.79 -55.9 5.69 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 CA-C-N 116.283 -0.417 . . . . 99.989999999999995 111.46 -177.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 797' ' ' SER . . . . . 0.52 ' HA ' ' HG ' ' A' ' 808' ' ' LEU . 92.0 p -177.74 162.61 1.77 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.118 -0.492 . . . . 99.989999999999995 110.373 -172.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 798' ' ' ILE . . . . . 0.652 ' HA ' ' O ' ' A' ' 752' ' ' THR . 9.4 tt -135.28 168.44 23.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 N-CA-C 109.599 -0.519 . . . . 99.989999999999995 109.599 178.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 799' ' ' LYS . . . . . 0.659 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 19.9 tttt -133.5 114.83 14.05 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.732 0.301 . . . . 99.989999999999995 111.274 -177.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 800' ' ' ASP . . . . . 0.54 ' HA ' ' CE2' ' A' ' 751' ' ' PHE . 1.6 m-20 -58.27 153.09 15.97 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.356 -0.838 . . . . 99.989999999999995 109.594 170.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 801' ' ' SER . . . . . 0.409 ' OG ' ' HD2' ' A' ' 750' ' ' PRO . 6.6 m -66.56 -4.72 9.2 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.828 -0.624 . . . . 99.989999999999995 112.141 -172.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 21.6 p -95.06 6.4 49.18 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.585 0.707 . . . . 99.989999999999995 109.889 175.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 803' ' ' GLY . . . . . 0.49 ' HA2' ' HE2' ' A' ' 799' ' ' LYS . . . 74.95 41.28 33.28 Favored Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 115.05 -0.977 . . . . 99.989999999999995 111.716 -178.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 804' ' ' CYS . . . . . . . . . . . . . 51.9 t -114.83 120.23 39.3 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.564 -0.532 . . . . 99.989999999999995 109.564 179.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 805' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 10.2 p -84.9 133.77 28.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 121.523 0.678 . . . . 99.989999999999995 110.684 -175.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 806' ' ' VAL . . . . . 0.494 HG11 ' HD2' ' A' ' 721' ' ' PRO . 24.8 t -117.03 135.45 57.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.15 -0.932 . . . . 99.989999999999995 109.995 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -74.91 122.59 7.07 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.274 -0.875 . . . . 99.989999999999995 111.865 -178.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 808' ' ' LEU . . . . . 0.524 ' CD2' ' HA ' ' A' ' 722' ' ' SER . 50.9 mt -89.11 127.56 35.72 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.059 0.456 . . . . 99.989999999999995 112.145 -177.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 20.1 m -144.27 85.58 1.8 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.834 -0.621 . . . . 99.989999999999995 109.882 172.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 810' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -145.82 170.85 7.26 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 115.534 -0.757 . . . . 99.989999999999995 109.251 177.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 811' ' ' PRO . . . . . . . . . . . . . 99.7 Cg_exo -42.98 139.84 3.37 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 123.204 2.603 . . . . 99.989999999999995 115.3 -170.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -103.38 167.35 9.87 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 114.475 -1.239 . . . . 99.989999999999995 110.207 178.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 813' ' ' ALA . . . . . 0.463 ' O ' ' HA ' ' A' ' 792' ' ' ILE . . . -116.58 150.15 38.49 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.851 -0.613 . . . . 99.989999999999995 110.381 178.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 814' ' ' LYS . . . . . 0.514 ' HG2' HG12 ' A' ' 792' ' ' ILE . 47.3 mttp -123.27 96.86 5.16 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 122.048 0.928 . . . . 99.989999999999995 111.106 176.161 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 815' ' ' ILE . . . . . 0.546 ' HA ' ' HB3' ' A' ' 731' ' ' LEU . 5.4 mp -87.71 110.82 21.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 CA-C-N 113.97 -1.468 . . . . 99.989999999999995 108.987 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 816' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -100.48 107.85 19.68 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.223 0.535 . . . . 99.989999999999995 110.226 -175.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 817' ' ' VAL . . . . . 0.459 ' HB ' ' H ' ' A' ' 789' ' ' GLY . 57.3 t -93.84 146.04 7.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.548 -0.751 . . . . 99.989999999999995 109.241 177.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 818' ' ' ARG . . . . . 0.431 ' N ' HG12 ' A' ' 817' ' ' VAL . 30.6 tpt180 . . . . . 0 C--N 1.317 -0.812 0 CA-C-O 121.09 0.471 . . . . 99.989999999999995 110.619 178.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 720' ' ' LYS . . . . . 0.482 ' HZ1' ' HB3' ' A' ' 720' ' ' LYS . 7.8 mtpm? . . . . . 0 N--CA 1.441 -0.91 0 N-CA-C 108.526 -0.916 . . . . 99.989999999999995 108.526 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 721' ' ' PRO . . . . . 0.485 ' HD2' HG22 ' A' ' 806' ' ' VAL . 57.4 Cg_endo -84.92 148.12 10.68 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 122.632 2.221 . . . . 99.989999999999995 111.268 -173.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 722' ' ' SER . . . . . 0.589 ' HA ' ' CD2' ' A' ' 808' ' ' LEU . 57.0 m -166.78 -161.83 0.47 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.26 -0.427 . . . . 99.989999999999995 109.857 -171.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 723' ' ' ALA . . . . . 0.55 ' HA ' ' HA ' ' A' ' 745' ' ' LEU . . . -149.03 140.56 23.39 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 120.797 -0.361 . . . . 99.989999999999995 110.336 173.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 19.0 m -126.7 104.96 8.36 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.163 -0.68 . . . . 99.989999999999995 109.163 -177.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 725' ' ' LEU . . . . . 0.541 ' CD2' ' HB ' ' A' ' 743' ' ' VAL . 14.8 mt -63.39 137.42 58.16 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-O 121.331 0.586 . . . . 99.989999999999995 110.839 -176.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 33.9 mtpt -89.76 -18.3 26.6 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 114.987 -1.006 . . . . 99.989999999999995 109.886 -175.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 727' ' ' LEU . . . . . . . . . . . . . 25.5 tp -68.15 109.59 3.61 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.722 -0.672 . . . . 99.989999999999995 109.248 175.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 11.6 t-80 -110.83 25.22 12.01 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.266 0.555 . . . . 99.989999999999995 111.534 -173.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 6.2 p80 -155.81 162.08 40.53 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.234 -0.439 . . . . 99.989999999999995 110.092 179.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 730' ' ' ASP . . . . . 0.529 ' OD1' ' HB2' ' A' ' 816' ' ' GLN . 16.5 t70 -72.25 131.41 42.69 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.807 0.813 . . . . 99.989999999999995 111.301 -176.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 731' ' ' LEU . . . . . 0.567 ' HB3' ' HA ' ' A' ' 815' ' ' ILE . 25.9 tp -87.17 110.13 19.94 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 114.114 -1.403 . . . . 99.989999999999995 110.671 -174.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 732' ' ' LYS . . . . . . . . . . . . . 26.5 mmmt -86.74 107.4 18.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.979 -0.555 . . . . 99.989999999999995 111.389 -172.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 733' ' ' LEU . . . . . 0.467 HD13 ' CG2' ' A' ' 815' ' ' ILE . 16.8 mt -119.32 163.92 16.45 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.848 0.356 . . . . 99.989999999999995 111.088 -179.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 734' ' ' CYS . . . . . 0.558 ' O ' ' HB2' ' A' ' 737' ' ' ASP . 15.5 t -116.97 -173.75 2.45 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.872 -0.788 . . . . 99.989999999999995 108.872 174.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 735' ' ' LEU . . . . . . . . . . . . . 18.6 tp -73.23 133.83 44.1 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.447 0.642 . . . . 99.989999999999995 111.724 -172.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 81.49 10.11 84.9 Favored Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 114.674 -1.148 . . . . 99.989999999999995 111.423 -178.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 737' ' ' ASP . . . . . 0.558 ' HB2' ' O ' ' A' ' 734' ' ' CYS . 0.9 OUTLIER -88.14 149.7 23.76 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.918 0.389 . . . . 99.989999999999995 111.315 175.99 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 25.6 p-80 -109.52 167.27 10.26 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.268 -1.382 . . . . 99.989999999999995 107.268 170.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 739' ' ' SER . . . . . 0.412 ' HB2' ' OG1' ' A' ' 782' ' ' THR . 0.3 OUTLIER -121.25 164.59 16.73 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 119.855 -0.738 . . . . 99.989999999999995 111.74 -173.206 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 62.8 m -143.35 128.15 18.28 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.126 -0.943 . . . . 99.989999999999995 108.941 178.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 741' ' ' VAL . . . . . 0.472 HG13 HD23 ' A' ' 793' ' ' LEU . 0.8 OUTLIER -138.06 114.85 9.24 Favored Pre-proline 0 C--N 1.312 -1.048 0 CA-C-O 121.337 0.589 . . . . 99.989999999999995 110.326 -177.866 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 742' ' ' PRO . . . . . 0.628 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 6.5 Cg_endo -76.66 136.35 17.05 Favored 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 122.389 2.059 . . . . 99.989999999999995 111.396 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 743' ' ' VAL . . . . . 0.541 ' HB ' ' CD2' ' A' ' 725' ' ' LEU . 1.6 p -131.64 119.44 42.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.253 0.549 . . . . 99.989999999999995 111.915 176.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 744' ' ' ALA . . . . . 0.408 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -84.0 111.65 19.48 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.165 -1.05 . . . . 99.989999999999995 108.165 168.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 745' ' ' LEU . . . . . 0.55 ' HA ' ' HA ' ' A' ' 723' ' ' ALA . 0.2 OUTLIER -94.11 154.78 17.42 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.645 -1.161 . . . . 99.989999999999995 110.9 -166.359 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -107.01 149.85 27.12 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.545 -0.752 . . . . 99.989999999999995 110.161 -178.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 747' ' ' GLY . . . . . 0.457 ' HA3' ' HB3' ' A' ' 721' ' ' PRO . . . 96.2 118.62 3.48 Favored Glycine 0 C--N 1.316 -0.559 0 N-CA-C 110.823 -0.911 . . . . 99.989999999999995 110.823 -174.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 27.4 mp0 -99.77 122.47 42.79 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.192 0.52 . . . . 99.989999999999995 112.115 -169.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 116.24 -170.75 13.46 Favored Glycine 0 C--O 1.218 -0.845 0 CA-C-N 114.991 -1.004 . . . . 99.989999999999995 111.439 -179.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 750' ' ' PRO . . . . . 0.439 ' HB3' ' HE2' ' A' ' 774' ' ' LYS . 88.8 Cg_endo -69.94 96.6 0.61 Allowed 'Trans proline' 0 CA--C 1.533 0.445 0 C-N-CA 123.506 2.804 . . . . 99.989999999999995 113.893 -178.291 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 751' ' ' PHE . . . . . 0.591 ' CD2' ' HA ' ' A' ' 800' ' ' ASP . 80.7 m-85 -115.19 148.14 39.44 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.104 -0.498 . . . . 99.989999999999995 111.176 178.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 752' ' ' THR . . . . . 0.728 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 98.2 m -90.56 104.16 16.77 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.231 0.538 . . . . 99.989999999999995 109.684 178.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 753' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.14 113.7 25.3 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.235 -0.893 . . . . 99.989999999999995 110.186 -170.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 754' ' ' THR . . . . . 0.517 HG23 ' HB2' ' A' ' 769' ' ' GLU . 1.6 m -109.89 134.42 52.09 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.746 -0.661 . . . . 99.989999999999995 110.455 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 755' ' ' TYR . . . . . 0.603 ' CE1' ' HB2' ' A' ' 768' ' ' PHE . 24.9 p90 -143.97 152.89 41.66 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.021 0.439 . . . . 99.989999999999995 112.133 179.194 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 756' ' ' ASP . . . . . 0.472 ' OD2' HG23 ' A' ' 758' ' ' ILE . 2.9 p30 -113.31 121.14 43.5 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 115.541 -0.754 . . . . 99.989999999999995 111.513 -178.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 757' ' ' ILE . . . . . 0.564 ' CD1' HD13 ' A' ' 793' ' ' LEU . 4.0 mp -93.89 96.16 5.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 107.3 -1.37 . . . . 99.989999999999995 107.3 165.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 758' ' ' ILE . . . . . 0.515 HG13 ' O ' ' A' ' 792' ' ' ILE . 2.2 pp -100.39 150.16 5.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.371 -0.831 . . . . 99.989999999999995 111.749 -170.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -92.96 115.85 28.51 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.502 -0.317 . . . . 99.989999999999995 110.764 -177.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 760' ' ' THR . . . . . 0.441 HG23 ' HB2' ' A' ' 790' ' ' ASP . 0.2 OUTLIER . . . . . 0 C--N 1.317 -0.824 0 CA-C-O 121.389 0.614 . . . . 99.989999999999995 109.781 178.169 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 765' ' ' ARG . . . . . 0.432 ' CG ' HG21 ' A' ' 758' ' ' ILE . 6.7 ttp180 . . . . . 0 N--CA 1.444 -0.749 0 CA-C-O 120.653 0.263 . . . . 99.989999999999995 110.506 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 766' ' ' LYS . . . . . 0.65 ' HD3' ' N ' ' A' ' 767' ' ' THR . 7.8 tmtm? -115.48 146.24 41.85 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 108.714 -0.847 . . . . 99.989999999999995 108.714 177.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 767' ' ' THR . . . . . 0.65 ' N ' ' HD3' ' A' ' 766' ' ' LYS . 90.7 m -132.49 135.83 46.27 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 116.512 -0.313 . . . . 99.989999999999995 111.42 -177.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 768' ' ' PHE . . . . . 0.603 ' HB2' ' CE1' ' A' ' 755' ' ' TYR . 20.8 m-85 -123.26 134.57 54.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 99.989999999999995 110.38 174.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 769' ' ' GLU . . . . . 0.517 ' HB2' HG23 ' A' ' 754' ' ' THR . 40.5 tt0 -126.9 104.83 8.24 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.07 -0.514 . . . . 99.989999999999995 110.591 177.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 770' ' ' ILE . . . . . 0.446 HD12 ' HH ' ' A' ' 755' ' ' TYR . 22.1 mt -105.22 117.55 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-N 116.192 -0.458 . . . . 99.989999999999995 110.422 -178.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 771' ' ' LYS . . . . . . . . . . . . . 17.7 mmtt -77.74 159.11 29.29 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.451 0.643 . . . . 99.989999999999995 111.006 -179.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 772' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 48.02 45.96 19.22 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 113.863 -1.517 . . . . 99.989999999999995 112.83 172.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 773' ' ' ILE . . . . . 0.475 HD11 HD12 ' A' ' 745' ' ' LEU . 0.5 OUTLIER -75.72 109.85 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 N-CA-C 107.149 -1.426 . . . . 99.989999999999995 107.149 172.149 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 774' ' ' LYS . . . . . 0.439 ' HE2' ' HB3' ' A' ' 750' ' ' PRO . 59.6 mttt -105.65 28.83 7.1 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.156 -1.053 . . . . 99.989999999999995 108.156 -177.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 775' ' ' THR . . . . . 0.465 ' O ' ' HB2' ' A' ' 776' ' ' ASN . 0.6 OUTLIER -95.32 -74.61 0.55 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.95 -1.023 . . . . 99.989999999999995 113.122 -166.726 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 776' ' ' ASN . . . . . 0.465 ' HB2' ' O ' ' A' ' 775' ' ' THR . 11.8 m120 84.48 1.86 0.83 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.76 1.224 . . . . 99.989999999999995 110.893 -176.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 777' ' ' GLU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 5.2 mp0 -156.05 83.17 1.0 Allowed 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.338 -0.986 . . . . 99.989999999999995 108.338 177.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 778' ' ' TYR . . . . . 0.483 ' HB3' HD11 ' A' ' 745' ' ' LEU . 67.1 t80 -125.97 127.68 46.31 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.516 -0.474 . . . . 99.989999999999995 111.582 -170.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 779' ' ' VAL . . . . . 0.628 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 15.5 t -88.55 108.6 18.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.285 0.564 . . . . 99.989999999999995 110.216 177.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 780' ' ' ILE . . . . . 0.474 HG23 ' N ' ' A' ' 781' ' ' LYS . 79.4 mt -76.41 143.56 12.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.293 -0.867 . . . . 99.989999999999995 110.63 -178.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 781' ' ' LYS . . . . . 0.474 ' N ' HG23 ' A' ' 780' ' ' ILE . 0.0 OUTLIER -122.73 106.6 11.08 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.237 -0.653 . . . . 99.989999999999995 109.237 175.656 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 782' ' ' THR . . . . . 0.412 ' OG1' ' HB2' ' A' ' 739' ' ' SER . 39.5 p -83.51 144.02 45.35 Favored Pre-proline 0 C--N 1.315 -0.9 0 CA-C-N 115.775 -0.648 . . . . 99.989999999999995 110.356 -177.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 783' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_exo -52.75 160.46 3.91 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 123.775 2.983 . . . . 99.989999999999995 112.798 -177.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 784' ' ' VAL . . . . . . . . . . . . . 14.9 p -66.34 135.2 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-N 115.888 -0.596 . . . . 99.989999999999995 110.495 -177.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 785' ' ' PHE . . . . . 0.406 ' C ' ' H ' ' A' ' 787' ' ' THR . 90.8 m-85 -102.54 99.43 9.44 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.561 0.696 . . . . 99.989999999999995 110.028 179.099 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 786' ' ' THR . . . . . 0.422 ' C ' ' HG1' ' A' ' 787' ' ' THR . 66.3 p -86.09 24.66 1.28 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.861 0.839 . . . . 99.989999999999995 110.295 -178.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 787' ' ' THR . . . . . 0.422 ' HG1' ' C ' ' A' ' 786' ' ' THR . 5.5 m -160.58 110.65 1.77 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.459 -1.246 . . . . 99.989999999999995 110.032 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 788' ' ' GLY . . . . . . . . . . . . . . . -49.91 147.73 6.88 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 121.241 -0.504 . . . . 99.989999999999995 113.718 173.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 789' ' ' GLY . . . . . . . . . . . . . . . 167.34 177.43 38.9 Favored Glycine 0 N--CA 1.443 -0.873 0 N-CA-C 110.215 -1.154 . . . . 99.989999999999995 110.215 -177.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 790' ' ' ASP . . . . . 0.441 ' HB2' HG23 ' A' ' 760' ' ' THR . 5.3 m-20 -109.03 128.8 55.28 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.97 -0.752 . . . . 99.989999999999995 108.97 -179.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 791' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -129.87 145.36 51.6 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.597 -0.52 . . . . 99.989999999999995 109.597 -177.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 792' ' ' ILE . . . . . 0.515 ' O ' HG13 ' A' ' 758' ' ' ILE . 20.3 mt -123.47 122.26 64.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 N-CA-C 109.641 -0.503 . . . . 99.989999999999995 109.641 177.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 793' ' ' LEU . . . . . 0.566 HD11 ' N ' ' A' ' 794' ' ' SER . 0.7 OUTLIER -89.42 115.21 26.69 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 108.823 -0.806 . . . . 99.989999999999995 108.823 176.859 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 794' ' ' SER . . . . . 0.566 ' N ' HD11 ' A' ' 793' ' ' LEU . 34.5 t -128.06 149.93 50.17 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.229 -0.896 . . . . 99.989999999999995 109.344 -176.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 795' ' ' LEU . . . . . 0.51 ' H ' HD22 ' A' ' 795' ' ' LEU . 1.3 mm? -78.85 130.35 35.57 Favored 'General case' 0 C--N 1.323 -0.579 0 O-C-N 122.158 -0.339 . . . . 99.989999999999995 111.383 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 796' ' ' VAL . . . . . . . . . . . . . 94.2 t -89.91 -56.77 4.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.05 0.452 . . . . 99.989999999999995 111.035 -177.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 797' ' ' SER . . . . . 0.625 ' HA ' ' HG ' ' A' ' 808' ' ' LEU . 30.0 m -171.83 160.75 5.67 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.436 -0.802 . . . . 99.989999999999995 109.657 -173.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 798' ' ' ILE . . . . . 0.609 ' HA ' ' O ' ' A' ' 752' ' ' THR . 11.7 tt -134.58 160.18 41.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 N-CA-C 108.322 -0.992 . . . . 99.989999999999995 108.322 176.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 799' ' ' LYS . . . . . 0.728 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 7.7 tmtt? -131.77 122.22 25.47 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.206 0.527 . . . . 99.989999999999995 110.595 179.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 800' ' ' ASP . . . . . 0.591 ' HA ' ' CD2' ' A' ' 751' ' ' PHE . 7.3 t70 -68.29 156.84 36.86 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.671 -1.149 . . . . 99.989999999999995 109.844 176.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 17.3 t -60.03 -14.22 15.34 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 124.093 0.87 . . . . 99.989999999999995 112.812 -172.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 802' ' ' THR . . . . . 0.482 HG21 ' OD2' ' A' ' 800' ' ' ASP . 13.9 t -90.33 -0.46 57.65 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.48 0.657 . . . . 99.989999999999995 109.733 176.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 803' ' ' GLY . . . . . . . . . . . . . . . 85.44 39.21 8.44 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.104 -0.953 . . . . 99.989999999999995 111.9 -178.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 804' ' ' CYS . . . . . . . . . . . . . 48.8 t -110.51 115.19 29.19 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.012 -0.366 . . . . 99.989999999999995 110.012 -178.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 805' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 7.6 p -86.34 134.24 27.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.215 0.531 . . . . 99.989999999999995 111.079 -176.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 806' ' ' VAL . . . . . 0.485 HG22 ' HD2' ' A' ' 721' ' ' PRO . 71.4 t -118.56 131.22 71.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.611 -0.722 . . . . 99.989999999999995 110.12 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -69.78 116.47 6.9 Favored Glycine 0 N--CA 1.453 -0.178 0 CA-C-N 115.6 -0.727 . . . . 99.989999999999995 111.907 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 808' ' ' LEU . . . . . 0.625 ' HG ' ' HA ' ' A' ' 797' ' ' SER . 32.2 mt -84.87 131.13 34.55 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.704 0.631 . . . . 99.989999999999995 112.704 -174.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 36.4 m -147.42 86.25 1.61 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.156 -0.929 . . . . 99.989999999999995 109.62 173.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 810' ' ' GLN . . . . . 0.518 ' HB3' ' HD2' ' A' ' 811' ' ' PRO . 89.1 mt-30 -139.18 169.53 12.2 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.43 -0.805 . . . . 99.989999999999995 109.261 177.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 811' ' ' PRO . . . . . 0.518 ' HD2' ' HB3' ' A' ' 810' ' ' GLN . 89.3 Cg_exo -45.68 135.84 12.91 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 122.847 2.364 . . . . 99.989999999999995 114.611 -175.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -107.13 167.36 9.96 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.729 -1.123 . . . . 99.989999999999995 110.343 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 813' ' ' ALA . . . . . 0.47 ' N ' HD12 ' A' ' 725' ' ' LEU . . . -119.67 152.79 36.56 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.159 -0.473 . . . . 99.989999999999995 110.404 -178.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 814' ' ' LYS . . . . . . . . . . . . . 16.9 ttpp -118.23 126.45 52.21 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 121.341 0.591 . . . . 99.989999999999995 110.562 178.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 815' ' ' ILE . . . . . 0.567 ' HA ' ' HB3' ' A' ' 731' ' ' LEU . 5.2 mp -112.71 119.28 60.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 114.946 -1.025 . . . . 99.989999999999995 109.08 178.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 816' ' ' GLN . . . . . 0.563 HE22 ' HG2' ' A' ' 818' ' ' ARG . 0.0 OUTLIER -107.32 115.04 29.46 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.829 -0.434 . . . . 99.989999999999995 109.829 179.68 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 817' ' ' VAL . . . . . 0.427 ' HA ' ' HB2' ' A' ' 733' ' ' LEU . 3.9 t -106.43 145.71 13.86 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 N-CA-C 109.203 -0.666 . . . . 99.989999999999995 109.203 177.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 818' ' ' ARG . . . . . 0.563 ' HG2' HE22 ' A' ' 816' ' ' GLN . 20.9 mmt85 . . . . . 0 C--N 1.319 -0.723 0 C-N-CA 120.524 -0.47 . . . . 99.989999999999995 111.621 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 720' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp . . . . . 0 N--CA 1.45 -0.456 0 N-CA-C 109.107 -0.701 . . . . 99.989999999999995 109.107 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 721' ' ' PRO . . . . . 0.528 ' HD2' HG11 ' A' ' 806' ' ' VAL . 95.3 Cg_endo -86.03 148.7 9.37 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 122.869 2.379 . . . . 99.989999999999995 112.35 -172.365 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 722' ' ' SER . . . . . 0.464 ' HB3' ' NE2' ' A' ' 810' ' ' GLN . 22.6 t -179.22 -154.05 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.774 -0.648 . . . . 99.989999999999995 109.362 -174.207 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 723' ' ' ALA . . . . . 0.465 ' HA ' ' HA ' ' A' ' 745' ' ' LEU . . . -144.77 144.82 31.37 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.892 -0.41 . . . . 99.989999999999995 109.892 176.148 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 7.8 m -128.97 98.96 5.1 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.801 -0.814 . . . . 99.989999999999995 108.801 -175.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 725' ' ' LEU . . . . . 0.625 HD21 ' CG2' ' A' ' 743' ' ' VAL . 1.7 mt -63.74 145.32 55.98 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-O 121.216 0.531 . . . . 99.989999999999995 110.96 -171.33 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 31.2 mtpt -101.23 -14.56 17.64 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.463 -0.789 . . . . 99.989999999999995 110.358 -177.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 727' ' ' LEU . . . . . 0.455 HD22 ' O ' ' A' ' 729' ' ' HIS . 0.6 OUTLIER -74.17 123.31 24.23 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.598 -0.89 . . . . 99.989999999999995 108.598 177.132 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 61.3 m-70 -87.7 -38.0 16.21 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.68 0.622 . . . . 99.989999999999995 112.68 -171.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 729' ' ' HIS . . . . . 0.455 ' O ' HD22 ' A' ' 727' ' ' LEU . 3.1 p80 -126.61 -176.63 3.74 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.715 -0.394 . . . . 99.989999999999995 111.991 -172.113 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 730' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -61.52 145.5 51.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.711 0.767 . . . . 99.989999999999995 111.427 178.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 731' ' ' LEU . . . . . 0.519 ' HB3' ' HA ' ' A' ' 815' ' ' ILE . 16.2 tp -105.37 108.62 20.23 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.86 -1.064 . . . . 99.989999999999995 110.927 -177.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 732' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -76.93 122.1 24.38 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.032 -0.531 . . . . 99.989999999999995 111.9 -175.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 733' ' ' LEU . . . . . 0.43 HD12 ' CB ' ' A' ' 739' ' ' SER . 85.3 mt -132.71 164.09 27.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.072 -0.513 . . . . 99.989999999999995 110.773 176.22 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 734' ' ' CYS . . . . . 0.541 ' O ' ' HB2' ' A' ' 737' ' ' ASP . 26.8 p -115.93 -174.06 2.47 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.087 -0.708 . . . . 99.989999999999995 109.087 172.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 735' ' ' LEU . . . . . . . . . . . . . 6.1 tp -66.61 135.48 54.17 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.778 0.799 . . . . 99.989999999999995 112.322 -175.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 81.97 4.72 90.19 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 114.357 -1.292 . . . . 99.989999999999995 111.767 178.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 737' ' ' ASP . . . . . 0.541 ' HB2' ' O ' ' A' ' 734' ' ' CYS . 6.8 m-20 -82.15 150.54 27.38 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.329 0.585 . . . . 99.989999999999995 112.422 -179.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 738' ' ' HIS . . . . . 0.484 ' HB2' ' O ' ' A' ' 782' ' ' THR . 42.6 p-80 -113.39 160.32 18.53 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 107.008 -1.478 . . . . 99.989999999999995 107.008 169.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 739' ' ' SER . . . . . 0.466 ' HB2' ' CD2' ' A' ' 731' ' ' LEU . 1.5 p -117.25 170.03 9.01 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 119.556 -0.857 . . . . 99.989999999999995 111.827 -172.05 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 740' ' ' SER . . . . . 0.474 ' HA ' ' O ' ' A' ' 780' ' ' ILE . 50.5 m -143.08 101.52 3.84 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.408 -0.814 . . . . 99.989999999999995 110.146 177.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 741' ' ' VAL . . . . . 0.438 HG13 HD13 ' A' ' 793' ' ' LEU . 1.2 p -108.74 109.46 61.22 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 115.462 -0.79 . . . . 99.989999999999995 109.546 178.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 742' ' ' PRO . . . . . 0.7 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 5.9 Cg_exo -72.41 128.89 14.13 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 122.252 1.968 . . . . 99.989999999999995 111.51 -177.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 743' ' ' VAL . . . . . 0.625 ' CG2' HD21 ' A' ' 725' ' ' LEU . 43.5 t -130.41 119.2 45.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 112.612 0.597 . . . . 99.989999999999995 112.612 -178.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 744' ' ' ALA . . . . . 0.557 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -84.27 117.97 23.89 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.95 -0.759 . . . . 99.989999999999995 108.95 170.296 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 745' ' ' LEU . . . . . 0.557 HD12 ' HB3' ' A' ' 778' ' ' TYR . 0.4 OUTLIER -95.45 150.67 20.04 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.875 -0.602 . . . . 99.989999999999995 111.931 -165.222 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -105.92 146.76 29.57 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.255 -0.884 . . . . 99.989999999999995 110.483 -177.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 747' ' ' GLY . . . . . . . . . . . . . . . 110.27 135.29 6.99 Favored Glycine 0 C--N 1.311 -0.842 0 N-CA-C 110.972 -0.851 . . . . 99.989999999999995 110.972 -173.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -114.16 106.33 14.25 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 117.053 0.426 . . . . 99.989999999999995 111.37 -171.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 129.17 -175.48 18.85 Favored Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 111.35 -0.7 . . . . 99.989999999999995 111.35 -178.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -68.01 93.46 0.39 Allowed 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.506 2.137 . . . . 99.989999999999995 112.119 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 751' ' ' PHE . . . . . 0.491 ' CE2' ' HA ' ' A' ' 800' ' ' ASP . 57.7 m-85 -109.66 140.42 43.53 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.805 -0.634 . . . . 99.989999999999995 111.119 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 752' ' ' THR . . . . . 0.721 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 53.8 m -90.24 102.73 15.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.358 0.599 . . . . 99.989999999999995 109.837 176.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 753' ' ' LEU . . . . . 0.41 HD22 ' N ' ' A' ' 754' ' ' THR . 0.4 OUTLIER -94.06 123.09 37.21 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.184 -0.916 . . . . 99.989999999999995 110.662 -169.695 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 754' ' ' THR . . . . . 0.41 ' N ' HD22 ' A' ' 753' ' ' LEU . 0.8 OUTLIER -119.49 139.88 51.37 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.221 -0.445 . . . . 99.989999999999995 111.281 -177.878 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 755' ' ' TYR . . . . . 0.609 ' CE1' ' HB3' ' A' ' 768' ' ' PHE . 23.8 p90 -146.41 155.82 42.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.938 0.399 . . . . 99.989999999999995 111.528 177.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 756' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -113.54 120.27 40.4 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.559 -0.746 . . . . 99.989999999999995 110.317 -178.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 757' ' ' ILE . . . . . 0.469 HG12 HG22 ' A' ' 782' ' ' THR . 4.2 mp -89.14 95.41 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 N-CA-C 107.754 -1.202 . . . . 99.989999999999995 107.754 169.358 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 758' ' ' ILE . . . . . 0.525 HG13 ' O ' ' A' ' 792' ' ' ILE . 1.6 pp -101.19 148.2 7.41 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 115.775 -0.648 . . . . 99.989999999999995 110.56 -174.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 759' ' ' GLU . . . . . 0.783 ' HB3' ' CE2' ' A' ' 791' ' ' TYR . 7.0 pt-20 -106.17 122.15 45.62 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 119.741 -0.784 . . . . 99.989999999999995 110.075 173.021 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 760' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.311 -1.069 0 CA-C-N 114.683 -1.144 . . . . 99.989999999999995 108.618 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 765' ' ' ARG . . . . . 0.459 ' HG3' HG21 ' A' ' 758' ' ' ILE . 23.0 ttp180 . . . . . 0 N--CA 1.446 -0.65 0 CA-C-O 120.879 0.371 . . . . 99.989999999999995 111.045 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 766' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -126.54 140.82 52.15 Favored 'General case' 0 C--O 1.215 -0.738 0 CA-C-N 115.891 -0.595 . . . . 99.989999999999995 109.847 -178.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 767' ' ' THR . . . . . . . . . . . . . 43.0 m -112.06 129.78 56.1 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 116.526 -0.307 . . . . 99.989999999999995 110.498 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 768' ' ' PHE . . . . . 0.609 ' HB3' ' CE1' ' A' ' 755' ' ' TYR . 2.5 t80 -126.1 135.83 52.19 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 108.753 -0.832 . . . . 99.989999999999995 108.753 178.334 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 769' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -132.42 127.98 36.53 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 116.171 -0.468 . . . . 99.989999999999995 110.933 -175.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 770' ' ' ILE . . . . . 0.455 HG21 HG22 ' A' ' 773' ' ' ILE . 4.6 mt -121.52 114.14 41.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.099 -0.704 . . . . 99.989999999999995 109.099 177.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 771' ' ' LYS . . . . . 0.547 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 0.1 OUTLIER -87.46 153.88 21.08 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 121.256 0.55 . . . . 99.989999999999995 111.842 -174.643 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 772' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 52.35 47.93 23.69 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.363 -1.29 . . . . 99.989999999999995 112.009 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 773' ' ' ILE . . . . . 0.455 ' O ' HG13 ' A' ' 773' ' ' ILE . 0.5 OUTLIER -75.17 114.79 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 N-CA-C 107.906 -1.146 . . . . 99.989999999999995 107.906 174.771 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 72.1 mttt -114.3 30.95 6.93 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 107.433 -1.321 . . . . 99.989999999999995 107.433 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 775' ' ' THR . . . . . 0.466 ' O ' ' HB2' ' A' ' 776' ' ' ASN . 2.5 m -97.01 -71.82 0.66 Allowed 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 113.488 -1.687 . . . . 99.989999999999995 112.415 -169.128 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 776' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 775' ' ' THR . 11.5 m120 83.17 7.99 0.69 Allowed 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.198 0.999 . . . . 99.989999999999995 110.138 -177.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 777' ' ' GLU . . . . . 0.557 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 22.5 tt0 -161.55 94.39 0.96 Allowed 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.004 -0.998 . . . . 99.989999999999995 109.725 175.445 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 778' ' ' TYR . . . . . 0.557 ' HB3' HD12 ' A' ' 745' ' ' LEU . 67.9 t80 -141.91 120.52 12.53 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.259 -0.882 . . . . 99.989999999999995 110.553 -172.113 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 779' ' ' VAL . . . . . 0.7 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 1.4 m -88.07 129.38 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 CA-C-O 122.035 0.921 . . . . 99.989999999999995 109.733 179.383 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 780' ' ' ILE . . . . . 0.474 ' O ' ' HA ' ' A' ' 740' ' ' SER . 89.7 mt -91.23 138.3 19.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 113.959 -1.473 . . . . 99.989999999999995 110.971 -172.301 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 781' ' ' LYS . . . . . 0.465 ' HD3' ' N ' ' A' ' 781' ' ' LYS . 0.0 OUTLIER -115.86 106.73 14.15 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.397 -0.594 . . . . 99.989999999999995 109.397 179.33 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 782' ' ' THR . . . . . 0.484 ' O ' ' HB2' ' A' ' 738' ' ' HIS . 32.5 p -78.22 143.26 64.72 Favored Pre-proline 0 C--N 1.32 -0.706 0 CA-C-N 116.296 -0.411 . . . . 99.989999999999995 110.102 -178.124 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 783' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 782' ' ' THR . 50.2 Cg_exo -55.79 161.65 7.86 Favored 'Trans proline' 0 CA--C 1.529 0.252 0 C-N-CA 123.513 2.809 . . . . 99.989999999999995 113.109 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 784' ' ' VAL . . . . . 0.52 HG12 HG21 ' A' ' 786' ' ' THR . 55.3 t -59.02 121.71 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-N 115.185 -0.916 . . . . 99.989999999999995 112.312 -177.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 785' ' ' PHE . . . . . 0.417 ' C ' ' H ' ' A' ' 787' ' ' THR . 31.0 m-85 -97.52 98.22 9.74 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.34 -0.845 . . . . 99.989999999999995 109.906 177.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 786' ' ' THR . . . . . 0.52 HG21 HG12 ' A' ' 784' ' ' VAL . 35.3 p -87.28 33.7 0.69 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 122.051 0.929 . . . . 99.989999999999995 110.092 178.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 787' ' ' THR . . . . . 0.417 ' H ' ' C ' ' A' ' 785' ' ' PHE . 28.7 m -153.52 104.98 2.78 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.38 -1.282 . . . . 99.989999999999995 110.223 -179.111 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 788' ' ' GLY . . . . . . . . . . . . . . . -49.59 113.37 1.76 Allowed Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.501 -0.857 . . . . 99.989999999999995 112.277 168.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 789' ' ' GLY . . . . . . . . . . . . . . . -160.49 -166.07 18.56 Favored Glycine 0 N--CA 1.441 -0.97 0 N-CA-C 110.332 -1.107 . . . . 99.989999999999995 110.332 -179.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -123.62 122.74 38.91 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 117.621 0.711 . . . . 99.989999999999995 109.319 -178.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 791' ' ' TYR . . . . . 0.783 ' CE2' ' HB3' ' A' ' 759' ' ' GLU . 88.8 m-85 -117.44 150.86 38.2 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.413 0.625 . . . . 99.989999999999995 111.407 -177.017 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 792' ' ' ILE . . . . . 0.525 ' O ' HG13 ' A' ' 758' ' ' ILE . 17.0 mt -131.53 113.04 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 CA-C-N 114.923 -1.035 . . . . 99.989999999999995 109.338 175.115 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 793' ' ' LEU . . . . . 0.438 HD13 HG13 ' A' ' 741' ' ' VAL . 7.9 tt -85.03 110.26 18.79 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 108.929 -0.767 . . . . 99.989999999999995 108.929 178.156 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 794' ' ' SER . . . . . . . . . . . . . 13.6 t -123.45 142.2 51.23 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.17 -0.468 . . . . 99.989999999999995 109.968 -177.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 795' ' ' LEU . . . . . 0.492 ' H ' HD22 ' A' ' 795' ' ' LEU . 1.2 mm? -67.91 140.22 56.47 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 120.904 0.383 . . . . 99.989999999999995 111.454 -178.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 796' ' ' VAL . . . . . . . . . . . . . 69.7 t -99.82 -55.28 6.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.141 -0.481 . . . . 99.989999999999995 111.015 -178.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 797' ' ' SER . . . . . 0.498 ' C ' HD13 ' A' ' 808' ' ' LEU . 89.5 p -173.66 176.94 2.62 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 115.917 -0.583 . . . . 99.989999999999995 110.345 -173.018 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 798' ' ' ILE . . . . . 0.617 ' HA ' ' O ' ' A' ' 752' ' ' THR . 11.0 tt -151.22 161.43 3.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 N-CA-C 108.635 -0.876 . . . . 99.989999999999995 108.635 179.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 799' ' ' LYS . . . . . 0.721 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 5.2 tttt -132.24 113.89 13.79 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 120.836 0.35 . . . . 99.989999999999995 110.521 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 800' ' ' ASP . . . . . 0.527 ' HB3' ' HB3' ' A' ' 804' ' ' CYS . 16.9 t70 -57.91 152.27 16.47 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.089 -0.959 . . . . 99.989999999999995 109.263 171.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 3.4 p -65.59 -7.51 15.3 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.637 0.606 . . . . 99.989999999999995 112.637 -171.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 35.5 p -93.6 1.7 56.59 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.659 0.743 . . . . 99.989999999999995 110.04 176.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 803' ' ' GLY . . . . . 0.482 ' HA2' ' HE2' ' A' ' 799' ' ' LYS . . . 82.76 44.73 7.09 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 115.05 -0.977 . . . . 99.989999999999995 111.873 -177.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 804' ' ' CYS . . . . . 0.527 ' HB3' ' HB3' ' A' ' 800' ' ' ASP . 45.1 t -111.68 106.93 15.87 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.285 -0.635 . . . . 99.989999999999995 109.285 177.039 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 805' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 3.9 t -86.06 119.32 34.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.38 0.609 . . . . 99.989999999999995 110.08 -176.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 806' ' ' VAL . . . . . 0.528 HG11 ' HD2' ' A' ' 721' ' ' PRO . 37.3 t -108.01 139.17 31.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 115.073 -0.967 . . . . 99.989999999999995 110.498 -176.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -80.06 110.3 3.07 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.662 -0.699 . . . . 99.989999999999995 112.557 -179.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 808' ' ' LEU . . . . . 0.498 HD13 ' C ' ' A' ' 797' ' ' SER . 10.8 mp -77.61 134.19 38.26 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 113.196 0.813 . . . . 99.989999999999995 113.196 177.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 19.9 m -149.5 85.76 1.45 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.166 -0.924 . . . . 99.989999999999995 109.175 169.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 810' ' ' GLN . . . . . 0.464 ' NE2' ' HB3' ' A' ' 722' ' ' SER . 4.6 mt-30 -132.26 170.8 10.41 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 115.895 -0.593 . . . . 99.989999999999995 110.009 177.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 811' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -45.3 144.08 4.78 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 123.038 2.492 . . . . 99.989999999999995 114.588 -176.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -111.15 166.21 11.26 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.984 -1.007 . . . . 99.989999999999995 110.656 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 813' ' ' ALA . . . . . 0.411 ' O ' ' HA ' ' A' ' 792' ' ' ILE . . . -117.87 147.57 42.96 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.698 -0.683 . . . . 99.989999999999995 110.257 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 814' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -108.8 125.44 51.96 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.513 0.673 . . . . 99.989999999999995 110.92 178.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 815' ' ' ILE . . . . . 0.519 ' HA ' ' HB3' ' A' ' 731' ' ' LEU . 5.1 mp -110.81 109.06 27.09 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-N 114.818 -1.083 . . . . 99.989999999999995 108.651 177.169 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 816' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -99.4 109.27 21.88 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.184 0.516 . . . . 99.989999999999995 110.15 -175.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 817' ' ' VAL . . . . . . . . . . . . . 2.6 t -105.71 146.18 12.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.743 -0.662 . . . . 99.989999999999995 109.356 -177.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 818' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 . . . . . 0 C--N 1.324 -0.525 0 CA-C-O 121.245 0.545 . . . . 99.989999999999995 111.887 -179.11 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 720' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt . . . . . 0 N--CA 1.447 -0.599 0 N-CA-C 109.22 -0.659 . . . . 99.989999999999995 109.22 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 721' ' ' PRO . . . . . 0.412 ' O ' HG23 ' A' ' 798' ' ' ILE . 37.6 Cg_endo -83.1 145.36 12.27 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 C-N-CA 122.424 2.083 . . . . 99.989999999999995 111.436 -175.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 722' ' ' SER . . . . . 0.489 ' HG ' HD21 ' A' ' 808' ' ' LEU . 25.6 t 177.42 -153.08 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 110.034 -0.358 . . . . 99.989999999999995 110.034 -171.362 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 723' ' ' ALA . . . . . 0.554 ' HA ' ' HA ' ' A' ' 745' ' ' LEU . . . -150.21 143.48 25.02 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.577 -0.283 . . . . 99.989999999999995 110.482 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 23.1 t -129.95 103.84 7.02 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.46 -0.57 . . . . 99.989999999999995 109.46 178.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 725' ' ' LEU . . . . . 0.455 ' CD2' ' HB ' ' A' ' 743' ' ' VAL . 13.2 mt -64.35 149.26 48.61 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 121.616 0.722 . . . . 99.989999999999995 111.839 -175.264 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 726' ' ' LYS . . . . . 0.444 ' HD2' ' HB1' ' A' ' 744' ' ' ALA . 20.2 mtpp -106.8 -10.09 16.18 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.714 -1.13 . . . . 99.989999999999995 110.46 -175.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 727' ' ' LEU . . . . . 0.451 ' HB2' ' HD2' ' A' ' 742' ' ' PRO . 0.3 OUTLIER -81.31 111.22 17.49 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.189 -1.041 . . . . 99.989999999999995 108.189 176.364 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 40.9 m80 -103.68 37.37 2.05 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.774 0.657 . . . . 99.989999999999995 112.774 -168.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 9.7 p80 -174.08 -177.05 1.25 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.662 0.268 . . . . 99.989999999999995 110.776 177.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 730' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -81.04 139.65 35.6 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.068 -0.514 . . . . 99.989999999999995 110.297 177.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 731' ' ' LEU . . . . . 0.554 ' HB2' ' HA ' ' A' ' 815' ' ' ILE . 36.4 mt -87.61 117.06 26.16 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.524 -0.762 . . . . 99.989999999999995 111.263 -178.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 732' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -84.09 113.01 20.73 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.276 -0.42 . . . . 99.989999999999995 110.333 -178.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 733' ' ' LEU . . . . . . . . . . . . . 43.5 mt -131.67 159.6 37.86 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 121.267 0.556 . . . . 99.989999999999995 111.9 -175.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 734' ' ' CYS . . . . . 0.616 ' HA ' ' O ' ' A' ' 818' ' ' ARG . 78.4 m -104.12 -173.75 2.38 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.148 -0.933 . . . . 99.989999999999995 110.131 176.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 735' ' ' LEU . . . . . . . . . . . . . 19.9 tp -73.79 134.71 43.44 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.174 0.511 . . . . 99.989999999999995 111.342 -178.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 74.72 11.56 83.16 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.439 -0.886 . . . . 99.989999999999995 111.285 -176.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 737' ' ' ASP . . . . . 0.588 ' HB2' ' O ' ' A' ' 734' ' ' CYS . 0.2 OUTLIER -84.77 150.11 25.29 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.119 0.485 . . . . 99.989999999999995 111.231 176.55 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 27.9 p-80 -114.25 175.27 5.55 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 107.417 -1.327 . . . . 99.989999999999995 107.417 168.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 739' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.0 166.66 24.04 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 120.083 -0.647 . . . . 99.989999999999995 111.999 -178.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 19.7 m -136.75 112.97 9.82 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.322 -0.854 . . . . 99.989999999999995 109.6 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 741' ' ' VAL . . . . . 0.483 HG13 HD23 ' A' ' 793' ' ' LEU . 0.9 OUTLIER -111.05 112.95 55.1 Favored Pre-proline 0 C--N 1.318 -0.799 0 CA-C-N 115.578 -0.737 . . . . 99.989999999999995 109.746 -179.621 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 742' ' ' PRO . . . . . 0.646 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 1.6 Cg_endo -73.43 134.97 21.52 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 122.517 2.145 . . . . 99.989999999999995 111.284 -179.306 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 743' ' ' VAL . . . . . 0.553 HG23 ' HB1' ' A' ' 723' ' ' ALA . 2.0 p -131.91 116.44 30.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.376 0.608 . . . . 99.989999999999995 112.032 176.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 744' ' ' ALA . . . . . 0.552 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -81.22 98.99 8.34 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 108.358 -0.979 . . . . 99.989999999999995 108.358 169.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 745' ' ' LEU . . . . . 0.554 ' HA ' ' HA ' ' A' ' 723' ' ' ALA . 0.3 OUTLIER -79.36 165.33 23.24 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.309 -1.314 . . . . 99.989999999999995 111.675 -167.385 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 17.3 ttmm -114.44 165.33 12.84 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.533 -0.758 . . . . 99.989999999999995 109.679 -179.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 747' ' ' GLY . . . . . . . . . . . . . . . 94.45 128.45 5.25 Favored Glycine 0 C--N 1.31 -0.863 0 N-CA-C 111.235 -0.746 . . . . 99.989999999999995 111.235 -175.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 748' ' ' GLN . . . . . 0.523 ' C ' ' HE1' ' A' ' 751' ' ' PHE . 48.3 mm-40 -110.85 98.62 7.71 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.749 -0.38 . . . . 99.989999999999995 111.061 -173.285 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 133.91 -159.23 23.66 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.716 -0.754 . . . . 99.989999999999995 111.549 -177.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -78.88 94.99 1.06 Allowed 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 122.944 2.43 . . . . 99.989999999999995 112.516 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 751' ' ' PHE . . . . . 0.689 ' CE2' ' HA ' ' A' ' 800' ' ' ASP . 94.6 m-85 -118.41 140.66 49.51 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.771 -0.65 . . . . 99.989999999999995 110.799 -178.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 752' ' ' THR . . . . . 0.665 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 92.3 m -95.31 106.7 18.77 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.623 0.725 . . . . 99.989999999999995 109.536 179.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 753' ' ' LEU . . . . . 0.411 HD22 ' N ' ' A' ' 754' ' ' THR . 0.4 OUTLIER -97.19 117.78 32.17 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.538 -1.21 . . . . 99.989999999999995 109.783 -170.354 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 754' ' ' THR . . . . . 0.531 HG23 ' HB2' ' A' ' 769' ' ' GLU . 1.2 m -116.71 137.04 52.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.567 -0.288 . . . . 99.989999999999995 110.897 -177.074 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 755' ' ' TYR . . . . . 0.671 ' CE1' ' HB2' ' A' ' 768' ' ' PHE . 24.3 p90 -144.64 155.38 43.58 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.465 0.543 . . . . 99.989999999999995 112.465 -179.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 756' ' ' ASP . . . . . 0.543 ' OD2' HG23 ' A' ' 758' ' ' ILE . 4.9 p-10 -116.94 119.94 36.88 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.658 -0.701 . . . . 99.989999999999995 111.551 -177.295 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 757' ' ' ILE . . . . . 0.58 ' CD1' HD13 ' A' ' 793' ' ' LEU . 4.0 mp -91.87 96.49 6.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 N-CA-C 107.563 -1.273 . . . . 99.989999999999995 107.563 167.376 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 758' ' ' ILE . . . . . 0.591 HG13 ' O ' ' A' ' 792' ' ' ILE . 2.4 pp -100.57 149.56 6.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.683 -0.689 . . . . 99.989999999999995 112.25 -170.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 759' ' ' GLU . . . . . 0.49 ' HG2' ' CE2' ' A' ' 791' ' ' TYR . 12.5 mt-10 -86.38 118.59 25.92 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 120.921 0.391 . . . . 99.989999999999995 111.13 -179.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 760' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.315 -0.9 0 CA-C-O 121.56 0.695 . . . . 99.989999999999995 109.533 174.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 765' ' ' ARG . . . . . 0.58 ' HD2' ' CG2' ' A' ' 758' ' ' ILE . 12.0 ttt180 . . . . . 0 N--CA 1.44 -0.948 0 N-CA-C 109.875 -0.417 . . . . 99.989999999999995 109.875 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 766' ' ' LYS . . . . . 0.609 ' HD3' ' N ' ' A' ' 767' ' ' THR . 2.0 tmtp? -120.48 146.32 46.38 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.723 -0.843 . . . . 99.989999999999995 108.723 178.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 767' ' ' THR . . . . . 0.609 ' N ' ' HD3' ' A' ' 766' ' ' LYS . 96.6 m -131.74 132.36 43.78 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 120.962 0.411 . . . . 99.989999999999995 111.751 -176.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 768' ' ' PHE . . . . . 0.671 ' HB2' ' CE1' ' A' ' 755' ' ' TYR . 42.9 m-85 -120.07 141.21 49.98 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.023 -0.535 . . . . 99.989999999999995 110.214 174.105 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 769' ' ' GLU . . . . . 0.531 ' HB2' HG23 ' A' ' 754' ' ' THR . 46.0 tt0 -131.27 109.37 10.34 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.931 -0.577 . . . . 99.989999999999995 110.383 178.073 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 21.2 mt -105.97 120.37 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 N-CA-C 109.395 -0.595 . . . . 99.989999999999995 109.395 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 771' ' ' LYS . . . . . 0.572 ' HD2' ' N ' ' A' ' 771' ' ' LYS . 0.1 OUTLIER -85.55 164.62 17.67 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.067 0.46 . . . . 99.989999999999995 111.144 -175.192 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 772' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 36.36 50.44 0.75 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 113.853 -1.521 . . . . 99.989999999999995 112.64 177.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 773' ' ' ILE . . . . . 0.435 ' O ' HG13 ' A' ' 773' ' ' ILE . 0.5 OUTLIER -76.71 111.98 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 N-CA-C 107.977 -1.12 . . . . 99.989999999999995 107.977 175.67 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 75.7 mttt -113.04 33.62 4.95 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 107.521 -1.289 . . . . 99.989999999999995 107.521 -179.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 775' ' ' THR . . . . . 0.433 ' H ' HD12 ' A' ' 773' ' ' ILE . 1.2 m -95.12 -71.64 0.66 Allowed 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 113.836 -1.529 . . . . 99.989999999999995 111.769 -169.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 776' ' ' ASN . . . . . 0.432 ' HB2' ' O ' ' A' ' 775' ' ' THR . 11.5 m120 81.92 4.11 1.28 Allowed 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.129 0.971 . . . . 99.989999999999995 110.79 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 777' ' ' GLU . . . . . 0.552 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 18.4 mt-10 -160.2 84.66 0.72 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.106 -0.952 . . . . 99.989999999999995 109.197 176.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 778' ' ' TYR . . . . . 0.494 ' HB3' HD11 ' A' ' 745' ' ' LEU . 79.4 t80 -128.89 129.08 45.05 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.843 0.354 . . . . 99.989999999999995 110.863 -172.439 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 779' ' ' VAL . . . . . 0.646 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 21.1 t -87.95 112.81 24.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 121.281 0.562 . . . . 99.989999999999995 110.515 178.015 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 780' ' ' ILE . . . . . . . . . . . . . 74.0 mt -80.2 141.48 15.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.271 -0.877 . . . . 99.989999999999995 110.603 -178.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -114.93 107.85 15.94 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.562 -0.533 . . . . 99.989999999999995 109.562 177.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 782' ' ' THR . . . . . . . . . . . . . 68.7 p -78.15 135.33 62.37 Favored Pre-proline 0 N--CA 1.441 -0.895 0 N-CA-C 109.344 -0.613 . . . . 99.989999999999995 109.344 178.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 783' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -57.05 158.32 18.0 Favored 'Trans proline' 0 CA--C 1.518 -0.278 0 C-N-CA 123.523 2.815 . . . . 99.989999999999995 112.401 -173.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 784' ' ' VAL . . . . . . . . . . . . . 12.8 p -60.47 136.43 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 115.854 -0.612 . . . . 99.989999999999995 110.697 -177.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 785' ' ' PHE . . . . . 0.429 ' C ' ' H ' ' A' ' 787' ' ' THR . 45.1 m-85 -110.08 97.15 6.7 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.816 -0.629 . . . . 99.989999999999995 109.617 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 82.1 p -83.77 25.16 0.81 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.725 0.774 . . . . 99.989999999999995 110.822 -176.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 787' ' ' THR . . . . . 0.429 ' H ' ' C ' ' A' ' 785' ' ' PHE . 36.7 m -156.47 120.97 4.51 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.007 -0.997 . . . . 99.989999999999995 110.446 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 788' ' ' GLY . . . . . 0.402 ' HA2' HG12 ' A' ' 817' ' ' VAL . . . -51.74 110.64 1.14 Allowed Glycine 0 N--CA 1.448 -0.554 0 O-C-N 123.669 0.605 . . . . 99.989999999999995 113.335 174.232 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 789' ' ' GLY . . . . . . . . . . . . . . . -157.28 166.37 33.63 Favored Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 110.571 -1.012 . . . . 99.989999999999995 110.571 177.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -107.97 132.29 53.67 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 117.305 0.552 . . . . 99.989999999999995 109.763 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 791' ' ' TYR . . . . . 0.49 ' CE2' ' HG2' ' A' ' 759' ' ' GLU . 89.4 m-85 -124.61 158.52 32.88 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.617 -0.72 . . . . 99.989999999999995 109.951 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 792' ' ' ILE . . . . . 0.591 ' O ' HG13 ' A' ' 758' ' ' ILE . 6.2 mt -134.21 117.71 25.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 108.853 -0.795 . . . . 99.989999999999995 108.853 171.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 793' ' ' LEU . . . . . 0.58 HD13 ' CD1' ' A' ' 757' ' ' ILE . 1.0 OUTLIER -84.91 112.21 20.36 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 109.34 -0.615 . . . . 99.989999999999995 109.34 179.408 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 794' ' ' SER . . . . . 0.537 ' N ' HD11 ' A' ' 793' ' ' LEU . 13.6 m -118.39 177.3 4.87 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 114.81 -1.086 . . . . 99.989999999999995 108.744 -177.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 795' ' ' LEU . . . . . . . . . . . . . 42.9 mt -103.79 132.3 50.17 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.784 0.326 . . . . 99.989999999999995 110.644 -179.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 796' ' ' VAL . . . . . . . . . . . . . 64.1 t -89.27 -56.72 4.88 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 CA-C-N 116.332 -0.394 . . . . 99.989999999999995 110.661 -177.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 797' ' ' SER . . . . . 0.45 ' HA ' ' HG ' ' A' ' 808' ' ' LEU . 26.6 m -173.36 172.83 3.66 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.59 -0.732 . . . . 99.989999999999995 109.855 -173.283 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 798' ' ' ILE . . . . . 0.653 ' O ' ' HA ' ' A' ' 805' ' ' VAL . 0.5 OUTLIER -146.34 166.76 7.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 108.455 -0.943 . . . . 99.989999999999995 108.455 -173.529 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 799' ' ' LYS . . . . . 0.665 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 34.5 tttt -135.29 117.4 15.42 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 120.33 -0.548 . . . . 99.989999999999995 111.281 -179.15 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 800' ' ' ASP . . . . . 0.689 ' HA ' ' CE2' ' A' ' 751' ' ' PHE . 8.0 t70 -68.65 153.02 44.56 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.963 -1.017 . . . . 99.989999999999995 109.192 173.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 24.2 p -62.44 -8.12 5.62 Favored 'General case' 0 C--N 1.33 -0.255 0 O-C-N 123.867 0.73 . . . . 99.989999999999995 112.375 -173.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 35.4 p -94.8 9.79 37.69 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.536 0.684 . . . . 99.989999999999995 109.673 176.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 803' ' ' GLY . . . . . 0.509 ' HA2' ' HE2' ' A' ' 799' ' ' LYS . . . 72.45 40.83 53.66 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 114.871 -1.059 . . . . 99.989999999999995 112.389 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 804' ' ' CYS . . . . . . . . . . . . . 59.6 m -114.09 116.32 28.95 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 110.198 -0.297 . . . . 99.989999999999995 110.198 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 805' ' ' VAL . . . . . 0.653 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 6.1 p -84.92 113.43 23.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.895 0.855 . . . . 99.989999999999995 110.821 -177.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 806' ' ' VAL . . . . . 0.62 ' HB ' HG22 ' A' ' 798' ' ' ILE . 41.0 t -96.05 138.42 21.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 114.933 -1.03 . . . . 99.989999999999995 110.604 -178.043 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -70.53 122.03 10.34 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.376 -0.829 . . . . 99.989999999999995 111.733 179.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 808' ' ' LEU . . . . . 0.539 HD22 ' HB ' ' A' ' 798' ' ' ILE . 24.1 mt -89.63 132.88 34.91 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 112.916 0.71 . . . . 99.989999999999995 112.916 -175.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 14.9 t -149.71 87.04 1.47 Allowed 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.452 -0.794 . . . . 99.989999999999995 109.62 172.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 810' ' ' GLN . . . . . 0.427 ' HB3' ' HD2' ' A' ' 811' ' ' PRO . 13.1 mt-30 -136.17 170.44 10.96 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.591 -0.732 . . . . 99.989999999999995 109.779 173.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 811' ' ' PRO . . . . . 0.427 ' HD2' ' HB3' ' A' ' 810' ' ' GLN . 89.2 Cg_exo -44.93 139.11 8.24 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 122.973 2.449 . . . . 99.989999999999995 114.192 -177.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -110.4 166.07 11.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.245 -0.889 . . . . 99.989999999999995 110.599 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 813' ' ' ALA . . . . . . . . . . . . . . . -114.57 154.62 27.98 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.215 -0.448 . . . . 99.989999999999995 110.257 -177.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 814' ' ' LYS . . . . . . . . . . . . . 50.6 tttp -115.0 130.05 56.85 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-O 121.129 0.49 . . . . 99.989999999999995 110.143 176.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 815' ' ' ILE . . . . . 0.554 ' HA ' ' HB2' ' A' ' 731' ' ' LEU . 4.8 mp -113.42 118.24 57.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 108.989 -0.745 . . . . 99.989999999999995 108.989 178.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 816' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -109.05 114.25 27.83 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.846 0.355 . . . . 99.989999999999995 110.81 -179.088 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 817' ' ' VAL . . . . . 0.402 HG12 ' HA2' ' A' ' 788' ' ' GLY . 92.5 t -110.07 124.55 66.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 109.793 -0.447 . . . . 99.989999999999995 109.793 176.258 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 818' ' ' ARG . . . . . 0.616 ' O ' ' HA ' ' A' ' 734' ' ' CYS . 15.0 mmt180 . . . . . 0 C--N 1.32 -0.685 0 N-CA-C 109.608 -0.515 . . . . 99.989999999999995 109.608 176.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 720' ' ' LYS . . . . . 0.431 ' HA ' ' HD3' ' A' ' 721' ' ' PRO . 12.9 mmmm . . . . . 0 N--CA 1.443 -0.793 0 N-CA-C 109.856 -0.424 . . . . 99.989999999999995 109.856 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 721' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 720' ' ' LYS . 5.9 Cg_endo -78.12 138.47 16.23 Favored 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 122.471 2.114 . . . . 99.989999999999995 110.174 -179.071 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 722' ' ' SER . . . . . 0.864 ' HB2' ' OE1' ' A' ' 810' ' ' GLN . 7.3 p -175.21 -153.05 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.549 -0.296 . . . . 99.989999999999995 110.347 -166.393 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 723' ' ' ALA . . . . . 0.541 ' HA ' ' HA ' ' A' ' 745' ' ' LEU . . . -157.73 151.27 23.75 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-N 118.518 0.599 . . . . 99.989999999999995 110.659 177.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 41.6 m -140.03 99.1 3.6 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 121.624 -0.672 . . . . 99.989999999999995 110.027 179.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 725' ' ' LEU . . . . . 0.672 HD11 ' CG1' ' A' ' 743' ' ' VAL . 5.2 mp -57.3 143.3 40.23 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-O 122.516 1.15 . . . . 99.989999999999995 112.661 -175.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 36.5 mtpt -96.82 -13.98 22.21 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 112.851 -1.977 . . . . 99.989999999999995 110.279 -177.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 727' ' ' LEU . . . . . 0.448 ' C ' HD13 ' A' ' 727' ' ' LEU . 3.1 tm? -50.4 128.91 20.93 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.387 -1.278 . . . . 99.989999999999995 109.966 176.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 35.4 m170 -89.9 -52.48 4.95 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.469 0.544 . . . . 99.989999999999995 112.469 -171.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -145.65 -177.0 5.35 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.535 -0.466 . . . . 99.989999999999995 111.513 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 730' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -48.06 133.12 15.26 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 124.019 0.824 . . . . 99.989999999999995 111.523 178.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 731' ' ' LEU . . . . . 0.556 ' CD2' ' HB2' ' A' ' 739' ' ' SER . 27.2 tp -99.53 111.49 23.83 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.264 -0.88 . . . . 99.989999999999995 111.526 -175.088 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 732' ' ' LYS . . . . . . . . . . . . . 40.5 mmtm -72.76 121.32 19.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.211 -0.449 . . . . 99.989999999999995 111.552 -179.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 733' ' ' LEU . . . . . 0.449 HD12 ' CG2' ' A' ' 815' ' ' ILE . 94.4 mt -138.26 160.54 39.2 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.265 -0.425 . . . . 99.989999999999995 110.445 178.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 734' ' ' CYS . . . . . 0.402 ' O ' ' HB2' ' A' ' 737' ' ' ASP . 63.8 m -109.96 -174.06 2.4 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.348 -0.387 . . . . 99.989999999999995 110.001 179.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 735' ' ' LEU . . . . . 0.403 ' HA ' HD11 ' A' ' 735' ' ' LEU . 38.4 tp -65.24 125.85 26.3 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.902 0.382 . . . . 99.989999999999995 111.36 -172.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 736' ' ' GLY . . . . . 0.482 ' O ' HG11 ' A' ' 784' ' ' VAL . . . 81.4 7.91 87.74 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.455 -0.879 . . . . 99.989999999999995 112.622 177.383 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 737' ' ' ASP . . . . . 0.402 ' HB2' ' O ' ' A' ' 734' ' ' CYS . 2.2 m-20 -78.58 150.37 32.79 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.024 0.44 . . . . 99.989999999999995 111.452 176.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 738' ' ' HIS . . . . . 0.612 ' HB2' ' O ' ' A' ' 782' ' ' THR . 39.8 p-80 -116.83 166.11 12.53 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 107.561 -1.274 . . . . 99.989999999999995 107.561 172.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 739' ' ' SER . . . . . 0.556 ' HB2' ' CD2' ' A' ' 731' ' ' LEU . 13.5 p -124.98 163.37 22.47 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 118.956 -1.098 . . . . 99.989999999999995 112.27 -172.357 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 740' ' ' SER . . . . . 0.488 ' HA ' ' O ' ' A' ' 780' ' ' ILE . 46.0 m -130.44 99.94 5.18 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 114.93 -1.032 . . . . 99.989999999999995 109.089 174.167 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 741' ' ' VAL . . . . . 0.492 ' HA ' ' HD3' ' A' ' 742' ' ' PRO . 0.1 OUTLIER -100.42 112.73 64.87 Favored Pre-proline 0 C--N 1.318 -0.79 0 CA-C-N 115.485 -0.779 . . . . 99.989999999999995 109.338 179.449 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 742' ' ' PRO . . . . . 0.673 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 6.3 Cg_exo -75.54 129.8 12.19 Favored 'Trans proline' 0 N--CA 1.445 -1.356 0 C-N-CA 122.215 1.944 . . . . 99.989999999999995 110.96 -176.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 743' ' ' VAL . . . . . 0.672 ' CG1' HD11 ' A' ' 725' ' ' LEU . 20.1 t -127.95 121.34 56.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.128 0.489 . . . . 99.989999999999995 112.247 178.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 744' ' ' ALA . . . . . 0.646 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -83.33 99.38 9.98 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 122.326 1.06 . . . . 99.989999999999995 108.275 169.319 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 745' ' ' LEU . . . . . 0.702 HD22 ' CD2' ' A' ' 753' ' ' LEU . 3.5 mt -77.39 164.9 25.07 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 113.52 -1.673 . . . . 99.989999999999995 110.742 -169.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 746' ' ' LYS . . . . . 0.433 ' HB3' ' OG ' ' A' ' 722' ' ' SER . 14.4 tppt? -123.46 161.31 25.08 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.079 0.466 . . . . 99.989999999999995 110.457 -176.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 747' ' ' GLY . . . . . 0.405 ' CA ' ' HA ' ' A' ' 721' ' ' PRO . . . 91.3 121.69 2.6 Favored Glycine 0 C--N 1.312 -0.783 0 N-CA-C 111.285 -0.726 . . . . 99.989999999999995 111.285 -175.181 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -95.34 117.97 31.26 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.28 0.562 . . . . 99.989999999999995 111.98 -172.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 116.65 -175.91 16.01 Favored Glycine 0 CA--C 1.499 -0.934 0 CA-C-N 115.31 -0.859 . . . . 99.989999999999995 111.506 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 750' ' ' PRO . . . . . 0.437 ' HB3' ' HE2' ' A' ' 774' ' ' LYS . 86.8 Cg_endo -69.07 94.88 0.48 Allowed 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 123.359 2.706 . . . . 99.989999999999995 113.187 -177.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 751' ' ' PHE . . . . . 0.577 ' CD2' ' HA ' ' A' ' 800' ' ' ASP . 64.0 m-85 -112.13 144.87 40.78 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.73 -0.668 . . . . 99.989999999999995 111.067 179.332 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 752' ' ' THR . . . . . 0.728 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 89.0 m -91.85 102.76 15.35 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.277 0.56 . . . . 99.989999999999995 109.921 179.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 753' ' ' LEU . . . . . 0.702 ' CD2' HD22 ' A' ' 745' ' ' LEU . 46.9 tp -97.0 121.52 38.97 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.096 -0.956 . . . . 99.989999999999995 111.298 -171.167 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 754' ' ' THR . . . . . 0.461 ' HB ' ' HB ' ' A' ' 796' ' ' VAL . 1.0 OUTLIER -109.66 135.98 49.75 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.099 -0.501 . . . . 99.989999999999995 111.131 -177.592 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 755' ' ' TYR . . . . . 0.603 ' CE1' ' HB3' ' A' ' 768' ' ' PHE . 29.6 p90 -143.1 152.43 41.84 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 120.977 0.418 . . . . 99.989999999999995 111.843 178.095 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 756' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -117.7 118.47 32.16 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.643 -0.708 . . . . 99.989999999999995 110.694 -179.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 757' ' ' ILE . . . . . 0.644 ' CD1' HD13 ' A' ' 793' ' ' LEU . 3.5 mp -87.7 96.56 5.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 N-CA-C 107.86 -1.163 . . . . 99.989999999999995 107.86 168.206 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 758' ' ' ILE . . . . . 0.556 HG13 ' O ' ' A' ' 792' ' ' ILE . 2.3 pp -94.53 149.89 4.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 121.322 0.582 . . . . 99.989999999999995 111.962 -171.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 759' ' ' GLU . . . . . 0.485 ' HG2' ' CE2' ' A' ' 791' ' ' TYR . 16.1 mt-10 -90.86 115.13 27.67 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 115.211 -0.904 . . . . 99.989999999999995 109.832 175.041 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 760' ' ' THR . . . . . . . . . . . . . 2.5 t . . . . . 0 C--N 1.312 -1.023 0 N-CA-C 108.114 -1.069 . . . . 99.989999999999995 108.114 172.789 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 765' ' ' ARG . . . . . 0.481 ' CG ' HG21 ' A' ' 758' ' ' ILE . 6.1 ttp180 . . . . . 0 N--CA 1.451 -0.411 0 CA-C-O 120.552 0.215 . . . . 99.989999999999995 110.903 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 766' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -123.7 134.38 53.72 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 120.922 0.391 . . . . 99.989999999999995 110.449 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 767' ' ' THR . . . . . . . . . . . . . 47.3 m -107.58 131.39 54.41 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.853 -0.612 . . . . 99.989999999999995 110.46 -177.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 768' ' ' PHE . . . . . 0.603 ' HB3' ' CE1' ' A' ' 755' ' ' TYR . 0.2 OUTLIER -137.16 135.84 37.7 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 109.204 -0.665 . . . . 99.989999999999995 109.204 179.203 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 769' ' ' GLU . . . . . 0.425 ' N ' ' HD1' ' A' ' 768' ' ' PHE . 39.3 tt0 -129.54 124.01 32.82 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.118 0.485 . . . . 99.989999999999995 111.692 -175.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 4.6 mm -102.38 110.66 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 CA-C-N 115.562 -0.745 . . . . 99.989999999999995 109.759 -179.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 771' ' ' LYS . . . . . 0.606 ' HD2' ' N ' ' A' ' 771' ' ' LYS . 0.0 OUTLIER -80.41 157.4 26.27 Favored 'General case' 0 C--N 1.312 -1.028 0 C-N-CA 120.104 -0.639 . . . . 99.989999999999995 109.983 179.293 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 772' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 41.77 50.33 3.98 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 113.871 -1.513 . . . . 99.989999999999995 113.515 178.387 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 773' ' ' ILE . . . . . 0.551 ' CD1' HD13 ' A' ' 745' ' ' LEU . 0.5 OUTLIER -75.35 111.37 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 107.145 -1.428 . . . . 99.989999999999995 107.145 171.135 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 774' ' ' LYS . . . . . 0.437 ' HE2' ' HB3' ' A' ' 750' ' ' PRO . 58.7 mttt -107.26 24.35 12.99 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.651 -0.87 . . . . 99.989999999999995 108.651 -178.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 775' ' ' THR . . . . . 0.641 ' O ' ' HB2' ' A' ' 776' ' ' ASN . 0.2 OUTLIER -95.38 -74.27 0.56 Allowed 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.392 0.886 . . . . 99.989999999999995 113.392 -165.763 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 776' ' ' ASN . . . . . 0.641 ' HB2' ' O ' ' A' ' 775' ' ' THR . 0.9 OUTLIER 91.07 4.13 0.1 Allowed 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.5 1.12 . . . . 99.989999999999995 110.596 -177.605 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 777' ' ' GLU . . . . . 0.646 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 13.9 tt0 -162.94 101.59 0.99 Allowed 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.347 -0.842 . . . . 99.989999999999995 109.133 174.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 778' ' ' TYR . . . . . 0.528 ' HB3' HD12 ' A' ' 745' ' ' LEU . 90.7 t80 -153.69 129.7 10.29 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.699 -0.682 . . . . 99.989999999999995 110.633 -171.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 779' ' ' VAL . . . . . 0.673 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 1.9 m -91.68 129.54 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 CA-C-O 122.15 0.976 . . . . 99.989999999999995 110.823 178.061 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 780' ' ' ILE . . . . . 0.488 ' O ' ' HA ' ' A' ' 740' ' ' SER . 88.2 mt -90.13 139.79 16.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 113.59 -1.641 . . . . 99.989999999999995 110.811 -174.028 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 781' ' ' LYS . . . . . 0.539 ' HB2' ' HZ2' ' A' ' 781' ' ' LYS . 0.1 OUTLIER -111.81 107.62 16.74 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.928 0.394 . . . . 99.989999999999995 110.323 179.623 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 782' ' ' THR . . . . . 0.612 ' O ' ' HB2' ' A' ' 738' ' ' HIS . 25.2 p -77.8 142.91 66.03 Favored Pre-proline 0 C--N 1.318 -0.761 0 CA-C-N 115.911 -0.586 . . . . 99.989999999999995 109.827 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 783' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -56.32 160.72 10.44 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 123.53 2.82 . . . . 99.989999999999995 113.2 -178.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 784' ' ' VAL . . . . . 0.511 HG12 HG21 ' A' ' 786' ' ' THR . 40.5 t -58.55 122.62 8.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.145 -0.934 . . . . 99.989999999999995 111.952 178.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 785' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -100.67 97.27 7.96 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.814 -0.63 . . . . 99.989999999999995 110.187 178.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 786' ' ' THR . . . . . 0.511 HG21 HG12 ' A' ' 784' ' ' VAL . 44.1 p -84.37 34.23 0.52 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.677 0.751 . . . . 99.989999999999995 111.165 -178.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 12.7 m -154.69 112.72 3.48 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.045 -0.979 . . . . 99.989999999999995 111.006 178.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 788' ' ' GLY . . . . . 0.499 ' HA2' HG12 ' A' ' 817' ' ' VAL . . . -50.13 112.49 1.52 Allowed Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 121.027 -0.606 . . . . 99.989999999999995 112.521 169.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 789' ' ' GLY . . . . . . . . . . . . . . . -157.51 -148.15 5.03 Favored Glycine 0 N--CA 1.443 -0.843 0 N-CA-C 111.205 -0.758 . . . . 99.989999999999995 111.205 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -144.86 124.77 13.47 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 108.868 -0.789 . . . . 99.989999999999995 108.868 179.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 791' ' ' TYR . . . . . 0.485 ' CE2' ' HG2' ' A' ' 759' ' ' GLU . 90.9 m-85 -118.99 145.14 46.07 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 116.118 -0.492 . . . . 99.989999999999995 110.998 -176.174 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 792' ' ' ILE . . . . . 0.556 ' O ' HG13 ' A' ' 758' ' ' ILE . 16.5 mt -123.56 110.41 25.92 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-N 115.71 -0.677 . . . . 99.989999999999995 109.508 173.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 793' ' ' LEU . . . . . 0.644 HD13 ' CD1' ' A' ' 757' ' ' ILE . 4.0 tp -84.75 109.55 18.14 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.428 0.632 . . . . 99.989999999999995 109.448 179.326 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 794' ' ' SER . . . . . . . . . . . . . 19.1 m -112.31 156.52 22.3 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.93 -1.032 . . . . 99.989999999999995 110.062 -174.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 795' ' ' LEU . . . . . . . . . . . . . 74.9 mt -91.13 130.5 37.02 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.903 0.382 . . . . 99.989999999999995 110.372 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 796' ' ' VAL . . . . . 0.461 ' HB ' ' HB ' ' A' ' 754' ' ' THR . 76.6 t -91.52 -55.53 6.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.863 -0.608 . . . . 99.989999999999995 111.159 -175.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 797' ' ' SER . . . . . 0.468 ' C ' HD13 ' A' ' 808' ' ' LEU . 88.9 p -179.43 179.12 0.64 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.137 -0.483 . . . . 99.989999999999995 110.503 -172.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 798' ' ' ILE . . . . . 0.613 ' HA ' ' O ' ' A' ' 752' ' ' THR . 10.3 tt -148.53 161.94 5.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 109.322 -0.621 . . . . 99.989999999999995 109.322 178.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 799' ' ' LYS . . . . . 0.728 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 7.6 tmtt? -133.31 122.02 23.25 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.037 0.446 . . . . 99.989999999999995 110.787 -178.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 800' ' ' ASP . . . . . 0.577 ' HA ' ' CD2' ' A' ' 751' ' ' PHE . 9.0 t70 -66.45 154.87 39.09 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.967 -1.015 . . . . 99.989999999999995 109.971 174.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 38.2 t -59.15 -14.18 9.56 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 124.236 0.96 . . . . 99.989999999999995 112.719 -172.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 61.8 p -96.25 5.57 50.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.554 0.692 . . . . 99.989999999999995 110.189 178.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 803' ' ' GLY . . . . . . . . . . . . . . . 82.23 40.19 10.48 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.07 -0.968 . . . . 99.989999999999995 112.148 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 804' ' ' CYS . . . . . 0.438 ' HB2' ' HB3' ' A' ' 800' ' ' ASP . 63.4 m -110.94 114.62 28.08 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 110.197 -0.297 . . . . 99.989999999999995 110.197 179.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 805' ' ' VAL . . . . . . . . . . . . . 11.4 p -85.75 137.54 20.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.487 0.66 . . . . 99.989999999999995 111.464 -173.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 806' ' ' VAL . . . . . 0.532 ' HB ' HG22 ' A' ' 798' ' ' ILE . 97.0 t -118.03 137.65 51.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.16 -0.927 . . . . 99.989999999999995 109.176 176.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -87.6 110.63 3.61 Favored Glycine 0 C--N 1.321 -0.277 0 C-N-CA 120.815 -0.707 . . . . 99.989999999999995 112.481 -178.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 808' ' ' LEU . . . . . 0.468 HD13 ' C ' ' A' ' 797' ' ' SER . 11.1 mp -79.78 129.69 34.7 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 113.303 0.853 . . . . 99.989999999999995 113.303 178.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 8.8 t -138.6 87.01 2.19 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 107.921 -1.14 . . . . 99.989999999999995 107.921 168.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 810' ' ' GLN . . . . . 0.864 ' OE1' ' HB2' ' A' ' 722' ' ' SER . 25.2 mt-30 -139.48 174.57 3.97 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.081 -0.963 . . . . 99.989999999999995 111.295 -170.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 811' ' ' PRO . . . . . 0.485 ' HD2' ' HB3' ' A' ' 810' ' ' GLN . 75.5 Cg_exo -44.69 146.68 2.12 Favored 'Trans proline' 0 C--N 1.36 1.14 0 C-N-CA 123.395 2.73 . . . . 99.989999999999995 114.376 -178.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -119.99 166.93 12.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.092 -0.958 . . . . 99.989999999999995 111.147 -177.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 813' ' ' ALA . . . . . 0.532 ' O ' ' HA ' ' A' ' 792' ' ' ILE . . . -105.19 146.18 29.6 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.265 -0.88 . . . . 99.989999999999995 110.212 178.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 814' ' ' LYS . . . . . 0.433 ' HG2' HG12 ' A' ' 792' ' ' ILE . 6.7 mtmp? -122.85 112.72 18.21 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.839 0.828 . . . . 99.989999999999995 110.605 172.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 815' ' ' ILE . . . . . 0.523 ' HA ' ' HB3' ' A' ' 731' ' ' LEU . 4.5 mp -109.89 109.07 27.06 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 114.088 -1.415 . . . . 99.989999999999995 109.25 -176.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 816' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -98.98 108.58 21.29 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.262 0.553 . . . . 99.989999999999995 110.263 -176.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 817' ' ' VAL . . . . . 0.499 HG12 ' HA2' ' A' ' 788' ' ' GLY . 96.1 t -98.46 145.56 9.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.807 -0.633 . . . . 99.989999999999995 109.599 -179.171 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 818' ' ' ARG . . . . . . . . . . . . . 20.0 tpt180 . . . . . 0 C--N 1.313 -0.992 0 N-CA-C 108.238 -1.023 . . . . 99.989999999999995 108.238 -178.556 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 720' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt . . . . . 0 N--CA 1.446 -0.649 0 N-CA-C 109.985 -0.376 . . . . 99.989999999999995 109.985 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 721' ' ' PRO . . . . . 0.457 ' HB3' ' HA3' ' A' ' 747' ' ' GLY . 36.3 Cg_endo -86.75 148.89 8.48 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 122.564 2.176 . . . . 99.989999999999995 110.801 177.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 722' ' ' SER . . . . . 0.463 ' HA ' ' CD2' ' A' ' 808' ' ' LEU . 8.4 t -178.78 -154.6 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.623 -0.51 . . . . 99.989999999999995 109.623 -171.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 723' ' ' ALA . . . . . 0.683 ' O ' HD13 ' A' ' 795' ' ' LEU . . . -150.99 140.17 21.21 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.902 0.382 . . . . 99.989999999999995 110.799 176.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 43.4 t -128.52 99.43 5.38 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.632 -0.877 . . . . 99.989999999999995 108.632 -174.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 725' ' ' LEU . . . . . 0.599 HD21 ' CG2' ' A' ' 743' ' ' VAL . 1.1 mt -65.02 146.25 55.26 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 115.809 -0.632 . . . . 99.989999999999995 110.604 -172.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 34.3 mtpt -103.88 -10.58 18.08 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.486 -0.779 . . . . 99.989999999999995 110.464 -174.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 727' ' ' LEU . . . . . 0.434 ' HB2' HG23 ' A' ' 741' ' ' VAL . 0.8 OUTLIER -74.46 109.67 8.14 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.138 -1.06 . . . . 99.989999999999995 108.138 175.751 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 41.6 m80 -105.43 38.06 2.06 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.765 0.654 . . . . 99.989999999999995 112.765 -169.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -169.51 -176.99 2.62 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.719 0.295 . . . . 99.989999999999995 111.104 179.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 730' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -66.21 137.1 56.74 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.827 -0.624 . . . . 99.989999999999995 109.953 173.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 731' ' ' LEU . . . . . 0.57 ' HB3' ' HA ' ' A' ' 815' ' ' ILE . 40.4 tp -103.23 100.17 10.06 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.88 -0.6 . . . . 99.989999999999995 109.973 178.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 732' ' ' LYS . . . . . 0.45 ' HD3' ' HB3' ' A' ' 816' ' ' GLN . 32.6 mmtp -78.63 124.26 27.99 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.454 0.645 . . . . 99.989999999999995 112.09 -175.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 733' ' ' LEU . . . . . 0.621 ' HG ' ' HB3' ' A' ' 737' ' ' ASP . 7.9 mp -120.4 165.13 15.32 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.671 -1.15 . . . . 99.989999999999995 109.705 177.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 734' ' ' CYS . . . . . 0.487 ' O ' ' HB2' ' A' ' 737' ' ' ASP . 31.2 p -120.16 -179.27 3.89 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 116.12 -0.491 . . . . 99.989999999999995 109.702 171.008 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 735' ' ' LEU . . . . . . . . . . . . . 2.8 tt -57.88 116.5 3.52 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.938 0.399 . . . . 99.989999999999995 110.34 -179.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 91.64 3.39 68.82 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.374 -0.917 . . . . 99.989999999999995 112.458 176.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 737' ' ' ASP . . . . . 0.621 ' HB3' ' HG ' ' A' ' 733' ' ' LEU . 0.3 OUTLIER -72.47 158.21 36.15 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.973 0.416 . . . . 99.989999999999995 111.146 177.957 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 37.0 p-80 -116.66 153.68 31.89 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 107.156 -1.424 . . . . 99.989999999999995 107.156 171.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 739' ' ' SER . . . . . 0.724 ' HB2' ' OG1' ' A' ' 782' ' ' THR . 10.8 m -98.15 159.0 15.22 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 119.126 -1.03 . . . . 99.989999999999995 111.235 -174.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 740' ' ' SER . . . . . 0.491 ' H ' HD22 ' A' ' 731' ' ' LEU . 10.5 t -143.37 101.09 3.73 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.915 -1.038 . . . . 99.989999999999995 108.657 -174.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 741' ' ' VAL . . . . . 0.451 HG13 HD22 ' A' ' 793' ' ' LEU . 2.1 p -121.26 112.51 32.98 Favored Pre-proline 0 C--N 1.316 -0.864 0 CA-C-O 121.283 0.563 . . . . 99.989999999999995 110.266 -177.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 742' ' ' PRO . . . . . 0.603 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 4.5 Cg_exo -71.33 125.93 11.8 Favored 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 122.294 1.996 . . . . 99.989999999999995 109.863 178.141 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 743' ' ' VAL . . . . . 0.599 ' CG2' HD21 ' A' ' 725' ' ' LEU . 24.0 t -129.31 114.77 32.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 112.595 0.591 . . . . 99.989999999999995 112.595 -178.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 744' ' ' ALA . . . . . 0.494 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -81.59 101.6 10.1 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.459 -0.941 . . . . 99.989999999999995 108.459 171.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 745' ' ' LEU . . . . . 0.548 ' HA ' ' HA ' ' A' ' 723' ' ' ALA . 0.2 OUTLIER -83.94 168.2 16.25 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 114.593 -1.185 . . . . 99.989999999999995 111.258 -167.814 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 44.1 tptt -122.24 156.18 34.33 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.855 -0.611 . . . . 99.989999999999995 110.405 -177.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 747' ' ' GLY . . . . . 0.457 ' HA3' ' HB3' ' A' ' 721' ' ' PRO . . . 93.66 123.62 3.65 Favored Glycine 0 C--N 1.311 -0.827 0 CA-C-N 115.241 -0.89 . . . . 99.989999999999995 111.378 -177.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 25.7 mp0 -106.69 114.45 28.56 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.119 0.485 . . . . 99.989999999999995 111.283 -173.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 130.69 -175.98 19.13 Favored Glycine 0 N--CA 1.446 -0.7 0 N-CA-C 110.906 -0.878 . . . . 99.989999999999995 110.906 -177.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -70.57 95.07 0.61 Allowed 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.658 2.238 . . . . 99.989999999999995 112.392 178.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 751' ' ' PHE . . . . . 0.486 ' HA ' ' O ' ' A' ' 799' ' ' LYS . 77.5 m-85 -113.34 140.88 47.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 99.989999999999995 111.522 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 752' ' ' THR . . . . . 0.708 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 86.6 m -91.05 104.61 17.17 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.344 0.592 . . . . 99.989999999999995 109.763 177.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 753' ' ' LEU . . . . . 0.535 ' CD1' HD22 ' A' ' 745' ' ' LEU . 1.8 tt -95.95 116.34 28.78 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.096 -0.956 . . . . 99.989999999999995 109.608 -171.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 754' ' ' THR . . . . . 0.451 HG23 ' HB2' ' A' ' 769' ' ' GLU . 1.0 OUTLIER -114.44 137.7 51.5 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.141 -0.481 . . . . 99.989999999999995 110.989 -179.1 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 755' ' ' TYR . . . . . 0.473 ' CE1' ' HB3' ' A' ' 768' ' ' PHE . 24.5 p90 -145.37 162.93 36.09 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 120.961 0.41 . . . . 99.989999999999995 111.541 178.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 756' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -128.73 121.13 27.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.609 -0.723 . . . . 99.989999999999995 110.677 -178.222 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 757' ' ' ILE . . . . . 0.535 ' CD1' HD13 ' A' ' 793' ' ' LEU . 3.5 mp -87.01 96.47 5.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 N-CA-C 107.708 -1.219 . . . . 99.989999999999995 107.708 169.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 758' ' ' ILE . . . . . 0.565 HG13 ' O ' ' A' ' 792' ' ' ILE . 2.3 pp -95.21 149.65 4.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 116.116 -0.493 . . . . 99.989999999999995 112.218 -169.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 759' ' ' GLU . . . . . 0.631 ' HG2' ' CE2' ' A' ' 791' ' ' TYR . 24.6 mt-10 -89.75 119.94 30.58 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.925 -0.58 . . . . 99.989999999999995 110.394 179.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 760' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.313 -0.995 0 CA-C-O 121.346 0.593 . . . . 99.989999999999995 109.564 175.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 765' ' ' ARG . . . . . 0.406 ' HD3' ' CG2' ' A' ' 758' ' ' ILE . 7.9 ttp180 . . . . . 0 CA--C 1.535 0.385 0 CA-C-O 120.87 0.367 . . . . 99.989999999999995 111.523 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 766' ' ' LYS . . . . . . . . . . . . . 9.7 tmtm? -115.98 135.45 53.95 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-O 121.088 0.47 . . . . 99.989999999999995 110.409 -177.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 767' ' ' THR . . . . . . . . . . . . . 27.7 m -109.04 137.03 47.59 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.777 -0.647 . . . . 99.989999999999995 110.833 -174.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 768' ' ' PHE . . . . . 0.473 ' HB3' ' CE1' ' A' ' 755' ' ' TYR . 3.2 t80 -139.72 139.74 36.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.96 0.41 . . . . 99.989999999999995 110.643 175.426 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 769' ' ' GLU . . . . . 0.451 ' HB2' HG23 ' A' ' 754' ' ' THR . 35.5 tt0 -129.76 129.98 44.81 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.699 -0.682 . . . . 99.989999999999995 110.848 -179.37 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 770' ' ' ILE . . . . . 0.453 HG21 HG22 ' A' ' 773' ' ' ILE . 5.0 mt -122.82 111.87 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 108.701 -0.852 . . . . 99.989999999999995 108.701 176.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 771' ' ' LYS . . . . . 0.587 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 9.5 mtpt -85.1 152.04 23.69 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-O 121.492 0.663 . . . . 99.989999999999995 111.328 -174.01 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 772' ' ' GLU . . . . . 0.405 ' O ' ' HG3' ' A' ' 774' ' ' LYS . 5.4 mt-10 54.7 47.11 23.24 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.211 -1.359 . . . . 99.989999999999995 112.532 177.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 773' ' ' ILE . . . . . 0.453 HG22 HG21 ' A' ' 770' ' ' ILE . 0.5 OUTLIER -73.8 119.89 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 107.819 -1.178 . . . . 99.989999999999995 107.819 173.835 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 774' ' ' LYS . . . . . 0.405 ' HG3' ' O ' ' A' ' 772' ' ' GLU . 73.0 mttt -118.21 30.66 7.11 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.617 -0.883 . . . . 99.989999999999995 108.617 -177.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 775' ' ' THR . . . . . 0.594 ' O ' ' HB2' ' A' ' 776' ' ' ASN . 0.6 OUTLIER -95.88 -72.24 0.64 Allowed 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 114.957 -1.019 . . . . 99.989999999999995 113.381 -171.394 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 776' ' ' ASN . . . . . 0.594 ' HB2' ' O ' ' A' ' 775' ' ' THR . 0.9 OUTLIER 83.82 4.67 0.78 Allowed 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.045 0.938 . . . . 99.989999999999995 110.389 -175.601 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 777' ' ' GLU . . . . . 0.494 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 6.9 tp10 -161.69 78.3 0.54 Allowed 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 108.682 -0.858 . . . . 99.989999999999995 108.682 -179.47 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 778' ' ' TYR . . . . . 0.404 ' HB3' ' CD1' ' A' ' 745' ' ' LEU . 82.4 t80 -132.86 125.65 30.44 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.115 0.483 . . . . 99.989999999999995 111.69 -169.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 779' ' ' VAL . . . . . 0.603 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 21.6 t -84.16 115.97 27.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.893 -0.594 . . . . 99.989999999999995 110.051 176.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 780' ' ' ILE . . . . . 0.446 ' HB ' HG11 ' A' ' 741' ' ' VAL . 77.2 mt -89.84 135.92 25.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.173 -0.921 . . . . 99.989999999999995 110.724 -176.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 781' ' ' LYS . . . . . 0.412 ' HD3' ' C ' ' A' ' 780' ' ' ILE . 0.0 OUTLIER -118.89 109.12 15.63 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.56 -0.533 . . . . 99.989999999999995 109.56 177.682 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 782' ' ' THR . . . . . 0.724 ' OG1' ' HB2' ' A' ' 739' ' ' SER . 82.6 p -82.6 148.62 58.75 Favored Pre-proline 0 C--O 1.244 0.811 0 CA-C-N 115.876 -0.602 . . . . 99.989999999999995 110.862 -176.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 783' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -49.27 157.0 2.17 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 124.09 3.193 . . . . 99.989999999999995 113.447 -178.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 784' ' ' VAL . . . . . 0.512 HG12 HG21 ' A' ' 786' ' ' THR . 70.1 t -61.19 131.24 26.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.086 -0.961 . . . . 99.989999999999995 112.803 -174.176 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 785' ' ' PHE . . . . . 0.447 ' C ' ' H ' ' A' ' 787' ' ' THR . 80.0 m-85 -103.68 88.96 3.19 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.949 -1.023 . . . . 99.989999999999995 110.01 177.164 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 786' ' ' THR . . . . . 0.512 HG21 HG12 ' A' ' 784' ' ' VAL . 32.5 p -83.47 29.42 0.51 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 122.077 0.941 . . . . 99.989999999999995 110.284 178.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 787' ' ' THR . . . . . 0.447 ' H ' ' C ' ' A' ' 785' ' ' PHE . 2.1 m -159.65 105.46 1.63 Allowed 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.644 -1.162 . . . . 99.989999999999995 109.941 -175.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 788' ' ' GLY . . . . . 0.597 ' HA2' HG22 ' A' ' 817' ' ' VAL . . . -49.46 137.76 19.55 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.75 -0.659 . . . . 99.989999999999995 113.648 172.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 789' ' ' GLY . . . . . 0.443 ' H ' HG13 ' A' ' 817' ' ' VAL . . . -176.84 -178.01 46.24 Favored Glycine 0 N--CA 1.44 -1.062 0 N-CA-C 109.555 -1.418 . . . . 99.989999999999995 109.555 -178.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -118.5 119.66 35.19 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 117.851 0.826 . . . . 99.989999999999995 109.029 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 791' ' ' TYR . . . . . 0.631 ' CE2' ' HG2' ' A' ' 759' ' ' GLU . 92.6 m-85 -122.24 148.88 44.44 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.677 -0.692 . . . . 99.989999999999995 110.582 -175.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 792' ' ' ILE . . . . . 0.565 ' O ' HG13 ' A' ' 758' ' ' ILE . 19.9 mt -124.64 114.33 40.21 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.065 0 N-CA-C 109.081 -0.711 . . . . 99.989999999999995 109.081 172.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 793' ' ' LEU . . . . . 0.546 HD11 ' N ' ' A' ' 794' ' ' SER . 0.5 OUTLIER -84.39 115.73 22.67 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 108.686 -0.857 . . . . 99.989999999999995 108.686 179.893 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 794' ' ' SER . . . . . 0.546 ' N ' HD11 ' A' ' 793' ' ' LEU . 23.1 m -130.51 161.42 31.5 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 114.701 -1.136 . . . . 99.989999999999995 109.084 -174.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 795' ' ' LEU . . . . . 0.683 HD13 ' O ' ' A' ' 723' ' ' ALA . 27.6 mt -87.3 148.07 25.24 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 120.813 0.34 . . . . 99.989999999999995 110.897 -177.022 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 796' ' ' VAL . . . . . . . . . . . . . 69.7 t -105.17 -56.03 5.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.069 -0.514 . . . . 99.989999999999995 111.004 178.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 797' ' ' SER . . . . . 0.573 ' HA ' ' HG ' ' A' ' 808' ' ' LEU . 95.9 p -176.47 154.14 1.25 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.02 -0.536 . . . . 99.989999999999995 110.202 -172.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 798' ' ' ILE . . . . . 0.611 ' HA ' ' O ' ' A' ' 752' ' ' THR . 12.4 tt -127.51 164.04 29.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.219 -0.66 . . . . 99.989999999999995 109.219 177.149 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 799' ' ' LYS . . . . . 0.708 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 28.0 tttt -131.19 120.17 22.91 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 120.668 0.271 . . . . 99.989999999999995 111.058 -176.026 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 800' ' ' ASP . . . . . 0.485 ' HA ' ' CE2' ' A' ' 751' ' ' PHE . 19.8 t70 -69.18 154.63 41.74 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.69 -0.686 . . . . 99.989999999999995 109.312 173.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 9.0 m -59.32 -13.77 9.26 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 124.042 0.839 . . . . 99.989999999999995 112.994 -170.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 52.1 p -93.47 -0.87 56.24 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.466 0.651 . . . . 99.989999999999995 110.136 179.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 803' ' ' GLY . . . . . 0.473 ' HA2' ' HE2' ' A' ' 799' ' ' LYS . . . 85.74 46.87 5.29 Favored Glycine 0 N--CA 1.444 -0.807 0 CA-C-N 115.086 -0.961 . . . . 99.989999999999995 111.702 -176.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 804' ' ' CYS . . . . . 0.411 ' HB2' ' HB3' ' A' ' 800' ' ' ASP . 61.3 m -116.71 110.76 18.88 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.98 -0.378 . . . . 99.989999999999995 109.98 177.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 805' ' ' VAL . . . . . 0.558 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 9.8 p -85.47 133.61 29.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.301 0.572 . . . . 99.989999999999995 111.006 -175.22 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 806' ' ' VAL . . . . . 0.482 ' HB ' HG22 ' A' ' 798' ' ' ILE . 84.5 t -112.02 133.76 56.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.711 -0.677 . . . . 99.989999999999995 110.009 178.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -70.49 113.19 4.71 Favored Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 111.31 -0.716 . . . . 99.989999999999995 111.31 177.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 808' ' ' LEU . . . . . 0.573 ' HG ' ' HA ' ' A' ' 797' ' ' SER . 40.0 mt -81.65 130.04 34.91 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.264 0.554 . . . . 99.989999999999995 112.462 -172.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 39.8 m -148.53 86.27 1.53 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.481 -0.782 . . . . 99.989999999999995 110.082 173.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 810' ' ' GLN . . . . . 0.57 ' HB3' ' HD2' ' A' ' 811' ' ' PRO . 75.1 mt-30 -135.54 173.27 5.89 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 108.43 -0.952 . . . . 99.989999999999995 108.43 174.229 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 811' ' ' PRO . . . . . 0.57 ' HD2' ' HB3' ' A' ' 810' ' ' GLN . 86.6 Cg_exo -45.28 139.44 9.01 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 122.654 2.236 . . . . 99.989999999999995 114.68 -177.302 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -111.42 166.15 11.37 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 114.992 -1.004 . . . . 99.989999999999995 110.301 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 813' ' ' ALA . . . . . 0.43 ' N ' HD12 ' A' ' 725' ' ' LEU . . . -116.42 154.14 30.83 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.166 -0.47 . . . . 99.989999999999995 110.357 -178.09 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 814' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -120.22 108.7 14.52 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.18 0.514 . . . . 99.989999999999995 110.498 177.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 815' ' ' ILE . . . . . 0.57 ' HA ' ' HB3' ' A' ' 731' ' ' LEU . 4.8 mp -97.5 123.71 50.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.486 -0.779 . . . . 99.989999999999995 109.481 -179.085 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 816' ' ' GLN . . . . . 0.45 ' HB3' ' HD3' ' A' ' 732' ' ' LYS . 0.1 OUTLIER -118.39 106.31 12.6 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.444 -0.576 . . . . 99.989999999999995 109.444 -179.873 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 817' ' ' VAL . . . . . 0.597 HG22 ' HA2' ' A' ' 788' ' ' GLY . 0.5 OUTLIER -100.61 143.61 13.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 109.386 -0.598 . . . . 99.989999999999995 109.386 -179.879 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 818' ' ' ARG . . . . . . . . . . . . . 20.9 tpt180 . . . . . 0 C--N 1.311 -1.105 0 CA-C-O 121.086 0.47 . . . . 99.989999999999995 110.683 -176.036 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 720' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt . . . . . 0 N--CA 1.448 -0.537 0 N-CA-C 109.201 -0.666 . . . . 99.989999999999995 109.201 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 721' ' ' PRO . . . . . 0.413 ' HB3' ' HA3' ' A' ' 747' ' ' GLY . 56.4 Cg_endo -88.04 144.91 6.25 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 123.381 2.721 . . . . 99.989999999999995 112.426 -174.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 722' ' ' SER . . . . . 0.525 ' HA ' ' CD2' ' A' ' 808' ' ' LEU . 61.8 m -169.27 -156.52 0.15 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.207 -0.664 . . . . 99.989999999999995 109.207 -172.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 723' ' ' ALA . . . . . 0.537 ' HA ' ' HA ' ' A' ' 745' ' ' LEU . . . -152.2 143.51 23.31 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 122.273 -0.267 . . . . 99.989999999999995 110.845 179.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 724' ' ' SER . . . . . 0.425 ' HB2' ' OE1' ' A' ' 810' ' ' GLN . 26.0 t -132.58 99.5 4.66 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.29 -0.633 . . . . 99.989999999999995 109.29 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 725' ' ' LEU . . . . . 0.628 HD11 ' N ' ' A' ' 725' ' ' LEU . 4.9 mp -62.42 143.4 57.1 Favored 'General case' 0 N--CA 1.426 -1.632 0 CA-C-O 122.428 1.109 . . . . 99.989999999999995 112.407 -176.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 30.8 mtpt -94.49 -16.47 23.31 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 113.26 -1.791 . . . . 99.989999999999995 110.417 -176.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 727' ' ' LEU . . . . . 0.47 ' HB2' ' HD2' ' A' ' 742' ' ' PRO . 1.5 tt -76.04 109.29 9.57 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.407 -0.96 . . . . 99.989999999999995 108.407 177.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 35.9 m80 -110.47 48.84 0.88 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.264 0.468 . . . . 99.989999999999995 112.264 -171.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -177.86 177.78 1.04 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.384 -0.371 . . . . 99.989999999999995 110.13 176.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 730' ' ' ASP . . . . . 0.427 ' HA ' ' O ' ' A' ' 814' ' ' LYS . 1.4 m-20 -67.01 134.94 52.94 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.967 0.413 . . . . 99.989999999999995 110.131 175.244 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 731' ' ' LEU . . . . . 0.558 ' HB3' ' HA ' ' A' ' 815' ' ' ILE . 28.2 tp -93.08 105.95 17.98 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.104 -0.498 . . . . 99.989999999999995 110.516 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 732' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -76.98 104.62 7.57 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.852 -0.613 . . . . 99.989999999999995 111.656 -174.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 733' ' ' LEU . . . . . 0.445 HD12 ' CB ' ' A' ' 739' ' ' SER . 85.2 mt -116.77 155.57 28.7 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.112 -0.495 . . . . 99.989999999999995 110.498 177.296 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 734' ' ' CYS . . . . . 0.471 ' O ' ' HB2' ' A' ' 737' ' ' ASP . 36.5 m -105.34 -173.38 2.29 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.781 -0.645 . . . . 99.989999999999995 109.84 179.101 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 735' ' ' LEU . . . . . . . . . . . . . 24.5 tp -67.05 135.8 54.25 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 110.143 -0.317 . . . . 99.989999999999995 110.143 178.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 736' ' ' GLY . . . . . 0.458 ' HA2' ' HA ' ' A' ' 786' ' ' THR . . . 80.02 7.84 88.17 Favored Glycine 0 C--N 1.321 -0.298 0 C-N-CA 120.339 -0.934 . . . . 99.989999999999995 112.673 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 737' ' ' ASP . . . . . 0.471 ' HB2' ' O ' ' A' ' 734' ' ' CYS . 0.7 OUTLIER -87.47 148.77 24.8 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.51 0.671 . . . . 99.989999999999995 112.628 179.078 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 738' ' ' HIS . . . . . 0.436 ' HB2' ' O ' ' A' ' 782' ' ' THR . 40.3 p-80 -110.93 164.98 12.24 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 106.642 -1.614 . . . . 99.989999999999995 106.642 166.19 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 739' ' ' SER . . . . . 0.469 ' HB2' ' CD2' ' A' ' 731' ' ' LEU . 4.5 p -109.99 162.7 14.27 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 119.277 -0.969 . . . . 99.989999999999995 112.0 -171.146 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 23.4 t -138.88 100.91 4.17 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 114.961 -1.018 . . . . 99.989999999999995 108.783 177.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 741' ' ' VAL . . . . . 0.445 HG13 HD13 ' A' ' 793' ' ' LEU . 1.5 p -117.1 111.45 40.54 Favored Pre-proline 0 C--N 1.318 -0.785 0 CA-C-N 115.552 -0.749 . . . . 99.989999999999995 110.115 -179.015 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 742' ' ' PRO . . . . . 0.64 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 4.6 Cg_endo -76.63 134.07 14.82 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 122.578 2.185 . . . . 99.989999999999995 111.58 -179.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 743' ' ' VAL . . . . . 0.546 ' HA ' ' HA ' ' A' ' 725' ' ' LEU . 1.6 p -131.32 120.91 47.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.51 0.671 . . . . 99.989999999999995 112.249 176.403 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 744' ' ' ALA . . . . . 0.466 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -83.22 103.25 12.48 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.484 -0.932 . . . . 99.989999999999995 108.484 169.072 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 745' ' ' LEU . . . . . 0.537 ' HA ' ' HA ' ' A' ' 723' ' ' ALA . 0.3 OUTLIER -85.36 166.26 16.58 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.622 -1.172 . . . . 99.989999999999995 111.538 -167.092 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -120.14 148.95 43.0 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.491 -0.777 . . . . 99.989999999999995 109.914 -176.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 747' ' ' GLY . . . . . 0.413 ' HA3' ' HB3' ' A' ' 721' ' ' PRO . . . 100.28 127.2 5.96 Favored Glycine 0 C--N 1.316 -0.546 0 N-CA-C 110.701 -0.96 . . . . 99.989999999999995 110.701 -173.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -102.08 124.59 47.94 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.327 0.584 . . . . 99.989999999999995 112.279 -170.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 108.06 -174.11 18.79 Favored Glycine 0 CA--C 1.501 -0.815 0 CA-C-N 115.147 -0.933 . . . . 99.989999999999995 111.542 178.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 750' ' ' PRO . . . . . 0.501 ' HB3' ' HE2' ' A' ' 774' ' ' LYS . 72.8 Cg_endo -65.93 100.62 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.384 0 C-N-CA 123.317 2.678 . . . . 99.989999999999995 113.619 -177.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 751' ' ' PHE . . . . . 0.66 ' CE2' ' HA ' ' A' ' 800' ' ' ASP . 62.1 m-85 -113.99 144.18 43.51 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.531 -0.758 . . . . 99.989999999999995 110.701 177.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 752' ' ' THR . . . . . 0.676 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 96.1 m -89.21 103.17 15.81 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 108.788 -0.819 . . . . 99.989999999999995 108.788 177.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 753' ' ' LEU . . . . . . . . . . . . . 24.9 tp -91.28 122.65 34.09 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.407 -1.27 . . . . 99.989999999999995 110.093 -171.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 754' ' ' THR . . . . . 0.42 HG23 ' HB2' ' A' ' 769' ' ' GLU . 0.6 OUTLIER -122.57 131.37 53.8 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.555 0.217 . . . . 99.989999999999995 110.748 179.795 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 755' ' ' TYR . . . . . 0.632 ' CE1' ' HB3' ' A' ' 768' ' ' PHE . 24.2 p90 -140.23 154.09 46.77 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.076 0.465 . . . . 99.989999999999995 111.453 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 756' ' ' ASP . . . . . 0.521 ' OD1' HG23 ' A' ' 758' ' ' ILE . 2.3 p30 -107.97 134.45 50.86 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.451 -0.795 . . . . 99.989999999999995 110.789 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 757' ' ' ILE . . . . . 0.449 HG21 ' HB3' ' A' ' 791' ' ' TYR . 4.5 mp -103.73 94.97 3.47 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 N-CA-C 107.036 -1.468 . . . . 99.989999999999995 107.036 167.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 758' ' ' ILE . . . . . 0.521 HG23 ' OD1' ' A' ' 756' ' ' ASP . 2.5 pp -100.77 145.99 10.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 115.461 -0.791 . . . . 99.989999999999995 111.769 -169.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -83.82 128.18 34.35 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 116.001 -0.545 . . . . 99.989999999999995 110.152 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 760' ' ' THR . . . . . 0.469 HG23 ' OD2' ' A' ' 790' ' ' ASP . 0.1 OUTLIER . . . . . 0 C--N 1.315 -0.921 0 CA-C-O 121.229 0.538 . . . . 99.989999999999995 110.055 175.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 765' ' ' ARG . . . . . 0.473 ' CG ' HG21 ' A' ' 758' ' ' ILE . 10.9 ttp180 . . . . . 0 N--CA 1.452 -0.373 0 N-CA-C 112.869 0.692 . . . . 99.989999999999995 112.869 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 766' ' ' LYS . . . . . 0.474 ' HD3' ' N ' ' A' ' 767' ' ' THR . 9.6 tmtm? -119.73 146.55 45.53 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 114.935 -1.03 . . . . 99.989999999999995 108.688 177.26 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 767' ' ' THR . . . . . 0.474 ' N ' ' HD3' ' A' ' 766' ' ' LYS . 89.1 m -123.31 131.36 53.64 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 120.62 0.248 . . . . 99.989999999999995 110.508 177.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 768' ' ' PHE . . . . . 0.632 ' HB3' ' CE1' ' A' ' 755' ' ' TYR . 1.8 t80 -127.78 135.06 49.58 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 109.025 -0.731 . . . . 99.989999999999995 109.025 178.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 769' ' ' GLU . . . . . 0.42 ' HB2' HG23 ' A' ' 754' ' ' THR . 34.5 tt0 -128.7 128.65 44.5 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.734 -0.666 . . . . 99.989999999999995 110.666 -177.244 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 770' ' ' ILE . . . . . 0.457 HG21 HG22 ' A' ' 773' ' ' ILE . 4.7 mt -123.12 113.33 37.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 109.182 -0.674 . . . . 99.989999999999995 109.182 177.117 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 771' ' ' LYS . . . . . 0.521 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 0.1 OUTLIER -84.3 155.76 22.25 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 121.181 0.515 . . . . 99.989999999999995 111.506 -175.914 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 772' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 53.72 44.57 29.46 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.316 -1.311 . . . . 99.989999999999995 112.318 176.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 773' ' ' ILE . . . . . 0.457 HG22 HG21 ' A' ' 770' ' ' ILE . 0.5 OUTLIER -73.44 112.1 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 N-CA-C 107.192 -1.41 . . . . 99.989999999999995 107.192 172.644 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 774' ' ' LYS . . . . . 0.501 ' HE2' ' HB3' ' A' ' 750' ' ' PRO . 71.3 mttt -107.8 26.37 10.41 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 108.273 -1.01 . . . . 99.989999999999995 108.273 -178.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 775' ' ' THR . . . . . 0.466 ' O ' ' HB2' ' A' ' 776' ' ' ASN . 0.4 OUTLIER -95.91 -74.8 0.54 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.067 -0.969 . . . . 99.989999999999995 113.488 -165.71 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 776' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 775' ' ' THR . 10.6 m120 83.53 7.86 0.65 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.344 1.057 . . . . 99.989999999999995 111.13 -175.486 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 777' ' ' GLU . . . . . 0.466 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 21.8 mt-10 -159.64 83.48 0.75 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.023 -0.99 . . . . 99.989999999999995 108.331 174.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 778' ' ' TYR . . . . . 0.528 ' HB3' HD11 ' A' ' 745' ' ' LEU . 83.2 t80 -129.61 129.39 44.3 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.347 -0.388 . . . . 99.989999999999995 110.911 -169.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 779' ' ' VAL . . . . . 0.64 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 14.1 t -89.42 111.26 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 CA-C-O 121.157 0.503 . . . . 99.989999999999995 110.213 178.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 780' ' ' ILE . . . . . 0.515 HG23 ' N ' ' A' ' 781' ' ' LYS . 72.9 mt -79.15 145.12 9.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.376 -0.829 . . . . 99.989999999999995 110.273 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 781' ' ' LYS . . . . . 0.515 ' N ' HG23 ' A' ' 780' ' ' ILE . 3.7 mppt? -130.3 108.8 10.28 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.717 -0.846 . . . . 99.989999999999995 108.717 174.226 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 782' ' ' THR . . . . . 0.436 ' O ' ' HB2' ' A' ' 738' ' ' HIS . 30.9 p -77.19 141.37 66.78 Favored Pre-proline 0 N--CA 1.444 -0.748 0 N-CA-C 109.238 -0.652 . . . . 99.989999999999995 109.238 -178.28 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 783' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -55.9 150.02 48.47 Favored 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 122.918 2.412 . . . . 99.989999999999995 111.274 -177.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 784' ' ' VAL . . . . . . . . . . . . . 14.9 p -61.81 133.03 27.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.433 0.635 . . . . 99.989999999999995 110.812 -172.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 785' ' ' PHE . . . . . 0.484 ' C ' ' H ' ' A' ' 787' ' ' THR . 88.9 m-85 -90.24 -37.47 14.09 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.64 -0.709 . . . . 99.989999999999995 111.834 -173.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 786' ' ' THR . . . . . 0.458 ' HA ' ' HA2' ' A' ' 736' ' ' GLY . 28.3 p 57.97 3.39 0.22 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.507 0.723 . . . . 99.989999999999995 111.744 -178.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 787' ' ' THR . . . . . 0.484 ' H ' ' C ' ' A' ' 785' ' ' PHE . 42.8 m -134.37 118.53 17.56 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.093 -0.503 . . . . 99.989999999999995 110.868 -179.165 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 788' ' ' GLY . . . . . . . . . . . . . . . -54.4 108.66 0.94 Allowed Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.523 -0.762 . . . . 99.989999999999995 113.224 174.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 789' ' ' GLY . . . . . 0.448 ' H ' ' HB ' ' A' ' 817' ' ' VAL . . . -155.56 167.16 33.0 Favored Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 110.438 -1.065 . . . . 99.989999999999995 110.438 174.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 790' ' ' ASP . . . . . 0.469 ' OD2' HG23 ' A' ' 760' ' ' THR . 0.2 OUTLIER -109.3 129.39 55.52 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 117.567 0.684 . . . . 99.989999999999995 109.906 179.335 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 791' ' ' TYR . . . . . 0.449 ' HB3' HG21 ' A' ' 757' ' ' ILE . 48.7 m-85 -130.0 156.17 44.91 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.33 -0.85 . . . . 99.989999999999995 110.213 -174.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 792' ' ' ILE . . . . . 0.5 ' O ' HG13 ' A' ' 758' ' ' ILE . 14.5 mt -128.45 119.07 49.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 109.354 -0.609 . . . . 99.989999999999995 109.354 174.241 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 793' ' ' LEU . . . . . 0.483 ' HA ' ' O ' ' A' ' 756' ' ' ASP . 10.1 tt -84.51 107.36 16.71 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 108.745 -0.835 . . . . 99.989999999999995 108.745 179.267 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 794' ' ' SER . . . . . 0.408 ' HB2' ' OD1' ' A' ' 756' ' ' ASP . 3.7 m -116.23 170.87 8.2 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.476 -0.783 . . . . 99.989999999999995 109.14 -179.099 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 795' ' ' LEU . . . . . . . . . . . . . 22.8 mt -97.68 129.6 44.73 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.603 0.239 . . . . 99.989999999999995 110.977 -175.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 796' ' ' VAL . . . . . . . . . . . . . 75.0 t -88.94 -56.1 5.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 99.989999999999995 110.812 -179.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 797' ' ' SER . . . . . 0.502 ' HA ' ' HG ' ' A' ' 808' ' ' LEU . 24.4 m -173.39 164.15 4.59 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.656 -0.702 . . . . 99.989999999999995 110.128 -173.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 798' ' ' ILE . . . . . 0.59 ' O ' ' HA ' ' A' ' 805' ' ' VAL . 11.5 tt -136.15 167.55 24.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 108.585 -0.894 . . . . 99.989999999999995 108.585 176.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 799' ' ' LYS . . . . . 0.676 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 83.6 tttt -136.04 120.56 18.18 Favored 'General case' 0 C--N 1.315 -0.932 0 C-N-CA 120.84 -0.344 . . . . 99.989999999999995 111.248 -176.096 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 800' ' ' ASP . . . . . 0.66 ' HA ' ' CE2' ' A' ' 751' ' ' PHE . 6.2 m-20 -63.12 156.46 24.98 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-N 115.497 -0.774 . . . . 99.989999999999995 109.279 174.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 4.0 m -64.81 -5.22 5.47 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 124.151 0.907 . . . . 99.989999999999995 112.212 -174.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 8.9 t -104.98 12.63 32.11 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.757 0.789 . . . . 99.989999999999995 109.617 175.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 803' ' ' GLY . . . . . 0.469 ' HA2' ' CE ' ' A' ' 799' ' ' LYS . . . 74.71 46.85 16.7 Favored Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.121 -0.945 . . . . 99.989999999999995 112.831 -179.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 804' ' ' CYS . . . . . 0.568 ' HB3' ' HB2' ' A' ' 800' ' ' ASP . 53.7 t -109.87 106.23 15.73 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.807 -0.442 . . . . 99.989999999999995 109.807 177.181 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 805' ' ' VAL . . . . . 0.59 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 2.6 t -86.69 104.95 14.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.591 0.71 . . . . 99.989999999999995 110.704 -175.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 806' ' ' VAL . . . . . . . . . . . . . 39.5 t -90.13 138.54 19.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 114.954 -1.021 . . . . 99.989999999999995 111.065 -178.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -74.96 113.21 3.91 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 115.31 -0.859 . . . . 99.989999999999995 111.662 178.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 808' ' ' LEU . . . . . 0.525 ' CD2' ' HA ' ' A' ' 722' ' ' SER . 30.8 mt -80.17 132.02 35.82 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.662 0.615 . . . . 99.989999999999995 112.662 -174.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 20.4 m -143.97 85.65 1.82 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.258 -0.883 . . . . 99.989999999999995 109.52 171.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 810' ' ' GLN . . . . . 0.479 ' HB3' ' O ' ' A' ' 723' ' ' ALA . 1.0 OUTLIER -146.69 173.91 3.83 Favored Pre-proline 0 CA--C 1.542 0.645 0 CA-C-N 115.452 -0.795 . . . . 99.989999999999995 109.363 177.501 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 811' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -44.0 154.47 0.26 Allowed 'Trans proline' 0 C--N 1.359 1.08 0 C-N-CA 123.782 2.988 . . . . 99.989999999999995 116.294 -173.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -131.35 167.83 18.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 113.797 -1.547 . . . . 99.989999999999995 109.613 -178.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 813' ' ' ALA . . . . . 0.445 ' HB2' HD21 ' A' ' 725' ' ' LEU . . . -127.69 148.65 50.4 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.748 0.308 . . . . 99.989999999999995 110.505 178.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 814' ' ' LYS . . . . . 0.427 ' O ' ' HA ' ' A' ' 730' ' ' ASP . 50.3 tttm -110.17 112.79 24.99 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.14 0.495 . . . . 99.989999999999995 110.704 -176.254 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 815' ' ' ILE . . . . . 0.558 ' HA ' ' HB3' ' A' ' 731' ' ' LEU . 5.3 mp -98.21 127.66 50.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.716 -0.675 . . . . 99.989999999999995 109.855 -178.307 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 816' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -114.42 110.6 20.13 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.742 0.306 . . . . 99.989999999999995 110.842 -178.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 817' ' ' VAL . . . . . 0.448 ' HB ' ' H ' ' A' ' 789' ' ' GLY . 61.3 t -105.66 127.66 60.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 108.814 -0.81 . . . . 99.989999999999995 108.814 175.391 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 818' ' ' ARG . . . . . . . . . . . . . 25.4 mmt180 . . . . . 0 C--N 1.327 -0.394 0 O-C-N 121.849 -0.532 . . . . 99.989999999999995 111.319 177.33 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 720' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp . . . . . 0 N--CA 1.451 -0.398 0 N-CA-C 109.36 -0.607 . . . . 99.989999999999995 109.36 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 721' ' ' PRO . . . . . 0.507 ' O ' HG23 ' A' ' 798' ' ' ILE . 46.3 Cg_endo -88.25 140.76 4.76 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 123.08 2.52 . . . . 99.989999999999995 112.115 -173.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 722' ' ' SER . . . . . 0.458 ' HG ' ' C ' ' A' ' 721' ' ' PRO . 25.2 m -174.83 -151.44 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.418 -0.586 . . . . 99.989999999999995 109.418 -170.096 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 723' ' ' ALA . . . . . 0.52 ' HB1' HG12 ' A' ' 743' ' ' VAL . . . -146.65 149.0 32.63 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 109.792 -0.447 . . . . 99.989999999999995 109.792 174.054 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 28.5 t -131.66 98.38 4.47 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.178 -1.045 . . . . 99.989999999999995 108.178 179.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 725' ' ' LEU . . . . . 0.601 HD21 ' CG2' ' A' ' 743' ' ' VAL . 2.0 mt -66.79 143.69 56.75 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-O 121.441 0.638 . . . . 99.989999999999995 110.984 -171.053 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 35.6 mtpt -94.45 -19.61 20.42 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.869 -1.06 . . . . 99.989999999999995 111.079 -174.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 727' ' ' LEU . . . . . . . . . . . . . 25.9 tp -56.67 129.54 41.5 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.833 -0.622 . . . . 99.989999999999995 110.04 178.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 8.3 t-160 -117.82 16.28 14.37 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.803 -0.359 . . . . 99.989999999999995 111.943 -173.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -169.84 -178.8 3.05 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 122.311 -0.243 . . . . 99.989999999999995 110.886 177.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 730' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.32 132.25 52.03 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.159 0.504 . . . . 99.989999999999995 110.726 175.048 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 731' ' ' LEU . . . . . 0.586 HD22 ' H ' ' A' ' 740' ' ' SER . 49.3 tp -91.56 102.1 14.75 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.652 -0.704 . . . . 99.989999999999995 110.07 177.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 732' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -77.51 122.57 25.42 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.118 -0.492 . . . . 99.989999999999995 111.647 -174.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 733' ' ' LEU . . . . . 0.62 ' HG ' ' HB3' ' A' ' 737' ' ' ASP . 7.8 mp -120.79 164.22 16.94 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.532 -0.758 . . . . 99.989999999999995 110.708 178.242 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 734' ' ' CYS . . . . . 0.55 ' O ' ' HB2' ' A' ' 737' ' ' ASP . 66.1 m -116.49 -178.27 3.38 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.314 -0.857 . . . . 99.989999999999995 109.089 173.001 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 735' ' ' LEU . . . . . . . . . . . . . 31.0 tp -63.42 122.92 17.44 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.894 0.378 . . . . 99.989999999999995 111.236 -176.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 82.43 7.64 87.3 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.438 -0.887 . . . . 99.989999999999995 112.384 178.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 737' ' ' ASP . . . . . 0.62 ' HB3' ' HG ' ' A' ' 733' ' ' LEU . 0.2 OUTLIER -72.2 154.04 41.26 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.909 0.385 . . . . 99.989999999999995 110.953 176.076 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 738' ' ' HIS . . . . . 0.477 ' HB3' HG21 ' A' ' 784' ' ' VAL . 37.9 p-80 -112.85 148.49 34.79 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 107.605 -1.257 . . . . 99.989999999999995 107.605 171.373 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 739' ' ' SER . . . . . 0.499 ' HB2' HG23 ' A' ' 782' ' ' THR . 4.6 m -94.93 158.09 15.63 Favored 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 119.966 -0.694 . . . . 99.989999999999995 110.927 -172.322 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 740' ' ' SER . . . . . 0.586 ' H ' HD22 ' A' ' 731' ' ' LEU . 12.5 p -144.19 100.85 3.62 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.941 -1.027 . . . . 99.989999999999995 109.213 -178.543 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 741' ' ' VAL . . . . . 0.482 HG13 HD12 ' A' ' 793' ' ' LEU . 0.4 OUTLIER -117.51 119.12 34.68 Favored Pre-proline 0 C--N 1.314 -0.968 0 CA-C-N 115.783 -0.644 . . . . 99.989999999999995 109.459 179.973 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 742' ' ' PRO . . . . . 0.664 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 10.1 Cg_endo -80.86 134.12 9.42 Favored 'Trans proline' 0 N--CA 1.435 -1.93 0 C-N-CA 121.712 1.608 . . . . 99.989999999999995 110.649 -179.482 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 743' ' ' VAL . . . . . 0.601 ' CG2' HD21 ' A' ' 725' ' ' LEU . 49.0 t -132.77 119.64 38.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 121.336 0.588 . . . . 99.989999999999995 111.913 -178.507 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 744' ' ' ALA . . . . . 0.598 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -81.77 95.33 7.24 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 122.129 0.966 . . . . 99.989999999999995 108.653 170.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 745' ' ' LEU . . . . . 0.509 ' HA ' ' HA ' ' A' ' 723' ' ' ALA . 1.9 mt -77.84 159.86 28.69 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.045 -1.434 . . . . 99.989999999999995 111.384 -168.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 8.5 tptp -111.58 166.47 11.12 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.076 -0.511 . . . . 99.989999999999995 110.626 -178.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 747' ' ' GLY . . . . . . . . . . . . . . . 96.1 124.87 4.64 Favored Glycine 0 C--N 1.312 -0.756 0 CA-C-N 115.309 -0.86 . . . . 99.989999999999995 111.714 -173.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 748' ' ' GLN . . . . . 0.442 ' C ' ' HE1' ' A' ' 751' ' ' PHE . 26.6 mm-40 -103.57 95.51 6.11 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 122.676 -0.308 . . . . 99.989999999999995 111.026 -176.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 134.48 -164.73 24.59 Favored Glycine 0 C--O 1.223 -0.589 0 N-CA-C 111.269 -0.732 . . . . 99.989999999999995 111.269 -178.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -74.25 94.35 0.9 Allowed 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.719 2.279 . . . . 99.989999999999995 112.084 179.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 751' ' ' PHE . . . . . 0.711 ' CE2' ' HA ' ' A' ' 800' ' ' ASP . 81.2 m-85 -115.71 141.67 47.77 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.616 -0.72 . . . . 99.989999999999995 110.585 -179.381 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 752' ' ' THR . . . . . 0.681 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 73.5 m -97.63 105.73 17.92 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-O 121.709 0.766 . . . . 99.989999999999995 109.352 -179.319 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 753' ' ' LEU . . . . . 0.477 HD13 ' HB3' ' A' ' 723' ' ' ALA . 3.9 tt -105.11 114.1 28.09 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 114.47 -1.241 . . . . 99.989999999999995 110.015 -168.206 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 754' ' ' THR . . . . . 0.481 HG23 ' HB2' ' A' ' 769' ' ' GLU . 1.5 m -107.9 136.3 47.84 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.384 -0.371 . . . . 99.989999999999995 110.769 -176.186 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 755' ' ' TYR . . . . . . . . . . . . . 26.2 p90 -135.6 159.6 41.11 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.036 0.446 . . . . 99.989999999999995 111.694 179.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 756' ' ' ASP . . . . . 0.573 ' OD2' ' HB3' ' A' ' 794' ' ' SER . 3.1 p30 -118.53 128.33 54.47 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.583 -0.735 . . . . 99.989999999999995 111.447 -178.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 757' ' ' ILE . . . . . 0.466 HG13 HD13 ' A' ' 793' ' ' LEU . 4.2 mp -98.18 94.04 3.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 107.425 -1.324 . . . . 99.989999999999995 107.425 167.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 758' ' ' ILE . . . . . 0.521 HG13 ' O ' ' A' ' 792' ' ' ILE . 2.6 pp -99.38 142.45 15.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-O 121.552 0.692 . . . . 99.989999999999995 112.033 -169.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 759' ' ' GLU . . . . . 0.54 ' HG2' ' CD2' ' A' ' 791' ' ' TYR . 24.8 mt-10 -96.54 101.14 12.72 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.999 -1.0 . . . . 99.989999999999995 110.145 -171.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 760' ' ' THR . . . . . 0.413 HG23 ' HB2' ' A' ' 790' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.32 -0.683 0 CA-C-N 115.072 -0.967 . . . . 99.989999999999995 111.382 -169.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 765' ' ' ARG . . . . . 0.451 ' HA ' ' HA ' ' A' ' 758' ' ' ILE . 16.4 ttp180 . . . . . 0 N--CA 1.443 -0.793 0 CA-C-O 120.974 0.416 . . . . 99.989999999999995 111.666 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 766' ' ' LYS . . . . . 0.667 ' HD3' ' N ' ' A' ' 767' ' ' THR . 10.4 tmtt? -123.48 147.59 47.04 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.187 -1.042 . . . . 99.989999999999995 108.187 178.168 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 767' ' ' THR . . . . . 0.667 ' N ' ' HD3' ' A' ' 766' ' ' LYS . 62.0 m -132.31 141.92 49.15 Favored 'General case' 0 C--N 1.314 -0.975 0 O-C-N 122.301 -0.25 . . . . 99.989999999999995 111.618 -176.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 768' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -145.49 144.35 30.52 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.724 0.297 . . . . 99.989999999999995 110.536 176.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 769' ' ' GLU . . . . . 0.481 ' HB2' HG23 ' A' ' 754' ' ' THR . 41.2 tt0 -127.06 126.05 42.4 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.13 -0.486 . . . . 99.989999999999995 111.498 -175.254 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 5.2 mm -107.22 103.39 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 N-CA-C 108.474 -0.936 . . . . 99.989999999999995 108.474 178.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 771' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 12.3 mtpt -83.22 149.93 26.51 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 120.289 -0.564 . . . . 99.989999999999995 110.648 -179.053 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 772' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 50.96 50.46 19.06 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.488 -1.233 . . . . 99.989999999999995 112.205 -179.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 773' ' ' ILE . . . . . 0.487 ' O ' HG13 ' A' ' 773' ' ' ILE . 0.5 OUTLIER -76.12 117.92 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 107.808 -1.182 . . . . 99.989999999999995 107.808 173.416 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 78.4 mttt -118.15 28.09 8.59 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 108.681 -0.859 . . . . 99.989999999999995 108.681 -178.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 775' ' ' THR . . . . . 0.466 ' O ' ' HB2' ' A' ' 776' ' ' ASN . 0.9 OUTLIER -95.18 -72.19 0.64 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.572 -1.195 . . . . 99.989999999999995 112.429 -171.538 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 776' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 775' ' ' THR . 10.8 m120 87.7 4.39 0.31 Allowed 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.703 1.201 . . . . 99.989999999999995 110.031 -178.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 777' ' ' GLU . . . . . 0.598 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 21.7 tt0 -162.69 96.28 0.93 Allowed 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 115.049 -0.978 . . . . 99.989999999999995 109.143 172.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 778' ' ' TYR . . . . . 0.495 ' HB3' HD12 ' A' ' 745' ' ' LEU . 83.3 t80 -139.63 128.83 23.88 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.54 -0.755 . . . . 99.989999999999995 111.081 -170.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 779' ' ' VAL . . . . . 0.664 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 7.6 t -84.73 105.91 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-N 116.044 -0.525 . . . . 99.989999999999995 110.196 -179.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 780' ' ' ILE . . . . . . . . . . . . . 70.1 mt -77.06 132.59 32.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.329 -0.85 . . . . 99.989999999999995 110.697 -178.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -117.18 109.58 17.08 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.385 0.612 . . . . 99.989999999999995 110.262 179.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 782' ' ' THR . . . . . 0.499 HG23 ' HB2' ' A' ' 739' ' ' SER . 1.1 p -80.82 149.22 66.88 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 115.239 -0.891 . . . . 99.989999999999995 109.526 -176.516 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 783' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -51.7 161.38 2.14 Favored 'Trans proline' 0 N--CA 1.473 0.292 0 C-N-CA 123.737 2.958 . . . . 99.989999999999995 113.34 -178.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 784' ' ' VAL . . . . . 0.512 HG12 HG21 ' A' ' 786' ' ' THR . 55.1 t -62.69 122.13 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 115.381 -0.827 . . . . 99.989999999999995 111.309 177.259 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 785' ' ' PHE . . . . . 0.416 ' C ' ' H ' ' A' ' 787' ' ' THR . 68.7 m-85 -103.31 96.09 6.53 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.705 -0.68 . . . . 99.989999999999995 110.557 178.064 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 786' ' ' THR . . . . . 0.512 HG21 HG12 ' A' ' 784' ' ' VAL . 46.0 p -85.12 36.98 0.65 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.926 0.87 . . . . 99.989999999999995 110.369 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 787' ' ' THR . . . . . 0.436 ' HG1' ' C ' ' A' ' 786' ' ' THR . 58.4 m -159.48 110.26 1.98 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.336 -1.302 . . . . 99.989999999999995 110.191 179.345 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 788' ' ' GLY . . . . . 0.646 ' HA2' ' CG2' ' A' ' 817' ' ' VAL . . . -54.39 134.56 45.59 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.919 -0.658 . . . . 99.989999999999995 113.241 173.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 789' ' ' GLY . . . . . 0.588 ' H ' HG13 ' A' ' 817' ' ' VAL . . . -178.35 -170.43 40.46 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 110.724 -0.95 . . . . 99.989999999999995 110.724 179.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 790' ' ' ASP . . . . . 0.462 ' OD2' ' HG2' ' A' ' 816' ' ' GLN . 6.6 m-20 -114.16 130.6 56.6 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.155 -0.683 . . . . 99.989999999999995 109.155 174.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 791' ' ' TYR . . . . . 0.54 ' CD2' ' HG2' ' A' ' 759' ' ' GLU . 60.2 m-85 -131.27 123.85 29.25 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.603 -0.517 . . . . 99.989999999999995 109.603 -179.119 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 792' ' ' ILE . . . . . 0.521 ' O ' HG13 ' A' ' 758' ' ' ILE . 19.8 mt -103.88 116.52 47.81 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 C-N-CA 120.445 -0.502 . . . . 99.989999999999995 109.778 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 793' ' ' LEU . . . . . 0.482 HD12 HG13 ' A' ' 741' ' ' VAL . 3.6 tt -83.87 106.28 15.43 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 108.364 -0.976 . . . . 99.989999999999995 108.364 177.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 794' ' ' SER . . . . . 0.573 ' HB3' ' OD2' ' A' ' 756' ' ' ASP . 15.2 t -117.77 179.46 4.07 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.852 -1.067 . . . . 99.989999999999995 108.765 -177.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 795' ' ' LEU . . . . . . . . . . . . . 58.2 mt -106.38 130.62 54.17 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 120.681 0.277 . . . . 99.989999999999995 111.01 -175.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 796' ' ' VAL . . . . . . . . . . . . . 51.4 t -88.89 -56.86 4.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.065 -0.516 . . . . 99.989999999999995 111.202 -177.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 797' ' ' SER . . . . . . . . . . . . . 24.4 m -173.45 168.89 4.49 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.027 -0.533 . . . . 99.989999999999995 110.012 -173.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 798' ' ' ILE . . . . . 0.645 HG22 ' HB ' ' A' ' 806' ' ' VAL . 0.4 OUTLIER -141.01 166.4 18.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 N-CA-C 108.636 -0.875 . . . . 99.989999999999995 108.636 -173.906 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 799' ' ' LYS . . . . . 0.681 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 26.0 tttm -140.31 118.42 11.94 Favored 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 120.4 -0.52 . . . . 99.989999999999995 111.533 -177.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 800' ' ' ASP . . . . . 0.711 ' HA ' ' CE2' ' A' ' 751' ' ' PHE . 12.4 t70 -70.6 156.93 38.79 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.884 -1.053 . . . . 99.989999999999995 109.114 174.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 12.8 t -67.28 -5.22 13.13 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 123.652 0.595 . . . . 99.989999999999995 111.287 -172.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 18.5 p -95.87 7.72 45.55 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.459 0.647 . . . . 99.989999999999995 109.919 174.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 803' ' ' GLY . . . . . . . . . . . . . . . 74.9 32.37 56.95 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.048 -0.978 . . . . 99.989999999999995 111.969 -177.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 804' ' ' CYS . . . . . 0.508 ' HB3' ' HB3' ' A' ' 800' ' ' ASP . 37.1 t -99.16 108.03 20.54 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.411 -0.588 . . . . 99.989999999999995 109.411 -179.132 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 805' ' ' VAL . . . . . 0.554 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 3.3 t -85.05 106.54 15.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.194 0.521 . . . . 99.989999999999995 110.303 -174.231 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 806' ' ' VAL . . . . . 0.645 ' HB ' HG22 ' A' ' 798' ' ' ILE . 22.9 t -92.88 136.84 23.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.53 -0.759 . . . . 99.989999999999995 110.021 -178.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -74.94 134.27 16.8 Favored Glycine 0 N--CA 1.451 -0.311 0 CA-C-N 115.702 -0.681 . . . . 99.989999999999995 111.465 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 808' ' ' LEU . . . . . 0.533 HD23 ' HB ' ' A' ' 798' ' ' ILE . 46.3 mt -99.06 130.81 45.42 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 113.239 0.829 . . . . 99.989999999999995 113.239 -173.489 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 6.1 t -145.83 85.65 1.7 Allowed 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.219 -0.901 . . . . 99.989999999999995 109.232 171.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 810' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -138.22 174.96 3.72 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-O 118.798 -0.62 . . . . 99.989999999999995 109.735 178.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 811' ' ' PRO . . . . . 0.472 ' O ' ' HG ' ' A' ' 725' ' ' LEU . 83.2 Cg_exo -43.79 152.86 0.3 Allowed 'Trans proline' 0 C--N 1.361 1.225 0 C-N-CA 123.347 2.698 . . . . 99.989999999999995 114.68 -177.395 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 812' ' ' ASP . . . . . 0.507 ' C ' HD12 ' A' ' 725' ' ' LEU . 7.9 p-10 -122.73 165.51 16.44 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.317 -0.856 . . . . 99.989999999999995 111.273 -176.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 813' ' ' ALA . . . . . 0.444 ' N ' HD12 ' A' ' 725' ' ' LEU . . . -120.98 113.04 19.51 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.0 -1.0 . . . . 99.989999999999995 110.193 -175.468 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 814' ' ' LYS . . . . . . . . . . . . . 41.6 tttm -93.4 112.15 23.99 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.436 0.636 . . . . 99.989999999999995 111.488 -177.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 815' ' ' ILE . . . . . 0.579 ' HA ' ' HB3' ' A' ' 731' ' ' LEU . 4.7 mp -93.25 135.54 27.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.278 -0.874 . . . . 99.989999999999995 109.254 175.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 816' ' ' GLN . . . . . 0.462 ' HG2' ' OD2' ' A' ' 790' ' ' ASP . 0.5 OUTLIER -128.87 106.95 9.26 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.943 0.401 . . . . 99.989999999999995 109.982 178.525 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 817' ' ' VAL . . . . . 0.646 ' CG2' ' HA2' ' A' ' 788' ' ' GLY . 0.2 OUTLIER -103.19 142.53 16.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-O 121.324 0.583 . . . . 99.989999999999995 110.577 179.052 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 818' ' ' ARG . . . . . 0.501 ' N ' HG22 ' A' ' 817' ' ' VAL . 35.6 mmt180 . . . . . 0 C--N 1.308 -1.212 0 N-CA-C 108.722 -0.844 . . . . 99.989999999999995 108.722 175.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 720' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm . . . . . 0 N--CA 1.452 -0.333 0 N-CA-C 109.735 -0.468 . . . . 99.989999999999995 109.735 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 721' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -86.91 152.2 8.49 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 122.46 2.107 . . . . 99.989999999999995 111.791 -176.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 722' ' ' SER . . . . . 0.536 ' HB3' ' NE2' ' A' ' 810' ' ' GLN . 21.6 t 177.53 -151.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.271 -0.64 . . . . 99.989999999999995 109.271 -172.314 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 723' ' ' ALA . . . . . 0.528 ' HB1' HG23 ' A' ' 743' ' ' VAL . . . -150.67 143.09 24.34 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 121.238 -0.185 . . . . 99.989999999999995 111.114 178.138 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 37.1 t -127.72 102.51 6.84 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 108.966 -0.753 . . . . 99.989999999999995 108.966 -179.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 725' ' ' LEU . . . . . 0.484 ' CD2' ' HB ' ' A' ' 743' ' ' VAL . 12.5 mt -63.88 147.08 52.78 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-O 121.641 0.734 . . . . 99.989999999999995 111.455 -175.215 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 34.2 mtpt -99.84 -15.85 18.26 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.809 -1.087 . . . . 99.989999999999995 110.042 -176.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 727' ' ' LEU . . . . . 0.457 HD21 ' HB3' ' A' ' 813' ' ' ALA . 48.3 tp -64.58 132.34 49.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.681 -0.69 . . . . 99.989999999999995 110.248 178.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -103.76 -26.26 12.8 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.095 0.405 . . . . 99.989999999999995 112.095 -173.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -122.98 173.12 8.01 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.792 -0.363 . . . . 99.989999999999995 111.807 -173.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 730' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -74.38 140.66 44.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.536 -0.756 . . . . 99.989999999999995 109.403 177.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 731' ' ' LEU . . . . . 0.607 ' HB2' ' HA ' ' A' ' 815' ' ' ILE . 73.5 mt -84.39 100.02 11.02 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.417 -0.356 . . . . 99.989999999999995 111.326 -179.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 732' ' ' LYS . . . . . 0.486 ' HE3' ' OE1' ' A' ' 816' ' ' GLN . 14.1 mmmm -76.97 112.87 14.05 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.838 -0.619 . . . . 99.989999999999995 110.637 -179.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 733' ' ' LEU . . . . . 0.47 HD13 ' CG2' ' A' ' 815' ' ' ILE . 58.2 mt -123.34 158.58 30.72 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.153 -0.476 . . . . 99.989999999999995 111.108 -178.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 734' ' ' CYS . . . . . 0.518 ' O ' ' HB2' ' A' ' 737' ' ' ASP . 21.2 p -107.68 -173.36 2.27 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 107.791 -1.189 . . . . 99.989999999999995 107.791 167.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 735' ' ' LEU . . . . . 0.54 ' CD1' ' H ' ' A' ' 788' ' ' GLY . 1.4 tp -71.95 148.92 45.52 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 120.055 -0.658 . . . . 99.989999999999995 111.032 -171.01 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 736' ' ' GLY . . . . . 0.471 ' HA2' ' HA ' ' A' ' 786' ' ' THR . . . 76.22 10.02 85.49 Favored Glycine 0 C--N 1.321 -0.258 0 CA-C-N 115.453 -0.794 . . . . 99.989999999999995 112.54 -179.587 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 737' ' ' ASP . . . . . 0.518 ' HB2' ' O ' ' A' ' 734' ' ' CYS . 0.7 OUTLIER -93.68 155.24 17.37 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 113.15 0.796 . . . . 99.989999999999995 113.15 -177.719 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 738' ' ' HIS . . . . . 0.498 ' HB2' ' O ' ' A' ' 782' ' ' THR . 37.4 p-80 -121.86 -175.57 3.13 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 107.51 -1.293 . . . . 99.989999999999995 107.51 168.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 739' ' ' SER . . . . . 0.483 ' HB3' HD11 ' A' ' 731' ' ' LEU . 67.9 m -145.85 176.37 9.72 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.128 -0.629 . . . . 99.989999999999995 112.502 178.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 740' ' ' SER . . . . . 0.455 ' HA ' ' O ' ' A' ' 780' ' ' ILE . 9.7 p -142.43 109.7 5.62 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.085 -0.961 . . . . 99.989999999999995 110.144 176.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 741' ' ' VAL . . . . . 0.458 HG12 HD13 ' A' ' 793' ' ' LEU . 2.3 p -105.04 116.01 61.39 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.758 -0.656 . . . . 99.989999999999995 109.708 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 742' ' ' PRO . . . . . 0.605 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 3.7 Cg_exo -75.13 131.15 13.82 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 122.244 1.963 . . . . 99.989999999999995 111.03 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 743' ' ' VAL . . . . . 0.528 HG23 ' HB1' ' A' ' 723' ' ' ALA . 1.8 p -131.47 120.07 44.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.656 0.741 . . . . 99.989999999999995 112.72 178.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 744' ' ' ALA . . . . . 0.545 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -82.41 109.9 17.06 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.582 -0.895 . . . . 99.989999999999995 108.582 168.373 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 745' ' ' LEU . . . . . 0.525 HD11 ' HB3' ' A' ' 778' ' ' TYR . 0.4 OUTLIER -93.23 157.94 16.01 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.828 -1.078 . . . . 99.989999999999995 111.599 -164.652 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 37.9 tptt -105.06 157.69 17.07 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.357 -0.838 . . . . 99.989999999999995 109.235 178.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 747' ' ' GLY . . . . . . . . . . . . . . . 93.42 120.76 3.06 Favored Glycine 0 C--N 1.305 -1.186 0 N-CA-C 110.835 -0.906 . . . . 99.989999999999995 110.835 -175.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -96.37 115.4 27.38 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.04 0.448 . . . . 99.989999999999995 112.081 -170.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 749' ' ' GLY . . . . . 0.41 ' O ' ' HD1' ' A' ' 751' ' ' PHE . . . 109.88 -167.66 12.86 Favored Glycine 0 CA--C 1.5 -0.853 0 CA-C-N 115.645 -0.707 . . . . 99.989999999999995 111.531 179.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 750' ' ' PRO . . . . . 0.45 ' HB3' ' HE2' ' A' ' 774' ' ' LYS . 85.5 Cg_endo -66.24 95.08 0.31 Allowed 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 123.73 2.953 . . . . 99.989999999999995 113.617 -175.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 751' ' ' PHE . . . . . 0.474 ' CE2' ' HA ' ' A' ' 800' ' ' ASP . 56.7 m-85 -112.43 142.68 44.68 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.574 -0.739 . . . . 99.989999999999995 110.68 177.482 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 752' ' ' THR . . . . . 0.713 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 96.4 m -88.93 106.14 18.22 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.28 -0.637 . . . . 99.989999999999995 109.28 178.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 753' ' ' LEU . . . . . . . . . . . . . 12.3 tp -100.2 110.11 22.37 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.052 -0.977 . . . . 99.989999999999995 111.091 -172.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 754' ' ' THR . . . . . 0.428 HG23 ' HB2' ' A' ' 769' ' ' GLU . 1.2 m -99.43 135.24 41.13 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 116.391 -0.368 . . . . 99.989999999999995 110.442 177.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 755' ' ' TYR . . . . . . . . . . . . . 39.3 p90 -136.29 148.34 47.93 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 121.147 0.499 . . . . 99.989999999999995 111.638 179.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 756' ' ' ASP . . . . . 0.578 ' O ' ' HA ' ' A' ' 793' ' ' LEU . 2.5 p30 -110.22 137.96 47.25 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 115.644 -0.707 . . . . 99.989999999999995 110.789 178.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 757' ' ' ILE . . . . . 0.423 HG21 ' HB3' ' A' ' 791' ' ' TYR . 4.3 mp -107.66 94.79 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.087 0 N-CA-C 107.373 -1.343 . . . . 99.989999999999995 107.373 166.091 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 758' ' ' ILE . . . . . 0.569 HG23 ' OD2' ' A' ' 756' ' ' ASP . 2.6 pp -99.84 150.36 5.38 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-N 115.864 -0.607 . . . . 99.989999999999995 111.92 -169.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 759' ' ' GLU . . . . . 0.615 ' HG2' ' CE2' ' A' ' 791' ' ' TYR . 9.4 mt-10 -88.16 120.92 29.98 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 115.991 -0.549 . . . . 99.989999999999995 111.174 -179.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 760' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.312 -1.052 0 N-CA-C 108.245 -1.02 . . . . 99.989999999999995 108.245 169.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 765' ' ' ARG . . . . . 0.414 ' HG3' HG21 ' A' ' 758' ' ' ILE . 12.3 ttp180 . . . . . 0 N--CA 1.452 -0.327 0 CA-C-O 121.193 0.521 . . . . 99.989999999999995 111.477 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 766' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -120.5 146.54 46.18 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 108.975 -0.75 . . . . 99.989999999999995 108.975 -178.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 767' ' ' THR . . . . . . . . . . . . . 90.0 m -128.48 136.22 50.52 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 120.573 0.225 . . . . 99.989999999999995 110.836 -179.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 768' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -141.09 145.07 35.32 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.897 -0.408 . . . . 99.989999999999995 109.897 177.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 769' ' ' GLU . . . . . 0.428 ' HB2' HG23 ' A' ' 754' ' ' THR . 32.9 tt0 -128.17 132.0 48.89 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.985 0.421 . . . . 99.989999999999995 111.447 -176.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 11.1 mm -111.73 100.57 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 N-CA-C 108.312 -0.996 . . . . 99.989999999999995 108.312 178.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 771' ' ' LYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 12.6 mtpt -79.98 150.54 30.42 Favored 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 120.044 -0.662 . . . . 99.989999999999995 111.04 -177.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 772' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 53.7 48.16 22.14 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.04 -1.437 . . . . 99.989999999999995 112.521 177.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -73.34 117.6 17.33 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.578 0 N-CA-C 107.138 -1.43 . . . . 99.989999999999995 107.138 171.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 774' ' ' LYS . . . . . 0.45 ' HE2' ' HB3' ' A' ' 750' ' ' PRO . 59.5 mttt -112.08 28.04 9.12 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 108.582 -0.896 . . . . 99.989999999999995 108.582 -179.248 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 775' ' ' THR . . . . . 0.485 ' O ' ' HB2' ' A' ' 776' ' ' ASN . 0.2 OUTLIER -95.69 -76.7 0.49 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.862 -1.063 . . . . 99.989999999999995 113.5 -167.874 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 776' ' ' ASN . . . . . 0.485 ' HB2' ' O ' ' A' ' 775' ' ' THR . 12.2 m120 88.48 3.91 0.25 Allowed 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.943 1.297 . . . . 99.989999999999995 111.054 -175.144 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 777' ' ' GLU . . . . . 0.545 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 9.9 mt-10 -161.07 88.29 0.75 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.461 -0.791 . . . . 99.989999999999995 109.025 172.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 778' ' ' TYR . . . . . 0.525 ' HB3' HD11 ' A' ' 745' ' ' LEU . 63.9 t80 -133.51 136.68 45.21 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.43 -0.35 . . . . 99.989999999999995 110.611 -170.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 779' ' ' VAL . . . . . 0.605 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 21.5 t -91.25 115.77 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 CA-C-O 121.337 0.589 . . . . 99.989999999999995 110.309 178.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 780' ' ' ILE . . . . . 0.455 ' O ' ' HA ' ' A' ' 740' ' ' SER . 61.7 mt -82.74 142.22 13.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.147 -0.933 . . . . 99.989999999999995 110.309 -179.125 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 781' ' ' LYS . . . . . 0.42 ' N ' HG23 ' A' ' 780' ' ' ILE . 0.0 OUTLIER -113.13 110.77 20.98 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.444 -0.576 . . . . 99.989999999999995 109.444 179.153 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 782' ' ' THR . . . . . 0.498 ' O ' ' HB2' ' A' ' 738' ' ' HIS . 70.3 p -77.01 133.35 69.38 Favored Pre-proline 0 N--CA 1.441 -0.899 0 CA-C-N 115.734 -0.666 . . . . 99.989999999999995 109.567 178.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 783' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 782' ' ' THR . 23.7 Cg_exo -62.88 151.32 84.96 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 122.942 2.428 . . . . 99.989999999999995 111.548 -175.444 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 784' ' ' VAL . . . . . . . . . . . . . 13.8 p -59.59 130.73 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-O 121.406 0.622 . . . . 99.989999999999995 110.477 -174.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 785' ' ' PHE . . . . . 0.534 ' C ' ' H ' ' A' ' 787' ' ' THR . 86.3 m-85 -87.21 -31.84 20.1 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.376 -0.829 . . . . 99.989999999999995 111.598 -171.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 786' ' ' THR . . . . . 0.471 ' HA ' ' HA2' ' A' ' 736' ' ' GLY . 30.9 p 58.05 -5.4 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.911 0.885 . . . . 99.989999999999995 112.94 176.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 787' ' ' THR . . . . . 0.534 ' H ' ' C ' ' A' ' 785' ' ' PHE . 1.3 m -145.76 124.65 12.7 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.752 0.311 . . . . 99.989999999999995 110.543 -176.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 788' ' ' GLY . . . . . 0.54 ' H ' ' CD1' ' A' ' 735' ' ' LEU . . . -50.28 125.9 22.1 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.354 -0.839 . . . . 99.989999999999995 113.353 173.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 789' ' ' GLY . . . . . . . . . . . . . . . -174.51 -179.88 45.4 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 110.141 -1.184 . . . . 99.989999999999995 110.141 179.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -119.46 128.02 53.61 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 117.773 0.786 . . . . 99.989999999999995 109.758 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 791' ' ' TYR . . . . . 0.615 ' CE2' ' HG2' ' A' ' 759' ' ' GLU . 84.0 m-85 -127.65 153.38 46.52 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.808 -0.633 . . . . 99.989999999999995 110.595 -176.022 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 792' ' ' ILE . . . . . 0.55 ' O ' HG13 ' A' ' 758' ' ' ILE . 13.0 mt -129.92 120.36 49.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.6 -0.519 . . . . 99.989999999999995 109.6 172.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 793' ' ' LEU . . . . . 0.578 ' HA ' ' O ' ' A' ' 756' ' ' ASP . 8.1 tt -85.28 110.34 19.0 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.095 -0.706 . . . . 99.989999999999995 109.095 178.28 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 794' ' ' SER . . . . . . . . . . . . . 3.7 m -119.45 148.89 42.72 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.083 -0.508 . . . . 99.989999999999995 110.023 -178.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 795' ' ' LEU . . . . . 0.477 ' H ' HD22 ' A' ' 795' ' ' LEU . 1.5 mm? -73.36 124.75 26.35 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-O 120.715 0.293 . . . . 99.989999999999995 111.028 177.143 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 796' ' ' VAL . . . . . 0.404 ' HB ' ' HB ' ' A' ' 754' ' ' THR . 53.7 t -85.67 -54.78 7.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.189 -0.46 . . . . 99.989999999999995 111.213 -177.207 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 797' ' ' SER . . . . . 0.568 ' HA ' ' HG ' ' A' ' 808' ' ' LEU . 87.9 p -172.42 152.66 2.73 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.981 -0.554 . . . . 99.989999999999995 110.202 -172.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 798' ' ' ILE . . . . . 0.636 ' HA ' ' O ' ' A' ' 752' ' ' THR . 5.9 tt -127.5 164.6 28.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 108.802 -0.814 . . . . 99.989999999999995 108.802 176.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 799' ' ' LYS . . . . . 0.713 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 8.0 tmtt? -139.51 118.86 12.84 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 120.618 -0.433 . . . . 99.989999999999995 111.14 -177.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 800' ' ' ASP . . . . . 0.508 ' HB2' ' HB3' ' A' ' 804' ' ' CYS . 14.1 m-20 -58.59 155.37 12.53 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-N 115.306 -0.861 . . . . 99.989999999999995 109.504 173.346 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 6.3 p -61.62 -11.86 13.39 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 124.021 0.826 . . . . 99.989999999999995 112.56 -174.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 8.9 t -91.06 -6.38 53.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.666 0.745 . . . . 99.989999999999995 109.836 178.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 803' ' ' GLY . . . . . 0.462 ' HA2' ' HE2' ' A' ' 799' ' ' LYS . . . 92.12 42.69 4.58 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 115.278 -0.874 . . . . 99.989999999999995 111.771 -177.26 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 804' ' ' CYS . . . . . 0.508 ' HB3' ' HB2' ' A' ' 800' ' ' ASP . 41.7 t -110.55 106.53 15.84 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.698 -0.482 . . . . 99.989999999999995 109.698 179.073 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 805' ' ' VAL . . . . . 0.55 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 15.7 t -88.27 110.78 21.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.285 0.564 . . . . 99.989999999999995 111.279 -175.336 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 806' ' ' VAL . . . . . 0.409 ' HB ' HG22 ' A' ' 798' ' ' ILE . 88.2 t -90.55 137.76 20.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.298 -0.865 . . . . 99.989999999999995 109.995 177.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -76.07 120.53 5.94 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 111.099 -0.8 . . . . 99.989999999999995 111.099 177.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 808' ' ' LEU . . . . . 0.568 ' HG ' ' HA ' ' A' ' 797' ' ' SER . 40.1 mt -88.81 133.7 34.17 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.749 0.648 . . . . 99.989999999999995 112.749 -173.007 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 31.8 t -149.67 86.73 1.47 Allowed 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.019 -0.992 . . . . 99.989999999999995 108.991 172.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 810' ' ' GLN . . . . . 0.536 ' NE2' ' HB3' ' A' ' 722' ' ' SER . 1.6 mt-30 -139.25 174.39 4.18 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.388 -0.823 . . . . 99.989999999999995 108.93 176.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 811' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_exo -44.0 139.17 6.0 Favored 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 123.049 2.499 . . . . 99.989999999999995 114.644 -175.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -115.67 165.76 12.68 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.694 -1.139 . . . . 99.989999999999995 110.204 -179.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 813' ' ' ALA . . . . . 0.457 ' HB3' HD21 ' A' ' 727' ' ' LEU . . . -115.06 155.63 26.66 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.035 -0.53 . . . . 99.989999999999995 110.492 -177.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 814' ' ' LYS . . . . . 0.438 ' HG3' HG12 ' A' ' 792' ' ' ILE . 2.7 mptm? -112.45 137.83 50.08 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.499 0.666 . . . . 99.989999999999995 110.647 175.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 815' ' ' ILE . . . . . 0.607 ' HA ' ' HB2' ' A' ' 731' ' ' LEU . 5.3 mp -124.27 111.85 30.2 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-N 114.792 -1.094 . . . . 99.989999999999995 108.155 177.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 816' ' ' GLN . . . . . 0.694 ' NE2' ' HG2' ' A' ' 818' ' ' ARG . 0.9 OUTLIER -108.72 109.16 20.26 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.023 0.44 . . . . 99.989999999999995 110.671 -177.22 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 817' ' ' VAL . . . . . 0.405 ' HA ' ' HB2' ' A' ' 733' ' ' LEU . 2.3 t -104.85 142.58 17.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 109.649 -0.5 . . . . 99.989999999999995 109.649 -179.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 818' ' ' ARG . . . . . 0.694 ' HG2' ' NE2' ' A' ' 816' ' ' GLN . 73.6 mmt-85 . . . . . 0 C--N 1.321 -0.654 0 N-CA-C 110.026 -0.361 . . . . 99.989999999999995 110.026 175.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 720' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt . . . . . 0 N--CA 1.441 -0.887 0 N-CA-C 109.398 -0.593 . . . . 99.989999999999995 109.398 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 721' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -88.75 151.35 6.11 Favored 'Trans proline' 0 N--CA 1.446 -1.298 0 C-N-CA 122.431 2.087 . . . . 99.989999999999995 111.488 -178.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 722' ' ' SER . . . . . 0.776 ' HB2' ' OE1' ' A' ' 810' ' ' GLN . 8.6 p -179.18 -159.32 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.294 -0.632 . . . . 99.989999999999995 109.294 -175.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 723' ' ' ALA . . . . . 0.519 ' HB2' ' HG ' ' A' ' 795' ' ' LEU . . . -151.67 140.74 21.19 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 118.807 0.73 . . . . 99.989999999999995 110.931 176.068 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 35.1 m -132.89 105.63 7.23 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.713 -0.477 . . . . 99.989999999999995 109.713 -177.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 725' ' ' LEU . . . . . 0.49 ' CD2' ' HB ' ' A' ' 743' ' ' VAL . 16.7 mt -62.22 144.92 54.87 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-O 121.478 0.656 . . . . 99.989999999999995 111.507 -176.087 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 29.3 mtpt -97.62 -14.41 20.99 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.856 -1.065 . . . . 99.989999999999995 109.638 -177.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 727' ' ' LEU . . . . . 0.433 HD21 ' HB3' ' A' ' 813' ' ' ALA . 38.7 tp -69.21 114.24 7.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.304 -0.862 . . . . 99.989999999999995 109.713 175.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 9.6 t-80 -115.71 43.5 2.08 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.816 0.341 . . . . 99.989999999999995 111.214 -174.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 9.5 p80 -175.24 -177.67 1.07 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.239 -0.437 . . . . 99.989999999999995 110.629 177.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 730' ' ' ASP . . . . . 0.516 ' HA ' ' O ' ' A' ' 814' ' ' LYS . 1.2 m-20 -76.53 148.22 37.24 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.69 -0.686 . . . . 99.989999999999995 110.564 177.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 731' ' ' LEU . . . . . 0.52 ' HB2' ' HA ' ' A' ' 815' ' ' ILE . 12.0 mt -101.93 104.45 15.15 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.887 -0.597 . . . . 99.989999999999995 110.555 173.345 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 732' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -81.23 93.24 6.46 Favored 'General case' 0 C--N 1.323 -0.56 0 O-C-N 123.712 0.632 . . . . 99.989999999999995 111.26 -172.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 733' ' ' LEU . . . . . 0.43 ' HB3' ' CB ' ' A' ' 737' ' ' ASP . 0.2 OUTLIER -107.38 163.69 12.83 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.107 0.48 . . . . 99.989999999999995 111.487 -178.415 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 734' ' ' CYS . . . . . 0.695 ' HA ' ' O ' ' A' ' 818' ' ' ARG . 69.2 m -113.14 -173.38 2.24 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.367 -0.833 . . . . 99.989999999999995 110.352 177.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 735' ' ' LEU . . . . . . . . . . . . . 3.5 tt -62.56 128.1 34.39 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.839 -0.619 . . . . 99.989999999999995 109.925 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 736' ' ' GLY . . . . . 0.469 ' HA2' ' HA ' ' A' ' 786' ' ' THR . . . 86.37 4.96 83.05 Favored Glycine 0 C--N 1.322 -0.199 0 C-N-CA 120.22 -0.991 . . . . 99.989999999999995 112.735 177.116 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 737' ' ' ASP . . . . . 0.493 ' HB2' ' O ' ' A' ' 734' ' ' CYS . 0.3 OUTLIER -84.26 153.3 23.66 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.364 0.602 . . . . 99.989999999999995 112.448 179.281 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 738' ' ' HIS . . . . . 0.479 ' HB2' ' O ' ' A' ' 782' ' ' THR . 47.0 p-80 -118.88 173.28 6.97 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 106.723 -1.584 . . . . 99.989999999999995 106.723 167.106 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 739' ' ' SER . . . . . 0.472 ' HB2' HD13 ' A' ' 731' ' ' LEU . 51.5 p -128.08 173.75 9.8 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 118.236 -1.385 . . . . 99.989999999999995 112.791 -173.043 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 10.4 p -144.98 103.93 3.93 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.743 -1.117 . . . . 99.989999999999995 109.861 -172.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 741' ' ' VAL . . . . . 0.473 HG13 HD22 ' A' ' 793' ' ' LEU . 0.4 OUTLIER -120.87 116.63 31.4 Favored Pre-proline 0 C--N 1.314 -0.963 0 CA-C-N 115.893 -0.594 . . . . 99.989999999999995 110.282 -177.804 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 742' ' ' PRO . . . . . 0.645 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 9.8 Cg_endo -77.66 137.32 16.12 Favored 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 122.252 1.968 . . . . 99.989999999999995 111.545 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 743' ' ' VAL . . . . . 0.49 ' HB ' ' CD2' ' A' ' 725' ' ' LEU . 2.2 p -130.33 119.54 46.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.452 0.644 . . . . 99.989999999999995 112.231 177.33 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 744' ' ' ALA . . . . . 0.568 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -78.81 95.01 5.26 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 122.237 1.017 . . . . 99.989999999999995 109.03 168.641 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 745' ' ' LEU . . . . . 0.536 HD13 HD11 ' A' ' 773' ' ' ILE . 1.7 mt -76.41 142.54 41.06 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 113.706 -1.588 . . . . 99.989999999999995 110.485 -173.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -100.01 163.14 12.56 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.442 0.639 . . . . 99.989999999999995 110.571 -176.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 747' ' ' GLY . . . . . . . . . . . . . . . 91.36 139.11 8.23 Favored Glycine 0 C--N 1.309 -0.928 0 CA-C-N 114.855 -1.066 . . . . 99.989999999999995 111.64 -175.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 748' ' ' GLN . . . . . 0.449 ' C ' ' HE1' ' A' ' 751' ' ' PHE . 20.9 mp0 -114.22 111.2 21.16 Favored 'General case' 0 C--N 1.32 -0.679 0 O-C-N 122.469 -0.43 . . . . 99.989999999999995 111.081 -175.137 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 132.75 -170.7 21.95 Favored Glycine 0 N--CA 1.445 -0.764 0 CA-C-N 115.792 -0.64 . . . . 99.989999999999995 112.034 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -73.5 93.84 0.84 Allowed 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.564 2.176 . . . . 99.989999999999995 111.676 -179.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 751' ' ' PHE . . . . . 0.594 ' CE2' ' HA ' ' A' ' 800' ' ' ASP . 80.0 m-85 -113.92 141.1 47.78 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.817 -0.629 . . . . 99.989999999999995 111.237 -178.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 752' ' ' THR . . . . . 0.652 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 86.7 m -91.66 105.28 17.62 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.38 -0.6 . . . . 99.989999999999995 109.38 177.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 753' ' ' LEU . . . . . 0.455 ' HG ' HD22 ' A' ' 745' ' ' LEU . 0.5 OUTLIER -98.79 123.0 42.74 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 115.227 -0.897 . . . . 99.989999999999995 110.362 -172.168 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 754' ' ' THR . . . . . 0.511 HG23 ' HB2' ' A' ' 769' ' ' GLU . 0.7 OUTLIER -117.89 136.29 53.56 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.105 -0.498 . . . . 99.989999999999995 110.659 -178.197 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 755' ' ' TYR . . . . . . . . . . . . . 17.2 p90 -143.29 153.95 43.29 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 111.922 0.341 . . . . 99.989999999999995 111.922 178.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 756' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -118.91 118.86 32.68 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.341 0.591 . . . . 99.989999999999995 111.86 -178.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 757' ' ' ILE . . . . . 0.526 ' CD1' HD13 ' A' ' 793' ' ' LEU . 4.0 mp -89.74 96.34 6.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 107.496 -1.298 . . . . 99.989999999999995 107.496 167.369 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 758' ' ' ILE . . . . . 0.617 HG13 ' O ' ' A' ' 792' ' ' ILE . 2.5 pp -103.89 149.72 7.57 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 N-CA-C 112.412 0.523 . . . . 99.989999999999995 112.412 -168.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 759' ' ' GLU . . . . . 0.517 ' HG2' ' CE2' ' A' ' 791' ' ' TYR . 19.8 mt-10 -87.48 123.99 32.98 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.843 -0.617 . . . . 99.989999999999995 110.164 178.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 760' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.313 -0.98 0 C-N-CA 120.426 -0.51 . . . . 99.989999999999995 110.309 175.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 66.5 mtm180 . . . . . 0 C--O 1.234 0.247 0 CA-C-O 121.221 0.534 . . . . 99.989999999999995 111.88 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 766' ' ' LYS . . . . . 0.651 ' HD3' ' N ' ' A' ' 767' ' ' THR . 9.0 tmtt? -124.84 145.51 49.74 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 108.331 -0.988 . . . . 99.989999999999995 108.331 175.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 767' ' ' THR . . . . . 0.651 ' N ' ' HD3' ' A' ' 766' ' ' LYS . 91.7 m -133.16 141.7 48.26 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 116.611 -0.268 . . . . 99.989999999999995 110.295 -179.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 768' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -136.21 141.74 44.02 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.05 0.452 . . . . 99.989999999999995 110.656 177.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 769' ' ' GLU . . . . . 0.511 ' HB2' HG23 ' A' ' 754' ' ' THR . 40.0 tt0 -126.41 121.08 31.45 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.246 -0.888 . . . . 99.989999999999995 110.487 -179.255 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 770' ' ' ILE . . . . . 0.453 HG21 HG22 ' A' ' 773' ' ' ILE . 9.4 mt -115.57 111.27 34.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 109.274 -0.639 . . . . 99.989999999999995 109.274 178.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 771' ' ' LYS . . . . . 0.569 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 7.8 mtpt -83.97 148.4 26.92 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.624 0.726 . . . . 99.989999999999995 111.521 -176.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 772' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 57.71 47.45 15.62 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 113.514 -1.675 . . . . 99.989999999999995 112.479 175.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 773' ' ' ILE . . . . . 0.536 HD11 HD13 ' A' ' 745' ' ' LEU . 0.5 OUTLIER -75.64 119.29 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 N-CA-C 108.233 -1.025 . . . . 99.989999999999995 108.233 175.426 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 79.7 mttt -117.88 33.26 5.72 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 107.974 -1.121 . . . . 99.989999999999995 107.974 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 775' ' ' THR . . . . . 0.464 ' O ' ' HB2' ' A' ' 776' ' ' ASN . 1.1 m -95.4 -72.32 0.63 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 113.939 -1.482 . . . . 99.989999999999995 112.289 -172.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 776' ' ' ASN . . . . . 0.464 ' HB2' ' O ' ' A' ' 775' ' ' THR . 12.2 m120 85.96 3.63 0.53 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.599 1.159 . . . . 99.989999999999995 110.934 -179.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 777' ' ' GLU . . . . . 0.568 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 12.3 mt-10 -161.84 88.7 0.7 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.171 -0.922 . . . . 99.989999999999995 108.799 172.302 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 778' ' ' TYR . . . . . 0.47 ' HB3' ' CD1' ' A' ' 745' ' ' LEU . 49.4 t80 -123.59 127.65 48.59 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 120.881 0.372 . . . . 99.989999999999995 110.778 -171.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 779' ' ' VAL . . . . . 0.645 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 15.1 t -85.52 105.42 14.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.206 0.527 . . . . 99.989999999999995 110.382 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 780' ' ' ILE . . . . . 0.456 HG13 HG11 ' A' ' 743' ' ' VAL . 83.1 mt -75.44 142.31 14.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.307 -0.861 . . . . 99.989999999999995 110.703 -178.471 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 781' ' ' LYS . . . . . 0.42 ' N ' HG23 ' A' ' 780' ' ' ILE . 0.0 OUTLIER -122.08 103.6 8.91 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.136 -0.69 . . . . 99.989999999999995 109.136 174.975 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 782' ' ' THR . . . . . 0.479 ' O ' ' HB2' ' A' ' 738' ' ' HIS . 2.9 p -75.36 143.6 76.65 Favored Pre-proline 0 C--N 1.319 -0.738 0 CA-C-N 115.803 -0.635 . . . . 99.989999999999995 109.985 -175.312 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 783' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.69 157.76 9.38 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 123.378 2.719 . . . . 99.989999999999995 111.963 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 784' ' ' VAL . . . . . 0.417 ' HA ' ' HB3' ' A' ' 738' ' ' HIS . 11.6 p -68.47 130.89 33.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.45 0.643 . . . . 99.989999999999995 110.283 -175.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 785' ' ' PHE . . . . . 0.499 ' C ' ' H ' ' A' ' 787' ' ' THR . 62.3 m-85 -85.87 -40.17 16.24 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-N 115.634 -0.712 . . . . 99.989999999999995 110.42 -175.008 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 786' ' ' THR . . . . . 0.469 ' HA ' ' HA2' ' A' ' 736' ' ' GLY . 27.3 p 60.26 -4.92 0.1 Allowed 'General case' 0 N--CA 1.469 0.495 0 O-C-N 124.451 1.094 . . . . 99.989999999999995 112.053 -178.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 787' ' ' THR . . . . . 0.499 ' H ' ' C ' ' A' ' 785' ' ' PHE . 43.1 m -130.94 116.12 17.43 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 116.182 -0.463 . . . . 99.989999999999995 110.879 -173.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 788' ' ' GLY . . . . . . . . . . . . . . . -52.59 118.56 7.95 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 120.745 -0.741 . . . . 99.989999999999995 112.963 171.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 789' ' ' GLY . . . . . 0.442 ' H ' ' HB ' ' A' ' 817' ' ' VAL . . . -175.86 -174.97 42.86 Favored Glycine 0 N--CA 1.448 -0.546 0 N-CA-C 110.041 -1.223 . . . . 99.989999999999995 110.041 179.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -115.41 130.11 56.79 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 118.267 1.033 . . . . 99.989999999999995 110.254 178.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 791' ' ' TYR . . . . . 0.517 ' CE2' ' HG2' ' A' ' 759' ' ' GLU . 69.2 m-85 -121.3 143.98 48.88 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.301 -0.863 . . . . 99.989999999999995 109.473 179.55 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 792' ' ' ILE . . . . . 0.617 ' O ' HG13 ' A' ' 758' ' ' ILE . 21.2 mt -120.84 113.68 40.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 N-CA-C 109.467 -0.568 . . . . 99.989999999999995 109.467 177.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 793' ' ' LEU . . . . . 0.535 HD11 ' N ' ' A' ' 794' ' ' SER . 0.7 OUTLIER -86.55 114.53 23.36 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.572 -0.74 . . . . 99.989999999999995 109.084 179.279 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 794' ' ' SER . . . . . 0.535 ' N ' HD11 ' A' ' 793' ' ' LEU . 23.1 t -123.86 159.68 29.1 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.91 -1.041 . . . . 99.989999999999995 108.763 -174.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 795' ' ' LEU . . . . . 0.519 ' HG ' ' HB2' ' A' ' 723' ' ' ALA . 1.2 mm? -87.51 135.31 33.4 Favored 'General case' 0 N--CA 1.44 -0.948 0 O-C-N 121.997 -0.44 . . . . 99.989999999999995 110.837 176.413 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 796' ' ' VAL . . . . . . . . . . . . . 73.3 t -92.64 -55.36 6.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.232 -0.44 . . . . 99.989999999999995 110.95 -178.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 797' ' ' SER . . . . . . . . . . . . . 58.7 m -169.18 168.35 9.91 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.057 -0.519 . . . . 99.989999999999995 110.091 -173.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 798' ' ' ILE . . . . . 0.621 ' HA ' ' O ' ' A' ' 752' ' ' THR . 9.1 tt -141.06 165.39 19.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 108.867 -0.79 . . . . 99.989999999999995 108.867 172.641 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 799' ' ' LYS . . . . . 0.652 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 85.3 tttt -136.96 121.67 18.58 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.887 0.375 . . . . 99.989999999999995 111.333 -174.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 800' ' ' ASP . . . . . 0.594 ' HA ' ' CE2' ' A' ' 751' ' ' PHE . 7.9 t70 -65.49 153.62 40.88 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.022 -0.99 . . . . 99.989999999999995 109.21 175.177 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 5.4 p -58.83 -13.97 7.64 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 124.199 0.937 . . . . 99.989999999999995 112.948 -174.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 52.2 p -89.68 -5.83 56.7 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.511 0.672 . . . . 99.989999999999995 109.847 177.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 803' ' ' GLY . . . . . 0.503 ' HA2' ' CE ' ' A' ' 799' ' ' LYS . . . 89.81 40.31 5.95 Favored Glycine 0 N--CA 1.44 -1.071 0 CA-C-N 114.934 -1.03 . . . . 99.989999999999995 111.601 -177.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 804' ' ' CYS . . . . . 0.478 ' HB3' ' HB3' ' A' ' 800' ' ' ASP . 42.0 t -111.69 113.8 26.4 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 110.056 -0.349 . . . . 99.989999999999995 110.056 -178.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 805' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 11.0 p -85.01 132.85 30.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.396 0.617 . . . . 99.989999999999995 110.948 -174.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 806' ' ' VAL . . . . . 0.468 ' HB ' HG22 ' A' ' 798' ' ' ILE . 85.0 t -109.29 138.34 37.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.296 -0.866 . . . . 99.989999999999995 109.769 178.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -76.28 111.24 3.24 Favored Glycine 0 N--CA 1.452 -0.28 0 CA-C-N 115.824 -0.625 . . . . 99.989999999999995 112.785 -178.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 808' ' ' LEU . . . . . 0.421 HD13 ' HA ' ' A' ' 722' ' ' SER . 2.6 mm? -76.07 127.31 32.69 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 113.824 1.046 . . . . 99.989999999999995 113.824 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 10.8 p -149.93 86.75 1.45 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.298 -0.864 . . . . 99.989999999999995 109.509 170.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 810' ' ' GLN . . . . . 0.776 ' OE1' ' HB2' ' A' ' 722' ' ' SER . 35.1 mt-30 -137.8 171.91 7.64 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.606 -0.724 . . . . 99.989999999999995 110.743 -176.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 811' ' ' PRO . . . . . 0.417 ' HD2' ' HB3' ' A' ' 810' ' ' GLN . 81.3 Cg_exo -47.78 140.32 17.78 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.798 2.332 . . . . 99.989999999999995 113.563 178.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -114.67 165.67 12.55 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.513 -0.767 . . . . 99.989999999999995 110.798 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 813' ' ' ALA . . . . . 0.433 ' HB3' HD21 ' A' ' 727' ' ' LEU . . . -111.33 151.37 28.49 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.744 -0.662 . . . . 99.989999999999995 110.278 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 814' ' ' LYS . . . . . 0.516 ' O ' ' HA ' ' A' ' 730' ' ' ASP . 19.5 ttpp -120.25 107.78 13.4 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.849 0.833 . . . . 99.989999999999995 110.827 178.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 815' ' ' ILE . . . . . 0.52 ' HA ' ' HB2' ' A' ' 731' ' ' LEU . 5.1 mp -86.65 116.94 30.12 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-N 114.539 -1.209 . . . . 99.989999999999995 108.68 177.452 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 816' ' ' GLN . . . . . 0.405 HE22 ' HB2' ' A' ' 818' ' ' ARG . 1.0 OUTLIER -107.88 106.57 16.9 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.686 0.755 . . . . 99.989999999999995 110.339 -177.041 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 817' ' ' VAL . . . . . 0.442 ' HB ' ' H ' ' A' ' 789' ' ' GLY . 1.9 t -101.43 146.43 9.79 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 N-CA-C 108.952 -0.759 . . . . 99.989999999999995 108.952 -177.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 818' ' ' ARG . . . . . 0.695 ' O ' ' HA ' ' A' ' 734' ' ' CYS . 17.2 tpt180 . . . . . 0 C--N 1.317 -0.833 0 N-CA-C 109.903 -0.406 . . . . 99.989999999999995 109.903 178.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 720' ' ' LYS . . . . . 0.421 ' HG2' ' O ' ' A' ' 720' ' ' LYS . 19.1 ttpt . . . . . 0 N--CA 1.416 -2.139 0 N-CA-C 108.273 -1.01 . . . . 99.989999999999995 108.273 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 721' ' ' PRO . . . . . 0.461 ' HG3' ' CE2' ' A' ' 751' ' ' PHE . 56.5 Cg_endo -87.91 155.41 7.26 Favored 'Trans proline' 0 N--CA 1.449 -1.121 0 C-N-CA 123.348 2.699 . . . . 99.989999999999995 112.092 -176.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 722' ' ' SER . . . . . 0.719 ' HA ' ' CD2' ' A' ' 808' ' ' LEU . 7.5 t -174.25 -159.84 0.1 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.638 -0.504 . . . . 99.989999999999995 109.638 -174.019 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 723' ' ' ALA . . . . . 0.623 ' O ' HD13 ' A' ' 795' ' ' LEU . . . -156.77 140.67 16.2 Favored 'General case' 0 C--O 1.218 -0.562 0 C-N-CA 121.383 -0.127 . . . . 99.989999999999995 110.741 177.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 22.6 t -136.06 101.25 4.66 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 109.535 -0.543 . . . . 99.989999999999995 109.535 -176.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 725' ' ' LEU . . . . . 0.638 HD11 ' N ' ' A' ' 725' ' ' LEU . 5.6 mp -60.7 139.41 57.88 Favored 'General case' 0 N--CA 1.425 -1.688 0 CA-C-O 122.396 1.093 . . . . 99.989999999999995 112.427 -175.117 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 33.4 mtpt -87.43 -18.12 30.67 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 113.002 -1.908 . . . . 99.989999999999995 109.356 -178.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 727' ' ' LEU . . . . . 0.48 ' HB2' ' HD2' ' A' ' 742' ' ' PRO . 21.2 tp -71.3 110.22 5.8 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.798 -0.816 . . . . 99.989999999999995 108.798 173.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 9.1 t60 -95.19 -48.4 5.94 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.755 -0.378 . . . . 99.989999999999995 111.528 -172.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -101.21 177.71 4.86 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.878 -0.329 . . . . 99.989999999999995 110.871 -177.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 730' ' ' ASP . . . . . 0.441 ' HA ' ' O ' ' A' ' 814' ' ' LYS . 7.7 p-10 -68.73 145.67 53.62 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.568 0.699 . . . . 99.989999999999995 110.933 -178.047 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 731' ' ' LEU . . . . . 0.512 ' HB3' ' HA ' ' A' ' 815' ' ' ILE . 36.4 tp -104.44 111.71 24.48 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.926 -1.034 . . . . 99.989999999999995 111.372 -175.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 732' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -70.35 127.47 32.88 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.258 -0.428 . . . . 99.989999999999995 111.884 -177.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 733' ' ' LEU . . . . . 0.48 HD13 ' CG2' ' A' ' 815' ' ' ILE . 55.4 mt -136.59 163.72 29.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.195 0.522 . . . . 99.989999999999995 111.144 177.101 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 734' ' ' CYS . . . . . 0.454 ' O ' ' HB2' ' A' ' 737' ' ' ASP . 72.1 m -108.58 -176.18 2.97 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.367 -0.833 . . . . 99.989999999999995 110.036 175.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 735' ' ' LEU . . . . . . . . . . . . . 24.7 tp -63.95 131.57 48.06 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.022 0.439 . . . . 99.989999999999995 111.068 -177.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 736' ' ' GLY . . . . . 0.436 ' O ' HG11 ' A' ' 784' ' ' VAL . . . 70.27 13.48 70.47 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.446 -0.797 . . . . 99.989999999999995 112.619 177.058 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 737' ' ' ASP . . . . . 0.454 ' HB2' ' O ' ' A' ' 734' ' ' CYS . 0.3 OUTLIER -77.7 150.76 34.43 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.792 0.329 . . . . 99.989999999999995 110.711 178.763 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 16.1 p-80 -111.9 163.06 14.64 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 106.767 -1.568 . . . . 99.989999999999995 106.767 171.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 739' ' ' SER . . . . . 0.415 ' HG ' HD11 ' A' ' 733' ' ' LEU . 0.0 OUTLIER -131.36 174.08 10.42 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 119.526 -0.869 . . . . 99.989999999999995 112.732 -173.325 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 5.6 p -131.36 115.51 16.34 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 114.743 -1.117 . . . . 99.989999999999995 109.282 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 741' ' ' VAL . . . . . . . . . . . . . 3.6 t -113.6 98.98 48.7 Favored Pre-proline 0 C--N 1.318 -0.768 0 CA-C-N 116.161 -0.472 . . . . 99.989999999999995 110.411 -175.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 742' ' ' PRO . . . . . 0.653 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 2.2 Cg_endo -75.88 121.65 6.36 Favored 'Trans proline' 0 N--CA 1.441 -1.579 0 C-N-CA 122.912 2.408 . . . . 99.989999999999995 110.712 -175.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 743' ' ' VAL . . . . . 0.567 ' HA ' ' HA ' ' A' ' 725' ' ' LEU . 1.4 p -125.67 121.52 60.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 121.662 0.744 . . . . 99.989999999999995 112.671 178.226 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 744' ' ' ALA . . . . . 0.564 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -83.42 111.67 19.24 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.544 -0.91 . . . . 99.989999999999995 108.544 169.255 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 745' ' ' LEU . . . . . 0.57 ' HA ' ' HA ' ' A' ' 723' ' ' ALA . 0.3 OUTLIER -95.11 168.99 10.42 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.705 -1.134 . . . . 99.989999999999995 111.251 -165.861 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 746' ' ' LYS . . . . . 0.435 ' HZ3' ' HB2' ' A' ' 746' ' ' LYS . 1.1 tppm? -122.9 147.59 46.41 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 115.27 -0.877 . . . . 99.989999999999995 110.287 -176.262 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 747' ' ' GLY . . . . . 0.429 ' HA3' ' HB3' ' A' ' 721' ' ' PRO . . . 100.73 129.97 6.87 Favored Glycine 0 C--N 1.311 -0.833 0 C-N-CA 120.796 -0.716 . . . . 99.989999999999995 111.451 -177.268 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 748' ' ' GLN . . . . . 0.429 ' C ' ' HE1' ' A' ' 751' ' ' PHE . 2.1 mp0 -108.76 115.71 30.6 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.917 0.389 . . . . 99.989999999999995 111.059 -175.054 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 134.52 -176.31 19.97 Favored Glycine 0 N--CA 1.444 -0.773 0 N-CA-C 111.501 -0.64 . . . . 99.989999999999995 111.501 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_exo -71.89 93.89 0.71 Allowed 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.545 2.163 . . . . 99.989999999999995 111.839 179.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 751' ' ' PHE . . . . . 0.5 ' CD2' ' HA ' ' A' ' 800' ' ' ASP . 78.2 m-85 -110.2 141.95 42.42 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.168 -0.469 . . . . 99.989999999999995 111.41 -178.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 752' ' ' THR . . . . . 0.729 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 94.7 m -90.85 102.66 15.42 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.725 0.774 . . . . 99.989999999999995 109.471 178.271 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 753' ' ' LEU . . . . . . . . . . . . . 24.3 tp -91.82 116.85 29.25 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 114.448 -1.251 . . . . 99.989999999999995 110.461 -171.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 754' ' ' THR . . . . . 0.48 HG23 ' HB2' ' A' ' 769' ' ' GLU . 1.3 m -115.1 130.11 56.85 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.541 -0.299 . . . . 99.989999999999995 111.028 179.363 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 755' ' ' TYR . . . . . 0.538 ' CE1' ' HB2' ' A' ' 768' ' ' PHE . 22.2 p90 -141.31 156.73 45.82 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.856 0.36 . . . . 99.989999999999995 111.338 178.405 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 756' ' ' ASP . . . . . 0.408 ' HA ' ' O ' ' A' ' 766' ' ' LYS . 0.2 OUTLIER -121.07 118.95 31.08 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 115.72 -0.673 . . . . 99.989999999999995 110.37 -176.628 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 757' ' ' ILE . . . . . 0.519 HG13 HD13 ' A' ' 793' ' ' LEU . 3.7 mp -87.98 96.24 5.72 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 107.421 -1.325 . . . . 99.989999999999995 107.421 168.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 758' ' ' ILE . . . . . 0.604 HG13 ' O ' ' A' ' 792' ' ' ILE . 2.5 pp -94.78 149.98 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 CA-C-N 115.306 -0.861 . . . . 99.989999999999995 110.215 -173.363 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -105.13 125.65 51.21 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 120.173 -0.611 . . . . 99.989999999999995 110.562 178.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 760' ' ' THR . . . . . 0.462 HG23 ' OD2' ' A' ' 790' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.319 -0.746 0 N-CA-C 108.561 -0.903 . . . . 99.989999999999995 108.561 177.444 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 765' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 765' ' ' ARG . 47.2 mtm105 . . . . . 0 C--O 1.233 0.21 0 CA-C-O 120.985 0.421 . . . . 99.989999999999995 111.569 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 766' ' ' LYS . . . . . 0.658 ' HD3' ' N ' ' A' ' 767' ' ' THR . 7.5 tmtm? -124.5 144.8 49.91 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 108.602 -0.888 . . . . 99.989999999999995 108.602 176.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 767' ' ' THR . . . . . 0.658 ' N ' ' HD3' ' A' ' 766' ' ' LYS . 91.4 m -125.05 137.84 54.21 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 120.879 0.371 . . . . 99.989999999999995 111.742 -176.34 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 768' ' ' PHE . . . . . 0.538 ' HB2' ' CE1' ' A' ' 755' ' ' TYR . 2.1 m-85 -131.89 130.25 41.38 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.903 -0.589 . . . . 99.989999999999995 110.047 171.074 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 769' ' ' GLU . . . . . 0.48 ' HB2' HG23 ' A' ' 754' ' ' THR . 37.1 tt0 -124.6 108.07 11.68 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.693 -0.685 . . . . 99.989999999999995 110.294 179.307 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 770' ' ' ILE . . . . . 0.418 HG21 HG22 ' A' ' 773' ' ' ILE . 4.3 mp -106.76 113.23 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 CA-C-N 116.109 -0.496 . . . . 99.989999999999995 110.196 -178.171 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 771' ' ' LYS . . . . . 0.564 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 1.7 mtpt -81.88 149.57 28.2 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.252 0.548 . . . . 99.989999999999995 111.125 -177.57 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 772' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 57.32 50.19 11.93 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.36 -1.291 . . . . 99.989999999999995 112.652 177.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 773' ' ' ILE . . . . . 0.418 HG22 HG21 ' A' ' 770' ' ' ILE . 0.5 OUTLIER -78.88 119.64 28.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 107.689 -1.226 . . . . 99.989999999999995 107.689 170.692 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 72.3 mttt -118.49 29.72 7.6 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.166 -1.05 . . . . 99.989999999999995 108.166 -177.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 775' ' ' THR . . . . . 0.594 ' O ' ' HB2' ' A' ' 776' ' ' ASN . 0.2 OUTLIER -94.08 -71.27 0.67 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.469 -1.241 . . . . 99.989999999999995 113.266 -167.753 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 776' ' ' ASN . . . . . 0.594 ' HB2' ' O ' ' A' ' 775' ' ' THR . 0.9 OUTLIER 84.8 2.86 0.73 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.326 1.05 . . . . 99.989999999999995 110.273 -176.739 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 777' ' ' GLU . . . . . 0.564 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 7.5 mt-10 -162.31 86.18 0.59 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.107 -0.951 . . . . 99.989999999999995 109.314 174.062 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 778' ' ' TYR . . . . . 0.533 ' HB3' HD11 ' A' ' 745' ' ' LEU . 69.9 t80 -132.38 131.1 41.52 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.614 -0.513 . . . . 99.989999999999995 109.614 -173.53 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 779' ' ' VAL . . . . . 0.653 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 1.5 m -96.93 132.46 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 CA-C-O 122.684 1.231 . . . . 99.989999999999995 110.337 176.685 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 780' ' ' ILE . . . . . . . . . . . . . 88.8 mt -89.21 147.76 4.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-N 112.88 -1.964 . . . . 99.989999999999995 110.143 -170.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -112.09 110.55 20.9 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 120.271 -0.572 . . . . 99.989999999999995 109.575 175.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 782' ' ' THR . . . . . 0.455 HG22 HG12 ' A' ' 757' ' ' ILE . 11.5 p -85.66 142.43 37.12 Favored Pre-proline 0 C--N 1.312 -1.065 0 CA-C-N 115.453 -0.794 . . . . 99.989999999999995 111.076 -177.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 783' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 782' ' ' THR . 32.2 Cg_exo -59.68 160.2 21.81 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 123.614 2.876 . . . . 99.989999999999995 113.233 -174.087 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 784' ' ' VAL . . . . . 0.491 HG12 HG21 ' A' ' 786' ' ' THR . 52.5 t -59.51 115.38 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-N 115.12 -0.945 . . . . 99.989999999999995 111.316 177.18 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 785' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -94.88 95.4 8.63 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.456 -0.793 . . . . 99.989999999999995 110.242 -179.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 786' ' ' THR . . . . . 0.491 HG21 HG12 ' A' ' 784' ' ' VAL . 33.4 p -86.67 35.23 0.67 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 122.026 0.917 . . . . 99.989999999999995 110.648 -178.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 44.3 m -152.79 109.31 3.42 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.457 -1.247 . . . . 99.989999999999995 110.902 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 788' ' ' GLY . . . . . 0.45 ' HA2' HG12 ' A' ' 817' ' ' VAL . . . -52.42 109.14 0.82 Allowed Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 121.046 -0.597 . . . . 99.989999999999995 112.16 169.503 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 789' ' ' GLY . . . . . . . . . . . . . . . -169.91 176.58 43.66 Favored Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 110.82 -0.912 . . . . 99.989999999999995 110.82 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 790' ' ' ASP . . . . . 0.462 ' OD2' HG23 ' A' ' 760' ' ' THR . 0.4 OUTLIER -103.12 133.12 48.75 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.384 0.612 . . . . 99.989999999999995 110.58 -178.563 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 791' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -123.66 148.41 46.51 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.342 -0.844 . . . . 99.989999999999995 109.697 -179.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 792' ' ' ILE . . . . . 0.604 ' O ' HG13 ' A' ' 758' ' ' ILE . 14.1 mt -128.62 114.28 32.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 N-CA-C 109.302 -0.629 . . . . 99.989999999999995 109.302 177.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 793' ' ' LEU . . . . . 0.552 HD11 ' N ' ' A' ' 794' ' ' SER . 0.7 OUTLIER -84.62 113.44 21.27 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 108.842 -0.799 . . . . 99.989999999999995 108.842 178.122 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 794' ' ' SER . . . . . 0.552 ' N ' HD11 ' A' ' 793' ' ' LEU . 13.7 p -124.68 164.34 20.1 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.344 -1.298 . . . . 99.989999999999995 109.315 -174.647 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 795' ' ' LEU . . . . . 0.623 HD13 ' O ' ' A' ' 723' ' ' ALA . 36.7 mt -89.4 144.85 25.74 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.688 -0.233 . . . . 99.989999999999995 110.942 -176.528 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 796' ' ' VAL . . . . . . . . . . . . . 68.8 t -104.88 -57.68 4.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.857 -0.337 . . . . 99.989999999999995 111.159 177.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 797' ' ' SER . . . . . 0.492 ' HA ' ' HG ' ' A' ' 808' ' ' LEU . 10.4 m -176.95 161.53 1.96 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.019 -0.537 . . . . 99.989999999999995 109.978 -175.283 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 798' ' ' ILE . . . . . 0.555 ' HA ' ' O ' ' A' ' 752' ' ' THR . 11.7 tt -132.07 162.11 40.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 108.679 -0.859 . . . . 99.989999999999995 108.679 176.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 799' ' ' LYS . . . . . 0.729 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 5.2 tmtt? -137.4 119.84 15.91 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.097 0.475 . . . . 99.989999999999995 111.024 -178.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 800' ' ' ASP . . . . . 0.5 ' HA ' ' CD2' ' A' ' 751' ' ' PHE . 11.7 t70 -64.23 153.0 39.36 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.256 -0.884 . . . . 99.989999999999995 108.982 174.046 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 3.5 p -68.02 0.92 3.08 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.423 0.527 . . . . 99.989999999999995 112.423 -173.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 24.3 p -92.95 -0.46 57.21 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.657 0.741 . . . . 99.989999999999995 109.511 172.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 803' ' ' GLY . . . . . 0.425 ' HA2' ' HE2' ' A' ' 799' ' ' LYS . . . 81.05 41.92 9.97 Favored Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 114.895 -1.048 . . . . 99.989999999999995 111.8 -177.459 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 804' ' ' CYS . . . . . . . . . . . . . 63.4 m -113.78 114.22 26.02 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 110.181 -0.303 . . . . 99.989999999999995 110.181 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 805' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 8.3 p -86.52 134.25 27.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.313 0.578 . . . . 99.989999999999995 110.831 -177.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 806' ' ' VAL . . . . . . . . . . . . . 53.2 t -123.04 134.84 64.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.717 0 CA-C-N 115.563 -0.744 . . . . 99.989999999999995 110.365 178.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -66.24 127.29 29.5 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 114.816 -1.084 . . . . 99.989999999999995 111.939 -179.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 808' ' ' LEU . . . . . 0.719 ' CD2' ' HA ' ' A' ' 722' ' ' SER . 45.6 mt -90.81 126.62 36.08 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 111.772 0.286 . . . . 99.989999999999995 111.772 -177.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 5.6 p -149.47 85.95 1.46 Allowed 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 121.522 0.677 . . . . 99.989999999999995 110.97 173.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 810' ' ' GLN . . . . . 0.612 ' HB2' ' O ' ' A' ' 723' ' ' ALA . 90.8 mt-30 -140.5 168.02 15.93 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 107.557 -1.275 . . . . 99.989999999999995 107.557 172.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 811' ' ' PRO . . . . . 0.488 ' HD2' ' HB3' ' A' ' 810' ' ' GLN . 86.6 Cg_exo -45.34 137.33 10.88 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 123.098 2.532 . . . . 99.989999999999995 115.228 -173.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -103.25 166.72 10.26 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 114.62 -1.173 . . . . 99.989999999999995 110.303 177.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 813' ' ' ALA . . . . . 0.404 ' CB ' HD21 ' A' ' 725' ' ' LEU . . . -119.68 161.11 21.24 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.575 -0.284 . . . . 99.989999999999995 111.245 -177.175 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 814' ' ' LYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 730' ' ' ASP . 73.9 tttt -123.98 125.2 44.16 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 121.163 0.506 . . . . 99.989999999999995 110.834 177.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 815' ' ' ILE . . . . . 0.512 ' HA ' ' HB3' ' A' ' 731' ' ' LEU . 5.3 mp -109.39 119.24 58.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 108.32 -0.992 . . . . 99.989999999999995 108.32 176.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 816' ' ' GLN . . . . . 0.683 ' NE2' ' HG2' ' A' ' 818' ' ' ARG . 0.8 OUTLIER -108.95 114.51 28.33 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.217 0.532 . . . . 99.989999999999995 111.062 -174.748 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 817' ' ' VAL . . . . . 0.45 HG12 ' HA2' ' A' ' 788' ' ' GLY . 84.4 t -103.97 140.52 21.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 115.786 -0.643 . . . . 99.989999999999995 110.316 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 818' ' ' ARG . . . . . 0.683 ' HG2' ' NE2' ' A' ' 816' ' ' GLN . 34.1 mmt180 . . . . . 0 C--N 1.322 -0.594 0 N-CA-C 108.745 -0.835 . . . . 99.989999999999995 108.745 172.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 720' ' ' LYS . . . . . . . . . . . . . 16.7 mtpp . . . . . 0 N--CA 1.444 -0.746 0 N-CA-C 109.64 -0.504 . . . . 99.989999999999995 109.64 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 721' ' ' PRO . . . . . 0.424 ' HG3' ' CE2' ' A' ' 751' ' ' PHE . 60.6 Cg_endo -88.5 154.93 6.48 Favored 'Trans proline' 0 N--CA 1.447 -1.217 0 C-N-CA 122.713 2.275 . . . . 99.989999999999995 112.472 -174.209 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 722' ' ' SER . . . . . 0.496 ' HA ' ' CD2' ' A' ' 808' ' ' LEU . 11.4 t 178.49 -152.4 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.783 -0.644 . . . . 99.989999999999995 109.871 -176.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 723' ' ' ALA . . . . . 0.574 ' HA ' ' HA ' ' A' ' 745' ' ' LEU . . . -152.53 153.65 33.87 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 109.548 -0.538 . . . . 99.989999999999995 109.548 178.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 49.7 m -144.45 98.67 3.24 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.213 0.53 . . . . 99.989999999999995 109.634 175.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 725' ' ' LEU . . . . . 0.658 HD11 ' N ' ' A' ' 725' ' ' LEU . 4.9 mp -62.38 141.45 58.32 Favored 'General case' 0 N--CA 1.424 -1.747 0 CA-C-O 122.4 1.095 . . . . 99.989999999999995 111.808 -175.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 726' ' ' LYS . . . . . 0.44 ' HD2' ' HB1' ' A' ' 744' ' ' ALA . 19.2 mtpp -94.79 -13.02 26.02 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 112.887 -1.96 . . . . 99.989999999999995 110.288 -173.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 727' ' ' LEU . . . . . 0.531 ' HB2' ' HD2' ' A' ' 742' ' ' PRO . 0.9 OUTLIER -82.3 112.38 19.24 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.363 -0.977 . . . . 99.989999999999995 108.363 176.096 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 51.5 m-70 -114.67 54.25 0.78 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.713 0.635 . . . . 99.989999999999995 112.713 -172.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 7.6 p80 -178.15 -178.08 0.63 Allowed 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.762 -0.199 . . . . 99.989999999999995 110.492 176.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 730' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -81.58 125.84 31.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.35 -0.387 . . . . 99.989999999999995 110.303 176.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 731' ' ' LEU . . . . . 0.578 ' HB2' ' HA ' ' A' ' 815' ' ' ILE . 21.2 mt -79.95 113.14 17.89 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.398 -0.364 . . . . 99.989999999999995 111.215 177.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 732' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -76.61 109.94 10.78 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.922 -0.581 . . . . 99.989999999999995 111.092 -176.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 733' ' ' LEU . . . . . 0.537 HD13 ' CG2' ' A' ' 815' ' ' ILE . 64.3 mt -122.94 164.21 18.92 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.16 0.505 . . . . 99.989999999999995 110.864 177.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 734' ' ' CYS . . . . . 0.522 ' O ' ' HB2' ' A' ' 737' ' ' ASP . 76.3 m -113.75 -174.28 2.44 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.262 -0.881 . . . . 99.989999999999995 109.023 170.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 735' ' ' LEU . . . . . . . . . . . . . 8.6 tp -68.37 135.24 51.5 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 121.448 0.642 . . . . 99.989999999999995 111.898 -176.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 81.37 8.74 86.77 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 114.854 -1.066 . . . . 99.989999999999995 111.996 -178.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 737' ' ' ASP . . . . . 0.522 ' HB2' ' O ' ' A' ' 734' ' ' CYS . 4.1 m-20 -89.67 151.48 21.85 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.849 0.685 . . . . 99.989999999999995 112.849 179.319 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 738' ' ' HIS . . . . . 0.433 ' HB2' ' O ' ' A' ' 782' ' ' THR . 45.4 p-80 -114.2 -175.53 2.7 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 108.071 -1.085 . . . . 99.989999999999995 108.071 169.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 739' ' ' SER . . . . . 0.476 ' HB2' ' OG1' ' A' ' 782' ' ' THR . 9.2 m -141.55 174.39 10.61 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.567 0.698 . . . . 99.989999999999995 112.471 178.021 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 14.1 t -141.67 103.04 4.3 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 114.714 -1.13 . . . . 99.989999999999995 108.489 178.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 741' ' ' VAL . . . . . 0.436 HG12 HD23 ' A' ' 793' ' ' LEU . 1.7 p -107.57 114.65 60.36 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 115.692 -0.685 . . . . 99.989999999999995 110.642 -175.542 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 742' ' ' PRO . . . . . 0.597 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 1.0 OUTLIER -73.64 129.19 13.34 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 122.488 2.126 . . . . 99.989999999999995 111.286 179.403 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 743' ' ' VAL . . . . . 0.514 ' HA ' ' HA ' ' A' ' 725' ' ' LEU . 1.5 p -128.53 119.92 51.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.308 0.575 . . . . 99.989999999999995 111.759 175.014 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 744' ' ' ALA . . . . . 0.554 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -85.1 105.51 15.88 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.08 -1.082 . . . . 99.989999999999995 108.08 169.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 745' ' ' LEU . . . . . 0.574 ' HA ' ' HA ' ' A' ' 723' ' ' ALA . 0.4 OUTLIER -85.23 168.0 15.15 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 114.525 -1.216 . . . . 99.989999999999995 111.156 -167.403 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 12.3 tttp -121.23 155.43 34.63 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.678 0.752 . . . . 99.989999999999995 110.724 -177.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 747' ' ' GLY . . . . . . . . . . . . . . . 97.66 135.92 8.92 Favored Glycine 0 C--N 1.306 -1.121 0 CA-C-N 114.441 -1.254 . . . . 99.989999999999995 111.229 -178.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 60.9 mm-40 -106.46 116.74 32.46 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.433 -0.507 . . . . 99.989999999999995 110.858 -173.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 130.28 164.77 11.42 Favored Glycine 0 CA--C 1.496 -1.114 0 CA-C-N 115.526 -0.761 . . . . 99.989999999999995 111.518 -175.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 750' ' ' PRO . . . . . 0.514 ' HB3' ' HE2' ' A' ' 774' ' ' LYS . 46.2 Cg_endo -60.31 94.08 0.1 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 123.388 2.725 . . . . 99.989999999999995 111.768 172.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 751' ' ' PHE . . . . . 0.462 ' CE2' ' HA ' ' A' ' 800' ' ' ASP . 44.0 m-85 -105.0 143.34 33.32 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.728 -0.669 . . . . 99.989999999999995 111.103 -177.149 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 752' ' ' THR . . . . . 0.739 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 93.0 m -88.44 102.97 15.42 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 121.563 0.697 . . . . 99.989999999999995 109.137 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 753' ' ' LEU . . . . . . . . . . . . . 23.6 tp -93.3 117.81 30.52 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.379 -1.282 . . . . 99.989999999999995 110.844 -169.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 754' ' ' THR . . . . . 0.501 HG23 ' HB2' ' A' ' 769' ' ' GLU . 1.4 m -117.99 132.11 56.42 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.707 0.289 . . . . 99.989999999999995 110.642 179.518 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 755' ' ' TYR . . . . . 0.522 ' CE1' ' HB3' ' A' ' 768' ' ' PHE . 24.1 p90 -142.45 156.94 45.22 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.89 0.376 . . . . 99.989999999999995 111.438 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 756' ' ' ASP . . . . . 0.487 ' HA ' ' O ' ' A' ' 766' ' ' LYS . 0.1 OUTLIER -119.76 118.83 31.89 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.559 -0.746 . . . . 99.989999999999995 110.526 -179.282 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 757' ' ' ILE . . . . . 0.596 ' CD1' HD13 ' A' ' 793' ' ' LEU . 3.6 mp -87.22 96.39 5.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 N-CA-C 107.279 -1.378 . . . . 99.989999999999995 107.279 167.348 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 758' ' ' ILE . . . . . 0.465 HG13 ' O ' ' A' ' 792' ' ' ILE . 2.4 pp -96.08 144.33 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 CA-C-N 115.699 -0.682 . . . . 99.989999999999995 110.562 -171.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 759' ' ' GLU . . . . . 0.458 ' O ' ' HG3' ' A' ' 759' ' ' GLU . 5.6 pt-20 -95.64 124.37 39.63 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 119.47 -0.892 . . . . 99.989999999999995 109.988 177.138 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 760' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.314 -0.975 0 N-CA-C 108.346 -0.983 . . . . 99.989999999999995 108.346 177.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 765' ' ' ARG . . . . . 0.431 ' HA ' ' HA ' ' A' ' 758' ' ' ILE . 42.4 mtm180 . . . . . 0 C--O 1.235 0.329 0 CA-C-O 120.916 0.389 . . . . 99.989999999999995 111.443 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 766' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 756' ' ' ASP . 1.0 OUTLIER -121.44 136.05 55.0 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.998 -0.546 . . . . 99.989999999999995 110.018 -179.037 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 767' ' ' THR . . . . . . . . . . . . . 60.7 m -115.38 136.73 52.79 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.995 -0.548 . . . . 99.989999999999995 110.89 -175.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 768' ' ' PHE . . . . . 0.522 ' HB3' ' CE1' ' A' ' 755' ' ' TYR . 2.8 t80 -138.33 135.68 35.65 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 109.079 -0.712 . . . . 99.989999999999995 109.079 175.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 769' ' ' GLU . . . . . 0.501 ' HB2' HG23 ' A' ' 754' ' ' THR . 33.2 tt0 -127.17 133.15 50.36 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.152 -0.476 . . . . 99.989999999999995 111.117 -179.277 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 4.1 mt -123.9 109.04 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 N-CA-C 108.649 -0.871 . . . . 99.989999999999995 108.649 175.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 771' ' ' LYS . . . . . 0.562 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 9.6 mtpt -80.12 151.59 29.73 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-O 121.35 0.595 . . . . 99.989999999999995 111.035 -176.162 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 772' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 55.35 50.66 14.41 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.312 -1.313 . . . . 99.989999999999995 112.393 176.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -74.99 122.07 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 107.447 -1.316 . . . . 99.989999999999995 107.447 170.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 774' ' ' LYS . . . . . 0.514 ' HE2' ' HB3' ' A' ' 750' ' ' PRO . 65.5 mttt -115.38 25.42 10.84 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.364 -0.835 . . . . 99.989999999999995 108.818 -176.329 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 775' ' ' THR . . . . . 0.621 ' O ' ' HB2' ' A' ' 776' ' ' ASN . 0.7 OUTLIER -96.33 -73.36 0.6 Allowed 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 114.002 1.112 . . . . 99.989999999999995 114.002 -169.551 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 776' ' ' ASN . . . . . 0.621 ' HB2' ' O ' ' A' ' 775' ' ' THR . 0.7 OUTLIER 85.97 3.65 0.53 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.548 1.139 . . . . 99.989999999999995 111.242 -173.345 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 777' ' ' GLU . . . . . 0.554 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 30.0 mt-10 -161.27 84.64 0.65 Allowed 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.977 -0.749 . . . . 99.989999999999995 108.977 177.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 778' ' ' TYR . . . . . 0.475 ' HB3' HD11 ' A' ' 745' ' ' LEU . 89.9 t80 -132.72 133.01 42.94 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.305 -0.407 . . . . 99.989999999999995 110.897 -169.588 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 779' ' ' VAL . . . . . 0.597 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 12.2 t -93.5 114.36 30.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.465 0.65 . . . . 99.989999999999995 110.555 179.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 780' ' ' ILE . . . . . 0.525 HG23 ' N ' ' A' ' 781' ' ' LYS . 70.6 mt -79.4 147.52 6.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 114.843 -1.071 . . . . 99.989999999999995 110.606 -177.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 781' ' ' LYS . . . . . 0.525 ' N ' HG23 ' A' ' 780' ' ' ILE . 0.0 OUTLIER -117.89 100.67 7.73 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.484 -0.561 . . . . 99.989999999999995 109.484 175.222 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 782' ' ' THR . . . . . 0.476 ' OG1' ' HB2' ' A' ' 739' ' ' SER . 62.1 p -70.16 135.19 87.08 Favored Pre-proline 0 N--CA 1.441 -0.884 0 CA-C-N 115.896 -0.593 . . . . 99.989999999999995 109.633 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 783' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 782' ' ' THR . 25.5 Cg_exo -62.66 156.21 54.28 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.793 2.329 . . . . 99.989999999999995 111.303 -175.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 784' ' ' VAL . . . . . 0.455 ' O ' HG11 ' A' ' 784' ' ' VAL . 14.6 p -58.64 127.87 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 CA-C-O 121.489 0.661 . . . . 99.989999999999995 109.974 -177.745 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 785' ' ' PHE . . . . . 0.516 ' C ' ' H ' ' A' ' 787' ' ' THR . 94.7 m-85 -81.88 -31.83 31.33 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.614 -0.721 . . . . 99.989999999999995 111.419 -172.122 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 43.1 p 56.64 2.49 0.1 Allowed 'General case' 0 N--CA 1.471 0.59 0 O-C-N 124.065 0.853 . . . . 99.989999999999995 112.233 178.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 787' ' ' THR . . . . . 0.516 ' H ' ' C ' ' A' ' 785' ' ' PHE . 14.8 m -139.93 122.91 16.68 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.211 -0.45 . . . . 99.989999999999995 111.05 -179.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 788' ' ' GLY . . . . . . . . . . . . . . . -58.76 111.23 3.11 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.542 -0.837 . . . . 99.989999999999995 112.304 168.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 789' ' ' GLY . . . . . 0.428 ' H ' ' HB ' ' A' ' 817' ' ' VAL . . . -166.89 167.21 39.58 Favored Glycine 0 N--CA 1.442 -0.916 0 N-CA-C 110.127 -1.189 . . . . 99.989999999999995 110.127 178.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -99.11 130.98 45.47 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 117.674 0.737 . . . . 99.989999999999995 109.72 -179.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 791' ' ' TYR . . . . . 0.413 ' CE2' ' HB3' ' A' ' 759' ' ' GLU . 86.9 m-85 -124.3 153.48 41.68 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.29 0.567 . . . . 99.989999999999995 110.885 -178.407 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 792' ' ' ILE . . . . . 0.465 ' O ' HG13 ' A' ' 758' ' ' ILE . 7.2 mt -130.72 113.97 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 CA-C-N 115.283 -0.871 . . . . 99.989999999999995 108.944 176.113 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 793' ' ' LEU . . . . . 0.596 HD13 ' CD1' ' A' ' 757' ' ' ILE . 1.3 tp -84.74 110.68 18.97 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 108.692 -0.855 . . . . 99.989999999999995 108.692 176.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 794' ' ' SER . . . . . 0.506 ' N ' HD11 ' A' ' 793' ' ' LEU . 6.1 p -124.7 157.5 35.49 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.53 -1.214 . . . . 99.989999999999995 109.729 -173.472 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 795' ' ' LEU . . . . . 0.428 HD22 ' HB2' ' A' ' 723' ' ' ALA . 51.4 mt -85.29 133.39 34.16 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.57 -0.287 . . . . 99.989999999999995 111.147 -174.42 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 796' ' ' VAL . . . . . . . . . . . . . 79.2 t -95.62 -55.06 6.45 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 CA-C-N 116.258 -0.428 . . . . 99.989999999999995 110.715 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 797' ' ' SER . . . . . 0.551 ' HA ' ' HG ' ' A' ' 808' ' ' LEU . 97.5 p -176.7 158.55 1.71 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.814 -0.63 . . . . 99.989999999999995 109.988 -173.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 798' ' ' ILE . . . . . 0.506 ' HA ' ' O ' ' A' ' 752' ' ' THR . 8.0 tt -131.01 163.88 35.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 108.398 -0.964 . . . . 99.989999999999995 108.398 176.182 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 799' ' ' LYS . . . . . 0.739 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 16.5 ttmt -140.91 125.82 18.2 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.06 0.457 . . . . 99.989999999999995 111.503 -177.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 800' ' ' ASP . . . . . 0.462 ' HA ' ' CE2' ' A' ' 751' ' ' PHE . 28.2 t70 -65.98 155.77 35.61 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.44 -0.8 . . . . 99.989999999999995 109.517 174.024 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 801' ' ' SER . . . . . 0.405 ' HB3' ' HG2' ' A' ' 750' ' ' PRO . 18.2 p -59.03 -10.05 2.33 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 113.016 0.747 . . . . 99.989999999999995 113.016 -171.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 36.1 p -96.76 8.83 43.39 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.37 0.605 . . . . 99.989999999999995 110.324 179.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 803' ' ' GLY . . . . . . . . . . . . . . . 76.17 41.37 26.83 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 115.321 -0.854 . . . . 99.989999999999995 112.038 -178.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 804' ' ' CYS . . . . . 0.405 ' HB2' ' HB3' ' A' ' 800' ' ' ASP . 76.7 m -109.72 111.74 23.38 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 110.08 -0.341 . . . . 99.989999999999995 110.08 178.247 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 805' ' ' VAL . . . . . 0.438 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 14.4 p -86.25 139.46 17.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.422 0.63 . . . . 99.989999999999995 111.702 -174.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 806' ' ' VAL . . . . . 0.452 ' HB ' HG22 ' A' ' 798' ' ' ILE . 52.0 t -119.21 131.99 70.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.075 -0.966 . . . . 99.989999999999995 109.551 177.318 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -72.99 114.07 4.62 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.798 -0.715 . . . . 99.989999999999995 111.791 179.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 808' ' ' LEU . . . . . 0.551 ' HG ' ' HA ' ' A' ' 797' ' ' SER . 36.0 mt -84.9 124.46 31.66 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.633 0.605 . . . . 99.989999999999995 112.633 -173.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 19.1 t -138.98 86.51 2.14 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.619 -0.719 . . . . 99.989999999999995 109.241 171.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 810' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -146.91 173.55 4.11 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-N 115.3 -0.864 . . . . 99.989999999999995 109.873 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 811' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_exo -43.53 144.36 2.12 Favored 'Trans proline' 0 C--N 1.357 1.019 0 C-N-CA 123.618 2.879 . . . . 99.989999999999995 115.812 -173.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -116.22 169.1 9.54 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 114.554 -1.203 . . . . 99.989999999999995 110.546 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 813' ' ' ALA . . . . . 0.47 ' HB2' HD21 ' A' ' 725' ' ' LEU . . . -120.68 160.15 23.87 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.732 -0.667 . . . . 99.989999999999995 109.994 175.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 814' ' ' LYS . . . . . 0.451 ' HG2' ' CG1' ' A' ' 792' ' ' ILE . 48.3 mttp -123.62 134.31 53.81 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.451 0.643 . . . . 99.989999999999995 110.648 177.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 815' ' ' ILE . . . . . 0.578 ' HA ' ' HB2' ' A' ' 731' ' ' LEU . 5.3 mp -121.16 108.48 22.66 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 CA-C-N 115.055 -0.975 . . . . 99.989999999999995 108.898 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 816' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -100.87 108.01 19.68 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.257 0.551 . . . . 99.989999999999995 110.441 -176.312 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 817' ' ' VAL . . . . . 0.49 ' HA ' ' HB2' ' A' ' 733' ' ' LEU . 2.9 t -101.91 146.86 9.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 N-CA-C 109.287 -0.634 . . . . 99.989999999999995 109.287 -179.312 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 818' ' ' ARG . . . . . . . . . . . . . 20.7 tpt180 . . . . . 0 C--N 1.323 -0.587 0 CA-C-O 121.467 0.651 . . . . 99.989999999999995 112.175 -178.396 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 718' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? . . . . . 0 CA--C 1.509 -0.617 0 N-CA-C 108.355 -0.979 . . . . 99.989999999999995 108.355 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 719' ' ' VAL . . . . . 0.538 ' O ' ' HD3' ' A' ' 721' ' ' PRO . 1.9 m -133.62 149.72 31.22 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 CA-C-N 115.856 -0.611 . . . . 99.989999999999995 109.569 -178.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 720' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -96.46 98.83 4.64 Favored Pre-proline 0 C--N 1.304 -1.41 0 CA-C-N 115.224 -0.898 . . . . 99.989999999999995 109.373 175.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 721' ' ' PRO . . . . . 0.538 ' HD3' ' O ' ' A' ' 719' ' ' VAL . 62.7 Cg_endo -87.62 155.97 7.67 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 122.948 2.432 . . . . 99.989999999999995 112.071 -174.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 722' ' ' SER . . . . . 0.505 ' HA ' ' CD2' ' A' ' 808' ' ' LEU . 12.7 t -176.77 -146.42 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.567 -0.531 . . . . 99.989999999999995 109.567 -174.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 723' ' ' ALA . . . . . 0.475 ' HA ' ' HA ' ' A' ' 745' ' ' LEU . . . -153.24 149.31 27.82 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.658 0.266 . . . . 99.989999999999995 110.621 177.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 70.6 m -135.11 98.42 3.99 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.588 -0.893 . . . . 99.989999999999995 108.588 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 725' ' ' LEU . . . . . 0.628 HD21 ' CG2' ' A' ' 743' ' ' VAL . 2.3 mt -64.67 141.91 58.61 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 115.867 -0.606 . . . . 99.989999999999995 110.571 -171.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 33.3 mtpt -93.47 -22.51 18.83 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.396 -0.82 . . . . 99.989999999999995 110.043 -176.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 727' ' ' LEU . . . . . 0.467 ' HB2' ' HD2' ' A' ' 742' ' ' PRO . 0.2 OUTLIER -70.24 108.7 4.29 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 107.733 -1.21 . . . . 99.989999999999995 107.733 173.771 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 34.2 m170 -104.78 42.93 1.15 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.508 0.559 . . . . 99.989999999999995 112.508 -169.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -179.45 -177.21 0.42 Allowed 'General case' 0 C--N 1.327 -0.402 0 O-C-N 123.238 0.336 . . . . 99.989999999999995 110.279 176.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 730' ' ' ASP . . . . . 0.446 ' HB3' ' HE2' ' A' ' 814' ' ' LYS . 5.0 p-10 -78.47 153.96 30.96 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.075 0.464 . . . . 99.989999999999995 110.86 179.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 731' ' ' LEU . . . . . 0.554 ' HB2' ' HA ' ' A' ' 815' ' ' ILE . 49.1 mt -102.53 137.35 40.88 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.505 -0.77 . . . . 99.989999999999995 110.672 178.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 732' ' ' LYS . . . . . . . . . . . . . 35.2 mmtm -104.12 103.83 13.67 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.155 0.503 . . . . 99.989999999999995 110.901 177.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 733' ' ' LEU . . . . . 0.492 ' HG ' ' HB3' ' A' ' 737' ' ' ASP . 0.8 OUTLIER -112.01 164.17 13.44 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.625 -0.716 . . . . 99.989999999999995 110.725 -178.972 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 734' ' ' CYS . . . . . 0.62 ' O ' ' HB2' ' A' ' 737' ' ' ASP . 56.6 m -104.65 -176.8 3.18 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.089 -1.078 . . . . 99.989999999999995 108.089 171.555 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 735' ' ' LEU . . . . . 0.494 HD13 ' HD2' ' A' ' 819' ' ' ARG . 10.3 tt -84.28 137.23 33.57 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 119.767 -0.773 . . . . 99.989999999999995 109.639 -175.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 82.97 8.02 86.36 Favored Glycine 0 N--CA 1.441 -0.989 0 CA-C-N 114.947 -1.024 . . . . 99.989999999999995 110.845 -171.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 737' ' ' ASP . . . . . 0.62 ' HB2' ' O ' ' A' ' 734' ' ' CYS . 0.5 OUTLIER -93.27 145.9 24.1 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.13 0.49 . . . . 99.989999999999995 111.546 177.262 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 738' ' ' HIS . . . . . 0.522 ' HB2' ' O ' ' A' ' 782' ' ' THR . 40.8 p-80 -110.76 175.82 5.28 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 107.353 -1.351 . . . . 99.989999999999995 107.353 170.173 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 739' ' ' SER . . . . . 0.405 ' CB ' HD23 ' A' ' 733' ' ' LEU . 0.0 OUTLIER -132.19 173.02 11.68 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 120.019 -0.672 . . . . 99.989999999999995 111.883 -177.344 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 36.8 m -143.03 106.82 4.65 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.032 -0.986 . . . . 99.989999999999995 109.702 178.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 741' ' ' VAL . . . . . 0.481 HG13 HD23 ' A' ' 793' ' ' LEU . 0.8 OUTLIER -110.32 111.92 57.41 Favored Pre-proline 0 C--N 1.318 -0.771 0 CA-C-N 115.931 -0.577 . . . . 99.989999999999995 110.177 -176.871 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 742' ' ' PRO . . . . . 0.704 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 4.0 Cg_exo -72.16 131.29 17.69 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 122.434 2.089 . . . . 99.989999999999995 111.249 -179.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 743' ' ' VAL . . . . . 0.628 ' CG2' HD21 ' A' ' 725' ' ' LEU . 41.2 t -131.3 118.05 38.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.503 0.668 . . . . 99.989999999999995 112.742 -179.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 744' ' ' ALA . . . . . 0.587 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -82.75 97.42 8.57 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 122.009 0.909 . . . . 99.989999999999995 108.621 170.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 745' ' ' LEU . . . . . 0.497 HD13 ' CD1' ' A' ' 773' ' ' ILE . 2.5 mt -76.72 159.72 29.93 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 113.972 -1.467 . . . . 99.989999999999995 111.86 -168.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -111.61 146.78 36.8 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.416 -0.811 . . . . 99.989999999999995 110.08 -178.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 747' ' ' GLY . . . . . 0.409 ' HA3' ' HB3' ' A' ' 721' ' ' PRO . . . 103.24 119.87 4.68 Favored Glycine 0 C--N 1.304 -1.204 0 CA-C-N 115.111 -0.95 . . . . 99.989999999999995 111.622 -178.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 748' ' ' GLN . . . . . 0.429 ' C ' ' HE1' ' A' ' 751' ' ' PHE . 0.0 OUTLIER -105.43 110.01 22.2 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.138 0.494 . . . . 99.989999999999995 111.2 -173.415 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 136.23 -175.68 20.76 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 115.207 -0.906 . . . . 99.989999999999995 110.877 -176.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -71.04 94.1 0.64 Allowed 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.397 2.064 . . . . 99.989999999999995 111.865 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 751' ' ' PHE . . . . . 0.566 ' HA ' ' O ' ' A' ' 799' ' ' LYS . 88.1 m-85 -113.2 140.46 47.92 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.327 -0.397 . . . . 99.989999999999995 111.368 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 752' ' ' THR . . . . . 0.652 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 98.0 m -89.92 104.99 17.5 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 121.556 0.693 . . . . 99.989999999999995 109.243 178.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 753' ' ' LEU . . . . . . . . . . . . . 21.3 tp -92.24 116.96 29.41 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 114.374 -1.285 . . . . 99.989999999999995 110.532 -172.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 754' ' ' THR . . . . . 0.471 HG23 ' HB2' ' A' ' 769' ' ' GLU . 0.9 OUTLIER -117.88 130.18 56.09 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.458 -0.337 . . . . 99.989999999999995 110.21 179.241 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 755' ' ' TYR . . . . . 0.539 ' CE1' ' HB3' ' A' ' 768' ' ' PHE . 20.8 p90 -139.43 153.8 47.66 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 120.741 -0.384 . . . . 99.989999999999995 111.582 -179.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 756' ' ' ASP . . . . . 0.435 ' HB2' HG23 ' A' ' 758' ' ' ILE . 7.6 p-10 -114.93 118.85 34.62 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 115.769 -0.651 . . . . 99.989999999999995 111.823 -176.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 757' ' ' ILE . . . . . 0.553 ' CD1' HD13 ' A' ' 793' ' ' LEU . 3.6 mp -91.68 95.36 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 N-CA-C 107.522 -1.288 . . . . 99.989999999999995 107.522 167.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 758' ' ' ILE . . . . . 0.51 HG13 ' O ' ' A' ' 792' ' ' ILE . 2.3 pp -103.93 149.67 7.62 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 115.413 -0.812 . . . . 99.989999999999995 111.061 -170.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 759' ' ' GLU . . . . . 0.556 ' CG ' ' H ' ' A' ' 764' ' ' LYS . 8.3 pt-20 -96.89 135.28 39.1 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 120.283 -0.567 . . . . 99.989999999999995 110.364 177.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 760' ' ' THR . . . . . 0.491 ' OG1' ' HB3' ' A' ' 790' ' ' ASP . 38.7 p -81.42 -4.11 54.84 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-O 121.904 0.859 . . . . 99.989999999999995 108.684 174.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 761' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -73.51 -35.7 65.63 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 114.139 -1.391 . . . . 99.989999999999995 110.534 -176.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 762' ' ' SER . . . . . . . . . . . . . 16.2 t -169.05 -80.75 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 111.862 0.319 . . . . 99.989999999999995 111.862 176.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 763' ' ' SER . . . . . . . . . . . . . 23.5 t -166.86 27.04 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 112.716 0.635 . . . . 99.989999999999995 112.716 -173.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 764' ' ' LYS . . . . . 0.556 ' H ' ' CG ' ' A' ' 759' ' ' GLU . 40.0 mttp -84.03 52.54 2.33 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 121.651 -0.656 . . . . 99.989999999999995 110.039 176.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 765' ' ' ARG . . . . . 0.444 ' HG3' HG21 ' A' ' 758' ' ' ILE . 15.2 ttp180 -62.32 120.62 11.36 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.071 -0.968 . . . . 99.989999999999995 111.88 -178.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 766' ' ' LYS . . . . . 0.583 ' HD3' ' N ' ' A' ' 767' ' ' THR . 9.3 tmtm? -97.99 144.11 27.85 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 108.406 -0.961 . . . . 99.989999999999995 108.406 177.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 767' ' ' THR . . . . . 0.583 ' N ' ' HD3' ' A' ' 766' ' ' LYS . 60.0 m -132.3 132.61 43.16 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 116.197 -0.456 . . . . 99.989999999999995 110.603 -178.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 768' ' ' PHE . . . . . 0.539 ' HB3' ' CE1' ' A' ' 755' ' ' TYR . 1.7 t80 -130.83 136.25 48.49 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.927 -0.768 . . . . 99.989999999999995 108.927 178.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 769' ' ' GLU . . . . . 0.471 ' HB2' HG23 ' A' ' 754' ' ' THR . 35.1 tt0 -128.83 118.71 23.19 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.073 -0.512 . . . . 99.989999999999995 110.954 -177.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 7.7 mt -115.68 112.26 39.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.222 -0.659 . . . . 99.989999999999995 109.222 178.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 771' ' ' LYS . . . . . 0.58 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 3.1 mtpt -82.25 150.61 27.21 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 121.431 0.634 . . . . 99.989999999999995 111.528 -176.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 772' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 56.21 48.32 17.6 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 113.985 -1.462 . . . . 99.989999999999995 112.549 176.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 773' ' ' ILE . . . . . 0.497 ' CD1' HD13 ' A' ' 745' ' ' LEU . 0.5 OUTLIER -74.58 119.09 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 N-CA-C 107.722 -1.214 . . . . 99.989999999999995 107.722 173.215 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 76.2 mttt -117.91 31.32 6.76 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 108.16 -1.052 . . . . 99.989999999999995 108.16 -178.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 775' ' ' THR . . . . . 0.577 ' O ' ' HB2' ' A' ' 776' ' ' ASN . 2.1 m -95.74 -69.99 0.73 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.388 -1.278 . . . . 99.989999999999995 112.55 -172.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 776' ' ' ASN . . . . . 0.577 ' HB2' ' O ' ' A' ' 775' ' ' THR . 0.9 OUTLIER 82.78 4.43 1.0 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.825 0.85 . . . . 99.989999999999995 110.547 -177.092 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 777' ' ' GLU . . . . . 0.587 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 9.4 mt-10 -160.88 85.8 0.7 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.046 -0.979 . . . . 99.989999999999995 109.344 175.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 778' ' ' TYR . . . . . 0.485 ' HB3' HD12 ' A' ' 745' ' ' LEU . 75.6 t80 -136.26 126.97 27.24 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.196 -0.456 . . . . 99.989999999999995 110.258 -172.09 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 779' ' ' VAL . . . . . 0.704 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 1.6 m -91.52 126.4 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 CA-C-O 122.435 1.112 . . . . 99.989999999999995 110.612 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 780' ' ' ILE . . . . . . . . . . . . . 71.0 mt -89.22 145.32 7.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 113.543 -1.662 . . . . 99.989999999999995 110.954 -172.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -112.75 115.45 28.54 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.009 -0.738 . . . . 99.989999999999995 109.009 175.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 782' ' ' THR . . . . . 0.522 ' O ' ' HB2' ' A' ' 738' ' ' HIS . 22.9 p -89.43 140.48 28.45 Favored Pre-proline 0 C--N 1.309 -1.158 0 CA-C-N 115.252 -0.886 . . . . 99.989999999999995 110.674 -178.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 783' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.02 156.56 28.5 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.641 2.894 . . . . 99.989999999999995 112.655 -174.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 784' ' ' VAL . . . . . . . . . . . . . 15.0 p -62.9 135.31 27.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.761 -0.654 . . . . 99.989999999999995 111.126 -176.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 785' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -105.04 102.72 12.21 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.895 -0.593 . . . . 99.989999999999995 109.744 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 81.4 p -84.54 19.35 1.99 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.96 -0.564 . . . . 99.989999999999995 111.386 -174.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -159.42 119.05 2.98 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.364 -0.835 . . . . 99.989999999999995 111.211 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 788' ' ' GLY . . . . . 0.46 ' HA2' HG12 ' A' ' 817' ' ' VAL . . . -46.08 116.29 2.11 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.431 -0.804 . . . . 99.989999999999995 113.571 170.233 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 789' ' ' GLY . . . . . 0.455 ' H ' ' HB ' ' A' ' 817' ' ' VAL . . . -156.8 -162.31 11.4 Favored Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 111.132 -0.787 . . . . 99.989999999999995 111.132 177.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 790' ' ' ASP . . . . . 0.491 ' HB3' ' OG1' ' A' ' 760' ' ' THR . 16.5 t70 -130.54 122.09 26.92 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.096 -0.705 . . . . 99.989999999999995 109.096 179.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 791' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -127.55 153.39 46.42 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 116.443 -0.344 . . . . 99.989999999999995 110.379 -174.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 792' ' ' ILE . . . . . 0.51 ' O ' HG13 ' A' ' 758' ' ' ILE . 19.2 mt -127.85 124.74 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 109.606 -0.516 . . . . 99.989999999999995 109.606 176.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 793' ' ' LEU . . . . . 0.553 HD13 ' CD1' ' A' ' 757' ' ' ILE . 1.2 tp -90.67 112.25 23.92 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 108.827 -0.805 . . . . 99.989999999999995 108.827 173.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 794' ' ' SER . . . . . 0.538 ' N ' HD11 ' A' ' 793' ' ' LEU . 9.4 t -118.79 175.16 5.88 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 114.451 -1.25 . . . . 99.989999999999995 108.492 -176.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 795' ' ' LEU . . . . . . . . . . . . . 21.5 mt -103.74 127.88 51.16 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 110.146 -0.316 . . . . 99.989999999999995 110.146 -178.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 796' ' ' VAL . . . . . . . . . . . . . 55.6 t -86.71 -57.6 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 CA-C-O 120.865 0.364 . . . . 99.989999999999995 110.773 -177.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 797' ' ' SER . . . . . 0.578 ' HA ' ' HG ' ' A' ' 808' ' ' LEU . 27.3 m -174.64 156.23 2.33 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.574 -0.739 . . . . 99.989999999999995 109.61 -173.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 798' ' ' ILE . . . . . 0.572 ' HA ' ' O ' ' A' ' 752' ' ' THR . 11.8 tt -128.8 168.06 22.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 N-CA-C 108.732 -0.84 . . . . 99.989999999999995 108.732 176.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 799' ' ' LYS . . . . . 0.652 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 42.9 tttp -139.62 121.89 15.95 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 120.739 -0.384 . . . . 99.989999999999995 111.312 -174.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 800' ' ' ASP . . . . . 0.544 ' HA ' ' CD2' ' A' ' 751' ' ' PHE . 12.6 t70 -69.22 156.94 37.9 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.429 -0.805 . . . . 99.989999999999995 109.236 176.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 27.4 t -64.6 -10.9 29.7 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 123.759 0.662 . . . . 99.989999999999995 112.208 -174.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 13.9 t -90.95 2.26 56.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.991 0.9 . . . . 99.989999999999995 109.137 175.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 803' ' ' GLY . . . . . 0.43 ' HA2' ' HE3' ' A' ' 799' ' ' LYS . . . 81.71 46.79 6.6 Favored Glycine 0 N--CA 1.44 -1.061 0 CA-C-N 114.764 -1.107 . . . . 99.989999999999995 111.781 -178.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 804' ' ' CYS . . . . . 0.41 ' HB3' ' HB3' ' A' ' 800' ' ' ASP . 42.7 t -114.12 113.23 24.42 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.927 -0.309 . . . . 99.989999999999995 110.39 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 805' ' ' VAL . . . . . 0.526 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 8.4 p -85.03 129.93 36.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.346 0.593 . . . . 99.989999999999995 110.549 -177.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 806' ' ' VAL . . . . . 0.437 ' HB ' HG22 ' A' ' 798' ' ' ILE . 74.0 t -112.97 133.61 58.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.346 -0.843 . . . . 99.989999999999995 110.022 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -69.87 113.34 4.94 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.772 -0.649 . . . . 99.989999999999995 111.755 178.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 808' ' ' LEU . . . . . 0.578 ' HG ' ' HA ' ' A' ' 797' ' ' SER . 38.0 mt -84.55 125.05 32.08 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 112.34 0.496 . . . . 99.989999999999995 112.34 -175.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 23.2 t -144.51 87.14 1.85 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.422 -0.808 . . . . 99.989999999999995 109.169 172.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 810' ' ' GLN . . . . . 0.486 ' HB3' ' HD2' ' A' ' 811' ' ' PRO . 10.6 mt-30 -143.88 171.22 7.11 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.434 -0.803 . . . . 99.989999999999995 109.132 178.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 811' ' ' PRO . . . . . 0.537 ' O ' ' HG ' ' A' ' 725' ' ' LEU . 79.2 Cg_exo -42.73 139.68 3.16 Favored 'Trans proline' 0 C--N 1.356 0.925 0 C-N-CA 123.045 2.497 . . . . 99.989999999999995 114.826 -171.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 812' ' ' ASP . . . . . 0.453 ' C ' HD12 ' A' ' 725' ' ' LEU . 9.3 p-10 -112.19 167.71 10.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.51 -1.223 . . . . 99.989999999999995 110.642 -177.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 813' ' ' ALA . . . . . 0.509 ' N ' HD12 ' A' ' 725' ' ' LEU . . . -118.19 155.85 29.78 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.96 -0.564 . . . . 99.989999999999995 109.604 179.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 814' ' ' LYS . . . . . 0.456 ' HG3' ' CG1' ' A' ' 792' ' ' ILE . 12.0 ttpt -121.24 134.42 55.18 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.137 -0.625 . . . . 99.989999999999995 110.528 176.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 815' ' ' ILE . . . . . 0.554 ' HA ' ' HB2' ' A' ' 731' ' ' LEU . 4.6 mp -116.38 108.15 24.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-N 115.21 -0.905 . . . . 99.989999999999995 108.68 177.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 816' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -103.05 108.43 19.6 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.545 0.688 . . . . 99.989999999999995 109.629 -178.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 817' ' ' VAL . . . . . 0.46 HG12 ' HA2' ' A' ' 788' ' ' GLY . 90.4 t -98.36 139.5 20.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-N 115.295 -0.866 . . . . 99.989999999999995 110.168 -177.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 818' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 -126.83 175.83 7.73 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 110.168 -0.308 . . . . 99.989999999999995 110.168 178.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 819' ' ' ARG . . . . . 0.494 ' HD2' HD13 ' A' ' 735' ' ' LEU . 46.6 ttt180 -114.74 114.15 25.23 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.123 0.487 . . . . 99.989999999999995 110.948 -179.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 820' ' ' ASP . . . . . 0.461 ' OD1' ' HB3' ' A' ' 734' ' ' CYS . 11.9 p-10 . . . . . 0 C--N 1.321 -0.643 0 CA-C-N 115.568 -0.742 . . . . 99.989999999999995 110.011 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 718' ' ' ARG . . . . . . . . . . . . . 25.6 tpt180 . . . . . 0 N--CA 1.447 -0.601 0 CA-C-O 121.656 0.741 . . . . 99.989999999999995 109.979 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 719' ' ' VAL . . . . . 0.429 ' O ' ' HD3' ' A' ' 721' ' ' PRO . 4.4 p -141.73 150.15 19.57 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-N 114.728 -1.124 . . . . 99.989999999999995 108.824 -177.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 720' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -81.18 104.94 3.3 Favored Pre-proline 0 C--N 1.308 -1.231 0 CA-C-N 115.427 -0.806 . . . . 99.989999999999995 109.545 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 721' ' ' PRO . . . . . 0.429 ' HD3' ' O ' ' A' ' 719' ' ' VAL . 63.3 Cg_endo -87.62 152.41 7.57 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 122.977 2.451 . . . . 99.989999999999995 112.401 -172.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 722' ' ' SER . . . . . 0.429 ' OG ' ' HG ' ' A' ' 808' ' ' LEU . 15.0 t -176.66 -148.5 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.168 -0.679 . . . . 99.989999999999995 109.168 -174.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 723' ' ' ALA . . . . . 0.524 ' HA ' ' HA ' ' A' ' 745' ' ' LEU . . . -157.18 155.41 30.88 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.264 -0.643 . . . . 99.989999999999995 109.264 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 20.8 p -147.47 107.53 4.02 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.969 0.414 . . . . 99.989999999999995 109.894 174.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 725' ' ' LEU . . . . . 0.573 ' CD2' ' HB ' ' A' ' 743' ' ' VAL . 14.6 mt -62.96 145.62 54.91 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 121.591 0.71 . . . . 99.989999999999995 111.683 -175.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 29.9 mtpt -95.85 -17.63 20.98 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 114.707 -1.133 . . . . 99.989999999999995 110.13 -177.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 727' ' ' LEU . . . . . 0.429 HD23 ' HG ' ' A' ' 731' ' ' LEU . 37.1 tp -67.15 115.14 6.5 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.607 -0.724 . . . . 99.989999999999995 110.213 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 34.5 m80 -109.48 30.02 7.02 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.968 0.413 . . . . 99.989999999999995 111.742 -176.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -162.23 179.9 7.54 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.043 -0.725 . . . . 99.989999999999995 109.043 175.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 730' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -91.72 143.47 26.51 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.023 0.439 . . . . 99.989999999999995 110.315 -178.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 731' ' ' LEU . . . . . 0.573 ' HB2' ' HA ' ' A' ' 815' ' ' ILE . 16.0 mt -78.48 108.44 11.85 Favored 'General case' 0 C--O 1.217 -0.629 0 CA-C-N 115.832 -0.622 . . . . 99.989999999999995 111.771 -177.254 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 732' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -77.5 103.91 7.72 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.718 0.294 . . . . 99.989999999999995 111.022 178.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 733' ' ' LEU . . . . . 0.598 ' HB2' ' HB ' ' A' ' 817' ' ' VAL . 30.9 mt -118.06 164.78 14.6 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.183 0.516 . . . . 99.989999999999995 111.794 -177.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 734' ' ' CYS . . . . . 0.497 ' SG ' ' HA ' ' A' ' 820' ' ' ASP . 11.2 t -120.77 -174.41 2.81 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.159 -0.928 . . . . 99.989999999999995 109.039 179.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 735' ' ' LEU . . . . . 0.501 ' CD1' ' HG3' ' A' ' 819' ' ' ARG . 0.4 OUTLIER -72.39 119.29 16.39 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.064 0.459 . . . . 99.989999999999995 110.858 -171.507 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 86.66 10.93 72.09 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.449 -0.796 . . . . 99.989999999999995 111.893 -179.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 737' ' ' ASP . . . . . 0.499 ' HB3' ' HB3' ' A' ' 733' ' ' LEU . 5.8 t0 -75.43 168.78 19.36 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.084 0.469 . . . . 99.989999999999995 110.417 177.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 47.7 p-80 -126.21 153.72 44.29 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.848 -1.167 . . . . 99.989999999999995 107.848 175.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 739' ' ' SER . . . . . 0.592 ' HB2' ' OG1' ' A' ' 782' ' ' THR . 1.4 m -101.96 152.69 20.64 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 119.817 -0.753 . . . . 99.989999999999995 111.07 -173.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 740' ' ' SER . . . . . 0.441 ' HA ' ' O ' ' A' ' 780' ' ' ILE . 54.6 p -140.97 104.91 4.76 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.494 0.664 . . . . 99.989999999999995 110.055 179.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 741' ' ' VAL . . . . . 0.45 HG13 HD13 ' A' ' 793' ' ' LEU . 1.5 p -118.67 114.94 35.6 Favored Pre-proline 0 C--N 1.317 -0.838 0 CA-C-N 115.605 -0.725 . . . . 99.989999999999995 109.918 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 742' ' ' PRO . . . . . 0.635 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 1.8 Cg_endo -75.86 130.37 12.37 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 122.431 2.087 . . . . 99.989999999999995 111.082 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 743' ' ' VAL . . . . . 0.573 ' HB ' ' CD2' ' A' ' 725' ' ' LEU . 1.6 p -126.7 121.29 58.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.547 0.689 . . . . 99.989999999999995 112.61 175.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 744' ' ' ALA . . . . . 0.474 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -82.67 102.23 11.35 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.203 -1.036 . . . . 99.989999999999995 108.203 168.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 745' ' ' LEU . . . . . 0.524 ' HA ' ' HA ' ' A' ' 723' ' ' ALA . 1.0 OUTLIER -81.11 168.63 18.39 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 114.282 -1.327 . . . . 99.989999999999995 111.258 -168.569 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 28.0 ttmt -123.02 154.82 37.97 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.307 0.575 . . . . 99.989999999999995 110.717 -177.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 747' ' ' GLY . . . . . . . . . . . . . . . 92.05 133.11 5.98 Favored Glycine 0 C--N 1.309 -0.926 0 CA-C-N 114.919 -1.037 . . . . 99.989999999999995 111.001 -174.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 748' ' ' GLN . . . . . 0.41 ' C ' ' HE1' ' A' ' 751' ' ' PHE . 65.7 mm-40 -101.89 123.03 45.13 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 112.505 0.557 . . . . 99.989999999999995 112.505 -170.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 107.98 -169.54 14.53 Favored Glycine 0 C--O 1.219 -0.815 0 CA-C-N 115.408 -0.814 . . . . 99.989999999999995 111.896 179.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -67.23 99.86 0.51 Allowed 'Trans proline' 0 CA--C 1.531 0.356 0 C-N-CA 123.561 2.84 . . . . 99.989999999999995 113.542 -178.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 751' ' ' PHE . . . . . 0.615 ' CE2' ' HA ' ' A' ' 800' ' ' ASP . 60.9 m-85 -115.29 142.8 46.18 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.894 -0.594 . . . . 99.989999999999995 111.384 178.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 752' ' ' THR . . . . . 0.725 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 91.0 m -87.91 102.84 15.1 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.575 0.702 . . . . 99.989999999999995 109.867 178.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 753' ' ' LEU . . . . . . . . . . . . . 17.4 tp -92.08 130.71 37.75 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.537 -1.211 . . . . 99.989999999999995 110.538 -170.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 754' ' ' THR . . . . . 0.483 HG23 ' HB2' ' A' ' 769' ' ' GLU . 0.6 OUTLIER -125.98 134.84 51.37 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.607 0.241 . . . . 99.989999999999995 111.327 179.813 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 755' ' ' TYR . . . . . 0.454 ' HH ' HD12 ' A' ' 770' ' ' ILE . 26.1 p90 -145.93 154.66 42.18 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.436 -0.347 . . . . 99.989999999999995 111.14 177.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 756' ' ' ASP . . . . . 0.46 ' OD2' ' HD2' ' A' ' 765' ' ' ARG . 49.8 m-20 -116.9 122.76 45.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.703 -0.68 . . . . 99.989999999999995 110.868 -179.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 757' ' ' ILE . . . . . 0.411 ' N ' HD13 ' A' ' 757' ' ' ILE . 4.2 mp -89.88 97.31 6.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 108.258 -1.015 . . . . 99.989999999999995 108.258 170.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 758' ' ' ILE . . . . . 0.491 ' HA ' ' HA ' ' A' ' 765' ' ' ARG . 2.1 pp -96.5 149.62 4.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.953 -0.567 . . . . 99.989999999999995 112.042 -169.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 759' ' ' GLU . . . . . 0.583 ' CD ' ' HB2' ' A' ' 764' ' ' LYS . 12.2 mt-10 -93.79 112.52 24.39 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.875 -0.602 . . . . 99.989999999999995 110.839 -176.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 760' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.32 -9.76 32.08 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.843 0.83 . . . . 99.989999999999995 109.252 179.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 761' ' ' PHE . . . . . 0.465 ' CB ' ' H ' ' A' ' 790' ' ' ASP . 90.5 t80 -87.59 -24.37 24.01 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.027 -0.988 . . . . 99.989999999999995 110.199 177.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 762' ' ' SER . . . . . . . . . . . . . 15.7 m -124.81 -87.03 0.62 Allowed 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 120.795 -0.362 . . . . 99.989999999999995 111.108 -179.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 763' ' ' SER . . . . . . . . . . . . . 32.2 t 177.04 -12.75 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.828 0.347 . . . . 99.989999999999995 110.981 -177.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 764' ' ' LYS . . . . . 0.583 ' HB2' ' CD ' ' A' ' 759' ' ' GLU . 98.7 mttt -77.82 -175.92 4.18 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.377 0.608 . . . . 99.989999999999995 111.318 -175.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 765' ' ' ARG . . . . . 0.491 ' HA ' ' HA ' ' A' ' 758' ' ' ILE . 3.8 ttp180 -162.93 134.54 5.08 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.317 -0.856 . . . . 99.989999999999995 110.341 -177.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 766' ' ' LYS . . . . . 0.466 ' HD3' ' N ' ' A' ' 767' ' ' THR . 1.3 tmtp? -109.78 146.12 35.51 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 108.916 -0.772 . . . . 99.989999999999995 108.916 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 767' ' ' THR . . . . . 0.466 ' N ' ' HD3' ' A' ' 766' ' ' LYS . 77.6 m -121.05 134.14 55.27 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 116.532 -0.304 . . . . 99.989999999999995 111.244 -176.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 768' ' ' PHE . . . . . 0.401 ' HB3' ' CE1' ' A' ' 755' ' ' TYR . 0.7 OUTLIER -133.66 131.48 39.58 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.995 0.426 . . . . 99.989999999999995 110.498 175.101 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 769' ' ' GLU . . . . . 0.483 ' HB2' HG23 ' A' ' 754' ' ' THR . 36.5 tt0 -127.25 117.23 21.89 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.526 -0.761 . . . . 99.989999999999995 110.681 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 770' ' ' ILE . . . . . 0.454 HD12 ' HH ' ' A' ' 755' ' ' TYR . 12.1 mt -111.43 112.02 38.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 108.99 -0.745 . . . . 99.989999999999995 108.99 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 771' ' ' LYS . . . . . 0.584 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 12.4 mtpt -83.79 153.03 24.32 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-O 121.496 0.665 . . . . 99.989999999999995 111.609 -175.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 772' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 56.64 46.16 20.79 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 113.979 -1.464 . . . . 99.989999999999995 112.558 177.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 773' ' ' ILE . . . . . 0.427 HD12 ' H ' ' A' ' 775' ' ' THR . 0.6 OUTLIER -74.29 113.84 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 107.588 -1.264 . . . . 99.989999999999995 107.588 171.949 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 53.6 mttt -107.31 29.65 6.95 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.31 -0.996 . . . . 99.989999999999995 108.31 -177.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 775' ' ' THR . . . . . 0.655 ' O ' ' HB2' ' A' ' 776' ' ' ASN . 0.2 OUTLIER -95.85 -82.32 0.39 Allowed 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 113.695 0.998 . . . . 99.989999999999995 113.695 -167.785 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 776' ' ' ASN . . . . . 0.655 ' HB2' ' O ' ' A' ' 775' ' ' THR . 0.8 OUTLIER 89.08 3.64 0.21 Allowed 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 124.521 1.129 . . . . 99.989999999999995 111.281 -171.741 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 777' ' ' GLU . . . . . 0.474 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 12.5 mt-10 -160.88 82.94 0.66 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.003 -0.74 . . . . 99.989999999999995 109.003 175.236 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 778' ' ' TYR . . . . . 0.478 ' HB3' HD11 ' A' ' 745' ' ' LEU . 87.9 t80 -127.33 127.68 44.68 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.772 -0.371 . . . . 99.989999999999995 111.128 -171.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 779' ' ' VAL . . . . . 0.635 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 20.8 t -87.25 116.44 29.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.111 0.481 . . . . 99.989999999999995 110.4 177.054 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 780' ' ' ILE . . . . . 0.441 ' O ' ' HA ' ' A' ' 740' ' ' SER . 75.9 mt -86.35 139.6 17.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.46 -0.791 . . . . 99.989999999999995 110.405 -178.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 781' ' ' LYS . . . . . 0.416 ' HA ' ' O ' ' A' ' 739' ' ' SER . 3.6 mppt? -125.33 104.11 8.29 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.139 -0.689 . . . . 99.989999999999995 109.139 176.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 782' ' ' THR . . . . . 0.592 ' OG1' ' HB2' ' A' ' 739' ' ' SER . 44.3 p -77.42 145.5 72.18 Favored Pre-proline 0 N--CA 1.443 -0.79 0 N-CA-C 109.728 -0.471 . . . . 99.989999999999995 109.728 -177.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 783' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_exo -50.69 158.92 2.55 Favored 'Trans proline' 0 CA--C 1.529 0.271 0 C-N-CA 123.711 2.94 . . . . 99.989999999999995 113.57 -177.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 784' ' ' VAL . . . . . 0.516 HG12 HG21 ' A' ' 786' ' ' THR . 54.7 t -58.65 127.26 17.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.238 -0.892 . . . . 99.989999999999995 112.308 -177.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 785' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -102.45 103.25 13.63 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.516 -0.765 . . . . 99.989999999999995 110.294 177.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 786' ' ' THR . . . . . 0.516 HG21 HG12 ' A' ' 784' ' ' VAL . 38.9 p -90.59 30.65 1.13 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.939 0.876 . . . . 99.989999999999995 110.846 -178.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 27.6 m -152.34 107.42 3.25 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.709 -1.132 . . . . 99.989999999999995 110.347 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 788' ' ' GLY . . . . . 0.692 ' HA2' ' CG2' ' A' ' 817' ' ' VAL . . . -51.24 107.96 0.49 Allowed Glycine 0 CA--C 1.525 0.676 0 C-N-CA 121.065 -0.588 . . . . 99.989999999999995 113.128 174.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 789' ' ' GLY . . . . . 0.511 ' H ' HG22 ' A' ' 817' ' ' VAL . . . -152.22 -173.33 21.7 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 110.709 -0.956 . . . . 99.989999999999995 110.709 -179.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 790' ' ' ASP . . . . . 0.465 ' H ' ' CB ' ' A' ' 761' ' ' PHE . 2.6 m-20 -121.5 129.95 53.25 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.023 -0.732 . . . . 99.989999999999995 109.023 -177.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 791' ' ' TYR . . . . . 0.4 ' HA ' ' O ' ' A' ' 758' ' ' ILE . 61.6 m-85 -134.12 161.31 35.22 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.085 -0.507 . . . . 99.989999999999995 110.077 -176.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 792' ' ' ILE . . . . . . . . . . . . . 9.9 mt -137.94 121.64 21.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-O 120.845 0.355 . . . . 99.989999999999995 110.087 176.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 793' ' ' LEU . . . . . 0.45 HD13 HG13 ' A' ' 741' ' ' VAL . 9.6 tt -84.76 107.77 17.11 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.953 -0.758 . . . . 99.989999999999995 108.953 178.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 794' ' ' SER . . . . . . . . . . . . . 21.7 m -112.6 150.63 31.12 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.783 -0.644 . . . . 99.989999999999995 110.297 -178.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 795' ' ' LEU . . . . . . . . . . . . . 34.6 mt -83.55 132.42 34.92 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.259 -0.428 . . . . 99.989999999999995 110.359 -178.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 796' ' ' VAL . . . . . . . . . . . . . 71.7 t -99.39 -57.88 4.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.926 -0.309 . . . . 99.989999999999995 111.794 -175.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 797' ' ' SER . . . . . 0.486 ' C ' HD13 ' A' ' 808' ' ' LEU . 22.9 m -172.32 177.28 3.14 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.075 -0.511 . . . . 99.989999999999995 110.379 -173.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 798' ' ' ILE . . . . . 0.639 ' HA ' ' O ' ' A' ' 752' ' ' THR . 8.4 tt -150.92 156.73 6.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 108.598 -0.89 . . . . 99.989999999999995 108.598 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 799' ' ' LYS . . . . . 0.725 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 8.9 tmtt? -124.81 119.25 28.33 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.749 -0.463 . . . . 99.989999999999995 109.749 177.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 800' ' ' ASP . . . . . 0.615 ' HA ' ' CE2' ' A' ' 751' ' ' PHE . 11.4 t70 -63.88 154.1 34.77 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.902 -1.045 . . . . 99.989999999999995 109.487 175.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 10.6 t -60.95 -12.04 9.98 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 123.94 0.775 . . . . 99.989999999999995 112.171 -171.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 39.9 p -91.35 1.0 57.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.485 0.66 . . . . 99.989999999999995 110.45 177.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 803' ' ' GLY . . . . . 0.435 ' HA2' ' HE2' ' A' ' 799' ' ' LYS . . . 81.5 39.01 12.92 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.015 -0.993 . . . . 99.989999999999995 111.713 -176.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 804' ' ' CYS . . . . . 0.414 ' HB3' ' HB3' ' A' ' 800' ' ' ASP . 49.4 t -111.77 110.71 21.21 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.643 -0.503 . . . . 99.989999999999995 109.643 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 805' ' ' VAL . . . . . . . . . . . . . 7.5 p -86.25 127.49 40.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.671 0.748 . . . . 99.989999999999995 111.377 -173.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 806' ' ' VAL . . . . . . . . . . . . . 81.1 t -112.42 139.0 39.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 114.94 -1.027 . . . . 99.989999999999995 109.851 -178.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -83.96 109.53 3.21 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.706 -0.759 . . . . 99.989999999999995 112.756 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 808' ' ' LEU . . . . . 0.486 HD13 ' C ' ' A' ' 797' ' ' SER . 10.4 mp -74.58 133.43 42.22 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 113.167 0.803 . . . . 99.989999999999995 113.167 178.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 38.3 m -148.28 85.64 1.53 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.911 -1.04 . . . . 99.989999999999995 109.166 170.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 810' ' ' GLN . . . . . 0.502 ' HB3' ' HD2' ' A' ' 811' ' ' PRO . 12.0 mt-30 -138.86 173.66 4.99 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.458 -0.792 . . . . 99.989999999999995 109.527 178.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 811' ' ' PRO . . . . . 0.502 ' HD2' ' HB3' ' A' ' 810' ' ' GLN . 86.9 Cg_exo -44.39 140.76 5.67 Favored 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 123.153 2.568 . . . . 99.989999999999995 115.273 -175.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -113.25 166.61 11.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.474 -1.239 . . . . 99.989999999999995 109.727 176.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 813' ' ' ALA . . . . . 0.414 ' HB3' HD21 ' A' ' 727' ' ' LEU . . . -124.45 143.79 50.44 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.456 -0.338 . . . . 99.989999999999995 110.909 -177.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 814' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -97.53 130.18 44.62 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.589 0.709 . . . . 99.989999999999995 110.952 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 815' ' ' ILE . . . . . 0.573 ' HA ' ' HB2' ' A' ' 731' ' ' LEU . 5.0 mp -107.28 119.64 57.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 114.833 -1.076 . . . . 99.989999999999995 108.824 176.238 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 816' ' ' GLN . . . . . 0.729 ' NE2' ' HG2' ' A' ' 818' ' ' ARG . 0.9 OUTLIER -117.02 106.66 13.63 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.272 0.558 . . . . 99.989999999999995 110.648 -177.842 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 817' ' ' VAL . . . . . 0.692 ' CG2' ' HA2' ' A' ' 788' ' ' GLY . 0.7 OUTLIER -111.29 143.97 20.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-O 121.113 0.482 . . . . 99.989999999999995 110.201 -179.167 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 818' ' ' ARG . . . . . 0.729 ' HG2' ' NE2' ' A' ' 816' ' ' GLN . 29.1 mmt180 -130.94 177.37 7.48 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.792 -0.64 . . . . 99.989999999999995 110.502 -179.027 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 819' ' ' ARG . . . . . 0.501 ' HG3' ' CD1' ' A' ' 735' ' ' LEU . 5.0 mpt_? -83.32 158.45 22.19 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.825 -0.625 . . . . 99.989999999999995 109.838 171.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 820' ' ' ASP . . . . . 0.497 ' HA ' ' SG ' ' A' ' 734' ' ' CYS . 9.1 p-10 . . . . . 0 C--N 1.324 -0.523 0 N-CA-C 110.015 -0.365 . . . . 99.989999999999995 110.015 177.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 718' ' ' ARG . . . . . . . . . . . . . 5.1 tpp180 . . . . . 0 N--CA 1.448 -0.562 0 CA-C-O 122.107 0.956 . . . . 99.989999999999995 111.151 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 719' ' ' VAL . . . . . 0.554 ' O ' ' HD3' ' A' ' 721' ' ' PRO . 3.4 p -152.71 150.45 12.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 CA-C-N 113.674 -1.603 . . . . 99.989999999999995 108.065 177.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 720' ' ' LYS . . . . . . . . . . . . . 49.5 mtpt -78.75 107.84 6.8 Favored Pre-proline 0 C--N 1.314 -0.948 0 O-C-N 123.533 0.52 . . . . 99.989999999999995 110.557 -178.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 721' ' ' PRO . . . . . 0.554 ' HD3' ' O ' ' A' ' 719' ' ' VAL . 38.7 Cg_endo -87.47 164.18 8.06 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.826 2.351 . . . . 99.989999999999995 111.291 179.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 722' ' ' SER . . . . . 0.584 ' HA ' ' CD2' ' A' ' 808' ' ' LEU . 8.8 t -174.76 -154.37 0.05 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.892 0.377 . . . . 99.989999999999995 110.521 -173.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 723' ' ' ALA . . . . . 0.527 ' HB1' HG23 ' A' ' 743' ' ' VAL . . . -151.73 143.03 23.38 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.771 -0.455 . . . . 99.989999999999995 109.771 178.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 14.9 t -134.57 98.97 4.21 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.51 -0.552 . . . . 99.989999999999995 109.51 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 725' ' ' LEU . . . . . 0.621 HD11 ' N ' ' A' ' 725' ' ' LEU . 5.7 mp -59.7 144.28 48.47 Favored 'General case' 0 N--CA 1.427 -1.589 0 CA-C-O 122.476 1.131 . . . . 99.989999999999995 112.752 -175.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 32.4 mtpt -93.23 -19.66 21.2 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 113.038 -1.892 . . . . 99.989999999999995 109.461 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 727' ' ' LEU . . . . . 0.465 ' HB2' ' HD2' ' A' ' 742' ' ' PRO . 0.6 OUTLIER -72.0 108.64 5.33 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.551 -0.907 . . . . 99.989999999999995 108.551 177.588 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 31.2 t-80 -115.56 52.32 0.89 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.705 0.288 . . . . 99.989999999999995 111.401 -172.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 7.8 p80 -175.92 -177.91 0.98 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.522 -0.308 . . . . 99.989999999999995 110.49 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 730' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -77.78 131.76 37.76 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.878 -0.786 . . . . 99.989999999999995 108.878 173.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 731' ' ' LEU . . . . . 0.546 ' HB3' ' HA ' ' A' ' 815' ' ' ILE . 9.8 tp -96.35 100.81 12.39 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 120.979 0.419 . . . . 99.989999999999995 110.053 -176.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 732' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -80.52 112.36 17.8 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.749 -0.659 . . . . 99.989999999999995 112.087 -171.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 733' ' ' LEU . . . . . 0.591 ' HG ' ' HB3' ' A' ' 737' ' ' ASP . 7.3 mp -113.58 163.26 15.18 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.605 -0.725 . . . . 99.989999999999995 110.88 177.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 734' ' ' CYS . . . . . 0.563 ' O ' ' HB2' ' A' ' 737' ' ' ASP . 51.6 t -104.69 -174.96 2.66 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.886 -1.052 . . . . 99.989999999999995 108.501 173.29 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 735' ' ' LEU . . . . . 0.478 ' N ' ' SG ' ' A' ' 734' ' ' CYS . 40.0 tp -72.47 130.14 39.96 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.195 0.522 . . . . 99.989999999999995 111.293 -178.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 78.92 4.17 88.36 Favored Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.314 -0.857 . . . . 99.989999999999995 111.608 -177.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 737' ' ' ASP . . . . . 0.591 ' HB3' ' HG ' ' A' ' 733' ' ' LEU . 0.3 OUTLIER -77.87 151.71 33.72 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.096 0.474 . . . . 99.989999999999995 111.687 179.327 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 738' ' ' HIS . . . . . 0.434 ' HB2' ' O ' ' A' ' 782' ' ' THR . 34.6 p-80 -114.95 161.7 17.94 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 106.89 -1.522 . . . . 99.989999999999995 106.89 170.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 739' ' ' SER . . . . . 0.432 ' HB2' ' CD2' ' A' ' 731' ' ' LEU . 8.0 p -120.36 171.78 8.27 Favored 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 119.159 -1.016 . . . . 99.989999999999995 111.522 -173.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 7.0 p -137.85 100.74 4.26 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 115.115 -0.948 . . . . 99.989999999999995 109.649 177.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 741' ' ' VAL . . . . . 0.436 HG13 HD13 ' A' ' 793' ' ' LEU . 0.7 OUTLIER -109.86 107.74 59.11 Favored Pre-proline 0 C--N 1.318 -0.775 0 CA-C-N 115.002 -0.999 . . . . 99.989999999999995 109.618 -179.119 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 742' ' ' PRO . . . . . 0.635 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 3.1 Cg_endo -76.84 137.83 18.15 Favored 'Trans proline' 0 N--CA 1.448 -1.183 0 C-N-CA 122.478 2.119 . . . . 99.989999999999995 111.545 -177.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 743' ' ' VAL . . . . . 0.591 ' HA ' ' HA ' ' A' ' 725' ' ' LEU . 1.7 p -131.01 118.58 42.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.697 0.76 . . . . 99.989999999999995 112.121 175.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 744' ' ' ALA . . . . . 0.582 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -80.62 95.61 6.6 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 108.237 -1.023 . . . . 99.989999999999995 108.237 169.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 745' ' ' LEU . . . . . 0.517 ' HA ' ' HA ' ' A' ' 723' ' ' ALA . 0.7 OUTLIER -73.31 159.23 33.68 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 113.901 -1.499 . . . . 99.989999999999995 111.472 -168.545 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -114.39 147.67 38.86 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.455 -0.793 . . . . 99.989999999999995 110.025 -174.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 747' ' ' GLY . . . . . . . . . . . . . . . 92.81 127.84 4.52 Favored Glycine 0 N--CA 1.442 -0.935 0 C-N-CA 120.166 -1.016 . . . . 99.989999999999995 110.625 -174.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 25.0 mp0 -101.68 127.07 48.6 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 121.194 0.521 . . . . 99.989999999999995 112.036 -171.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 112.88 -177.12 18.09 Favored Glycine 0 CA--C 1.5 -0.853 0 CA-C-N 115.169 -0.923 . . . . 99.989999999999995 111.936 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 750' ' ' PRO . . . . . 0.454 ' HB3' ' HE2' ' A' ' 774' ' ' LYS . 74.4 Cg_endo -65.87 94.91 0.28 Allowed 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 123.838 3.025 . . . . 99.989999999999995 113.71 -177.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 751' ' ' PHE . . . . . 0.515 ' CE2' ' HA ' ' A' ' 800' ' ' ASP . 68.6 m-85 -113.91 144.06 43.67 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.94 -0.573 . . . . 99.989999999999995 110.997 178.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 752' ' ' THR . . . . . 0.699 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 63.8 m -89.41 107.93 19.35 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 109.062 -0.718 . . . . 99.989999999999995 109.062 177.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 753' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.73 112.16 24.32 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 115.411 -0.813 . . . . 99.989999999999995 110.285 -171.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 754' ' ' THR . . . . . 0.491 HG23 ' HB2' ' A' ' 769' ' ' GLU . 2.2 m -109.74 135.32 50.85 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 116.092 -0.503 . . . . 99.989999999999995 111.41 -179.144 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 755' ' ' TYR . . . . . 0.501 ' CE1' ' HB3' ' A' ' 768' ' ' PHE . 29.2 p90 -143.43 157.01 44.8 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 120.968 0.413 . . . . 99.989999999999995 111.208 177.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 756' ' ' ASP . . . . . 0.411 ' OD2' ' HD2' ' A' ' 765' ' ' ARG . 41.2 m-20 -115.57 120.29 38.98 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.598 -0.728 . . . . 99.989999999999995 110.694 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 757' ' ' ILE . . . . . . . . . . . . . 3.3 mp -84.71 94.73 3.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 107.621 -1.252 . . . . 99.989999999999995 107.621 167.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 758' ' ' ILE . . . . . 0.453 ' HA ' ' HA ' ' A' ' 765' ' ' ARG . 2.2 pp -91.75 140.7 15.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 C-N-CA 120.258 -0.577 . . . . 99.989999999999995 111.429 -171.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 759' ' ' GLU . . . . . 0.4 ' HB2' ' HB2' ' A' ' 764' ' ' LYS . 6.8 mt-10 -93.19 99.88 12.36 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.304 -0.862 . . . . 99.989999999999995 110.06 -174.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 760' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -88.75 -2.04 58.39 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.819 0.819 . . . . 99.989999999999995 109.358 -175.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 761' ' ' PHE . . . . . 0.509 ' HB2' ' H ' ' A' ' 790' ' ' ASP . 58.0 t80 -62.65 -32.94 74.09 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 114.903 -1.044 . . . . 99.989999999999995 110.388 174.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 762' ' ' SER . . . . . . . . . . . . . 49.8 m -146.8 -96.1 0.09 Allowed 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 116.227 -0.442 . . . . 99.989999999999995 111.191 178.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 763' ' ' SER . . . . . . . . . . . . . 50.4 m -156.06 55.73 0.59 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.025 0.44 . . . . 99.989999999999995 110.843 178.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 764' ' ' LYS . . . . . 0.4 ' HB2' ' HB2' ' A' ' 759' ' ' GLU . 87.7 mttt -127.88 175.54 8.27 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.37 -0.377 . . . . 99.989999999999995 110.003 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 765' ' ' ARG . . . . . 0.453 ' HA ' ' HA ' ' A' ' 758' ' ' ILE . 6.7 ttp180 -164.48 140.07 5.87 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.247 0.546 . . . . 99.989999999999995 111.417 -178.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 766' ' ' LYS . . . . . 0.521 ' HD3' ' N ' ' A' ' 767' ' ' THR . 9.8 tmtm? -111.89 146.02 38.48 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 108.45 -0.944 . . . . 99.989999999999995 108.45 178.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 767' ' ' THR . . . . . 0.521 ' N ' ' HD3' ' A' ' 766' ' ' LYS . 88.4 m -123.76 135.14 53.65 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 116.471 -0.331 . . . . 99.989999999999995 110.9 -178.17 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 768' ' ' PHE . . . . . 0.501 ' HB3' ' CE1' ' A' ' 755' ' ' TYR . 3.0 t80 -139.73 137.53 35.2 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 109.678 -0.49 . . . . 99.989999999999995 109.678 177.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 769' ' ' GLU . . . . . 0.491 ' HB2' HG23 ' A' ' 754' ' ' THR . 31.8 tt0 -131.2 132.8 44.95 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.054 -0.521 . . . . 99.989999999999995 111.003 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 770' ' ' ILE . . . . . 0.452 HG21 HG22 ' A' ' 773' ' ' ILE . 4.1 mt -121.99 111.57 31.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 108.975 -0.75 . . . . 99.989999999999995 108.975 177.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 771' ' ' LYS . . . . . 0.509 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 5.2 mtpt -85.15 157.31 20.7 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.176 0.512 . . . . 99.989999999999995 111.349 -175.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 772' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 53.71 44.29 29.88 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.546 -1.206 . . . . 99.989999999999995 112.19 177.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 773' ' ' ILE . . . . . 0.452 HG22 HG21 ' A' ' 770' ' ' ILE . 0.5 OUTLIER -75.15 111.36 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 107.373 -1.343 . . . . 99.989999999999995 107.373 173.342 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 774' ' ' LYS . . . . . 0.454 ' HE2' ' HB3' ' A' ' 750' ' ' PRO . 56.9 mttt -108.36 29.87 6.96 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 107.743 -1.206 . . . . 99.989999999999995 107.743 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 775' ' ' THR . . . . . 0.485 ' O ' ' HB2' ' A' ' 776' ' ' ASN . 2.1 m -96.11 -81.39 0.41 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.913 -1.039 . . . . 99.989999999999995 113.392 -166.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 776' ' ' ASN . . . . . 0.485 ' HB2' ' O ' ' A' ' 775' ' ' THR . 10.3 m120 93.79 4.18 0.05 OUTLIER 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.268 1.427 . . . . 99.989999999999995 110.971 -176.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 777' ' ' GLU . . . . . 0.582 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 4.9 mt-10 -161.11 87.96 0.73 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.66 -0.7 . . . . 99.989999999999995 109.364 171.041 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 778' ' ' TYR . . . . . 0.502 ' HB3' HD11 ' A' ' 745' ' ' LEU . 73.7 t80 -125.92 128.29 47.31 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.036 -0.529 . . . . 99.989999999999995 110.418 -172.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 779' ' ' VAL . . . . . 0.635 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 21.2 t -86.33 113.27 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 CA-C-O 121.14 0.495 . . . . 99.989999999999995 110.46 179.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 780' ' ' ILE . . . . . 0.436 HD13 ' CE2' ' A' ' 755' ' ' TYR . 76.2 mt -82.39 143.69 11.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.525 -0.761 . . . . 99.989999999999995 109.958 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 781' ' ' LYS . . . . . 0.417 ' N ' HG23 ' A' ' 780' ' ' ILE . 3.9 mppt? -123.8 112.77 17.7 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.166 -0.679 . . . . 99.989999999999995 109.166 175.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 782' ' ' THR . . . . . 0.434 ' O ' ' HB2' ' A' ' 738' ' ' HIS . 44.2 p -77.01 142.19 68.69 Favored Pre-proline 0 C--N 1.318 -0.77 0 CA-C-N 116.097 -0.501 . . . . 99.989999999999995 109.75 -179.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 783' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 782' ' ' THR . 51.2 Cg_exo -55.3 161.5 7.03 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 123.509 2.806 . . . . 99.989999999999995 112.899 -178.307 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 784' ' ' VAL . . . . . 0.528 HG12 HG21 ' A' ' 786' ' ' THR . 46.5 t -58.39 124.21 11.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.423 -0.808 . . . . 99.989999999999995 112.094 -179.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 785' ' ' PHE . . . . . 0.433 ' HE1' ' OG1' ' A' ' 782' ' ' THR . 99.5 m-85 -99.44 95.53 7.08 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.037 -0.529 . . . . 99.989999999999995 110.741 178.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 786' ' ' THR . . . . . 0.528 HG21 HG12 ' A' ' 784' ' ' VAL . 59.9 p -84.71 28.97 0.64 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.526 0.679 . . . . 99.989999999999995 110.912 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.05 108.92 3.68 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.103 -0.953 . . . . 99.989999999999995 110.56 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 788' ' ' GLY . . . . . . . . . . . . . . . -52.44 107.46 0.51 Allowed Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.951 -0.642 . . . . 99.989999999999995 112.465 171.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 789' ' ' GLY . . . . . 0.464 ' H ' ' HB ' ' A' ' 817' ' ' VAL . . . -152.22 -151.58 5.69 Favored Glycine 0 N--CA 1.444 -0.803 0 N-CA-C 111.105 -0.798 . . . . 99.989999999999995 111.105 -179.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 790' ' ' ASP . . . . . 0.509 ' H ' ' HB2' ' A' ' 761' ' ' PHE . 11.3 t70 -141.07 133.16 27.85 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.381 -0.97 . . . . 99.989999999999995 108.381 179.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 791' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -135.0 149.06 50.12 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.49 -0.323 . . . . 99.989999999999995 110.382 -174.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 792' ' ' ILE . . . . . . . . . . . . . 13.8 mt -127.61 116.32 42.96 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-O 121.091 0.472 . . . . 99.989999999999995 110.046 178.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 793' ' ' LEU . . . . . 0.436 HD13 HG13 ' A' ' 741' ' ' VAL . 10.3 tt -84.15 106.79 16.06 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.716 -0.846 . . . . 99.989999999999995 108.716 178.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 794' ' ' SER . . . . . . . . . . . . . 19.3 m -116.33 150.92 36.89 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.332 -0.849 . . . . 99.989999999999995 109.861 -177.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 795' ' ' LEU . . . . . . . . . . . . . 52.9 mt -83.0 136.55 34.47 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.495 -0.321 . . . . 99.989999999999995 110.861 -178.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 796' ' ' VAL . . . . . . . . . . . . . 77.2 t -100.35 -57.44 4.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.317 -0.401 . . . . 99.989999999999995 111.642 -176.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 797' ' ' SER . . . . . 0.545 ' HA ' ' HG ' ' A' ' 808' ' ' LEU . 25.9 m -170.86 153.54 3.97 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.017 -0.538 . . . . 99.989999999999995 110.305 -173.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 798' ' ' ILE . . . . . 0.606 ' HA ' ' O ' ' A' ' 752' ' ' THR . 9.1 tt -125.41 166.45 21.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 108.989 -0.745 . . . . 99.989999999999995 108.989 176.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 799' ' ' LYS . . . . . 0.699 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 87.7 tttt -137.53 123.09 19.71 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 120.74 -0.384 . . . . 99.989999999999995 111.407 -173.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 800' ' ' ASP . . . . . 0.563 ' HB3' ' HB3' ' A' ' 804' ' ' CYS . 13.4 t70 -70.93 157.64 37.83 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.978 -1.01 . . . . 99.989999999999995 109.469 175.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 10.4 p -60.68 -9.62 4.17 Favored 'General case' 0 CA--C 1.532 0.251 0 O-C-N 124.007 0.817 . . . . 99.989999999999995 112.799 -174.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 42.8 p -97.38 7.38 46.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.577 0.703 . . . . 99.989999999999995 110.308 176.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 803' ' ' GLY . . . . . 0.489 ' HA2' ' CE ' ' A' ' 799' ' ' LYS . . . 76.68 31.41 54.02 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.072 -0.967 . . . . 99.989999999999995 111.841 -176.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 804' ' ' CYS . . . . . 0.563 ' HB3' ' HB3' ' A' ' 800' ' ' ASP . 35.5 t -96.41 103.43 15.34 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.225 -0.657 . . . . 99.989999999999995 109.225 -179.089 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 805' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 3.2 t -86.17 119.9 35.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.165 0.507 . . . . 99.989999999999995 110.889 -173.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 806' ' ' VAL . . . . . 0.452 HG22 ' HD2' ' A' ' 721' ' ' PRO . 73.0 t -103.56 133.6 47.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.291 -0.868 . . . . 99.989999999999995 110.245 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -67.14 134.09 31.35 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 121.077 -0.582 . . . . 99.989999999999995 111.664 178.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 808' ' ' LEU . . . . . 0.584 ' CD2' ' HA ' ' A' ' 722' ' ' SER . 69.2 mt -100.73 132.82 45.93 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.565 0.58 . . . . 99.989999999999995 112.565 -176.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 22.0 t -146.77 87.18 1.68 Allowed 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.377 -0.829 . . . . 99.989999999999995 109.921 171.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 810' ' ' GLN . . . . . 0.464 ' HB3' ' HD2' ' A' ' 811' ' ' PRO . 8.7 mt-30 -139.83 173.76 4.74 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.553 -0.748 . . . . 99.989999999999995 109.678 173.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 811' ' ' PRO . . . . . 0.464 ' HD2' ' HB3' ' A' ' 810' ' ' GLN . 78.9 Cg_exo -44.58 141.1 5.77 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 122.971 2.447 . . . . 99.989999999999995 115.209 -176.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -108.36 168.05 9.59 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.285 -1.325 . . . . 99.989999999999995 109.495 176.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 813' ' ' ALA . . . . . 0.453 ' HB2' HD21 ' A' ' 725' ' ' LEU . . . -126.03 137.26 53.63 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.403 -0.362 . . . . 99.989999999999995 110.36 176.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 814' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -103.14 114.83 29.44 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 120.911 0.386 . . . . 99.989999999999995 110.441 -177.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 815' ' ' ILE . . . . . 0.546 ' HA ' ' HB3' ' A' ' 731' ' ' LEU . 5.2 mp -97.81 109.39 23.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.704 -0.68 . . . . 99.989999999999995 109.493 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 816' ' ' GLN . . . . . 0.687 ' NE2' ' HG2' ' A' ' 818' ' ' ARG . 0.8 OUTLIER -95.32 124.17 39.22 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.848 -0.615 . . . . 99.989999999999995 109.871 -178.592 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 817' ' ' VAL . . . . . 0.464 ' HB ' ' H ' ' A' ' 789' ' ' GLY . 59.7 t -117.09 135.17 58.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 109.958 -0.386 . . . . 99.989999999999995 109.958 -177.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 818' ' ' ARG . . . . . 0.687 ' HG2' ' NE2' ' A' ' 816' ' ' GLN . 35.2 mmt180 -142.14 145.53 34.32 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 121.841 -0.537 . . . . 99.989999999999995 111.372 176.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 819' ' ' ARG . . . . . 0.424 ' HB3' ' HB2' ' A' ' 735' ' ' LEU . 0.0 OUTLIER -94.03 117.72 30.5 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.918 -0.583 . . . . 99.989999999999995 109.508 171.102 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 820' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 . . . . . 0 C--N 1.319 -0.731 0 CA-C-N 116.571 -0.286 . . . . 99.989999999999995 110.252 -179.992 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 718' ' ' ARG . . . . . . . . . . . . . 9.2 tpp180 . . . . . 0 CA--C 1.507 -0.69 0 CA-C-O 122.037 0.923 . . . . 99.989999999999995 110.663 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 719' ' ' VAL . . . . . 0.465 ' O ' ' HD3' ' A' ' 721' ' ' PRO . 1.2 m -143.99 159.46 15.92 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-N 113.533 -1.667 . . . . 99.989999999999995 108.418 178.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 720' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -84.25 108.87 15.82 Favored Pre-proline 0 C--N 1.31 -1.111 0 O-C-N 123.605 0.566 . . . . 99.989999999999995 109.601 175.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 721' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' A' ' 719' ' ' VAL . 57.1 Cg_endo -87.48 150.03 7.66 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 122.82 2.346 . . . . 99.989999999999995 111.869 -177.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 16.1 t -176.71 -150.15 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.186 -0.672 . . . . 99.989999999999995 109.186 -172.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 723' ' ' ALA . . . . . 0.515 ' HB1' HG23 ' A' ' 743' ' ' VAL . . . -153.95 143.41 21.56 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 110.449 -0.204 . . . . 99.989999999999995 110.449 178.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 4.2 p -134.36 105.44 6.6 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.494 -0.558 . . . . 99.989999999999995 109.494 178.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 725' ' ' LEU . . . . . 0.489 ' CD2' ' HB ' ' A' ' 743' ' ' VAL . 14.4 mt -65.4 148.95 50.83 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-N 115.391 -0.822 . . . . 99.989999999999995 111.728 -173.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 32.1 mtpt -105.75 -0.45 25.4 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.471 -1.241 . . . . 99.989999999999995 109.408 -177.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 727' ' ' LEU . . . . . 0.418 ' HB2' ' HD2' ' A' ' 742' ' ' PRO . 2.6 tm? -81.78 124.74 29.9 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.818 -1.083 . . . . 99.989999999999995 108.953 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 48.6 m80 -86.08 -85.14 0.16 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.291 0.478 . . . . 99.989999999999995 112.291 -173.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 10.7 p80 -92.56 174.83 7.07 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 120.587 -0.445 . . . . 99.989999999999995 111.235 -176.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 730' ' ' ASP . . . . . 0.401 ' HA ' ' O ' ' A' ' 814' ' ' LYS . 4.0 p30 -53.11 144.3 15.81 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.638 0.732 . . . . 99.989999999999995 111.898 -177.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 731' ' ' LEU . . . . . 0.543 ' HB2' ' HA ' ' A' ' 815' ' ' ILE . 15.8 mt -83.27 118.85 23.93 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.972 -1.013 . . . . 99.989999999999995 111.272 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 732' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -85.18 117.94 24.43 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.405 -0.361 . . . . 99.989999999999995 110.457 179.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 733' ' ' LEU . . . . . 0.46 HD11 ' OD2' ' A' ' 737' ' ' ASP . 4.6 mt -142.48 164.64 29.57 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.913 0.387 . . . . 99.989999999999995 111.488 -173.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 734' ' ' CYS . . . . . 0.684 ' HA ' ' O ' ' A' ' 818' ' ' ARG . 18.5 p -117.78 -174.15 2.58 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.961 -0.563 . . . . 99.989999999999995 111.129 -177.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 735' ' ' LEU . . . . . 0.419 HD11 ' HB3' ' A' ' 819' ' ' ARG . 1.4 tt -61.0 127.84 33.54 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.444 -0.343 . . . . 99.989999999999995 110.552 -177.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 78.52 16.48 79.29 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.377 -0.916 . . . . 99.989999999999995 112.033 174.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 737' ' ' ASP . . . . . 0.46 ' OD2' HD11 ' A' ' 733' ' ' LEU . 0.9 OUTLIER -64.99 165.72 10.47 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.377 0.608 . . . . 99.989999999999995 111.096 176.995 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 22.0 p-80 -137.52 129.33 28.7 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 106.108 -1.812 . . . . 99.989999999999995 106.108 162.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 739' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -97.86 171.76 8.09 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 119.674 -0.81 . . . . 99.989999999999995 111.165 -165.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 740' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 780' ' ' ILE . 50.2 m -142.45 107.68 4.99 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.833 -0.622 . . . . 99.989999999999995 110.16 -178.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 741' ' ' VAL . . . . . 0.442 HG13 HD13 ' A' ' 793' ' ' LEU . 1.0 OUTLIER -114.51 105.67 53.39 Favored Pre-proline 0 C--N 1.315 -0.924 0 CA-C-N 115.31 -0.859 . . . . 99.989999999999995 109.075 179.672 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 742' ' ' PRO . . . . . 0.696 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 5.9 Cg_exo -73.76 135.5 21.72 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 122.248 1.965 . . . . 99.989999999999995 111.441 -176.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 743' ' ' VAL . . . . . 0.515 HG23 ' HB1' ' A' ' 723' ' ' ALA . 2.1 p -133.54 122.76 44.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 113.126 0.787 . . . . 99.989999999999995 113.126 178.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 744' ' ' ALA . . . . . 0.575 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -82.77 98.6 9.19 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.381 -0.97 . . . . 99.989999999999995 108.381 167.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 745' ' ' LEU . . . . . 0.492 HD11 ' HB3' ' A' ' 778' ' ' TYR . 1.8 mt -77.53 157.69 30.26 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.262 -1.335 . . . . 99.989999999999995 111.471 -170.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 22.2 ttmm -112.56 155.48 24.28 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 115.539 -0.755 . . . . 99.989999999999995 110.284 -176.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 747' ' ' GLY . . . . . 0.418 ' HA3' ' HB3' ' A' ' 721' ' ' PRO . . . 100.19 120.43 4.52 Favored Glycine 0 C--N 1.305 -1.161 0 CA-C-N 115.131 -0.941 . . . . 99.989999999999995 111.62 -175.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 20.2 mm-40 -100.34 106.35 17.95 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 120.942 -0.303 . . . . 99.989999999999995 111.003 -174.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 136.14 -174.52 21.4 Favored Glycine 0 N--CA 1.448 -0.546 0 N-CA-C 111.64 -0.584 . . . . 99.989999999999995 111.64 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -68.47 94.41 0.43 Allowed 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 122.642 2.228 . . . . 99.989999999999995 111.983 178.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 751' ' ' PHE . . . . . 0.554 ' CE2' ' HA ' ' A' ' 800' ' ' ASP . 73.8 m-85 -113.35 136.53 52.67 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.937 -0.574 . . . . 99.989999999999995 111.391 -179.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 752' ' ' THR . . . . . 0.757 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 59.8 m -90.44 102.46 15.19 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 121.961 0.886 . . . . 99.989999999999995 109.287 178.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 753' ' ' LEU . . . . . . . . . . . . . 16.4 tp -89.0 131.71 35.06 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 113.803 -1.544 . . . . 99.989999999999995 110.48 -170.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 754' ' ' THR . . . . . 0.451 HG23 ' HB2' ' A' ' 769' ' ' GLU . 1.2 m -131.61 132.89 44.41 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 121.012 -0.275 . . . . 99.989999999999995 111.17 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 755' ' ' TYR . . . . . 0.455 ' CE2' HD13 ' A' ' 780' ' ' ILE . 22.4 p90 -141.52 153.93 45.18 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.072 0.463 . . . . 99.989999999999995 111.758 179.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 756' ' ' ASP . . . . . 0.431 ' CG ' ' HD2' ' A' ' 765' ' ' ARG . 5.5 m-20 -115.13 119.63 37.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.273 -0.876 . . . . 99.989999999999995 110.451 -179.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 757' ' ' ILE . . . . . 0.445 HG12 HG22 ' A' ' 782' ' ' THR . 4.8 mp -90.88 95.56 5.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 107.5 -1.296 . . . . 99.989999999999995 107.5 168.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 758' ' ' ILE . . . . . 0.474 ' HA ' ' HA ' ' A' ' 765' ' ' ARG . 2.2 pp -90.21 140.06 16.54 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-O 121.413 0.625 . . . . 99.989999999999995 111.188 -170.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -92.73 98.72 11.59 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.346 -0.843 . . . . 99.989999999999995 109.724 -174.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 760' ' ' THR . . . . . . . . . . . . . 1.4 t -87.83 -10.92 49.38 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.45 -0.795 . . . . 99.989999999999995 109.663 -172.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 761' ' ' PHE . . . . . 0.582 ' HB2' ' H ' ' A' ' 790' ' ' ASP . 51.6 t80 -65.18 -34.67 78.94 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.149 -0.932 . . . . 99.989999999999995 110.276 175.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 762' ' ' SER . . . . . . . . . . . . . 34.4 p -126.06 -102.09 0.36 Allowed 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 116.188 -0.46 . . . . 99.989999999999995 110.798 178.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 763' ' ' SER . . . . . . . . . . . . . 19.3 m -156.24 15.44 0.33 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.027 0.441 . . . . 99.989999999999995 110.525 178.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 764' ' ' LYS . . . . . . . . . . . . . 47.8 mtpt -90.66 -179.05 5.45 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.08 -0.509 . . . . 99.989999999999995 111.055 -176.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 765' ' ' ARG . . . . . 0.474 ' HA ' ' HA ' ' A' ' 758' ' ' ILE . 16.7 ttp180 -166.8 144.53 4.99 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.851 -0.613 . . . . 99.989999999999995 110.155 -179.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 766' ' ' LYS . . . . . 0.585 ' HD3' ' N ' ' A' ' 767' ' ' THR . 10.3 tmtt? -120.89 146.5 46.54 Favored 'General case' 0 C--O 1.218 -0.579 0 N-CA-C 109.138 -0.69 . . . . 99.989999999999995 109.138 -179.038 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 767' ' ' THR . . . . . 0.585 ' N ' ' HD3' ' A' ' 766' ' ' LYS . 31.1 m -123.67 143.24 50.38 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 116.725 -0.216 . . . . 99.989999999999995 111.13 -176.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 768' ' ' PHE . . . . . 0.428 ' HB3' ' CE1' ' A' ' 755' ' ' TYR . 4.5 t80 -142.34 137.32 30.46 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 120.995 0.426 . . . . 99.989999999999995 110.485 172.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 769' ' ' GLU . . . . . 0.451 ' HB2' HG23 ' A' ' 754' ' ' THR . 26.5 tt0 -128.33 123.67 34.55 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.667 -0.697 . . . . 99.989999999999995 110.951 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 770' ' ' ILE . . . . . 0.46 HG21 HG22 ' A' ' 773' ' ' ILE . 7.4 mt -116.56 112.69 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 108.773 -0.825 . . . . 99.989999999999995 108.773 178.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 771' ' ' LYS . . . . . 0.534 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 4.1 mtpt -84.61 150.39 25.21 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.31 0.576 . . . . 99.989999999999995 111.777 -173.043 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 772' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 51.69 52.89 13.67 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.315 -1.311 . . . . 99.989999999999995 111.943 178.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 773' ' ' ILE . . . . . 0.46 HG22 HG21 ' A' ' 770' ' ' ILE . 0.5 OUTLIER -76.81 117.82 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 107.891 -1.152 . . . . 99.989999999999995 107.891 173.437 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -116.29 30.62 7.23 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 107.912 -1.144 . . . . 99.989999999999995 107.912 -178.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 775' ' ' THR . . . . . 0.446 ' O ' ' HB2' ' A' ' 776' ' ' ASN . 1.6 m -96.62 -72.25 0.64 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 113.76 -1.563 . . . . 99.989999999999995 112.215 -171.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 776' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 775' ' ' THR . 11.7 m120 85.43 6.37 0.45 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.349 1.06 . . . . 99.989999999999995 110.238 178.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 777' ' ' GLU . . . . . 0.575 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 2.3 tm-20 -162.1 93.46 0.88 Allowed 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 114.374 -1.285 . . . . 99.989999999999995 107.702 176.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 778' ' ' TYR . . . . . 0.492 ' HB3' HD11 ' A' ' 745' ' ' LEU . 52.8 t80 -144.57 128.68 17.62 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.22 -0.9 . . . . 99.989999999999995 109.666 -169.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 779' ' ' VAL . . . . . 0.696 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 1.3 m -94.52 129.09 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.082 0 C-N-CA 118.861 -1.136 . . . . 99.989999999999995 110.506 179.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 780' ' ' ILE . . . . . 0.455 HD13 ' CE2' ' A' ' 755' ' ' TYR . 83.0 mt -89.43 142.94 12.18 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-N 114.072 -1.422 . . . . 99.989999999999995 110.828 -174.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -118.38 107.52 13.95 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.854 -0.612 . . . . 99.989999999999995 109.942 178.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 782' ' ' THR . . . . . 0.445 HG22 HG12 ' A' ' 757' ' ' ILE . 25.1 p -76.91 141.13 67.61 Favored Pre-proline 0 C--N 1.315 -0.902 0 CA-C-N 115.526 -0.761 . . . . 99.989999999999995 110.376 -177.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 783' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 782' ' ' THR . 50.2 Cg_exo -55.07 161.4 6.7 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.719 2.946 . . . . 99.989999999999995 112.837 -174.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 784' ' ' VAL . . . . . 0.552 HG22 HG21 ' A' ' 786' ' ' THR . 7.4 p -58.83 131.46 23.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.572 -0.74 . . . . 99.989999999999995 111.107 -178.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 785' ' ' PHE . . . . . 0.458 ' C ' ' H ' ' A' ' 787' ' ' THR . 32.0 m-85 -112.14 88.59 2.85 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.367 -0.833 . . . . 99.989999999999995 109.716 177.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 786' ' ' THR . . . . . 0.552 HG21 HG22 ' A' ' 784' ' ' VAL . 44.8 p -82.23 31.71 0.39 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.796 0.808 . . . . 99.989999999999995 110.918 -178.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 787' ' ' THR . . . . . 0.458 ' H ' ' C ' ' A' ' 785' ' ' PHE . 12.4 m -157.38 107.46 2.22 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.721 -1.127 . . . . 99.989999999999995 110.282 -179.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 788' ' ' GLY . . . . . 0.415 ' H ' ' HG2' ' A' ' 819' ' ' ARG . . . -45.66 124.39 6.9 Favored Glycine 0 C--N 1.334 0.471 0 CA-C-N 116.174 -0.466 . . . . 99.989999999999995 113.243 174.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 789' ' ' GLY . . . . . 0.504 ' H ' ' HB ' ' A' ' 817' ' ' VAL . . . -165.88 -151.24 6.62 Favored Glycine 0 N--CA 1.443 -0.861 0 N-CA-C 110.952 -0.859 . . . . 99.989999999999995 110.952 179.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 790' ' ' ASP . . . . . 0.582 ' H ' ' HB2' ' A' ' 761' ' ' PHE . 6.4 t70 -147.15 133.43 19.5 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.429 -0.952 . . . . 99.989999999999995 108.429 -178.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 791' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -132.73 154.66 49.99 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.969 -0.559 . . . . 99.989999999999995 109.777 -174.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 792' ' ' ILE . . . . . 0.426 ' CG1' ' HG3' ' A' ' 814' ' ' LYS . 12.6 mt -131.2 116.79 34.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 109.914 -0.402 . . . . 99.989999999999995 109.914 176.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 793' ' ' LEU . . . . . 0.442 HD13 HG13 ' A' ' 741' ' ' VAL . 10.1 tt -84.72 107.29 16.84 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.949 -0.76 . . . . 99.989999999999995 108.949 178.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 794' ' ' SER . . . . . . . . . . . . . 19.3 m -114.18 164.96 13.17 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.176 -0.92 . . . . 99.989999999999995 109.319 179.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 795' ' ' LEU . . . . . . . . . . . . . 48.9 mt -94.89 132.61 39.52 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 120.71 0.29 . . . . 99.989999999999995 110.905 -175.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 796' ' ' VAL . . . . . . . . . . . . . 85.4 t -88.95 -56.99 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.386 0 CA-C-N 116.262 -0.426 . . . . 99.989999999999995 110.705 -178.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 797' ' ' SER . . . . . 0.477 ' C ' HD13 ' A' ' 808' ' ' LEU . 7.1 m 178.46 177.26 0.45 Allowed 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.013 0.821 . . . . 99.989999999999995 109.583 -175.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 798' ' ' ILE . . . . . 0.527 ' O ' ' HA ' ' A' ' 805' ' ' VAL . 11.4 tt -146.31 164.67 9.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 108.183 -1.043 . . . . 99.989999999999995 108.183 177.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 799' ' ' LYS . . . . . 0.757 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 7.4 tttm -135.08 120.02 18.58 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.045 0.45 . . . . 99.989999999999995 111.142 -176.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 800' ' ' ASP . . . . . 0.554 ' HA ' ' CE2' ' A' ' 751' ' ' PHE . 19.3 t70 -63.65 159.36 19.18 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.085 -0.961 . . . . 99.989999999999995 109.877 176.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 24.9 t -61.19 -20.91 63.3 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 123.902 0.751 . . . . 99.989999999999995 111.422 -175.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 39.7 p -83.8 -5.29 59.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.698 0.761 . . . . 99.989999999999995 109.676 178.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 803' ' ' GLY . . . . . . . . . . . . . . . 87.88 43.86 5.59 Favored Glycine 0 N--CA 1.439 -1.14 0 CA-C-N 114.435 -1.257 . . . . 99.989999999999995 111.258 -177.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 804' ' ' CYS . . . . . 0.474 ' HB3' ' HB3' ' A' ' 800' ' ' ASP . 30.6 t -107.99 108.69 19.92 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.926 -0.398 . . . . 99.989999999999995 109.926 -179.027 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 805' ' ' VAL . . . . . 0.527 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 4.8 t -85.75 110.53 19.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 121.178 0.514 . . . . 99.989999999999995 110.616 -175.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 806' ' ' VAL . . . . . . . . . . . . . 94.1 t -94.69 141.12 15.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.258 -0.883 . . . . 99.989999999999995 110.233 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -80.89 109.83 3.03 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.803 -0.713 . . . . 99.989999999999995 112.146 178.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 808' ' ' LEU . . . . . 0.477 HD13 ' C ' ' A' ' 797' ' ' SER . 10.5 mp -73.61 126.85 31.21 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 113.24 0.83 . . . . 99.989999999999995 113.24 178.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 20.5 m -141.59 85.7 1.96 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.448 -0.796 . . . . 99.989999999999995 109.171 170.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 810' ' ' GLN . . . . . 0.479 ' HB3' ' HD2' ' A' ' 811' ' ' PRO . 11.0 mt-30 -145.56 169.36 9.89 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 115.305 -0.861 . . . . 99.989999999999995 109.303 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 811' ' ' PRO . . . . . 0.479 ' HD2' ' HB3' ' A' ' 810' ' ' GLN . 88.1 Cg_exo -43.94 139.19 5.86 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 123.336 2.69 . . . . 99.989999999999995 115.714 -171.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -107.78 167.94 9.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.355 -1.293 . . . . 99.989999999999995 109.763 175.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 813' ' ' ALA . . . . . . . . . . . . . . . -127.36 151.9 48.19 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.099 -0.5 . . . . 99.989999999999995 110.304 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 814' ' ' LYS . . . . . 0.426 ' HG3' ' CG1' ' A' ' 792' ' ' ILE . 13.9 ttpp -113.54 127.86 56.23 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 121.709 0.766 . . . . 99.989999999999995 111.265 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 815' ' ' ILE . . . . . 0.543 ' HA ' ' HB2' ' A' ' 731' ' ' LEU . 4.3 mp -106.01 125.09 61.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 114.712 -1.131 . . . . 99.989999999999995 109.386 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 816' ' ' GLN . . . . . 0.637 ' NE2' ' HG2' ' A' ' 818' ' ' ARG . 0.8 OUTLIER -115.19 116.65 28.71 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.275 0.56 . . . . 99.989999999999995 111.027 -178.291 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 817' ' ' VAL . . . . . 0.504 ' HB ' ' H ' ' A' ' 789' ' ' GLY . 58.7 t -109.94 133.22 55.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 116.133 -0.485 . . . . 99.989999999999995 109.882 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 818' ' ' ARG . . . . . 0.684 ' O ' ' HA ' ' A' ' 734' ' ' CYS . 85.4 mmt-85 -137.32 130.94 31.48 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.914 0.388 . . . . 99.989999999999995 110.395 175.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 819' ' ' ARG . . . . . 0.419 ' HB3' HD11 ' A' ' 735' ' ' LEU . 18.1 mtm180 -68.1 131.61 45.73 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.721 -0.672 . . . . 99.989999999999995 110.822 -177.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 820' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 . . . . . 0 C--N 1.319 -0.729 0 CA-C-N 116.102 -0.499 . . . . 99.989999999999995 110.099 179.124 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 718' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? . . . . . 0 CA--C 1.509 -0.611 0 CA-C-O 121.609 0.719 . . . . 99.989999999999995 110.598 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 719' ' ' VAL . . . . . 0.488 ' O ' ' HD3' ' A' ' 721' ' ' PRO . 3.5 m -129.53 -167.98 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 CA-C-N 114.435 -1.257 . . . . 99.989999999999995 108.618 -176.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 720' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -97.95 104.89 24.24 Favored Pre-proline 0 C--N 1.304 -1.395 0 CA-C-N 115.793 -0.64 . . . . 99.989999999999995 110.402 174.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 721' ' ' PRO . . . . . 0.488 ' HD3' ' O ' ' A' ' 719' ' ' VAL . 60.7 Cg_endo -88.6 145.16 5.71 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 122.897 2.398 . . . . 99.989999999999995 111.429 177.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 722' ' ' SER . . . . . 0.575 ' HA ' ' CD2' ' A' ' 808' ' ' LEU . 10.7 t -175.9 -153.04 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.82 0.343 . . . . 99.989999999999995 110.524 -175.197 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 723' ' ' ALA . . . . . 0.498 ' HB1' HG23 ' A' ' 743' ' ' VAL . . . -149.49 143.19 25.49 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.361 -0.381 . . . . 99.989999999999995 109.99 179.044 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 9.4 m -131.37 98.61 4.58 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.281 -0.637 . . . . 99.989999999999995 109.281 178.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 725' ' ' LEU . . . . . 0.467 HD21 ' CG2' ' A' ' 743' ' ' VAL . 12.7 mt -64.42 143.49 57.87 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-O 121.695 0.759 . . . . 99.989999999999995 111.557 -175.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 34.2 mtpt -96.77 -18.75 19.4 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 114.6 -1.182 . . . . 99.989999999999995 109.866 -176.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 727' ' ' LEU . . . . . 0.421 HD21 ' HB3' ' A' ' 813' ' ' ALA . 33.7 tp -69.66 112.67 6.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.682 -0.69 . . . . 99.989999999999995 109.854 175.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 31.3 t-80 -112.78 45.83 1.28 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.695 0.283 . . . . 99.989999999999995 111.573 -174.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -177.77 -177.91 0.68 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.698 -0.228 . . . . 99.989999999999995 110.643 177.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 730' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -76.42 137.6 39.83 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.194 0.521 . . . . 99.989999999999995 109.71 175.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 731' ' ' LEU . . . . . 0.521 ' CD2' ' HB2' ' A' ' 739' ' ' SER . 25.9 tp -100.42 113.05 25.5 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.363 -0.835 . . . . 99.989999999999995 110.865 -176.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 732' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -78.29 110.8 13.63 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.746 -0.661 . . . . 99.989999999999995 112.047 -173.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 733' ' ' LEU . . . . . 0.613 ' HG ' ' HB3' ' A' ' 737' ' ' ASP . 8.5 mp -117.5 163.75 15.94 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.233 -0.44 . . . . 99.989999999999995 110.489 175.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 734' ' ' CYS . . . . . 0.526 ' HA ' ' O ' ' A' ' 818' ' ' ARG . 74.5 m -115.82 -173.85 2.42 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.721 -0.672 . . . . 99.989999999999995 109.826 175.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 735' ' ' LEU . . . . . 0.584 ' HB2' ' HA ' ' A' ' 819' ' ' ARG . 16.7 tp -65.92 123.71 20.54 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.794 0.33 . . . . 99.989999999999995 110.531 -177.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 79.64 13.29 82.65 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.472 -0.87 . . . . 99.989999999999995 112.312 179.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 737' ' ' ASP . . . . . 0.613 ' HB3' ' HG ' ' A' ' 733' ' ' LEU . 0.3 OUTLIER -80.72 151.99 28.59 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.03 0.443 . . . . 99.989999999999995 111.057 175.987 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 738' ' ' HIS . . . . . 0.47 ' HB2' ' O ' ' A' ' 782' ' ' THR . 38.6 p-80 -117.08 149.22 40.67 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.087 -1.449 . . . . 99.989999999999995 107.087 170.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 739' ' ' SER . . . . . 0.521 ' HB2' ' CD2' ' A' ' 731' ' ' LEU . 5.3 p -103.95 167.63 9.65 Favored 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 119.387 -0.925 . . . . 99.989999999999995 111.549 -169.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 740' ' ' SER . . . . . 0.458 ' HA ' ' O ' ' A' ' 780' ' ' ILE . 40.4 m -139.07 100.41 4.02 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.251 -0.886 . . . . 99.989999999999995 109.327 176.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 741' ' ' VAL . . . . . 0.443 HG13 HD23 ' A' ' 793' ' ' LEU . 0.9 OUTLIER -111.86 113.87 52.22 Favored Pre-proline 0 C--N 1.317 -0.831 0 CA-C-N 115.305 -0.861 . . . . 99.989999999999995 109.873 -179.434 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 742' ' ' PRO . . . . . 0.648 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 1.0 OUTLIER -74.98 132.95 16.03 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 122.278 1.985 . . . . 99.989999999999995 111.454 -179.093 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 743' ' ' VAL . . . . . 0.498 HG23 ' HB1' ' A' ' 723' ' ' ALA . 2.0 p -130.21 120.35 48.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.405 0.622 . . . . 99.989999999999995 112.316 175.037 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 744' ' ' ALA . . . . . 0.616 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -80.72 95.26 6.56 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 122.098 0.951 . . . . 99.989999999999995 108.697 168.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 745' ' ' LEU . . . . . 0.485 ' HA ' ' HA ' ' A' ' 723' ' ' ALA . 3.0 mt -74.92 151.62 38.89 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.165 -1.38 . . . . 99.989999999999995 111.477 -170.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 19.8 ttmm -106.36 162.26 13.84 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.873 -0.603 . . . . 99.989999999999995 110.001 -178.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 747' ' ' GLY . . . . . . . . . . . . . . . 99.74 129.87 6.76 Favored Glycine 0 C--N 1.308 -0.975 0 CA-C-N 115.738 -0.665 . . . . 99.989999999999995 111.458 -175.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 40.1 mm-40 -107.43 107.8 18.85 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.895 -0.322 . . . . 99.989999999999995 110.856 -174.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 125.89 -171.43 17.72 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.848 -0.691 . . . . 99.989999999999995 111.927 -179.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -70.2 95.11 0.58 Allowed 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.953 2.435 . . . . 99.989999999999995 112.177 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 751' ' ' PHE . . . . . 0.526 ' HA ' ' O ' ' A' ' 799' ' ' LYS . 76.2 m-85 -117.25 135.39 53.85 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.98 -0.554 . . . . 99.989999999999995 111.239 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 752' ' ' THR . . . . . 0.704 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 89.8 m -85.95 107.65 17.83 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 109.398 -0.593 . . . . 99.989999999999995 109.398 178.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 753' ' ' LEU . . . . . 0.448 ' HG ' HD22 ' A' ' 745' ' ' LEU . 0.6 OUTLIER -97.93 117.73 32.9 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 114.992 -1.004 . . . . 99.989999999999995 110.322 -171.944 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 754' ' ' THR . . . . . 0.436 HG23 ' HB2' ' A' ' 769' ' ' GLU . 1.0 OUTLIER -118.17 139.28 51.5 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.913 -0.585 . . . . 99.989999999999995 111.056 -177.002 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 755' ' ' TYR . . . . . 0.675 ' CE1' ' HB3' ' A' ' 768' ' ' PHE . 22.5 p90 -147.1 158.81 44.06 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.018 0.377 . . . . 99.989999999999995 112.018 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 756' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -122.77 120.5 33.76 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 115.675 -0.693 . . . . 99.989999999999995 110.833 -178.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 757' ' ' ILE . . . . . 0.586 ' CD1' HD13 ' A' ' 793' ' ' LEU . 3.8 mp -89.3 96.51 6.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 N-CA-C 108.01 -1.107 . . . . 99.989999999999995 108.01 170.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 758' ' ' ILE . . . . . 0.528 HG13 ' O ' ' A' ' 792' ' ' ILE . 2.5 pp -98.65 152.01 4.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 121.52 0.676 . . . . 99.989999999999995 112.593 -168.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 759' ' ' GLU . . . . . 0.635 ' OE2' ' HB2' ' A' ' 762' ' ' SER . 2.6 mt-10 -91.15 120.08 31.8 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.181 -0.918 . . . . 99.989999999999995 112.422 -179.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 760' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -96.5 -4.65 41.09 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.372 -0.831 . . . . 99.989999999999995 109.725 172.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 761' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -102.44 -33.65 9.46 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.602 -0.726 . . . . 99.989999999999995 111.196 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 762' ' ' SER . . . . . 0.635 ' HB2' ' OE2' ' A' ' 759' ' ' GLU . 32.6 m -141.19 -96.69 0.14 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.211 0.448 . . . . 99.989999999999995 112.211 -178.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 763' ' ' SER . . . . . . . . . . . . . 26.5 t -167.62 0.68 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.608 0.595 . . . . 99.989999999999995 112.608 -174.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 764' ' ' LYS . . . . . 0.551 ' HZ2' ' CD ' ' A' ' 759' ' ' GLU . 9.4 mtmp? -82.78 60.41 5.3 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.998 0.428 . . . . 99.989999999999995 111.816 -174.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 68.8 mtm180 -61.42 160.33 11.14 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.935 -0.575 . . . . 99.989999999999995 109.907 172.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 766' ' ' LYS . . . . . 0.627 ' HD3' ' N ' ' A' ' 767' ' ' THR . 8.1 tmtt? -145.11 136.93 25.57 Favored 'General case' 0 C--O 1.216 -0.686 0 CA-C-O 120.971 0.415 . . . . 99.989999999999995 110.423 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 767' ' ' THR . . . . . 0.627 ' N ' ' HD3' ' A' ' 766' ' ' LYS . 84.8 m -114.0 128.14 56.26 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 116.333 -0.394 . . . . 99.989999999999995 110.544 -176.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 768' ' ' PHE . . . . . 0.675 ' HB3' ' CE1' ' A' ' 755' ' ' TYR . 2.9 t80 -128.62 137.24 51.57 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 109.166 -0.679 . . . . 99.989999999999995 109.166 178.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 769' ' ' GLU . . . . . 0.436 ' HB2' HG23 ' A' ' 754' ' ' THR . 34.7 tt0 -130.58 122.38 27.4 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.736 -0.665 . . . . 99.989999999999995 110.706 -175.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 770' ' ' ILE . . . . . 0.462 HG21 HG22 ' A' ' 773' ' ' ILE . 6.0 mt -117.14 111.15 33.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 108.463 -0.94 . . . . 99.989999999999995 108.463 177.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 771' ' ' LYS . . . . . 0.571 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 13.4 mtpt -85.03 150.2 25.05 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-O 121.547 0.689 . . . . 99.989999999999995 112.065 -173.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 772' ' ' GLU . . . . . 0.416 ' O ' ' HG3' ' A' ' 774' ' ' LYS . 3.6 mt-10 52.1 49.63 20.22 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 113.897 -1.501 . . . . 99.989999999999995 111.865 177.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 773' ' ' ILE . . . . . 0.462 HG22 HG21 ' A' ' 770' ' ' ILE . 0.5 OUTLIER -73.75 118.6 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 108.255 -1.017 . . . . 99.989999999999995 108.255 176.266 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 774' ' ' LYS . . . . . 0.416 ' HG3' ' O ' ' A' ' 772' ' ' GLU . 73.9 mttt -116.23 30.16 7.51 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 107.92 -1.141 . . . . 99.989999999999995 107.92 -178.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 775' ' ' THR . . . . . 0.487 ' O ' ' HB2' ' A' ' 776' ' ' ASN . 1.6 m -95.9 -73.25 0.6 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 113.79 -1.55 . . . . 99.989999999999995 112.238 -171.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 776' ' ' ASN . . . . . 0.487 ' HB2' ' O ' ' A' ' 775' ' ' THR . 11.6 m120 88.14 5.59 0.23 Allowed 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.622 1.169 . . . . 99.989999999999995 110.62 179.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 777' ' ' GLU . . . . . 0.616 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 30.7 tt0 -161.94 100.47 1.12 Allowed 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 114.989 -1.005 . . . . 99.989999999999995 108.875 171.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 778' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -141.92 129.98 22.02 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.794 -0.639 . . . . 99.989999999999995 110.63 -170.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 779' ' ' VAL . . . . . 0.648 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 14.4 t -89.22 114.11 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 CA-C-O 121.259 0.552 . . . . 99.989999999999995 110.094 -179.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 780' ' ' ILE . . . . . 0.458 ' O ' ' HA ' ' A' ' 740' ' ' SER . 77.7 mt -81.17 141.72 14.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.004 -0.998 . . . . 99.989999999999995 110.604 -178.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 781' ' ' LYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 739' ' ' SER . 0.0 OUTLIER -121.54 109.4 14.77 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.324 -0.621 . . . . 99.989999999999995 109.324 176.288 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 782' ' ' THR . . . . . 0.47 ' O ' ' HB2' ' A' ' 738' ' ' HIS . 38.7 p -79.08 143.51 61.33 Favored Pre-proline 0 C--N 1.32 -0.705 0 N-CA-C 109.705 -0.48 . . . . 99.989999999999995 109.705 -178.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 783' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.17 158.19 7.41 Favored 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 123.546 2.83 . . . . 99.989999999999995 113.179 -177.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 784' ' ' VAL . . . . . 0.53 HG12 HG21 ' A' ' 786' ' ' THR . 53.5 t -58.93 118.69 2.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.11 -0.95 . . . . 99.989999999999995 112.157 -179.062 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 785' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -98.43 97.19 8.56 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.374 -0.83 . . . . 99.989999999999995 109.913 178.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 786' ' ' THR . . . . . 0.53 HG21 HG12 ' A' ' 784' ' ' VAL . 38.4 p -84.71 31.49 0.53 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.711 0.767 . . . . 99.989999999999995 111.201 -178.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 77.6 m -152.27 112.59 4.08 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.847 -1.07 . . . . 99.989999999999995 110.829 179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 788' ' ' GLY . . . . . . . . . . . . . . . -51.57 114.13 2.84 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 116.069 -0.514 . . . . 99.989999999999995 112.648 171.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 789' ' ' GLY . . . . . 0.495 ' H ' ' HB ' ' A' ' 817' ' ' VAL . . . -158.52 -167.26 19.08 Favored Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 110.391 -1.083 . . . . 99.989999999999995 110.391 -178.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -128.3 124.75 37.3 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 117.629 0.715 . . . . 99.989999999999995 109.864 -178.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 791' ' ' TYR . . . . . 0.59 ' CE2' ' HG2' ' A' ' 759' ' ' GLU . 97.7 m-85 -120.67 149.48 42.43 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.737 -0.665 . . . . 99.989999999999995 111.32 -176.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 792' ' ' ILE . . . . . 0.528 ' O ' HG13 ' A' ' 758' ' ' ILE . 12.5 mt -126.88 116.46 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 109.042 -0.725 . . . . 99.989999999999995 109.042 171.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 793' ' ' LEU . . . . . 0.586 HD13 ' CD1' ' A' ' 757' ' ' ILE . 0.9 OUTLIER -84.95 113.14 21.19 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 109.134 -0.691 . . . . 99.989999999999995 109.134 178.211 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 794' ' ' SER . . . . . 0.546 ' N ' HD11 ' A' ' 793' ' ' LEU . 21.6 t -122.76 164.6 18.03 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.864 -1.062 . . . . 99.989999999999995 108.997 -176.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 795' ' ' LEU . . . . . . . . . . . . . 21.6 mt -94.49 134.11 37.37 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.525 -0.307 . . . . 99.989999999999995 110.992 -173.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 796' ' ' VAL . . . . . . . . . . . . . 67.8 t -95.51 -55.79 5.79 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 CA-C-N 116.302 -0.408 . . . . 99.989999999999995 111.767 -176.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 797' ' ' SER . . . . . 0.56 ' HA ' ' HG ' ' A' ' 808' ' ' LEU . 87.5 p -177.33 160.22 1.65 Allowed 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.785 -0.366 . . . . 99.989999999999995 110.755 -174.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 798' ' ' ILE . . . . . 0.673 ' HA ' ' O ' ' A' ' 752' ' ' THR . 9.4 tt -131.35 166.95 27.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 109.273 -0.64 . . . . 99.989999999999995 109.273 177.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 799' ' ' LYS . . . . . 0.704 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 15.6 tttm -136.62 117.25 13.91 Favored 'General case' 0 C--N 1.322 -0.623 0 O-C-N 122.26 -0.275 . . . . 99.989999999999995 111.65 -174.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 800' ' ' ASP . . . . . 0.454 ' HB3' ' HB3' ' A' ' 804' ' ' CYS . 24.2 t70 -69.9 157.14 37.98 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.306 -0.627 . . . . 99.989999999999995 109.306 170.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 58.0 p -63.09 -8.92 8.67 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 112.755 0.65 . . . . 99.989999999999995 112.755 -170.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 26.6 p -89.0 -1.75 58.26 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.636 0.731 . . . . 99.989999999999995 109.875 176.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 803' ' ' GLY . . . . . 0.463 ' HA2' ' HZ1' ' A' ' 799' ' ' LYS . . . 84.59 27.14 36.39 Favored Glycine 0 N--CA 1.439 -1.111 0 CA-C-N 114.907 -1.042 . . . . 99.989999999999995 111.028 -176.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 804' ' ' CYS . . . . . 0.454 ' HB3' ' HB3' ' A' ' 800' ' ' ASP . 46.1 t -94.43 108.94 20.84 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.429 -0.582 . . . . 99.989999999999995 109.429 -178.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 805' ' ' VAL . . . . . 0.524 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 4.2 p -85.58 119.6 34.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.875 0.845 . . . . 99.989999999999995 110.626 -176.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 806' ' ' VAL . . . . . 0.451 HG11 ' HD2' ' A' ' 721' ' ' PRO . 21.4 t -102.03 135.36 39.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 114.588 -1.187 . . . . 99.989999999999995 110.106 -178.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -73.12 125.24 9.5 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.425 -0.807 . . . . 99.989999999999995 111.997 -177.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 808' ' ' LEU . . . . . 0.575 ' CD2' ' HA ' ' A' ' 722' ' ' SER . 49.3 mt -89.91 123.36 33.78 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.162 0.506 . . . . 99.989999999999995 112.225 -177.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 22.5 m -142.12 86.61 1.98 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.648 -0.706 . . . . 99.989999999999995 110.101 175.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 810' ' ' GLN . . . . . 0.439 ' HB3' ' HD2' ' A' ' 811' ' ' PRO . 8.1 mt-30 -144.54 173.58 4.24 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.645 -0.707 . . . . 99.989999999999995 110.23 175.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 811' ' ' PRO . . . . . 0.439 ' HD2' ' HB3' ' A' ' 810' ' ' GLN . 82.5 Cg_exo -45.0 140.86 6.75 Favored 'Trans proline' 0 C--N 1.358 1.05 0 C-N-CA 123.102 2.534 . . . . 99.989999999999995 114.716 -177.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -109.09 167.21 10.27 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.653 -1.158 . . . . 99.989999999999995 110.418 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 813' ' ' ALA . . . . . 0.421 ' HB3' HD21 ' A' ' 727' ' ' LEU . . . -116.25 156.82 25.92 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.03 -0.532 . . . . 99.989999999999995 110.687 -179.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 814' ' ' LYS . . . . . 0.403 ' HG2' HG12 ' A' ' 792' ' ' ILE . 49.2 mttp -118.76 125.04 48.74 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.121 0.486 . . . . 99.989999999999995 110.821 177.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 815' ' ' ILE . . . . . 0.511 ' HA ' ' HB3' ' A' ' 731' ' ' LEU . 5.3 mp -113.02 117.4 55.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 115.311 -0.859 . . . . 99.989999999999995 108.888 178.008 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 816' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -103.71 113.36 26.82 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.445 -0.343 . . . . 99.989999999999995 110.195 -177.243 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 817' ' ' VAL . . . . . 0.495 ' HB ' ' H ' ' A' ' 789' ' ' GLY . 43.8 t -106.02 137.28 36.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.665 -0.495 . . . . 99.989999999999995 109.665 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 818' ' ' ARG . . . . . 0.526 ' O ' ' HA ' ' A' ' 734' ' ' CYS . 22.4 tpt180 -148.79 140.22 23.37 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.725 -0.472 . . . . 99.989999999999995 109.725 -178.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 819' ' ' ARG . . . . . 0.584 ' HA ' ' HB2' ' A' ' 735' ' ' LEU . 0.0 OUTLIER -78.83 125.39 29.31 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.5 0.667 . . . . 99.989999999999995 111.557 -179.717 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 820' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 . . . . . 0 C--N 1.318 -0.767 0 CA-C-N 114.691 -1.141 . . . . 99.989999999999995 110.335 179.891 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 718' ' ' ARG . . . . . . . . . . . . . 21.2 mmm180 . . . . . 0 CA--C 1.503 -0.841 0 CA-C-O 121.8 0.809 . . . . 99.989999999999995 111.178 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 719' ' ' VAL . . . . . . . . . . . . . 3.2 m -139.72 -173.63 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 CA-C-N 113.986 -1.461 . . . . 99.989999999999995 109.057 -177.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 720' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -102.16 115.49 64.52 Favored Pre-proline 0 C--N 1.303 -1.427 0 CA-C-N 115.366 -0.834 . . . . 99.989999999999995 110.17 179.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 721' ' ' PRO . . . . . 0.527 ' HD2' HG13 ' A' ' 806' ' ' VAL . 36.4 Cg_endo -83.95 137.92 7.75 Favored 'Trans proline' 0 N--CA 1.447 -1.227 0 C-N-CA 122.597 2.198 . . . . 99.989999999999995 110.601 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 32.4 p -176.25 -150.58 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.361 -0.381 . . . . 99.989999999999995 110.205 -167.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 723' ' ' ALA . . . . . 0.545 ' HA ' ' HA ' ' A' ' 745' ' ' LEU . . . -155.09 149.4 26.08 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 110.428 -0.212 . . . . 99.989999999999995 110.428 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 15.9 m -139.89 98.78 3.54 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.172 -0.677 . . . . 99.989999999999995 109.172 178.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 725' ' ' LEU . . . . . 0.628 HD11 ' N ' ' A' ' 725' ' ' LEU . 6.2 mp -59.84 142.19 53.95 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 122.328 1.061 . . . . 99.989999999999995 112.551 -175.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 36.9 mtpt -91.41 -16.7 26.96 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 113.269 -1.787 . . . . 99.989999999999995 110.309 -176.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 727' ' ' LEU . . . . . 0.434 HD21 ' HB3' ' A' ' 813' ' ' ALA . 51.1 tp -70.24 126.93 31.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.935 -0.575 . . . . 99.989999999999995 110.016 178.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -119.26 29.93 7.39 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.427 0.529 . . . . 99.989999999999995 112.427 -174.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 9.7 p80 -166.94 170.78 11.81 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.73 0.3 . . . . 99.989999999999995 110.434 177.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 730' ' ' ASP . . . . . 0.509 ' HA ' ' O ' ' A' ' 814' ' ' LYS . 10.3 p-10 -79.44 138.57 37.64 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.759 -0.655 . . . . 99.989999999999995 110.69 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 731' ' ' LEU . . . . . 0.518 ' HB2' ' HA ' ' A' ' 815' ' ' ILE . 35.1 mt -87.23 107.76 18.63 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.473 -0.785 . . . . 99.989999999999995 111.485 -177.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 732' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt -81.59 96.71 7.56 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.203 -0.453 . . . . 99.989999999999995 111.013 -176.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 733' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.95 163.97 14.01 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.328 0.585 . . . . 99.989999999999995 111.904 -178.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 734' ' ' CYS . . . . . 0.587 ' O ' ' HB2' ' A' ' 737' ' ' ASP . 72.5 m -105.39 -172.98 2.19 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.032 -0.986 . . . . 99.989999999999995 109.66 176.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 735' ' ' LEU . . . . . 0.518 ' HB2' ' HA ' ' A' ' 819' ' ' ARG . 13.4 tp -73.83 138.68 44.59 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.444 0.64 . . . . 99.989999999999995 112.03 -172.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 74.38 14.8 80.59 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 114.756 -1.111 . . . . 99.989999999999995 111.286 -177.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 737' ' ' ASP . . . . . 0.587 ' HB2' ' O ' ' A' ' 734' ' ' CYS . 1.0 OUTLIER -89.34 147.09 24.27 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.394 0.616 . . . . 99.989999999999995 112.036 177.61 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 738' ' ' HIS . . . . . 0.63 ' HB2' ' O ' ' A' ' 782' ' ' THR . 46.5 p-80 -110.31 177.49 4.68 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 106.511 -1.663 . . . . 99.989999999999995 106.511 167.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 739' ' ' SER . . . . . 0.508 ' HB2' HD11 ' A' ' 731' ' ' LEU . 16.5 p -138.36 171.08 14.9 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 118.519 -1.272 . . . . 99.989999999999995 112.503 -174.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 12.4 p -133.44 110.86 10.28 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.093 -0.958 . . . . 99.989999999999995 110.314 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 741' ' ' VAL . . . . . 0.464 HG13 HD23 ' A' ' 793' ' ' LEU . 1.5 p -119.31 113.9 35.04 Favored Pre-proline 0 C--N 1.319 -0.745 0 CA-C-N 115.62 -0.718 . . . . 99.989999999999995 110.031 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 742' ' ' PRO . . . . . 0.634 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 2.2 Cg_endo -77.9 136.35 14.86 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.389 2.059 . . . . 99.989999999999995 111.641 -178.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 743' ' ' VAL . . . . . 0.558 ' HA ' ' HA ' ' A' ' 725' ' ' LEU . 2.1 p -132.45 121.52 45.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.602 0.715 . . . . 99.989999999999995 112.466 177.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 744' ' ' ALA . . . . . 0.597 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -79.46 95.69 5.87 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 122.17 0.985 . . . . 99.989999999999995 108.769 168.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 745' ' ' LEU . . . . . 0.545 ' HA ' ' HA ' ' A' ' 723' ' ' ALA . 2.0 mt -77.68 160.18 28.65 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 114.074 -1.421 . . . . 99.989999999999995 111.137 -172.111 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 31.8 ttmt -116.29 167.15 11.27 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.992 -0.549 . . . . 99.989999999999995 109.793 -178.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 747' ' ' GLY . . . . . . . . . . . . . . . 93.78 125.0 3.99 Favored Glycine 0 C--N 1.309 -0.921 0 CA-C-N 115.562 -0.744 . . . . 99.989999999999995 111.384 -173.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 67.0 mm-40 -100.24 114.29 27.61 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.877 0.37 . . . . 99.989999999999995 111.532 -175.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 119.98 -175.92 16.02 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.926 -0.654 . . . . 99.989999999999995 111.923 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -67.95 94.39 0.4 Allowed 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.929 2.419 . . . . 99.989999999999995 112.259 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 751' ' ' PHE . . . . . 0.422 ' HB3' HG12 ' A' ' 798' ' ' ILE . 53.7 m-85 -108.98 141.62 40.81 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.086 -0.506 . . . . 99.989999999999995 111.313 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 752' ' ' THR . . . . . 0.724 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 99.2 m -88.39 101.77 14.22 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 121.737 0.779 . . . . 99.989999999999995 109.645 177.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 753' ' ' LEU . . . . . . . . . . . . . 16.9 tp -90.19 125.2 35.39 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 114.409 -1.269 . . . . 99.989999999999995 110.511 -171.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 754' ' ' THR . . . . . 0.418 HG23 ' HB2' ' A' ' 769' ' ' GLU . 0.6 OUTLIER -123.48 131.24 53.58 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.428 -0.351 . . . . 99.989999999999995 111.159 -179.866 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 755' ' ' TYR . . . . . 0.564 ' CE1' ' HB3' ' A' ' 768' ' ' PHE . 22.3 p90 -141.39 157.34 45.31 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.801 0.334 . . . . 99.989999999999995 111.207 178.167 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 756' ' ' ASP . . . . . 0.469 ' HA ' ' O ' ' A' ' 766' ' ' LYS . 0.5 OUTLIER -119.82 118.48 30.92 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 115.64 -0.709 . . . . 99.989999999999995 110.256 -176.386 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 757' ' ' ILE . . . . . 0.522 ' CD1' HD13 ' A' ' 793' ' ' LEU . 3.5 mp -87.93 95.91 5.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 N-CA-C 107.075 -1.454 . . . . 99.989999999999995 107.075 168.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 758' ' ' ILE . . . . . 0.592 HG13 ' O ' ' A' ' 792' ' ' ILE . 2.3 pp -94.68 149.62 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 CA-C-N 115.637 -0.711 . . . . 99.989999999999995 110.256 -173.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 759' ' ' GLU . . . . . 0.643 ' HB3' ' CE2' ' A' ' 791' ' ' TYR . 8.7 pt-20 -107.09 129.36 54.83 Favored 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 120.148 -0.621 . . . . 99.989999999999995 111.132 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 760' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -92.38 -5.26 52.47 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.757 -0.831 . . . . 99.989999999999995 108.757 176.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 761' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -68.36 -35.66 78.05 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 114.971 -1.013 . . . . 99.989999999999995 110.537 175.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 762' ' ' SER . . . . . 0.534 ' HB2' ' OE1' ' A' ' 759' ' ' GLU . 14.8 m -150.43 -97.87 0.07 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.541 -0.299 . . . . 99.989999999999995 111.06 175.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 763' ' ' SER . . . . . . . . . . . . . 62.5 m -167.15 31.01 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.495 0.554 . . . . 99.989999999999995 112.495 -174.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 764' ' ' LYS . . . . . 0.543 ' H ' ' CG ' ' A' ' 759' ' ' GLU . 66.9 mttm -105.06 73.35 1.05 Allowed 'General case' 0 C--N 1.328 -0.366 0 O-C-N 121.776 -0.578 . . . . 99.989999999999995 110.335 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 765' ' ' ARG . . . . . 0.428 ' HA ' ' HA ' ' A' ' 758' ' ' ILE . 48.7 mtm180 -63.13 142.98 58.18 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.849 -0.614 . . . . 99.989999999999995 110.707 177.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 766' ' ' LYS . . . . . 0.469 ' O ' ' HA ' ' A' ' 756' ' ' ASP . 0.7 OUTLIER -120.5 143.12 48.72 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 109.627 -0.508 . . . . 99.989999999999995 109.627 -179.887 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 767' ' ' THR . . . . . . . . . . . . . 87.6 m -119.32 130.71 55.51 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 116.229 -0.441 . . . . 99.989999999999995 110.949 -176.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 768' ' ' PHE . . . . . 0.564 ' HB3' ' CE1' ' A' ' 755' ' ' TYR . 1.8 t80 -127.09 128.67 46.61 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.477 -0.564 . . . . 99.989999999999995 109.477 174.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 769' ' ' GLU . . . . . 0.418 ' HB2' HG23 ' A' ' 754' ' ' THR . 40.0 tt0 -126.22 118.27 24.82 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.275 -0.875 . . . . 99.989999999999995 110.782 -175.062 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 770' ' ' ILE . . . . . 0.453 HD12 ' HH ' ' A' ' 755' ' ' TYR . 9.0 mt -116.12 113.29 42.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.021 -0.536 . . . . 99.989999999999995 109.557 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 771' ' ' LYS . . . . . 0.603 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 6.1 mtpt -82.56 151.98 26.17 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-O 121.394 0.616 . . . . 99.989999999999995 111.079 -178.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 772' ' ' GLU . . . . . 0.409 ' O ' ' HG3' ' A' ' 774' ' ' LYS . 8.0 mt-10 57.75 46.92 16.38 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.169 -1.378 . . . . 99.989999999999995 112.28 176.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 773' ' ' ILE . . . . . 0.429 HD11 HD13 ' A' ' 745' ' ' LEU . 0.5 OUTLIER -73.85 119.46 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 107.711 -1.218 . . . . 99.989999999999995 107.711 172.969 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 774' ' ' LYS . . . . . 0.409 ' HG3' ' O ' ' A' ' 772' ' ' GLU . 74.0 mttt -118.21 30.53 7.18 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 107.842 -1.17 . . . . 99.989999999999995 107.842 -177.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 775' ' ' THR . . . . . 0.452 ' O ' ' HB2' ' A' ' 776' ' ' ASN . 0.2 OUTLIER -96.06 -73.57 0.59 Allowed 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 113.988 -1.46 . . . . 99.989999999999995 112.498 -171.43 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 776' ' ' ASN . . . . . 0.452 ' HB2' ' O ' ' A' ' 775' ' ' THR . 11.7 m120 83.48 4.3 0.86 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.504 1.121 . . . . 99.989999999999995 110.431 -176.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 777' ' ' GLU . . . . . 0.597 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 22.5 mt-10 -161.56 88.41 0.71 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.998 -1.001 . . . . 99.989999999999995 108.643 173.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 778' ' ' TYR . . . . . 0.501 ' HB3' ' CD1' ' A' ' 745' ' ' LEU . 50.2 t80 -130.88 132.41 45.13 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.252 -0.431 . . . . 99.989999999999995 110.644 -169.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 779' ' ' VAL . . . . . 0.634 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 20.1 t -87.07 113.78 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 CA-C-O 121.209 0.528 . . . . 99.989999999999995 110.396 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 780' ' ' ILE . . . . . 0.472 HG23 ' N ' ' A' ' 781' ' ' LYS . 66.0 mt -82.79 143.41 12.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.343 -0.844 . . . . 99.989999999999995 110.577 -178.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 781' ' ' LYS . . . . . 0.472 ' N ' HG23 ' A' ' 780' ' ' ILE . 0.0 OUTLIER -117.73 110.55 17.97 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.188 -0.671 . . . . 99.989999999999995 109.188 176.042 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 782' ' ' THR . . . . . 0.63 ' O ' ' HB2' ' A' ' 738' ' ' HIS . 29.8 p -77.56 142.07 66.02 Favored Pre-proline 0 C--N 1.317 -0.834 0 N-CA-C 109.49 -0.559 . . . . 99.989999999999995 109.49 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 783' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 782' ' ' THR . 38.0 Cg_exo -57.46 166.02 5.2 Favored 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 123.364 2.709 . . . . 99.989999999999995 112.229 -179.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 784' ' ' VAL . . . . . . . . . . . . . 14.1 p -67.53 135.26 28.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.291 0.567 . . . . 99.989999999999995 111.065 -175.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 785' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -104.77 103.64 13.29 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.612 -0.722 . . . . 99.989999999999995 109.539 178.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 82.3 p -86.21 18.54 3.09 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.546 -0.752 . . . . 99.989999999999995 111.463 -172.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 29.9 m -158.11 121.77 4.01 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.457 -0.792 . . . . 99.989999999999995 110.66 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 788' ' ' GLY . . . . . . . . . . . . . . . -48.85 118.22 4.77 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.888 -0.596 . . . . 99.989999999999995 112.791 171.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 789' ' ' GLY . . . . . 0.474 ' H ' ' HB ' ' A' ' 817' ' ' VAL . . . -174.88 168.39 40.99 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 110.058 -1.217 . . . . 99.989999999999995 110.058 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -97.32 135.93 38.52 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 118.066 0.933 . . . . 99.989999999999995 110.692 -178.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 791' ' ' TYR . . . . . 0.643 ' CE2' ' HB3' ' A' ' 759' ' ' GLU . 70.3 m-85 -123.18 150.21 43.63 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.504 -0.771 . . . . 99.989999999999995 109.671 176.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 792' ' ' ILE . . . . . 0.592 ' O ' HG13 ' A' ' 758' ' ' ILE . 11.3 mt -128.7 110.38 21.0 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 N-CA-C 108.901 -0.777 . . . . 99.989999999999995 108.901 177.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 793' ' ' LEU . . . . . 0.538 HD11 ' N ' ' A' ' 794' ' ' SER . 1.1 tp -84.2 111.75 19.65 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.96 -0.756 . . . . 99.989999999999995 108.96 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 794' ' ' SER . . . . . 0.538 ' N ' HD11 ' A' ' 793' ' ' LEU . 40.5 t -122.48 161.07 24.26 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.322 -1.308 . . . . 99.989999999999995 108.875 -175.024 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 795' ' ' LEU . . . . . . . . . . . . . 39.9 mt -88.71 142.67 27.48 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.658 -0.247 . . . . 99.989999999999995 110.738 -176.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 796' ' ' VAL . . . . . . . . . . . . . 73.4 t -102.73 -55.18 6.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.198 -0.455 . . . . 99.989999999999995 111.186 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 797' ' ' SER . . . . . 0.47 ' C ' HD13 ' A' ' 808' ' ' LEU . 7.4 t -178.03 177.78 1.0 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.429 -0.35 . . . . 99.989999999999995 110.475 -173.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 798' ' ' ILE . . . . . 0.634 ' HA ' ' O ' ' A' ' 752' ' ' THR . 9.2 tt -150.15 163.12 3.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 108.527 -0.916 . . . . 99.989999999999995 108.527 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 799' ' ' LYS . . . . . 0.724 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 9.6 tmtt? -138.71 119.53 14.22 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.895 0.379 . . . . 99.989999999999995 111.0 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 800' ' ' ASP . . . . . 0.538 ' HB3' ' HB3' ' A' ' 804' ' ' CYS . 14.1 t70 -64.12 155.72 30.62 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.244 -0.889 . . . . 99.989999999999995 109.729 174.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 3.5 m -60.01 -17.22 37.15 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 124.071 0.857 . . . . 99.989999999999995 112.596 -173.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 802' ' ' THR . . . . . 0.417 HG21 ' OD1' ' A' ' 800' ' ' ASP . 13.0 t -89.86 -0.55 57.63 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 121.836 0.827 . . . . 99.989999999999995 109.636 177.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 803' ' ' GLY . . . . . 0.432 ' HA2' ' HE2' ' A' ' 799' ' ' LYS . . . 86.68 38.23 8.24 Favored Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 115.001 -1.0 . . . . 99.989999999999995 111.846 -178.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 804' ' ' CYS . . . . . 0.538 ' HB3' ' HB3' ' A' ' 800' ' ' ASP . 46.5 t -99.73 105.15 16.92 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.206 -0.664 . . . . 99.989999999999995 109.206 178.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 805' ' ' VAL . . . . . . . . . . . . . 5.9 t -85.51 122.87 38.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.246 0.546 . . . . 99.989999999999995 110.143 -176.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 806' ' ' VAL . . . . . 0.527 HG13 ' HD2' ' A' ' 721' ' ' PRO . 32.4 t -114.43 136.99 49.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.154 -0.93 . . . . 99.989999999999995 110.552 -174.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -81.89 110.31 3.16 Favored Glycine 0 C--N 1.322 -0.207 0 C-N-CA 120.76 -0.733 . . . . 99.989999999999995 113.279 -176.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 808' ' ' LEU . . . . . 0.47 HD13 ' C ' ' A' ' 797' ' ' SER . 10.9 mp -81.36 123.58 28.66 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 113.502 0.927 . . . . 99.989999999999995 113.502 178.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 9.7 t -141.91 86.78 2.0 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.765 -1.198 . . . . 99.989999999999995 107.765 168.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 810' ' ' GLN . . . . . 0.446 ' HB3' ' O ' ' A' ' 723' ' ' ALA . 0.9 OUTLIER -146.07 176.07 2.4 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 115.261 -0.881 . . . . 99.989999999999995 109.879 -171.238 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 811' ' ' PRO . . . . . 0.403 ' O ' HD13 ' A' ' 725' ' ' LEU . 70.7 Cg_exo -41.61 142.91 1.11 Allowed 'Trans proline' 0 C--N 1.362 1.258 0 C-N-CA 123.559 2.839 . . . . 99.989999999999995 115.495 -171.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -125.37 167.57 14.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.348 -1.296 . . . . 99.989999999999995 110.577 -176.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 813' ' ' ALA . . . . . 0.47 ' HB2' HD21 ' A' ' 725' ' ' LEU . . . -122.31 158.56 29.29 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.939 -0.573 . . . . 99.989999999999995 110.714 178.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 814' ' ' LYS . . . . . 0.509 ' O ' ' HA ' ' A' ' 730' ' ' ASP . 21.5 ttpp -123.55 111.42 16.25 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.381 0.61 . . . . 99.989999999999995 110.521 175.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 815' ' ' ILE . . . . . 0.518 ' HA ' ' HB2' ' A' ' 731' ' ' LEU . 5.4 mp -92.54 113.67 28.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 115.364 -0.834 . . . . 99.989999999999995 108.837 177.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 816' ' ' GLN . . . . . 0.46 HE22 ' HB2' ' A' ' 818' ' ' ARG . 1.1 tm0? -99.55 108.38 20.78 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.258 0.551 . . . . 99.989999999999995 110.119 -177.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 817' ' ' VAL . . . . . 0.474 ' HB ' ' H ' ' A' ' 789' ' ' GLY . 42.0 t -99.08 143.66 13.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.948 -0.569 . . . . 99.989999999999995 109.81 -179.156 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 818' ' ' ARG . . . . . 0.46 ' HB2' HE22 ' A' ' 816' ' ' GLN . 30.1 tpt180 -142.12 175.6 9.62 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.921 -0.77 . . . . 99.989999999999995 108.921 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 819' ' ' ARG . . . . . 0.518 ' HA ' ' HB2' ' A' ' 735' ' ' LEU . 10.8 mmm180 -71.77 155.64 40.22 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 110.117 -0.327 . . . . 99.989999999999995 110.117 172.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 820' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 . . . . . 0 C--N 1.323 -0.565 0 N-CA-C 109.577 -0.527 . . . . 99.989999999999995 109.577 177.948 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 718' ' ' ARG . . . . . . . . . . . . . 23.8 mmm180 . . . . . 0 CA--C 1.499 -1.004 0 CA-C-O 122.0 0.905 . . . . 99.989999999999995 111.039 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 719' ' ' VAL . . . . . 0.511 ' O ' ' HD3' ' A' ' 721' ' ' PRO . 2.3 m -142.55 157.61 18.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-N 113.45 -1.705 . . . . 99.989999999999995 109.816 -175.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 720' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -96.11 97.08 2.81 Favored Pre-proline 0 C--N 1.306 -1.315 0 CA-C-N 115.154 -0.93 . . . . 99.989999999999995 108.609 173.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 721' ' ' PRO . . . . . 0.511 ' HD3' ' O ' ' A' ' 719' ' ' VAL . 59.5 Cg_endo -84.79 146.65 10.55 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 122.106 1.871 . . . . 99.989999999999995 112.042 -172.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 722' ' ' SER . . . . . 0.454 ' CB ' HE21 ' A' ' 810' ' ' GLN . 22.7 t -177.39 -157.29 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.911 -0.586 . . . . 99.989999999999995 109.597 -171.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 723' ' ' ALA . . . . . 0.519 ' HA ' ' HA ' ' A' ' 745' ' ' LEU . . . -148.97 142.07 24.91 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 110.289 -0.263 . . . . 99.989999999999995 110.289 176.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 724' ' ' SER . . . . . 0.444 ' HB2' ' OE1' ' A' ' 810' ' ' GLN . 23.0 t -130.98 105.04 7.48 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 109.488 -0.56 . . . . 99.989999999999995 109.488 -178.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 725' ' ' LEU . . . . . 0.479 ' CD2' ' HB ' ' A' ' 743' ' ' VAL . 14.0 mt -65.31 149.17 50.42 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-O 121.854 0.835 . . . . 99.989999999999995 112.31 -173.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 40.0 mtpt -100.32 -17.05 17.46 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 114.072 -1.422 . . . . 99.989999999999995 109.547 -177.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 727' ' ' LEU . . . . . . . . . . . . . 23.6 tp -66.13 117.24 8.16 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.248 -0.887 . . . . 99.989999999999995 109.845 177.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 9.8 t-80 -111.85 33.34 4.85 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 111.898 0.333 . . . . 99.989999999999995 111.898 -170.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -172.62 168.73 5.2 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.543 0.211 . . . . 99.989999999999995 110.546 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 730' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -73.25 126.63 30.53 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.479 0.657 . . . . 99.989999999999995 110.042 176.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 731' ' ' LEU . . . . . 0.52 ' HB3' ' HA ' ' A' ' 815' ' ' ILE . 16.2 tp -85.94 101.29 12.76 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.01 -0.995 . . . . 99.989999999999995 111.473 -173.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 732' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -77.72 115.79 17.75 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.679 -0.691 . . . . 99.989999999999995 110.876 -177.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 733' ' ' LEU . . . . . 0.463 ' HB3' ' HB3' ' A' ' 737' ' ' ASP . 23.9 mt -118.77 165.41 14.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 99.989999999999995 111.414 -178.036 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 734' ' ' CYS . . . . . . . . . . . . . 69.4 m -106.18 -176.79 3.18 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.797 -0.638 . . . . 99.989999999999995 110.413 174.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 735' ' ' LEU . . . . . 0.454 HD11 ' HB3' ' A' ' 819' ' ' ARG . 2.4 tt -63.75 130.49 44.42 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.195 -0.457 . . . . 99.989999999999995 110.425 -175.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 736' ' ' GLY . . . . . 0.403 ' N ' HD21 ' A' ' 735' ' ' LEU . . . 72.05 15.76 76.53 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.733 -0.746 . . . . 99.989999999999995 112.212 175.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 737' ' ' ASP . . . . . 0.463 ' HB3' ' HB3' ' A' ' 733' ' ' LEU . 20.6 t0 -80.59 161.4 24.75 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.18 0.514 . . . . 99.989999999999995 110.102 178.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 50.3 p-80 -120.72 153.18 37.3 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 106.658 -1.608 . . . . 99.989999999999995 106.658 173.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 739' ' ' SER . . . . . 0.478 ' HB2' HD21 ' A' ' 731' ' ' LEU . 1.4 p -101.56 160.64 14.27 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 118.954 -1.099 . . . . 99.989999999999995 111.383 -171.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 39.3 t -132.73 100.41 4.92 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 114.822 -1.081 . . . . 99.989999999999995 108.703 179.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 741' ' ' VAL . . . . . 0.434 HG13 HD13 ' A' ' 793' ' ' LEU . 1.3 p -120.05 108.59 38.32 Favored Pre-proline 0 C--N 1.316 -0.883 0 CA-C-N 115.57 -0.741 . . . . 99.989999999999995 109.884 -177.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 742' ' ' PRO . . . . . 0.643 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 2.5 Cg_endo -74.36 137.26 23.03 Favored 'Trans proline' 0 N--CA 1.448 -1.179 0 C-N-CA 122.316 2.011 . . . . 99.989999999999995 110.895 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 743' ' ' VAL . . . . . 0.48 HG23 ' HB1' ' A' ' 723' ' ' ALA . 1.6 p -135.64 120.38 27.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.49 0.662 . . . . 99.989999999999995 112.267 177.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 744' ' ' ALA . . . . . 0.481 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -83.4 100.91 10.99 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.086 -1.079 . . . . 99.989999999999995 108.086 168.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 745' ' ' LEU . . . . . 0.543 HD11 ' HB3' ' A' ' 778' ' ' TYR . 0.2 OUTLIER -82.47 168.64 17.23 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 113.936 -1.483 . . . . 99.989999999999995 111.073 -167.222 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -123.39 146.19 48.17 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 115.805 -0.634 . . . . 99.989999999999995 110.675 -175.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 747' ' ' GLY . . . . . . . . . . . . . . . 101.86 123.38 5.21 Favored Glycine 0 C--N 1.312 -0.782 0 CA-C-N 115.769 -0.65 . . . . 99.989999999999995 111.869 -178.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -103.6 120.81 41.63 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.793 0.33 . . . . 99.989999999999995 110.851 -174.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 127.31 179.83 16.01 Favored Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 115.812 -0.631 . . . . 99.989999999999995 111.74 -178.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -70.56 93.53 0.59 Allowed 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.339 2.026 . . . . 99.989999999999995 111.936 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 751' ' ' PHE . . . . . 0.487 ' CD2' ' HA ' ' A' ' 800' ' ' ASP . 82.9 m-85 -112.19 142.09 45.08 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.781 -0.645 . . . . 99.989999999999995 110.901 179.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 752' ' ' THR . . . . . 0.686 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 85.0 m -92.18 106.01 18.11 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.374 -0.602 . . . . 99.989999999999995 109.374 177.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 753' ' ' LEU . . . . . 0.509 ' CD2' HD22 ' A' ' 745' ' ' LEU . 59.2 tp -94.6 114.69 26.69 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.949 -1.023 . . . . 99.989999999999995 110.924 -172.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 754' ' ' THR . . . . . 0.462 HG23 ' HB2' ' A' ' 769' ' ' GLU . 1.5 m -113.92 134.59 54.72 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.987 -0.551 . . . . 99.989999999999995 110.683 179.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 755' ' ' TYR . . . . . 0.62 ' CE1' ' HB3' ' A' ' 768' ' ' PHE . 25.6 p90 -143.2 156.79 44.84 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.088 0.471 . . . . 99.989999999999995 111.177 178.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 756' ' ' ASP . . . . . 0.519 ' OD2' HG23 ' A' ' 758' ' ' ILE . 2.2 p30 -106.41 125.76 51.41 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.508 -0.769 . . . . 99.989999999999995 111.211 -178.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 757' ' ' ILE . . . . . 0.427 ' HB ' ' HB3' ' A' ' 766' ' ' LYS . 3.5 mp -94.47 93.23 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 N-CA-C 106.761 -1.57 . . . . 99.989999999999995 106.761 163.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 758' ' ' ILE . . . . . 0.519 HG23 ' OD2' ' A' ' 756' ' ' ASP . 2.3 pp -95.12 143.46 11.81 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-O 121.12 0.486 . . . . 99.989999999999995 111.6 -170.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -91.16 101.46 14.19 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 115.703 -0.681 . . . . 99.989999999999995 110.226 -176.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 760' ' ' THR . . . . . 0.45 HG23 ' CB ' ' A' ' 790' ' ' ASP . 0.5 OUTLIER -84.42 -7.28 59.34 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.869 0.842 . . . . 99.989999999999995 108.939 -178.872 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 761' ' ' PHE . . . . . 0.509 ' HB2' ' H ' ' A' ' 790' ' ' ASP . 67.4 t80 -62.86 -34.05 76.55 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 114.674 -1.148 . . . . 99.989999999999995 110.805 174.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 762' ' ' SER . . . . . . . . . . . . . 16.1 p -140.0 -93.17 0.16 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 116.403 -0.362 . . . . 99.989999999999995 111.383 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 763' ' ' SER . . . . . . . . . . . . . 18.8 p -161.68 14.99 0.09 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.08 -0.509 . . . . 99.989999999999995 110.891 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 764' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -88.68 174.96 7.73 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.19 -0.459 . . . . 99.989999999999995 110.557 -178.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 765' ' ' ARG . . . . . 0.463 ' HA ' ' HA ' ' A' ' 758' ' ' ILE . 21.6 ttp180 -162.05 144.31 11.33 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-O 121.004 0.431 . . . . 99.989999999999995 111.001 -175.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 766' ' ' LYS . . . . . 0.665 ' HD3' ' N ' ' A' ' 767' ' ' THR . 8.4 tmtm? -118.2 146.36 44.29 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 108.144 -1.058 . . . . 99.989999999999995 108.144 175.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 767' ' ' THR . . . . . 0.665 ' N ' ' HD3' ' A' ' 766' ' ' LYS . 32.3 m -124.41 125.19 43.88 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 110.048 -0.352 . . . . 99.989999999999995 110.048 178.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 768' ' ' PHE . . . . . 0.62 ' HB3' ' CE1' ' A' ' 755' ' ' TYR . 3.4 t80 -122.5 137.73 54.79 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 108.828 -0.805 . . . . 99.989999999999995 108.828 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 769' ' ' GLU . . . . . 0.462 ' HB2' HG23 ' A' ' 754' ' ' THR . 38.3 tt0 -133.23 130.37 38.96 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 116.122 -0.49 . . . . 99.989999999999995 111.397 -175.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 770' ' ' ILE . . . . . 0.449 HG21 HG22 ' A' ' 773' ' ' ILE . 3.7 mt -121.91 110.61 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 108.318 -0.993 . . . . 99.989999999999995 108.318 177.142 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 771' ' ' LYS . . . . . 0.584 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 11.4 mtpt -83.87 150.79 25.5 Favored 'General case' 0 N--CA 1.436 -1.175 0 CA-C-O 121.243 0.544 . . . . 99.989999999999995 110.889 -175.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 772' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 55.53 50.82 13.78 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.39 -1.277 . . . . 99.989999999999995 111.998 177.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 773' ' ' ILE . . . . . 0.451 ' O ' HG13 ' A' ' 773' ' ' ILE . 0.5 OUTLIER -77.86 116.88 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 107.949 -1.13 . . . . 99.989999999999995 107.949 173.377 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 70.0 mttt -117.61 29.5 7.82 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.356 -0.979 . . . . 99.989999999999995 108.356 -177.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 775' ' ' THR . . . . . 0.619 ' O ' ' HB2' ' A' ' 776' ' ' ASN . 1.8 m -97.2 -72.58 0.64 Allowed 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 114.748 -1.115 . . . . 99.989999999999995 112.868 -172.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 776' ' ' ASN . . . . . 0.619 ' HB2' ' O ' ' A' ' 775' ' ' THR . 0.9 OUTLIER 87.26 6.18 0.27 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.512 1.125 . . . . 99.989999999999995 109.915 -178.074 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 777' ' ' GLU . . . . . 0.481 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 1.4 tm-20 -161.91 86.16 0.63 Allowed 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 114.846 -1.07 . . . . 99.989999999999995 108.333 179.001 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 778' ' ' TYR . . . . . 0.543 ' HB3' HD11 ' A' ' 745' ' ' LEU . 87.3 t80 -137.28 134.36 36.03 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 116.244 -0.435 . . . . 99.989999999999995 111.686 -170.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 779' ' ' VAL . . . . . 0.643 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 23.5 t -89.94 117.96 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 CA-C-O 121.022 0.439 . . . . 99.989999999999995 110.529 177.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 780' ' ' ILE . . . . . 0.486 HG23 ' N ' ' A' ' 781' ' ' LYS . 68.3 mt -88.47 143.26 11.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.621 -0.718 . . . . 99.989999999999995 110.782 -178.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 781' ' ' LYS . . . . . 0.486 ' N ' HG23 ' A' ' 780' ' ' ILE . 3.8 mppt? -124.21 109.39 13.36 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.849 -0.797 . . . . 99.989999999999995 108.849 175.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 782' ' ' THR . . . . . . . . . . . . . 42.9 p -78.06 144.92 68.45 Favored Pre-proline 0 C--N 1.321 -0.653 0 N-CA-C 109.987 -0.375 . . . . 99.989999999999995 109.987 -177.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 783' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -51.32 158.33 3.82 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 123.465 2.777 . . . . 99.989999999999995 113.193 -178.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 784' ' ' VAL . . . . . 0.518 HG12 HG21 ' A' ' 786' ' ' THR . 53.4 t -58.81 126.71 16.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.066 -0.97 . . . . 99.989999999999995 112.208 -176.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 785' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -103.85 98.2 8.08 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.576 -0.738 . . . . 99.989999999999995 109.883 176.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 786' ' ' THR . . . . . 0.518 HG21 HG12 ' A' ' 784' ' ' VAL . 37.1 p -87.22 32.48 0.69 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.704 0.764 . . . . 99.989999999999995 110.989 -178.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.45 110.97 3.51 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.533 -1.212 . . . . 99.989999999999995 110.59 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 788' ' ' GLY . . . . . . . . . . . . . . . -53.1 112.62 2.35 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.623 -0.799 . . . . 99.989999999999995 112.253 171.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 789' ' ' GLY . . . . . 0.446 ' H ' ' HB ' ' A' ' 817' ' ' VAL . . . -154.5 -151.55 5.84 Favored Glycine 0 N--CA 1.443 -0.893 0 N-CA-C 110.806 -0.917 . . . . 99.989999999999995 110.806 -178.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 790' ' ' ASP . . . . . 0.509 ' H ' ' HB2' ' A' ' 761' ' ' PHE . 4.3 m-20 -137.57 124.01 20.77 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.301 -0.629 . . . . 99.989999999999995 109.301 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 791' ' ' TYR . . . . . 0.485 ' HA ' ' O ' ' A' ' 758' ' ' ILE . 80.9 m-85 -124.64 152.91 43.05 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.294 -0.412 . . . . 99.989999999999995 109.99 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 792' ' ' ILE . . . . . 0.514 ' HB ' HD12 ' A' ' 758' ' ' ILE . 14.4 mt -133.39 122.84 45.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 109.664 -0.495 . . . . 99.989999999999995 109.664 171.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 793' ' ' LEU . . . . . 0.446 ' HA ' ' O ' ' A' ' 756' ' ' ASP . 10.4 tt -87.71 108.01 18.91 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.253 -0.647 . . . . 99.989999999999995 109.253 178.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 794' ' ' SER . . . . . 0.436 ' HB3' ' OD2' ' A' ' 756' ' ' ASP . 31.3 t -121.54 146.06 47.33 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.53 -0.759 . . . . 99.989999999999995 109.166 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 795' ' ' LEU . . . . . 0.483 ' H ' HD22 ' A' ' 795' ' ' LEU . 1.4 mm? -72.98 135.15 44.94 Favored 'General case' 0 N--CA 1.448 -0.569 0 O-C-N 122.062 -0.399 . . . . 99.989999999999995 111.481 -179.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 796' ' ' VAL . . . . . . . . . . . . . 66.7 t -95.91 -57.46 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 CA-C-N 116.207 -0.451 . . . . 99.989999999999995 111.207 -177.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 797' ' ' SER . . . . . 0.58 ' HA ' ' HG ' ' A' ' 808' ' ' LEU . 35.7 m -171.38 157.02 4.77 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.779 -0.646 . . . . 99.989999999999995 109.719 -173.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 798' ' ' ILE . . . . . 0.556 ' HA ' ' O ' ' A' ' 752' ' ' THR . 13.2 tt -132.22 162.07 40.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 109.016 -0.735 . . . . 99.989999999999995 109.016 177.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 799' ' ' LYS . . . . . 0.686 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 22.1 tttt -129.83 118.19 21.37 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 120.967 0.413 . . . . 99.989999999999995 110.993 -174.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 800' ' ' ASP . . . . . 0.487 ' HA ' ' CD2' ' A' ' 751' ' ' PHE . 21.6 t70 -65.3 152.89 42.65 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.259 -0.882 . . . . 99.989999999999995 108.854 173.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 4.4 m -62.62 -8.56 6.71 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 123.768 0.667 . . . . 99.989999999999995 112.503 -171.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 40.1 p -96.67 5.62 50.32 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.426 0.631 . . . . 99.989999999999995 110.191 176.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 803' ' ' GLY . . . . . 0.486 ' HA2' ' HE2' ' A' ' 799' ' ' LYS . . . 77.98 42.25 16.6 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.202 -0.908 . . . . 99.989999999999995 112.029 -177.014 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 804' ' ' CYS . . . . . 0.48 ' HB2' ' HB3' ' A' ' 800' ' ' ASP . 69.4 m -110.24 106.87 16.45 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.574 -0.528 . . . . 99.989999999999995 109.574 176.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 805' ' ' VAL . . . . . 0.524 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 3.5 t -86.24 112.36 22.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.279 0.561 . . . . 99.989999999999995 111.071 -173.094 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 806' ' ' VAL . . . . . 0.41 ' HB ' HG22 ' A' ' 798' ' ' ILE . 73.4 t -90.0 135.14 27.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.349 -0.842 . . . . 99.989999999999995 110.152 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -73.7 120.57 6.95 Favored Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 111.601 -0.599 . . . . 99.989999999999995 111.601 178.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 808' ' ' LEU . . . . . 0.58 ' HG ' ' HA ' ' A' ' 797' ' ' SER . 45.4 mt -88.71 132.96 34.37 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 112.747 0.647 . . . . 99.989999999999995 112.747 -175.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 44.7 m -149.86 87.2 1.47 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.023 -0.989 . . . . 99.989999999999995 109.633 172.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 810' ' ' GLN . . . . . 0.455 ' HB3' ' HD2' ' A' ' 811' ' ' PRO . 11.3 mt-30 -135.34 171.84 8.23 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.82 -0.627 . . . . 99.989999999999995 110.336 174.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 811' ' ' PRO . . . . . 0.455 ' HD2' ' HB3' ' A' ' 810' ' ' GLN . 97.0 Cg_exo -45.81 137.82 12.18 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 122.999 2.466 . . . . 99.989999999999995 114.328 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -109.1 167.29 10.21 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.623 -1.171 . . . . 99.989999999999995 110.217 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 813' ' ' ALA . . . . . 0.419 ' HB2' HD11 ' A' ' 725' ' ' LEU . . . -126.7 141.17 51.92 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.892 -0.594 . . . . 99.989999999999995 110.571 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 814' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -100.24 129.56 46.26 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.143 0.497 . . . . 99.989999999999995 110.555 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 815' ' ' ILE . . . . . 0.52 ' HA ' ' HB3' ' A' ' 731' ' ' LEU . 5.3 mp -112.55 109.75 29.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 N-CA-C 108.699 -0.852 . . . . 99.989999999999995 108.699 176.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 816' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -106.08 109.05 20.86 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.061 0.457 . . . . 99.989999999999995 109.991 -175.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 817' ' ' VAL . . . . . 0.446 ' HB ' ' H ' ' A' ' 789' ' ' GLY . 4.7 t -99.74 141.27 17.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 116.02 -0.536 . . . . 99.989999999999995 110.513 -174.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 818' ' ' ARG . . . . . . . . . . . . . 39.9 mmt180 -127.69 177.01 7.09 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.975 -0.75 . . . . 99.989999999999995 108.975 177.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 819' ' ' ARG . . . . . 0.454 ' HB3' HD11 ' A' ' 735' ' ' LEU . 26.1 mtm180 -118.21 130.95 56.38 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.951 0.405 . . . . 99.989999999999995 110.69 177.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 820' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 . . . . . 0 C--N 1.322 -0.615 0 CA-C-N 115.985 -0.552 . . . . 99.989999999999995 110.399 179.861 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 718' ' ' ARG . . . . . . . . . . . . . 14.6 tpp180 . . . . . 0 CA--C 1.509 -0.62 0 CA-C-O 122.092 0.948 . . . . 99.989999999999995 110.721 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 719' ' ' VAL . . . . . . . . . . . . . 4.7 m -125.66 -171.62 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 113.637 -1.619 . . . . 99.989999999999995 108.808 177.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 720' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -116.88 90.71 33.28 Favored Pre-proline 0 C--N 1.306 -1.325 0 CA-C-N 115.588 -0.733 . . . . 99.989999999999995 109.652 178.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 721' ' ' PRO . . . . . 0.421 ' C ' ' HG ' ' A' ' 722' ' ' SER . 47.2 Cg_endo -86.46 140.34 6.26 Favored 'Trans proline' 0 N--CA 1.445 -1.353 0 C-N-CA 122.233 1.955 . . . . 99.989999999999995 111.204 178.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 722' ' ' SER . . . . . 0.436 ' HA ' ' CD2' ' A' ' 808' ' ' LEU . 50.2 m -167.42 -157.19 0.23 Allowed 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.353 -0.61 . . . . 99.989999999999995 109.353 -172.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 723' ' ' ALA . . . . . 0.51 ' HB1' HG23 ' A' ' 743' ' ' VAL . . . -145.77 142.62 29.08 Favored 'General case' 0 N--CA 1.449 -0.521 0 O-C-N 122.093 -0.38 . . . . 99.989999999999995 110.27 175.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -129.72 100.4 5.49 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.36 -0.607 . . . . 99.989999999999995 109.36 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 725' ' ' LEU . . . . . 0.481 ' CD2' ' HB ' ' A' ' 743' ' ' VAL . 13.2 mt -62.65 144.09 56.65 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 121.765 0.793 . . . . 99.989999999999995 111.869 -173.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 33.4 mtpt -95.22 -18.92 20.47 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.544 -1.207 . . . . 99.989999999999995 109.366 -178.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 727' ' ' LEU . . . . . 0.512 ' HB2' ' HD2' ' A' ' 742' ' ' PRO . 0.7 OUTLIER -76.67 109.97 10.87 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.755 -0.832 . . . . 99.989999999999995 108.755 177.304 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 33.4 m80 -115.83 46.19 1.58 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.02 0.438 . . . . 99.989999999999995 110.532 -176.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -148.31 174.33 12.13 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.873 -0.603 . . . . 99.989999999999995 110.92 -176.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 730' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -100.5 108.78 20.82 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.773 -0.825 . . . . 99.989999999999995 108.773 175.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 731' ' ' LEU . . . . . 0.569 ' HB2' ' HA ' ' A' ' 815' ' ' ILE . 53.9 mt -72.03 100.82 2.58 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.236 -0.438 . . . . 99.989999999999995 111.984 -173.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 732' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -79.43 121.6 25.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.36 -0.382 . . . . 99.989999999999995 110.681 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 733' ' ' LEU . . . . . 0.674 ' HB2' ' HB ' ' A' ' 817' ' ' VAL . 25.6 mt -126.41 169.52 12.9 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.372 0.606 . . . . 99.989999999999995 111.835 -174.154 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 734' ' ' CYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 818' ' ' ARG . 13.2 p -105.39 -176.97 3.23 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.8 -1.091 . . . . 99.989999999999995 109.107 176.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 735' ' ' LEU . . . . . . . . . . . . . 36.2 tp -71.41 122.54 20.56 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.536 -0.302 . . . . 99.989999999999995 110.569 -178.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 79.94 16.46 76.92 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.191 -1.004 . . . . 99.989999999999995 112.317 178.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 737' ' ' ASP . . . . . 0.519 ' HB3' ' HB3' ' A' ' 733' ' ' LEU . 25.3 t0 -86.22 157.63 19.91 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.769 0.318 . . . . 99.989999999999995 110.713 174.217 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 27.1 p-80 -117.16 -177.86 3.31 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.375 -0.972 . . . . 99.989999999999995 108.375 174.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 739' ' ' SER . . . . . 0.56 ' HB2' ' OG1' ' A' ' 782' ' ' THR . 29.8 m -142.22 169.43 17.6 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 119.777 -0.769 . . . . 99.989999999999995 112.894 179.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 5.7 p -138.07 109.66 7.04 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 114.433 -1.258 . . . . 99.989999999999995 109.4 177.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 741' ' ' VAL . . . . . 0.431 HG13 HD13 ' A' ' 793' ' ' LEU . 0.6 OUTLIER -113.1 112.44 49.86 Favored Pre-proline 0 C--N 1.316 -0.877 0 CA-C-N 115.671 -0.695 . . . . 99.989999999999995 110.226 -177.912 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 742' ' ' PRO . . . . . 0.638 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 4.1 Cg_endo -75.48 135.38 18.15 Favored 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 122.422 2.081 . . . . 99.989999999999995 111.652 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 743' ' ' VAL . . . . . 0.51 HG23 ' HB1' ' A' ' 723' ' ' ALA . 1.7 p -131.05 119.31 44.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.564 0.697 . . . . 99.989999999999995 111.981 176.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 744' ' ' ALA . . . . . 0.436 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -83.89 101.47 11.69 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 107.791 -1.188 . . . . 99.989999999999995 107.791 169.102 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 745' ' ' LEU . . . . . 0.511 HD11 ' HB3' ' A' ' 778' ' ' TYR . 0.3 OUTLIER -80.4 161.37 25.0 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 114.26 -1.336 . . . . 99.989999999999995 111.2 -166.752 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -110.91 146.31 36.79 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.686 -0.688 . . . . 99.989999999999995 109.628 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 747' ' ' GLY . . . . . . . . . . . . . . . 98.87 122.92 4.79 Favored Glycine 0 C--N 1.305 -1.168 0 N-CA-C 110.54 -1.024 . . . . 99.989999999999995 110.54 -176.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.95 128.68 53.96 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.321 0.581 . . . . 99.989999999999995 111.811 -169.22 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 109.44 -178.7 20.64 Favored Glycine 0 C--O 1.22 -0.724 0 CA-C-N 114.902 -1.044 . . . . 99.989999999999995 111.044 -175.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 750' ' ' PRO . . . . . 0.478 ' HB3' ' HE2' ' A' ' 774' ' ' LYS . 73.3 Cg_endo -65.51 100.96 0.42 Allowed 'Trans proline' 0 C--O 1.235 0.363 0 C-N-CA 123.37 2.714 . . . . 99.989999999999995 113.821 -178.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 751' ' ' PHE . . . . . 0.582 ' CE2' ' HA ' ' A' ' 800' ' ' ASP . 75.6 m-85 -117.0 146.86 42.78 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.643 -0.708 . . . . 99.989999999999995 110.743 176.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 752' ' ' THR . . . . . 0.653 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 33.4 m -89.64 106.64 18.59 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 109.07 -0.715 . . . . 99.989999999999995 109.07 176.04 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 753' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -96.72 111.26 23.49 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.713 -0.676 . . . . 99.989999999999995 110.338 -172.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 754' ' ' THR . . . . . 0.486 HG23 ' HB2' ' A' ' 769' ' ' GLU . 1.6 m -108.81 137.26 47.03 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.558 -0.747 . . . . 99.989999999999995 111.269 -178.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 755' ' ' TYR . . . . . 0.448 ' HH ' ' CD1' ' A' ' 770' ' ' ILE . 29.9 p90 -148.16 156.89 43.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.88 0.371 . . . . 99.989999999999995 110.953 176.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 756' ' ' ASP . . . . . 0.631 ' OD2' HG23 ' A' ' 796' ' ' VAL . 0.7 OUTLIER -125.18 121.76 35.11 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.782 -0.644 . . . . 99.989999999999995 110.513 178.667 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 757' ' ' ILE . . . . . 0.442 ' N ' HD13 ' A' ' 757' ' ' ILE . 4.2 mp -83.72 96.59 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 N-CA-C 107.728 -1.212 . . . . 99.989999999999995 107.728 172.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 758' ' ' ILE . . . . . 0.53 HG13 ' O ' ' A' ' 792' ' ' ILE . 2.4 pp -93.92 148.25 5.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 115.682 -0.69 . . . . 99.989999999999995 112.248 -167.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 759' ' ' GLU . . . . . 0.655 ' OE2' ' HB3' ' A' ' 762' ' ' SER . 23.9 mt-10 -88.68 117.82 27.92 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.425 -0.807 . . . . 99.989999999999995 109.921 176.097 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 760' ' ' THR . . . . . . . . . . . . . 1.2 t -94.51 -4.18 48.53 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 121.512 0.672 . . . . 99.989999999999995 109.227 176.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 761' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -103.83 -24.09 13.33 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.549 -0.751 . . . . 99.989999999999995 111.781 178.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 762' ' ' SER . . . . . 0.655 ' HB3' ' OE2' ' A' ' 759' ' ' GLU . 9.2 t -137.53 -101.8 0.19 Allowed 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 119.884 -0.726 . . . . 99.989999999999995 111.302 178.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 763' ' ' SER . . . . . . . . . . . . . 69.3 m -164.57 -5.31 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.999 0.74 . . . . 99.989999999999995 112.999 -173.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 764' ' ' LYS . . . . . 0.51 ' HB3' ' HZ3' ' A' ' 764' ' ' LYS . 8.6 mtpm? -87.22 54.29 3.11 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.329 0.585 . . . . 99.989999999999995 112.043 -171.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 765' ' ' ARG . . . . . 0.445 ' HD2' ' CG2' ' A' ' 758' ' ' ILE . 19.0 ttt180 -55.21 129.77 39.58 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.117 -0.947 . . . . 99.989999999999995 110.8 172.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 766' ' ' LYS . . . . . 0.402 ' HD3' ' N ' ' A' ' 767' ' ' THR . 9.7 tmtm? -106.78 140.47 39.57 Favored 'General case' 0 C--O 1.216 -0.674 0 CA-C-N 115.994 -0.548 . . . . 99.989999999999995 109.794 -175.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 767' ' ' THR . . . . . 0.402 ' N ' ' HD3' ' A' ' 766' ' ' LYS . 21.1 m -111.39 134.83 52.69 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 116.046 -0.525 . . . . 99.989999999999995 111.016 -176.015 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 768' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -140.46 137.89 34.26 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.01 0.433 . . . . 99.989999999999995 110.742 173.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 769' ' ' GLU . . . . . 0.486 ' HB2' HG23 ' A' ' 754' ' ' THR . 27.7 tt0 -131.86 123.17 26.97 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.738 -0.664 . . . . 99.989999999999995 110.558 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 770' ' ' ILE . . . . . 0.448 ' CD1' ' HH ' ' A' ' 755' ' ' TYR . 6.5 mt -114.45 112.23 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 109.065 -0.717 . . . . 99.989999999999995 109.065 178.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 771' ' ' LYS . . . . . 0.534 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 9.7 mtpt -85.88 154.64 21.38 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.927 -0.579 . . . . 99.989999999999995 111.52 -173.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 772' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 54.6 44.06 29.25 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.388 -1.278 . . . . 99.989999999999995 111.984 175.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 773' ' ' ILE . . . . . 0.448 HG22 HG21 ' A' ' 770' ' ' ILE . 0.5 OUTLIER -73.95 116.21 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 N-CA-C 106.977 -1.49 . . . . 99.989999999999995 106.977 172.142 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 774' ' ' LYS . . . . . 0.478 ' HE2' ' HB3' ' A' ' 750' ' ' PRO . 58.0 mttt -111.88 26.36 10.69 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 108.093 -1.077 . . . . 99.989999999999995 108.093 -178.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 775' ' ' THR . . . . . 0.67 ' O ' ' HB2' ' A' ' 776' ' ' ASN . 0.2 OUTLIER -96.22 -75.86 0.52 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 114.767 -1.106 . . . . 99.989999999999995 113.676 -166.333 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 776' ' ' ASN . . . . . 0.67 ' HB2' ' O ' ' A' ' 775' ' ' THR . 0.8 OUTLIER 89.98 2.52 0.19 Allowed 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.892 1.277 . . . . 99.989999999999995 110.565 -172.897 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 777' ' ' GLU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 9.4 mp0 -154.6 90.65 1.33 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.757 -0.831 . . . . 99.989999999999995 108.757 175.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 778' ' ' TYR . . . . . 0.511 ' HB3' HD11 ' A' ' 745' ' ' LEU . 81.7 t80 -132.12 128.8 38.89 Favored 'General case' 0 C--N 1.315 -0.932 0 C-N-CA 120.249 -0.58 . . . . 99.989999999999995 111.212 -172.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 779' ' ' VAL . . . . . 0.638 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 17.3 t -89.18 112.82 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-O 121.308 0.575 . . . . 99.989999999999995 110.4 178.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 780' ' ' ILE . . . . . 0.528 HG23 ' N ' ' A' ' 781' ' ' LYS . 77.8 mt -81.29 147.05 6.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.179 -0.919 . . . . 99.989999999999995 110.549 -178.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 781' ' ' LYS . . . . . 0.528 ' N ' HG23 ' A' ' 780' ' ' ILE . 3.8 mppt? -120.1 108.23 14.01 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.5 -0.555 . . . . 99.989999999999995 109.5 175.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 782' ' ' THR . . . . . 0.56 ' OG1' ' HB2' ' A' ' 739' ' ' SER . 54.6 p -77.51 141.41 65.35 Favored Pre-proline 0 C--N 1.319 -0.758 0 CA-C-N 116.084 -0.507 . . . . 99.989999999999995 110.359 -178.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 783' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 782' ' ' THR . 52.3 Cg_exo -53.91 158.57 8.54 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 123.758 2.972 . . . . 99.989999999999995 112.515 -175.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 784' ' ' VAL . . . . . 0.436 ' O ' HG11 ' A' ' 784' ' ' VAL . 12.9 p -65.7 128.93 29.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.33 0.586 . . . . 99.989999999999995 109.974 -178.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 785' ' ' PHE . . . . . 0.404 ' CG ' HG12 ' A' ' 817' ' ' VAL . 89.8 m-85 -97.48 96.61 8.45 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.965 -0.561 . . . . 99.989999999999995 110.321 -176.164 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 69.8 p -84.32 18.63 2.13 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.395 0.616 . . . . 99.989999999999995 111.473 -174.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 3.0 m -155.72 124.22 5.93 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.622 -0.717 . . . . 99.989999999999995 110.629 177.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 788' ' ' GLY . . . . . 0.684 ' HA2' ' CG2' ' A' ' 817' ' ' VAL . . . -50.89 123.69 17.8 Favored Glycine 0 CA--C 1.524 0.645 0 O-C-N 123.522 0.513 . . . . 99.989999999999995 112.336 172.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 789' ' ' GLY . . . . . . . . . . . . . . . -164.03 -165.76 21.77 Favored Glycine 0 N--CA 1.442 -0.964 0 N-CA-C 110.981 -0.848 . . . . 99.989999999999995 110.981 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -133.41 124.18 26.66 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.577 -0.897 . . . . 99.989999999999995 108.577 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 791' ' ' TYR . . . . . 0.619 ' CE2' ' HG2' ' A' ' 759' ' ' GLU . 81.5 m-85 -124.78 148.68 48.0 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.106 0.479 . . . . 99.989999999999995 111.286 -173.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 792' ' ' ILE . . . . . 0.53 ' O ' HG13 ' A' ' 758' ' ' ILE . 13.2 mt -126.07 116.36 45.56 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-N 115.612 -0.722 . . . . 99.989999999999995 109.656 175.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 793' ' ' LEU . . . . . 0.46 ' C ' HD21 ' A' ' 793' ' ' LEU . 9.3 tt -84.25 111.23 19.2 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.634 -0.876 . . . . 99.989999999999995 108.634 178.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 794' ' ' SER . . . . . . . . . . . . . 17.8 m -120.65 139.66 52.69 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.912 -0.585 . . . . 99.989999999999995 110.389 -178.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 795' ' ' LEU . . . . . 0.494 ' H ' HD22 ' A' ' 795' ' ' LEU . 1.6 mm? -69.25 132.07 45.9 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 116.533 -0.303 . . . . 99.989999999999995 110.619 176.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 796' ' ' VAL . . . . . 0.631 HG23 ' OD2' ' A' ' 756' ' ' ASP . 53.4 t -97.61 -51.71 10.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-O 120.993 0.425 . . . . 99.989999999999995 111.272 -178.063 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 797' ' ' SER . . . . . 0.541 ' HA ' ' HG ' ' A' ' 808' ' ' LEU . 81.1 p -168.42 155.62 7.75 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 116.032 -0.531 . . . . 99.989999999999995 110.391 -172.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 798' ' ' ILE . . . . . 0.633 ' HA ' ' O ' ' A' ' 752' ' ' THR . 8.7 tt -130.15 167.2 25.88 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 108.862 -0.792 . . . . 99.989999999999995 108.862 177.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 799' ' ' LYS . . . . . 0.653 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 2.7 ttmp? -135.74 118.32 15.93 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 120.732 -0.387 . . . . 99.989999999999995 111.626 -176.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 800' ' ' ASP . . . . . 0.582 ' HA ' ' CE2' ' A' ' 751' ' ' PHE . 12.0 m-20 -58.88 154.91 14.15 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.192 -0.913 . . . . 99.989999999999995 109.805 171.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 5.8 m -62.06 -10.21 9.43 Favored 'General case' 0 C--N 1.326 -0.415 0 O-C-N 124.14 0.9 . . . . 99.989999999999995 112.505 -172.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 14.0 t -96.24 4.99 51.98 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.559 0.695 . . . . 99.989999999999995 109.636 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 803' ' ' GLY . . . . . . . . . . . . . . . 81.19 43.36 8.73 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 115.316 -0.857 . . . . 99.989999999999995 112.135 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 804' ' ' CYS . . . . . . . . . . . . . 46.4 t -114.71 119.75 37.74 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.765 -0.457 . . . . 99.989999999999995 109.765 178.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 805' ' ' VAL . . . . . 0.537 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 3.0 t -94.22 124.79 46.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.327 0.584 . . . . 99.989999999999995 111.562 -172.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 806' ' ' VAL . . . . . . . . . . . . . 39.5 t -104.72 135.64 41.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.197 -0.91 . . . . 99.989999999999995 110.299 177.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -74.16 127.91 10.41 Favored Glycine 0 C--N 1.323 -0.177 0 CA-C-N 115.673 -0.694 . . . . 99.989999999999995 111.47 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 808' ' ' LEU . . . . . 0.541 ' HG ' ' HA ' ' A' ' 797' ' ' SER . 64.2 mt -98.05 136.96 37.55 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 113.054 0.761 . . . . 99.989999999999995 113.054 -172.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 43.0 m -148.71 86.39 1.52 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.822 -1.081 . . . . 99.989999999999995 109.173 170.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 810' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -139.79 172.92 5.65 Favored Pre-proline 0 CA--C 1.539 0.539 0 CA-C-N 115.194 -0.912 . . . . 99.989999999999995 109.132 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 811' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -44.4 138.77 7.21 Favored 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 123.059 2.506 . . . . 99.989999999999995 115.159 -173.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 812' ' ' ASP . . . . . 0.4 ' C ' HD12 ' A' ' 725' ' ' LEU . 7.8 p-10 -104.47 167.46 9.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.541 -1.209 . . . . 99.989999999999995 110.327 178.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 813' ' ' ALA . . . . . . . . . . . . . . . -123.88 152.01 42.84 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.314 -0.857 . . . . 99.989999999999995 109.437 175.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 814' ' ' LYS . . . . . 0.475 ' HG2' HG12 ' A' ' 792' ' ' ILE . 48.8 mttp -118.18 127.7 54.0 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.718 0.771 . . . . 99.989999999999995 111.241 -178.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 815' ' ' ILE . . . . . 0.597 ' CG2' HD13 ' A' ' 733' ' ' LEU . 5.3 mp -116.44 107.29 22.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 114.552 -1.204 . . . . 99.989999999999995 108.797 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 816' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -108.68 107.24 17.62 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.313 0.578 . . . . 99.989999999999995 110.024 -177.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 817' ' ' VAL . . . . . 0.684 ' CG2' ' HA2' ' A' ' 788' ' ' GLY . 1.9 m -102.21 147.46 8.87 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 N-CA-C 109.169 -0.678 . . . . 99.989999999999995 109.169 -178.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 818' ' ' ARG . . . . . 0.473 ' O ' ' HA ' ' A' ' 734' ' ' CYS . 16.1 tpt180 -147.07 154.76 41.55 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 109.587 -0.523 . . . . 99.989999999999995 109.587 -172.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 819' ' ' ARG . . . . . . . . . . . . . 18.6 mmt180 -68.6 132.98 47.82 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.434 -0.58 . . . . 99.989999999999995 109.434 178.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 820' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 . . . . . 0 C--N 1.321 -0.654 0 N-CA-C 110.163 -0.31 . . . . 99.989999999999995 110.163 178.865 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 718' ' ' ARG . . . . . . . . . . . . . 7.6 mpt_? . . . . . 0 C--O 1.234 0.28 0 CA-C-O 121.63 0.729 . . . . 99.989999999999995 111.053 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 719' ' ' VAL . . . . . 0.647 ' O ' ' HD3' ' A' ' 721' ' ' PRO . 4.7 p -148.75 152.01 12.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.077 -0.965 . . . . 99.989999999999995 109.005 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 720' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -84.49 105.14 5.48 Favored Pre-proline 0 C--N 1.312 -1.026 0 CA-C-N 115.514 -0.766 . . . . 99.989999999999995 111.119 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 721' ' ' PRO . . . . . 0.647 ' HD3' ' O ' ' A' ' 719' ' ' VAL . 74.1 Cg_endo -88.35 148.3 6.44 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 123.279 2.653 . . . . 99.989999999999995 111.249 177.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 722' ' ' SER . . . . . 0.524 ' HA ' ' CD2' ' A' ' 808' ' ' LEU . 11.6 p 179.44 -158.25 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.982 -0.554 . . . . 99.989999999999995 109.802 -171.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 723' ' ' ALA . . . . . 0.528 ' HB1' HG23 ' A' ' 743' ' ' VAL . . . -144.15 142.03 30.32 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 110.168 -0.308 . . . . 99.989999999999995 110.168 177.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 11.7 m -129.31 99.0 5.05 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.245 -0.65 . . . . 99.989999999999995 109.245 -178.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 725' ' ' LEU . . . . . 0.462 HD11 ' HB2' ' A' ' 813' ' ' ALA . 8.3 mt -64.22 143.63 57.74 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-O 121.811 0.815 . . . . 99.989999999999995 112.366 -172.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 29.1 mtpt -93.67 -18.91 21.62 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.216 -1.356 . . . . 99.989999999999995 108.583 177.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 727' ' ' LEU . . . . . 0.431 HD11 ' C ' ' A' ' 727' ' ' LEU . 3.0 tm? -60.43 119.2 7.55 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 114.905 -1.043 . . . . 99.989999999999995 108.569 173.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -88.93 -48.26 7.57 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.234 0.457 . . . . 99.989999999999995 112.234 -170.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 729' ' ' HIS . . . . . 0.43 ' O ' HD13 ' A' ' 727' ' ' LEU . 8.8 p80 -136.11 -175.7 4.07 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.798 -0.361 . . . . 99.989999999999995 111.224 -177.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 730' ' ' ASP . . . . . 0.45 ' HA ' ' O ' ' A' ' 814' ' ' LYS . 9.1 p-10 -40.65 133.98 1.9 Allowed 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.66 0.743 . . . . 99.989999999999995 112.098 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 731' ' ' LEU . . . . . 0.546 ' HB3' ' HA ' ' A' ' 815' ' ' ILE . 22.1 tp -104.26 104.68 14.62 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.225 -0.898 . . . . 99.989999999999995 110.258 -177.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 732' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -74.19 112.74 10.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.611 -0.722 . . . . 99.989999999999995 112.481 -171.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 733' ' ' LEU . . . . . 0.612 ' HG ' ' HB3' ' A' ' 737' ' ' ASP . 9.2 mp -120.01 164.97 15.31 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.679 -0.691 . . . . 99.989999999999995 109.73 173.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 734' ' ' CYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 818' ' ' ARG . 2.1 p -124.4 -173.62 2.82 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.266 -0.425 . . . . 99.989999999999995 110.486 173.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 735' ' ' LEU . . . . . 0.556 HD11 ' HG3' ' A' ' 819' ' ' ARG . 2.6 tt -53.64 115.65 2.08 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.088 0.471 . . . . 99.989999999999995 111.284 -174.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 87.88 3.27 80.27 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.592 -0.814 . . . . 99.989999999999995 112.965 173.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 737' ' ' ASP . . . . . 0.612 ' HB3' ' HG ' ' A' ' 733' ' ' LEU . 0.3 OUTLIER -76.99 148.98 35.95 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.253 0.549 . . . . 99.989999999999995 111.684 178.076 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 738' ' ' HIS . . . . . 0.483 ' HB2' ' O ' ' A' ' 782' ' ' THR . 36.1 p-80 -113.1 151.05 31.26 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 106.751 -1.574 . . . . 99.989999999999995 106.751 170.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 739' ' ' SER . . . . . 0.515 ' O ' ' HA ' ' A' ' 781' ' ' LYS . 17.3 p -108.6 167.56 9.96 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 119.219 -0.992 . . . . 99.989999999999995 111.803 -170.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 740' ' ' SER . . . . . 0.418 ' HA ' ' O ' ' A' ' 780' ' ' ILE . 12.9 p -132.7 99.62 4.68 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 114.924 -1.035 . . . . 99.989999999999995 109.301 175.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 741' ' ' VAL . . . . . 0.452 HG13 HD13 ' A' ' 793' ' ' LEU . 0.5 OUTLIER -104.98 105.04 49.85 Favored Pre-proline 0 C--N 1.316 -0.877 0 CA-C-N 115.037 -0.983 . . . . 99.989999999999995 108.799 179.02 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 742' ' ' PRO . . . . . 0.682 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 2.1 Cg_endo -74.97 131.91 14.85 Favored 'Trans proline' 0 N--CA 1.441 -1.589 0 C-N-CA 122.097 1.865 . . . . 99.989999999999995 110.777 -177.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 743' ' ' VAL . . . . . 0.528 HG23 ' HB1' ' A' ' 723' ' ' ALA . 1.4 p -131.99 120.88 45.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.769 0.795 . . . . 99.989999999999995 112.788 177.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 744' ' ' ALA . . . . . 0.514 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -81.02 99.88 8.68 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.134 -1.062 . . . . 99.989999999999995 108.134 168.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 745' ' ' LEU . . . . . 0.592 HD22 ' CD1' ' A' ' 753' ' ' LEU . 0.2 OUTLIER -83.59 165.33 19.13 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 114.536 -1.211 . . . . 99.989999999999995 111.28 -167.475 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 34.9 tptt -114.51 165.0 13.21 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.664 -0.698 . . . . 99.989999999999995 109.699 -178.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 747' ' ' GLY . . . . . . . . . . . . . . . 90.16 129.61 4.04 Favored Glycine 0 C--N 1.306 -1.089 0 CA-C-N 115.276 -0.874 . . . . 99.989999999999995 111.538 -175.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 748' ' ' GLN . . . . . 0.46 ' NE2' HG23 ' A' ' 719' ' ' VAL . 0.0 OUTLIER -112.34 113.82 26.23 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.201 0.524 . . . . 99.989999999999995 111.636 -173.89 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 123.77 -174.88 16.81 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.371 -0.832 . . . . 99.989999999999995 111.045 -177.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 750' ' ' PRO . . . . . 0.409 ' HD2' ' OG ' ' A' ' 801' ' ' SER . 14.0 Cg_exo -69.69 93.89 0.52 Allowed 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.552 2.168 . . . . 99.989999999999995 112.317 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 751' ' ' PHE . . . . . 0.564 ' HA ' ' O ' ' A' ' 799' ' ' LYS . 75.6 m-85 -109.84 139.97 44.31 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.741 -0.663 . . . . 99.989999999999995 110.45 177.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 752' ' ' THR . . . . . 0.659 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 92.6 m -91.04 108.22 19.72 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 109.505 -0.554 . . . . 99.989999999999995 109.505 176.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 753' ' ' LEU . . . . . 0.592 ' CD1' HD22 ' A' ' 745' ' ' LEU . 3.7 tt -100.46 118.41 36.61 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.517 -0.765 . . . . 99.989999999999995 110.094 -171.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 754' ' ' THR . . . . . 0.433 HG23 ' HB2' ' A' ' 769' ' ' GLU . 1.6 m -114.66 138.25 50.92 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.936 -0.575 . . . . 99.989999999999995 110.967 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 755' ' ' TYR . . . . . 0.619 ' CE1' ' HB3' ' A' ' 768' ' ' PHE . 28.9 p90 -146.47 153.91 40.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.998 0.428 . . . . 99.989999999999995 111.392 178.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 756' ' ' ASP . . . . . 0.423 ' CG ' ' HD2' ' A' ' 765' ' ' ARG . 39.3 m-20 -112.04 120.85 43.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.555 -0.748 . . . . 99.989999999999995 110.818 -178.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 757' ' ' ILE . . . . . . . . . . . . . 3.3 mp -88.02 95.77 5.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 107.887 -1.153 . . . . 99.989999999999995 107.887 168.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 758' ' ' ILE . . . . . 0.442 HG21 ' HD3' ' A' ' 765' ' ' ARG . 2.3 pp -96.09 140.58 16.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-O 121.595 0.712 . . . . 99.989999999999995 112.056 -170.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 759' ' ' GLU . . . . . 0.433 ' CD ' ' HB2' ' A' ' 764' ' ' LYS . 13.4 mt-10 -95.64 103.32 15.19 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.839 -1.073 . . . . 99.989999999999995 109.336 -176.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 760' ' ' THR . . . . . 0.447 HG23 ' HB3' ' A' ' 790' ' ' ASP . 0.5 OUTLIER -80.71 -11.47 59.62 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.627 -0.715 . . . . 99.989999999999995 111.132 -168.799 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 761' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -94.22 -29.2 15.22 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.017 -0.538 . . . . 99.989999999999995 111.169 -178.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 762' ' ' SER . . . . . 0.549 ' O ' ' HB2' ' A' ' 763' ' ' SER . 3.2 p -111.11 -5.15 14.81 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.53 0.567 . . . . 99.989999999999995 112.53 -175.058 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 763' ' ' SER . . . . . 0.549 ' HB2' ' O ' ' A' ' 762' ' ' SER . 64.6 m 73.29 4.02 4.76 Favored 'General case' 0 C--O 1.234 0.277 0 O-C-N 123.62 0.575 . . . . 99.989999999999995 111.006 -177.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 764' ' ' LYS . . . . . 0.433 ' HB2' ' CD ' ' A' ' 759' ' ' GLU . 6.6 mtpm? -86.23 177.26 7.56 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.08 -0.509 . . . . 99.989999999999995 109.932 179.28 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 765' ' ' ARG . . . . . 0.442 ' HD3' HG21 ' A' ' 758' ' ' ILE . 5.4 ttp180 -163.32 146.82 10.56 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-O 120.958 0.408 . . . . 99.989999999999995 111.531 -175.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 766' ' ' LYS . . . . . 0.462 ' HD3' ' N ' ' A' ' 767' ' ' THR . 9.6 tmtm? -117.91 146.42 43.96 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.691 -0.855 . . . . 99.989999999999995 108.691 177.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 767' ' ' THR . . . . . 0.462 ' N ' ' HD3' ' A' ' 766' ' ' LYS . 90.0 m -121.09 133.9 55.24 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 116.629 -0.26 . . . . 99.989999999999995 110.473 178.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 768' ' ' PHE . . . . . 0.619 ' HB3' ' CE1' ' A' ' 755' ' ' TYR . 1.2 t80 -134.74 135.93 42.29 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.152 -0.685 . . . . 99.989999999999995 109.152 177.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 769' ' ' GLU . . . . . 0.433 ' HB2' HG23 ' A' ' 754' ' ' THR . 42.8 tt0 -131.94 135.25 46.46 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.005 -0.543 . . . . 99.989999999999995 111.054 -178.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 770' ' ' ILE . . . . . 0.403 HG21 HG22 ' A' ' 773' ' ' ILE . 3.8 mt -126.81 112.0 27.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 108.637 -0.875 . . . . 99.989999999999995 108.637 176.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 771' ' ' LYS . . . . . 0.584 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 11.3 mtpt -83.49 154.96 23.62 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-O 121.035 0.445 . . . . 99.989999999999995 110.897 -177.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 772' ' ' GLU . . . . . 0.406 ' O ' ' HG3' ' A' ' 774' ' ' LYS . 5.2 mt-10 53.58 48.45 21.65 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.674 -1.148 . . . . 99.989999999999995 111.932 177.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 773' ' ' ILE . . . . . 0.425 ' O ' HG13 ' A' ' 773' ' ' ILE . 0.5 OUTLIER -74.77 115.34 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 107.965 -1.124 . . . . 99.989999999999995 107.965 174.278 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 774' ' ' LYS . . . . . 0.406 ' HG3' ' O ' ' A' ' 772' ' ' GLU . 72.0 mttt -116.33 32.28 6.22 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 107.894 -1.15 . . . . 99.989999999999995 107.894 -178.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 775' ' ' THR . . . . . 0.467 HG22 ' HB2' ' A' ' 778' ' ' TYR . 0.2 OUTLIER -96.56 -72.37 0.64 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.212 -1.358 . . . . 99.989999999999995 112.522 -171.598 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 776' ' ' ASN . . . . . 0.45 ' H ' HD13 ' A' ' 745' ' ' LEU . 11.5 m120 79.36 5.35 2.15 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.035 0.934 . . . . 99.989999999999995 110.506 -176.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 777' ' ' GLU . . . . . 0.514 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 21.8 mt-10 -160.36 79.45 0.66 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.7 -1.136 . . . . 99.989999999999995 108.826 176.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 778' ' ' TYR . . . . . 0.531 ' HB3' HD11 ' A' ' 745' ' ' LEU . 91.4 t80 -132.61 130.72 40.59 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.904 -0.589 . . . . 99.989999999999995 109.964 -171.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 779' ' ' VAL . . . . . 0.682 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 2.0 m -95.73 126.16 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 CA-C-O 122.331 1.062 . . . . 99.989999999999995 110.575 176.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 780' ' ' ILE . . . . . 0.435 HG23 ' N ' ' A' ' 781' ' ' LYS . 79.6 mt -89.04 145.57 7.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 113.542 -1.663 . . . . 99.989999999999995 110.465 -174.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 781' ' ' LYS . . . . . 0.515 ' HA ' ' O ' ' A' ' 739' ' ' SER . 3.9 mppt? -118.07 111.91 19.53 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.389 -0.597 . . . . 99.989999999999995 109.389 177.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 782' ' ' THR . . . . . 0.483 ' O ' ' HB2' ' A' ' 738' ' ' HIS . 30.8 p -74.75 142.87 77.58 Favored Pre-proline 0 C--N 1.319 -0.727 0 N-CA-C 109.037 -0.727 . . . . 99.989999999999995 109.037 177.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 783' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_exo -52.03 161.52 2.39 Favored 'Trans proline' 0 N--CA 1.472 0.22 0 C-N-CA 123.681 2.921 . . . . 99.989999999999995 113.171 -177.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 784' ' ' VAL . . . . . 0.433 HG21 ' HB3' ' A' ' 738' ' ' HIS . 51.1 t -63.4 113.7 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 115.653 -0.703 . . . . 99.989999999999995 111.046 177.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 785' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -104.16 102.3 12.03 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.802 -0.635 . . . . 99.989999999999995 110.351 178.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 77.2 p -85.94 26.64 0.97 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.781 0.8 . . . . 99.989999999999995 111.058 -176.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 92.4 m -144.74 111.47 5.77 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.735 -1.12 . . . . 99.989999999999995 110.173 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 788' ' ' GLY . . . . . 0.44 ' H ' ' HB2' ' A' ' 819' ' ' ARG . . . -49.65 121.4 9.11 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.971 -0.633 . . . . 99.989999999999995 113.201 171.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 789' ' ' GLY . . . . . 0.459 ' H ' ' HB ' ' A' ' 817' ' ' VAL . . . -175.19 173.94 46.51 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 110.041 -1.224 . . . . 99.989999999999995 110.041 178.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 790' ' ' ASP . . . . . 0.447 ' HB3' HG23 ' A' ' 760' ' ' THR . 13.2 t70 -100.19 133.98 43.79 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 117.819 0.809 . . . . 99.989999999999995 109.606 -179.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 791' ' ' TYR . . . . . 0.442 ' HA ' ' O ' ' A' ' 758' ' ' ILE . 68.1 m-85 -129.63 118.62 22.26 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.063 0.459 . . . . 99.989999999999995 110.702 -177.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 792' ' ' ILE . . . . . 0.514 HG12 ' HG2' ' A' ' 814' ' ' LYS . 17.8 mt -97.01 116.09 38.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 115.979 -0.555 . . . . 99.989999999999995 110.066 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 793' ' ' LEU . . . . . 0.452 HD13 HG13 ' A' ' 741' ' ' VAL . 10.1 tt -84.45 106.49 16.07 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 108.312 -0.995 . . . . 99.989999999999995 108.312 175.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 794' ' ' SER . . . . . . . . . . . . . 23.0 t -115.88 148.42 40.0 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.242 -0.89 . . . . 99.989999999999995 109.397 -177.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 795' ' ' LEU . . . . . . . . . . . . . 44.9 mt -82.39 134.23 35.24 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.829 0.347 . . . . 99.989999999999995 110.681 -176.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 796' ' ' VAL . . . . . . . . . . . . . 77.6 t -95.79 -55.9 5.69 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 CA-C-N 116.283 -0.417 . . . . 99.989999999999995 111.46 -177.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 797' ' ' SER . . . . . 0.52 ' HA ' ' HG ' ' A' ' 808' ' ' LEU . 92.0 p -177.74 162.61 1.77 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.118 -0.492 . . . . 99.989999999999995 110.373 -172.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 798' ' ' ILE . . . . . 0.652 ' HA ' ' O ' ' A' ' 752' ' ' THR . 9.4 tt -135.28 168.44 23.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 N-CA-C 109.599 -0.519 . . . . 99.989999999999995 109.599 178.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 799' ' ' LYS . . . . . 0.659 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 19.9 tttt -133.5 114.83 14.05 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.732 0.301 . . . . 99.989999999999995 111.274 -177.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 800' ' ' ASP . . . . . 0.54 ' HA ' ' CE2' ' A' ' 751' ' ' PHE . 1.6 m-20 -58.27 153.09 15.97 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.356 -0.838 . . . . 99.989999999999995 109.594 170.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 801' ' ' SER . . . . . 0.409 ' OG ' ' HD2' ' A' ' 750' ' ' PRO . 6.6 m -66.56 -4.72 9.2 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.828 -0.624 . . . . 99.989999999999995 112.141 -172.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 21.6 p -95.06 6.4 49.18 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.585 0.707 . . . . 99.989999999999995 109.889 175.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 803' ' ' GLY . . . . . 0.49 ' HA2' ' HE2' ' A' ' 799' ' ' LYS . . . 74.95 41.28 33.28 Favored Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 115.05 -0.977 . . . . 99.989999999999995 111.716 -178.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 804' ' ' CYS . . . . . . . . . . . . . 51.9 t -114.83 120.23 39.3 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.564 -0.532 . . . . 99.989999999999995 109.564 179.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 805' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 10.2 p -84.9 133.77 28.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 121.523 0.678 . . . . 99.989999999999995 110.684 -175.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 806' ' ' VAL . . . . . 0.494 HG11 ' HD2' ' A' ' 721' ' ' PRO . 24.8 t -117.03 135.45 57.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.15 -0.932 . . . . 99.989999999999995 109.995 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -74.91 122.59 7.07 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.274 -0.875 . . . . 99.989999999999995 111.865 -178.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 808' ' ' LEU . . . . . 0.524 ' CD2' ' HA ' ' A' ' 722' ' ' SER . 50.9 mt -89.11 127.56 35.72 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.059 0.456 . . . . 99.989999999999995 112.145 -177.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 20.1 m -144.27 85.58 1.8 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.834 -0.621 . . . . 99.989999999999995 109.882 172.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 810' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -145.82 170.85 7.26 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 115.534 -0.757 . . . . 99.989999999999995 109.251 177.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 811' ' ' PRO . . . . . . . . . . . . . 99.7 Cg_exo -42.98 139.84 3.37 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 123.204 2.603 . . . . 99.989999999999995 115.3 -170.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -103.38 167.35 9.87 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 114.475 -1.239 . . . . 99.989999999999995 110.207 178.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 813' ' ' ALA . . . . . 0.463 ' O ' ' HA ' ' A' ' 792' ' ' ILE . . . -116.58 150.15 38.49 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.851 -0.613 . . . . 99.989999999999995 110.381 178.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 814' ' ' LYS . . . . . 0.514 ' HG2' HG12 ' A' ' 792' ' ' ILE . 47.3 mttp -123.27 96.86 5.16 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 122.048 0.928 . . . . 99.989999999999995 111.106 176.161 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 815' ' ' ILE . . . . . 0.546 ' HA ' ' HB3' ' A' ' 731' ' ' LEU . 5.4 mp -87.71 110.82 21.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 CA-C-N 113.97 -1.468 . . . . 99.989999999999995 108.987 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 816' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -100.48 107.85 19.68 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.223 0.535 . . . . 99.989999999999995 110.226 -175.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 817' ' ' VAL . . . . . 0.459 ' HB ' ' H ' ' A' ' 789' ' ' GLY . 57.3 t -93.84 146.04 7.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.548 -0.751 . . . . 99.989999999999995 109.241 177.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 818' ' ' ARG . . . . . 0.431 ' N ' HG12 ' A' ' 817' ' ' VAL . 30.6 tpt180 -137.11 124.22 21.64 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.09 0.471 . . . . 99.989999999999995 110.619 178.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 819' ' ' ARG . . . . . 0.556 ' HG3' HD11 ' A' ' 735' ' ' LEU . 9.3 ttp180 -79.39 113.12 17.27 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.79 -0.641 . . . . 99.989999999999995 110.105 -179.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 820' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 . . . . . 0 C--N 1.318 -0.771 0 CA-C-N 115.172 -0.922 . . . . 99.989999999999995 110.161 -178.725 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 718' ' ' ARG . . . . . . . . . . . . . 17.2 tpp180 . . . . . 0 CA--C 1.511 -0.537 0 N-CA-C 109.37 -0.604 . . . . 99.989999999999995 109.37 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 719' ' ' VAL . . . . . 0.577 ' O ' ' HD3' ' A' ' 721' ' ' PRO . 2.1 t -113.63 164.51 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.201 0 N-CA-C 107.124 -1.435 . . . . 99.989999999999995 107.124 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 720' ' ' LYS . . . . . 0.482 ' HZ1' ' HB3' ' A' ' 720' ' ' LYS . 7.8 mtpm? -94.89 96.26 1.88 Allowed Pre-proline 0 C--N 1.299 -1.596 0 N-CA-C 108.526 -0.916 . . . . 99.989999999999995 108.526 168.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 721' ' ' PRO . . . . . 0.577 ' HD3' ' O ' ' A' ' 719' ' ' VAL . 57.4 Cg_endo -84.92 148.12 10.68 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 122.632 2.221 . . . . 99.989999999999995 111.268 -173.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 722' ' ' SER . . . . . 0.589 ' HA ' ' CD2' ' A' ' 808' ' ' LEU . 57.0 m -166.78 -161.83 0.47 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.26 -0.427 . . . . 99.989999999999995 109.857 -171.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 723' ' ' ALA . . . . . 0.55 ' HA ' ' HA ' ' A' ' 745' ' ' LEU . . . -149.03 140.56 23.39 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 120.797 -0.361 . . . . 99.989999999999995 110.336 173.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 19.0 m -126.7 104.96 8.36 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.163 -0.68 . . . . 99.989999999999995 109.163 -177.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 725' ' ' LEU . . . . . 0.541 ' CD2' ' HB ' ' A' ' 743' ' ' VAL . 14.8 mt -63.39 137.42 58.16 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-O 121.331 0.586 . . . . 99.989999999999995 110.839 -176.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 33.9 mtpt -89.76 -18.3 26.6 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 114.987 -1.006 . . . . 99.989999999999995 109.886 -175.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 727' ' ' LEU . . . . . . . . . . . . . 25.5 tp -68.15 109.59 3.61 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.722 -0.672 . . . . 99.989999999999995 109.248 175.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 11.6 t-80 -110.83 25.22 12.01 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.266 0.555 . . . . 99.989999999999995 111.534 -173.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 6.2 p80 -155.81 162.08 40.53 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.234 -0.439 . . . . 99.989999999999995 110.092 179.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 730' ' ' ASP . . . . . 0.529 ' OD1' ' HB2' ' A' ' 816' ' ' GLN . 16.5 t70 -72.25 131.41 42.69 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.807 0.813 . . . . 99.989999999999995 111.301 -176.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 731' ' ' LEU . . . . . 0.567 ' HB3' ' HA ' ' A' ' 815' ' ' ILE . 25.9 tp -87.17 110.13 19.94 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 114.114 -1.403 . . . . 99.989999999999995 110.671 -174.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 732' ' ' LYS . . . . . . . . . . . . . 26.5 mmmt -86.74 107.4 18.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.979 -0.555 . . . . 99.989999999999995 111.389 -172.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 733' ' ' LEU . . . . . 0.467 HD13 ' CG2' ' A' ' 815' ' ' ILE . 16.8 mt -119.32 163.92 16.45 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.848 0.356 . . . . 99.989999999999995 111.088 -179.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 734' ' ' CYS . . . . . 0.558 ' O ' ' HB2' ' A' ' 737' ' ' ASP . 15.5 t -116.97 -173.75 2.45 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.872 -0.788 . . . . 99.989999999999995 108.872 174.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 735' ' ' LEU . . . . . 0.439 ' HB2' ' HA ' ' A' ' 819' ' ' ARG . 18.6 tp -73.23 133.83 44.1 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.447 0.642 . . . . 99.989999999999995 111.724 -172.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 81.49 10.11 84.9 Favored Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 114.674 -1.148 . . . . 99.989999999999995 111.423 -178.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 737' ' ' ASP . . . . . 0.558 ' HB2' ' O ' ' A' ' 734' ' ' CYS . 0.9 OUTLIER -88.14 149.7 23.76 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.918 0.389 . . . . 99.989999999999995 111.315 175.99 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 25.6 p-80 -109.52 167.27 10.26 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.268 -1.382 . . . . 99.989999999999995 107.268 170.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 739' ' ' SER . . . . . 0.412 ' HB2' ' OG1' ' A' ' 782' ' ' THR . 0.3 OUTLIER -121.25 164.59 16.73 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 119.855 -0.738 . . . . 99.989999999999995 111.74 -173.206 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 62.8 m -143.35 128.15 18.28 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.126 -0.943 . . . . 99.989999999999995 108.941 178.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 741' ' ' VAL . . . . . 0.472 HG13 HD23 ' A' ' 793' ' ' LEU . 0.8 OUTLIER -138.06 114.85 9.24 Favored Pre-proline 0 C--N 1.312 -1.048 0 CA-C-O 121.337 0.589 . . . . 99.989999999999995 110.326 -177.866 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 742' ' ' PRO . . . . . 0.628 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 6.5 Cg_endo -76.66 136.35 17.05 Favored 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 122.389 2.059 . . . . 99.989999999999995 111.396 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 743' ' ' VAL . . . . . 0.541 ' HB ' ' CD2' ' A' ' 725' ' ' LEU . 1.6 p -131.64 119.44 42.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.253 0.549 . . . . 99.989999999999995 111.915 176.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 744' ' ' ALA . . . . . 0.408 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -84.0 111.65 19.48 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.165 -1.05 . . . . 99.989999999999995 108.165 168.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 745' ' ' LEU . . . . . 0.55 ' HA ' ' HA ' ' A' ' 723' ' ' ALA . 0.2 OUTLIER -94.11 154.78 17.42 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.645 -1.161 . . . . 99.989999999999995 110.9 -166.359 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -107.01 149.85 27.12 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.545 -0.752 . . . . 99.989999999999995 110.161 -178.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 747' ' ' GLY . . . . . 0.457 ' HA3' ' HB3' ' A' ' 721' ' ' PRO . . . 96.2 118.62 3.48 Favored Glycine 0 C--N 1.316 -0.559 0 N-CA-C 110.823 -0.911 . . . . 99.989999999999995 110.823 -174.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 27.4 mp0 -99.77 122.47 42.79 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.192 0.52 . . . . 99.989999999999995 112.115 -169.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 116.24 -170.75 13.46 Favored Glycine 0 C--O 1.218 -0.845 0 CA-C-N 114.991 -1.004 . . . . 99.989999999999995 111.439 -179.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 750' ' ' PRO . . . . . 0.439 ' HB3' ' HE2' ' A' ' 774' ' ' LYS . 88.8 Cg_endo -69.94 96.6 0.61 Allowed 'Trans proline' 0 CA--C 1.533 0.445 0 C-N-CA 123.506 2.804 . . . . 99.989999999999995 113.893 -178.291 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 751' ' ' PHE . . . . . 0.591 ' CD2' ' HA ' ' A' ' 800' ' ' ASP . 80.7 m-85 -115.19 148.14 39.44 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.104 -0.498 . . . . 99.989999999999995 111.176 178.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 752' ' ' THR . . . . . 0.728 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 98.2 m -90.56 104.16 16.77 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.231 0.538 . . . . 99.989999999999995 109.684 178.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 753' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.14 113.7 25.3 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.235 -0.893 . . . . 99.989999999999995 110.186 -170.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 754' ' ' THR . . . . . 0.517 HG23 ' HB2' ' A' ' 769' ' ' GLU . 1.6 m -109.89 134.42 52.09 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.746 -0.661 . . . . 99.989999999999995 110.455 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 755' ' ' TYR . . . . . 0.603 ' CE1' ' HB2' ' A' ' 768' ' ' PHE . 24.9 p90 -143.97 152.89 41.66 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.021 0.439 . . . . 99.989999999999995 112.133 179.194 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 756' ' ' ASP . . . . . 0.472 ' OD2' HG23 ' A' ' 758' ' ' ILE . 2.9 p30 -113.31 121.14 43.5 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 115.541 -0.754 . . . . 99.989999999999995 111.513 -178.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 757' ' ' ILE . . . . . 0.564 ' CD1' HD13 ' A' ' 793' ' ' LEU . 4.0 mp -93.89 96.16 5.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 107.3 -1.37 . . . . 99.989999999999995 107.3 165.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 758' ' ' ILE . . . . . 0.515 HG13 ' O ' ' A' ' 792' ' ' ILE . 2.2 pp -100.39 150.16 5.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.371 -0.831 . . . . 99.989999999999995 111.749 -170.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 759' ' ' GLU . . . . . 0.554 ' HG3' ' C ' ' A' ' 764' ' ' LYS . 10.2 mt-10 -92.96 115.85 28.51 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.502 -0.317 . . . . 99.989999999999995 110.764 -177.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 760' ' ' THR . . . . . 0.441 HG23 ' HB2' ' A' ' 790' ' ' ASP . 0.2 OUTLIER -96.4 -5.68 39.23 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.389 0.614 . . . . 99.989999999999995 109.781 178.169 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 761' ' ' PHE . . . . . 0.51 ' CB ' ' H ' ' A' ' 790' ' ' ASP . 91.3 t80 -95.34 -28.12 15.12 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.569 -0.741 . . . . 99.989999999999995 110.747 178.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 762' ' ' SER . . . . . . . . . . . . . 49.1 m -120.62 -102.67 0.41 Allowed 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 120.56 -0.456 . . . . 99.989999999999995 111.153 177.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 763' ' ' SER . . . . . . . . . . . . . 28.7 p -167.54 5.73 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.313 0.486 . . . . 99.989999999999995 112.313 -175.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 764' ' ' LYS . . . . . 0.554 ' C ' ' HG3' ' A' ' 759' ' ' GLU . 9.2 mtmp? -95.75 -178.35 4.35 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.484 -0.486 . . . . 99.989999999999995 111.039 -178.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 765' ' ' ARG . . . . . 0.432 ' CG ' HG21 ' A' ' 758' ' ' ILE . 6.7 ttp180 -163.43 137.0 5.71 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.761 -0.654 . . . . 99.989999999999995 110.506 -175.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 766' ' ' LYS . . . . . 0.65 ' HD3' ' N ' ' A' ' 767' ' ' THR . 7.8 tmtm? -115.48 146.24 41.85 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 108.714 -0.847 . . . . 99.989999999999995 108.714 177.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 767' ' ' THR . . . . . 0.65 ' N ' ' HD3' ' A' ' 766' ' ' LYS . 90.7 m -132.49 135.83 46.27 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 116.512 -0.313 . . . . 99.989999999999995 111.42 -177.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 768' ' ' PHE . . . . . 0.603 ' HB2' ' CE1' ' A' ' 755' ' ' TYR . 20.8 m-85 -123.26 134.57 54.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 99.989999999999995 110.38 174.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 769' ' ' GLU . . . . . 0.517 ' HB2' HG23 ' A' ' 754' ' ' THR . 40.5 tt0 -126.9 104.83 8.24 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.07 -0.514 . . . . 99.989999999999995 110.591 177.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 770' ' ' ILE . . . . . 0.446 HD12 ' HH ' ' A' ' 755' ' ' TYR . 22.1 mt -105.22 117.55 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-N 116.192 -0.458 . . . . 99.989999999999995 110.422 -178.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 771' ' ' LYS . . . . . . . . . . . . . 17.7 mmtt -77.74 159.11 29.29 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.451 0.643 . . . . 99.989999999999995 111.006 -179.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 772' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 48.02 45.96 19.22 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 113.863 -1.517 . . . . 99.989999999999995 112.83 172.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 773' ' ' ILE . . . . . 0.475 HD11 HD12 ' A' ' 745' ' ' LEU . 0.5 OUTLIER -75.72 109.85 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 N-CA-C 107.149 -1.426 . . . . 99.989999999999995 107.149 172.149 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 774' ' ' LYS . . . . . 0.439 ' HE2' ' HB3' ' A' ' 750' ' ' PRO . 59.6 mttt -105.65 28.83 7.1 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.156 -1.053 . . . . 99.989999999999995 108.156 -177.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 775' ' ' THR . . . . . 0.465 ' O ' ' HB2' ' A' ' 776' ' ' ASN . 0.6 OUTLIER -95.32 -74.61 0.55 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.95 -1.023 . . . . 99.989999999999995 113.122 -166.726 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 776' ' ' ASN . . . . . 0.465 ' HB2' ' O ' ' A' ' 775' ' ' THR . 11.8 m120 84.48 1.86 0.83 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.76 1.224 . . . . 99.989999999999995 110.893 -176.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 777' ' ' GLU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 5.2 mp0 -156.05 83.17 1.0 Allowed 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.338 -0.986 . . . . 99.989999999999995 108.338 177.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 778' ' ' TYR . . . . . 0.483 ' HB3' HD11 ' A' ' 745' ' ' LEU . 67.1 t80 -125.97 127.68 46.31 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.516 -0.474 . . . . 99.989999999999995 111.582 -170.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 779' ' ' VAL . . . . . 0.628 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 15.5 t -88.55 108.6 18.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.285 0.564 . . . . 99.989999999999995 110.216 177.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 780' ' ' ILE . . . . . 0.474 HG23 ' N ' ' A' ' 781' ' ' LYS . 79.4 mt -76.41 143.56 12.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.293 -0.867 . . . . 99.989999999999995 110.63 -178.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 781' ' ' LYS . . . . . 0.474 ' N ' HG23 ' A' ' 780' ' ' ILE . 0.0 OUTLIER -122.73 106.6 11.08 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.237 -0.653 . . . . 99.989999999999995 109.237 175.656 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 782' ' ' THR . . . . . 0.412 ' OG1' ' HB2' ' A' ' 739' ' ' SER . 39.5 p -83.51 144.02 45.35 Favored Pre-proline 0 C--N 1.315 -0.9 0 CA-C-N 115.775 -0.648 . . . . 99.989999999999995 110.356 -177.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 783' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_exo -52.75 160.46 3.91 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 123.775 2.983 . . . . 99.989999999999995 112.798 -177.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 784' ' ' VAL . . . . . . . . . . . . . 14.9 p -66.34 135.2 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-N 115.888 -0.596 . . . . 99.989999999999995 110.495 -177.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 785' ' ' PHE . . . . . 0.406 ' C ' ' H ' ' A' ' 787' ' ' THR . 90.8 m-85 -102.54 99.43 9.44 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.561 0.696 . . . . 99.989999999999995 110.028 179.099 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 786' ' ' THR . . . . . 0.422 ' C ' ' HG1' ' A' ' 787' ' ' THR . 66.3 p -86.09 24.66 1.28 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.861 0.839 . . . . 99.989999999999995 110.295 -178.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 787' ' ' THR . . . . . 0.422 ' HG1' ' C ' ' A' ' 786' ' ' THR . 5.5 m -160.58 110.65 1.77 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.459 -1.246 . . . . 99.989999999999995 110.032 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 788' ' ' GLY . . . . . . . . . . . . . . . -49.91 147.73 6.88 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 121.241 -0.504 . . . . 99.989999999999995 113.718 173.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 789' ' ' GLY . . . . . . . . . . . . . . . 167.34 177.43 38.9 Favored Glycine 0 N--CA 1.443 -0.873 0 N-CA-C 110.215 -1.154 . . . . 99.989999999999995 110.215 -177.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 790' ' ' ASP . . . . . 0.51 ' H ' ' CB ' ' A' ' 761' ' ' PHE . 5.3 m-20 -109.03 128.8 55.28 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.97 -0.752 . . . . 99.989999999999995 108.97 -179.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 791' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -129.87 145.36 51.6 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.597 -0.52 . . . . 99.989999999999995 109.597 -177.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 792' ' ' ILE . . . . . 0.515 ' O ' HG13 ' A' ' 758' ' ' ILE . 20.3 mt -123.47 122.26 64.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 N-CA-C 109.641 -0.503 . . . . 99.989999999999995 109.641 177.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 793' ' ' LEU . . . . . 0.566 HD11 ' N ' ' A' ' 794' ' ' SER . 0.7 OUTLIER -89.42 115.21 26.69 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 108.823 -0.806 . . . . 99.989999999999995 108.823 176.859 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 794' ' ' SER . . . . . 0.566 ' N ' HD11 ' A' ' 793' ' ' LEU . 34.5 t -128.06 149.93 50.17 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.229 -0.896 . . . . 99.989999999999995 109.344 -176.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 795' ' ' LEU . . . . . 0.51 ' H ' HD22 ' A' ' 795' ' ' LEU . 1.3 mm? -78.85 130.35 35.57 Favored 'General case' 0 C--N 1.323 -0.579 0 O-C-N 122.158 -0.339 . . . . 99.989999999999995 111.383 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 796' ' ' VAL . . . . . . . . . . . . . 94.2 t -89.91 -56.77 4.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.05 0.452 . . . . 99.989999999999995 111.035 -177.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 797' ' ' SER . . . . . 0.625 ' HA ' ' HG ' ' A' ' 808' ' ' LEU . 30.0 m -171.83 160.75 5.67 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.436 -0.802 . . . . 99.989999999999995 109.657 -173.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 798' ' ' ILE . . . . . 0.609 ' HA ' ' O ' ' A' ' 752' ' ' THR . 11.7 tt -134.58 160.18 41.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 N-CA-C 108.322 -0.992 . . . . 99.989999999999995 108.322 176.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 799' ' ' LYS . . . . . 0.728 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 7.7 tmtt? -131.77 122.22 25.47 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.206 0.527 . . . . 99.989999999999995 110.595 179.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 800' ' ' ASP . . . . . 0.591 ' HA ' ' CD2' ' A' ' 751' ' ' PHE . 7.3 t70 -68.29 156.84 36.86 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.671 -1.149 . . . . 99.989999999999995 109.844 176.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 17.3 t -60.03 -14.22 15.34 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 124.093 0.87 . . . . 99.989999999999995 112.812 -172.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 802' ' ' THR . . . . . 0.482 HG21 ' OD2' ' A' ' 800' ' ' ASP . 13.9 t -90.33 -0.46 57.65 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.48 0.657 . . . . 99.989999999999995 109.733 176.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 803' ' ' GLY . . . . . . . . . . . . . . . 85.44 39.21 8.44 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.104 -0.953 . . . . 99.989999999999995 111.9 -178.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 804' ' ' CYS . . . . . . . . . . . . . 48.8 t -110.51 115.19 29.19 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.012 -0.366 . . . . 99.989999999999995 110.012 -178.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 805' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 7.6 p -86.34 134.24 27.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.215 0.531 . . . . 99.989999999999995 111.079 -176.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 806' ' ' VAL . . . . . 0.485 HG22 ' HD2' ' A' ' 721' ' ' PRO . 71.4 t -118.56 131.22 71.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.611 -0.722 . . . . 99.989999999999995 110.12 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -69.78 116.47 6.9 Favored Glycine 0 N--CA 1.453 -0.178 0 CA-C-N 115.6 -0.727 . . . . 99.989999999999995 111.907 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 808' ' ' LEU . . . . . 0.625 ' HG ' ' HA ' ' A' ' 797' ' ' SER . 32.2 mt -84.87 131.13 34.55 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.704 0.631 . . . . 99.989999999999995 112.704 -174.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 36.4 m -147.42 86.25 1.61 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.156 -0.929 . . . . 99.989999999999995 109.62 173.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 810' ' ' GLN . . . . . 0.518 ' HB3' ' HD2' ' A' ' 811' ' ' PRO . 89.1 mt-30 -139.18 169.53 12.2 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.43 -0.805 . . . . 99.989999999999995 109.261 177.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 811' ' ' PRO . . . . . 0.518 ' HD2' ' HB3' ' A' ' 810' ' ' GLN . 89.3 Cg_exo -45.68 135.84 12.91 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 122.847 2.364 . . . . 99.989999999999995 114.611 -175.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -107.13 167.36 9.96 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.729 -1.123 . . . . 99.989999999999995 110.343 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 813' ' ' ALA . . . . . 0.47 ' N ' HD12 ' A' ' 725' ' ' LEU . . . -119.67 152.79 36.56 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.159 -0.473 . . . . 99.989999999999995 110.404 -178.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 814' ' ' LYS . . . . . . . . . . . . . 16.9 ttpp -118.23 126.45 52.21 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 121.341 0.591 . . . . 99.989999999999995 110.562 178.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 815' ' ' ILE . . . . . 0.567 ' HA ' ' HB3' ' A' ' 731' ' ' LEU . 5.2 mp -112.71 119.28 60.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 114.946 -1.025 . . . . 99.989999999999995 109.08 178.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 816' ' ' GLN . . . . . 0.563 HE22 ' HG2' ' A' ' 818' ' ' ARG . 0.0 OUTLIER -107.32 115.04 29.46 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.829 -0.434 . . . . 99.989999999999995 109.829 179.68 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 817' ' ' VAL . . . . . 0.427 ' HA ' ' HB2' ' A' ' 733' ' ' LEU . 3.9 t -106.43 145.71 13.86 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 N-CA-C 109.203 -0.666 . . . . 99.989999999999995 109.203 177.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 818' ' ' ARG . . . . . 0.563 ' HG2' HE22 ' A' ' 816' ' ' GLN . 20.9 mmt85 -129.43 174.19 9.86 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 120.524 -0.47 . . . . 99.989999999999995 111.621 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 819' ' ' ARG . . . . . 0.439 ' HA ' ' HB2' ' A' ' 735' ' ' LEU . 45.5 ttt180 -124.75 124.54 42.36 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.292 -0.867 . . . . 99.989999999999995 109.75 174.122 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 820' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 . . . . . 0 C--N 1.32 -0.694 0 CA-C-N 116.328 -0.397 . . . . 99.989999999999995 110.77 -177.437 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 718' ' ' ARG . . . . . . . . . . . . . 22.7 tpt180 . . . . . 0 CA--C 1.506 -0.714 0 CA-C-O 121.533 0.682 . . . . 99.989999999999995 109.683 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 719' ' ' VAL . . . . . 0.648 ' O ' ' HD3' ' A' ' 721' ' ' PRO . 2.3 m -142.77 168.24 13.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 114.506 -1.225 . . . . 99.989999999999995 108.785 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 720' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -94.06 96.06 1.58 Allowed Pre-proline 0 C--N 1.307 -1.241 0 CA-C-N 115.644 -0.707 . . . . 99.989999999999995 109.107 174.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 721' ' ' PRO . . . . . 0.648 ' HD3' ' O ' ' A' ' 719' ' ' VAL . 95.3 Cg_endo -86.03 148.7 9.37 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 122.869 2.379 . . . . 99.989999999999995 112.35 -172.365 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 722' ' ' SER . . . . . 0.464 ' HB3' ' NE2' ' A' ' 810' ' ' GLN . 22.6 t -179.22 -154.05 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.774 -0.648 . . . . 99.989999999999995 109.362 -174.207 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 723' ' ' ALA . . . . . 0.465 ' HA ' ' HA ' ' A' ' 745' ' ' LEU . . . -144.77 144.82 31.37 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.892 -0.41 . . . . 99.989999999999995 109.892 176.148 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 7.8 m -128.97 98.96 5.1 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.801 -0.814 . . . . 99.989999999999995 108.801 -175.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 725' ' ' LEU . . . . . 0.625 HD21 ' CG2' ' A' ' 743' ' ' VAL . 1.7 mt -63.74 145.32 55.98 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-O 121.216 0.531 . . . . 99.989999999999995 110.96 -171.33 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 31.2 mtpt -101.23 -14.56 17.64 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.463 -0.789 . . . . 99.989999999999995 110.358 -177.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 727' ' ' LEU . . . . . 0.455 HD22 ' O ' ' A' ' 729' ' ' HIS . 0.6 OUTLIER -74.17 123.31 24.23 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.598 -0.89 . . . . 99.989999999999995 108.598 177.132 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 61.3 m-70 -87.7 -38.0 16.21 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.68 0.622 . . . . 99.989999999999995 112.68 -171.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 729' ' ' HIS . . . . . 0.455 ' O ' HD22 ' A' ' 727' ' ' LEU . 3.1 p80 -126.61 -176.63 3.74 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.715 -0.394 . . . . 99.989999999999995 111.991 -172.113 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 730' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -61.52 145.5 51.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.711 0.767 . . . . 99.989999999999995 111.427 178.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 731' ' ' LEU . . . . . 0.519 ' HB3' ' HA ' ' A' ' 815' ' ' ILE . 16.2 tp -105.37 108.62 20.23 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.86 -1.064 . . . . 99.989999999999995 110.927 -177.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 732' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -76.93 122.1 24.38 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.032 -0.531 . . . . 99.989999999999995 111.9 -175.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 733' ' ' LEU . . . . . 0.43 HD12 ' CB ' ' A' ' 739' ' ' SER . 85.3 mt -132.71 164.09 27.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.072 -0.513 . . . . 99.989999999999995 110.773 176.22 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 734' ' ' CYS . . . . . 0.541 ' O ' ' HB2' ' A' ' 737' ' ' ASP . 26.8 p -115.93 -174.06 2.47 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.087 -0.708 . . . . 99.989999999999995 109.087 172.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 735' ' ' LEU . . . . . 0.45 HD21 ' HG3' ' A' ' 819' ' ' ARG . 6.1 tp -66.61 135.48 54.17 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.778 0.799 . . . . 99.989999999999995 112.322 -175.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 81.97 4.72 90.19 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 114.357 -1.292 . . . . 99.989999999999995 111.767 178.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 737' ' ' ASP . . . . . 0.541 ' HB2' ' O ' ' A' ' 734' ' ' CYS . 6.8 m-20 -82.15 150.54 27.38 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.329 0.585 . . . . 99.989999999999995 112.422 -179.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 738' ' ' HIS . . . . . 0.484 ' HB2' ' O ' ' A' ' 782' ' ' THR . 42.6 p-80 -113.39 160.32 18.53 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 107.008 -1.478 . . . . 99.989999999999995 107.008 169.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 739' ' ' SER . . . . . 0.466 ' HB2' ' CD2' ' A' ' 731' ' ' LEU . 1.5 p -117.25 170.03 9.01 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 119.556 -0.857 . . . . 99.989999999999995 111.827 -172.05 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 740' ' ' SER . . . . . 0.474 ' HA ' ' O ' ' A' ' 780' ' ' ILE . 50.5 m -143.08 101.52 3.84 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.408 -0.814 . . . . 99.989999999999995 110.146 177.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 741' ' ' VAL . . . . . 0.438 HG13 HD13 ' A' ' 793' ' ' LEU . 1.2 p -108.74 109.46 61.22 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 115.462 -0.79 . . . . 99.989999999999995 109.546 178.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 742' ' ' PRO . . . . . 0.7 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 5.9 Cg_exo -72.41 128.89 14.13 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 122.252 1.968 . . . . 99.989999999999995 111.51 -177.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 743' ' ' VAL . . . . . 0.625 ' CG2' HD21 ' A' ' 725' ' ' LEU . 43.5 t -130.41 119.2 45.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 112.612 0.597 . . . . 99.989999999999995 112.612 -178.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 744' ' ' ALA . . . . . 0.557 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -84.27 117.97 23.89 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.95 -0.759 . . . . 99.989999999999995 108.95 170.296 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 745' ' ' LEU . . . . . 0.557 HD12 ' HB3' ' A' ' 778' ' ' TYR . 0.4 OUTLIER -95.45 150.67 20.04 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.875 -0.602 . . . . 99.989999999999995 111.931 -165.222 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -105.92 146.76 29.57 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.255 -0.884 . . . . 99.989999999999995 110.483 -177.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 747' ' ' GLY . . . . . . . . . . . . . . . 110.27 135.29 6.99 Favored Glycine 0 C--N 1.311 -0.842 0 N-CA-C 110.972 -0.851 . . . . 99.989999999999995 110.972 -173.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -114.16 106.33 14.25 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 117.053 0.426 . . . . 99.989999999999995 111.37 -171.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 129.17 -175.48 18.85 Favored Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 111.35 -0.7 . . . . 99.989999999999995 111.35 -178.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -68.01 93.46 0.39 Allowed 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.506 2.137 . . . . 99.989999999999995 112.119 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 751' ' ' PHE . . . . . 0.491 ' CE2' ' HA ' ' A' ' 800' ' ' ASP . 57.7 m-85 -109.66 140.42 43.53 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.805 -0.634 . . . . 99.989999999999995 111.119 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 752' ' ' THR . . . . . 0.721 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 53.8 m -90.24 102.73 15.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.358 0.599 . . . . 99.989999999999995 109.837 176.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 753' ' ' LEU . . . . . 0.41 HD22 ' N ' ' A' ' 754' ' ' THR . 0.4 OUTLIER -94.06 123.09 37.21 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.184 -0.916 . . . . 99.989999999999995 110.662 -169.695 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 754' ' ' THR . . . . . 0.41 ' N ' HD22 ' A' ' 753' ' ' LEU . 0.8 OUTLIER -119.49 139.88 51.37 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.221 -0.445 . . . . 99.989999999999995 111.281 -177.878 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 755' ' ' TYR . . . . . 0.609 ' CE1' ' HB3' ' A' ' 768' ' ' PHE . 23.8 p90 -146.41 155.82 42.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.938 0.399 . . . . 99.989999999999995 111.528 177.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 756' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -113.54 120.27 40.4 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.559 -0.746 . . . . 99.989999999999995 110.317 -178.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 757' ' ' ILE . . . . . 0.469 HG12 HG22 ' A' ' 782' ' ' THR . 4.2 mp -89.14 95.41 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 N-CA-C 107.754 -1.202 . . . . 99.989999999999995 107.754 169.358 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 758' ' ' ILE . . . . . 0.525 HG13 ' O ' ' A' ' 792' ' ' ILE . 1.6 pp -101.19 148.2 7.41 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 115.775 -0.648 . . . . 99.989999999999995 110.56 -174.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 759' ' ' GLU . . . . . 0.783 ' HB3' ' CE2' ' A' ' 791' ' ' TYR . 7.0 pt-20 -106.17 122.15 45.62 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 119.741 -0.784 . . . . 99.989999999999995 110.075 173.021 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 760' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -84.12 -9.06 58.89 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.683 -1.144 . . . . 99.989999999999995 108.618 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 761' ' ' PHE . . . . . 0.438 ' HB2' ' H ' ' A' ' 790' ' ' ASP . 38.5 t80 -70.54 -35.65 73.24 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 114.618 -1.174 . . . . 99.989999999999995 110.782 177.03 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 762' ' ' SER . . . . . 0.612 ' HB2' ' OE2' ' A' ' 759' ' ' GLU . 20.1 m -151.71 -99.29 0.06 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 120.963 -0.295 . . . . 99.989999999999995 111.666 175.386 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 763' ' ' SER . . . . . . . . . . . . . 64.2 m -164.14 44.83 0.1 Allowed 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 112.702 0.63 . . . . 99.989999999999995 112.702 -170.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 764' ' ' LYS . . . . . 0.642 ' H ' ' CG ' ' A' ' 759' ' ' GLU . 39.0 mttp -113.03 66.02 0.65 Allowed 'General case' 0 C--N 1.327 -0.38 0 O-C-N 121.976 -0.453 . . . . 99.989999999999995 110.306 175.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 765' ' ' ARG . . . . . 0.459 ' HG3' HG21 ' A' ' 758' ' ' ILE . 23.0 ttp180 -72.9 139.71 47.02 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.064 -0.516 . . . . 99.989999999999995 111.045 177.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 766' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -126.54 140.82 52.15 Favored 'General case' 0 C--O 1.215 -0.738 0 CA-C-N 115.891 -0.595 . . . . 99.989999999999995 109.847 -178.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 767' ' ' THR . . . . . . . . . . . . . 43.0 m -112.06 129.78 56.1 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 116.526 -0.307 . . . . 99.989999999999995 110.498 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 768' ' ' PHE . . . . . 0.609 ' HB3' ' CE1' ' A' ' 755' ' ' TYR . 2.5 t80 -126.1 135.83 52.19 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 108.753 -0.832 . . . . 99.989999999999995 108.753 178.334 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 769' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -132.42 127.98 36.53 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 116.171 -0.468 . . . . 99.989999999999995 110.933 -175.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 770' ' ' ILE . . . . . 0.455 HG21 HG22 ' A' ' 773' ' ' ILE . 4.6 mt -121.52 114.14 41.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.099 -0.704 . . . . 99.989999999999995 109.099 177.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 771' ' ' LYS . . . . . 0.547 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 0.1 OUTLIER -87.46 153.88 21.08 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 121.256 0.55 . . . . 99.989999999999995 111.842 -174.643 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 772' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 52.35 47.93 23.69 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.363 -1.29 . . . . 99.989999999999995 112.009 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 773' ' ' ILE . . . . . 0.455 ' O ' HG13 ' A' ' 773' ' ' ILE . 0.5 OUTLIER -75.17 114.79 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 N-CA-C 107.906 -1.146 . . . . 99.989999999999995 107.906 174.771 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 72.1 mttt -114.3 30.95 6.93 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 107.433 -1.321 . . . . 99.989999999999995 107.433 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 775' ' ' THR . . . . . 0.466 ' O ' ' HB2' ' A' ' 776' ' ' ASN . 2.5 m -97.01 -71.82 0.66 Allowed 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 113.488 -1.687 . . . . 99.989999999999995 112.415 -169.128 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 776' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 775' ' ' THR . 11.5 m120 83.17 7.99 0.69 Allowed 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.198 0.999 . . . . 99.989999999999995 110.138 -177.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 777' ' ' GLU . . . . . 0.557 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 22.5 tt0 -161.55 94.39 0.96 Allowed 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.004 -0.998 . . . . 99.989999999999995 109.725 175.445 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 778' ' ' TYR . . . . . 0.557 ' HB3' HD12 ' A' ' 745' ' ' LEU . 67.9 t80 -141.91 120.52 12.53 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.259 -0.882 . . . . 99.989999999999995 110.553 -172.113 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 779' ' ' VAL . . . . . 0.7 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 1.4 m -88.07 129.38 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 CA-C-O 122.035 0.921 . . . . 99.989999999999995 109.733 179.383 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 780' ' ' ILE . . . . . 0.474 ' O ' ' HA ' ' A' ' 740' ' ' SER . 89.7 mt -91.23 138.3 19.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 113.959 -1.473 . . . . 99.989999999999995 110.971 -172.301 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 781' ' ' LYS . . . . . 0.465 ' HD3' ' N ' ' A' ' 781' ' ' LYS . 0.0 OUTLIER -115.86 106.73 14.15 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.397 -0.594 . . . . 99.989999999999995 109.397 179.33 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 782' ' ' THR . . . . . 0.484 ' O ' ' HB2' ' A' ' 738' ' ' HIS . 32.5 p -78.22 143.26 64.72 Favored Pre-proline 0 C--N 1.32 -0.706 0 CA-C-N 116.296 -0.411 . . . . 99.989999999999995 110.102 -178.124 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 783' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 782' ' ' THR . 50.2 Cg_exo -55.79 161.65 7.86 Favored 'Trans proline' 0 CA--C 1.529 0.252 0 C-N-CA 123.513 2.809 . . . . 99.989999999999995 113.109 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 784' ' ' VAL . . . . . 0.52 HG12 HG21 ' A' ' 786' ' ' THR . 55.3 t -59.02 121.71 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-N 115.185 -0.916 . . . . 99.989999999999995 112.312 -177.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 785' ' ' PHE . . . . . 0.417 ' C ' ' H ' ' A' ' 787' ' ' THR . 31.0 m-85 -97.52 98.22 9.74 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.34 -0.845 . . . . 99.989999999999995 109.906 177.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 786' ' ' THR . . . . . 0.52 HG21 HG12 ' A' ' 784' ' ' VAL . 35.3 p -87.28 33.7 0.69 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 122.051 0.929 . . . . 99.989999999999995 110.092 178.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 787' ' ' THR . . . . . 0.417 ' H ' ' C ' ' A' ' 785' ' ' PHE . 28.7 m -153.52 104.98 2.78 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.38 -1.282 . . . . 99.989999999999995 110.223 -179.111 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 788' ' ' GLY . . . . . . . . . . . . . . . -49.59 113.37 1.76 Allowed Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.501 -0.857 . . . . 99.989999999999995 112.277 168.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 789' ' ' GLY . . . . . . . . . . . . . . . -160.49 -166.07 18.56 Favored Glycine 0 N--CA 1.441 -0.97 0 N-CA-C 110.332 -1.107 . . . . 99.989999999999995 110.332 -179.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 790' ' ' ASP . . . . . 0.438 ' H ' ' HB2' ' A' ' 761' ' ' PHE . 19.3 m-20 -123.62 122.74 38.91 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 117.621 0.711 . . . . 99.989999999999995 109.319 -178.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 791' ' ' TYR . . . . . 0.783 ' CE2' ' HB3' ' A' ' 759' ' ' GLU . 88.8 m-85 -117.44 150.86 38.2 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.413 0.625 . . . . 99.989999999999995 111.407 -177.017 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 792' ' ' ILE . . . . . 0.525 ' O ' HG13 ' A' ' 758' ' ' ILE . 17.0 mt -131.53 113.04 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 CA-C-N 114.923 -1.035 . . . . 99.989999999999995 109.338 175.115 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 793' ' ' LEU . . . . . 0.438 HD13 HG13 ' A' ' 741' ' ' VAL . 7.9 tt -85.03 110.26 18.79 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 108.929 -0.767 . . . . 99.989999999999995 108.929 178.156 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 794' ' ' SER . . . . . . . . . . . . . 13.6 t -123.45 142.2 51.23 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.17 -0.468 . . . . 99.989999999999995 109.968 -177.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 795' ' ' LEU . . . . . 0.492 ' H ' HD22 ' A' ' 795' ' ' LEU . 1.2 mm? -67.91 140.22 56.47 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 120.904 0.383 . . . . 99.989999999999995 111.454 -178.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 796' ' ' VAL . . . . . . . . . . . . . 69.7 t -99.82 -55.28 6.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.141 -0.481 . . . . 99.989999999999995 111.015 -178.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 797' ' ' SER . . . . . 0.498 ' C ' HD13 ' A' ' 808' ' ' LEU . 89.5 p -173.66 176.94 2.62 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 115.917 -0.583 . . . . 99.989999999999995 110.345 -173.018 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 798' ' ' ILE . . . . . 0.617 ' HA ' ' O ' ' A' ' 752' ' ' THR . 11.0 tt -151.22 161.43 3.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 N-CA-C 108.635 -0.876 . . . . 99.989999999999995 108.635 179.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 799' ' ' LYS . . . . . 0.721 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 5.2 tttt -132.24 113.89 13.79 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 120.836 0.35 . . . . 99.989999999999995 110.521 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 800' ' ' ASP . . . . . 0.527 ' HB3' ' HB3' ' A' ' 804' ' ' CYS . 16.9 t70 -57.91 152.27 16.47 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.089 -0.959 . . . . 99.989999999999995 109.263 171.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 3.4 p -65.59 -7.51 15.3 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.637 0.606 . . . . 99.989999999999995 112.637 -171.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 35.5 p -93.6 1.7 56.59 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.659 0.743 . . . . 99.989999999999995 110.04 176.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 803' ' ' GLY . . . . . 0.482 ' HA2' ' HE2' ' A' ' 799' ' ' LYS . . . 82.76 44.73 7.09 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 115.05 -0.977 . . . . 99.989999999999995 111.873 -177.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 804' ' ' CYS . . . . . 0.527 ' HB3' ' HB3' ' A' ' 800' ' ' ASP . 45.1 t -111.68 106.93 15.87 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.285 -0.635 . . . . 99.989999999999995 109.285 177.039 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 805' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 3.9 t -86.06 119.32 34.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.38 0.609 . . . . 99.989999999999995 110.08 -176.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 806' ' ' VAL . . . . . 0.528 HG11 ' HD2' ' A' ' 721' ' ' PRO . 37.3 t -108.01 139.17 31.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 115.073 -0.967 . . . . 99.989999999999995 110.498 -176.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -80.06 110.3 3.07 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.662 -0.699 . . . . 99.989999999999995 112.557 -179.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 808' ' ' LEU . . . . . 0.498 HD13 ' C ' ' A' ' 797' ' ' SER . 10.8 mp -77.61 134.19 38.26 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 113.196 0.813 . . . . 99.989999999999995 113.196 177.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 19.9 m -149.5 85.76 1.45 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.166 -0.924 . . . . 99.989999999999995 109.175 169.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 810' ' ' GLN . . . . . 0.464 ' NE2' ' HB3' ' A' ' 722' ' ' SER . 4.6 mt-30 -132.26 170.8 10.41 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 115.895 -0.593 . . . . 99.989999999999995 110.009 177.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 811' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -45.3 144.08 4.78 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 123.038 2.492 . . . . 99.989999999999995 114.588 -176.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -111.15 166.21 11.26 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.984 -1.007 . . . . 99.989999999999995 110.656 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 813' ' ' ALA . . . . . 0.411 ' O ' ' HA ' ' A' ' 792' ' ' ILE . . . -117.87 147.57 42.96 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.698 -0.683 . . . . 99.989999999999995 110.257 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 814' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -108.8 125.44 51.96 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.513 0.673 . . . . 99.989999999999995 110.92 178.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 815' ' ' ILE . . . . . 0.519 ' HA ' ' HB3' ' A' ' 731' ' ' LEU . 5.1 mp -110.81 109.06 27.09 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-N 114.818 -1.083 . . . . 99.989999999999995 108.651 177.169 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 816' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -99.4 109.27 21.88 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.184 0.516 . . . . 99.989999999999995 110.15 -175.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 817' ' ' VAL . . . . . . . . . . . . . 2.6 t -105.71 146.18 12.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.743 -0.662 . . . . 99.989999999999995 109.356 -177.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 818' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -136.67 133.42 36.18 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.245 0.545 . . . . 99.989999999999995 111.887 -179.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 819' ' ' ARG . . . . . 0.45 ' HG3' HD21 ' A' ' 735' ' ' LEU . 31.5 ttt180 -103.52 118.12 36.0 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.38 -0.827 . . . . 99.989999999999995 109.107 174.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 820' ' ' ASP . . . . . . . . . . . . . 36.4 t70 . . . . . 0 C--N 1.328 -0.353 0 O-C-N 123.599 0.562 . . . . 99.989999999999995 110.844 -177.447 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 718' ' ' ARG . . . . . . . . . . . . . 7.5 tpp180 . . . . . 0 CA--C 1.508 -0.657 0 CA-C-O 121.686 0.755 . . . . 99.989999999999995 110.241 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 719' ' ' VAL . . . . . . . . . . . . . 3.3 m -134.55 -170.79 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 CA-C-N 114.298 -1.319 . . . . 99.989999999999995 109.175 -178.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 720' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -117.85 85.19 22.12 Favored Pre-proline 0 C--N 1.307 -1.274 0 CA-C-N 115.492 -0.776 . . . . 99.989999999999995 109.22 175.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 721' ' ' PRO . . . . . 0.412 ' O ' HG23 ' A' ' 798' ' ' ILE . 37.6 Cg_endo -83.1 145.36 12.27 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 C-N-CA 122.424 2.083 . . . . 99.989999999999995 111.436 -175.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 722' ' ' SER . . . . . 0.489 ' HG ' HD21 ' A' ' 808' ' ' LEU . 25.6 t 177.42 -153.08 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 110.034 -0.358 . . . . 99.989999999999995 110.034 -171.362 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 723' ' ' ALA . . . . . 0.554 ' HA ' ' HA ' ' A' ' 745' ' ' LEU . . . -150.21 143.48 25.02 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.577 -0.283 . . . . 99.989999999999995 110.482 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 23.1 t -129.95 103.84 7.02 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.46 -0.57 . . . . 99.989999999999995 109.46 178.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 725' ' ' LEU . . . . . 0.455 ' CD2' ' HB ' ' A' ' 743' ' ' VAL . 13.2 mt -64.35 149.26 48.61 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 121.616 0.722 . . . . 99.989999999999995 111.839 -175.264 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 726' ' ' LYS . . . . . 0.444 ' HD2' ' HB1' ' A' ' 744' ' ' ALA . 20.2 mtpp -106.8 -10.09 16.18 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.714 -1.13 . . . . 99.989999999999995 110.46 -175.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 727' ' ' LEU . . . . . 0.451 ' HB2' ' HD2' ' A' ' 742' ' ' PRO . 0.3 OUTLIER -81.31 111.22 17.49 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.189 -1.041 . . . . 99.989999999999995 108.189 176.364 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 40.9 m80 -103.68 37.37 2.05 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.774 0.657 . . . . 99.989999999999995 112.774 -168.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 9.7 p80 -174.08 -177.05 1.25 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.662 0.268 . . . . 99.989999999999995 110.776 177.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 730' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -81.04 139.65 35.6 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.068 -0.514 . . . . 99.989999999999995 110.297 177.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 731' ' ' LEU . . . . . 0.554 ' HB2' ' HA ' ' A' ' 815' ' ' ILE . 36.4 mt -87.61 117.06 26.16 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.524 -0.762 . . . . 99.989999999999995 111.263 -178.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 732' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -84.09 113.01 20.73 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.276 -0.42 . . . . 99.989999999999995 110.333 -178.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 733' ' ' LEU . . . . . . . . . . . . . 43.5 mt -131.67 159.6 37.86 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 121.267 0.556 . . . . 99.989999999999995 111.9 -175.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 734' ' ' CYS . . . . . 0.616 ' HA ' ' O ' ' A' ' 818' ' ' ARG . 78.4 m -104.12 -173.75 2.38 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.148 -0.933 . . . . 99.989999999999995 110.131 176.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 735' ' ' LEU . . . . . 0.546 ' HB2' ' HA ' ' A' ' 819' ' ' ARG . 19.9 tp -73.79 134.71 43.44 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.174 0.511 . . . . 99.989999999999995 111.342 -178.439 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 74.72 11.56 83.16 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.439 -0.886 . . . . 99.989999999999995 111.285 -176.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 737' ' ' ASP . . . . . 0.588 ' HB2' ' O ' ' A' ' 734' ' ' CYS . 0.2 OUTLIER -84.77 150.11 25.29 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.119 0.485 . . . . 99.989999999999995 111.231 176.55 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 27.9 p-80 -114.25 175.27 5.55 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 107.417 -1.327 . . . . 99.989999999999995 107.417 168.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 739' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.0 166.66 24.04 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 120.083 -0.647 . . . . 99.989999999999995 111.999 -178.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 19.7 m -136.75 112.97 9.82 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.322 -0.854 . . . . 99.989999999999995 109.6 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 741' ' ' VAL . . . . . 0.483 HG13 HD23 ' A' ' 793' ' ' LEU . 0.9 OUTLIER -111.05 112.95 55.1 Favored Pre-proline 0 C--N 1.318 -0.799 0 CA-C-N 115.578 -0.737 . . . . 99.989999999999995 109.746 -179.621 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 742' ' ' PRO . . . . . 0.646 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 1.6 Cg_endo -73.43 134.97 21.52 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 122.517 2.145 . . . . 99.989999999999995 111.284 -179.306 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 743' ' ' VAL . . . . . 0.553 HG23 ' HB1' ' A' ' 723' ' ' ALA . 2.0 p -131.91 116.44 30.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.376 0.608 . . . . 99.989999999999995 112.032 176.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 744' ' ' ALA . . . . . 0.552 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -81.22 98.99 8.34 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 108.358 -0.979 . . . . 99.989999999999995 108.358 169.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 745' ' ' LEU . . . . . 0.554 ' HA ' ' HA ' ' A' ' 723' ' ' ALA . 0.3 OUTLIER -79.36 165.33 23.24 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.309 -1.314 . . . . 99.989999999999995 111.675 -167.385 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 17.3 ttmm -114.44 165.33 12.84 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.533 -0.758 . . . . 99.989999999999995 109.679 -179.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 747' ' ' GLY . . . . . . . . . . . . . . . 94.45 128.45 5.25 Favored Glycine 0 C--N 1.31 -0.863 0 N-CA-C 111.235 -0.746 . . . . 99.989999999999995 111.235 -175.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 748' ' ' GLN . . . . . 0.523 ' C ' ' HE1' ' A' ' 751' ' ' PHE . 48.3 mm-40 -110.85 98.62 7.71 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.749 -0.38 . . . . 99.989999999999995 111.061 -173.285 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 133.91 -159.23 23.66 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.716 -0.754 . . . . 99.989999999999995 111.549 -177.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -78.88 94.99 1.06 Allowed 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 122.944 2.43 . . . . 99.989999999999995 112.516 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 751' ' ' PHE . . . . . 0.689 ' CE2' ' HA ' ' A' ' 800' ' ' ASP . 94.6 m-85 -118.41 140.66 49.51 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.771 -0.65 . . . . 99.989999999999995 110.799 -178.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 752' ' ' THR . . . . . 0.665 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 92.3 m -95.31 106.7 18.77 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.623 0.725 . . . . 99.989999999999995 109.536 179.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 753' ' ' LEU . . . . . 0.411 HD22 ' N ' ' A' ' 754' ' ' THR . 0.4 OUTLIER -97.19 117.78 32.17 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.538 -1.21 . . . . 99.989999999999995 109.783 -170.354 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 754' ' ' THR . . . . . 0.531 HG23 ' HB2' ' A' ' 769' ' ' GLU . 1.2 m -116.71 137.04 52.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.567 -0.288 . . . . 99.989999999999995 110.897 -177.074 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 755' ' ' TYR . . . . . 0.671 ' CE1' ' HB2' ' A' ' 768' ' ' PHE . 24.3 p90 -144.64 155.38 43.58 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.465 0.543 . . . . 99.989999999999995 112.465 -179.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 756' ' ' ASP . . . . . 0.543 ' OD2' HG23 ' A' ' 758' ' ' ILE . 4.9 p-10 -116.94 119.94 36.88 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.658 -0.701 . . . . 99.989999999999995 111.551 -177.295 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 757' ' ' ILE . . . . . 0.58 ' CD1' HD13 ' A' ' 793' ' ' LEU . 4.0 mp -91.87 96.49 6.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 N-CA-C 107.563 -1.273 . . . . 99.989999999999995 107.563 167.376 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 758' ' ' ILE . . . . . 0.591 HG13 ' O ' ' A' ' 792' ' ' ILE . 2.4 pp -100.57 149.56 6.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.683 -0.689 . . . . 99.989999999999995 112.25 -170.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 759' ' ' GLU . . . . . 0.621 ' OE2' ' HB2' ' A' ' 762' ' ' SER . 12.5 mt-10 -86.38 118.59 25.92 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 120.921 0.391 . . . . 99.989999999999995 111.13 -179.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 760' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -97.42 -6.32 34.22 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.56 0.695 . . . . 99.989999999999995 109.533 174.11 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 761' ' ' PHE . . . . . 0.529 ' CB ' ' H ' ' A' ' 790' ' ' ASP . 85.3 t80 -96.44 -34.17 11.61 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.349 -0.841 . . . . 99.989999999999995 110.928 178.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 762' ' ' SER . . . . . 0.621 ' HB2' ' OE2' ' A' ' 759' ' ' GLU . 16.5 m -118.25 -99.12 0.45 Allowed 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 120.251 -0.58 . . . . 99.989999999999995 111.49 -177.251 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 763' ' ' SER . . . . . . . . . . . . . 70.8 p -166.88 -4.84 0.02 OUTLIER 'General case' 0 C--O 1.232 0.164 0 N-CA-C 112.59 0.589 . . . . 99.989999999999995 112.59 -176.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 764' ' ' LYS . . . . . 0.496 ' C ' ' HG3' ' A' ' 759' ' ' GLU . 62.0 mttp -89.5 -173.55 4.01 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.54 0.686 . . . . 99.989999999999995 111.569 -175.351 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 765' ' ' ARG . . . . . 0.58 ' HD2' ' CG2' ' A' ' 758' ' ' ILE . 12.0 ttt180 -168.88 140.8 2.61 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-N 114.741 -1.118 . . . . 99.989999999999995 109.875 -175.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 766' ' ' LYS . . . . . 0.609 ' HD3' ' N ' ' A' ' 767' ' ' THR . 2.0 tmtp? -120.48 146.32 46.38 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.723 -0.843 . . . . 99.989999999999995 108.723 178.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 767' ' ' THR . . . . . 0.609 ' N ' ' HD3' ' A' ' 766' ' ' LYS . 96.6 m -131.74 132.36 43.78 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 120.962 0.411 . . . . 99.989999999999995 111.751 -176.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 768' ' ' PHE . . . . . 0.671 ' HB2' ' CE1' ' A' ' 755' ' ' TYR . 42.9 m-85 -120.07 141.21 49.98 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.023 -0.535 . . . . 99.989999999999995 110.214 174.105 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 769' ' ' GLU . . . . . 0.531 ' HB2' HG23 ' A' ' 754' ' ' THR . 46.0 tt0 -131.27 109.37 10.34 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.931 -0.577 . . . . 99.989999999999995 110.383 178.073 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 21.2 mt -105.97 120.37 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 N-CA-C 109.395 -0.595 . . . . 99.989999999999995 109.395 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 771' ' ' LYS . . . . . 0.572 ' HD2' ' N ' ' A' ' 771' ' ' LYS . 0.1 OUTLIER -85.55 164.62 17.67 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.067 0.46 . . . . 99.989999999999995 111.144 -175.192 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 772' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 36.36 50.44 0.75 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 113.853 -1.521 . . . . 99.989999999999995 112.64 177.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 773' ' ' ILE . . . . . 0.435 ' O ' HG13 ' A' ' 773' ' ' ILE . 0.5 OUTLIER -76.71 111.98 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 N-CA-C 107.977 -1.12 . . . . 99.989999999999995 107.977 175.67 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 75.7 mttt -113.04 33.62 4.95 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 107.521 -1.289 . . . . 99.989999999999995 107.521 -179.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 775' ' ' THR . . . . . 0.433 ' H ' HD12 ' A' ' 773' ' ' ILE . 1.2 m -95.12 -71.64 0.66 Allowed 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 113.836 -1.529 . . . . 99.989999999999995 111.769 -169.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 776' ' ' ASN . . . . . 0.432 ' HB2' ' O ' ' A' ' 775' ' ' THR . 11.5 m120 81.92 4.11 1.28 Allowed 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.129 0.971 . . . . 99.989999999999995 110.79 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 777' ' ' GLU . . . . . 0.552 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 18.4 mt-10 -160.2 84.66 0.72 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.106 -0.952 . . . . 99.989999999999995 109.197 176.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 778' ' ' TYR . . . . . 0.494 ' HB3' HD11 ' A' ' 745' ' ' LEU . 79.4 t80 -128.89 129.08 45.05 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.843 0.354 . . . . 99.989999999999995 110.863 -172.439 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 779' ' ' VAL . . . . . 0.646 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 21.1 t -87.95 112.81 24.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 121.281 0.562 . . . . 99.989999999999995 110.515 178.015 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 780' ' ' ILE . . . . . . . . . . . . . 74.0 mt -80.2 141.48 15.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.271 -0.877 . . . . 99.989999999999995 110.603 -178.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -114.93 107.85 15.94 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.562 -0.533 . . . . 99.989999999999995 109.562 177.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 782' ' ' THR . . . . . . . . . . . . . 68.7 p -78.15 135.33 62.37 Favored Pre-proline 0 N--CA 1.441 -0.895 0 N-CA-C 109.344 -0.613 . . . . 99.989999999999995 109.344 178.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 783' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -57.05 158.32 18.0 Favored 'Trans proline' 0 CA--C 1.518 -0.278 0 C-N-CA 123.523 2.815 . . . . 99.989999999999995 112.401 -173.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 784' ' ' VAL . . . . . . . . . . . . . 12.8 p -60.47 136.43 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 115.854 -0.612 . . . . 99.989999999999995 110.697 -177.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 785' ' ' PHE . . . . . 0.429 ' C ' ' H ' ' A' ' 787' ' ' THR . 45.1 m-85 -110.08 97.15 6.7 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.816 -0.629 . . . . 99.989999999999995 109.617 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 82.1 p -83.77 25.16 0.81 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.725 0.774 . . . . 99.989999999999995 110.822 -176.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 787' ' ' THR . . . . . 0.429 ' H ' ' C ' ' A' ' 785' ' ' PHE . 36.7 m -156.47 120.97 4.51 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.007 -0.997 . . . . 99.989999999999995 110.446 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 788' ' ' GLY . . . . . 0.402 ' HA2' HG12 ' A' ' 817' ' ' VAL . . . -51.74 110.64 1.14 Allowed Glycine 0 N--CA 1.448 -0.554 0 O-C-N 123.669 0.605 . . . . 99.989999999999995 113.335 174.232 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 789' ' ' GLY . . . . . . . . . . . . . . . -157.28 166.37 33.63 Favored Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 110.571 -1.012 . . . . 99.989999999999995 110.571 177.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 790' ' ' ASP . . . . . 0.529 ' H ' ' CB ' ' A' ' 761' ' ' PHE . 2.7 m-20 -107.97 132.29 53.67 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 117.305 0.552 . . . . 99.989999999999995 109.763 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 791' ' ' TYR . . . . . 0.49 ' CE2' ' HG2' ' A' ' 759' ' ' GLU . 89.4 m-85 -124.61 158.52 32.88 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.617 -0.72 . . . . 99.989999999999995 109.951 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 792' ' ' ILE . . . . . 0.591 ' O ' HG13 ' A' ' 758' ' ' ILE . 6.2 mt -134.21 117.71 25.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 108.853 -0.795 . . . . 99.989999999999995 108.853 171.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 793' ' ' LEU . . . . . 0.58 HD13 ' CD1' ' A' ' 757' ' ' ILE . 1.0 OUTLIER -84.91 112.21 20.36 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 109.34 -0.615 . . . . 99.989999999999995 109.34 179.408 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 794' ' ' SER . . . . . 0.537 ' N ' HD11 ' A' ' 793' ' ' LEU . 13.6 m -118.39 177.3 4.87 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 114.81 -1.086 . . . . 99.989999999999995 108.744 -177.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 795' ' ' LEU . . . . . . . . . . . . . 42.9 mt -103.79 132.3 50.17 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.784 0.326 . . . . 99.989999999999995 110.644 -179.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 796' ' ' VAL . . . . . . . . . . . . . 64.1 t -89.27 -56.72 4.88 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 CA-C-N 116.332 -0.394 . . . . 99.989999999999995 110.661 -177.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 797' ' ' SER . . . . . 0.45 ' HA ' ' HG ' ' A' ' 808' ' ' LEU . 26.6 m -173.36 172.83 3.66 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.59 -0.732 . . . . 99.989999999999995 109.855 -173.283 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 798' ' ' ILE . . . . . 0.653 ' O ' ' HA ' ' A' ' 805' ' ' VAL . 0.5 OUTLIER -146.34 166.76 7.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 108.455 -0.943 . . . . 99.989999999999995 108.455 -173.529 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 799' ' ' LYS . . . . . 0.665 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 34.5 tttt -135.29 117.4 15.42 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 120.33 -0.548 . . . . 99.989999999999995 111.281 -179.15 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 800' ' ' ASP . . . . . 0.689 ' HA ' ' CE2' ' A' ' 751' ' ' PHE . 8.0 t70 -68.65 153.02 44.56 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.963 -1.017 . . . . 99.989999999999995 109.192 173.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 24.2 p -62.44 -8.12 5.62 Favored 'General case' 0 C--N 1.33 -0.255 0 O-C-N 123.867 0.73 . . . . 99.989999999999995 112.375 -173.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 35.4 p -94.8 9.79 37.69 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.536 0.684 . . . . 99.989999999999995 109.673 176.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 803' ' ' GLY . . . . . 0.509 ' HA2' ' HE2' ' A' ' 799' ' ' LYS . . . 72.45 40.83 53.66 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 114.871 -1.059 . . . . 99.989999999999995 112.389 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 804' ' ' CYS . . . . . . . . . . . . . 59.6 m -114.09 116.32 28.95 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 110.198 -0.297 . . . . 99.989999999999995 110.198 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 805' ' ' VAL . . . . . 0.653 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 6.1 p -84.92 113.43 23.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.895 0.855 . . . . 99.989999999999995 110.821 -177.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 806' ' ' VAL . . . . . 0.62 ' HB ' HG22 ' A' ' 798' ' ' ILE . 41.0 t -96.05 138.42 21.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 114.933 -1.03 . . . . 99.989999999999995 110.604 -178.043 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -70.53 122.03 10.34 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.376 -0.829 . . . . 99.989999999999995 111.733 179.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 808' ' ' LEU . . . . . 0.539 HD22 ' HB ' ' A' ' 798' ' ' ILE . 24.1 mt -89.63 132.88 34.91 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 112.916 0.71 . . . . 99.989999999999995 112.916 -175.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 14.9 t -149.71 87.04 1.47 Allowed 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.452 -0.794 . . . . 99.989999999999995 109.62 172.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 810' ' ' GLN . . . . . 0.427 ' HB3' ' HD2' ' A' ' 811' ' ' PRO . 13.1 mt-30 -136.17 170.44 10.96 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.591 -0.732 . . . . 99.989999999999995 109.779 173.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 811' ' ' PRO . . . . . 0.427 ' HD2' ' HB3' ' A' ' 810' ' ' GLN . 89.2 Cg_exo -44.93 139.11 8.24 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 122.973 2.449 . . . . 99.989999999999995 114.192 -177.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -110.4 166.07 11.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.245 -0.889 . . . . 99.989999999999995 110.599 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 813' ' ' ALA . . . . . . . . . . . . . . . -114.57 154.62 27.98 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.215 -0.448 . . . . 99.989999999999995 110.257 -177.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 814' ' ' LYS . . . . . . . . . . . . . 50.6 tttp -115.0 130.05 56.85 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-O 121.129 0.49 . . . . 99.989999999999995 110.143 176.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 815' ' ' ILE . . . . . 0.554 ' HA ' ' HB2' ' A' ' 731' ' ' LEU . 4.8 mp -113.42 118.24 57.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 108.989 -0.745 . . . . 99.989999999999995 108.989 178.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 816' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -109.05 114.25 27.83 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.846 0.355 . . . . 99.989999999999995 110.81 -179.088 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 817' ' ' VAL . . . . . 0.402 HG12 ' HA2' ' A' ' 788' ' ' GLY . 92.5 t -110.07 124.55 66.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 109.793 -0.447 . . . . 99.989999999999995 109.793 176.258 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 818' ' ' ARG . . . . . 0.616 ' O ' ' HA ' ' A' ' 734' ' ' CYS . 15.0 mmt180 -142.17 144.96 33.67 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.608 -0.515 . . . . 99.989999999999995 109.608 176.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 819' ' ' ARG . . . . . 0.546 ' HA ' ' HB2' ' A' ' 735' ' ' LEU . 27.0 mtm180 -67.26 132.95 48.76 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.093 -0.503 . . . . 99.989999999999995 110.998 -174.345 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 820' ' ' ASP . . . . . . . . . . . . . 32.3 t70 . . . . . 0 C--N 1.323 -0.568 0 CA-C-N 115.795 -0.638 . . . . 99.989999999999995 110.497 -176.802 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 718' ' ' ARG . . . . . . . . . . . . . 18.4 tpt180 . . . . . 0 CA--C 1.511 -0.545 0 CA-C-O 121.358 0.599 . . . . 99.989999999999995 110.438 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 719' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -150.35 -168.95 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 114.649 -1.16 . . . . 99.989999999999995 108.375 178.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 720' ' ' LYS . . . . . 0.431 ' HA ' ' HD3' ' A' ' 721' ' ' PRO . 12.9 mmmm -80.06 119.45 76.63 Favored Pre-proline 0 C--N 1.305 -1.365 0 CA-C-N 116.138 -0.483 . . . . 99.989999999999995 109.856 176.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 721' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 720' ' ' LYS . 5.9 Cg_endo -78.12 138.47 16.23 Favored 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 122.471 2.114 . . . . 99.989999999999995 110.174 -179.071 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 722' ' ' SER . . . . . 0.864 ' HB2' ' OE1' ' A' ' 810' ' ' GLN . 7.3 p -175.21 -153.05 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.549 -0.296 . . . . 99.989999999999995 110.347 -166.393 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 723' ' ' ALA . . . . . 0.541 ' HA ' ' HA ' ' A' ' 745' ' ' LEU . . . -157.73 151.27 23.75 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-N 118.518 0.599 . . . . 99.989999999999995 110.659 177.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 41.6 m -140.03 99.1 3.6 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 121.624 -0.672 . . . . 99.989999999999995 110.027 179.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 725' ' ' LEU . . . . . 0.672 HD11 ' CG1' ' A' ' 743' ' ' VAL . 5.2 mp -57.3 143.3 40.23 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-O 122.516 1.15 . . . . 99.989999999999995 112.661 -175.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 36.5 mtpt -96.82 -13.98 22.21 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 112.851 -1.977 . . . . 99.989999999999995 110.279 -177.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 727' ' ' LEU . . . . . 0.448 ' C ' HD13 ' A' ' 727' ' ' LEU . 3.1 tm? -50.4 128.91 20.93 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.387 -1.278 . . . . 99.989999999999995 109.966 176.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 35.4 m170 -89.9 -52.48 4.95 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.469 0.544 . . . . 99.989999999999995 112.469 -171.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -145.65 -177.0 5.35 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.535 -0.466 . . . . 99.989999999999995 111.513 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 730' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -48.06 133.12 15.26 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 124.019 0.824 . . . . 99.989999999999995 111.523 178.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 731' ' ' LEU . . . . . 0.556 ' CD2' ' HB2' ' A' ' 739' ' ' SER . 27.2 tp -99.53 111.49 23.83 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.264 -0.88 . . . . 99.989999999999995 111.526 -175.088 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 732' ' ' LYS . . . . . . . . . . . . . 40.5 mmtm -72.76 121.32 19.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.211 -0.449 . . . . 99.989999999999995 111.552 -179.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 733' ' ' LEU . . . . . 0.449 HD12 ' CG2' ' A' ' 815' ' ' ILE . 94.4 mt -138.26 160.54 39.2 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.265 -0.425 . . . . 99.989999999999995 110.445 178.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 734' ' ' CYS . . . . . 0.402 ' O ' ' HB2' ' A' ' 737' ' ' ASP . 63.8 m -109.96 -174.06 2.4 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.348 -0.387 . . . . 99.989999999999995 110.001 179.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 735' ' ' LEU . . . . . 0.403 ' HA ' HD11 ' A' ' 735' ' ' LEU . 38.4 tp -65.24 125.85 26.3 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.902 0.382 . . . . 99.989999999999995 111.36 -172.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 736' ' ' GLY . . . . . 0.482 ' O ' HG11 ' A' ' 784' ' ' VAL . . . 81.4 7.91 87.74 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.455 -0.879 . . . . 99.989999999999995 112.622 177.383 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 737' ' ' ASP . . . . . 0.402 ' HB2' ' O ' ' A' ' 734' ' ' CYS . 2.2 m-20 -78.58 150.37 32.79 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.024 0.44 . . . . 99.989999999999995 111.452 176.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 738' ' ' HIS . . . . . 0.612 ' HB2' ' O ' ' A' ' 782' ' ' THR . 39.8 p-80 -116.83 166.11 12.53 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 107.561 -1.274 . . . . 99.989999999999995 107.561 172.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 739' ' ' SER . . . . . 0.556 ' HB2' ' CD2' ' A' ' 731' ' ' LEU . 13.5 p -124.98 163.37 22.47 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 118.956 -1.098 . . . . 99.989999999999995 112.27 -172.357 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 740' ' ' SER . . . . . 0.488 ' HA ' ' O ' ' A' ' 780' ' ' ILE . 46.0 m -130.44 99.94 5.18 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 114.93 -1.032 . . . . 99.989999999999995 109.089 174.167 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 741' ' ' VAL . . . . . 0.492 ' HA ' ' HD3' ' A' ' 742' ' ' PRO . 0.1 OUTLIER -100.42 112.73 64.87 Favored Pre-proline 0 C--N 1.318 -0.79 0 CA-C-N 115.485 -0.779 . . . . 99.989999999999995 109.338 179.449 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 742' ' ' PRO . . . . . 0.673 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 6.3 Cg_exo -75.54 129.8 12.19 Favored 'Trans proline' 0 N--CA 1.445 -1.356 0 C-N-CA 122.215 1.944 . . . . 99.989999999999995 110.96 -176.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 743' ' ' VAL . . . . . 0.672 ' CG1' HD11 ' A' ' 725' ' ' LEU . 20.1 t -127.95 121.34 56.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.128 0.489 . . . . 99.989999999999995 112.247 178.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 744' ' ' ALA . . . . . 0.646 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -83.33 99.38 9.98 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 122.326 1.06 . . . . 99.989999999999995 108.275 169.319 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 745' ' ' LEU . . . . . 0.702 HD22 ' CD2' ' A' ' 753' ' ' LEU . 3.5 mt -77.39 164.9 25.07 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 113.52 -1.673 . . . . 99.989999999999995 110.742 -169.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 746' ' ' LYS . . . . . 0.433 ' HB3' ' OG ' ' A' ' 722' ' ' SER . 14.4 tppt? -123.46 161.31 25.08 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.079 0.466 . . . . 99.989999999999995 110.457 -176.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 747' ' ' GLY . . . . . 0.405 ' CA ' ' HA ' ' A' ' 721' ' ' PRO . . . 91.3 121.69 2.6 Favored Glycine 0 C--N 1.312 -0.783 0 N-CA-C 111.285 -0.726 . . . . 99.989999999999995 111.285 -175.181 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -95.34 117.97 31.26 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.28 0.562 . . . . 99.989999999999995 111.98 -172.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 116.65 -175.91 16.01 Favored Glycine 0 CA--C 1.499 -0.934 0 CA-C-N 115.31 -0.859 . . . . 99.989999999999995 111.506 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 750' ' ' PRO . . . . . 0.437 ' HB3' ' HE2' ' A' ' 774' ' ' LYS . 86.8 Cg_endo -69.07 94.88 0.48 Allowed 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 123.359 2.706 . . . . 99.989999999999995 113.187 -177.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 751' ' ' PHE . . . . . 0.577 ' CD2' ' HA ' ' A' ' 800' ' ' ASP . 64.0 m-85 -112.13 144.87 40.78 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.73 -0.668 . . . . 99.989999999999995 111.067 179.332 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 752' ' ' THR . . . . . 0.728 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 89.0 m -91.85 102.76 15.35 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.277 0.56 . . . . 99.989999999999995 109.921 179.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 753' ' ' LEU . . . . . 0.702 ' CD2' HD22 ' A' ' 745' ' ' LEU . 46.9 tp -97.0 121.52 38.97 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.096 -0.956 . . . . 99.989999999999995 111.298 -171.167 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 754' ' ' THR . . . . . 0.461 ' HB ' ' HB ' ' A' ' 796' ' ' VAL . 1.0 OUTLIER -109.66 135.98 49.75 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.099 -0.501 . . . . 99.989999999999995 111.131 -177.592 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 755' ' ' TYR . . . . . 0.603 ' CE1' ' HB3' ' A' ' 768' ' ' PHE . 29.6 p90 -143.1 152.43 41.84 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 120.977 0.418 . . . . 99.989999999999995 111.843 178.095 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 756' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -117.7 118.47 32.16 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.643 -0.708 . . . . 99.989999999999995 110.694 -179.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 757' ' ' ILE . . . . . 0.644 ' CD1' HD13 ' A' ' 793' ' ' LEU . 3.5 mp -87.7 96.56 5.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 N-CA-C 107.86 -1.163 . . . . 99.989999999999995 107.86 168.206 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 758' ' ' ILE . . . . . 0.556 HG13 ' O ' ' A' ' 792' ' ' ILE . 2.3 pp -94.53 149.89 4.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 121.322 0.582 . . . . 99.989999999999995 111.962 -171.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 759' ' ' GLU . . . . . 0.507 ' HG3' ' C ' ' A' ' 764' ' ' LYS . 16.1 mt-10 -90.86 115.13 27.67 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 115.211 -0.904 . . . . 99.989999999999995 109.832 175.041 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 760' ' ' THR . . . . . . . . . . . . . 2.5 t -95.04 -0.17 53.92 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 108.114 -1.069 . . . . 99.989999999999995 108.114 172.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 761' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -94.08 -34.48 12.97 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 114.329 -1.305 . . . . 99.989999999999995 110.45 176.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 762' ' ' SER . . . . . 0.476 ' HB2' ' OE2' ' A' ' 759' ' ' GLU . 65.6 m -141.11 -93.55 0.14 Allowed 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 120.959 -0.297 . . . . 99.989999999999995 111.74 177.327 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 763' ' ' SER . . . . . . . . . . . . . 34.4 p -170.56 -0.91 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 113.379 0.881 . . . . 99.989999999999995 113.379 -174.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 764' ' ' LYS . . . . . 0.507 ' C ' ' HG3' ' A' ' 759' ' ' GLU . 9.7 mtpm? -82.9 55.66 3.15 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.164 0.507 . . . . 99.989999999999995 112.072 -174.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 765' ' ' ARG . . . . . 0.481 ' CG ' HG21 ' A' ' 758' ' ' ILE . 6.1 ttp180 -55.19 141.37 35.38 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.338 -0.846 . . . . 99.989999999999995 110.903 172.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 766' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -123.7 134.38 53.72 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 120.922 0.391 . . . . 99.989999999999995 110.449 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 767' ' ' THR . . . . . . . . . . . . . 47.3 m -107.58 131.39 54.41 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.853 -0.612 . . . . 99.989999999999995 110.46 -177.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 768' ' ' PHE . . . . . 0.603 ' HB3' ' CE1' ' A' ' 755' ' ' TYR . 0.2 OUTLIER -137.16 135.84 37.7 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 109.204 -0.665 . . . . 99.989999999999995 109.204 179.203 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 769' ' ' GLU . . . . . 0.425 ' N ' ' HD1' ' A' ' 768' ' ' PHE . 39.3 tt0 -129.54 124.01 32.82 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.118 0.485 . . . . 99.989999999999995 111.692 -175.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 4.6 mm -102.38 110.66 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 CA-C-N 115.562 -0.745 . . . . 99.989999999999995 109.759 -179.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 771' ' ' LYS . . . . . 0.606 ' HD2' ' N ' ' A' ' 771' ' ' LYS . 0.0 OUTLIER -80.41 157.4 26.27 Favored 'General case' 0 C--N 1.312 -1.028 0 C-N-CA 120.104 -0.639 . . . . 99.989999999999995 109.983 179.293 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 772' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 41.77 50.33 3.98 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 113.871 -1.513 . . . . 99.989999999999995 113.515 178.387 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 773' ' ' ILE . . . . . 0.551 ' CD1' HD13 ' A' ' 745' ' ' LEU . 0.5 OUTLIER -75.35 111.37 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 107.145 -1.428 . . . . 99.989999999999995 107.145 171.135 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 774' ' ' LYS . . . . . 0.437 ' HE2' ' HB3' ' A' ' 750' ' ' PRO . 58.7 mttt -107.26 24.35 12.99 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.651 -0.87 . . . . 99.989999999999995 108.651 -178.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 775' ' ' THR . . . . . 0.641 ' O ' ' HB2' ' A' ' 776' ' ' ASN . 0.2 OUTLIER -95.38 -74.27 0.56 Allowed 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.392 0.886 . . . . 99.989999999999995 113.392 -165.763 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 776' ' ' ASN . . . . . 0.641 ' HB2' ' O ' ' A' ' 775' ' ' THR . 0.9 OUTLIER 91.07 4.13 0.1 Allowed 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.5 1.12 . . . . 99.989999999999995 110.596 -177.605 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 777' ' ' GLU . . . . . 0.646 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 13.9 tt0 -162.94 101.59 0.99 Allowed 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.347 -0.842 . . . . 99.989999999999995 109.133 174.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 778' ' ' TYR . . . . . 0.528 ' HB3' HD12 ' A' ' 745' ' ' LEU . 90.7 t80 -153.69 129.7 10.29 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.699 -0.682 . . . . 99.989999999999995 110.633 -171.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 779' ' ' VAL . . . . . 0.673 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 1.9 m -91.68 129.54 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 CA-C-O 122.15 0.976 . . . . 99.989999999999995 110.823 178.061 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 780' ' ' ILE . . . . . 0.488 ' O ' ' HA ' ' A' ' 740' ' ' SER . 88.2 mt -90.13 139.79 16.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 113.59 -1.641 . . . . 99.989999999999995 110.811 -174.028 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 781' ' ' LYS . . . . . 0.539 ' HB2' ' HZ2' ' A' ' 781' ' ' LYS . 0.1 OUTLIER -111.81 107.62 16.74 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.928 0.394 . . . . 99.989999999999995 110.323 179.623 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 782' ' ' THR . . . . . 0.612 ' O ' ' HB2' ' A' ' 738' ' ' HIS . 25.2 p -77.8 142.91 66.03 Favored Pre-proline 0 C--N 1.318 -0.761 0 CA-C-N 115.911 -0.586 . . . . 99.989999999999995 109.827 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 783' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -56.32 160.72 10.44 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 123.53 2.82 . . . . 99.989999999999995 113.2 -178.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 784' ' ' VAL . . . . . 0.511 HG12 HG21 ' A' ' 786' ' ' THR . 40.5 t -58.55 122.62 8.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.145 -0.934 . . . . 99.989999999999995 111.952 178.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 785' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -100.67 97.27 7.96 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.814 -0.63 . . . . 99.989999999999995 110.187 178.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 786' ' ' THR . . . . . 0.511 HG21 HG12 ' A' ' 784' ' ' VAL . 44.1 p -84.37 34.23 0.52 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.677 0.751 . . . . 99.989999999999995 111.165 -178.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 12.7 m -154.69 112.72 3.48 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.045 -0.979 . . . . 99.989999999999995 111.006 178.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 788' ' ' GLY . . . . . 0.499 ' HA2' HG12 ' A' ' 817' ' ' VAL . . . -50.13 112.49 1.52 Allowed Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 121.027 -0.606 . . . . 99.989999999999995 112.521 169.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 789' ' ' GLY . . . . . . . . . . . . . . . -157.51 -148.15 5.03 Favored Glycine 0 N--CA 1.443 -0.843 0 N-CA-C 111.205 -0.758 . . . . 99.989999999999995 111.205 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -144.86 124.77 13.47 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 108.868 -0.789 . . . . 99.989999999999995 108.868 179.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 791' ' ' TYR . . . . . 0.485 ' CE2' ' HG2' ' A' ' 759' ' ' GLU . 90.9 m-85 -118.99 145.14 46.07 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 116.118 -0.492 . . . . 99.989999999999995 110.998 -176.174 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 792' ' ' ILE . . . . . 0.556 ' O ' HG13 ' A' ' 758' ' ' ILE . 16.5 mt -123.56 110.41 25.92 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-N 115.71 -0.677 . . . . 99.989999999999995 109.508 173.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 793' ' ' LEU . . . . . 0.644 HD13 ' CD1' ' A' ' 757' ' ' ILE . 4.0 tp -84.75 109.55 18.14 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.428 0.632 . . . . 99.989999999999995 109.448 179.326 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 794' ' ' SER . . . . . . . . . . . . . 19.1 m -112.31 156.52 22.3 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.93 -1.032 . . . . 99.989999999999995 110.062 -174.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 795' ' ' LEU . . . . . . . . . . . . . 74.9 mt -91.13 130.5 37.02 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.903 0.382 . . . . 99.989999999999995 110.372 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 796' ' ' VAL . . . . . 0.461 ' HB ' ' HB ' ' A' ' 754' ' ' THR . 76.6 t -91.52 -55.53 6.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.863 -0.608 . . . . 99.989999999999995 111.159 -175.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 797' ' ' SER . . . . . 0.468 ' C ' HD13 ' A' ' 808' ' ' LEU . 88.9 p -179.43 179.12 0.64 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.137 -0.483 . . . . 99.989999999999995 110.503 -172.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 798' ' ' ILE . . . . . 0.613 ' HA ' ' O ' ' A' ' 752' ' ' THR . 10.3 tt -148.53 161.94 5.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 109.322 -0.621 . . . . 99.989999999999995 109.322 178.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 799' ' ' LYS . . . . . 0.728 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 7.6 tmtt? -133.31 122.02 23.25 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.037 0.446 . . . . 99.989999999999995 110.787 -178.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 800' ' ' ASP . . . . . 0.577 ' HA ' ' CD2' ' A' ' 751' ' ' PHE . 9.0 t70 -66.45 154.87 39.09 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.967 -1.015 . . . . 99.989999999999995 109.971 174.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 38.2 t -59.15 -14.18 9.56 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 124.236 0.96 . . . . 99.989999999999995 112.719 -172.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 61.8 p -96.25 5.57 50.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.554 0.692 . . . . 99.989999999999995 110.189 178.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 803' ' ' GLY . . . . . . . . . . . . . . . 82.23 40.19 10.48 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.07 -0.968 . . . . 99.989999999999995 112.148 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 804' ' ' CYS . . . . . 0.438 ' HB2' ' HB3' ' A' ' 800' ' ' ASP . 63.4 m -110.94 114.62 28.08 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 110.197 -0.297 . . . . 99.989999999999995 110.197 179.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 805' ' ' VAL . . . . . . . . . . . . . 11.4 p -85.75 137.54 20.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.487 0.66 . . . . 99.989999999999995 111.464 -173.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 806' ' ' VAL . . . . . 0.532 ' HB ' HG22 ' A' ' 798' ' ' ILE . 97.0 t -118.03 137.65 51.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.16 -0.927 . . . . 99.989999999999995 109.176 176.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -87.6 110.63 3.61 Favored Glycine 0 C--N 1.321 -0.277 0 C-N-CA 120.815 -0.707 . . . . 99.989999999999995 112.481 -178.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 808' ' ' LEU . . . . . 0.468 HD13 ' C ' ' A' ' 797' ' ' SER . 11.1 mp -79.78 129.69 34.7 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 113.303 0.853 . . . . 99.989999999999995 113.303 178.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 8.8 t -138.6 87.01 2.19 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 107.921 -1.14 . . . . 99.989999999999995 107.921 168.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 810' ' ' GLN . . . . . 0.864 ' OE1' ' HB2' ' A' ' 722' ' ' SER . 25.2 mt-30 -139.48 174.57 3.97 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.081 -0.963 . . . . 99.989999999999995 111.295 -170.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 811' ' ' PRO . . . . . 0.485 ' HD2' ' HB3' ' A' ' 810' ' ' GLN . 75.5 Cg_exo -44.69 146.68 2.12 Favored 'Trans proline' 0 C--N 1.36 1.14 0 C-N-CA 123.395 2.73 . . . . 99.989999999999995 114.376 -178.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -119.99 166.93 12.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.092 -0.958 . . . . 99.989999999999995 111.147 -177.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 813' ' ' ALA . . . . . 0.532 ' O ' ' HA ' ' A' ' 792' ' ' ILE . . . -105.19 146.18 29.6 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.265 -0.88 . . . . 99.989999999999995 110.212 178.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 814' ' ' LYS . . . . . 0.433 ' HG2' HG12 ' A' ' 792' ' ' ILE . 6.7 mtmp? -122.85 112.72 18.21 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.839 0.828 . . . . 99.989999999999995 110.605 172.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 815' ' ' ILE . . . . . 0.523 ' HA ' ' HB3' ' A' ' 731' ' ' LEU . 4.5 mp -109.89 109.07 27.06 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 114.088 -1.415 . . . . 99.989999999999995 109.25 -176.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 816' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -98.98 108.58 21.29 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.262 0.553 . . . . 99.989999999999995 110.263 -176.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 817' ' ' VAL . . . . . 0.499 HG12 ' HA2' ' A' ' 788' ' ' GLY . 96.1 t -98.46 145.56 9.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.807 -0.633 . . . . 99.989999999999995 109.599 -179.171 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 818' ' ' ARG . . . . . 0.459 ' HG3' ' H ' ' A' ' 819' ' ' ARG . 20.0 tpt180 -138.36 176.39 8.74 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.238 -1.023 . . . . 99.989999999999995 108.238 -178.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 819' ' ' ARG . . . . . 0.459 ' H ' ' HG3' ' A' ' 818' ' ' ARG . 13.6 mmm180 -76.91 155.48 32.79 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 120.632 -0.427 . . . . 99.989999999999995 110.112 175.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 820' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 . . . . . 0 C--N 1.322 -0.593 0 N-CA-C 109.468 -0.567 . . . . 99.989999999999995 109.468 178.026 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 718' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.517 -0.299 0 CA-C-O 121.6 0.714 . . . . 99.989999999999995 110.671 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 719' ' ' VAL . . . . . 0.439 ' O ' ' HD3' ' A' ' 721' ' ' PRO . 7.8 p -141.9 161.18 20.69 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-N 115.201 -0.909 . . . . 99.989999999999995 108.7 -179.213 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 720' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -89.91 110.06 37.15 Favored Pre-proline 0 C--N 1.305 -1.341 0 CA-C-N 115.443 -0.799 . . . . 99.989999999999995 109.985 176.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 721' ' ' PRO . . . . . 0.457 ' HB3' ' HA3' ' A' ' 747' ' ' GLY . 36.3 Cg_endo -86.75 148.89 8.48 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 122.564 2.176 . . . . 99.989999999999995 110.801 177.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 722' ' ' SER . . . . . 0.463 ' HA ' ' CD2' ' A' ' 808' ' ' LEU . 8.4 t -178.78 -154.6 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.623 -0.51 . . . . 99.989999999999995 109.623 -171.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 723' ' ' ALA . . . . . 0.683 ' O ' HD13 ' A' ' 795' ' ' LEU . . . -150.99 140.17 21.21 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.902 0.382 . . . . 99.989999999999995 110.799 176.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 43.4 t -128.52 99.43 5.38 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.632 -0.877 . . . . 99.989999999999995 108.632 -174.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 725' ' ' LEU . . . . . 0.599 HD21 ' CG2' ' A' ' 743' ' ' VAL . 1.1 mt -65.02 146.25 55.26 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 115.809 -0.632 . . . . 99.989999999999995 110.604 -172.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 34.3 mtpt -103.88 -10.58 18.08 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.486 -0.779 . . . . 99.989999999999995 110.464 -174.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 727' ' ' LEU . . . . . 0.434 ' HB2' HG23 ' A' ' 741' ' ' VAL . 0.8 OUTLIER -74.46 109.67 8.14 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.138 -1.06 . . . . 99.989999999999995 108.138 175.751 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 41.6 m80 -105.43 38.06 2.06 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.765 0.654 . . . . 99.989999999999995 112.765 -169.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -169.51 -176.99 2.62 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.719 0.295 . . . . 99.989999999999995 111.104 179.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 730' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -66.21 137.1 56.74 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.827 -0.624 . . . . 99.989999999999995 109.953 173.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 731' ' ' LEU . . . . . 0.57 ' HB3' ' HA ' ' A' ' 815' ' ' ILE . 40.4 tp -103.23 100.17 10.06 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.88 -0.6 . . . . 99.989999999999995 109.973 178.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 732' ' ' LYS . . . . . 0.45 ' HD3' ' HB3' ' A' ' 816' ' ' GLN . 32.6 mmtp -78.63 124.26 27.99 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.454 0.645 . . . . 99.989999999999995 112.09 -175.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 733' ' ' LEU . . . . . 0.621 ' HG ' ' HB3' ' A' ' 737' ' ' ASP . 7.9 mp -120.4 165.13 15.32 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.671 -1.15 . . . . 99.989999999999995 109.705 177.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 734' ' ' CYS . . . . . 0.487 ' O ' ' HB2' ' A' ' 737' ' ' ASP . 31.2 p -120.16 -179.27 3.89 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 116.12 -0.491 . . . . 99.989999999999995 109.702 171.008 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 735' ' ' LEU . . . . . 0.502 HD11 ' HG3' ' A' ' 819' ' ' ARG . 2.8 tt -57.88 116.5 3.52 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.938 0.399 . . . . 99.989999999999995 110.34 -179.161 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 91.64 3.39 68.82 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.374 -0.917 . . . . 99.989999999999995 112.458 176.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 737' ' ' ASP . . . . . 0.621 ' HB3' ' HG ' ' A' ' 733' ' ' LEU . 0.3 OUTLIER -72.47 158.21 36.15 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.973 0.416 . . . . 99.989999999999995 111.146 177.957 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 37.0 p-80 -116.66 153.68 31.89 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 107.156 -1.424 . . . . 99.989999999999995 107.156 171.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 739' ' ' SER . . . . . 0.724 ' HB2' ' OG1' ' A' ' 782' ' ' THR . 10.8 m -98.15 159.0 15.22 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 119.126 -1.03 . . . . 99.989999999999995 111.235 -174.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 740' ' ' SER . . . . . 0.491 ' H ' HD22 ' A' ' 731' ' ' LEU . 10.5 t -143.37 101.09 3.73 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.915 -1.038 . . . . 99.989999999999995 108.657 -174.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 741' ' ' VAL . . . . . 0.451 HG13 HD22 ' A' ' 793' ' ' LEU . 2.1 p -121.26 112.51 32.98 Favored Pre-proline 0 C--N 1.316 -0.864 0 CA-C-O 121.283 0.563 . . . . 99.989999999999995 110.266 -177.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 742' ' ' PRO . . . . . 0.603 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 4.5 Cg_exo -71.33 125.93 11.8 Favored 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 122.294 1.996 . . . . 99.989999999999995 109.863 178.141 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 743' ' ' VAL . . . . . 0.599 ' CG2' HD21 ' A' ' 725' ' ' LEU . 24.0 t -129.31 114.77 32.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 112.595 0.591 . . . . 99.989999999999995 112.595 -178.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 744' ' ' ALA . . . . . 0.494 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -81.59 101.6 10.1 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.459 -0.941 . . . . 99.989999999999995 108.459 171.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 745' ' ' LEU . . . . . 0.548 ' HA ' ' HA ' ' A' ' 723' ' ' ALA . 0.2 OUTLIER -83.94 168.2 16.25 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 114.593 -1.185 . . . . 99.989999999999995 111.258 -167.814 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 44.1 tptt -122.24 156.18 34.33 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.855 -0.611 . . . . 99.989999999999995 110.405 -177.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 747' ' ' GLY . . . . . 0.457 ' HA3' ' HB3' ' A' ' 721' ' ' PRO . . . 93.66 123.62 3.65 Favored Glycine 0 C--N 1.311 -0.827 0 CA-C-N 115.241 -0.89 . . . . 99.989999999999995 111.378 -177.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 25.7 mp0 -106.69 114.45 28.56 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.119 0.485 . . . . 99.989999999999995 111.283 -173.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 130.69 -175.98 19.13 Favored Glycine 0 N--CA 1.446 -0.7 0 N-CA-C 110.906 -0.878 . . . . 99.989999999999995 110.906 -177.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -70.57 95.07 0.61 Allowed 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.658 2.238 . . . . 99.989999999999995 112.392 178.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 751' ' ' PHE . . . . . 0.486 ' HA ' ' O ' ' A' ' 799' ' ' LYS . 77.5 m-85 -113.34 140.88 47.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 99.989999999999995 111.522 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 752' ' ' THR . . . . . 0.708 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 86.6 m -91.05 104.61 17.17 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.344 0.592 . . . . 99.989999999999995 109.763 177.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 753' ' ' LEU . . . . . 0.535 ' CD1' HD22 ' A' ' 745' ' ' LEU . 1.8 tt -95.95 116.34 28.78 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.096 -0.956 . . . . 99.989999999999995 109.608 -171.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 754' ' ' THR . . . . . 0.451 HG23 ' HB2' ' A' ' 769' ' ' GLU . 1.0 OUTLIER -114.44 137.7 51.5 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.141 -0.481 . . . . 99.989999999999995 110.989 -179.1 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 755' ' ' TYR . . . . . 0.473 ' CE1' ' HB3' ' A' ' 768' ' ' PHE . 24.5 p90 -145.37 162.93 36.09 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 120.961 0.41 . . . . 99.989999999999995 111.541 178.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 756' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -128.73 121.13 27.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.609 -0.723 . . . . 99.989999999999995 110.677 -178.222 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 757' ' ' ILE . . . . . 0.535 ' CD1' HD13 ' A' ' 793' ' ' LEU . 3.5 mp -87.01 96.47 5.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 N-CA-C 107.708 -1.219 . . . . 99.989999999999995 107.708 169.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 758' ' ' ILE . . . . . 0.565 HG13 ' O ' ' A' ' 792' ' ' ILE . 2.3 pp -95.21 149.65 4.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 116.116 -0.493 . . . . 99.989999999999995 112.218 -169.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 759' ' ' GLU . . . . . 0.631 ' HG2' ' CE2' ' A' ' 791' ' ' TYR . 24.6 mt-10 -89.75 119.94 30.58 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.925 -0.58 . . . . 99.989999999999995 110.394 179.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 760' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.55 -3.1 43.68 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.346 0.593 . . . . 99.989999999999995 109.564 175.44 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 761' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -103.46 -21.74 13.74 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.731 -0.668 . . . . 99.989999999999995 111.245 178.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 762' ' ' SER . . . . . 0.578 ' HB2' ' OE1' ' A' ' 759' ' ' GLU . 69.7 m -140.64 -97.01 0.14 Allowed 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 120.557 -0.457 . . . . 99.989999999999995 111.569 174.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 763' ' ' SER . . . . . . . . . . . . . 50.5 p -174.17 -1.16 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 113.028 0.751 . . . . 99.989999999999995 113.028 -175.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 764' ' ' LYS . . . . . 0.45 ' C ' ' HG3' ' A' ' 759' ' ' GLU . 59.6 mtpt -85.73 56.84 4.14 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.616 0.722 . . . . 99.989999999999995 111.65 -173.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 765' ' ' ARG . . . . . 0.406 ' HD3' ' CG2' ' A' ' 758' ' ' ILE . 7.9 ttp180 -52.64 138.48 28.34 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.552 -1.204 . . . . 99.989999999999995 111.523 174.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 766' ' ' LYS . . . . . . . . . . . . . 9.7 tmtm? -115.98 135.45 53.95 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-O 121.088 0.47 . . . . 99.989999999999995 110.409 -177.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 767' ' ' THR . . . . . . . . . . . . . 27.7 m -109.04 137.03 47.59 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.777 -0.647 . . . . 99.989999999999995 110.833 -174.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 768' ' ' PHE . . . . . 0.473 ' HB3' ' CE1' ' A' ' 755' ' ' TYR . 3.2 t80 -139.72 139.74 36.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.96 0.41 . . . . 99.989999999999995 110.643 175.426 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 769' ' ' GLU . . . . . 0.451 ' HB2' HG23 ' A' ' 754' ' ' THR . 35.5 tt0 -129.76 129.98 44.81 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.699 -0.682 . . . . 99.989999999999995 110.848 -179.37 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 770' ' ' ILE . . . . . 0.453 HG21 HG22 ' A' ' 773' ' ' ILE . 5.0 mt -122.82 111.87 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 108.701 -0.852 . . . . 99.989999999999995 108.701 176.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 771' ' ' LYS . . . . . 0.587 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 9.5 mtpt -85.1 152.04 23.69 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-O 121.492 0.663 . . . . 99.989999999999995 111.328 -174.01 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 772' ' ' GLU . . . . . 0.405 ' O ' ' HG3' ' A' ' 774' ' ' LYS . 5.4 mt-10 54.7 47.11 23.24 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.211 -1.359 . . . . 99.989999999999995 112.532 177.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 773' ' ' ILE . . . . . 0.453 HG22 HG21 ' A' ' 770' ' ' ILE . 0.5 OUTLIER -73.8 119.89 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 107.819 -1.178 . . . . 99.989999999999995 107.819 173.835 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 774' ' ' LYS . . . . . 0.405 ' HG3' ' O ' ' A' ' 772' ' ' GLU . 73.0 mttt -118.21 30.66 7.11 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.617 -0.883 . . . . 99.989999999999995 108.617 -177.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 775' ' ' THR . . . . . 0.594 ' O ' ' HB2' ' A' ' 776' ' ' ASN . 0.6 OUTLIER -95.88 -72.24 0.64 Allowed 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 114.957 -1.019 . . . . 99.989999999999995 113.381 -171.394 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 776' ' ' ASN . . . . . 0.594 ' HB2' ' O ' ' A' ' 775' ' ' THR . 0.9 OUTLIER 83.82 4.67 0.78 Allowed 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.045 0.938 . . . . 99.989999999999995 110.389 -175.601 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 777' ' ' GLU . . . . . 0.494 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 6.9 tp10 -161.69 78.3 0.54 Allowed 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 108.682 -0.858 . . . . 99.989999999999995 108.682 -179.47 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 778' ' ' TYR . . . . . 0.404 ' HB3' ' CD1' ' A' ' 745' ' ' LEU . 82.4 t80 -132.86 125.65 30.44 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.115 0.483 . . . . 99.989999999999995 111.69 -169.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 779' ' ' VAL . . . . . 0.603 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 21.6 t -84.16 115.97 27.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.893 -0.594 . . . . 99.989999999999995 110.051 176.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 780' ' ' ILE . . . . . 0.446 ' HB ' HG11 ' A' ' 741' ' ' VAL . 77.2 mt -89.84 135.92 25.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.173 -0.921 . . . . 99.989999999999995 110.724 -176.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 781' ' ' LYS . . . . . 0.412 ' HD3' ' C ' ' A' ' 780' ' ' ILE . 0.0 OUTLIER -118.89 109.12 15.63 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.56 -0.533 . . . . 99.989999999999995 109.56 177.682 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 782' ' ' THR . . . . . 0.724 ' OG1' ' HB2' ' A' ' 739' ' ' SER . 82.6 p -82.6 148.62 58.75 Favored Pre-proline 0 C--O 1.244 0.811 0 CA-C-N 115.876 -0.602 . . . . 99.989999999999995 110.862 -176.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 783' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -49.27 157.0 2.17 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 124.09 3.193 . . . . 99.989999999999995 113.447 -178.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 784' ' ' VAL . . . . . 0.512 HG12 HG21 ' A' ' 786' ' ' THR . 70.1 t -61.19 131.24 26.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.086 -0.961 . . . . 99.989999999999995 112.803 -174.176 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 785' ' ' PHE . . . . . 0.447 ' C ' ' H ' ' A' ' 787' ' ' THR . 80.0 m-85 -103.68 88.96 3.19 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.949 -1.023 . . . . 99.989999999999995 110.01 177.164 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 786' ' ' THR . . . . . 0.512 HG21 HG12 ' A' ' 784' ' ' VAL . 32.5 p -83.47 29.42 0.51 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 122.077 0.941 . . . . 99.989999999999995 110.284 178.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 787' ' ' THR . . . . . 0.447 ' H ' ' C ' ' A' ' 785' ' ' PHE . 2.1 m -159.65 105.46 1.63 Allowed 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.644 -1.162 . . . . 99.989999999999995 109.941 -175.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 788' ' ' GLY . . . . . 0.597 ' HA2' HG22 ' A' ' 817' ' ' VAL . . . -49.46 137.76 19.55 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.75 -0.659 . . . . 99.989999999999995 113.648 172.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 789' ' ' GLY . . . . . 0.443 ' H ' HG13 ' A' ' 817' ' ' VAL . . . -176.84 -178.01 46.24 Favored Glycine 0 N--CA 1.44 -1.062 0 N-CA-C 109.555 -1.418 . . . . 99.989999999999995 109.555 -178.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -118.5 119.66 35.19 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 117.851 0.826 . . . . 99.989999999999995 109.029 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 791' ' ' TYR . . . . . 0.631 ' CE2' ' HG2' ' A' ' 759' ' ' GLU . 92.6 m-85 -122.24 148.88 44.44 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.677 -0.692 . . . . 99.989999999999995 110.582 -175.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 792' ' ' ILE . . . . . 0.565 ' O ' HG13 ' A' ' 758' ' ' ILE . 19.9 mt -124.64 114.33 40.21 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.065 0 N-CA-C 109.081 -0.711 . . . . 99.989999999999995 109.081 172.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 793' ' ' LEU . . . . . 0.546 HD11 ' N ' ' A' ' 794' ' ' SER . 0.5 OUTLIER -84.39 115.73 22.67 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 108.686 -0.857 . . . . 99.989999999999995 108.686 179.893 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 794' ' ' SER . . . . . 0.546 ' N ' HD11 ' A' ' 793' ' ' LEU . 23.1 m -130.51 161.42 31.5 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 114.701 -1.136 . . . . 99.989999999999995 109.084 -174.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 795' ' ' LEU . . . . . 0.683 HD13 ' O ' ' A' ' 723' ' ' ALA . 27.6 mt -87.3 148.07 25.24 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 120.813 0.34 . . . . 99.989999999999995 110.897 -177.022 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 796' ' ' VAL . . . . . . . . . . . . . 69.7 t -105.17 -56.03 5.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.069 -0.514 . . . . 99.989999999999995 111.004 178.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 797' ' ' SER . . . . . 0.573 ' HA ' ' HG ' ' A' ' 808' ' ' LEU . 95.9 p -176.47 154.14 1.25 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.02 -0.536 . . . . 99.989999999999995 110.202 -172.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 798' ' ' ILE . . . . . 0.611 ' HA ' ' O ' ' A' ' 752' ' ' THR . 12.4 tt -127.51 164.04 29.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.219 -0.66 . . . . 99.989999999999995 109.219 177.149 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 799' ' ' LYS . . . . . 0.708 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 28.0 tttt -131.19 120.17 22.91 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 120.668 0.271 . . . . 99.989999999999995 111.058 -176.026 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 800' ' ' ASP . . . . . 0.485 ' HA ' ' CE2' ' A' ' 751' ' ' PHE . 19.8 t70 -69.18 154.63 41.74 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.69 -0.686 . . . . 99.989999999999995 109.312 173.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 9.0 m -59.32 -13.77 9.26 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 124.042 0.839 . . . . 99.989999999999995 112.994 -170.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 52.1 p -93.47 -0.87 56.24 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.466 0.651 . . . . 99.989999999999995 110.136 179.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 803' ' ' GLY . . . . . 0.473 ' HA2' ' HE2' ' A' ' 799' ' ' LYS . . . 85.74 46.87 5.29 Favored Glycine 0 N--CA 1.444 -0.807 0 CA-C-N 115.086 -0.961 . . . . 99.989999999999995 111.702 -176.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 804' ' ' CYS . . . . . 0.411 ' HB2' ' HB3' ' A' ' 800' ' ' ASP . 61.3 m -116.71 110.76 18.88 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.98 -0.378 . . . . 99.989999999999995 109.98 177.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 805' ' ' VAL . . . . . 0.558 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 9.8 p -85.47 133.61 29.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.301 0.572 . . . . 99.989999999999995 111.006 -175.22 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 806' ' ' VAL . . . . . 0.482 ' HB ' HG22 ' A' ' 798' ' ' ILE . 84.5 t -112.02 133.76 56.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.711 -0.677 . . . . 99.989999999999995 110.009 178.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -70.49 113.19 4.71 Favored Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 111.31 -0.716 . . . . 99.989999999999995 111.31 177.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 808' ' ' LEU . . . . . 0.573 ' HG ' ' HA ' ' A' ' 797' ' ' SER . 40.0 mt -81.65 130.04 34.91 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.264 0.554 . . . . 99.989999999999995 112.462 -172.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 39.8 m -148.53 86.27 1.53 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.481 -0.782 . . . . 99.989999999999995 110.082 173.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 810' ' ' GLN . . . . . 0.57 ' HB3' ' HD2' ' A' ' 811' ' ' PRO . 75.1 mt-30 -135.54 173.27 5.89 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 108.43 -0.952 . . . . 99.989999999999995 108.43 174.229 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 811' ' ' PRO . . . . . 0.57 ' HD2' ' HB3' ' A' ' 810' ' ' GLN . 86.6 Cg_exo -45.28 139.44 9.01 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 122.654 2.236 . . . . 99.989999999999995 114.68 -177.302 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -111.42 166.15 11.37 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 114.992 -1.004 . . . . 99.989999999999995 110.301 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 813' ' ' ALA . . . . . 0.43 ' N ' HD12 ' A' ' 725' ' ' LEU . . . -116.42 154.14 30.83 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.166 -0.47 . . . . 99.989999999999995 110.357 -178.09 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 814' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -120.22 108.7 14.52 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.18 0.514 . . . . 99.989999999999995 110.498 177.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 815' ' ' ILE . . . . . 0.57 ' HA ' ' HB3' ' A' ' 731' ' ' LEU . 4.8 mp -97.5 123.71 50.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.486 -0.779 . . . . 99.989999999999995 109.481 -179.085 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 816' ' ' GLN . . . . . 0.45 ' HB3' ' HD3' ' A' ' 732' ' ' LYS . 0.1 OUTLIER -118.39 106.31 12.6 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.444 -0.576 . . . . 99.989999999999995 109.444 -179.873 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 817' ' ' VAL . . . . . 0.597 HG22 ' HA2' ' A' ' 788' ' ' GLY . 0.5 OUTLIER -100.61 143.61 13.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 109.386 -0.598 . . . . 99.989999999999995 109.386 -179.879 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 818' ' ' ARG . . . . . . . . . . . . . 20.9 tpt180 -124.3 123.55 40.47 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 121.086 0.47 . . . . 99.989999999999995 110.683 -176.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 819' ' ' ARG . . . . . 0.543 ' HB2' ' H ' ' A' ' 788' ' ' GLY . 11.2 ttt180 -90.35 114.28 26.33 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.741 -0.663 . . . . 99.989999999999995 110.254 179.031 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 820' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 . . . . . 0 C--N 1.32 -0.705 0 CA-C-N 115.687 -0.688 . . . . 99.989999999999995 110.353 178.561 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 718' ' ' ARG . . . . . 0.455 ' HA ' ' NE ' ' A' ' 718' ' ' ARG . 4.1 mmp_? . . . . . 0 CA--C 1.502 -0.873 0 CA-C-O 122.114 0.959 . . . . 99.989999999999995 111.463 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 719' ' ' VAL . . . . . 0.568 ' O ' ' HD3' ' A' ' 721' ' ' PRO . 6.0 p -132.39 179.68 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.392 0 CA-C-N 113.735 -1.575 . . . . 99.989999999999995 107.477 -177.342 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 720' ' ' LYS . . . . . 0.535 ' H ' HG22 ' A' ' 719' ' ' VAL . 55.6 mtpt -109.19 88.2 5.59 Favored Pre-proline 0 C--N 1.301 -1.503 0 N-CA-C 109.201 -0.666 . . . . 99.989999999999995 109.201 177.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 721' ' ' PRO . . . . . 0.568 ' HD3' ' O ' ' A' ' 719' ' ' VAL . 56.4 Cg_endo -88.04 144.91 6.25 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 123.381 2.721 . . . . 99.989999999999995 112.426 -174.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 722' ' ' SER . . . . . 0.525 ' HA ' ' CD2' ' A' ' 808' ' ' LEU . 61.8 m -169.27 -156.52 0.15 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.207 -0.664 . . . . 99.989999999999995 109.207 -172.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 723' ' ' ALA . . . . . 0.537 ' HA ' ' HA ' ' A' ' 745' ' ' LEU . . . -152.2 143.51 23.31 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 122.273 -0.267 . . . . 99.989999999999995 110.845 179.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 724' ' ' SER . . . . . 0.425 ' HB2' ' OE1' ' A' ' 810' ' ' GLN . 26.0 t -132.58 99.5 4.66 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.29 -0.633 . . . . 99.989999999999995 109.29 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 725' ' ' LEU . . . . . 0.628 HD11 ' N ' ' A' ' 725' ' ' LEU . 4.9 mp -62.42 143.4 57.1 Favored 'General case' 0 N--CA 1.426 -1.632 0 CA-C-O 122.428 1.109 . . . . 99.989999999999995 112.407 -176.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 30.8 mtpt -94.49 -16.47 23.31 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 113.26 -1.791 . . . . 99.989999999999995 110.417 -176.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 727' ' ' LEU . . . . . 0.47 ' HB2' ' HD2' ' A' ' 742' ' ' PRO . 1.5 tt -76.04 109.29 9.57 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.407 -0.96 . . . . 99.989999999999995 108.407 177.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 35.9 m80 -110.47 48.84 0.88 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.264 0.468 . . . . 99.989999999999995 112.264 -171.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -177.86 177.78 1.04 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.384 -0.371 . . . . 99.989999999999995 110.13 176.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 730' ' ' ASP . . . . . 0.427 ' HA ' ' O ' ' A' ' 814' ' ' LYS . 1.4 m-20 -67.01 134.94 52.94 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.967 0.413 . . . . 99.989999999999995 110.131 175.244 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 731' ' ' LEU . . . . . 0.558 ' HB3' ' HA ' ' A' ' 815' ' ' ILE . 28.2 tp -93.08 105.95 17.98 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.104 -0.498 . . . . 99.989999999999995 110.516 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 732' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -76.98 104.62 7.57 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.852 -0.613 . . . . 99.989999999999995 111.656 -174.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 733' ' ' LEU . . . . . 0.445 HD12 ' CB ' ' A' ' 739' ' ' SER . 85.2 mt -116.77 155.57 28.7 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.112 -0.495 . . . . 99.989999999999995 110.498 177.296 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 734' ' ' CYS . . . . . 0.471 ' O ' ' HB2' ' A' ' 737' ' ' ASP . 36.5 m -105.34 -173.38 2.29 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.781 -0.645 . . . . 99.989999999999995 109.84 179.101 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 735' ' ' LEU . . . . . 0.441 HD21 ' HB3' ' A' ' 819' ' ' ARG . 24.5 tp -67.05 135.8 54.25 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 110.143 -0.317 . . . . 99.989999999999995 110.143 178.421 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 736' ' ' GLY . . . . . 0.458 ' HA2' ' HA ' ' A' ' 786' ' ' THR . . . 80.02 7.84 88.17 Favored Glycine 0 C--N 1.321 -0.298 0 C-N-CA 120.339 -0.934 . . . . 99.989999999999995 112.673 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 737' ' ' ASP . . . . . 0.471 ' HB2' ' O ' ' A' ' 734' ' ' CYS . 0.7 OUTLIER -87.47 148.77 24.8 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.51 0.671 . . . . 99.989999999999995 112.628 179.078 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 738' ' ' HIS . . . . . 0.436 ' HB2' ' O ' ' A' ' 782' ' ' THR . 40.3 p-80 -110.93 164.98 12.24 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 106.642 -1.614 . . . . 99.989999999999995 106.642 166.19 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 739' ' ' SER . . . . . 0.469 ' HB2' ' CD2' ' A' ' 731' ' ' LEU . 4.5 p -109.99 162.7 14.27 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 119.277 -0.969 . . . . 99.989999999999995 112.0 -171.146 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 23.4 t -138.88 100.91 4.17 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 114.961 -1.018 . . . . 99.989999999999995 108.783 177.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 741' ' ' VAL . . . . . 0.445 HG13 HD13 ' A' ' 793' ' ' LEU . 1.5 p -117.1 111.45 40.54 Favored Pre-proline 0 C--N 1.318 -0.785 0 CA-C-N 115.552 -0.749 . . . . 99.989999999999995 110.115 -179.015 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 742' ' ' PRO . . . . . 0.64 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 4.6 Cg_endo -76.63 134.07 14.82 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 122.578 2.185 . . . . 99.989999999999995 111.58 -179.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 743' ' ' VAL . . . . . 0.546 ' HA ' ' HA ' ' A' ' 725' ' ' LEU . 1.6 p -131.32 120.91 47.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.51 0.671 . . . . 99.989999999999995 112.249 176.403 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 744' ' ' ALA . . . . . 0.466 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -83.22 103.25 12.48 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.484 -0.932 . . . . 99.989999999999995 108.484 169.072 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 745' ' ' LEU . . . . . 0.537 ' HA ' ' HA ' ' A' ' 723' ' ' ALA . 0.3 OUTLIER -85.36 166.26 16.58 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.622 -1.172 . . . . 99.989999999999995 111.538 -167.092 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -120.14 148.95 43.0 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.491 -0.777 . . . . 99.989999999999995 109.914 -176.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 747' ' ' GLY . . . . . 0.413 ' HA3' ' HB3' ' A' ' 721' ' ' PRO . . . 100.28 127.2 5.96 Favored Glycine 0 C--N 1.316 -0.546 0 N-CA-C 110.701 -0.96 . . . . 99.989999999999995 110.701 -173.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -102.08 124.59 47.94 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.327 0.584 . . . . 99.989999999999995 112.279 -170.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 108.06 -174.11 18.79 Favored Glycine 0 CA--C 1.501 -0.815 0 CA-C-N 115.147 -0.933 . . . . 99.989999999999995 111.542 178.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 750' ' ' PRO . . . . . 0.501 ' HB3' ' HE2' ' A' ' 774' ' ' LYS . 72.8 Cg_endo -65.93 100.62 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.384 0 C-N-CA 123.317 2.678 . . . . 99.989999999999995 113.619 -177.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 751' ' ' PHE . . . . . 0.66 ' CE2' ' HA ' ' A' ' 800' ' ' ASP . 62.1 m-85 -113.99 144.18 43.51 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.531 -0.758 . . . . 99.989999999999995 110.701 177.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 752' ' ' THR . . . . . 0.676 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 96.1 m -89.21 103.17 15.81 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 108.788 -0.819 . . . . 99.989999999999995 108.788 177.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 753' ' ' LEU . . . . . . . . . . . . . 24.9 tp -91.28 122.65 34.09 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.407 -1.27 . . . . 99.989999999999995 110.093 -171.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 754' ' ' THR . . . . . 0.42 HG23 ' HB2' ' A' ' 769' ' ' GLU . 0.6 OUTLIER -122.57 131.37 53.8 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.555 0.217 . . . . 99.989999999999995 110.748 179.795 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 755' ' ' TYR . . . . . 0.632 ' CE1' ' HB3' ' A' ' 768' ' ' PHE . 24.2 p90 -140.23 154.09 46.77 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.076 0.465 . . . . 99.989999999999995 111.453 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 756' ' ' ASP . . . . . 0.521 ' OD1' HG23 ' A' ' 758' ' ' ILE . 2.3 p30 -107.97 134.45 50.86 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.451 -0.795 . . . . 99.989999999999995 110.789 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 757' ' ' ILE . . . . . 0.449 HG21 ' HB3' ' A' ' 791' ' ' TYR . 4.5 mp -103.73 94.97 3.47 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 N-CA-C 107.036 -1.468 . . . . 99.989999999999995 107.036 167.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 758' ' ' ILE . . . . . 0.521 HG23 ' OD1' ' A' ' 756' ' ' ASP . 2.5 pp -100.77 145.99 10.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 115.461 -0.791 . . . . 99.989999999999995 111.769 -169.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 759' ' ' GLU . . . . . 0.414 ' OE1' ' HB2' ' A' ' 762' ' ' SER . 13.0 mt-10 -83.82 128.18 34.35 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 116.001 -0.545 . . . . 99.989999999999995 110.152 -179.643 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 760' ' ' THR . . . . . 0.469 HG23 ' OD2' ' A' ' 790' ' ' ASP . 0.1 OUTLIER -95.7 -2.93 46.96 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.229 0.538 . . . . 99.989999999999995 110.055 175.586 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 761' ' ' PHE . . . . . . . . . . . . . 35.9 p90 -100.87 -28.81 12.57 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.967 -0.561 . . . . 99.989999999999995 111.152 176.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 762' ' ' SER . . . . . 0.414 ' HB2' ' OE1' ' A' ' 759' ' ' GLU . 66.3 m -135.05 -103.12 0.22 Allowed 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 120.38 -0.528 . . . . 99.989999999999995 111.829 178.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 763' ' ' SER . . . . . . . . . . . . . 35.4 p -173.17 4.64 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.507 0.558 . . . . 99.989999999999995 112.507 -173.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 764' ' ' LYS . . . . . 0.408 ' HZ3' ' HB2' ' A' ' 764' ' ' LYS . 10.0 mtmp? -86.85 58.65 5.19 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.738 0.78 . . . . 99.989999999999995 111.25 -174.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 765' ' ' ARG . . . . . 0.473 ' CG ' HG21 ' A' ' 758' ' ' ILE . 10.9 ttp180 -49.84 147.24 3.9 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 114.124 -1.398 . . . . 99.989999999999995 112.869 176.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 766' ' ' LYS . . . . . 0.474 ' HD3' ' N ' ' A' ' 767' ' ' THR . 9.6 tmtm? -119.73 146.55 45.53 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 114.935 -1.03 . . . . 99.989999999999995 108.688 177.26 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 767' ' ' THR . . . . . 0.474 ' N ' ' HD3' ' A' ' 766' ' ' LYS . 89.1 m -123.31 131.36 53.64 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 120.62 0.248 . . . . 99.989999999999995 110.508 177.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 768' ' ' PHE . . . . . 0.632 ' HB3' ' CE1' ' A' ' 755' ' ' TYR . 1.8 t80 -127.78 135.06 49.58 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 109.025 -0.731 . . . . 99.989999999999995 109.025 178.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 769' ' ' GLU . . . . . 0.42 ' HB2' HG23 ' A' ' 754' ' ' THR . 34.5 tt0 -128.7 128.65 44.5 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.734 -0.666 . . . . 99.989999999999995 110.666 -177.244 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 770' ' ' ILE . . . . . 0.457 HG21 HG22 ' A' ' 773' ' ' ILE . 4.7 mt -123.12 113.33 37.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 109.182 -0.674 . . . . 99.989999999999995 109.182 177.117 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 771' ' ' LYS . . . . . 0.521 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 0.1 OUTLIER -84.3 155.76 22.25 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 121.181 0.515 . . . . 99.989999999999995 111.506 -175.914 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 772' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 53.72 44.57 29.46 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.316 -1.311 . . . . 99.989999999999995 112.318 176.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 773' ' ' ILE . . . . . 0.457 HG22 HG21 ' A' ' 770' ' ' ILE . 0.5 OUTLIER -73.44 112.1 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 N-CA-C 107.192 -1.41 . . . . 99.989999999999995 107.192 172.644 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 774' ' ' LYS . . . . . 0.501 ' HE2' ' HB3' ' A' ' 750' ' ' PRO . 71.3 mttt -107.8 26.37 10.41 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 108.273 -1.01 . . . . 99.989999999999995 108.273 -178.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 775' ' ' THR . . . . . 0.466 ' O ' ' HB2' ' A' ' 776' ' ' ASN . 0.4 OUTLIER -95.91 -74.8 0.54 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.067 -0.969 . . . . 99.989999999999995 113.488 -165.71 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 776' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 775' ' ' THR . 10.6 m120 83.53 7.86 0.65 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.344 1.057 . . . . 99.989999999999995 111.13 -175.486 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 777' ' ' GLU . . . . . 0.466 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 21.8 mt-10 -159.64 83.48 0.75 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.023 -0.99 . . . . 99.989999999999995 108.331 174.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 778' ' ' TYR . . . . . 0.528 ' HB3' HD11 ' A' ' 745' ' ' LEU . 83.2 t80 -129.61 129.39 44.3 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.347 -0.388 . . . . 99.989999999999995 110.911 -169.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 779' ' ' VAL . . . . . 0.64 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 14.1 t -89.42 111.26 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 CA-C-O 121.157 0.503 . . . . 99.989999999999995 110.213 178.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 780' ' ' ILE . . . . . 0.515 HG23 ' N ' ' A' ' 781' ' ' LYS . 72.9 mt -79.15 145.12 9.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.376 -0.829 . . . . 99.989999999999995 110.273 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 781' ' ' LYS . . . . . 0.515 ' N ' HG23 ' A' ' 780' ' ' ILE . 3.7 mppt? -130.3 108.8 10.28 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.717 -0.846 . . . . 99.989999999999995 108.717 174.226 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 782' ' ' THR . . . . . 0.436 ' O ' ' HB2' ' A' ' 738' ' ' HIS . 30.9 p -77.19 141.37 66.78 Favored Pre-proline 0 N--CA 1.444 -0.748 0 N-CA-C 109.238 -0.652 . . . . 99.989999999999995 109.238 -178.28 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 783' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -55.9 150.02 48.47 Favored 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 122.918 2.412 . . . . 99.989999999999995 111.274 -177.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 784' ' ' VAL . . . . . . . . . . . . . 14.9 p -61.81 133.03 27.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.433 0.635 . . . . 99.989999999999995 110.812 -172.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 785' ' ' PHE . . . . . 0.484 ' C ' ' H ' ' A' ' 787' ' ' THR . 88.9 m-85 -90.24 -37.47 14.09 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.64 -0.709 . . . . 99.989999999999995 111.834 -173.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 786' ' ' THR . . . . . 0.458 ' HA ' ' HA2' ' A' ' 736' ' ' GLY . 28.3 p 57.97 3.39 0.22 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.507 0.723 . . . . 99.989999999999995 111.744 -178.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 787' ' ' THR . . . . . 0.484 ' H ' ' C ' ' A' ' 785' ' ' PHE . 42.8 m -134.37 118.53 17.56 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.093 -0.503 . . . . 99.989999999999995 110.868 -179.165 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 788' ' ' GLY . . . . . . . . . . . . . . . -54.4 108.66 0.94 Allowed Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.523 -0.762 . . . . 99.989999999999995 113.224 174.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 789' ' ' GLY . . . . . 0.448 ' H ' ' HB ' ' A' ' 817' ' ' VAL . . . -155.56 167.16 33.0 Favored Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 110.438 -1.065 . . . . 99.989999999999995 110.438 174.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 790' ' ' ASP . . . . . 0.469 ' OD2' HG23 ' A' ' 760' ' ' THR . 0.2 OUTLIER -109.3 129.39 55.52 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 117.567 0.684 . . . . 99.989999999999995 109.906 179.335 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 791' ' ' TYR . . . . . 0.449 ' HB3' HG21 ' A' ' 757' ' ' ILE . 48.7 m-85 -130.0 156.17 44.91 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.33 -0.85 . . . . 99.989999999999995 110.213 -174.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 792' ' ' ILE . . . . . 0.5 ' O ' HG13 ' A' ' 758' ' ' ILE . 14.5 mt -128.45 119.07 49.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 109.354 -0.609 . . . . 99.989999999999995 109.354 174.241 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 793' ' ' LEU . . . . . 0.483 ' HA ' ' O ' ' A' ' 756' ' ' ASP . 10.1 tt -84.51 107.36 16.71 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 108.745 -0.835 . . . . 99.989999999999995 108.745 179.267 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 794' ' ' SER . . . . . 0.408 ' HB2' ' OD1' ' A' ' 756' ' ' ASP . 3.7 m -116.23 170.87 8.2 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.476 -0.783 . . . . 99.989999999999995 109.14 -179.099 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 795' ' ' LEU . . . . . . . . . . . . . 22.8 mt -97.68 129.6 44.73 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.603 0.239 . . . . 99.989999999999995 110.977 -175.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 796' ' ' VAL . . . . . . . . . . . . . 75.0 t -88.94 -56.1 5.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 99.989999999999995 110.812 -179.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 797' ' ' SER . . . . . 0.502 ' HA ' ' HG ' ' A' ' 808' ' ' LEU . 24.4 m -173.39 164.15 4.59 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.656 -0.702 . . . . 99.989999999999995 110.128 -173.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 798' ' ' ILE . . . . . 0.59 ' O ' ' HA ' ' A' ' 805' ' ' VAL . 11.5 tt -136.15 167.55 24.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 108.585 -0.894 . . . . 99.989999999999995 108.585 176.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 799' ' ' LYS . . . . . 0.676 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 83.6 tttt -136.04 120.56 18.18 Favored 'General case' 0 C--N 1.315 -0.932 0 C-N-CA 120.84 -0.344 . . . . 99.989999999999995 111.248 -176.096 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 800' ' ' ASP . . . . . 0.66 ' HA ' ' CE2' ' A' ' 751' ' ' PHE . 6.2 m-20 -63.12 156.46 24.98 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-N 115.497 -0.774 . . . . 99.989999999999995 109.279 174.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 4.0 m -64.81 -5.22 5.47 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 124.151 0.907 . . . . 99.989999999999995 112.212 -174.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 8.9 t -104.98 12.63 32.11 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.757 0.789 . . . . 99.989999999999995 109.617 175.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 803' ' ' GLY . . . . . 0.469 ' HA2' ' CE ' ' A' ' 799' ' ' LYS . . . 74.71 46.85 16.7 Favored Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.121 -0.945 . . . . 99.989999999999995 112.831 -179.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 804' ' ' CYS . . . . . 0.568 ' HB3' ' HB2' ' A' ' 800' ' ' ASP . 53.7 t -109.87 106.23 15.73 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.807 -0.442 . . . . 99.989999999999995 109.807 177.181 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 805' ' ' VAL . . . . . 0.59 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 2.6 t -86.69 104.95 14.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.591 0.71 . . . . 99.989999999999995 110.704 -175.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 806' ' ' VAL . . . . . . . . . . . . . 39.5 t -90.13 138.54 19.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 114.954 -1.021 . . . . 99.989999999999995 111.065 -178.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -74.96 113.21 3.91 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 115.31 -0.859 . . . . 99.989999999999995 111.662 178.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 808' ' ' LEU . . . . . 0.525 ' CD2' ' HA ' ' A' ' 722' ' ' SER . 30.8 mt -80.17 132.02 35.82 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.662 0.615 . . . . 99.989999999999995 112.662 -174.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 20.4 m -143.97 85.65 1.82 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.258 -0.883 . . . . 99.989999999999995 109.52 171.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 810' ' ' GLN . . . . . 0.479 ' HB3' ' O ' ' A' ' 723' ' ' ALA . 1.0 OUTLIER -146.69 173.91 3.83 Favored Pre-proline 0 CA--C 1.542 0.645 0 CA-C-N 115.452 -0.795 . . . . 99.989999999999995 109.363 177.501 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 811' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -44.0 154.47 0.26 Allowed 'Trans proline' 0 C--N 1.359 1.08 0 C-N-CA 123.782 2.988 . . . . 99.989999999999995 116.294 -173.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -131.35 167.83 18.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 113.797 -1.547 . . . . 99.989999999999995 109.613 -178.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 813' ' ' ALA . . . . . 0.445 ' HB2' HD21 ' A' ' 725' ' ' LEU . . . -127.69 148.65 50.4 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.748 0.308 . . . . 99.989999999999995 110.505 178.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 814' ' ' LYS . . . . . 0.427 ' O ' ' HA ' ' A' ' 730' ' ' ASP . 50.3 tttm -110.17 112.79 24.99 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.14 0.495 . . . . 99.989999999999995 110.704 -176.254 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 815' ' ' ILE . . . . . 0.558 ' HA ' ' HB3' ' A' ' 731' ' ' LEU . 5.3 mp -98.21 127.66 50.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.716 -0.675 . . . . 99.989999999999995 109.855 -178.307 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 816' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -114.42 110.6 20.13 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.742 0.306 . . . . 99.989999999999995 110.842 -178.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 817' ' ' VAL . . . . . 0.448 ' HB ' ' H ' ' A' ' 789' ' ' GLY . 61.3 t -105.66 127.66 60.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 108.814 -0.81 . . . . 99.989999999999995 108.814 175.391 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 818' ' ' ARG . . . . . . . . . . . . . 25.4 mmt180 -148.25 144.51 27.71 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 121.849 -0.532 . . . . 99.989999999999995 111.319 177.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 819' ' ' ARG . . . . . 0.441 ' HB3' HD21 ' A' ' 735' ' ' LEU . 0.0 OUTLIER -91.96 147.24 23.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.012 -0.54 . . . . 99.989999999999995 110.408 177.401 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 820' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 . . . . . 0 C--N 1.32 -0.68 0 CA-C-N 116.235 -0.438 . . . . 99.989999999999995 109.983 178.916 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 718' ' ' ARG . . . . . . . . . . . . . 13.8 tpp180 . . . . . 0 CA--C 1.51 -0.558 0 CA-C-O 121.401 0.62 . . . . 99.989999999999995 110.399 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 719' ' ' VAL . . . . . 0.583 HG22 ' H ' ' A' ' 720' ' ' LYS . 5.0 p -143.42 -176.56 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 N-CA-C 107.751 -1.203 . . . . 99.989999999999995 107.751 -178.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 720' ' ' LYS . . . . . 0.583 ' H ' HG22 ' A' ' 719' ' ' VAL . 27.7 mtpp -110.28 85.62 4.6 Favored Pre-proline 0 C--N 1.308 -1.224 0 N-CA-C 109.36 -0.607 . . . . 99.989999999999995 109.36 177.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 721' ' ' PRO . . . . . 0.568 ' HD3' ' O ' ' A' ' 719' ' ' VAL . 46.3 Cg_endo -88.25 140.76 4.76 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 123.08 2.52 . . . . 99.989999999999995 112.115 -173.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 722' ' ' SER . . . . . 0.458 ' HG ' ' C ' ' A' ' 721' ' ' PRO . 25.2 m -174.83 -151.44 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.418 -0.586 . . . . 99.989999999999995 109.418 -170.096 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 723' ' ' ALA . . . . . 0.52 ' HB1' HG12 ' A' ' 743' ' ' VAL . . . -146.65 149.0 32.63 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 109.792 -0.447 . . . . 99.989999999999995 109.792 174.054 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 28.5 t -131.66 98.38 4.47 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.178 -1.045 . . . . 99.989999999999995 108.178 179.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 725' ' ' LEU . . . . . 0.601 HD21 ' CG2' ' A' ' 743' ' ' VAL . 2.0 mt -66.79 143.69 56.75 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-O 121.441 0.638 . . . . 99.989999999999995 110.984 -171.053 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 35.6 mtpt -94.45 -19.61 20.42 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.869 -1.06 . . . . 99.989999999999995 111.079 -174.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 727' ' ' LEU . . . . . . . . . . . . . 25.9 tp -56.67 129.54 41.5 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.833 -0.622 . . . . 99.989999999999995 110.04 178.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 8.3 t-160 -117.82 16.28 14.37 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.803 -0.359 . . . . 99.989999999999995 111.943 -173.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -169.84 -178.8 3.05 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 122.311 -0.243 . . . . 99.989999999999995 110.886 177.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 730' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.32 132.25 52.03 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.159 0.504 . . . . 99.989999999999995 110.726 175.048 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 731' ' ' LEU . . . . . 0.586 HD22 ' H ' ' A' ' 740' ' ' SER . 49.3 tp -91.56 102.1 14.75 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.652 -0.704 . . . . 99.989999999999995 110.07 177.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 732' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -77.51 122.57 25.42 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.118 -0.492 . . . . 99.989999999999995 111.647 -174.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 733' ' ' LEU . . . . . 0.62 ' HG ' ' HB3' ' A' ' 737' ' ' ASP . 7.8 mp -120.79 164.22 16.94 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.532 -0.758 . . . . 99.989999999999995 110.708 178.242 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 734' ' ' CYS . . . . . 0.55 ' O ' ' HB2' ' A' ' 737' ' ' ASP . 66.1 m -116.49 -178.27 3.38 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.314 -0.857 . . . . 99.989999999999995 109.089 173.001 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 735' ' ' LEU . . . . . 0.443 ' HB2' ' HA ' ' A' ' 819' ' ' ARG . 31.0 tp -63.42 122.92 17.44 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.894 0.378 . . . . 99.989999999999995 111.236 -176.11 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 82.43 7.64 87.3 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.438 -0.887 . . . . 99.989999999999995 112.384 178.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 737' ' ' ASP . . . . . 0.62 ' HB3' ' HG ' ' A' ' 733' ' ' LEU . 0.2 OUTLIER -72.2 154.04 41.26 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.909 0.385 . . . . 99.989999999999995 110.953 176.076 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 738' ' ' HIS . . . . . 0.477 ' HB3' HG21 ' A' ' 784' ' ' VAL . 37.9 p-80 -112.85 148.49 34.79 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 107.605 -1.257 . . . . 99.989999999999995 107.605 171.373 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 739' ' ' SER . . . . . 0.499 ' HB2' HG23 ' A' ' 782' ' ' THR . 4.6 m -94.93 158.09 15.63 Favored 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 119.966 -0.694 . . . . 99.989999999999995 110.927 -172.322 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 740' ' ' SER . . . . . 0.586 ' H ' HD22 ' A' ' 731' ' ' LEU . 12.5 p -144.19 100.85 3.62 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.941 -1.027 . . . . 99.989999999999995 109.213 -178.543 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 741' ' ' VAL . . . . . 0.482 HG13 HD12 ' A' ' 793' ' ' LEU . 0.4 OUTLIER -117.51 119.12 34.68 Favored Pre-proline 0 C--N 1.314 -0.968 0 CA-C-N 115.783 -0.644 . . . . 99.989999999999995 109.459 179.973 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 742' ' ' PRO . . . . . 0.664 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 10.1 Cg_endo -80.86 134.12 9.42 Favored 'Trans proline' 0 N--CA 1.435 -1.93 0 C-N-CA 121.712 1.608 . . . . 99.989999999999995 110.649 -179.482 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 743' ' ' VAL . . . . . 0.601 ' CG2' HD21 ' A' ' 725' ' ' LEU . 49.0 t -132.77 119.64 38.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 121.336 0.588 . . . . 99.989999999999995 111.913 -178.507 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 744' ' ' ALA . . . . . 0.598 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -81.77 95.33 7.24 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 122.129 0.966 . . . . 99.989999999999995 108.653 170.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 745' ' ' LEU . . . . . 0.509 ' HA ' ' HA ' ' A' ' 723' ' ' ALA . 1.9 mt -77.84 159.86 28.69 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.045 -1.434 . . . . 99.989999999999995 111.384 -168.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 8.5 tptp -111.58 166.47 11.12 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.076 -0.511 . . . . 99.989999999999995 110.626 -178.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 747' ' ' GLY . . . . . . . . . . . . . . . 96.1 124.87 4.64 Favored Glycine 0 C--N 1.312 -0.756 0 CA-C-N 115.309 -0.86 . . . . 99.989999999999995 111.714 -173.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 748' ' ' GLN . . . . . 0.442 ' C ' ' HE1' ' A' ' 751' ' ' PHE . 26.6 mm-40 -103.57 95.51 6.11 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 122.676 -0.308 . . . . 99.989999999999995 111.026 -176.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 134.48 -164.73 24.59 Favored Glycine 0 C--O 1.223 -0.589 0 N-CA-C 111.269 -0.732 . . . . 99.989999999999995 111.269 -178.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -74.25 94.35 0.9 Allowed 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.719 2.279 . . . . 99.989999999999995 112.084 179.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 751' ' ' PHE . . . . . 0.711 ' CE2' ' HA ' ' A' ' 800' ' ' ASP . 81.2 m-85 -115.71 141.67 47.77 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.616 -0.72 . . . . 99.989999999999995 110.585 -179.381 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 752' ' ' THR . . . . . 0.681 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 73.5 m -97.63 105.73 17.92 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-O 121.709 0.766 . . . . 99.989999999999995 109.352 -179.319 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 753' ' ' LEU . . . . . 0.477 HD13 ' HB3' ' A' ' 723' ' ' ALA . 3.9 tt -105.11 114.1 28.09 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 114.47 -1.241 . . . . 99.989999999999995 110.015 -168.206 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 754' ' ' THR . . . . . 0.481 HG23 ' HB2' ' A' ' 769' ' ' GLU . 1.5 m -107.9 136.3 47.84 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.384 -0.371 . . . . 99.989999999999995 110.769 -176.186 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 755' ' ' TYR . . . . . . . . . . . . . 26.2 p90 -135.6 159.6 41.11 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.036 0.446 . . . . 99.989999999999995 111.694 179.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 756' ' ' ASP . . . . . 0.573 ' OD2' ' HB3' ' A' ' 794' ' ' SER . 3.1 p30 -118.53 128.33 54.47 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.583 -0.735 . . . . 99.989999999999995 111.447 -178.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 757' ' ' ILE . . . . . 0.466 HG13 HD13 ' A' ' 793' ' ' LEU . 4.2 mp -98.18 94.04 3.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 107.425 -1.324 . . . . 99.989999999999995 107.425 167.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 758' ' ' ILE . . . . . 0.521 HG13 ' O ' ' A' ' 792' ' ' ILE . 2.6 pp -99.38 142.45 15.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-O 121.552 0.692 . . . . 99.989999999999995 112.033 -169.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 759' ' ' GLU . . . . . 0.54 ' HG2' ' CD2' ' A' ' 791' ' ' TYR . 24.8 mt-10 -96.54 101.14 12.72 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.999 -1.0 . . . . 99.989999999999995 110.145 -171.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 760' ' ' THR . . . . . 0.413 HG23 ' HB2' ' A' ' 790' ' ' ASP . 0.0 OUTLIER -87.91 0.81 55.38 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.072 -0.967 . . . . 99.989999999999995 111.382 -169.742 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 761' ' ' PHE . . . . . 0.418 ' CE1' ' HB3' ' A' ' 759' ' ' GLU . 46.2 p90 -85.43 -10.05 56.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.403 -0.362 . . . . 99.989999999999995 110.703 177.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 762' ' ' SER . . . . . . . . . . . . . 18.9 p -144.83 -98.57 0.1 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 116.392 -0.367 . . . . 99.989999999999995 110.802 175.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 763' ' ' SER . . . . . . . . . . . . . 73.8 p -160.87 16.73 0.12 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.251 0.548 . . . . 99.989999999999995 110.325 179.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 764' ' ' LYS . . . . . 0.485 ' HB3' ' HZ2' ' A' ' 764' ' ' LYS . 7.4 mtpm? -90.16 174.29 7.7 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.828 -0.623 . . . . 99.989999999999995 110.47 -175.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 765' ' ' ARG . . . . . 0.451 ' HA ' ' HA ' ' A' ' 758' ' ' ILE . 16.4 ttp180 -165.68 146.79 7.03 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-O 120.974 0.416 . . . . 99.989999999999995 111.666 -173.379 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 766' ' ' LYS . . . . . 0.667 ' HD3' ' N ' ' A' ' 767' ' ' THR . 10.4 tmtt? -123.48 147.59 47.04 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.187 -1.042 . . . . 99.989999999999995 108.187 178.168 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 767' ' ' THR . . . . . 0.667 ' N ' ' HD3' ' A' ' 766' ' ' LYS . 62.0 m -132.31 141.92 49.15 Favored 'General case' 0 C--N 1.314 -0.975 0 O-C-N 122.301 -0.25 . . . . 99.989999999999995 111.618 -176.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 768' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -145.49 144.35 30.52 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.724 0.297 . . . . 99.989999999999995 110.536 176.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 769' ' ' GLU . . . . . 0.481 ' HB2' HG23 ' A' ' 754' ' ' THR . 41.2 tt0 -127.06 126.05 42.4 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.13 -0.486 . . . . 99.989999999999995 111.498 -175.254 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 5.2 mm -107.22 103.39 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 N-CA-C 108.474 -0.936 . . . . 99.989999999999995 108.474 178.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 771' ' ' LYS . . . . . 0.446 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 12.3 mtpt -83.22 149.93 26.51 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 120.289 -0.564 . . . . 99.989999999999995 110.648 -179.053 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 772' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 50.96 50.46 19.06 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.488 -1.233 . . . . 99.989999999999995 112.205 -179.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 773' ' ' ILE . . . . . 0.487 ' O ' HG13 ' A' ' 773' ' ' ILE . 0.5 OUTLIER -76.12 117.92 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 107.808 -1.182 . . . . 99.989999999999995 107.808 173.416 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 78.4 mttt -118.15 28.09 8.59 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 108.681 -0.859 . . . . 99.989999999999995 108.681 -178.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 775' ' ' THR . . . . . 0.466 ' O ' ' HB2' ' A' ' 776' ' ' ASN . 0.9 OUTLIER -95.18 -72.19 0.64 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.572 -1.195 . . . . 99.989999999999995 112.429 -171.538 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 776' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 775' ' ' THR . 10.8 m120 87.7 4.39 0.31 Allowed 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.703 1.201 . . . . 99.989999999999995 110.031 -178.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 777' ' ' GLU . . . . . 0.598 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 21.7 tt0 -162.69 96.28 0.93 Allowed 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 115.049 -0.978 . . . . 99.989999999999995 109.143 172.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 778' ' ' TYR . . . . . 0.495 ' HB3' HD12 ' A' ' 745' ' ' LEU . 83.3 t80 -139.63 128.83 23.88 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.54 -0.755 . . . . 99.989999999999995 111.081 -170.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 779' ' ' VAL . . . . . 0.664 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 7.6 t -84.73 105.91 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-N 116.044 -0.525 . . . . 99.989999999999995 110.196 -179.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 780' ' ' ILE . . . . . . . . . . . . . 70.1 mt -77.06 132.59 32.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.329 -0.85 . . . . 99.989999999999995 110.697 -178.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -117.18 109.58 17.08 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.385 0.612 . . . . 99.989999999999995 110.262 179.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 782' ' ' THR . . . . . 0.499 HG23 ' HB2' ' A' ' 739' ' ' SER . 1.1 p -80.82 149.22 66.88 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 115.239 -0.891 . . . . 99.989999999999995 109.526 -176.516 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 783' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -51.7 161.38 2.14 Favored 'Trans proline' 0 N--CA 1.473 0.292 0 C-N-CA 123.737 2.958 . . . . 99.989999999999995 113.34 -178.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 784' ' ' VAL . . . . . 0.512 HG12 HG21 ' A' ' 786' ' ' THR . 55.1 t -62.69 122.13 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 115.381 -0.827 . . . . 99.989999999999995 111.309 177.259 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 785' ' ' PHE . . . . . 0.416 ' C ' ' H ' ' A' ' 787' ' ' THR . 68.7 m-85 -103.31 96.09 6.53 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.705 -0.68 . . . . 99.989999999999995 110.557 178.064 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 786' ' ' THR . . . . . 0.512 HG21 HG12 ' A' ' 784' ' ' VAL . 46.0 p -85.12 36.98 0.65 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.926 0.87 . . . . 99.989999999999995 110.369 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 787' ' ' THR . . . . . 0.436 ' HG1' ' C ' ' A' ' 786' ' ' THR . 58.4 m -159.48 110.26 1.98 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.336 -1.302 . . . . 99.989999999999995 110.191 179.345 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 788' ' ' GLY . . . . . 0.646 ' HA2' ' CG2' ' A' ' 817' ' ' VAL . . . -54.39 134.56 45.59 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.919 -0.658 . . . . 99.989999999999995 113.241 173.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 789' ' ' GLY . . . . . 0.588 ' H ' HG13 ' A' ' 817' ' ' VAL . . . -178.35 -170.43 40.46 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 110.724 -0.95 . . . . 99.989999999999995 110.724 179.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 790' ' ' ASP . . . . . 0.462 ' OD2' ' HG2' ' A' ' 816' ' ' GLN . 6.6 m-20 -114.16 130.6 56.6 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.155 -0.683 . . . . 99.989999999999995 109.155 174.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 791' ' ' TYR . . . . . 0.54 ' CD2' ' HG2' ' A' ' 759' ' ' GLU . 60.2 m-85 -131.27 123.85 29.25 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.603 -0.517 . . . . 99.989999999999995 109.603 -179.119 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 792' ' ' ILE . . . . . 0.521 ' O ' HG13 ' A' ' 758' ' ' ILE . 19.8 mt -103.88 116.52 47.81 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 C-N-CA 120.445 -0.502 . . . . 99.989999999999995 109.778 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 793' ' ' LEU . . . . . 0.482 HD12 HG13 ' A' ' 741' ' ' VAL . 3.6 tt -83.87 106.28 15.43 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 108.364 -0.976 . . . . 99.989999999999995 108.364 177.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 794' ' ' SER . . . . . 0.573 ' HB3' ' OD2' ' A' ' 756' ' ' ASP . 15.2 t -117.77 179.46 4.07 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.852 -1.067 . . . . 99.989999999999995 108.765 -177.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 795' ' ' LEU . . . . . . . . . . . . . 58.2 mt -106.38 130.62 54.17 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 120.681 0.277 . . . . 99.989999999999995 111.01 -175.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 796' ' ' VAL . . . . . . . . . . . . . 51.4 t -88.89 -56.86 4.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.065 -0.516 . . . . 99.989999999999995 111.202 -177.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 797' ' ' SER . . . . . . . . . . . . . 24.4 m -173.45 168.89 4.49 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.027 -0.533 . . . . 99.989999999999995 110.012 -173.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 798' ' ' ILE . . . . . 0.645 HG22 ' HB ' ' A' ' 806' ' ' VAL . 0.4 OUTLIER -141.01 166.4 18.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 N-CA-C 108.636 -0.875 . . . . 99.989999999999995 108.636 -173.906 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 799' ' ' LYS . . . . . 0.681 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 26.0 tttm -140.31 118.42 11.94 Favored 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 120.4 -0.52 . . . . 99.989999999999995 111.533 -177.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 800' ' ' ASP . . . . . 0.711 ' HA ' ' CE2' ' A' ' 751' ' ' PHE . 12.4 t70 -70.6 156.93 38.79 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.884 -1.053 . . . . 99.989999999999995 109.114 174.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 12.8 t -67.28 -5.22 13.13 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 123.652 0.595 . . . . 99.989999999999995 111.287 -172.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 18.5 p -95.87 7.72 45.55 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.459 0.647 . . . . 99.989999999999995 109.919 174.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 803' ' ' GLY . . . . . . . . . . . . . . . 74.9 32.37 56.95 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.048 -0.978 . . . . 99.989999999999995 111.969 -177.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 804' ' ' CYS . . . . . 0.508 ' HB3' ' HB3' ' A' ' 800' ' ' ASP . 37.1 t -99.16 108.03 20.54 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.411 -0.588 . . . . 99.989999999999995 109.411 -179.132 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 805' ' ' VAL . . . . . 0.554 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 3.3 t -85.05 106.54 15.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.194 0.521 . . . . 99.989999999999995 110.303 -174.231 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 806' ' ' VAL . . . . . 0.645 ' HB ' HG22 ' A' ' 798' ' ' ILE . 22.9 t -92.88 136.84 23.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.53 -0.759 . . . . 99.989999999999995 110.021 -178.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -74.94 134.27 16.8 Favored Glycine 0 N--CA 1.451 -0.311 0 CA-C-N 115.702 -0.681 . . . . 99.989999999999995 111.465 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 808' ' ' LEU . . . . . 0.533 HD23 ' HB ' ' A' ' 798' ' ' ILE . 46.3 mt -99.06 130.81 45.42 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 113.239 0.829 . . . . 99.989999999999995 113.239 -173.489 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 6.1 t -145.83 85.65 1.7 Allowed 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.219 -0.901 . . . . 99.989999999999995 109.232 171.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 810' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -138.22 174.96 3.72 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-O 118.798 -0.62 . . . . 99.989999999999995 109.735 178.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 811' ' ' PRO . . . . . 0.472 ' O ' ' HG ' ' A' ' 725' ' ' LEU . 83.2 Cg_exo -43.79 152.86 0.3 Allowed 'Trans proline' 0 C--N 1.361 1.225 0 C-N-CA 123.347 2.698 . . . . 99.989999999999995 114.68 -177.395 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 812' ' ' ASP . . . . . 0.507 ' C ' HD12 ' A' ' 725' ' ' LEU . 7.9 p-10 -122.73 165.51 16.44 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.317 -0.856 . . . . 99.989999999999995 111.273 -176.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 813' ' ' ALA . . . . . 0.444 ' N ' HD12 ' A' ' 725' ' ' LEU . . . -120.98 113.04 19.51 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.0 -1.0 . . . . 99.989999999999995 110.193 -175.468 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 814' ' ' LYS . . . . . . . . . . . . . 41.6 tttm -93.4 112.15 23.99 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.436 0.636 . . . . 99.989999999999995 111.488 -177.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 815' ' ' ILE . . . . . 0.579 ' HA ' ' HB3' ' A' ' 731' ' ' LEU . 4.7 mp -93.25 135.54 27.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.278 -0.874 . . . . 99.989999999999995 109.254 175.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 816' ' ' GLN . . . . . 0.462 ' HG2' ' OD2' ' A' ' 790' ' ' ASP . 0.5 OUTLIER -128.87 106.95 9.26 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.943 0.401 . . . . 99.989999999999995 109.982 178.525 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 817' ' ' VAL . . . . . 0.646 ' CG2' ' HA2' ' A' ' 788' ' ' GLY . 0.2 OUTLIER -103.19 142.53 16.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-O 121.324 0.583 . . . . 99.989999999999995 110.577 179.052 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 818' ' ' ARG . . . . . 0.501 ' N ' HG22 ' A' ' 817' ' ' VAL . 35.6 mmt180 -133.31 175.56 9.29 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 108.722 -0.844 . . . . 99.989999999999995 108.722 175.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 819' ' ' ARG . . . . . 0.443 ' HA ' ' HB2' ' A' ' 735' ' ' LEU . 0.3 OUTLIER -74.88 153.19 38.76 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 109.654 -0.498 . . . . 99.989999999999995 109.654 173.409 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 820' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 . . . . . 0 C--N 1.321 -0.636 0 N-CA-C 110.011 -0.366 . . . . 99.989999999999995 110.011 -178.733 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 718' ' ' ARG . . . . . . . . . . . . . 25.2 mmm180 . . . . . 0 CA--C 1.5 -0.965 0 CA-C-O 122.133 0.968 . . . . 99.989999999999995 111.048 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 719' ' ' VAL . . . . . 0.503 ' O ' ' HD3' ' A' ' 721' ' ' PRO . 7.5 p -164.23 157.68 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 CA-C-N 113.222 -1.808 . . . . 99.989999999999995 108.578 -175.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 720' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -80.74 104.69 2.91 Favored Pre-proline 0 C--N 1.31 -1.14 0 CA-C-N 115.667 -0.697 . . . . 99.989999999999995 109.735 178.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 721' ' ' PRO . . . . . 0.503 ' HD3' ' O ' ' A' ' 719' ' ' VAL . 51.9 Cg_endo -86.91 152.2 8.49 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 122.46 2.107 . . . . 99.989999999999995 111.791 -176.281 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 722' ' ' SER . . . . . 0.536 ' HB3' ' NE2' ' A' ' 810' ' ' GLN . 21.6 t 177.53 -151.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.271 -0.64 . . . . 99.989999999999995 109.271 -172.314 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 723' ' ' ALA . . . . . 0.528 ' HB1' HG23 ' A' ' 743' ' ' VAL . . . -150.67 143.09 24.34 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 121.238 -0.185 . . . . 99.989999999999995 111.114 178.138 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 37.1 t -127.72 102.51 6.84 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 108.966 -0.753 . . . . 99.989999999999995 108.966 -179.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 725' ' ' LEU . . . . . 0.484 ' CD2' ' HB ' ' A' ' 743' ' ' VAL . 12.5 mt -63.88 147.08 52.78 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-O 121.641 0.734 . . . . 99.989999999999995 111.455 -175.215 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 34.2 mtpt -99.84 -15.85 18.26 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.809 -1.087 . . . . 99.989999999999995 110.042 -176.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 727' ' ' LEU . . . . . 0.457 HD21 ' HB3' ' A' ' 813' ' ' ALA . 48.3 tp -64.58 132.34 49.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.681 -0.69 . . . . 99.989999999999995 110.248 178.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -103.76 -26.26 12.8 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.095 0.405 . . . . 99.989999999999995 112.095 -173.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -122.98 173.12 8.01 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.792 -0.363 . . . . 99.989999999999995 111.807 -173.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 730' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -74.38 140.66 44.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.536 -0.756 . . . . 99.989999999999995 109.403 177.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 731' ' ' LEU . . . . . 0.607 ' HB2' ' HA ' ' A' ' 815' ' ' ILE . 73.5 mt -84.39 100.02 11.02 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.417 -0.356 . . . . 99.989999999999995 111.326 -179.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 732' ' ' LYS . . . . . 0.486 ' HE3' ' OE1' ' A' ' 816' ' ' GLN . 14.1 mmmm -76.97 112.87 14.05 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.838 -0.619 . . . . 99.989999999999995 110.637 -179.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 733' ' ' LEU . . . . . 0.47 HD13 ' CG2' ' A' ' 815' ' ' ILE . 58.2 mt -123.34 158.58 30.72 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.153 -0.476 . . . . 99.989999999999995 111.108 -178.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 734' ' ' CYS . . . . . 0.518 ' O ' ' HB2' ' A' ' 737' ' ' ASP . 21.2 p -107.68 -173.36 2.27 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 107.791 -1.189 . . . . 99.989999999999995 107.791 167.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 735' ' ' LEU . . . . . 0.54 ' CD1' ' H ' ' A' ' 788' ' ' GLY . 1.4 tp -71.95 148.92 45.52 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 120.055 -0.658 . . . . 99.989999999999995 111.032 -171.01 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 736' ' ' GLY . . . . . 0.471 ' HA2' ' HA ' ' A' ' 786' ' ' THR . . . 76.22 10.02 85.49 Favored Glycine 0 C--N 1.321 -0.258 0 CA-C-N 115.453 -0.794 . . . . 99.989999999999995 112.54 -179.587 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 737' ' ' ASP . . . . . 0.518 ' HB2' ' O ' ' A' ' 734' ' ' CYS . 0.7 OUTLIER -93.68 155.24 17.37 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 113.15 0.796 . . . . 99.989999999999995 113.15 -177.719 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 738' ' ' HIS . . . . . 0.498 ' HB2' ' O ' ' A' ' 782' ' ' THR . 37.4 p-80 -121.86 -175.57 3.13 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 107.51 -1.293 . . . . 99.989999999999995 107.51 168.445 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 739' ' ' SER . . . . . 0.483 ' HB3' HD11 ' A' ' 731' ' ' LEU . 67.9 m -145.85 176.37 9.72 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.128 -0.629 . . . . 99.989999999999995 112.502 178.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 740' ' ' SER . . . . . 0.455 ' HA ' ' O ' ' A' ' 780' ' ' ILE . 9.7 p -142.43 109.7 5.62 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.085 -0.961 . . . . 99.989999999999995 110.144 176.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 741' ' ' VAL . . . . . 0.458 HG12 HD13 ' A' ' 793' ' ' LEU . 2.3 p -105.04 116.01 61.39 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.758 -0.656 . . . . 99.989999999999995 109.708 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 742' ' ' PRO . . . . . 0.605 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 3.7 Cg_exo -75.13 131.15 13.82 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 122.244 1.963 . . . . 99.989999999999995 111.03 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 743' ' ' VAL . . . . . 0.528 HG23 ' HB1' ' A' ' 723' ' ' ALA . 1.8 p -131.47 120.07 44.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.656 0.741 . . . . 99.989999999999995 112.72 178.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 744' ' ' ALA . . . . . 0.545 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -82.41 109.9 17.06 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.582 -0.895 . . . . 99.989999999999995 108.582 168.373 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 745' ' ' LEU . . . . . 0.525 HD11 ' HB3' ' A' ' 778' ' ' TYR . 0.4 OUTLIER -93.23 157.94 16.01 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.828 -1.078 . . . . 99.989999999999995 111.599 -164.652 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 37.9 tptt -105.06 157.69 17.07 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.357 -0.838 . . . . 99.989999999999995 109.235 178.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 747' ' ' GLY . . . . . . . . . . . . . . . 93.42 120.76 3.06 Favored Glycine 0 C--N 1.305 -1.186 0 N-CA-C 110.835 -0.906 . . . . 99.989999999999995 110.835 -175.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -96.37 115.4 27.38 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.04 0.448 . . . . 99.989999999999995 112.081 -170.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 749' ' ' GLY . . . . . 0.41 ' O ' ' HD1' ' A' ' 751' ' ' PHE . . . 109.88 -167.66 12.86 Favored Glycine 0 CA--C 1.5 -0.853 0 CA-C-N 115.645 -0.707 . . . . 99.989999999999995 111.531 179.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 750' ' ' PRO . . . . . 0.45 ' HB3' ' HE2' ' A' ' 774' ' ' LYS . 85.5 Cg_endo -66.24 95.08 0.31 Allowed 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 123.73 2.953 . . . . 99.989999999999995 113.617 -175.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 751' ' ' PHE . . . . . 0.474 ' CE2' ' HA ' ' A' ' 800' ' ' ASP . 56.7 m-85 -112.43 142.68 44.68 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.574 -0.739 . . . . 99.989999999999995 110.68 177.482 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 752' ' ' THR . . . . . 0.713 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 96.4 m -88.93 106.14 18.22 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.28 -0.637 . . . . 99.989999999999995 109.28 178.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 753' ' ' LEU . . . . . . . . . . . . . 12.3 tp -100.2 110.11 22.37 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.052 -0.977 . . . . 99.989999999999995 111.091 -172.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 754' ' ' THR . . . . . 0.428 HG23 ' HB2' ' A' ' 769' ' ' GLU . 1.2 m -99.43 135.24 41.13 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 116.391 -0.368 . . . . 99.989999999999995 110.442 177.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 755' ' ' TYR . . . . . . . . . . . . . 39.3 p90 -136.29 148.34 47.93 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 121.147 0.499 . . . . 99.989999999999995 111.638 179.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 756' ' ' ASP . . . . . 0.578 ' O ' ' HA ' ' A' ' 793' ' ' LEU . 2.5 p30 -110.22 137.96 47.25 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 115.644 -0.707 . . . . 99.989999999999995 110.789 178.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 757' ' ' ILE . . . . . 0.423 HG21 ' HB3' ' A' ' 791' ' ' TYR . 4.3 mp -107.66 94.79 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.087 0 N-CA-C 107.373 -1.343 . . . . 99.989999999999995 107.373 166.091 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 758' ' ' ILE . . . . . 0.569 HG23 ' OD2' ' A' ' 756' ' ' ASP . 2.6 pp -99.84 150.36 5.38 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-N 115.864 -0.607 . . . . 99.989999999999995 111.92 -169.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 759' ' ' GLU . . . . . 0.683 ' OE1' ' HB2' ' A' ' 762' ' ' SER . 9.4 mt-10 -88.16 120.92 29.98 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 115.991 -0.549 . . . . 99.989999999999995 111.174 -179.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 760' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.17 -5.28 44.35 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 108.245 -1.02 . . . . 99.989999999999995 108.245 169.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 761' ' ' PHE . . . . . 0.447 ' HB2' ' H ' ' A' ' 790' ' ' ASP . 77.4 t80 -94.44 -32.05 13.71 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 114.468 -1.242 . . . . 99.989999999999995 110.972 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 762' ' ' SER . . . . . 0.683 ' HB2' ' OE1' ' A' ' 759' ' ' GLU . 22.2 m -146.62 -93.88 0.09 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 120.594 -0.443 . . . . 99.989999999999995 112.066 179.384 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 763' ' ' SER . . . . . . . . . . . . . 21.5 t -172.37 0.86 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 112.617 0.599 . . . . 99.989999999999995 112.617 -174.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 764' ' ' LYS . . . . . 0.44 ' C ' ' HG3' ' A' ' 759' ' ' GLU . 51.8 mtmt -82.36 55.5 2.92 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.435 0.636 . . . . 99.989999999999995 111.315 -176.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 765' ' ' ARG . . . . . 0.414 ' HG3' HG21 ' A' ' 758' ' ' ILE . 12.3 ttp180 -56.06 140.33 43.99 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.93 -1.032 . . . . 99.989999999999995 111.477 175.034 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 766' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -120.5 146.54 46.18 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 108.975 -0.75 . . . . 99.989999999999995 108.975 -178.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 767' ' ' THR . . . . . . . . . . . . . 90.0 m -128.48 136.22 50.52 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 120.573 0.225 . . . . 99.989999999999995 110.836 -179.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 768' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -141.09 145.07 35.32 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.897 -0.408 . . . . 99.989999999999995 109.897 177.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 769' ' ' GLU . . . . . 0.428 ' HB2' HG23 ' A' ' 754' ' ' THR . 32.9 tt0 -128.17 132.0 48.89 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.985 0.421 . . . . 99.989999999999995 111.447 -176.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 11.1 mm -111.73 100.57 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 N-CA-C 108.312 -0.996 . . . . 99.989999999999995 108.312 178.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 771' ' ' LYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 12.6 mtpt -79.98 150.54 30.42 Favored 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 120.044 -0.662 . . . . 99.989999999999995 111.04 -177.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 772' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 53.7 48.16 22.14 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.04 -1.437 . . . . 99.989999999999995 112.521 177.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -73.34 117.6 17.33 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.578 0 N-CA-C 107.138 -1.43 . . . . 99.989999999999995 107.138 171.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 774' ' ' LYS . . . . . 0.45 ' HE2' ' HB3' ' A' ' 750' ' ' PRO . 59.5 mttt -112.08 28.04 9.12 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 108.582 -0.896 . . . . 99.989999999999995 108.582 -179.248 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 775' ' ' THR . . . . . 0.485 ' O ' ' HB2' ' A' ' 776' ' ' ASN . 0.2 OUTLIER -95.69 -76.7 0.49 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.862 -1.063 . . . . 99.989999999999995 113.5 -167.874 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 776' ' ' ASN . . . . . 0.485 ' HB2' ' O ' ' A' ' 775' ' ' THR . 12.2 m120 88.48 3.91 0.25 Allowed 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.943 1.297 . . . . 99.989999999999995 111.054 -175.144 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 777' ' ' GLU . . . . . 0.545 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 9.9 mt-10 -161.07 88.29 0.75 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.461 -0.791 . . . . 99.989999999999995 109.025 172.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 778' ' ' TYR . . . . . 0.525 ' HB3' HD11 ' A' ' 745' ' ' LEU . 63.9 t80 -133.51 136.68 45.21 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.43 -0.35 . . . . 99.989999999999995 110.611 -170.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 779' ' ' VAL . . . . . 0.605 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 21.5 t -91.25 115.77 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 CA-C-O 121.337 0.589 . . . . 99.989999999999995 110.309 178.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 780' ' ' ILE . . . . . 0.455 ' O ' ' HA ' ' A' ' 740' ' ' SER . 61.7 mt -82.74 142.22 13.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.147 -0.933 . . . . 99.989999999999995 110.309 -179.125 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 781' ' ' LYS . . . . . 0.42 ' N ' HG23 ' A' ' 780' ' ' ILE . 0.0 OUTLIER -113.13 110.77 20.98 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.444 -0.576 . . . . 99.989999999999995 109.444 179.153 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 782' ' ' THR . . . . . 0.498 ' O ' ' HB2' ' A' ' 738' ' ' HIS . 70.3 p -77.01 133.35 69.38 Favored Pre-proline 0 N--CA 1.441 -0.899 0 CA-C-N 115.734 -0.666 . . . . 99.989999999999995 109.567 178.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 783' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 782' ' ' THR . 23.7 Cg_exo -62.88 151.32 84.96 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 122.942 2.428 . . . . 99.989999999999995 111.548 -175.444 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 784' ' ' VAL . . . . . . . . . . . . . 13.8 p -59.59 130.73 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-O 121.406 0.622 . . . . 99.989999999999995 110.477 -174.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 785' ' ' PHE . . . . . 0.534 ' C ' ' H ' ' A' ' 787' ' ' THR . 86.3 m-85 -87.21 -31.84 20.1 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.376 -0.829 . . . . 99.989999999999995 111.598 -171.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 786' ' ' THR . . . . . 0.471 ' HA ' ' HA2' ' A' ' 736' ' ' GLY . 30.9 p 58.05 -5.4 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.911 0.885 . . . . 99.989999999999995 112.94 176.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 787' ' ' THR . . . . . 0.534 ' H ' ' C ' ' A' ' 785' ' ' PHE . 1.3 m -145.76 124.65 12.7 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.752 0.311 . . . . 99.989999999999995 110.543 -176.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 788' ' ' GLY . . . . . 0.54 ' H ' ' CD1' ' A' ' 735' ' ' LEU . . . -50.28 125.9 22.1 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.354 -0.839 . . . . 99.989999999999995 113.353 173.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 789' ' ' GLY . . . . . . . . . . . . . . . -174.51 -179.88 45.4 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 110.141 -1.184 . . . . 99.989999999999995 110.141 179.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 790' ' ' ASP . . . . . 0.447 ' H ' ' HB2' ' A' ' 761' ' ' PHE . 3.3 m-20 -119.46 128.02 53.61 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 117.773 0.786 . . . . 99.989999999999995 109.758 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 791' ' ' TYR . . . . . 0.615 ' CE2' ' HG2' ' A' ' 759' ' ' GLU . 84.0 m-85 -127.65 153.38 46.52 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.808 -0.633 . . . . 99.989999999999995 110.595 -176.022 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 792' ' ' ILE . . . . . 0.55 ' O ' HG13 ' A' ' 758' ' ' ILE . 13.0 mt -129.92 120.36 49.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.6 -0.519 . . . . 99.989999999999995 109.6 172.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 793' ' ' LEU . . . . . 0.578 ' HA ' ' O ' ' A' ' 756' ' ' ASP . 8.1 tt -85.28 110.34 19.0 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.095 -0.706 . . . . 99.989999999999995 109.095 178.28 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 794' ' ' SER . . . . . . . . . . . . . 3.7 m -119.45 148.89 42.72 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.083 -0.508 . . . . 99.989999999999995 110.023 -178.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 795' ' ' LEU . . . . . 0.477 ' H ' HD22 ' A' ' 795' ' ' LEU . 1.5 mm? -73.36 124.75 26.35 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-O 120.715 0.293 . . . . 99.989999999999995 111.028 177.143 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 796' ' ' VAL . . . . . 0.404 ' HB ' ' HB ' ' A' ' 754' ' ' THR . 53.7 t -85.67 -54.78 7.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.189 -0.46 . . . . 99.989999999999995 111.213 -177.207 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 797' ' ' SER . . . . . 0.568 ' HA ' ' HG ' ' A' ' 808' ' ' LEU . 87.9 p -172.42 152.66 2.73 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.981 -0.554 . . . . 99.989999999999995 110.202 -172.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 798' ' ' ILE . . . . . 0.636 ' HA ' ' O ' ' A' ' 752' ' ' THR . 5.9 tt -127.5 164.6 28.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 108.802 -0.814 . . . . 99.989999999999995 108.802 176.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 799' ' ' LYS . . . . . 0.713 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 8.0 tmtt? -139.51 118.86 12.84 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 120.618 -0.433 . . . . 99.989999999999995 111.14 -177.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 800' ' ' ASP . . . . . 0.508 ' HB2' ' HB3' ' A' ' 804' ' ' CYS . 14.1 m-20 -58.59 155.37 12.53 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-N 115.306 -0.861 . . . . 99.989999999999995 109.504 173.346 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 6.3 p -61.62 -11.86 13.39 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 124.021 0.826 . . . . 99.989999999999995 112.56 -174.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 8.9 t -91.06 -6.38 53.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.666 0.745 . . . . 99.989999999999995 109.836 178.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 803' ' ' GLY . . . . . 0.462 ' HA2' ' HE2' ' A' ' 799' ' ' LYS . . . 92.12 42.69 4.58 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 115.278 -0.874 . . . . 99.989999999999995 111.771 -177.26 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 804' ' ' CYS . . . . . 0.508 ' HB3' ' HB2' ' A' ' 800' ' ' ASP . 41.7 t -110.55 106.53 15.84 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.698 -0.482 . . . . 99.989999999999995 109.698 179.073 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 805' ' ' VAL . . . . . 0.55 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 15.7 t -88.27 110.78 21.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.285 0.564 . . . . 99.989999999999995 111.279 -175.336 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 806' ' ' VAL . . . . . 0.409 ' HB ' HG22 ' A' ' 798' ' ' ILE . 88.2 t -90.55 137.76 20.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.298 -0.865 . . . . 99.989999999999995 109.995 177.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -76.07 120.53 5.94 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 111.099 -0.8 . . . . 99.989999999999995 111.099 177.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 808' ' ' LEU . . . . . 0.568 ' HG ' ' HA ' ' A' ' 797' ' ' SER . 40.1 mt -88.81 133.7 34.17 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.749 0.648 . . . . 99.989999999999995 112.749 -173.007 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 31.8 t -149.67 86.73 1.47 Allowed 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.019 -0.992 . . . . 99.989999999999995 108.991 172.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 810' ' ' GLN . . . . . 0.536 ' NE2' ' HB3' ' A' ' 722' ' ' SER . 1.6 mt-30 -139.25 174.39 4.18 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.388 -0.823 . . . . 99.989999999999995 108.93 176.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 811' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_exo -44.0 139.17 6.0 Favored 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 123.049 2.499 . . . . 99.989999999999995 114.644 -175.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -115.67 165.76 12.68 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.694 -1.139 . . . . 99.989999999999995 110.204 -179.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 813' ' ' ALA . . . . . 0.457 ' HB3' HD21 ' A' ' 727' ' ' LEU . . . -115.06 155.63 26.66 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.035 -0.53 . . . . 99.989999999999995 110.492 -177.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 814' ' ' LYS . . . . . 0.438 ' HG3' HG12 ' A' ' 792' ' ' ILE . 2.7 mptm? -112.45 137.83 50.08 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.499 0.666 . . . . 99.989999999999995 110.647 175.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 815' ' ' ILE . . . . . 0.607 ' HA ' ' HB2' ' A' ' 731' ' ' LEU . 5.3 mp -124.27 111.85 30.2 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-N 114.792 -1.094 . . . . 99.989999999999995 108.155 177.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 816' ' ' GLN . . . . . 0.694 ' NE2' ' HG2' ' A' ' 818' ' ' ARG . 0.9 OUTLIER -108.72 109.16 20.26 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.023 0.44 . . . . 99.989999999999995 110.671 -177.22 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 817' ' ' VAL . . . . . 0.405 ' HA ' ' HB2' ' A' ' 733' ' ' LEU . 2.3 t -104.85 142.58 17.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 109.649 -0.5 . . . . 99.989999999999995 109.649 -179.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 818' ' ' ARG . . . . . 0.694 ' HG2' ' NE2' ' A' ' 816' ' ' GLN . 73.6 mmt-85 -137.48 174.43 10.61 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 110.026 -0.361 . . . . 99.989999999999995 110.026 175.016 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 819' ' ' ARG . . . . . 0.427 ' CB ' HD11 ' A' ' 735' ' ' LEU . 33.9 ttt180 -107.96 115.16 29.63 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.781 -0.451 . . . . 99.989999999999995 109.781 179.14 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 820' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 . . . . . 0 C--N 1.32 -0.686 0 CA-C-N 115.806 -0.634 . . . . 99.989999999999995 110.469 -176.023 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 718' ' ' ARG . . . . . 0.43 ' HD3' ' N ' ' A' ' 718' ' ' ARG . 0.5 OUTLIER . . . . . 0 N--CA 1.453 -0.278 0 CA-C-O 120.784 0.326 . . . . 99.989999999999995 110.23 . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 719' ' ' VAL . . . . . 0.635 HG13 ' H ' ' A' ' 720' ' ' LYS . 2.5 p -101.42 -99.07 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.379 -0.6 . . . . 99.989999999999995 109.379 177.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 720' ' ' LYS . . . . . 0.635 ' H ' HG13 ' A' ' 719' ' ' VAL . 52.6 mtpt -128.44 117.49 20.0 Favored Pre-proline 0 C--N 1.314 -0.95 0 N-CA-C 109.398 -0.593 . . . . 99.989999999999995 109.398 170.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 721' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -88.75 151.35 6.11 Favored 'Trans proline' 0 N--CA 1.446 -1.298 0 C-N-CA 122.431 2.087 . . . . 99.989999999999995 111.488 -178.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 722' ' ' SER . . . . . 0.776 ' HB2' ' OE1' ' A' ' 810' ' ' GLN . 8.6 p -179.18 -159.32 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.294 -0.632 . . . . 99.989999999999995 109.294 -175.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 723' ' ' ALA . . . . . 0.519 ' HB2' ' HG ' ' A' ' 795' ' ' LEU . . . -151.67 140.74 21.19 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 118.807 0.73 . . . . 99.989999999999995 110.931 176.068 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 35.1 m -132.89 105.63 7.23 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.713 -0.477 . . . . 99.989999999999995 109.713 -177.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 725' ' ' LEU . . . . . 0.49 ' CD2' ' HB ' ' A' ' 743' ' ' VAL . 16.7 mt -62.22 144.92 54.87 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-O 121.478 0.656 . . . . 99.989999999999995 111.507 -176.087 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 29.3 mtpt -97.62 -14.41 20.99 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.856 -1.065 . . . . 99.989999999999995 109.638 -177.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 727' ' ' LEU . . . . . 0.433 HD21 ' HB3' ' A' ' 813' ' ' ALA . 38.7 tp -69.21 114.24 7.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.304 -0.862 . . . . 99.989999999999995 109.713 175.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 9.6 t-80 -115.71 43.5 2.08 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.816 0.341 . . . . 99.989999999999995 111.214 -174.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 9.5 p80 -175.24 -177.67 1.07 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.239 -0.437 . . . . 99.989999999999995 110.629 177.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 730' ' ' ASP . . . . . 0.516 ' HA ' ' O ' ' A' ' 814' ' ' LYS . 1.2 m-20 -76.53 148.22 37.24 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.69 -0.686 . . . . 99.989999999999995 110.564 177.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 731' ' ' LEU . . . . . 0.52 ' HB2' ' HA ' ' A' ' 815' ' ' ILE . 12.0 mt -101.93 104.45 15.15 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.887 -0.597 . . . . 99.989999999999995 110.555 173.345 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 732' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -81.23 93.24 6.46 Favored 'General case' 0 C--N 1.323 -0.56 0 O-C-N 123.712 0.632 . . . . 99.989999999999995 111.26 -172.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 733' ' ' LEU . . . . . 0.43 ' HB3' ' CB ' ' A' ' 737' ' ' ASP . 0.2 OUTLIER -107.38 163.69 12.83 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.107 0.48 . . . . 99.989999999999995 111.487 -178.415 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 734' ' ' CYS . . . . . 0.695 ' HA ' ' O ' ' A' ' 818' ' ' ARG . 69.2 m -113.14 -173.38 2.24 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.367 -0.833 . . . . 99.989999999999995 110.352 177.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 735' ' ' LEU . . . . . 0.439 ' HG ' ' HD3' ' A' ' 819' ' ' ARG . 3.5 tt -62.56 128.1 34.39 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.839 -0.619 . . . . 99.989999999999995 109.925 -179.289 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 736' ' ' GLY . . . . . 0.469 ' HA2' ' HA ' ' A' ' 786' ' ' THR . . . 86.37 4.96 83.05 Favored Glycine 0 C--N 1.322 -0.199 0 C-N-CA 120.22 -0.991 . . . . 99.989999999999995 112.735 177.116 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 737' ' ' ASP . . . . . 0.493 ' HB2' ' O ' ' A' ' 734' ' ' CYS . 0.3 OUTLIER -84.26 153.3 23.66 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.364 0.602 . . . . 99.989999999999995 112.448 179.281 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 738' ' ' HIS . . . . . 0.479 ' HB2' ' O ' ' A' ' 782' ' ' THR . 47.0 p-80 -118.88 173.28 6.97 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 106.723 -1.584 . . . . 99.989999999999995 106.723 167.106 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 739' ' ' SER . . . . . 0.472 ' HB2' HD13 ' A' ' 731' ' ' LEU . 51.5 p -128.08 173.75 9.8 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 118.236 -1.385 . . . . 99.989999999999995 112.791 -173.043 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 10.4 p -144.98 103.93 3.93 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.743 -1.117 . . . . 99.989999999999995 109.861 -172.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 741' ' ' VAL . . . . . 0.473 HG13 HD22 ' A' ' 793' ' ' LEU . 0.4 OUTLIER -120.87 116.63 31.4 Favored Pre-proline 0 C--N 1.314 -0.963 0 CA-C-N 115.893 -0.594 . . . . 99.989999999999995 110.282 -177.804 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 742' ' ' PRO . . . . . 0.645 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 9.8 Cg_endo -77.66 137.32 16.12 Favored 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 122.252 1.968 . . . . 99.989999999999995 111.545 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 743' ' ' VAL . . . . . 0.49 ' HB ' ' CD2' ' A' ' 725' ' ' LEU . 2.2 p -130.33 119.54 46.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.452 0.644 . . . . 99.989999999999995 112.231 177.33 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 744' ' ' ALA . . . . . 0.568 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -78.81 95.01 5.26 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 122.237 1.017 . . . . 99.989999999999995 109.03 168.641 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 745' ' ' LEU . . . . . 0.536 HD13 HD11 ' A' ' 773' ' ' ILE . 1.7 mt -76.41 142.54 41.06 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 113.706 -1.588 . . . . 99.989999999999995 110.485 -173.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -100.01 163.14 12.56 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.442 0.639 . . . . 99.989999999999995 110.571 -176.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 747' ' ' GLY . . . . . . . . . . . . . . . 91.36 139.11 8.23 Favored Glycine 0 C--N 1.309 -0.928 0 CA-C-N 114.855 -1.066 . . . . 99.989999999999995 111.64 -175.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 748' ' ' GLN . . . . . 0.449 ' C ' ' HE1' ' A' ' 751' ' ' PHE . 20.9 mp0 -114.22 111.2 21.16 Favored 'General case' 0 C--N 1.32 -0.679 0 O-C-N 122.469 -0.43 . . . . 99.989999999999995 111.081 -175.137 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 132.75 -170.7 21.95 Favored Glycine 0 N--CA 1.445 -0.764 0 CA-C-N 115.792 -0.64 . . . . 99.989999999999995 112.034 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -73.5 93.84 0.84 Allowed 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.564 2.176 . . . . 99.989999999999995 111.676 -179.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 751' ' ' PHE . . . . . 0.594 ' CE2' ' HA ' ' A' ' 800' ' ' ASP . 80.0 m-85 -113.92 141.1 47.78 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.817 -0.629 . . . . 99.989999999999995 111.237 -178.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 752' ' ' THR . . . . . 0.652 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 86.7 m -91.66 105.28 17.62 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.38 -0.6 . . . . 99.989999999999995 109.38 177.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 753' ' ' LEU . . . . . 0.455 ' HG ' HD22 ' A' ' 745' ' ' LEU . 0.5 OUTLIER -98.79 123.0 42.74 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 115.227 -0.897 . . . . 99.989999999999995 110.362 -172.168 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 754' ' ' THR . . . . . 0.511 HG23 ' HB2' ' A' ' 769' ' ' GLU . 0.7 OUTLIER -117.89 136.29 53.56 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.105 -0.498 . . . . 99.989999999999995 110.659 -178.197 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 755' ' ' TYR . . . . . . . . . . . . . 17.2 p90 -143.29 153.95 43.29 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 111.922 0.341 . . . . 99.989999999999995 111.922 178.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 756' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -118.91 118.86 32.68 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.341 0.591 . . . . 99.989999999999995 111.86 -178.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 757' ' ' ILE . . . . . 0.526 ' CD1' HD13 ' A' ' 793' ' ' LEU . 4.0 mp -89.74 96.34 6.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 107.496 -1.298 . . . . 99.989999999999995 107.496 167.369 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 758' ' ' ILE . . . . . 0.617 HG13 ' O ' ' A' ' 792' ' ' ILE . 2.5 pp -103.89 149.72 7.57 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 N-CA-C 112.412 0.523 . . . . 99.989999999999995 112.412 -168.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 759' ' ' GLU . . . . . 0.712 ' OE1' ' HB3' ' A' ' 762' ' ' SER . 19.8 mt-10 -87.48 123.99 32.98 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.843 -0.617 . . . . 99.989999999999995 110.164 178.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 760' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.38 -4.85 41.13 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 120.426 -0.51 . . . . 99.989999999999995 110.309 175.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 761' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -103.41 -29.02 11.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.467 . . . . 99.989999999999995 111.798 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 762' ' ' SER . . . . . 0.712 ' HB3' ' OE1' ' A' ' 759' ' ' GLU . 18.5 t -128.57 -95.86 0.41 Allowed 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 120.215 -0.594 . . . . 99.989999999999995 110.848 -178.022 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 763' ' ' SER . . . . . . . . . . . . . 9.3 t -179.79 -1.93 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 120.939 -0.304 . . . . 99.989999999999995 111.811 -177.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 764' ' ' LYS . . . . . 0.48 ' HB2' ' CD ' ' A' ' 759' ' ' GLU . 49.7 mtpt -82.72 54.76 2.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.492 0.663 . . . . 99.989999999999995 111.54 -173.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 66.5 mtm180 -52.04 147.54 7.19 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.692 -1.14 . . . . 99.989999999999995 111.88 176.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 766' ' ' LYS . . . . . 0.651 ' HD3' ' N ' ' A' ' 767' ' ' THR . 9.0 tmtt? -124.84 145.51 49.74 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 108.331 -0.988 . . . . 99.989999999999995 108.331 175.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 767' ' ' THR . . . . . 0.651 ' N ' ' HD3' ' A' ' 766' ' ' LYS . 91.7 m -133.16 141.7 48.26 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 116.611 -0.268 . . . . 99.989999999999995 110.295 -179.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 768' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -136.21 141.74 44.02 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.05 0.452 . . . . 99.989999999999995 110.656 177.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 769' ' ' GLU . . . . . 0.511 ' HB2' HG23 ' A' ' 754' ' ' THR . 40.0 tt0 -126.41 121.08 31.45 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.246 -0.888 . . . . 99.989999999999995 110.487 -179.255 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 770' ' ' ILE . . . . . 0.453 HG21 HG22 ' A' ' 773' ' ' ILE . 9.4 mt -115.57 111.27 34.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 109.274 -0.639 . . . . 99.989999999999995 109.274 178.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 771' ' ' LYS . . . . . 0.569 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 7.8 mtpt -83.97 148.4 26.92 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.624 0.726 . . . . 99.989999999999995 111.521 -176.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 772' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 57.71 47.45 15.62 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 113.514 -1.675 . . . . 99.989999999999995 112.479 175.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 773' ' ' ILE . . . . . 0.536 HD11 HD13 ' A' ' 745' ' ' LEU . 0.5 OUTLIER -75.64 119.29 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 N-CA-C 108.233 -1.025 . . . . 99.989999999999995 108.233 175.426 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 79.7 mttt -117.88 33.26 5.72 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 107.974 -1.121 . . . . 99.989999999999995 107.974 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 775' ' ' THR . . . . . 0.464 ' O ' ' HB2' ' A' ' 776' ' ' ASN . 1.1 m -95.4 -72.32 0.63 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 113.939 -1.482 . . . . 99.989999999999995 112.289 -172.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 776' ' ' ASN . . . . . 0.464 ' HB2' ' O ' ' A' ' 775' ' ' THR . 12.2 m120 85.96 3.63 0.53 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.599 1.159 . . . . 99.989999999999995 110.934 -179.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 777' ' ' GLU . . . . . 0.568 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 12.3 mt-10 -161.84 88.7 0.7 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.171 -0.922 . . . . 99.989999999999995 108.799 172.302 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 778' ' ' TYR . . . . . 0.47 ' HB3' ' CD1' ' A' ' 745' ' ' LEU . 49.4 t80 -123.59 127.65 48.59 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 120.881 0.372 . . . . 99.989999999999995 110.778 -171.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 779' ' ' VAL . . . . . 0.645 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 15.1 t -85.52 105.42 14.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.206 0.527 . . . . 99.989999999999995 110.382 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 780' ' ' ILE . . . . . 0.456 HG13 HG11 ' A' ' 743' ' ' VAL . 83.1 mt -75.44 142.31 14.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.307 -0.861 . . . . 99.989999999999995 110.703 -178.471 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 781' ' ' LYS . . . . . 0.42 ' N ' HG23 ' A' ' 780' ' ' ILE . 0.0 OUTLIER -122.08 103.6 8.91 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.136 -0.69 . . . . 99.989999999999995 109.136 174.975 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 782' ' ' THR . . . . . 0.479 ' O ' ' HB2' ' A' ' 738' ' ' HIS . 2.9 p -75.36 143.6 76.65 Favored Pre-proline 0 C--N 1.319 -0.738 0 CA-C-N 115.803 -0.635 . . . . 99.989999999999995 109.985 -175.312 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 783' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.69 157.76 9.38 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 123.378 2.719 . . . . 99.989999999999995 111.963 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 784' ' ' VAL . . . . . 0.417 ' HA ' ' HB3' ' A' ' 738' ' ' HIS . 11.6 p -68.47 130.89 33.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.45 0.643 . . . . 99.989999999999995 110.283 -175.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 785' ' ' PHE . . . . . 0.499 ' C ' ' H ' ' A' ' 787' ' ' THR . 62.3 m-85 -85.87 -40.17 16.24 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-N 115.634 -0.712 . . . . 99.989999999999995 110.42 -175.008 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 786' ' ' THR . . . . . 0.469 ' HA ' ' HA2' ' A' ' 736' ' ' GLY . 27.3 p 60.26 -4.92 0.1 Allowed 'General case' 0 N--CA 1.469 0.495 0 O-C-N 124.451 1.094 . . . . 99.989999999999995 112.053 -178.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 787' ' ' THR . . . . . 0.499 ' H ' ' C ' ' A' ' 785' ' ' PHE . 43.1 m -130.94 116.12 17.43 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 116.182 -0.463 . . . . 99.989999999999995 110.879 -173.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 788' ' ' GLY . . . . . . . . . . . . . . . -52.59 118.56 7.95 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 120.745 -0.741 . . . . 99.989999999999995 112.963 171.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 789' ' ' GLY . . . . . 0.442 ' H ' ' HB ' ' A' ' 817' ' ' VAL . . . -175.86 -174.97 42.86 Favored Glycine 0 N--CA 1.448 -0.546 0 N-CA-C 110.041 -1.223 . . . . 99.989999999999995 110.041 179.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -115.41 130.11 56.79 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 118.267 1.033 . . . . 99.989999999999995 110.254 178.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 791' ' ' TYR . . . . . 0.517 ' CE2' ' HG2' ' A' ' 759' ' ' GLU . 69.2 m-85 -121.3 143.98 48.88 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.301 -0.863 . . . . 99.989999999999995 109.473 179.55 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 792' ' ' ILE . . . . . 0.617 ' O ' HG13 ' A' ' 758' ' ' ILE . 21.2 mt -120.84 113.68 40.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 N-CA-C 109.467 -0.568 . . . . 99.989999999999995 109.467 177.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 793' ' ' LEU . . . . . 0.535 HD11 ' N ' ' A' ' 794' ' ' SER . 0.7 OUTLIER -86.55 114.53 23.36 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.572 -0.74 . . . . 99.989999999999995 109.084 179.279 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 794' ' ' SER . . . . . 0.535 ' N ' HD11 ' A' ' 793' ' ' LEU . 23.1 t -123.86 159.68 29.1 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.91 -1.041 . . . . 99.989999999999995 108.763 -174.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 795' ' ' LEU . . . . . 0.519 ' HG ' ' HB2' ' A' ' 723' ' ' ALA . 1.2 mm? -87.51 135.31 33.4 Favored 'General case' 0 N--CA 1.44 -0.948 0 O-C-N 121.997 -0.44 . . . . 99.989999999999995 110.837 176.413 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 796' ' ' VAL . . . . . . . . . . . . . 73.3 t -92.64 -55.36 6.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.232 -0.44 . . . . 99.989999999999995 110.95 -178.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 797' ' ' SER . . . . . . . . . . . . . 58.7 m -169.18 168.35 9.91 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.057 -0.519 . . . . 99.989999999999995 110.091 -173.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 798' ' ' ILE . . . . . 0.621 ' HA ' ' O ' ' A' ' 752' ' ' THR . 9.1 tt -141.06 165.39 19.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 108.867 -0.79 . . . . 99.989999999999995 108.867 172.641 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 799' ' ' LYS . . . . . 0.652 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 85.3 tttt -136.96 121.67 18.58 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.887 0.375 . . . . 99.989999999999995 111.333 -174.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 800' ' ' ASP . . . . . 0.594 ' HA ' ' CE2' ' A' ' 751' ' ' PHE . 7.9 t70 -65.49 153.62 40.88 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.022 -0.99 . . . . 99.989999999999995 109.21 175.177 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 5.4 p -58.83 -13.97 7.64 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 124.199 0.937 . . . . 99.989999999999995 112.948 -174.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 52.2 p -89.68 -5.83 56.7 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.511 0.672 . . . . 99.989999999999995 109.847 177.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 803' ' ' GLY . . . . . 0.503 ' HA2' ' CE ' ' A' ' 799' ' ' LYS . . . 89.81 40.31 5.95 Favored Glycine 0 N--CA 1.44 -1.071 0 CA-C-N 114.934 -1.03 . . . . 99.989999999999995 111.601 -177.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 804' ' ' CYS . . . . . 0.478 ' HB3' ' HB3' ' A' ' 800' ' ' ASP . 42.0 t -111.69 113.8 26.4 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 110.056 -0.349 . . . . 99.989999999999995 110.056 -178.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 805' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 11.0 p -85.01 132.85 30.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.396 0.617 . . . . 99.989999999999995 110.948 -174.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 806' ' ' VAL . . . . . 0.468 ' HB ' HG22 ' A' ' 798' ' ' ILE . 85.0 t -109.29 138.34 37.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.296 -0.866 . . . . 99.989999999999995 109.769 178.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -76.28 111.24 3.24 Favored Glycine 0 N--CA 1.452 -0.28 0 CA-C-N 115.824 -0.625 . . . . 99.989999999999995 112.785 -178.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 808' ' ' LEU . . . . . 0.421 HD13 ' HA ' ' A' ' 722' ' ' SER . 2.6 mm? -76.07 127.31 32.69 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 113.824 1.046 . . . . 99.989999999999995 113.824 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 10.8 p -149.93 86.75 1.45 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.298 -0.864 . . . . 99.989999999999995 109.509 170.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 810' ' ' GLN . . . . . 0.776 ' OE1' ' HB2' ' A' ' 722' ' ' SER . 35.1 mt-30 -137.8 171.91 7.64 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.606 -0.724 . . . . 99.989999999999995 110.743 -176.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 811' ' ' PRO . . . . . 0.417 ' HD2' ' HB3' ' A' ' 810' ' ' GLN . 81.3 Cg_exo -47.78 140.32 17.78 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.798 2.332 . . . . 99.989999999999995 113.563 178.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -114.67 165.67 12.55 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.513 -0.767 . . . . 99.989999999999995 110.798 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 813' ' ' ALA . . . . . 0.433 ' HB3' HD21 ' A' ' 727' ' ' LEU . . . -111.33 151.37 28.49 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.744 -0.662 . . . . 99.989999999999995 110.278 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 814' ' ' LYS . . . . . 0.516 ' O ' ' HA ' ' A' ' 730' ' ' ASP . 19.5 ttpp -120.25 107.78 13.4 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.849 0.833 . . . . 99.989999999999995 110.827 178.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 815' ' ' ILE . . . . . 0.52 ' HA ' ' HB2' ' A' ' 731' ' ' LEU . 5.1 mp -86.65 116.94 30.12 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-N 114.539 -1.209 . . . . 99.989999999999995 108.68 177.452 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 816' ' ' GLN . . . . . 0.405 HE22 ' HB2' ' A' ' 818' ' ' ARG . 1.0 OUTLIER -107.88 106.57 16.9 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.686 0.755 . . . . 99.989999999999995 110.339 -177.041 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 817' ' ' VAL . . . . . 0.442 ' HB ' ' H ' ' A' ' 789' ' ' GLY . 1.9 t -101.43 146.43 9.79 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 N-CA-C 108.952 -0.759 . . . . 99.989999999999995 108.952 -177.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 818' ' ' ARG . . . . . 0.695 ' O ' ' HA ' ' A' ' 734' ' ' CYS . 17.2 tpt180 -150.53 136.63 18.52 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.903 -0.406 . . . . 99.989999999999995 109.903 178.412 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 819' ' ' ARG . . . . . 0.439 ' HD3' ' HG ' ' A' ' 735' ' ' LEU . 21.2 mmt180 -62.88 124.14 20.3 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.091 -0.707 . . . . 99.989999999999995 109.091 176.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 820' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 . . . . . 0 C--N 1.321 -0.655 0 N-CA-C 109.693 -0.484 . . . . 99.989999999999995 109.693 178.514 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 718' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? . . . . . 0 CA--C 1.512 -0.504 0 CA-C-O 121.928 0.87 . . . . 99.989999999999995 109.621 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 719' ' ' VAL . . . . . 0.532 ' O ' ' HD3' ' A' ' 721' ' ' PRO . 11.5 p -139.27 166.71 21.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-N 114.625 -1.17 . . . . 99.989999999999995 108.413 -176.452 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 720' ' ' LYS . . . . . 0.421 ' HG2' ' O ' ' A' ' 720' ' ' LYS . 19.1 ttpt -109.68 91.97 11.4 Favored Pre-proline 0 N--CA 1.416 -2.139 0 N-CA-C 108.273 -1.01 . . . . 99.989999999999995 108.273 179.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 721' ' ' PRO . . . . . 0.532 ' HD3' ' O ' ' A' ' 719' ' ' VAL . 56.5 Cg_endo -87.91 155.41 7.26 Favored 'Trans proline' 0 N--CA 1.449 -1.121 0 C-N-CA 123.348 2.699 . . . . 99.989999999999995 112.092 -176.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 722' ' ' SER . . . . . 0.719 ' HA ' ' CD2' ' A' ' 808' ' ' LEU . 7.5 t -174.25 -159.84 0.1 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.638 -0.504 . . . . 99.989999999999995 109.638 -174.019 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 723' ' ' ALA . . . . . 0.623 ' O ' HD13 ' A' ' 795' ' ' LEU . . . -156.77 140.67 16.2 Favored 'General case' 0 C--O 1.218 -0.562 0 C-N-CA 121.383 -0.127 . . . . 99.989999999999995 110.741 177.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 22.6 t -136.06 101.25 4.66 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 109.535 -0.543 . . . . 99.989999999999995 109.535 -176.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 725' ' ' LEU . . . . . 0.638 HD11 ' N ' ' A' ' 725' ' ' LEU . 5.6 mp -60.7 139.41 57.88 Favored 'General case' 0 N--CA 1.425 -1.688 0 CA-C-O 122.396 1.093 . . . . 99.989999999999995 112.427 -175.117 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 33.4 mtpt -87.43 -18.12 30.67 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 113.002 -1.908 . . . . 99.989999999999995 109.356 -178.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 727' ' ' LEU . . . . . 0.48 ' HB2' ' HD2' ' A' ' 742' ' ' PRO . 21.2 tp -71.3 110.22 5.8 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.798 -0.816 . . . . 99.989999999999995 108.798 173.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 9.1 t60 -95.19 -48.4 5.94 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.755 -0.378 . . . . 99.989999999999995 111.528 -172.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -101.21 177.71 4.86 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.878 -0.329 . . . . 99.989999999999995 110.871 -177.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 730' ' ' ASP . . . . . 0.441 ' HA ' ' O ' ' A' ' 814' ' ' LYS . 7.7 p-10 -68.73 145.67 53.62 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.568 0.699 . . . . 99.989999999999995 110.933 -178.047 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 731' ' ' LEU . . . . . 0.512 ' HB3' ' HA ' ' A' ' 815' ' ' ILE . 36.4 tp -104.44 111.71 24.48 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.926 -1.034 . . . . 99.989999999999995 111.372 -175.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 732' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -70.35 127.47 32.88 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.258 -0.428 . . . . 99.989999999999995 111.884 -177.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 733' ' ' LEU . . . . . 0.48 HD13 ' CG2' ' A' ' 815' ' ' ILE . 55.4 mt -136.59 163.72 29.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.195 0.522 . . . . 99.989999999999995 111.144 177.101 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 734' ' ' CYS . . . . . 0.478 ' HB3' ' OD2' ' A' ' 820' ' ' ASP . 72.1 m -108.58 -176.18 2.97 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.367 -0.833 . . . . 99.989999999999995 110.036 175.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 735' ' ' LEU . . . . . 0.446 ' HB2' ' HA ' ' A' ' 819' ' ' ARG . 24.7 tp -63.95 131.57 48.06 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.022 0.439 . . . . 99.989999999999995 111.068 -177.285 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 736' ' ' GLY . . . . . 0.436 ' O ' HG11 ' A' ' 784' ' ' VAL . . . 70.27 13.48 70.47 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.446 -0.797 . . . . 99.989999999999995 112.619 177.058 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 737' ' ' ASP . . . . . 0.454 ' HB2' ' O ' ' A' ' 734' ' ' CYS . 0.3 OUTLIER -77.7 150.76 34.43 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.792 0.329 . . . . 99.989999999999995 110.711 178.763 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 16.1 p-80 -111.9 163.06 14.64 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 106.767 -1.568 . . . . 99.989999999999995 106.767 171.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 739' ' ' SER . . . . . 0.415 ' HG ' HD11 ' A' ' 733' ' ' LEU . 0.0 OUTLIER -131.36 174.08 10.42 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 119.526 -0.869 . . . . 99.989999999999995 112.732 -173.325 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 5.6 p -131.36 115.51 16.34 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 114.743 -1.117 . . . . 99.989999999999995 109.282 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 741' ' ' VAL . . . . . . . . . . . . . 3.6 t -113.6 98.98 48.7 Favored Pre-proline 0 C--N 1.318 -0.768 0 CA-C-N 116.161 -0.472 . . . . 99.989999999999995 110.411 -175.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 742' ' ' PRO . . . . . 0.653 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 2.2 Cg_endo -75.88 121.65 6.36 Favored 'Trans proline' 0 N--CA 1.441 -1.579 0 C-N-CA 122.912 2.408 . . . . 99.989999999999995 110.712 -175.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 743' ' ' VAL . . . . . 0.567 ' HA ' ' HA ' ' A' ' 725' ' ' LEU . 1.4 p -125.67 121.52 60.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 121.662 0.744 . . . . 99.989999999999995 112.671 178.226 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 744' ' ' ALA . . . . . 0.564 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -83.42 111.67 19.24 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.544 -0.91 . . . . 99.989999999999995 108.544 169.255 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 745' ' ' LEU . . . . . 0.57 ' HA ' ' HA ' ' A' ' 723' ' ' ALA . 0.3 OUTLIER -95.11 168.99 10.42 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.705 -1.134 . . . . 99.989999999999995 111.251 -165.861 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 746' ' ' LYS . . . . . 0.435 ' HZ3' ' HB2' ' A' ' 746' ' ' LYS . 1.1 tppm? -122.9 147.59 46.41 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 115.27 -0.877 . . . . 99.989999999999995 110.287 -176.262 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 747' ' ' GLY . . . . . 0.429 ' HA3' ' HB3' ' A' ' 721' ' ' PRO . . . 100.73 129.97 6.87 Favored Glycine 0 C--N 1.311 -0.833 0 C-N-CA 120.796 -0.716 . . . . 99.989999999999995 111.451 -177.268 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 748' ' ' GLN . . . . . 0.429 ' C ' ' HE1' ' A' ' 751' ' ' PHE . 2.1 mp0 -108.76 115.71 30.6 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.917 0.389 . . . . 99.989999999999995 111.059 -175.054 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 134.52 -176.31 19.97 Favored Glycine 0 N--CA 1.444 -0.773 0 N-CA-C 111.501 -0.64 . . . . 99.989999999999995 111.501 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_exo -71.89 93.89 0.71 Allowed 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.545 2.163 . . . . 99.989999999999995 111.839 179.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 751' ' ' PHE . . . . . 0.5 ' CD2' ' HA ' ' A' ' 800' ' ' ASP . 78.2 m-85 -110.2 141.95 42.42 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.168 -0.469 . . . . 99.989999999999995 111.41 -178.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 752' ' ' THR . . . . . 0.729 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 94.7 m -90.85 102.66 15.42 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.725 0.774 . . . . 99.989999999999995 109.471 178.271 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 753' ' ' LEU . . . . . . . . . . . . . 24.3 tp -91.82 116.85 29.25 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 114.448 -1.251 . . . . 99.989999999999995 110.461 -171.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 754' ' ' THR . . . . . 0.48 HG23 ' HB2' ' A' ' 769' ' ' GLU . 1.3 m -115.1 130.11 56.85 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.541 -0.299 . . . . 99.989999999999995 111.028 179.363 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 755' ' ' TYR . . . . . 0.538 ' CE1' ' HB2' ' A' ' 768' ' ' PHE . 22.2 p90 -141.31 156.73 45.82 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.856 0.36 . . . . 99.989999999999995 111.338 178.405 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 756' ' ' ASP . . . . . 0.408 ' HA ' ' O ' ' A' ' 766' ' ' LYS . 0.2 OUTLIER -121.07 118.95 31.08 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 115.72 -0.673 . . . . 99.989999999999995 110.37 -176.628 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 757' ' ' ILE . . . . . 0.519 HG13 HD13 ' A' ' 793' ' ' LEU . 3.7 mp -87.98 96.24 5.72 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 107.421 -1.325 . . . . 99.989999999999995 107.421 168.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 758' ' ' ILE . . . . . 0.604 HG13 ' O ' ' A' ' 792' ' ' ILE . 2.5 pp -94.78 149.98 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 CA-C-N 115.306 -0.861 . . . . 99.989999999999995 110.215 -173.363 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 759' ' ' GLU . . . . . 0.573 ' OE2' ' HB2' ' A' ' 762' ' ' SER . 8.2 pt-20 -105.13 125.65 51.21 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 120.173 -0.611 . . . . 99.989999999999995 110.562 178.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 760' ' ' THR . . . . . 0.462 HG23 ' OD2' ' A' ' 790' ' ' ASP . 0.0 OUTLIER -89.94 -3.16 58.19 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.561 -0.903 . . . . 99.989999999999995 108.561 177.444 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 761' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -69.74 -36.18 75.62 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 114.712 -1.131 . . . . 99.989999999999995 110.971 175.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 762' ' ' SER . . . . . 0.573 ' HB2' ' OE2' ' A' ' 759' ' ' GLU . 66.9 m -150.76 -88.8 0.07 Allowed 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 111.675 0.25 . . . . 99.989999999999995 111.675 177.321 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 763' ' ' SER . . . . . . . . . . . . . 26.3 p -176.2 26.14 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.235 0.828 . . . . 99.989999999999995 113.235 -175.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 764' ' ' LYS . . . . . 0.554 ' H ' ' CG ' ' A' ' 759' ' ' GLU . 10.5 mtmp? -105.46 75.89 1.18 Allowed 'General case' 0 C--N 1.327 -0.377 0 O-C-N 121.623 -0.673 . . . . 99.989999999999995 110.408 -178.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 765' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 765' ' ' ARG . 47.2 mtm105 -62.49 152.88 33.3 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.185 -0.916 . . . . 99.989999999999995 111.569 179.247 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 766' ' ' LYS . . . . . 0.658 ' HD3' ' N ' ' A' ' 767' ' ' THR . 7.5 tmtm? -124.5 144.8 49.91 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 108.602 -0.888 . . . . 99.989999999999995 108.602 176.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 767' ' ' THR . . . . . 0.658 ' N ' ' HD3' ' A' ' 766' ' ' LYS . 91.4 m -125.05 137.84 54.21 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 120.879 0.371 . . . . 99.989999999999995 111.742 -176.34 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 768' ' ' PHE . . . . . 0.538 ' HB2' ' CE1' ' A' ' 755' ' ' TYR . 2.1 m-85 -131.89 130.25 41.38 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.903 -0.589 . . . . 99.989999999999995 110.047 171.074 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 769' ' ' GLU . . . . . 0.48 ' HB2' HG23 ' A' ' 754' ' ' THR . 37.1 tt0 -124.6 108.07 11.68 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.693 -0.685 . . . . 99.989999999999995 110.294 179.307 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 770' ' ' ILE . . . . . 0.418 HG21 HG22 ' A' ' 773' ' ' ILE . 4.3 mp -106.76 113.23 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 CA-C-N 116.109 -0.496 . . . . 99.989999999999995 110.196 -178.171 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 771' ' ' LYS . . . . . 0.564 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 1.7 mtpt -81.88 149.57 28.2 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.252 0.548 . . . . 99.989999999999995 111.125 -177.57 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 772' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 57.32 50.19 11.93 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.36 -1.291 . . . . 99.989999999999995 112.652 177.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 773' ' ' ILE . . . . . 0.418 HG22 HG21 ' A' ' 770' ' ' ILE . 0.5 OUTLIER -78.88 119.64 28.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 107.689 -1.226 . . . . 99.989999999999995 107.689 170.692 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 72.3 mttt -118.49 29.72 7.6 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.166 -1.05 . . . . 99.989999999999995 108.166 -177.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 775' ' ' THR . . . . . 0.594 ' O ' ' HB2' ' A' ' 776' ' ' ASN . 0.2 OUTLIER -94.08 -71.27 0.67 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.469 -1.241 . . . . 99.989999999999995 113.266 -167.753 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 776' ' ' ASN . . . . . 0.594 ' HB2' ' O ' ' A' ' 775' ' ' THR . 0.9 OUTLIER 84.8 2.86 0.73 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.326 1.05 . . . . 99.989999999999995 110.273 -176.739 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 777' ' ' GLU . . . . . 0.564 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 7.5 mt-10 -162.31 86.18 0.59 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.107 -0.951 . . . . 99.989999999999995 109.314 174.062 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 778' ' ' TYR . . . . . 0.533 ' HB3' HD11 ' A' ' 745' ' ' LEU . 69.9 t80 -132.38 131.1 41.52 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.614 -0.513 . . . . 99.989999999999995 109.614 -173.53 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 779' ' ' VAL . . . . . 0.653 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 1.5 m -96.93 132.46 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 CA-C-O 122.684 1.231 . . . . 99.989999999999995 110.337 176.685 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 780' ' ' ILE . . . . . . . . . . . . . 88.8 mt -89.21 147.76 4.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-N 112.88 -1.964 . . . . 99.989999999999995 110.143 -170.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -112.09 110.55 20.9 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 120.271 -0.572 . . . . 99.989999999999995 109.575 175.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 782' ' ' THR . . . . . 0.455 HG22 HG12 ' A' ' 757' ' ' ILE . 11.5 p -85.66 142.43 37.12 Favored Pre-proline 0 C--N 1.312 -1.065 0 CA-C-N 115.453 -0.794 . . . . 99.989999999999995 111.076 -177.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 783' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 782' ' ' THR . 32.2 Cg_exo -59.68 160.2 21.81 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 123.614 2.876 . . . . 99.989999999999995 113.233 -174.087 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 784' ' ' VAL . . . . . 0.491 HG12 HG21 ' A' ' 786' ' ' THR . 52.5 t -59.51 115.38 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-N 115.12 -0.945 . . . . 99.989999999999995 111.316 177.18 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 785' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -94.88 95.4 8.63 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.456 -0.793 . . . . 99.989999999999995 110.242 -179.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 786' ' ' THR . . . . . 0.491 HG21 HG12 ' A' ' 784' ' ' VAL . 33.4 p -86.67 35.23 0.67 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 122.026 0.917 . . . . 99.989999999999995 110.648 -178.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 44.3 m -152.79 109.31 3.42 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.457 -1.247 . . . . 99.989999999999995 110.902 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 788' ' ' GLY . . . . . 0.45 ' HA2' HG12 ' A' ' 817' ' ' VAL . . . -52.42 109.14 0.82 Allowed Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 121.046 -0.597 . . . . 99.989999999999995 112.16 169.503 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 789' ' ' GLY . . . . . . . . . . . . . . . -169.91 176.58 43.66 Favored Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 110.82 -0.912 . . . . 99.989999999999995 110.82 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 790' ' ' ASP . . . . . 0.462 ' OD2' HG23 ' A' ' 760' ' ' THR . 0.4 OUTLIER -103.12 133.12 48.75 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.384 0.612 . . . . 99.989999999999995 110.58 -178.563 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 791' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -123.66 148.41 46.51 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.342 -0.844 . . . . 99.989999999999995 109.697 -179.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 792' ' ' ILE . . . . . 0.604 ' O ' HG13 ' A' ' 758' ' ' ILE . 14.1 mt -128.62 114.28 32.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 N-CA-C 109.302 -0.629 . . . . 99.989999999999995 109.302 177.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 793' ' ' LEU . . . . . 0.552 HD11 ' N ' ' A' ' 794' ' ' SER . 0.7 OUTLIER -84.62 113.44 21.27 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 108.842 -0.799 . . . . 99.989999999999995 108.842 178.122 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 794' ' ' SER . . . . . 0.552 ' N ' HD11 ' A' ' 793' ' ' LEU . 13.7 p -124.68 164.34 20.1 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.344 -1.298 . . . . 99.989999999999995 109.315 -174.647 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 795' ' ' LEU . . . . . 0.623 HD13 ' O ' ' A' ' 723' ' ' ALA . 36.7 mt -89.4 144.85 25.74 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.688 -0.233 . . . . 99.989999999999995 110.942 -176.528 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 796' ' ' VAL . . . . . . . . . . . . . 68.8 t -104.88 -57.68 4.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.857 -0.337 . . . . 99.989999999999995 111.159 177.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 797' ' ' SER . . . . . 0.492 ' HA ' ' HG ' ' A' ' 808' ' ' LEU . 10.4 m -176.95 161.53 1.96 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.019 -0.537 . . . . 99.989999999999995 109.978 -175.283 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 798' ' ' ILE . . . . . 0.555 ' HA ' ' O ' ' A' ' 752' ' ' THR . 11.7 tt -132.07 162.11 40.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 108.679 -0.859 . . . . 99.989999999999995 108.679 176.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 799' ' ' LYS . . . . . 0.729 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 5.2 tmtt? -137.4 119.84 15.91 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.097 0.475 . . . . 99.989999999999995 111.024 -178.819 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 800' ' ' ASP . . . . . 0.5 ' HA ' ' CD2' ' A' ' 751' ' ' PHE . 11.7 t70 -64.23 153.0 39.36 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.256 -0.884 . . . . 99.989999999999995 108.982 174.046 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 3.5 p -68.02 0.92 3.08 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.423 0.527 . . . . 99.989999999999995 112.423 -173.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 24.3 p -92.95 -0.46 57.21 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.657 0.741 . . . . 99.989999999999995 109.511 172.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 803' ' ' GLY . . . . . 0.425 ' HA2' ' HE2' ' A' ' 799' ' ' LYS . . . 81.05 41.92 9.97 Favored Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 114.895 -1.048 . . . . 99.989999999999995 111.8 -177.459 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 804' ' ' CYS . . . . . . . . . . . . . 63.4 m -113.78 114.22 26.02 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 110.181 -0.303 . . . . 99.989999999999995 110.181 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 805' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 8.3 p -86.52 134.25 27.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.313 0.578 . . . . 99.989999999999995 110.831 -177.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 806' ' ' VAL . . . . . . . . . . . . . 53.2 t -123.04 134.84 64.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.717 0 CA-C-N 115.563 -0.744 . . . . 99.989999999999995 110.365 178.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -66.24 127.29 29.5 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 114.816 -1.084 . . . . 99.989999999999995 111.939 -179.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 808' ' ' LEU . . . . . 0.719 ' CD2' ' HA ' ' A' ' 722' ' ' SER . 45.6 mt -90.81 126.62 36.08 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 111.772 0.286 . . . . 99.989999999999995 111.772 -177.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 5.6 p -149.47 85.95 1.46 Allowed 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 121.522 0.677 . . . . 99.989999999999995 110.97 173.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 810' ' ' GLN . . . . . 0.612 ' HB2' ' O ' ' A' ' 723' ' ' ALA . 90.8 mt-30 -140.5 168.02 15.93 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 107.557 -1.275 . . . . 99.989999999999995 107.557 172.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 811' ' ' PRO . . . . . 0.488 ' HD2' ' HB3' ' A' ' 810' ' ' GLN . 86.6 Cg_exo -45.34 137.33 10.88 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 123.098 2.532 . . . . 99.989999999999995 115.228 -173.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -103.25 166.72 10.26 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 114.62 -1.173 . . . . 99.989999999999995 110.303 177.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 813' ' ' ALA . . . . . 0.404 ' CB ' HD21 ' A' ' 725' ' ' LEU . . . -119.68 161.11 21.24 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.575 -0.284 . . . . 99.989999999999995 111.245 -177.175 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 814' ' ' LYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 730' ' ' ASP . 73.9 tttt -123.98 125.2 44.16 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 121.163 0.506 . . . . 99.989999999999995 110.834 177.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 815' ' ' ILE . . . . . 0.512 ' HA ' ' HB3' ' A' ' 731' ' ' LEU . 5.3 mp -109.39 119.24 58.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 108.32 -0.992 . . . . 99.989999999999995 108.32 176.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 816' ' ' GLN . . . . . 0.683 ' NE2' ' HG2' ' A' ' 818' ' ' ARG . 0.8 OUTLIER -108.95 114.51 28.33 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.217 0.532 . . . . 99.989999999999995 111.062 -174.748 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 817' ' ' VAL . . . . . 0.45 HG12 ' HA2' ' A' ' 788' ' ' GLY . 84.4 t -103.97 140.52 21.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 115.786 -0.643 . . . . 99.989999999999995 110.316 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 818' ' ' ARG . . . . . 0.683 ' HG2' ' NE2' ' A' ' 816' ' ' GLN . 34.1 mmt180 -141.85 154.95 45.52 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.745 -0.835 . . . . 99.989999999999995 108.745 172.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 819' ' ' ARG . . . . . 0.446 ' HA ' ' HB2' ' A' ' 735' ' ' LEU . 9.1 mtm180 -85.91 140.0 30.74 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.618 -0.433 . . . . 99.989999999999995 110.724 -174.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 820' ' ' ASP . . . . . 0.478 ' OD2' ' HB3' ' A' ' 734' ' ' CYS . 11.3 p-10 . . . . . 0 C--N 1.317 -0.812 0 CA-C-N 115.785 -0.643 . . . . 99.989999999999995 109.766 178.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 718' ' ' ARG . . . . . . . . . . . . . 18.9 tpt180 . . . . . 0 CA--C 1.513 -0.453 0 CA-C-O 121.983 0.897 . . . . 99.989999999999995 110.361 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 719' ' ' VAL . . . . . . . . . . . . . 2.5 m -133.16 155.78 41.3 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 CA-C-N 114.744 -1.116 . . . . 99.989999999999995 109.463 -175.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 720' ' ' LYS . . . . . . . . . . . . . 16.7 mtpp -87.27 110.65 35.35 Favored Pre-proline 0 C--N 1.307 -1.277 0 CA-C-N 115.2 -0.909 . . . . 99.989999999999995 109.64 -178.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 721' ' ' PRO . . . . . 0.424 ' HG3' ' CE2' ' A' ' 751' ' ' PHE . 60.6 Cg_endo -88.5 154.93 6.48 Favored 'Trans proline' 0 N--CA 1.447 -1.217 0 C-N-CA 122.713 2.275 . . . . 99.989999999999995 112.472 -174.209 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 722' ' ' SER . . . . . 0.496 ' HA ' ' CD2' ' A' ' 808' ' ' LEU . 11.4 t 178.49 -152.4 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.783 -0.644 . . . . 99.989999999999995 109.871 -176.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 723' ' ' ALA . . . . . 0.574 ' HA ' ' HA ' ' A' ' 745' ' ' LEU . . . -152.53 153.65 33.87 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 109.548 -0.538 . . . . 99.989999999999995 109.548 178.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 49.7 m -144.45 98.67 3.24 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.213 0.53 . . . . 99.989999999999995 109.634 175.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 725' ' ' LEU . . . . . 0.658 HD11 ' N ' ' A' ' 725' ' ' LEU . 4.9 mp -62.38 141.45 58.32 Favored 'General case' 0 N--CA 1.424 -1.747 0 CA-C-O 122.4 1.095 . . . . 99.989999999999995 111.808 -175.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 726' ' ' LYS . . . . . 0.44 ' HD2' ' HB1' ' A' ' 744' ' ' ALA . 19.2 mtpp -94.79 -13.02 26.02 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 112.887 -1.96 . . . . 99.989999999999995 110.288 -173.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 727' ' ' LEU . . . . . 0.531 ' HB2' ' HD2' ' A' ' 742' ' ' PRO . 0.9 OUTLIER -82.3 112.38 19.24 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.363 -0.977 . . . . 99.989999999999995 108.363 176.096 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 51.5 m-70 -114.67 54.25 0.78 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.713 0.635 . . . . 99.989999999999995 112.713 -172.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 7.6 p80 -178.15 -178.08 0.63 Allowed 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.762 -0.199 . . . . 99.989999999999995 110.492 176.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 730' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -81.58 125.84 31.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.35 -0.387 . . . . 99.989999999999995 110.303 176.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 731' ' ' LEU . . . . . 0.578 ' HB2' ' HA ' ' A' ' 815' ' ' ILE . 21.2 mt -79.95 113.14 17.89 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.398 -0.364 . . . . 99.989999999999995 111.215 177.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 732' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -76.61 109.94 10.78 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.922 -0.581 . . . . 99.989999999999995 111.092 -176.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 733' ' ' LEU . . . . . 0.537 HD13 ' CG2' ' A' ' 815' ' ' ILE . 64.3 mt -122.94 164.21 18.92 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.16 0.505 . . . . 99.989999999999995 110.864 177.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 734' ' ' CYS . . . . . 0.522 ' O ' ' HB2' ' A' ' 737' ' ' ASP . 76.3 m -113.75 -174.28 2.44 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.262 -0.881 . . . . 99.989999999999995 109.023 170.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 735' ' ' LEU . . . . . . . . . . . . . 8.6 tp -68.37 135.24 51.5 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 121.448 0.642 . . . . 99.989999999999995 111.898 -176.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 81.37 8.74 86.77 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 114.854 -1.066 . . . . 99.989999999999995 111.996 -178.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 737' ' ' ASP . . . . . 0.522 ' HB2' ' O ' ' A' ' 734' ' ' CYS . 4.1 m-20 -89.67 151.48 21.85 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.849 0.685 . . . . 99.989999999999995 112.849 179.319 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 738' ' ' HIS . . . . . 0.433 ' HB2' ' O ' ' A' ' 782' ' ' THR . 45.4 p-80 -114.2 -175.53 2.7 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 108.071 -1.085 . . . . 99.989999999999995 108.071 169.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 739' ' ' SER . . . . . 0.476 ' HB2' ' OG1' ' A' ' 782' ' ' THR . 9.2 m -141.55 174.39 10.61 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.567 0.698 . . . . 99.989999999999995 112.471 178.021 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 14.1 t -141.67 103.04 4.3 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 114.714 -1.13 . . . . 99.989999999999995 108.489 178.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 741' ' ' VAL . . . . . 0.436 HG12 HD23 ' A' ' 793' ' ' LEU . 1.7 p -107.57 114.65 60.36 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 115.692 -0.685 . . . . 99.989999999999995 110.642 -175.542 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 742' ' ' PRO . . . . . 0.597 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 1.0 OUTLIER -73.64 129.19 13.34 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 122.488 2.126 . . . . 99.989999999999995 111.286 179.403 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 743' ' ' VAL . . . . . 0.514 ' HA ' ' HA ' ' A' ' 725' ' ' LEU . 1.5 p -128.53 119.92 51.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.308 0.575 . . . . 99.989999999999995 111.759 175.014 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 744' ' ' ALA . . . . . 0.554 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -85.1 105.51 15.88 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.08 -1.082 . . . . 99.989999999999995 108.08 169.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 745' ' ' LEU . . . . . 0.574 ' HA ' ' HA ' ' A' ' 723' ' ' ALA . 0.4 OUTLIER -85.23 168.0 15.15 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 114.525 -1.216 . . . . 99.989999999999995 111.156 -167.403 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 12.3 tttp -121.23 155.43 34.63 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.678 0.752 . . . . 99.989999999999995 110.724 -177.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 747' ' ' GLY . . . . . . . . . . . . . . . 97.66 135.92 8.92 Favored Glycine 0 C--N 1.306 -1.121 0 CA-C-N 114.441 -1.254 . . . . 99.989999999999995 111.229 -178.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 60.9 mm-40 -106.46 116.74 32.46 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.433 -0.507 . . . . 99.989999999999995 110.858 -173.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 130.28 164.77 11.42 Favored Glycine 0 CA--C 1.496 -1.114 0 CA-C-N 115.526 -0.761 . . . . 99.989999999999995 111.518 -175.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 750' ' ' PRO . . . . . 0.514 ' HB3' ' HE2' ' A' ' 774' ' ' LYS . 46.2 Cg_endo -60.31 94.08 0.1 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 123.388 2.725 . . . . 99.989999999999995 111.768 172.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 751' ' ' PHE . . . . . 0.462 ' CE2' ' HA ' ' A' ' 800' ' ' ASP . 44.0 m-85 -105.0 143.34 33.32 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.728 -0.669 . . . . 99.989999999999995 111.103 -177.149 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 752' ' ' THR . . . . . 0.739 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 93.0 m -88.44 102.97 15.42 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 121.563 0.697 . . . . 99.989999999999995 109.137 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 753' ' ' LEU . . . . . . . . . . . . . 23.6 tp -93.3 117.81 30.52 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.379 -1.282 . . . . 99.989999999999995 110.844 -169.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 754' ' ' THR . . . . . 0.501 HG23 ' HB2' ' A' ' 769' ' ' GLU . 1.4 m -117.99 132.11 56.42 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.707 0.289 . . . . 99.989999999999995 110.642 179.518 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 755' ' ' TYR . . . . . 0.522 ' CE1' ' HB3' ' A' ' 768' ' ' PHE . 24.1 p90 -142.45 156.94 45.22 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.89 0.376 . . . . 99.989999999999995 111.438 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 756' ' ' ASP . . . . . 0.487 ' HA ' ' O ' ' A' ' 766' ' ' LYS . 0.1 OUTLIER -119.76 118.83 31.89 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.559 -0.746 . . . . 99.989999999999995 110.526 -179.282 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 757' ' ' ILE . . . . . 0.596 ' CD1' HD13 ' A' ' 793' ' ' LEU . 3.6 mp -87.22 96.39 5.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 N-CA-C 107.279 -1.378 . . . . 99.989999999999995 107.279 167.348 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 758' ' ' ILE . . . . . 0.465 HG13 ' O ' ' A' ' 792' ' ' ILE . 2.4 pp -96.08 144.33 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 CA-C-N 115.699 -0.682 . . . . 99.989999999999995 110.562 -171.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 759' ' ' GLU . . . . . 0.54 ' CG ' ' H ' ' A' ' 764' ' ' LYS . 5.6 pt-20 -95.64 124.37 39.63 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 119.47 -0.892 . . . . 99.989999999999995 109.988 177.138 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 760' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.19 -0.24 57.52 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.346 -0.983 . . . . 99.989999999999995 108.346 177.44 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 761' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -69.01 -36.3 77.63 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 114.596 -1.183 . . . . 99.989999999999995 109.996 175.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 762' ' ' SER . . . . . 0.463 ' HB2' ' OE1' ' A' ' 759' ' ' GLU . 1.2 m -148.6 -81.51 0.12 Allowed 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.358 -0.383 . . . . 99.989999999999995 110.464 174.276 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 763' ' ' SER . . . . . . . . . . . . . 81.1 p -174.35 10.99 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.234 0.827 . . . . 99.989999999999995 113.234 -176.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 764' ' ' LYS . . . . . 0.54 ' H ' ' CG ' ' A' ' 759' ' ' GLU . 96.7 mttt -83.56 73.81 10.18 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.262 0.553 . . . . 99.989999999999995 110.414 -173.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 765' ' ' ARG . . . . . 0.431 ' HA ' ' HA ' ' A' ' 758' ' ' ILE . 42.4 mtm180 -65.96 141.99 58.01 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.506 -0.77 . . . . 99.989999999999995 111.443 -179.084 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 766' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 756' ' ' ASP . 1.0 OUTLIER -121.44 136.05 55.0 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.998 -0.546 . . . . 99.989999999999995 110.018 -179.037 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 767' ' ' THR . . . . . . . . . . . . . 60.7 m -115.38 136.73 52.79 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.995 -0.548 . . . . 99.989999999999995 110.89 -175.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 768' ' ' PHE . . . . . 0.522 ' HB3' ' CE1' ' A' ' 755' ' ' TYR . 2.8 t80 -138.33 135.68 35.65 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 109.079 -0.712 . . . . 99.989999999999995 109.079 175.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 769' ' ' GLU . . . . . 0.501 ' HB2' HG23 ' A' ' 754' ' ' THR . 33.2 tt0 -127.17 133.15 50.36 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.152 -0.476 . . . . 99.989999999999995 111.117 -179.277 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 4.1 mt -123.9 109.04 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 N-CA-C 108.649 -0.871 . . . . 99.989999999999995 108.649 175.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 771' ' ' LYS . . . . . 0.562 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 9.6 mtpt -80.12 151.59 29.73 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-O 121.35 0.595 . . . . 99.989999999999995 111.035 -176.162 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 772' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 55.35 50.66 14.41 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.312 -1.313 . . . . 99.989999999999995 112.393 176.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 773' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -74.99 122.07 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 107.447 -1.316 . . . . 99.989999999999995 107.447 170.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 774' ' ' LYS . . . . . 0.514 ' HE2' ' HB3' ' A' ' 750' ' ' PRO . 65.5 mttt -115.38 25.42 10.84 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.364 -0.835 . . . . 99.989999999999995 108.818 -176.329 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 775' ' ' THR . . . . . 0.621 ' O ' ' HB2' ' A' ' 776' ' ' ASN . 0.7 OUTLIER -96.33 -73.36 0.6 Allowed 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 114.002 1.112 . . . . 99.989999999999995 114.002 -169.551 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 776' ' ' ASN . . . . . 0.621 ' HB2' ' O ' ' A' ' 775' ' ' THR . 0.7 OUTLIER 85.97 3.65 0.53 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.548 1.139 . . . . 99.989999999999995 111.242 -173.345 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 777' ' ' GLU . . . . . 0.554 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 30.0 mt-10 -161.27 84.64 0.65 Allowed 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.977 -0.749 . . . . 99.989999999999995 108.977 177.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 778' ' ' TYR . . . . . 0.475 ' HB3' HD11 ' A' ' 745' ' ' LEU . 89.9 t80 -132.72 133.01 42.94 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.305 -0.407 . . . . 99.989999999999995 110.897 -169.588 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 779' ' ' VAL . . . . . 0.597 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 12.2 t -93.5 114.36 30.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.465 0.65 . . . . 99.989999999999995 110.555 179.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 780' ' ' ILE . . . . . 0.525 HG23 ' N ' ' A' ' 781' ' ' LYS . 70.6 mt -79.4 147.52 6.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 114.843 -1.071 . . . . 99.989999999999995 110.606 -177.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 781' ' ' LYS . . . . . 0.525 ' N ' HG23 ' A' ' 780' ' ' ILE . 0.0 OUTLIER -117.89 100.67 7.73 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.484 -0.561 . . . . 99.989999999999995 109.484 175.222 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 782' ' ' THR . . . . . 0.476 ' OG1' ' HB2' ' A' ' 739' ' ' SER . 62.1 p -70.16 135.19 87.08 Favored Pre-proline 0 N--CA 1.441 -0.884 0 CA-C-N 115.896 -0.593 . . . . 99.989999999999995 109.633 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 783' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 782' ' ' THR . 25.5 Cg_exo -62.66 156.21 54.28 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.793 2.329 . . . . 99.989999999999995 111.303 -175.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 784' ' ' VAL . . . . . 0.455 ' O ' HG11 ' A' ' 784' ' ' VAL . 14.6 p -58.64 127.87 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 CA-C-O 121.489 0.661 . . . . 99.989999999999995 109.974 -177.745 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 785' ' ' PHE . . . . . 0.516 ' C ' ' H ' ' A' ' 787' ' ' THR . 94.7 m-85 -81.88 -31.83 31.33 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.614 -0.721 . . . . 99.989999999999995 111.419 -172.122 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 43.1 p 56.64 2.49 0.1 Allowed 'General case' 0 N--CA 1.471 0.59 0 O-C-N 124.065 0.853 . . . . 99.989999999999995 112.233 178.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 787' ' ' THR . . . . . 0.516 ' H ' ' C ' ' A' ' 785' ' ' PHE . 14.8 m -139.93 122.91 16.68 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.211 -0.45 . . . . 99.989999999999995 111.05 -179.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 788' ' ' GLY . . . . . . . . . . . . . . . -58.76 111.23 3.11 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.542 -0.837 . . . . 99.989999999999995 112.304 168.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 789' ' ' GLY . . . . . 0.428 ' H ' ' HB ' ' A' ' 817' ' ' VAL . . . -166.89 167.21 39.58 Favored Glycine 0 N--CA 1.442 -0.916 0 N-CA-C 110.127 -1.189 . . . . 99.989999999999995 110.127 178.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -99.11 130.98 45.47 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 117.674 0.737 . . . . 99.989999999999995 109.72 -179.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 791' ' ' TYR . . . . . 0.413 ' CE2' ' HB3' ' A' ' 759' ' ' GLU . 86.9 m-85 -124.3 153.48 41.68 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.29 0.567 . . . . 99.989999999999995 110.885 -178.407 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 792' ' ' ILE . . . . . 0.465 ' O ' HG13 ' A' ' 758' ' ' ILE . 7.2 mt -130.72 113.97 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 CA-C-N 115.283 -0.871 . . . . 99.989999999999995 108.944 176.113 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 793' ' ' LEU . . . . . 0.596 HD13 ' CD1' ' A' ' 757' ' ' ILE . 1.3 tp -84.74 110.68 18.97 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 108.692 -0.855 . . . . 99.989999999999995 108.692 176.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 794' ' ' SER . . . . . 0.506 ' N ' HD11 ' A' ' 793' ' ' LEU . 6.1 p -124.7 157.5 35.49 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.53 -1.214 . . . . 99.989999999999995 109.729 -173.472 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 795' ' ' LEU . . . . . 0.428 HD22 ' HB2' ' A' ' 723' ' ' ALA . 51.4 mt -85.29 133.39 34.16 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.57 -0.287 . . . . 99.989999999999995 111.147 -174.42 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 796' ' ' VAL . . . . . . . . . . . . . 79.2 t -95.62 -55.06 6.45 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 CA-C-N 116.258 -0.428 . . . . 99.989999999999995 110.715 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 797' ' ' SER . . . . . 0.551 ' HA ' ' HG ' ' A' ' 808' ' ' LEU . 97.5 p -176.7 158.55 1.71 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.814 -0.63 . . . . 99.989999999999995 109.988 -173.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 798' ' ' ILE . . . . . 0.506 ' HA ' ' O ' ' A' ' 752' ' ' THR . 8.0 tt -131.01 163.88 35.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 108.398 -0.964 . . . . 99.989999999999995 108.398 176.182 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 799' ' ' LYS . . . . . 0.739 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 16.5 ttmt -140.91 125.82 18.2 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.06 0.457 . . . . 99.989999999999995 111.503 -177.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 800' ' ' ASP . . . . . 0.462 ' HA ' ' CE2' ' A' ' 751' ' ' PHE . 28.2 t70 -65.98 155.77 35.61 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.44 -0.8 . . . . 99.989999999999995 109.517 174.024 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 801' ' ' SER . . . . . 0.405 ' HB3' ' HG2' ' A' ' 750' ' ' PRO . 18.2 p -59.03 -10.05 2.33 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 113.016 0.747 . . . . 99.989999999999995 113.016 -171.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 36.1 p -96.76 8.83 43.39 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.37 0.605 . . . . 99.989999999999995 110.324 179.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 803' ' ' GLY . . . . . . . . . . . . . . . 76.17 41.37 26.83 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 115.321 -0.854 . . . . 99.989999999999995 112.038 -178.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 804' ' ' CYS . . . . . 0.405 ' HB2' ' HB3' ' A' ' 800' ' ' ASP . 76.7 m -109.72 111.74 23.38 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 110.08 -0.341 . . . . 99.989999999999995 110.08 178.247 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 805' ' ' VAL . . . . . 0.438 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 14.4 p -86.25 139.46 17.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.422 0.63 . . . . 99.989999999999995 111.702 -174.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 806' ' ' VAL . . . . . 0.452 ' HB ' HG22 ' A' ' 798' ' ' ILE . 52.0 t -119.21 131.99 70.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.075 -0.966 . . . . 99.989999999999995 109.551 177.318 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -72.99 114.07 4.62 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.798 -0.715 . . . . 99.989999999999995 111.791 179.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 808' ' ' LEU . . . . . 0.551 ' HG ' ' HA ' ' A' ' 797' ' ' SER . 36.0 mt -84.9 124.46 31.66 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.633 0.605 . . . . 99.989999999999995 112.633 -173.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 19.1 t -138.98 86.51 2.14 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.619 -0.719 . . . . 99.989999999999995 109.241 171.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 810' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -146.91 173.55 4.11 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-N 115.3 -0.864 . . . . 99.989999999999995 109.873 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 811' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_exo -43.53 144.36 2.12 Favored 'Trans proline' 0 C--N 1.357 1.019 0 C-N-CA 123.618 2.879 . . . . 99.989999999999995 115.812 -173.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -116.22 169.1 9.54 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 114.554 -1.203 . . . . 99.989999999999995 110.546 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 813' ' ' ALA . . . . . 0.47 ' HB2' HD21 ' A' ' 725' ' ' LEU . . . -120.68 160.15 23.87 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.732 -0.667 . . . . 99.989999999999995 109.994 175.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 814' ' ' LYS . . . . . 0.451 ' HG2' ' CG1' ' A' ' 792' ' ' ILE . 48.3 mttp -123.62 134.31 53.81 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.451 0.643 . . . . 99.989999999999995 110.648 177.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 815' ' ' ILE . . . . . 0.578 ' HA ' ' HB2' ' A' ' 731' ' ' LEU . 5.3 mp -121.16 108.48 22.66 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 CA-C-N 115.055 -0.975 . . . . 99.989999999999995 108.898 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 816' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -100.87 108.01 19.68 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.257 0.551 . . . . 99.989999999999995 110.441 -176.312 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 817' ' ' VAL . . . . . 0.49 ' HA ' ' HB2' ' A' ' 733' ' ' LEU . 2.9 t -101.91 146.86 9.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 N-CA-C 109.287 -0.634 . . . . 99.989999999999995 109.287 -179.312 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 818' ' ' ARG . . . . . . . . . . . . . 20.7 tpt180 -140.79 131.63 25.91 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.467 0.651 . . . . 99.989999999999995 112.175 -178.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 819' ' ' ARG . . . . . . . . . . . . . 20.9 ttt180 -99.09 117.73 34.23 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.132 -0.94 . . . . 99.989999999999995 109.274 173.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 820' ' ' ASP . . . . . . . . . . . . . 38.6 t70 . . . . . 0 C--N 1.328 -0.327 0 O-C-N 123.494 0.496 . . . . 99.989999999999995 110.798 -176.55 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 720' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp . . . . . 0 N--CA 1.446 -0.657 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 721' ' ' PRO . . . . . 0.516 ' HB2' HD13 ' A' ' 798' ' ' ILE . 62.7 Cg_endo -87.62 155.97 7.67 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 122.948 2.432 . . . . 0.0 112.071 -174.296 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 722' ' ' SER . . . . . 0.588 ' HA ' HD22 ' A' ' 808' ' ' LEU . 12.7 t -176.77 -146.42 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -174.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 723' ' ' ALA . . . . . 0.521 ' HA ' ' HA ' ' A' ' 745' ' ' LEU . . . -153.24 149.31 27.82 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.658 0.266 . . . . 0.0 110.621 177.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 70.6 m -135.11 98.42 3.99 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 725' ' ' LEU . . . . . 0.578 HD22 ' CG2' ' A' ' 743' ' ' VAL . 2.3 mt -64.67 141.91 58.61 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.571 -171.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 33.3 mtpt -93.47 -22.51 18.83 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.043 -176.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 727' ' ' LEU . . . . . 0.491 ' HB2' ' HD2' ' A' ' 742' ' ' PRO . 0.2 OUTLIER -70.24 108.7 4.29 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 173.771 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 34.2 m170 -104.78 42.93 1.15 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -169.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 729' ' ' HIS . . . . . 0.403 ' O ' HD12 ' A' ' 727' ' ' LEU . 6.7 p80 -179.45 -177.21 0.42 Allowed 'General case' 0 C--N 1.327 -0.402 0 O-C-N 123.238 0.336 . . . . 0.0 110.279 176.004 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 730' ' ' ASP . . . . . 0.492 ' HB3' ' HE2' ' A' ' 814' ' ' LYS . 5.0 p-10 -78.47 153.96 30.96 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.075 0.464 . . . . 0.0 110.86 179.198 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 731' ' ' LEU . . . . . 0.565 ' HB2' ' HA ' ' A' ' 815' ' ' ILE . 49.1 mt -102.53 137.35 40.88 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.672 178.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 732' ' ' LYS . . . . . . . . . . . . . 35.2 mmtm -104.12 103.83 13.67 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.155 0.503 . . . . 0.0 110.901 177.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 733' ' ' LEU . . . . . 0.585 HD22 HG23 ' A' ' 815' ' ' ILE . 0.8 OUTLIER -112.01 164.17 13.44 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.725 -178.972 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 734' ' ' CYS . . . . . 0.632 ' O ' ' HB2' ' A' ' 737' ' ' ASP . 56.6 m -104.65 -176.8 3.18 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 171.555 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 735' ' ' LEU . . . . . . . . . . . . . 10.3 tt -84.28 137.23 33.57 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 119.767 -0.773 . . . . 0.0 109.639 -175.21 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 82.97 8.02 86.36 Favored Glycine 0 N--CA 1.441 -0.989 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.845 -171.217 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 737' ' ' ASP . . . . . 0.632 ' HB2' ' O ' ' A' ' 734' ' ' CYS . 0.5 OUTLIER -93.27 145.9 24.1 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.13 0.49 . . . . 0.0 111.546 177.262 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 738' ' ' HIS . . . . . 0.532 ' HB2' ' O ' ' A' ' 782' ' ' THR . 40.8 p-80 -110.76 175.82 5.28 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 170.173 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 739' ' ' SER . . . . . 0.409 ' CB ' HD21 ' A' ' 733' ' ' LEU . 0.0 OUTLIER -132.19 173.02 11.68 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 120.019 -0.672 . . . . 0.0 111.883 -177.344 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 36.8 m -143.03 106.82 4.65 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.032 -0.986 . . . . 0.0 109.702 178.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 741' ' ' VAL . . . . . 0.604 HG11 HD23 ' A' ' 793' ' ' LEU . 0.8 OUTLIER -110.32 111.92 57.41 Favored Pre-proline 0 C--N 1.318 -0.771 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.177 -176.871 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 742' ' ' PRO . . . . . 0.792 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 4.0 Cg_exo -72.16 131.29 17.69 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 122.434 2.089 . . . . 0.0 111.249 -179.378 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 743' ' ' VAL . . . . . 0.578 ' CG2' HD22 ' A' ' 725' ' ' LEU . 41.2 t -131.3 118.05 38.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.503 0.668 . . . . 0.0 112.742 -179.187 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 744' ' ' ALA . . . . . 0.614 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -82.75 97.42 8.57 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 122.009 0.909 . . . . 0.0 108.621 170.533 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 745' ' ' LEU . . . . . 0.739 HD11 ' HB3' ' A' ' 778' ' ' TYR . 2.5 mt -76.72 159.72 29.93 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 113.972 -1.467 . . . . 0.0 111.86 -168.528 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -111.61 146.78 36.8 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.08 -178.631 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 747' ' ' GLY . . . . . 0.435 ' HA3' ' HB3' ' A' ' 721' ' ' PRO . . . 103.24 119.87 4.68 Favored Glycine 0 C--N 1.304 -1.204 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.622 -178.416 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 748' ' ' GLN . . . . . 0.429 ' C ' ' HE1' ' A' ' 751' ' ' PHE . 0.0 OUTLIER -105.43 110.01 22.2 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.138 0.494 . . . . 0.0 111.2 -173.415 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 136.23 -175.68 20.76 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.877 -176.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -71.04 94.1 0.64 Allowed 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.397 2.064 . . . . 0.0 111.865 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 751' ' ' PHE . . . . . 0.574 ' HA ' ' O ' ' A' ' 799' ' ' LYS . 88.1 m-85 -113.2 140.46 47.92 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.368 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 752' ' ' THR . . . . . 0.682 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 98.0 m -89.92 104.99 17.5 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 121.556 0.693 . . . . 0.0 109.243 178.237 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 753' ' ' LEU . . . . . . . . . . . . . 21.3 tp -92.24 116.96 29.41 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 114.374 -1.285 . . . . 0.0 110.532 -172.323 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 754' ' ' THR . . . . . 0.453 HG23 ' HB2' ' A' ' 769' ' ' GLU . 0.9 OUTLIER -117.88 130.18 56.09 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.21 179.241 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 755' ' ' TYR . . . . . 0.565 ' CE1' ' HB3' ' A' ' 768' ' ' PHE . 20.8 p90 -139.43 153.8 47.66 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 120.741 -0.384 . . . . 0.0 111.582 -179.375 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 756' ' ' ASP . . . . . 0.488 ' HB2' HG23 ' A' ' 758' ' ' ILE . 7.6 p-10 -114.93 118.85 34.62 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.823 -176.566 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 757' ' ' ILE . . . . . 0.513 HG13 HD13 ' A' ' 793' ' ' LEU . 3.6 mp -91.68 95.36 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 167.462 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 758' ' ' ILE . . . . . 0.527 HG13 ' O ' ' A' ' 792' ' ' ILE . 2.3 pp -103.93 149.67 7.62 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.061 -170.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -96.89 135.28 39.1 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.364 177.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 760' ' ' THR . . . . . 0.48 ' OG1' ' HB3' ' A' ' 790' ' ' ASP . 38.7 p . . . . . 0 N--CA 1.44 -0.938 0 CA-C-O 121.904 0.859 . . . . 0.0 108.684 174.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 765' ' ' ARG . . . . . 0.473 ' CG ' HG22 ' A' ' 758' ' ' ILE . 15.2 ttp180 . . . . . 0 N--CA 1.445 -0.688 0 CA-C-O 121.252 0.548 . . . . 0.0 111.88 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 766' ' ' LYS . . . . . 0.584 ' HD3' ' N ' ' A' ' 767' ' ' THR . 9.3 tmtm? -97.99 144.11 27.85 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 177.202 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 767' ' ' THR . . . . . 0.584 ' N ' ' HD3' ' A' ' 766' ' ' LYS . 60.0 m -132.3 132.61 43.16 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.603 -178.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 768' ' ' PHE . . . . . 0.565 ' HB3' ' CE1' ' A' ' 755' ' ' TYR . 1.7 t80 -130.83 136.25 48.49 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 769' ' ' GLU . . . . . 0.453 ' HB2' HG23 ' A' ' 754' ' ' THR . 35.1 tt0 -128.83 118.71 23.19 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.954 -177.413 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 770' ' ' ILE . . . . . 0.437 HG22 HG22 ' A' ' 773' ' ' ILE . 7.7 mt -115.68 112.26 39.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 178.146 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 771' ' ' LYS . . . . . 0.635 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 3.1 mtpt -82.25 150.61 27.21 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 121.431 0.634 . . . . 0.0 111.528 -176.347 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 772' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 56.21 48.32 17.6 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 113.985 -1.462 . . . . 0.0 112.549 176.099 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 773' ' ' ILE . . . . . 0.668 HD12 ' H ' ' A' ' 775' ' ' THR . 0.5 OUTLIER -74.58 119.09 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 173.215 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 76.2 mttt -117.91 31.32 6.76 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -178.09 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 775' ' ' THR . . . . . 0.668 ' H ' HD12 ' A' ' 773' ' ' ILE . 2.1 m -95.74 -69.99 0.73 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.388 -1.278 . . . . 0.0 112.55 -172.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 776' ' ' ASN . . . . . 0.579 ' HB2' ' O ' ' A' ' 775' ' ' THR . 0.9 OUTLIER 82.78 4.43 1.0 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.825 0.85 . . . . 0.0 110.547 -177.092 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 777' ' ' GLU . . . . . 0.614 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 9.4 mt-10 -160.88 85.8 0.7 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.344 175.492 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 778' ' ' TYR . . . . . 0.739 ' HB3' HD11 ' A' ' 745' ' ' LEU . 75.6 t80 -136.26 126.97 27.24 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.258 -172.09 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 779' ' ' VAL . . . . . 0.792 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 1.6 m -91.52 126.4 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 CA-C-O 122.435 1.112 . . . . 0.0 110.612 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 780' ' ' ILE . . . . . . . . . . . . . 71.0 mt -89.22 145.32 7.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 113.543 -1.662 . . . . 0.0 110.954 -172.216 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -112.75 115.45 28.54 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 175.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 782' ' ' THR . . . . . 0.532 ' O ' ' HB2' ' A' ' 738' ' ' HIS . 22.9 p -89.43 140.48 28.45 Favored Pre-proline 0 C--N 1.309 -1.158 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.674 -178.253 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 783' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.02 156.56 28.5 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.641 2.894 . . . . 0.0 112.655 -174.399 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 784' ' ' VAL . . . . . . . . . . . . . 15.0 p -62.9 135.31 27.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.126 -176.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 785' ' ' PHE . . . . . 0.401 ' CB ' HG21 ' A' ' 817' ' ' VAL . 69.1 m-85 -105.04 102.72 12.21 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.744 179.349 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 81.4 p -84.54 19.35 1.99 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.386 -174.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -159.42 119.05 2.98 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.211 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 788' ' ' GLY . . . . . 0.785 ' HA2' HG12 ' A' ' 817' ' ' VAL . . . -46.08 116.29 2.11 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.431 -0.804 . . . . 0.0 113.571 170.233 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 789' ' ' GLY . . . . . 0.511 ' H ' ' HB ' ' A' ' 817' ' ' VAL . . . -156.8 -162.31 11.4 Favored Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 177.47 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 790' ' ' ASP . . . . . 0.48 ' HB3' ' OG1' ' A' ' 760' ' ' THR . 16.5 t70 -130.54 122.09 26.92 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.361 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 791' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -127.55 153.39 46.42 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.379 -174.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 792' ' ' ILE . . . . . 0.527 ' O ' HG13 ' A' ' 758' ' ' ILE . 19.2 mt -127.85 124.74 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 176.166 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 793' ' ' LEU . . . . . 0.604 HD23 HG11 ' A' ' 741' ' ' VAL . 1.2 tp -90.67 112.25 23.92 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 173.573 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 794' ' ' SER . . . . . 0.518 ' N ' HD12 ' A' ' 793' ' ' LEU . 9.4 t -118.79 175.16 5.88 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 114.451 -1.25 . . . . 0.0 108.492 -176.502 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 795' ' ' LEU . . . . . 0.545 HD21 HD21 ' A' ' 725' ' ' LEU . 21.5 mt -103.74 127.88 51.16 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 -178.318 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 796' ' ' VAL . . . . . . . . . . . . . 55.6 t -86.71 -57.6 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 CA-C-O 120.865 0.364 . . . . 0.0 110.773 -177.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 797' ' ' SER . . . . . 0.586 ' HA ' ' HG ' ' A' ' 808' ' ' LEU . 27.3 m -174.64 156.23 2.33 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.61 -173.469 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 798' ' ' ILE . . . . . 0.574 ' HA ' ' O ' ' A' ' 752' ' ' THR . 11.8 tt -128.8 168.06 22.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 176.688 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 799' ' ' LYS . . . . . 0.682 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 42.9 tttp -139.62 121.89 15.95 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 120.739 -0.384 . . . . 0.0 111.312 -174.102 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 800' ' ' ASP . . . . . 0.546 ' HA ' ' CD2' ' A' ' 751' ' ' PHE . 12.6 t70 -69.22 156.94 37.9 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.236 176.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 27.4 t -64.6 -10.9 29.7 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 123.759 0.662 . . . . 0.0 112.208 -174.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 13.9 t -90.95 2.26 56.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.991 0.9 . . . . 0.0 109.137 175.091 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 803' ' ' GLY . . . . . 0.452 ' HA2' ' HE3' ' A' ' 799' ' ' LYS . . . 81.71 46.79 6.6 Favored Glycine 0 N--CA 1.44 -1.061 0 CA-C-N 114.764 -1.107 . . . . 0.0 111.781 -178.414 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 804' ' ' CYS . . . . . 0.459 ' HB3' ' HB3' ' A' ' 800' ' ' ASP . 42.7 t -114.12 113.23 24.42 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.39 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 805' ' ' VAL . . . . . 0.525 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 8.4 p -85.03 129.93 36.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.346 0.593 . . . . 0.0 110.549 -177.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 806' ' ' VAL . . . . . 0.485 ' HB ' HG22 ' A' ' 798' ' ' ILE . 74.0 t -112.97 133.61 58.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.022 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -69.87 113.34 4.94 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.755 178.25 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 808' ' ' LEU . . . . . 0.588 HD22 ' HA ' ' A' ' 722' ' ' SER . 38.0 mt -84.55 125.05 32.08 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -175.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 23.2 t -144.51 87.14 1.85 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.169 172.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 810' ' ' GLN . . . . . 0.494 ' HB3' ' HD2' ' A' ' 811' ' ' PRO . 10.6 mt-30 -143.88 171.22 7.11 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.132 178.067 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 811' ' ' PRO . . . . . 0.523 ' O ' ' HG ' ' A' ' 725' ' ' LEU . 79.2 Cg_exo -42.73 139.68 3.16 Favored 'Trans proline' 0 C--N 1.356 0.925 0 C-N-CA 123.045 2.497 . . . . 0.0 114.826 -171.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -112.19 167.71 10.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.642 -177.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 813' ' ' ALA . . . . . 0.414 ' N ' HD12 ' A' ' 725' ' ' LEU . . . -118.19 155.85 29.78 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.604 179.129 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 814' ' ' LYS . . . . . 0.492 ' HE2' ' HB3' ' A' ' 730' ' ' ASP . 12.0 ttpt -121.24 134.42 55.18 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.137 -0.625 . . . . 0.0 110.528 176.29 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 815' ' ' ILE . . . . . 0.585 HG23 HD22 ' A' ' 733' ' ' LEU . 4.6 mp -116.38 108.15 24.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-N 115.21 -0.905 . . . . 0.0 108.68 177.794 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 816' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -103.05 108.43 19.6 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.545 0.688 . . . . 0.0 109.629 -178.507 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 817' ' ' VAL . . . . . 0.785 HG12 ' HA2' ' A' ' 788' ' ' GLY . 90.4 t -98.36 139.5 20.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.168 -177.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 818' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 . . . . . 0 C--N 1.312 -1.028 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 178.371 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 720' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp . . . . . 0 N--CA 1.45 -0.443 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 721' ' ' PRO . . . . . 0.467 ' HD2' HG21 ' A' ' 806' ' ' VAL . 63.3 Cg_endo -87.62 152.41 7.57 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 122.977 2.451 . . . . 0.0 112.401 -172.334 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 722' ' ' SER . . . . . 0.458 ' OG ' ' HG ' ' A' ' 808' ' ' LEU . 15.0 t -176.66 -148.5 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -174.591 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 723' ' ' ALA . . . . . 0.58 ' HA ' ' HA ' ' A' ' 745' ' ' LEU . . . -157.18 155.41 30.88 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 20.8 p -147.47 107.53 4.02 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.969 0.414 . . . . 0.0 109.894 174.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 725' ' ' LEU . . . . . 0.589 ' CD2' ' HB ' ' A' ' 743' ' ' VAL . 14.6 mt -62.96 145.62 54.91 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 121.591 0.71 . . . . 0.0 111.683 -175.639 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 726' ' ' LYS . . . . . 0.448 ' HB3' ' HE2' ' A' ' 726' ' ' LYS . 29.9 mtpt -95.85 -17.63 20.98 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.13 -177.13 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 727' ' ' LEU . . . . . 0.582 HD23 ' HB1' ' A' ' 813' ' ' ALA . 37.1 tp -67.15 115.14 6.5 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.213 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 34.5 m80 -109.48 30.02 7.02 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.968 0.413 . . . . 0.0 111.742 -176.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -162.23 179.9 7.54 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 175.153 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 730' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -91.72 143.47 26.51 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.023 0.439 . . . . 0.0 110.315 -178.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 731' ' ' LEU . . . . . 0.588 ' HB2' ' HA ' ' A' ' 815' ' ' ILE . 16.0 mt -78.48 108.44 11.85 Favored 'General case' 0 C--O 1.217 -0.629 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.771 -177.254 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 732' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -77.5 103.91 7.72 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.718 0.294 . . . . 0.0 111.022 178.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 733' ' ' LEU . . . . . 0.647 ' HB2' ' HB ' ' A' ' 817' ' ' VAL . 30.9 mt -118.06 164.78 14.6 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.183 0.516 . . . . 0.0 111.794 -177.11 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 734' ' ' CYS . . . . . . . . . . . . . 11.2 t -120.77 -174.41 2.81 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.039 179.095 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 735' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.39 119.29 16.39 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.064 0.459 . . . . 0.0 110.858 -171.507 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 86.66 10.93 72.09 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.893 -179.121 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 737' ' ' ASP . . . . . 0.535 ' HB3' ' HB3' ' A' ' 733' ' ' LEU . 5.8 t0 -75.43 168.78 19.36 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.084 0.469 . . . . 0.0 110.417 177.558 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 47.7 p-80 -126.21 153.72 44.29 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 175.149 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 739' ' ' SER . . . . . 0.581 ' HB2' ' OG1' ' A' ' 782' ' ' THR . 1.4 m -101.96 152.69 20.64 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.07 -173.303 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 740' ' ' SER . . . . . 0.456 ' HA ' ' O ' ' A' ' 780' ' ' ILE . 54.6 p -140.97 104.91 4.76 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.494 0.664 . . . . 0.0 110.055 179.315 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 741' ' ' VAL . . . . . 0.561 HG11 HD13 ' A' ' 793' ' ' LEU . 1.5 p -118.67 114.94 35.6 Favored Pre-proline 0 C--N 1.317 -0.838 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.918 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 742' ' ' PRO . . . . . 0.658 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 1.8 Cg_endo -75.86 130.37 12.37 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 122.431 2.087 . . . . 0.0 111.082 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 743' ' ' VAL . . . . . 0.589 ' HB ' ' CD2' ' A' ' 725' ' ' LEU . 1.6 p -126.7 121.29 58.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.547 0.689 . . . . 0.0 112.61 175.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 744' ' ' ALA . . . . . 0.495 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -82.67 102.23 11.35 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 168.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 745' ' ' LEU . . . . . 0.922 HD13 HD13 ' A' ' 773' ' ' ILE . 1.0 OUTLIER -81.11 168.63 18.39 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 114.282 -1.327 . . . . 0.0 111.258 -168.569 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 746' ' ' LYS . . . . . 0.408 ' HE3' ' HB2' ' A' ' 746' ' ' LYS . 28.0 ttmt -123.02 154.82 37.97 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.307 0.575 . . . . 0.0 110.717 -177.006 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 747' ' ' GLY . . . . . 0.404 ' HA3' ' HB3' ' A' ' 721' ' ' PRO . . . 92.05 133.11 5.98 Favored Glycine 0 C--N 1.309 -0.926 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.001 -174.016 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 748' ' ' GLN . . . . . 0.411 ' C ' ' HE1' ' A' ' 751' ' ' PHE . 65.7 mm-40 -101.89 123.03 45.13 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -170.602 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 107.98 -169.54 14.53 Favored Glycine 0 C--O 1.219 -0.815 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.896 179.095 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -67.23 99.86 0.51 Allowed 'Trans proline' 0 CA--C 1.531 0.356 0 C-N-CA 123.561 2.84 . . . . 0.0 113.542 -178.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 751' ' ' PHE . . . . . 0.634 ' CE2' ' HA ' ' A' ' 800' ' ' ASP . 60.9 m-85 -115.29 142.8 46.18 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.384 178.339 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 752' ' ' THR . . . . . 0.76 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 91.0 m -87.91 102.84 15.1 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.575 0.702 . . . . 0.0 109.867 178.708 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 753' ' ' LEU . . . . . 0.461 HD22 HD22 ' A' ' 745' ' ' LEU . 17.4 tp -92.08 130.71 37.75 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.537 -1.211 . . . . 0.0 110.538 -170.468 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 754' ' ' THR . . . . . 0.45 HG23 ' HB2' ' A' ' 769' ' ' GLU . 0.6 OUTLIER -125.98 134.84 51.37 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.607 0.241 . . . . 0.0 111.327 179.813 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 755' ' ' TYR . . . . . 0.422 ' CE1' ' HB3' ' A' ' 768' ' ' PHE . 26.1 p90 -145.93 154.66 42.18 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.14 177.731 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 756' ' ' ASP . . . . . 0.475 ' OD2' ' HD2' ' A' ' 765' ' ' ARG . 49.8 m-20 -116.9 122.76 45.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.868 -179.354 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 757' ' ' ILE . . . . . . . . . . . . . 4.2 mp -89.88 97.31 6.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 170.278 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 758' ' ' ILE . . . . . 0.555 HG22 ' HD3' ' A' ' 765' ' ' ARG . 2.1 pp -96.5 149.62 4.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.042 -169.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -93.79 112.52 24.39 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.839 -176.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 760' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.32 -0.704 0 CA-C-O 121.843 0.83 . . . . 0.0 109.252 179.102 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 765' ' ' ARG . . . . . 0.555 ' HD3' HG22 ' A' ' 758' ' ' ILE . 3.8 ttp180 . . . . . 0 N--CA 1.441 -0.908 0 CA-C-O 120.641 0.258 . . . . 0.0 110.341 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 766' ' ' LYS . . . . . 0.466 ' HD3' ' N ' ' A' ' 767' ' ' THR . 1.3 tmtp? -109.78 146.12 35.51 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 767' ' ' THR . . . . . 0.466 ' N ' ' HD3' ' A' ' 766' ' ' LYS . 77.6 m -121.05 134.14 55.27 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.244 -176.396 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 768' ' ' PHE . . . . . 0.422 ' HB3' ' CE1' ' A' ' 755' ' ' TYR . 0.7 OUTLIER -133.66 131.48 39.58 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.995 0.426 . . . . 0.0 110.498 175.101 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 769' ' ' GLU . . . . . 0.45 ' HB2' HG23 ' A' ' 754' ' ' THR . 36.5 tt0 -127.25 117.23 21.89 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.681 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 770' ' ' ILE . . . . . 0.43 HG22 HG22 ' A' ' 773' ' ' ILE . 12.1 mt -111.43 112.02 38.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 771' ' ' LYS . . . . . 0.625 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 12.4 mtpt -83.79 153.03 24.32 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-O 121.496 0.665 . . . . 0.0 111.609 -175.705 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 772' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 56.64 46.16 20.79 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 113.979 -1.464 . . . . 0.0 112.558 177.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 773' ' ' ILE . . . . . 0.922 HD13 HD13 ' A' ' 745' ' ' LEU . 0.6 OUTLIER -74.29 113.84 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 171.949 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 53.6 mttt -107.31 29.65 6.95 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -177.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 775' ' ' THR . . . . . 0.705 ' H ' HD12 ' A' ' 773' ' ' ILE . 0.2 OUTLIER -95.85 -82.32 0.39 Allowed 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -167.785 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 776' ' ' ASN . . . . . 0.657 ' HB2' ' O ' ' A' ' 775' ' ' THR . 0.8 OUTLIER 89.08 3.64 0.21 Allowed 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 124.521 1.129 . . . . 0.0 111.281 -171.741 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 777' ' ' GLU . . . . . 0.495 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 12.5 mt-10 -160.88 82.94 0.66 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 175.236 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 778' ' ' TYR . . . . . 0.832 ' HB3' HD11 ' A' ' 745' ' ' LEU . 87.9 t80 -127.33 127.68 44.68 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.128 -171.281 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 779' ' ' VAL . . . . . 0.658 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 20.8 t -87.25 116.44 29.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.111 0.481 . . . . 0.0 110.4 177.054 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 780' ' ' ILE . . . . . 0.456 ' O ' ' HA ' ' A' ' 740' ' ' SER . 75.9 mt -86.35 139.6 17.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.405 -178.584 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 781' ' ' LYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 739' ' ' SER . 3.6 mppt? -125.33 104.11 8.29 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 176.506 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 782' ' ' THR . . . . . 0.581 ' OG1' ' HB2' ' A' ' 739' ' ' SER . 44.3 p -77.42 145.5 72.18 Favored Pre-proline 0 N--CA 1.443 -0.79 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -177.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 783' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_exo -50.69 158.92 2.55 Favored 'Trans proline' 0 CA--C 1.529 0.271 0 C-N-CA 123.711 2.94 . . . . 0.0 113.57 -177.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 784' ' ' VAL . . . . . 0.423 HG12 HG23 ' A' ' 786' ' ' THR . 54.7 t -58.65 127.26 17.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.308 -177.339 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 785' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -102.45 103.25 13.63 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.294 177.044 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 786' ' ' THR . . . . . 0.423 HG23 HG12 ' A' ' 784' ' ' VAL . 38.9 p -90.59 30.65 1.13 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.939 0.876 . . . . 0.0 110.846 -178.072 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 27.6 m -152.34 107.42 3.25 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.347 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 788' ' ' GLY . . . . . 0.771 ' HA2' HG22 ' A' ' 817' ' ' VAL . . . -51.24 107.96 0.49 Allowed Glycine 0 CA--C 1.525 0.676 0 C-N-CA 121.065 -0.588 . . . . 0.0 113.128 174.179 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 789' ' ' GLY . . . . . 0.538 ' H ' HG22 ' A' ' 817' ' ' VAL . . . -152.22 -173.33 21.7 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 -179.468 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -121.5 129.95 53.25 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -177.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 791' ' ' TYR . . . . . 0.416 ' HA ' ' O ' ' A' ' 758' ' ' ILE . 61.6 m-85 -134.12 161.31 35.22 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.077 -176.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 792' ' ' ILE . . . . . . . . . . . . . 9.9 mt -137.94 121.64 21.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-O 120.845 0.355 . . . . 0.0 110.087 176.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 793' ' ' LEU . . . . . 0.561 HD13 HG11 ' A' ' 741' ' ' VAL . 9.6 tt -84.76 107.77 17.11 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.055 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 794' ' ' SER . . . . . . . . . . . . . 21.7 m -112.6 150.63 31.12 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.297 -178.387 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 795' ' ' LEU . . . . . 0.481 HD22 ' HB3' ' A' ' 723' ' ' ALA . 34.6 mt -83.55 132.42 34.92 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.359 -178.049 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 796' ' ' VAL . . . . . . . . . . . . . 71.7 t -99.39 -57.88 4.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.926 -0.309 . . . . 0.0 111.794 -175.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 797' ' ' SER . . . . . 0.508 ' HA ' HD13 ' A' ' 808' ' ' LEU . 22.9 m -172.32 177.28 3.14 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.379 -173.713 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 798' ' ' ILE . . . . . 0.641 ' HA ' ' O ' ' A' ' 752' ' ' THR . 8.4 tt -150.92 156.73 6.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 799' ' ' LYS . . . . . 0.76 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 8.9 tmtt? -124.81 119.25 28.33 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 177.336 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 800' ' ' ASP . . . . . 0.634 ' HA ' ' CE2' ' A' ' 751' ' ' PHE . 11.4 t70 -63.88 154.1 34.77 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.487 175.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 10.6 t -60.95 -12.04 9.98 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 123.94 0.775 . . . . 0.0 112.171 -171.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 39.9 p -91.35 1.0 57.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.485 0.66 . . . . 0.0 110.45 177.208 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 803' ' ' GLY . . . . . 0.456 ' HA2' ' HE2' ' A' ' 799' ' ' LYS . . . 81.5 39.01 12.92 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.713 -176.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 804' ' ' CYS . . . . . 0.452 ' HB3' ' HB3' ' A' ' 800' ' ' ASP . 49.4 t -111.77 110.71 21.21 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 805' ' ' VAL . . . . . . . . . . . . . 7.5 p -86.25 127.49 40.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.671 0.748 . . . . 0.0 111.377 -173.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 806' ' ' VAL . . . . . 0.467 HG21 ' HD2' ' A' ' 721' ' ' PRO . 81.1 t -112.42 139.0 39.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.851 -178.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -83.96 109.53 3.21 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.756 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 808' ' ' LEU . . . . . 0.508 HD13 ' HA ' ' A' ' 797' ' ' SER . 10.4 mp -74.58 133.43 42.22 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 178.636 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 38.3 m -148.28 85.64 1.53 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.911 -1.04 . . . . 0.0 109.166 170.025 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 810' ' ' GLN . . . . . 0.507 ' HB3' ' HD2' ' A' ' 811' ' ' PRO . 12.0 mt-30 -138.86 173.66 4.99 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.527 178.611 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 811' ' ' PRO . . . . . 0.507 ' HD2' ' HB3' ' A' ' 810' ' ' GLN . 86.9 Cg_exo -44.39 140.76 5.67 Favored 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 123.153 2.568 . . . . 0.0 115.273 -175.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -113.25 166.61 11.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.474 -1.239 . . . . 0.0 109.727 176.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 813' ' ' ALA . . . . . 0.582 ' HB1' HD23 ' A' ' 727' ' ' LEU . . . -124.45 143.79 50.44 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.909 -177.44 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 814' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -97.53 130.18 44.62 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.589 0.709 . . . . 0.0 110.952 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 815' ' ' ILE . . . . . 0.588 ' HA ' ' HB2' ' A' ' 731' ' ' LEU . 5.0 mp -107.28 119.64 57.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.824 176.238 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 816' ' ' GLN . . . . . 0.745 ' NE2' ' HG2' ' A' ' 818' ' ' ARG . 0.9 OUTLIER -117.02 106.66 13.63 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.272 0.558 . . . . 0.0 110.648 -177.842 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 817' ' ' VAL . . . . . 0.771 HG22 ' HA2' ' A' ' 788' ' ' GLY . 0.7 OUTLIER -111.29 143.97 20.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-O 121.113 0.482 . . . . 0.0 110.201 -179.167 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 818' ' ' ARG . . . . . 0.745 ' HG2' ' NE2' ' A' ' 816' ' ' GLN . 29.1 mmt180 . . . . . 0 C--N 1.315 -0.907 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.502 -179.027 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 720' ' ' LYS . . . . . . . . . . . . . 49.5 mtpt . . . . . 0 N--CA 1.455 -0.199 0 N-CA-C 110.557 -0.164 . . . . 0.0 110.557 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 721' ' ' PRO . . . . . 0.455 ' HD2' HG21 ' A' ' 806' ' ' VAL . 38.7 Cg_endo -87.47 164.18 8.06 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.826 2.351 . . . . 0.0 111.291 179.28 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 722' ' ' SER . . . . . 0.6 ' HA ' ' CD2' ' A' ' 808' ' ' LEU . 8.8 t -174.76 -154.37 0.05 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.892 0.377 . . . . 0.0 110.521 -173.45 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 723' ' ' ALA . . . . . 0.65 ' HB1' HG21 ' A' ' 743' ' ' VAL . . . -151.73 143.03 23.38 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 178.401 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 14.9 t -134.57 98.97 4.21 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 725' ' ' LEU . . . . . 0.629 ' HA ' ' HA ' ' A' ' 743' ' ' VAL . 5.7 mp -59.7 144.28 48.47 Favored 'General case' 0 N--CA 1.427 -1.589 0 CA-C-O 122.476 1.131 . . . . 0.0 112.752 -175.51 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 32.4 mtpt -93.23 -19.66 21.2 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 113.038 -1.892 . . . . 0.0 109.461 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 727' ' ' LEU . . . . . 0.486 ' HB2' ' HD2' ' A' ' 742' ' ' PRO . 0.6 OUTLIER -72.0 108.64 5.33 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 177.588 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 31.2 t-80 -115.56 52.32 0.89 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.705 0.288 . . . . 0.0 111.401 -172.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 7.8 p80 -175.92 -177.91 0.98 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.49 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 730' ' ' ASP . . . . . 0.427 ' HB2' ' HE3' ' A' ' 732' ' ' LYS . 12.3 m-20 -77.78 131.76 37.76 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 173.396 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 731' ' ' LEU . . . . . 0.574 ' HB3' ' HA ' ' A' ' 815' ' ' ILE . 9.8 tp -96.35 100.81 12.39 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 120.979 0.419 . . . . 0.0 110.053 -176.636 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 732' ' ' LYS . . . . . 0.427 ' HE3' ' HB2' ' A' ' 730' ' ' ASP . 33.4 mmtp -80.52 112.36 17.8 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.749 -0.659 . . . . 0.0 112.087 -171.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 733' ' ' LEU . . . . . 0.607 ' HG ' ' HB3' ' A' ' 737' ' ' ASP . 7.3 mp -113.58 163.26 15.18 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.88 177.158 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 734' ' ' CYS . . . . . 0.575 ' O ' ' HB2' ' A' ' 737' ' ' ASP . 51.6 t -104.69 -174.96 2.66 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.501 173.29 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 735' ' ' LEU . . . . . 0.478 ' N ' ' SG ' ' A' ' 734' ' ' CYS . 40.0 tp -72.47 130.14 39.96 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.195 0.522 . . . . 0.0 111.293 -178.324 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 78.92 4.17 88.36 Favored Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.608 -177.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 737' ' ' ASP . . . . . 0.607 ' HB3' ' HG ' ' A' ' 733' ' ' LEU . 0.3 OUTLIER -77.87 151.71 33.72 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.096 0.474 . . . . 0.0 111.687 179.327 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 738' ' ' HIS . . . . . 0.445 ' HB2' ' O ' ' A' ' 782' ' ' THR . 34.6 p-80 -114.95 161.7 17.94 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 170.333 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 739' ' ' SER . . . . . 0.444 ' HB3' HD21 ' A' ' 733' ' ' LEU . 8.0 p -120.36 171.78 8.27 Favored 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 119.159 -1.016 . . . . 0.0 111.522 -173.707 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 7.0 p -137.85 100.74 4.26 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.649 177.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 741' ' ' VAL . . . . . 0.579 HG11 HD13 ' A' ' 793' ' ' LEU . 0.7 OUTLIER -109.86 107.74 59.11 Favored Pre-proline 0 C--N 1.318 -0.775 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.618 -179.119 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 742' ' ' PRO . . . . . 0.665 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 3.1 Cg_endo -76.84 137.83 18.15 Favored 'Trans proline' 0 N--CA 1.448 -1.183 0 C-N-CA 122.478 2.119 . . . . 0.0 111.545 -177.757 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 743' ' ' VAL . . . . . 0.65 HG21 ' HB1' ' A' ' 723' ' ' ALA . 1.7 p -131.01 118.58 42.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.697 0.76 . . . . 0.0 112.121 175.631 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 744' ' ' ALA . . . . . 0.606 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -80.62 95.61 6.6 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 169.563 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 745' ' ' LEU . . . . . 1.018 HD13 HD13 ' A' ' 773' ' ' ILE . 0.7 OUTLIER -73.31 159.23 33.68 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 113.901 -1.499 . . . . 0.0 111.472 -168.545 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -114.39 147.67 38.86 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.025 -174.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 747' ' ' GLY . . . . . . . . . . . . . . . 92.81 127.84 4.52 Favored Glycine 0 N--CA 1.442 -0.935 0 C-N-CA 120.166 -1.016 . . . . 0.0 110.625 -174.21 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 25.0 mp0 -101.68 127.07 48.6 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 121.194 0.521 . . . . 0.0 112.036 -171.198 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 112.88 -177.12 18.09 Favored Glycine 0 CA--C 1.5 -0.853 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.936 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 750' ' ' PRO . . . . . 0.501 ' HB3' ' HE2' ' A' ' 774' ' ' LYS . 74.4 Cg_endo -65.87 94.91 0.28 Allowed 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 123.838 3.025 . . . . 0.0 113.71 -177.516 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 751' ' ' PHE . . . . . 0.53 ' CE2' ' HA ' ' A' ' 800' ' ' ASP . 68.6 m-85 -113.91 144.06 43.67 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.997 178.474 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 752' ' ' THR . . . . . 0.749 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 63.8 m -89.41 107.93 19.35 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 753' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.73 112.16 24.32 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.285 -171.744 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 754' ' ' THR . . . . . 0.491 HG23 ' HB2' ' A' ' 769' ' ' GLU . 2.2 m -109.74 135.32 50.85 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.41 -179.144 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 755' ' ' TYR . . . . . 0.532 ' CE1' ' HB3' ' A' ' 768' ' ' PHE . 29.2 p90 -143.43 157.01 44.8 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 120.968 0.413 . . . . 0.0 111.208 177.553 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 756' ' ' ASP . . . . . 0.425 ' OD2' ' HD2' ' A' ' 765' ' ' ARG . 41.2 m-20 -115.57 120.29 38.98 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.694 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 757' ' ' ILE . . . . . 0.403 ' HB ' ' HB3' ' A' ' 766' ' ' LYS . 3.3 mp -84.71 94.73 3.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 167.114 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 758' ' ' ILE . . . . . 0.56 HG22 ' HD3' ' A' ' 765' ' ' ARG . 2.2 pp -91.75 140.7 15.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 C-N-CA 120.258 -0.577 . . . . 0.0 111.429 -171.611 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -93.19 99.88 12.36 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.06 -174.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 760' ' ' THR . . . . . 0.412 HG22 ' H ' ' A' ' 760' ' ' THR . 0.9 OUTLIER . . . . . 0 C--N 1.321 -0.642 0 CA-C-O 121.819 0.819 . . . . 0.0 109.358 -175.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 765' ' ' ARG . . . . . 0.56 ' HD3' HG22 ' A' ' 758' ' ' ILE . 6.7 ttp180 . . . . . 0 N--CA 1.443 -0.813 0 CA-C-O 121.247 0.546 . . . . 0.0 111.417 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 766' ' ' LYS . . . . . 0.521 ' HD3' ' N ' ' A' ' 767' ' ' THR . 9.8 tmtm? -111.89 146.02 38.48 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 178.094 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 767' ' ' THR . . . . . 0.521 ' N ' ' HD3' ' A' ' 766' ' ' LYS . 88.4 m -123.76 135.14 53.65 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.9 -178.17 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 768' ' ' PHE . . . . . 0.532 ' HB3' ' CE1' ' A' ' 755' ' ' TYR . 3.0 t80 -139.73 137.53 35.2 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 177.442 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 769' ' ' GLU . . . . . 0.491 ' HB2' HG23 ' A' ' 754' ' ' THR . 31.8 tt0 -131.2 132.8 44.95 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.003 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 770' ' ' ILE . . . . . 0.575 HG22 HG22 ' A' ' 773' ' ' ILE . 4.1 mt -121.99 111.57 31.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 177.044 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 771' ' ' LYS . . . . . 0.559 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 5.2 mtpt -85.15 157.31 20.7 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.176 0.512 . . . . 0.0 111.349 -175.281 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 772' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 53.71 44.29 29.88 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.546 -1.206 . . . . 0.0 112.19 177.139 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 773' ' ' ILE . . . . . 1.018 HD13 HD13 ' A' ' 745' ' ' LEU . 0.5 OUTLIER -75.15 111.36 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 173.342 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 774' ' ' LYS . . . . . 0.501 ' HE2' ' HB3' ' A' ' 750' ' ' PRO . 56.9 mttt -108.36 29.87 6.96 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 775' ' ' THR . . . . . 0.678 ' H ' HD12 ' A' ' 773' ' ' ILE . 2.1 m -96.11 -81.39 0.41 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.913 -1.039 . . . . 0.0 113.392 -166.007 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 776' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' A' ' 775' ' ' THR . 10.3 m120 93.79 4.18 0.05 OUTLIER 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.268 1.427 . . . . 0.0 110.971 -176.247 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 777' ' ' GLU . . . . . 0.606 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 4.9 mt-10 -161.11 87.96 0.73 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.364 171.041 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 778' ' ' TYR . . . . . 0.817 ' HB3' HD11 ' A' ' 745' ' ' LEU . 73.7 t80 -125.92 128.29 47.31 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.418 -172.757 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 779' ' ' VAL . . . . . 0.665 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 21.2 t -86.33 113.27 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 CA-C-O 121.14 0.495 . . . . 0.0 110.46 179.143 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 780' ' ' ILE . . . . . 0.434 ' HB ' HG13 ' A' ' 741' ' ' VAL . 76.2 mt -82.39 143.69 11.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.958 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -123.8 112.77 17.7 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 175.153 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 782' ' ' THR . . . . . 0.445 ' O ' ' HB2' ' A' ' 738' ' ' HIS . 44.2 p -77.01 142.19 68.69 Favored Pre-proline 0 C--N 1.318 -0.77 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.75 -179.419 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 783' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 782' ' ' THR . 51.2 Cg_exo -55.3 161.5 7.03 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 123.509 2.806 . . . . 0.0 112.899 -178.307 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 784' ' ' VAL . . . . . 0.443 HG12 HG23 ' A' ' 786' ' ' THR . 46.5 t -58.39 124.21 11.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.094 -179.046 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 785' ' ' PHE . . . . . 0.432 ' HE1' ' OG1' ' A' ' 782' ' ' THR . 99.5 m-85 -99.44 95.53 7.08 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.741 178.474 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 786' ' ' THR . . . . . 0.443 HG23 HG12 ' A' ' 784' ' ' VAL . 59.9 p -84.71 28.97 0.64 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.526 0.679 . . . . 0.0 110.912 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.05 108.92 3.68 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.56 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 788' ' ' GLY . . . . . 0.656 ' HA2' HG12 ' A' ' 817' ' ' VAL . . . -52.44 107.46 0.51 Allowed Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.465 171.248 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 789' ' ' GLY . . . . . 0.53 ' H ' ' HB ' ' A' ' 817' ' ' VAL . . . -152.22 -151.58 5.69 Favored Glycine 0 N--CA 1.444 -0.803 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 -179.488 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -141.07 133.16 27.85 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 791' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -135.0 149.06 50.12 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.382 -174.018 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 792' ' ' ILE . . . . . 0.418 ' O ' HG13 ' A' ' 758' ' ' ILE . 13.8 mt -127.61 116.32 42.96 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-O 121.091 0.472 . . . . 0.0 110.046 178.368 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 793' ' ' LEU . . . . . 0.579 HD13 HG11 ' A' ' 741' ' ' VAL . 10.3 tt -84.15 106.79 16.06 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.007 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 794' ' ' SER . . . . . . . . . . . . . 19.3 m -116.33 150.92 36.89 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.861 -177.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 795' ' ' LEU . . . . . 0.459 HD21 HD11 ' A' ' 725' ' ' LEU . 52.9 mt -83.0 136.55 34.47 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.861 -178.182 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 796' ' ' VAL . . . . . . . . . . . . . 77.2 t -100.35 -57.44 4.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.642 -176.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 797' ' ' SER . . . . . 0.56 ' HA ' ' HG ' ' A' ' 808' ' ' LEU . 25.9 m -170.86 153.54 3.97 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.305 -173.289 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 798' ' ' ILE . . . . . 0.607 ' HA ' ' O ' ' A' ' 752' ' ' THR . 9.1 tt -125.41 166.45 21.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 176.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 799' ' ' LYS . . . . . 0.749 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 87.7 tttt -137.53 123.09 19.71 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.407 -173.452 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 800' ' ' ASP . . . . . 0.623 ' HB3' ' HB3' ' A' ' 804' ' ' CYS . 13.4 t70 -70.93 157.64 37.83 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.469 175.629 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 10.4 p -60.68 -9.62 4.17 Favored 'General case' 0 CA--C 1.532 0.251 0 O-C-N 124.007 0.817 . . . . 0.0 112.799 -174.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 42.8 p -97.38 7.38 46.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.577 0.703 . . . . 0.0 110.308 176.04 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 803' ' ' GLY . . . . . 0.514 ' HA2' ' CE ' ' A' ' 799' ' ' LYS . . . 76.68 31.41 54.02 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.841 -176.592 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 804' ' ' CYS . . . . . 0.623 ' HB3' ' HB3' ' A' ' 800' ' ' ASP . 35.5 t -96.41 103.43 15.34 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -179.089 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 805' ' ' VAL . . . . . 0.484 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 3.2 t -86.17 119.9 35.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.165 0.507 . . . . 0.0 110.889 -173.48 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 806' ' ' VAL . . . . . 0.455 HG21 ' HD2' ' A' ' 721' ' ' PRO . 73.0 t -103.56 133.6 47.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.245 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -67.14 134.09 31.35 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 121.077 -0.582 . . . . 0.0 111.664 178.268 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 808' ' ' LEU . . . . . 0.6 ' CD2' ' HA ' ' A' ' 722' ' ' SER . 69.2 mt -100.73 132.82 45.93 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -176.126 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 22.0 t -146.77 87.18 1.68 Allowed 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.921 171.287 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 810' ' ' GLN . . . . . 0.472 ' HB3' ' HD2' ' A' ' 811' ' ' PRO . 8.7 mt-30 -139.83 173.76 4.74 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.678 173.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 811' ' ' PRO . . . . . 0.472 ' HD2' ' HB3' ' A' ' 810' ' ' GLN . 78.9 Cg_exo -44.58 141.1 5.77 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 122.971 2.447 . . . . 0.0 115.209 -176.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -108.36 168.05 9.59 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.285 -1.325 . . . . 0.0 109.495 176.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 813' ' ' ALA . . . . . . . . . . . . . . . -126.03 137.26 53.63 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.36 176.469 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 814' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -103.14 114.83 29.44 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 120.911 0.386 . . . . 0.0 110.441 -177.281 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 815' ' ' ILE . . . . . 0.574 ' HA ' ' HB3' ' A' ' 731' ' ' LEU . 5.2 mp -97.81 109.39 23.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.493 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 816' ' ' GLN . . . . . 0.548 ' OE1' ' HG2' ' A' ' 818' ' ' ARG . 0.1 OUTLIER -95.32 124.17 39.22 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.871 -178.592 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 817' ' ' VAL . . . . . 0.656 HG12 ' HA2' ' A' ' 788' ' ' GLY . 59.7 t -117.09 135.17 58.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 -177.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 818' ' ' ARG . . . . . 0.548 ' HG2' ' OE1' ' A' ' 816' ' ' GLN . 35.2 mmt180 . . . . . 0 C--N 1.327 -0.384 0 O-C-N 121.841 -0.537 . . . . 0.0 111.372 176.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 720' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp . . . . . 0 N--CA 1.447 -0.597 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 721' ' ' PRO . . . . . 0.441 ' HB3' ' HA3' ' A' ' 747' ' ' GLY . 57.1 Cg_endo -87.48 150.03 7.66 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 122.82 2.346 . . . . 0.0 111.869 -177.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 722' ' ' SER . . . . . 0.41 ' HA ' ' HG ' ' A' ' 808' ' ' LEU . 16.1 t -176.71 -150.15 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -172.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 723' ' ' ALA . . . . . 0.593 ' HB1' HG21 ' A' ' 743' ' ' VAL . . . -153.95 143.41 21.56 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 110.449 -0.204 . . . . 0.0 110.449 178.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 4.2 p -134.36 105.44 6.6 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.29 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 725' ' ' LEU . . . . . 0.507 ' CD2' ' HB ' ' A' ' 743' ' ' VAL . 14.4 mt -65.4 148.95 50.83 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.728 -173.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 32.1 mtpt -105.75 -0.45 25.4 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.471 -1.241 . . . . 0.0 109.408 -177.069 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 727' ' ' LEU . . . . . 0.441 ' HB2' ' HD2' ' A' ' 742' ' ' PRO . 2.6 tm? -81.78 124.74 29.9 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.818 -1.083 . . . . 0.0 108.953 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 48.6 m80 -86.08 -85.14 0.16 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -173.127 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 48.6 p-80 -92.56 174.83 7.07 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 120.587 -0.445 . . . . 0.0 111.235 -176.457 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 730' ' ' ASP . . . . . 0.405 ' HA ' ' O ' ' A' ' 814' ' ' LYS . 4.0 p30 -53.11 144.3 15.81 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.638 0.732 . . . . 0.0 111.898 -177.229 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 731' ' ' LEU . . . . . 0.558 ' HB2' ' HA ' ' A' ' 815' ' ' ILE . 15.8 mt -83.27 118.85 23.93 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.272 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 732' ' ' LYS . . . . . 0.42 ' C ' ' HG ' ' A' ' 733' ' ' LEU . 14.4 mmmm -85.18 117.94 24.43 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.457 179.039 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 733' ' ' LEU . . . . . 0.466 HD13 ' OD2' ' A' ' 737' ' ' ASP . 4.6 mt -142.48 164.64 29.57 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.913 0.387 . . . . 0.0 111.488 -173.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 734' ' ' CYS . . . . . 0.694 ' HA ' ' O ' ' A' ' 818' ' ' ARG . 18.5 p -117.78 -174.15 2.58 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.129 -177.579 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 735' ' ' LEU . . . . . . . . . . . . . 1.4 tt -61.0 127.84 33.54 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.552 -177.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 78.52 16.48 79.29 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.377 -0.916 . . . . 0.0 112.033 174.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 737' ' ' ASP . . . . . 0.466 ' OD2' HD13 ' A' ' 733' ' ' LEU . 0.9 OUTLIER -64.99 165.72 10.47 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.377 0.608 . . . . 0.0 111.096 176.995 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 22.0 p-80 -137.52 129.33 28.7 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 162.165 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 739' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -97.86 171.76 8.09 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 119.674 -0.81 . . . . 0.0 111.165 -165.618 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 740' ' ' SER . . . . . 0.421 ' HA ' ' O ' ' A' ' 780' ' ' ILE . 50.2 m -142.45 107.68 4.99 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.16 -178.044 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 741' ' ' VAL . . . . . 0.636 HG11 HD13 ' A' ' 793' ' ' LEU . 1.0 OUTLIER -114.51 105.67 53.39 Favored Pre-proline 0 C--N 1.315 -0.924 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.075 179.672 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 742' ' ' PRO . . . . . 0.81 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 5.9 Cg_exo -73.76 135.5 21.72 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 122.248 1.965 . . . . 0.0 111.441 -176.421 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 743' ' ' VAL . . . . . 0.593 HG21 ' HB1' ' A' ' 723' ' ' ALA . 2.1 p -133.54 122.76 44.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 178.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 744' ' ' ALA . . . . . 0.574 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -82.77 98.6 9.19 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 167.649 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 745' ' ' LEU . . . . . 0.726 HD11 ' HB3' ' A' ' 778' ' ' TYR . 1.8 mt -77.53 157.69 30.26 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.262 -1.335 . . . . 0.0 111.471 -170.444 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 22.2 ttmm -112.56 155.48 24.28 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.284 -176.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 747' ' ' GLY . . . . . 0.441 ' HA3' ' HB3' ' A' ' 721' ' ' PRO . . . 100.19 120.43 4.52 Favored Glycine 0 C--N 1.305 -1.161 0 CA-C-N 115.131 -0.941 . . . . 0.0 111.62 -175.452 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 8.3 mm100 -100.34 106.35 17.95 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.003 -174.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 136.14 -174.52 21.4 Favored Glycine 0 N--CA 1.448 -0.546 0 N-CA-C 111.64 -0.584 . . . . 0.0 111.64 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -68.47 94.41 0.43 Allowed 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 122.642 2.228 . . . . 0.0 111.983 178.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 751' ' ' PHE . . . . . 0.564 ' CE2' ' HA ' ' A' ' 800' ' ' ASP . 73.8 m-85 -113.35 136.53 52.67 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.391 -179.478 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 752' ' ' THR . . . . . 0.807 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 59.8 m -90.44 102.46 15.19 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 121.961 0.886 . . . . 0.0 109.287 178.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 753' ' ' LEU . . . . . 0.419 HD22 HD22 ' A' ' 745' ' ' LEU . 16.4 tp -89.0 131.71 35.06 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 113.803 -1.544 . . . . 0.0 110.48 -170.042 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 754' ' ' THR . . . . . 0.449 HG23 ' HB2' ' A' ' 769' ' ' GLU . 1.2 m -131.61 132.89 44.41 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.17 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 755' ' ' TYR . . . . . 0.452 ' CE1' ' HB3' ' A' ' 768' ' ' PHE . 22.4 p90 -141.52 153.93 45.18 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.072 0.463 . . . . 0.0 111.758 179.382 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 756' ' ' ASP . . . . . 0.44 ' CG ' ' HD2' ' A' ' 765' ' ' ARG . 5.5 m-20 -115.13 119.63 37.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.451 -179.032 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 757' ' ' ILE . . . . . 0.401 HG12 HG22 ' A' ' 782' ' ' THR . 4.8 mp -90.88 95.56 5.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 168.793 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 758' ' ' ILE . . . . . 0.673 HG22 ' HD3' ' A' ' 765' ' ' ARG . 2.2 pp -90.21 140.06 16.54 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-O 121.413 0.625 . . . . 0.0 111.188 -170.406 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -92.73 98.72 11.59 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.724 -174.456 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 760' ' ' THR . . . . . 0.402 HG22 ' H ' ' A' ' 760' ' ' THR . 1.4 t . . . . . 0 C--N 1.321 -0.647 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.663 -172.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 765' ' ' ARG . . . . . 0.673 ' HD3' HG22 ' A' ' 758' ' ' ILE . 16.7 ttp180 . . . . . 0 N--CA 1.445 -0.715 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 766' ' ' LYS . . . . . 0.587 ' HD3' ' N ' ' A' ' 767' ' ' THR . 10.3 tmtt? -120.89 146.5 46.54 Favored 'General case' 0 C--O 1.218 -0.579 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -179.038 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 767' ' ' THR . . . . . 0.587 ' N ' ' HD3' ' A' ' 766' ' ' LYS . 31.1 m -123.67 143.24 50.38 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 116.725 -0.216 . . . . 0.0 111.13 -176.678 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 768' ' ' PHE . . . . . 0.452 ' HB3' ' CE1' ' A' ' 755' ' ' TYR . 4.5 t80 -142.34 137.32 30.46 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 120.995 0.426 . . . . 0.0 110.485 172.456 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 769' ' ' GLU . . . . . 0.449 ' HB2' HG23 ' A' ' 754' ' ' THR . 26.5 tt0 -128.33 123.67 34.55 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.951 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 770' ' ' ILE . . . . . 0.485 HG22 HG22 ' A' ' 773' ' ' ILE . 7.4 mt -116.56 112.69 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.459 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 771' ' ' LYS . . . . . 0.594 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 4.1 mtpt -84.61 150.39 25.21 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.31 0.576 . . . . 0.0 111.777 -173.043 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 772' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 51.69 52.89 13.67 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.315 -1.311 . . . . 0.0 111.943 178.08 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 773' ' ' ILE . . . . . 0.687 HD12 ' H ' ' A' ' 775' ' ' THR . 0.5 OUTLIER -76.81 117.82 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 173.437 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -116.29 30.62 7.23 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -178.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 775' ' ' THR . . . . . 0.687 ' H ' HD12 ' A' ' 773' ' ' ILE . 1.6 m -96.62 -72.25 0.64 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 113.76 -1.563 . . . . 0.0 112.215 -171.647 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 776' ' ' ASN . . . . . 0.426 ' HB2' ' O ' ' A' ' 775' ' ' THR . 11.7 m120 85.43 6.37 0.45 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.349 1.06 . . . . 0.0 110.238 178.068 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 777' ' ' GLU . . . . . 0.574 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 2.3 tm-20 -162.1 93.46 0.88 Allowed 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 114.374 -1.285 . . . . 0.0 107.702 176.313 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 778' ' ' TYR . . . . . 0.726 ' HB3' HD11 ' A' ' 745' ' ' LEU . 52.8 t80 -144.57 128.68 17.62 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.666 -169.621 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 779' ' ' VAL . . . . . 0.81 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 1.3 m -94.52 129.09 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.082 0 C-N-CA 118.861 -1.136 . . . . 0.0 110.506 179.592 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 780' ' ' ILE . . . . . 0.421 ' O ' ' HA ' ' A' ' 740' ' ' SER . 83.0 mt -89.43 142.94 12.18 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-N 114.072 -1.422 . . . . 0.0 110.828 -174.412 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -118.38 107.52 13.95 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.942 178.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 782' ' ' THR . . . . . 0.457 ' HA ' ' HD3' ' A' ' 783' ' ' PRO . 25.1 p -76.91 141.13 67.61 Favored Pre-proline 0 C--N 1.315 -0.902 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.376 -177.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 783' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 782' ' ' THR . 50.2 Cg_exo -55.07 161.4 6.7 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.719 2.946 . . . . 0.0 112.837 -174.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 784' ' ' VAL . . . . . 0.509 HG22 HG23 ' A' ' 786' ' ' THR . 7.4 p -58.83 131.46 23.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.107 -178.017 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 785' ' ' PHE . . . . . 0.409 ' C ' ' H ' ' A' ' 787' ' ' THR . 32.0 m-85 -112.14 88.59 2.85 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.716 177.541 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 786' ' ' THR . . . . . 0.509 HG23 HG22 ' A' ' 784' ' ' VAL . 44.8 p -82.23 31.71 0.39 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.796 0.808 . . . . 0.0 110.918 -178.584 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 787' ' ' THR . . . . . 0.409 ' H ' ' C ' ' A' ' 785' ' ' PHE . 12.4 m -157.38 107.46 2.22 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.282 -179.526 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 788' ' ' GLY . . . . . 0.723 ' HA2' HG12 ' A' ' 817' ' ' VAL . . . -45.66 124.39 6.9 Favored Glycine 0 C--N 1.334 0.471 0 CA-C-N 116.174 -0.466 . . . . 0.0 113.243 174.272 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 789' ' ' GLY . . . . . 0.557 ' H ' ' HB ' ' A' ' 817' ' ' VAL . . . -165.88 -151.24 6.62 Favored Glycine 0 N--CA 1.443 -0.861 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 179.188 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -147.15 133.43 19.5 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -178.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 791' ' ' TYR . . . . . 0.421 ' HB2' ' HB ' ' A' ' 815' ' ' ILE . 41.8 m-85 -132.73 154.66 49.99 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.777 -174.191 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 792' ' ' ILE . . . . . 0.437 ' CG1' ' HG3' ' A' ' 814' ' ' LYS . 12.6 mt -131.2 116.79 34.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 176.668 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 793' ' ' LEU . . . . . 0.636 HD13 HG11 ' A' ' 741' ' ' VAL . 10.1 tt -84.72 107.29 16.84 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.368 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 794' ' ' SER . . . . . . . . . . . . . 19.3 m -114.18 164.96 13.17 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.319 179.159 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 795' ' ' LEU . . . . . . . . . . . . . 48.9 mt -94.89 132.61 39.52 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 120.71 0.29 . . . . 0.0 110.905 -175.214 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 796' ' ' VAL . . . . . . . . . . . . . 85.4 t -88.95 -56.99 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.386 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.705 -178.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 797' ' ' SER . . . . . 0.515 ' HA ' HD13 ' A' ' 808' ' ' LEU . 7.1 m 178.46 177.26 0.45 Allowed 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.013 0.821 . . . . 0.0 109.583 -175.333 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 798' ' ' ILE . . . . . 0.523 ' O ' ' HA ' ' A' ' 805' ' ' VAL . 11.4 tt -146.31 164.67 9.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 177.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 799' ' ' LYS . . . . . 0.807 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 7.4 tttm -135.08 120.02 18.58 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.045 0.45 . . . . 0.0 111.142 -176.632 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 800' ' ' ASP . . . . . 0.564 ' HA ' ' CE2' ' A' ' 751' ' ' PHE . 19.3 t70 -63.65 159.36 19.18 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.877 176.101 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 24.9 t -61.19 -20.91 63.3 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 123.902 0.751 . . . . 0.0 111.422 -175.209 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 39.7 p -83.8 -5.29 59.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.698 0.761 . . . . 0.0 109.676 178.005 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 803' ' ' GLY . . . . . . . . . . . . . . . 87.88 43.86 5.59 Favored Glycine 0 N--CA 1.439 -1.14 0 CA-C-N 114.435 -1.257 . . . . 0.0 111.258 -177.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 804' ' ' CYS . . . . . 0.528 ' HB3' ' HB3' ' A' ' 800' ' ' ASP . 30.6 t -107.99 108.69 19.92 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 -179.027 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 805' ' ' VAL . . . . . 0.523 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 4.8 t -85.75 110.53 19.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 121.178 0.514 . . . . 0.0 110.616 -175.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 806' ' ' VAL . . . . . 0.418 HG21 ' HD2' ' A' ' 721' ' ' PRO . 94.1 t -94.69 141.12 15.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.233 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -80.89 109.83 3.03 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.146 178.22 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 808' ' ' LEU . . . . . 0.515 HD13 ' HA ' ' A' ' 797' ' ' SER . 10.5 mp -73.61 126.85 31.21 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 178.465 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 20.5 m -141.59 85.7 1.96 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.171 170.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 810' ' ' GLN . . . . . 0.488 ' HB3' ' HD2' ' A' ' 811' ' ' PRO . 11.0 mt-30 -145.56 169.36 9.89 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.303 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 811' ' ' PRO . . . . . 0.488 ' HD2' ' HB3' ' A' ' 810' ' ' GLN . 88.1 Cg_exo -43.94 139.19 5.86 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 123.336 2.69 . . . . 0.0 115.714 -171.06 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -107.78 167.94 9.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.355 -1.293 . . . . 0.0 109.763 175.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 813' ' ' ALA . . . . . . . . . . . . . . . -127.36 151.9 48.19 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.304 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 814' ' ' LYS . . . . . 0.437 ' HG3' ' CG1' ' A' ' 792' ' ' ILE . 13.9 ttpp -113.54 127.86 56.23 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 121.709 0.766 . . . . 0.0 111.265 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 815' ' ' ILE . . . . . 0.558 ' HA ' ' HB2' ' A' ' 731' ' ' LEU . 4.3 mp -106.01 125.09 61.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.386 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 816' ' ' GLN . . . . . 0.659 ' NE2' ' HG2' ' A' ' 818' ' ' ARG . 0.8 OUTLIER -115.19 116.65 28.71 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.275 0.56 . . . . 0.0 111.027 -178.291 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 817' ' ' VAL . . . . . 0.723 HG12 ' HA2' ' A' ' 788' ' ' GLY . 58.7 t -109.94 133.22 55.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.882 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 818' ' ' ARG . . . . . 0.694 ' O ' ' HA ' ' A' ' 734' ' ' CYS . 85.4 mmt-85 . . . . . 0 C--N 1.324 -0.519 0 CA-C-O 120.914 0.388 . . . . 0.0 110.395 175.271 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 720' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt . . . . . 0 N--CA 1.446 -0.63 0 CA-C-O 120.695 0.283 . . . . 0.0 110.402 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 721' ' ' PRO . . . . . 0.513 ' HB2' HD13 ' A' ' 798' ' ' ILE . 60.7 Cg_endo -88.6 145.16 5.71 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 122.897 2.398 . . . . 0.0 111.429 177.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 722' ' ' SER . . . . . 0.643 ' HA ' HD22 ' A' ' 808' ' ' LEU . 10.7 t -175.9 -153.04 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.82 0.343 . . . . 0.0 110.524 -175.197 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 723' ' ' ALA . . . . . 0.536 ' HA ' ' HA ' ' A' ' 745' ' ' LEU . . . -149.49 143.19 25.49 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.361 -0.381 . . . . 0.0 109.99 179.044 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 9.4 m -131.37 98.61 4.58 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 725' ' ' LEU . . . . . 0.471 ' CD2' ' HB ' ' A' ' 743' ' ' VAL . 12.7 mt -64.42 143.49 57.87 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-O 121.695 0.759 . . . . 0.0 111.557 -175.592 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 34.2 mtpt -96.77 -18.75 19.4 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.866 -176.276 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 727' ' ' LEU . . . . . 0.533 HD21 ' HB2' ' A' ' 731' ' ' LEU . 33.7 tp -69.66 112.67 6.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.854 175.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 31.3 t-80 -112.78 45.83 1.28 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.695 0.283 . . . . 0.0 111.573 -174.1 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -177.77 -177.91 0.68 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.698 -0.228 . . . . 0.0 110.643 177.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 730' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -76.42 137.6 39.83 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.194 0.521 . . . . 0.0 109.71 175.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 731' ' ' LEU . . . . . 0.556 HD23 ' HB2' ' A' ' 739' ' ' SER . 25.9 tp -100.42 113.05 25.5 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.865 -176.109 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 732' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -78.29 110.8 13.63 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.047 -173.547 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 733' ' ' LEU . . . . . 0.634 ' HG ' ' HB3' ' A' ' 737' ' ' ASP . 8.5 mp -117.5 163.75 15.94 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.489 175.313 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 734' ' ' CYS . . . . . 0.538 ' HA ' ' O ' ' A' ' 818' ' ' ARG . 74.5 m -115.82 -173.85 2.42 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.826 175.157 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 735' ' ' LEU . . . . . . . . . . . . . 16.7 tp -65.92 123.71 20.54 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.794 0.33 . . . . 0.0 110.531 -177.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 79.64 13.29 82.65 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.472 -0.87 . . . . 0.0 112.312 179.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 737' ' ' ASP . . . . . 0.634 ' HB3' ' HG ' ' A' ' 733' ' ' LEU . 0.3 OUTLIER -80.72 151.99 28.59 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.03 0.443 . . . . 0.0 111.057 175.987 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 738' ' ' HIS . . . . . 0.485 ' HB2' ' O ' ' A' ' 782' ' ' THR . 38.6 p-80 -117.08 149.22 40.67 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 170.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 739' ' ' SER . . . . . 0.556 ' HB2' HD23 ' A' ' 731' ' ' LEU . 5.3 p -103.95 167.63 9.65 Favored 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 119.387 -0.925 . . . . 0.0 111.549 -169.62 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 740' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 780' ' ' ILE . 40.4 m -139.07 100.41 4.02 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.327 176.746 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 741' ' ' VAL . . . . . 0.614 HG11 HD23 ' A' ' 793' ' ' LEU . 0.9 OUTLIER -111.86 113.87 52.22 Favored Pre-proline 0 C--N 1.317 -0.831 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.873 -179.434 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 742' ' ' PRO . . . . . 0.691 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 1.0 OUTLIER -74.98 132.95 16.03 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 122.278 1.985 . . . . 0.0 111.454 -179.093 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 743' ' ' VAL . . . . . 0.514 HG21 ' HB1' ' A' ' 723' ' ' ALA . 2.0 p -130.21 120.35 48.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.405 0.622 . . . . 0.0 112.316 175.037 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 744' ' ' ALA . . . . . 0.643 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -80.72 95.26 6.56 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 122.098 0.951 . . . . 0.0 108.697 168.212 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 745' ' ' LEU . . . . . 0.603 HD11 ' HB3' ' A' ' 778' ' ' TYR . 3.0 mt -74.92 151.62 38.89 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.165 -1.38 . . . . 0.0 111.477 -170.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 19.8 ttmm -106.36 162.26 13.84 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.001 -178.077 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 747' ' ' GLY . . . . . . . . . . . . . . . 99.74 129.87 6.76 Favored Glycine 0 C--N 1.308 -0.975 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.458 -175.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 40.1 mm-40 -107.43 107.8 18.85 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.856 -174.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 125.89 -171.43 17.72 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.848 -0.691 . . . . 0.0 111.927 -179.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -70.2 95.11 0.58 Allowed 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.953 2.435 . . . . 0.0 112.177 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 751' ' ' PHE . . . . . 0.539 ' HA ' ' O ' ' A' ' 799' ' ' LYS . 76.2 m-85 -117.25 135.39 53.85 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.239 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 752' ' ' THR . . . . . 0.751 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 89.8 m -85.95 107.65 17.83 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.177 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 753' ' ' LEU . . . . . 0.497 ' HG ' HD22 ' A' ' 745' ' ' LEU . 0.6 OUTLIER -97.93 117.73 32.9 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.322 -171.944 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 754' ' ' THR . . . . . 0.447 HG23 ' HB2' ' A' ' 769' ' ' GLU . 1.0 OUTLIER -118.17 139.28 51.5 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.056 -177.002 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 755' ' ' TYR . . . . . 0.7 ' CE1' ' HB3' ' A' ' 768' ' ' PHE . 22.5 p90 -147.1 158.81 44.06 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 756' ' ' ASP . . . . . 0.467 ' HB3' HG23 ' A' ' 758' ' ' ILE . 0.4 OUTLIER -122.77 120.5 33.76 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.833 -178.262 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 757' ' ' ILE . . . . . 0.554 ' CD1' HD13 ' A' ' 793' ' ' LEU . 3.8 mp -89.3 96.51 6.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 170.101 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 758' ' ' ILE . . . . . 0.55 HG13 ' O ' ' A' ' 792' ' ' ILE . 2.5 pp -98.65 152.01 4.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 121.52 0.676 . . . . 0.0 112.593 -168.143 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 759' ' ' GLU . . . . . 0.609 ' HG2' ' CE2' ' A' ' 791' ' ' TYR . 2.6 mt-10 -91.15 120.08 31.8 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.422 -179.193 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 760' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.312 -1.028 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.725 172.023 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 765' ' ' ARG . . . . . 0.525 ' HD2' HG22 ' A' ' 758' ' ' ILE . 68.8 mtm180 . . . . . 0 N--CA 1.464 0.24 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 766' ' ' LYS . . . . . 0.628 ' HD3' ' N ' ' A' ' 767' ' ' THR . 8.1 tmtt? -145.11 136.93 25.57 Favored 'General case' 0 C--O 1.216 -0.686 0 CA-C-O 120.971 0.415 . . . . 0.0 110.423 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 767' ' ' THR . . . . . 0.628 ' N ' ' HD3' ' A' ' 766' ' ' LYS . 84.8 m -114.0 128.14 56.26 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.544 -176.274 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 768' ' ' PHE . . . . . 0.7 ' HB3' ' CE1' ' A' ' 755' ' ' TYR . 2.9 t80 -128.62 137.24 51.57 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 769' ' ' GLU . . . . . 0.447 ' HB2' HG23 ' A' ' 754' ' ' THR . 34.7 tt0 -130.58 122.38 27.4 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.706 -175.549 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 770' ' ' ILE . . . . . 0.621 HG22 HG22 ' A' ' 773' ' ' ILE . 6.0 mt -117.14 111.15 33.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 177.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 771' ' ' LYS . . . . . 0.633 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 13.4 mtpt -85.03 150.2 25.05 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-O 121.547 0.689 . . . . 0.0 112.065 -173.469 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 772' ' ' GLU . . . . . 0.425 ' O ' ' HG3' ' A' ' 774' ' ' LYS . 3.6 mt-10 52.1 49.63 20.22 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 113.897 -1.501 . . . . 0.0 111.865 177.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 773' ' ' ILE . . . . . 0.718 HD12 ' H ' ' A' ' 775' ' ' THR . 0.5 OUTLIER -73.75 118.6 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 176.266 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 774' ' ' LYS . . . . . 0.425 ' HG3' ' O ' ' A' ' 772' ' ' GLU . 73.9 mttt -116.23 30.16 7.51 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -178.576 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 775' ' ' THR . . . . . 0.718 ' H ' HD12 ' A' ' 773' ' ' ILE . 1.6 m -95.9 -73.25 0.6 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 113.79 -1.55 . . . . 0.0 112.238 -171.562 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 776' ' ' ASN . . . . . 0.472 ' HB2' ' O ' ' A' ' 775' ' ' THR . 11.6 m120 88.14 5.59 0.23 Allowed 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.622 1.169 . . . . 0.0 110.62 179.375 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 777' ' ' GLU . . . . . 0.643 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 30.7 tt0 -161.94 100.47 1.12 Allowed 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.875 171.557 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 778' ' ' TYR . . . . . 0.603 ' HB3' HD11 ' A' ' 745' ' ' LEU . 81.8 t80 -141.92 129.98 22.02 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.63 -170.278 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 779' ' ' VAL . . . . . 0.691 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 14.4 t -89.22 114.11 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 CA-C-O 121.259 0.552 . . . . 0.0 110.094 -179.27 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 780' ' ' ILE . . . . . 0.472 ' O ' ' HA ' ' A' ' 740' ' ' SER . 77.7 mt -81.17 141.72 14.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.604 -178.101 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 781' ' ' LYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 739' ' ' SER . 0.0 OUTLIER -121.54 109.4 14.77 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 176.288 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 782' ' ' THR . . . . . 0.485 ' O ' ' HB2' ' A' ' 738' ' ' HIS . 38.7 p -79.08 143.51 61.33 Favored Pre-proline 0 C--N 1.32 -0.705 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -178.612 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 783' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 782' ' ' THR . 52.4 Cg_exo -53.17 158.19 7.41 Favored 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 123.546 2.83 . . . . 0.0 113.179 -177.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 784' ' ' VAL . . . . . 0.472 HG12 HG23 ' A' ' 786' ' ' THR . 53.5 t -58.93 118.69 2.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.157 -179.062 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 785' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -98.43 97.19 8.56 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.913 178.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 786' ' ' THR . . . . . 0.472 HG23 HG12 ' A' ' 784' ' ' VAL . 38.4 p -84.71 31.49 0.53 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.711 0.767 . . . . 0.0 111.201 -178.448 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 77.6 m -152.27 112.59 4.08 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.847 -1.07 . . . . 0.0 110.829 179.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 788' ' ' GLY . . . . . 0.628 ' HA2' HG12 ' A' ' 817' ' ' VAL . . . -51.57 114.13 2.84 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.648 171.365 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 789' ' ' GLY . . . . . 0.573 ' H ' ' HB ' ' A' ' 817' ' ' VAL . . . -158.52 -167.26 19.08 Favored Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 110.391 -1.083 . . . . 0.0 110.391 -178.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -128.3 124.75 37.3 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 117.629 0.715 . . . . 0.0 109.864 -178.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 791' ' ' TYR . . . . . 0.609 ' CE2' ' HG2' ' A' ' 759' ' ' GLU . 97.7 m-85 -120.67 149.48 42.43 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.32 -176.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 792' ' ' ILE . . . . . 0.55 ' O ' HG13 ' A' ' 758' ' ' ILE . 12.5 mt -126.88 116.46 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 171.594 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 793' ' ' LEU . . . . . 0.614 HD23 HG11 ' A' ' 741' ' ' VAL . 0.9 OUTLIER -84.95 113.14 21.19 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.211 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 794' ' ' SER . . . . . 0.527 ' N ' HD12 ' A' ' 793' ' ' LEU . 21.6 t -122.76 164.6 18.03 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.997 -176.191 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 795' ' ' LEU . . . . . 0.432 HD13 ' HB3' ' A' ' 723' ' ' ALA . 21.6 mt -94.49 134.11 37.37 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.992 -173.432 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 796' ' ' VAL . . . . . . . . . . . . . 67.8 t -95.51 -55.79 5.79 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.767 -176.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 797' ' ' SER . . . . . 0.583 ' HA ' ' HG ' ' A' ' 808' ' ' LEU . 87.5 p -177.33 160.22 1.65 Allowed 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.755 -174.174 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 798' ' ' ILE . . . . . 0.685 ' HA ' ' O ' ' A' ' 752' ' ' THR . 9.4 tt -131.35 166.95 27.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 177.699 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 799' ' ' LYS . . . . . 0.751 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 15.6 tttm -136.62 117.25 13.91 Favored 'General case' 0 C--N 1.322 -0.623 0 O-C-N 122.26 -0.275 . . . . 0.0 111.65 -174.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 800' ' ' ASP . . . . . 0.489 ' HB3' ' HB3' ' A' ' 804' ' ' CYS . 24.2 t70 -69.9 157.14 37.98 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 170.247 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 58.0 p -63.09 -8.92 8.67 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -170.363 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 26.6 p -89.0 -1.75 58.26 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.636 0.731 . . . . 0.0 109.875 176.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 803' ' ' GLY . . . . . . . . . . . . . . . 84.59 27.14 36.39 Favored Glycine 0 N--CA 1.439 -1.111 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.028 -176.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 804' ' ' CYS . . . . . 0.489 ' HB3' ' HB3' ' A' ' 800' ' ' ASP . 46.1 t -94.43 108.94 20.84 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -178.703 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 805' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 4.2 p -85.58 119.6 34.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.875 0.845 . . . . 0.0 110.626 -176.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 806' ' ' VAL . . . . . 0.464 HG11 ' HD2' ' A' ' 721' ' ' PRO . 21.4 t -102.03 135.36 39.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.106 -178.52 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -73.12 125.24 9.5 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.997 -177.352 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 808' ' ' LEU . . . . . 0.643 HD22 ' HA ' ' A' ' 722' ' ' SER . 49.3 mt -89.91 123.36 33.78 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.162 0.506 . . . . 0.0 112.225 -177.515 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 22.5 m -142.12 86.61 1.98 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.101 175.116 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 810' ' ' GLN . . . . . 0.45 ' HB3' ' HD2' ' A' ' 811' ' ' PRO . 8.1 mt-30 -144.54 173.58 4.24 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.23 175.714 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 811' ' ' PRO . . . . . 0.45 ' HD2' ' HB3' ' A' ' 810' ' ' GLN . 82.5 Cg_exo -45.0 140.86 6.75 Favored 'Trans proline' 0 C--N 1.358 1.05 0 C-N-CA 123.102 2.534 . . . . 0.0 114.716 -177.455 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -109.09 167.21 10.27 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.653 -1.158 . . . . 0.0 110.418 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 813' ' ' ALA . . . . . 0.503 ' HB1' HD23 ' A' ' 727' ' ' LEU . . . -116.25 156.82 25.92 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.687 -179.529 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 814' ' ' LYS . . . . . 0.456 ' HG2' HG12 ' A' ' 792' ' ' ILE . 49.2 mttp -118.76 125.04 48.74 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.121 0.486 . . . . 0.0 110.821 177.64 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 815' ' ' ILE . . . . . 0.538 ' HA ' ' HB3' ' A' ' 731' ' ' LEU . 5.3 mp -113.02 117.4 55.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 115.311 -0.859 . . . . 0.0 108.888 178.008 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 816' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -103.71 113.36 26.82 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.195 -177.243 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 817' ' ' VAL . . . . . 0.628 HG12 ' HA2' ' A' ' 788' ' ' GLY . 43.8 t -106.02 137.28 36.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 818' ' ' ARG . . . . . 0.538 ' O ' ' HA ' ' A' ' 734' ' ' CYS . 22.4 tpt180 . . . . . 0 C--N 1.322 -0.595 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -178.479 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 720' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt . . . . . 0 N--CA 1.444 -0.734 0 CA-C-O 120.772 0.32 . . . . 0.0 110.17 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 721' ' ' PRO . . . . . 0.746 ' HD2' HG11 ' A' ' 806' ' ' VAL . 36.4 Cg_endo -83.95 137.92 7.75 Favored 'Trans proline' 0 N--CA 1.447 -1.227 0 C-N-CA 122.597 2.198 . . . . 0.0 110.601 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 32.4 p -176.25 -150.58 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.205 -167.295 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 723' ' ' ALA . . . . . 0.602 ' HA ' ' HA ' ' A' ' 745' ' ' LEU . . . -155.09 149.4 26.08 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 110.428 -0.212 . . . . 0.0 110.428 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 15.9 m -139.89 98.78 3.54 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.181 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 725' ' ' LEU . . . . . 0.578 ' HA ' ' HA ' ' A' ' 743' ' ' VAL . 6.2 mp -59.84 142.19 53.95 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 122.328 1.061 . . . . 0.0 112.551 -175.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 36.9 mtpt -91.41 -16.7 26.96 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 113.269 -1.787 . . . . 0.0 110.309 -176.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 727' ' ' LEU . . . . . 0.547 HD23 ' HB1' ' A' ' 813' ' ' ALA . 51.1 tp -70.24 126.93 31.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.016 178.577 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -119.26 29.93 7.39 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -174.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 9.7 p80 -166.94 170.78 11.81 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.73 0.3 . . . . 0.0 110.434 177.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 730' ' ' ASP . . . . . 0.527 ' HA ' ' O ' ' A' ' 814' ' ' LYS . 10.3 p-10 -79.44 138.57 37.64 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.69 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 731' ' ' LEU . . . . . 0.591 HD13 ' HB2' ' A' ' 739' ' ' SER . 35.1 mt -87.23 107.76 18.63 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.485 -177.149 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 732' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt -81.59 96.71 7.56 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.013 -176.468 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 733' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.95 163.97 14.01 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.328 0.585 . . . . 0.0 111.904 -178.189 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 734' ' ' CYS . . . . . 0.588 ' O ' ' HB2' ' A' ' 737' ' ' ASP . 72.5 m -105.39 -172.98 2.19 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.032 -0.986 . . . . 0.0 109.66 176.498 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 735' ' ' LEU . . . . . . . . . . . . . 13.4 tp -73.83 138.68 44.59 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.444 0.64 . . . . 0.0 112.03 -172.361 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 74.38 14.8 80.59 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 114.756 -1.111 . . . . 0.0 111.286 -177.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 737' ' ' ASP . . . . . 0.588 ' HB2' ' O ' ' A' ' 734' ' ' CYS . 1.0 OUTLIER -89.34 147.09 24.27 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.394 0.616 . . . . 0.0 112.036 177.61 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 738' ' ' HIS . . . . . 0.643 ' HB2' ' O ' ' A' ' 782' ' ' THR . 46.5 p-80 -110.31 177.49 4.68 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 167.059 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 739' ' ' SER . . . . . 0.591 ' HB2' HD13 ' A' ' 731' ' ' LEU . 16.5 p -138.36 171.08 14.9 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 118.519 -1.272 . . . . 0.0 112.503 -174.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 12.4 p -133.44 110.86 10.28 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.314 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 741' ' ' VAL . . . . . 0.567 HG11 HD23 ' A' ' 793' ' ' LEU . 1.5 p -119.31 113.9 35.04 Favored Pre-proline 0 C--N 1.319 -0.745 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.031 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 742' ' ' PRO . . . . . 0.669 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 2.2 Cg_endo -77.9 136.35 14.86 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.389 2.059 . . . . 0.0 111.641 -178.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 743' ' ' VAL . . . . . 0.578 ' HA ' ' HA ' ' A' ' 725' ' ' LEU . 2.1 p -132.45 121.52 45.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.602 0.715 . . . . 0.0 112.466 177.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 744' ' ' ALA . . . . . 0.619 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -79.46 95.69 5.87 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 122.17 0.985 . . . . 0.0 108.769 168.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 745' ' ' LEU . . . . . 0.744 HD11 ' HB3' ' A' ' 778' ' ' TYR . 2.0 mt -77.68 160.18 28.65 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 114.074 -1.421 . . . . 0.0 111.137 -172.111 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 31.8 ttmt -116.29 167.15 11.27 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.793 -178.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 747' ' ' GLY . . . . . . . . . . . . . . . 93.78 125.0 3.99 Favored Glycine 0 C--N 1.309 -0.921 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.384 -173.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 67.0 mm-40 -100.24 114.29 27.61 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.877 0.37 . . . . 0.0 111.532 -175.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 119.98 -175.92 16.02 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.923 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -67.95 94.39 0.4 Allowed 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.929 2.419 . . . . 0.0 112.259 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 751' ' ' PHE . . . . . 0.415 ' HB3' HG12 ' A' ' 798' ' ' ILE . 53.7 m-85 -108.98 141.62 40.81 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.313 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 752' ' ' THR . . . . . 0.768 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 99.2 m -88.39 101.77 14.22 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 121.737 0.779 . . . . 0.0 109.645 177.21 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 753' ' ' LEU . . . . . . . . . . . . . 16.9 tp -90.19 125.2 35.39 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 114.409 -1.269 . . . . 0.0 110.511 -171.612 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 754' ' ' THR . . . . . 0.449 HG23 ' HB2' ' A' ' 769' ' ' GLU . 0.6 OUTLIER -123.48 131.24 53.58 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.159 -179.866 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 755' ' ' TYR . . . . . 0.587 ' CE1' ' HB3' ' A' ' 768' ' ' PHE . 22.3 p90 -141.39 157.34 45.31 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.801 0.334 . . . . 0.0 111.207 178.167 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 756' ' ' ASP . . . . . 0.463 ' HB3' HG23 ' A' ' 758' ' ' ILE . 0.5 OUTLIER -119.82 118.48 30.92 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.256 -176.386 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 757' ' ' ILE . . . . . 0.509 HG13 HD13 ' A' ' 793' ' ' LEU . 3.5 mp -87.93 95.91 5.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 168.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 758' ' ' ILE . . . . . 0.615 HG13 ' O ' ' A' ' 792' ' ' ILE . 2.3 pp -94.68 149.62 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.256 -173.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 759' ' ' GLU . . . . . 0.667 ' HB3' ' CE2' ' A' ' 791' ' ' TYR . 8.7 pt-20 -107.09 129.36 54.83 Favored 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.132 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 760' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.319 -0.754 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 176.464 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 765' ' ' ARG . . . . . 0.45 ' HA ' ' HA ' ' A' ' 758' ' ' ILE . 48.7 mtm180 . . . . . 0 C--O 1.232 0.183 0 CA-C-O 120.882 0.373 . . . . 0.0 110.707 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 766' ' ' LYS . . . . . 0.46 ' O ' ' HA ' ' A' ' 756' ' ' ASP . 0.7 OUTLIER -120.5 143.12 48.72 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 -179.887 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 767' ' ' THR . . . . . . . . . . . . . 87.6 m -119.32 130.71 55.51 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.949 -176.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 768' ' ' PHE . . . . . 0.587 ' HB3' ' CE1' ' A' ' 755' ' ' TYR . 1.8 t80 -127.09 128.67 46.61 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 174.739 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 769' ' ' GLU . . . . . 0.449 ' HB2' HG23 ' A' ' 754' ' ' THR . 40.0 tt0 -126.22 118.27 24.82 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.782 -175.062 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 9.0 mt -116.12 113.29 42.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.557 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 771' ' ' LYS . . . . . 0.647 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 6.1 mtpt -82.56 151.98 26.17 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-O 121.394 0.616 . . . . 0.0 111.079 -178.083 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 772' ' ' GLU . . . . . 0.42 ' O ' ' HG3' ' A' ' 774' ' ' LYS . 8.0 mt-10 57.75 46.92 16.38 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.169 -1.378 . . . . 0.0 112.28 176.502 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 773' ' ' ILE . . . . . 0.637 HD12 ' H ' ' A' ' 775' ' ' THR . 0.5 OUTLIER -73.85 119.46 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 172.969 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 774' ' ' LYS . . . . . 0.42 ' HG3' ' O ' ' A' ' 772' ' ' GLU . 74.0 mttt -118.21 30.53 7.18 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -177.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 775' ' ' THR . . . . . 0.637 ' H ' HD12 ' A' ' 773' ' ' ILE . 0.2 OUTLIER -96.06 -73.57 0.59 Allowed 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 113.988 -1.46 . . . . 0.0 112.498 -171.43 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 776' ' ' ASN . . . . . 0.439 ' HB2' ' O ' ' A' ' 775' ' ' THR . 11.7 m120 83.48 4.3 0.86 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.504 1.121 . . . . 0.0 110.431 -176.573 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 777' ' ' GLU . . . . . 0.619 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 22.5 mt-10 -161.56 88.41 0.71 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.998 -1.001 . . . . 0.0 108.643 173.502 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 778' ' ' TYR . . . . . 0.744 ' HB3' HD11 ' A' ' 745' ' ' LEU . 50.2 t80 -130.88 132.41 45.13 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.644 -169.662 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 779' ' ' VAL . . . . . 0.669 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 20.1 t -87.07 113.78 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 CA-C-O 121.209 0.528 . . . . 0.0 110.396 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 780' ' ' ILE . . . . . . . . . . . . . 66.0 mt -82.79 143.41 12.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.577 -178.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.73 110.55 17.97 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 176.042 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 782' ' ' THR . . . . . 0.643 ' O ' ' HB2' ' A' ' 738' ' ' HIS . 29.8 p -77.56 142.07 66.02 Favored Pre-proline 0 C--N 1.317 -0.834 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 783' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 782' ' ' THR . 38.0 Cg_exo -57.46 166.02 5.2 Favored 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 123.364 2.709 . . . . 0.0 112.229 -179.439 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 784' ' ' VAL . . . . . . . . . . . . . 14.1 p -67.53 135.26 28.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.291 0.567 . . . . 0.0 111.065 -175.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 785' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -104.77 103.64 13.29 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.539 178.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 82.3 p -86.21 18.54 3.09 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.463 -172.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 29.9 m -158.11 121.77 4.01 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.66 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 788' ' ' GLY . . . . . 0.572 ' HA2' HG12 ' A' ' 817' ' ' VAL . . . -48.85 118.22 4.77 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.888 -0.596 . . . . 0.0 112.791 171.557 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 789' ' ' GLY . . . . . 0.545 ' H ' ' HB ' ' A' ' 817' ' ' VAL . . . -174.88 168.39 40.99 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -97.32 135.93 38.52 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 118.066 0.933 . . . . 0.0 110.692 -178.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 791' ' ' TYR . . . . . 0.667 ' CE2' ' HB3' ' A' ' 759' ' ' GLU . 70.3 m-85 -123.18 150.21 43.63 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.671 176.369 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 792' ' ' ILE . . . . . 0.615 ' O ' HG13 ' A' ' 758' ' ' ILE . 11.3 mt -128.7 110.38 21.0 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 793' ' ' LEU . . . . . 0.567 HD23 HG11 ' A' ' 741' ' ' VAL . 1.1 tp -84.2 111.75 19.65 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 794' ' ' SER . . . . . 0.517 ' N ' HD12 ' A' ' 793' ' ' LEU . 40.5 t -122.48 161.07 24.26 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.322 -1.308 . . . . 0.0 108.875 -175.024 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 795' ' ' LEU . . . . . . . . . . . . . 39.9 mt -88.71 142.67 27.48 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.658 -0.247 . . . . 0.0 110.738 -176.062 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 796' ' ' VAL . . . . . . . . . . . . . 73.4 t -102.73 -55.18 6.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.186 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 797' ' ' SER . . . . . 0.511 ' HA ' HD13 ' A' ' 808' ' ' LEU . 7.4 t -178.03 177.78 1.0 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.475 -173.725 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 798' ' ' ILE . . . . . 0.634 ' HA ' ' O ' ' A' ' 752' ' ' THR . 9.2 tt -150.15 163.12 3.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 799' ' ' LYS . . . . . 0.768 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 9.6 tmtt? -138.71 119.53 14.22 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.895 0.379 . . . . 0.0 111.0 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 800' ' ' ASP . . . . . 0.595 ' HB3' ' HB3' ' A' ' 804' ' ' CYS . 14.1 t70 -64.12 155.72 30.62 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.729 174.317 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 3.5 m -60.01 -17.22 37.15 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 124.071 0.857 . . . . 0.0 112.596 -173.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 802' ' ' THR . . . . . 0.423 HG22 ' OD1' ' A' ' 800' ' ' ASP . 13.0 t -89.86 -0.55 57.63 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 121.836 0.827 . . . . 0.0 109.636 177.685 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 803' ' ' GLY . . . . . 0.454 ' HA2' ' HE2' ' A' ' 799' ' ' LYS . . . 86.68 38.23 8.24 Favored Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.846 -178.451 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 804' ' ' CYS . . . . . 0.595 ' HB3' ' HB3' ' A' ' 800' ' ' ASP . 46.5 t -99.73 105.15 16.92 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.49 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 805' ' ' VAL . . . . . . . . . . . . . 5.9 t -85.51 122.87 38.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.246 0.546 . . . . 0.0 110.143 -176.047 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 806' ' ' VAL . . . . . 0.746 HG11 ' HD2' ' A' ' 721' ' ' PRO . 32.4 t -114.43 136.99 49.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.552 -174.204 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -81.89 110.31 3.16 Favored Glycine 0 C--N 1.322 -0.207 0 C-N-CA 120.76 -0.733 . . . . 0.0 113.279 -176.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 808' ' ' LEU . . . . . 0.511 HD13 ' HA ' ' A' ' 797' ' ' SER . 10.9 mp -81.36 123.58 28.66 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 178.239 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 9.7 t -141.91 86.78 2.0 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 168.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 810' ' ' GLN . . . . . 0.459 ' HB3' ' O ' ' A' ' 723' ' ' ALA . 0.9 OUTLIER -146.07 176.07 2.4 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.879 -171.238 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 811' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_exo -41.61 142.91 1.11 Allowed 'Trans proline' 0 C--N 1.362 1.258 0 C-N-CA 123.559 2.839 . . . . 0.0 115.495 -171.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -125.37 167.57 14.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.348 -1.296 . . . . 0.0 110.577 -176.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 813' ' ' ALA . . . . . 0.547 ' HB1' HD23 ' A' ' 727' ' ' LEU . . . -122.31 158.56 29.29 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.714 178.543 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 814' ' ' LYS . . . . . 0.527 ' O ' ' HA ' ' A' ' 730' ' ' ASP . 21.5 ttpp -123.55 111.42 16.25 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.381 0.61 . . . . 0.0 110.521 175.099 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 815' ' ' ILE . . . . . 0.53 ' HA ' ' HB2' ' A' ' 731' ' ' LEU . 5.4 mp -92.54 113.67 28.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 115.364 -0.834 . . . . 0.0 108.837 177.555 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 816' ' ' GLN . . . . . 0.53 HE22 ' HB2' ' A' ' 818' ' ' ARG . 1.1 tm0? -99.55 108.38 20.78 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.258 0.551 . . . . 0.0 110.119 -177.638 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 817' ' ' VAL . . . . . 0.572 HG12 ' HA2' ' A' ' 788' ' ' GLY . 42.0 t -99.08 143.66 13.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.81 -179.156 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 818' ' ' ARG . . . . . 0.53 ' HB2' HE22 ' A' ' 816' ' ' GLN . 30.1 tpt180 . . . . . 0 C--N 1.318 -0.761 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 720' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp . . . . . 0 N--CA 1.447 -0.585 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 721' ' ' PRO . . . . . 0.455 ' HB2' HD13 ' A' ' 798' ' ' ILE . 59.5 Cg_endo -84.79 146.65 10.55 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 122.106 1.871 . . . . 0.0 112.042 -172.153 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 722' ' ' SER . . . . . 0.542 ' HA ' HD22 ' A' ' 808' ' ' LEU . 22.7 t -177.39 -157.29 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.597 -171.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 723' ' ' ALA . . . . . 0.643 ' HB1' HG21 ' A' ' 743' ' ' VAL . . . -148.97 142.07 24.91 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 176.594 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 724' ' ' SER . . . . . 0.436 ' HB2' ' OE1' ' A' ' 810' ' ' GLN . 23.0 t -130.98 105.04 7.48 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -178.721 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 725' ' ' LEU . . . . . 0.495 ' CD2' ' HB ' ' A' ' 743' ' ' VAL . 14.0 mt -65.31 149.17 50.42 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-O 121.854 0.835 . . . . 0.0 112.31 -173.156 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 726' ' ' LYS . . . . . 0.403 ' HB2' ' HB2' ' A' ' 742' ' ' PRO . 40.0 mtpt -100.32 -17.05 17.46 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 114.072 -1.422 . . . . 0.0 109.547 -177.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 727' ' ' LEU . . . . . 0.58 HD23 ' HB1' ' A' ' 813' ' ' ALA . 23.6 tp -66.13 117.24 8.16 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.845 177.48 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 9.8 t-80 -111.85 33.34 4.85 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -170.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -172.62 168.73 5.2 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.543 0.211 . . . . 0.0 110.546 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 730' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -73.25 126.63 30.53 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.479 0.657 . . . . 0.0 110.042 176.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 731' ' ' LEU . . . . . 0.682 HD23 ' HB2' ' A' ' 739' ' ' SER . 16.2 tp -85.94 101.29 12.76 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.01 -0.995 . . . . 0.0 111.473 -173.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 732' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -77.72 115.79 17.75 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.876 -177.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 733' ' ' LEU . . . . . 0.568 HD21 ' HG ' ' A' ' 731' ' ' LEU . 23.9 mt -118.77 165.41 14.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.414 -178.036 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 734' ' ' CYS . . . . . . . . . . . . . 69.4 m -106.18 -176.79 3.18 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.413 174.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 735' ' ' LEU . . . . . 0.511 HD23 ' N ' ' A' ' 736' ' ' GLY . 2.4 tt -63.75 130.49 44.42 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.425 -175.363 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 736' ' ' GLY . . . . . 0.511 ' N ' HD23 ' A' ' 735' ' ' LEU . . . 72.05 15.76 76.53 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.212 175.505 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 737' ' ' ASP . . . . . 0.499 ' HB3' ' HB3' ' A' ' 733' ' ' LEU . 20.6 t0 -80.59 161.4 24.75 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.18 0.514 . . . . 0.0 110.102 178.288 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 50.3 p-80 -120.72 153.18 37.3 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 173.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 739' ' ' SER . . . . . 0.682 ' HB2' HD23 ' A' ' 731' ' ' LEU . 1.4 p -101.56 160.64 14.27 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 118.954 -1.099 . . . . 0.0 111.383 -171.282 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 740' ' ' SER . . . . . 0.431 ' H ' HD21 ' A' ' 731' ' ' LEU . 39.3 t -132.73 100.41 4.92 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.703 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 741' ' ' VAL . . . . . 0.588 HG11 HD13 ' A' ' 793' ' ' LEU . 1.3 p -120.05 108.59 38.32 Favored Pre-proline 0 C--N 1.316 -0.883 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.884 -177.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 742' ' ' PRO . . . . . 0.687 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 2.5 Cg_endo -74.36 137.26 23.03 Favored 'Trans proline' 0 N--CA 1.448 -1.179 0 C-N-CA 122.316 2.011 . . . . 0.0 110.895 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 743' ' ' VAL . . . . . 0.643 HG21 ' HB1' ' A' ' 723' ' ' ALA . 1.6 p -135.64 120.38 27.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.49 0.662 . . . . 0.0 112.267 177.27 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 744' ' ' ALA . . . . . 0.49 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -83.4 100.91 10.99 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 168.534 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 745' ' ' LEU . . . . . 0.917 HD13 HD13 ' A' ' 773' ' ' ILE . 0.2 OUTLIER -82.47 168.64 17.23 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 113.936 -1.483 . . . . 0.0 111.073 -167.222 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -123.39 146.19 48.17 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.675 -175.646 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 747' ' ' GLY . . . . . . . . . . . . . . . 101.86 123.38 5.21 Favored Glycine 0 C--N 1.312 -0.782 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.869 -178.305 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -103.6 120.81 41.63 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.793 0.33 . . . . 0.0 110.851 -174.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 127.31 179.83 16.01 Favored Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.74 -178.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -70.56 93.53 0.59 Allowed 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.339 2.026 . . . . 0.0 111.936 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 751' ' ' PHE . . . . . 0.503 ' CE2' ' HA ' ' A' ' 800' ' ' ASP . 82.9 m-85 -112.19 142.09 45.08 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.901 179.317 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 752' ' ' THR . . . . . 0.733 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 85.0 m -92.18 106.01 18.11 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 177.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 753' ' ' LEU . . . . . 0.504 ' CD2' HD22 ' A' ' 745' ' ' LEU . 59.2 tp -94.6 114.69 26.69 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.924 -172.401 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 754' ' ' THR . . . . . 0.491 HG23 ' HB2' ' A' ' 769' ' ' GLU . 1.5 m -113.92 134.59 54.72 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.683 179.159 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 755' ' ' TYR . . . . . 0.636 ' CE1' ' HB3' ' A' ' 768' ' ' PHE . 25.6 p90 -143.2 156.79 44.84 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.088 0.471 . . . . 0.0 111.177 178.575 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 756' ' ' ASP . . . . . 0.541 ' HB2' HG23 ' A' ' 758' ' ' ILE . 2.2 p30 -106.41 125.76 51.41 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.211 -178.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 757' ' ' ILE . . . . . 0.446 ' HB ' ' HB3' ' A' ' 766' ' ' LYS . 3.5 mp -94.47 93.23 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 163.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 758' ' ' ILE . . . . . 0.552 HG22 ' HD3' ' A' ' 765' ' ' ARG . 2.3 pp -95.12 143.46 11.81 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-O 121.12 0.486 . . . . 0.0 111.6 -170.318 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -91.16 101.46 14.19 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.226 -176.271 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 760' ' ' THR . . . . . 0.462 HG23 ' CB ' ' A' ' 790' ' ' ASP . 0.5 OUTLIER . . . . . 0 C--N 1.317 -0.823 0 CA-C-O 121.869 0.842 . . . . 0.0 108.939 -178.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 765' ' ' ARG . . . . . 0.552 ' HD3' HG22 ' A' ' 758' ' ' ILE . 21.6 ttp180 . . . . . 0 N--CA 1.439 -0.983 0 CA-C-O 121.004 0.431 . . . . 0.0 111.001 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 766' ' ' LYS . . . . . 0.667 ' HD3' ' N ' ' A' ' 767' ' ' THR . 8.4 tmtm? -118.2 146.36 44.29 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 175.095 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 767' ' ' THR . . . . . 0.667 ' N ' ' HD3' ' A' ' 766' ' ' LYS . 32.3 m -124.41 125.19 43.88 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 110.048 -0.352 . . . . 0.0 110.048 178.124 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 768' ' ' PHE . . . . . 0.636 ' HB3' ' CE1' ' A' ' 755' ' ' TYR . 3.4 t80 -122.5 137.73 54.79 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 769' ' ' GLU . . . . . 0.491 ' HB2' HG23 ' A' ' 754' ' ' THR . 38.3 tt0 -133.23 130.37 38.96 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.397 -175.381 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 770' ' ' ILE . . . . . 0.579 HG22 HG22 ' A' ' 773' ' ' ILE . 3.7 mt -121.91 110.61 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 177.142 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 771' ' ' LYS . . . . . 0.626 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 11.4 mtpt -83.87 150.79 25.5 Favored 'General case' 0 N--CA 1.436 -1.175 0 CA-C-O 121.243 0.544 . . . . 0.0 110.889 -175.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 772' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 55.53 50.82 13.78 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.39 -1.277 . . . . 0.0 111.998 177.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 773' ' ' ILE . . . . . 0.917 HD13 HD13 ' A' ' 745' ' ' LEU . 0.5 OUTLIER -77.86 116.88 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 173.377 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 70.0 mttt -117.61 29.5 7.82 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -177.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 775' ' ' THR . . . . . 0.7 ' H ' HD12 ' A' ' 773' ' ' ILE . 1.8 m -97.2 -72.58 0.64 Allowed 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 114.748 -1.115 . . . . 0.0 112.868 -172.381 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 776' ' ' ASN . . . . . 0.62 ' HB2' ' O ' ' A' ' 775' ' ' THR . 0.9 OUTLIER 87.26 6.18 0.27 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.512 1.125 . . . . 0.0 109.915 -178.074 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 777' ' ' GLU . . . . . 0.49 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 1.4 tm-20 -161.91 86.16 0.63 Allowed 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 114.846 -1.07 . . . . 0.0 108.333 179.001 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 778' ' ' TYR . . . . . 0.812 ' HB3' HD11 ' A' ' 745' ' ' LEU . 87.3 t80 -137.28 134.36 36.03 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.686 -170.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 779' ' ' VAL . . . . . 0.687 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 23.5 t -89.94 117.96 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 CA-C-O 121.022 0.439 . . . . 0.0 110.529 177.373 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 780' ' ' ILE . . . . . 0.418 ' HB ' HG13 ' A' ' 741' ' ' VAL . 68.3 mt -88.47 143.26 11.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.782 -178.677 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 781' ' ' LYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 739' ' ' SER . 3.8 mppt? -124.21 109.39 13.36 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 175.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 782' ' ' THR . . . . . . . . . . . . . 42.9 p -78.06 144.92 68.45 Favored Pre-proline 0 C--N 1.321 -0.653 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -177.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 783' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -51.32 158.33 3.82 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 123.465 2.777 . . . . 0.0 113.193 -178.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 784' ' ' VAL . . . . . 0.508 HG12 HG23 ' A' ' 786' ' ' THR . 53.4 t -58.81 126.71 16.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.066 -0.97 . . . . 0.0 112.208 -176.478 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 785' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -103.85 98.2 8.08 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.883 176.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 786' ' ' THR . . . . . 0.508 HG23 HG12 ' A' ' 784' ' ' VAL . 37.1 p -87.22 32.48 0.69 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.704 0.764 . . . . 0.0 110.989 -178.743 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.45 110.97 3.51 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.533 -1.212 . . . . 0.0 110.59 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 788' ' ' GLY . . . . . . . . . . . . . . . -53.1 112.62 2.35 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.253 171.098 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 789' ' ' GLY . . . . . 0.485 ' H ' ' HB ' ' A' ' 817' ' ' VAL . . . -154.5 -151.55 5.84 Favored Glycine 0 N--CA 1.443 -0.893 0 N-CA-C 110.806 -0.917 . . . . 0.0 110.806 -178.533 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 790' ' ' ASP . . . . . 0.462 ' CB ' HG23 ' A' ' 760' ' ' THR . 4.3 m-20 -137.57 124.01 20.77 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 791' ' ' TYR . . . . . 0.488 ' HA ' ' O ' ' A' ' 758' ' ' ILE . 80.9 m-85 -124.64 152.91 43.05 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.294 -0.412 . . . . 0.0 109.99 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 792' ' ' ILE . . . . . 0.48 ' O ' HG13 ' A' ' 758' ' ' ILE . 14.4 mt -133.39 122.84 45.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 171.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 793' ' ' LEU . . . . . 0.588 HD13 HG11 ' A' ' 741' ' ' VAL . 10.4 tt -87.71 108.01 18.91 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.354 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 794' ' ' SER . . . . . 0.449 ' HB3' ' OD2' ' A' ' 756' ' ' ASP . 31.3 t -121.54 146.06 47.33 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.166 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 795' ' ' LEU . . . . . 0.515 ' H ' HD22 ' A' ' 795' ' ' LEU . 1.4 mm? -72.98 135.15 44.94 Favored 'General case' 0 N--CA 1.448 -0.569 0 O-C-N 122.062 -0.399 . . . . 0.0 111.481 -179.12 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 796' ' ' VAL . . . . . . . . . . . . . 66.7 t -95.91 -57.46 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.207 -177.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 797' ' ' SER . . . . . 0.588 ' HA ' ' HG ' ' A' ' 808' ' ' LEU . 35.7 m -171.38 157.02 4.77 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.719 -173.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 798' ' ' ILE . . . . . 0.558 ' HA ' ' O ' ' A' ' 752' ' ' THR . 13.2 tt -132.22 162.07 40.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 177.483 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 799' ' ' LYS . . . . . 0.733 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 22.1 tttt -129.83 118.19 21.37 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 120.967 0.413 . . . . 0.0 110.993 -174.462 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 800' ' ' ASP . . . . . 0.507 ' HB3' ' HB2' ' A' ' 804' ' ' CYS . 21.6 t70 -65.3 152.89 42.65 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.259 -0.882 . . . . 0.0 108.854 173.07 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 4.4 m -62.62 -8.56 6.71 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 123.768 0.667 . . . . 0.0 112.503 -171.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 40.1 p -96.67 5.62 50.32 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.426 0.631 . . . . 0.0 110.191 176.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 803' ' ' GLY . . . . . 0.53 ' HA2' ' HE2' ' A' ' 799' ' ' LYS . . . 77.98 42.25 16.6 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.029 -177.014 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 804' ' ' CYS . . . . . 0.507 ' HB2' ' HB3' ' A' ' 800' ' ' ASP . 69.4 m -110.24 106.87 16.45 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 176.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 805' ' ' VAL . . . . . 0.52 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 3.5 t -86.24 112.36 22.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.279 0.561 . . . . 0.0 111.071 -173.094 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 806' ' ' VAL . . . . . 0.452 ' HB ' HG22 ' A' ' 798' ' ' ILE . 73.4 t -90.0 135.14 27.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.152 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -73.7 120.57 6.95 Favored Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 111.601 -0.599 . . . . 0.0 111.601 178.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 808' ' ' LEU . . . . . 0.588 ' HG ' ' HA ' ' A' ' 797' ' ' SER . 45.4 mt -88.71 132.96 34.37 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -175.394 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 44.7 m -149.86 87.2 1.47 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.023 -0.989 . . . . 0.0 109.633 172.413 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 810' ' ' GLN . . . . . 0.516 HE21 ' CB ' ' A' ' 722' ' ' SER . 11.3 mt-30 -135.34 171.84 8.23 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.336 174.193 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 811' ' ' PRO . . . . . 0.464 ' HD2' ' HB3' ' A' ' 810' ' ' GLN . 97.0 Cg_exo -45.81 137.82 12.18 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 122.999 2.466 . . . . 0.0 114.328 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -109.1 167.29 10.21 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.217 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 813' ' ' ALA . . . . . 0.58 ' HB1' HD23 ' A' ' 727' ' ' LEU . . . -126.7 141.17 51.92 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.571 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 814' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -100.24 129.56 46.26 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.143 0.497 . . . . 0.0 110.555 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 815' ' ' ILE . . . . . 0.541 ' HA ' ' HB3' ' A' ' 731' ' ' LEU . 5.3 mp -112.55 109.75 29.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 176.514 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 816' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -106.08 109.05 20.86 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.061 0.457 . . . . 0.0 109.991 -175.679 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 817' ' ' VAL . . . . . 0.485 ' HB ' ' H ' ' A' ' 789' ' ' GLY . 4.7 t -99.74 141.27 17.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.513 -174.604 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 818' ' ' ARG . . . . . . . . . . . . . 39.9 mmt180 . . . . . 0 C--N 1.319 -0.724 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 177.521 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 720' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt . . . . . 0 N--CA 1.442 -0.828 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 721' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -86.46 140.34 6.26 Favored 'Trans proline' 0 N--CA 1.445 -1.353 0 C-N-CA 122.233 1.955 . . . . 0.0 111.204 178.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 722' ' ' SER . . . . . 0.454 ' HA ' ' CD2' ' A' ' 808' ' ' LEU . 50.2 m -167.42 -157.19 0.23 Allowed 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -172.409 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 723' ' ' ALA . . . . . 0.752 ' HB1' HG21 ' A' ' 743' ' ' VAL . . . -145.77 142.62 29.08 Favored 'General case' 0 N--CA 1.449 -0.521 0 O-C-N 122.093 -0.38 . . . . 0.0 110.27 175.289 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -129.72 100.4 5.49 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 725' ' ' LEU . . . . . 0.494 ' CD2' ' HB ' ' A' ' 743' ' ' VAL . 13.2 mt -62.65 144.09 56.65 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 121.765 0.793 . . . . 0.0 111.869 -173.152 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 33.4 mtpt -95.22 -18.92 20.47 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.544 -1.207 . . . . 0.0 109.366 -178.367 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 727' ' ' LEU . . . . . 0.544 ' HB2' ' HD2' ' A' ' 742' ' ' PRO . 0.7 OUTLIER -76.67 109.97 10.87 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 177.304 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 33.4 m80 -115.83 46.19 1.58 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.02 0.438 . . . . 0.0 110.532 -176.244 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -148.31 174.33 12.13 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.92 -176.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 730' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -100.5 108.78 20.82 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 175.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 731' ' ' LEU . . . . . 0.59 ' HB2' ' HA ' ' A' ' 815' ' ' ILE . 53.9 mt -72.03 100.82 2.58 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.984 -173.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 732' ' ' LYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 816' ' ' GLN . 32.2 mmtp -79.43 121.6 25.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.681 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 733' ' ' LEU . . . . . 0.721 ' HB2' ' HB ' ' A' ' 817' ' ' VAL . 25.6 mt -126.41 169.52 12.9 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.372 0.606 . . . . 0.0 111.835 -174.154 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 734' ' ' CYS . . . . . 0.467 ' HA ' ' O ' ' A' ' 818' ' ' ARG . 13.2 p -105.39 -176.97 3.23 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.107 176.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 735' ' ' LEU . . . . . . . . . . . . . 36.2 tp -71.41 122.54 20.56 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.569 -178.179 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 79.94 16.46 76.92 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.191 -1.004 . . . . 0.0 112.317 178.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 737' ' ' ASP . . . . . 0.568 ' HB3' ' HB3' ' A' ' 733' ' ' LEU . 25.3 t0 -86.22 157.63 19.91 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.769 0.318 . . . . 0.0 110.713 174.217 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 27.1 p-80 -117.16 -177.86 3.31 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 174.092 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 739' ' ' SER . . . . . 0.574 ' HB2' ' OG1' ' A' ' 782' ' ' THR . 29.8 m -142.22 169.43 17.6 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 119.777 -0.769 . . . . 0.0 112.894 179.26 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 740' ' ' SER . . . . . 0.412 ' HA ' ' O ' ' A' ' 780' ' ' ILE . 5.7 p -138.07 109.66 7.04 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 114.433 -1.258 . . . . 0.0 109.4 177.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 741' ' ' VAL . . . . . 0.592 HG11 HD13 ' A' ' 793' ' ' LEU . 0.6 OUTLIER -113.1 112.44 49.86 Favored Pre-proline 0 C--N 1.316 -0.877 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.226 -177.912 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 742' ' ' PRO . . . . . 0.649 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 4.1 Cg_endo -75.48 135.38 18.15 Favored 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 122.422 2.081 . . . . 0.0 111.652 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 743' ' ' VAL . . . . . 0.752 HG21 ' HB1' ' A' ' 723' ' ' ALA . 1.7 p -131.05 119.31 44.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.564 0.697 . . . . 0.0 111.981 176.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 744' ' ' ALA . . . . . 0.464 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -83.89 101.47 11.69 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 169.102 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 745' ' ' LEU . . . . . 0.978 HD13 HD13 ' A' ' 773' ' ' ILE . 0.3 OUTLIER -80.4 161.37 25.0 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 114.26 -1.336 . . . . 0.0 111.2 -166.752 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -110.91 146.31 36.79 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.628 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 747' ' ' GLY . . . . . . . . . . . . . . . 98.87 122.92 4.79 Favored Glycine 0 C--N 1.305 -1.168 0 N-CA-C 110.54 -1.024 . . . . 0.0 110.54 -176.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.95 128.68 53.96 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.321 0.581 . . . . 0.0 111.811 -169.22 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 109.44 -178.7 20.64 Favored Glycine 0 C--O 1.22 -0.724 0 CA-C-N 114.902 -1.044 . . . . 0.0 111.044 -175.112 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 750' ' ' PRO . . . . . 0.525 ' HB3' ' HE2' ' A' ' 774' ' ' LYS . 73.3 Cg_endo -65.51 100.96 0.42 Allowed 'Trans proline' 0 C--O 1.235 0.363 0 C-N-CA 123.37 2.714 . . . . 0.0 113.821 -178.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 751' ' ' PHE . . . . . 0.601 ' CE2' ' HA ' ' A' ' 800' ' ' ASP . 75.6 m-85 -117.0 146.86 42.78 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.743 176.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 752' ' ' THR . . . . . 0.713 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 33.4 m -89.64 106.64 18.59 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 176.04 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 753' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -96.72 111.26 23.49 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.338 -172.56 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 754' ' ' THR . . . . . 0.487 HG23 ' HB2' ' A' ' 769' ' ' GLU . 1.6 m -108.81 137.26 47.03 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.558 -0.747 . . . . 0.0 111.269 -178.437 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 755' ' ' TYR . . . . . . . . . . . . . 29.9 p90 -148.16 156.89 43.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.88 0.371 . . . . 0.0 110.953 176.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 756' ' ' ASP . . . . . 0.587 ' OD2' HG21 ' A' ' 796' ' ' VAL . 0.7 OUTLIER -125.18 121.76 35.11 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.513 178.667 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 757' ' ' ILE . . . . . 0.412 ' N ' HD12 ' A' ' 757' ' ' ILE . 4.2 mp -83.72 96.59 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 172.612 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 758' ' ' ILE . . . . . 0.659 HG22 ' HD2' ' A' ' 765' ' ' ARG . 2.4 pp -93.92 148.25 5.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.248 -167.426 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 759' ' ' GLU . . . . . 0.638 ' HG2' ' CE2' ' A' ' 791' ' ' TYR . 23.9 mt-10 -88.68 117.82 27.92 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.921 176.097 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 760' ' ' THR . . . . . . . . . . . . . 1.2 t . . . . . 0 C--N 1.313 -1.016 0 CA-C-O 121.512 0.672 . . . . 0.0 109.227 176.501 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 765' ' ' ARG . . . . . 0.659 ' HD2' HG22 ' A' ' 758' ' ' ILE . 19.0 ttt180 . . . . . 0 N--CA 1.453 -0.29 0 CA-C-O 120.952 0.406 . . . . 0.0 110.8 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 766' ' ' LYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 756' ' ' ASP . 9.7 tmtm? -106.78 140.47 39.57 Favored 'General case' 0 C--O 1.216 -0.674 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.794 -175.687 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 767' ' ' THR . . . . . . . . . . . . . 21.1 m -111.39 134.83 52.69 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.016 -176.015 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 768' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -140.46 137.89 34.26 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.01 0.433 . . . . 0.0 110.742 173.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 769' ' ' GLU . . . . . 0.487 ' HB2' HG23 ' A' ' 754' ' ' THR . 27.7 tt0 -131.86 123.17 26.97 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.558 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 770' ' ' ILE . . . . . 0.553 HG22 HG22 ' A' ' 773' ' ' ILE . 6.5 mt -114.45 112.23 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.631 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 771' ' ' LYS . . . . . 0.581 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 9.7 mtpt -85.88 154.64 21.38 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.52 -173.529 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 772' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 54.6 44.06 29.25 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.388 -1.278 . . . . 0.0 111.984 175.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 773' ' ' ILE . . . . . 0.978 HD13 HD13 ' A' ' 745' ' ' LEU . 0.5 OUTLIER -73.95 116.21 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 172.142 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 774' ' ' LYS . . . . . 0.525 ' HE2' ' HB3' ' A' ' 750' ' ' PRO . 58.0 mttt -111.88 26.36 10.69 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -178.123 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 775' ' ' THR . . . . . 0.683 ' H ' HD12 ' A' ' 773' ' ' ILE . 0.2 OUTLIER -96.22 -75.86 0.52 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 114.767 -1.106 . . . . 0.0 113.676 -166.333 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 776' ' ' ASN . . . . . 0.672 ' HB2' ' O ' ' A' ' 775' ' ' THR . 0.8 OUTLIER 89.98 2.52 0.19 Allowed 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.892 1.277 . . . . 0.0 110.565 -172.897 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 777' ' ' GLU . . . . . 0.464 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 9.4 mp0 -154.6 90.65 1.33 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 175.716 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 778' ' ' TYR . . . . . 0.703 ' HB3' HD11 ' A' ' 745' ' ' LEU . 81.7 t80 -132.12 128.8 38.89 Favored 'General case' 0 C--N 1.315 -0.932 0 C-N-CA 120.249 -0.58 . . . . 0.0 111.212 -172.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 779' ' ' VAL . . . . . 0.649 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 17.3 t -89.18 112.82 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-O 121.308 0.575 . . . . 0.0 110.4 178.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 780' ' ' ILE . . . . . 0.457 ' HB ' HG13 ' A' ' 741' ' ' VAL . 77.8 mt -81.29 147.05 6.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.549 -178.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -120.1 108.23 14.01 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 175.172 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 782' ' ' THR . . . . . 0.574 ' OG1' ' HB2' ' A' ' 739' ' ' SER . 54.6 p -77.51 141.41 65.35 Favored Pre-proline 0 C--N 1.319 -0.758 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.359 -178.707 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 783' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 782' ' ' THR . 52.3 Cg_exo -53.91 158.57 8.54 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 123.758 2.972 . . . . 0.0 112.515 -175.409 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 784' ' ' VAL . . . . . . . . . . . . . 12.9 p -65.7 128.93 29.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.33 0.586 . . . . 0.0 109.974 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 785' ' ' PHE . . . . . 0.414 ' CG ' HG11 ' A' ' 817' ' ' VAL . 89.8 m-85 -97.48 96.61 8.45 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.321 -176.164 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 69.8 p -84.32 18.63 2.13 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.395 0.616 . . . . 0.0 111.473 -174.188 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 3.0 m -155.72 124.22 5.93 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.629 177.486 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 788' ' ' GLY . . . . . 0.694 ' HA2' HG22 ' A' ' 817' ' ' VAL . . . -50.89 123.69 17.8 Favored Glycine 0 CA--C 1.524 0.645 0 O-C-N 123.522 0.513 . . . . 0.0 112.336 172.405 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 789' ' ' GLY . . . . . . . . . . . . . . . -164.03 -165.76 21.77 Favored Glycine 0 N--CA 1.442 -0.964 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -133.41 124.18 26.66 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 791' ' ' TYR . . . . . 0.638 ' CE2' ' HG2' ' A' ' 759' ' ' GLU . 81.5 m-85 -124.78 148.68 48.0 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.106 0.479 . . . . 0.0 111.286 -173.291 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 792' ' ' ILE . . . . . 0.547 ' O ' HG13 ' A' ' 758' ' ' ILE . 13.2 mt -126.07 116.36 45.56 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.656 175.252 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 793' ' ' LEU . . . . . 0.592 HD13 HG11 ' A' ' 741' ' ' VAL . 9.3 tt -84.25 111.23 19.2 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.049 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 794' ' ' SER . . . . . . . . . . . . . 17.8 m -120.65 139.66 52.69 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.389 -178.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 795' ' ' LEU . . . . . 0.672 ' HG ' ' HB3' ' A' ' 723' ' ' ALA . 1.6 mm? -69.25 132.07 45.9 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.619 176.728 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 796' ' ' VAL . . . . . 0.587 HG21 ' OD2' ' A' ' 756' ' ' ASP . 53.4 t -97.61 -51.71 10.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-O 120.993 0.425 . . . . 0.0 111.272 -178.063 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 797' ' ' SER . . . . . 0.569 ' HA ' ' HG ' ' A' ' 808' ' ' LEU . 81.1 p -168.42 155.62 7.75 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.391 -172.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 798' ' ' ILE . . . . . 0.63 ' HA ' ' O ' ' A' ' 752' ' ' THR . 8.7 tt -130.15 167.2 25.88 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 177.106 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 799' ' ' LYS . . . . . 0.713 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 2.7 ttmp? -135.74 118.32 15.93 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.626 -176.434 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 800' ' ' ASP . . . . . 0.601 ' HA ' ' CE2' ' A' ' 751' ' ' PHE . 12.0 m-20 -58.88 154.91 14.15 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.805 171.727 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 801' ' ' SER . . . . . 0.404 ' OG ' ' HG2' ' A' ' 750' ' ' PRO . 5.8 m -62.06 -10.21 9.43 Favored 'General case' 0 C--N 1.326 -0.415 0 O-C-N 124.14 0.9 . . . . 0.0 112.505 -172.447 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 14.0 t -96.24 4.99 51.98 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.559 0.695 . . . . 0.0 109.636 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 803' ' ' GLY . . . . . . . . . . . . . . . 81.19 43.36 8.73 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 115.316 -0.857 . . . . 0.0 112.135 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 804' ' ' CYS . . . . . 0.418 ' HB3' ' HB2' ' A' ' 800' ' ' ASP . 46.4 t -114.71 119.75 37.74 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 178.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 805' ' ' VAL . . . . . 0.535 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 3.0 t -94.22 124.79 46.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.327 0.584 . . . . 0.0 111.562 -172.434 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 806' ' ' VAL . . . . . . . . . . . . . 39.5 t -104.72 135.64 41.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.299 177.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -74.16 127.91 10.41 Favored Glycine 0 C--N 1.323 -0.177 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.47 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 808' ' ' LEU . . . . . 0.569 ' HG ' ' HA ' ' A' ' 797' ' ' SER . 64.2 mt -98.05 136.96 37.55 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -172.755 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 43.0 m -148.71 86.39 1.52 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.822 -1.081 . . . . 0.0 109.173 170.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 810' ' ' GLN . . . . . 0.428 ' HG2' ' HD2' ' A' ' 811' ' ' PRO . 0.7 OUTLIER -139.79 172.92 5.65 Favored Pre-proline 0 CA--C 1.539 0.539 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.132 179.373 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 811' ' ' PRO . . . . . 0.428 ' HD2' ' HG2' ' A' ' 810' ' ' GLN . 92.7 Cg_exo -44.4 138.77 7.21 Favored 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 123.059 2.506 . . . . 0.0 115.159 -173.176 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -104.47 167.46 9.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.541 -1.209 . . . . 0.0 110.327 178.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 813' ' ' ALA . . . . . . . . . . . . . . . -123.88 152.01 42.84 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.437 175.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 814' ' ' LYS . . . . . 0.531 ' HG2' HG12 ' A' ' 792' ' ' ILE . 48.8 mttp -118.18 127.7 54.0 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.718 0.771 . . . . 0.0 111.241 -178.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 815' ' ' ILE . . . . . 0.59 ' HA ' ' HB2' ' A' ' 731' ' ' LEU . 5.3 mp -116.44 107.29 22.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 114.552 -1.204 . . . . 0.0 108.797 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 816' ' ' GLN . . . . . 0.405 ' O ' ' HA ' ' A' ' 732' ' ' LYS . 0.0 OUTLIER -108.68 107.24 17.62 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.313 0.578 . . . . 0.0 110.024 -177.179 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 817' ' ' VAL . . . . . 0.721 ' HB ' ' HB2' ' A' ' 733' ' ' LEU . 1.9 m -102.21 147.46 8.87 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -178.48 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 818' ' ' ARG . . . . . 0.467 ' O ' ' HA ' ' A' ' 734' ' ' CYS . 16.1 tpt180 . . . . . 0 C--N 1.313 -1.019 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -172.262 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 720' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm . . . . . 0 N--CA 1.45 -0.45 0 CA-C-O 120.926 0.393 . . . . 0.0 111.119 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 721' ' ' PRO . . . . . 0.519 ' HD2' HG11 ' A' ' 806' ' ' VAL . 74.1 Cg_endo -88.35 148.3 6.44 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 123.279 2.653 . . . . 0.0 111.249 177.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 722' ' ' SER . . . . . 0.727 ' HA ' HD22 ' A' ' 808' ' ' LEU . 11.6 p 179.44 -158.25 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.802 -171.335 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 723' ' ' ALA . . . . . 0.723 ' HB1' HG21 ' A' ' 743' ' ' VAL . . . -144.15 142.03 30.32 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 177.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 11.7 m -129.31 99.0 5.05 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -178.342 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 725' ' ' LEU . . . . . 0.496 HD22 ' HB ' ' A' ' 743' ' ' VAL . 8.3 mt -64.22 143.63 57.74 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-O 121.811 0.815 . . . . 0.0 112.366 -172.257 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 29.1 mtpt -93.67 -18.91 21.62 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.216 -1.356 . . . . 0.0 108.583 177.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 727' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -60.43 119.2 7.55 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.569 173.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -88.93 -48.26 7.57 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -170.06 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 8.8 p80 -136.11 -175.7 4.07 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.224 -177.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 730' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' A' ' 814' ' ' LYS . 9.1 p-10 -40.65 133.98 1.9 Allowed 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.66 0.743 . . . . 0.0 112.098 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 731' ' ' LEU . . . . . 0.574 ' HB3' ' HA ' ' A' ' 815' ' ' ILE . 22.1 tp -104.26 104.68 14.62 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.258 -177.318 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 732' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -74.19 112.74 10.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.481 -171.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 733' ' ' LEU . . . . . 0.619 ' HG ' ' HB3' ' A' ' 737' ' ' ASP . 9.2 mp -120.01 164.97 15.31 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.73 173.362 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 734' ' ' CYS . . . . . 0.451 ' HA ' ' O ' ' A' ' 818' ' ' ARG . 2.1 p -124.4 -173.62 2.82 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.486 173.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 735' ' ' LEU . . . . . . . . . . . . . 2.6 tt -53.64 115.65 2.08 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.088 0.471 . . . . 0.0 111.284 -174.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 87.88 3.27 80.27 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.592 -0.814 . . . . 0.0 112.965 173.566 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 737' ' ' ASP . . . . . 0.619 ' HB3' ' HG ' ' A' ' 733' ' ' LEU . 0.3 OUTLIER -76.99 148.98 35.95 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.253 0.549 . . . . 0.0 111.684 178.076 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 738' ' ' HIS . . . . . 0.494 ' HB2' ' O ' ' A' ' 782' ' ' THR . 36.1 p-80 -113.1 151.05 31.26 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 170.466 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 739' ' ' SER . . . . . 0.533 ' O ' ' HA ' ' A' ' 781' ' ' LYS . 17.3 p -108.6 167.56 9.96 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 119.219 -0.992 . . . . 0.0 111.803 -170.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 740' ' ' SER . . . . . 0.428 ' HA ' ' O ' ' A' ' 780' ' ' ILE . 12.9 p -132.7 99.62 4.68 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 114.924 -1.035 . . . . 0.0 109.301 175.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 741' ' ' VAL . . . . . 0.62 HG11 HD13 ' A' ' 793' ' ' LEU . 0.5 OUTLIER -104.98 105.04 49.85 Favored Pre-proline 0 C--N 1.316 -0.877 0 CA-C-N 115.037 -0.983 . . . . 0.0 108.799 179.02 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 742' ' ' PRO . . . . . 0.778 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 2.1 Cg_endo -74.97 131.91 14.85 Favored 'Trans proline' 0 N--CA 1.441 -1.589 0 C-N-CA 122.097 1.865 . . . . 0.0 110.777 -177.239 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 743' ' ' VAL . . . . . 0.723 HG21 ' HB1' ' A' ' 723' ' ' ALA . 1.4 p -131.99 120.88 45.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.769 0.795 . . . . 0.0 112.788 177.632 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 744' ' ' ALA . . . . . 0.518 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -81.02 99.88 8.68 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 168.529 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 745' ' ' LEU . . . . . 0.905 HD13 HD13 ' A' ' 773' ' ' ILE . 0.2 OUTLIER -83.59 165.33 19.13 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 114.536 -1.211 . . . . 0.0 111.28 -167.475 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 34.9 tptt -114.51 165.0 13.21 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.699 -178.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 747' ' ' GLY . . . . . . . . . . . . . . . 90.16 129.61 4.04 Favored Glycine 0 C--N 1.306 -1.089 0 CA-C-N 115.276 -0.874 . . . . 0.0 111.538 -175.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 748' ' ' GLN . . . . . 0.419 ' C ' ' HE1' ' A' ' 751' ' ' PHE . 0.0 OUTLIER -112.34 113.82 26.23 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.201 0.524 . . . . 0.0 111.636 -173.89 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 123.77 -174.88 16.81 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.371 -0.832 . . . . 0.0 111.045 -177.23 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 750' ' ' PRO . . . . . 0.402 ' HD2' ' OG ' ' A' ' 801' ' ' SER . 14.0 Cg_exo -69.69 93.89 0.52 Allowed 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.552 2.168 . . . . 0.0 112.317 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 751' ' ' PHE . . . . . 0.564 ' HA ' ' O ' ' A' ' 799' ' ' LYS . 75.6 m-85 -109.84 139.97 44.31 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.45 177.727 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 752' ' ' THR . . . . . 0.701 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 92.6 m -91.04 108.22 19.72 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 176.645 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 753' ' ' LEU . . . . . 0.553 ' CD1' HD22 ' A' ' 745' ' ' LEU . 3.7 tt -100.46 118.41 36.61 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.094 -171.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 754' ' ' THR . . . . . 0.47 HG23 ' HB2' ' A' ' 769' ' ' GLU . 1.6 m -114.66 138.25 50.92 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.967 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 755' ' ' TYR . . . . . 0.643 ' CE1' ' HB3' ' A' ' 768' ' ' PHE . 28.9 p90 -146.47 153.91 40.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.998 0.428 . . . . 0.0 111.392 178.372 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 756' ' ' ASP . . . . . 0.435 ' CG ' ' HD2' ' A' ' 765' ' ' ARG . 39.3 m-20 -112.04 120.85 43.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.818 -178.747 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 757' ' ' ILE . . . . . . . . . . . . . 3.3 mp -88.02 95.77 5.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 168.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 758' ' ' ILE . . . . . 0.638 HG22 ' HD3' ' A' ' 765' ' ' ARG . 2.3 pp -96.09 140.58 16.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-O 121.595 0.712 . . . . 0.0 112.056 -170.523 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 759' ' ' GLU . . . . . 0.414 ' HG2' ' CD2' ' A' ' 791' ' ' TYR . 13.4 mt-10 -95.64 103.32 15.19 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.336 -176.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 760' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.315 -0.918 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.132 -168.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 765' ' ' ARG . . . . . 0.638 ' HD3' HG22 ' A' ' 758' ' ' ILE . 5.4 ttp180 . . . . . 0 N--CA 1.443 -0.788 0 CA-C-O 120.958 0.408 . . . . 0.0 111.531 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 766' ' ' LYS . . . . . 0.461 ' HD3' ' N ' ' A' ' 767' ' ' THR . 9.6 tmtm? -117.91 146.42 43.96 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 177.604 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 767' ' ' THR . . . . . 0.461 ' N ' ' HD3' ' A' ' 766' ' ' LYS . 90.0 m -121.09 133.9 55.24 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 116.629 -0.26 . . . . 0.0 110.473 178.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 768' ' ' PHE . . . . . 0.643 ' HB3' ' CE1' ' A' ' 755' ' ' TYR . 1.2 t80 -134.74 135.93 42.29 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 177.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 769' ' ' GLU . . . . . 0.47 ' HB2' HG23 ' A' ' 754' ' ' THR . 42.8 tt0 -131.94 135.25 46.46 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.054 -178.353 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 770' ' ' ILE . . . . . 0.554 HG22 HG22 ' A' ' 773' ' ' ILE . 3.8 mt -126.81 112.0 27.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 176.455 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 771' ' ' LYS . . . . . 0.635 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 11.3 mtpt -83.49 154.96 23.62 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-O 121.035 0.445 . . . . 0.0 110.897 -177.328 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 772' ' ' GLU . . . . . 0.416 ' O ' ' HG3' ' A' ' 774' ' ' LYS . 5.2 mt-10 53.58 48.45 21.65 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.674 -1.148 . . . . 0.0 111.932 177.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 773' ' ' ILE . . . . . 0.905 HD13 HD13 ' A' ' 745' ' ' LEU . 0.5 OUTLIER -74.77 115.34 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 174.278 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 774' ' ' LYS . . . . . 0.416 ' HG3' ' O ' ' A' ' 772' ' ' GLU . 72.0 mttt -116.33 32.28 6.22 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 -178.328 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 775' ' ' THR . . . . . 0.679 ' H ' HD12 ' A' ' 773' ' ' ILE . 0.2 OUTLIER -96.56 -72.37 0.64 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.212 -1.358 . . . . 0.0 112.522 -171.598 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 776' ' ' ASN . . . . . 0.416 ' O ' ' HG3' ' A' ' 777' ' ' GLU . 11.5 m120 79.36 5.35 2.15 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.035 0.934 . . . . 0.0 110.506 -176.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 777' ' ' GLU . . . . . 0.518 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 21.8 mt-10 -160.36 79.45 0.66 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.7 -1.136 . . . . 0.0 108.826 176.155 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 778' ' ' TYR . . . . . 0.79 ' HB3' HD11 ' A' ' 745' ' ' LEU . 91.4 t80 -132.61 130.72 40.59 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.964 -171.762 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 779' ' ' VAL . . . . . 0.778 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 2.0 m -95.73 126.16 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 CA-C-O 122.331 1.062 . . . . 0.0 110.575 176.792 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 780' ' ' ILE . . . . . 0.443 ' HB ' HG13 ' A' ' 741' ' ' VAL . 79.6 mt -89.04 145.57 7.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 113.542 -1.663 . . . . 0.0 110.465 -174.423 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 781' ' ' LYS . . . . . 0.533 ' HA ' ' O ' ' A' ' 739' ' ' SER . 3.9 mppt? -118.07 111.91 19.53 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 177.469 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 782' ' ' THR . . . . . 0.494 ' O ' ' HB2' ' A' ' 738' ' ' HIS . 30.8 p -74.75 142.87 77.58 Favored Pre-proline 0 C--N 1.319 -0.727 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 177.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 783' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_exo -52.03 161.52 2.39 Favored 'Trans proline' 0 N--CA 1.472 0.22 0 C-N-CA 123.681 2.921 . . . . 0.0 113.171 -177.408 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 784' ' ' VAL . . . . . . . . . . . . . 51.1 t -63.4 113.7 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.046 177.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 785' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -104.16 102.3 12.03 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.351 178.011 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 77.2 p -85.94 26.64 0.97 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.781 0.8 . . . . 0.0 111.058 -176.376 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 92.4 m -144.74 111.47 5.77 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.173 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 788' ' ' GLY . . . . . 0.741 ' HA2' HG12 ' A' ' 817' ' ' VAL . . . -49.65 121.4 9.11 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.971 -0.633 . . . . 0.0 113.201 171.705 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 789' ' ' GLY . . . . . 0.52 ' H ' ' HB ' ' A' ' 817' ' ' VAL . . . -175.19 173.94 46.51 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 178.672 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -100.19 133.98 43.79 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 117.819 0.809 . . . . 0.0 109.606 -179.253 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 791' ' ' TYR . . . . . 0.452 ' HA ' ' O ' ' A' ' 758' ' ' ILE . 68.1 m-85 -129.63 118.62 22.26 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.063 0.459 . . . . 0.0 110.702 -177.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 792' ' ' ILE . . . . . 0.578 HG12 ' HG2' ' A' ' 814' ' ' LYS . 17.8 mt -97.01 116.09 38.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.066 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 793' ' ' LEU . . . . . 0.62 HD13 HG11 ' A' ' 741' ' ' VAL . 10.1 tt -84.45 106.49 16.07 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 175.399 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 794' ' ' SER . . . . . . . . . . . . . 23.0 t -115.88 148.42 40.0 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.397 -177.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 795' ' ' LEU . . . . . . . . . . . . . 44.9 mt -82.39 134.23 35.24 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.829 0.347 . . . . 0.0 110.681 -176.162 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 796' ' ' VAL . . . . . . . . . . . . . 77.6 t -95.79 -55.9 5.69 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.46 -177.228 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 797' ' ' SER . . . . . 0.544 ' HA ' ' HG ' ' A' ' 808' ' ' LEU . 92.0 p -177.74 162.61 1.77 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.373 -172.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 798' ' ' ILE . . . . . 0.656 ' HA ' ' O ' ' A' ' 752' ' ' THR . 9.4 tt -135.28 168.44 23.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 178.691 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 799' ' ' LYS . . . . . 0.701 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 19.9 tttt -133.5 114.83 14.05 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.732 0.301 . . . . 0.0 111.274 -177.617 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 800' ' ' ASP . . . . . 0.562 ' HA ' ' CE2' ' A' ' 751' ' ' PHE . 1.6 m-20 -58.27 153.09 15.97 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.594 170.269 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 801' ' ' SER . . . . . 0.402 ' OG ' ' HD2' ' A' ' 750' ' ' PRO . 6.6 m -66.56 -4.72 9.2 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.141 -172.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 21.6 p -95.06 6.4 49.18 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.585 0.707 . . . . 0.0 109.889 175.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 803' ' ' GLY . . . . . 0.533 ' HA2' ' HE2' ' A' ' 799' ' ' LYS . . . 74.95 41.28 33.28 Favored Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.716 -178.125 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 804' ' ' CYS . . . . . 0.419 ' HB3' ' HB2' ' A' ' 800' ' ' ASP . 51.9 t -114.83 120.23 39.3 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.283 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 805' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 10.2 p -84.9 133.77 28.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 121.523 0.678 . . . . 0.0 110.684 -175.447 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 806' ' ' VAL . . . . . 0.519 HG11 ' HD2' ' A' ' 721' ' ' PRO . 24.8 t -117.03 135.45 57.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.995 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -74.91 122.59 7.07 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.865 -178.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 808' ' ' LEU . . . . . 0.727 HD22 ' HA ' ' A' ' 722' ' ' SER . 50.9 mt -89.11 127.56 35.72 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.059 0.456 . . . . 0.0 112.145 -177.22 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 20.1 m -144.27 85.58 1.8 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.882 172.304 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 810' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -145.82 170.85 7.26 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.251 177.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 811' ' ' PRO . . . . . . . . . . . . . 99.7 Cg_exo -42.98 139.84 3.37 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 123.204 2.603 . . . . 0.0 115.3 -170.17 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -103.38 167.35 9.87 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 114.475 -1.239 . . . . 0.0 110.207 178.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 813' ' ' ALA . . . . . 0.478 ' HB3' ' HB3' ' A' ' 793' ' ' LEU . . . -116.58 150.15 38.49 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.381 178.331 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 814' ' ' LYS . . . . . 0.578 ' HG2' HG12 ' A' ' 792' ' ' ILE . 47.3 mttp -123.27 96.86 5.16 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 122.048 0.928 . . . . 0.0 111.106 176.161 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 815' ' ' ILE . . . . . 0.574 ' HA ' ' HB3' ' A' ' 731' ' ' LEU . 5.4 mp -87.71 110.82 21.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 CA-C-N 113.97 -1.468 . . . . 0.0 108.987 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 816' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -100.48 107.85 19.68 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.223 0.535 . . . . 0.0 110.226 -175.46 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 817' ' ' VAL . . . . . 0.741 HG12 ' HA2' ' A' ' 788' ' ' GLY . 57.3 t -93.84 146.04 7.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.241 177.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 818' ' ' ARG . . . . . 0.451 ' O ' ' HA ' ' A' ' 734' ' ' CYS . 30.6 tpt180 . . . . . 0 C--N 1.317 -0.812 0 CA-C-O 121.09 0.471 . . . . 0.0 110.619 178.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 720' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? . . . . . 0 N--CA 1.441 -0.91 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 721' ' ' PRO . . . . . 0.506 ' HD2' HG21 ' A' ' 806' ' ' VAL . 57.4 Cg_endo -84.92 148.12 10.68 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 122.632 2.221 . . . . 0.0 111.268 -173.39 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 722' ' ' SER . . . . . 0.666 ' HA ' HD22 ' A' ' 808' ' ' LEU . 57.0 m -166.78 -161.83 0.47 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.857 -171.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 723' ' ' ALA . . . . . 0.627 ' HB1' HG21 ' A' ' 743' ' ' VAL . . . -149.03 140.56 23.39 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.336 173.371 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 724' ' ' SER . . . . . 0.416 ' C ' HG23 ' A' ' 743' ' ' VAL . 19.0 m -126.7 104.96 8.36 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -177.638 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 725' ' ' LEU . . . . . 0.556 ' CD2' ' HB ' ' A' ' 743' ' ' VAL . 14.8 mt -63.39 137.42 58.16 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-O 121.331 0.586 . . . . 0.0 110.839 -176.664 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 726' ' ' LYS . . . . . 0.439 ' HD2' ' HB2' ' A' ' 744' ' ' ALA . 33.9 mtpt -89.76 -18.3 26.6 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.886 -175.351 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 727' ' ' LEU . . . . . 0.422 ' HB2' ' HD2' ' A' ' 742' ' ' PRO . 25.5 tp -68.15 109.59 3.61 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.248 175.167 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 11.6 t-80 -110.83 25.22 12.01 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.266 0.555 . . . . 0.0 111.534 -173.35 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 6.2 p80 -155.81 162.08 40.53 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.092 179.457 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 730' ' ' ASP . . . . . 0.541 ' OD1' ' HB2' ' A' ' 816' ' ' GLN . 16.5 t70 -72.25 131.41 42.69 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.807 0.813 . . . . 0.0 111.301 -176.411 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 731' ' ' LEU . . . . . 0.597 ' HG ' HD21 ' A' ' 733' ' ' LEU . 25.9 tp -87.17 110.13 19.94 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 114.114 -1.403 . . . . 0.0 110.671 -174.62 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 732' ' ' LYS . . . . . . . . . . . . . 26.5 mmmt -86.74 107.4 18.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.389 -172.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 733' ' ' LEU . . . . . 0.723 HD12 HG22 ' A' ' 817' ' ' VAL . 16.8 mt -119.32 163.92 16.45 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.848 0.356 . . . . 0.0 111.088 -179.336 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 734' ' ' CYS . . . . . 0.562 ' O ' ' HB2' ' A' ' 737' ' ' ASP . 15.5 t -116.97 -173.75 2.45 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 174.138 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 735' ' ' LEU . . . . . . . . . . . . . 18.6 tp -73.23 133.83 44.1 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.447 0.642 . . . . 0.0 111.724 -172.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 81.49 10.11 84.9 Favored Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 114.674 -1.148 . . . . 0.0 111.423 -178.275 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 737' ' ' ASP . . . . . 0.562 ' HB2' ' O ' ' A' ' 734' ' ' CYS . 0.9 OUTLIER -88.14 149.7 23.76 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.918 0.389 . . . . 0.0 111.315 175.99 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 25.6 p-80 -109.52 167.27 10.26 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 170.41 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 739' ' ' SER . . . . . 0.429 ' HB3' HD23 ' A' ' 731' ' ' LEU . 0.3 OUTLIER -121.25 164.59 16.73 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 119.855 -0.738 . . . . 0.0 111.74 -173.206 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 62.8 m -143.35 128.15 18.28 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.126 -0.943 . . . . 0.0 108.941 178.069 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 741' ' ' VAL . . . . . 0.722 HG11 HD23 ' A' ' 793' ' ' LEU . 0.8 OUTLIER -138.06 114.85 9.24 Favored Pre-proline 0 C--N 1.312 -1.048 0 CA-C-O 121.337 0.589 . . . . 0.0 110.326 -177.866 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 742' ' ' PRO . . . . . 0.659 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 6.5 Cg_endo -76.66 136.35 17.05 Favored 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 122.389 2.059 . . . . 0.0 111.396 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 743' ' ' VAL . . . . . 0.627 HG21 ' HB1' ' A' ' 723' ' ' ALA . 1.6 p -131.64 119.44 42.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.253 0.549 . . . . 0.0 111.915 176.489 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 744' ' ' ALA . . . . . 0.439 ' HB2' ' HD2' ' A' ' 726' ' ' LYS . . . -84.0 111.65 19.48 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 168.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 745' ' ' LEU . . . . . 0.908 HD13 HD13 ' A' ' 773' ' ' ILE . 0.2 OUTLIER -94.11 154.78 17.42 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.645 -1.161 . . . . 0.0 110.9 -166.359 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -107.01 149.85 27.12 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.161 -178.221 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 747' ' ' GLY . . . . . 0.489 ' HA3' ' HB3' ' A' ' 721' ' ' PRO . . . 96.2 118.62 3.48 Favored Glycine 0 C--N 1.316 -0.559 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -174.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 27.4 mp0 -99.77 122.47 42.79 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.192 0.52 . . . . 0.0 112.115 -169.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 116.24 -170.75 13.46 Favored Glycine 0 C--O 1.218 -0.845 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.439 -179.092 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 750' ' ' PRO . . . . . 0.497 ' HB3' ' HE2' ' A' ' 774' ' ' LYS . 88.8 Cg_endo -69.94 96.6 0.61 Allowed 'Trans proline' 0 CA--C 1.533 0.445 0 C-N-CA 123.506 2.804 . . . . 0.0 113.893 -178.291 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 751' ' ' PHE . . . . . 0.597 ' CD2' ' HA ' ' A' ' 800' ' ' ASP . 80.7 m-85 -115.19 148.14 39.44 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.176 178.681 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 752' ' ' THR . . . . . 0.761 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 98.2 m -90.56 104.16 16.77 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.231 0.538 . . . . 0.0 109.684 178.223 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 753' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.14 113.7 25.3 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.186 -170.46 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 754' ' ' THR . . . . . 0.474 HG23 ' HB2' ' A' ' 769' ' ' GLU . 1.6 m -109.89 134.42 52.09 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.455 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 755' ' ' TYR . . . . . 0.616 ' CE1' ' HB2' ' A' ' 768' ' ' PHE . 24.9 p90 -143.97 152.89 41.66 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.021 0.439 . . . . 0.0 112.133 179.194 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 756' ' ' ASP . . . . . 0.468 ' HB2' HG23 ' A' ' 758' ' ' ILE . 2.9 p30 -113.31 121.14 43.5 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.513 -178.582 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 757' ' ' ILE . . . . . 0.532 ' CD1' HD13 ' A' ' 793' ' ' LEU . 4.0 mp -93.89 96.16 5.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 165.285 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 758' ' ' ILE . . . . . 0.535 HG13 ' O ' ' A' ' 792' ' ' ILE . 2.2 pp -100.39 150.16 5.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.749 -170.33 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -92.96 115.85 28.51 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.764 -177.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 760' ' ' THR . . . . . 0.473 HG23 ' HB2' ' A' ' 790' ' ' ASP . 0.2 OUTLIER . . . . . 0 C--N 1.317 -0.824 0 CA-C-O 121.389 0.614 . . . . 0.0 109.781 178.169 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 765' ' ' ARG . . . . . 0.527 ' HD3' HG22 ' A' ' 758' ' ' ILE . 6.7 ttp180 . . . . . 0 N--CA 1.444 -0.749 0 CA-C-O 120.653 0.263 . . . . 0.0 110.506 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 766' ' ' LYS . . . . . 0.658 ' HD3' ' N ' ' A' ' 767' ' ' THR . 7.8 tmtm? -115.48 146.24 41.85 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 177.145 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 767' ' ' THR . . . . . 0.658 ' N ' ' HD3' ' A' ' 766' ' ' LYS . 90.7 m -132.49 135.83 46.27 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.42 -177.382 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 768' ' ' PHE . . . . . 0.616 ' HB2' ' CE1' ' A' ' 755' ' ' TYR . 20.8 m-85 -123.26 134.57 54.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.38 174.003 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 769' ' ' GLU . . . . . 0.474 ' HB2' HG23 ' A' ' 754' ' ' THR . 40.5 tt0 -126.9 104.83 8.24 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.591 177.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 770' ' ' ILE . . . . . 0.402 HG22 HG22 ' A' ' 773' ' ' ILE . 22.1 mt -105.22 117.55 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.422 -178.67 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 771' ' ' LYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 17.7 mmtt -77.74 159.11 29.29 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.451 0.643 . . . . 0.0 111.006 -179.204 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 772' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 48.02 45.96 19.22 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 113.863 -1.517 . . . . 0.0 112.83 172.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 773' ' ' ILE . . . . . 0.908 HD13 HD13 ' A' ' 745' ' ' LEU . 0.5 OUTLIER -75.72 109.85 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 172.149 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 774' ' ' LYS . . . . . 0.497 ' HE2' ' HB3' ' A' ' 750' ' ' PRO . 59.6 mttt -105.65 28.83 7.1 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 -177.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 775' ' ' THR . . . . . 0.687 ' H ' HD12 ' A' ' 773' ' ' ILE . 0.6 OUTLIER -95.32 -74.61 0.55 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.95 -1.023 . . . . 0.0 113.122 -166.726 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 776' ' ' ASN . . . . . 0.461 ' HA ' ' HB2' ' A' ' 745' ' ' LEU . 11.8 m120 84.48 1.86 0.83 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.76 1.224 . . . . 0.0 110.893 -176.583 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 777' ' ' GLU . . . . . 0.424 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 5.2 mp0 -156.05 83.17 1.0 Allowed 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 177.405 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 778' ' ' TYR . . . . . 0.645 ' HB3' HD11 ' A' ' 745' ' ' LEU . 67.1 t80 -125.97 127.68 46.31 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.582 -170.13 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 779' ' ' VAL . . . . . 0.659 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 15.5 t -88.55 108.6 18.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.285 0.564 . . . . 0.0 110.216 177.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 780' ' ' ILE . . . . . . . . . . . . . 79.4 mt -76.41 143.56 12.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.63 -178.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.73 106.6 11.08 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 175.656 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 782' ' ' THR . . . . . 0.423 ' HA ' ' HD3' ' A' ' 783' ' ' PRO . 39.5 p -83.51 144.02 45.35 Favored Pre-proline 0 C--N 1.315 -0.9 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.356 -177.546 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 783' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 782' ' ' THR . 60.3 Cg_exo -52.75 160.46 3.91 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 123.775 2.983 . . . . 0.0 112.798 -177.291 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 784' ' ' VAL . . . . . . . . . . . . . 14.9 p -66.34 135.2 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.495 -177.485 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 785' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -102.54 99.43 9.44 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.561 0.696 . . . . 0.0 110.028 179.099 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 66.3 p -86.09 24.66 1.28 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.861 0.839 . . . . 0.0 110.295 -178.296 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 5.5 m -160.58 110.65 1.77 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.459 -1.246 . . . . 0.0 110.032 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 788' ' ' GLY . . . . . . . . . . . . . . . -49.91 147.73 6.88 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 121.241 -0.504 . . . . 0.0 113.718 173.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 789' ' ' GLY . . . . . . . . . . . . . . . 167.34 177.43 38.9 Favored Glycine 0 N--CA 1.443 -0.873 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 -177.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 790' ' ' ASP . . . . . 0.473 ' HB2' HG23 ' A' ' 760' ' ' THR . 5.3 m-20 -109.03 128.8 55.28 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -179.457 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 791' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -129.87 145.36 51.6 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -177.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 792' ' ' ILE . . . . . 0.535 ' O ' HG13 ' A' ' 758' ' ' ILE . 20.3 mt -123.47 122.26 64.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 177.391 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 793' ' ' LEU . . . . . 0.722 HD23 HG11 ' A' ' 741' ' ' VAL . 0.7 OUTLIER -89.42 115.21 26.69 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 176.859 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 794' ' ' SER . . . . . 0.546 ' N ' HD12 ' A' ' 793' ' ' LEU . 34.5 t -128.06 149.93 50.17 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.344 -176.031 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 795' ' ' LEU . . . . . 0.506 ' H ' HD22 ' A' ' 795' ' ' LEU . 1.3 mm? -78.85 130.35 35.57 Favored 'General case' 0 C--N 1.323 -0.579 0 O-C-N 122.158 -0.339 . . . . 0.0 111.383 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 796' ' ' VAL . . . . . . . . . . . . . 94.2 t -89.91 -56.77 4.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.05 0.452 . . . . 0.0 111.035 -177.249 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 797' ' ' SER . . . . . 0.636 ' HA ' ' HG ' ' A' ' 808' ' ' LEU . 30.0 m -171.83 160.75 5.67 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.657 -173.438 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 798' ' ' ILE . . . . . 0.61 ' HA ' ' O ' ' A' ' 752' ' ' THR . 11.7 tt -134.58 160.18 41.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 176.757 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 799' ' ' LYS . . . . . 0.761 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 7.7 tmtt? -131.77 122.22 25.47 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.206 0.527 . . . . 0.0 110.595 179.233 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 800' ' ' ASP . . . . . 0.597 ' HA ' ' CD2' ' A' ' 751' ' ' PHE . 7.3 t70 -68.29 156.84 36.86 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.671 -1.149 . . . . 0.0 109.844 176.33 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 17.3 t -60.03 -14.22 15.34 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 124.093 0.87 . . . . 0.0 112.812 -172.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 802' ' ' THR . . . . . 0.495 HG22 ' OD2' ' A' ' 800' ' ' ASP . 13.9 t -90.33 -0.46 57.65 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.48 0.657 . . . . 0.0 109.733 176.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 803' ' ' GLY . . . . . . . . . . . . . . . 85.44 39.21 8.44 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.9 -178.299 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 804' ' ' CYS . . . . . . . . . . . . . 48.8 t -110.51 115.19 29.19 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 -178.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 805' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 7.6 p -86.34 134.24 27.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.215 0.531 . . . . 0.0 111.079 -176.304 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 806' ' ' VAL . . . . . 0.506 HG21 ' HD2' ' A' ' 721' ' ' PRO . 71.4 t -118.56 131.22 71.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.12 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -69.78 116.47 6.9 Favored Glycine 0 N--CA 1.453 -0.178 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.907 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 808' ' ' LEU . . . . . 0.666 HD22 ' HA ' ' A' ' 722' ' ' SER . 32.2 mt -84.87 131.13 34.55 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -174.445 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 36.4 m -147.42 86.25 1.61 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.62 173.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 810' ' ' GLN . . . . . 0.562 ' HB3' ' HD2' ' A' ' 811' ' ' PRO . 89.1 mt-30 -139.18 169.53 12.2 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.261 177.266 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 811' ' ' PRO . . . . . 0.562 ' HD2' ' HB3' ' A' ' 810' ' ' GLN . 89.3 Cg_exo -45.68 135.84 12.91 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 122.847 2.364 . . . . 0.0 114.611 -175.354 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -107.13 167.36 9.96 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.343 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 813' ' ' ALA . . . . . 0.528 ' N ' HD12 ' A' ' 725' ' ' LEU . . . -119.67 152.79 36.56 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.404 -178.635 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 814' ' ' LYS . . . . . . . . . . . . . 16.9 ttpp -118.23 126.45 52.21 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 121.341 0.591 . . . . 0.0 110.562 178.1 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 815' ' ' ILE . . . . . 0.594 ' HA ' ' HB3' ' A' ' 731' ' ' LEU . 5.2 mp -112.71 119.28 60.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 114.946 -1.025 . . . . 0.0 109.08 178.434 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 816' ' ' GLN . . . . . 0.6 ' NE2' ' HE ' ' A' ' 818' ' ' ARG . 2.9 tm0? -107.32 115.04 29.46 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 817' ' ' VAL . . . . . 0.723 HG22 HD12 ' A' ' 733' ' ' LEU . 3.9 t -106.43 145.71 13.86 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 177.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 818' ' ' ARG . . . . . 0.6 ' HE ' ' NE2' ' A' ' 816' ' ' GLN . 20.9 mmt85 . . . . . 0 C--N 1.319 -0.723 0 C-N-CA 120.524 -0.47 . . . . 0.0 111.621 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 720' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp . . . . . 0 N--CA 1.45 -0.456 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 721' ' ' PRO . . . . . 0.541 ' HB2' HD13 ' A' ' 798' ' ' ILE . 95.3 Cg_endo -86.03 148.7 9.37 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 122.869 2.379 . . . . 0.0 112.35 -172.365 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 722' ' ' SER . . . . . 0.402 ' HA ' ' CG ' ' A' ' 808' ' ' LEU . 22.6 t -179.22 -154.05 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.362 -174.207 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 723' ' ' ALA . . . . . 0.542 ' HB3' ' HG ' ' A' ' 795' ' ' LEU . . . -144.77 144.82 31.37 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 176.148 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 7.8 m -128.97 98.96 5.1 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 -175.001 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 725' ' ' LEU . . . . . 0.577 HD22 ' CG2' ' A' ' 743' ' ' VAL . 1.7 mt -63.74 145.32 55.98 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-O 121.216 0.531 . . . . 0.0 110.96 -171.33 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 31.2 mtpt -101.23 -14.56 17.64 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.358 -177.08 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 727' ' ' LEU . . . . . 0.475 ' HB2' HG23 ' A' ' 741' ' ' VAL . 0.6 OUTLIER -74.17 123.31 24.23 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 177.132 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 61.3 m-70 -87.7 -38.0 16.21 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -171.407 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 729' ' ' HIS . . . . . 0.422 ' O ' HD22 ' A' ' 727' ' ' LEU . 3.1 p80 -126.61 -176.63 3.74 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.991 -172.113 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 730' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -61.52 145.5 51.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.711 0.767 . . . . 0.0 111.427 178.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 731' ' ' LEU . . . . . 0.559 HD23 ' HB2' ' A' ' 739' ' ' SER . 16.2 tp -105.37 108.62 20.23 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.927 -177.634 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 732' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -76.93 122.1 24.38 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.9 -175.462 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 733' ' ' LEU . . . . . 0.495 HD11 ' HB3' ' A' ' 739' ' ' SER . 85.3 mt -132.71 164.09 27.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.773 176.22 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 734' ' ' CYS . . . . . 0.535 ' O ' ' HB2' ' A' ' 737' ' ' ASP . 26.8 p -115.93 -174.06 2.47 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 172.776 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 735' ' ' LEU . . . . . . . . . . . . . 6.1 tp -66.61 135.48 54.17 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.778 0.799 . . . . 0.0 112.322 -175.158 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 81.97 4.72 90.19 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 114.357 -1.292 . . . . 0.0 111.767 178.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 737' ' ' ASP . . . . . 0.535 ' HB2' ' O ' ' A' ' 734' ' ' CYS . 6.8 m-20 -82.15 150.54 27.38 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.329 0.585 . . . . 0.0 112.422 -179.382 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 738' ' ' HIS . . . . . 0.497 ' HB2' ' O ' ' A' ' 782' ' ' THR . 42.6 p-80 -113.39 160.32 18.53 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 169.555 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 739' ' ' SER . . . . . 0.559 ' HB2' HD23 ' A' ' 731' ' ' LEU . 1.5 p -117.25 170.03 9.01 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 119.556 -0.857 . . . . 0.0 111.827 -172.05 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 740' ' ' SER . . . . . 0.486 ' HA ' ' O ' ' A' ' 780' ' ' ILE . 50.5 m -143.08 101.52 3.84 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.146 177.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 741' ' ' VAL . . . . . 0.547 HG11 HD13 ' A' ' 793' ' ' LEU . 1.2 p -108.74 109.46 61.22 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.546 178.786 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 742' ' ' PRO . . . . . 0.806 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 5.9 Cg_exo -72.41 128.89 14.13 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 122.252 1.968 . . . . 0.0 111.51 -177.427 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 743' ' ' VAL . . . . . 0.577 ' CG2' HD22 ' A' ' 725' ' ' LEU . 43.5 t -130.41 119.2 45.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -178.761 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 744' ' ' ALA . . . . . 0.572 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -84.27 117.97 23.89 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 170.296 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 745' ' ' LEU . . . . . 0.926 HD13 HD13 ' A' ' 773' ' ' ILE . 0.4 OUTLIER -95.45 150.67 20.04 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.931 -165.222 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -105.92 146.76 29.57 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.483 -177.028 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 747' ' ' GLY . . . . . . . . . . . . . . . 110.27 135.29 6.99 Favored Glycine 0 C--N 1.311 -0.842 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 -173.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -114.16 106.33 14.25 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 117.053 0.426 . . . . 0.0 111.37 -171.672 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 129.17 -175.48 18.85 Favored Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 -178.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -68.01 93.46 0.39 Allowed 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.506 2.137 . . . . 0.0 112.119 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 751' ' ' PHE . . . . . 0.496 ' CE2' ' HA ' ' A' ' 800' ' ' ASP . 57.7 m-85 -109.66 140.42 43.53 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.119 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 752' ' ' THR . . . . . 0.759 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 53.8 m -90.24 102.73 15.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.358 0.599 . . . . 0.0 109.837 176.577 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 753' ' ' LEU . . . . . 0.428 HD22 ' N ' ' A' ' 754' ' ' THR . 0.4 OUTLIER -94.06 123.09 37.21 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.662 -169.695 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 754' ' ' THR . . . . . 0.428 ' N ' HD22 ' A' ' 753' ' ' LEU . 0.8 OUTLIER -119.49 139.88 51.37 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.281 -177.878 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 755' ' ' TYR . . . . . 0.636 ' CE1' ' HB3' ' A' ' 768' ' ' PHE . 23.8 p90 -146.41 155.82 42.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.938 0.399 . . . . 0.0 111.528 177.598 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 756' ' ' ASP . . . . . 0.465 ' HB3' HG23 ' A' ' 758' ' ' ILE . 5.2 m-20 -113.54 120.27 40.4 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.317 -178.233 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 757' ' ' ILE . . . . . 0.453 HG13 HD12 ' A' ' 793' ' ' LEU . 4.2 mp -89.14 95.41 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 169.358 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 758' ' ' ILE . . . . . 0.549 HG13 ' O ' ' A' ' 792' ' ' ILE . 1.6 pp -101.19 148.2 7.41 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.56 -174.806 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 759' ' ' GLU . . . . . 0.796 ' HB3' ' CE2' ' A' ' 791' ' ' TYR . 7.0 pt-20 -106.17 122.15 45.62 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.075 173.021 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 760' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.311 -1.069 0 CA-C-N 114.683 -1.144 . . . . 0.0 108.618 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 765' ' ' ARG . . . . . 0.474 ' CG ' HG22 ' A' ' 758' ' ' ILE . 23.0 ttp180 . . . . . 0 N--CA 1.446 -0.65 0 CA-C-O 120.879 0.371 . . . . 0.0 111.045 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 766' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -126.54 140.82 52.15 Favored 'General case' 0 C--O 1.215 -0.738 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.847 -178.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 767' ' ' THR . . . . . . . . . . . . . 43.0 m -112.06 129.78 56.1 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.498 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 768' ' ' PHE . . . . . 0.636 ' HB3' ' CE1' ' A' ' 755' ' ' TYR . 2.5 t80 -126.1 135.83 52.19 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.334 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 769' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -132.42 127.98 36.53 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.933 -175.744 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 770' ' ' ILE . . . . . 0.596 HG22 HG22 ' A' ' 773' ' ' ILE . 4.6 mt -121.52 114.14 41.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 177.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 771' ' ' LYS . . . . . 0.595 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 0.1 OUTLIER -87.46 153.88 21.08 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 121.256 0.55 . . . . 0.0 111.842 -174.643 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 772' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 52.35 47.93 23.69 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.363 -1.29 . . . . 0.0 112.009 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 773' ' ' ILE . . . . . 0.926 HD13 HD13 ' A' ' 745' ' ' LEU . 0.5 OUTLIER -75.17 114.79 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 174.771 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 72.1 mttt -114.3 30.95 6.93 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 775' ' ' THR . . . . . 0.706 ' H ' HD12 ' A' ' 773' ' ' ILE . 2.5 m -97.01 -71.82 0.66 Allowed 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 113.488 -1.687 . . . . 0.0 112.415 -169.128 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 776' ' ' ASN . . . . . 0.452 ' HB2' ' O ' ' A' ' 775' ' ' THR . 82.0 m-20 83.17 7.99 0.69 Allowed 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.198 0.999 . . . . 0.0 110.138 -177.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 777' ' ' GLU . . . . . 0.572 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 22.5 tt0 -161.55 94.39 0.96 Allowed 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.725 175.445 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 778' ' ' TYR . . . . . 0.901 ' HB3' HD11 ' A' ' 745' ' ' LEU . 67.9 t80 -141.91 120.52 12.53 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.553 -172.113 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 779' ' ' VAL . . . . . 0.806 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 1.4 m -88.07 129.38 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 CA-C-O 122.035 0.921 . . . . 0.0 109.733 179.383 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 780' ' ' ILE . . . . . 0.486 ' O ' ' HA ' ' A' ' 740' ' ' SER . 89.7 mt -91.23 138.3 19.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 113.959 -1.473 . . . . 0.0 110.971 -172.301 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 781' ' ' LYS . . . . . 0.453 ' HD3' ' N ' ' A' ' 781' ' ' LYS . 0.0 OUTLIER -115.86 106.73 14.15 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.33 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 782' ' ' THR . . . . . 0.497 ' O ' ' HB2' ' A' ' 738' ' ' HIS . 32.5 p -78.22 143.26 64.72 Favored Pre-proline 0 C--N 1.32 -0.706 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.102 -178.124 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 783' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -55.79 161.65 7.86 Favored 'Trans proline' 0 CA--C 1.529 0.252 0 C-N-CA 123.513 2.809 . . . . 0.0 113.109 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 784' ' ' VAL . . . . . 0.467 HG12 HG23 ' A' ' 786' ' ' THR . 55.3 t -59.02 121.71 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.312 -177.709 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 785' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -97.52 98.22 9.74 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.906 177.627 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 786' ' ' THR . . . . . 0.467 HG23 HG12 ' A' ' 784' ' ' VAL . 35.3 p -87.28 33.7 0.69 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 122.051 0.929 . . . . 0.0 110.092 178.482 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 28.7 m -153.52 104.98 2.78 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.38 -1.282 . . . . 0.0 110.223 -179.111 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 788' ' ' GLY . . . . . . . . . . . . . . . -49.59 113.37 1.76 Allowed Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.277 168.524 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 789' ' ' GLY . . . . . 0.403 ' H ' ' HB ' ' A' ' 817' ' ' VAL . . . -160.49 -166.07 18.56 Favored Glycine 0 N--CA 1.441 -0.97 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 -179.209 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -123.62 122.74 38.91 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 117.621 0.711 . . . . 0.0 109.319 -178.598 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 791' ' ' TYR . . . . . 0.796 ' CE2' ' HB3' ' A' ' 759' ' ' GLU . 88.8 m-85 -117.44 150.86 38.2 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.413 0.625 . . . . 0.0 111.407 -177.017 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 792' ' ' ILE . . . . . 0.549 ' O ' HG13 ' A' ' 758' ' ' ILE . 17.0 mt -131.53 113.04 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.338 175.115 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 793' ' ' LEU . . . . . 0.547 HD13 HG11 ' A' ' 741' ' ' VAL . 7.9 tt -85.03 110.26 18.79 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.156 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 794' ' ' SER . . . . . . . . . . . . . 13.6 t -123.45 142.2 51.23 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.968 -177.034 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 795' ' ' LEU . . . . . 0.578 ' H ' HD22 ' A' ' 795' ' ' LEU . 1.2 mm? -67.91 140.22 56.47 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 120.904 0.383 . . . . 0.0 111.454 -178.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 796' ' ' VAL . . . . . . . . . . . . . 69.7 t -99.82 -55.28 6.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.015 -178.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 797' ' ' SER . . . . . 0.568 ' HA ' HD13 ' A' ' 808' ' ' LEU . 89.5 p -173.66 176.94 2.62 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.345 -173.018 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 798' ' ' ILE . . . . . 0.621 ' HA ' ' O ' ' A' ' 752' ' ' THR . 11.0 tt -151.22 161.43 3.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.379 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 799' ' ' LYS . . . . . 0.759 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 5.2 tttt -132.24 113.89 13.79 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 120.836 0.35 . . . . 0.0 110.521 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 800' ' ' ASP . . . . . 0.577 ' HB3' ' HB3' ' A' ' 804' ' ' CYS . 16.9 t70 -57.91 152.27 16.47 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.263 171.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 3.4 p -65.59 -7.51 15.3 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -171.03 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 35.5 p -93.6 1.7 56.59 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.659 0.743 . . . . 0.0 110.04 176.002 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 803' ' ' GLY . . . . . 0.512 ' HA2' ' HE2' ' A' ' 799' ' ' LYS . . . 82.76 44.73 7.09 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.873 -177.565 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 804' ' ' CYS . . . . . 0.577 ' HB3' ' HB3' ' A' ' 800' ' ' ASP . 45.1 t -111.68 106.93 15.87 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 177.039 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 805' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 3.9 t -86.06 119.32 34.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.38 0.609 . . . . 0.0 110.08 -176.663 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 806' ' ' VAL . . . . . 0.541 HG11 ' HD2' ' A' ' 721' ' ' PRO . 37.3 t -108.01 139.17 31.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.498 -176.24 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -80.06 110.3 3.07 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.557 -179.294 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 808' ' ' LEU . . . . . 0.568 HD13 ' HA ' ' A' ' 797' ' ' SER . 10.8 mp -77.61 134.19 38.26 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 177.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 19.9 m -149.5 85.76 1.45 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.166 -0.924 . . . . 0.0 109.175 169.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 810' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -132.26 170.8 10.41 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.009 177.467 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 811' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -45.3 144.08 4.78 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 123.038 2.492 . . . . 0.0 114.588 -176.659 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -111.15 166.21 11.26 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.656 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 813' ' ' ALA . . . . . 0.42 ' O ' ' HA ' ' A' ' 792' ' ' ILE . . . -117.87 147.57 42.96 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.257 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 814' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -108.8 125.44 51.96 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.513 0.673 . . . . 0.0 110.92 178.587 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 815' ' ' ILE . . . . . 0.544 ' HA ' ' HB3' ' A' ' 731' ' ' LEU . 5.1 mp -110.81 109.06 27.09 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-N 114.818 -1.083 . . . . 0.0 108.651 177.169 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 816' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -99.4 109.27 21.88 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.184 0.516 . . . . 0.0 110.15 -175.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 817' ' ' VAL . . . . . 0.403 ' HB ' ' H ' ' A' ' 789' ' ' GLY . 2.6 t -105.71 146.18 12.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.356 -177.355 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 818' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 . . . . . 0 C--N 1.324 -0.525 0 CA-C-O 121.245 0.545 . . . . 0.0 111.887 -179.11 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 720' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt . . . . . 0 N--CA 1.447 -0.599 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 721' ' ' PRO . . . . . 0.422 ' O ' HG21 ' A' ' 798' ' ' ILE . 37.6 Cg_endo -83.1 145.36 12.27 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 C-N-CA 122.424 2.083 . . . . 0.0 111.436 -175.133 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 722' ' ' SER . . . . . 0.497 ' OG ' HD22 ' A' ' 808' ' ' LEU . 25.6 t 177.42 -153.08 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -171.362 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 723' ' ' ALA . . . . . 0.737 ' HB1' HG21 ' A' ' 743' ' ' VAL . . . -150.21 143.48 25.02 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.482 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 23.1 t -129.95 103.84 7.02 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 725' ' ' LEU . . . . . 0.465 ' CD2' ' HB ' ' A' ' 743' ' ' VAL . 13.2 mt -64.35 149.26 48.61 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 121.616 0.722 . . . . 0.0 111.839 -175.264 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 726' ' ' LYS . . . . . 0.543 ' HD2' ' HB2' ' A' ' 744' ' ' ALA . 20.2 mtpp -106.8 -10.09 16.18 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.46 -175.721 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 727' ' ' LEU . . . . . 0.465 ' HB2' ' HD2' ' A' ' 742' ' ' PRO . 0.3 OUTLIER -81.31 111.22 17.49 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 176.364 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 40.9 m80 -103.68 37.37 2.05 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -168.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 9.7 p80 -174.08 -177.05 1.25 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.662 0.268 . . . . 0.0 110.776 177.597 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 730' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -81.04 139.65 35.6 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.297 177.137 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 731' ' ' LEU . . . . . 0.559 ' HB2' ' HA ' ' A' ' 815' ' ' ILE . 36.4 mt -87.61 117.06 26.16 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.263 -178.53 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 732' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -84.09 113.01 20.73 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.333 -178.701 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 733' ' ' LEU . . . . . 0.522 HD11 ' HB3' ' A' ' 739' ' ' SER . 43.5 mt -131.67 159.6 37.86 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 121.267 0.556 . . . . 0.0 111.9 -175.656 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 734' ' ' CYS . . . . . 0.624 ' HA ' ' O ' ' A' ' 818' ' ' ARG . 78.4 m -104.12 -173.75 2.38 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.131 176.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 735' ' ' LEU . . . . . . . . . . . . . 19.9 tp -73.79 134.71 43.44 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.174 0.511 . . . . 0.0 111.342 -178.439 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 74.72 11.56 83.16 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.439 -0.886 . . . . 0.0 111.285 -176.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 737' ' ' ASP . . . . . 0.603 ' HB2' ' O ' ' A' ' 734' ' ' CYS . 0.2 OUTLIER -84.77 150.11 25.29 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.119 0.485 . . . . 0.0 111.231 176.55 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 27.9 p-80 -114.25 175.27 5.55 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 168.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 739' ' ' SER . . . . . 0.522 ' HB3' HD11 ' A' ' 733' ' ' LEU . 0.0 OUTLIER -140.0 166.66 24.04 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 120.083 -0.647 . . . . 0.0 111.999 -178.615 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 19.7 m -136.75 112.97 9.82 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.6 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 741' ' ' VAL . . . . . 0.664 HG11 HD23 ' A' ' 793' ' ' LEU . 0.9 OUTLIER -111.05 112.95 55.1 Favored Pre-proline 0 C--N 1.318 -0.799 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.746 -179.621 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 742' ' ' PRO . . . . . 0.678 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 1.6 Cg_endo -73.43 134.97 21.52 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 122.517 2.145 . . . . 0.0 111.284 -179.306 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 743' ' ' VAL . . . . . 0.737 HG21 ' HB1' ' A' ' 723' ' ' ALA . 2.0 p -131.91 116.44 30.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.376 0.608 . . . . 0.0 112.032 176.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 744' ' ' ALA . . . . . 0.574 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -81.22 98.99 8.34 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 169.552 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 745' ' ' LEU . . . . . 0.968 HD13 HD13 ' A' ' 773' ' ' ILE . 0.3 OUTLIER -79.36 165.33 23.24 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.675 -167.385 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 17.3 ttmm -114.44 165.33 12.84 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.679 -179.599 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 747' ' ' GLY . . . . . . . . . . . . . . . 94.45 128.45 5.25 Favored Glycine 0 C--N 1.31 -0.863 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 -175.271 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 748' ' ' GLN . . . . . 0.522 ' C ' ' HE1' ' A' ' 751' ' ' PHE . 48.3 mm-40 -110.85 98.62 7.71 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.749 -0.38 . . . . 0.0 111.061 -173.285 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 133.91 -159.23 23.66 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.549 -177.14 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -78.88 94.99 1.06 Allowed 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 122.944 2.43 . . . . 0.0 112.516 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 751' ' ' PHE . . . . . 0.717 ' CE2' ' HA ' ' A' ' 800' ' ' ASP . 94.6 m-85 -118.41 140.66 49.51 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.799 -178.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 752' ' ' THR . . . . . 0.701 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 92.3 m -95.31 106.7 18.77 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.623 0.725 . . . . 0.0 109.536 179.47 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 753' ' ' LEU . . . . . 0.485 HD23 HG12 ' A' ' 798' ' ' ILE . 0.4 OUTLIER -97.19 117.78 32.17 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.538 -1.21 . . . . 0.0 109.783 -170.354 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 754' ' ' THR . . . . . 0.486 HG23 ' HB2' ' A' ' 769' ' ' GLU . 1.2 m -116.71 137.04 52.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.897 -177.074 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 755' ' ' TYR . . . . . 0.681 ' CE1' ' HB2' ' A' ' 768' ' ' PHE . 24.3 p90 -144.64 155.38 43.58 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -179.366 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 756' ' ' ASP . . . . . 0.413 ' OD2' ' HB2' ' A' ' 794' ' ' SER . 4.9 p-10 -116.94 119.94 36.88 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.551 -177.295 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 757' ' ' ILE . . . . . 0.536 ' CD1' HD13 ' A' ' 793' ' ' LEU . 4.0 mp -91.87 96.49 6.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 167.376 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 758' ' ' ILE . . . . . 0.659 HG22 ' HD2' ' A' ' 765' ' ' ARG . 2.4 pp -100.57 149.56 6.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.25 -170.14 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 759' ' ' GLU . . . . . 0.503 ' HG2' ' CE2' ' A' ' 791' ' ' TYR . 12.5 mt-10 -86.38 118.59 25.92 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 120.921 0.391 . . . . 0.0 111.13 -179.38 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 760' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.315 -0.9 0 CA-C-O 121.56 0.695 . . . . 0.0 109.533 174.11 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 765' ' ' ARG . . . . . 0.659 ' HD2' HG22 ' A' ' 758' ' ' ILE . 12.0 ttt180 . . . . . 0 N--CA 1.44 -0.948 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 766' ' ' LYS . . . . . 0.614 ' HD3' ' N ' ' A' ' 767' ' ' THR . 2.0 tmtp? -120.48 146.32 46.38 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.727 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 767' ' ' THR . . . . . 0.614 ' N ' ' HD3' ' A' ' 766' ' ' LYS . 96.6 m -131.74 132.36 43.78 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 120.962 0.411 . . . . 0.0 111.751 -176.223 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 768' ' ' PHE . . . . . 0.681 ' HB2' ' CE1' ' A' ' 755' ' ' TYR . 42.9 m-85 -120.07 141.21 49.98 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.214 174.105 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 769' ' ' GLU . . . . . 0.486 ' HB2' HG23 ' A' ' 754' ' ' THR . 46.0 tt0 -131.27 109.37 10.34 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.383 178.073 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 770' ' ' ILE . . . . . 0.564 HG22 HG22 ' A' ' 773' ' ' ILE . 21.2 mt -105.97 120.37 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 771' ' ' LYS . . . . . 0.577 ' HD2' ' N ' ' A' ' 771' ' ' LYS . 0.1 OUTLIER -85.55 164.62 17.67 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.067 0.46 . . . . 0.0 111.144 -175.192 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 772' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 36.36 50.44 0.75 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 113.853 -1.521 . . . . 0.0 112.64 177.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 773' ' ' ILE . . . . . 0.968 HD13 HD13 ' A' ' 745' ' ' LEU . 0.5 OUTLIER -76.71 111.98 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 175.67 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 75.7 mttt -113.04 33.62 4.95 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 -179.457 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 775' ' ' THR . . . . . 0.691 ' H ' HD12 ' A' ' 773' ' ' ILE . 1.2 m -95.12 -71.64 0.66 Allowed 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 113.836 -1.529 . . . . 0.0 111.769 -169.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 776' ' ' ASN . . . . . 0.417 ' HB2' ' O ' ' A' ' 775' ' ' THR . 11.5 m120 81.92 4.11 1.28 Allowed 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.129 0.971 . . . . 0.0 110.79 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 777' ' ' GLU . . . . . 0.574 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 18.4 mt-10 -160.2 84.66 0.72 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.197 176.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 778' ' ' TYR . . . . . 0.808 ' HB3' HD11 ' A' ' 745' ' ' LEU . 79.4 t80 -128.89 129.08 45.05 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.843 0.354 . . . . 0.0 110.863 -172.439 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 779' ' ' VAL . . . . . 0.678 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 21.1 t -87.95 112.81 24.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 121.281 0.562 . . . . 0.0 110.515 178.015 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 780' ' ' ILE . . . . . . . . . . . . . 74.0 mt -80.2 141.48 15.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.603 -178.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -114.93 107.85 15.94 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 177.183 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 782' ' ' THR . . . . . 0.403 ' HA ' ' HD3' ' A' ' 783' ' ' PRO . 68.7 p -78.15 135.33 62.37 Favored Pre-proline 0 N--CA 1.441 -0.895 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.639 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 783' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 782' ' ' THR . 46.3 Cg_exo -57.05 158.32 18.0 Favored 'Trans proline' 0 CA--C 1.518 -0.278 0 C-N-CA 123.523 2.815 . . . . 0.0 112.401 -173.262 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 784' ' ' VAL . . . . . . . . . . . . . 12.8 p -60.47 136.43 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.697 -177.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 785' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -110.08 97.15 6.7 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.617 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 82.1 p -83.77 25.16 0.81 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.725 0.774 . . . . 0.0 110.822 -176.276 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 36.7 m -156.47 120.97 4.51 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.446 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 788' ' ' GLY . . . . . 0.673 ' HA2' HG12 ' A' ' 817' ' ' VAL . . . -51.74 110.64 1.14 Allowed Glycine 0 N--CA 1.448 -0.554 0 O-C-N 123.669 0.605 . . . . 0.0 113.335 174.232 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 789' ' ' GLY . . . . . 0.415 ' H ' ' HB ' ' A' ' 817' ' ' VAL . . . -157.28 166.37 33.63 Favored Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 110.571 -1.012 . . . . 0.0 110.571 177.176 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -107.97 132.29 53.67 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 117.305 0.552 . . . . 0.0 109.763 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 791' ' ' TYR . . . . . 0.503 ' CE2' ' HG2' ' A' ' 759' ' ' GLU . 89.4 m-85 -124.61 158.52 32.88 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.951 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 792' ' ' ILE . . . . . 0.609 ' O ' HG13 ' A' ' 758' ' ' ILE . 6.2 mt -134.21 117.71 25.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 171.593 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 793' ' ' LEU . . . . . 0.664 HD23 HG11 ' A' ' 741' ' ' VAL . 1.0 OUTLIER -84.91 112.21 20.36 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.408 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 794' ' ' SER . . . . . 0.516 ' N ' HD12 ' A' ' 793' ' ' LEU . 13.6 m -118.39 177.3 4.87 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 114.81 -1.086 . . . . 0.0 108.744 -177.544 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 795' ' ' LEU . . . . . 0.423 HD11 ' O ' ' A' ' 723' ' ' ALA . 42.9 mt -103.79 132.3 50.17 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.784 0.326 . . . . 0.0 110.644 -179.005 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 796' ' ' VAL . . . . . . . . . . . . . 64.1 t -89.27 -56.72 4.88 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.661 -177.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 797' ' ' SER . . . . . 0.44 ' HA ' ' HG ' ' A' ' 808' ' ' LEU . 26.6 m -173.36 172.83 3.66 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.855 -173.283 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 798' ' ' ILE . . . . . 0.725 ' HB ' HD21 ' A' ' 808' ' ' LEU . 0.5 OUTLIER -146.34 166.76 7.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -173.529 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 799' ' ' LYS . . . . . 0.701 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 34.5 tttt -135.29 117.4 15.42 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.281 -179.15 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 800' ' ' ASP . . . . . 0.717 ' HA ' ' CE2' ' A' ' 751' ' ' PHE . 8.0 t70 -68.65 153.02 44.56 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.192 173.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 24.2 p -62.44 -8.12 5.62 Favored 'General case' 0 C--N 1.33 -0.255 0 O-C-N 123.867 0.73 . . . . 0.0 112.375 -173.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 35.4 p -94.8 9.79 37.69 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.536 0.684 . . . . 0.0 109.673 176.132 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 803' ' ' GLY . . . . . 0.554 ' HA2' ' HE2' ' A' ' 799' ' ' LYS . . . 72.45 40.83 53.66 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 114.871 -1.059 . . . . 0.0 112.389 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 804' ' ' CYS . . . . . . . . . . . . . 59.6 m -114.09 116.32 28.95 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 805' ' ' VAL . . . . . 0.658 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 6.1 p -84.92 113.43 23.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.895 0.855 . . . . 0.0 110.821 -177.331 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 806' ' ' VAL . . . . . 0.671 ' HB ' HG22 ' A' ' 798' ' ' ILE . 41.0 t -96.05 138.42 21.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.604 -178.043 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -70.53 122.03 10.34 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.733 179.352 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 808' ' ' LEU . . . . . 0.725 HD21 ' HB ' ' A' ' 798' ' ' ILE . 24.1 mt -89.63 132.88 34.91 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -175.794 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 14.9 t -149.71 87.04 1.47 Allowed 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.452 -0.794 . . . . 0.0 109.62 172.533 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 810' ' ' GLN . . . . . 0.438 ' HB3' ' HD2' ' A' ' 811' ' ' PRO . 13.1 mt-30 -136.17 170.44 10.96 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.591 -0.732 . . . . 0.0 109.779 173.581 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 811' ' ' PRO . . . . . 0.438 ' HD2' ' HB3' ' A' ' 810' ' ' GLN . 89.2 Cg_exo -44.93 139.11 8.24 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 122.973 2.449 . . . . 0.0 114.192 -177.478 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -110.4 166.07 11.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.599 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 813' ' ' ALA . . . . . . . . . . . . . . . -114.57 154.62 27.98 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.257 -177.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 814' ' ' LYS . . . . . . . . . . . . . 50.6 tttp -115.0 130.05 56.85 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-O 121.129 0.49 . . . . 0.0 110.143 176.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 815' ' ' ILE . . . . . 0.559 ' HA ' ' HB2' ' A' ' 731' ' ' LEU . 4.8 mp -113.42 118.24 57.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.722 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 816' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -109.05 114.25 27.83 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.846 0.355 . . . . 0.0 110.81 -179.088 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 817' ' ' VAL . . . . . 0.673 HG12 ' HA2' ' A' ' 788' ' ' GLY . 92.5 t -110.07 124.55 66.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 176.258 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 818' ' ' ARG . . . . . 0.624 ' O ' ' HA ' ' A' ' 734' ' ' CYS . 15.0 mmt180 . . . . . 0 C--N 1.32 -0.685 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 176.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 720' ' ' LYS . . . . . 0.456 ' HA ' ' HD3' ' A' ' 721' ' ' PRO . 12.9 mmmm . . . . . 0 N--CA 1.443 -0.793 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 721' ' ' PRO . . . . . 0.545 ' HD2' HG21 ' A' ' 806' ' ' VAL . 5.9 Cg_endo -78.12 138.47 16.23 Favored 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 122.471 2.114 . . . . 0.0 110.174 -179.071 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 722' ' ' SER . . . . . 0.881 ' HB2' ' OE1' ' A' ' 810' ' ' GLN . 7.3 p -175.21 -153.05 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.347 -166.393 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 723' ' ' ALA . . . . . 0.605 ' HA ' ' HA ' ' A' ' 745' ' ' LEU . . . -157.73 151.27 23.75 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-N 118.518 0.599 . . . . 0.0 110.659 177.638 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 41.6 m -140.03 99.1 3.6 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 121.624 -0.672 . . . . 0.0 110.027 179.425 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 725' ' ' LEU . . . . . 0.938 ' HG ' HG22 ' A' ' 743' ' ' VAL . 5.2 mp -57.3 143.3 40.23 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-O 122.516 1.15 . . . . 0.0 112.661 -175.731 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 36.5 mtpt -96.82 -13.98 22.21 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 112.851 -1.977 . . . . 0.0 110.279 -177.594 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 727' ' ' LEU . . . . . 0.518 ' HB2' HG23 ' A' ' 741' ' ' VAL . 3.1 tm? -50.4 128.91 20.93 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.387 -1.278 . . . . 0.0 109.966 176.736 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 35.4 m170 -89.9 -52.48 4.95 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -171.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -145.65 -177.0 5.35 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.535 -0.466 . . . . 0.0 111.513 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 730' ' ' ASP . . . . . 0.406 ' HA ' ' O ' ' A' ' 814' ' ' LYS . 9.5 p-10 -48.06 133.12 15.26 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 124.019 0.824 . . . . 0.0 111.523 178.513 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 731' ' ' LEU . . . . . 0.575 ' CD2' ' HB2' ' A' ' 739' ' ' SER . 27.2 tp -99.53 111.49 23.83 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.526 -175.088 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 732' ' ' LYS . . . . . 0.417 ' HE3' ' NE2' ' A' ' 816' ' ' GLN . 40.5 mmtm -72.76 121.32 19.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.552 -179.465 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 733' ' ' LEU . . . . . 0.49 HD12 ' CG2' ' A' ' 815' ' ' ILE . 94.4 mt -138.26 160.54 39.2 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.445 178.517 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 734' ' ' CYS . . . . . . . . . . . . . 63.8 m -109.96 -174.06 2.4 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.001 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 735' ' ' LEU . . . . . . . . . . . . . 38.4 tp -65.24 125.85 26.3 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.902 0.382 . . . . 0.0 111.36 -172.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 736' ' ' GLY . . . . . 0.508 ' O ' HG13 ' A' ' 784' ' ' VAL . . . 81.4 7.91 87.74 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.455 -0.879 . . . . 0.0 112.622 177.383 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 737' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -78.58 150.37 32.79 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.024 0.44 . . . . 0.0 111.452 176.486 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 738' ' ' HIS . . . . . 0.622 ' HB2' ' O ' ' A' ' 782' ' ' THR . 39.8 p-80 -116.83 166.11 12.53 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 172.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 739' ' ' SER . . . . . 0.575 ' HB2' ' CD2' ' A' ' 731' ' ' LEU . 13.5 p -124.98 163.37 22.47 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 118.956 -1.098 . . . . 0.0 112.27 -172.357 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 740' ' ' SER . . . . . 0.497 ' HA ' ' O ' ' A' ' 780' ' ' ILE . 46.0 m -130.44 99.94 5.18 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.089 174.167 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 741' ' ' VAL . . . . . 0.541 HG11 HD23 ' A' ' 793' ' ' LEU . 0.1 OUTLIER -100.42 112.73 64.87 Favored Pre-proline 0 C--N 1.318 -0.79 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.338 179.449 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 742' ' ' PRO . . . . . 0.753 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 6.3 Cg_exo -75.54 129.8 12.19 Favored 'Trans proline' 0 N--CA 1.445 -1.356 0 C-N-CA 122.215 1.944 . . . . 0.0 110.96 -176.413 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 743' ' ' VAL . . . . . 0.938 HG22 ' HG ' ' A' ' 725' ' ' LEU . 20.1 t -127.95 121.34 56.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.128 0.489 . . . . 0.0 112.247 178.459 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 744' ' ' ALA . . . . . 0.661 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -83.33 99.38 9.98 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 122.326 1.06 . . . . 0.0 108.275 169.319 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 745' ' ' LEU . . . . . 0.877 HD11 ' HB3' ' A' ' 778' ' ' TYR . 3.5 mt -77.39 164.9 25.07 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 113.52 -1.673 . . . . 0.0 110.742 -169.778 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 746' ' ' LYS . . . . . 0.469 ' HB3' ' OG ' ' A' ' 722' ' ' SER . 14.4 tppt? -123.46 161.31 25.08 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.079 0.466 . . . . 0.0 110.457 -176.819 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 747' ' ' GLY . . . . . . . . . . . . . . . 91.3 121.69 2.6 Favored Glycine 0 C--N 1.312 -0.783 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 -175.181 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -95.34 117.97 31.26 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.28 0.562 . . . . 0.0 111.98 -172.397 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 116.65 -175.91 16.01 Favored Glycine 0 CA--C 1.499 -0.934 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.506 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 750' ' ' PRO . . . . . 0.488 ' HB3' ' HE2' ' A' ' 774' ' ' LYS . 86.8 Cg_endo -69.07 94.88 0.48 Allowed 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 123.359 2.706 . . . . 0.0 113.187 -177.543 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 751' ' ' PHE . . . . . 0.583 ' CD2' ' HA ' ' A' ' 800' ' ' ASP . 64.0 m-85 -112.13 144.87 40.78 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.067 179.332 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 752' ' ' THR . . . . . 0.766 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 89.0 m -91.85 102.76 15.35 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.277 0.56 . . . . 0.0 109.921 179.368 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 753' ' ' LEU . . . . . 0.71 ' CD2' HD22 ' A' ' 745' ' ' LEU . 46.9 tp -97.0 121.52 38.97 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.298 -171.167 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 754' ' ' THR . . . . . 0.481 ' HB ' ' HB ' ' A' ' 796' ' ' VAL . 1.0 OUTLIER -109.66 135.98 49.75 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.131 -177.592 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 755' ' ' TYR . . . . . 0.628 ' CE1' ' HB3' ' A' ' 768' ' ' PHE . 29.6 p90 -143.1 152.43 41.84 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 120.977 0.418 . . . . 0.0 111.843 178.095 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 756' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -117.7 118.47 32.16 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.694 -179.17 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 757' ' ' ILE . . . . . 0.611 ' CD1' HD13 ' A' ' 793' ' ' LEU . 3.5 mp -87.7 96.56 5.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 168.206 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 758' ' ' ILE . . . . . 0.624 HG22 ' HD3' ' A' ' 765' ' ' ARG . 2.3 pp -94.53 149.89 4.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 121.322 0.582 . . . . 0.0 111.962 -171.764 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 759' ' ' GLU . . . . . 0.503 ' HG2' ' CE2' ' A' ' 791' ' ' TYR . 16.1 mt-10 -90.86 115.13 27.67 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.832 175.041 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 760' ' ' THR . . . . . . . . . . . . . 2.5 t . . . . . 0 C--N 1.312 -1.023 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 172.789 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 765' ' ' ARG . . . . . 0.624 ' HD3' HG22 ' A' ' 758' ' ' ILE . 6.1 ttp180 . . . . . 0 N--CA 1.451 -0.411 0 CA-C-O 120.552 0.215 . . . . 0.0 110.903 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 766' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -123.7 134.38 53.72 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 120.922 0.391 . . . . 0.0 110.449 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 767' ' ' THR . . . . . . . . . . . . . 47.3 m -107.58 131.39 54.41 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.46 -177.422 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 768' ' ' PHE . . . . . 0.628 ' HB3' ' CE1' ' A' ' 755' ' ' TYR . 0.2 OUTLIER -137.16 135.84 37.7 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.203 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 769' ' ' GLU . . . . . 0.46 ' HB2' HG23 ' A' ' 754' ' ' THR . 39.3 tt0 -129.54 124.01 32.82 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.118 0.485 . . . . 0.0 111.692 -175.749 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 4.6 mm -102.38 110.66 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.759 -179.096 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 771' ' ' LYS . . . . . 0.616 ' HD2' ' N ' ' A' ' 771' ' ' LYS . 0.0 OUTLIER -80.41 157.4 26.27 Favored 'General case' 0 C--N 1.312 -1.028 0 C-N-CA 120.104 -0.639 . . . . 0.0 109.983 179.293 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 772' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 41.77 50.33 3.98 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 113.871 -1.513 . . . . 0.0 113.515 178.387 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 773' ' ' ILE . . . . . 0.843 HD12 ' H ' ' A' ' 775' ' ' THR . 0.5 OUTLIER -75.35 111.37 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 171.135 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 774' ' ' LYS . . . . . 0.488 ' HE2' ' HB3' ' A' ' 750' ' ' PRO . 58.7 mttt -107.26 24.35 12.99 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -178.586 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 775' ' ' THR . . . . . 0.843 ' H ' HD12 ' A' ' 773' ' ' ILE . 0.2 OUTLIER -95.38 -74.27 0.56 Allowed 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -165.763 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 776' ' ' ASN . . . . . 0.637 ' HB2' ' O ' ' A' ' 775' ' ' THR . 0.9 OUTLIER 91.07 4.13 0.1 Allowed 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.5 1.12 . . . . 0.0 110.596 -177.605 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 777' ' ' GLU . . . . . 0.661 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 13.9 tt0 -162.94 101.59 0.99 Allowed 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.133 174.59 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 778' ' ' TYR . . . . . 0.877 ' HB3' HD11 ' A' ' 745' ' ' LEU . 90.7 t80 -153.69 129.7 10.29 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.633 -171.66 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 779' ' ' VAL . . . . . 0.753 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 1.9 m -91.68 129.54 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 CA-C-O 122.15 0.976 . . . . 0.0 110.823 178.061 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 780' ' ' ILE . . . . . 0.497 ' O ' ' HA ' ' A' ' 740' ' ' SER . 88.2 mt -90.13 139.79 16.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 113.59 -1.641 . . . . 0.0 110.811 -174.028 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 781' ' ' LYS . . . . . 0.45 ' HD3' ' N ' ' A' ' 781' ' ' LYS . 0.1 OUTLIER -111.81 107.62 16.74 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.928 0.394 . . . . 0.0 110.323 179.623 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 782' ' ' THR . . . . . 0.622 ' O ' ' HB2' ' A' ' 738' ' ' HIS . 25.2 p -77.8 142.91 66.03 Favored Pre-proline 0 C--N 1.318 -0.761 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.827 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 783' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 782' ' ' THR . 53.0 Cg_exo -56.32 160.72 10.44 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 123.53 2.82 . . . . 0.0 113.2 -178.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 784' ' ' VAL . . . . . 0.508 HG13 ' O ' ' A' ' 736' ' ' GLY . 40.5 t -58.55 122.62 8.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.952 178.396 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 785' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -100.67 97.27 7.96 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.187 178.563 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 786' ' ' THR . . . . . 0.45 HG23 HG12 ' A' ' 784' ' ' VAL . 44.1 p -84.37 34.23 0.52 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.677 0.751 . . . . 0.0 111.165 -178.507 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 12.7 m -154.69 112.72 3.48 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.045 -0.979 . . . . 0.0 111.006 178.435 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 788' ' ' GLY . . . . . 0.689 ' HA2' HG12 ' A' ' 817' ' ' VAL . . . -50.13 112.49 1.52 Allowed Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.521 169.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 789' ' ' GLY . . . . . . . . . . . . . . . -157.51 -148.15 5.03 Favored Glycine 0 N--CA 1.443 -0.843 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -144.86 124.77 13.47 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 179.133 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 791' ' ' TYR . . . . . 0.503 ' CE2' ' HG2' ' A' ' 759' ' ' GLU . 90.9 m-85 -118.99 145.14 46.07 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.998 -176.174 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 792' ' ' ILE . . . . . 0.576 ' O ' HG13 ' A' ' 758' ' ' ILE . 16.5 mt -123.56 110.41 25.92 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.508 173.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 793' ' ' LEU . . . . . 0.848 ' HB3' ' HB3' ' A' ' 813' ' ' ALA . 4.0 tp -84.75 109.55 18.14 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.428 0.632 . . . . 0.0 109.448 179.326 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 794' ' ' SER . . . . . . . . . . . . . 19.1 m -112.31 156.52 22.3 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.062 -174.439 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 795' ' ' LEU . . . . . 0.485 HD13 ' HB3' ' A' ' 723' ' ' ALA . 74.9 mt -91.13 130.5 37.02 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.903 0.382 . . . . 0.0 110.372 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 796' ' ' VAL . . . . . 0.481 ' HB ' ' HB ' ' A' ' 754' ' ' THR . 76.6 t -91.52 -55.53 6.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.159 -175.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 797' ' ' SER . . . . . 0.608 ' HA ' HD13 ' A' ' 808' ' ' LEU . 88.9 p -179.43 179.12 0.64 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.503 -172.375 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 798' ' ' ILE . . . . . 0.62 ' HA ' ' O ' ' A' ' 752' ' ' THR . 10.3 tt -148.53 161.94 5.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 178.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 799' ' ' LYS . . . . . 0.766 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 7.6 tmtt? -133.31 122.02 23.25 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.037 0.446 . . . . 0.0 110.787 -178.751 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 800' ' ' ASP . . . . . 0.583 ' HA ' ' CD2' ' A' ' 751' ' ' PHE . 9.0 t70 -66.45 154.87 39.09 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.971 174.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 38.2 t -59.15 -14.18 9.56 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 124.236 0.96 . . . . 0.0 112.719 -172.225 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 61.8 p -96.25 5.57 50.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.554 0.692 . . . . 0.0 110.189 178.354 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 803' ' ' GLY . . . . . . . . . . . . . . . 82.23 40.19 10.48 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.07 -0.968 . . . . 0.0 112.148 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 804' ' ' CYS . . . . . 0.464 ' HB2' ' HB3' ' A' ' 800' ' ' ASP . 63.4 m -110.94 114.62 28.08 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 179.602 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 805' ' ' VAL . . . . . . . . . . . . . 11.4 p -85.75 137.54 20.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.487 0.66 . . . . 0.0 111.464 -173.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 806' ' ' VAL . . . . . 0.582 ' HB ' HG22 ' A' ' 798' ' ' ILE . 97.0 t -118.03 137.65 51.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.176 176.663 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -87.6 110.63 3.61 Favored Glycine 0 C--N 1.321 -0.277 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.481 -178.618 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 808' ' ' LEU . . . . . 0.608 HD13 ' HA ' ' A' ' 797' ' ' SER . 11.1 mp -79.78 129.69 34.7 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 178.848 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 8.8 t -138.6 87.01 2.19 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 168.234 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 810' ' ' GLN . . . . . 0.881 ' OE1' ' HB2' ' A' ' 722' ' ' SER . 25.2 mt-30 -139.48 174.57 3.97 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.295 -170.565 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 811' ' ' PRO . . . . . 0.499 ' HD2' ' HB3' ' A' ' 810' ' ' GLN . 75.5 Cg_exo -44.69 146.68 2.12 Favored 'Trans proline' 0 C--N 1.36 1.14 0 C-N-CA 123.395 2.73 . . . . 0.0 114.376 -178.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -119.99 166.93 12.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.147 -177.644 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 813' ' ' ALA . . . . . 0.848 ' HB3' ' HB3' ' A' ' 793' ' ' LEU . . . -105.19 146.18 29.6 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.212 178.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 814' ' ' LYS . . . . . 0.479 ' HG2' HG12 ' A' ' 792' ' ' ILE . 6.7 mtmp? -122.85 112.72 18.21 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.839 0.828 . . . . 0.0 110.605 172.542 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 815' ' ' ILE . . . . . 0.544 ' HA ' ' HB3' ' A' ' 731' ' ' LEU . 4.5 mp -109.89 109.07 27.06 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 114.088 -1.415 . . . . 0.0 109.25 -176.598 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 816' ' ' GLN . . . . . 0.417 ' NE2' ' HE3' ' A' ' 732' ' ' LYS . 0.1 OUTLIER -98.98 108.58 21.29 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.262 0.553 . . . . 0.0 110.263 -176.468 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 817' ' ' VAL . . . . . 0.689 HG12 ' HA2' ' A' ' 788' ' ' GLY . 96.1 t -98.46 145.56 9.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.599 -179.171 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 818' ' ' ARG . . . . . . . . . . . . . 20.0 tpt180 . . . . . 0 C--N 1.313 -0.992 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -178.556 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 720' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt . . . . . 0 N--CA 1.446 -0.649 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 721' ' ' PRO . . . . . 0.488 ' HB3' ' HA3' ' A' ' 747' ' ' GLY . 36.3 Cg_endo -86.75 148.89 8.48 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 122.564 2.176 . . . . 0.0 110.801 177.793 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 722' ' ' SER . . . . . 0.578 ' HA ' HD22 ' A' ' 808' ' ' LEU . 8.4 t -178.78 -154.6 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -171.796 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 723' ' ' ALA . . . . . 0.696 ' O ' HD11 ' A' ' 795' ' ' LEU . . . -150.99 140.17 21.21 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.902 0.382 . . . . 0.0 110.799 176.288 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 43.4 t -128.52 99.43 5.38 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -174.224 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 725' ' ' LEU . . . . . 0.55 ' HG ' ' O ' ' A' ' 811' ' ' PRO . 1.1 mt -65.02 146.25 55.26 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.604 -172.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 726' ' ' LYS . . . . . 0.41 ' HD2' ' HB2' ' A' ' 744' ' ' ALA . 34.3 mtpt -103.88 -10.58 18.08 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.464 -174.649 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 727' ' ' LEU . . . . . 0.475 ' HB2' HG23 ' A' ' 741' ' ' VAL . 0.8 OUTLIER -74.46 109.67 8.14 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 175.751 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 41.6 m80 -105.43 38.06 2.06 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -169.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -169.51 -176.99 2.62 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.719 0.295 . . . . 0.0 111.104 179.475 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 730' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -66.21 137.1 56.74 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.953 173.447 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 731' ' ' LEU . . . . . 0.598 ' HB3' ' HA ' ' A' ' 815' ' ' ILE . 40.4 tp -103.23 100.17 10.06 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.973 178.809 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 732' ' ' LYS . . . . . 0.48 ' HD3' ' HB3' ' A' ' 816' ' ' GLN . 32.6 mmtp -78.63 124.26 27.99 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.454 0.645 . . . . 0.0 112.09 -175.395 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 733' ' ' LEU . . . . . 0.638 ' HG ' ' HB3' ' A' ' 737' ' ' ASP . 7.9 mp -120.4 165.13 15.32 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.671 -1.15 . . . . 0.0 109.705 177.832 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 734' ' ' CYS . . . . . 0.5 ' O ' ' HB2' ' A' ' 737' ' ' ASP . 31.2 p -120.16 -179.27 3.89 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.702 171.008 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 735' ' ' LEU . . . . . . . . . . . . . 2.8 tt -57.88 116.5 3.52 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.938 0.399 . . . . 0.0 110.34 -179.161 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 736' ' ' GLY . . . . . 0.515 ' HA2' HG22 ' A' ' 786' ' ' THR . . . 91.64 3.39 68.82 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.458 176.137 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 737' ' ' ASP . . . . . 0.638 ' HB3' ' HG ' ' A' ' 733' ' ' LEU . 0.3 OUTLIER -72.47 158.21 36.15 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.973 0.416 . . . . 0.0 111.146 177.957 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 37.0 p-80 -116.66 153.68 31.89 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 171.291 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 739' ' ' SER . . . . . 0.728 ' HB2' ' OG1' ' A' ' 782' ' ' THR . 10.8 m -98.15 159.0 15.22 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 119.126 -1.03 . . . . 0.0 111.235 -174.301 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 740' ' ' SER . . . . . 0.539 ' H ' HD21 ' A' ' 731' ' ' LEU . 10.5 t -143.37 101.09 3.73 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.915 -1.038 . . . . 0.0 108.657 -174.593 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 741' ' ' VAL . . . . . 0.475 HG23 ' HB2' ' A' ' 727' ' ' LEU . 2.1 p -121.26 112.51 32.98 Favored Pre-proline 0 C--N 1.316 -0.864 0 CA-C-O 121.283 0.563 . . . . 0.0 110.266 -177.251 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 742' ' ' PRO . . . . . 0.662 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 4.5 Cg_exo -71.33 125.93 11.8 Favored 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 122.294 1.996 . . . . 0.0 109.863 178.141 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 743' ' ' VAL . . . . . 0.514 ' CG2' HD22 ' A' ' 725' ' ' LEU . 24.0 t -129.31 114.77 32.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -178.593 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 744' ' ' ALA . . . . . 0.49 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -81.59 101.6 10.1 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 171.634 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 745' ' ' LEU . . . . . 0.962 HD11 ' HB3' ' A' ' 778' ' ' TYR . 0.2 OUTLIER -83.94 168.2 16.25 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.258 -167.814 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 44.1 tptt -122.24 156.18 34.33 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.405 -177.474 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 747' ' ' GLY . . . . . 0.488 ' HA3' ' HB3' ' A' ' 721' ' ' PRO . . . 93.66 123.62 3.65 Favored Glycine 0 C--N 1.311 -0.827 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.378 -177.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 25.7 mp0 -106.69 114.45 28.56 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.119 0.485 . . . . 0.0 111.283 -173.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 130.69 -175.98 19.13 Favored Glycine 0 N--CA 1.446 -0.7 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 -177.206 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -70.57 95.07 0.61 Allowed 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.658 2.238 . . . . 0.0 112.392 178.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 751' ' ' PHE . . . . . 0.502 ' CE2' ' HA ' ' A' ' 800' ' ' ASP . 77.5 m-85 -113.34 140.88 47.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.522 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 752' ' ' THR . . . . . 0.752 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 86.6 m -91.05 104.61 17.17 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.344 0.592 . . . . 0.0 109.763 177.843 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 753' ' ' LEU . . . . . 0.564 ' CD1' HD22 ' A' ' 745' ' ' LEU . 1.8 tt -95.95 116.34 28.78 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.608 -171.459 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 754' ' ' THR . . . . . 0.458 HG23 ' HB2' ' A' ' 769' ' ' GLU . 1.0 OUTLIER -114.44 137.7 51.5 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.989 -179.1 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 755' ' ' TYR . . . . . 0.505 ' CD1' HD11 ' A' ' 793' ' ' LEU . 24.5 p90 -145.37 162.93 36.09 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 120.961 0.41 . . . . 0.0 111.541 178.645 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 756' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -128.73 121.13 27.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.677 -178.222 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 757' ' ' ILE . . . . . 0.521 HG13 HD13 ' A' ' 793' ' ' LEU . 3.5 mp -87.01 96.47 5.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 169.661 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 758' ' ' ILE . . . . . 0.715 HG22 ' HD3' ' A' ' 765' ' ' ARG . 2.3 pp -95.21 149.65 4.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 116.116 -0.493 . . . . 0.0 112.218 -169.343 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 759' ' ' GLU . . . . . 0.647 ' HG2' ' CE2' ' A' ' 791' ' ' TYR . 24.6 mt-10 -89.75 119.94 30.58 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.394 179.366 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 760' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.313 -0.995 0 CA-C-O 121.346 0.593 . . . . 0.0 109.564 175.44 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 765' ' ' ARG . . . . . 0.715 ' HD3' HG22 ' A' ' 758' ' ' ILE . 7.9 ttp180 . . . . . 0 CA--C 1.535 0.385 0 CA-C-O 120.87 0.367 . . . . 0.0 111.523 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 766' ' ' LYS . . . . . . . . . . . . . 9.7 tmtm? -115.98 135.45 53.95 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-O 121.088 0.47 . . . . 0.0 110.409 -177.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 767' ' ' THR . . . . . . . . . . . . . 27.7 m -109.04 137.03 47.59 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.833 -174.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 768' ' ' PHE . . . . . 0.495 ' HB3' ' CE1' ' A' ' 755' ' ' TYR . 3.2 t80 -139.72 139.74 36.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.96 0.41 . . . . 0.0 110.643 175.426 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 769' ' ' GLU . . . . . 0.458 ' HB2' HG23 ' A' ' 754' ' ' THR . 35.5 tt0 -129.76 129.98 44.81 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.848 -179.37 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 770' ' ' ILE . . . . . 0.531 HG22 HG22 ' A' ' 773' ' ' ILE . 5.0 mt -122.82 111.87 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 176.325 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 771' ' ' LYS . . . . . 0.637 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 9.5 mtpt -85.1 152.04 23.69 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-O 121.492 0.663 . . . . 0.0 111.328 -174.01 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 772' ' ' GLU . . . . . 0.415 ' O ' ' HG3' ' A' ' 774' ' ' LYS . 5.4 mt-10 54.7 47.11 23.24 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.211 -1.359 . . . . 0.0 112.532 177.202 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 773' ' ' ILE . . . . . 0.931 HD13 HD13 ' A' ' 745' ' ' LEU . 0.5 OUTLIER -73.8 119.89 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 173.835 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 774' ' ' LYS . . . . . 0.415 ' HG3' ' O ' ' A' ' 772' ' ' GLU . 73.0 mttt -118.21 30.66 7.11 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -177.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 775' ' ' THR . . . . . 0.686 ' H ' HD12 ' A' ' 773' ' ' ILE . 0.6 OUTLIER -95.88 -72.24 0.64 Allowed 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 114.957 -1.019 . . . . 0.0 113.381 -171.394 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 776' ' ' ASN . . . . . 0.595 ' HB2' ' O ' ' A' ' 775' ' ' THR . 0.9 OUTLIER 83.82 4.67 0.78 Allowed 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.045 0.938 . . . . 0.0 110.389 -175.601 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 777' ' ' GLU . . . . . 0.49 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 6.9 tp10 -161.69 78.3 0.54 Allowed 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 -179.47 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 778' ' ' TYR . . . . . 0.962 ' HB3' HD11 ' A' ' 745' ' ' LEU . 82.4 t80 -132.86 125.65 30.44 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.115 0.483 . . . . 0.0 111.69 -169.632 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 779' ' ' VAL . . . . . 0.662 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 21.6 t -84.16 115.97 27.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.051 176.843 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 780' ' ' ILE . . . . . 0.479 HD12 HG21 ' A' ' 743' ' ' VAL . 77.2 mt -89.84 135.92 25.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.724 -176.201 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 781' ' ' LYS . . . . . 0.415 ' HD3' ' C ' ' A' ' 780' ' ' ILE . 0.0 OUTLIER -118.89 109.12 15.63 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 177.682 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 782' ' ' THR . . . . . 0.728 ' OG1' ' HB2' ' A' ' 739' ' ' SER . 82.6 p -82.6 148.62 58.75 Favored Pre-proline 0 C--O 1.244 0.811 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.862 -176.378 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 783' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -49.27 157.0 2.17 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 124.09 3.193 . . . . 0.0 113.447 -178.457 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 784' ' ' VAL . . . . . 0.533 HG12 HG23 ' A' ' 786' ' ' THR . 70.1 t -61.19 131.24 26.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.086 -0.961 . . . . 0.0 112.803 -174.176 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 785' ' ' PHE . . . . . 0.415 ' C ' ' H ' ' A' ' 787' ' ' THR . 80.0 m-85 -103.68 88.96 3.19 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.01 177.164 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 786' ' ' THR . . . . . 0.533 HG23 HG12 ' A' ' 784' ' ' VAL . 32.5 p -83.47 29.42 0.51 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 122.077 0.941 . . . . 0.0 110.284 178.791 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 787' ' ' THR . . . . . 0.415 ' H ' ' C ' ' A' ' 785' ' ' PHE . 2.1 m -159.65 105.46 1.63 Allowed 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.941 -175.734 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 788' ' ' GLY . . . . . 0.825 ' HA2' HG22 ' A' ' 817' ' ' VAL . . . -49.46 137.76 19.55 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.75 -0.659 . . . . 0.0 113.648 172.765 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 789' ' ' GLY . . . . . 0.514 ' H ' HG13 ' A' ' 817' ' ' VAL . . . -176.84 -178.01 46.24 Favored Glycine 0 N--CA 1.44 -1.062 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -178.66 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -118.5 119.66 35.19 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 117.851 0.826 . . . . 0.0 109.029 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 791' ' ' TYR . . . . . 0.647 ' CE2' ' HG2' ' A' ' 759' ' ' GLU . 92.6 m-85 -122.24 148.88 44.44 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.582 -175.378 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 792' ' ' ILE . . . . . 0.586 ' O ' HG13 ' A' ' 758' ' ' ILE . 19.9 mt -124.64 114.33 40.21 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.065 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 172.706 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 793' ' ' LEU . . . . . 0.524 HD12 ' N ' ' A' ' 794' ' ' SER . 0.5 OUTLIER -84.39 115.73 22.67 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.893 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 794' ' ' SER . . . . . 0.524 ' N ' HD12 ' A' ' 793' ' ' LEU . 23.1 m -130.51 161.42 31.5 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 114.701 -1.136 . . . . 0.0 109.084 -174.677 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 795' ' ' LEU . . . . . 0.696 HD11 ' O ' ' A' ' 723' ' ' ALA . 27.6 mt -87.3 148.07 25.24 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 120.813 0.34 . . . . 0.0 110.897 -177.022 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 796' ' ' VAL . . . . . . . . . . . . . 69.7 t -105.17 -56.03 5.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.004 178.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 797' ' ' SER . . . . . 0.593 ' HA ' ' HG ' ' A' ' 808' ' ' LEU . 95.9 p -176.47 154.14 1.25 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.202 -172.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 798' ' ' ILE . . . . . 0.615 ' HA ' ' O ' ' A' ' 752' ' ' THR . 12.4 tt -127.51 164.04 29.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 177.149 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 799' ' ' LYS . . . . . 0.752 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 28.0 tttt -131.19 120.17 22.91 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 120.668 0.271 . . . . 0.0 111.058 -176.026 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 800' ' ' ASP . . . . . 0.502 ' HA ' ' CE2' ' A' ' 751' ' ' PHE . 19.8 t70 -69.18 154.63 41.74 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.312 173.705 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 9.0 m -59.32 -13.77 9.26 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 124.042 0.839 . . . . 0.0 112.994 -170.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 52.1 p -93.47 -0.87 56.24 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.466 0.651 . . . . 0.0 110.136 179.076 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 803' ' ' GLY . . . . . 0.519 ' HA2' ' HE2' ' A' ' 799' ' ' LYS . . . 85.74 46.87 5.29 Favored Glycine 0 N--CA 1.444 -0.807 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.702 -176.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 804' ' ' CYS . . . . . 0.435 ' HB2' ' HB3' ' A' ' 800' ' ' ASP . 61.3 m -116.71 110.76 18.88 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 177.553 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 805' ' ' VAL . . . . . 0.56 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 9.8 p -85.47 133.61 29.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.301 0.572 . . . . 0.0 111.006 -175.22 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 806' ' ' VAL . . . . . 0.511 ' HB ' HG22 ' A' ' 798' ' ' ILE . 84.5 t -112.02 133.76 56.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.009 178.519 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -70.49 113.19 4.71 Favored Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 177.034 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 808' ' ' LEU . . . . . 0.593 ' HG ' ' HA ' ' A' ' 797' ' ' SER . 40.0 mt -81.65 130.04 34.91 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.264 0.554 . . . . 0.0 112.462 -172.655 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 39.8 m -148.53 86.27 1.53 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.082 173.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 810' ' ' GLN . . . . . 0.616 ' HB3' ' HD2' ' A' ' 811' ' ' PRO . 75.1 mt-30 -135.54 173.27 5.89 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 174.229 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 811' ' ' PRO . . . . . 0.616 ' HD2' ' HB3' ' A' ' 810' ' ' GLN . 86.6 Cg_exo -45.28 139.44 9.01 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 122.654 2.236 . . . . 0.0 114.68 -177.302 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -111.42 166.15 11.37 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.301 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 813' ' ' ALA . . . . . . . . . . . . . . . -116.42 154.14 30.83 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.357 -178.09 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 814' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -120.22 108.7 14.52 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.18 0.514 . . . . 0.0 110.498 177.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 815' ' ' ILE . . . . . 0.598 ' HA ' ' HB3' ' A' ' 731' ' ' LEU . 4.8 mp -97.5 123.71 50.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.481 -179.085 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 816' ' ' GLN . . . . . 0.48 ' HB3' ' HD3' ' A' ' 732' ' ' LYS . 0.1 OUTLIER -118.39 106.31 12.6 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -179.873 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 817' ' ' VAL . . . . . 0.825 HG22 ' HA2' ' A' ' 788' ' ' GLY . 0.5 OUTLIER -100.61 143.61 13.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -179.879 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 818' ' ' ARG . . . . . . . . . . . . . 20.9 tpt180 . . . . . 0 C--N 1.311 -1.105 0 CA-C-O 121.086 0.47 . . . . 0.0 110.683 -176.036 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 720' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt . . . . . 0 N--CA 1.448 -0.537 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 721' ' ' PRO . . . . . 0.463 ' HB2' HD13 ' A' ' 798' ' ' ILE . 56.4 Cg_endo -88.04 144.91 6.25 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 123.381 2.721 . . . . 0.0 112.426 -174.742 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 722' ' ' SER . . . . . 0.609 ' HA ' HD22 ' A' ' 808' ' ' LEU . 61.8 m -169.27 -156.52 0.15 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -172.751 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 723' ' ' ALA . . . . . 0.676 ' HB1' HG21 ' A' ' 743' ' ' VAL . . . -152.2 143.51 23.31 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 122.273 -0.267 . . . . 0.0 110.845 179.454 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 724' ' ' SER . . . . . 0.429 ' HB2' ' OE1' ' A' ' 810' ' ' GLN . 26.0 t -132.58 99.5 4.66 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 725' ' ' LEU . . . . . 0.576 HD21 HD22 ' A' ' 793' ' ' LEU . 4.9 mp -62.42 143.4 57.1 Favored 'General case' 0 N--CA 1.426 -1.632 0 CA-C-O 122.428 1.109 . . . . 0.0 112.407 -176.398 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 30.8 mtpt -94.49 -16.47 23.31 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 113.26 -1.791 . . . . 0.0 110.417 -176.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 727' ' ' LEU . . . . . 0.501 ' HB2' ' HD2' ' A' ' 742' ' ' PRO . 1.5 tt -76.04 109.29 9.57 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 177.626 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 35.9 m80 -110.47 48.84 0.88 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -171.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -177.86 177.78 1.04 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.13 176.262 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 730' ' ' ASP . . . . . 0.428 ' HA ' ' O ' ' A' ' 814' ' ' LYS . 1.4 m-20 -67.01 134.94 52.94 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.967 0.413 . . . . 0.0 110.131 175.244 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 731' ' ' LEU . . . . . 0.58 ' HB3' ' HA ' ' A' ' 815' ' ' ILE . 28.2 tp -93.08 105.95 17.98 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.516 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 732' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -76.98 104.62 7.57 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.656 -174.579 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 733' ' ' LEU . . . . . 0.455 HD11 ' CB ' ' A' ' 739' ' ' SER . 85.2 mt -116.77 155.57 28.7 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.498 177.296 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 734' ' ' CYS . . . . . 0.473 ' O ' ' HB2' ' A' ' 737' ' ' ASP . 36.5 m -105.34 -173.38 2.29 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.84 179.101 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 735' ' ' LEU . . . . . . . . . . . . . 24.5 tp -67.05 135.8 54.25 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 178.421 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 736' ' ' GLY . . . . . 0.485 ' HA2' ' HA ' ' A' ' 786' ' ' THR . . . 80.02 7.84 88.17 Favored Glycine 0 C--N 1.321 -0.298 0 C-N-CA 120.339 -0.934 . . . . 0.0 112.673 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 737' ' ' ASP . . . . . 0.473 ' HB2' ' O ' ' A' ' 734' ' ' CYS . 0.7 OUTLIER -87.47 148.77 24.8 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.51 0.671 . . . . 0.0 112.628 179.078 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 738' ' ' HIS . . . . . 0.444 ' HB2' ' O ' ' A' ' 782' ' ' THR . 40.3 p-80 -110.93 164.98 12.24 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 166.19 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 739' ' ' SER . . . . . 0.578 ' HB2' HD23 ' A' ' 731' ' ' LEU . 4.5 p -109.99 162.7 14.27 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 119.277 -0.969 . . . . 0.0 112.0 -171.146 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 23.4 t -138.88 100.91 4.17 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 114.961 -1.018 . . . . 0.0 108.783 177.161 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 741' ' ' VAL . . . . . 0.529 HG11 HD13 ' A' ' 793' ' ' LEU . 1.5 p -117.1 111.45 40.54 Favored Pre-proline 0 C--N 1.318 -0.785 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.115 -179.015 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 742' ' ' PRO . . . . . 0.661 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 4.6 Cg_endo -76.63 134.07 14.82 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 122.578 2.185 . . . . 0.0 111.58 -179.184 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 743' ' ' VAL . . . . . 0.676 HG21 ' HB1' ' A' ' 723' ' ' ALA . 1.6 p -131.32 120.91 47.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.51 0.671 . . . . 0.0 112.249 176.403 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 744' ' ' ALA . . . . . 0.475 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -83.22 103.25 12.48 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 169.072 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 745' ' ' LEU . . . . . 0.934 HD13 HD13 ' A' ' 773' ' ' ILE . 0.3 OUTLIER -85.36 166.26 16.58 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.622 -1.172 . . . . 0.0 111.538 -167.092 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -120.14 148.95 43.0 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.914 -176.523 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 747' ' ' GLY . . . . . 0.431 ' HA3' ' HB3' ' A' ' 721' ' ' PRO . . . 100.28 127.2 5.96 Favored Glycine 0 C--N 1.316 -0.546 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 -173.783 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -102.08 124.59 47.94 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.327 0.584 . . . . 0.0 112.279 -170.459 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 108.06 -174.11 18.79 Favored Glycine 0 CA--C 1.501 -0.815 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.542 178.723 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 750' ' ' PRO . . . . . 0.547 ' HB3' ' HE2' ' A' ' 774' ' ' LYS . 72.8 Cg_endo -65.93 100.62 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.384 0 C-N-CA 123.317 2.678 . . . . 0.0 113.619 -177.862 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 751' ' ' PHE . . . . . 0.69 ' CE2' ' HA ' ' A' ' 800' ' ' ASP . 62.1 m-85 -113.99 144.18 43.51 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.701 177.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 752' ' ' THR . . . . . 0.731 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 96.1 m -89.21 103.17 15.81 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 177.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 753' ' ' LEU . . . . . 0.436 HD22 HD22 ' A' ' 745' ' ' LEU . 24.9 tp -91.28 122.65 34.09 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.407 -1.27 . . . . 0.0 110.093 -171.594 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 754' ' ' THR . . . . . 0.441 HG23 ' HB2' ' A' ' 769' ' ' GLU . 0.6 OUTLIER -122.57 131.37 53.8 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.555 0.217 . . . . 0.0 110.748 179.795 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 755' ' ' TYR . . . . . 0.663 ' CE1' ' HB3' ' A' ' 768' ' ' PHE . 24.2 p90 -140.23 154.09 46.77 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.076 0.465 . . . . 0.0 111.453 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 756' ' ' ASP . . . . . 0.485 ' O ' ' HA ' ' A' ' 793' ' ' LEU . 2.3 p30 -107.97 134.45 50.86 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.789 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 757' ' ' ILE . . . . . 0.561 HG21 ' HZ ' ' A' ' 785' ' ' PHE . 4.5 mp -103.73 94.97 3.47 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 167.599 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 758' ' ' ILE . . . . . 0.599 HG22 ' HD3' ' A' ' 765' ' ' ARG . 2.5 pp -100.77 145.99 10.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.769 -169.521 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -83.82 128.18 34.35 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.152 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 760' ' ' THR . . . . . 0.463 HG23 ' OD2' ' A' ' 790' ' ' ASP . 0.1 OUTLIER . . . . . 0 C--N 1.315 -0.921 0 CA-C-O 121.229 0.538 . . . . 0.0 110.055 175.586 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 765' ' ' ARG . . . . . 0.599 ' HD3' HG22 ' A' ' 758' ' ' ILE . 10.9 ttp180 . . . . . 0 N--CA 1.452 -0.373 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 766' ' ' LYS . . . . . 0.471 ' HD3' ' N ' ' A' ' 767' ' ' THR . 9.6 tmtm? -119.73 146.55 45.53 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 114.935 -1.03 . . . . 0.0 108.688 177.26 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 767' ' ' THR . . . . . 0.471 ' N ' ' HD3' ' A' ' 766' ' ' LYS . 89.1 m -123.31 131.36 53.64 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 120.62 0.248 . . . . 0.0 110.508 177.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 768' ' ' PHE . . . . . 0.663 ' HB3' ' CE1' ' A' ' 755' ' ' TYR . 1.8 t80 -127.78 135.06 49.58 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 178.689 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 769' ' ' GLU . . . . . 0.441 ' HB2' HG23 ' A' ' 754' ' ' THR . 34.5 tt0 -128.7 128.65 44.5 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.666 -177.244 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 770' ' ' ILE . . . . . 0.522 HG22 HG22 ' A' ' 773' ' ' ILE . 4.7 mt -123.12 113.33 37.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 109.182 -0.674 . . . . 0.0 109.182 177.117 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 771' ' ' LYS . . . . . 0.584 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 0.1 OUTLIER -84.3 155.76 22.25 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 121.181 0.515 . . . . 0.0 111.506 -175.914 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 772' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 53.72 44.57 29.46 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.316 -1.311 . . . . 0.0 112.318 176.665 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 773' ' ' ILE . . . . . 0.934 HD13 HD13 ' A' ' 745' ' ' LEU . 0.5 OUTLIER -73.44 112.1 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 172.644 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 774' ' ' LYS . . . . . 0.547 ' HE2' ' HB3' ' A' ' 750' ' ' PRO . 71.3 mttt -107.8 26.37 10.41 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -178.54 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 775' ' ' THR . . . . . 0.645 ' H ' HD12 ' A' ' 773' ' ' ILE . 0.4 OUTLIER -95.91 -74.8 0.54 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.067 -0.969 . . . . 0.0 113.488 -165.71 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 776' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' A' ' 775' ' ' THR . 10.6 m120 83.53 7.86 0.65 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.344 1.057 . . . . 0.0 111.13 -175.486 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 777' ' ' GLU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 21.8 mt-10 -159.64 83.48 0.75 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.023 -0.99 . . . . 0.0 108.331 174.297 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 778' ' ' TYR . . . . . 0.773 ' HB3' HD11 ' A' ' 745' ' ' LEU . 83.2 t80 -129.61 129.39 44.3 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.911 -169.222 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 779' ' ' VAL . . . . . 0.661 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 14.1 t -89.42 111.26 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 CA-C-O 121.157 0.503 . . . . 0.0 110.213 178.609 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 780' ' ' ILE . . . . . 0.444 ' HB ' HG13 ' A' ' 741' ' ' VAL . 72.9 mt -79.15 145.12 9.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.273 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 781' ' ' LYS . . . . . 0.432 ' HA ' ' O ' ' A' ' 739' ' ' SER . 3.7 mppt? -130.3 108.8 10.28 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 174.226 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 782' ' ' THR . . . . . 0.444 ' O ' ' HB2' ' A' ' 738' ' ' HIS . 30.9 p -77.19 141.37 66.78 Favored Pre-proline 0 N--CA 1.444 -0.748 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 -178.28 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 783' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -55.9 150.02 48.47 Favored 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 122.918 2.412 . . . . 0.0 111.274 -177.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 784' ' ' VAL . . . . . . . . . . . . . 14.9 p -61.81 133.03 27.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.433 0.635 . . . . 0.0 110.812 -172.57 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 785' ' ' PHE . . . . . 0.561 ' HZ ' HG21 ' A' ' 757' ' ' ILE . 88.9 m-85 -90.24 -37.47 14.09 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.834 -173.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 786' ' ' THR . . . . . 0.485 ' HA ' ' HA2' ' A' ' 736' ' ' GLY . 28.3 p 57.97 3.39 0.22 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.507 0.723 . . . . 0.0 111.744 -178.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 787' ' ' THR . . . . . 0.436 ' H ' ' C ' ' A' ' 785' ' ' PHE . 42.8 m -134.37 118.53 17.56 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.868 -179.165 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 788' ' ' GLY . . . . . 0.645 ' HA2' HG12 ' A' ' 817' ' ' VAL . . . -54.4 108.66 0.94 Allowed Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.523 -0.762 . . . . 0.0 113.224 174.349 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 789' ' ' GLY . . . . . 0.501 ' H ' ' HB ' ' A' ' 817' ' ' VAL . . . -155.56 167.16 33.0 Favored Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 174.594 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 790' ' ' ASP . . . . . 0.463 ' OD2' HG23 ' A' ' 760' ' ' THR . 0.2 OUTLIER -109.3 129.39 55.52 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 117.567 0.684 . . . . 0.0 109.906 179.335 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 791' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -130.0 156.17 44.91 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.213 -174.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 792' ' ' ILE . . . . . 0.519 ' O ' HG13 ' A' ' 758' ' ' ILE . 14.5 mt -128.45 119.07 49.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 109.354 -0.609 . . . . 0.0 109.354 174.241 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 793' ' ' LEU . . . . . 0.576 HD22 HD21 ' A' ' 725' ' ' LEU . 10.1 tt -84.51 107.36 16.71 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.267 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 794' ' ' SER . . . . . . . . . . . . . 3.7 m -116.23 170.87 8.2 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.14 -179.099 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 795' ' ' LEU . . . . . . . . . . . . . 22.8 mt -97.68 129.6 44.73 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.603 0.239 . . . . 0.0 110.977 -175.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 796' ' ' VAL . . . . . . . . . . . . . 75.0 t -88.94 -56.1 5.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.812 -179.264 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 797' ' ' SER . . . . . 0.511 ' HA ' ' HG ' ' A' ' 808' ' ' LEU . 24.4 m -173.39 164.15 4.59 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.128 -173.417 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 798' ' ' ILE . . . . . 0.587 ' O ' ' HA ' ' A' ' 805' ' ' VAL . 11.5 tt -136.15 167.55 24.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 176.588 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 799' ' ' LYS . . . . . 0.731 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 83.6 tttt -136.04 120.56 18.18 Favored 'General case' 0 C--N 1.315 -0.932 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.248 -176.096 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 800' ' ' ASP . . . . . 0.69 ' HA ' ' CE2' ' A' ' 751' ' ' PHE . 6.2 m-20 -63.12 156.46 24.98 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.279 174.235 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 4.0 m -64.81 -5.22 5.47 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 124.151 0.907 . . . . 0.0 112.212 -174.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 8.9 t -104.98 12.63 32.11 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.757 0.789 . . . . 0.0 109.617 175.472 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 803' ' ' GLY . . . . . 0.49 ' HA2' ' CE ' ' A' ' 799' ' ' LYS . . . 74.71 46.85 16.7 Favored Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.121 -0.945 . . . . 0.0 112.831 -179.462 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 804' ' ' CYS . . . . . 0.597 ' HB3' ' HB2' ' A' ' 800' ' ' ASP . 53.7 t -109.87 106.23 15.73 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 177.181 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 805' ' ' VAL . . . . . 0.587 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 2.6 t -86.69 104.95 14.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.591 0.71 . . . . 0.0 110.704 -175.444 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 806' ' ' VAL . . . . . . . . . . . . . 39.5 t -90.13 138.54 19.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.065 -178.591 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -74.96 113.21 3.91 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.662 178.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 808' ' ' LEU . . . . . 0.609 HD22 ' HA ' ' A' ' 722' ' ' SER . 30.8 mt -80.17 132.02 35.82 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 -174.184 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 20.4 m -143.97 85.65 1.82 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.52 171.203 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 810' ' ' GLN . . . . . 0.494 ' HB3' ' O ' ' A' ' 723' ' ' ALA . 1.0 OUTLIER -146.69 173.91 3.83 Favored Pre-proline 0 CA--C 1.542 0.645 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.363 177.501 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 811' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -44.0 154.47 0.26 Allowed 'Trans proline' 0 C--N 1.359 1.08 0 C-N-CA 123.782 2.988 . . . . 0.0 116.294 -173.491 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -131.35 167.83 18.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 113.797 -1.547 . . . . 0.0 109.613 -178.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 813' ' ' ALA . . . . . . . . . . . . . . . -127.69 148.65 50.4 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.748 0.308 . . . . 0.0 110.505 178.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 814' ' ' LYS . . . . . 0.428 ' O ' ' HA ' ' A' ' 730' ' ' ASP . 50.3 tttm -110.17 112.79 24.99 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.14 0.495 . . . . 0.0 110.704 -176.254 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 815' ' ' ILE . . . . . 0.58 ' HA ' ' HB3' ' A' ' 731' ' ' LEU . 5.3 mp -98.21 127.66 50.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.855 -178.307 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 816' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -114.42 110.6 20.13 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.742 0.306 . . . . 0.0 110.842 -178.83 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 817' ' ' VAL . . . . . 0.645 HG12 ' HA2' ' A' ' 788' ' ' GLY . 61.3 t -105.66 127.66 60.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 175.391 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 818' ' ' ARG . . . . . . . . . . . . . 25.4 mmt180 . . . . . 0 C--N 1.327 -0.394 0 O-C-N 121.849 -0.532 . . . . 0.0 111.319 177.33 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 720' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp . . . . . 0 N--CA 1.451 -0.398 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 721' ' ' PRO . . . . . 0.523 ' O ' HG21 ' A' ' 798' ' ' ILE . 46.3 Cg_endo -88.25 140.76 4.76 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 123.08 2.52 . . . . 0.0 112.115 -173.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 25.2 m -174.83 -151.44 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -170.096 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 723' ' ' ALA . . . . . 0.562 ' HA ' ' HA ' ' A' ' 745' ' ' LEU . . . -146.65 149.0 32.63 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 174.054 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 28.5 t -131.66 98.38 4.47 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.323 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 725' ' ' LEU . . . . . 0.563 HD21 HD21 ' A' ' 795' ' ' LEU . 2.0 mt -66.79 143.69 56.75 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-O 121.441 0.638 . . . . 0.0 110.984 -171.053 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 35.6 mtpt -94.45 -19.61 20.42 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.869 -1.06 . . . . 0.0 111.079 -174.574 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 727' ' ' LEU . . . . . 0.686 HD23 ' HB1' ' A' ' 813' ' ' ALA . 25.9 tp -56.67 129.54 41.5 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.04 178.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 8.3 t-160 -117.82 16.28 14.37 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.943 -173.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -169.84 -178.8 3.05 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 122.311 -0.243 . . . . 0.0 110.886 177.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 730' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.32 132.25 52.03 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.159 0.504 . . . . 0.0 110.726 175.048 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 731' ' ' LEU . . . . . 0.637 HD21 ' H ' ' A' ' 740' ' ' SER . 49.3 tp -91.56 102.1 14.75 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.07 177.757 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 732' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -77.51 122.57 25.42 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.647 -174.261 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 733' ' ' LEU . . . . . 0.633 ' HG ' ' HB3' ' A' ' 737' ' ' ASP . 7.8 mp -120.79 164.22 16.94 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.708 178.242 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 734' ' ' CYS . . . . . 0.564 ' O ' ' HB2' ' A' ' 737' ' ' ASP . 66.1 m -116.49 -178.27 3.38 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.089 173.001 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 735' ' ' LEU . . . . . . . . . . . . . 31.0 tp -63.42 122.92 17.44 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.894 0.378 . . . . 0.0 111.236 -176.11 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 82.43 7.64 87.3 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.438 -0.887 . . . . 0.0 112.384 178.272 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 737' ' ' ASP . . . . . 0.633 ' HB3' ' HG ' ' A' ' 733' ' ' LEU . 0.2 OUTLIER -72.2 154.04 41.26 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.909 0.385 . . . . 0.0 110.953 176.076 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 37.9 p-80 -112.85 148.49 34.79 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 171.373 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 739' ' ' SER . . . . . 0.481 ' HB3' HD23 ' A' ' 731' ' ' LEU . 4.6 m -94.93 158.09 15.63 Favored 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 119.966 -0.694 . . . . 0.0 110.927 -172.322 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 740' ' ' SER . . . . . 0.637 ' H ' HD21 ' A' ' 731' ' ' LEU . 12.5 p -144.19 100.85 3.62 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.213 -178.543 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 741' ' ' VAL . . . . . 0.479 HG11 HD13 ' A' ' 793' ' ' LEU . 0.4 OUTLIER -117.51 119.12 34.68 Favored Pre-proline 0 C--N 1.314 -0.968 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.459 179.973 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 742' ' ' PRO . . . . . 0.717 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 10.1 Cg_endo -80.86 134.12 9.42 Favored 'Trans proline' 0 N--CA 1.435 -1.93 0 C-N-CA 121.712 1.608 . . . . 0.0 110.649 -179.482 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 743' ' ' VAL . . . . . 0.519 ' CG2' HD22 ' A' ' 725' ' ' LEU . 49.0 t -132.77 119.64 38.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 121.336 0.588 . . . . 0.0 111.913 -178.507 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 744' ' ' ALA . . . . . 0.618 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -81.77 95.33 7.24 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 122.129 0.966 . . . . 0.0 108.653 170.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 745' ' ' LEU . . . . . 0.83 HD11 ' HB3' ' A' ' 778' ' ' TYR . 1.9 mt -77.84 159.86 28.69 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.045 -1.434 . . . . 0.0 111.384 -168.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 8.5 tptp -111.58 166.47 11.12 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.626 -178.237 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 747' ' ' GLY . . . . . . . . . . . . . . . 96.1 124.87 4.64 Favored Glycine 0 C--N 1.312 -0.756 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.714 -173.696 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 748' ' ' GLN . . . . . 0.442 ' C ' ' HE1' ' A' ' 751' ' ' PHE . 11.3 mm100 -103.57 95.51 6.11 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 122.676 -0.308 . . . . 0.0 111.026 -176.615 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 134.48 -164.73 24.59 Favored Glycine 0 C--O 1.223 -0.589 0 N-CA-C 111.269 -0.732 . . . . 0.0 111.269 -178.361 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -74.25 94.35 0.9 Allowed 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.719 2.279 . . . . 0.0 112.084 179.315 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 751' ' ' PHE . . . . . 0.73 ' CE2' ' HA ' ' A' ' 800' ' ' ASP . 81.2 m-85 -115.71 141.67 47.77 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.585 -179.381 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 752' ' ' THR . . . . . 0.737 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 73.5 m -97.63 105.73 17.92 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-O 121.709 0.766 . . . . 0.0 109.352 -179.319 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 753' ' ' LEU . . . . . 0.694 HD13 HD22 ' A' ' 745' ' ' LEU . 3.9 tt -105.11 114.1 28.09 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 114.47 -1.241 . . . . 0.0 110.015 -168.206 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 754' ' ' THR . . . . . 0.459 HG23 ' HB2' ' A' ' 769' ' ' GLU . 1.5 m -107.9 136.3 47.84 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.769 -176.186 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 755' ' ' TYR . . . . . 0.404 ' CE1' ' HB3' ' A' ' 768' ' ' PHE . 26.2 p90 -135.6 159.6 41.11 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.036 0.446 . . . . 0.0 111.694 179.146 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 756' ' ' ASP . . . . . 0.588 ' OD2' ' HB3' ' A' ' 794' ' ' SER . 3.1 p30 -118.53 128.33 54.47 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.447 -178.777 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 757' ' ' ILE . . . . . 0.526 HG13 HD12 ' A' ' 793' ' ' LEU . 4.2 mp -98.18 94.04 3.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 167.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 758' ' ' ILE . . . . . 0.541 HG13 ' O ' ' A' ' 792' ' ' ILE . 2.6 pp -99.38 142.45 15.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-O 121.552 0.692 . . . . 0.0 112.033 -169.524 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 759' ' ' GLU . . . . . 0.559 ' HG2' ' CD2' ' A' ' 791' ' ' TYR . 24.8 mt-10 -96.54 101.14 12.72 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.145 -171.289 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 760' ' ' THR . . . . . 0.461 HG23 ' HB2' ' A' ' 790' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.32 -0.683 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.382 -169.742 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 765' ' ' ARG . . . . . 0.494 ' HD3' HG22 ' A' ' 758' ' ' ILE . 16.4 ttp180 . . . . . 0 N--CA 1.443 -0.793 0 CA-C-O 120.974 0.416 . . . . 0.0 111.666 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 766' ' ' LYS . . . . . 0.676 ' HD3' ' N ' ' A' ' 767' ' ' THR . 10.4 tmtt? -123.48 147.59 47.04 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 178.168 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 767' ' ' THR . . . . . 0.676 ' N ' ' HD3' ' A' ' 766' ' ' LYS . 62.0 m -132.31 141.92 49.15 Favored 'General case' 0 C--N 1.314 -0.975 0 O-C-N 122.301 -0.25 . . . . 0.0 111.618 -176.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 768' ' ' PHE . . . . . 0.404 ' HB3' ' CE1' ' A' ' 755' ' ' TYR . 2.9 t80 -145.49 144.35 30.52 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.724 0.297 . . . . 0.0 110.536 176.216 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 769' ' ' GLU . . . . . 0.459 ' HB2' HG23 ' A' ' 754' ' ' THR . 41.2 tt0 -127.06 126.05 42.4 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.498 -175.254 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 5.2 mm -107.22 103.39 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 178.286 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 771' ' ' LYS . . . . . 0.486 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 12.3 mtpt -83.22 149.93 26.51 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.648 -179.053 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 772' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 50.96 50.46 19.06 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.488 -1.233 . . . . 0.0 112.205 -179.235 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 773' ' ' ILE . . . . . 0.77 HD12 ' H ' ' A' ' 775' ' ' THR . 0.5 OUTLIER -76.12 117.92 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 173.416 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 78.4 mttt -118.15 28.09 8.59 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -178.432 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 775' ' ' THR . . . . . 0.77 ' H ' HD12 ' A' ' 773' ' ' ILE . 0.9 OUTLIER -95.18 -72.19 0.64 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.572 -1.195 . . . . 0.0 112.429 -171.538 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 776' ' ' ASN . . . . . 0.451 ' HB2' ' O ' ' A' ' 775' ' ' THR . 78.6 m-20 87.7 4.39 0.31 Allowed 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.703 1.201 . . . . 0.0 110.031 -178.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 777' ' ' GLU . . . . . 0.618 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 21.7 tt0 -162.69 96.28 0.93 Allowed 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.143 172.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 778' ' ' TYR . . . . . 0.83 ' HB3' HD11 ' A' ' 745' ' ' LEU . 83.3 t80 -139.63 128.83 23.88 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.081 -170.39 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 779' ' ' VAL . . . . . 0.717 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 7.6 t -84.73 105.91 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.196 -179.705 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 780' ' ' ILE . . . . . . . . . . . . . 70.1 mt -77.06 132.59 32.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.697 -178.179 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -117.18 109.58 17.08 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.385 0.612 . . . . 0.0 110.262 179.232 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 782' ' ' THR . . . . . 0.468 ' CG2' ' HB2' ' A' ' 739' ' ' SER . 1.1 p -80.82 149.22 66.88 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.526 -176.516 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 783' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -51.7 161.38 2.14 Favored 'Trans proline' 0 N--CA 1.473 0.292 0 C-N-CA 123.737 2.958 . . . . 0.0 113.34 -178.167 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 784' ' ' VAL . . . . . 0.497 HG12 HG23 ' A' ' 786' ' ' THR . 55.1 t -62.69 122.13 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.309 177.259 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 785' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -103.31 96.09 6.53 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.557 178.064 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 786' ' ' THR . . . . . 0.497 HG23 HG12 ' A' ' 784' ' ' VAL . 46.0 p -85.12 36.98 0.65 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.926 0.87 . . . . 0.0 110.369 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 58.4 m -159.48 110.26 1.98 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.336 -1.302 . . . . 0.0 110.191 179.345 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 788' ' ' GLY . . . . . 1.034 ' HA2' HG22 ' A' ' 817' ' ' VAL . . . -54.39 134.56 45.59 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.919 -0.658 . . . . 0.0 113.241 173.685 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 789' ' ' GLY . . . . . 0.65 ' H ' HG13 ' A' ' 817' ' ' VAL . . . -178.35 -170.43 40.46 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 179.504 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 790' ' ' ASP . . . . . 0.485 ' OD2' ' HG2' ' A' ' 816' ' ' GLN . 6.6 m-20 -114.16 130.6 56.6 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 174.869 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 791' ' ' TYR . . . . . 0.559 ' CD2' ' HG2' ' A' ' 759' ' ' GLU . 60.2 m-85 -131.27 123.85 29.25 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -179.119 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 792' ' ' ILE . . . . . 0.541 ' O ' HG13 ' A' ' 758' ' ' ILE . 19.8 mt -103.88 116.52 47.81 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 C-N-CA 120.445 -0.502 . . . . 0.0 109.778 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 793' ' ' LEU . . . . . 0.562 ' HB3' ' HB3' ' A' ' 813' ' ' ALA . 3.6 tt -83.87 106.28 15.43 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 177.722 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 794' ' ' SER . . . . . 0.588 ' HB3' ' OD2' ' A' ' 756' ' ' ASP . 15.2 t -117.77 179.46 4.07 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.852 -1.067 . . . . 0.0 108.765 -177.798 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 795' ' ' LEU . . . . . 0.563 HD21 HD21 ' A' ' 725' ' ' LEU . 58.2 mt -106.38 130.62 54.17 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 120.681 0.277 . . . . 0.0 111.01 -175.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 796' ' ' VAL . . . . . . . . . . . . . 51.4 t -88.89 -56.86 4.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.202 -177.42 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 797' ' ' SER . . . . . . . . . . . . . 24.4 m -173.45 168.89 4.49 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.012 -173.15 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 798' ' ' ILE . . . . . 0.7 HG22 ' HB ' ' A' ' 806' ' ' VAL . 0.4 OUTLIER -141.01 166.4 18.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 -173.906 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 799' ' ' LYS . . . . . 0.737 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 26.0 tttm -140.31 118.42 11.94 Favored 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 120.4 -0.52 . . . . 0.0 111.533 -177.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 800' ' ' ASP . . . . . 0.73 ' HA ' ' CE2' ' A' ' 751' ' ' PHE . 12.4 t70 -70.6 156.93 38.79 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.114 174.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 12.8 t -67.28 -5.22 13.13 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 123.652 0.595 . . . . 0.0 111.287 -172.1 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 18.5 p -95.87 7.72 45.55 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.459 0.647 . . . . 0.0 109.919 174.182 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 803' ' ' GLY . . . . . . . . . . . . . . . 74.9 32.37 56.95 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.969 -177.141 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 804' ' ' CYS . . . . . 0.557 ' HB3' ' HB3' ' A' ' 800' ' ' ASP . 37.1 t -99.16 108.03 20.54 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 -179.132 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 805' ' ' VAL . . . . . 0.547 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 3.3 t -85.05 106.54 15.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.194 0.521 . . . . 0.0 110.303 -174.231 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 806' ' ' VAL . . . . . 0.7 ' HB ' HG22 ' A' ' 798' ' ' ILE . 22.9 t -92.88 136.84 23.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.021 -178.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -74.94 134.27 16.8 Favored Glycine 0 N--CA 1.451 -0.311 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.465 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 808' ' ' LEU . . . . . 0.585 HD21 ' HB ' ' A' ' 798' ' ' ILE . 46.3 mt -99.06 130.81 45.42 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -173.489 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 6.1 t -145.83 85.65 1.7 Allowed 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.219 -0.901 . . . . 0.0 109.232 171.322 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 810' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -138.22 174.96 3.72 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-O 118.798 -0.62 . . . . 0.0 109.735 178.481 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 811' ' ' PRO . . . . . 0.447 ' O ' ' HG ' ' A' ' 725' ' ' LEU . 83.2 Cg_exo -43.79 152.86 0.3 Allowed 'Trans proline' 0 C--N 1.361 1.225 0 C-N-CA 123.347 2.698 . . . . 0.0 114.68 -177.395 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 812' ' ' ASP . . . . . 0.476 ' C ' HD12 ' A' ' 725' ' ' LEU . 7.9 p-10 -122.73 165.51 16.44 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.273 -176.739 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 813' ' ' ALA . . . . . 0.686 ' HB1' HD23 ' A' ' 727' ' ' LEU . . . -120.98 113.04 19.51 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.193 -175.468 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 814' ' ' LYS . . . . . . . . . . . . . 41.6 tttm -93.4 112.15 23.99 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.436 0.636 . . . . 0.0 111.488 -177.527 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 815' ' ' ILE . . . . . 0.607 ' HA ' ' HB3' ' A' ' 731' ' ' LEU . 4.7 mp -93.25 135.54 27.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.254 175.822 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 816' ' ' GLN . . . . . 0.485 ' HG2' ' OD2' ' A' ' 790' ' ' ASP . 0.5 OUTLIER -128.87 106.95 9.26 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.943 0.401 . . . . 0.0 109.982 178.525 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 817' ' ' VAL . . . . . 1.034 HG22 ' HA2' ' A' ' 788' ' ' GLY . 0.2 OUTLIER -103.19 142.53 16.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-O 121.324 0.583 . . . . 0.0 110.577 179.052 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 818' ' ' ARG . . . . . 0.466 ' HG2' HE22 ' A' ' 816' ' ' GLN . 35.6 mmt180 . . . . . 0 C--N 1.308 -1.212 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 175.766 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 720' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm . . . . . 0 N--CA 1.452 -0.333 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 721' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -86.91 152.2 8.49 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 122.46 2.107 . . . . 0.0 111.791 -176.281 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 722' ' ' SER . . . . . 0.541 ' HB3' ' NE2' ' A' ' 810' ' ' GLN . 21.6 t 177.53 -151.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -172.314 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 723' ' ' ALA . . . . . 0.76 ' HB1' HG21 ' A' ' 743' ' ' VAL . . . -150.67 143.09 24.34 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 121.238 -0.185 . . . . 0.0 111.114 178.138 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 37.1 t -127.72 102.51 6.84 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -179.345 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 725' ' ' LEU . . . . . 0.494 ' CD2' ' HB ' ' A' ' 743' ' ' VAL . 12.5 mt -63.88 147.08 52.78 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-O 121.641 0.734 . . . . 0.0 111.455 -175.215 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 34.2 mtpt -99.84 -15.85 18.26 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.042 -176.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 727' ' ' LEU . . . . . 0.521 HD21 ' HG ' ' A' ' 731' ' ' LEU . 48.3 tp -64.58 132.34 49.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.248 178.695 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -103.76 -26.26 12.8 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.095 0.405 . . . . 0.0 112.095 -173.094 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -122.98 173.12 8.01 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.807 -173.451 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 730' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -74.38 140.66 44.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.403 177.166 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 731' ' ' LEU . . . . . 0.69 HD12 HG13 ' A' ' 815' ' ' ILE . 73.5 mt -84.39 100.02 11.02 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.326 -179.196 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 732' ' ' LYS . . . . . 0.491 ' HE3' ' OE1' ' A' ' 816' ' ' GLN . 14.1 mmmm -76.97 112.87 14.05 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.637 -179.679 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 733' ' ' LEU . . . . . 0.774 HD12 HG22 ' A' ' 817' ' ' VAL . 58.2 mt -123.34 158.58 30.72 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.108 -178.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 734' ' ' CYS . . . . . 0.517 ' O ' ' HB2' ' A' ' 737' ' ' ASP . 21.2 p -107.68 -173.36 2.27 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 167.811 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 735' ' ' LEU . . . . . 0.525 ' CD1' ' H ' ' A' ' 788' ' ' GLY . 1.4 tp -71.95 148.92 45.52 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 120.055 -0.658 . . . . 0.0 111.032 -171.01 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 736' ' ' GLY . . . . . 0.5 ' HA2' ' HA ' ' A' ' 786' ' ' THR . . . 76.22 10.02 85.49 Favored Glycine 0 C--N 1.321 -0.258 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.54 -179.587 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 737' ' ' ASP . . . . . 0.517 ' HB2' ' O ' ' A' ' 734' ' ' CYS . 0.7 OUTLIER -93.68 155.24 17.37 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -177.719 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 738' ' ' HIS . . . . . 0.508 ' HB2' ' O ' ' A' ' 782' ' ' THR . 37.4 p-80 -121.86 -175.57 3.13 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 168.445 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 739' ' ' SER . . . . . 0.65 ' HB3' HD13 ' A' ' 731' ' ' LEU . 67.9 m -145.85 176.37 9.72 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.128 -0.629 . . . . 0.0 112.502 178.633 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 740' ' ' SER . . . . . 0.48 ' HA ' ' O ' ' A' ' 780' ' ' ILE . 9.7 p -142.43 109.7 5.62 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.144 176.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 741' ' ' VAL . . . . . 0.51 HG11 HD13 ' A' ' 793' ' ' LEU . 2.3 p -105.04 116.01 61.39 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.708 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 742' ' ' PRO . . . . . 0.657 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 3.7 Cg_exo -75.13 131.15 13.82 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 122.244 1.963 . . . . 0.0 111.03 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 743' ' ' VAL . . . . . 0.76 HG21 ' HB1' ' A' ' 723' ' ' ALA . 1.8 p -131.47 120.07 44.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.656 0.741 . . . . 0.0 112.72 178.379 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 744' ' ' ALA . . . . . 0.565 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -82.41 109.9 17.06 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 168.373 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 745' ' ' LEU . . . . . 0.914 HD13 HD13 ' A' ' 773' ' ' ILE . 0.4 OUTLIER -93.23 157.94 16.01 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.828 -1.078 . . . . 0.0 111.599 -164.652 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 37.9 tptt -105.06 157.69 17.07 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.235 178.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 747' ' ' GLY . . . . . . . . . . . . . . . 93.42 120.76 3.06 Favored Glycine 0 C--N 1.305 -1.186 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -175.636 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -96.37 115.4 27.38 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.04 0.448 . . . . 0.0 112.081 -170.63 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 749' ' ' GLY . . . . . 0.41 ' O ' ' HD1' ' A' ' 751' ' ' PHE . . . 109.88 -167.66 12.86 Favored Glycine 0 CA--C 1.5 -0.853 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.531 179.333 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 750' ' ' PRO . . . . . 0.502 ' HB3' ' HE2' ' A' ' 774' ' ' LYS . 85.5 Cg_endo -66.24 95.08 0.31 Allowed 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 123.73 2.953 . . . . 0.0 113.617 -175.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 751' ' ' PHE . . . . . 0.498 ' CE2' ' HA ' ' A' ' 800' ' ' ASP . 56.7 m-85 -112.43 142.68 44.68 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.68 177.482 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 752' ' ' THR . . . . . 0.758 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 96.4 m -88.93 106.14 18.22 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.496 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 753' ' ' LEU . . . . . 0.623 HD22 HD22 ' A' ' 745' ' ' LEU . 12.3 tp -100.2 110.11 22.37 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.052 -0.977 . . . . 0.0 111.091 -172.167 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 754' ' ' THR . . . . . 0.463 HG23 ' HB2' ' A' ' 769' ' ' GLU . 1.2 m -99.43 135.24 41.13 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.442 177.652 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 755' ' ' TYR . . . . . . . . . . . . . 39.3 p90 -136.29 148.34 47.93 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 121.147 0.499 . . . . 0.0 111.638 179.281 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 756' ' ' ASP . . . . . 0.591 ' O ' ' HA ' ' A' ' 793' ' ' LEU . 2.5 p30 -110.22 137.96 47.25 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.789 178.878 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 757' ' ' ILE . . . . . . . . . . . . . 4.3 mp -107.66 94.79 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.087 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 166.091 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 758' ' ' ILE . . . . . 0.595 HG22 ' HD3' ' A' ' 765' ' ' ARG . 2.6 pp -99.84 150.36 5.38 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.92 -169.421 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 759' ' ' GLU . . . . . 0.632 ' HG2' ' CE2' ' A' ' 791' ' ' TYR . 9.4 mt-10 -88.16 120.92 29.98 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.174 -179.349 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 760' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.312 -1.052 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 169.568 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 765' ' ' ARG . . . . . 0.595 ' HD3' HG22 ' A' ' 758' ' ' ILE . 12.3 ttp180 . . . . . 0 N--CA 1.452 -0.327 0 CA-C-O 121.193 0.521 . . . . 0.0 111.477 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 766' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -120.5 146.54 46.18 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -178.561 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 767' ' ' THR . . . . . . . . . . . . . 90.0 m -128.48 136.22 50.52 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 120.573 0.225 . . . . 0.0 110.836 -179.312 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 768' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -141.09 145.07 35.32 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 177.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 769' ' ' GLU . . . . . 0.463 ' HB2' HG23 ' A' ' 754' ' ' THR . 32.9 tt0 -128.17 132.0 48.89 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.985 0.421 . . . . 0.0 111.447 -176.279 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 11.1 mm -111.73 100.57 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.526 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 771' ' ' LYS . . . . . 0.494 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 12.6 mtpt -79.98 150.54 30.42 Favored 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 120.044 -0.662 . . . . 0.0 111.04 -177.783 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 772' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 53.7 48.16 22.14 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.04 -1.437 . . . . 0.0 112.521 177.62 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 773' ' ' ILE . . . . . 0.914 HD13 HD13 ' A' ' 745' ' ' LEU . 0.5 OUTLIER -73.34 117.6 17.33 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.578 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 171.538 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 774' ' ' LYS . . . . . 0.502 ' HE2' ' HB3' ' A' ' 750' ' ' PRO . 59.5 mttt -112.08 28.04 9.12 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 -179.248 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 775' ' ' THR . . . . . 0.691 ' H ' HD12 ' A' ' 773' ' ' ILE . 0.2 OUTLIER -95.69 -76.7 0.49 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.862 -1.063 . . . . 0.0 113.5 -167.874 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 776' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 775' ' ' THR . 12.2 m120 88.48 3.91 0.25 Allowed 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.943 1.297 . . . . 0.0 111.054 -175.144 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 777' ' ' GLU . . . . . 0.565 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 9.9 mt-10 -161.07 88.29 0.75 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.025 172.782 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 778' ' ' TYR . . . . . 0.676 ' HB3' HD11 ' A' ' 745' ' ' LEU . 63.9 t80 -133.51 136.68 45.21 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.611 -170.583 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 779' ' ' VAL . . . . . 0.657 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 21.5 t -91.25 115.77 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 CA-C-O 121.337 0.589 . . . . 0.0 110.309 178.66 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 780' ' ' ILE . . . . . 0.48 ' O ' ' HA ' ' A' ' 740' ' ' SER . 61.7 mt -82.74 142.22 13.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.309 -179.125 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 781' ' ' LYS . . . . . 0.4 ' HD3' ' C ' ' A' ' 780' ' ' ILE . 0.0 OUTLIER -113.13 110.77 20.98 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.153 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 782' ' ' THR . . . . . 0.508 ' O ' ' HB2' ' A' ' 738' ' ' HIS . 70.3 p -77.01 133.35 69.38 Favored Pre-proline 0 N--CA 1.441 -0.899 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.567 178.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 783' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 782' ' ' THR . 23.7 Cg_exo -62.88 151.32 84.96 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 122.942 2.428 . . . . 0.0 111.548 -175.444 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 784' ' ' VAL . . . . . . . . . . . . . 13.8 p -59.59 130.73 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-O 121.406 0.622 . . . . 0.0 110.477 -174.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 785' ' ' PHE . . . . . 0.478 ' C ' ' H ' ' A' ' 787' ' ' THR . 86.3 m-85 -87.21 -31.84 20.1 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.598 -171.714 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 786' ' ' THR . . . . . 0.5 ' HA ' ' HA2' ' A' ' 736' ' ' GLY . 30.9 p 58.05 -5.4 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.911 0.885 . . . . 0.0 112.94 176.333 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 787' ' ' THR . . . . . 0.478 ' H ' ' C ' ' A' ' 785' ' ' PHE . 1.3 m -145.76 124.65 12.7 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.752 0.311 . . . . 0.0 110.543 -176.776 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 788' ' ' GLY . . . . . 0.525 ' H ' ' CD1' ' A' ' 735' ' ' LEU . . . -50.28 125.9 22.1 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.354 -0.839 . . . . 0.0 113.353 173.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 789' ' ' GLY . . . . . . . . . . . . . . . -174.51 -179.88 45.4 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 179.31 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -119.46 128.02 53.61 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 117.773 0.786 . . . . 0.0 109.758 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 791' ' ' TYR . . . . . 0.632 ' CE2' ' HG2' ' A' ' 759' ' ' GLU . 84.0 m-85 -127.65 153.38 46.52 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.595 -176.022 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 792' ' ' ILE . . . . . 0.567 ' O ' HG13 ' A' ' 758' ' ' ILE . 13.0 mt -129.92 120.36 49.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 172.881 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 793' ' ' LEU . . . . . 0.591 ' HA ' ' O ' ' A' ' 756' ' ' ASP . 8.1 tt -85.28 110.34 19.0 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 178.28 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 794' ' ' SER . . . . . . . . . . . . . 3.7 m -119.45 148.89 42.72 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.023 -178.304 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 795' ' ' LEU . . . . . 0.64 ' HG ' ' HB3' ' A' ' 723' ' ' ALA . 1.5 mm? -73.36 124.75 26.35 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-O 120.715 0.293 . . . . 0.0 111.028 177.143 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 796' ' ' VAL . . . . . 0.423 ' HB ' ' HB ' ' A' ' 754' ' ' THR . 53.7 t -85.67 -54.78 7.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.213 -177.207 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 797' ' ' SER . . . . . 0.589 ' HA ' ' HG ' ' A' ' 808' ' ' LEU . 87.9 p -172.42 152.66 2.73 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.202 -172.708 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 798' ' ' ILE . . . . . 0.636 ' HA ' ' O ' ' A' ' 752' ' ' THR . 5.9 tt -127.5 164.6 28.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 176.641 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 799' ' ' LYS . . . . . 0.758 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 8.0 tmtt? -139.51 118.86 12.84 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.14 -177.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 800' ' ' ASP . . . . . 0.532 ' HB2' ' HB3' ' A' ' 804' ' ' CYS . 14.1 m-20 -58.59 155.37 12.53 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.504 173.346 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 6.3 p -61.62 -11.86 13.39 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 124.021 0.826 . . . . 0.0 112.56 -174.255 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 8.9 t -91.06 -6.38 53.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.666 0.745 . . . . 0.0 109.836 178.339 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 803' ' ' GLY . . . . . 0.485 ' HA2' ' HE2' ' A' ' 799' ' ' LYS . . . 92.12 42.69 4.58 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.771 -177.26 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 804' ' ' CYS . . . . . 0.532 ' HB3' ' HB2' ' A' ' 800' ' ' ASP . 41.7 t -110.55 106.53 15.84 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.073 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 805' ' ' VAL . . . . . 0.549 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 15.7 t -88.27 110.78 21.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.285 0.564 . . . . 0.0 111.279 -175.336 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 806' ' ' VAL . . . . . 0.434 ' HB ' HG22 ' A' ' 798' ' ' ILE . 88.2 t -90.55 137.76 20.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.995 177.629 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -76.07 120.53 5.94 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 111.099 -0.8 . . . . 0.0 111.099 177.777 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 808' ' ' LEU . . . . . 0.589 ' HG ' ' HA ' ' A' ' 797' ' ' SER . 40.1 mt -88.81 133.7 34.17 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -173.007 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 31.8 t -149.67 86.73 1.47 Allowed 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.019 -0.992 . . . . 0.0 108.991 172.287 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 810' ' ' GLN . . . . . 0.541 ' NE2' ' HB3' ' A' ' 722' ' ' SER . 1.6 mt-30 -139.25 174.39 4.18 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.388 -0.823 . . . . 0.0 108.93 176.404 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 811' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_exo -44.0 139.17 6.0 Favored 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 123.049 2.499 . . . . 0.0 114.644 -175.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -115.67 165.76 12.68 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.204 -179.127 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 813' ' ' ALA . . . . . 0.501 ' HB1' HD23 ' A' ' 727' ' ' LEU . . . -115.06 155.63 26.66 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.492 -177.686 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 814' ' ' LYS . . . . . 0.457 ' HG3' HG12 ' A' ' 792' ' ' ILE . 2.7 mptm? -112.45 137.83 50.08 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.499 0.666 . . . . 0.0 110.647 175.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 815' ' ' ILE . . . . . 0.69 HG13 HD12 ' A' ' 731' ' ' LEU . 5.3 mp -124.27 111.85 30.2 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-N 114.792 -1.094 . . . . 0.0 108.155 177.823 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 816' ' ' GLN . . . . . 0.714 ' NE2' ' HG2' ' A' ' 818' ' ' ARG . 0.9 OUTLIER -108.72 109.16 20.26 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.023 0.44 . . . . 0.0 110.671 -177.22 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 817' ' ' VAL . . . . . 0.774 HG22 HD12 ' A' ' 733' ' ' LEU . 2.3 t -104.85 142.58 17.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 -179.279 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 818' ' ' ARG . . . . . 0.714 ' HG2' ' NE2' ' A' ' 816' ' ' GLN . 73.6 mmt-85 . . . . . 0 C--N 1.321 -0.654 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 175.016 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 720' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt . . . . . 0 N--CA 1.441 -0.887 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 721' ' ' PRO . . . . . 0.453 ' HD2' HG21 ' A' ' 806' ' ' VAL . 72.0 Cg_endo -88.75 151.35 6.11 Favored 'Trans proline' 0 N--CA 1.446 -1.298 0 C-N-CA 122.431 2.087 . . . . 0.0 111.488 -178.4 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 722' ' ' SER . . . . . 0.782 ' HB2' ' OE1' ' A' ' 810' ' ' GLN . 8.6 p -179.18 -159.32 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -175.807 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 723' ' ' ALA . . . . . 0.595 ' HB3' ' HG ' ' A' ' 795' ' ' LEU . . . -151.67 140.74 21.19 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 118.807 0.73 . . . . 0.0 110.931 176.068 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 35.1 m -132.89 105.63 7.23 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 -177.019 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 725' ' ' LEU . . . . . 0.51 ' CD2' ' HB ' ' A' ' 743' ' ' VAL . 16.7 mt -62.22 144.92 54.87 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-O 121.478 0.656 . . . . 0.0 111.507 -176.087 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 29.3 mtpt -97.62 -14.41 20.99 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.856 -1.065 . . . . 0.0 109.638 -177.066 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 727' ' ' LEU . . . . . 0.591 HD23 ' HB1' ' A' ' 813' ' ' ALA . 38.7 tp -69.21 114.24 7.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.713 175.646 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 9.6 t-80 -115.71 43.5 2.08 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.816 0.341 . . . . 0.0 111.214 -174.637 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 9.5 p80 -175.24 -177.67 1.07 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.629 177.441 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 730' ' ' ASP . . . . . 0.515 ' HA ' ' O ' ' A' ' 814' ' ' LYS . 1.2 m-20 -76.53 148.22 37.24 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.564 177.806 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 731' ' ' LEU . . . . . 0.601 HD13 ' HB2' ' A' ' 739' ' ' SER . 12.0 mt -101.93 104.45 15.15 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.555 173.345 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 732' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -81.23 93.24 6.46 Favored 'General case' 0 C--N 1.323 -0.56 0 O-C-N 123.712 0.632 . . . . 0.0 111.26 -172.744 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 733' ' ' LEU . . . . . 0.438 ' HB3' ' CB ' ' A' ' 737' ' ' ASP . 0.2 OUTLIER -107.38 163.69 12.83 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.107 0.48 . . . . 0.0 111.487 -178.415 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 734' ' ' CYS . . . . . 0.699 ' HA ' ' O ' ' A' ' 818' ' ' ARG . 69.2 m -113.14 -173.38 2.24 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.352 177.71 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 735' ' ' LEU . . . . . 0.449 HD23 ' N ' ' A' ' 736' ' ' GLY . 3.5 tt -62.56 128.1 34.39 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.925 -179.289 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 736' ' ' GLY . . . . . 0.48 ' HA2' ' HA ' ' A' ' 786' ' ' THR . . . 86.37 4.96 83.05 Favored Glycine 0 C--N 1.322 -0.199 0 C-N-CA 120.22 -0.991 . . . . 0.0 112.735 177.116 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 737' ' ' ASP . . . . . 0.501 ' HB2' ' O ' ' A' ' 734' ' ' CYS . 0.3 OUTLIER -84.26 153.3 23.66 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.364 0.602 . . . . 0.0 112.448 179.281 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 738' ' ' HIS . . . . . 0.486 ' HB2' ' O ' ' A' ' 782' ' ' THR . 47.0 p-80 -118.88 173.28 6.97 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 167.106 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 739' ' ' SER . . . . . 0.601 ' HB2' HD13 ' A' ' 731' ' ' LEU . 51.5 p -128.08 173.75 9.8 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 118.236 -1.385 . . . . 0.0 112.791 -173.043 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 10.4 p -144.98 103.93 3.93 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.861 -172.754 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 741' ' ' VAL . . . . . 0.813 HG11 HD23 ' A' ' 793' ' ' LEU . 0.4 OUTLIER -120.87 116.63 31.4 Favored Pre-proline 0 C--N 1.314 -0.963 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.282 -177.804 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 742' ' ' PRO . . . . . 0.643 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 9.8 Cg_endo -77.66 137.32 16.12 Favored 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 122.252 1.968 . . . . 0.0 111.545 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 743' ' ' VAL . . . . . 0.51 HG21 ' HB1' ' A' ' 723' ' ' ALA . 2.2 p -130.33 119.54 46.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.452 0.644 . . . . 0.0 112.231 177.33 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 744' ' ' ALA . . . . . 0.578 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -78.81 95.01 5.26 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 122.237 1.017 . . . . 0.0 109.03 168.641 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 745' ' ' LEU . . . . . 0.823 HD11 ' HB3' ' A' ' 778' ' ' TYR . 1.7 mt -76.41 142.54 41.06 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 113.706 -1.588 . . . . 0.0 110.485 -173.398 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -100.01 163.14 12.56 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.442 0.639 . . . . 0.0 110.571 -176.18 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 747' ' ' GLY . . . . . . . . . . . . . . . 91.36 139.11 8.23 Favored Glycine 0 C--N 1.309 -0.928 0 CA-C-N 114.855 -1.066 . . . . 0.0 111.64 -175.399 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 748' ' ' GLN . . . . . 0.45 ' C ' ' HE1' ' A' ' 751' ' ' PHE . 20.9 mp0 -114.22 111.2 21.16 Favored 'General case' 0 C--N 1.32 -0.679 0 O-C-N 122.469 -0.43 . . . . 0.0 111.081 -175.137 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 132.75 -170.7 21.95 Favored Glycine 0 N--CA 1.445 -0.764 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.034 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -73.5 93.84 0.84 Allowed 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.564 2.176 . . . . 0.0 111.676 -179.266 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 751' ' ' PHE . . . . . 0.607 ' CE2' ' HA ' ' A' ' 800' ' ' ASP . 80.0 m-85 -113.92 141.1 47.78 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.237 -178.779 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 752' ' ' THR . . . . . 0.695 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 86.7 m -91.66 105.28 17.62 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 177.809 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 753' ' ' LEU . . . . . 0.474 HD23 HD12 ' A' ' 798' ' ' ILE . 0.5 OUTLIER -98.79 123.0 42.74 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.362 -172.168 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 754' ' ' THR . . . . . 0.476 HG23 ' HB2' ' A' ' 769' ' ' GLU . 0.7 OUTLIER -117.89 136.29 53.56 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.659 -178.197 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 755' ' ' TYR . . . . . 0.4 ' CE1' ' HB3' ' A' ' 768' ' ' PHE . 17.2 p90 -143.29 153.95 43.29 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 178.589 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 756' ' ' ASP . . . . . 0.419 ' HB2' HG23 ' A' ' 758' ' ' ILE . 14.9 p-10 -118.91 118.86 32.68 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.341 0.591 . . . . 0.0 111.86 -178.576 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 757' ' ' ILE . . . . . 0.503 HG13 HD13 ' A' ' 793' ' ' LEU . 4.0 mp -89.74 96.34 6.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 167.369 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 758' ' ' ILE . . . . . 0.64 HG13 ' O ' ' A' ' 792' ' ' ILE . 2.5 pp -103.89 149.72 7.57 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -168.808 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 759' ' ' GLU . . . . . 0.536 ' HG2' ' CE2' ' A' ' 791' ' ' TYR . 19.8 mt-10 -87.48 123.99 32.98 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.164 178.367 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 760' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.313 -0.98 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.309 175.583 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 66.5 mtm180 . . . . . 0 C--O 1.234 0.247 0 CA-C-O 121.221 0.534 . . . . 0.0 111.88 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 766' ' ' LYS . . . . . 0.66 ' HD3' ' N ' ' A' ' 767' ' ' THR . 9.0 tmtt? -124.84 145.51 49.74 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 175.533 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 767' ' ' THR . . . . . 0.66 ' N ' ' HD3' ' A' ' 766' ' ' LYS . 91.7 m -133.16 141.7 48.26 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.295 -179.604 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 768' ' ' PHE . . . . . 0.4 ' HB3' ' CE1' ' A' ' 755' ' ' TYR . 4.1 t80 -136.21 141.74 44.02 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.05 0.452 . . . . 0.0 110.656 177.302 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 769' ' ' GLU . . . . . 0.476 ' HB2' HG23 ' A' ' 754' ' ' THR . 40.0 tt0 -126.41 121.08 31.45 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.487 -179.255 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 770' ' ' ILE . . . . . 0.645 HG22 HG22 ' A' ' 773' ' ' ILE . 9.4 mt -115.57 111.27 34.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.801 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 771' ' ' LYS . . . . . 0.619 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 7.8 mtpt -83.97 148.4 26.92 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.624 0.726 . . . . 0.0 111.521 -176.781 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 772' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 57.71 47.45 15.62 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 113.514 -1.675 . . . . 0.0 112.479 175.715 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 773' ' ' ILE . . . . . 0.74 HD12 ' H ' ' A' ' 775' ' ' THR . 0.5 OUTLIER -75.64 119.29 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 175.426 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 79.7 mttt -117.88 33.26 5.72 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 775' ' ' THR . . . . . 0.74 ' H ' HD12 ' A' ' 773' ' ' ILE . 1.1 m -95.4 -72.32 0.63 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 113.939 -1.482 . . . . 0.0 112.289 -172.668 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 776' ' ' ASN . . . . . 0.465 ' HA ' ' O ' ' A' ' 745' ' ' LEU . 12.2 m120 85.96 3.63 0.53 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.599 1.159 . . . . 0.0 110.934 -179.39 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 777' ' ' GLU . . . . . 0.578 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 12.3 mt-10 -161.84 88.7 0.7 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.171 -0.922 . . . . 0.0 108.799 172.302 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 778' ' ' TYR . . . . . 0.823 ' HB3' HD11 ' A' ' 745' ' ' LEU . 49.4 t80 -123.59 127.65 48.59 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 120.881 0.372 . . . . 0.0 110.778 -171.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 779' ' ' VAL . . . . . 0.643 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 15.1 t -85.52 105.42 14.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.206 0.527 . . . . 0.0 110.382 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 780' ' ' ILE . . . . . 0.429 ' HB ' ' O ' ' A' ' 741' ' ' VAL . 83.1 mt -75.44 142.31 14.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.703 -178.471 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.08 103.6 8.91 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 174.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 782' ' ' THR . . . . . 0.486 ' O ' ' HB2' ' A' ' 738' ' ' HIS . 2.9 p -75.36 143.6 76.65 Favored Pre-proline 0 C--N 1.319 -0.738 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.985 -175.312 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 783' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.69 157.76 9.38 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 123.378 2.719 . . . . 0.0 111.963 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 784' ' ' VAL . . . . . 0.45 ' HA ' ' HB3' ' A' ' 738' ' ' HIS . 11.6 p -68.47 130.89 33.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.45 0.643 . . . . 0.0 110.283 -175.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 785' ' ' PHE . . . . . 0.473 ' C ' ' H ' ' A' ' 787' ' ' THR . 62.3 m-85 -85.87 -40.17 16.24 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.42 -175.008 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 786' ' ' THR . . . . . 0.48 ' HA ' ' HA2' ' A' ' 736' ' ' GLY . 27.3 p 60.26 -4.92 0.1 Allowed 'General case' 0 N--CA 1.469 0.495 0 O-C-N 124.451 1.094 . . . . 0.0 112.053 -178.571 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 787' ' ' THR . . . . . 0.473 ' H ' ' C ' ' A' ' 785' ' ' PHE . 43.1 m -130.94 116.12 17.43 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.879 -173.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 788' ' ' GLY . . . . . . . . . . . . . . . -52.59 118.56 7.95 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.963 171.636 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 789' ' ' GLY . . . . . 0.453 ' H ' ' HB ' ' A' ' 817' ' ' VAL . . . -175.86 -174.97 42.86 Favored Glycine 0 N--CA 1.448 -0.546 0 N-CA-C 110.041 -1.223 . . . . 0.0 110.041 179.678 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -115.41 130.11 56.79 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 118.267 1.033 . . . . 0.0 110.254 178.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 791' ' ' TYR . . . . . 0.536 ' CE2' ' HG2' ' A' ' 759' ' ' GLU . 69.2 m-85 -121.3 143.98 48.88 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.473 179.55 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 792' ' ' ILE . . . . . 0.64 ' O ' HG13 ' A' ' 758' ' ' ILE . 21.2 mt -120.84 113.68 40.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 177.546 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 793' ' ' LEU . . . . . 0.813 HD23 HG11 ' A' ' 741' ' ' VAL . 0.7 OUTLIER -86.55 114.53 23.36 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.084 179.279 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 794' ' ' SER . . . . . 0.511 ' N ' HD12 ' A' ' 793' ' ' LEU . 23.1 t -123.86 159.68 29.1 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.763 -174.685 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 795' ' ' LEU . . . . . 0.595 ' HG ' ' HB3' ' A' ' 723' ' ' ALA . 1.2 mm? -87.51 135.31 33.4 Favored 'General case' 0 N--CA 1.44 -0.948 0 O-C-N 121.997 -0.44 . . . . 0.0 110.837 176.413 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 796' ' ' VAL . . . . . 0.405 ' HB ' ' HB ' ' A' ' 754' ' ' THR . 73.3 t -92.64 -55.36 6.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.95 -178.703 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 797' ' ' SER . . . . . 0.415 ' HA ' HD23 ' A' ' 808' ' ' LEU . 58.7 m -169.18 168.35 9.91 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.091 -173.616 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 798' ' ' ILE . . . . . 0.616 ' HA ' ' O ' ' A' ' 752' ' ' THR . 9.1 tt -141.06 165.39 19.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 172.641 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 799' ' ' LYS . . . . . 0.695 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 85.3 tttt -136.96 121.67 18.58 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.887 0.375 . . . . 0.0 111.333 -174.636 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 800' ' ' ASP . . . . . 0.607 ' HA ' ' CE2' ' A' ' 751' ' ' PHE . 7.9 t70 -65.49 153.62 40.88 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.21 175.177 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 5.4 p -58.83 -13.97 7.64 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 124.199 0.937 . . . . 0.0 112.948 -174.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 52.2 p -89.68 -5.83 56.7 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.511 0.672 . . . . 0.0 109.847 177.322 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 803' ' ' GLY . . . . . 0.529 ' HA2' ' CE ' ' A' ' 799' ' ' LYS . . . 89.81 40.31 5.95 Favored Glycine 0 N--CA 1.44 -1.071 0 CA-C-N 114.934 -1.03 . . . . 0.0 111.601 -177.867 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 804' ' ' CYS . . . . . 0.518 ' HB3' ' HB3' ' A' ' 800' ' ' ASP . 42.0 t -111.69 113.8 26.4 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 110.056 -0.349 . . . . 0.0 110.056 -178.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 805' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 11.0 p -85.01 132.85 30.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.396 0.617 . . . . 0.0 110.948 -174.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 806' ' ' VAL . . . . . 0.492 ' HB ' HG22 ' A' ' 798' ' ' ILE . 85.0 t -109.29 138.34 37.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.769 178.815 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -76.28 111.24 3.24 Favored Glycine 0 N--CA 1.452 -0.28 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.785 -178.064 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 808' ' ' LEU . . . . . 0.439 HD12 ' CB ' ' A' ' 795' ' ' LEU . 2.6 mm? -76.07 127.31 32.69 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 10.8 p -149.93 86.75 1.45 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.509 170.384 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 810' ' ' GLN . . . . . 0.782 ' OE1' ' HB2' ' A' ' 722' ' ' SER . 35.1 mt-30 -137.8 171.91 7.64 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.743 -176.837 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 811' ' ' PRO . . . . . 0.421 ' HD2' ' HB3' ' A' ' 810' ' ' GLN . 81.3 Cg_exo -47.78 140.32 17.78 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.798 2.332 . . . . 0.0 113.563 178.526 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -114.67 165.67 12.55 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.798 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 813' ' ' ALA . . . . . 0.591 ' HB1' HD23 ' A' ' 727' ' ' LEU . . . -111.33 151.37 28.49 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.278 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 814' ' ' LYS . . . . . 0.515 ' O ' ' HA ' ' A' ' 730' ' ' ASP . 19.5 ttpp -120.25 107.78 13.4 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.849 0.833 . . . . 0.0 110.827 178.566 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 815' ' ' ILE . . . . . 0.53 ' HA ' ' HB2' ' A' ' 731' ' ' LEU . 5.1 mp -86.65 116.94 30.12 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-N 114.539 -1.209 . . . . 0.0 108.68 177.452 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 816' ' ' GLN . . . . . 0.469 HE22 ' HB2' ' A' ' 818' ' ' ARG . 1.0 OUTLIER -107.88 106.57 16.9 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.686 0.755 . . . . 0.0 110.339 -177.041 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 817' ' ' VAL . . . . . 0.453 ' HB ' ' H ' ' A' ' 789' ' ' GLY . 1.9 t -101.43 146.43 9.79 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -177.596 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 818' ' ' ARG . . . . . 0.699 ' O ' ' HA ' ' A' ' 734' ' ' CYS . 17.2 tpt180 . . . . . 0 C--N 1.317 -0.833 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 178.412 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 720' ' ' LYS . . . . . 0.416 ' HG2' ' O ' ' A' ' 720' ' ' LYS . 19.1 ttpt . . . . . 0 N--CA 1.416 -2.139 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 721' ' ' PRO . . . . . 0.465 ' HG3' ' CE2' ' A' ' 751' ' ' PHE . 56.5 Cg_endo -87.91 155.41 7.26 Favored 'Trans proline' 0 N--CA 1.449 -1.121 0 C-N-CA 123.348 2.699 . . . . 0.0 112.092 -176.43 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 722' ' ' SER . . . . . 0.744 ' HA ' ' CD2' ' A' ' 808' ' ' LEU . 7.5 t -174.25 -159.84 0.1 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -174.019 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 723' ' ' ALA . . . . . 0.63 ' O ' ' HB2' ' A' ' 810' ' ' GLN . . . -156.77 140.67 16.2 Favored 'General case' 0 C--O 1.218 -0.562 0 C-N-CA 121.383 -0.127 . . . . 0.0 110.741 177.875 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 22.6 t -136.06 101.25 4.66 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 -176.237 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 725' ' ' LEU . . . . . 0.584 ' HA ' ' HA ' ' A' ' 743' ' ' VAL . 5.6 mp -60.7 139.41 57.88 Favored 'General case' 0 N--CA 1.425 -1.688 0 CA-C-O 122.396 1.093 . . . . 0.0 112.427 -175.117 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 33.4 mtpt -87.43 -18.12 30.67 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 113.002 -1.908 . . . . 0.0 109.356 -178.518 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 727' ' ' LEU . . . . . 0.528 ' HB2' ' HD2' ' A' ' 742' ' ' PRO . 21.2 tp -71.3 110.22 5.8 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 173.839 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 9.1 t60 -95.19 -48.4 5.94 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.528 -172.57 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 39.9 p-80 -101.21 177.71 4.86 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.871 -177.694 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 730' ' ' ASP . . . . . 0.449 ' HA ' ' O ' ' A' ' 814' ' ' LYS . 7.7 p-10 -68.73 145.67 53.62 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.568 0.699 . . . . 0.0 110.933 -178.047 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 731' ' ' LEU . . . . . 0.537 ' HB3' ' HA ' ' A' ' 815' ' ' ILE . 36.4 tp -104.44 111.71 24.48 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.372 -175.598 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 732' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -70.35 127.47 32.88 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.884 -177.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 733' ' ' LEU . . . . . 0.485 HD11 ' OG ' ' A' ' 739' ' ' SER . 55.4 mt -136.59 163.72 29.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.195 0.522 . . . . 0.0 111.144 177.101 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 734' ' ' CYS . . . . . 0.472 ' O ' ' HB2' ' A' ' 737' ' ' ASP . 72.1 m -108.58 -176.18 2.97 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.036 175.442 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 735' ' ' LEU . . . . . . . . . . . . . 24.7 tp -63.95 131.57 48.06 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.022 0.439 . . . . 0.0 111.068 -177.285 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 736' ' ' GLY . . . . . 0.476 ' O ' HG13 ' A' ' 784' ' ' VAL . . . 70.27 13.48 70.47 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.619 177.058 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 737' ' ' ASP . . . . . 0.472 ' HB2' ' O ' ' A' ' 734' ' ' CYS . 0.3 OUTLIER -77.7 150.76 34.43 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.792 0.329 . . . . 0.0 110.711 178.763 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 16.1 p-80 -111.9 163.06 14.64 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 171.337 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 739' ' ' SER . . . . . 0.485 ' OG ' HD11 ' A' ' 733' ' ' LEU . 0.0 OUTLIER -131.36 174.08 10.42 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 119.526 -0.869 . . . . 0.0 112.732 -173.325 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 5.6 p -131.36 115.51 16.34 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.282 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 741' ' ' VAL . . . . . 0.412 ' HB ' ' HB ' ' A' ' 780' ' ' ILE . 3.6 t -113.6 98.98 48.7 Favored Pre-proline 0 C--N 1.318 -0.768 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.411 -175.356 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 742' ' ' PRO . . . . . 0.762 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 2.2 Cg_endo -75.88 121.65 6.36 Favored 'Trans proline' 0 N--CA 1.441 -1.579 0 C-N-CA 122.912 2.408 . . . . 0.0 110.712 -175.264 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 743' ' ' VAL . . . . . 0.584 ' HA ' ' HA ' ' A' ' 725' ' ' LEU . 1.4 p -125.67 121.52 60.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 121.662 0.744 . . . . 0.0 112.671 178.226 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 744' ' ' ALA . . . . . 0.586 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -83.42 111.67 19.24 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 169.255 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 745' ' ' LEU . . . . . 0.886 HD13 HD13 ' A' ' 773' ' ' ILE . 0.3 OUTLIER -95.11 168.99 10.42 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.705 -1.134 . . . . 0.0 111.251 -165.861 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 1.1 tppm? -122.9 147.59 46.41 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.287 -176.262 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 747' ' ' GLY . . . . . 0.45 ' HA3' ' HB3' ' A' ' 721' ' ' PRO . . . 100.73 129.97 6.87 Favored Glycine 0 C--N 1.311 -0.833 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.451 -177.268 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 748' ' ' GLN . . . . . 0.428 ' C ' ' HE1' ' A' ' 751' ' ' PHE . 2.1 mp0 -108.76 115.71 30.6 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.917 0.389 . . . . 0.0 111.059 -175.054 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 134.52 -176.31 19.97 Favored Glycine 0 N--CA 1.444 -0.773 0 N-CA-C 111.501 -0.64 . . . . 0.0 111.501 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_exo -71.89 93.89 0.71 Allowed 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.545 2.163 . . . . 0.0 111.839 179.06 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 751' ' ' PHE . . . . . 0.501 ' CD2' ' HA ' ' A' ' 800' ' ' ASP . 78.2 m-85 -110.2 141.95 42.42 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.41 -178.734 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 752' ' ' THR . . . . . 0.771 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 94.7 m -90.85 102.66 15.42 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.725 0.774 . . . . 0.0 109.471 178.271 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 753' ' ' LEU . . . . . 0.456 HD22 HD22 ' A' ' 745' ' ' LEU . 24.3 tp -91.82 116.85 29.25 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 114.448 -1.251 . . . . 0.0 110.461 -171.368 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 754' ' ' THR . . . . . 0.448 HG23 ' HB2' ' A' ' 769' ' ' GLU . 1.3 m -115.1 130.11 56.85 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.028 179.363 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 755' ' ' TYR . . . . . 0.557 ' CE1' ' HB2' ' A' ' 768' ' ' PHE . 22.2 p90 -141.31 156.73 45.82 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.856 0.36 . . . . 0.0 111.338 178.405 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 756' ' ' ASP . . . . . 0.442 ' HB3' HG23 ' A' ' 758' ' ' ILE . 0.2 OUTLIER -121.07 118.95 31.08 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.37 -176.628 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 757' ' ' ILE . . . . . 0.512 HG13 HD13 ' A' ' 793' ' ' LEU . 3.7 mp -87.98 96.24 5.72 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 168.712 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 758' ' ' ILE . . . . . 0.625 HG13 ' O ' ' A' ' 792' ' ' ILE . 2.5 pp -94.78 149.98 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.215 -173.363 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -105.13 125.65 51.21 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 120.173 -0.611 . . . . 0.0 110.562 178.791 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 760' ' ' THR . . . . . 0.462 HG23 ' OD2' ' A' ' 790' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.319 -0.746 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 177.444 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 765' ' ' ARG . . . . . 0.418 HH11 ' HD2' ' A' ' 765' ' ' ARG . 47.2 mtm105 . . . . . 0 C--O 1.233 0.21 0 CA-C-O 120.985 0.421 . . . . 0.0 111.569 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 766' ' ' LYS . . . . . 0.665 ' HD3' ' N ' ' A' ' 767' ' ' THR . 7.5 tmtm? -124.5 144.8 49.91 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 176.805 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 767' ' ' THR . . . . . 0.665 ' N ' ' HD3' ' A' ' 766' ' ' LYS . 91.4 m -125.05 137.84 54.21 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 120.879 0.371 . . . . 0.0 111.742 -176.34 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 768' ' ' PHE . . . . . 0.557 ' HB2' ' CE1' ' A' ' 755' ' ' TYR . 2.1 m-85 -131.89 130.25 41.38 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.047 171.074 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 769' ' ' GLU . . . . . 0.448 ' HB2' HG23 ' A' ' 754' ' ' THR . 37.1 tt0 -124.6 108.07 11.68 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.294 179.307 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 770' ' ' ILE . . . . . 0.429 ' N ' HD12 ' A' ' 770' ' ' ILE . 4.3 mp -106.76 113.23 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.196 -178.171 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 771' ' ' LYS . . . . . 0.612 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 1.7 mtpt -81.88 149.57 28.2 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.252 0.548 . . . . 0.0 111.125 -177.57 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 772' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 57.32 50.19 11.93 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.36 -1.291 . . . . 0.0 112.652 177.723 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 773' ' ' ILE . . . . . 0.886 HD13 HD13 ' A' ' 745' ' ' LEU . 0.5 OUTLIER -78.88 119.64 28.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 170.692 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 72.3 mttt -118.49 29.72 7.6 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 -177.206 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 775' ' ' THR . . . . . 0.659 ' H ' HD12 ' A' ' 773' ' ' ILE . 0.2 OUTLIER -94.08 -71.27 0.67 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.469 -1.241 . . . . 0.0 113.266 -167.753 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 776' ' ' ASN . . . . . 0.594 ' HB2' ' O ' ' A' ' 775' ' ' THR . 0.9 OUTLIER 84.8 2.86 0.73 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.326 1.05 . . . . 0.0 110.273 -176.739 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 777' ' ' GLU . . . . . 0.586 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 7.5 mt-10 -162.31 86.18 0.59 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.314 174.062 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 778' ' ' TYR . . . . . 0.685 ' HB3' HD11 ' A' ' 745' ' ' LEU . 69.9 t80 -132.38 131.1 41.52 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -173.53 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 779' ' ' VAL . . . . . 0.762 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 1.5 m -96.93 132.46 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 CA-C-O 122.684 1.231 . . . . 0.0 110.337 176.685 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 780' ' ' ILE . . . . . 0.412 ' HB ' ' HB ' ' A' ' 741' ' ' VAL . 88.8 mt -89.21 147.76 4.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-N 112.88 -1.964 . . . . 0.0 110.143 -170.677 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -112.09 110.55 20.9 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 120.271 -0.572 . . . . 0.0 109.575 175.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 782' ' ' THR . . . . . 0.497 HG22 HG12 ' A' ' 757' ' ' ILE . 11.5 p -85.66 142.43 37.12 Favored Pre-proline 0 C--N 1.312 -1.065 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.076 -177.869 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 783' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 782' ' ' THR . 32.2 Cg_exo -59.68 160.2 21.81 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 123.614 2.876 . . . . 0.0 113.233 -174.087 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 784' ' ' VAL . . . . . 0.531 HG12 HG23 ' A' ' 786' ' ' THR . 52.5 t -59.51 115.38 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.316 177.18 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 785' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -94.88 95.4 8.63 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.242 -179.187 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 786' ' ' THR . . . . . 0.531 HG23 HG12 ' A' ' 784' ' ' VAL . 33.4 p -86.67 35.23 0.67 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 122.026 0.917 . . . . 0.0 110.648 -178.858 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 44.3 m -152.79 109.31 3.42 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.457 -1.247 . . . . 0.0 110.902 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 788' ' ' GLY . . . . . 0.706 ' HA2' HG12 ' A' ' 817' ' ' VAL . . . -52.42 109.14 0.82 Allowed Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.16 169.503 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 789' ' ' GLY . . . . . 0.433 ' H ' ' HB ' ' A' ' 817' ' ' VAL . . . -169.91 176.58 43.66 Favored Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -179.47 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 790' ' ' ASP . . . . . 0.462 ' OD2' HG23 ' A' ' 760' ' ' THR . 0.4 OUTLIER -103.12 133.12 48.75 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.384 0.612 . . . . 0.0 110.58 -178.563 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 791' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -123.66 148.41 46.51 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.342 -0.844 . . . . 0.0 109.697 -179.498 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 792' ' ' ILE . . . . . 0.625 ' O ' HG13 ' A' ' 758' ' ' ILE . 14.1 mt -128.62 114.28 32.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 177.494 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 793' ' ' LEU . . . . . 0.536 HD12 ' N ' ' A' ' 794' ' ' SER . 0.7 OUTLIER -84.62 113.44 21.27 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.122 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 794' ' ' SER . . . . . 0.536 ' N ' HD12 ' A' ' 793' ' ' LEU . 13.7 p -124.68 164.34 20.1 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.344 -1.298 . . . . 0.0 109.315 -174.647 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 795' ' ' LEU . . . . . 0.619 HD11 ' O ' ' A' ' 723' ' ' ALA . 36.7 mt -89.4 144.85 25.74 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.688 -0.233 . . . . 0.0 110.942 -176.528 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 796' ' ' VAL . . . . . . . . . . . . . 68.8 t -104.88 -57.68 4.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.159 177.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 797' ' ' SER . . . . . 0.504 ' HA ' ' HG ' ' A' ' 808' ' ' LEU . 10.4 m -176.95 161.53 1.96 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.978 -175.283 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 798' ' ' ILE . . . . . 0.557 ' HA ' ' O ' ' A' ' 752' ' ' THR . 11.7 tt -132.07 162.11 40.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 176.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 799' ' ' LYS . . . . . 0.771 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 5.2 tmtt? -137.4 119.84 15.91 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.097 0.475 . . . . 0.0 111.024 -178.819 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 800' ' ' ASP . . . . . 0.501 ' HA ' ' CD2' ' A' ' 751' ' ' PHE . 11.7 t70 -64.23 153.0 39.36 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.256 -0.884 . . . . 0.0 108.982 174.046 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 3.5 p -68.02 0.92 3.08 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -173.676 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 24.3 p -92.95 -0.46 57.21 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.657 0.741 . . . . 0.0 109.511 172.123 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 803' ' ' GLY . . . . . 0.45 ' HA2' ' HE2' ' A' ' 799' ' ' LYS . . . 81.05 41.92 9.97 Favored Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.8 -177.459 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 804' ' ' CYS . . . . . . . . . . . . . 63.4 m -113.78 114.22 26.02 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 805' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 8.3 p -86.52 134.25 27.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.313 0.578 . . . . 0.0 110.831 -177.558 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 806' ' ' VAL . . . . . . . . . . . . . 53.2 t -123.04 134.84 64.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.717 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.365 178.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -66.24 127.29 29.5 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 114.816 -1.084 . . . . 0.0 111.939 -179.645 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 808' ' ' LEU . . . . . 0.744 ' CD2' ' HA ' ' A' ' 722' ' ' SER . 45.6 mt -90.81 126.62 36.08 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -177.628 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 5.6 p -149.47 85.95 1.46 Allowed 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 121.522 0.677 . . . . 0.0 110.97 173.407 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 810' ' ' GLN . . . . . 0.63 ' HB2' ' O ' ' A' ' 723' ' ' ALA . 90.8 mt-30 -140.5 168.02 15.93 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 172.72 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 811' ' ' PRO . . . . . 0.524 ' HD2' ' HB3' ' A' ' 810' ' ' GLN . 86.6 Cg_exo -45.34 137.33 10.88 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 123.098 2.532 . . . . 0.0 115.228 -173.796 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -103.25 166.72 10.26 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.303 177.835 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 813' ' ' ALA . . . . . . . . . . . . . . . -119.68 161.11 21.24 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.245 -177.175 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 814' ' ' LYS . . . . . 0.449 ' O ' ' HA ' ' A' ' 730' ' ' ASP . 73.9 tttt -123.98 125.2 44.16 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 121.163 0.506 . . . . 0.0 110.834 177.849 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 815' ' ' ILE . . . . . 0.537 ' HA ' ' HB3' ' A' ' 731' ' ' LEU . 5.3 mp -109.39 119.24 58.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 176.532 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 816' ' ' GLN . . . . . 0.557 ' OE1' ' HG2' ' A' ' 818' ' ' ARG . 0.1 OUTLIER -108.95 114.51 28.33 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.217 0.532 . . . . 0.0 111.062 -174.748 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 817' ' ' VAL . . . . . 0.706 HG12 ' HA2' ' A' ' 788' ' ' GLY . 84.4 t -103.97 140.52 21.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.316 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 818' ' ' ARG . . . . . 0.557 ' HG2' ' OE1' ' A' ' 816' ' ' GLN . 34.1 mmt180 . . . . . 0 C--N 1.322 -0.594 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 172.551 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 720' ' ' LYS . . . . . . . . . . . . . 16.7 mtpp . . . . . 0 N--CA 1.444 -0.746 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 721' ' ' PRO . . . . . 0.427 ' HG3' ' CE2' ' A' ' 751' ' ' PHE . 60.6 Cg_endo -88.5 154.93 6.48 Favored 'Trans proline' 0 N--CA 1.447 -1.217 0 C-N-CA 122.713 2.275 . . . . 0.0 112.472 -174.209 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 722' ' ' SER . . . . . 0.51 ' HA ' ' CD2' ' A' ' 808' ' ' LEU . 11.4 t 178.49 -152.4 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.871 -176.677 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 723' ' ' ALA . . . . . 0.639 ' HA ' ' HA ' ' A' ' 745' ' ' LEU . . . -152.53 153.65 33.87 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 178.779 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 49.7 m -144.45 98.67 3.24 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.213 0.53 . . . . 0.0 109.634 175.221 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 725' ' ' LEU . . . . . 0.535 ' HA ' ' HA ' ' A' ' 743' ' ' VAL . 4.9 mp -62.38 141.45 58.32 Favored 'General case' 0 N--CA 1.424 -1.747 0 CA-C-O 122.4 1.095 . . . . 0.0 111.808 -175.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 726' ' ' LYS . . . . . 0.522 ' HD2' ' HB2' ' A' ' 744' ' ' ALA . 19.2 mtpp -94.79 -13.02 26.02 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 112.887 -1.96 . . . . 0.0 110.288 -173.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 727' ' ' LEU . . . . . 0.554 ' HB2' ' HD2' ' A' ' 742' ' ' PRO . 0.9 OUTLIER -82.3 112.38 19.24 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 176.096 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 56.3 m80 -114.67 54.25 0.78 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.713 0.635 . . . . 0.0 112.713 -172.417 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 7.6 p80 -178.15 -178.08 0.63 Allowed 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.762 -0.199 . . . . 0.0 110.492 176.679 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 730' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -81.58 125.84 31.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.303 176.457 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 731' ' ' LEU . . . . . 0.6 ' HB2' ' HA ' ' A' ' 815' ' ' ILE . 21.2 mt -79.95 113.14 17.89 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.215 177.712 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 732' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -76.61 109.94 10.78 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.092 -176.726 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 733' ' ' LEU . . . . . 0.815 HD12 HG22 ' A' ' 817' ' ' VAL . 64.3 mt -122.94 164.21 18.92 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.16 0.505 . . . . 0.0 110.864 177.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 734' ' ' CYS . . . . . 0.517 ' O ' ' HB2' ' A' ' 737' ' ' ASP . 76.3 m -113.75 -174.28 2.44 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.023 170.862 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 735' ' ' LEU . . . . . . . . . . . . . 8.6 tp -68.37 135.24 51.5 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 121.448 0.642 . . . . 0.0 111.898 -176.425 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 81.37 8.74 86.77 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 114.854 -1.066 . . . . 0.0 111.996 -178.42 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 737' ' ' ASP . . . . . 0.517 ' HB2' ' O ' ' A' ' 734' ' ' CYS . 4.1 m-20 -89.67 151.48 21.85 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 179.319 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 738' ' ' HIS . . . . . 0.444 ' HB2' ' O ' ' A' ' 782' ' ' THR . 45.4 p-80 -114.2 -175.53 2.7 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 169.428 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 739' ' ' SER . . . . . 0.594 ' OG ' HD11 ' A' ' 733' ' ' LEU . 9.2 m -141.55 174.39 10.61 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.567 0.698 . . . . 0.0 112.471 178.021 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 740' ' ' SER . . . . . 0.415 ' HA ' ' O ' ' A' ' 780' ' ' ILE . 14.1 t -141.67 103.04 4.3 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.489 178.251 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 741' ' ' VAL . . . . . 0.692 HG11 HD23 ' A' ' 793' ' ' LEU . 1.7 p -107.57 114.65 60.36 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.642 -175.542 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 742' ' ' PRO . . . . . 0.651 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 1.0 OUTLIER -73.64 129.19 13.34 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 122.488 2.126 . . . . 0.0 111.286 179.403 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 743' ' ' VAL . . . . . 0.535 ' HA ' ' HA ' ' A' ' 725' ' ' LEU . 1.5 p -128.53 119.92 51.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.308 0.575 . . . . 0.0 111.759 175.014 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 744' ' ' ALA . . . . . 0.583 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -85.1 105.51 15.88 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 169.626 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 745' ' ' LEU . . . . . 0.817 HD13 HD13 ' A' ' 773' ' ' ILE . 0.4 OUTLIER -85.23 168.0 15.15 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.156 -167.403 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 12.3 tttp -121.23 155.43 34.63 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.678 0.752 . . . . 0.0 110.724 -177.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 747' ' ' GLY . . . . . . . . . . . . . . . 97.66 135.92 8.92 Favored Glycine 0 C--N 1.306 -1.121 0 CA-C-N 114.441 -1.254 . . . . 0.0 111.229 -178.317 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 60.9 mm-40 -106.46 116.74 32.46 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.858 -173.785 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 130.28 164.77 11.42 Favored Glycine 0 CA--C 1.496 -1.114 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.518 -175.566 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 750' ' ' PRO . . . . . 0.573 ' HB3' ' HE2' ' A' ' 774' ' ' LYS . 46.2 Cg_endo -60.31 94.08 0.1 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 123.388 2.725 . . . . 0.0 111.768 172.522 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 751' ' ' PHE . . . . . 0.467 ' CE2' ' HA ' ' A' ' 800' ' ' ASP . 44.0 m-85 -105.0 143.34 33.32 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.103 -177.149 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 752' ' ' THR . . . . . 0.783 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 93.0 m -88.44 102.97 15.42 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 121.563 0.697 . . . . 0.0 109.137 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 753' ' ' LEU . . . . . 0.438 HD22 HD22 ' A' ' 745' ' ' LEU . 23.6 tp -93.3 117.81 30.52 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.844 -169.804 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 754' ' ' THR . . . . . 0.501 HG23 ' HB2' ' A' ' 769' ' ' GLU . 1.4 m -117.99 132.11 56.42 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.707 0.289 . . . . 0.0 110.642 179.518 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 755' ' ' TYR . . . . . 0.551 ' CE1' ' HB3' ' A' ' 768' ' ' PHE . 24.1 p90 -142.45 156.94 45.22 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.89 0.376 . . . . 0.0 111.438 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 756' ' ' ASP . . . . . 0.526 ' HB3' HG23 ' A' ' 758' ' ' ILE . 0.1 OUTLIER -119.76 118.83 31.89 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.526 -179.282 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 757' ' ' ILE . . . . . 0.567 ' CD1' HD13 ' A' ' 793' ' ' LEU . 3.6 mp -87.22 96.39 5.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 167.348 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 758' ' ' ILE . . . . . 0.526 HG23 ' HB3' ' A' ' 756' ' ' ASP . 2.4 pp -96.08 144.33 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.562 -171.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 759' ' ' GLU . . . . . 0.458 ' O ' ' HG3' ' A' ' 759' ' ' GLU . 5.6 pt-20 -95.64 124.37 39.63 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 119.47 -0.892 . . . . 0.0 109.988 177.138 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 760' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.314 -0.975 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 177.44 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 765' ' ' ARG . . . . . 0.449 ' HA ' ' HA ' ' A' ' 758' ' ' ILE . 42.4 mtm180 . . . . . 0 C--O 1.235 0.329 0 CA-C-O 120.916 0.389 . . . . 0.0 111.443 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 766' ' ' LYS . . . . . 0.478 ' O ' ' HA ' ' A' ' 756' ' ' ASP . 1.0 OUTLIER -121.44 136.05 55.0 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.018 -179.037 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 767' ' ' THR . . . . . . . . . . . . . 60.7 m -115.38 136.73 52.79 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.89 -175.22 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 768' ' ' PHE . . . . . 0.551 ' HB3' ' CE1' ' A' ' 755' ' ' TYR . 2.8 t80 -138.33 135.68 35.65 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 175.696 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 769' ' ' GLU . . . . . 0.501 ' HB2' HG23 ' A' ' 754' ' ' THR . 33.2 tt0 -127.17 133.15 50.36 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.117 -179.277 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 770' ' ' ILE . . . . . 0.413 HG22 HG22 ' A' ' 773' ' ' ILE . 4.1 mt -123.9 109.04 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 175.839 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 771' ' ' LYS . . . . . 0.609 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 9.6 mtpt -80.12 151.59 29.73 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-O 121.35 0.595 . . . . 0.0 111.035 -176.162 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 772' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 55.35 50.66 14.41 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.312 -1.313 . . . . 0.0 112.393 176.08 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 773' ' ' ILE . . . . . 0.817 HD13 HD13 ' A' ' 745' ' ' LEU . 0.5 OUTLIER -74.99 122.07 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 170.989 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 774' ' ' LYS . . . . . 0.573 ' HE2' ' HB3' ' A' ' 750' ' ' PRO . 65.5 mttt -115.38 25.42 10.84 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.364 -0.835 . . . . 0.0 108.818 -176.329 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 775' ' ' THR . . . . . 0.692 ' H ' HD12 ' A' ' 773' ' ' ILE . 0.7 OUTLIER -96.33 -73.36 0.6 Allowed 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -169.551 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 776' ' ' ASN . . . . . 0.629 ' HB2' ' O ' ' A' ' 775' ' ' THR . 0.7 OUTLIER 85.97 3.65 0.53 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.548 1.139 . . . . 0.0 111.242 -173.345 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 777' ' ' GLU . . . . . 0.583 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 30.0 mt-10 -161.27 84.64 0.65 Allowed 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 177.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 778' ' ' TYR . . . . . 0.686 ' HB3' HD11 ' A' ' 745' ' ' LEU . 89.9 t80 -132.72 133.01 42.94 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.897 -169.588 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 779' ' ' VAL . . . . . 0.651 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 12.2 t -93.5 114.36 30.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.465 0.65 . . . . 0.0 110.555 179.614 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 780' ' ' ILE . . . . . 0.548 ' HB ' HG13 ' A' ' 741' ' ' VAL . 70.6 mt -79.4 147.52 6.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.606 -177.714 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 781' ' ' LYS . . . . . 0.43 ' HD3' ' C ' ' A' ' 780' ' ' ILE . 0.0 OUTLIER -117.89 100.67 7.73 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 175.222 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 782' ' ' THR . . . . . 0.493 ' OG1' ' HB2' ' A' ' 739' ' ' SER . 62.1 p -70.16 135.19 87.08 Favored Pre-proline 0 N--CA 1.441 -0.884 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.633 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 783' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 782' ' ' THR . 25.5 Cg_exo -62.66 156.21 54.28 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.793 2.329 . . . . 0.0 111.303 -175.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 784' ' ' VAL . . . . . . . . . . . . . 14.6 p -58.64 127.87 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 CA-C-O 121.489 0.661 . . . . 0.0 109.974 -177.745 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 785' ' ' PHE . . . . . 0.454 ' C ' ' H ' ' A' ' 787' ' ' THR . 94.7 m-85 -81.88 -31.83 31.33 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.419 -172.122 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 43.1 p 56.64 2.49 0.1 Allowed 'General case' 0 N--CA 1.471 0.59 0 O-C-N 124.065 0.853 . . . . 0.0 112.233 178.175 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 787' ' ' THR . . . . . 0.454 ' H ' ' C ' ' A' ' 785' ' ' PHE . 14.8 m -139.93 122.91 16.68 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.05 -179.487 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 788' ' ' GLY . . . . . . . . . . . . . . . -58.76 111.23 3.11 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.304 168.358 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 789' ' ' GLY . . . . . 0.459 ' H ' ' HB ' ' A' ' 817' ' ' VAL . . . -166.89 167.21 39.58 Favored Glycine 0 N--CA 1.442 -0.916 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 178.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -99.11 130.98 45.47 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 117.674 0.737 . . . . 0.0 109.72 -179.482 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 791' ' ' TYR . . . . . 0.438 ' CE2' ' HB3' ' A' ' 759' ' ' GLU . 86.9 m-85 -124.3 153.48 41.68 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.29 0.567 . . . . 0.0 110.885 -178.407 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 792' ' ' ILE . . . . . 0.484 ' O ' HG13 ' A' ' 758' ' ' ILE . 7.2 mt -130.72 113.97 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 CA-C-N 115.283 -0.871 . . . . 0.0 108.944 176.113 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 793' ' ' LEU . . . . . 0.692 HD23 HG11 ' A' ' 741' ' ' VAL . 1.3 tp -84.74 110.68 18.97 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 176.389 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 794' ' ' SER . . . . . 0.492 ' N ' HD12 ' A' ' 793' ' ' LEU . 6.1 p -124.7 157.5 35.49 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.53 -1.214 . . . . 0.0 109.729 -173.472 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 795' ' ' LEU . . . . . 0.509 ' CD2' ' HB3' ' A' ' 723' ' ' ALA . 51.4 mt -85.29 133.39 34.16 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.57 -0.287 . . . . 0.0 111.147 -174.42 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 796' ' ' VAL . . . . . . . . . . . . . 79.2 t -95.62 -55.06 6.45 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.715 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 797' ' ' SER . . . . . 0.566 ' HA ' ' HG ' ' A' ' 808' ' ' LEU . 97.5 p -176.7 158.55 1.71 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.988 -173.776 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 798' ' ' ILE . . . . . 0.503 ' HA ' ' O ' ' A' ' 752' ' ' THR . 8.0 tt -131.01 163.88 35.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 176.182 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 799' ' ' LYS . . . . . 0.783 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 16.5 ttmt -140.91 125.82 18.2 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.06 0.457 . . . . 0.0 111.503 -177.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 800' ' ' ASP . . . . . 0.467 ' HA ' ' CE2' ' A' ' 751' ' ' PHE . 28.2 t70 -65.98 155.77 35.61 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.517 174.024 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 801' ' ' SER . . . . . 0.458 ' HB3' ' HG2' ' A' ' 750' ' ' PRO . 18.2 p -59.03 -10.05 2.33 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -171.298 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 36.1 p -96.76 8.83 43.39 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.37 0.605 . . . . 0.0 110.324 179.078 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 803' ' ' GLY . . . . . . . . . . . . . . . 76.17 41.37 26.83 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.038 -178.563 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 804' ' ' CYS . . . . . 0.429 ' HB2' ' HB3' ' A' ' 800' ' ' ASP . 76.7 m -109.72 111.74 23.38 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 178.247 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 805' ' ' VAL . . . . . 0.438 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 14.4 p -86.25 139.46 17.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.422 0.63 . . . . 0.0 111.702 -174.758 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 806' ' ' VAL . . . . . 0.494 ' HB ' HG22 ' A' ' 798' ' ' ILE . 52.0 t -119.21 131.99 70.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.551 177.318 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -72.99 114.07 4.62 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.791 179.05 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 808' ' ' LEU . . . . . 0.566 ' HG ' ' HA ' ' A' ' 797' ' ' SER . 36.0 mt -84.9 124.46 31.66 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -173.449 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 19.1 t -138.98 86.51 2.14 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.241 171.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 810' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -146.91 173.55 4.11 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.873 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 811' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_exo -43.53 144.36 2.12 Favored 'Trans proline' 0 C--N 1.357 1.019 0 C-N-CA 123.618 2.879 . . . . 0.0 115.812 -173.068 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -116.22 169.1 9.54 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 114.554 -1.203 . . . . 0.0 110.546 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 813' ' ' ALA . . . . . . . . . . . . . . . -120.68 160.15 23.87 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.994 175.528 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 814' ' ' LYS . . . . . 0.468 ' HG2' ' CG1' ' A' ' 792' ' ' ILE . 48.3 mttp -123.62 134.31 53.81 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.451 0.643 . . . . 0.0 110.648 177.55 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 815' ' ' ILE . . . . . 0.6 ' HA ' ' HB2' ' A' ' 731' ' ' LEU . 5.3 mp -121.16 108.48 22.66 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 CA-C-N 115.055 -0.975 . . . . 0.0 108.898 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 816' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -100.87 108.01 19.68 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.257 0.551 . . . . 0.0 110.441 -176.312 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 817' ' ' VAL . . . . . 0.815 HG22 HD12 ' A' ' 733' ' ' LEU . 2.9 t -101.91 146.86 9.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -179.312 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 818' ' ' ARG . . . . . . . . . . . . . 20.7 tpt180 . . . . . 0 C--N 1.323 -0.587 0 CA-C-O 121.467 0.651 . . . . 0.0 112.175 -178.396 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 718' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? . . . . . 0 CA--C 1.509 -0.617 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 719' ' ' VAL . . . . . 0.543 ' O ' ' HD3' ' A' ' 721' ' ' PRO . 1.9 m -133.62 149.72 31.22 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.569 -178.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 720' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -96.46 98.83 4.64 Favored Pre-proline 0 C--N 1.304 -1.41 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.373 175.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 721' ' ' PRO . . . . . 0.543 ' HD3' ' O ' ' A' ' 719' ' ' VAL . 62.7 Cg_endo -87.62 155.97 7.67 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 122.948 2.432 . . . . 0.0 112.071 -174.296 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 722' ' ' SER . . . . . 0.588 ' HA ' HD22 ' A' ' 808' ' ' LEU . 12.7 t -176.77 -146.42 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -174.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 723' ' ' ALA . . . . . 0.521 ' HA ' ' HA ' ' A' ' 745' ' ' LEU . . . -153.24 149.31 27.82 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.658 0.266 . . . . 0.0 110.621 177.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 70.6 m -135.11 98.42 3.99 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 725' ' ' LEU . . . . . 0.578 HD22 ' CG2' ' A' ' 743' ' ' VAL . 2.3 mt -64.67 141.91 58.61 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.571 -171.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 33.3 mtpt -93.47 -22.51 18.83 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.043 -176.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 727' ' ' LEU . . . . . 0.491 ' HB2' ' HD2' ' A' ' 742' ' ' PRO . 0.2 OUTLIER -70.24 108.7 4.29 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 173.771 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 34.2 m170 -104.78 42.93 1.15 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -169.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 729' ' ' HIS . . . . . 0.403 ' O ' HD12 ' A' ' 727' ' ' LEU . 6.7 p80 -179.45 -177.21 0.42 Allowed 'General case' 0 C--N 1.327 -0.402 0 O-C-N 123.238 0.336 . . . . 0.0 110.279 176.004 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 730' ' ' ASP . . . . . 0.492 ' HB3' ' HE2' ' A' ' 814' ' ' LYS . 5.0 p-10 -78.47 153.96 30.96 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.075 0.464 . . . . 0.0 110.86 179.198 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 731' ' ' LEU . . . . . 0.565 ' HB2' ' HA ' ' A' ' 815' ' ' ILE . 49.1 mt -102.53 137.35 40.88 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.672 178.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 732' ' ' LYS . . . . . . . . . . . . . 35.2 mmtm -104.12 103.83 13.67 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.155 0.503 . . . . 0.0 110.901 177.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 733' ' ' LEU . . . . . 0.585 HD22 HG23 ' A' ' 815' ' ' ILE . 0.8 OUTLIER -112.01 164.17 13.44 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.725 -178.972 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 734' ' ' CYS . . . . . 0.632 ' O ' ' HB2' ' A' ' 737' ' ' ASP . 56.6 m -104.65 -176.8 3.18 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 171.555 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 735' ' ' LEU . . . . . 0.578 HD13 ' HD2' ' A' ' 819' ' ' ARG . 10.3 tt -84.28 137.23 33.57 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 119.767 -0.773 . . . . 0.0 109.639 -175.21 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 82.97 8.02 86.36 Favored Glycine 0 N--CA 1.441 -0.989 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.845 -171.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 737' ' ' ASP . . . . . 0.632 ' HB2' ' O ' ' A' ' 734' ' ' CYS . 0.5 OUTLIER -93.27 145.9 24.1 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.13 0.49 . . . . 0.0 111.546 177.262 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 738' ' ' HIS . . . . . 0.532 ' HB2' ' O ' ' A' ' 782' ' ' THR . 40.8 p-80 -110.76 175.82 5.28 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 170.173 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 739' ' ' SER . . . . . 0.409 ' CB ' HD21 ' A' ' 733' ' ' LEU . 0.0 OUTLIER -132.19 173.02 11.68 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 120.019 -0.672 . . . . 0.0 111.883 -177.344 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 36.8 m -143.03 106.82 4.65 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.032 -0.986 . . . . 0.0 109.702 178.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 741' ' ' VAL . . . . . 0.604 HG11 HD23 ' A' ' 793' ' ' LEU . 0.8 OUTLIER -110.32 111.92 57.41 Favored Pre-proline 0 C--N 1.318 -0.771 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.177 -176.871 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 742' ' ' PRO . . . . . 0.792 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 4.0 Cg_exo -72.16 131.29 17.69 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 122.434 2.089 . . . . 0.0 111.249 -179.378 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 743' ' ' VAL . . . . . 0.578 ' CG2' HD22 ' A' ' 725' ' ' LEU . 41.2 t -131.3 118.05 38.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.503 0.668 . . . . 0.0 112.742 -179.187 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 744' ' ' ALA . . . . . 0.614 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -82.75 97.42 8.57 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 122.009 0.909 . . . . 0.0 108.621 170.533 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 745' ' ' LEU . . . . . 0.739 HD11 ' HB3' ' A' ' 778' ' ' TYR . 2.5 mt -76.72 159.72 29.93 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 113.972 -1.467 . . . . 0.0 111.86 -168.528 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -111.61 146.78 36.8 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.08 -178.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 747' ' ' GLY . . . . . 0.435 ' HA3' ' HB3' ' A' ' 721' ' ' PRO . . . 103.24 119.87 4.68 Favored Glycine 0 C--N 1.304 -1.204 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.622 -178.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 748' ' ' GLN . . . . . 0.429 ' C ' ' HE1' ' A' ' 751' ' ' PHE . 0.0 OUTLIER -105.43 110.01 22.2 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.138 0.494 . . . . 0.0 111.2 -173.415 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 136.23 -175.68 20.76 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.877 -176.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -71.04 94.1 0.64 Allowed 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.397 2.064 . . . . 0.0 111.865 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 751' ' ' PHE . . . . . 0.574 ' HA ' ' O ' ' A' ' 799' ' ' LYS . 88.1 m-85 -113.2 140.46 47.92 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.368 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 752' ' ' THR . . . . . 0.682 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 98.0 m -89.92 104.99 17.5 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 121.556 0.693 . . . . 0.0 109.243 178.237 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 753' ' ' LEU . . . . . . . . . . . . . 21.3 tp -92.24 116.96 29.41 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 114.374 -1.285 . . . . 0.0 110.532 -172.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 754' ' ' THR . . . . . 0.453 HG23 ' HB2' ' A' ' 769' ' ' GLU . 0.9 OUTLIER -117.88 130.18 56.09 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.21 179.241 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 755' ' ' TYR . . . . . 0.565 ' CE1' ' HB3' ' A' ' 768' ' ' PHE . 20.8 p90 -139.43 153.8 47.66 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 120.741 -0.384 . . . . 0.0 111.582 -179.375 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 756' ' ' ASP . . . . . 0.488 ' HB2' HG23 ' A' ' 758' ' ' ILE . 7.6 p-10 -114.93 118.85 34.62 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.823 -176.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 757' ' ' ILE . . . . . 0.513 HG13 HD13 ' A' ' 793' ' ' LEU . 3.6 mp -91.68 95.36 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 167.462 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 758' ' ' ILE . . . . . 0.527 HG13 ' O ' ' A' ' 792' ' ' ILE . 2.3 pp -103.93 149.67 7.62 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.061 -170.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 759' ' ' GLU . . . . . 0.599 ' CG ' ' H ' ' A' ' 764' ' ' LYS . 8.3 pt-20 -96.89 135.28 39.1 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.364 177.386 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 760' ' ' THR . . . . . 0.48 ' OG1' ' HB3' ' A' ' 790' ' ' ASP . 38.7 p -81.42 -4.11 54.84 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-O 121.904 0.859 . . . . 0.0 108.684 174.292 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 761' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -73.51 -35.7 65.63 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 114.139 -1.391 . . . . 0.0 110.534 -176.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 762' ' ' SER . . . . . . . . . . . . . 16.2 t -169.05 -80.75 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 176.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 763' ' ' SER . . . . . . . . . . . . . 23.5 t -166.86 27.04 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 112.716 0.635 . . . . 0.0 112.716 -173.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 764' ' ' LYS . . . . . 0.599 ' H ' ' CG ' ' A' ' 759' ' ' GLU . 40.0 mttp -84.03 52.54 2.33 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 121.651 -0.656 . . . . 0.0 110.039 176.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 765' ' ' ARG . . . . . 0.473 ' CG ' HG22 ' A' ' 758' ' ' ILE . 15.2 ttp180 -62.32 120.62 11.36 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.88 -178.287 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 766' ' ' LYS . . . . . 0.584 ' HD3' ' N ' ' A' ' 767' ' ' THR . 9.3 tmtm? -97.99 144.11 27.85 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 177.202 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 767' ' ' THR . . . . . 0.584 ' N ' ' HD3' ' A' ' 766' ' ' LYS . 60.0 m -132.3 132.61 43.16 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.603 -178.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 768' ' ' PHE . . . . . 0.565 ' HB3' ' CE1' ' A' ' 755' ' ' TYR . 1.7 t80 -130.83 136.25 48.49 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 769' ' ' GLU . . . . . 0.453 ' HB2' HG23 ' A' ' 754' ' ' THR . 35.1 tt0 -128.83 118.71 23.19 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.954 -177.413 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 770' ' ' ILE . . . . . 0.437 HG22 HG22 ' A' ' 773' ' ' ILE . 7.7 mt -115.68 112.26 39.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 178.146 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 771' ' ' LYS . . . . . 0.635 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 3.1 mtpt -82.25 150.61 27.21 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 121.431 0.634 . . . . 0.0 111.528 -176.347 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 772' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 56.21 48.32 17.6 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 113.985 -1.462 . . . . 0.0 112.549 176.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 773' ' ' ILE . . . . . 0.668 HD12 ' H ' ' A' ' 775' ' ' THR . 0.5 OUTLIER -74.58 119.09 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 173.215 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 76.2 mttt -117.91 31.32 6.76 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -178.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 775' ' ' THR . . . . . 0.668 ' H ' HD12 ' A' ' 773' ' ' ILE . 2.1 m -95.74 -69.99 0.73 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.388 -1.278 . . . . 0.0 112.55 -172.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 776' ' ' ASN . . . . . 0.579 ' HB2' ' O ' ' A' ' 775' ' ' THR . 0.9 OUTLIER 82.78 4.43 1.0 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.825 0.85 . . . . 0.0 110.547 -177.092 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 777' ' ' GLU . . . . . 0.614 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 9.4 mt-10 -160.88 85.8 0.7 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.344 175.492 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 778' ' ' TYR . . . . . 0.739 ' HB3' HD11 ' A' ' 745' ' ' LEU . 75.6 t80 -136.26 126.97 27.24 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.258 -172.09 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 779' ' ' VAL . . . . . 0.792 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 1.6 m -91.52 126.4 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 CA-C-O 122.435 1.112 . . . . 0.0 110.612 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 780' ' ' ILE . . . . . . . . . . . . . 71.0 mt -89.22 145.32 7.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 113.543 -1.662 . . . . 0.0 110.954 -172.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -112.75 115.45 28.54 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 175.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 782' ' ' THR . . . . . 0.532 ' O ' ' HB2' ' A' ' 738' ' ' HIS . 22.9 p -89.43 140.48 28.45 Favored Pre-proline 0 C--N 1.309 -1.158 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.674 -178.253 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 783' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.02 156.56 28.5 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.641 2.894 . . . . 0.0 112.655 -174.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 784' ' ' VAL . . . . . . . . . . . . . 15.0 p -62.9 135.31 27.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.126 -176.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 785' ' ' PHE . . . . . 0.401 ' CB ' HG21 ' A' ' 817' ' ' VAL . 69.1 m-85 -105.04 102.72 12.21 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.744 179.349 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 81.4 p -84.54 19.35 1.99 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.386 -174.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -159.42 119.05 2.98 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.211 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 788' ' ' GLY . . . . . 0.785 ' HA2' HG12 ' A' ' 817' ' ' VAL . . . -46.08 116.29 2.11 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.431 -0.804 . . . . 0.0 113.571 170.233 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 789' ' ' GLY . . . . . 0.511 ' H ' ' HB ' ' A' ' 817' ' ' VAL . . . -156.8 -162.31 11.4 Favored Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 177.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 790' ' ' ASP . . . . . 0.48 ' HB3' ' OG1' ' A' ' 760' ' ' THR . 16.5 t70 -130.54 122.09 26.92 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.361 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 791' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -127.55 153.39 46.42 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.379 -174.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 792' ' ' ILE . . . . . 0.527 ' O ' HG13 ' A' ' 758' ' ' ILE . 19.2 mt -127.85 124.74 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 176.166 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 793' ' ' LEU . . . . . 0.604 HD23 HG11 ' A' ' 741' ' ' VAL . 1.2 tp -90.67 112.25 23.92 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 173.573 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 794' ' ' SER . . . . . 0.518 ' N ' HD12 ' A' ' 793' ' ' LEU . 9.4 t -118.79 175.16 5.88 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 114.451 -1.25 . . . . 0.0 108.492 -176.502 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 795' ' ' LEU . . . . . 0.545 HD21 HD21 ' A' ' 725' ' ' LEU . 21.5 mt -103.74 127.88 51.16 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 -178.318 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 796' ' ' VAL . . . . . . . . . . . . . 55.6 t -86.71 -57.6 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 CA-C-O 120.865 0.364 . . . . 0.0 110.773 -177.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 797' ' ' SER . . . . . 0.586 ' HA ' ' HG ' ' A' ' 808' ' ' LEU . 27.3 m -174.64 156.23 2.33 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.61 -173.469 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 798' ' ' ILE . . . . . 0.574 ' HA ' ' O ' ' A' ' 752' ' ' THR . 11.8 tt -128.8 168.06 22.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 176.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 799' ' ' LYS . . . . . 0.682 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 42.9 tttp -139.62 121.89 15.95 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 120.739 -0.384 . . . . 0.0 111.312 -174.102 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 800' ' ' ASP . . . . . 0.546 ' HA ' ' CD2' ' A' ' 751' ' ' PHE . 12.6 t70 -69.22 156.94 37.9 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.236 176.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 27.4 t -64.6 -10.9 29.7 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 123.759 0.662 . . . . 0.0 112.208 -174.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 13.9 t -90.95 2.26 56.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.991 0.9 . . . . 0.0 109.137 175.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 803' ' ' GLY . . . . . 0.452 ' HA2' ' HE3' ' A' ' 799' ' ' LYS . . . 81.71 46.79 6.6 Favored Glycine 0 N--CA 1.44 -1.061 0 CA-C-N 114.764 -1.107 . . . . 0.0 111.781 -178.414 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 804' ' ' CYS . . . . . 0.459 ' HB3' ' HB3' ' A' ' 800' ' ' ASP . 42.7 t -114.12 113.23 24.42 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.39 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 805' ' ' VAL . . . . . 0.525 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 8.4 p -85.03 129.93 36.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.346 0.593 . . . . 0.0 110.549 -177.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 806' ' ' VAL . . . . . 0.485 ' HB ' HG22 ' A' ' 798' ' ' ILE . 74.0 t -112.97 133.61 58.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.022 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -69.87 113.34 4.94 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.755 178.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 808' ' ' LEU . . . . . 0.588 HD22 ' HA ' ' A' ' 722' ' ' SER . 38.0 mt -84.55 125.05 32.08 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -175.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 23.2 t -144.51 87.14 1.85 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.169 172.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 810' ' ' GLN . . . . . 0.494 ' HB3' ' HD2' ' A' ' 811' ' ' PRO . 10.6 mt-30 -143.88 171.22 7.11 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.132 178.067 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 811' ' ' PRO . . . . . 0.523 ' O ' ' HG ' ' A' ' 725' ' ' LEU . 79.2 Cg_exo -42.73 139.68 3.16 Favored 'Trans proline' 0 C--N 1.356 0.925 0 C-N-CA 123.045 2.497 . . . . 0.0 114.826 -171.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -112.19 167.71 10.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.642 -177.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 813' ' ' ALA . . . . . 0.414 ' N ' HD12 ' A' ' 725' ' ' LEU . . . -118.19 155.85 29.78 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.604 179.129 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 814' ' ' LYS . . . . . 0.492 ' HE2' ' HB3' ' A' ' 730' ' ' ASP . 12.0 ttpt -121.24 134.42 55.18 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.137 -0.625 . . . . 0.0 110.528 176.29 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 815' ' ' ILE . . . . . 0.585 HG23 HD22 ' A' ' 733' ' ' LEU . 4.6 mp -116.38 108.15 24.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-N 115.21 -0.905 . . . . 0.0 108.68 177.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 816' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -103.05 108.43 19.6 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.545 0.688 . . . . 0.0 109.629 -178.507 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 817' ' ' VAL . . . . . 0.785 HG12 ' HA2' ' A' ' 788' ' ' GLY . 90.4 t -98.36 139.5 20.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.168 -177.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 818' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 -126.83 175.83 7.73 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 178.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 819' ' ' ARG . . . . . 0.578 ' HD2' HD13 ' A' ' 735' ' ' LEU . 46.6 ttt180 -114.74 114.15 25.23 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.123 0.487 . . . . 0.0 110.948 -179.333 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 820' ' ' ASP . . . . . 0.477 ' OD1' ' HB3' ' A' ' 734' ' ' CYS . 11.9 p-10 . . . . . 0 C--N 1.321 -0.643 0 CA-C-N 115.568 -0.742 . . . . 99.989999999999995 110.011 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 718' ' ' ARG . . . . . . . . . . . . . 25.6 tpt180 . . . . . 0 N--CA 1.447 -0.601 0 CA-C-O 121.656 0.741 . . . . 0.0 109.979 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 719' ' ' VAL . . . . . 0.42 ' O ' ' HD3' ' A' ' 721' ' ' PRO . 4.4 p -141.73 150.15 19.57 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-N 114.728 -1.124 . . . . 0.0 108.824 -177.371 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 720' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -81.18 104.94 3.3 Favored Pre-proline 0 C--N 1.308 -1.231 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.545 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 721' ' ' PRO . . . . . 0.467 ' HD2' HG21 ' A' ' 806' ' ' VAL . 63.3 Cg_endo -87.62 152.41 7.57 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 122.977 2.451 . . . . 0.0 112.401 -172.334 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 722' ' ' SER . . . . . 0.458 ' OG ' ' HG ' ' A' ' 808' ' ' LEU . 15.0 t -176.66 -148.5 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -174.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 723' ' ' ALA . . . . . 0.58 ' HA ' ' HA ' ' A' ' 745' ' ' LEU . . . -157.18 155.41 30.88 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 20.8 p -147.47 107.53 4.02 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.969 0.414 . . . . 0.0 109.894 174.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 725' ' ' LEU . . . . . 0.589 ' CD2' ' HB ' ' A' ' 743' ' ' VAL . 14.6 mt -62.96 145.62 54.91 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 121.591 0.71 . . . . 0.0 111.683 -175.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 726' ' ' LYS . . . . . 0.448 ' HB3' ' HE2' ' A' ' 726' ' ' LYS . 29.9 mtpt -95.85 -17.63 20.98 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.13 -177.13 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 727' ' ' LEU . . . . . 0.582 HD23 ' HB1' ' A' ' 813' ' ' ALA . 37.1 tp -67.15 115.14 6.5 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.213 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 34.5 m80 -109.48 30.02 7.02 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.968 0.413 . . . . 0.0 111.742 -176.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -162.23 179.9 7.54 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 175.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 730' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -91.72 143.47 26.51 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.023 0.439 . . . . 0.0 110.315 -178.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 731' ' ' LEU . . . . . 0.588 ' HB2' ' HA ' ' A' ' 815' ' ' ILE . 16.0 mt -78.48 108.44 11.85 Favored 'General case' 0 C--O 1.217 -0.629 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.771 -177.254 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 732' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -77.5 103.91 7.72 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.718 0.294 . . . . 0.0 111.022 178.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 733' ' ' LEU . . . . . 0.647 ' HB2' ' HB ' ' A' ' 817' ' ' VAL . 30.9 mt -118.06 164.78 14.6 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.183 0.516 . . . . 0.0 111.794 -177.11 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 734' ' ' CYS . . . . . 0.515 ' SG ' ' HA ' ' A' ' 820' ' ' ASP . 11.2 t -120.77 -174.41 2.81 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.039 179.095 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 735' ' ' LEU . . . . . 0.509 ' CD1' ' HG3' ' A' ' 819' ' ' ARG . 0.4 OUTLIER -72.39 119.29 16.39 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.064 0.459 . . . . 0.0 110.858 -171.507 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 86.66 10.93 72.09 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.893 -179.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 737' ' ' ASP . . . . . 0.535 ' HB3' ' HB3' ' A' ' 733' ' ' LEU . 5.8 t0 -75.43 168.78 19.36 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.084 0.469 . . . . 0.0 110.417 177.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 47.7 p-80 -126.21 153.72 44.29 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 175.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 739' ' ' SER . . . . . 0.581 ' HB2' ' OG1' ' A' ' 782' ' ' THR . 1.4 m -101.96 152.69 20.64 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.07 -173.303 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 740' ' ' SER . . . . . 0.456 ' HA ' ' O ' ' A' ' 780' ' ' ILE . 54.6 p -140.97 104.91 4.76 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.494 0.664 . . . . 0.0 110.055 179.315 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 741' ' ' VAL . . . . . 0.561 HG11 HD13 ' A' ' 793' ' ' LEU . 1.5 p -118.67 114.94 35.6 Favored Pre-proline 0 C--N 1.317 -0.838 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.918 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 742' ' ' PRO . . . . . 0.658 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 1.8 Cg_endo -75.86 130.37 12.37 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 122.431 2.087 . . . . 0.0 111.082 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 743' ' ' VAL . . . . . 0.589 ' HB ' ' CD2' ' A' ' 725' ' ' LEU . 1.6 p -126.7 121.29 58.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.547 0.689 . . . . 0.0 112.61 175.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 744' ' ' ALA . . . . . 0.495 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -82.67 102.23 11.35 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 168.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 745' ' ' LEU . . . . . 0.922 HD13 HD13 ' A' ' 773' ' ' ILE . 1.0 OUTLIER -81.11 168.63 18.39 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 114.282 -1.327 . . . . 0.0 111.258 -168.569 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 746' ' ' LYS . . . . . 0.408 ' HE3' ' HB2' ' A' ' 746' ' ' LYS . 28.0 ttmt -123.02 154.82 37.97 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.307 0.575 . . . . 0.0 110.717 -177.006 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 747' ' ' GLY . . . . . 0.404 ' HA3' ' HB3' ' A' ' 721' ' ' PRO . . . 92.05 133.11 5.98 Favored Glycine 0 C--N 1.309 -0.926 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.001 -174.016 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 748' ' ' GLN . . . . . 0.411 ' C ' ' HE1' ' A' ' 751' ' ' PHE . 65.7 mm-40 -101.89 123.03 45.13 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -170.602 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 107.98 -169.54 14.53 Favored Glycine 0 C--O 1.219 -0.815 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.896 179.095 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -67.23 99.86 0.51 Allowed 'Trans proline' 0 CA--C 1.531 0.356 0 C-N-CA 123.561 2.84 . . . . 0.0 113.542 -178.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 751' ' ' PHE . . . . . 0.634 ' CE2' ' HA ' ' A' ' 800' ' ' ASP . 60.9 m-85 -115.29 142.8 46.18 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.384 178.339 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 752' ' ' THR . . . . . 0.76 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 91.0 m -87.91 102.84 15.1 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.575 0.702 . . . . 0.0 109.867 178.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 753' ' ' LEU . . . . . 0.461 HD22 HD22 ' A' ' 745' ' ' LEU . 17.4 tp -92.08 130.71 37.75 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.537 -1.211 . . . . 0.0 110.538 -170.468 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 754' ' ' THR . . . . . 0.45 HG23 ' HB2' ' A' ' 769' ' ' GLU . 0.6 OUTLIER -125.98 134.84 51.37 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.607 0.241 . . . . 0.0 111.327 179.813 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 755' ' ' TYR . . . . . 0.422 ' CE1' ' HB3' ' A' ' 768' ' ' PHE . 26.1 p90 -145.93 154.66 42.18 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.14 177.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 756' ' ' ASP . . . . . 0.475 ' OD2' ' HD2' ' A' ' 765' ' ' ARG . 49.8 m-20 -116.9 122.76 45.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.868 -179.354 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 757' ' ' ILE . . . . . . . . . . . . . 4.2 mp -89.88 97.31 6.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 170.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 758' ' ' ILE . . . . . 0.555 HG22 ' HD3' ' A' ' 765' ' ' ARG . 2.1 pp -96.5 149.62 4.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.042 -169.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 759' ' ' GLU . . . . . 0.596 ' CD ' ' HB2' ' A' ' 764' ' ' LYS . 12.2 mt-10 -93.79 112.52 24.39 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.839 -176.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 760' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.32 -9.76 32.08 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.843 0.83 . . . . 0.0 109.252 179.102 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 761' ' ' PHE . . . . . 0.553 ' HB2' ' H ' ' A' ' 790' ' ' ASP . 90.5 t80 -87.59 -24.37 24.01 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.199 177.319 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 762' ' ' SER . . . . . . . . . . . . . 15.7 m -124.81 -87.03 0.62 Allowed 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.108 -179.067 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 763' ' ' SER . . . . . . . . . . . . . 32.2 t 177.04 -12.75 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.828 0.347 . . . . 0.0 110.981 -177.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 764' ' ' LYS . . . . . 0.596 ' HB2' ' CD ' ' A' ' 759' ' ' GLU . 98.7 mttt -77.82 -175.92 4.18 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.377 0.608 . . . . 0.0 111.318 -175.35 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 765' ' ' ARG . . . . . 0.555 ' HD3' HG22 ' A' ' 758' ' ' ILE . 3.8 ttp180 -162.93 134.54 5.08 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.341 -177.308 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 766' ' ' LYS . . . . . 0.466 ' HD3' ' N ' ' A' ' 767' ' ' THR . 1.3 tmtp? -109.78 146.12 35.51 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 767' ' ' THR . . . . . 0.466 ' N ' ' HD3' ' A' ' 766' ' ' LYS . 77.6 m -121.05 134.14 55.27 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.244 -176.396 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 768' ' ' PHE . . . . . 0.422 ' HB3' ' CE1' ' A' ' 755' ' ' TYR . 0.7 OUTLIER -133.66 131.48 39.58 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.995 0.426 . . . . 0.0 110.498 175.101 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 769' ' ' GLU . . . . . 0.45 ' HB2' HG23 ' A' ' 754' ' ' THR . 36.5 tt0 -127.25 117.23 21.89 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.681 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 770' ' ' ILE . . . . . 0.43 HG22 HG22 ' A' ' 773' ' ' ILE . 12.1 mt -111.43 112.02 38.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 771' ' ' LYS . . . . . 0.625 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 12.4 mtpt -83.79 153.03 24.32 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-O 121.496 0.665 . . . . 0.0 111.609 -175.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 772' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 56.64 46.16 20.79 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 113.979 -1.464 . . . . 0.0 112.558 177.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 773' ' ' ILE . . . . . 0.922 HD13 HD13 ' A' ' 745' ' ' LEU . 0.6 OUTLIER -74.29 113.84 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 171.949 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 53.6 mttt -107.31 29.65 6.95 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -177.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 775' ' ' THR . . . . . 0.705 ' H ' HD12 ' A' ' 773' ' ' ILE . 0.2 OUTLIER -95.85 -82.32 0.39 Allowed 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -167.785 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 776' ' ' ASN . . . . . 0.657 ' HB2' ' O ' ' A' ' 775' ' ' THR . 0.8 OUTLIER 89.08 3.64 0.21 Allowed 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 124.521 1.129 . . . . 0.0 111.281 -171.741 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 777' ' ' GLU . . . . . 0.495 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 12.5 mt-10 -160.88 82.94 0.66 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 175.236 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 778' ' ' TYR . . . . . 0.832 ' HB3' HD11 ' A' ' 745' ' ' LEU . 87.9 t80 -127.33 127.68 44.68 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.128 -171.281 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 779' ' ' VAL . . . . . 0.658 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 20.8 t -87.25 116.44 29.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.111 0.481 . . . . 0.0 110.4 177.054 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 780' ' ' ILE . . . . . 0.456 ' O ' ' HA ' ' A' ' 740' ' ' SER . 75.9 mt -86.35 139.6 17.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.405 -178.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 781' ' ' LYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 739' ' ' SER . 3.6 mppt? -125.33 104.11 8.29 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 176.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 782' ' ' THR . . . . . 0.581 ' OG1' ' HB2' ' A' ' 739' ' ' SER . 44.3 p -77.42 145.5 72.18 Favored Pre-proline 0 N--CA 1.443 -0.79 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -177.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 783' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_exo -50.69 158.92 2.55 Favored 'Trans proline' 0 CA--C 1.529 0.271 0 C-N-CA 123.711 2.94 . . . . 0.0 113.57 -177.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 784' ' ' VAL . . . . . 0.423 HG12 HG23 ' A' ' 786' ' ' THR . 54.7 t -58.65 127.26 17.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.308 -177.339 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 785' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -102.45 103.25 13.63 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.294 177.044 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 786' ' ' THR . . . . . 0.423 HG23 HG12 ' A' ' 784' ' ' VAL . 38.9 p -90.59 30.65 1.13 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.939 0.876 . . . . 0.0 110.846 -178.072 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 27.6 m -152.34 107.42 3.25 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.347 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 788' ' ' GLY . . . . . 0.771 ' HA2' HG22 ' A' ' 817' ' ' VAL . . . -51.24 107.96 0.49 Allowed Glycine 0 CA--C 1.525 0.676 0 C-N-CA 121.065 -0.588 . . . . 0.0 113.128 174.179 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 789' ' ' GLY . . . . . 0.538 ' H ' HG22 ' A' ' 817' ' ' VAL . . . -152.22 -173.33 21.7 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 -179.468 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 790' ' ' ASP . . . . . 0.553 ' H ' ' HB2' ' A' ' 761' ' ' PHE . 2.6 m-20 -121.5 129.95 53.25 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -177.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 791' ' ' TYR . . . . . 0.416 ' HA ' ' O ' ' A' ' 758' ' ' ILE . 61.6 m-85 -134.12 161.31 35.22 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.077 -176.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 792' ' ' ILE . . . . . . . . . . . . . 9.9 mt -137.94 121.64 21.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-O 120.845 0.355 . . . . 0.0 110.087 176.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 793' ' ' LEU . . . . . 0.561 HD13 HG11 ' A' ' 741' ' ' VAL . 9.6 tt -84.76 107.77 17.11 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.055 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 794' ' ' SER . . . . . . . . . . . . . 21.7 m -112.6 150.63 31.12 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.297 -178.387 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 795' ' ' LEU . . . . . 0.481 HD22 ' HB3' ' A' ' 723' ' ' ALA . 34.6 mt -83.55 132.42 34.92 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.359 -178.049 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 796' ' ' VAL . . . . . . . . . . . . . 71.7 t -99.39 -57.88 4.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.926 -0.309 . . . . 0.0 111.794 -175.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 797' ' ' SER . . . . . 0.508 ' HA ' HD13 ' A' ' 808' ' ' LEU . 22.9 m -172.32 177.28 3.14 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.379 -173.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 798' ' ' ILE . . . . . 0.641 ' HA ' ' O ' ' A' ' 752' ' ' THR . 8.4 tt -150.92 156.73 6.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 799' ' ' LYS . . . . . 0.76 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 8.9 tmtt? -124.81 119.25 28.33 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 177.336 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 800' ' ' ASP . . . . . 0.634 ' HA ' ' CE2' ' A' ' 751' ' ' PHE . 11.4 t70 -63.88 154.1 34.77 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.487 175.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 10.6 t -60.95 -12.04 9.98 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 123.94 0.775 . . . . 0.0 112.171 -171.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 39.9 p -91.35 1.0 57.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.485 0.66 . . . . 0.0 110.45 177.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 803' ' ' GLY . . . . . 0.456 ' HA2' ' HE2' ' A' ' 799' ' ' LYS . . . 81.5 39.01 12.92 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.713 -176.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 804' ' ' CYS . . . . . 0.452 ' HB3' ' HB3' ' A' ' 800' ' ' ASP . 49.4 t -111.77 110.71 21.21 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 805' ' ' VAL . . . . . . . . . . . . . 7.5 p -86.25 127.49 40.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.671 0.748 . . . . 0.0 111.377 -173.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 806' ' ' VAL . . . . . 0.467 HG21 ' HD2' ' A' ' 721' ' ' PRO . 81.1 t -112.42 139.0 39.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.851 -178.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -83.96 109.53 3.21 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.756 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 808' ' ' LEU . . . . . 0.508 HD13 ' HA ' ' A' ' 797' ' ' SER . 10.4 mp -74.58 133.43 42.22 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 178.636 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 38.3 m -148.28 85.64 1.53 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.911 -1.04 . . . . 0.0 109.166 170.025 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 810' ' ' GLN . . . . . 0.507 ' HB3' ' HD2' ' A' ' 811' ' ' PRO . 12.0 mt-30 -138.86 173.66 4.99 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.527 178.611 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 811' ' ' PRO . . . . . 0.507 ' HD2' ' HB3' ' A' ' 810' ' ' GLN . 86.9 Cg_exo -44.39 140.76 5.67 Favored 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 123.153 2.568 . . . . 0.0 115.273 -175.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -113.25 166.61 11.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.474 -1.239 . . . . 0.0 109.727 176.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 813' ' ' ALA . . . . . 0.582 ' HB1' HD23 ' A' ' 727' ' ' LEU . . . -124.45 143.79 50.44 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.909 -177.44 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 814' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -97.53 130.18 44.62 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.589 0.709 . . . . 0.0 110.952 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 815' ' ' ILE . . . . . 0.588 ' HA ' ' HB2' ' A' ' 731' ' ' LEU . 5.0 mp -107.28 119.64 57.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.824 176.238 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 816' ' ' GLN . . . . . 0.745 ' NE2' ' HG2' ' A' ' 818' ' ' ARG . 0.9 OUTLIER -117.02 106.66 13.63 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.272 0.558 . . . . 0.0 110.648 -177.842 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 817' ' ' VAL . . . . . 0.771 HG22 ' HA2' ' A' ' 788' ' ' GLY . 0.7 OUTLIER -111.29 143.97 20.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-O 121.113 0.482 . . . . 0.0 110.201 -179.167 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 818' ' ' ARG . . . . . 0.745 ' HG2' ' NE2' ' A' ' 816' ' ' GLN . 29.1 mmt180 -130.94 177.37 7.48 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.502 -179.027 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 819' ' ' ARG . . . . . 0.509 ' HG3' ' CD1' ' A' ' 735' ' ' LEU . 5.0 mpt_? -83.32 158.45 22.19 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.838 171.416 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 820' ' ' ASP . . . . . 0.515 ' HA ' ' SG ' ' A' ' 734' ' ' CYS . 9.1 p-10 . . . . . 0 C--N 1.324 -0.523 0 N-CA-C 110.015 -0.365 . . . . 99.989999999999995 110.015 177.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 718' ' ' ARG . . . . . . . . . . . . . 5.1 tpp180 . . . . . 0 N--CA 1.448 -0.562 0 CA-C-O 122.107 0.956 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 719' ' ' VAL . . . . . 0.547 ' O ' ' HD3' ' A' ' 721' ' ' PRO . 3.4 p -152.71 150.45 12.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 CA-C-N 113.674 -1.603 . . . . 0.0 108.065 177.223 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 720' ' ' LYS . . . . . . . . . . . . . 49.5 mtpt -78.75 107.84 6.8 Favored Pre-proline 0 C--N 1.314 -0.948 0 O-C-N 123.533 0.52 . . . . 0.0 110.557 -178.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 721' ' ' PRO . . . . . 0.547 ' HD3' ' O ' ' A' ' 719' ' ' VAL . 38.7 Cg_endo -87.47 164.18 8.06 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.826 2.351 . . . . 0.0 111.291 179.28 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 722' ' ' SER . . . . . 0.6 ' HA ' ' CD2' ' A' ' 808' ' ' LEU . 8.8 t -174.76 -154.37 0.05 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.892 0.377 . . . . 0.0 110.521 -173.45 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 723' ' ' ALA . . . . . 0.65 ' HB1' HG21 ' A' ' 743' ' ' VAL . . . -151.73 143.03 23.38 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 178.401 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 14.9 t -134.57 98.97 4.21 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 725' ' ' LEU . . . . . 0.629 ' HA ' ' HA ' ' A' ' 743' ' ' VAL . 5.7 mp -59.7 144.28 48.47 Favored 'General case' 0 N--CA 1.427 -1.589 0 CA-C-O 122.476 1.131 . . . . 0.0 112.752 -175.51 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 32.4 mtpt -93.23 -19.66 21.2 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 113.038 -1.892 . . . . 0.0 109.461 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 727' ' ' LEU . . . . . 0.486 ' HB2' ' HD2' ' A' ' 742' ' ' PRO . 0.6 OUTLIER -72.0 108.64 5.33 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 177.588 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 31.2 t-80 -115.56 52.32 0.89 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.705 0.288 . . . . 0.0 111.401 -172.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 7.8 p80 -175.92 -177.91 0.98 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.49 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 730' ' ' ASP . . . . . 0.427 ' HB2' ' HE3' ' A' ' 732' ' ' LYS . 12.3 m-20 -77.78 131.76 37.76 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 173.396 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 731' ' ' LEU . . . . . 0.574 ' HB3' ' HA ' ' A' ' 815' ' ' ILE . 9.8 tp -96.35 100.81 12.39 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 120.979 0.419 . . . . 0.0 110.053 -176.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 732' ' ' LYS . . . . . 0.427 ' HE3' ' HB2' ' A' ' 730' ' ' ASP . 33.4 mmtp -80.52 112.36 17.8 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.749 -0.659 . . . . 0.0 112.087 -171.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 733' ' ' LEU . . . . . 0.607 ' HG ' ' HB3' ' A' ' 737' ' ' ASP . 7.3 mp -113.58 163.26 15.18 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.88 177.158 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 734' ' ' CYS . . . . . 0.575 ' O ' ' HB2' ' A' ' 737' ' ' ASP . 51.6 t -104.69 -174.96 2.66 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.501 173.29 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 735' ' ' LEU . . . . . 0.478 ' N ' ' SG ' ' A' ' 734' ' ' CYS . 40.0 tp -72.47 130.14 39.96 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.195 0.522 . . . . 0.0 111.293 -178.324 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 78.92 4.17 88.36 Favored Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.608 -177.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 737' ' ' ASP . . . . . 0.607 ' HB3' ' HG ' ' A' ' 733' ' ' LEU . 0.3 OUTLIER -77.87 151.71 33.72 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.096 0.474 . . . . 0.0 111.687 179.327 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 738' ' ' HIS . . . . . 0.445 ' HB2' ' O ' ' A' ' 782' ' ' THR . 34.6 p-80 -114.95 161.7 17.94 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 170.333 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 739' ' ' SER . . . . . 0.444 ' HB3' HD21 ' A' ' 733' ' ' LEU . 8.0 p -120.36 171.78 8.27 Favored 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 119.159 -1.016 . . . . 0.0 111.522 -173.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 7.0 p -137.85 100.74 4.26 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.649 177.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 741' ' ' VAL . . . . . 0.579 HG11 HD13 ' A' ' 793' ' ' LEU . 0.7 OUTLIER -109.86 107.74 59.11 Favored Pre-proline 0 C--N 1.318 -0.775 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.618 -179.119 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 742' ' ' PRO . . . . . 0.665 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 3.1 Cg_endo -76.84 137.83 18.15 Favored 'Trans proline' 0 N--CA 1.448 -1.183 0 C-N-CA 122.478 2.119 . . . . 0.0 111.545 -177.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 743' ' ' VAL . . . . . 0.65 HG21 ' HB1' ' A' ' 723' ' ' ALA . 1.7 p -131.01 118.58 42.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.697 0.76 . . . . 0.0 112.121 175.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 744' ' ' ALA . . . . . 0.606 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -80.62 95.61 6.6 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 169.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 745' ' ' LEU . . . . . 1.018 HD13 HD13 ' A' ' 773' ' ' ILE . 0.7 OUTLIER -73.31 159.23 33.68 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 113.901 -1.499 . . . . 0.0 111.472 -168.545 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -114.39 147.67 38.86 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.025 -174.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 747' ' ' GLY . . . . . . . . . . . . . . . 92.81 127.84 4.52 Favored Glycine 0 N--CA 1.442 -0.935 0 C-N-CA 120.166 -1.016 . . . . 0.0 110.625 -174.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 25.0 mp0 -101.68 127.07 48.6 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 121.194 0.521 . . . . 0.0 112.036 -171.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 112.88 -177.12 18.09 Favored Glycine 0 CA--C 1.5 -0.853 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.936 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 750' ' ' PRO . . . . . 0.501 ' HB3' ' HE2' ' A' ' 774' ' ' LYS . 74.4 Cg_endo -65.87 94.91 0.28 Allowed 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 123.838 3.025 . . . . 0.0 113.71 -177.516 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 751' ' ' PHE . . . . . 0.53 ' CE2' ' HA ' ' A' ' 800' ' ' ASP . 68.6 m-85 -113.91 144.06 43.67 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.997 178.474 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 752' ' ' THR . . . . . 0.749 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 63.8 m -89.41 107.93 19.35 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 753' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.73 112.16 24.32 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.285 -171.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 754' ' ' THR . . . . . 0.491 HG23 ' HB2' ' A' ' 769' ' ' GLU . 2.2 m -109.74 135.32 50.85 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.41 -179.144 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 755' ' ' TYR . . . . . 0.532 ' CE1' ' HB3' ' A' ' 768' ' ' PHE . 29.2 p90 -143.43 157.01 44.8 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 120.968 0.413 . . . . 0.0 111.208 177.553 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 756' ' ' ASP . . . . . 0.425 ' OD2' ' HD2' ' A' ' 765' ' ' ARG . 41.2 m-20 -115.57 120.29 38.98 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.694 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 757' ' ' ILE . . . . . 0.403 ' HB ' ' HB3' ' A' ' 766' ' ' LYS . 3.3 mp -84.71 94.73 3.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 167.114 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 758' ' ' ILE . . . . . 0.56 HG22 ' HD3' ' A' ' 765' ' ' ARG . 2.2 pp -91.75 140.7 15.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 C-N-CA 120.258 -0.577 . . . . 0.0 111.429 -171.611 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 759' ' ' GLU . . . . . 0.409 ' HB2' ' HB2' ' A' ' 764' ' ' LYS . 6.8 mt-10 -93.19 99.88 12.36 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.06 -174.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 760' ' ' THR . . . . . 0.412 HG22 ' H ' ' A' ' 760' ' ' THR . 0.9 OUTLIER -88.75 -2.04 58.39 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.819 0.819 . . . . 0.0 109.358 -175.754 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 761' ' ' PHE . . . . . 0.548 ' HB2' ' H ' ' A' ' 790' ' ' ASP . 58.0 t80 -62.65 -32.94 74.09 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.388 174.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 762' ' ' SER . . . . . . . . . . . . . 49.8 m -146.8 -96.1 0.09 Allowed 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.191 178.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 763' ' ' SER . . . . . . . . . . . . . 50.4 m -156.06 55.73 0.59 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.025 0.44 . . . . 0.0 110.843 178.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 764' ' ' LYS . . . . . 0.409 ' HB2' ' HB2' ' A' ' 759' ' ' GLU . 87.7 mttt -127.88 175.54 8.27 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.003 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 765' ' ' ARG . . . . . 0.56 ' HD3' HG22 ' A' ' 758' ' ' ILE . 6.7 ttp180 -164.48 140.07 5.87 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.247 0.546 . . . . 0.0 111.417 -178.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 766' ' ' LYS . . . . . 0.521 ' HD3' ' N ' ' A' ' 767' ' ' THR . 9.8 tmtm? -111.89 146.02 38.48 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 178.094 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 767' ' ' THR . . . . . 0.521 ' N ' ' HD3' ' A' ' 766' ' ' LYS . 88.4 m -123.76 135.14 53.65 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.9 -178.17 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 768' ' ' PHE . . . . . 0.532 ' HB3' ' CE1' ' A' ' 755' ' ' TYR . 3.0 t80 -139.73 137.53 35.2 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 177.442 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 769' ' ' GLU . . . . . 0.491 ' HB2' HG23 ' A' ' 754' ' ' THR . 31.8 tt0 -131.2 132.8 44.95 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.003 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 770' ' ' ILE . . . . . 0.575 HG22 HG22 ' A' ' 773' ' ' ILE . 4.1 mt -121.99 111.57 31.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 177.044 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 771' ' ' LYS . . . . . 0.559 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 5.2 mtpt -85.15 157.31 20.7 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.176 0.512 . . . . 0.0 111.349 -175.281 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 772' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 53.71 44.29 29.88 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.546 -1.206 . . . . 0.0 112.19 177.139 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 773' ' ' ILE . . . . . 1.018 HD13 HD13 ' A' ' 745' ' ' LEU . 0.5 OUTLIER -75.15 111.36 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 173.342 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 774' ' ' LYS . . . . . 0.501 ' HE2' ' HB3' ' A' ' 750' ' ' PRO . 56.9 mttt -108.36 29.87 6.96 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 775' ' ' THR . . . . . 0.678 ' H ' HD12 ' A' ' 773' ' ' ILE . 2.1 m -96.11 -81.39 0.41 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.913 -1.039 . . . . 0.0 113.392 -166.007 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 776' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' A' ' 775' ' ' THR . 10.3 m120 93.79 4.18 0.05 OUTLIER 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.268 1.427 . . . . 0.0 110.971 -176.247 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 777' ' ' GLU . . . . . 0.606 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 4.9 mt-10 -161.11 87.96 0.73 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.364 171.041 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 778' ' ' TYR . . . . . 0.817 ' HB3' HD11 ' A' ' 745' ' ' LEU . 73.7 t80 -125.92 128.29 47.31 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.418 -172.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 779' ' ' VAL . . . . . 0.665 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 21.2 t -86.33 113.27 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 CA-C-O 121.14 0.495 . . . . 0.0 110.46 179.143 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 780' ' ' ILE . . . . . 0.434 ' HB ' HG13 ' A' ' 741' ' ' VAL . 76.2 mt -82.39 143.69 11.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.958 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -123.8 112.77 17.7 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 175.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 782' ' ' THR . . . . . 0.445 ' O ' ' HB2' ' A' ' 738' ' ' HIS . 44.2 p -77.01 142.19 68.69 Favored Pre-proline 0 C--N 1.318 -0.77 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.75 -179.419 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 783' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 782' ' ' THR . 51.2 Cg_exo -55.3 161.5 7.03 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 123.509 2.806 . . . . 0.0 112.899 -178.307 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 784' ' ' VAL . . . . . 0.443 HG12 HG23 ' A' ' 786' ' ' THR . 46.5 t -58.39 124.21 11.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.094 -179.046 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 785' ' ' PHE . . . . . 0.432 ' HE1' ' OG1' ' A' ' 782' ' ' THR . 99.5 m-85 -99.44 95.53 7.08 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.741 178.474 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 786' ' ' THR . . . . . 0.443 HG23 HG12 ' A' ' 784' ' ' VAL . 59.9 p -84.71 28.97 0.64 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.526 0.679 . . . . 0.0 110.912 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.05 108.92 3.68 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.56 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 788' ' ' GLY . . . . . 0.656 ' HA2' HG12 ' A' ' 817' ' ' VAL . . . -52.44 107.46 0.51 Allowed Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.465 171.248 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 789' ' ' GLY . . . . . 0.53 ' H ' ' HB ' ' A' ' 817' ' ' VAL . . . -152.22 -151.58 5.69 Favored Glycine 0 N--CA 1.444 -0.803 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 -179.488 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 790' ' ' ASP . . . . . 0.548 ' H ' ' HB2' ' A' ' 761' ' ' PHE . 11.3 t70 -141.07 133.16 27.85 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.431 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 791' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -135.0 149.06 50.12 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.382 -174.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 792' ' ' ILE . . . . . 0.418 ' O ' HG13 ' A' ' 758' ' ' ILE . 13.8 mt -127.61 116.32 42.96 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-O 121.091 0.472 . . . . 0.0 110.046 178.368 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 793' ' ' LEU . . . . . 0.579 HD13 HG11 ' A' ' 741' ' ' VAL . 10.3 tt -84.15 106.79 16.06 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.007 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 794' ' ' SER . . . . . . . . . . . . . 19.3 m -116.33 150.92 36.89 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.861 -177.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 795' ' ' LEU . . . . . 0.459 HD21 HD11 ' A' ' 725' ' ' LEU . 52.9 mt -83.0 136.55 34.47 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.861 -178.182 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 796' ' ' VAL . . . . . . . . . . . . . 77.2 t -100.35 -57.44 4.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.642 -176.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 797' ' ' SER . . . . . 0.56 ' HA ' ' HG ' ' A' ' 808' ' ' LEU . 25.9 m -170.86 153.54 3.97 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.305 -173.289 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 798' ' ' ILE . . . . . 0.607 ' HA ' ' O ' ' A' ' 752' ' ' THR . 9.1 tt -125.41 166.45 21.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 176.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 799' ' ' LYS . . . . . 0.749 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 87.7 tttt -137.53 123.09 19.71 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.407 -173.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 800' ' ' ASP . . . . . 0.623 ' HB3' ' HB3' ' A' ' 804' ' ' CYS . 13.4 t70 -70.93 157.64 37.83 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.469 175.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 10.4 p -60.68 -9.62 4.17 Favored 'General case' 0 CA--C 1.532 0.251 0 O-C-N 124.007 0.817 . . . . 0.0 112.799 -174.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 42.8 p -97.38 7.38 46.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.577 0.703 . . . . 0.0 110.308 176.04 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 803' ' ' GLY . . . . . 0.514 ' HA2' ' CE ' ' A' ' 799' ' ' LYS . . . 76.68 31.41 54.02 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.841 -176.592 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 804' ' ' CYS . . . . . 0.623 ' HB3' ' HB3' ' A' ' 800' ' ' ASP . 35.5 t -96.41 103.43 15.34 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -179.089 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 805' ' ' VAL . . . . . 0.484 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 3.2 t -86.17 119.9 35.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.165 0.507 . . . . 0.0 110.889 -173.48 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 806' ' ' VAL . . . . . 0.455 HG21 ' HD2' ' A' ' 721' ' ' PRO . 73.0 t -103.56 133.6 47.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.245 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -67.14 134.09 31.35 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 121.077 -0.582 . . . . 0.0 111.664 178.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 808' ' ' LEU . . . . . 0.6 ' CD2' ' HA ' ' A' ' 722' ' ' SER . 69.2 mt -100.73 132.82 45.93 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -176.126 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 22.0 t -146.77 87.18 1.68 Allowed 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.921 171.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 810' ' ' GLN . . . . . 0.472 ' HB3' ' HD2' ' A' ' 811' ' ' PRO . 8.7 mt-30 -139.83 173.76 4.74 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.678 173.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 811' ' ' PRO . . . . . 0.472 ' HD2' ' HB3' ' A' ' 810' ' ' GLN . 78.9 Cg_exo -44.58 141.1 5.77 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 122.971 2.447 . . . . 0.0 115.209 -176.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -108.36 168.05 9.59 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.285 -1.325 . . . . 0.0 109.495 176.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 813' ' ' ALA . . . . . . . . . . . . . . . -126.03 137.26 53.63 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.36 176.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 814' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -103.14 114.83 29.44 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 120.911 0.386 . . . . 0.0 110.441 -177.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 815' ' ' ILE . . . . . 0.574 ' HA ' ' HB3' ' A' ' 731' ' ' LEU . 5.2 mp -97.81 109.39 23.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.493 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 816' ' ' GLN . . . . . 0.548 ' OE1' ' HG2' ' A' ' 818' ' ' ARG . 0.1 OUTLIER -95.32 124.17 39.22 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.871 -178.592 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 817' ' ' VAL . . . . . 0.656 HG12 ' HA2' ' A' ' 788' ' ' GLY . 59.7 t -117.09 135.17 58.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 -177.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 818' ' ' ARG . . . . . 0.548 ' HG2' ' OE1' ' A' ' 816' ' ' GLN . 35.2 mmt180 -142.14 145.53 34.32 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 121.841 -0.537 . . . . 0.0 111.372 176.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 819' ' ' ARG . . . . . 0.456 ' HB3' ' HB2' ' A' ' 735' ' ' LEU . 0.0 OUTLIER -94.03 117.72 30.5 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.508 171.102 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 820' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 . . . . . 0 C--N 1.319 -0.731 0 CA-C-N 116.571 -0.286 . . . . 99.989999999999995 110.252 -179.992 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 718' ' ' ARG . . . . . . . . . . . . . 9.2 tpp180 . . . . . 0 CA--C 1.507 -0.69 0 CA-C-O 122.037 0.923 . . . . 0.0 110.663 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 719' ' ' VAL . . . . . 0.463 ' O ' ' HD3' ' A' ' 721' ' ' PRO . 1.2 m -143.99 159.46 15.92 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-N 113.533 -1.667 . . . . 0.0 108.418 178.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 720' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -84.25 108.87 15.82 Favored Pre-proline 0 C--N 1.31 -1.111 0 O-C-N 123.605 0.566 . . . . 0.0 109.601 175.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 721' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 719' ' ' VAL . 57.1 Cg_endo -87.48 150.03 7.66 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 122.82 2.346 . . . . 0.0 111.869 -177.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 722' ' ' SER . . . . . 0.41 ' HA ' ' HG ' ' A' ' 808' ' ' LEU . 16.1 t -176.71 -150.15 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -172.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 723' ' ' ALA . . . . . 0.593 ' HB1' HG21 ' A' ' 743' ' ' VAL . . . -153.95 143.41 21.56 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 110.449 -0.204 . . . . 0.0 110.449 178.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 4.2 p -134.36 105.44 6.6 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 725' ' ' LEU . . . . . 0.507 ' CD2' ' HB ' ' A' ' 743' ' ' VAL . 14.4 mt -65.4 148.95 50.83 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.728 -173.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 32.1 mtpt -105.75 -0.45 25.4 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.471 -1.241 . . . . 0.0 109.408 -177.069 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 727' ' ' LEU . . . . . 0.441 ' HB2' ' HD2' ' A' ' 742' ' ' PRO . 2.6 tm? -81.78 124.74 29.9 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.818 -1.083 . . . . 0.0 108.953 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 48.6 m80 -86.08 -85.14 0.16 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -173.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 48.6 p-80 -92.56 174.83 7.07 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 120.587 -0.445 . . . . 0.0 111.235 -176.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 730' ' ' ASP . . . . . 0.405 ' HA ' ' O ' ' A' ' 814' ' ' LYS . 4.0 p30 -53.11 144.3 15.81 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.638 0.732 . . . . 0.0 111.898 -177.229 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 731' ' ' LEU . . . . . 0.558 ' HB2' ' HA ' ' A' ' 815' ' ' ILE . 15.8 mt -83.27 118.85 23.93 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.272 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 732' ' ' LYS . . . . . 0.42 ' C ' ' HG ' ' A' ' 733' ' ' LEU . 14.4 mmmm -85.18 117.94 24.43 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.457 179.039 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 733' ' ' LEU . . . . . 0.466 HD13 ' OD2' ' A' ' 737' ' ' ASP . 4.6 mt -142.48 164.64 29.57 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.913 0.387 . . . . 0.0 111.488 -173.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 734' ' ' CYS . . . . . 0.694 ' HA ' ' O ' ' A' ' 818' ' ' ARG . 18.5 p -117.78 -174.15 2.58 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.129 -177.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 735' ' ' LEU . . . . . 0.414 ' HB2' ' HA ' ' A' ' 819' ' ' ARG . 1.4 tt -61.0 127.84 33.54 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.552 -177.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 78.52 16.48 79.29 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.377 -0.916 . . . . 0.0 112.033 174.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 737' ' ' ASP . . . . . 0.466 ' OD2' HD13 ' A' ' 733' ' ' LEU . 0.9 OUTLIER -64.99 165.72 10.47 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.377 0.608 . . . . 0.0 111.096 176.995 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 22.0 p-80 -137.52 129.33 28.7 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 162.165 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 739' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -97.86 171.76 8.09 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 119.674 -0.81 . . . . 0.0 111.165 -165.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 740' ' ' SER . . . . . 0.421 ' HA ' ' O ' ' A' ' 780' ' ' ILE . 50.2 m -142.45 107.68 4.99 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.16 -178.044 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 741' ' ' VAL . . . . . 0.636 HG11 HD13 ' A' ' 793' ' ' LEU . 1.0 OUTLIER -114.51 105.67 53.39 Favored Pre-proline 0 C--N 1.315 -0.924 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.075 179.672 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 742' ' ' PRO . . . . . 0.81 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 5.9 Cg_exo -73.76 135.5 21.72 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 122.248 1.965 . . . . 0.0 111.441 -176.421 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 743' ' ' VAL . . . . . 0.593 HG21 ' HB1' ' A' ' 723' ' ' ALA . 2.1 p -133.54 122.76 44.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 178.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 744' ' ' ALA . . . . . 0.574 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -82.77 98.6 9.19 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 167.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 745' ' ' LEU . . . . . 0.726 HD11 ' HB3' ' A' ' 778' ' ' TYR . 1.8 mt -77.53 157.69 30.26 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.262 -1.335 . . . . 0.0 111.471 -170.444 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 22.2 ttmm -112.56 155.48 24.28 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.284 -176.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 747' ' ' GLY . . . . . 0.441 ' HA3' ' HB3' ' A' ' 721' ' ' PRO . . . 100.19 120.43 4.52 Favored Glycine 0 C--N 1.305 -1.161 0 CA-C-N 115.131 -0.941 . . . . 0.0 111.62 -175.452 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 8.3 mm100 -100.34 106.35 17.95 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.003 -174.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 136.14 -174.52 21.4 Favored Glycine 0 N--CA 1.448 -0.546 0 N-CA-C 111.64 -0.584 . . . . 0.0 111.64 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -68.47 94.41 0.43 Allowed 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 122.642 2.228 . . . . 0.0 111.983 178.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 751' ' ' PHE . . . . . 0.564 ' CE2' ' HA ' ' A' ' 800' ' ' ASP . 73.8 m-85 -113.35 136.53 52.67 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.391 -179.478 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 752' ' ' THR . . . . . 0.807 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 59.8 m -90.44 102.46 15.19 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 121.961 0.886 . . . . 0.0 109.287 178.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 753' ' ' LEU . . . . . 0.419 HD22 HD22 ' A' ' 745' ' ' LEU . 16.4 tp -89.0 131.71 35.06 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 113.803 -1.544 . . . . 0.0 110.48 -170.042 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 754' ' ' THR . . . . . 0.449 HG23 ' HB2' ' A' ' 769' ' ' GLU . 1.2 m -131.61 132.89 44.41 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.17 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 755' ' ' TYR . . . . . 0.452 ' CE1' ' HB3' ' A' ' 768' ' ' PHE . 22.4 p90 -141.52 153.93 45.18 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.072 0.463 . . . . 0.0 111.758 179.382 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 756' ' ' ASP . . . . . 0.44 ' CG ' ' HD2' ' A' ' 765' ' ' ARG . 5.5 m-20 -115.13 119.63 37.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.451 -179.032 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 757' ' ' ILE . . . . . 0.401 HG12 HG22 ' A' ' 782' ' ' THR . 4.8 mp -90.88 95.56 5.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 168.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 758' ' ' ILE . . . . . 0.673 HG22 ' HD3' ' A' ' 765' ' ' ARG . 2.2 pp -90.21 140.06 16.54 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-O 121.413 0.625 . . . . 0.0 111.188 -170.406 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -92.73 98.72 11.59 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.724 -174.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 760' ' ' THR . . . . . 0.402 HG22 ' H ' ' A' ' 760' ' ' THR . 1.4 t -87.83 -10.92 49.38 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.663 -172.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 761' ' ' PHE . . . . . 0.639 ' HB2' ' H ' ' A' ' 790' ' ' ASP . 51.6 t80 -65.18 -34.67 78.94 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.276 175.605 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 762' ' ' SER . . . . . . . . . . . . . 34.4 p -126.06 -102.09 0.36 Allowed 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.798 178.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 763' ' ' SER . . . . . . . . . . . . . 19.3 m -156.24 15.44 0.33 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.027 0.441 . . . . 0.0 110.525 178.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 764' ' ' LYS . . . . . . . . . . . . . 47.8 mtpt -90.66 -179.05 5.45 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.055 -176.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 765' ' ' ARG . . . . . 0.673 ' HD3' HG22 ' A' ' 758' ' ' ILE . 16.7 ttp180 -166.8 144.53 4.99 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.155 -179.434 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 766' ' ' LYS . . . . . 0.587 ' HD3' ' N ' ' A' ' 767' ' ' THR . 10.3 tmtt? -120.89 146.5 46.54 Favored 'General case' 0 C--O 1.218 -0.579 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -179.038 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 767' ' ' THR . . . . . 0.587 ' N ' ' HD3' ' A' ' 766' ' ' LYS . 31.1 m -123.67 143.24 50.38 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 116.725 -0.216 . . . . 0.0 111.13 -176.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 768' ' ' PHE . . . . . 0.452 ' HB3' ' CE1' ' A' ' 755' ' ' TYR . 4.5 t80 -142.34 137.32 30.46 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 120.995 0.426 . . . . 0.0 110.485 172.456 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 769' ' ' GLU . . . . . 0.449 ' HB2' HG23 ' A' ' 754' ' ' THR . 26.5 tt0 -128.33 123.67 34.55 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.951 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 770' ' ' ILE . . . . . 0.485 HG22 HG22 ' A' ' 773' ' ' ILE . 7.4 mt -116.56 112.69 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.459 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 771' ' ' LYS . . . . . 0.594 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 4.1 mtpt -84.61 150.39 25.21 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.31 0.576 . . . . 0.0 111.777 -173.043 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 772' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 51.69 52.89 13.67 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.315 -1.311 . . . . 0.0 111.943 178.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 773' ' ' ILE . . . . . 0.687 HD12 ' H ' ' A' ' 775' ' ' THR . 0.5 OUTLIER -76.81 117.82 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 173.437 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -116.29 30.62 7.23 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -178.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 775' ' ' THR . . . . . 0.687 ' H ' HD12 ' A' ' 773' ' ' ILE . 1.6 m -96.62 -72.25 0.64 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 113.76 -1.563 . . . . 0.0 112.215 -171.647 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 776' ' ' ASN . . . . . 0.426 ' HB2' ' O ' ' A' ' 775' ' ' THR . 11.7 m120 85.43 6.37 0.45 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.349 1.06 . . . . 0.0 110.238 178.068 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 777' ' ' GLU . . . . . 0.574 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 2.3 tm-20 -162.1 93.46 0.88 Allowed 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 114.374 -1.285 . . . . 0.0 107.702 176.313 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 778' ' ' TYR . . . . . 0.726 ' HB3' HD11 ' A' ' 745' ' ' LEU . 52.8 t80 -144.57 128.68 17.62 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.666 -169.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 779' ' ' VAL . . . . . 0.81 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 1.3 m -94.52 129.09 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.082 0 C-N-CA 118.861 -1.136 . . . . 0.0 110.506 179.592 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 780' ' ' ILE . . . . . 0.421 ' O ' ' HA ' ' A' ' 740' ' ' SER . 83.0 mt -89.43 142.94 12.18 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-N 114.072 -1.422 . . . . 0.0 110.828 -174.412 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -118.38 107.52 13.95 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.942 178.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 782' ' ' THR . . . . . 0.457 ' HA ' ' HD3' ' A' ' 783' ' ' PRO . 25.1 p -76.91 141.13 67.61 Favored Pre-proline 0 C--N 1.315 -0.902 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.376 -177.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 783' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 782' ' ' THR . 50.2 Cg_exo -55.07 161.4 6.7 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.719 2.946 . . . . 0.0 112.837 -174.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 784' ' ' VAL . . . . . 0.509 HG22 HG23 ' A' ' 786' ' ' THR . 7.4 p -58.83 131.46 23.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.107 -178.017 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 785' ' ' PHE . . . . . 0.409 ' C ' ' H ' ' A' ' 787' ' ' THR . 32.0 m-85 -112.14 88.59 2.85 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.716 177.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 786' ' ' THR . . . . . 0.509 HG23 HG22 ' A' ' 784' ' ' VAL . 44.8 p -82.23 31.71 0.39 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.796 0.808 . . . . 0.0 110.918 -178.584 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 787' ' ' THR . . . . . 0.409 ' H ' ' C ' ' A' ' 785' ' ' PHE . 12.4 m -157.38 107.46 2.22 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.282 -179.526 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 788' ' ' GLY . . . . . 0.723 ' HA2' HG12 ' A' ' 817' ' ' VAL . . . -45.66 124.39 6.9 Favored Glycine 0 C--N 1.334 0.471 0 CA-C-N 116.174 -0.466 . . . . 0.0 113.243 174.272 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 789' ' ' GLY . . . . . 0.557 ' H ' ' HB ' ' A' ' 817' ' ' VAL . . . -165.88 -151.24 6.62 Favored Glycine 0 N--CA 1.443 -0.861 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 179.188 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 790' ' ' ASP . . . . . 0.639 ' H ' ' HB2' ' A' ' 761' ' ' PHE . 6.4 t70 -147.15 133.43 19.5 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -178.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 791' ' ' TYR . . . . . 0.421 ' HB2' ' HB ' ' A' ' 815' ' ' ILE . 41.8 m-85 -132.73 154.66 49.99 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.777 -174.191 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 792' ' ' ILE . . . . . 0.437 ' CG1' ' HG3' ' A' ' 814' ' ' LYS . 12.6 mt -131.2 116.79 34.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 176.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 793' ' ' LEU . . . . . 0.636 HD13 HG11 ' A' ' 741' ' ' VAL . 10.1 tt -84.72 107.29 16.84 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.368 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 794' ' ' SER . . . . . . . . . . . . . 19.3 m -114.18 164.96 13.17 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.319 179.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 795' ' ' LEU . . . . . . . . . . . . . 48.9 mt -94.89 132.61 39.52 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 120.71 0.29 . . . . 0.0 110.905 -175.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 796' ' ' VAL . . . . . . . . . . . . . 85.4 t -88.95 -56.99 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.386 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.705 -178.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 797' ' ' SER . . . . . 0.515 ' HA ' HD13 ' A' ' 808' ' ' LEU . 7.1 m 178.46 177.26 0.45 Allowed 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.013 0.821 . . . . 0.0 109.583 -175.333 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 798' ' ' ILE . . . . . 0.523 ' O ' ' HA ' ' A' ' 805' ' ' VAL . 11.4 tt -146.31 164.67 9.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 177.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 799' ' ' LYS . . . . . 0.807 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 7.4 tttm -135.08 120.02 18.58 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.045 0.45 . . . . 0.0 111.142 -176.632 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 800' ' ' ASP . . . . . 0.564 ' HA ' ' CE2' ' A' ' 751' ' ' PHE . 19.3 t70 -63.65 159.36 19.18 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.877 176.101 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 24.9 t -61.19 -20.91 63.3 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 123.902 0.751 . . . . 0.0 111.422 -175.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 39.7 p -83.8 -5.29 59.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.698 0.761 . . . . 0.0 109.676 178.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 803' ' ' GLY . . . . . . . . . . . . . . . 87.88 43.86 5.59 Favored Glycine 0 N--CA 1.439 -1.14 0 CA-C-N 114.435 -1.257 . . . . 0.0 111.258 -177.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 804' ' ' CYS . . . . . 0.528 ' HB3' ' HB3' ' A' ' 800' ' ' ASP . 30.6 t -107.99 108.69 19.92 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 -179.027 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 805' ' ' VAL . . . . . 0.523 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 4.8 t -85.75 110.53 19.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 121.178 0.514 . . . . 0.0 110.616 -175.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 806' ' ' VAL . . . . . 0.418 HG21 ' HD2' ' A' ' 721' ' ' PRO . 94.1 t -94.69 141.12 15.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.233 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -80.89 109.83 3.03 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.146 178.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 808' ' ' LEU . . . . . 0.515 HD13 ' HA ' ' A' ' 797' ' ' SER . 10.5 mp -73.61 126.85 31.21 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 178.465 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 20.5 m -141.59 85.7 1.96 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.171 170.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 810' ' ' GLN . . . . . 0.488 ' HB3' ' HD2' ' A' ' 811' ' ' PRO . 11.0 mt-30 -145.56 169.36 9.89 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.303 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 811' ' ' PRO . . . . . 0.488 ' HD2' ' HB3' ' A' ' 810' ' ' GLN . 88.1 Cg_exo -43.94 139.19 5.86 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 123.336 2.69 . . . . 0.0 115.714 -171.06 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -107.78 167.94 9.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.355 -1.293 . . . . 0.0 109.763 175.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 813' ' ' ALA . . . . . . . . . . . . . . . -127.36 151.9 48.19 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.304 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 814' ' ' LYS . . . . . 0.437 ' HG3' ' CG1' ' A' ' 792' ' ' ILE . 13.9 ttpp -113.54 127.86 56.23 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 121.709 0.766 . . . . 0.0 111.265 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 815' ' ' ILE . . . . . 0.558 ' HA ' ' HB2' ' A' ' 731' ' ' LEU . 4.3 mp -106.01 125.09 61.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.386 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 816' ' ' GLN . . . . . 0.659 ' NE2' ' HG2' ' A' ' 818' ' ' ARG . 0.8 OUTLIER -115.19 116.65 28.71 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.275 0.56 . . . . 0.0 111.027 -178.291 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 817' ' ' VAL . . . . . 0.723 HG12 ' HA2' ' A' ' 788' ' ' GLY . 58.7 t -109.94 133.22 55.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.882 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 818' ' ' ARG . . . . . 0.694 ' O ' ' HA ' ' A' ' 734' ' ' CYS . 85.4 mmt-85 -137.32 130.94 31.48 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.914 0.388 . . . . 0.0 110.395 175.271 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 819' ' ' ARG . . . . . 0.496 ' HG2' ' H ' ' A' ' 788' ' ' GLY . 18.1 mtm180 -68.1 131.61 45.73 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.822 -177.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 820' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 . . . . . 0 C--N 1.319 -0.729 0 CA-C-N 116.102 -0.499 . . . . 99.989999999999995 110.099 179.124 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 718' ' ' ARG . . . . . 0.406 ' HD2' ' N ' ' A' ' 718' ' ' ARG . 3.6 mpt_? . . . . . 0 CA--C 1.509 -0.611 0 CA-C-O 121.609 0.719 . . . . 0.0 110.598 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 719' ' ' VAL . . . . . 0.501 ' O ' ' HD3' ' A' ' 721' ' ' PRO . 3.5 m -129.53 -167.98 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 CA-C-N 114.435 -1.257 . . . . 0.0 108.618 -176.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 720' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -97.95 104.89 24.24 Favored Pre-proline 0 C--N 1.304 -1.395 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.402 174.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 721' ' ' PRO . . . . . 0.513 ' HB2' HD13 ' A' ' 798' ' ' ILE . 60.7 Cg_endo -88.6 145.16 5.71 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 122.897 2.398 . . . . 0.0 111.429 177.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 722' ' ' SER . . . . . 0.643 ' HA ' HD22 ' A' ' 808' ' ' LEU . 10.7 t -175.9 -153.04 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.82 0.343 . . . . 0.0 110.524 -175.197 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 723' ' ' ALA . . . . . 0.536 ' HA ' ' HA ' ' A' ' 745' ' ' LEU . . . -149.49 143.19 25.49 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.361 -0.381 . . . . 0.0 109.99 179.044 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 9.4 m -131.37 98.61 4.58 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 725' ' ' LEU . . . . . 0.471 ' CD2' ' HB ' ' A' ' 743' ' ' VAL . 12.7 mt -64.42 143.49 57.87 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-O 121.695 0.759 . . . . 0.0 111.557 -175.592 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 34.2 mtpt -96.77 -18.75 19.4 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.866 -176.276 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 727' ' ' LEU . . . . . 0.533 HD21 ' HB2' ' A' ' 731' ' ' LEU . 33.7 tp -69.66 112.67 6.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.854 175.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 31.3 t-80 -112.78 45.83 1.28 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.695 0.283 . . . . 0.0 111.573 -174.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -177.77 -177.91 0.68 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.698 -0.228 . . . . 0.0 110.643 177.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 730' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -76.42 137.6 39.83 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.194 0.521 . . . . 0.0 109.71 175.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 731' ' ' LEU . . . . . 0.556 HD23 ' HB2' ' A' ' 739' ' ' SER . 25.9 tp -100.42 113.05 25.5 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.865 -176.109 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 732' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -78.29 110.8 13.63 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.047 -173.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 733' ' ' LEU . . . . . 0.634 ' HG ' ' HB3' ' A' ' 737' ' ' ASP . 8.5 mp -117.5 163.75 15.94 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.489 175.313 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 734' ' ' CYS . . . . . 0.538 ' HA ' ' O ' ' A' ' 818' ' ' ARG . 74.5 m -115.82 -173.85 2.42 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.826 175.157 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 735' ' ' LEU . . . . . 0.625 ' HB2' ' HA ' ' A' ' 819' ' ' ARG . 16.7 tp -65.92 123.71 20.54 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.794 0.33 . . . . 0.0 110.531 -177.599 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 79.64 13.29 82.65 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.472 -0.87 . . . . 0.0 112.312 179.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 737' ' ' ASP . . . . . 0.634 ' HB3' ' HG ' ' A' ' 733' ' ' LEU . 0.3 OUTLIER -80.72 151.99 28.59 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.03 0.443 . . . . 0.0 111.057 175.987 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 738' ' ' HIS . . . . . 0.485 ' HB2' ' O ' ' A' ' 782' ' ' THR . 38.6 p-80 -117.08 149.22 40.67 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 170.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 739' ' ' SER . . . . . 0.556 ' HB2' HD23 ' A' ' 731' ' ' LEU . 5.3 p -103.95 167.63 9.65 Favored 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 119.387 -0.925 . . . . 0.0 111.549 -169.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 740' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 780' ' ' ILE . 40.4 m -139.07 100.41 4.02 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.327 176.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 741' ' ' VAL . . . . . 0.614 HG11 HD23 ' A' ' 793' ' ' LEU . 0.9 OUTLIER -111.86 113.87 52.22 Favored Pre-proline 0 C--N 1.317 -0.831 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.873 -179.434 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 742' ' ' PRO . . . . . 0.691 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 1.0 OUTLIER -74.98 132.95 16.03 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 122.278 1.985 . . . . 0.0 111.454 -179.093 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 743' ' ' VAL . . . . . 0.514 HG21 ' HB1' ' A' ' 723' ' ' ALA . 2.0 p -130.21 120.35 48.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.405 0.622 . . . . 0.0 112.316 175.037 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 744' ' ' ALA . . . . . 0.643 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -80.72 95.26 6.56 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 122.098 0.951 . . . . 0.0 108.697 168.212 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 745' ' ' LEU . . . . . 0.603 HD11 ' HB3' ' A' ' 778' ' ' TYR . 3.0 mt -74.92 151.62 38.89 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.165 -1.38 . . . . 0.0 111.477 -170.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 19.8 ttmm -106.36 162.26 13.84 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.001 -178.077 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 747' ' ' GLY . . . . . . . . . . . . . . . 99.74 129.87 6.76 Favored Glycine 0 C--N 1.308 -0.975 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.458 -175.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 40.1 mm-40 -107.43 107.8 18.85 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.856 -174.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 125.89 -171.43 17.72 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.848 -0.691 . . . . 0.0 111.927 -179.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -70.2 95.11 0.58 Allowed 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.953 2.435 . . . . 0.0 112.177 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 751' ' ' PHE . . . . . 0.539 ' HA ' ' O ' ' A' ' 799' ' ' LYS . 76.2 m-85 -117.25 135.39 53.85 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.239 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 752' ' ' THR . . . . . 0.751 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 89.8 m -85.95 107.65 17.83 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.177 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 753' ' ' LEU . . . . . 0.497 ' HG ' HD22 ' A' ' 745' ' ' LEU . 0.6 OUTLIER -97.93 117.73 32.9 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.322 -171.944 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 754' ' ' THR . . . . . 0.447 HG23 ' HB2' ' A' ' 769' ' ' GLU . 1.0 OUTLIER -118.17 139.28 51.5 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.056 -177.002 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 755' ' ' TYR . . . . . 0.7 ' CE1' ' HB3' ' A' ' 768' ' ' PHE . 22.5 p90 -147.1 158.81 44.06 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 756' ' ' ASP . . . . . 0.467 ' HB3' HG23 ' A' ' 758' ' ' ILE . 0.4 OUTLIER -122.77 120.5 33.76 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.833 -178.262 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 757' ' ' ILE . . . . . 0.554 ' CD1' HD13 ' A' ' 793' ' ' LEU . 3.8 mp -89.3 96.51 6.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 170.101 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 758' ' ' ILE . . . . . 0.55 HG13 ' O ' ' A' ' 792' ' ' ILE . 2.5 pp -98.65 152.01 4.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 121.52 0.676 . . . . 0.0 112.593 -168.143 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 759' ' ' GLU . . . . . 0.649 ' OE2' ' HB2' ' A' ' 762' ' ' SER . 2.6 mt-10 -91.15 120.08 31.8 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.422 -179.193 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 760' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -96.5 -4.65 41.09 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.725 172.023 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 761' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -102.44 -33.65 9.46 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.196 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 762' ' ' SER . . . . . 0.649 ' HB2' ' OE2' ' A' ' 759' ' ' GLU . 32.6 m -141.19 -96.69 0.14 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -178.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 763' ' ' SER . . . . . . . . . . . . . 26.5 t -167.62 0.68 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 -174.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 764' ' ' LYS . . . . . 0.537 ' HZ2' ' CD ' ' A' ' 759' ' ' GLU . 9.4 mtmp? -82.78 60.41 5.3 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.998 0.428 . . . . 0.0 111.816 -174.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 765' ' ' ARG . . . . . 0.525 ' HD2' HG22 ' A' ' 758' ' ' ILE . 68.8 mtm180 -61.42 160.33 11.14 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.907 172.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 766' ' ' LYS . . . . . 0.628 ' HD3' ' N ' ' A' ' 767' ' ' THR . 8.1 tmtt? -145.11 136.93 25.57 Favored 'General case' 0 C--O 1.216 -0.686 0 CA-C-O 120.971 0.415 . . . . 0.0 110.423 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 767' ' ' THR . . . . . 0.628 ' N ' ' HD3' ' A' ' 766' ' ' LYS . 84.8 m -114.0 128.14 56.26 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.544 -176.274 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 768' ' ' PHE . . . . . 0.7 ' HB3' ' CE1' ' A' ' 755' ' ' TYR . 2.9 t80 -128.62 137.24 51.57 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 769' ' ' GLU . . . . . 0.447 ' HB2' HG23 ' A' ' 754' ' ' THR . 34.7 tt0 -130.58 122.38 27.4 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.706 -175.549 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 770' ' ' ILE . . . . . 0.621 HG22 HG22 ' A' ' 773' ' ' ILE . 6.0 mt -117.14 111.15 33.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 177.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 771' ' ' LYS . . . . . 0.633 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 13.4 mtpt -85.03 150.2 25.05 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-O 121.547 0.689 . . . . 0.0 112.065 -173.469 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 772' ' ' GLU . . . . . 0.425 ' O ' ' HG3' ' A' ' 774' ' ' LYS . 3.6 mt-10 52.1 49.63 20.22 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 113.897 -1.501 . . . . 0.0 111.865 177.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 773' ' ' ILE . . . . . 0.718 HD12 ' H ' ' A' ' 775' ' ' THR . 0.5 OUTLIER -73.75 118.6 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 176.266 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 774' ' ' LYS . . . . . 0.425 ' HG3' ' O ' ' A' ' 772' ' ' GLU . 73.9 mttt -116.23 30.16 7.51 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -178.576 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 775' ' ' THR . . . . . 0.718 ' H ' HD12 ' A' ' 773' ' ' ILE . 1.6 m -95.9 -73.25 0.6 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 113.79 -1.55 . . . . 0.0 112.238 -171.562 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 776' ' ' ASN . . . . . 0.472 ' HB2' ' O ' ' A' ' 775' ' ' THR . 11.6 m120 88.14 5.59 0.23 Allowed 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.622 1.169 . . . . 0.0 110.62 179.375 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 777' ' ' GLU . . . . . 0.643 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 30.7 tt0 -161.94 100.47 1.12 Allowed 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.875 171.557 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 778' ' ' TYR . . . . . 0.603 ' HB3' HD11 ' A' ' 745' ' ' LEU . 81.8 t80 -141.92 129.98 22.02 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.63 -170.278 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 779' ' ' VAL . . . . . 0.691 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 14.4 t -89.22 114.11 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 CA-C-O 121.259 0.552 . . . . 0.0 110.094 -179.27 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 780' ' ' ILE . . . . . 0.472 ' O ' ' HA ' ' A' ' 740' ' ' SER . 77.7 mt -81.17 141.72 14.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.604 -178.101 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 781' ' ' LYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 739' ' ' SER . 0.0 OUTLIER -121.54 109.4 14.77 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 176.288 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 782' ' ' THR . . . . . 0.485 ' O ' ' HB2' ' A' ' 738' ' ' HIS . 38.7 p -79.08 143.51 61.33 Favored Pre-proline 0 C--N 1.32 -0.705 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -178.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 783' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 782' ' ' THR . 52.4 Cg_exo -53.17 158.19 7.41 Favored 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 123.546 2.83 . . . . 0.0 113.179 -177.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 784' ' ' VAL . . . . . 0.472 HG12 HG23 ' A' ' 786' ' ' THR . 53.5 t -58.93 118.69 2.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.157 -179.062 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 785' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -98.43 97.19 8.56 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.913 178.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 786' ' ' THR . . . . . 0.472 HG23 HG12 ' A' ' 784' ' ' VAL . 38.4 p -84.71 31.49 0.53 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.711 0.767 . . . . 0.0 111.201 -178.448 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 77.6 m -152.27 112.59 4.08 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.847 -1.07 . . . . 0.0 110.829 179.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 788' ' ' GLY . . . . . 0.628 ' HA2' HG12 ' A' ' 817' ' ' VAL . . . -51.57 114.13 2.84 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.648 171.365 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 789' ' ' GLY . . . . . 0.573 ' H ' ' HB ' ' A' ' 817' ' ' VAL . . . -158.52 -167.26 19.08 Favored Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 110.391 -1.083 . . . . 0.0 110.391 -178.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -128.3 124.75 37.3 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 117.629 0.715 . . . . 0.0 109.864 -178.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 791' ' ' TYR . . . . . 0.609 ' CE2' ' HG2' ' A' ' 759' ' ' GLU . 97.7 m-85 -120.67 149.48 42.43 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.32 -176.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 792' ' ' ILE . . . . . 0.55 ' O ' HG13 ' A' ' 758' ' ' ILE . 12.5 mt -126.88 116.46 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 171.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 793' ' ' LEU . . . . . 0.614 HD23 HG11 ' A' ' 741' ' ' VAL . 0.9 OUTLIER -84.95 113.14 21.19 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.211 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 794' ' ' SER . . . . . 0.527 ' N ' HD12 ' A' ' 793' ' ' LEU . 21.6 t -122.76 164.6 18.03 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.997 -176.191 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 795' ' ' LEU . . . . . 0.432 HD13 ' HB3' ' A' ' 723' ' ' ALA . 21.6 mt -94.49 134.11 37.37 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.992 -173.432 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 796' ' ' VAL . . . . . . . . . . . . . 67.8 t -95.51 -55.79 5.79 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.767 -176.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 797' ' ' SER . . . . . 0.583 ' HA ' ' HG ' ' A' ' 808' ' ' LEU . 87.5 p -177.33 160.22 1.65 Allowed 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.755 -174.174 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 798' ' ' ILE . . . . . 0.685 ' HA ' ' O ' ' A' ' 752' ' ' THR . 9.4 tt -131.35 166.95 27.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 177.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 799' ' ' LYS . . . . . 0.751 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 15.6 tttm -136.62 117.25 13.91 Favored 'General case' 0 C--N 1.322 -0.623 0 O-C-N 122.26 -0.275 . . . . 0.0 111.65 -174.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 800' ' ' ASP . . . . . 0.489 ' HB3' ' HB3' ' A' ' 804' ' ' CYS . 24.2 t70 -69.9 157.14 37.98 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 170.247 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 58.0 p -63.09 -8.92 8.67 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -170.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 26.6 p -89.0 -1.75 58.26 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.636 0.731 . . . . 0.0 109.875 176.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 803' ' ' GLY . . . . . . . . . . . . . . . 84.59 27.14 36.39 Favored Glycine 0 N--CA 1.439 -1.111 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.028 -176.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 804' ' ' CYS . . . . . 0.489 ' HB3' ' HB3' ' A' ' 800' ' ' ASP . 46.1 t -94.43 108.94 20.84 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -178.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 805' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 4.2 p -85.58 119.6 34.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.875 0.845 . . . . 0.0 110.626 -176.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 806' ' ' VAL . . . . . 0.464 HG11 ' HD2' ' A' ' 721' ' ' PRO . 21.4 t -102.03 135.36 39.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.106 -178.52 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -73.12 125.24 9.5 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.997 -177.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 808' ' ' LEU . . . . . 0.643 HD22 ' HA ' ' A' ' 722' ' ' SER . 49.3 mt -89.91 123.36 33.78 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.162 0.506 . . . . 0.0 112.225 -177.515 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 22.5 m -142.12 86.61 1.98 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.101 175.116 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 810' ' ' GLN . . . . . 0.45 ' HB3' ' HD2' ' A' ' 811' ' ' PRO . 8.1 mt-30 -144.54 173.58 4.24 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.23 175.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 811' ' ' PRO . . . . . 0.45 ' HD2' ' HB3' ' A' ' 810' ' ' GLN . 82.5 Cg_exo -45.0 140.86 6.75 Favored 'Trans proline' 0 C--N 1.358 1.05 0 C-N-CA 123.102 2.534 . . . . 0.0 114.716 -177.455 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -109.09 167.21 10.27 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.653 -1.158 . . . . 0.0 110.418 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 813' ' ' ALA . . . . . 0.503 ' HB1' HD23 ' A' ' 727' ' ' LEU . . . -116.25 156.82 25.92 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.687 -179.529 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 814' ' ' LYS . . . . . 0.456 ' HG2' HG12 ' A' ' 792' ' ' ILE . 49.2 mttp -118.76 125.04 48.74 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.121 0.486 . . . . 0.0 110.821 177.64 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 815' ' ' ILE . . . . . 0.538 ' HA ' ' HB3' ' A' ' 731' ' ' LEU . 5.3 mp -113.02 117.4 55.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 115.311 -0.859 . . . . 0.0 108.888 178.008 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 816' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -103.71 113.36 26.82 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.195 -177.243 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 817' ' ' VAL . . . . . 0.628 HG12 ' HA2' ' A' ' 788' ' ' GLY . 43.8 t -106.02 137.28 36.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 818' ' ' ARG . . . . . 0.538 ' O ' ' HA ' ' A' ' 734' ' ' CYS . 22.4 tpt180 -148.79 140.22 23.37 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -178.479 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 819' ' ' ARG . . . . . 0.625 ' HA ' ' HB2' ' A' ' 735' ' ' LEU . 0.0 OUTLIER -78.83 125.39 29.31 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.5 0.667 . . . . 0.0 111.557 -179.717 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 820' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 . . . . . 0 C--N 1.318 -0.767 0 CA-C-N 114.691 -1.141 . . . . 99.989999999999995 110.335 179.891 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 718' ' ' ARG . . . . . . . . . . . . . 21.2 mmm180 . . . . . 0 CA--C 1.503 -0.841 0 CA-C-O 121.8 0.809 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 719' ' ' VAL . . . . . . . . . . . . . 3.2 m -139.72 -173.63 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 CA-C-N 113.986 -1.461 . . . . 0.0 109.057 -177.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 720' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -102.16 115.49 64.52 Favored Pre-proline 0 C--N 1.303 -1.427 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.17 179.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 721' ' ' PRO . . . . . 0.746 ' HD2' HG11 ' A' ' 806' ' ' VAL . 36.4 Cg_endo -83.95 137.92 7.75 Favored 'Trans proline' 0 N--CA 1.447 -1.227 0 C-N-CA 122.597 2.198 . . . . 0.0 110.601 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 32.4 p -176.25 -150.58 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.205 -167.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 723' ' ' ALA . . . . . 0.602 ' HA ' ' HA ' ' A' ' 745' ' ' LEU . . . -155.09 149.4 26.08 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 110.428 -0.212 . . . . 0.0 110.428 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 15.9 m -139.89 98.78 3.54 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 725' ' ' LEU . . . . . 0.578 ' HA ' ' HA ' ' A' ' 743' ' ' VAL . 6.2 mp -59.84 142.19 53.95 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 122.328 1.061 . . . . 0.0 112.551 -175.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 36.9 mtpt -91.41 -16.7 26.96 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 113.269 -1.787 . . . . 0.0 110.309 -176.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 727' ' ' LEU . . . . . 0.547 HD23 ' HB1' ' A' ' 813' ' ' ALA . 51.1 tp -70.24 126.93 31.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.016 178.577 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -119.26 29.93 7.39 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -174.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 9.7 p80 -166.94 170.78 11.81 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.73 0.3 . . . . 0.0 110.434 177.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 730' ' ' ASP . . . . . 0.527 ' HA ' ' O ' ' A' ' 814' ' ' LYS . 10.3 p-10 -79.44 138.57 37.64 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.69 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 731' ' ' LEU . . . . . 0.591 HD13 ' HB2' ' A' ' 739' ' ' SER . 35.1 mt -87.23 107.76 18.63 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.485 -177.149 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 732' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt -81.59 96.71 7.56 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.013 -176.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 733' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.95 163.97 14.01 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.328 0.585 . . . . 0.0 111.904 -178.189 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 734' ' ' CYS . . . . . 0.588 ' O ' ' HB2' ' A' ' 737' ' ' ASP . 72.5 m -105.39 -172.98 2.19 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.032 -0.986 . . . . 0.0 109.66 176.498 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 735' ' ' LEU . . . . . 0.576 ' HB2' ' HA ' ' A' ' 819' ' ' ARG . 13.4 tp -73.83 138.68 44.59 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.444 0.64 . . . . 0.0 112.03 -172.361 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 74.38 14.8 80.59 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 114.756 -1.111 . . . . 0.0 111.286 -177.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 737' ' ' ASP . . . . . 0.588 ' HB2' ' O ' ' A' ' 734' ' ' CYS . 1.0 OUTLIER -89.34 147.09 24.27 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.394 0.616 . . . . 0.0 112.036 177.61 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 738' ' ' HIS . . . . . 0.643 ' HB2' ' O ' ' A' ' 782' ' ' THR . 46.5 p-80 -110.31 177.49 4.68 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 167.059 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 739' ' ' SER . . . . . 0.591 ' HB2' HD13 ' A' ' 731' ' ' LEU . 16.5 p -138.36 171.08 14.9 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 118.519 -1.272 . . . . 0.0 112.503 -174.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 12.4 p -133.44 110.86 10.28 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.314 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 741' ' ' VAL . . . . . 0.567 HG11 HD23 ' A' ' 793' ' ' LEU . 1.5 p -119.31 113.9 35.04 Favored Pre-proline 0 C--N 1.319 -0.745 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.031 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 742' ' ' PRO . . . . . 0.669 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 2.2 Cg_endo -77.9 136.35 14.86 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.389 2.059 . . . . 0.0 111.641 -178.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 743' ' ' VAL . . . . . 0.578 ' HA ' ' HA ' ' A' ' 725' ' ' LEU . 2.1 p -132.45 121.52 45.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.602 0.715 . . . . 0.0 112.466 177.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 744' ' ' ALA . . . . . 0.619 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -79.46 95.69 5.87 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 122.17 0.985 . . . . 0.0 108.769 168.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 745' ' ' LEU . . . . . 0.744 HD11 ' HB3' ' A' ' 778' ' ' TYR . 2.0 mt -77.68 160.18 28.65 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 114.074 -1.421 . . . . 0.0 111.137 -172.111 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 31.8 ttmt -116.29 167.15 11.27 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.793 -178.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 747' ' ' GLY . . . . . . . . . . . . . . . 93.78 125.0 3.99 Favored Glycine 0 C--N 1.309 -0.921 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.384 -173.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 67.0 mm-40 -100.24 114.29 27.61 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.877 0.37 . . . . 0.0 111.532 -175.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 119.98 -175.92 16.02 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.923 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -67.95 94.39 0.4 Allowed 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.929 2.419 . . . . 0.0 112.259 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 751' ' ' PHE . . . . . 0.415 ' HB3' HG12 ' A' ' 798' ' ' ILE . 53.7 m-85 -108.98 141.62 40.81 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.313 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 752' ' ' THR . . . . . 0.768 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 99.2 m -88.39 101.77 14.22 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 121.737 0.779 . . . . 0.0 109.645 177.21 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 753' ' ' LEU . . . . . . . . . . . . . 16.9 tp -90.19 125.2 35.39 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 114.409 -1.269 . . . . 0.0 110.511 -171.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 754' ' ' THR . . . . . 0.449 HG23 ' HB2' ' A' ' 769' ' ' GLU . 0.6 OUTLIER -123.48 131.24 53.58 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.159 -179.866 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 755' ' ' TYR . . . . . 0.587 ' CE1' ' HB3' ' A' ' 768' ' ' PHE . 22.3 p90 -141.39 157.34 45.31 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.801 0.334 . . . . 0.0 111.207 178.167 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 756' ' ' ASP . . . . . 0.463 ' HB3' HG23 ' A' ' 758' ' ' ILE . 0.5 OUTLIER -119.82 118.48 30.92 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.256 -176.386 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 757' ' ' ILE . . . . . 0.509 HG13 HD13 ' A' ' 793' ' ' LEU . 3.5 mp -87.93 95.91 5.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 168.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 758' ' ' ILE . . . . . 0.615 HG13 ' O ' ' A' ' 792' ' ' ILE . 2.3 pp -94.68 149.62 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.256 -173.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 759' ' ' GLU . . . . . 0.667 ' HB3' ' CE2' ' A' ' 791' ' ' TYR . 8.7 pt-20 -107.09 129.36 54.83 Favored 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.132 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 760' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -92.38 -5.26 52.47 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 176.464 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 761' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -68.36 -35.66 78.05 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.537 175.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 762' ' ' SER . . . . . 0.534 ' HB2' ' OE1' ' A' ' 759' ' ' GLU . 14.8 m -150.43 -97.87 0.07 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.06 175.342 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 763' ' ' SER . . . . . . . . . . . . . 62.5 m -167.15 31.01 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -174.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 764' ' ' LYS . . . . . 0.567 ' H ' ' CG ' ' A' ' 759' ' ' GLU . 66.9 mttm -105.06 73.35 1.05 Allowed 'General case' 0 C--N 1.328 -0.366 0 O-C-N 121.776 -0.578 . . . . 0.0 110.335 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 765' ' ' ARG . . . . . 0.45 ' HA ' ' HA ' ' A' ' 758' ' ' ILE . 48.7 mtm180 -63.13 142.98 58.18 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.707 177.322 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 766' ' ' LYS . . . . . 0.46 ' O ' ' HA ' ' A' ' 756' ' ' ASP . 0.7 OUTLIER -120.5 143.12 48.72 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 -179.887 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 767' ' ' THR . . . . . . . . . . . . . 87.6 m -119.32 130.71 55.51 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.949 -176.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 768' ' ' PHE . . . . . 0.587 ' HB3' ' CE1' ' A' ' 755' ' ' TYR . 1.8 t80 -127.09 128.67 46.61 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 174.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 769' ' ' GLU . . . . . 0.449 ' HB2' HG23 ' A' ' 754' ' ' THR . 40.0 tt0 -126.22 118.27 24.82 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.782 -175.062 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 9.0 mt -116.12 113.29 42.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.557 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 771' ' ' LYS . . . . . 0.647 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 6.1 mtpt -82.56 151.98 26.17 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-O 121.394 0.616 . . . . 0.0 111.079 -178.083 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 772' ' ' GLU . . . . . 0.42 ' O ' ' HG3' ' A' ' 774' ' ' LYS . 8.0 mt-10 57.75 46.92 16.38 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.169 -1.378 . . . . 0.0 112.28 176.502 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 773' ' ' ILE . . . . . 0.637 HD12 ' H ' ' A' ' 775' ' ' THR . 0.5 OUTLIER -73.85 119.46 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 172.969 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 774' ' ' LYS . . . . . 0.42 ' HG3' ' O ' ' A' ' 772' ' ' GLU . 74.0 mttt -118.21 30.53 7.18 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -177.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 775' ' ' THR . . . . . 0.637 ' H ' HD12 ' A' ' 773' ' ' ILE . 0.2 OUTLIER -96.06 -73.57 0.59 Allowed 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 113.988 -1.46 . . . . 0.0 112.498 -171.43 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 776' ' ' ASN . . . . . 0.439 ' HB2' ' O ' ' A' ' 775' ' ' THR . 11.7 m120 83.48 4.3 0.86 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.504 1.121 . . . . 0.0 110.431 -176.573 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 777' ' ' GLU . . . . . 0.619 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 22.5 mt-10 -161.56 88.41 0.71 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.998 -1.001 . . . . 0.0 108.643 173.502 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 778' ' ' TYR . . . . . 0.744 ' HB3' HD11 ' A' ' 745' ' ' LEU . 50.2 t80 -130.88 132.41 45.13 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.644 -169.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 779' ' ' VAL . . . . . 0.669 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 20.1 t -87.07 113.78 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 CA-C-O 121.209 0.528 . . . . 0.0 110.396 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 780' ' ' ILE . . . . . . . . . . . . . 66.0 mt -82.79 143.41 12.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.577 -178.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.73 110.55 17.97 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 176.042 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 782' ' ' THR . . . . . 0.643 ' O ' ' HB2' ' A' ' 738' ' ' HIS . 29.8 p -77.56 142.07 66.02 Favored Pre-proline 0 C--N 1.317 -0.834 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 783' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 782' ' ' THR . 38.0 Cg_exo -57.46 166.02 5.2 Favored 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 123.364 2.709 . . . . 0.0 112.229 -179.439 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 784' ' ' VAL . . . . . . . . . . . . . 14.1 p -67.53 135.26 28.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.291 0.567 . . . . 0.0 111.065 -175.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 785' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -104.77 103.64 13.29 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.539 178.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 82.3 p -86.21 18.54 3.09 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.463 -172.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 29.9 m -158.11 121.77 4.01 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.66 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 788' ' ' GLY . . . . . 0.572 ' HA2' HG12 ' A' ' 817' ' ' VAL . . . -48.85 118.22 4.77 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.888 -0.596 . . . . 0.0 112.791 171.557 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 789' ' ' GLY . . . . . 0.545 ' H ' ' HB ' ' A' ' 817' ' ' VAL . . . -174.88 168.39 40.99 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -97.32 135.93 38.52 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 118.066 0.933 . . . . 0.0 110.692 -178.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 791' ' ' TYR . . . . . 0.667 ' CE2' ' HB3' ' A' ' 759' ' ' GLU . 70.3 m-85 -123.18 150.21 43.63 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.671 176.369 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 792' ' ' ILE . . . . . 0.615 ' O ' HG13 ' A' ' 758' ' ' ILE . 11.3 mt -128.7 110.38 21.0 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 793' ' ' LEU . . . . . 0.567 HD23 HG11 ' A' ' 741' ' ' VAL . 1.1 tp -84.2 111.75 19.65 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 794' ' ' SER . . . . . 0.517 ' N ' HD12 ' A' ' 793' ' ' LEU . 40.5 t -122.48 161.07 24.26 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.322 -1.308 . . . . 0.0 108.875 -175.024 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 795' ' ' LEU . . . . . . . . . . . . . 39.9 mt -88.71 142.67 27.48 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.658 -0.247 . . . . 0.0 110.738 -176.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 796' ' ' VAL . . . . . . . . . . . . . 73.4 t -102.73 -55.18 6.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.186 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 797' ' ' SER . . . . . 0.511 ' HA ' HD13 ' A' ' 808' ' ' LEU . 7.4 t -178.03 177.78 1.0 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.475 -173.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 798' ' ' ILE . . . . . 0.634 ' HA ' ' O ' ' A' ' 752' ' ' THR . 9.2 tt -150.15 163.12 3.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 799' ' ' LYS . . . . . 0.768 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 9.6 tmtt? -138.71 119.53 14.22 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.895 0.379 . . . . 0.0 111.0 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 800' ' ' ASP . . . . . 0.595 ' HB3' ' HB3' ' A' ' 804' ' ' CYS . 14.1 t70 -64.12 155.72 30.62 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.729 174.317 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 3.5 m -60.01 -17.22 37.15 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 124.071 0.857 . . . . 0.0 112.596 -173.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 802' ' ' THR . . . . . 0.423 HG22 ' OD1' ' A' ' 800' ' ' ASP . 13.0 t -89.86 -0.55 57.63 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 121.836 0.827 . . . . 0.0 109.636 177.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 803' ' ' GLY . . . . . 0.454 ' HA2' ' HE2' ' A' ' 799' ' ' LYS . . . 86.68 38.23 8.24 Favored Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.846 -178.451 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 804' ' ' CYS . . . . . 0.595 ' HB3' ' HB3' ' A' ' 800' ' ' ASP . 46.5 t -99.73 105.15 16.92 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.49 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 805' ' ' VAL . . . . . . . . . . . . . 5.9 t -85.51 122.87 38.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.246 0.546 . . . . 0.0 110.143 -176.047 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 806' ' ' VAL . . . . . 0.746 HG11 ' HD2' ' A' ' 721' ' ' PRO . 32.4 t -114.43 136.99 49.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.552 -174.204 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -81.89 110.31 3.16 Favored Glycine 0 C--N 1.322 -0.207 0 C-N-CA 120.76 -0.733 . . . . 0.0 113.279 -176.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 808' ' ' LEU . . . . . 0.511 HD13 ' HA ' ' A' ' 797' ' ' SER . 10.9 mp -81.36 123.58 28.66 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 178.239 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 9.7 t -141.91 86.78 2.0 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 168.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 810' ' ' GLN . . . . . 0.459 ' HB3' ' O ' ' A' ' 723' ' ' ALA . 0.9 OUTLIER -146.07 176.07 2.4 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.879 -171.238 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 811' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_exo -41.61 142.91 1.11 Allowed 'Trans proline' 0 C--N 1.362 1.258 0 C-N-CA 123.559 2.839 . . . . 0.0 115.495 -171.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -125.37 167.57 14.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.348 -1.296 . . . . 0.0 110.577 -176.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 813' ' ' ALA . . . . . 0.547 ' HB1' HD23 ' A' ' 727' ' ' LEU . . . -122.31 158.56 29.29 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.714 178.543 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 814' ' ' LYS . . . . . 0.527 ' O ' ' HA ' ' A' ' 730' ' ' ASP . 21.5 ttpp -123.55 111.42 16.25 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.381 0.61 . . . . 0.0 110.521 175.099 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 815' ' ' ILE . . . . . 0.53 ' HA ' ' HB2' ' A' ' 731' ' ' LEU . 5.4 mp -92.54 113.67 28.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 115.364 -0.834 . . . . 0.0 108.837 177.555 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 816' ' ' GLN . . . . . 0.53 HE22 ' HB2' ' A' ' 818' ' ' ARG . 1.1 tm0? -99.55 108.38 20.78 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.258 0.551 . . . . 0.0 110.119 -177.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 817' ' ' VAL . . . . . 0.572 HG12 ' HA2' ' A' ' 788' ' ' GLY . 42.0 t -99.08 143.66 13.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.81 -179.156 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 818' ' ' ARG . . . . . 0.53 ' HB2' HE22 ' A' ' 816' ' ' GLN . 30.1 tpt180 -142.12 175.6 9.62 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 819' ' ' ARG . . . . . 0.576 ' HA ' ' HB2' ' A' ' 735' ' ' LEU . 10.8 mmm180 -71.77 155.64 40.22 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 172.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 820' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 . . . . . 0 C--N 1.323 -0.565 0 N-CA-C 109.577 -0.527 . . . . 99.989999999999995 109.577 177.948 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 718' ' ' ARG . . . . . . . . . . . . . 23.8 mmm180 . . . . . 0 CA--C 1.499 -1.004 0 CA-C-O 122.0 0.905 . . . . 0.0 111.039 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 719' ' ' VAL . . . . . 0.515 ' O ' ' HD3' ' A' ' 721' ' ' PRO . 2.3 m -142.55 157.61 18.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-N 113.45 -1.705 . . . . 0.0 109.816 -175.235 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 720' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -96.11 97.08 2.81 Favored Pre-proline 0 C--N 1.306 -1.315 0 CA-C-N 115.154 -0.93 . . . . 0.0 108.609 173.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 721' ' ' PRO . . . . . 0.515 ' HD3' ' O ' ' A' ' 719' ' ' VAL . 59.5 Cg_endo -84.79 146.65 10.55 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 122.106 1.871 . . . . 0.0 112.042 -172.153 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 722' ' ' SER . . . . . 0.542 ' HA ' HD22 ' A' ' 808' ' ' LEU . 22.7 t -177.39 -157.29 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.597 -171.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 723' ' ' ALA . . . . . 0.643 ' HB1' HG21 ' A' ' 743' ' ' VAL . . . -148.97 142.07 24.91 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 176.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 724' ' ' SER . . . . . 0.436 ' HB2' ' OE1' ' A' ' 810' ' ' GLN . 23.0 t -130.98 105.04 7.48 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -178.721 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 725' ' ' LEU . . . . . 0.495 ' CD2' ' HB ' ' A' ' 743' ' ' VAL . 14.0 mt -65.31 149.17 50.42 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-O 121.854 0.835 . . . . 0.0 112.31 -173.156 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 726' ' ' LYS . . . . . 0.403 ' HB2' ' HB2' ' A' ' 742' ' ' PRO . 40.0 mtpt -100.32 -17.05 17.46 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 114.072 -1.422 . . . . 0.0 109.547 -177.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 727' ' ' LEU . . . . . 0.58 HD23 ' HB1' ' A' ' 813' ' ' ALA . 23.6 tp -66.13 117.24 8.16 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.845 177.48 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 9.8 t-80 -111.85 33.34 4.85 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -170.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -172.62 168.73 5.2 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.543 0.211 . . . . 0.0 110.546 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 730' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -73.25 126.63 30.53 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.479 0.657 . . . . 0.0 110.042 176.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 731' ' ' LEU . . . . . 0.682 HD23 ' HB2' ' A' ' 739' ' ' SER . 16.2 tp -85.94 101.29 12.76 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.01 -0.995 . . . . 0.0 111.473 -173.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 732' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -77.72 115.79 17.75 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.876 -177.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 733' ' ' LEU . . . . . 0.568 HD21 ' HG ' ' A' ' 731' ' ' LEU . 23.9 mt -118.77 165.41 14.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.414 -178.036 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 734' ' ' CYS . . . . . . . . . . . . . 69.4 m -106.18 -176.79 3.18 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.413 174.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 735' ' ' LEU . . . . . 0.511 HD23 ' N ' ' A' ' 736' ' ' GLY . 2.4 tt -63.75 130.49 44.42 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.425 -175.363 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 736' ' ' GLY . . . . . 0.511 ' N ' HD23 ' A' ' 735' ' ' LEU . . . 72.05 15.76 76.53 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.212 175.505 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 737' ' ' ASP . . . . . 0.499 ' HB3' ' HB3' ' A' ' 733' ' ' LEU . 20.6 t0 -80.59 161.4 24.75 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.18 0.514 . . . . 0.0 110.102 178.288 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 50.3 p-80 -120.72 153.18 37.3 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 173.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 739' ' ' SER . . . . . 0.682 ' HB2' HD23 ' A' ' 731' ' ' LEU . 1.4 p -101.56 160.64 14.27 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 118.954 -1.099 . . . . 0.0 111.383 -171.282 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 740' ' ' SER . . . . . 0.431 ' H ' HD21 ' A' ' 731' ' ' LEU . 39.3 t -132.73 100.41 4.92 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.703 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 741' ' ' VAL . . . . . 0.588 HG11 HD13 ' A' ' 793' ' ' LEU . 1.3 p -120.05 108.59 38.32 Favored Pre-proline 0 C--N 1.316 -0.883 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.884 -177.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 742' ' ' PRO . . . . . 0.687 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 2.5 Cg_endo -74.36 137.26 23.03 Favored 'Trans proline' 0 N--CA 1.448 -1.179 0 C-N-CA 122.316 2.011 . . . . 0.0 110.895 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 743' ' ' VAL . . . . . 0.643 HG21 ' HB1' ' A' ' 723' ' ' ALA . 1.6 p -135.64 120.38 27.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.49 0.662 . . . . 0.0 112.267 177.27 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 744' ' ' ALA . . . . . 0.49 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -83.4 100.91 10.99 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 168.534 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 745' ' ' LEU . . . . . 0.917 HD13 HD13 ' A' ' 773' ' ' ILE . 0.2 OUTLIER -82.47 168.64 17.23 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 113.936 -1.483 . . . . 0.0 111.073 -167.222 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -123.39 146.19 48.17 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.675 -175.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 747' ' ' GLY . . . . . . . . . . . . . . . 101.86 123.38 5.21 Favored Glycine 0 C--N 1.312 -0.782 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.869 -178.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -103.6 120.81 41.63 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.793 0.33 . . . . 0.0 110.851 -174.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 127.31 179.83 16.01 Favored Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.74 -178.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -70.56 93.53 0.59 Allowed 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.339 2.026 . . . . 0.0 111.936 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 751' ' ' PHE . . . . . 0.503 ' CE2' ' HA ' ' A' ' 800' ' ' ASP . 82.9 m-85 -112.19 142.09 45.08 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.901 179.317 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 752' ' ' THR . . . . . 0.733 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 85.0 m -92.18 106.01 18.11 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 177.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 753' ' ' LEU . . . . . 0.504 ' CD2' HD22 ' A' ' 745' ' ' LEU . 59.2 tp -94.6 114.69 26.69 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.924 -172.401 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 754' ' ' THR . . . . . 0.491 HG23 ' HB2' ' A' ' 769' ' ' GLU . 1.5 m -113.92 134.59 54.72 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.683 179.159 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 755' ' ' TYR . . . . . 0.636 ' CE1' ' HB3' ' A' ' 768' ' ' PHE . 25.6 p90 -143.2 156.79 44.84 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.088 0.471 . . . . 0.0 111.177 178.575 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 756' ' ' ASP . . . . . 0.541 ' HB2' HG23 ' A' ' 758' ' ' ILE . 2.2 p30 -106.41 125.76 51.41 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.211 -178.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 757' ' ' ILE . . . . . 0.446 ' HB ' ' HB3' ' A' ' 766' ' ' LYS . 3.5 mp -94.47 93.23 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 163.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 758' ' ' ILE . . . . . 0.552 HG22 ' HD3' ' A' ' 765' ' ' ARG . 2.3 pp -95.12 143.46 11.81 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-O 121.12 0.486 . . . . 0.0 111.6 -170.318 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -91.16 101.46 14.19 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.226 -176.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 760' ' ' THR . . . . . 0.462 HG23 ' CB ' ' A' ' 790' ' ' ASP . 0.5 OUTLIER -84.42 -7.28 59.34 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.869 0.842 . . . . 0.0 108.939 -178.872 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 761' ' ' PHE . . . . . 0.571 ' HB2' ' H ' ' A' ' 790' ' ' ASP . 67.4 t80 -62.86 -34.05 76.55 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.805 174.26 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 762' ' ' SER . . . . . . . . . . . . . 16.1 p -140.0 -93.17 0.16 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.383 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 763' ' ' SER . . . . . . . . . . . . . 18.8 p -161.68 14.99 0.09 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.891 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 764' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -88.68 174.96 7.73 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.557 -178.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 765' ' ' ARG . . . . . 0.552 ' HD3' HG22 ' A' ' 758' ' ' ILE . 21.6 ttp180 -162.05 144.31 11.33 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-O 121.004 0.431 . . . . 0.0 111.001 -175.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 766' ' ' LYS . . . . . 0.667 ' HD3' ' N ' ' A' ' 767' ' ' THR . 8.4 tmtm? -118.2 146.36 44.29 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 175.095 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 767' ' ' THR . . . . . 0.667 ' N ' ' HD3' ' A' ' 766' ' ' LYS . 32.3 m -124.41 125.19 43.88 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 110.048 -0.352 . . . . 0.0 110.048 178.124 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 768' ' ' PHE . . . . . 0.636 ' HB3' ' CE1' ' A' ' 755' ' ' TYR . 3.4 t80 -122.5 137.73 54.79 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 769' ' ' GLU . . . . . 0.491 ' HB2' HG23 ' A' ' 754' ' ' THR . 38.3 tt0 -133.23 130.37 38.96 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.397 -175.381 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 770' ' ' ILE . . . . . 0.579 HG22 HG22 ' A' ' 773' ' ' ILE . 3.7 mt -121.91 110.61 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 177.142 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 771' ' ' LYS . . . . . 0.626 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 11.4 mtpt -83.87 150.79 25.5 Favored 'General case' 0 N--CA 1.436 -1.175 0 CA-C-O 121.243 0.544 . . . . 0.0 110.889 -175.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 772' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 55.53 50.82 13.78 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.39 -1.277 . . . . 0.0 111.998 177.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 773' ' ' ILE . . . . . 0.917 HD13 HD13 ' A' ' 745' ' ' LEU . 0.5 OUTLIER -77.86 116.88 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 173.377 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 70.0 mttt -117.61 29.5 7.82 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -177.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 775' ' ' THR . . . . . 0.7 ' H ' HD12 ' A' ' 773' ' ' ILE . 1.8 m -97.2 -72.58 0.64 Allowed 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 114.748 -1.115 . . . . 0.0 112.868 -172.381 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 776' ' ' ASN . . . . . 0.62 ' HB2' ' O ' ' A' ' 775' ' ' THR . 0.9 OUTLIER 87.26 6.18 0.27 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.512 1.125 . . . . 0.0 109.915 -178.074 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 777' ' ' GLU . . . . . 0.49 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 1.4 tm-20 -161.91 86.16 0.63 Allowed 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 114.846 -1.07 . . . . 0.0 108.333 179.001 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 778' ' ' TYR . . . . . 0.812 ' HB3' HD11 ' A' ' 745' ' ' LEU . 87.3 t80 -137.28 134.36 36.03 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.686 -170.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 779' ' ' VAL . . . . . 0.687 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 23.5 t -89.94 117.96 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 CA-C-O 121.022 0.439 . . . . 0.0 110.529 177.373 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 780' ' ' ILE . . . . . 0.418 ' HB ' HG13 ' A' ' 741' ' ' VAL . 68.3 mt -88.47 143.26 11.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.782 -178.677 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 781' ' ' LYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 739' ' ' SER . 3.8 mppt? -124.21 109.39 13.36 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 175.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 782' ' ' THR . . . . . . . . . . . . . 42.9 p -78.06 144.92 68.45 Favored Pre-proline 0 C--N 1.321 -0.653 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -177.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 783' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -51.32 158.33 3.82 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 123.465 2.777 . . . . 0.0 113.193 -178.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 784' ' ' VAL . . . . . 0.508 HG12 HG23 ' A' ' 786' ' ' THR . 53.4 t -58.81 126.71 16.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.066 -0.97 . . . . 0.0 112.208 -176.478 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 785' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -103.85 98.2 8.08 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.883 176.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 786' ' ' THR . . . . . 0.508 HG23 HG12 ' A' ' 784' ' ' VAL . 37.1 p -87.22 32.48 0.69 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.704 0.764 . . . . 0.0 110.989 -178.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.45 110.97 3.51 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.533 -1.212 . . . . 0.0 110.59 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 788' ' ' GLY . . . . . . . . . . . . . . . -53.1 112.62 2.35 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.253 171.098 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 789' ' ' GLY . . . . . 0.485 ' H ' ' HB ' ' A' ' 817' ' ' VAL . . . -154.5 -151.55 5.84 Favored Glycine 0 N--CA 1.443 -0.893 0 N-CA-C 110.806 -0.917 . . . . 0.0 110.806 -178.533 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 790' ' ' ASP . . . . . 0.571 ' H ' ' HB2' ' A' ' 761' ' ' PHE . 4.3 m-20 -137.57 124.01 20.77 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 791' ' ' TYR . . . . . 0.488 ' HA ' ' O ' ' A' ' 758' ' ' ILE . 80.9 m-85 -124.64 152.91 43.05 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.294 -0.412 . . . . 0.0 109.99 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 792' ' ' ILE . . . . . 0.48 ' O ' HG13 ' A' ' 758' ' ' ILE . 14.4 mt -133.39 122.84 45.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 171.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 793' ' ' LEU . . . . . 0.588 HD13 HG11 ' A' ' 741' ' ' VAL . 10.4 tt -87.71 108.01 18.91 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.354 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 794' ' ' SER . . . . . 0.449 ' HB3' ' OD2' ' A' ' 756' ' ' ASP . 31.3 t -121.54 146.06 47.33 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.166 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 795' ' ' LEU . . . . . 0.515 ' H ' HD22 ' A' ' 795' ' ' LEU . 1.4 mm? -72.98 135.15 44.94 Favored 'General case' 0 N--CA 1.448 -0.569 0 O-C-N 122.062 -0.399 . . . . 0.0 111.481 -179.12 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 796' ' ' VAL . . . . . . . . . . . . . 66.7 t -95.91 -57.46 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.207 -177.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 797' ' ' SER . . . . . 0.588 ' HA ' ' HG ' ' A' ' 808' ' ' LEU . 35.7 m -171.38 157.02 4.77 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.719 -173.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 798' ' ' ILE . . . . . 0.558 ' HA ' ' O ' ' A' ' 752' ' ' THR . 13.2 tt -132.22 162.07 40.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 177.483 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 799' ' ' LYS . . . . . 0.733 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 22.1 tttt -129.83 118.19 21.37 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 120.967 0.413 . . . . 0.0 110.993 -174.462 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 800' ' ' ASP . . . . . 0.507 ' HB3' ' HB2' ' A' ' 804' ' ' CYS . 21.6 t70 -65.3 152.89 42.65 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.259 -0.882 . . . . 0.0 108.854 173.07 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 4.4 m -62.62 -8.56 6.71 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 123.768 0.667 . . . . 0.0 112.503 -171.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 40.1 p -96.67 5.62 50.32 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.426 0.631 . . . . 0.0 110.191 176.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 803' ' ' GLY . . . . . 0.53 ' HA2' ' HE2' ' A' ' 799' ' ' LYS . . . 77.98 42.25 16.6 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.029 -177.014 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 804' ' ' CYS . . . . . 0.507 ' HB2' ' HB3' ' A' ' 800' ' ' ASP . 69.4 m -110.24 106.87 16.45 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 176.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 805' ' ' VAL . . . . . 0.52 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 3.5 t -86.24 112.36 22.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.279 0.561 . . . . 0.0 111.071 -173.094 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 806' ' ' VAL . . . . . 0.452 ' HB ' HG22 ' A' ' 798' ' ' ILE . 73.4 t -90.0 135.14 27.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.152 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -73.7 120.57 6.95 Favored Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 111.601 -0.599 . . . . 0.0 111.601 178.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 808' ' ' LEU . . . . . 0.588 ' HG ' ' HA ' ' A' ' 797' ' ' SER . 45.4 mt -88.71 132.96 34.37 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -175.394 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 44.7 m -149.86 87.2 1.47 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.023 -0.989 . . . . 0.0 109.633 172.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 810' ' ' GLN . . . . . 0.516 HE21 ' CB ' ' A' ' 722' ' ' SER . 11.3 mt-30 -135.34 171.84 8.23 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.336 174.193 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 811' ' ' PRO . . . . . 0.464 ' HD2' ' HB3' ' A' ' 810' ' ' GLN . 97.0 Cg_exo -45.81 137.82 12.18 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 122.999 2.466 . . . . 0.0 114.328 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -109.1 167.29 10.21 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.217 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 813' ' ' ALA . . . . . 0.58 ' HB1' HD23 ' A' ' 727' ' ' LEU . . . -126.7 141.17 51.92 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.571 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 814' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -100.24 129.56 46.26 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.143 0.497 . . . . 0.0 110.555 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 815' ' ' ILE . . . . . 0.541 ' HA ' ' HB3' ' A' ' 731' ' ' LEU . 5.3 mp -112.55 109.75 29.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 176.514 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 816' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -106.08 109.05 20.86 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.061 0.457 . . . . 0.0 109.991 -175.679 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 817' ' ' VAL . . . . . 0.485 ' HB ' ' H ' ' A' ' 789' ' ' GLY . 4.7 t -99.74 141.27 17.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.513 -174.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 818' ' ' ARG . . . . . . . . . . . . . 39.9 mmt180 -127.69 177.01 7.09 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 177.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 819' ' ' ARG . . . . . 0.44 ' HA ' ' HB2' ' A' ' 735' ' ' LEU . 26.1 mtm180 -118.21 130.95 56.38 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.951 0.405 . . . . 0.0 110.69 177.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 820' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 . . . . . 0 C--N 1.322 -0.615 0 CA-C-N 115.985 -0.552 . . . . 99.989999999999995 110.399 179.861 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 718' ' ' ARG . . . . . . . . . . . . . 14.6 tpp180 . . . . . 0 CA--C 1.509 -0.62 0 CA-C-O 122.092 0.948 . . . . 0.0 110.721 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 719' ' ' VAL . . . . . . . . . . . . . 4.7 m -125.66 -171.62 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 113.637 -1.619 . . . . 0.0 108.808 177.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 720' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -116.88 90.71 33.28 Favored Pre-proline 0 C--N 1.306 -1.325 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.652 178.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 721' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -86.46 140.34 6.26 Favored 'Trans proline' 0 N--CA 1.445 -1.353 0 C-N-CA 122.233 1.955 . . . . 0.0 111.204 178.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 722' ' ' SER . . . . . 0.454 ' HA ' ' CD2' ' A' ' 808' ' ' LEU . 50.2 m -167.42 -157.19 0.23 Allowed 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -172.409 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 723' ' ' ALA . . . . . 0.752 ' HB1' HG21 ' A' ' 743' ' ' VAL . . . -145.77 142.62 29.08 Favored 'General case' 0 N--CA 1.449 -0.521 0 O-C-N 122.093 -0.38 . . . . 0.0 110.27 175.289 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -129.72 100.4 5.49 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 725' ' ' LEU . . . . . 0.494 ' CD2' ' HB ' ' A' ' 743' ' ' VAL . 13.2 mt -62.65 144.09 56.65 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 121.765 0.793 . . . . 0.0 111.869 -173.152 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 33.4 mtpt -95.22 -18.92 20.47 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.544 -1.207 . . . . 0.0 109.366 -178.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 727' ' ' LEU . . . . . 0.544 ' HB2' ' HD2' ' A' ' 742' ' ' PRO . 0.7 OUTLIER -76.67 109.97 10.87 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 177.304 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 33.4 m80 -115.83 46.19 1.58 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.02 0.438 . . . . 0.0 110.532 -176.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -148.31 174.33 12.13 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.92 -176.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 730' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -100.5 108.78 20.82 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 175.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 731' ' ' LEU . . . . . 0.59 ' HB2' ' HA ' ' A' ' 815' ' ' ILE . 53.9 mt -72.03 100.82 2.58 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.984 -173.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 732' ' ' LYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 816' ' ' GLN . 32.2 mmtp -79.43 121.6 25.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.681 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 733' ' ' LEU . . . . . 0.721 ' HB2' ' HB ' ' A' ' 817' ' ' VAL . 25.6 mt -126.41 169.52 12.9 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.372 0.606 . . . . 0.0 111.835 -174.154 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 734' ' ' CYS . . . . . 0.467 ' HA ' ' O ' ' A' ' 818' ' ' ARG . 13.2 p -105.39 -176.97 3.23 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.107 176.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 735' ' ' LEU . . . . . 0.436 HD13 ' HD3' ' A' ' 819' ' ' ARG . 36.2 tp -71.41 122.54 20.56 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.569 -178.179 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 79.94 16.46 76.92 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.191 -1.004 . . . . 0.0 112.317 178.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 737' ' ' ASP . . . . . 0.568 ' HB3' ' HB3' ' A' ' 733' ' ' LEU . 25.3 t0 -86.22 157.63 19.91 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.769 0.318 . . . . 0.0 110.713 174.217 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 27.1 p-80 -117.16 -177.86 3.31 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 174.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 739' ' ' SER . . . . . 0.574 ' HB2' ' OG1' ' A' ' 782' ' ' THR . 29.8 m -142.22 169.43 17.6 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 119.777 -0.769 . . . . 0.0 112.894 179.26 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 740' ' ' SER . . . . . 0.412 ' HA ' ' O ' ' A' ' 780' ' ' ILE . 5.7 p -138.07 109.66 7.04 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 114.433 -1.258 . . . . 0.0 109.4 177.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 741' ' ' VAL . . . . . 0.592 HG11 HD13 ' A' ' 793' ' ' LEU . 0.6 OUTLIER -113.1 112.44 49.86 Favored Pre-proline 0 C--N 1.316 -0.877 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.226 -177.912 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 742' ' ' PRO . . . . . 0.649 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 4.1 Cg_endo -75.48 135.38 18.15 Favored 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 122.422 2.081 . . . . 0.0 111.652 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 743' ' ' VAL . . . . . 0.752 HG21 ' HB1' ' A' ' 723' ' ' ALA . 1.7 p -131.05 119.31 44.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.564 0.697 . . . . 0.0 111.981 176.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 744' ' ' ALA . . . . . 0.464 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -83.89 101.47 11.69 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 169.102 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 745' ' ' LEU . . . . . 0.978 HD13 HD13 ' A' ' 773' ' ' ILE . 0.3 OUTLIER -80.4 161.37 25.0 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 114.26 -1.336 . . . . 0.0 111.2 -166.752 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -110.91 146.31 36.79 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.628 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 747' ' ' GLY . . . . . . . . . . . . . . . 98.87 122.92 4.79 Favored Glycine 0 C--N 1.305 -1.168 0 N-CA-C 110.54 -1.024 . . . . 0.0 110.54 -176.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.95 128.68 53.96 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.321 0.581 . . . . 0.0 111.811 -169.22 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 109.44 -178.7 20.64 Favored Glycine 0 C--O 1.22 -0.724 0 CA-C-N 114.902 -1.044 . . . . 0.0 111.044 -175.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 750' ' ' PRO . . . . . 0.525 ' HB3' ' HE2' ' A' ' 774' ' ' LYS . 73.3 Cg_endo -65.51 100.96 0.42 Allowed 'Trans proline' 0 C--O 1.235 0.363 0 C-N-CA 123.37 2.714 . . . . 0.0 113.821 -178.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 751' ' ' PHE . . . . . 0.601 ' CE2' ' HA ' ' A' ' 800' ' ' ASP . 75.6 m-85 -117.0 146.86 42.78 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.743 176.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 752' ' ' THR . . . . . 0.713 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 33.4 m -89.64 106.64 18.59 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 176.04 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 753' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -96.72 111.26 23.49 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.338 -172.56 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 754' ' ' THR . . . . . 0.487 HG23 ' HB2' ' A' ' 769' ' ' GLU . 1.6 m -108.81 137.26 47.03 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.558 -0.747 . . . . 0.0 111.269 -178.437 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 755' ' ' TYR . . . . . . . . . . . . . 29.9 p90 -148.16 156.89 43.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.88 0.371 . . . . 0.0 110.953 176.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 756' ' ' ASP . . . . . 0.587 ' OD2' HG21 ' A' ' 796' ' ' VAL . 0.7 OUTLIER -125.18 121.76 35.11 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.513 178.667 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 757' ' ' ILE . . . . . 0.412 ' N ' HD12 ' A' ' 757' ' ' ILE . 4.2 mp -83.72 96.59 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 172.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 758' ' ' ILE . . . . . 0.659 HG22 ' HD2' ' A' ' 765' ' ' ARG . 2.4 pp -93.92 148.25 5.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.248 -167.426 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 759' ' ' GLU . . . . . 0.669 ' OE2' ' HB3' ' A' ' 762' ' ' SER . 23.9 mt-10 -88.68 117.82 27.92 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.921 176.097 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 760' ' ' THR . . . . . . . . . . . . . 1.2 t -94.51 -4.18 48.53 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 121.512 0.672 . . . . 0.0 109.227 176.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 761' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -103.83 -24.09 13.33 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.781 178.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 762' ' ' SER . . . . . 0.669 ' HB3' ' OE2' ' A' ' 759' ' ' GLU . 9.2 t -137.53 -101.8 0.19 Allowed 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 119.884 -0.726 . . . . 0.0 111.302 178.539 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 763' ' ' SER . . . . . . . . . . . . . 69.3 m -164.57 -5.31 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -173.177 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 764' ' ' LYS . . . . . 0.511 ' C ' ' HG3' ' A' ' 759' ' ' GLU . 8.6 mtpm? -87.22 54.29 3.11 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.329 0.585 . . . . 0.0 112.043 -171.178 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 765' ' ' ARG . . . . . 0.659 ' HD2' HG22 ' A' ' 758' ' ' ILE . 19.0 ttt180 -55.21 129.77 39.58 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.8 172.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 766' ' ' LYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 756' ' ' ASP . 9.7 tmtm? -106.78 140.47 39.57 Favored 'General case' 0 C--O 1.216 -0.674 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.794 -175.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 767' ' ' THR . . . . . . . . . . . . . 21.1 m -111.39 134.83 52.69 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.016 -176.015 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 768' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -140.46 137.89 34.26 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.01 0.433 . . . . 0.0 110.742 173.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 769' ' ' GLU . . . . . 0.487 ' HB2' HG23 ' A' ' 754' ' ' THR . 27.7 tt0 -131.86 123.17 26.97 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.558 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 770' ' ' ILE . . . . . 0.553 HG22 HG22 ' A' ' 773' ' ' ILE . 6.5 mt -114.45 112.23 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 771' ' ' LYS . . . . . 0.581 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 9.7 mtpt -85.88 154.64 21.38 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.52 -173.529 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 772' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 54.6 44.06 29.25 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.388 -1.278 . . . . 0.0 111.984 175.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 773' ' ' ILE . . . . . 0.978 HD13 HD13 ' A' ' 745' ' ' LEU . 0.5 OUTLIER -73.95 116.21 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 172.142 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 774' ' ' LYS . . . . . 0.525 ' HE2' ' HB3' ' A' ' 750' ' ' PRO . 58.0 mttt -111.88 26.36 10.69 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -178.123 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 775' ' ' THR . . . . . 0.683 ' H ' HD12 ' A' ' 773' ' ' ILE . 0.2 OUTLIER -96.22 -75.86 0.52 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 114.767 -1.106 . . . . 0.0 113.676 -166.333 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 776' ' ' ASN . . . . . 0.672 ' HB2' ' O ' ' A' ' 775' ' ' THR . 0.8 OUTLIER 89.98 2.52 0.19 Allowed 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.892 1.277 . . . . 0.0 110.565 -172.897 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 777' ' ' GLU . . . . . 0.464 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 9.4 mp0 -154.6 90.65 1.33 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 175.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 778' ' ' TYR . . . . . 0.703 ' HB3' HD11 ' A' ' 745' ' ' LEU . 81.7 t80 -132.12 128.8 38.89 Favored 'General case' 0 C--N 1.315 -0.932 0 C-N-CA 120.249 -0.58 . . . . 0.0 111.212 -172.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 779' ' ' VAL . . . . . 0.649 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 17.3 t -89.18 112.82 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-O 121.308 0.575 . . . . 0.0 110.4 178.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 780' ' ' ILE . . . . . 0.457 ' HB ' HG13 ' A' ' 741' ' ' VAL . 77.8 mt -81.29 147.05 6.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.549 -178.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -120.1 108.23 14.01 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 175.172 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 782' ' ' THR . . . . . 0.574 ' OG1' ' HB2' ' A' ' 739' ' ' SER . 54.6 p -77.51 141.41 65.35 Favored Pre-proline 0 C--N 1.319 -0.758 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.359 -178.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 783' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 782' ' ' THR . 52.3 Cg_exo -53.91 158.57 8.54 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 123.758 2.972 . . . . 0.0 112.515 -175.409 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 784' ' ' VAL . . . . . . . . . . . . . 12.9 p -65.7 128.93 29.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.33 0.586 . . . . 0.0 109.974 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 785' ' ' PHE . . . . . 0.414 ' CG ' HG11 ' A' ' 817' ' ' VAL . 89.8 m-85 -97.48 96.61 8.45 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.321 -176.164 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 69.8 p -84.32 18.63 2.13 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.395 0.616 . . . . 0.0 111.473 -174.188 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 3.0 m -155.72 124.22 5.93 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.629 177.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 788' ' ' GLY . . . . . 0.694 ' HA2' HG22 ' A' ' 817' ' ' VAL . . . -50.89 123.69 17.8 Favored Glycine 0 CA--C 1.524 0.645 0 O-C-N 123.522 0.513 . . . . 0.0 112.336 172.405 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 789' ' ' GLY . . . . . . . . . . . . . . . -164.03 -165.76 21.77 Favored Glycine 0 N--CA 1.442 -0.964 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -133.41 124.18 26.66 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 791' ' ' TYR . . . . . 0.638 ' CE2' ' HG2' ' A' ' 759' ' ' GLU . 81.5 m-85 -124.78 148.68 48.0 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.106 0.479 . . . . 0.0 111.286 -173.291 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 792' ' ' ILE . . . . . 0.547 ' O ' HG13 ' A' ' 758' ' ' ILE . 13.2 mt -126.07 116.36 45.56 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.656 175.252 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 793' ' ' LEU . . . . . 0.592 HD13 HG11 ' A' ' 741' ' ' VAL . 9.3 tt -84.25 111.23 19.2 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.049 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 794' ' ' SER . . . . . . . . . . . . . 17.8 m -120.65 139.66 52.69 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.389 -178.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 795' ' ' LEU . . . . . 0.672 ' HG ' ' HB3' ' A' ' 723' ' ' ALA . 1.6 mm? -69.25 132.07 45.9 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.619 176.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 796' ' ' VAL . . . . . 0.587 HG21 ' OD2' ' A' ' 756' ' ' ASP . 53.4 t -97.61 -51.71 10.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-O 120.993 0.425 . . . . 0.0 111.272 -178.063 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 797' ' ' SER . . . . . 0.569 ' HA ' ' HG ' ' A' ' 808' ' ' LEU . 81.1 p -168.42 155.62 7.75 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.391 -172.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 798' ' ' ILE . . . . . 0.63 ' HA ' ' O ' ' A' ' 752' ' ' THR . 8.7 tt -130.15 167.2 25.88 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 177.106 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 799' ' ' LYS . . . . . 0.713 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 2.7 ttmp? -135.74 118.32 15.93 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.626 -176.434 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 800' ' ' ASP . . . . . 0.601 ' HA ' ' CE2' ' A' ' 751' ' ' PHE . 12.0 m-20 -58.88 154.91 14.15 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.805 171.727 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 801' ' ' SER . . . . . 0.404 ' OG ' ' HG2' ' A' ' 750' ' ' PRO . 5.8 m -62.06 -10.21 9.43 Favored 'General case' 0 C--N 1.326 -0.415 0 O-C-N 124.14 0.9 . . . . 0.0 112.505 -172.447 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 14.0 t -96.24 4.99 51.98 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.559 0.695 . . . . 0.0 109.636 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 803' ' ' GLY . . . . . . . . . . . . . . . 81.19 43.36 8.73 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 115.316 -0.857 . . . . 0.0 112.135 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 804' ' ' CYS . . . . . 0.418 ' HB3' ' HB2' ' A' ' 800' ' ' ASP . 46.4 t -114.71 119.75 37.74 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 178.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 805' ' ' VAL . . . . . 0.535 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 3.0 t -94.22 124.79 46.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.327 0.584 . . . . 0.0 111.562 -172.434 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 806' ' ' VAL . . . . . . . . . . . . . 39.5 t -104.72 135.64 41.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.299 177.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -74.16 127.91 10.41 Favored Glycine 0 C--N 1.323 -0.177 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.47 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 808' ' ' LEU . . . . . 0.569 ' HG ' ' HA ' ' A' ' 797' ' ' SER . 64.2 mt -98.05 136.96 37.55 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -172.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 43.0 m -148.71 86.39 1.52 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.822 -1.081 . . . . 0.0 109.173 170.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 810' ' ' GLN . . . . . 0.428 ' HG2' ' HD2' ' A' ' 811' ' ' PRO . 0.7 OUTLIER -139.79 172.92 5.65 Favored Pre-proline 0 CA--C 1.539 0.539 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.132 179.373 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 811' ' ' PRO . . . . . 0.428 ' HD2' ' HG2' ' A' ' 810' ' ' GLN . 92.7 Cg_exo -44.4 138.77 7.21 Favored 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 123.059 2.506 . . . . 0.0 115.159 -173.176 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -104.47 167.46 9.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.541 -1.209 . . . . 0.0 110.327 178.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 813' ' ' ALA . . . . . . . . . . . . . . . -123.88 152.01 42.84 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.437 175.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 814' ' ' LYS . . . . . 0.531 ' HG2' HG12 ' A' ' 792' ' ' ILE . 48.8 mttp -118.18 127.7 54.0 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.718 0.771 . . . . 0.0 111.241 -178.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 815' ' ' ILE . . . . . 0.59 ' HA ' ' HB2' ' A' ' 731' ' ' LEU . 5.3 mp -116.44 107.29 22.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 114.552 -1.204 . . . . 0.0 108.797 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 816' ' ' GLN . . . . . 0.405 ' O ' ' HA ' ' A' ' 732' ' ' LYS . 0.0 OUTLIER -108.68 107.24 17.62 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.313 0.578 . . . . 0.0 110.024 -177.179 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 817' ' ' VAL . . . . . 0.721 ' HB ' ' HB2' ' A' ' 733' ' ' LEU . 1.9 m -102.21 147.46 8.87 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -178.48 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 818' ' ' ARG . . . . . 0.467 ' O ' ' HA ' ' A' ' 734' ' ' CYS . 16.1 tpt180 -147.07 154.76 41.55 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -172.262 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 819' ' ' ARG . . . . . 0.436 ' HD3' HD13 ' A' ' 735' ' ' LEU . 18.6 mmt180 -68.6 132.98 47.82 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 820' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 . . . . . 0 C--N 1.321 -0.654 0 N-CA-C 110.163 -0.31 . . . . 99.989999999999995 110.163 178.865 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 718' ' ' ARG . . . . . . . . . . . . . 7.6 mpt_? . . . . . 0 C--O 1.234 0.28 0 CA-C-O 121.63 0.729 . . . . 0.0 111.053 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 719' ' ' VAL . . . . . 0.652 ' O ' ' HD3' ' A' ' 721' ' ' PRO . 4.7 p -148.75 152.01 12.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.005 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 720' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -84.49 105.14 5.48 Favored Pre-proline 0 C--N 1.312 -1.026 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.119 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 721' ' ' PRO . . . . . 0.652 ' HD3' ' O ' ' A' ' 719' ' ' VAL . 74.1 Cg_endo -88.35 148.3 6.44 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 123.279 2.653 . . . . 0.0 111.249 177.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 722' ' ' SER . . . . . 0.727 ' HA ' HD22 ' A' ' 808' ' ' LEU . 11.6 p 179.44 -158.25 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.802 -171.335 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 723' ' ' ALA . . . . . 0.723 ' HB1' HG21 ' A' ' 743' ' ' VAL . . . -144.15 142.03 30.32 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 177.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 11.7 m -129.31 99.0 5.05 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -178.342 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 725' ' ' LEU . . . . . 0.496 HD22 ' HB ' ' A' ' 743' ' ' VAL . 8.3 mt -64.22 143.63 57.74 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-O 121.811 0.815 . . . . 0.0 112.366 -172.257 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 29.1 mtpt -93.67 -18.91 21.62 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.216 -1.356 . . . . 0.0 108.583 177.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 727' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -60.43 119.2 7.55 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.569 173.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -88.93 -48.26 7.57 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -170.06 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 8.8 p80 -136.11 -175.7 4.07 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.224 -177.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 730' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' A' ' 814' ' ' LYS . 9.1 p-10 -40.65 133.98 1.9 Allowed 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.66 0.743 . . . . 0.0 112.098 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 731' ' ' LEU . . . . . 0.574 ' HB3' ' HA ' ' A' ' 815' ' ' ILE . 22.1 tp -104.26 104.68 14.62 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.258 -177.318 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 732' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -74.19 112.74 10.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.481 -171.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 733' ' ' LEU . . . . . 0.619 ' HG ' ' HB3' ' A' ' 737' ' ' ASP . 9.2 mp -120.01 164.97 15.31 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.73 173.362 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 734' ' ' CYS . . . . . 0.451 ' HA ' ' O ' ' A' ' 818' ' ' ARG . 2.1 p -124.4 -173.62 2.82 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.486 173.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 735' ' ' LEU . . . . . 0.549 HD12 ' HG3' ' A' ' 819' ' ' ARG . 2.6 tt -53.64 115.65 2.08 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.088 0.471 . . . . 0.0 111.284 -174.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 87.88 3.27 80.27 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.592 -0.814 . . . . 0.0 112.965 173.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 737' ' ' ASP . . . . . 0.619 ' HB3' ' HG ' ' A' ' 733' ' ' LEU . 0.3 OUTLIER -76.99 148.98 35.95 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.253 0.549 . . . . 0.0 111.684 178.076 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 738' ' ' HIS . . . . . 0.494 ' HB2' ' O ' ' A' ' 782' ' ' THR . 36.1 p-80 -113.1 151.05 31.26 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 170.466 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 739' ' ' SER . . . . . 0.533 ' O ' ' HA ' ' A' ' 781' ' ' LYS . 17.3 p -108.6 167.56 9.96 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 119.219 -0.992 . . . . 0.0 111.803 -170.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 740' ' ' SER . . . . . 0.428 ' HA ' ' O ' ' A' ' 780' ' ' ILE . 12.9 p -132.7 99.62 4.68 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 114.924 -1.035 . . . . 0.0 109.301 175.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 741' ' ' VAL . . . . . 0.62 HG11 HD13 ' A' ' 793' ' ' LEU . 0.5 OUTLIER -104.98 105.04 49.85 Favored Pre-proline 0 C--N 1.316 -0.877 0 CA-C-N 115.037 -0.983 . . . . 0.0 108.799 179.02 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 742' ' ' PRO . . . . . 0.778 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 2.1 Cg_endo -74.97 131.91 14.85 Favored 'Trans proline' 0 N--CA 1.441 -1.589 0 C-N-CA 122.097 1.865 . . . . 0.0 110.777 -177.239 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 743' ' ' VAL . . . . . 0.723 HG21 ' HB1' ' A' ' 723' ' ' ALA . 1.4 p -131.99 120.88 45.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.769 0.795 . . . . 0.0 112.788 177.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 744' ' ' ALA . . . . . 0.518 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -81.02 99.88 8.68 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 168.529 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 745' ' ' LEU . . . . . 0.905 HD13 HD13 ' A' ' 773' ' ' ILE . 0.2 OUTLIER -83.59 165.33 19.13 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 114.536 -1.211 . . . . 0.0 111.28 -167.475 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 34.9 tptt -114.51 165.0 13.21 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.699 -178.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 747' ' ' GLY . . . . . . . . . . . . . . . 90.16 129.61 4.04 Favored Glycine 0 C--N 1.306 -1.089 0 CA-C-N 115.276 -0.874 . . . . 0.0 111.538 -175.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 748' ' ' GLN . . . . . 0.419 ' C ' ' HE1' ' A' ' 751' ' ' PHE . 0.1 OUTLIER -112.34 113.82 26.23 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.201 0.524 . . . . 0.0 111.636 -173.89 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 123.77 -174.88 16.81 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.371 -0.832 . . . . 0.0 111.045 -177.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 750' ' ' PRO . . . . . 0.402 ' HD2' ' OG ' ' A' ' 801' ' ' SER . 14.0 Cg_exo -69.69 93.89 0.52 Allowed 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.552 2.168 . . . . 0.0 112.317 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 751' ' ' PHE . . . . . 0.564 ' HA ' ' O ' ' A' ' 799' ' ' LYS . 75.6 m-85 -109.84 139.97 44.31 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.45 177.727 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 752' ' ' THR . . . . . 0.701 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 92.6 m -91.04 108.22 19.72 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 176.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 753' ' ' LEU . . . . . 0.553 ' CD1' HD22 ' A' ' 745' ' ' LEU . 3.7 tt -100.46 118.41 36.61 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.094 -171.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 754' ' ' THR . . . . . 0.47 HG23 ' HB2' ' A' ' 769' ' ' GLU . 1.6 m -114.66 138.25 50.92 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.967 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 755' ' ' TYR . . . . . 0.643 ' CE1' ' HB3' ' A' ' 768' ' ' PHE . 28.9 p90 -146.47 153.91 40.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.998 0.428 . . . . 0.0 111.392 178.372 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 756' ' ' ASP . . . . . 0.435 ' CG ' ' HD2' ' A' ' 765' ' ' ARG . 39.3 m-20 -112.04 120.85 43.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.818 -178.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 757' ' ' ILE . . . . . . . . . . . . . 3.3 mp -88.02 95.77 5.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 168.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 758' ' ' ILE . . . . . 0.638 HG22 ' HD3' ' A' ' 765' ' ' ARG . 2.3 pp -96.09 140.58 16.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-O 121.595 0.712 . . . . 0.0 112.056 -170.523 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 759' ' ' GLU . . . . . 0.457 ' CD ' ' HB2' ' A' ' 764' ' ' LYS . 13.4 mt-10 -95.64 103.32 15.19 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.336 -176.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 760' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -80.71 -11.47 59.62 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.132 -168.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 761' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -94.22 -29.2 15.22 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.169 -178.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 762' ' ' SER . . . . . 0.513 ' O ' ' HB2' ' A' ' 763' ' ' SER . 3.2 p -111.11 -5.15 14.81 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -175.058 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 763' ' ' SER . . . . . 0.513 ' HB2' ' O ' ' A' ' 762' ' ' SER . 64.6 m 73.29 4.02 4.76 Favored 'General case' 0 C--O 1.234 0.277 0 O-C-N 123.62 0.575 . . . . 0.0 111.006 -177.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 764' ' ' LYS . . . . . 0.457 ' HB2' ' CD ' ' A' ' 759' ' ' GLU . 6.6 mtpm? -86.23 177.26 7.56 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.932 179.28 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 765' ' ' ARG . . . . . 0.638 ' HD3' HG22 ' A' ' 758' ' ' ILE . 5.4 ttp180 -163.32 146.82 10.56 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-O 120.958 0.408 . . . . 0.0 111.531 -175.391 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 766' ' ' LYS . . . . . 0.461 ' HD3' ' N ' ' A' ' 767' ' ' THR . 9.6 tmtm? -117.91 146.42 43.96 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 177.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 767' ' ' THR . . . . . 0.461 ' N ' ' HD3' ' A' ' 766' ' ' LYS . 90.0 m -121.09 133.9 55.24 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 116.629 -0.26 . . . . 0.0 110.473 178.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 768' ' ' PHE . . . . . 0.643 ' HB3' ' CE1' ' A' ' 755' ' ' TYR . 1.2 t80 -134.74 135.93 42.29 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 177.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 769' ' ' GLU . . . . . 0.47 ' HB2' HG23 ' A' ' 754' ' ' THR . 42.8 tt0 -131.94 135.25 46.46 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.054 -178.353 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 770' ' ' ILE . . . . . 0.554 HG22 HG22 ' A' ' 773' ' ' ILE . 3.8 mt -126.81 112.0 27.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 176.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 771' ' ' LYS . . . . . 0.635 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 11.3 mtpt -83.49 154.96 23.62 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-O 121.035 0.445 . . . . 0.0 110.897 -177.328 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 772' ' ' GLU . . . . . 0.416 ' O ' ' HG3' ' A' ' 774' ' ' LYS . 5.2 mt-10 53.58 48.45 21.65 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.674 -1.148 . . . . 0.0 111.932 177.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 773' ' ' ILE . . . . . 0.905 HD13 HD13 ' A' ' 745' ' ' LEU . 0.5 OUTLIER -74.77 115.34 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 174.278 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 774' ' ' LYS . . . . . 0.416 ' HG3' ' O ' ' A' ' 772' ' ' GLU . 72.0 mttt -116.33 32.28 6.22 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 -178.328 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 775' ' ' THR . . . . . 0.679 ' H ' HD12 ' A' ' 773' ' ' ILE . 0.2 OUTLIER -96.56 -72.37 0.64 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.212 -1.358 . . . . 0.0 112.522 -171.598 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 776' ' ' ASN . . . . . 0.416 ' O ' ' HG3' ' A' ' 777' ' ' GLU . 11.5 m120 79.36 5.35 2.15 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.035 0.934 . . . . 0.0 110.506 -176.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 777' ' ' GLU . . . . . 0.518 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 21.8 mt-10 -160.36 79.45 0.66 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.7 -1.136 . . . . 0.0 108.826 176.155 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 778' ' ' TYR . . . . . 0.79 ' HB3' HD11 ' A' ' 745' ' ' LEU . 91.4 t80 -132.61 130.72 40.59 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.964 -171.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 779' ' ' VAL . . . . . 0.778 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 2.0 m -95.73 126.16 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 CA-C-O 122.331 1.062 . . . . 0.0 110.575 176.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 780' ' ' ILE . . . . . 0.443 ' HB ' HG13 ' A' ' 741' ' ' VAL . 79.6 mt -89.04 145.57 7.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 113.542 -1.663 . . . . 0.0 110.465 -174.423 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 781' ' ' LYS . . . . . 0.533 ' HA ' ' O ' ' A' ' 739' ' ' SER . 3.9 mppt? -118.07 111.91 19.53 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 177.469 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 782' ' ' THR . . . . . 0.494 ' O ' ' HB2' ' A' ' 738' ' ' HIS . 30.8 p -74.75 142.87 77.58 Favored Pre-proline 0 C--N 1.319 -0.727 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 177.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 783' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_exo -52.03 161.52 2.39 Favored 'Trans proline' 0 N--CA 1.472 0.22 0 C-N-CA 123.681 2.921 . . . . 0.0 113.171 -177.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 784' ' ' VAL . . . . . . . . . . . . . 51.1 t -63.4 113.7 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.046 177.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 785' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -104.16 102.3 12.03 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.351 178.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 77.2 p -85.94 26.64 0.97 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.781 0.8 . . . . 0.0 111.058 -176.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 92.4 m -144.74 111.47 5.77 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.173 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 788' ' ' GLY . . . . . 0.741 ' HA2' HG12 ' A' ' 817' ' ' VAL . . . -49.65 121.4 9.11 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.971 -0.633 . . . . 0.0 113.201 171.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 789' ' ' GLY . . . . . 0.52 ' H ' ' HB ' ' A' ' 817' ' ' VAL . . . -175.19 173.94 46.51 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 178.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -100.19 133.98 43.79 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 117.819 0.809 . . . . 0.0 109.606 -179.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 791' ' ' TYR . . . . . 0.452 ' HA ' ' O ' ' A' ' 758' ' ' ILE . 68.1 m-85 -129.63 118.62 22.26 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.063 0.459 . . . . 0.0 110.702 -177.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 792' ' ' ILE . . . . . 0.578 HG12 ' HG2' ' A' ' 814' ' ' LYS . 17.8 mt -97.01 116.09 38.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.066 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 793' ' ' LEU . . . . . 0.62 HD13 HG11 ' A' ' 741' ' ' VAL . 10.1 tt -84.45 106.49 16.07 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 175.399 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 794' ' ' SER . . . . . . . . . . . . . 23.0 t -115.88 148.42 40.0 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.397 -177.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 795' ' ' LEU . . . . . . . . . . . . . 44.9 mt -82.39 134.23 35.24 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.829 0.347 . . . . 0.0 110.681 -176.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 796' ' ' VAL . . . . . . . . . . . . . 77.6 t -95.79 -55.9 5.69 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.46 -177.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 797' ' ' SER . . . . . 0.544 ' HA ' ' HG ' ' A' ' 808' ' ' LEU . 92.0 p -177.74 162.61 1.77 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.373 -172.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 798' ' ' ILE . . . . . 0.656 ' HA ' ' O ' ' A' ' 752' ' ' THR . 9.4 tt -135.28 168.44 23.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 178.691 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 799' ' ' LYS . . . . . 0.701 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 19.9 tttt -133.5 114.83 14.05 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.732 0.301 . . . . 0.0 111.274 -177.617 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 800' ' ' ASP . . . . . 0.562 ' HA ' ' CE2' ' A' ' 751' ' ' PHE . 1.6 m-20 -58.27 153.09 15.97 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.594 170.269 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 801' ' ' SER . . . . . 0.402 ' OG ' ' HD2' ' A' ' 750' ' ' PRO . 6.6 m -66.56 -4.72 9.2 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.141 -172.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 21.6 p -95.06 6.4 49.18 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.585 0.707 . . . . 0.0 109.889 175.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 803' ' ' GLY . . . . . 0.533 ' HA2' ' HE2' ' A' ' 799' ' ' LYS . . . 74.95 41.28 33.28 Favored Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.716 -178.125 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 804' ' ' CYS . . . . . 0.419 ' HB3' ' HB2' ' A' ' 800' ' ' ASP . 51.9 t -114.83 120.23 39.3 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.283 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 805' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 10.2 p -84.9 133.77 28.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 121.523 0.678 . . . . 0.0 110.684 -175.447 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 806' ' ' VAL . . . . . 0.519 HG11 ' HD2' ' A' ' 721' ' ' PRO . 24.8 t -117.03 135.45 57.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.995 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -74.91 122.59 7.07 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.865 -178.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 808' ' ' LEU . . . . . 0.727 HD22 ' HA ' ' A' ' 722' ' ' SER . 50.9 mt -89.11 127.56 35.72 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.059 0.456 . . . . 0.0 112.145 -177.22 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 20.1 m -144.27 85.58 1.8 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.882 172.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 810' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -145.82 170.85 7.26 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.251 177.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 811' ' ' PRO . . . . . . . . . . . . . 99.7 Cg_exo -42.98 139.84 3.37 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 123.204 2.603 . . . . 0.0 115.3 -170.17 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -103.38 167.35 9.87 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 114.475 -1.239 . . . . 0.0 110.207 178.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 813' ' ' ALA . . . . . 0.478 ' HB3' ' HB3' ' A' ' 793' ' ' LEU . . . -116.58 150.15 38.49 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.381 178.331 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 814' ' ' LYS . . . . . 0.578 ' HG2' HG12 ' A' ' 792' ' ' ILE . 47.3 mttp -123.27 96.86 5.16 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 122.048 0.928 . . . . 0.0 111.106 176.161 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 815' ' ' ILE . . . . . 0.574 ' HA ' ' HB3' ' A' ' 731' ' ' LEU . 5.4 mp -87.71 110.82 21.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 CA-C-N 113.97 -1.468 . . . . 0.0 108.987 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 816' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -100.48 107.85 19.68 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.223 0.535 . . . . 0.0 110.226 -175.46 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 817' ' ' VAL . . . . . 0.741 HG12 ' HA2' ' A' ' 788' ' ' GLY . 57.3 t -93.84 146.04 7.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.241 177.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 818' ' ' ARG . . . . . 0.451 ' O ' ' HA ' ' A' ' 734' ' ' CYS . 30.6 tpt180 -137.11 124.22 21.64 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.09 0.471 . . . . 0.0 110.619 178.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 819' ' ' ARG . . . . . 0.549 ' HG3' HD12 ' A' ' 735' ' ' LEU . 9.3 ttp180 -79.39 113.12 17.27 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.105 -179.029 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 820' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 . . . . . 0 C--N 1.318 -0.771 0 CA-C-N 115.172 -0.922 . . . . 99.989999999999995 110.161 -178.725 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 718' ' ' ARG . . . . . . . . . . . . . 17.2 tpp180 . . . . . 0 CA--C 1.511 -0.537 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 719' ' ' VAL . . . . . 0.587 ' O ' ' HD3' ' A' ' 721' ' ' PRO . 2.1 t -113.63 164.51 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.201 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 720' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -94.89 96.26 1.88 Allowed Pre-proline 0 C--N 1.299 -1.596 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 168.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 721' ' ' PRO . . . . . 0.587 ' HD3' ' O ' ' A' ' 719' ' ' VAL . 57.4 Cg_endo -84.92 148.12 10.68 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 122.632 2.221 . . . . 0.0 111.268 -173.39 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 722' ' ' SER . . . . . 0.666 ' HA ' HD22 ' A' ' 808' ' ' LEU . 57.0 m -166.78 -161.83 0.47 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.857 -171.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 723' ' ' ALA . . . . . 0.627 ' HB1' HG21 ' A' ' 743' ' ' VAL . . . -149.03 140.56 23.39 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.336 173.371 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 724' ' ' SER . . . . . 0.416 ' C ' HG23 ' A' ' 743' ' ' VAL . 19.0 m -126.7 104.96 8.36 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -177.638 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 725' ' ' LEU . . . . . 0.556 ' CD2' ' HB ' ' A' ' 743' ' ' VAL . 14.8 mt -63.39 137.42 58.16 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-O 121.331 0.586 . . . . 0.0 110.839 -176.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 726' ' ' LYS . . . . . 0.439 ' HD2' ' HB2' ' A' ' 744' ' ' ALA . 33.9 mtpt -89.76 -18.3 26.6 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.886 -175.351 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 727' ' ' LEU . . . . . 0.422 ' HB2' ' HD2' ' A' ' 742' ' ' PRO . 25.5 tp -68.15 109.59 3.61 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.248 175.167 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 11.6 t-80 -110.83 25.22 12.01 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.266 0.555 . . . . 0.0 111.534 -173.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 6.2 p80 -155.81 162.08 40.53 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.092 179.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 730' ' ' ASP . . . . . 0.541 ' OD1' ' HB2' ' A' ' 816' ' ' GLN . 16.5 t70 -72.25 131.41 42.69 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.807 0.813 . . . . 0.0 111.301 -176.411 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 731' ' ' LEU . . . . . 0.597 ' HG ' HD21 ' A' ' 733' ' ' LEU . 25.9 tp -87.17 110.13 19.94 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 114.114 -1.403 . . . . 0.0 110.671 -174.62 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 732' ' ' LYS . . . . . . . . . . . . . 26.5 mmmt -86.74 107.4 18.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.389 -172.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 733' ' ' LEU . . . . . 0.723 HD12 HG22 ' A' ' 817' ' ' VAL . 16.8 mt -119.32 163.92 16.45 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.848 0.356 . . . . 0.0 111.088 -179.336 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 734' ' ' CYS . . . . . 0.562 ' O ' ' HB2' ' A' ' 737' ' ' ASP . 15.5 t -116.97 -173.75 2.45 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 174.138 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 735' ' ' LEU . . . . . 0.495 ' HB2' ' HA ' ' A' ' 819' ' ' ARG . 18.6 tp -73.23 133.83 44.1 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.447 0.642 . . . . 0.0 111.724 -172.584 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 81.49 10.11 84.9 Favored Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 114.674 -1.148 . . . . 0.0 111.423 -178.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 737' ' ' ASP . . . . . 0.562 ' HB2' ' O ' ' A' ' 734' ' ' CYS . 0.9 OUTLIER -88.14 149.7 23.76 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.918 0.389 . . . . 0.0 111.315 175.99 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 25.6 p-80 -109.52 167.27 10.26 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 170.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 739' ' ' SER . . . . . 0.429 ' HB3' HD23 ' A' ' 731' ' ' LEU . 0.3 OUTLIER -121.25 164.59 16.73 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 119.855 -0.738 . . . . 0.0 111.74 -173.206 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 62.8 m -143.35 128.15 18.28 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.126 -0.943 . . . . 0.0 108.941 178.069 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 741' ' ' VAL . . . . . 0.722 HG11 HD23 ' A' ' 793' ' ' LEU . 0.8 OUTLIER -138.06 114.85 9.24 Favored Pre-proline 0 C--N 1.312 -1.048 0 CA-C-O 121.337 0.589 . . . . 0.0 110.326 -177.866 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 742' ' ' PRO . . . . . 0.659 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 6.5 Cg_endo -76.66 136.35 17.05 Favored 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 122.389 2.059 . . . . 0.0 111.396 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 743' ' ' VAL . . . . . 0.627 HG21 ' HB1' ' A' ' 723' ' ' ALA . 1.6 p -131.64 119.44 42.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.253 0.549 . . . . 0.0 111.915 176.489 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 744' ' ' ALA . . . . . 0.439 ' HB2' ' HD2' ' A' ' 726' ' ' LYS . . . -84.0 111.65 19.48 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 168.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 745' ' ' LEU . . . . . 0.908 HD13 HD13 ' A' ' 773' ' ' ILE . 0.2 OUTLIER -94.11 154.78 17.42 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.645 -1.161 . . . . 0.0 110.9 -166.359 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -107.01 149.85 27.12 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.161 -178.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 747' ' ' GLY . . . . . 0.489 ' HA3' ' HB3' ' A' ' 721' ' ' PRO . . . 96.2 118.62 3.48 Favored Glycine 0 C--N 1.316 -0.559 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -174.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 27.4 mp0 -99.77 122.47 42.79 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.192 0.52 . . . . 0.0 112.115 -169.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 116.24 -170.75 13.46 Favored Glycine 0 C--O 1.218 -0.845 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.439 -179.092 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 750' ' ' PRO . . . . . 0.497 ' HB3' ' HE2' ' A' ' 774' ' ' LYS . 88.8 Cg_endo -69.94 96.6 0.61 Allowed 'Trans proline' 0 CA--C 1.533 0.445 0 C-N-CA 123.506 2.804 . . . . 0.0 113.893 -178.291 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 751' ' ' PHE . . . . . 0.597 ' CD2' ' HA ' ' A' ' 800' ' ' ASP . 80.7 m-85 -115.19 148.14 39.44 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.176 178.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 752' ' ' THR . . . . . 0.761 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 98.2 m -90.56 104.16 16.77 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.231 0.538 . . . . 0.0 109.684 178.223 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 753' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.14 113.7 25.3 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.186 -170.46 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 754' ' ' THR . . . . . 0.474 HG23 ' HB2' ' A' ' 769' ' ' GLU . 1.6 m -109.89 134.42 52.09 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.455 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 755' ' ' TYR . . . . . 0.616 ' CE1' ' HB2' ' A' ' 768' ' ' PHE . 24.9 p90 -143.97 152.89 41.66 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.021 0.439 . . . . 0.0 112.133 179.194 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 756' ' ' ASP . . . . . 0.468 ' HB2' HG23 ' A' ' 758' ' ' ILE . 2.9 p30 -113.31 121.14 43.5 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.513 -178.582 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 757' ' ' ILE . . . . . 0.532 ' CD1' HD13 ' A' ' 793' ' ' LEU . 4.0 mp -93.89 96.16 5.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 165.285 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 758' ' ' ILE . . . . . 0.535 HG13 ' O ' ' A' ' 792' ' ' ILE . 2.2 pp -100.39 150.16 5.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.749 -170.33 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 759' ' ' GLU . . . . . 0.559 ' CD ' ' HB2' ' A' ' 764' ' ' LYS . 10.2 mt-10 -92.96 115.85 28.51 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.764 -177.549 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 760' ' ' THR . . . . . 0.473 HG23 ' HB2' ' A' ' 790' ' ' ASP . 0.2 OUTLIER -96.4 -5.68 39.23 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.389 0.614 . . . . 0.0 109.781 178.169 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 761' ' ' PHE . . . . . 0.559 ' CB ' ' H ' ' A' ' 790' ' ' ASP . 91.3 t80 -95.34 -28.12 15.12 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.747 178.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 762' ' ' SER . . . . . . . . . . . . . 49.1 m -120.62 -102.67 0.41 Allowed 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.153 177.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 763' ' ' SER . . . . . . . . . . . . . 28.7 p -167.54 5.73 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -175.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 764' ' ' LYS . . . . . 0.559 ' HB2' ' CD ' ' A' ' 759' ' ' GLU . 9.2 mtmp? -95.75 -178.35 4.35 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.484 -0.486 . . . . 0.0 111.039 -178.254 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 765' ' ' ARG . . . . . 0.527 ' HD3' HG22 ' A' ' 758' ' ' ILE . 6.7 ttp180 -163.43 137.0 5.71 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.506 -175.299 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 766' ' ' LYS . . . . . 0.658 ' HD3' ' N ' ' A' ' 767' ' ' THR . 7.8 tmtm? -115.48 146.24 41.85 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 177.145 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 767' ' ' THR . . . . . 0.658 ' N ' ' HD3' ' A' ' 766' ' ' LYS . 90.7 m -132.49 135.83 46.27 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.42 -177.382 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 768' ' ' PHE . . . . . 0.616 ' HB2' ' CE1' ' A' ' 755' ' ' TYR . 20.8 m-85 -123.26 134.57 54.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.38 174.003 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 769' ' ' GLU . . . . . 0.474 ' HB2' HG23 ' A' ' 754' ' ' THR . 40.5 tt0 -126.9 104.83 8.24 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.591 177.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 770' ' ' ILE . . . . . 0.402 HG22 HG22 ' A' ' 773' ' ' ILE . 22.1 mt -105.22 117.55 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.422 -178.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 771' ' ' LYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 17.7 mmtt -77.74 159.11 29.29 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.451 0.643 . . . . 0.0 111.006 -179.204 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 772' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 48.02 45.96 19.22 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 113.863 -1.517 . . . . 0.0 112.83 172.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 773' ' ' ILE . . . . . 0.908 HD13 HD13 ' A' ' 745' ' ' LEU . 0.5 OUTLIER -75.72 109.85 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 172.149 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 774' ' ' LYS . . . . . 0.497 ' HE2' ' HB3' ' A' ' 750' ' ' PRO . 59.6 mttt -105.65 28.83 7.1 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 -177.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 775' ' ' THR . . . . . 0.687 ' H ' HD12 ' A' ' 773' ' ' ILE . 0.6 OUTLIER -95.32 -74.61 0.55 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.95 -1.023 . . . . 0.0 113.122 -166.726 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 776' ' ' ASN . . . . . 0.461 ' HA ' ' HB2' ' A' ' 745' ' ' LEU . 11.8 m120 84.48 1.86 0.83 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.76 1.224 . . . . 0.0 110.893 -176.583 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 777' ' ' GLU . . . . . 0.424 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 5.2 mp0 -156.05 83.17 1.0 Allowed 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 177.405 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 778' ' ' TYR . . . . . 0.645 ' HB3' HD11 ' A' ' 745' ' ' LEU . 67.1 t80 -125.97 127.68 46.31 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.582 -170.13 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 779' ' ' VAL . . . . . 0.659 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 15.5 t -88.55 108.6 18.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.285 0.564 . . . . 0.0 110.216 177.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 780' ' ' ILE . . . . . . . . . . . . . 79.4 mt -76.41 143.56 12.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.63 -178.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.73 106.6 11.08 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 175.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 782' ' ' THR . . . . . 0.423 ' HA ' ' HD3' ' A' ' 783' ' ' PRO . 39.5 p -83.51 144.02 45.35 Favored Pre-proline 0 C--N 1.315 -0.9 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.356 -177.546 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 783' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 782' ' ' THR . 60.3 Cg_exo -52.75 160.46 3.91 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 123.775 2.983 . . . . 0.0 112.798 -177.291 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 784' ' ' VAL . . . . . . . . . . . . . 14.9 p -66.34 135.2 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.495 -177.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 785' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -102.54 99.43 9.44 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.561 0.696 . . . . 0.0 110.028 179.099 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 66.3 p -86.09 24.66 1.28 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.861 0.839 . . . . 0.0 110.295 -178.296 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 5.5 m -160.58 110.65 1.77 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.459 -1.246 . . . . 0.0 110.032 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 788' ' ' GLY . . . . . . . . . . . . . . . -49.91 147.73 6.88 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 121.241 -0.504 . . . . 0.0 113.718 173.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 789' ' ' GLY . . . . . . . . . . . . . . . 167.34 177.43 38.9 Favored Glycine 0 N--CA 1.443 -0.873 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 -177.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 790' ' ' ASP . . . . . 0.559 ' H ' ' CB ' ' A' ' 761' ' ' PHE . 5.3 m-20 -109.03 128.8 55.28 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -179.457 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 791' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -129.87 145.36 51.6 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -177.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 792' ' ' ILE . . . . . 0.535 ' O ' HG13 ' A' ' 758' ' ' ILE . 20.3 mt -123.47 122.26 64.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 177.391 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 793' ' ' LEU . . . . . 0.722 HD23 HG11 ' A' ' 741' ' ' VAL . 0.7 OUTLIER -89.42 115.21 26.69 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 176.859 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 794' ' ' SER . . . . . 0.546 ' N ' HD12 ' A' ' 793' ' ' LEU . 34.5 t -128.06 149.93 50.17 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.344 -176.031 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 795' ' ' LEU . . . . . 0.506 ' H ' HD22 ' A' ' 795' ' ' LEU . 1.3 mm? -78.85 130.35 35.57 Favored 'General case' 0 C--N 1.323 -0.579 0 O-C-N 122.158 -0.339 . . . . 0.0 111.383 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 796' ' ' VAL . . . . . . . . . . . . . 94.2 t -89.91 -56.77 4.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.05 0.452 . . . . 0.0 111.035 -177.249 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 797' ' ' SER . . . . . 0.636 ' HA ' ' HG ' ' A' ' 808' ' ' LEU . 30.0 m -171.83 160.75 5.67 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.657 -173.438 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 798' ' ' ILE . . . . . 0.61 ' HA ' ' O ' ' A' ' 752' ' ' THR . 11.7 tt -134.58 160.18 41.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 176.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 799' ' ' LYS . . . . . 0.761 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 7.7 tmtt? -131.77 122.22 25.47 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.206 0.527 . . . . 0.0 110.595 179.233 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 800' ' ' ASP . . . . . 0.597 ' HA ' ' CD2' ' A' ' 751' ' ' PHE . 7.3 t70 -68.29 156.84 36.86 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.671 -1.149 . . . . 0.0 109.844 176.33 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 17.3 t -60.03 -14.22 15.34 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 124.093 0.87 . . . . 0.0 112.812 -172.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 802' ' ' THR . . . . . 0.495 HG22 ' OD2' ' A' ' 800' ' ' ASP . 13.9 t -90.33 -0.46 57.65 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.48 0.657 . . . . 0.0 109.733 176.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 803' ' ' GLY . . . . . . . . . . . . . . . 85.44 39.21 8.44 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.9 -178.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 804' ' ' CYS . . . . . . . . . . . . . 48.8 t -110.51 115.19 29.19 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 -178.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 805' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 7.6 p -86.34 134.24 27.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.215 0.531 . . . . 0.0 111.079 -176.304 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 806' ' ' VAL . . . . . 0.506 HG21 ' HD2' ' A' ' 721' ' ' PRO . 71.4 t -118.56 131.22 71.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.12 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -69.78 116.47 6.9 Favored Glycine 0 N--CA 1.453 -0.178 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.907 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 808' ' ' LEU . . . . . 0.666 HD22 ' HA ' ' A' ' 722' ' ' SER . 32.2 mt -84.87 131.13 34.55 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -174.445 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 36.4 m -147.42 86.25 1.61 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.62 173.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 810' ' ' GLN . . . . . 0.562 ' HB3' ' HD2' ' A' ' 811' ' ' PRO . 89.1 mt-30 -139.18 169.53 12.2 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.261 177.266 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 811' ' ' PRO . . . . . 0.562 ' HD2' ' HB3' ' A' ' 810' ' ' GLN . 89.3 Cg_exo -45.68 135.84 12.91 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 122.847 2.364 . . . . 0.0 114.611 -175.354 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -107.13 167.36 9.96 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.343 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 813' ' ' ALA . . . . . 0.528 ' N ' HD12 ' A' ' 725' ' ' LEU . . . -119.67 152.79 36.56 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.404 -178.635 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 814' ' ' LYS . . . . . . . . . . . . . 16.9 ttpp -118.23 126.45 52.21 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 121.341 0.591 . . . . 0.0 110.562 178.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 815' ' ' ILE . . . . . 0.594 ' HA ' ' HB3' ' A' ' 731' ' ' LEU . 5.2 mp -112.71 119.28 60.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 114.946 -1.025 . . . . 0.0 109.08 178.434 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 816' ' ' GLN . . . . . 0.6 ' NE2' ' HE ' ' A' ' 818' ' ' ARG . 2.9 tm0? -107.32 115.04 29.46 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 817' ' ' VAL . . . . . 0.723 HG22 HD12 ' A' ' 733' ' ' LEU . 3.9 t -106.43 145.71 13.86 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 177.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 818' ' ' ARG . . . . . 0.6 ' HE ' ' NE2' ' A' ' 816' ' ' GLN . 20.9 mmt85 -129.43 174.19 9.86 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 120.524 -0.47 . . . . 0.0 111.621 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 819' ' ' ARG . . . . . 0.495 ' HA ' ' HB2' ' A' ' 735' ' ' LEU . 45.5 ttt180 -124.75 124.54 42.36 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.75 174.122 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 820' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 . . . . . 0 C--N 1.32 -0.694 0 CA-C-N 116.328 -0.397 . . . . 99.989999999999995 110.77 -177.437 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 718' ' ' ARG . . . . . . . . . . . . . 22.7 tpt180 . . . . . 0 CA--C 1.506 -0.714 0 CA-C-O 121.533 0.682 . . . . 0.0 109.683 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 719' ' ' VAL . . . . . 0.655 ' O ' ' HD3' ' A' ' 721' ' ' PRO . 2.3 m -142.77 168.24 13.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 114.506 -1.225 . . . . 0.0 108.785 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 720' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -94.06 96.06 1.58 Allowed Pre-proline 0 C--N 1.307 -1.241 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.107 174.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 721' ' ' PRO . . . . . 0.655 ' HD3' ' O ' ' A' ' 719' ' ' VAL . 95.3 Cg_endo -86.03 148.7 9.37 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 122.869 2.379 . . . . 0.0 112.35 -172.365 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 722' ' ' SER . . . . . 0.402 ' HA ' ' CG ' ' A' ' 808' ' ' LEU . 22.6 t -179.22 -154.05 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.362 -174.207 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 723' ' ' ALA . . . . . 0.542 ' HB3' ' HG ' ' A' ' 795' ' ' LEU . . . -144.77 144.82 31.37 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 176.148 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 7.8 m -128.97 98.96 5.1 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 -175.001 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 725' ' ' LEU . . . . . 0.577 HD22 ' CG2' ' A' ' 743' ' ' VAL . 1.7 mt -63.74 145.32 55.98 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-O 121.216 0.531 . . . . 0.0 110.96 -171.33 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 31.2 mtpt -101.23 -14.56 17.64 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.358 -177.08 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 727' ' ' LEU . . . . . 0.475 ' HB2' HG23 ' A' ' 741' ' ' VAL . 0.6 OUTLIER -74.17 123.31 24.23 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 177.132 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 61.3 m-70 -87.7 -38.0 16.21 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -171.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 729' ' ' HIS . . . . . 0.422 ' O ' HD22 ' A' ' 727' ' ' LEU . 3.1 p80 -126.61 -176.63 3.74 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.991 -172.113 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 730' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -61.52 145.5 51.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.711 0.767 . . . . 0.0 111.427 178.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 731' ' ' LEU . . . . . 0.559 HD23 ' HB2' ' A' ' 739' ' ' SER . 16.2 tp -105.37 108.62 20.23 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.927 -177.634 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 732' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -76.93 122.1 24.38 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.9 -175.462 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 733' ' ' LEU . . . . . 0.495 HD11 ' HB3' ' A' ' 739' ' ' SER . 85.3 mt -132.71 164.09 27.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.773 176.22 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 734' ' ' CYS . . . . . 0.535 ' O ' ' HB2' ' A' ' 737' ' ' ASP . 26.8 p -115.93 -174.06 2.47 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 172.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 735' ' ' LEU . . . . . . . . . . . . . 6.1 tp -66.61 135.48 54.17 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.778 0.799 . . . . 0.0 112.322 -175.158 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 81.97 4.72 90.19 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 114.357 -1.292 . . . . 0.0 111.767 178.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 737' ' ' ASP . . . . . 0.535 ' HB2' ' O ' ' A' ' 734' ' ' CYS . 6.8 m-20 -82.15 150.54 27.38 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.329 0.585 . . . . 0.0 112.422 -179.382 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 738' ' ' HIS . . . . . 0.497 ' HB2' ' O ' ' A' ' 782' ' ' THR . 42.6 p-80 -113.39 160.32 18.53 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 169.555 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 739' ' ' SER . . . . . 0.559 ' HB2' HD23 ' A' ' 731' ' ' LEU . 1.5 p -117.25 170.03 9.01 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 119.556 -0.857 . . . . 0.0 111.827 -172.05 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 740' ' ' SER . . . . . 0.486 ' HA ' ' O ' ' A' ' 780' ' ' ILE . 50.5 m -143.08 101.52 3.84 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.146 177.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 741' ' ' VAL . . . . . 0.547 HG11 HD13 ' A' ' 793' ' ' LEU . 1.2 p -108.74 109.46 61.22 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.546 178.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 742' ' ' PRO . . . . . 0.806 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 5.9 Cg_exo -72.41 128.89 14.13 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 122.252 1.968 . . . . 0.0 111.51 -177.427 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 743' ' ' VAL . . . . . 0.577 ' CG2' HD22 ' A' ' 725' ' ' LEU . 43.5 t -130.41 119.2 45.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -178.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 744' ' ' ALA . . . . . 0.572 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -84.27 117.97 23.89 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 170.296 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 745' ' ' LEU . . . . . 0.926 HD13 HD13 ' A' ' 773' ' ' ILE . 0.4 OUTLIER -95.45 150.67 20.04 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.931 -165.222 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -105.92 146.76 29.57 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.483 -177.028 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 747' ' ' GLY . . . . . . . . . . . . . . . 110.27 135.29 6.99 Favored Glycine 0 C--N 1.311 -0.842 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 -173.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -114.16 106.33 14.25 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 117.053 0.426 . . . . 0.0 111.37 -171.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 129.17 -175.48 18.85 Favored Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 -178.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -68.01 93.46 0.39 Allowed 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.506 2.137 . . . . 0.0 112.119 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 751' ' ' PHE . . . . . 0.496 ' CE2' ' HA ' ' A' ' 800' ' ' ASP . 57.7 m-85 -109.66 140.42 43.53 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.119 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 752' ' ' THR . . . . . 0.759 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 53.8 m -90.24 102.73 15.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.358 0.599 . . . . 0.0 109.837 176.577 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 753' ' ' LEU . . . . . 0.428 HD22 ' N ' ' A' ' 754' ' ' THR . 0.4 OUTLIER -94.06 123.09 37.21 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.662 -169.695 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 754' ' ' THR . . . . . 0.428 ' N ' HD22 ' A' ' 753' ' ' LEU . 0.8 OUTLIER -119.49 139.88 51.37 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.281 -177.878 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 755' ' ' TYR . . . . . 0.636 ' CE1' ' HB3' ' A' ' 768' ' ' PHE . 23.8 p90 -146.41 155.82 42.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.938 0.399 . . . . 0.0 111.528 177.598 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 756' ' ' ASP . . . . . 0.465 ' HB3' HG23 ' A' ' 758' ' ' ILE . 5.2 m-20 -113.54 120.27 40.4 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.317 -178.233 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 757' ' ' ILE . . . . . 0.453 HG13 HD12 ' A' ' 793' ' ' LEU . 4.2 mp -89.14 95.41 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 169.358 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 758' ' ' ILE . . . . . 0.549 HG13 ' O ' ' A' ' 792' ' ' ILE . 1.6 pp -101.19 148.2 7.41 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.56 -174.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 759' ' ' GLU . . . . . 0.796 ' HB3' ' CE2' ' A' ' 791' ' ' TYR . 7.0 pt-20 -106.17 122.15 45.62 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.075 173.021 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 760' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -84.12 -9.06 58.89 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.683 -1.144 . . . . 0.0 108.618 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 761' ' ' PHE . . . . . 0.513 ' HB2' ' H ' ' A' ' 790' ' ' ASP . 38.5 t80 -70.54 -35.65 73.24 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 114.618 -1.174 . . . . 0.0 110.782 177.03 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 762' ' ' SER . . . . . 0.62 ' HB2' ' OE2' ' A' ' 759' ' ' GLU . 20.1 m -151.71 -99.29 0.06 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.666 175.386 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 763' ' ' SER . . . . . . . . . . . . . 64.2 m -164.14 44.83 0.1 Allowed 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -170.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 764' ' ' LYS . . . . . 0.698 ' H ' ' CG ' ' A' ' 759' ' ' GLU . 39.0 mttp -113.03 66.02 0.65 Allowed 'General case' 0 C--N 1.327 -0.38 0 O-C-N 121.976 -0.453 . . . . 0.0 110.306 175.549 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 765' ' ' ARG . . . . . 0.474 ' CG ' HG22 ' A' ' 758' ' ' ILE . 23.0 ttp180 -72.9 139.71 47.02 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.045 177.791 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 766' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -126.54 140.82 52.15 Favored 'General case' 0 C--O 1.215 -0.738 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.847 -178.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 767' ' ' THR . . . . . . . . . . . . . 43.0 m -112.06 129.78 56.1 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.498 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 768' ' ' PHE . . . . . 0.636 ' HB3' ' CE1' ' A' ' 755' ' ' TYR . 2.5 t80 -126.1 135.83 52.19 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.334 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 769' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -132.42 127.98 36.53 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.933 -175.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 770' ' ' ILE . . . . . 0.596 HG22 HG22 ' A' ' 773' ' ' ILE . 4.6 mt -121.52 114.14 41.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 177.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 771' ' ' LYS . . . . . 0.595 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 0.1 OUTLIER -87.46 153.88 21.08 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 121.256 0.55 . . . . 0.0 111.842 -174.643 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 772' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 52.35 47.93 23.69 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.363 -1.29 . . . . 0.0 112.009 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 773' ' ' ILE . . . . . 0.926 HD13 HD13 ' A' ' 745' ' ' LEU . 0.5 OUTLIER -75.17 114.79 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 174.771 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 72.1 mttt -114.3 30.95 6.93 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 775' ' ' THR . . . . . 0.706 ' H ' HD12 ' A' ' 773' ' ' ILE . 2.5 m -97.01 -71.82 0.66 Allowed 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 113.488 -1.687 . . . . 0.0 112.415 -169.128 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 776' ' ' ASN . . . . . 0.452 ' HB2' ' O ' ' A' ' 775' ' ' THR . 82.0 m-20 83.17 7.99 0.69 Allowed 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.198 0.999 . . . . 0.0 110.138 -177.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 777' ' ' GLU . . . . . 0.572 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 22.5 tt0 -161.55 94.39 0.96 Allowed 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.725 175.445 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 778' ' ' TYR . . . . . 0.901 ' HB3' HD11 ' A' ' 745' ' ' LEU . 67.9 t80 -141.91 120.52 12.53 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.553 -172.113 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 779' ' ' VAL . . . . . 0.806 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 1.4 m -88.07 129.38 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 CA-C-O 122.035 0.921 . . . . 0.0 109.733 179.383 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 780' ' ' ILE . . . . . 0.486 ' O ' ' HA ' ' A' ' 740' ' ' SER . 89.7 mt -91.23 138.3 19.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 113.959 -1.473 . . . . 0.0 110.971 -172.301 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 781' ' ' LYS . . . . . 0.453 ' HD3' ' N ' ' A' ' 781' ' ' LYS . 0.0 OUTLIER -115.86 106.73 14.15 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.33 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 782' ' ' THR . . . . . 0.497 ' O ' ' HB2' ' A' ' 738' ' ' HIS . 32.5 p -78.22 143.26 64.72 Favored Pre-proline 0 C--N 1.32 -0.706 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.102 -178.124 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 783' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -55.79 161.65 7.86 Favored 'Trans proline' 0 CA--C 1.529 0.252 0 C-N-CA 123.513 2.809 . . . . 0.0 113.109 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 784' ' ' VAL . . . . . 0.467 HG12 HG23 ' A' ' 786' ' ' THR . 55.3 t -59.02 121.71 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.312 -177.709 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 785' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -97.52 98.22 9.74 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.906 177.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 786' ' ' THR . . . . . 0.467 HG23 HG12 ' A' ' 784' ' ' VAL . 35.3 p -87.28 33.7 0.69 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 122.051 0.929 . . . . 0.0 110.092 178.482 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 28.7 m -153.52 104.98 2.78 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.38 -1.282 . . . . 0.0 110.223 -179.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 788' ' ' GLY . . . . . 0.44 ' H ' ' HB2' ' A' ' 819' ' ' ARG . . . -49.59 113.37 1.76 Allowed Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.277 168.524 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 789' ' ' GLY . . . . . 0.403 ' H ' ' HB ' ' A' ' 817' ' ' VAL . . . -160.49 -166.07 18.56 Favored Glycine 0 N--CA 1.441 -0.97 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 -179.209 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 790' ' ' ASP . . . . . 0.513 ' H ' ' HB2' ' A' ' 761' ' ' PHE . 19.3 m-20 -123.62 122.74 38.91 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 117.621 0.711 . . . . 0.0 109.319 -178.598 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 791' ' ' TYR . . . . . 0.796 ' CE2' ' HB3' ' A' ' 759' ' ' GLU . 88.8 m-85 -117.44 150.86 38.2 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.413 0.625 . . . . 0.0 111.407 -177.017 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 792' ' ' ILE . . . . . 0.549 ' O ' HG13 ' A' ' 758' ' ' ILE . 17.0 mt -131.53 113.04 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.338 175.115 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 793' ' ' LEU . . . . . 0.547 HD13 HG11 ' A' ' 741' ' ' VAL . 7.9 tt -85.03 110.26 18.79 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.156 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 794' ' ' SER . . . . . . . . . . . . . 13.6 t -123.45 142.2 51.23 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.968 -177.034 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 795' ' ' LEU . . . . . 0.578 ' H ' HD22 ' A' ' 795' ' ' LEU . 1.2 mm? -67.91 140.22 56.47 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 120.904 0.383 . . . . 0.0 111.454 -178.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 796' ' ' VAL . . . . . . . . . . . . . 69.7 t -99.82 -55.28 6.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.015 -178.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 797' ' ' SER . . . . . 0.568 ' HA ' HD13 ' A' ' 808' ' ' LEU . 89.5 p -173.66 176.94 2.62 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.345 -173.018 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 798' ' ' ILE . . . . . 0.621 ' HA ' ' O ' ' A' ' 752' ' ' THR . 11.0 tt -151.22 161.43 3.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.379 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 799' ' ' LYS . . . . . 0.759 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 5.2 tttt -132.24 113.89 13.79 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 120.836 0.35 . . . . 0.0 110.521 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 800' ' ' ASP . . . . . 0.577 ' HB3' ' HB3' ' A' ' 804' ' ' CYS . 16.9 t70 -57.91 152.27 16.47 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.263 171.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 3.4 p -65.59 -7.51 15.3 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -171.03 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 35.5 p -93.6 1.7 56.59 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.659 0.743 . . . . 0.0 110.04 176.002 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 803' ' ' GLY . . . . . 0.512 ' HA2' ' HE2' ' A' ' 799' ' ' LYS . . . 82.76 44.73 7.09 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.873 -177.565 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 804' ' ' CYS . . . . . 0.577 ' HB3' ' HB3' ' A' ' 800' ' ' ASP . 45.1 t -111.68 106.93 15.87 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 177.039 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 805' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 3.9 t -86.06 119.32 34.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.38 0.609 . . . . 0.0 110.08 -176.663 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 806' ' ' VAL . . . . . 0.541 HG11 ' HD2' ' A' ' 721' ' ' PRO . 37.3 t -108.01 139.17 31.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.498 -176.24 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -80.06 110.3 3.07 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.557 -179.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 808' ' ' LEU . . . . . 0.568 HD13 ' HA ' ' A' ' 797' ' ' SER . 10.8 mp -77.61 134.19 38.26 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 177.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 19.9 m -149.5 85.76 1.45 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.166 -0.924 . . . . 0.0 109.175 169.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 810' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -132.26 170.8 10.41 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.009 177.467 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 811' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -45.3 144.08 4.78 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 123.038 2.492 . . . . 0.0 114.588 -176.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -111.15 166.21 11.26 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.656 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 813' ' ' ALA . . . . . 0.42 ' O ' ' HA ' ' A' ' 792' ' ' ILE . . . -117.87 147.57 42.96 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.257 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 814' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -108.8 125.44 51.96 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.513 0.673 . . . . 0.0 110.92 178.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 815' ' ' ILE . . . . . 0.544 ' HA ' ' HB3' ' A' ' 731' ' ' LEU . 5.1 mp -110.81 109.06 27.09 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-N 114.818 -1.083 . . . . 0.0 108.651 177.169 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 816' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -99.4 109.27 21.88 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.184 0.516 . . . . 0.0 110.15 -175.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 817' ' ' VAL . . . . . 0.403 ' HB ' ' H ' ' A' ' 789' ' ' GLY . 2.6 t -105.71 146.18 12.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.356 -177.355 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 818' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -136.67 133.42 36.18 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.245 0.545 . . . . 0.0 111.887 -179.11 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 819' ' ' ARG . . . . . 0.44 ' HB2' ' H ' ' A' ' 788' ' ' GLY . 31.5 ttt180 -103.52 118.12 36.0 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.107 174.344 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 820' ' ' ASP . . . . . . . . . . . . . 36.4 t70 . . . . . 0 C--N 1.328 -0.353 0 O-C-N 123.599 0.562 . . . . 99.989999999999995 110.844 -177.447 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 718' ' ' ARG . . . . . . . . . . . . . 7.5 tpp180 . . . . . 0 CA--C 1.508 -0.657 0 CA-C-O 121.686 0.755 . . . . 0.0 110.241 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 719' ' ' VAL . . . . . . . . . . . . . 3.3 m -134.55 -170.79 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 CA-C-N 114.298 -1.319 . . . . 0.0 109.175 -178.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 720' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -117.85 85.19 22.12 Favored Pre-proline 0 C--N 1.307 -1.274 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.22 175.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 721' ' ' PRO . . . . . 0.422 ' O ' HG21 ' A' ' 798' ' ' ILE . 37.6 Cg_endo -83.1 145.36 12.27 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 C-N-CA 122.424 2.083 . . . . 0.0 111.436 -175.133 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 722' ' ' SER . . . . . 0.497 ' OG ' HD22 ' A' ' 808' ' ' LEU . 25.6 t 177.42 -153.08 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -171.362 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 723' ' ' ALA . . . . . 0.737 ' HB1' HG21 ' A' ' 743' ' ' VAL . . . -150.21 143.48 25.02 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.482 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 23.1 t -129.95 103.84 7.02 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 725' ' ' LEU . . . . . 0.465 ' CD2' ' HB ' ' A' ' 743' ' ' VAL . 13.2 mt -64.35 149.26 48.61 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 121.616 0.722 . . . . 0.0 111.839 -175.264 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 726' ' ' LYS . . . . . 0.543 ' HD2' ' HB2' ' A' ' 744' ' ' ALA . 20.2 mtpp -106.8 -10.09 16.18 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.46 -175.721 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 727' ' ' LEU . . . . . 0.465 ' HB2' ' HD2' ' A' ' 742' ' ' PRO . 0.3 OUTLIER -81.31 111.22 17.49 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 176.364 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 40.9 m80 -103.68 37.37 2.05 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -168.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 9.7 p80 -174.08 -177.05 1.25 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.662 0.268 . . . . 0.0 110.776 177.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 730' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -81.04 139.65 35.6 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.297 177.137 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 731' ' ' LEU . . . . . 0.559 ' HB2' ' HA ' ' A' ' 815' ' ' ILE . 36.4 mt -87.61 117.06 26.16 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.263 -178.53 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 732' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -84.09 113.01 20.73 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.333 -178.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 733' ' ' LEU . . . . . 0.522 HD11 ' HB3' ' A' ' 739' ' ' SER . 43.5 mt -131.67 159.6 37.86 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 121.267 0.556 . . . . 0.0 111.9 -175.656 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 734' ' ' CYS . . . . . 0.624 ' HA ' ' O ' ' A' ' 818' ' ' ARG . 78.4 m -104.12 -173.75 2.38 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.131 176.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 735' ' ' LEU . . . . . 0.587 ' HB2' ' HA ' ' A' ' 819' ' ' ARG . 19.9 tp -73.79 134.71 43.44 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.174 0.511 . . . . 0.0 111.342 -178.439 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 74.72 11.56 83.16 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.439 -0.886 . . . . 0.0 111.285 -176.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 737' ' ' ASP . . . . . 0.603 ' HB2' ' O ' ' A' ' 734' ' ' CYS . 0.2 OUTLIER -84.77 150.11 25.29 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.119 0.485 . . . . 0.0 111.231 176.55 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 27.9 p-80 -114.25 175.27 5.55 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 168.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 739' ' ' SER . . . . . 0.522 ' HB3' HD11 ' A' ' 733' ' ' LEU . 0.0 OUTLIER -140.0 166.66 24.04 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 120.083 -0.647 . . . . 0.0 111.999 -178.615 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 19.7 m -136.75 112.97 9.82 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.6 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 741' ' ' VAL . . . . . 0.664 HG11 HD23 ' A' ' 793' ' ' LEU . 0.9 OUTLIER -111.05 112.95 55.1 Favored Pre-proline 0 C--N 1.318 -0.799 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.746 -179.621 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 742' ' ' PRO . . . . . 0.678 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 1.6 Cg_endo -73.43 134.97 21.52 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 122.517 2.145 . . . . 0.0 111.284 -179.306 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 743' ' ' VAL . . . . . 0.737 HG21 ' HB1' ' A' ' 723' ' ' ALA . 2.0 p -131.91 116.44 30.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.376 0.608 . . . . 0.0 112.032 176.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 744' ' ' ALA . . . . . 0.574 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -81.22 98.99 8.34 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 169.552 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 745' ' ' LEU . . . . . 0.968 HD13 HD13 ' A' ' 773' ' ' ILE . 0.3 OUTLIER -79.36 165.33 23.24 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.675 -167.385 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 17.3 ttmm -114.44 165.33 12.84 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.679 -179.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 747' ' ' GLY . . . . . . . . . . . . . . . 94.45 128.45 5.25 Favored Glycine 0 C--N 1.31 -0.863 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 -175.271 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 748' ' ' GLN . . . . . 0.522 ' C ' ' HE1' ' A' ' 751' ' ' PHE . 48.3 mm-40 -110.85 98.62 7.71 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.749 -0.38 . . . . 0.0 111.061 -173.285 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 133.91 -159.23 23.66 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.549 -177.14 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -78.88 94.99 1.06 Allowed 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 122.944 2.43 . . . . 0.0 112.516 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 751' ' ' PHE . . . . . 0.717 ' CE2' ' HA ' ' A' ' 800' ' ' ASP . 94.6 m-85 -118.41 140.66 49.51 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.799 -178.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 752' ' ' THR . . . . . 0.701 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 92.3 m -95.31 106.7 18.77 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.623 0.725 . . . . 0.0 109.536 179.47 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 753' ' ' LEU . . . . . 0.485 HD23 HG12 ' A' ' 798' ' ' ILE . 0.4 OUTLIER -97.19 117.78 32.17 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.538 -1.21 . . . . 0.0 109.783 -170.354 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 754' ' ' THR . . . . . 0.486 HG23 ' HB2' ' A' ' 769' ' ' GLU . 1.2 m -116.71 137.04 52.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.897 -177.074 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 755' ' ' TYR . . . . . 0.681 ' CE1' ' HB2' ' A' ' 768' ' ' PHE . 24.3 p90 -144.64 155.38 43.58 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -179.366 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 756' ' ' ASP . . . . . 0.413 ' OD2' ' HB2' ' A' ' 794' ' ' SER . 4.9 p-10 -116.94 119.94 36.88 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.551 -177.295 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 757' ' ' ILE . . . . . 0.536 ' CD1' HD13 ' A' ' 793' ' ' LEU . 4.0 mp -91.87 96.49 6.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 167.376 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 758' ' ' ILE . . . . . 0.659 HG22 ' HD2' ' A' ' 765' ' ' ARG . 2.4 pp -100.57 149.56 6.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.25 -170.14 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 759' ' ' GLU . . . . . 0.638 ' OE2' ' HB2' ' A' ' 762' ' ' SER . 12.5 mt-10 -86.38 118.59 25.92 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 120.921 0.391 . . . . 0.0 111.13 -179.38 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 760' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -97.42 -6.32 34.22 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.56 0.695 . . . . 0.0 109.533 174.11 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 761' ' ' PHE . . . . . 0.579 ' CB ' ' H ' ' A' ' 790' ' ' ASP . 85.3 t80 -96.44 -34.17 11.61 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.928 178.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 762' ' ' SER . . . . . 0.638 ' HB2' ' OE2' ' A' ' 759' ' ' GLU . 16.5 m -118.25 -99.12 0.45 Allowed 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 120.251 -0.58 . . . . 0.0 111.49 -177.251 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 763' ' ' SER . . . . . . . . . . . . . 70.8 p -166.88 -4.84 0.02 OUTLIER 'General case' 0 C--O 1.232 0.164 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -176.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 764' ' ' LYS . . . . . 0.497 ' C ' ' HG3' ' A' ' 759' ' ' GLU . 62.0 mttp -89.5 -173.55 4.01 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.54 0.686 . . . . 0.0 111.569 -175.351 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 765' ' ' ARG . . . . . 0.659 ' HD2' HG22 ' A' ' 758' ' ' ILE . 12.0 ttt180 -168.88 140.8 2.61 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-N 114.741 -1.118 . . . . 0.0 109.875 -175.478 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 766' ' ' LYS . . . . . 0.614 ' HD3' ' N ' ' A' ' 767' ' ' THR . 2.0 tmtp? -120.48 146.32 46.38 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.727 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 767' ' ' THR . . . . . 0.614 ' N ' ' HD3' ' A' ' 766' ' ' LYS . 96.6 m -131.74 132.36 43.78 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 120.962 0.411 . . . . 0.0 111.751 -176.223 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 768' ' ' PHE . . . . . 0.681 ' HB2' ' CE1' ' A' ' 755' ' ' TYR . 42.9 m-85 -120.07 141.21 49.98 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.214 174.105 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 769' ' ' GLU . . . . . 0.486 ' HB2' HG23 ' A' ' 754' ' ' THR . 46.0 tt0 -131.27 109.37 10.34 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.383 178.073 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 770' ' ' ILE . . . . . 0.564 HG22 HG22 ' A' ' 773' ' ' ILE . 21.2 mt -105.97 120.37 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 771' ' ' LYS . . . . . 0.577 ' HD2' ' N ' ' A' ' 771' ' ' LYS . 0.1 OUTLIER -85.55 164.62 17.67 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.067 0.46 . . . . 0.0 111.144 -175.192 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 772' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 36.36 50.44 0.75 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 113.853 -1.521 . . . . 0.0 112.64 177.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 773' ' ' ILE . . . . . 0.968 HD13 HD13 ' A' ' 745' ' ' LEU . 0.5 OUTLIER -76.71 111.98 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 175.67 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 75.7 mttt -113.04 33.62 4.95 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 -179.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 775' ' ' THR . . . . . 0.691 ' H ' HD12 ' A' ' 773' ' ' ILE . 1.2 m -95.12 -71.64 0.66 Allowed 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 113.836 -1.529 . . . . 0.0 111.769 -169.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 776' ' ' ASN . . . . . 0.417 ' HB2' ' O ' ' A' ' 775' ' ' THR . 11.5 m120 81.92 4.11 1.28 Allowed 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.129 0.971 . . . . 0.0 110.79 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 777' ' ' GLU . . . . . 0.574 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 18.4 mt-10 -160.2 84.66 0.72 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.197 176.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 778' ' ' TYR . . . . . 0.808 ' HB3' HD11 ' A' ' 745' ' ' LEU . 79.4 t80 -128.89 129.08 45.05 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.843 0.354 . . . . 0.0 110.863 -172.439 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 779' ' ' VAL . . . . . 0.678 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 21.1 t -87.95 112.81 24.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 121.281 0.562 . . . . 0.0 110.515 178.015 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 780' ' ' ILE . . . . . . . . . . . . . 74.0 mt -80.2 141.48 15.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.603 -178.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -114.93 107.85 15.94 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 177.183 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 782' ' ' THR . . . . . 0.403 ' HA ' ' HD3' ' A' ' 783' ' ' PRO . 68.7 p -78.15 135.33 62.37 Favored Pre-proline 0 N--CA 1.441 -0.895 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.639 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 783' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 782' ' ' THR . 46.3 Cg_exo -57.05 158.32 18.0 Favored 'Trans proline' 0 CA--C 1.518 -0.278 0 C-N-CA 123.523 2.815 . . . . 0.0 112.401 -173.262 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 784' ' ' VAL . . . . . . . . . . . . . 12.8 p -60.47 136.43 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.697 -177.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 785' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -110.08 97.15 6.7 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.617 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 82.1 p -83.77 25.16 0.81 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.725 0.774 . . . . 0.0 110.822 -176.276 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 36.7 m -156.47 120.97 4.51 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.446 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 788' ' ' GLY . . . . . 0.673 ' HA2' HG12 ' A' ' 817' ' ' VAL . . . -51.74 110.64 1.14 Allowed Glycine 0 N--CA 1.448 -0.554 0 O-C-N 123.669 0.605 . . . . 0.0 113.335 174.232 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 789' ' ' GLY . . . . . 0.415 ' H ' ' HB ' ' A' ' 817' ' ' VAL . . . -157.28 166.37 33.63 Favored Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 110.571 -1.012 . . . . 0.0 110.571 177.176 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 790' ' ' ASP . . . . . 0.579 ' H ' ' CB ' ' A' ' 761' ' ' PHE . 2.7 m-20 -107.97 132.29 53.67 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 117.305 0.552 . . . . 0.0 109.763 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 791' ' ' TYR . . . . . 0.503 ' CE2' ' HG2' ' A' ' 759' ' ' GLU . 89.4 m-85 -124.61 158.52 32.88 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.951 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 792' ' ' ILE . . . . . 0.609 ' O ' HG13 ' A' ' 758' ' ' ILE . 6.2 mt -134.21 117.71 25.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 171.593 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 793' ' ' LEU . . . . . 0.664 HD23 HG11 ' A' ' 741' ' ' VAL . 1.0 OUTLIER -84.91 112.21 20.36 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.408 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 794' ' ' SER . . . . . 0.516 ' N ' HD12 ' A' ' 793' ' ' LEU . 13.6 m -118.39 177.3 4.87 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 114.81 -1.086 . . . . 0.0 108.744 -177.544 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 795' ' ' LEU . . . . . 0.423 HD11 ' O ' ' A' ' 723' ' ' ALA . 42.9 mt -103.79 132.3 50.17 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.784 0.326 . . . . 0.0 110.644 -179.005 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 796' ' ' VAL . . . . . . . . . . . . . 64.1 t -89.27 -56.72 4.88 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.661 -177.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 797' ' ' SER . . . . . 0.44 ' HA ' ' HG ' ' A' ' 808' ' ' LEU . 26.6 m -173.36 172.83 3.66 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.855 -173.283 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 798' ' ' ILE . . . . . 0.725 ' HB ' HD21 ' A' ' 808' ' ' LEU . 0.5 OUTLIER -146.34 166.76 7.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -173.529 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 799' ' ' LYS . . . . . 0.701 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 34.5 tttt -135.29 117.4 15.42 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.281 -179.15 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 800' ' ' ASP . . . . . 0.717 ' HA ' ' CE2' ' A' ' 751' ' ' PHE . 8.0 t70 -68.65 153.02 44.56 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.192 173.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 24.2 p -62.44 -8.12 5.62 Favored 'General case' 0 C--N 1.33 -0.255 0 O-C-N 123.867 0.73 . . . . 0.0 112.375 -173.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 35.4 p -94.8 9.79 37.69 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.536 0.684 . . . . 0.0 109.673 176.132 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 803' ' ' GLY . . . . . 0.554 ' HA2' ' HE2' ' A' ' 799' ' ' LYS . . . 72.45 40.83 53.66 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 114.871 -1.059 . . . . 0.0 112.389 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 804' ' ' CYS . . . . . . . . . . . . . 59.6 m -114.09 116.32 28.95 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 805' ' ' VAL . . . . . 0.658 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 6.1 p -84.92 113.43 23.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.895 0.855 . . . . 0.0 110.821 -177.331 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 806' ' ' VAL . . . . . 0.671 ' HB ' HG22 ' A' ' 798' ' ' ILE . 41.0 t -96.05 138.42 21.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.604 -178.043 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -70.53 122.03 10.34 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.733 179.352 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 808' ' ' LEU . . . . . 0.725 HD21 ' HB ' ' A' ' 798' ' ' ILE . 24.1 mt -89.63 132.88 34.91 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -175.794 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 14.9 t -149.71 87.04 1.47 Allowed 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.452 -0.794 . . . . 0.0 109.62 172.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 810' ' ' GLN . . . . . 0.438 ' HB3' ' HD2' ' A' ' 811' ' ' PRO . 13.1 mt-30 -136.17 170.44 10.96 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.591 -0.732 . . . . 0.0 109.779 173.581 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 811' ' ' PRO . . . . . 0.438 ' HD2' ' HB3' ' A' ' 810' ' ' GLN . 89.2 Cg_exo -44.93 139.11 8.24 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 122.973 2.449 . . . . 0.0 114.192 -177.478 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -110.4 166.07 11.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.599 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 813' ' ' ALA . . . . . . . . . . . . . . . -114.57 154.62 27.98 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.257 -177.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 814' ' ' LYS . . . . . . . . . . . . . 50.6 tttp -115.0 130.05 56.85 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-O 121.129 0.49 . . . . 0.0 110.143 176.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 815' ' ' ILE . . . . . 0.559 ' HA ' ' HB2' ' A' ' 731' ' ' LEU . 4.8 mp -113.42 118.24 57.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.722 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 816' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -109.05 114.25 27.83 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.846 0.355 . . . . 0.0 110.81 -179.088 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 817' ' ' VAL . . . . . 0.673 HG12 ' HA2' ' A' ' 788' ' ' GLY . 92.5 t -110.07 124.55 66.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 176.258 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 818' ' ' ARG . . . . . 0.624 ' O ' ' HA ' ' A' ' 734' ' ' CYS . 15.0 mmt180 -142.17 144.96 33.67 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 176.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 819' ' ' ARG . . . . . 0.587 ' HA ' ' HB2' ' A' ' 735' ' ' LEU . 27.0 mtm180 -67.26 132.95 48.76 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.998 -174.345 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 820' ' ' ASP . . . . . . . . . . . . . 32.3 t70 . . . . . 0 C--N 1.323 -0.568 0 CA-C-N 115.795 -0.638 . . . . 99.989999999999995 110.497 -176.802 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 718' ' ' ARG . . . . . . . . . . . . . 18.4 tpt180 . . . . . 0 CA--C 1.511 -0.545 0 CA-C-O 121.358 0.599 . . . . 0.0 110.438 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 719' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -150.35 -168.95 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 114.649 -1.16 . . . . 0.0 108.375 178.284 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 720' ' ' LYS . . . . . 0.456 ' HA ' ' HD3' ' A' ' 721' ' ' PRO . 12.9 mmmm -80.06 119.45 76.63 Favored Pre-proline 0 C--N 1.305 -1.365 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.856 176.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 721' ' ' PRO . . . . . 0.545 ' HD2' HG21 ' A' ' 806' ' ' VAL . 5.9 Cg_endo -78.12 138.47 16.23 Favored 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 122.471 2.114 . . . . 0.0 110.174 -179.071 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 722' ' ' SER . . . . . 0.881 ' HB2' ' OE1' ' A' ' 810' ' ' GLN . 7.3 p -175.21 -153.05 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.347 -166.393 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 723' ' ' ALA . . . . . 0.605 ' HA ' ' HA ' ' A' ' 745' ' ' LEU . . . -157.73 151.27 23.75 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-N 118.518 0.599 . . . . 0.0 110.659 177.638 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 41.6 m -140.03 99.1 3.6 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 121.624 -0.672 . . . . 0.0 110.027 179.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 725' ' ' LEU . . . . . 0.938 ' HG ' HG22 ' A' ' 743' ' ' VAL . 5.2 mp -57.3 143.3 40.23 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-O 122.516 1.15 . . . . 0.0 112.661 -175.731 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 36.5 mtpt -96.82 -13.98 22.21 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 112.851 -1.977 . . . . 0.0 110.279 -177.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 727' ' ' LEU . . . . . 0.518 ' HB2' HG23 ' A' ' 741' ' ' VAL . 3.1 tm? -50.4 128.91 20.93 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.387 -1.278 . . . . 0.0 109.966 176.736 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 35.4 m170 -89.9 -52.48 4.95 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -171.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -145.65 -177.0 5.35 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.535 -0.466 . . . . 0.0 111.513 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 730' ' ' ASP . . . . . 0.406 ' HA ' ' O ' ' A' ' 814' ' ' LYS . 9.5 p-10 -48.06 133.12 15.26 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 124.019 0.824 . . . . 0.0 111.523 178.513 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 731' ' ' LEU . . . . . 0.575 ' CD2' ' HB2' ' A' ' 739' ' ' SER . 27.2 tp -99.53 111.49 23.83 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.526 -175.088 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 732' ' ' LYS . . . . . 0.417 ' HE3' ' NE2' ' A' ' 816' ' ' GLN . 40.5 mmtm -72.76 121.32 19.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.552 -179.465 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 733' ' ' LEU . . . . . 0.49 HD12 ' CG2' ' A' ' 815' ' ' ILE . 94.4 mt -138.26 160.54 39.2 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.445 178.517 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 734' ' ' CYS . . . . . . . . . . . . . 63.8 m -109.96 -174.06 2.4 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.001 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 735' ' ' LEU . . . . . 0.415 ' HB2' ' HA ' ' A' ' 819' ' ' ARG . 38.4 tp -65.24 125.85 26.3 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.902 0.382 . . . . 0.0 111.36 -172.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 736' ' ' GLY . . . . . 0.508 ' O ' HG13 ' A' ' 784' ' ' VAL . . . 81.4 7.91 87.74 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.455 -0.879 . . . . 0.0 112.622 177.383 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 737' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -78.58 150.37 32.79 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.024 0.44 . . . . 0.0 111.452 176.486 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 738' ' ' HIS . . . . . 0.622 ' HB2' ' O ' ' A' ' 782' ' ' THR . 39.8 p-80 -116.83 166.11 12.53 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 172.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 739' ' ' SER . . . . . 0.575 ' HB2' ' CD2' ' A' ' 731' ' ' LEU . 13.5 p -124.98 163.37 22.47 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 118.956 -1.098 . . . . 0.0 112.27 -172.357 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 740' ' ' SER . . . . . 0.497 ' HA ' ' O ' ' A' ' 780' ' ' ILE . 46.0 m -130.44 99.94 5.18 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.089 174.167 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 741' ' ' VAL . . . . . 0.541 HG11 HD23 ' A' ' 793' ' ' LEU . 0.1 OUTLIER -100.42 112.73 64.87 Favored Pre-proline 0 C--N 1.318 -0.79 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.338 179.449 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 742' ' ' PRO . . . . . 0.753 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 6.3 Cg_exo -75.54 129.8 12.19 Favored 'Trans proline' 0 N--CA 1.445 -1.356 0 C-N-CA 122.215 1.944 . . . . 0.0 110.96 -176.413 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 743' ' ' VAL . . . . . 0.938 HG22 ' HG ' ' A' ' 725' ' ' LEU . 20.1 t -127.95 121.34 56.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.128 0.489 . . . . 0.0 112.247 178.459 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 744' ' ' ALA . . . . . 0.661 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -83.33 99.38 9.98 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 122.326 1.06 . . . . 0.0 108.275 169.319 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 745' ' ' LEU . . . . . 0.877 HD11 ' HB3' ' A' ' 778' ' ' TYR . 3.5 mt -77.39 164.9 25.07 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 113.52 -1.673 . . . . 0.0 110.742 -169.778 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 746' ' ' LYS . . . . . 0.469 ' HB3' ' OG ' ' A' ' 722' ' ' SER . 14.4 tppt? -123.46 161.31 25.08 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.079 0.466 . . . . 0.0 110.457 -176.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 747' ' ' GLY . . . . . . . . . . . . . . . 91.3 121.69 2.6 Favored Glycine 0 C--N 1.312 -0.783 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 -175.181 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -95.34 117.97 31.26 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.28 0.562 . . . . 0.0 111.98 -172.397 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 116.65 -175.91 16.01 Favored Glycine 0 CA--C 1.499 -0.934 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.506 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 750' ' ' PRO . . . . . 0.488 ' HB3' ' HE2' ' A' ' 774' ' ' LYS . 86.8 Cg_endo -69.07 94.88 0.48 Allowed 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 123.359 2.706 . . . . 0.0 113.187 -177.543 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 751' ' ' PHE . . . . . 0.583 ' CD2' ' HA ' ' A' ' 800' ' ' ASP . 64.0 m-85 -112.13 144.87 40.78 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.067 179.332 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 752' ' ' THR . . . . . 0.766 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 89.0 m -91.85 102.76 15.35 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.277 0.56 . . . . 0.0 109.921 179.368 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 753' ' ' LEU . . . . . 0.71 ' CD2' HD22 ' A' ' 745' ' ' LEU . 46.9 tp -97.0 121.52 38.97 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.298 -171.167 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 754' ' ' THR . . . . . 0.481 ' HB ' ' HB ' ' A' ' 796' ' ' VAL . 1.0 OUTLIER -109.66 135.98 49.75 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.131 -177.592 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 755' ' ' TYR . . . . . 0.628 ' CE1' ' HB3' ' A' ' 768' ' ' PHE . 29.6 p90 -143.1 152.43 41.84 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 120.977 0.418 . . . . 0.0 111.843 178.095 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 756' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -117.7 118.47 32.16 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.694 -179.17 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 757' ' ' ILE . . . . . 0.611 ' CD1' HD13 ' A' ' 793' ' ' LEU . 3.5 mp -87.7 96.56 5.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 168.206 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 758' ' ' ILE . . . . . 0.624 HG22 ' HD3' ' A' ' 765' ' ' ARG . 2.3 pp -94.53 149.89 4.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 121.322 0.582 . . . . 0.0 111.962 -171.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 759' ' ' GLU . . . . . 0.513 ' HG3' ' C ' ' A' ' 764' ' ' LYS . 16.1 mt-10 -90.86 115.13 27.67 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.832 175.041 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 760' ' ' THR . . . . . . . . . . . . . 2.5 t -95.04 -0.17 53.92 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 172.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 761' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -94.08 -34.48 12.97 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.45 176.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 762' ' ' SER . . . . . 0.49 ' HB2' ' OE2' ' A' ' 759' ' ' GLU . 65.6 m -141.11 -93.55 0.14 Allowed 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 120.959 -0.297 . . . . 0.0 111.74 177.327 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 763' ' ' SER . . . . . . . . . . . . . 34.4 p -170.56 -0.91 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -174.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 764' ' ' LYS . . . . . 0.513 ' C ' ' HG3' ' A' ' 759' ' ' GLU . 9.7 mtpm? -82.9 55.66 3.15 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.164 0.507 . . . . 0.0 112.072 -174.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 765' ' ' ARG . . . . . 0.624 ' HD3' HG22 ' A' ' 758' ' ' ILE . 6.1 ttp180 -55.19 141.37 35.38 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.903 172.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 766' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -123.7 134.38 53.72 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 120.922 0.391 . . . . 0.0 110.449 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 767' ' ' THR . . . . . . . . . . . . . 47.3 m -107.58 131.39 54.41 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.46 -177.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 768' ' ' PHE . . . . . 0.628 ' HB3' ' CE1' ' A' ' 755' ' ' TYR . 0.2 OUTLIER -137.16 135.84 37.7 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.203 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 769' ' ' GLU . . . . . 0.46 ' HB2' HG23 ' A' ' 754' ' ' THR . 39.3 tt0 -129.54 124.01 32.82 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.118 0.485 . . . . 0.0 111.692 -175.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 4.6 mm -102.38 110.66 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.759 -179.096 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 771' ' ' LYS . . . . . 0.616 ' HD2' ' N ' ' A' ' 771' ' ' LYS . 0.0 OUTLIER -80.41 157.4 26.27 Favored 'General case' 0 C--N 1.312 -1.028 0 C-N-CA 120.104 -0.639 . . . . 0.0 109.983 179.293 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 772' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 41.77 50.33 3.98 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 113.871 -1.513 . . . . 0.0 113.515 178.387 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 773' ' ' ILE . . . . . 0.843 HD12 ' H ' ' A' ' 775' ' ' THR . 0.5 OUTLIER -75.35 111.37 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 171.135 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 774' ' ' LYS . . . . . 0.488 ' HE2' ' HB3' ' A' ' 750' ' ' PRO . 58.7 mttt -107.26 24.35 12.99 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -178.586 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 775' ' ' THR . . . . . 0.843 ' H ' HD12 ' A' ' 773' ' ' ILE . 0.2 OUTLIER -95.38 -74.27 0.56 Allowed 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -165.763 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 776' ' ' ASN . . . . . 0.637 ' HB2' ' O ' ' A' ' 775' ' ' THR . 0.9 OUTLIER 91.07 4.13 0.1 Allowed 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.5 1.12 . . . . 0.0 110.596 -177.605 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 777' ' ' GLU . . . . . 0.661 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 13.9 tt0 -162.94 101.59 0.99 Allowed 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.133 174.59 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 778' ' ' TYR . . . . . 0.877 ' HB3' HD11 ' A' ' 745' ' ' LEU . 90.7 t80 -153.69 129.7 10.29 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.633 -171.66 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 779' ' ' VAL . . . . . 0.753 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 1.9 m -91.68 129.54 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 CA-C-O 122.15 0.976 . . . . 0.0 110.823 178.061 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 780' ' ' ILE . . . . . 0.497 ' O ' ' HA ' ' A' ' 740' ' ' SER . 88.2 mt -90.13 139.79 16.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 113.59 -1.641 . . . . 0.0 110.811 -174.028 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 781' ' ' LYS . . . . . 0.45 ' HD3' ' N ' ' A' ' 781' ' ' LYS . 0.1 OUTLIER -111.81 107.62 16.74 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.928 0.394 . . . . 0.0 110.323 179.623 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 782' ' ' THR . . . . . 0.622 ' O ' ' HB2' ' A' ' 738' ' ' HIS . 25.2 p -77.8 142.91 66.03 Favored Pre-proline 0 C--N 1.318 -0.761 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.827 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 783' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 782' ' ' THR . 53.0 Cg_exo -56.32 160.72 10.44 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 123.53 2.82 . . . . 0.0 113.2 -178.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 784' ' ' VAL . . . . . 0.508 HG13 ' O ' ' A' ' 736' ' ' GLY . 40.5 t -58.55 122.62 8.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.952 178.396 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 785' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -100.67 97.27 7.96 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.187 178.563 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 786' ' ' THR . . . . . 0.45 HG23 HG12 ' A' ' 784' ' ' VAL . 44.1 p -84.37 34.23 0.52 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.677 0.751 . . . . 0.0 111.165 -178.507 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 12.7 m -154.69 112.72 3.48 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.045 -0.979 . . . . 0.0 111.006 178.435 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 788' ' ' GLY . . . . . 0.689 ' HA2' HG12 ' A' ' 817' ' ' VAL . . . -50.13 112.49 1.52 Allowed Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.521 169.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 789' ' ' GLY . . . . . . . . . . . . . . . -157.51 -148.15 5.03 Favored Glycine 0 N--CA 1.443 -0.843 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -144.86 124.77 13.47 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 179.133 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 791' ' ' TYR . . . . . 0.503 ' CE2' ' HG2' ' A' ' 759' ' ' GLU . 90.9 m-85 -118.99 145.14 46.07 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.998 -176.174 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 792' ' ' ILE . . . . . 0.576 ' O ' HG13 ' A' ' 758' ' ' ILE . 16.5 mt -123.56 110.41 25.92 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.508 173.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 793' ' ' LEU . . . . . 0.848 ' HB3' ' HB3' ' A' ' 813' ' ' ALA . 4.0 tp -84.75 109.55 18.14 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.428 0.632 . . . . 0.0 109.448 179.326 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 794' ' ' SER . . . . . . . . . . . . . 19.1 m -112.31 156.52 22.3 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.062 -174.439 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 795' ' ' LEU . . . . . 0.485 HD13 ' HB3' ' A' ' 723' ' ' ALA . 74.9 mt -91.13 130.5 37.02 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.903 0.382 . . . . 0.0 110.372 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 796' ' ' VAL . . . . . 0.481 ' HB ' ' HB ' ' A' ' 754' ' ' THR . 76.6 t -91.52 -55.53 6.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.159 -175.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 797' ' ' SER . . . . . 0.608 ' HA ' HD13 ' A' ' 808' ' ' LEU . 88.9 p -179.43 179.12 0.64 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.503 -172.375 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 798' ' ' ILE . . . . . 0.62 ' HA ' ' O ' ' A' ' 752' ' ' THR . 10.3 tt -148.53 161.94 5.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 178.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 799' ' ' LYS . . . . . 0.766 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 7.6 tmtt? -133.31 122.02 23.25 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.037 0.446 . . . . 0.0 110.787 -178.751 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 800' ' ' ASP . . . . . 0.583 ' HA ' ' CD2' ' A' ' 751' ' ' PHE . 9.0 t70 -66.45 154.87 39.09 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.971 174.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 38.2 t -59.15 -14.18 9.56 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 124.236 0.96 . . . . 0.0 112.719 -172.225 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 61.8 p -96.25 5.57 50.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.554 0.692 . . . . 0.0 110.189 178.354 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 803' ' ' GLY . . . . . . . . . . . . . . . 82.23 40.19 10.48 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.07 -0.968 . . . . 0.0 112.148 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 804' ' ' CYS . . . . . 0.464 ' HB2' ' HB3' ' A' ' 800' ' ' ASP . 63.4 m -110.94 114.62 28.08 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 179.602 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 805' ' ' VAL . . . . . . . . . . . . . 11.4 p -85.75 137.54 20.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.487 0.66 . . . . 0.0 111.464 -173.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 806' ' ' VAL . . . . . 0.582 ' HB ' HG22 ' A' ' 798' ' ' ILE . 97.0 t -118.03 137.65 51.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.176 176.663 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -87.6 110.63 3.61 Favored Glycine 0 C--N 1.321 -0.277 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.481 -178.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 808' ' ' LEU . . . . . 0.608 HD13 ' HA ' ' A' ' 797' ' ' SER . 11.1 mp -79.78 129.69 34.7 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 178.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 8.8 t -138.6 87.01 2.19 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 168.234 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 810' ' ' GLN . . . . . 0.881 ' OE1' ' HB2' ' A' ' 722' ' ' SER . 25.2 mt-30 -139.48 174.57 3.97 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.295 -170.565 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 811' ' ' PRO . . . . . 0.499 ' HD2' ' HB3' ' A' ' 810' ' ' GLN . 75.5 Cg_exo -44.69 146.68 2.12 Favored 'Trans proline' 0 C--N 1.36 1.14 0 C-N-CA 123.395 2.73 . . . . 0.0 114.376 -178.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -119.99 166.93 12.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.147 -177.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 813' ' ' ALA . . . . . 0.848 ' HB3' ' HB3' ' A' ' 793' ' ' LEU . . . -105.19 146.18 29.6 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.212 178.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 814' ' ' LYS . . . . . 0.479 ' HG2' HG12 ' A' ' 792' ' ' ILE . 6.7 mtmp? -122.85 112.72 18.21 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.839 0.828 . . . . 0.0 110.605 172.542 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 815' ' ' ILE . . . . . 0.544 ' HA ' ' HB3' ' A' ' 731' ' ' LEU . 4.5 mp -109.89 109.07 27.06 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 114.088 -1.415 . . . . 0.0 109.25 -176.598 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 816' ' ' GLN . . . . . 0.417 ' NE2' ' HE3' ' A' ' 732' ' ' LYS . 0.1 OUTLIER -98.98 108.58 21.29 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.262 0.553 . . . . 0.0 110.263 -176.468 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 817' ' ' VAL . . . . . 0.689 HG12 ' HA2' ' A' ' 788' ' ' GLY . 96.1 t -98.46 145.56 9.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.599 -179.171 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 818' ' ' ARG . . . . . 0.424 ' HG3' ' H ' ' A' ' 819' ' ' ARG . 20.0 tpt180 -138.36 176.39 8.74 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -178.556 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 819' ' ' ARG . . . . . 0.424 ' H ' ' HG3' ' A' ' 818' ' ' ARG . 13.6 mmm180 -76.91 155.48 32.79 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.112 175.691 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 820' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 . . . . . 0 C--N 1.322 -0.593 0 N-CA-C 109.468 -0.567 . . . . 99.989999999999995 109.468 178.026 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 718' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.517 -0.299 0 CA-C-O 121.6 0.714 . . . . 0.0 110.671 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 719' ' ' VAL . . . . . 0.445 ' O ' ' HD3' ' A' ' 721' ' ' PRO . 7.8 p -141.9 161.18 20.69 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-N 115.201 -0.909 . . . . 0.0 108.7 -179.213 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 720' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -89.91 110.06 37.15 Favored Pre-proline 0 C--N 1.305 -1.341 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.985 176.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 721' ' ' PRO . . . . . 0.488 ' HB3' ' HA3' ' A' ' 747' ' ' GLY . 36.3 Cg_endo -86.75 148.89 8.48 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 122.564 2.176 . . . . 0.0 110.801 177.793 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 722' ' ' SER . . . . . 0.578 ' HA ' HD22 ' A' ' 808' ' ' LEU . 8.4 t -178.78 -154.6 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -171.796 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 723' ' ' ALA . . . . . 0.696 ' O ' HD11 ' A' ' 795' ' ' LEU . . . -150.99 140.17 21.21 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.902 0.382 . . . . 0.0 110.799 176.288 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 43.4 t -128.52 99.43 5.38 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -174.224 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 725' ' ' LEU . . . . . 0.55 ' HG ' ' O ' ' A' ' 811' ' ' PRO . 1.1 mt -65.02 146.25 55.26 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.604 -172.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 726' ' ' LYS . . . . . 0.41 ' HD2' ' HB2' ' A' ' 744' ' ' ALA . 34.3 mtpt -103.88 -10.58 18.08 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.464 -174.649 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 727' ' ' LEU . . . . . 0.475 ' HB2' HG23 ' A' ' 741' ' ' VAL . 0.8 OUTLIER -74.46 109.67 8.14 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 175.751 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 41.6 m80 -105.43 38.06 2.06 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -169.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -169.51 -176.99 2.62 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.719 0.295 . . . . 0.0 111.104 179.475 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 730' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -66.21 137.1 56.74 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.953 173.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 731' ' ' LEU . . . . . 0.598 ' HB3' ' HA ' ' A' ' 815' ' ' ILE . 40.4 tp -103.23 100.17 10.06 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.973 178.809 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 732' ' ' LYS . . . . . 0.48 ' HD3' ' HB3' ' A' ' 816' ' ' GLN . 32.6 mmtp -78.63 124.26 27.99 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.454 0.645 . . . . 0.0 112.09 -175.395 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 733' ' ' LEU . . . . . 0.638 ' HG ' ' HB3' ' A' ' 737' ' ' ASP . 7.9 mp -120.4 165.13 15.32 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.671 -1.15 . . . . 0.0 109.705 177.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 734' ' ' CYS . . . . . 0.5 ' O ' ' HB2' ' A' ' 737' ' ' ASP . 31.2 p -120.16 -179.27 3.89 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.702 171.008 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 735' ' ' LEU . . . . . 0.494 HD12 ' HG3' ' A' ' 819' ' ' ARG . 2.8 tt -57.88 116.5 3.52 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.938 0.399 . . . . 0.0 110.34 -179.161 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 736' ' ' GLY . . . . . 0.515 ' HA2' HG22 ' A' ' 786' ' ' THR . . . 91.64 3.39 68.82 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.458 176.137 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 737' ' ' ASP . . . . . 0.638 ' HB3' ' HG ' ' A' ' 733' ' ' LEU . 0.3 OUTLIER -72.47 158.21 36.15 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.973 0.416 . . . . 0.0 111.146 177.957 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 37.0 p-80 -116.66 153.68 31.89 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 171.291 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 739' ' ' SER . . . . . 0.728 ' HB2' ' OG1' ' A' ' 782' ' ' THR . 10.8 m -98.15 159.0 15.22 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 119.126 -1.03 . . . . 0.0 111.235 -174.301 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 740' ' ' SER . . . . . 0.539 ' H ' HD21 ' A' ' 731' ' ' LEU . 10.5 t -143.37 101.09 3.73 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.915 -1.038 . . . . 0.0 108.657 -174.593 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 741' ' ' VAL . . . . . 0.475 HG23 ' HB2' ' A' ' 727' ' ' LEU . 2.1 p -121.26 112.51 32.98 Favored Pre-proline 0 C--N 1.316 -0.864 0 CA-C-O 121.283 0.563 . . . . 0.0 110.266 -177.251 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 742' ' ' PRO . . . . . 0.662 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 4.5 Cg_exo -71.33 125.93 11.8 Favored 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 122.294 1.996 . . . . 0.0 109.863 178.141 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 743' ' ' VAL . . . . . 0.514 ' CG2' HD22 ' A' ' 725' ' ' LEU . 24.0 t -129.31 114.77 32.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -178.593 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 744' ' ' ALA . . . . . 0.49 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -81.59 101.6 10.1 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 171.634 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 745' ' ' LEU . . . . . 0.962 HD11 ' HB3' ' A' ' 778' ' ' TYR . 0.2 OUTLIER -83.94 168.2 16.25 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.258 -167.814 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 44.1 tptt -122.24 156.18 34.33 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.405 -177.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 747' ' ' GLY . . . . . 0.488 ' HA3' ' HB3' ' A' ' 721' ' ' PRO . . . 93.66 123.62 3.65 Favored Glycine 0 C--N 1.311 -0.827 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.378 -177.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 25.7 mp0 -106.69 114.45 28.56 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.119 0.485 . . . . 0.0 111.283 -173.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 130.69 -175.98 19.13 Favored Glycine 0 N--CA 1.446 -0.7 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 -177.206 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -70.57 95.07 0.61 Allowed 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.658 2.238 . . . . 0.0 112.392 178.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 751' ' ' PHE . . . . . 0.502 ' CE2' ' HA ' ' A' ' 800' ' ' ASP . 77.5 m-85 -113.34 140.88 47.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.522 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 752' ' ' THR . . . . . 0.752 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 86.6 m -91.05 104.61 17.17 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.344 0.592 . . . . 0.0 109.763 177.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 753' ' ' LEU . . . . . 0.564 ' CD1' HD22 ' A' ' 745' ' ' LEU . 1.8 tt -95.95 116.34 28.78 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.608 -171.459 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 754' ' ' THR . . . . . 0.458 HG23 ' HB2' ' A' ' 769' ' ' GLU . 1.0 OUTLIER -114.44 137.7 51.5 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.989 -179.1 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 755' ' ' TYR . . . . . 0.505 ' CD1' HD11 ' A' ' 793' ' ' LEU . 24.5 p90 -145.37 162.93 36.09 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 120.961 0.41 . . . . 0.0 111.541 178.645 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 756' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -128.73 121.13 27.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.677 -178.222 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 757' ' ' ILE . . . . . 0.521 HG13 HD13 ' A' ' 793' ' ' LEU . 3.5 mp -87.01 96.47 5.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 169.661 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 758' ' ' ILE . . . . . 0.715 HG22 ' HD3' ' A' ' 765' ' ' ARG . 2.3 pp -95.21 149.65 4.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 116.116 -0.493 . . . . 0.0 112.218 -169.343 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 759' ' ' GLU . . . . . 0.647 ' HG2' ' CE2' ' A' ' 791' ' ' TYR . 24.6 mt-10 -89.75 119.94 30.58 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.394 179.366 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 760' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.55 -3.1 43.68 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.346 0.593 . . . . 0.0 109.564 175.44 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 761' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -103.46 -21.74 13.74 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.245 178.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 762' ' ' SER . . . . . 0.593 ' HB2' ' OE1' ' A' ' 759' ' ' GLU . 69.7 m -140.64 -97.01 0.14 Allowed 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.569 174.614 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 763' ' ' SER . . . . . . . . . . . . . 50.5 p -174.17 -1.16 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -175.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 764' ' ' LYS . . . . . 0.457 ' C ' ' HG3' ' A' ' 759' ' ' GLU . 59.6 mtpt -85.73 56.84 4.14 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.616 0.722 . . . . 0.0 111.65 -173.64 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 765' ' ' ARG . . . . . 0.715 ' HD3' HG22 ' A' ' 758' ' ' ILE . 7.9 ttp180 -52.64 138.48 28.34 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.552 -1.204 . . . . 0.0 111.523 174.668 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 766' ' ' LYS . . . . . . . . . . . . . 9.7 tmtm? -115.98 135.45 53.95 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-O 121.088 0.47 . . . . 0.0 110.409 -177.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 767' ' ' THR . . . . . . . . . . . . . 27.7 m -109.04 137.03 47.59 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.833 -174.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 768' ' ' PHE . . . . . 0.495 ' HB3' ' CE1' ' A' ' 755' ' ' TYR . 3.2 t80 -139.72 139.74 36.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.96 0.41 . . . . 0.0 110.643 175.426 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 769' ' ' GLU . . . . . 0.458 ' HB2' HG23 ' A' ' 754' ' ' THR . 35.5 tt0 -129.76 129.98 44.81 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.848 -179.37 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 770' ' ' ILE . . . . . 0.531 HG22 HG22 ' A' ' 773' ' ' ILE . 5.0 mt -122.82 111.87 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 176.325 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 771' ' ' LYS . . . . . 0.637 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 9.5 mtpt -85.1 152.04 23.69 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-O 121.492 0.663 . . . . 0.0 111.328 -174.01 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 772' ' ' GLU . . . . . 0.415 ' O ' ' HG3' ' A' ' 774' ' ' LYS . 5.4 mt-10 54.7 47.11 23.24 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.211 -1.359 . . . . 0.0 112.532 177.202 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 773' ' ' ILE . . . . . 0.931 HD13 HD13 ' A' ' 745' ' ' LEU . 0.5 OUTLIER -73.8 119.89 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 173.835 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 774' ' ' LYS . . . . . 0.415 ' HG3' ' O ' ' A' ' 772' ' ' GLU . 73.0 mttt -118.21 30.66 7.11 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -177.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 775' ' ' THR . . . . . 0.686 ' H ' HD12 ' A' ' 773' ' ' ILE . 0.6 OUTLIER -95.88 -72.24 0.64 Allowed 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 114.957 -1.019 . . . . 0.0 113.381 -171.394 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 776' ' ' ASN . . . . . 0.595 ' HB2' ' O ' ' A' ' 775' ' ' THR . 0.9 OUTLIER 83.82 4.67 0.78 Allowed 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.045 0.938 . . . . 0.0 110.389 -175.601 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 777' ' ' GLU . . . . . 0.49 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 6.9 tp10 -161.69 78.3 0.54 Allowed 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 -179.47 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 778' ' ' TYR . . . . . 0.962 ' HB3' HD11 ' A' ' 745' ' ' LEU . 82.4 t80 -132.86 125.65 30.44 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.115 0.483 . . . . 0.0 111.69 -169.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 779' ' ' VAL . . . . . 0.662 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 21.6 t -84.16 115.97 27.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.051 176.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 780' ' ' ILE . . . . . 0.479 HD12 HG21 ' A' ' 743' ' ' VAL . 77.2 mt -89.84 135.92 25.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.724 -176.201 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 781' ' ' LYS . . . . . 0.415 ' HD3' ' C ' ' A' ' 780' ' ' ILE . 0.0 OUTLIER -118.89 109.12 15.63 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 177.682 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 782' ' ' THR . . . . . 0.728 ' OG1' ' HB2' ' A' ' 739' ' ' SER . 82.6 p -82.6 148.62 58.75 Favored Pre-proline 0 C--O 1.244 0.811 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.862 -176.378 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 783' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -49.27 157.0 2.17 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 124.09 3.193 . . . . 0.0 113.447 -178.457 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 784' ' ' VAL . . . . . 0.533 HG12 HG23 ' A' ' 786' ' ' THR . 70.1 t -61.19 131.24 26.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.086 -0.961 . . . . 0.0 112.803 -174.176 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 785' ' ' PHE . . . . . 0.415 ' C ' ' H ' ' A' ' 787' ' ' THR . 80.0 m-85 -103.68 88.96 3.19 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.01 177.164 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 786' ' ' THR . . . . . 0.533 HG23 HG12 ' A' ' 784' ' ' VAL . 32.5 p -83.47 29.42 0.51 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 122.077 0.941 . . . . 0.0 110.284 178.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 787' ' ' THR . . . . . 0.415 ' H ' ' C ' ' A' ' 785' ' ' PHE . 2.1 m -159.65 105.46 1.63 Allowed 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.941 -175.734 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 788' ' ' GLY . . . . . 0.825 ' HA2' HG22 ' A' ' 817' ' ' VAL . . . -49.46 137.76 19.55 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.75 -0.659 . . . . 0.0 113.648 172.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 789' ' ' GLY . . . . . 0.514 ' H ' HG13 ' A' ' 817' ' ' VAL . . . -176.84 -178.01 46.24 Favored Glycine 0 N--CA 1.44 -1.062 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -178.66 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -118.5 119.66 35.19 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 117.851 0.826 . . . . 0.0 109.029 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 791' ' ' TYR . . . . . 0.647 ' CE2' ' HG2' ' A' ' 759' ' ' GLU . 92.6 m-85 -122.24 148.88 44.44 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.582 -175.378 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 792' ' ' ILE . . . . . 0.586 ' O ' HG13 ' A' ' 758' ' ' ILE . 19.9 mt -124.64 114.33 40.21 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.065 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 172.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 793' ' ' LEU . . . . . 0.524 HD12 ' N ' ' A' ' 794' ' ' SER . 0.5 OUTLIER -84.39 115.73 22.67 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.893 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 794' ' ' SER . . . . . 0.524 ' N ' HD12 ' A' ' 793' ' ' LEU . 23.1 m -130.51 161.42 31.5 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 114.701 -1.136 . . . . 0.0 109.084 -174.677 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 795' ' ' LEU . . . . . 0.696 HD11 ' O ' ' A' ' 723' ' ' ALA . 27.6 mt -87.3 148.07 25.24 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 120.813 0.34 . . . . 0.0 110.897 -177.022 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 796' ' ' VAL . . . . . . . . . . . . . 69.7 t -105.17 -56.03 5.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.004 178.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 797' ' ' SER . . . . . 0.593 ' HA ' ' HG ' ' A' ' 808' ' ' LEU . 95.9 p -176.47 154.14 1.25 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.202 -172.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 798' ' ' ILE . . . . . 0.615 ' HA ' ' O ' ' A' ' 752' ' ' THR . 12.4 tt -127.51 164.04 29.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 177.149 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 799' ' ' LYS . . . . . 0.752 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 28.0 tttt -131.19 120.17 22.91 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 120.668 0.271 . . . . 0.0 111.058 -176.026 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 800' ' ' ASP . . . . . 0.502 ' HA ' ' CE2' ' A' ' 751' ' ' PHE . 19.8 t70 -69.18 154.63 41.74 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.312 173.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 9.0 m -59.32 -13.77 9.26 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 124.042 0.839 . . . . 0.0 112.994 -170.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 52.1 p -93.47 -0.87 56.24 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.466 0.651 . . . . 0.0 110.136 179.076 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 803' ' ' GLY . . . . . 0.519 ' HA2' ' HE2' ' A' ' 799' ' ' LYS . . . 85.74 46.87 5.29 Favored Glycine 0 N--CA 1.444 -0.807 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.702 -176.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 804' ' ' CYS . . . . . 0.435 ' HB2' ' HB3' ' A' ' 800' ' ' ASP . 61.3 m -116.71 110.76 18.88 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 177.553 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 805' ' ' VAL . . . . . 0.56 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 9.8 p -85.47 133.61 29.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.301 0.572 . . . . 0.0 111.006 -175.22 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 806' ' ' VAL . . . . . 0.511 ' HB ' HG22 ' A' ' 798' ' ' ILE . 84.5 t -112.02 133.76 56.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.009 178.519 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -70.49 113.19 4.71 Favored Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 177.034 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 808' ' ' LEU . . . . . 0.593 ' HG ' ' HA ' ' A' ' 797' ' ' SER . 40.0 mt -81.65 130.04 34.91 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.264 0.554 . . . . 0.0 112.462 -172.655 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 39.8 m -148.53 86.27 1.53 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.082 173.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 810' ' ' GLN . . . . . 0.616 ' HB3' ' HD2' ' A' ' 811' ' ' PRO . 75.1 mt-30 -135.54 173.27 5.89 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 174.229 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 811' ' ' PRO . . . . . 0.616 ' HD2' ' HB3' ' A' ' 810' ' ' GLN . 86.6 Cg_exo -45.28 139.44 9.01 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 122.654 2.236 . . . . 0.0 114.68 -177.302 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -111.42 166.15 11.37 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.301 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 813' ' ' ALA . . . . . . . . . . . . . . . -116.42 154.14 30.83 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.357 -178.09 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 814' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -120.22 108.7 14.52 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.18 0.514 . . . . 0.0 110.498 177.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 815' ' ' ILE . . . . . 0.598 ' HA ' ' HB3' ' A' ' 731' ' ' LEU . 4.8 mp -97.5 123.71 50.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.481 -179.085 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 816' ' ' GLN . . . . . 0.48 ' HB3' ' HD3' ' A' ' 732' ' ' LYS . 0.1 OUTLIER -118.39 106.31 12.6 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -179.873 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 817' ' ' VAL . . . . . 0.825 HG22 ' HA2' ' A' ' 788' ' ' GLY . 0.5 OUTLIER -100.61 143.61 13.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -179.879 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 818' ' ' ARG . . . . . . . . . . . . . 20.9 tpt180 -124.3 123.55 40.47 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 121.086 0.47 . . . . 0.0 110.683 -176.036 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 819' ' ' ARG . . . . . 0.617 ' HB2' ' H ' ' A' ' 788' ' ' GLY . 11.2 ttt180 -90.35 114.28 26.33 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.254 179.031 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 820' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 . . . . . 0 C--N 1.32 -0.705 0 CA-C-N 115.687 -0.688 . . . . 99.989999999999995 110.353 178.561 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 718' ' ' ARG . . . . . 0.487 ' HA ' ' NE ' ' A' ' 718' ' ' ARG . 4.1 mmp_? . . . . . 0 CA--C 1.502 -0.873 0 CA-C-O 122.114 0.959 . . . . 0.0 111.463 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 719' ' ' VAL . . . . . 0.629 HG22 ' H ' ' A' ' 720' ' ' LYS . 6.0 p -132.39 179.68 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.392 0 CA-C-N 113.735 -1.575 . . . . 0.0 107.477 -177.342 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 720' ' ' LYS . . . . . 0.629 ' H ' HG22 ' A' ' 719' ' ' VAL . 55.6 mtpt -109.19 88.2 5.59 Favored Pre-proline 0 C--N 1.301 -1.503 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 177.674 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 721' ' ' PRO . . . . . 0.578 ' HD3' ' O ' ' A' ' 719' ' ' VAL . 56.4 Cg_endo -88.04 144.91 6.25 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 123.381 2.721 . . . . 0.0 112.426 -174.742 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 722' ' ' SER . . . . . 0.609 ' HA ' HD22 ' A' ' 808' ' ' LEU . 61.8 m -169.27 -156.52 0.15 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -172.751 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 723' ' ' ALA . . . . . 0.676 ' HB1' HG21 ' A' ' 743' ' ' VAL . . . -152.2 143.51 23.31 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 122.273 -0.267 . . . . 0.0 110.845 179.454 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 724' ' ' SER . . . . . 0.429 ' HB2' ' OE1' ' A' ' 810' ' ' GLN . 26.0 t -132.58 99.5 4.66 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 725' ' ' LEU . . . . . 0.576 HD21 HD22 ' A' ' 793' ' ' LEU . 4.9 mp -62.42 143.4 57.1 Favored 'General case' 0 N--CA 1.426 -1.632 0 CA-C-O 122.428 1.109 . . . . 0.0 112.407 -176.398 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 30.8 mtpt -94.49 -16.47 23.31 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 113.26 -1.791 . . . . 0.0 110.417 -176.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 727' ' ' LEU . . . . . 0.501 ' HB2' ' HD2' ' A' ' 742' ' ' PRO . 1.5 tt -76.04 109.29 9.57 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 177.626 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 35.9 m80 -110.47 48.84 0.88 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -171.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -177.86 177.78 1.04 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.13 176.262 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 730' ' ' ASP . . . . . 0.428 ' HA ' ' O ' ' A' ' 814' ' ' LYS . 1.4 m-20 -67.01 134.94 52.94 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.967 0.413 . . . . 0.0 110.131 175.244 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 731' ' ' LEU . . . . . 0.58 ' HB3' ' HA ' ' A' ' 815' ' ' ILE . 28.2 tp -93.08 105.95 17.98 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.516 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 732' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -76.98 104.62 7.57 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.656 -174.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 733' ' ' LEU . . . . . 0.455 HD11 ' CB ' ' A' ' 739' ' ' SER . 85.2 mt -116.77 155.57 28.7 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.498 177.296 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 734' ' ' CYS . . . . . 0.473 ' O ' ' HB2' ' A' ' 737' ' ' ASP . 36.5 m -105.34 -173.38 2.29 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.84 179.101 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 735' ' ' LEU . . . . . 0.476 HD22 ' HB3' ' A' ' 819' ' ' ARG . 24.5 tp -67.05 135.8 54.25 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 178.421 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 736' ' ' GLY . . . . . 0.485 ' HA2' ' HA ' ' A' ' 786' ' ' THR . . . 80.02 7.84 88.17 Favored Glycine 0 C--N 1.321 -0.298 0 C-N-CA 120.339 -0.934 . . . . 0.0 112.673 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 737' ' ' ASP . . . . . 0.473 ' HB2' ' O ' ' A' ' 734' ' ' CYS . 0.7 OUTLIER -87.47 148.77 24.8 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.51 0.671 . . . . 0.0 112.628 179.078 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 738' ' ' HIS . . . . . 0.444 ' HB2' ' O ' ' A' ' 782' ' ' THR . 40.3 p-80 -110.93 164.98 12.24 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 166.19 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 739' ' ' SER . . . . . 0.578 ' HB2' HD23 ' A' ' 731' ' ' LEU . 4.5 p -109.99 162.7 14.27 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 119.277 -0.969 . . . . 0.0 112.0 -171.146 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 23.4 t -138.88 100.91 4.17 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 114.961 -1.018 . . . . 0.0 108.783 177.161 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 741' ' ' VAL . . . . . 0.529 HG11 HD13 ' A' ' 793' ' ' LEU . 1.5 p -117.1 111.45 40.54 Favored Pre-proline 0 C--N 1.318 -0.785 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.115 -179.015 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 742' ' ' PRO . . . . . 0.661 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 4.6 Cg_endo -76.63 134.07 14.82 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 122.578 2.185 . . . . 0.0 111.58 -179.184 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 743' ' ' VAL . . . . . 0.676 HG21 ' HB1' ' A' ' 723' ' ' ALA . 1.6 p -131.32 120.91 47.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.51 0.671 . . . . 0.0 112.249 176.403 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 744' ' ' ALA . . . . . 0.475 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -83.22 103.25 12.48 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 169.072 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 745' ' ' LEU . . . . . 0.934 HD13 HD13 ' A' ' 773' ' ' ILE . 0.3 OUTLIER -85.36 166.26 16.58 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.622 -1.172 . . . . 0.0 111.538 -167.092 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -120.14 148.95 43.0 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.914 -176.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 747' ' ' GLY . . . . . 0.431 ' HA3' ' HB3' ' A' ' 721' ' ' PRO . . . 100.28 127.2 5.96 Favored Glycine 0 C--N 1.316 -0.546 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 -173.783 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -102.08 124.59 47.94 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.327 0.584 . . . . 0.0 112.279 -170.459 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 108.06 -174.11 18.79 Favored Glycine 0 CA--C 1.501 -0.815 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.542 178.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 750' ' ' PRO . . . . . 0.547 ' HB3' ' HE2' ' A' ' 774' ' ' LYS . 72.8 Cg_endo -65.93 100.62 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.384 0 C-N-CA 123.317 2.678 . . . . 0.0 113.619 -177.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 751' ' ' PHE . . . . . 0.69 ' CE2' ' HA ' ' A' ' 800' ' ' ASP . 62.1 m-85 -113.99 144.18 43.51 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.701 177.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 752' ' ' THR . . . . . 0.731 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 96.1 m -89.21 103.17 15.81 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 177.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 753' ' ' LEU . . . . . 0.436 HD22 HD22 ' A' ' 745' ' ' LEU . 24.9 tp -91.28 122.65 34.09 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.407 -1.27 . . . . 0.0 110.093 -171.594 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 754' ' ' THR . . . . . 0.441 HG23 ' HB2' ' A' ' 769' ' ' GLU . 0.6 OUTLIER -122.57 131.37 53.8 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.555 0.217 . . . . 0.0 110.748 179.795 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 755' ' ' TYR . . . . . 0.663 ' CE1' ' HB3' ' A' ' 768' ' ' PHE . 24.2 p90 -140.23 154.09 46.77 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.076 0.465 . . . . 0.0 111.453 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 756' ' ' ASP . . . . . 0.485 ' O ' ' HA ' ' A' ' 793' ' ' LEU . 2.3 p30 -107.97 134.45 50.86 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.789 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 757' ' ' ILE . . . . . 0.561 HG21 ' HZ ' ' A' ' 785' ' ' PHE . 4.5 mp -103.73 94.97 3.47 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 167.599 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 758' ' ' ILE . . . . . 0.599 HG22 ' HD3' ' A' ' 765' ' ' ARG . 2.5 pp -100.77 145.99 10.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.769 -169.521 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 759' ' ' GLU . . . . . 0.431 ' OE1' ' HB2' ' A' ' 762' ' ' SER . 13.0 mt-10 -83.82 128.18 34.35 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.152 -179.643 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 760' ' ' THR . . . . . 0.463 HG23 ' OD2' ' A' ' 790' ' ' ASP . 0.1 OUTLIER -95.7 -2.93 46.96 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.229 0.538 . . . . 0.0 110.055 175.586 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 761' ' ' PHE . . . . . . . . . . . . . 35.9 p90 -100.87 -28.81 12.57 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.152 176.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 762' ' ' SER . . . . . 0.431 ' HB2' ' OE1' ' A' ' 759' ' ' GLU . 66.3 m -135.05 -103.12 0.22 Allowed 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 120.38 -0.528 . . . . 0.0 111.829 178.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 763' ' ' SER . . . . . . . . . . . . . 35.4 p -173.17 4.64 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -173.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 764' ' ' LYS . . . . . 0.408 ' HB2' ' CD ' ' A' ' 759' ' ' GLU . 10.0 mtmp? -86.85 58.65 5.19 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.738 0.78 . . . . 0.0 111.25 -174.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 765' ' ' ARG . . . . . 0.599 ' HD3' HG22 ' A' ' 758' ' ' ILE . 10.9 ttp180 -49.84 147.24 3.9 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 114.124 -1.398 . . . . 0.0 112.869 176.537 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 766' ' ' LYS . . . . . 0.471 ' HD3' ' N ' ' A' ' 767' ' ' THR . 9.6 tmtm? -119.73 146.55 45.53 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 114.935 -1.03 . . . . 0.0 108.688 177.26 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 767' ' ' THR . . . . . 0.471 ' N ' ' HD3' ' A' ' 766' ' ' LYS . 89.1 m -123.31 131.36 53.64 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 120.62 0.248 . . . . 0.0 110.508 177.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 768' ' ' PHE . . . . . 0.663 ' HB3' ' CE1' ' A' ' 755' ' ' TYR . 1.8 t80 -127.78 135.06 49.58 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 178.689 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 769' ' ' GLU . . . . . 0.441 ' HB2' HG23 ' A' ' 754' ' ' THR . 34.5 tt0 -128.7 128.65 44.5 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.666 -177.244 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 770' ' ' ILE . . . . . 0.522 HG22 HG22 ' A' ' 773' ' ' ILE . 4.7 mt -123.12 113.33 37.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 109.182 -0.674 . . . . 0.0 109.182 177.117 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 771' ' ' LYS . . . . . 0.584 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 0.1 OUTLIER -84.3 155.76 22.25 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 121.181 0.515 . . . . 0.0 111.506 -175.914 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 772' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 53.72 44.57 29.46 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.316 -1.311 . . . . 0.0 112.318 176.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 773' ' ' ILE . . . . . 0.934 HD13 HD13 ' A' ' 745' ' ' LEU . 0.5 OUTLIER -73.44 112.1 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 172.644 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 774' ' ' LYS . . . . . 0.547 ' HE2' ' HB3' ' A' ' 750' ' ' PRO . 71.3 mttt -107.8 26.37 10.41 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -178.54 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 775' ' ' THR . . . . . 0.645 ' H ' HD12 ' A' ' 773' ' ' ILE . 0.4 OUTLIER -95.91 -74.8 0.54 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.067 -0.969 . . . . 0.0 113.488 -165.71 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 776' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' A' ' 775' ' ' THR . 10.6 m120 83.53 7.86 0.65 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.344 1.057 . . . . 0.0 111.13 -175.486 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 777' ' ' GLU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 21.8 mt-10 -159.64 83.48 0.75 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.023 -0.99 . . . . 0.0 108.331 174.297 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 778' ' ' TYR . . . . . 0.773 ' HB3' HD11 ' A' ' 745' ' ' LEU . 83.2 t80 -129.61 129.39 44.3 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.911 -169.222 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 779' ' ' VAL . . . . . 0.661 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 14.1 t -89.42 111.26 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 CA-C-O 121.157 0.503 . . . . 0.0 110.213 178.609 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 780' ' ' ILE . . . . . 0.444 ' HB ' HG13 ' A' ' 741' ' ' VAL . 72.9 mt -79.15 145.12 9.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.273 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 781' ' ' LYS . . . . . 0.432 ' HA ' ' O ' ' A' ' 739' ' ' SER . 3.7 mppt? -130.3 108.8 10.28 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 174.226 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 782' ' ' THR . . . . . 0.444 ' O ' ' HB2' ' A' ' 738' ' ' HIS . 30.9 p -77.19 141.37 66.78 Favored Pre-proline 0 N--CA 1.444 -0.748 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 -178.28 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 783' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -55.9 150.02 48.47 Favored 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 122.918 2.412 . . . . 0.0 111.274 -177.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 784' ' ' VAL . . . . . . . . . . . . . 14.9 p -61.81 133.03 27.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.433 0.635 . . . . 0.0 110.812 -172.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 785' ' ' PHE . . . . . 0.561 ' HZ ' HG21 ' A' ' 757' ' ' ILE . 88.9 m-85 -90.24 -37.47 14.09 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.834 -173.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 786' ' ' THR . . . . . 0.485 ' HA ' ' HA2' ' A' ' 736' ' ' GLY . 28.3 p 57.97 3.39 0.22 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.507 0.723 . . . . 0.0 111.744 -178.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 787' ' ' THR . . . . . 0.436 ' H ' ' C ' ' A' ' 785' ' ' PHE . 42.8 m -134.37 118.53 17.56 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.868 -179.165 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 788' ' ' GLY . . . . . 0.645 ' HA2' HG12 ' A' ' 817' ' ' VAL . . . -54.4 108.66 0.94 Allowed Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.523 -0.762 . . . . 0.0 113.224 174.349 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 789' ' ' GLY . . . . . 0.501 ' H ' ' HB ' ' A' ' 817' ' ' VAL . . . -155.56 167.16 33.0 Favored Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 174.594 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 790' ' ' ASP . . . . . 0.463 ' OD2' HG23 ' A' ' 760' ' ' THR . 0.2 OUTLIER -109.3 129.39 55.52 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 117.567 0.684 . . . . 0.0 109.906 179.335 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 791' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -130.0 156.17 44.91 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.213 -174.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 792' ' ' ILE . . . . . 0.519 ' O ' HG13 ' A' ' 758' ' ' ILE . 14.5 mt -128.45 119.07 49.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 109.354 -0.609 . . . . 0.0 109.354 174.241 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 793' ' ' LEU . . . . . 0.576 HD22 HD21 ' A' ' 725' ' ' LEU . 10.1 tt -84.51 107.36 16.71 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.267 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 794' ' ' SER . . . . . . . . . . . . . 3.7 m -116.23 170.87 8.2 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.14 -179.099 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 795' ' ' LEU . . . . . . . . . . . . . 22.8 mt -97.68 129.6 44.73 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.603 0.239 . . . . 0.0 110.977 -175.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 796' ' ' VAL . . . . . . . . . . . . . 75.0 t -88.94 -56.1 5.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.812 -179.264 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 797' ' ' SER . . . . . 0.511 ' HA ' ' HG ' ' A' ' 808' ' ' LEU . 24.4 m -173.39 164.15 4.59 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.128 -173.417 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 798' ' ' ILE . . . . . 0.587 ' O ' ' HA ' ' A' ' 805' ' ' VAL . 11.5 tt -136.15 167.55 24.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 176.588 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 799' ' ' LYS . . . . . 0.731 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 83.6 tttt -136.04 120.56 18.18 Favored 'General case' 0 C--N 1.315 -0.932 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.248 -176.096 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 800' ' ' ASP . . . . . 0.69 ' HA ' ' CE2' ' A' ' 751' ' ' PHE . 6.2 m-20 -63.12 156.46 24.98 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.279 174.235 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 4.0 m -64.81 -5.22 5.47 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 124.151 0.907 . . . . 0.0 112.212 -174.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 8.9 t -104.98 12.63 32.11 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.757 0.789 . . . . 0.0 109.617 175.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 803' ' ' GLY . . . . . 0.49 ' HA2' ' CE ' ' A' ' 799' ' ' LYS . . . 74.71 46.85 16.7 Favored Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.121 -0.945 . . . . 0.0 112.831 -179.462 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 804' ' ' CYS . . . . . 0.597 ' HB3' ' HB2' ' A' ' 800' ' ' ASP . 53.7 t -109.87 106.23 15.73 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 177.181 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 805' ' ' VAL . . . . . 0.587 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 2.6 t -86.69 104.95 14.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.591 0.71 . . . . 0.0 110.704 -175.444 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 806' ' ' VAL . . . . . . . . . . . . . 39.5 t -90.13 138.54 19.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.065 -178.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -74.96 113.21 3.91 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.662 178.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 808' ' ' LEU . . . . . 0.609 HD22 ' HA ' ' A' ' 722' ' ' SER . 30.8 mt -80.17 132.02 35.82 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 -174.184 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 20.4 m -143.97 85.65 1.82 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.52 171.203 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 810' ' ' GLN . . . . . 0.494 ' HB3' ' O ' ' A' ' 723' ' ' ALA . 1.0 OUTLIER -146.69 173.91 3.83 Favored Pre-proline 0 CA--C 1.542 0.645 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.363 177.501 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 811' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -44.0 154.47 0.26 Allowed 'Trans proline' 0 C--N 1.359 1.08 0 C-N-CA 123.782 2.988 . . . . 0.0 116.294 -173.491 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -131.35 167.83 18.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 113.797 -1.547 . . . . 0.0 109.613 -178.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 813' ' ' ALA . . . . . . . . . . . . . . . -127.69 148.65 50.4 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.748 0.308 . . . . 0.0 110.505 178.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 814' ' ' LYS . . . . . 0.428 ' O ' ' HA ' ' A' ' 730' ' ' ASP . 50.3 tttm -110.17 112.79 24.99 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.14 0.495 . . . . 0.0 110.704 -176.254 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 815' ' ' ILE . . . . . 0.58 ' HA ' ' HB3' ' A' ' 731' ' ' LEU . 5.3 mp -98.21 127.66 50.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.855 -178.307 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 816' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -114.42 110.6 20.13 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.742 0.306 . . . . 0.0 110.842 -178.83 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 817' ' ' VAL . . . . . 0.645 HG12 ' HA2' ' A' ' 788' ' ' GLY . 61.3 t -105.66 127.66 60.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 175.391 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 818' ' ' ARG . . . . . . . . . . . . . 25.4 mmt180 -148.25 144.51 27.71 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 121.849 -0.532 . . . . 0.0 111.319 177.33 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 819' ' ' ARG . . . . . 0.476 ' HB3' HD22 ' A' ' 735' ' ' LEU . 0.0 OUTLIER -91.96 147.24 23.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.408 177.401 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 820' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 . . . . . 0 C--N 1.32 -0.68 0 CA-C-N 116.235 -0.438 . . . . 99.989999999999995 109.983 178.916 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 718' ' ' ARG . . . . . . . . . . . . . 13.8 tpp180 . . . . . 0 CA--C 1.51 -0.558 0 CA-C-O 121.401 0.62 . . . . 0.0 110.399 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 719' ' ' VAL . . . . . 0.669 HG22 ' H ' ' A' ' 720' ' ' LYS . 5.0 p -143.42 -176.56 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 -178.588 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 720' ' ' LYS . . . . . 0.669 ' H ' HG22 ' A' ' 719' ' ' VAL . 27.7 mtpp -110.28 85.62 4.6 Favored Pre-proline 0 C--N 1.308 -1.224 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 177.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 721' ' ' PRO . . . . . 0.583 ' HD3' ' O ' ' A' ' 719' ' ' VAL . 46.3 Cg_endo -88.25 140.76 4.76 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 123.08 2.52 . . . . 0.0 112.115 -173.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 25.2 m -174.83 -151.44 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -170.096 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 723' ' ' ALA . . . . . 0.562 ' HA ' ' HA ' ' A' ' 745' ' ' LEU . . . -146.65 149.0 32.63 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 174.054 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 28.5 t -131.66 98.38 4.47 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.323 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 725' ' ' LEU . . . . . 0.563 HD21 HD21 ' A' ' 795' ' ' LEU . 2.0 mt -66.79 143.69 56.75 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-O 121.441 0.638 . . . . 0.0 110.984 -171.053 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 35.6 mtpt -94.45 -19.61 20.42 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.869 -1.06 . . . . 0.0 111.079 -174.574 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 727' ' ' LEU . . . . . 0.686 HD23 ' HB1' ' A' ' 813' ' ' ALA . 25.9 tp -56.67 129.54 41.5 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.04 178.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 8.3 t-160 -117.82 16.28 14.37 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.943 -173.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -169.84 -178.8 3.05 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 122.311 -0.243 . . . . 0.0 110.886 177.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 730' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.32 132.25 52.03 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.159 0.504 . . . . 0.0 110.726 175.048 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 731' ' ' LEU . . . . . 0.637 HD21 ' H ' ' A' ' 740' ' ' SER . 49.3 tp -91.56 102.1 14.75 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.07 177.757 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 732' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -77.51 122.57 25.42 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.647 -174.261 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 733' ' ' LEU . . . . . 0.633 ' HG ' ' HB3' ' A' ' 737' ' ' ASP . 7.8 mp -120.79 164.22 16.94 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.708 178.242 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 734' ' ' CYS . . . . . 0.564 ' O ' ' HB2' ' A' ' 737' ' ' ASP . 66.1 m -116.49 -178.27 3.38 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.089 173.001 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 735' ' ' LEU . . . . . 0.475 ' HB2' ' HA ' ' A' ' 819' ' ' ARG . 31.0 tp -63.42 122.92 17.44 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.894 0.378 . . . . 0.0 111.236 -176.11 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 82.43 7.64 87.3 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.438 -0.887 . . . . 0.0 112.384 178.272 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 737' ' ' ASP . . . . . 0.633 ' HB3' ' HG ' ' A' ' 733' ' ' LEU . 0.2 OUTLIER -72.2 154.04 41.26 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.909 0.385 . . . . 0.0 110.953 176.076 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 37.9 p-80 -112.85 148.49 34.79 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 171.373 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 739' ' ' SER . . . . . 0.481 ' HB3' HD23 ' A' ' 731' ' ' LEU . 4.6 m -94.93 158.09 15.63 Favored 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 119.966 -0.694 . . . . 0.0 110.927 -172.322 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 740' ' ' SER . . . . . 0.637 ' H ' HD21 ' A' ' 731' ' ' LEU . 12.5 p -144.19 100.85 3.62 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.213 -178.543 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 741' ' ' VAL . . . . . 0.479 HG11 HD13 ' A' ' 793' ' ' LEU . 0.4 OUTLIER -117.51 119.12 34.68 Favored Pre-proline 0 C--N 1.314 -0.968 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.459 179.973 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 742' ' ' PRO . . . . . 0.717 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 10.1 Cg_endo -80.86 134.12 9.42 Favored 'Trans proline' 0 N--CA 1.435 -1.93 0 C-N-CA 121.712 1.608 . . . . 0.0 110.649 -179.482 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 743' ' ' VAL . . . . . 0.519 ' CG2' HD22 ' A' ' 725' ' ' LEU . 49.0 t -132.77 119.64 38.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 121.336 0.588 . . . . 0.0 111.913 -178.507 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 744' ' ' ALA . . . . . 0.618 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -81.77 95.33 7.24 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 122.129 0.966 . . . . 0.0 108.653 170.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 745' ' ' LEU . . . . . 0.83 HD11 ' HB3' ' A' ' 778' ' ' TYR . 1.9 mt -77.84 159.86 28.69 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.045 -1.434 . . . . 0.0 111.384 -168.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 8.5 tptp -111.58 166.47 11.12 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.626 -178.237 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 747' ' ' GLY . . . . . . . . . . . . . . . 96.1 124.87 4.64 Favored Glycine 0 C--N 1.312 -0.756 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.714 -173.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 748' ' ' GLN . . . . . 0.442 ' C ' ' HE1' ' A' ' 751' ' ' PHE . 11.3 mm100 -103.57 95.51 6.11 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 122.676 -0.308 . . . . 0.0 111.026 -176.615 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 134.48 -164.73 24.59 Favored Glycine 0 C--O 1.223 -0.589 0 N-CA-C 111.269 -0.732 . . . . 0.0 111.269 -178.361 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -74.25 94.35 0.9 Allowed 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.719 2.279 . . . . 0.0 112.084 179.315 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 751' ' ' PHE . . . . . 0.73 ' CE2' ' HA ' ' A' ' 800' ' ' ASP . 81.2 m-85 -115.71 141.67 47.77 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.585 -179.381 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 752' ' ' THR . . . . . 0.737 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 73.5 m -97.63 105.73 17.92 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-O 121.709 0.766 . . . . 0.0 109.352 -179.319 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 753' ' ' LEU . . . . . 0.694 HD13 HD22 ' A' ' 745' ' ' LEU . 3.9 tt -105.11 114.1 28.09 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 114.47 -1.241 . . . . 0.0 110.015 -168.206 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 754' ' ' THR . . . . . 0.459 HG23 ' HB2' ' A' ' 769' ' ' GLU . 1.5 m -107.9 136.3 47.84 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.769 -176.186 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 755' ' ' TYR . . . . . 0.404 ' CE1' ' HB3' ' A' ' 768' ' ' PHE . 26.2 p90 -135.6 159.6 41.11 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.036 0.446 . . . . 0.0 111.694 179.146 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 756' ' ' ASP . . . . . 0.588 ' OD2' ' HB3' ' A' ' 794' ' ' SER . 3.1 p30 -118.53 128.33 54.47 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.447 -178.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 757' ' ' ILE . . . . . 0.526 HG13 HD12 ' A' ' 793' ' ' LEU . 4.2 mp -98.18 94.04 3.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 167.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 758' ' ' ILE . . . . . 0.541 HG13 ' O ' ' A' ' 792' ' ' ILE . 2.6 pp -99.38 142.45 15.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-O 121.552 0.692 . . . . 0.0 112.033 -169.524 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 759' ' ' GLU . . . . . 0.559 ' HG2' ' CD2' ' A' ' 791' ' ' TYR . 24.8 mt-10 -96.54 101.14 12.72 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.145 -171.289 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 760' ' ' THR . . . . . 0.461 HG23 ' HB2' ' A' ' 790' ' ' ASP . 0.0 OUTLIER -87.91 0.81 55.38 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.382 -169.742 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 761' ' ' PHE . . . . . 0.424 ' CE1' ' HB3' ' A' ' 759' ' ' GLU . 46.2 p90 -85.43 -10.05 56.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.703 177.761 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 762' ' ' SER . . . . . . . . . . . . . 18.9 p -144.83 -98.57 0.1 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.802 175.364 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 763' ' ' SER . . . . . . . . . . . . . 73.8 p -160.87 16.73 0.12 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.251 0.548 . . . . 0.0 110.325 179.104 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 764' ' ' LYS . . . . . 0.445 ' HZ2' ' CD ' ' A' ' 759' ' ' GLU . 7.4 mtpm? -90.16 174.29 7.7 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.47 -175.467 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 765' ' ' ARG . . . . . 0.494 ' HD3' HG22 ' A' ' 758' ' ' ILE . 16.4 ttp180 -165.68 146.79 7.03 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-O 120.974 0.416 . . . . 0.0 111.666 -173.379 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 766' ' ' LYS . . . . . 0.676 ' HD3' ' N ' ' A' ' 767' ' ' THR . 10.4 tmtt? -123.48 147.59 47.04 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 178.168 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 767' ' ' THR . . . . . 0.676 ' N ' ' HD3' ' A' ' 766' ' ' LYS . 62.0 m -132.31 141.92 49.15 Favored 'General case' 0 C--N 1.314 -0.975 0 O-C-N 122.301 -0.25 . . . . 0.0 111.618 -176.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 768' ' ' PHE . . . . . 0.404 ' HB3' ' CE1' ' A' ' 755' ' ' TYR . 2.9 t80 -145.49 144.35 30.52 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.724 0.297 . . . . 0.0 110.536 176.216 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 769' ' ' GLU . . . . . 0.459 ' HB2' HG23 ' A' ' 754' ' ' THR . 41.2 tt0 -127.06 126.05 42.4 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.498 -175.254 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 5.2 mm -107.22 103.39 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 178.286 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 771' ' ' LYS . . . . . 0.486 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 12.3 mtpt -83.22 149.93 26.51 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.648 -179.053 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 772' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 50.96 50.46 19.06 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.488 -1.233 . . . . 0.0 112.205 -179.235 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 773' ' ' ILE . . . . . 0.77 HD12 ' H ' ' A' ' 775' ' ' THR . 0.5 OUTLIER -76.12 117.92 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 173.416 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 78.4 mttt -118.15 28.09 8.59 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -178.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 775' ' ' THR . . . . . 0.77 ' H ' HD12 ' A' ' 773' ' ' ILE . 0.9 OUTLIER -95.18 -72.19 0.64 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.572 -1.195 . . . . 0.0 112.429 -171.538 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 776' ' ' ASN . . . . . 0.451 ' HB2' ' O ' ' A' ' 775' ' ' THR . 78.6 m-20 87.7 4.39 0.31 Allowed 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.703 1.201 . . . . 0.0 110.031 -178.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 777' ' ' GLU . . . . . 0.618 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 21.7 tt0 -162.69 96.28 0.93 Allowed 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.143 172.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 778' ' ' TYR . . . . . 0.83 ' HB3' HD11 ' A' ' 745' ' ' LEU . 83.3 t80 -139.63 128.83 23.88 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.081 -170.39 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 779' ' ' VAL . . . . . 0.717 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 7.6 t -84.73 105.91 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.196 -179.705 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 780' ' ' ILE . . . . . . . . . . . . . 70.1 mt -77.06 132.59 32.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.697 -178.179 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -117.18 109.58 17.08 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.385 0.612 . . . . 0.0 110.262 179.232 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 782' ' ' THR . . . . . 0.468 ' CG2' ' HB2' ' A' ' 739' ' ' SER . 1.1 p -80.82 149.22 66.88 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.526 -176.516 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 783' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -51.7 161.38 2.14 Favored 'Trans proline' 0 N--CA 1.473 0.292 0 C-N-CA 123.737 2.958 . . . . 0.0 113.34 -178.167 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 784' ' ' VAL . . . . . 0.497 HG12 HG23 ' A' ' 786' ' ' THR . 55.1 t -62.69 122.13 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.309 177.259 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 785' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -103.31 96.09 6.53 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.557 178.064 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 786' ' ' THR . . . . . 0.497 HG23 HG12 ' A' ' 784' ' ' VAL . 46.0 p -85.12 36.98 0.65 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.926 0.87 . . . . 0.0 110.369 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 58.4 m -159.48 110.26 1.98 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.336 -1.302 . . . . 0.0 110.191 179.345 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 788' ' ' GLY . . . . . 1.034 ' HA2' HG22 ' A' ' 817' ' ' VAL . . . -54.39 134.56 45.59 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.919 -0.658 . . . . 0.0 113.241 173.685 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 789' ' ' GLY . . . . . 0.65 ' H ' HG13 ' A' ' 817' ' ' VAL . . . -178.35 -170.43 40.46 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 179.504 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 790' ' ' ASP . . . . . 0.485 ' OD2' ' HG2' ' A' ' 816' ' ' GLN . 6.6 m-20 -114.16 130.6 56.6 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 174.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 791' ' ' TYR . . . . . 0.559 ' CD2' ' HG2' ' A' ' 759' ' ' GLU . 60.2 m-85 -131.27 123.85 29.25 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -179.119 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 792' ' ' ILE . . . . . 0.541 ' O ' HG13 ' A' ' 758' ' ' ILE . 19.8 mt -103.88 116.52 47.81 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 C-N-CA 120.445 -0.502 . . . . 0.0 109.778 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 793' ' ' LEU . . . . . 0.562 ' HB3' ' HB3' ' A' ' 813' ' ' ALA . 3.6 tt -83.87 106.28 15.43 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 177.722 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 794' ' ' SER . . . . . 0.588 ' HB3' ' OD2' ' A' ' 756' ' ' ASP . 15.2 t -117.77 179.46 4.07 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.852 -1.067 . . . . 0.0 108.765 -177.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 795' ' ' LEU . . . . . 0.563 HD21 HD21 ' A' ' 725' ' ' LEU . 58.2 mt -106.38 130.62 54.17 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 120.681 0.277 . . . . 0.0 111.01 -175.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 796' ' ' VAL . . . . . . . . . . . . . 51.4 t -88.89 -56.86 4.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.202 -177.42 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 797' ' ' SER . . . . . . . . . . . . . 24.4 m -173.45 168.89 4.49 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.012 -173.15 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 798' ' ' ILE . . . . . 0.7 HG22 ' HB ' ' A' ' 806' ' ' VAL . 0.4 OUTLIER -141.01 166.4 18.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 -173.906 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 799' ' ' LYS . . . . . 0.737 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 26.0 tttm -140.31 118.42 11.94 Favored 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 120.4 -0.52 . . . . 0.0 111.533 -177.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 800' ' ' ASP . . . . . 0.73 ' HA ' ' CE2' ' A' ' 751' ' ' PHE . 12.4 t70 -70.6 156.93 38.79 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.114 174.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 12.8 t -67.28 -5.22 13.13 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 123.652 0.595 . . . . 0.0 111.287 -172.1 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 18.5 p -95.87 7.72 45.55 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.459 0.647 . . . . 0.0 109.919 174.182 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 803' ' ' GLY . . . . . . . . . . . . . . . 74.9 32.37 56.95 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.969 -177.141 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 804' ' ' CYS . . . . . 0.557 ' HB3' ' HB3' ' A' ' 800' ' ' ASP . 37.1 t -99.16 108.03 20.54 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 -179.132 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 805' ' ' VAL . . . . . 0.547 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 3.3 t -85.05 106.54 15.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.194 0.521 . . . . 0.0 110.303 -174.231 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 806' ' ' VAL . . . . . 0.7 ' HB ' HG22 ' A' ' 798' ' ' ILE . 22.9 t -92.88 136.84 23.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.021 -178.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -74.94 134.27 16.8 Favored Glycine 0 N--CA 1.451 -0.311 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.465 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 808' ' ' LEU . . . . . 0.585 HD21 ' HB ' ' A' ' 798' ' ' ILE . 46.3 mt -99.06 130.81 45.42 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -173.489 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 6.1 t -145.83 85.65 1.7 Allowed 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.219 -0.901 . . . . 0.0 109.232 171.322 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 810' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -138.22 174.96 3.72 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-O 118.798 -0.62 . . . . 0.0 109.735 178.481 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 811' ' ' PRO . . . . . 0.447 ' O ' ' HG ' ' A' ' 725' ' ' LEU . 83.2 Cg_exo -43.79 152.86 0.3 Allowed 'Trans proline' 0 C--N 1.361 1.225 0 C-N-CA 123.347 2.698 . . . . 0.0 114.68 -177.395 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 812' ' ' ASP . . . . . 0.476 ' C ' HD12 ' A' ' 725' ' ' LEU . 7.9 p-10 -122.73 165.51 16.44 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.273 -176.739 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 813' ' ' ALA . . . . . 0.686 ' HB1' HD23 ' A' ' 727' ' ' LEU . . . -120.98 113.04 19.51 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.193 -175.468 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 814' ' ' LYS . . . . . . . . . . . . . 41.6 tttm -93.4 112.15 23.99 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.436 0.636 . . . . 0.0 111.488 -177.527 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 815' ' ' ILE . . . . . 0.607 ' HA ' ' HB3' ' A' ' 731' ' ' LEU . 4.7 mp -93.25 135.54 27.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.254 175.822 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 816' ' ' GLN . . . . . 0.485 ' HG2' ' OD2' ' A' ' 790' ' ' ASP . 0.5 OUTLIER -128.87 106.95 9.26 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.943 0.401 . . . . 0.0 109.982 178.525 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 817' ' ' VAL . . . . . 1.034 HG22 ' HA2' ' A' ' 788' ' ' GLY . 0.2 OUTLIER -103.19 142.53 16.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-O 121.324 0.583 . . . . 0.0 110.577 179.052 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 818' ' ' ARG . . . . . 0.466 ' HG2' HE22 ' A' ' 816' ' ' GLN . 35.6 mmt180 -133.31 175.56 9.29 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 175.766 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 819' ' ' ARG . . . . . 0.475 ' HA ' ' HB2' ' A' ' 735' ' ' LEU . 0.3 OUTLIER -74.88 153.19 38.76 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 173.409 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 820' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 . . . . . 0 C--N 1.321 -0.636 0 N-CA-C 110.011 -0.366 . . . . 99.989999999999995 110.011 -178.733 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 718' ' ' ARG . . . . . . . . . . . . . 25.2 mmm180 . . . . . 0 CA--C 1.5 -0.965 0 CA-C-O 122.133 0.968 . . . . 0.0 111.048 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 719' ' ' VAL . . . . . 0.499 ' O ' ' HD3' ' A' ' 721' ' ' PRO . 7.5 p -164.23 157.68 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 CA-C-N 113.222 -1.808 . . . . 0.0 108.578 -175.794 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 720' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -80.74 104.69 2.91 Favored Pre-proline 0 C--N 1.31 -1.14 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.735 178.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 721' ' ' PRO . . . . . 0.499 ' HD3' ' O ' ' A' ' 719' ' ' VAL . 51.9 Cg_endo -86.91 152.2 8.49 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 122.46 2.107 . . . . 0.0 111.791 -176.281 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 722' ' ' SER . . . . . 0.541 ' HB3' ' NE2' ' A' ' 810' ' ' GLN . 21.6 t 177.53 -151.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -172.314 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 723' ' ' ALA . . . . . 0.76 ' HB1' HG21 ' A' ' 743' ' ' VAL . . . -150.67 143.09 24.34 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 121.238 -0.185 . . . . 0.0 111.114 178.138 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 37.1 t -127.72 102.51 6.84 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -179.345 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 725' ' ' LEU . . . . . 0.494 ' CD2' ' HB ' ' A' ' 743' ' ' VAL . 12.5 mt -63.88 147.08 52.78 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-O 121.641 0.734 . . . . 0.0 111.455 -175.215 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 34.2 mtpt -99.84 -15.85 18.26 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.042 -176.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 727' ' ' LEU . . . . . 0.521 HD21 ' HG ' ' A' ' 731' ' ' LEU . 48.3 tp -64.58 132.34 49.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.248 178.695 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -103.76 -26.26 12.8 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.095 0.405 . . . . 0.0 112.095 -173.094 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -122.98 173.12 8.01 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.807 -173.451 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 730' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -74.38 140.66 44.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.403 177.166 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 731' ' ' LEU . . . . . 0.69 HD12 HG13 ' A' ' 815' ' ' ILE . 73.5 mt -84.39 100.02 11.02 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.326 -179.196 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 732' ' ' LYS . . . . . 0.491 ' HE3' ' OE1' ' A' ' 816' ' ' GLN . 14.1 mmmm -76.97 112.87 14.05 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.637 -179.679 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 733' ' ' LEU . . . . . 0.774 HD12 HG22 ' A' ' 817' ' ' VAL . 58.2 mt -123.34 158.58 30.72 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.108 -178.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 734' ' ' CYS . . . . . 0.517 ' O ' ' HB2' ' A' ' 737' ' ' ASP . 21.2 p -107.68 -173.36 2.27 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 167.811 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 735' ' ' LEU . . . . . 0.525 ' CD1' ' H ' ' A' ' 788' ' ' GLY . 1.4 tp -71.95 148.92 45.52 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 120.055 -0.658 . . . . 0.0 111.032 -171.01 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 736' ' ' GLY . . . . . 0.5 ' HA2' ' HA ' ' A' ' 786' ' ' THR . . . 76.22 10.02 85.49 Favored Glycine 0 C--N 1.321 -0.258 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.54 -179.587 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 737' ' ' ASP . . . . . 0.517 ' HB2' ' O ' ' A' ' 734' ' ' CYS . 0.7 OUTLIER -93.68 155.24 17.37 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -177.719 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 738' ' ' HIS . . . . . 0.508 ' HB2' ' O ' ' A' ' 782' ' ' THR . 37.4 p-80 -121.86 -175.57 3.13 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 168.445 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 739' ' ' SER . . . . . 0.65 ' HB3' HD13 ' A' ' 731' ' ' LEU . 67.9 m -145.85 176.37 9.72 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.128 -0.629 . . . . 0.0 112.502 178.633 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 740' ' ' SER . . . . . 0.48 ' HA ' ' O ' ' A' ' 780' ' ' ILE . 9.7 p -142.43 109.7 5.62 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.144 176.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 741' ' ' VAL . . . . . 0.51 HG11 HD13 ' A' ' 793' ' ' LEU . 2.3 p -105.04 116.01 61.39 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.708 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 742' ' ' PRO . . . . . 0.657 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 3.7 Cg_exo -75.13 131.15 13.82 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 122.244 1.963 . . . . 0.0 111.03 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 743' ' ' VAL . . . . . 0.76 HG21 ' HB1' ' A' ' 723' ' ' ALA . 1.8 p -131.47 120.07 44.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.656 0.741 . . . . 0.0 112.72 178.379 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 744' ' ' ALA . . . . . 0.565 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -82.41 109.9 17.06 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 168.373 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 745' ' ' LEU . . . . . 0.914 HD13 HD13 ' A' ' 773' ' ' ILE . 0.4 OUTLIER -93.23 157.94 16.01 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.828 -1.078 . . . . 0.0 111.599 -164.652 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 37.9 tptt -105.06 157.69 17.07 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.235 178.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 747' ' ' GLY . . . . . . . . . . . . . . . 93.42 120.76 3.06 Favored Glycine 0 C--N 1.305 -1.186 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -175.636 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -96.37 115.4 27.38 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.04 0.448 . . . . 0.0 112.081 -170.63 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 749' ' ' GLY . . . . . 0.41 ' O ' ' HD1' ' A' ' 751' ' ' PHE . . . 109.88 -167.66 12.86 Favored Glycine 0 CA--C 1.5 -0.853 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.531 179.333 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 750' ' ' PRO . . . . . 0.502 ' HB3' ' HE2' ' A' ' 774' ' ' LYS . 85.5 Cg_endo -66.24 95.08 0.31 Allowed 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 123.73 2.953 . . . . 0.0 113.617 -175.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 751' ' ' PHE . . . . . 0.498 ' CE2' ' HA ' ' A' ' 800' ' ' ASP . 56.7 m-85 -112.43 142.68 44.68 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.68 177.482 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 752' ' ' THR . . . . . 0.758 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 96.4 m -88.93 106.14 18.22 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.496 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 753' ' ' LEU . . . . . 0.623 HD22 HD22 ' A' ' 745' ' ' LEU . 12.3 tp -100.2 110.11 22.37 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.052 -0.977 . . . . 0.0 111.091 -172.167 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 754' ' ' THR . . . . . 0.463 HG23 ' HB2' ' A' ' 769' ' ' GLU . 1.2 m -99.43 135.24 41.13 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.442 177.652 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 755' ' ' TYR . . . . . . . . . . . . . 39.3 p90 -136.29 148.34 47.93 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 121.147 0.499 . . . . 0.0 111.638 179.281 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 756' ' ' ASP . . . . . 0.591 ' O ' ' HA ' ' A' ' 793' ' ' LEU . 2.5 p30 -110.22 137.96 47.25 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.789 178.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 757' ' ' ILE . . . . . . . . . . . . . 4.3 mp -107.66 94.79 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.087 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 166.091 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 758' ' ' ILE . . . . . 0.595 HG22 ' HD3' ' A' ' 765' ' ' ARG . 2.6 pp -99.84 150.36 5.38 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.92 -169.421 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 759' ' ' GLU . . . . . 0.69 ' OE1' ' HB2' ' A' ' 762' ' ' SER . 9.4 mt-10 -88.16 120.92 29.98 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.174 -179.349 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 760' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.17 -5.28 44.35 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 169.568 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 761' ' ' PHE . . . . . 0.537 ' HB2' ' H ' ' A' ' 790' ' ' ASP . 77.4 t80 -94.44 -32.05 13.71 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 114.468 -1.242 . . . . 0.0 110.972 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 762' ' ' SER . . . . . 0.69 ' HB2' ' OE1' ' A' ' 759' ' ' GLU . 22.2 m -146.62 -93.88 0.09 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 120.594 -0.443 . . . . 0.0 112.066 179.384 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 763' ' ' SER . . . . . . . . . . . . . 21.5 t -172.37 0.86 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -174.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 764' ' ' LYS . . . . . 0.451 ' C ' ' HG3' ' A' ' 759' ' ' GLU . 51.8 mtmt -82.36 55.5 2.92 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.435 0.636 . . . . 0.0 111.315 -176.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 765' ' ' ARG . . . . . 0.595 ' HD3' HG22 ' A' ' 758' ' ' ILE . 12.3 ttp180 -56.06 140.33 43.99 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.477 175.034 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 766' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -120.5 146.54 46.18 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -178.561 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 767' ' ' THR . . . . . . . . . . . . . 90.0 m -128.48 136.22 50.52 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 120.573 0.225 . . . . 0.0 110.836 -179.312 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 768' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -141.09 145.07 35.32 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 177.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 769' ' ' GLU . . . . . 0.463 ' HB2' HG23 ' A' ' 754' ' ' THR . 32.9 tt0 -128.17 132.0 48.89 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.985 0.421 . . . . 0.0 111.447 -176.279 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 11.1 mm -111.73 100.57 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.526 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 771' ' ' LYS . . . . . 0.494 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 12.6 mtpt -79.98 150.54 30.42 Favored 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 120.044 -0.662 . . . . 0.0 111.04 -177.783 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 772' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 53.7 48.16 22.14 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.04 -1.437 . . . . 0.0 112.521 177.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 773' ' ' ILE . . . . . 0.914 HD13 HD13 ' A' ' 745' ' ' LEU . 0.5 OUTLIER -73.34 117.6 17.33 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.578 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 171.538 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 774' ' ' LYS . . . . . 0.502 ' HE2' ' HB3' ' A' ' 750' ' ' PRO . 59.5 mttt -112.08 28.04 9.12 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 -179.248 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 775' ' ' THR . . . . . 0.691 ' H ' HD12 ' A' ' 773' ' ' ILE . 0.2 OUTLIER -95.69 -76.7 0.49 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.862 -1.063 . . . . 0.0 113.5 -167.874 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 776' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 775' ' ' THR . 12.2 m120 88.48 3.91 0.25 Allowed 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.943 1.297 . . . . 0.0 111.054 -175.144 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 777' ' ' GLU . . . . . 0.565 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 9.9 mt-10 -161.07 88.29 0.75 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.025 172.782 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 778' ' ' TYR . . . . . 0.676 ' HB3' HD11 ' A' ' 745' ' ' LEU . 63.9 t80 -133.51 136.68 45.21 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.611 -170.583 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 779' ' ' VAL . . . . . 0.657 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 21.5 t -91.25 115.77 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 CA-C-O 121.337 0.589 . . . . 0.0 110.309 178.66 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 780' ' ' ILE . . . . . 0.48 ' O ' ' HA ' ' A' ' 740' ' ' SER . 61.7 mt -82.74 142.22 13.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.309 -179.125 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 781' ' ' LYS . . . . . 0.4 ' HD3' ' C ' ' A' ' 780' ' ' ILE . 0.0 OUTLIER -113.13 110.77 20.98 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.153 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 782' ' ' THR . . . . . 0.508 ' O ' ' HB2' ' A' ' 738' ' ' HIS . 70.3 p -77.01 133.35 69.38 Favored Pre-proline 0 N--CA 1.441 -0.899 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.567 178.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 783' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 782' ' ' THR . 23.7 Cg_exo -62.88 151.32 84.96 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 122.942 2.428 . . . . 0.0 111.548 -175.444 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 784' ' ' VAL . . . . . . . . . . . . . 13.8 p -59.59 130.73 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-O 121.406 0.622 . . . . 0.0 110.477 -174.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 785' ' ' PHE . . . . . 0.478 ' C ' ' H ' ' A' ' 787' ' ' THR . 86.3 m-85 -87.21 -31.84 20.1 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.598 -171.714 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 786' ' ' THR . . . . . 0.5 ' HA ' ' HA2' ' A' ' 736' ' ' GLY . 30.9 p 58.05 -5.4 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.911 0.885 . . . . 0.0 112.94 176.333 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 787' ' ' THR . . . . . 0.478 ' H ' ' C ' ' A' ' 785' ' ' PHE . 1.3 m -145.76 124.65 12.7 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.752 0.311 . . . . 0.0 110.543 -176.776 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 788' ' ' GLY . . . . . 0.525 ' H ' ' CD1' ' A' ' 735' ' ' LEU . . . -50.28 125.9 22.1 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.354 -0.839 . . . . 0.0 113.353 173.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 789' ' ' GLY . . . . . . . . . . . . . . . -174.51 -179.88 45.4 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 179.31 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 790' ' ' ASP . . . . . 0.537 ' H ' ' HB2' ' A' ' 761' ' ' PHE . 3.3 m-20 -119.46 128.02 53.61 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 117.773 0.786 . . . . 0.0 109.758 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 791' ' ' TYR . . . . . 0.632 ' CE2' ' HG2' ' A' ' 759' ' ' GLU . 84.0 m-85 -127.65 153.38 46.52 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.595 -176.022 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 792' ' ' ILE . . . . . 0.567 ' O ' HG13 ' A' ' 758' ' ' ILE . 13.0 mt -129.92 120.36 49.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 172.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 793' ' ' LEU . . . . . 0.591 ' HA ' ' O ' ' A' ' 756' ' ' ASP . 8.1 tt -85.28 110.34 19.0 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 178.28 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 794' ' ' SER . . . . . . . . . . . . . 3.7 m -119.45 148.89 42.72 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.023 -178.304 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 795' ' ' LEU . . . . . 0.64 ' HG ' ' HB3' ' A' ' 723' ' ' ALA . 1.5 mm? -73.36 124.75 26.35 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-O 120.715 0.293 . . . . 0.0 111.028 177.143 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 796' ' ' VAL . . . . . 0.423 ' HB ' ' HB ' ' A' ' 754' ' ' THR . 53.7 t -85.67 -54.78 7.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.213 -177.207 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 797' ' ' SER . . . . . 0.589 ' HA ' ' HG ' ' A' ' 808' ' ' LEU . 87.9 p -172.42 152.66 2.73 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.202 -172.708 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 798' ' ' ILE . . . . . 0.636 ' HA ' ' O ' ' A' ' 752' ' ' THR . 5.9 tt -127.5 164.6 28.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 176.641 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 799' ' ' LYS . . . . . 0.758 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 8.0 tmtt? -139.51 118.86 12.84 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.14 -177.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 800' ' ' ASP . . . . . 0.532 ' HB2' ' HB3' ' A' ' 804' ' ' CYS . 14.1 m-20 -58.59 155.37 12.53 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.504 173.346 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 6.3 p -61.62 -11.86 13.39 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 124.021 0.826 . . . . 0.0 112.56 -174.255 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 8.9 t -91.06 -6.38 53.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.666 0.745 . . . . 0.0 109.836 178.339 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 803' ' ' GLY . . . . . 0.485 ' HA2' ' HE2' ' A' ' 799' ' ' LYS . . . 92.12 42.69 4.58 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.771 -177.26 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 804' ' ' CYS . . . . . 0.532 ' HB3' ' HB2' ' A' ' 800' ' ' ASP . 41.7 t -110.55 106.53 15.84 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.073 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 805' ' ' VAL . . . . . 0.549 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 15.7 t -88.27 110.78 21.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.285 0.564 . . . . 0.0 111.279 -175.336 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 806' ' ' VAL . . . . . 0.434 ' HB ' HG22 ' A' ' 798' ' ' ILE . 88.2 t -90.55 137.76 20.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.995 177.629 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -76.07 120.53 5.94 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 111.099 -0.8 . . . . 0.0 111.099 177.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 808' ' ' LEU . . . . . 0.589 ' HG ' ' HA ' ' A' ' 797' ' ' SER . 40.1 mt -88.81 133.7 34.17 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -173.007 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 31.8 t -149.67 86.73 1.47 Allowed 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.019 -0.992 . . . . 0.0 108.991 172.287 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 810' ' ' GLN . . . . . 0.541 ' NE2' ' HB3' ' A' ' 722' ' ' SER . 1.6 mt-30 -139.25 174.39 4.18 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.388 -0.823 . . . . 0.0 108.93 176.404 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 811' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_exo -44.0 139.17 6.0 Favored 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 123.049 2.499 . . . . 0.0 114.644 -175.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -115.67 165.76 12.68 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.204 -179.127 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 813' ' ' ALA . . . . . 0.501 ' HB1' HD23 ' A' ' 727' ' ' LEU . . . -115.06 155.63 26.66 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.492 -177.686 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 814' ' ' LYS . . . . . 0.457 ' HG3' HG12 ' A' ' 792' ' ' ILE . 2.7 mptm? -112.45 137.83 50.08 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.499 0.666 . . . . 0.0 110.647 175.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 815' ' ' ILE . . . . . 0.69 HG13 HD12 ' A' ' 731' ' ' LEU . 5.3 mp -124.27 111.85 30.2 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-N 114.792 -1.094 . . . . 0.0 108.155 177.823 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 816' ' ' GLN . . . . . 0.714 ' NE2' ' HG2' ' A' ' 818' ' ' ARG . 0.9 OUTLIER -108.72 109.16 20.26 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.023 0.44 . . . . 0.0 110.671 -177.22 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 817' ' ' VAL . . . . . 0.774 HG22 HD12 ' A' ' 733' ' ' LEU . 2.3 t -104.85 142.58 17.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 -179.279 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 818' ' ' ARG . . . . . 0.714 ' HG2' ' NE2' ' A' ' 816' ' ' GLN . 73.6 mmt-85 -137.48 174.43 10.61 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 175.016 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 819' ' ' ARG . . . . . 0.427 ' HA ' ' HB2' ' A' ' 735' ' ' LEU . 33.9 ttt180 -107.96 115.16 29.63 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.14 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 820' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 . . . . . 0 C--N 1.32 -0.686 0 CA-C-N 115.806 -0.634 . . . . 99.989999999999995 110.469 -176.023 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 718' ' ' ARG . . . . . 0.409 ' HD3' ' N ' ' A' ' 718' ' ' ARG . 0.5 OUTLIER . . . . . 0 N--CA 1.453 -0.278 0 CA-C-O 120.784 0.326 . . . . 0.0 110.23 . . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 719' ' ' VAL . . . . . 0.671 HG13 ' H ' ' A' ' 720' ' ' LYS . 2.5 p -101.42 -99.07 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 177.77 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 720' ' ' LYS . . . . . 0.671 ' H ' HG13 ' A' ' 719' ' ' VAL . 52.6 mtpt -128.44 117.49 20.0 Favored Pre-proline 0 C--N 1.314 -0.95 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 170.793 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 721' ' ' PRO . . . . . 0.453 ' HD2' HG21 ' A' ' 806' ' ' VAL . 72.0 Cg_endo -88.75 151.35 6.11 Favored 'Trans proline' 0 N--CA 1.446 -1.298 0 C-N-CA 122.431 2.087 . . . . 0.0 111.488 -178.4 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 722' ' ' SER . . . . . 0.782 ' HB2' ' OE1' ' A' ' 810' ' ' GLN . 8.6 p -179.18 -159.32 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -175.807 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 723' ' ' ALA . . . . . 0.595 ' HB3' ' HG ' ' A' ' 795' ' ' LEU . . . -151.67 140.74 21.19 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 118.807 0.73 . . . . 0.0 110.931 176.068 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 35.1 m -132.89 105.63 7.23 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 -177.019 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 725' ' ' LEU . . . . . 0.51 ' CD2' ' HB ' ' A' ' 743' ' ' VAL . 16.7 mt -62.22 144.92 54.87 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-O 121.478 0.656 . . . . 0.0 111.507 -176.087 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 29.3 mtpt -97.62 -14.41 20.99 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.856 -1.065 . . . . 0.0 109.638 -177.066 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 727' ' ' LEU . . . . . 0.591 HD23 ' HB1' ' A' ' 813' ' ' ALA . 38.7 tp -69.21 114.24 7.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.713 175.646 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 9.6 t-80 -115.71 43.5 2.08 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.816 0.341 . . . . 0.0 111.214 -174.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 9.5 p80 -175.24 -177.67 1.07 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.629 177.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 730' ' ' ASP . . . . . 0.515 ' HA ' ' O ' ' A' ' 814' ' ' LYS . 1.2 m-20 -76.53 148.22 37.24 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.564 177.806 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 731' ' ' LEU . . . . . 0.601 HD13 ' HB2' ' A' ' 739' ' ' SER . 12.0 mt -101.93 104.45 15.15 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.555 173.345 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 732' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -81.23 93.24 6.46 Favored 'General case' 0 C--N 1.323 -0.56 0 O-C-N 123.712 0.632 . . . . 0.0 111.26 -172.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 733' ' ' LEU . . . . . 0.438 ' HB3' ' CB ' ' A' ' 737' ' ' ASP . 0.2 OUTLIER -107.38 163.69 12.83 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.107 0.48 . . . . 0.0 111.487 -178.415 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 734' ' ' CYS . . . . . 0.699 ' HA ' ' O ' ' A' ' 818' ' ' ARG . 69.2 m -113.14 -173.38 2.24 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.352 177.71 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 735' ' ' LEU . . . . . 0.473 ' HG ' ' HD3' ' A' ' 819' ' ' ARG . 3.5 tt -62.56 128.1 34.39 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.925 -179.289 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 736' ' ' GLY . . . . . 0.48 ' HA2' ' HA ' ' A' ' 786' ' ' THR . . . 86.37 4.96 83.05 Favored Glycine 0 C--N 1.322 -0.199 0 C-N-CA 120.22 -0.991 . . . . 0.0 112.735 177.116 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 737' ' ' ASP . . . . . 0.501 ' HB2' ' O ' ' A' ' 734' ' ' CYS . 0.3 OUTLIER -84.26 153.3 23.66 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.364 0.602 . . . . 0.0 112.448 179.281 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 738' ' ' HIS . . . . . 0.486 ' HB2' ' O ' ' A' ' 782' ' ' THR . 47.0 p-80 -118.88 173.28 6.97 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 167.106 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 739' ' ' SER . . . . . 0.601 ' HB2' HD13 ' A' ' 731' ' ' LEU . 51.5 p -128.08 173.75 9.8 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 118.236 -1.385 . . . . 0.0 112.791 -173.043 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 10.4 p -144.98 103.93 3.93 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.861 -172.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 741' ' ' VAL . . . . . 0.813 HG11 HD23 ' A' ' 793' ' ' LEU . 0.4 OUTLIER -120.87 116.63 31.4 Favored Pre-proline 0 C--N 1.314 -0.963 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.282 -177.804 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 742' ' ' PRO . . . . . 0.643 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 9.8 Cg_endo -77.66 137.32 16.12 Favored 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 122.252 1.968 . . . . 0.0 111.545 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 743' ' ' VAL . . . . . 0.51 HG21 ' HB1' ' A' ' 723' ' ' ALA . 2.2 p -130.33 119.54 46.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.452 0.644 . . . . 0.0 112.231 177.33 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 744' ' ' ALA . . . . . 0.578 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -78.81 95.01 5.26 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 122.237 1.017 . . . . 0.0 109.03 168.641 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 745' ' ' LEU . . . . . 0.823 HD11 ' HB3' ' A' ' 778' ' ' TYR . 1.7 mt -76.41 142.54 41.06 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 113.706 -1.588 . . . . 0.0 110.485 -173.398 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -100.01 163.14 12.56 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.442 0.639 . . . . 0.0 110.571 -176.18 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 747' ' ' GLY . . . . . . . . . . . . . . . 91.36 139.11 8.23 Favored Glycine 0 C--N 1.309 -0.928 0 CA-C-N 114.855 -1.066 . . . . 0.0 111.64 -175.399 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 748' ' ' GLN . . . . . 0.45 ' C ' ' HE1' ' A' ' 751' ' ' PHE . 20.9 mp0 -114.22 111.2 21.16 Favored 'General case' 0 C--N 1.32 -0.679 0 O-C-N 122.469 -0.43 . . . . 0.0 111.081 -175.137 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 132.75 -170.7 21.95 Favored Glycine 0 N--CA 1.445 -0.764 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.034 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -73.5 93.84 0.84 Allowed 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.564 2.176 . . . . 0.0 111.676 -179.266 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 751' ' ' PHE . . . . . 0.607 ' CE2' ' HA ' ' A' ' 800' ' ' ASP . 80.0 m-85 -113.92 141.1 47.78 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.237 -178.779 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 752' ' ' THR . . . . . 0.695 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 86.7 m -91.66 105.28 17.62 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 177.809 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 753' ' ' LEU . . . . . 0.474 HD23 HD12 ' A' ' 798' ' ' ILE . 0.5 OUTLIER -98.79 123.0 42.74 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.362 -172.168 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 754' ' ' THR . . . . . 0.476 HG23 ' HB2' ' A' ' 769' ' ' GLU . 0.7 OUTLIER -117.89 136.29 53.56 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.659 -178.197 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 755' ' ' TYR . . . . . 0.4 ' CE1' ' HB3' ' A' ' 768' ' ' PHE . 17.2 p90 -143.29 153.95 43.29 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 178.589 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 756' ' ' ASP . . . . . 0.419 ' HB2' HG23 ' A' ' 758' ' ' ILE . 14.9 p-10 -118.91 118.86 32.68 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.341 0.591 . . . . 0.0 111.86 -178.576 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 757' ' ' ILE . . . . . 0.503 HG13 HD13 ' A' ' 793' ' ' LEU . 4.0 mp -89.74 96.34 6.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 167.369 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 758' ' ' ILE . . . . . 0.64 HG13 ' O ' ' A' ' 792' ' ' ILE . 2.5 pp -103.89 149.72 7.57 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -168.808 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 759' ' ' GLU . . . . . 0.721 ' OE1' ' HB3' ' A' ' 762' ' ' SER . 19.8 mt-10 -87.48 123.99 32.98 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.164 178.367 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 760' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.38 -4.85 41.13 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.309 175.583 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 761' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -103.41 -29.02 11.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.798 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 762' ' ' SER . . . . . 0.721 ' HB3' ' OE1' ' A' ' 759' ' ' GLU . 18.5 t -128.57 -95.86 0.41 Allowed 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 120.215 -0.594 . . . . 0.0 110.848 -178.022 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 763' ' ' SER . . . . . . . . . . . . . 9.3 t -179.79 -1.93 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 120.939 -0.304 . . . . 0.0 111.811 -177.386 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 764' ' ' LYS . . . . . 0.482 ' HB2' ' CD ' ' A' ' 759' ' ' GLU . 49.7 mtpt -82.72 54.76 2.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.492 0.663 . . . . 0.0 111.54 -173.457 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 66.5 mtm180 -52.04 147.54 7.19 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.692 -1.14 . . . . 0.0 111.88 176.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 766' ' ' LYS . . . . . 0.66 ' HD3' ' N ' ' A' ' 767' ' ' THR . 9.0 tmtt? -124.84 145.51 49.74 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 175.533 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 767' ' ' THR . . . . . 0.66 ' N ' ' HD3' ' A' ' 766' ' ' LYS . 91.7 m -133.16 141.7 48.26 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.295 -179.604 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 768' ' ' PHE . . . . . 0.4 ' HB3' ' CE1' ' A' ' 755' ' ' TYR . 4.1 t80 -136.21 141.74 44.02 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.05 0.452 . . . . 0.0 110.656 177.302 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 769' ' ' GLU . . . . . 0.476 ' HB2' HG23 ' A' ' 754' ' ' THR . 40.0 tt0 -126.41 121.08 31.45 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.487 -179.255 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 770' ' ' ILE . . . . . 0.645 HG22 HG22 ' A' ' 773' ' ' ILE . 9.4 mt -115.57 111.27 34.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.801 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 771' ' ' LYS . . . . . 0.619 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 7.8 mtpt -83.97 148.4 26.92 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.624 0.726 . . . . 0.0 111.521 -176.781 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 772' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 57.71 47.45 15.62 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 113.514 -1.675 . . . . 0.0 112.479 175.715 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 773' ' ' ILE . . . . . 0.74 HD12 ' H ' ' A' ' 775' ' ' THR . 0.5 OUTLIER -75.64 119.29 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 175.426 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 79.7 mttt -117.88 33.26 5.72 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 775' ' ' THR . . . . . 0.74 ' H ' HD12 ' A' ' 773' ' ' ILE . 1.1 m -95.4 -72.32 0.63 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 113.939 -1.482 . . . . 0.0 112.289 -172.668 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 776' ' ' ASN . . . . . 0.465 ' HA ' ' O ' ' A' ' 745' ' ' LEU . 12.2 m120 85.96 3.63 0.53 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.599 1.159 . . . . 0.0 110.934 -179.39 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 777' ' ' GLU . . . . . 0.578 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 12.3 mt-10 -161.84 88.7 0.7 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.171 -0.922 . . . . 0.0 108.799 172.302 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 778' ' ' TYR . . . . . 0.823 ' HB3' HD11 ' A' ' 745' ' ' LEU . 49.4 t80 -123.59 127.65 48.59 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 120.881 0.372 . . . . 0.0 110.778 -171.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 779' ' ' VAL . . . . . 0.643 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 15.1 t -85.52 105.42 14.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.206 0.527 . . . . 0.0 110.382 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 780' ' ' ILE . . . . . 0.429 ' HB ' ' O ' ' A' ' 741' ' ' VAL . 83.1 mt -75.44 142.31 14.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.703 -178.471 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.08 103.6 8.91 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 174.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 782' ' ' THR . . . . . 0.486 ' O ' ' HB2' ' A' ' 738' ' ' HIS . 2.9 p -75.36 143.6 76.65 Favored Pre-proline 0 C--N 1.319 -0.738 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.985 -175.312 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 783' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.69 157.76 9.38 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 123.378 2.719 . . . . 0.0 111.963 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 784' ' ' VAL . . . . . 0.45 ' HA ' ' HB3' ' A' ' 738' ' ' HIS . 11.6 p -68.47 130.89 33.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.45 0.643 . . . . 0.0 110.283 -175.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 785' ' ' PHE . . . . . 0.473 ' C ' ' H ' ' A' ' 787' ' ' THR . 62.3 m-85 -85.87 -40.17 16.24 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.42 -175.008 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 786' ' ' THR . . . . . 0.48 ' HA ' ' HA2' ' A' ' 736' ' ' GLY . 27.3 p 60.26 -4.92 0.1 Allowed 'General case' 0 N--CA 1.469 0.495 0 O-C-N 124.451 1.094 . . . . 0.0 112.053 -178.571 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 787' ' ' THR . . . . . 0.473 ' H ' ' C ' ' A' ' 785' ' ' PHE . 43.1 m -130.94 116.12 17.43 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.879 -173.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 788' ' ' GLY . . . . . . . . . . . . . . . -52.59 118.56 7.95 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.963 171.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 789' ' ' GLY . . . . . 0.453 ' H ' ' HB ' ' A' ' 817' ' ' VAL . . . -175.86 -174.97 42.86 Favored Glycine 0 N--CA 1.448 -0.546 0 N-CA-C 110.041 -1.223 . . . . 0.0 110.041 179.678 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -115.41 130.11 56.79 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 118.267 1.033 . . . . 0.0 110.254 178.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 791' ' ' TYR . . . . . 0.536 ' CE2' ' HG2' ' A' ' 759' ' ' GLU . 69.2 m-85 -121.3 143.98 48.88 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.473 179.55 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 792' ' ' ILE . . . . . 0.64 ' O ' HG13 ' A' ' 758' ' ' ILE . 21.2 mt -120.84 113.68 40.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 177.546 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 793' ' ' LEU . . . . . 0.813 HD23 HG11 ' A' ' 741' ' ' VAL . 0.7 OUTLIER -86.55 114.53 23.36 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.084 179.279 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 794' ' ' SER . . . . . 0.511 ' N ' HD12 ' A' ' 793' ' ' LEU . 23.1 t -123.86 159.68 29.1 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.763 -174.685 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 795' ' ' LEU . . . . . 0.595 ' HG ' ' HB3' ' A' ' 723' ' ' ALA . 1.2 mm? -87.51 135.31 33.4 Favored 'General case' 0 N--CA 1.44 -0.948 0 O-C-N 121.997 -0.44 . . . . 0.0 110.837 176.413 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 796' ' ' VAL . . . . . 0.405 ' HB ' ' HB ' ' A' ' 754' ' ' THR . 73.3 t -92.64 -55.36 6.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.95 -178.703 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 797' ' ' SER . . . . . 0.415 ' HA ' HD23 ' A' ' 808' ' ' LEU . 58.7 m -169.18 168.35 9.91 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.091 -173.616 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 798' ' ' ILE . . . . . 0.616 ' HA ' ' O ' ' A' ' 752' ' ' THR . 9.1 tt -141.06 165.39 19.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 172.641 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 799' ' ' LYS . . . . . 0.695 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 85.3 tttt -136.96 121.67 18.58 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.887 0.375 . . . . 0.0 111.333 -174.636 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 800' ' ' ASP . . . . . 0.607 ' HA ' ' CE2' ' A' ' 751' ' ' PHE . 7.9 t70 -65.49 153.62 40.88 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.21 175.177 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 5.4 p -58.83 -13.97 7.64 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 124.199 0.937 . . . . 0.0 112.948 -174.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 52.2 p -89.68 -5.83 56.7 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.511 0.672 . . . . 0.0 109.847 177.322 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 803' ' ' GLY . . . . . 0.529 ' HA2' ' CE ' ' A' ' 799' ' ' LYS . . . 89.81 40.31 5.95 Favored Glycine 0 N--CA 1.44 -1.071 0 CA-C-N 114.934 -1.03 . . . . 0.0 111.601 -177.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 804' ' ' CYS . . . . . 0.518 ' HB3' ' HB3' ' A' ' 800' ' ' ASP . 42.0 t -111.69 113.8 26.4 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 110.056 -0.349 . . . . 0.0 110.056 -178.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 805' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 11.0 p -85.01 132.85 30.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.396 0.617 . . . . 0.0 110.948 -174.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 806' ' ' VAL . . . . . 0.492 ' HB ' HG22 ' A' ' 798' ' ' ILE . 85.0 t -109.29 138.34 37.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.769 178.815 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -76.28 111.24 3.24 Favored Glycine 0 N--CA 1.452 -0.28 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.785 -178.064 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 808' ' ' LEU . . . . . 0.439 HD12 ' CB ' ' A' ' 795' ' ' LEU . 2.6 mm? -76.07 127.31 32.69 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 10.8 p -149.93 86.75 1.45 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.509 170.384 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 810' ' ' GLN . . . . . 0.782 ' OE1' ' HB2' ' A' ' 722' ' ' SER . 35.1 mt-30 -137.8 171.91 7.64 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.743 -176.837 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 811' ' ' PRO . . . . . 0.421 ' HD2' ' HB3' ' A' ' 810' ' ' GLN . 81.3 Cg_exo -47.78 140.32 17.78 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.798 2.332 . . . . 0.0 113.563 178.526 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -114.67 165.67 12.55 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.798 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 813' ' ' ALA . . . . . 0.591 ' HB1' HD23 ' A' ' 727' ' ' LEU . . . -111.33 151.37 28.49 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.278 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 814' ' ' LYS . . . . . 0.515 ' O ' ' HA ' ' A' ' 730' ' ' ASP . 19.5 ttpp -120.25 107.78 13.4 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.849 0.833 . . . . 0.0 110.827 178.566 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 815' ' ' ILE . . . . . 0.53 ' HA ' ' HB2' ' A' ' 731' ' ' LEU . 5.1 mp -86.65 116.94 30.12 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-N 114.539 -1.209 . . . . 0.0 108.68 177.452 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 816' ' ' GLN . . . . . 0.469 HE22 ' HB2' ' A' ' 818' ' ' ARG . 1.0 OUTLIER -107.88 106.57 16.9 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.686 0.755 . . . . 0.0 110.339 -177.041 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 817' ' ' VAL . . . . . 0.453 ' HB ' ' H ' ' A' ' 789' ' ' GLY . 1.9 t -101.43 146.43 9.79 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -177.596 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 818' ' ' ARG . . . . . 0.699 ' O ' ' HA ' ' A' ' 734' ' ' CYS . 17.2 tpt180 -150.53 136.63 18.52 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 178.412 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 819' ' ' ARG . . . . . 0.473 ' HD3' ' HG ' ' A' ' 735' ' ' LEU . 21.2 mmt180 -62.88 124.14 20.3 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 176.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 820' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 . . . . . 0 C--N 1.321 -0.655 0 N-CA-C 109.693 -0.484 . . . . 99.989999999999995 109.693 178.514 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 718' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? . . . . . 0 CA--C 1.512 -0.504 0 CA-C-O 121.928 0.87 . . . . 0.0 109.621 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 719' ' ' VAL . . . . . 0.544 ' O ' ' HD3' ' A' ' 721' ' ' PRO . 11.5 p -139.27 166.71 21.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-N 114.625 -1.17 . . . . 0.0 108.413 -176.452 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 720' ' ' LYS . . . . . 0.443 ' N ' HG22 ' A' ' 719' ' ' VAL . 19.1 ttpt -109.68 91.97 11.4 Favored Pre-proline 0 N--CA 1.416 -2.139 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.639 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 721' ' ' PRO . . . . . 0.544 ' HD3' ' O ' ' A' ' 719' ' ' VAL . 56.5 Cg_endo -87.91 155.41 7.26 Favored 'Trans proline' 0 N--CA 1.449 -1.121 0 C-N-CA 123.348 2.699 . . . . 0.0 112.092 -176.43 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 722' ' ' SER . . . . . 0.744 ' HA ' ' CD2' ' A' ' 808' ' ' LEU . 7.5 t -174.25 -159.84 0.1 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -174.019 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 723' ' ' ALA . . . . . 0.63 ' O ' ' HB2' ' A' ' 810' ' ' GLN . . . -156.77 140.67 16.2 Favored 'General case' 0 C--O 1.218 -0.562 0 C-N-CA 121.383 -0.127 . . . . 0.0 110.741 177.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 22.6 t -136.06 101.25 4.66 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 -176.237 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 725' ' ' LEU . . . . . 0.584 ' HA ' ' HA ' ' A' ' 743' ' ' VAL . 5.6 mp -60.7 139.41 57.88 Favored 'General case' 0 N--CA 1.425 -1.688 0 CA-C-O 122.396 1.093 . . . . 0.0 112.427 -175.117 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 33.4 mtpt -87.43 -18.12 30.67 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 113.002 -1.908 . . . . 0.0 109.356 -178.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 727' ' ' LEU . . . . . 0.528 ' HB2' ' HD2' ' A' ' 742' ' ' PRO . 21.2 tp -71.3 110.22 5.8 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 173.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 9.1 t60 -95.19 -48.4 5.94 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.528 -172.57 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 39.9 p-80 -101.21 177.71 4.86 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.871 -177.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 730' ' ' ASP . . . . . 0.449 ' HA ' ' O ' ' A' ' 814' ' ' LYS . 7.7 p-10 -68.73 145.67 53.62 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.568 0.699 . . . . 0.0 110.933 -178.047 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 731' ' ' LEU . . . . . 0.537 ' HB3' ' HA ' ' A' ' 815' ' ' ILE . 36.4 tp -104.44 111.71 24.48 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.372 -175.598 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 732' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -70.35 127.47 32.88 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.884 -177.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 733' ' ' LEU . . . . . 0.485 HD11 ' OG ' ' A' ' 739' ' ' SER . 55.4 mt -136.59 163.72 29.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.195 0.522 . . . . 0.0 111.144 177.101 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 734' ' ' CYS . . . . . 0.492 ' HB3' ' OD2' ' A' ' 820' ' ' ASP . 72.1 m -108.58 -176.18 2.97 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.036 175.442 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 735' ' ' LEU . . . . . 0.479 HD13 ' HD2' ' A' ' 819' ' ' ARG . 24.7 tp -63.95 131.57 48.06 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.022 0.439 . . . . 0.0 111.068 -177.285 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 736' ' ' GLY . . . . . 0.476 ' O ' HG13 ' A' ' 784' ' ' VAL . . . 70.27 13.48 70.47 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.619 177.058 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 737' ' ' ASP . . . . . 0.472 ' HB2' ' O ' ' A' ' 734' ' ' CYS . 0.3 OUTLIER -77.7 150.76 34.43 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.792 0.329 . . . . 0.0 110.711 178.763 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 16.1 p-80 -111.9 163.06 14.64 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 171.337 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 739' ' ' SER . . . . . 0.485 ' OG ' HD11 ' A' ' 733' ' ' LEU . 0.0 OUTLIER -131.36 174.08 10.42 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 119.526 -0.869 . . . . 0.0 112.732 -173.325 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 5.6 p -131.36 115.51 16.34 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.282 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 741' ' ' VAL . . . . . 0.412 ' HB ' ' HB ' ' A' ' 780' ' ' ILE . 3.6 t -113.6 98.98 48.7 Favored Pre-proline 0 C--N 1.318 -0.768 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.411 -175.356 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 742' ' ' PRO . . . . . 0.762 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 2.2 Cg_endo -75.88 121.65 6.36 Favored 'Trans proline' 0 N--CA 1.441 -1.579 0 C-N-CA 122.912 2.408 . . . . 0.0 110.712 -175.264 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 743' ' ' VAL . . . . . 0.584 ' HA ' ' HA ' ' A' ' 725' ' ' LEU . 1.4 p -125.67 121.52 60.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 121.662 0.744 . . . . 0.0 112.671 178.226 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 744' ' ' ALA . . . . . 0.586 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -83.42 111.67 19.24 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 169.255 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 745' ' ' LEU . . . . . 0.886 HD13 HD13 ' A' ' 773' ' ' ILE . 0.3 OUTLIER -95.11 168.99 10.42 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.705 -1.134 . . . . 0.0 111.251 -165.861 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 1.1 tppm? -122.9 147.59 46.41 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.287 -176.262 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 747' ' ' GLY . . . . . 0.45 ' HA3' ' HB3' ' A' ' 721' ' ' PRO . . . 100.73 129.97 6.87 Favored Glycine 0 C--N 1.311 -0.833 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.451 -177.268 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 748' ' ' GLN . . . . . 0.428 ' C ' ' HE1' ' A' ' 751' ' ' PHE . 2.1 mp0 -108.76 115.71 30.6 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.917 0.389 . . . . 0.0 111.059 -175.054 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 134.52 -176.31 19.97 Favored Glycine 0 N--CA 1.444 -0.773 0 N-CA-C 111.501 -0.64 . . . . 0.0 111.501 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_exo -71.89 93.89 0.71 Allowed 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.545 2.163 . . . . 0.0 111.839 179.06 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 751' ' ' PHE . . . . . 0.501 ' CD2' ' HA ' ' A' ' 800' ' ' ASP . 78.2 m-85 -110.2 141.95 42.42 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.41 -178.734 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 752' ' ' THR . . . . . 0.771 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 94.7 m -90.85 102.66 15.42 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.725 0.774 . . . . 0.0 109.471 178.271 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 753' ' ' LEU . . . . . 0.456 HD22 HD22 ' A' ' 745' ' ' LEU . 24.3 tp -91.82 116.85 29.25 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 114.448 -1.251 . . . . 0.0 110.461 -171.368 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 754' ' ' THR . . . . . 0.448 HG23 ' HB2' ' A' ' 769' ' ' GLU . 1.3 m -115.1 130.11 56.85 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.028 179.363 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 755' ' ' TYR . . . . . 0.557 ' CE1' ' HB2' ' A' ' 768' ' ' PHE . 22.2 p90 -141.31 156.73 45.82 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.856 0.36 . . . . 0.0 111.338 178.405 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 756' ' ' ASP . . . . . 0.442 ' HB3' HG23 ' A' ' 758' ' ' ILE . 0.2 OUTLIER -121.07 118.95 31.08 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.37 -176.628 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 757' ' ' ILE . . . . . 0.512 HG13 HD13 ' A' ' 793' ' ' LEU . 3.7 mp -87.98 96.24 5.72 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 168.712 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 758' ' ' ILE . . . . . 0.625 HG13 ' O ' ' A' ' 792' ' ' ILE . 2.5 pp -94.78 149.98 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.215 -173.363 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 759' ' ' GLU . . . . . 0.582 ' OE2' ' HB2' ' A' ' 762' ' ' SER . 8.2 pt-20 -105.13 125.65 51.21 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 120.173 -0.611 . . . . 0.0 110.562 178.791 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 760' ' ' THR . . . . . 0.462 HG23 ' OD2' ' A' ' 790' ' ' ASP . 0.0 OUTLIER -89.94 -3.16 58.19 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 177.444 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 761' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -69.74 -36.18 75.62 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 114.712 -1.131 . . . . 0.0 110.971 175.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 762' ' ' SER . . . . . 0.582 ' HB2' ' OE2' ' A' ' 759' ' ' GLU . 66.9 m -150.76 -88.8 0.07 Allowed 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 177.321 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 763' ' ' SER . . . . . . . . . . . . . 26.3 p -176.2 26.14 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -175.302 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 764' ' ' LYS . . . . . 0.575 ' H ' ' CD ' ' A' ' 759' ' ' GLU . 10.5 mtmp? -105.46 75.89 1.18 Allowed 'General case' 0 C--N 1.327 -0.377 0 O-C-N 121.623 -0.673 . . . . 0.0 110.408 -178.553 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 765' ' ' ARG . . . . . 0.418 HH11 ' HD2' ' A' ' 765' ' ' ARG . 47.2 mtm105 -62.49 152.88 33.3 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.569 179.247 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 766' ' ' LYS . . . . . 0.665 ' HD3' ' N ' ' A' ' 767' ' ' THR . 7.5 tmtm? -124.5 144.8 49.91 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 176.805 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 767' ' ' THR . . . . . 0.665 ' N ' ' HD3' ' A' ' 766' ' ' LYS . 91.4 m -125.05 137.84 54.21 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 120.879 0.371 . . . . 0.0 111.742 -176.34 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 768' ' ' PHE . . . . . 0.557 ' HB2' ' CE1' ' A' ' 755' ' ' TYR . 2.1 m-85 -131.89 130.25 41.38 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.047 171.074 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 769' ' ' GLU . . . . . 0.448 ' HB2' HG23 ' A' ' 754' ' ' THR . 37.1 tt0 -124.6 108.07 11.68 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.294 179.307 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 770' ' ' ILE . . . . . 0.429 ' N ' HD12 ' A' ' 770' ' ' ILE . 4.3 mp -106.76 113.23 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.196 -178.171 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 771' ' ' LYS . . . . . 0.612 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 1.7 mtpt -81.88 149.57 28.2 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.252 0.548 . . . . 0.0 111.125 -177.57 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 772' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 57.32 50.19 11.93 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.36 -1.291 . . . . 0.0 112.652 177.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 773' ' ' ILE . . . . . 0.886 HD13 HD13 ' A' ' 745' ' ' LEU . 0.5 OUTLIER -78.88 119.64 28.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 170.692 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 72.3 mttt -118.49 29.72 7.6 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 -177.206 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 775' ' ' THR . . . . . 0.659 ' H ' HD12 ' A' ' 773' ' ' ILE . 0.2 OUTLIER -94.08 -71.27 0.67 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.469 -1.241 . . . . 0.0 113.266 -167.753 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 776' ' ' ASN . . . . . 0.594 ' HB2' ' O ' ' A' ' 775' ' ' THR . 0.9 OUTLIER 84.8 2.86 0.73 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.326 1.05 . . . . 0.0 110.273 -176.739 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 777' ' ' GLU . . . . . 0.586 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 7.5 mt-10 -162.31 86.18 0.59 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.314 174.062 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 778' ' ' TYR . . . . . 0.685 ' HB3' HD11 ' A' ' 745' ' ' LEU . 69.9 t80 -132.38 131.1 41.52 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -173.53 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 779' ' ' VAL . . . . . 0.762 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 1.5 m -96.93 132.46 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 CA-C-O 122.684 1.231 . . . . 0.0 110.337 176.685 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 780' ' ' ILE . . . . . 0.412 ' HB ' ' HB ' ' A' ' 741' ' ' VAL . 88.8 mt -89.21 147.76 4.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-N 112.88 -1.964 . . . . 0.0 110.143 -170.677 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -112.09 110.55 20.9 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 120.271 -0.572 . . . . 0.0 109.575 175.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 782' ' ' THR . . . . . 0.497 HG22 HG12 ' A' ' 757' ' ' ILE . 11.5 p -85.66 142.43 37.12 Favored Pre-proline 0 C--N 1.312 -1.065 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.076 -177.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 783' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 782' ' ' THR . 32.2 Cg_exo -59.68 160.2 21.81 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 123.614 2.876 . . . . 0.0 113.233 -174.087 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 784' ' ' VAL . . . . . 0.531 HG12 HG23 ' A' ' 786' ' ' THR . 52.5 t -59.51 115.38 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.316 177.18 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 785' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -94.88 95.4 8.63 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.242 -179.187 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 786' ' ' THR . . . . . 0.531 HG23 HG12 ' A' ' 784' ' ' VAL . 33.4 p -86.67 35.23 0.67 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 122.026 0.917 . . . . 0.0 110.648 -178.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 44.3 m -152.79 109.31 3.42 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.457 -1.247 . . . . 0.0 110.902 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 788' ' ' GLY . . . . . 0.706 ' HA2' HG12 ' A' ' 817' ' ' VAL . . . -52.42 109.14 0.82 Allowed Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.16 169.503 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 789' ' ' GLY . . . . . 0.433 ' H ' ' HB ' ' A' ' 817' ' ' VAL . . . -169.91 176.58 43.66 Favored Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -179.47 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 790' ' ' ASP . . . . . 0.462 ' OD2' HG23 ' A' ' 760' ' ' THR . 0.4 OUTLIER -103.12 133.12 48.75 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.384 0.612 . . . . 0.0 110.58 -178.563 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 791' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -123.66 148.41 46.51 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.342 -0.844 . . . . 0.0 109.697 -179.498 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 792' ' ' ILE . . . . . 0.625 ' O ' HG13 ' A' ' 758' ' ' ILE . 14.1 mt -128.62 114.28 32.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 177.494 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 793' ' ' LEU . . . . . 0.536 HD12 ' N ' ' A' ' 794' ' ' SER . 0.7 OUTLIER -84.62 113.44 21.27 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.122 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 794' ' ' SER . . . . . 0.536 ' N ' HD12 ' A' ' 793' ' ' LEU . 13.7 p -124.68 164.34 20.1 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.344 -1.298 . . . . 0.0 109.315 -174.647 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 795' ' ' LEU . . . . . 0.619 HD11 ' O ' ' A' ' 723' ' ' ALA . 36.7 mt -89.4 144.85 25.74 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.688 -0.233 . . . . 0.0 110.942 -176.528 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 796' ' ' VAL . . . . . . . . . . . . . 68.8 t -104.88 -57.68 4.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.159 177.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 797' ' ' SER . . . . . 0.504 ' HA ' ' HG ' ' A' ' 808' ' ' LEU . 10.4 m -176.95 161.53 1.96 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.978 -175.283 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 798' ' ' ILE . . . . . 0.557 ' HA ' ' O ' ' A' ' 752' ' ' THR . 11.7 tt -132.07 162.11 40.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 176.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 799' ' ' LYS . . . . . 0.771 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 5.2 tmtt? -137.4 119.84 15.91 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.097 0.475 . . . . 0.0 111.024 -178.819 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 800' ' ' ASP . . . . . 0.501 ' HA ' ' CD2' ' A' ' 751' ' ' PHE . 11.7 t70 -64.23 153.0 39.36 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.256 -0.884 . . . . 0.0 108.982 174.046 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 3.5 p -68.02 0.92 3.08 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -173.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 24.3 p -92.95 -0.46 57.21 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.657 0.741 . . . . 0.0 109.511 172.123 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 803' ' ' GLY . . . . . 0.45 ' HA2' ' HE2' ' A' ' 799' ' ' LYS . . . 81.05 41.92 9.97 Favored Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.8 -177.459 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 804' ' ' CYS . . . . . . . . . . . . . 63.4 m -113.78 114.22 26.02 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 805' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 8.3 p -86.52 134.25 27.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.313 0.578 . . . . 0.0 110.831 -177.558 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 806' ' ' VAL . . . . . . . . . . . . . 53.2 t -123.04 134.84 64.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.717 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.365 178.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -66.24 127.29 29.5 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 114.816 -1.084 . . . . 0.0 111.939 -179.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 808' ' ' LEU . . . . . 0.744 ' CD2' ' HA ' ' A' ' 722' ' ' SER . 45.6 mt -90.81 126.62 36.08 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -177.628 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 5.6 p -149.47 85.95 1.46 Allowed 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 121.522 0.677 . . . . 0.0 110.97 173.407 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 810' ' ' GLN . . . . . 0.63 ' HB2' ' O ' ' A' ' 723' ' ' ALA . 90.8 mt-30 -140.5 168.02 15.93 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 172.72 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 811' ' ' PRO . . . . . 0.524 ' HD2' ' HB3' ' A' ' 810' ' ' GLN . 86.6 Cg_exo -45.34 137.33 10.88 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 123.098 2.532 . . . . 0.0 115.228 -173.796 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -103.25 166.72 10.26 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.303 177.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 813' ' ' ALA . . . . . . . . . . . . . . . -119.68 161.11 21.24 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.245 -177.175 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 814' ' ' LYS . . . . . 0.449 ' O ' ' HA ' ' A' ' 730' ' ' ASP . 73.9 tttt -123.98 125.2 44.16 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 121.163 0.506 . . . . 0.0 110.834 177.849 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 815' ' ' ILE . . . . . 0.537 ' HA ' ' HB3' ' A' ' 731' ' ' LEU . 5.3 mp -109.39 119.24 58.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 176.532 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 816' ' ' GLN . . . . . 0.557 ' OE1' ' HG2' ' A' ' 818' ' ' ARG . 0.1 OUTLIER -108.95 114.51 28.33 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.217 0.532 . . . . 0.0 111.062 -174.748 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 817' ' ' VAL . . . . . 0.706 HG12 ' HA2' ' A' ' 788' ' ' GLY . 84.4 t -103.97 140.52 21.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.316 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 818' ' ' ARG . . . . . 0.557 ' HG2' ' OE1' ' A' ' 816' ' ' GLN . 34.1 mmt180 -141.85 154.95 45.52 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 172.551 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 819' ' ' ARG . . . . . 0.479 ' HD2' HD13 ' A' ' 735' ' ' LEU . 9.1 mtm180 -85.91 140.0 30.74 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.724 -174.571 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 820' ' ' ASP . . . . . 0.492 ' OD2' ' HB3' ' A' ' 734' ' ' CYS . 11.3 p-10 . . . . . 0 C--N 1.317 -0.812 0 CA-C-N 115.785 -0.643 . . . . 99.989999999999995 109.766 178.107 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 718' ' ' ARG . . . . . . . . . . . . . 18.9 tpt180 . . . . . 0 CA--C 1.513 -0.453 0 CA-C-O 121.983 0.897 . . . . 0.0 110.361 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 719' ' ' VAL . . . . . . . . . . . . . 2.5 m -133.16 155.78 41.3 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.463 -175.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 720' ' ' LYS . . . . . . . . . . . . . 16.7 mtpp -87.27 110.65 35.35 Favored Pre-proline 0 C--N 1.307 -1.277 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.64 -178.181 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 721' ' ' PRO . . . . . 0.427 ' HG3' ' CE2' ' A' ' 751' ' ' PHE . 60.6 Cg_endo -88.5 154.93 6.48 Favored 'Trans proline' 0 N--CA 1.447 -1.217 0 C-N-CA 122.713 2.275 . . . . 0.0 112.472 -174.209 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 722' ' ' SER . . . . . 0.51 ' HA ' ' CD2' ' A' ' 808' ' ' LEU . 11.4 t 178.49 -152.4 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.871 -176.677 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 723' ' ' ALA . . . . . 0.639 ' HA ' ' HA ' ' A' ' 745' ' ' LEU . . . -152.53 153.65 33.87 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 178.779 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 49.7 m -144.45 98.67 3.24 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.213 0.53 . . . . 0.0 109.634 175.221 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 725' ' ' LEU . . . . . 0.535 ' HA ' ' HA ' ' A' ' 743' ' ' VAL . 4.9 mp -62.38 141.45 58.32 Favored 'General case' 0 N--CA 1.424 -1.747 0 CA-C-O 122.4 1.095 . . . . 0.0 111.808 -175.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 726' ' ' LYS . . . . . 0.522 ' HD2' ' HB2' ' A' ' 744' ' ' ALA . 19.2 mtpp -94.79 -13.02 26.02 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 112.887 -1.96 . . . . 0.0 110.288 -173.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 727' ' ' LEU . . . . . 0.554 ' HB2' ' HD2' ' A' ' 742' ' ' PRO . 0.9 OUTLIER -82.3 112.38 19.24 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 176.096 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 56.3 m80 -114.67 54.25 0.78 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.713 0.635 . . . . 0.0 112.713 -172.417 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 7.6 p80 -178.15 -178.08 0.63 Allowed 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.762 -0.199 . . . . 0.0 110.492 176.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 730' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -81.58 125.84 31.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.303 176.457 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 731' ' ' LEU . . . . . 0.6 ' HB2' ' HA ' ' A' ' 815' ' ' ILE . 21.2 mt -79.95 113.14 17.89 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.215 177.712 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 732' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -76.61 109.94 10.78 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.092 -176.726 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 733' ' ' LEU . . . . . 0.815 HD12 HG22 ' A' ' 817' ' ' VAL . 64.3 mt -122.94 164.21 18.92 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.16 0.505 . . . . 0.0 110.864 177.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 734' ' ' CYS . . . . . 0.517 ' O ' ' HB2' ' A' ' 737' ' ' ASP . 76.3 m -113.75 -174.28 2.44 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.023 170.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 735' ' ' LEU . . . . . . . . . . . . . 8.6 tp -68.37 135.24 51.5 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 121.448 0.642 . . . . 0.0 111.898 -176.425 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 81.37 8.74 86.77 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 114.854 -1.066 . . . . 0.0 111.996 -178.42 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 737' ' ' ASP . . . . . 0.517 ' HB2' ' O ' ' A' ' 734' ' ' CYS . 4.1 m-20 -89.67 151.48 21.85 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 179.319 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 738' ' ' HIS . . . . . 0.444 ' HB2' ' O ' ' A' ' 782' ' ' THR . 45.4 p-80 -114.2 -175.53 2.7 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 169.428 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 739' ' ' SER . . . . . 0.594 ' OG ' HD11 ' A' ' 733' ' ' LEU . 9.2 m -141.55 174.39 10.61 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.567 0.698 . . . . 0.0 112.471 178.021 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 740' ' ' SER . . . . . 0.415 ' HA ' ' O ' ' A' ' 780' ' ' ILE . 14.1 t -141.67 103.04 4.3 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.489 178.251 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 741' ' ' VAL . . . . . 0.692 HG11 HD23 ' A' ' 793' ' ' LEU . 1.7 p -107.57 114.65 60.36 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.642 -175.542 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 742' ' ' PRO . . . . . 0.651 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 1.0 OUTLIER -73.64 129.19 13.34 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 122.488 2.126 . . . . 0.0 111.286 179.403 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 743' ' ' VAL . . . . . 0.535 ' HA ' ' HA ' ' A' ' 725' ' ' LEU . 1.5 p -128.53 119.92 51.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.308 0.575 . . . . 0.0 111.759 175.014 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 744' ' ' ALA . . . . . 0.583 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -85.1 105.51 15.88 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 169.626 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 745' ' ' LEU . . . . . 0.817 HD13 HD13 ' A' ' 773' ' ' ILE . 0.4 OUTLIER -85.23 168.0 15.15 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.156 -167.403 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 12.3 tttp -121.23 155.43 34.63 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.678 0.752 . . . . 0.0 110.724 -177.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 747' ' ' GLY . . . . . . . . . . . . . . . 97.66 135.92 8.92 Favored Glycine 0 C--N 1.306 -1.121 0 CA-C-N 114.441 -1.254 . . . . 0.0 111.229 -178.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 60.9 mm-40 -106.46 116.74 32.46 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.858 -173.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 130.28 164.77 11.42 Favored Glycine 0 CA--C 1.496 -1.114 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.518 -175.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 750' ' ' PRO . . . . . 0.573 ' HB3' ' HE2' ' A' ' 774' ' ' LYS . 46.2 Cg_endo -60.31 94.08 0.1 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 123.388 2.725 . . . . 0.0 111.768 172.522 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 751' ' ' PHE . . . . . 0.467 ' CE2' ' HA ' ' A' ' 800' ' ' ASP . 44.0 m-85 -105.0 143.34 33.32 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.103 -177.149 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 752' ' ' THR . . . . . 0.783 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 93.0 m -88.44 102.97 15.42 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 121.563 0.697 . . . . 0.0 109.137 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 753' ' ' LEU . . . . . 0.438 HD22 HD22 ' A' ' 745' ' ' LEU . 23.6 tp -93.3 117.81 30.52 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.844 -169.804 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 754' ' ' THR . . . . . 0.501 HG23 ' HB2' ' A' ' 769' ' ' GLU . 1.4 m -117.99 132.11 56.42 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.707 0.289 . . . . 0.0 110.642 179.518 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 755' ' ' TYR . . . . . 0.551 ' CE1' ' HB3' ' A' ' 768' ' ' PHE . 24.1 p90 -142.45 156.94 45.22 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.89 0.376 . . . . 0.0 111.438 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 756' ' ' ASP . . . . . 0.526 ' HB3' HG23 ' A' ' 758' ' ' ILE . 0.1 OUTLIER -119.76 118.83 31.89 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.526 -179.282 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 757' ' ' ILE . . . . . 0.567 ' CD1' HD13 ' A' ' 793' ' ' LEU . 3.6 mp -87.22 96.39 5.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 167.348 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 758' ' ' ILE . . . . . 0.526 HG23 ' HB3' ' A' ' 756' ' ' ASP . 2.4 pp -96.08 144.33 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.562 -171.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 759' ' ' GLU . . . . . 0.539 ' CG ' ' H ' ' A' ' 764' ' ' LYS . 5.6 pt-20 -95.64 124.37 39.63 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 119.47 -0.892 . . . . 0.0 109.988 177.138 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 760' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.19 -0.24 57.52 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 177.44 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 761' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -69.01 -36.3 77.63 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 114.596 -1.183 . . . . 0.0 109.996 175.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 762' ' ' SER . . . . . 0.451 ' HB2' ' OE1' ' A' ' 759' ' ' GLU . 1.2 m -148.6 -81.51 0.12 Allowed 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.464 174.276 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 763' ' ' SER . . . . . . . . . . . . . 81.1 p -174.35 10.99 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -176.04 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 764' ' ' LYS . . . . . 0.539 ' H ' ' CG ' ' A' ' 759' ' ' GLU . 96.7 mttt -83.56 73.81 10.18 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.262 0.553 . . . . 0.0 110.414 -173.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 765' ' ' ARG . . . . . 0.449 ' HA ' ' HA ' ' A' ' 758' ' ' ILE . 42.4 mtm180 -65.96 141.99 58.01 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.443 -179.084 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 766' ' ' LYS . . . . . 0.478 ' O ' ' HA ' ' A' ' 756' ' ' ASP . 1.0 OUTLIER -121.44 136.05 55.0 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.018 -179.037 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 767' ' ' THR . . . . . . . . . . . . . 60.7 m -115.38 136.73 52.79 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.89 -175.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 768' ' ' PHE . . . . . 0.551 ' HB3' ' CE1' ' A' ' 755' ' ' TYR . 2.8 t80 -138.33 135.68 35.65 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 175.696 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 769' ' ' GLU . . . . . 0.501 ' HB2' HG23 ' A' ' 754' ' ' THR . 33.2 tt0 -127.17 133.15 50.36 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.117 -179.277 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 770' ' ' ILE . . . . . 0.413 HG22 HG22 ' A' ' 773' ' ' ILE . 4.1 mt -123.9 109.04 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 175.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 771' ' ' LYS . . . . . 0.609 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 9.6 mtpt -80.12 151.59 29.73 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-O 121.35 0.595 . . . . 0.0 111.035 -176.162 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 772' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 55.35 50.66 14.41 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.312 -1.313 . . . . 0.0 112.393 176.08 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 773' ' ' ILE . . . . . 0.817 HD13 HD13 ' A' ' 745' ' ' LEU . 0.5 OUTLIER -74.99 122.07 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 170.989 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 774' ' ' LYS . . . . . 0.573 ' HE2' ' HB3' ' A' ' 750' ' ' PRO . 65.5 mttt -115.38 25.42 10.84 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.364 -0.835 . . . . 0.0 108.818 -176.329 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 775' ' ' THR . . . . . 0.692 ' H ' HD12 ' A' ' 773' ' ' ILE . 0.7 OUTLIER -96.33 -73.36 0.6 Allowed 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -169.551 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 776' ' ' ASN . . . . . 0.629 ' HB2' ' O ' ' A' ' 775' ' ' THR . 0.7 OUTLIER 85.97 3.65 0.53 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.548 1.139 . . . . 0.0 111.242 -173.345 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 777' ' ' GLU . . . . . 0.583 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 30.0 mt-10 -161.27 84.64 0.65 Allowed 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 177.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 778' ' ' TYR . . . . . 0.686 ' HB3' HD11 ' A' ' 745' ' ' LEU . 89.9 t80 -132.72 133.01 42.94 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.897 -169.588 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 779' ' ' VAL . . . . . 0.651 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 12.2 t -93.5 114.36 30.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.465 0.65 . . . . 0.0 110.555 179.614 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 780' ' ' ILE . . . . . 0.548 ' HB ' HG13 ' A' ' 741' ' ' VAL . 70.6 mt -79.4 147.52 6.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.606 -177.714 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 781' ' ' LYS . . . . . 0.43 ' HD3' ' C ' ' A' ' 780' ' ' ILE . 0.0 OUTLIER -117.89 100.67 7.73 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 175.222 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 782' ' ' THR . . . . . 0.493 ' OG1' ' HB2' ' A' ' 739' ' ' SER . 62.1 p -70.16 135.19 87.08 Favored Pre-proline 0 N--CA 1.441 -0.884 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.633 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 783' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 782' ' ' THR . 25.5 Cg_exo -62.66 156.21 54.28 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.793 2.329 . . . . 0.0 111.303 -175.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 784' ' ' VAL . . . . . . . . . . . . . 14.6 p -58.64 127.87 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 CA-C-O 121.489 0.661 . . . . 0.0 109.974 -177.745 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 785' ' ' PHE . . . . . 0.454 ' C ' ' H ' ' A' ' 787' ' ' THR . 94.7 m-85 -81.88 -31.83 31.33 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.419 -172.122 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 43.1 p 56.64 2.49 0.1 Allowed 'General case' 0 N--CA 1.471 0.59 0 O-C-N 124.065 0.853 . . . . 0.0 112.233 178.175 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 787' ' ' THR . . . . . 0.454 ' H ' ' C ' ' A' ' 785' ' ' PHE . 14.8 m -139.93 122.91 16.68 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.05 -179.487 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 788' ' ' GLY . . . . . . . . . . . . . . . -58.76 111.23 3.11 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.304 168.358 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 789' ' ' GLY . . . . . 0.459 ' H ' ' HB ' ' A' ' 817' ' ' VAL . . . -166.89 167.21 39.58 Favored Glycine 0 N--CA 1.442 -0.916 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 178.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -99.11 130.98 45.47 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 117.674 0.737 . . . . 0.0 109.72 -179.482 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 791' ' ' TYR . . . . . 0.438 ' CE2' ' HB3' ' A' ' 759' ' ' GLU . 86.9 m-85 -124.3 153.48 41.68 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.29 0.567 . . . . 0.0 110.885 -178.407 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 792' ' ' ILE . . . . . 0.484 ' O ' HG13 ' A' ' 758' ' ' ILE . 7.2 mt -130.72 113.97 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 CA-C-N 115.283 -0.871 . . . . 0.0 108.944 176.113 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 793' ' ' LEU . . . . . 0.692 HD23 HG11 ' A' ' 741' ' ' VAL . 1.3 tp -84.74 110.68 18.97 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 176.389 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 794' ' ' SER . . . . . 0.492 ' N ' HD12 ' A' ' 793' ' ' LEU . 6.1 p -124.7 157.5 35.49 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.53 -1.214 . . . . 0.0 109.729 -173.472 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 795' ' ' LEU . . . . . 0.509 ' CD2' ' HB3' ' A' ' 723' ' ' ALA . 51.4 mt -85.29 133.39 34.16 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.57 -0.287 . . . . 0.0 111.147 -174.42 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 796' ' ' VAL . . . . . . . . . . . . . 79.2 t -95.62 -55.06 6.45 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.715 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 797' ' ' SER . . . . . 0.566 ' HA ' ' HG ' ' A' ' 808' ' ' LEU . 97.5 p -176.7 158.55 1.71 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.988 -173.776 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 798' ' ' ILE . . . . . 0.503 ' HA ' ' O ' ' A' ' 752' ' ' THR . 8.0 tt -131.01 163.88 35.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 176.182 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 799' ' ' LYS . . . . . 0.783 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 16.5 ttmt -140.91 125.82 18.2 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.06 0.457 . . . . 0.0 111.503 -177.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 800' ' ' ASP . . . . . 0.467 ' HA ' ' CE2' ' A' ' 751' ' ' PHE . 28.2 t70 -65.98 155.77 35.61 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.517 174.024 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 801' ' ' SER . . . . . 0.458 ' HB3' ' HG2' ' A' ' 750' ' ' PRO . 18.2 p -59.03 -10.05 2.33 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -171.298 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 36.1 p -96.76 8.83 43.39 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.37 0.605 . . . . 0.0 110.324 179.078 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 803' ' ' GLY . . . . . . . . . . . . . . . 76.17 41.37 26.83 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.038 -178.563 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 804' ' ' CYS . . . . . 0.429 ' HB2' ' HB3' ' A' ' 800' ' ' ASP . 76.7 m -109.72 111.74 23.38 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 178.247 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 805' ' ' VAL . . . . . 0.438 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 14.4 p -86.25 139.46 17.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.422 0.63 . . . . 0.0 111.702 -174.758 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 806' ' ' VAL . . . . . 0.494 ' HB ' HG22 ' A' ' 798' ' ' ILE . 52.0 t -119.21 131.99 70.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.551 177.318 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -72.99 114.07 4.62 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.791 179.05 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 808' ' ' LEU . . . . . 0.566 ' HG ' ' HA ' ' A' ' 797' ' ' SER . 36.0 mt -84.9 124.46 31.66 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -173.449 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 19.1 t -138.98 86.51 2.14 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.241 171.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 810' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -146.91 173.55 4.11 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.873 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 811' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_exo -43.53 144.36 2.12 Favored 'Trans proline' 0 C--N 1.357 1.019 0 C-N-CA 123.618 2.879 . . . . 0.0 115.812 -173.068 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -116.22 169.1 9.54 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 114.554 -1.203 . . . . 0.0 110.546 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 813' ' ' ALA . . . . . . . . . . . . . . . -120.68 160.15 23.87 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.994 175.528 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 814' ' ' LYS . . . . . 0.468 ' HG2' ' CG1' ' A' ' 792' ' ' ILE . 48.3 mttp -123.62 134.31 53.81 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.451 0.643 . . . . 0.0 110.648 177.55 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 815' ' ' ILE . . . . . 0.6 ' HA ' ' HB2' ' A' ' 731' ' ' LEU . 5.3 mp -121.16 108.48 22.66 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 CA-C-N 115.055 -0.975 . . . . 0.0 108.898 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 816' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -100.87 108.01 19.68 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.257 0.551 . . . . 0.0 110.441 -176.312 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 817' ' ' VAL . . . . . 0.815 HG22 HD12 ' A' ' 733' ' ' LEU . 2.9 t -101.91 146.86 9.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -179.312 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 818' ' ' ARG . . . . . . . . . . . . . 20.7 tpt180 -140.79 131.63 25.91 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.467 0.651 . . . . 0.0 112.175 -178.396 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 819' ' ' ARG . . . . . . . . . . . . . 20.9 ttt180 -99.09 117.73 34.23 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.274 173.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 820' ' ' ASP . . . . . . . . . . . . . 38.6 t70 . . . . . 0 C--N 1.328 -0.327 0 O-C-N 123.494 0.496 . . . . 99.989999999999995 110.798 -176.55 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 720' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp . . . . . 0 N--CA 1.446 -0.657 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 721' ' ' PRO . . . . . 0.516 ' HB2' HD13 ' A' ' 798' ' ' ILE . 62.7 Cg_endo -87.62 155.97 7.67 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 122.948 2.432 . . . . 0.0 112.071 -174.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 722' ' ' SER . . . . . 0.588 ' HA ' HD22 ' A' ' 808' ' ' LEU . 12.7 t -176.77 -146.42 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -174.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 723' ' ' ALA . . . . . 0.521 ' HA ' ' HA ' ' A' ' 745' ' ' LEU . . . -153.24 149.31 27.82 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.658 0.266 . . . . 0.0 110.621 177.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 70.6 m -135.11 98.42 3.99 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 725' ' ' LEU . . . . . 0.578 HD22 ' CG2' ' A' ' 743' ' ' VAL . 2.3 mt -64.67 141.91 58.61 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.571 -171.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 33.3 mtpt -93.47 -22.51 18.83 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.043 -176.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 727' ' ' LEU . . . . . 0.491 ' HB2' ' HD2' ' A' ' 742' ' ' PRO . 0.2 OUTLIER -70.24 108.7 4.29 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 173.771 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 34.2 m170 -104.78 42.93 1.15 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -169.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 729' ' ' HIS . . . . . 0.403 ' O ' HD12 ' A' ' 727' ' ' LEU . 6.7 p80 -179.45 -177.21 0.42 Allowed 'General case' 0 C--N 1.327 -0.402 0 O-C-N 123.238 0.336 . . . . 0.0 110.279 176.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 730' ' ' ASP . . . . . 0.492 ' HB3' ' HE2' ' A' ' 814' ' ' LYS . 5.0 p-10 -78.47 153.96 30.96 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.075 0.464 . . . . 0.0 110.86 179.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 731' ' ' LEU . . . . . 0.565 ' HB2' ' HA ' ' A' ' 815' ' ' ILE . 49.1 mt -102.53 137.35 40.88 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.672 178.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 732' ' ' LYS . . . . . . . . . . . . . 35.2 mmtm -104.12 103.83 13.67 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.155 0.503 . . . . 0.0 110.901 177.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 733' ' ' LEU . . . . . 0.585 HD22 HG23 ' A' ' 815' ' ' ILE . 0.8 OUTLIER -112.01 164.17 13.44 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.725 -178.972 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 734' ' ' CYS . . . . . 0.632 ' O ' ' HB2' ' A' ' 737' ' ' ASP . 56.6 m -104.65 -176.8 3.18 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 171.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 735' ' ' LEU . . . . . . . . . . . . . 10.3 tt -84.28 137.23 33.57 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 119.767 -0.773 . . . . 0.0 109.639 -175.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 82.97 8.02 86.36 Favored Glycine 0 N--CA 1.441 -0.989 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.845 -171.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 737' ' ' ASP . . . . . 0.632 ' HB2' ' O ' ' A' ' 734' ' ' CYS . 0.5 OUTLIER -93.27 145.9 24.1 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.13 0.49 . . . . 0.0 111.546 177.262 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 738' ' ' HIS . . . . . 0.532 ' HB2' ' O ' ' A' ' 782' ' ' THR . 40.8 p-80 -110.76 175.82 5.28 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 170.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 739' ' ' SER . . . . . 0.409 ' CB ' HD21 ' A' ' 733' ' ' LEU . 0.0 OUTLIER -132.19 173.02 11.68 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 120.019 -0.672 . . . . 0.0 111.883 -177.344 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 36.8 m -143.03 106.82 4.65 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.032 -0.986 . . . . 0.0 109.702 178.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 741' ' ' VAL . . . . . 0.604 HG11 HD23 ' A' ' 793' ' ' LEU . 0.8 OUTLIER -110.32 111.92 57.41 Favored Pre-proline 0 C--N 1.318 -0.771 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.177 -176.871 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 742' ' ' PRO . . . . . 0.792 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 4.0 Cg_exo -72.16 131.29 17.69 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 122.434 2.089 . . . . 0.0 111.249 -179.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 743' ' ' VAL . . . . . 0.578 ' CG2' HD22 ' A' ' 725' ' ' LEU . 41.2 t -131.3 118.05 38.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.503 0.668 . . . . 0.0 112.742 -179.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 744' ' ' ALA . . . . . 0.614 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -82.75 97.42 8.57 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 122.009 0.909 . . . . 0.0 108.621 170.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 745' ' ' LEU . . . . . 0.739 HD11 ' HB3' ' A' ' 778' ' ' TYR . 2.5 mt -76.72 159.72 29.93 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 113.972 -1.467 . . . . 0.0 111.86 -168.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -111.61 146.78 36.8 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.08 -178.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 747' ' ' GLY . . . . . 0.435 ' HA3' ' HB3' ' A' ' 721' ' ' PRO . . . 103.24 119.87 4.68 Favored Glycine 0 C--N 1.304 -1.204 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.622 -178.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 748' ' ' GLN . . . . . 0.429 ' C ' ' HE1' ' A' ' 751' ' ' PHE . 0.0 OUTLIER -105.43 110.01 22.2 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.138 0.494 . . . . 0.0 111.2 -173.415 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 136.23 -175.68 20.76 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.877 -176.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -71.04 94.1 0.64 Allowed 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.397 2.064 . . . . 0.0 111.865 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 751' ' ' PHE . . . . . 0.574 ' HA ' ' O ' ' A' ' 799' ' ' LYS . 88.1 m-85 -113.2 140.46 47.92 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.368 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 752' ' ' THR . . . . . 0.682 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 98.0 m -89.92 104.99 17.5 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 121.556 0.693 . . . . 0.0 109.243 178.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 753' ' ' LEU . . . . . . . . . . . . . 21.3 tp -92.24 116.96 29.41 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 114.374 -1.285 . . . . 0.0 110.532 -172.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 754' ' ' THR . . . . . 0.453 HG23 ' HB2' ' A' ' 769' ' ' GLU . 0.9 OUTLIER -117.88 130.18 56.09 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.21 179.241 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 755' ' ' TYR . . . . . 0.565 ' CE1' ' HB3' ' A' ' 768' ' ' PHE . 20.8 p90 -139.43 153.8 47.66 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 120.741 -0.384 . . . . 0.0 111.582 -179.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 756' ' ' ASP . . . . . 0.488 ' HB2' HG23 ' A' ' 758' ' ' ILE . 7.6 p-10 -114.93 118.85 34.62 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.823 -176.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 757' ' ' ILE . . . . . 0.513 HG13 HD13 ' A' ' 793' ' ' LEU . 3.6 mp -91.68 95.36 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 167.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 758' ' ' ILE . . . . . 0.527 HG13 ' O ' ' A' ' 792' ' ' ILE . 2.3 pp -103.93 149.67 7.62 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.061 -170.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -96.89 135.28 39.1 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.364 177.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 760' ' ' THR . . . . . 0.48 ' OG1' ' HB3' ' A' ' 790' ' ' ASP . 38.7 p . . . . . 0 N--CA 1.44 -0.938 0 CA-C-O 121.904 0.859 . . . . 0.0 108.684 174.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 765' ' ' ARG . . . . . 0.473 ' CG ' HG22 ' A' ' 758' ' ' ILE . 15.2 ttp180 . . . . . 0 N--CA 1.445 -0.688 0 CA-C-O 121.252 0.548 . . . . 0.0 111.88 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 766' ' ' LYS . . . . . 0.584 ' HD3' ' N ' ' A' ' 767' ' ' THR . 9.3 tmtm? -97.99 144.11 27.85 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 177.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 767' ' ' THR . . . . . 0.584 ' N ' ' HD3' ' A' ' 766' ' ' LYS . 60.0 m -132.3 132.61 43.16 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.603 -178.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 768' ' ' PHE . . . . . 0.565 ' HB3' ' CE1' ' A' ' 755' ' ' TYR . 1.7 t80 -130.83 136.25 48.49 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 769' ' ' GLU . . . . . 0.453 ' HB2' HG23 ' A' ' 754' ' ' THR . 35.1 tt0 -128.83 118.71 23.19 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.954 -177.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 770' ' ' ILE . . . . . 0.437 HG22 HG22 ' A' ' 773' ' ' ILE . 7.7 mt -115.68 112.26 39.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 178.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 771' ' ' LYS . . . . . 0.635 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 3.1 mtpt -82.25 150.61 27.21 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 121.431 0.634 . . . . 0.0 111.528 -176.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 772' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 56.21 48.32 17.6 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 113.985 -1.462 . . . . 0.0 112.549 176.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 773' ' ' ILE . . . . . 0.668 HD12 ' H ' ' A' ' 775' ' ' THR . 0.5 OUTLIER -74.58 119.09 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 173.215 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 76.2 mttt -117.91 31.32 6.76 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -178.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 775' ' ' THR . . . . . 0.668 ' H ' HD12 ' A' ' 773' ' ' ILE . 2.1 m -95.74 -69.99 0.73 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.388 -1.278 . . . . 0.0 112.55 -172.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 776' ' ' ASN . . . . . 0.579 ' HB2' ' O ' ' A' ' 775' ' ' THR . 0.9 OUTLIER 82.78 4.43 1.0 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.825 0.85 . . . . 0.0 110.547 -177.092 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 777' ' ' GLU . . . . . 0.614 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 9.4 mt-10 -160.88 85.8 0.7 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.344 175.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 778' ' ' TYR . . . . . 0.739 ' HB3' HD11 ' A' ' 745' ' ' LEU . 75.6 t80 -136.26 126.97 27.24 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.258 -172.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 779' ' ' VAL . . . . . 0.792 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 1.6 m -91.52 126.4 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 CA-C-O 122.435 1.112 . . . . 0.0 110.612 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 780' ' ' ILE . . . . . . . . . . . . . 71.0 mt -89.22 145.32 7.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 113.543 -1.662 . . . . 0.0 110.954 -172.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -112.75 115.45 28.54 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 175.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 782' ' ' THR . . . . . 0.532 ' O ' ' HB2' ' A' ' 738' ' ' HIS . 22.9 p -89.43 140.48 28.45 Favored Pre-proline 0 C--N 1.309 -1.158 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.674 -178.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 783' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.02 156.56 28.5 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.641 2.894 . . . . 0.0 112.655 -174.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 784' ' ' VAL . . . . . . . . . . . . . 15.0 p -62.9 135.31 27.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.126 -176.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 785' ' ' PHE . . . . . 0.401 ' CB ' HG21 ' A' ' 817' ' ' VAL . 69.1 m-85 -105.04 102.72 12.21 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.744 179.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 81.4 p -84.54 19.35 1.99 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.386 -174.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -159.42 119.05 2.98 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.211 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 788' ' ' GLY . . . . . 0.785 ' HA2' HG12 ' A' ' 817' ' ' VAL . . . -46.08 116.29 2.11 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.431 -0.804 . . . . 0.0 113.571 170.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 789' ' ' GLY . . . . . 0.511 ' H ' ' HB ' ' A' ' 817' ' ' VAL . . . -156.8 -162.31 11.4 Favored Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 177.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 790' ' ' ASP . . . . . 0.48 ' HB3' ' OG1' ' A' ' 760' ' ' THR . 16.5 t70 -130.54 122.09 26.92 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 791' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -127.55 153.39 46.42 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.379 -174.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 792' ' ' ILE . . . . . 0.527 ' O ' HG13 ' A' ' 758' ' ' ILE . 19.2 mt -127.85 124.74 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 176.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 793' ' ' LEU . . . . . 0.604 HD23 HG11 ' A' ' 741' ' ' VAL . 1.2 tp -90.67 112.25 23.92 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 173.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 794' ' ' SER . . . . . 0.518 ' N ' HD12 ' A' ' 793' ' ' LEU . 9.4 t -118.79 175.16 5.88 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 114.451 -1.25 . . . . 0.0 108.492 -176.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 795' ' ' LEU . . . . . 0.545 HD21 HD21 ' A' ' 725' ' ' LEU . 21.5 mt -103.74 127.88 51.16 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 -178.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 796' ' ' VAL . . . . . . . . . . . . . 55.6 t -86.71 -57.6 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 CA-C-O 120.865 0.364 . . . . 0.0 110.773 -177.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 797' ' ' SER . . . . . 0.586 ' HA ' ' HG ' ' A' ' 808' ' ' LEU . 27.3 m -174.64 156.23 2.33 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.61 -173.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 798' ' ' ILE . . . . . 0.574 ' HA ' ' O ' ' A' ' 752' ' ' THR . 11.8 tt -128.8 168.06 22.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 176.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 799' ' ' LYS . . . . . 0.682 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 42.9 tttp -139.62 121.89 15.95 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 120.739 -0.384 . . . . 0.0 111.312 -174.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 800' ' ' ASP . . . . . 0.546 ' HA ' ' CD2' ' A' ' 751' ' ' PHE . 12.6 t70 -69.22 156.94 37.9 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.236 176.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 27.4 t -64.6 -10.9 29.7 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 123.759 0.662 . . . . 0.0 112.208 -174.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 13.9 t -90.95 2.26 56.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.991 0.9 . . . . 0.0 109.137 175.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 803' ' ' GLY . . . . . 0.452 ' HA2' ' HE3' ' A' ' 799' ' ' LYS . . . 81.71 46.79 6.6 Favored Glycine 0 N--CA 1.44 -1.061 0 CA-C-N 114.764 -1.107 . . . . 0.0 111.781 -178.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 804' ' ' CYS . . . . . 0.459 ' HB3' ' HB3' ' A' ' 800' ' ' ASP . 42.7 t -114.12 113.23 24.42 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.39 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 805' ' ' VAL . . . . . 0.525 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 8.4 p -85.03 129.93 36.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.346 0.593 . . . . 0.0 110.549 -177.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 806' ' ' VAL . . . . . 0.485 ' HB ' HG22 ' A' ' 798' ' ' ILE . 74.0 t -112.97 133.61 58.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.022 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -69.87 113.34 4.94 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.755 178.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 808' ' ' LEU . . . . . 0.588 HD22 ' HA ' ' A' ' 722' ' ' SER . 38.0 mt -84.55 125.05 32.08 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -175.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 23.2 t -144.51 87.14 1.85 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.169 172.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 810' ' ' GLN . . . . . 0.494 ' HB3' ' HD2' ' A' ' 811' ' ' PRO . 10.6 mt-30 -143.88 171.22 7.11 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.132 178.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 811' ' ' PRO . . . . . 0.523 ' O ' ' HG ' ' A' ' 725' ' ' LEU . 79.2 Cg_exo -42.73 139.68 3.16 Favored 'Trans proline' 0 C--N 1.356 0.925 0 C-N-CA 123.045 2.497 . . . . 0.0 114.826 -171.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -112.19 167.71 10.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.642 -177.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 813' ' ' ALA . . . . . 0.414 ' N ' HD12 ' A' ' 725' ' ' LEU . . . -118.19 155.85 29.78 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.604 179.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 814' ' ' LYS . . . . . 0.492 ' HE2' ' HB3' ' A' ' 730' ' ' ASP . 12.0 ttpt -121.24 134.42 55.18 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.137 -0.625 . . . . 0.0 110.528 176.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 815' ' ' ILE . . . . . 0.585 HG23 HD22 ' A' ' 733' ' ' LEU . 4.6 mp -116.38 108.15 24.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-N 115.21 -0.905 . . . . 0.0 108.68 177.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 816' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -103.05 108.43 19.6 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.545 0.688 . . . . 0.0 109.629 -178.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 817' ' ' VAL . . . . . 0.785 HG12 ' HA2' ' A' ' 788' ' ' GLY . 90.4 t -98.36 139.5 20.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.168 -177.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 818' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 . . . . . 0 C--N 1.312 -1.028 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 178.371 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 720' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp . . . . . 0 N--CA 1.45 -0.443 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 721' ' ' PRO . . . . . 0.467 ' HD2' HG21 ' A' ' 806' ' ' VAL . 63.3 Cg_endo -87.62 152.41 7.57 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 122.977 2.451 . . . . 0.0 112.401 -172.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 722' ' ' SER . . . . . 0.458 ' OG ' ' HG ' ' A' ' 808' ' ' LEU . 15.0 t -176.66 -148.5 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -174.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 723' ' ' ALA . . . . . 0.58 ' HA ' ' HA ' ' A' ' 745' ' ' LEU . . . -157.18 155.41 30.88 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 20.8 p -147.47 107.53 4.02 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.969 0.414 . . . . 0.0 109.894 174.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 725' ' ' LEU . . . . . 0.589 ' CD2' ' HB ' ' A' ' 743' ' ' VAL . 14.6 mt -62.96 145.62 54.91 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 121.591 0.71 . . . . 0.0 111.683 -175.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 726' ' ' LYS . . . . . 0.448 ' HB3' ' HE2' ' A' ' 726' ' ' LYS . 29.9 mtpt -95.85 -17.63 20.98 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.13 -177.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 727' ' ' LEU . . . . . 0.582 HD23 ' HB1' ' A' ' 813' ' ' ALA . 37.1 tp -67.15 115.14 6.5 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.213 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 34.5 m80 -109.48 30.02 7.02 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.968 0.413 . . . . 0.0 111.742 -176.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -162.23 179.9 7.54 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 175.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 730' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -91.72 143.47 26.51 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.023 0.439 . . . . 0.0 110.315 -178.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 731' ' ' LEU . . . . . 0.588 ' HB2' ' HA ' ' A' ' 815' ' ' ILE . 16.0 mt -78.48 108.44 11.85 Favored 'General case' 0 C--O 1.217 -0.629 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.771 -177.254 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 732' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -77.5 103.91 7.72 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.718 0.294 . . . . 0.0 111.022 178.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 733' ' ' LEU . . . . . 0.647 ' HB2' ' HB ' ' A' ' 817' ' ' VAL . 30.9 mt -118.06 164.78 14.6 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.183 0.516 . . . . 0.0 111.794 -177.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 734' ' ' CYS . . . . . . . . . . . . . 11.2 t -120.77 -174.41 2.81 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.039 179.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 735' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.39 119.29 16.39 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.064 0.459 . . . . 0.0 110.858 -171.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 86.66 10.93 72.09 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.893 -179.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 737' ' ' ASP . . . . . 0.535 ' HB3' ' HB3' ' A' ' 733' ' ' LEU . 5.8 t0 -75.43 168.78 19.36 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.084 0.469 . . . . 0.0 110.417 177.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 47.7 p-80 -126.21 153.72 44.29 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 175.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 739' ' ' SER . . . . . 0.581 ' HB2' ' OG1' ' A' ' 782' ' ' THR . 1.4 m -101.96 152.69 20.64 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.07 -173.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 740' ' ' SER . . . . . 0.456 ' HA ' ' O ' ' A' ' 780' ' ' ILE . 54.6 p -140.97 104.91 4.76 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.494 0.664 . . . . 0.0 110.055 179.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 741' ' ' VAL . . . . . 0.561 HG11 HD13 ' A' ' 793' ' ' LEU . 1.5 p -118.67 114.94 35.6 Favored Pre-proline 0 C--N 1.317 -0.838 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.918 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 742' ' ' PRO . . . . . 0.658 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 1.8 Cg_endo -75.86 130.37 12.37 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 122.431 2.087 . . . . 0.0 111.082 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 743' ' ' VAL . . . . . 0.589 ' HB ' ' CD2' ' A' ' 725' ' ' LEU . 1.6 p -126.7 121.29 58.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.547 0.689 . . . . 0.0 112.61 175.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 744' ' ' ALA . . . . . 0.495 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -82.67 102.23 11.35 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 168.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 745' ' ' LEU . . . . . 0.922 HD13 HD13 ' A' ' 773' ' ' ILE . 1.0 OUTLIER -81.11 168.63 18.39 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 114.282 -1.327 . . . . 0.0 111.258 -168.569 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 746' ' ' LYS . . . . . 0.408 ' HE3' ' HB2' ' A' ' 746' ' ' LYS . 28.0 ttmt -123.02 154.82 37.97 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.307 0.575 . . . . 0.0 110.717 -177.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 747' ' ' GLY . . . . . 0.404 ' HA3' ' HB3' ' A' ' 721' ' ' PRO . . . 92.05 133.11 5.98 Favored Glycine 0 C--N 1.309 -0.926 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.001 -174.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 748' ' ' GLN . . . . . 0.411 ' C ' ' HE1' ' A' ' 751' ' ' PHE . 65.7 mm-40 -101.89 123.03 45.13 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -170.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 107.98 -169.54 14.53 Favored Glycine 0 C--O 1.219 -0.815 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.896 179.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -67.23 99.86 0.51 Allowed 'Trans proline' 0 CA--C 1.531 0.356 0 C-N-CA 123.561 2.84 . . . . 0.0 113.542 -178.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 751' ' ' PHE . . . . . 0.634 ' CE2' ' HA ' ' A' ' 800' ' ' ASP . 60.9 m-85 -115.29 142.8 46.18 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.384 178.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 752' ' ' THR . . . . . 0.76 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 91.0 m -87.91 102.84 15.1 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.575 0.702 . . . . 0.0 109.867 178.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 753' ' ' LEU . . . . . 0.461 HD22 HD22 ' A' ' 745' ' ' LEU . 17.4 tp -92.08 130.71 37.75 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.537 -1.211 . . . . 0.0 110.538 -170.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 754' ' ' THR . . . . . 0.45 HG23 ' HB2' ' A' ' 769' ' ' GLU . 0.6 OUTLIER -125.98 134.84 51.37 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.607 0.241 . . . . 0.0 111.327 179.813 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 755' ' ' TYR . . . . . 0.422 ' CE1' ' HB3' ' A' ' 768' ' ' PHE . 26.1 p90 -145.93 154.66 42.18 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.14 177.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 756' ' ' ASP . . . . . 0.475 ' OD2' ' HD2' ' A' ' 765' ' ' ARG . 49.8 m-20 -116.9 122.76 45.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.868 -179.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 757' ' ' ILE . . . . . . . . . . . . . 4.2 mp -89.88 97.31 6.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 170.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 758' ' ' ILE . . . . . 0.555 HG22 ' HD3' ' A' ' 765' ' ' ARG . 2.1 pp -96.5 149.62 4.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.042 -169.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -93.79 112.52 24.39 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.839 -176.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 760' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.32 -0.704 0 CA-C-O 121.843 0.83 . . . . 0.0 109.252 179.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 765' ' ' ARG . . . . . 0.555 ' HD3' HG22 ' A' ' 758' ' ' ILE . 3.8 ttp180 . . . . . 0 N--CA 1.441 -0.908 0 CA-C-O 120.641 0.258 . . . . 0.0 110.341 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 766' ' ' LYS . . . . . 0.466 ' HD3' ' N ' ' A' ' 767' ' ' THR . 1.3 tmtp? -109.78 146.12 35.51 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 767' ' ' THR . . . . . 0.466 ' N ' ' HD3' ' A' ' 766' ' ' LYS . 77.6 m -121.05 134.14 55.27 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.244 -176.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 768' ' ' PHE . . . . . 0.422 ' HB3' ' CE1' ' A' ' 755' ' ' TYR . 0.7 OUTLIER -133.66 131.48 39.58 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.995 0.426 . . . . 0.0 110.498 175.101 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 769' ' ' GLU . . . . . 0.45 ' HB2' HG23 ' A' ' 754' ' ' THR . 36.5 tt0 -127.25 117.23 21.89 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.681 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 770' ' ' ILE . . . . . 0.43 HG22 HG22 ' A' ' 773' ' ' ILE . 12.1 mt -111.43 112.02 38.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 771' ' ' LYS . . . . . 0.625 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 12.4 mtpt -83.79 153.03 24.32 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-O 121.496 0.665 . . . . 0.0 111.609 -175.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 772' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 56.64 46.16 20.79 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 113.979 -1.464 . . . . 0.0 112.558 177.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 773' ' ' ILE . . . . . 0.922 HD13 HD13 ' A' ' 745' ' ' LEU . 0.6 OUTLIER -74.29 113.84 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 171.949 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 53.6 mttt -107.31 29.65 6.95 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -177.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 775' ' ' THR . . . . . 0.705 ' H ' HD12 ' A' ' 773' ' ' ILE . 0.2 OUTLIER -95.85 -82.32 0.39 Allowed 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -167.785 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 776' ' ' ASN . . . . . 0.657 ' HB2' ' O ' ' A' ' 775' ' ' THR . 0.8 OUTLIER 89.08 3.64 0.21 Allowed 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 124.521 1.129 . . . . 0.0 111.281 -171.741 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 777' ' ' GLU . . . . . 0.495 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 12.5 mt-10 -160.88 82.94 0.66 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 175.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 778' ' ' TYR . . . . . 0.832 ' HB3' HD11 ' A' ' 745' ' ' LEU . 87.9 t80 -127.33 127.68 44.68 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.128 -171.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 779' ' ' VAL . . . . . 0.658 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 20.8 t -87.25 116.44 29.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.111 0.481 . . . . 0.0 110.4 177.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 780' ' ' ILE . . . . . 0.456 ' O ' ' HA ' ' A' ' 740' ' ' SER . 75.9 mt -86.35 139.6 17.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.405 -178.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 781' ' ' LYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 739' ' ' SER . 3.6 mppt? -125.33 104.11 8.29 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 176.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 782' ' ' THR . . . . . 0.581 ' OG1' ' HB2' ' A' ' 739' ' ' SER . 44.3 p -77.42 145.5 72.18 Favored Pre-proline 0 N--CA 1.443 -0.79 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -177.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 783' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_exo -50.69 158.92 2.55 Favored 'Trans proline' 0 CA--C 1.529 0.271 0 C-N-CA 123.711 2.94 . . . . 0.0 113.57 -177.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 784' ' ' VAL . . . . . 0.423 HG12 HG23 ' A' ' 786' ' ' THR . 54.7 t -58.65 127.26 17.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.308 -177.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 785' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -102.45 103.25 13.63 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.294 177.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 786' ' ' THR . . . . . 0.423 HG23 HG12 ' A' ' 784' ' ' VAL . 38.9 p -90.59 30.65 1.13 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.939 0.876 . . . . 0.0 110.846 -178.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 27.6 m -152.34 107.42 3.25 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.347 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 788' ' ' GLY . . . . . 0.771 ' HA2' HG22 ' A' ' 817' ' ' VAL . . . -51.24 107.96 0.49 Allowed Glycine 0 CA--C 1.525 0.676 0 C-N-CA 121.065 -0.588 . . . . 0.0 113.128 174.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 789' ' ' GLY . . . . . 0.538 ' H ' HG22 ' A' ' 817' ' ' VAL . . . -152.22 -173.33 21.7 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 -179.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -121.5 129.95 53.25 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -177.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 791' ' ' TYR . . . . . 0.416 ' HA ' ' O ' ' A' ' 758' ' ' ILE . 61.6 m-85 -134.12 161.31 35.22 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.077 -176.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 792' ' ' ILE . . . . . . . . . . . . . 9.9 mt -137.94 121.64 21.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-O 120.845 0.355 . . . . 0.0 110.087 176.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 793' ' ' LEU . . . . . 0.561 HD13 HG11 ' A' ' 741' ' ' VAL . 9.6 tt -84.76 107.77 17.11 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 794' ' ' SER . . . . . . . . . . . . . 21.7 m -112.6 150.63 31.12 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.297 -178.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 795' ' ' LEU . . . . . 0.481 HD22 ' HB3' ' A' ' 723' ' ' ALA . 34.6 mt -83.55 132.42 34.92 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.359 -178.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 796' ' ' VAL . . . . . . . . . . . . . 71.7 t -99.39 -57.88 4.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.926 -0.309 . . . . 0.0 111.794 -175.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 797' ' ' SER . . . . . 0.508 ' HA ' HD13 ' A' ' 808' ' ' LEU . 22.9 m -172.32 177.28 3.14 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.379 -173.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 798' ' ' ILE . . . . . 0.641 ' HA ' ' O ' ' A' ' 752' ' ' THR . 8.4 tt -150.92 156.73 6.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 799' ' ' LYS . . . . . 0.76 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 8.9 tmtt? -124.81 119.25 28.33 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 177.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 800' ' ' ASP . . . . . 0.634 ' HA ' ' CE2' ' A' ' 751' ' ' PHE . 11.4 t70 -63.88 154.1 34.77 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.487 175.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 10.6 t -60.95 -12.04 9.98 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 123.94 0.775 . . . . 0.0 112.171 -171.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 39.9 p -91.35 1.0 57.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.485 0.66 . . . . 0.0 110.45 177.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 803' ' ' GLY . . . . . 0.456 ' HA2' ' HE2' ' A' ' 799' ' ' LYS . . . 81.5 39.01 12.92 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.713 -176.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 804' ' ' CYS . . . . . 0.452 ' HB3' ' HB3' ' A' ' 800' ' ' ASP . 49.4 t -111.77 110.71 21.21 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 805' ' ' VAL . . . . . . . . . . . . . 7.5 p -86.25 127.49 40.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.671 0.748 . . . . 0.0 111.377 -173.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 806' ' ' VAL . . . . . 0.467 HG21 ' HD2' ' A' ' 721' ' ' PRO . 81.1 t -112.42 139.0 39.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.851 -178.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -83.96 109.53 3.21 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.756 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 808' ' ' LEU . . . . . 0.508 HD13 ' HA ' ' A' ' 797' ' ' SER . 10.4 mp -74.58 133.43 42.22 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 178.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 38.3 m -148.28 85.64 1.53 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.911 -1.04 . . . . 0.0 109.166 170.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 810' ' ' GLN . . . . . 0.507 ' HB3' ' HD2' ' A' ' 811' ' ' PRO . 12.0 mt-30 -138.86 173.66 4.99 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.527 178.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 811' ' ' PRO . . . . . 0.507 ' HD2' ' HB3' ' A' ' 810' ' ' GLN . 86.9 Cg_exo -44.39 140.76 5.67 Favored 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 123.153 2.568 . . . . 0.0 115.273 -175.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -113.25 166.61 11.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.474 -1.239 . . . . 0.0 109.727 176.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 813' ' ' ALA . . . . . 0.582 ' HB1' HD23 ' A' ' 727' ' ' LEU . . . -124.45 143.79 50.44 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.909 -177.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 814' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -97.53 130.18 44.62 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.589 0.709 . . . . 0.0 110.952 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 815' ' ' ILE . . . . . 0.588 ' HA ' ' HB2' ' A' ' 731' ' ' LEU . 5.0 mp -107.28 119.64 57.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.824 176.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 816' ' ' GLN . . . . . 0.745 ' NE2' ' HG2' ' A' ' 818' ' ' ARG . 0.9 OUTLIER -117.02 106.66 13.63 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.272 0.558 . . . . 0.0 110.648 -177.842 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 817' ' ' VAL . . . . . 0.771 HG22 ' HA2' ' A' ' 788' ' ' GLY . 0.7 OUTLIER -111.29 143.97 20.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-O 121.113 0.482 . . . . 0.0 110.201 -179.167 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 818' ' ' ARG . . . . . 0.745 ' HG2' ' NE2' ' A' ' 816' ' ' GLN . 29.1 mmt180 . . . . . 0 C--N 1.315 -0.907 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.502 -179.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 720' ' ' LYS . . . . . . . . . . . . . 49.5 mtpt . . . . . 0 N--CA 1.455 -0.199 0 N-CA-C 110.557 -0.164 . . . . 0.0 110.557 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 721' ' ' PRO . . . . . 0.455 ' HD2' HG21 ' A' ' 806' ' ' VAL . 38.7 Cg_endo -87.47 164.18 8.06 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.826 2.351 . . . . 0.0 111.291 179.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 722' ' ' SER . . . . . 0.6 ' HA ' ' CD2' ' A' ' 808' ' ' LEU . 8.8 t -174.76 -154.37 0.05 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.892 0.377 . . . . 0.0 110.521 -173.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 723' ' ' ALA . . . . . 0.65 ' HB1' HG21 ' A' ' 743' ' ' VAL . . . -151.73 143.03 23.38 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 178.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 14.9 t -134.57 98.97 4.21 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 725' ' ' LEU . . . . . 0.629 ' HA ' ' HA ' ' A' ' 743' ' ' VAL . 5.7 mp -59.7 144.28 48.47 Favored 'General case' 0 N--CA 1.427 -1.589 0 CA-C-O 122.476 1.131 . . . . 0.0 112.752 -175.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 32.4 mtpt -93.23 -19.66 21.2 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 113.038 -1.892 . . . . 0.0 109.461 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 727' ' ' LEU . . . . . 0.486 ' HB2' ' HD2' ' A' ' 742' ' ' PRO . 0.6 OUTLIER -72.0 108.64 5.33 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 177.588 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 31.2 t-80 -115.56 52.32 0.89 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.705 0.288 . . . . 0.0 111.401 -172.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 7.8 p80 -175.92 -177.91 0.98 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.49 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 730' ' ' ASP . . . . . 0.427 ' HB2' ' HE3' ' A' ' 732' ' ' LYS . 12.3 m-20 -77.78 131.76 37.76 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 173.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 731' ' ' LEU . . . . . 0.574 ' HB3' ' HA ' ' A' ' 815' ' ' ILE . 9.8 tp -96.35 100.81 12.39 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 120.979 0.419 . . . . 0.0 110.053 -176.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 732' ' ' LYS . . . . . 0.427 ' HE3' ' HB2' ' A' ' 730' ' ' ASP . 33.4 mmtp -80.52 112.36 17.8 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.749 -0.659 . . . . 0.0 112.087 -171.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 733' ' ' LEU . . . . . 0.607 ' HG ' ' HB3' ' A' ' 737' ' ' ASP . 7.3 mp -113.58 163.26 15.18 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.88 177.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 734' ' ' CYS . . . . . 0.575 ' O ' ' HB2' ' A' ' 737' ' ' ASP . 51.6 t -104.69 -174.96 2.66 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.501 173.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 735' ' ' LEU . . . . . 0.478 ' N ' ' SG ' ' A' ' 734' ' ' CYS . 40.0 tp -72.47 130.14 39.96 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.195 0.522 . . . . 0.0 111.293 -178.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 78.92 4.17 88.36 Favored Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.608 -177.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 737' ' ' ASP . . . . . 0.607 ' HB3' ' HG ' ' A' ' 733' ' ' LEU . 0.3 OUTLIER -77.87 151.71 33.72 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.096 0.474 . . . . 0.0 111.687 179.327 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 738' ' ' HIS . . . . . 0.445 ' HB2' ' O ' ' A' ' 782' ' ' THR . 34.6 p-80 -114.95 161.7 17.94 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 170.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 739' ' ' SER . . . . . 0.444 ' HB3' HD21 ' A' ' 733' ' ' LEU . 8.0 p -120.36 171.78 8.27 Favored 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 119.159 -1.016 . . . . 0.0 111.522 -173.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 7.0 p -137.85 100.74 4.26 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.649 177.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 741' ' ' VAL . . . . . 0.579 HG11 HD13 ' A' ' 793' ' ' LEU . 0.7 OUTLIER -109.86 107.74 59.11 Favored Pre-proline 0 C--N 1.318 -0.775 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.618 -179.119 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 742' ' ' PRO . . . . . 0.665 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 3.1 Cg_endo -76.84 137.83 18.15 Favored 'Trans proline' 0 N--CA 1.448 -1.183 0 C-N-CA 122.478 2.119 . . . . 0.0 111.545 -177.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 743' ' ' VAL . . . . . 0.65 HG21 ' HB1' ' A' ' 723' ' ' ALA . 1.7 p -131.01 118.58 42.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.697 0.76 . . . . 0.0 112.121 175.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 744' ' ' ALA . . . . . 0.606 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -80.62 95.61 6.6 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 169.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 745' ' ' LEU . . . . . 1.018 HD13 HD13 ' A' ' 773' ' ' ILE . 0.7 OUTLIER -73.31 159.23 33.68 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 113.901 -1.499 . . . . 0.0 111.472 -168.545 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -114.39 147.67 38.86 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.025 -174.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 747' ' ' GLY . . . . . . . . . . . . . . . 92.81 127.84 4.52 Favored Glycine 0 N--CA 1.442 -0.935 0 C-N-CA 120.166 -1.016 . . . . 0.0 110.625 -174.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 25.0 mp0 -101.68 127.07 48.6 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 121.194 0.521 . . . . 0.0 112.036 -171.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 112.88 -177.12 18.09 Favored Glycine 0 CA--C 1.5 -0.853 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.936 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 750' ' ' PRO . . . . . 0.501 ' HB3' ' HE2' ' A' ' 774' ' ' LYS . 74.4 Cg_endo -65.87 94.91 0.28 Allowed 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 123.838 3.025 . . . . 0.0 113.71 -177.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 751' ' ' PHE . . . . . 0.53 ' CE2' ' HA ' ' A' ' 800' ' ' ASP . 68.6 m-85 -113.91 144.06 43.67 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.997 178.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 752' ' ' THR . . . . . 0.749 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 63.8 m -89.41 107.93 19.35 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 753' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.73 112.16 24.32 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.285 -171.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 754' ' ' THR . . . . . 0.491 HG23 ' HB2' ' A' ' 769' ' ' GLU . 2.2 m -109.74 135.32 50.85 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.41 -179.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 755' ' ' TYR . . . . . 0.532 ' CE1' ' HB3' ' A' ' 768' ' ' PHE . 29.2 p90 -143.43 157.01 44.8 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 120.968 0.413 . . . . 0.0 111.208 177.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 756' ' ' ASP . . . . . 0.425 ' OD2' ' HD2' ' A' ' 765' ' ' ARG . 41.2 m-20 -115.57 120.29 38.98 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.694 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 757' ' ' ILE . . . . . 0.403 ' HB ' ' HB3' ' A' ' 766' ' ' LYS . 3.3 mp -84.71 94.73 3.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 167.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 758' ' ' ILE . . . . . 0.56 HG22 ' HD3' ' A' ' 765' ' ' ARG . 2.2 pp -91.75 140.7 15.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 C-N-CA 120.258 -0.577 . . . . 0.0 111.429 -171.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -93.19 99.88 12.36 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.06 -174.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 760' ' ' THR . . . . . 0.412 HG22 ' H ' ' A' ' 760' ' ' THR . 0.9 OUTLIER . . . . . 0 C--N 1.321 -0.642 0 CA-C-O 121.819 0.819 . . . . 0.0 109.358 -175.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 765' ' ' ARG . . . . . 0.56 ' HD3' HG22 ' A' ' 758' ' ' ILE . 6.7 ttp180 . . . . . 0 N--CA 1.443 -0.813 0 CA-C-O 121.247 0.546 . . . . 0.0 111.417 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 766' ' ' LYS . . . . . 0.521 ' HD3' ' N ' ' A' ' 767' ' ' THR . 9.8 tmtm? -111.89 146.02 38.48 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 178.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 767' ' ' THR . . . . . 0.521 ' N ' ' HD3' ' A' ' 766' ' ' LYS . 88.4 m -123.76 135.14 53.65 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.9 -178.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 768' ' ' PHE . . . . . 0.532 ' HB3' ' CE1' ' A' ' 755' ' ' TYR . 3.0 t80 -139.73 137.53 35.2 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 177.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 769' ' ' GLU . . . . . 0.491 ' HB2' HG23 ' A' ' 754' ' ' THR . 31.8 tt0 -131.2 132.8 44.95 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.003 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 770' ' ' ILE . . . . . 0.575 HG22 HG22 ' A' ' 773' ' ' ILE . 4.1 mt -121.99 111.57 31.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 177.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 771' ' ' LYS . . . . . 0.559 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 5.2 mtpt -85.15 157.31 20.7 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.176 0.512 . . . . 0.0 111.349 -175.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 772' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 53.71 44.29 29.88 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.546 -1.206 . . . . 0.0 112.19 177.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 773' ' ' ILE . . . . . 1.018 HD13 HD13 ' A' ' 745' ' ' LEU . 0.5 OUTLIER -75.15 111.36 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 173.342 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 774' ' ' LYS . . . . . 0.501 ' HE2' ' HB3' ' A' ' 750' ' ' PRO . 56.9 mttt -108.36 29.87 6.96 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 775' ' ' THR . . . . . 0.678 ' H ' HD12 ' A' ' 773' ' ' ILE . 2.1 m -96.11 -81.39 0.41 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.913 -1.039 . . . . 0.0 113.392 -166.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 776' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' A' ' 775' ' ' THR . 10.3 m120 93.79 4.18 0.05 OUTLIER 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.268 1.427 . . . . 0.0 110.971 -176.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 777' ' ' GLU . . . . . 0.606 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 4.9 mt-10 -161.11 87.96 0.73 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.364 171.041 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 778' ' ' TYR . . . . . 0.817 ' HB3' HD11 ' A' ' 745' ' ' LEU . 73.7 t80 -125.92 128.29 47.31 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.418 -172.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 779' ' ' VAL . . . . . 0.665 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 21.2 t -86.33 113.27 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 CA-C-O 121.14 0.495 . . . . 0.0 110.46 179.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 780' ' ' ILE . . . . . 0.434 ' HB ' HG13 ' A' ' 741' ' ' VAL . 76.2 mt -82.39 143.69 11.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.958 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -123.8 112.77 17.7 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 175.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 782' ' ' THR . . . . . 0.445 ' O ' ' HB2' ' A' ' 738' ' ' HIS . 44.2 p -77.01 142.19 68.69 Favored Pre-proline 0 C--N 1.318 -0.77 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.75 -179.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 783' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 782' ' ' THR . 51.2 Cg_exo -55.3 161.5 7.03 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 123.509 2.806 . . . . 0.0 112.899 -178.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 784' ' ' VAL . . . . . 0.443 HG12 HG23 ' A' ' 786' ' ' THR . 46.5 t -58.39 124.21 11.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.094 -179.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 785' ' ' PHE . . . . . 0.432 ' HE1' ' OG1' ' A' ' 782' ' ' THR . 99.5 m-85 -99.44 95.53 7.08 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.741 178.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 786' ' ' THR . . . . . 0.443 HG23 HG12 ' A' ' 784' ' ' VAL . 59.9 p -84.71 28.97 0.64 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.526 0.679 . . . . 0.0 110.912 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.05 108.92 3.68 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.56 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 788' ' ' GLY . . . . . 0.656 ' HA2' HG12 ' A' ' 817' ' ' VAL . . . -52.44 107.46 0.51 Allowed Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.465 171.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 789' ' ' GLY . . . . . 0.53 ' H ' ' HB ' ' A' ' 817' ' ' VAL . . . -152.22 -151.58 5.69 Favored Glycine 0 N--CA 1.444 -0.803 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 -179.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -141.07 133.16 27.85 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 791' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -135.0 149.06 50.12 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.382 -174.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 792' ' ' ILE . . . . . 0.418 ' O ' HG13 ' A' ' 758' ' ' ILE . 13.8 mt -127.61 116.32 42.96 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-O 121.091 0.472 . . . . 0.0 110.046 178.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 793' ' ' LEU . . . . . 0.579 HD13 HG11 ' A' ' 741' ' ' VAL . 10.3 tt -84.15 106.79 16.06 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 794' ' ' SER . . . . . . . . . . . . . 19.3 m -116.33 150.92 36.89 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.861 -177.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 795' ' ' LEU . . . . . 0.459 HD21 HD11 ' A' ' 725' ' ' LEU . 52.9 mt -83.0 136.55 34.47 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.861 -178.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 796' ' ' VAL . . . . . . . . . . . . . 77.2 t -100.35 -57.44 4.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.642 -176.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 797' ' ' SER . . . . . 0.56 ' HA ' ' HG ' ' A' ' 808' ' ' LEU . 25.9 m -170.86 153.54 3.97 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.305 -173.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 798' ' ' ILE . . . . . 0.607 ' HA ' ' O ' ' A' ' 752' ' ' THR . 9.1 tt -125.41 166.45 21.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 176.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 799' ' ' LYS . . . . . 0.749 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 87.7 tttt -137.53 123.09 19.71 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.407 -173.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 800' ' ' ASP . . . . . 0.623 ' HB3' ' HB3' ' A' ' 804' ' ' CYS . 13.4 t70 -70.93 157.64 37.83 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.469 175.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 10.4 p -60.68 -9.62 4.17 Favored 'General case' 0 CA--C 1.532 0.251 0 O-C-N 124.007 0.817 . . . . 0.0 112.799 -174.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 42.8 p -97.38 7.38 46.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.577 0.703 . . . . 0.0 110.308 176.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 803' ' ' GLY . . . . . 0.514 ' HA2' ' CE ' ' A' ' 799' ' ' LYS . . . 76.68 31.41 54.02 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.841 -176.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 804' ' ' CYS . . . . . 0.623 ' HB3' ' HB3' ' A' ' 800' ' ' ASP . 35.5 t -96.41 103.43 15.34 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -179.089 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 805' ' ' VAL . . . . . 0.484 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 3.2 t -86.17 119.9 35.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.165 0.507 . . . . 0.0 110.889 -173.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 806' ' ' VAL . . . . . 0.455 HG21 ' HD2' ' A' ' 721' ' ' PRO . 73.0 t -103.56 133.6 47.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.245 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -67.14 134.09 31.35 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 121.077 -0.582 . . . . 0.0 111.664 178.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 808' ' ' LEU . . . . . 0.6 ' CD2' ' HA ' ' A' ' 722' ' ' SER . 69.2 mt -100.73 132.82 45.93 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -176.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 22.0 t -146.77 87.18 1.68 Allowed 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.921 171.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 810' ' ' GLN . . . . . 0.472 ' HB3' ' HD2' ' A' ' 811' ' ' PRO . 8.7 mt-30 -139.83 173.76 4.74 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.678 173.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 811' ' ' PRO . . . . . 0.472 ' HD2' ' HB3' ' A' ' 810' ' ' GLN . 78.9 Cg_exo -44.58 141.1 5.77 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 122.971 2.447 . . . . 0.0 115.209 -176.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -108.36 168.05 9.59 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.285 -1.325 . . . . 0.0 109.495 176.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 813' ' ' ALA . . . . . . . . . . . . . . . -126.03 137.26 53.63 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.36 176.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 814' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -103.14 114.83 29.44 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 120.911 0.386 . . . . 0.0 110.441 -177.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 815' ' ' ILE . . . . . 0.574 ' HA ' ' HB3' ' A' ' 731' ' ' LEU . 5.2 mp -97.81 109.39 23.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.493 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 816' ' ' GLN . . . . . 0.703 ' NE2' ' HG2' ' A' ' 818' ' ' ARG . 0.8 OUTLIER -95.32 124.17 39.22 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.871 -178.592 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 817' ' ' VAL . . . . . 0.656 HG12 ' HA2' ' A' ' 788' ' ' GLY . 59.7 t -117.09 135.17 58.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 -177.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 818' ' ' ARG . . . . . 0.703 ' HG2' ' NE2' ' A' ' 816' ' ' GLN . 35.2 mmt180 . . . . . 0 C--N 1.327 -0.384 0 O-C-N 121.841 -0.537 . . . . 0.0 111.372 176.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 720' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp . . . . . 0 N--CA 1.447 -0.597 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 721' ' ' PRO . . . . . 0.441 ' HB3' ' HA3' ' A' ' 747' ' ' GLY . 57.1 Cg_endo -87.48 150.03 7.66 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 122.82 2.346 . . . . 0.0 111.869 -177.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 722' ' ' SER . . . . . 0.41 ' HA ' ' HG ' ' A' ' 808' ' ' LEU . 16.1 t -176.71 -150.15 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -172.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 723' ' ' ALA . . . . . 0.593 ' HB1' HG21 ' A' ' 743' ' ' VAL . . . -153.95 143.41 21.56 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 110.449 -0.204 . . . . 0.0 110.449 178.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 4.2 p -134.36 105.44 6.6 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 725' ' ' LEU . . . . . 0.507 ' CD2' ' HB ' ' A' ' 743' ' ' VAL . 14.4 mt -65.4 148.95 50.83 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.728 -173.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 32.1 mtpt -105.75 -0.45 25.4 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.471 -1.241 . . . . 0.0 109.408 -177.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 727' ' ' LEU . . . . . 0.441 ' HB2' ' HD2' ' A' ' 742' ' ' PRO . 2.6 tm? -81.78 124.74 29.9 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.818 -1.083 . . . . 0.0 108.953 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 48.6 m80 -86.08 -85.14 0.16 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -173.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 10.7 p80 -92.56 174.83 7.07 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 120.587 -0.445 . . . . 0.0 111.235 -176.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 730' ' ' ASP . . . . . 0.405 ' HA ' ' O ' ' A' ' 814' ' ' LYS . 4.0 p30 -53.11 144.3 15.81 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.638 0.732 . . . . 0.0 111.898 -177.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 731' ' ' LEU . . . . . 0.558 ' HB2' ' HA ' ' A' ' 815' ' ' ILE . 15.8 mt -83.27 118.85 23.93 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.272 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 732' ' ' LYS . . . . . 0.42 ' C ' ' HG ' ' A' ' 733' ' ' LEU . 14.4 mmmm -85.18 117.94 24.43 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.457 179.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 733' ' ' LEU . . . . . 0.466 HD13 ' OD2' ' A' ' 737' ' ' ASP . 4.6 mt -142.48 164.64 29.57 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.913 0.387 . . . . 0.0 111.488 -173.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 734' ' ' CYS . . . . . 0.694 ' HA ' ' O ' ' A' ' 818' ' ' ARG . 18.5 p -117.78 -174.15 2.58 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.129 -177.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 735' ' ' LEU . . . . . . . . . . . . . 1.4 tt -61.0 127.84 33.54 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.552 -177.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 78.52 16.48 79.29 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.377 -0.916 . . . . 0.0 112.033 174.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 737' ' ' ASP . . . . . 0.466 ' OD2' HD13 ' A' ' 733' ' ' LEU . 0.9 OUTLIER -64.99 165.72 10.47 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.377 0.608 . . . . 0.0 111.096 176.995 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 22.0 p-80 -137.52 129.33 28.7 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 162.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 739' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -97.86 171.76 8.09 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 119.674 -0.81 . . . . 0.0 111.165 -165.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 740' ' ' SER . . . . . 0.421 ' HA ' ' O ' ' A' ' 780' ' ' ILE . 50.2 m -142.45 107.68 4.99 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.16 -178.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 741' ' ' VAL . . . . . 0.636 HG11 HD13 ' A' ' 793' ' ' LEU . 1.0 OUTLIER -114.51 105.67 53.39 Favored Pre-proline 0 C--N 1.315 -0.924 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.075 179.672 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 742' ' ' PRO . . . . . 0.81 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 5.9 Cg_exo -73.76 135.5 21.72 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 122.248 1.965 . . . . 0.0 111.441 -176.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 743' ' ' VAL . . . . . 0.593 HG21 ' HB1' ' A' ' 723' ' ' ALA . 2.1 p -133.54 122.76 44.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 178.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 744' ' ' ALA . . . . . 0.574 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -82.77 98.6 9.19 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 167.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 745' ' ' LEU . . . . . 0.726 HD11 ' HB3' ' A' ' 778' ' ' TYR . 1.8 mt -77.53 157.69 30.26 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.262 -1.335 . . . . 0.0 111.471 -170.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 22.2 ttmm -112.56 155.48 24.28 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.284 -176.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 747' ' ' GLY . . . . . 0.441 ' HA3' ' HB3' ' A' ' 721' ' ' PRO . . . 100.19 120.43 4.52 Favored Glycine 0 C--N 1.305 -1.161 0 CA-C-N 115.131 -0.941 . . . . 0.0 111.62 -175.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 20.2 mm-40 -100.34 106.35 17.95 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.003 -174.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 136.14 -174.52 21.4 Favored Glycine 0 N--CA 1.448 -0.546 0 N-CA-C 111.64 -0.584 . . . . 0.0 111.64 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -68.47 94.41 0.43 Allowed 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 122.642 2.228 . . . . 0.0 111.983 178.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 751' ' ' PHE . . . . . 0.564 ' CE2' ' HA ' ' A' ' 800' ' ' ASP . 73.8 m-85 -113.35 136.53 52.67 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.391 -179.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 752' ' ' THR . . . . . 0.807 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 59.8 m -90.44 102.46 15.19 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 121.961 0.886 . . . . 0.0 109.287 178.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 753' ' ' LEU . . . . . 0.419 HD22 HD22 ' A' ' 745' ' ' LEU . 16.4 tp -89.0 131.71 35.06 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 113.803 -1.544 . . . . 0.0 110.48 -170.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 754' ' ' THR . . . . . 0.449 HG23 ' HB2' ' A' ' 769' ' ' GLU . 1.2 m -131.61 132.89 44.41 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.17 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 755' ' ' TYR . . . . . 0.452 ' CE1' ' HB3' ' A' ' 768' ' ' PHE . 22.4 p90 -141.52 153.93 45.18 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.072 0.463 . . . . 0.0 111.758 179.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 756' ' ' ASP . . . . . 0.44 ' CG ' ' HD2' ' A' ' 765' ' ' ARG . 5.5 m-20 -115.13 119.63 37.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.451 -179.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 757' ' ' ILE . . . . . 0.401 HG12 HG22 ' A' ' 782' ' ' THR . 4.8 mp -90.88 95.56 5.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 168.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 758' ' ' ILE . . . . . 0.673 HG22 ' HD3' ' A' ' 765' ' ' ARG . 2.2 pp -90.21 140.06 16.54 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-O 121.413 0.625 . . . . 0.0 111.188 -170.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -92.73 98.72 11.59 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.724 -174.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 760' ' ' THR . . . . . 0.402 HG22 ' H ' ' A' ' 760' ' ' THR . 1.4 t . . . . . 0 C--N 1.321 -0.647 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.663 -172.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 765' ' ' ARG . . . . . 0.673 ' HD3' HG22 ' A' ' 758' ' ' ILE . 16.7 ttp180 . . . . . 0 N--CA 1.445 -0.715 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 766' ' ' LYS . . . . . 0.587 ' HD3' ' N ' ' A' ' 767' ' ' THR . 10.3 tmtt? -120.89 146.5 46.54 Favored 'General case' 0 C--O 1.218 -0.579 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -179.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 767' ' ' THR . . . . . 0.587 ' N ' ' HD3' ' A' ' 766' ' ' LYS . 31.1 m -123.67 143.24 50.38 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 116.725 -0.216 . . . . 0.0 111.13 -176.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 768' ' ' PHE . . . . . 0.452 ' HB3' ' CE1' ' A' ' 755' ' ' TYR . 4.5 t80 -142.34 137.32 30.46 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 120.995 0.426 . . . . 0.0 110.485 172.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 769' ' ' GLU . . . . . 0.449 ' HB2' HG23 ' A' ' 754' ' ' THR . 26.5 tt0 -128.33 123.67 34.55 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.951 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 770' ' ' ILE . . . . . 0.485 HG22 HG22 ' A' ' 773' ' ' ILE . 7.4 mt -116.56 112.69 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 771' ' ' LYS . . . . . 0.594 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 4.1 mtpt -84.61 150.39 25.21 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.31 0.576 . . . . 0.0 111.777 -173.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 772' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 51.69 52.89 13.67 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.315 -1.311 . . . . 0.0 111.943 178.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 773' ' ' ILE . . . . . 0.687 HD12 ' H ' ' A' ' 775' ' ' THR . 0.5 OUTLIER -76.81 117.82 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 173.437 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -116.29 30.62 7.23 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -178.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 775' ' ' THR . . . . . 0.687 ' H ' HD12 ' A' ' 773' ' ' ILE . 1.6 m -96.62 -72.25 0.64 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 113.76 -1.563 . . . . 0.0 112.215 -171.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 776' ' ' ASN . . . . . 0.426 ' HB2' ' O ' ' A' ' 775' ' ' THR . 11.7 m120 85.43 6.37 0.45 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.349 1.06 . . . . 0.0 110.238 178.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 777' ' ' GLU . . . . . 0.574 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 2.3 tm-20 -162.1 93.46 0.88 Allowed 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 114.374 -1.285 . . . . 0.0 107.702 176.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 778' ' ' TYR . . . . . 0.726 ' HB3' HD11 ' A' ' 745' ' ' LEU . 52.8 t80 -144.57 128.68 17.62 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.666 -169.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 779' ' ' VAL . . . . . 0.81 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 1.3 m -94.52 129.09 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.082 0 C-N-CA 118.861 -1.136 . . . . 0.0 110.506 179.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 780' ' ' ILE . . . . . 0.421 ' O ' ' HA ' ' A' ' 740' ' ' SER . 83.0 mt -89.43 142.94 12.18 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-N 114.072 -1.422 . . . . 0.0 110.828 -174.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -118.38 107.52 13.95 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.942 178.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 782' ' ' THR . . . . . 0.457 ' HA ' ' HD3' ' A' ' 783' ' ' PRO . 25.1 p -76.91 141.13 67.61 Favored Pre-proline 0 C--N 1.315 -0.902 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.376 -177.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 783' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 782' ' ' THR . 50.2 Cg_exo -55.07 161.4 6.7 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.719 2.946 . . . . 0.0 112.837 -174.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 784' ' ' VAL . . . . . 0.509 HG22 HG23 ' A' ' 786' ' ' THR . 7.4 p -58.83 131.46 23.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.107 -178.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 785' ' ' PHE . . . . . 0.409 ' C ' ' H ' ' A' ' 787' ' ' THR . 32.0 m-85 -112.14 88.59 2.85 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.716 177.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 786' ' ' THR . . . . . 0.509 HG23 HG22 ' A' ' 784' ' ' VAL . 44.8 p -82.23 31.71 0.39 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.796 0.808 . . . . 0.0 110.918 -178.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 787' ' ' THR . . . . . 0.409 ' H ' ' C ' ' A' ' 785' ' ' PHE . 12.4 m -157.38 107.46 2.22 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.282 -179.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 788' ' ' GLY . . . . . 0.723 ' HA2' HG12 ' A' ' 817' ' ' VAL . . . -45.66 124.39 6.9 Favored Glycine 0 C--N 1.334 0.471 0 CA-C-N 116.174 -0.466 . . . . 0.0 113.243 174.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 789' ' ' GLY . . . . . 0.557 ' H ' ' HB ' ' A' ' 817' ' ' VAL . . . -165.88 -151.24 6.62 Favored Glycine 0 N--CA 1.443 -0.861 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 179.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -147.15 133.43 19.5 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -178.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 791' ' ' TYR . . . . . 0.421 ' HB2' ' HB ' ' A' ' 815' ' ' ILE . 41.8 m-85 -132.73 154.66 49.99 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.777 -174.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 792' ' ' ILE . . . . . 0.437 ' CG1' ' HG3' ' A' ' 814' ' ' LYS . 12.6 mt -131.2 116.79 34.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 176.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 793' ' ' LEU . . . . . 0.636 HD13 HG11 ' A' ' 741' ' ' VAL . 10.1 tt -84.72 107.29 16.84 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 794' ' ' SER . . . . . . . . . . . . . 19.3 m -114.18 164.96 13.17 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.319 179.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 795' ' ' LEU . . . . . . . . . . . . . 48.9 mt -94.89 132.61 39.52 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 120.71 0.29 . . . . 0.0 110.905 -175.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 796' ' ' VAL . . . . . . . . . . . . . 85.4 t -88.95 -56.99 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.386 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.705 -178.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 797' ' ' SER . . . . . 0.515 ' HA ' HD13 ' A' ' 808' ' ' LEU . 7.1 m 178.46 177.26 0.45 Allowed 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.013 0.821 . . . . 0.0 109.583 -175.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 798' ' ' ILE . . . . . 0.523 ' O ' ' HA ' ' A' ' 805' ' ' VAL . 11.4 tt -146.31 164.67 9.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 177.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 799' ' ' LYS . . . . . 0.807 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 7.4 tttm -135.08 120.02 18.58 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.045 0.45 . . . . 0.0 111.142 -176.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 800' ' ' ASP . . . . . 0.564 ' HA ' ' CE2' ' A' ' 751' ' ' PHE . 19.3 t70 -63.65 159.36 19.18 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.877 176.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 24.9 t -61.19 -20.91 63.3 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 123.902 0.751 . . . . 0.0 111.422 -175.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 39.7 p -83.8 -5.29 59.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.698 0.761 . . . . 0.0 109.676 178.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 803' ' ' GLY . . . . . . . . . . . . . . . 87.88 43.86 5.59 Favored Glycine 0 N--CA 1.439 -1.14 0 CA-C-N 114.435 -1.257 . . . . 0.0 111.258 -177.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 804' ' ' CYS . . . . . 0.528 ' HB3' ' HB3' ' A' ' 800' ' ' ASP . 30.6 t -107.99 108.69 19.92 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 -179.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 805' ' ' VAL . . . . . 0.523 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 4.8 t -85.75 110.53 19.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 121.178 0.514 . . . . 0.0 110.616 -175.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 806' ' ' VAL . . . . . 0.418 HG21 ' HD2' ' A' ' 721' ' ' PRO . 94.1 t -94.69 141.12 15.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.233 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -80.89 109.83 3.03 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.146 178.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 808' ' ' LEU . . . . . 0.515 HD13 ' HA ' ' A' ' 797' ' ' SER . 10.5 mp -73.61 126.85 31.21 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 178.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 20.5 m -141.59 85.7 1.96 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.171 170.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 810' ' ' GLN . . . . . 0.488 ' HB3' ' HD2' ' A' ' 811' ' ' PRO . 11.0 mt-30 -145.56 169.36 9.89 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.303 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 811' ' ' PRO . . . . . 0.488 ' HD2' ' HB3' ' A' ' 810' ' ' GLN . 88.1 Cg_exo -43.94 139.19 5.86 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 123.336 2.69 . . . . 0.0 115.714 -171.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -107.78 167.94 9.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.355 -1.293 . . . . 0.0 109.763 175.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 813' ' ' ALA . . . . . . . . . . . . . . . -127.36 151.9 48.19 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.304 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 814' ' ' LYS . . . . . 0.437 ' HG3' ' CG1' ' A' ' 792' ' ' ILE . 13.9 ttpp -113.54 127.86 56.23 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 121.709 0.766 . . . . 0.0 111.265 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 815' ' ' ILE . . . . . 0.558 ' HA ' ' HB2' ' A' ' 731' ' ' LEU . 4.3 mp -106.01 125.09 61.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.386 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 816' ' ' GLN . . . . . 0.659 ' NE2' ' HG2' ' A' ' 818' ' ' ARG . 0.8 OUTLIER -115.19 116.65 28.71 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.275 0.56 . . . . 0.0 111.027 -178.291 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 817' ' ' VAL . . . . . 0.723 HG12 ' HA2' ' A' ' 788' ' ' GLY . 58.7 t -109.94 133.22 55.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.882 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 818' ' ' ARG . . . . . 0.694 ' O ' ' HA ' ' A' ' 734' ' ' CYS . 85.4 mmt-85 . . . . . 0 C--N 1.324 -0.519 0 CA-C-O 120.914 0.388 . . . . 0.0 110.395 175.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 720' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt . . . . . 0 N--CA 1.446 -0.63 0 CA-C-O 120.695 0.283 . . . . 0.0 110.402 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 721' ' ' PRO . . . . . 0.513 ' HB2' HD13 ' A' ' 798' ' ' ILE . 60.7 Cg_endo -88.6 145.16 5.71 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 122.897 2.398 . . . . 0.0 111.429 177.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 722' ' ' SER . . . . . 0.643 ' HA ' HD22 ' A' ' 808' ' ' LEU . 10.7 t -175.9 -153.04 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.82 0.343 . . . . 0.0 110.524 -175.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 723' ' ' ALA . . . . . 0.536 ' HA ' ' HA ' ' A' ' 745' ' ' LEU . . . -149.49 143.19 25.49 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.361 -0.381 . . . . 0.0 109.99 179.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 9.4 m -131.37 98.61 4.58 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 725' ' ' LEU . . . . . 0.471 ' CD2' ' HB ' ' A' ' 743' ' ' VAL . 12.7 mt -64.42 143.49 57.87 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-O 121.695 0.759 . . . . 0.0 111.557 -175.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 34.2 mtpt -96.77 -18.75 19.4 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.866 -176.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 727' ' ' LEU . . . . . 0.533 HD21 ' HB2' ' A' ' 731' ' ' LEU . 33.7 tp -69.66 112.67 6.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.854 175.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 31.3 t-80 -112.78 45.83 1.28 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.695 0.283 . . . . 0.0 111.573 -174.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -177.77 -177.91 0.68 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.698 -0.228 . . . . 0.0 110.643 177.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 730' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -76.42 137.6 39.83 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.194 0.521 . . . . 0.0 109.71 175.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 731' ' ' LEU . . . . . 0.556 HD23 ' HB2' ' A' ' 739' ' ' SER . 25.9 tp -100.42 113.05 25.5 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.865 -176.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 732' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -78.29 110.8 13.63 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.047 -173.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 733' ' ' LEU . . . . . 0.634 ' HG ' ' HB3' ' A' ' 737' ' ' ASP . 8.5 mp -117.5 163.75 15.94 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.489 175.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 734' ' ' CYS . . . . . 0.538 ' HA ' ' O ' ' A' ' 818' ' ' ARG . 74.5 m -115.82 -173.85 2.42 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.826 175.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 735' ' ' LEU . . . . . . . . . . . . . 16.7 tp -65.92 123.71 20.54 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.794 0.33 . . . . 0.0 110.531 -177.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 79.64 13.29 82.65 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.472 -0.87 . . . . 0.0 112.312 179.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 737' ' ' ASP . . . . . 0.634 ' HB3' ' HG ' ' A' ' 733' ' ' LEU . 0.3 OUTLIER -80.72 151.99 28.59 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.03 0.443 . . . . 0.0 111.057 175.987 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 738' ' ' HIS . . . . . 0.485 ' HB2' ' O ' ' A' ' 782' ' ' THR . 38.6 p-80 -117.08 149.22 40.67 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 170.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 739' ' ' SER . . . . . 0.556 ' HB2' HD23 ' A' ' 731' ' ' LEU . 5.3 p -103.95 167.63 9.65 Favored 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 119.387 -0.925 . . . . 0.0 111.549 -169.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 740' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 780' ' ' ILE . 40.4 m -139.07 100.41 4.02 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.327 176.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 741' ' ' VAL . . . . . 0.614 HG11 HD23 ' A' ' 793' ' ' LEU . 0.9 OUTLIER -111.86 113.87 52.22 Favored Pre-proline 0 C--N 1.317 -0.831 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.873 -179.434 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 742' ' ' PRO . . . . . 0.691 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 1.0 OUTLIER -74.98 132.95 16.03 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 122.278 1.985 . . . . 0.0 111.454 -179.093 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 743' ' ' VAL . . . . . 0.514 HG21 ' HB1' ' A' ' 723' ' ' ALA . 2.0 p -130.21 120.35 48.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.405 0.622 . . . . 0.0 112.316 175.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 744' ' ' ALA . . . . . 0.643 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -80.72 95.26 6.56 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 122.098 0.951 . . . . 0.0 108.697 168.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 745' ' ' LEU . . . . . 0.603 HD11 ' HB3' ' A' ' 778' ' ' TYR . 3.0 mt -74.92 151.62 38.89 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.165 -1.38 . . . . 0.0 111.477 -170.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 19.8 ttmm -106.36 162.26 13.84 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.001 -178.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 747' ' ' GLY . . . . . . . . . . . . . . . 99.74 129.87 6.76 Favored Glycine 0 C--N 1.308 -0.975 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.458 -175.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 40.1 mm-40 -107.43 107.8 18.85 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.856 -174.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 125.89 -171.43 17.72 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.848 -0.691 . . . . 0.0 111.927 -179.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -70.2 95.11 0.58 Allowed 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.953 2.435 . . . . 0.0 112.177 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 751' ' ' PHE . . . . . 0.539 ' HA ' ' O ' ' A' ' 799' ' ' LYS . 76.2 m-85 -117.25 135.39 53.85 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.239 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 752' ' ' THR . . . . . 0.751 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 89.8 m -85.95 107.65 17.83 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 753' ' ' LEU . . . . . 0.497 ' HG ' HD22 ' A' ' 745' ' ' LEU . 0.6 OUTLIER -97.93 117.73 32.9 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.322 -171.944 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 754' ' ' THR . . . . . 0.447 HG23 ' HB2' ' A' ' 769' ' ' GLU . 1.0 OUTLIER -118.17 139.28 51.5 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.056 -177.002 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 755' ' ' TYR . . . . . 0.7 ' CE1' ' HB3' ' A' ' 768' ' ' PHE . 22.5 p90 -147.1 158.81 44.06 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 756' ' ' ASP . . . . . 0.467 ' HB3' HG23 ' A' ' 758' ' ' ILE . 0.4 OUTLIER -122.77 120.5 33.76 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.833 -178.262 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 757' ' ' ILE . . . . . 0.554 ' CD1' HD13 ' A' ' 793' ' ' LEU . 3.8 mp -89.3 96.51 6.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 170.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 758' ' ' ILE . . . . . 0.55 HG13 ' O ' ' A' ' 792' ' ' ILE . 2.5 pp -98.65 152.01 4.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 121.52 0.676 . . . . 0.0 112.593 -168.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 759' ' ' GLU . . . . . 0.609 ' HG2' ' CE2' ' A' ' 791' ' ' TYR . 2.6 mt-10 -91.15 120.08 31.8 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.422 -179.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 760' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.312 -1.028 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.725 172.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 765' ' ' ARG . . . . . 0.525 ' HD2' HG22 ' A' ' 758' ' ' ILE . 68.8 mtm180 . . . . . 0 N--CA 1.464 0.24 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 766' ' ' LYS . . . . . 0.628 ' HD3' ' N ' ' A' ' 767' ' ' THR . 8.1 tmtt? -145.11 136.93 25.57 Favored 'General case' 0 C--O 1.216 -0.686 0 CA-C-O 120.971 0.415 . . . . 0.0 110.423 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 767' ' ' THR . . . . . 0.628 ' N ' ' HD3' ' A' ' 766' ' ' LYS . 84.8 m -114.0 128.14 56.26 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.544 -176.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 768' ' ' PHE . . . . . 0.7 ' HB3' ' CE1' ' A' ' 755' ' ' TYR . 2.9 t80 -128.62 137.24 51.57 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 769' ' ' GLU . . . . . 0.447 ' HB2' HG23 ' A' ' 754' ' ' THR . 34.7 tt0 -130.58 122.38 27.4 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.706 -175.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 770' ' ' ILE . . . . . 0.621 HG22 HG22 ' A' ' 773' ' ' ILE . 6.0 mt -117.14 111.15 33.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 177.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 771' ' ' LYS . . . . . 0.633 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 13.4 mtpt -85.03 150.2 25.05 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-O 121.547 0.689 . . . . 0.0 112.065 -173.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 772' ' ' GLU . . . . . 0.425 ' O ' ' HG3' ' A' ' 774' ' ' LYS . 3.6 mt-10 52.1 49.63 20.22 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 113.897 -1.501 . . . . 0.0 111.865 177.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 773' ' ' ILE . . . . . 0.718 HD12 ' H ' ' A' ' 775' ' ' THR . 0.5 OUTLIER -73.75 118.6 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 176.266 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 774' ' ' LYS . . . . . 0.425 ' HG3' ' O ' ' A' ' 772' ' ' GLU . 73.9 mttt -116.23 30.16 7.51 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -178.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 775' ' ' THR . . . . . 0.718 ' H ' HD12 ' A' ' 773' ' ' ILE . 1.6 m -95.9 -73.25 0.6 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 113.79 -1.55 . . . . 0.0 112.238 -171.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 776' ' ' ASN . . . . . 0.472 ' HB2' ' O ' ' A' ' 775' ' ' THR . 11.6 m120 88.14 5.59 0.23 Allowed 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.622 1.169 . . . . 0.0 110.62 179.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 777' ' ' GLU . . . . . 0.643 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 30.7 tt0 -161.94 100.47 1.12 Allowed 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.875 171.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 778' ' ' TYR . . . . . 0.603 ' HB3' HD11 ' A' ' 745' ' ' LEU . 81.8 t80 -141.92 129.98 22.02 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.63 -170.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 779' ' ' VAL . . . . . 0.691 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 14.4 t -89.22 114.11 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 CA-C-O 121.259 0.552 . . . . 0.0 110.094 -179.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 780' ' ' ILE . . . . . 0.472 ' O ' ' HA ' ' A' ' 740' ' ' SER . 77.7 mt -81.17 141.72 14.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.604 -178.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 781' ' ' LYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 739' ' ' SER . 0.0 OUTLIER -121.54 109.4 14.77 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 176.288 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 782' ' ' THR . . . . . 0.485 ' O ' ' HB2' ' A' ' 738' ' ' HIS . 38.7 p -79.08 143.51 61.33 Favored Pre-proline 0 C--N 1.32 -0.705 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -178.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 783' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 782' ' ' THR . 52.4 Cg_exo -53.17 158.19 7.41 Favored 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 123.546 2.83 . . . . 0.0 113.179 -177.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 784' ' ' VAL . . . . . 0.472 HG12 HG23 ' A' ' 786' ' ' THR . 53.5 t -58.93 118.69 2.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.157 -179.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 785' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -98.43 97.19 8.56 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.913 178.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 786' ' ' THR . . . . . 0.472 HG23 HG12 ' A' ' 784' ' ' VAL . 38.4 p -84.71 31.49 0.53 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.711 0.767 . . . . 0.0 111.201 -178.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 77.6 m -152.27 112.59 4.08 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.847 -1.07 . . . . 0.0 110.829 179.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 788' ' ' GLY . . . . . 0.628 ' HA2' HG12 ' A' ' 817' ' ' VAL . . . -51.57 114.13 2.84 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.648 171.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 789' ' ' GLY . . . . . 0.573 ' H ' ' HB ' ' A' ' 817' ' ' VAL . . . -158.52 -167.26 19.08 Favored Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 110.391 -1.083 . . . . 0.0 110.391 -178.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -128.3 124.75 37.3 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 117.629 0.715 . . . . 0.0 109.864 -178.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 791' ' ' TYR . . . . . 0.609 ' CE2' ' HG2' ' A' ' 759' ' ' GLU . 97.7 m-85 -120.67 149.48 42.43 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.32 -176.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 792' ' ' ILE . . . . . 0.55 ' O ' HG13 ' A' ' 758' ' ' ILE . 12.5 mt -126.88 116.46 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 171.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 793' ' ' LEU . . . . . 0.614 HD23 HG11 ' A' ' 741' ' ' VAL . 0.9 OUTLIER -84.95 113.14 21.19 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.211 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 794' ' ' SER . . . . . 0.527 ' N ' HD12 ' A' ' 793' ' ' LEU . 21.6 t -122.76 164.6 18.03 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.997 -176.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 795' ' ' LEU . . . . . 0.432 HD13 ' HB3' ' A' ' 723' ' ' ALA . 21.6 mt -94.49 134.11 37.37 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.992 -173.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 796' ' ' VAL . . . . . . . . . . . . . 67.8 t -95.51 -55.79 5.79 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.767 -176.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 797' ' ' SER . . . . . 0.583 ' HA ' ' HG ' ' A' ' 808' ' ' LEU . 87.5 p -177.33 160.22 1.65 Allowed 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.755 -174.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 798' ' ' ILE . . . . . 0.685 ' HA ' ' O ' ' A' ' 752' ' ' THR . 9.4 tt -131.35 166.95 27.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 177.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 799' ' ' LYS . . . . . 0.751 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 15.6 tttm -136.62 117.25 13.91 Favored 'General case' 0 C--N 1.322 -0.623 0 O-C-N 122.26 -0.275 . . . . 0.0 111.65 -174.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 800' ' ' ASP . . . . . 0.489 ' HB3' ' HB3' ' A' ' 804' ' ' CYS . 24.2 t70 -69.9 157.14 37.98 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 170.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 58.0 p -63.09 -8.92 8.67 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -170.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 26.6 p -89.0 -1.75 58.26 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.636 0.731 . . . . 0.0 109.875 176.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 803' ' ' GLY . . . . . . . . . . . . . . . 84.59 27.14 36.39 Favored Glycine 0 N--CA 1.439 -1.111 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.028 -176.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 804' ' ' CYS . . . . . 0.489 ' HB3' ' HB3' ' A' ' 800' ' ' ASP . 46.1 t -94.43 108.94 20.84 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -178.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 805' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 4.2 p -85.58 119.6 34.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.875 0.845 . . . . 0.0 110.626 -176.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 806' ' ' VAL . . . . . 0.464 HG11 ' HD2' ' A' ' 721' ' ' PRO . 21.4 t -102.03 135.36 39.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.106 -178.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -73.12 125.24 9.5 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.997 -177.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 808' ' ' LEU . . . . . 0.643 HD22 ' HA ' ' A' ' 722' ' ' SER . 49.3 mt -89.91 123.36 33.78 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.162 0.506 . . . . 0.0 112.225 -177.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 22.5 m -142.12 86.61 1.98 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.101 175.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 810' ' ' GLN . . . . . 0.45 ' HB3' ' HD2' ' A' ' 811' ' ' PRO . 8.1 mt-30 -144.54 173.58 4.24 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.23 175.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 811' ' ' PRO . . . . . 0.45 ' HD2' ' HB3' ' A' ' 810' ' ' GLN . 82.5 Cg_exo -45.0 140.86 6.75 Favored 'Trans proline' 0 C--N 1.358 1.05 0 C-N-CA 123.102 2.534 . . . . 0.0 114.716 -177.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -109.09 167.21 10.27 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.653 -1.158 . . . . 0.0 110.418 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 813' ' ' ALA . . . . . 0.503 ' HB1' HD23 ' A' ' 727' ' ' LEU . . . -116.25 156.82 25.92 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.687 -179.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 814' ' ' LYS . . . . . 0.456 ' HG2' HG12 ' A' ' 792' ' ' ILE . 49.2 mttp -118.76 125.04 48.74 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.121 0.486 . . . . 0.0 110.821 177.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 815' ' ' ILE . . . . . 0.538 ' HA ' ' HB3' ' A' ' 731' ' ' LEU . 5.3 mp -113.02 117.4 55.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 115.311 -0.859 . . . . 0.0 108.888 178.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 816' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -103.71 113.36 26.82 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.195 -177.243 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 817' ' ' VAL . . . . . 0.628 HG12 ' HA2' ' A' ' 788' ' ' GLY . 43.8 t -106.02 137.28 36.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 818' ' ' ARG . . . . . 0.538 ' O ' ' HA ' ' A' ' 734' ' ' CYS . 22.4 tpt180 . . . . . 0 C--N 1.322 -0.595 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -178.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 720' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt . . . . . 0 N--CA 1.444 -0.734 0 CA-C-O 120.772 0.32 . . . . 0.0 110.17 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 721' ' ' PRO . . . . . 0.746 ' HD2' HG11 ' A' ' 806' ' ' VAL . 36.4 Cg_endo -83.95 137.92 7.75 Favored 'Trans proline' 0 N--CA 1.447 -1.227 0 C-N-CA 122.597 2.198 . . . . 0.0 110.601 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 32.4 p -176.25 -150.58 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.205 -167.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 723' ' ' ALA . . . . . 0.602 ' HA ' ' HA ' ' A' ' 745' ' ' LEU . . . -155.09 149.4 26.08 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 110.428 -0.212 . . . . 0.0 110.428 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 15.9 m -139.89 98.78 3.54 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 725' ' ' LEU . . . . . 0.578 ' HA ' ' HA ' ' A' ' 743' ' ' VAL . 6.2 mp -59.84 142.19 53.95 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 122.328 1.061 . . . . 0.0 112.551 -175.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 36.9 mtpt -91.41 -16.7 26.96 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 113.269 -1.787 . . . . 0.0 110.309 -176.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 727' ' ' LEU . . . . . 0.547 HD23 ' HB1' ' A' ' 813' ' ' ALA . 51.1 tp -70.24 126.93 31.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.016 178.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -119.26 29.93 7.39 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -174.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 9.7 p80 -166.94 170.78 11.81 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.73 0.3 . . . . 0.0 110.434 177.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 730' ' ' ASP . . . . . 0.527 ' HA ' ' O ' ' A' ' 814' ' ' LYS . 10.3 p-10 -79.44 138.57 37.64 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.69 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 731' ' ' LEU . . . . . 0.591 HD13 ' HB2' ' A' ' 739' ' ' SER . 35.1 mt -87.23 107.76 18.63 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.485 -177.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 732' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt -81.59 96.71 7.56 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.013 -176.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 733' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.95 163.97 14.01 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.328 0.585 . . . . 0.0 111.904 -178.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 734' ' ' CYS . . . . . 0.588 ' O ' ' HB2' ' A' ' 737' ' ' ASP . 72.5 m -105.39 -172.98 2.19 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.032 -0.986 . . . . 0.0 109.66 176.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 735' ' ' LEU . . . . . . . . . . . . . 13.4 tp -73.83 138.68 44.59 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.444 0.64 . . . . 0.0 112.03 -172.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 74.38 14.8 80.59 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 114.756 -1.111 . . . . 0.0 111.286 -177.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 737' ' ' ASP . . . . . 0.588 ' HB2' ' O ' ' A' ' 734' ' ' CYS . 1.0 OUTLIER -89.34 147.09 24.27 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.394 0.616 . . . . 0.0 112.036 177.61 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 738' ' ' HIS . . . . . 0.643 ' HB2' ' O ' ' A' ' 782' ' ' THR . 46.5 p-80 -110.31 177.49 4.68 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 167.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 739' ' ' SER . . . . . 0.591 ' HB2' HD13 ' A' ' 731' ' ' LEU . 16.5 p -138.36 171.08 14.9 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 118.519 -1.272 . . . . 0.0 112.503 -174.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 12.4 p -133.44 110.86 10.28 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.314 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 741' ' ' VAL . . . . . 0.567 HG11 HD23 ' A' ' 793' ' ' LEU . 1.5 p -119.31 113.9 35.04 Favored Pre-proline 0 C--N 1.319 -0.745 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.031 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 742' ' ' PRO . . . . . 0.669 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 2.2 Cg_endo -77.9 136.35 14.86 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.389 2.059 . . . . 0.0 111.641 -178.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 743' ' ' VAL . . . . . 0.578 ' HA ' ' HA ' ' A' ' 725' ' ' LEU . 2.1 p -132.45 121.52 45.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.602 0.715 . . . . 0.0 112.466 177.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 744' ' ' ALA . . . . . 0.619 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -79.46 95.69 5.87 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 122.17 0.985 . . . . 0.0 108.769 168.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 745' ' ' LEU . . . . . 0.744 HD11 ' HB3' ' A' ' 778' ' ' TYR . 2.0 mt -77.68 160.18 28.65 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 114.074 -1.421 . . . . 0.0 111.137 -172.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 31.8 ttmt -116.29 167.15 11.27 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.793 -178.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 747' ' ' GLY . . . . . . . . . . . . . . . 93.78 125.0 3.99 Favored Glycine 0 C--N 1.309 -0.921 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.384 -173.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 67.0 mm-40 -100.24 114.29 27.61 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.877 0.37 . . . . 0.0 111.532 -175.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 119.98 -175.92 16.02 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.923 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -67.95 94.39 0.4 Allowed 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.929 2.419 . . . . 0.0 112.259 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 751' ' ' PHE . . . . . 0.415 ' HB3' HG12 ' A' ' 798' ' ' ILE . 53.7 m-85 -108.98 141.62 40.81 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.313 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 752' ' ' THR . . . . . 0.768 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 99.2 m -88.39 101.77 14.22 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 121.737 0.779 . . . . 0.0 109.645 177.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 753' ' ' LEU . . . . . . . . . . . . . 16.9 tp -90.19 125.2 35.39 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 114.409 -1.269 . . . . 0.0 110.511 -171.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 754' ' ' THR . . . . . 0.449 HG23 ' HB2' ' A' ' 769' ' ' GLU . 0.6 OUTLIER -123.48 131.24 53.58 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.159 -179.866 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 755' ' ' TYR . . . . . 0.587 ' CE1' ' HB3' ' A' ' 768' ' ' PHE . 22.3 p90 -141.39 157.34 45.31 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.801 0.334 . . . . 0.0 111.207 178.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 756' ' ' ASP . . . . . 0.463 ' HB3' HG23 ' A' ' 758' ' ' ILE . 0.5 OUTLIER -119.82 118.48 30.92 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.256 -176.386 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 757' ' ' ILE . . . . . 0.509 HG13 HD13 ' A' ' 793' ' ' LEU . 3.5 mp -87.93 95.91 5.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 168.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 758' ' ' ILE . . . . . 0.615 HG13 ' O ' ' A' ' 792' ' ' ILE . 2.3 pp -94.68 149.62 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.256 -173.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 759' ' ' GLU . . . . . 0.667 ' HB3' ' CE2' ' A' ' 791' ' ' TYR . 8.7 pt-20 -107.09 129.36 54.83 Favored 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.132 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 760' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.319 -0.754 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 176.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 765' ' ' ARG . . . . . 0.45 ' HA ' ' HA ' ' A' ' 758' ' ' ILE . 48.7 mtm180 . . . . . 0 C--O 1.232 0.183 0 CA-C-O 120.882 0.373 . . . . 0.0 110.707 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 766' ' ' LYS . . . . . 0.46 ' O ' ' HA ' ' A' ' 756' ' ' ASP . 0.7 OUTLIER -120.5 143.12 48.72 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 -179.887 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 767' ' ' THR . . . . . . . . . . . . . 87.6 m -119.32 130.71 55.51 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.949 -176.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 768' ' ' PHE . . . . . 0.587 ' HB3' ' CE1' ' A' ' 755' ' ' TYR . 1.8 t80 -127.09 128.67 46.61 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 174.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 769' ' ' GLU . . . . . 0.449 ' HB2' HG23 ' A' ' 754' ' ' THR . 40.0 tt0 -126.22 118.27 24.82 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.782 -175.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 9.0 mt -116.12 113.29 42.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.557 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 771' ' ' LYS . . . . . 0.647 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 6.1 mtpt -82.56 151.98 26.17 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-O 121.394 0.616 . . . . 0.0 111.079 -178.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 772' ' ' GLU . . . . . 0.42 ' O ' ' HG3' ' A' ' 774' ' ' LYS . 8.0 mt-10 57.75 46.92 16.38 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.169 -1.378 . . . . 0.0 112.28 176.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 773' ' ' ILE . . . . . 0.637 HD12 ' H ' ' A' ' 775' ' ' THR . 0.5 OUTLIER -73.85 119.46 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 172.969 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 774' ' ' LYS . . . . . 0.42 ' HG3' ' O ' ' A' ' 772' ' ' GLU . 74.0 mttt -118.21 30.53 7.18 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -177.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 775' ' ' THR . . . . . 0.637 ' H ' HD12 ' A' ' 773' ' ' ILE . 0.2 OUTLIER -96.06 -73.57 0.59 Allowed 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 113.988 -1.46 . . . . 0.0 112.498 -171.43 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 776' ' ' ASN . . . . . 0.439 ' HB2' ' O ' ' A' ' 775' ' ' THR . 11.7 m120 83.48 4.3 0.86 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.504 1.121 . . . . 0.0 110.431 -176.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 777' ' ' GLU . . . . . 0.619 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 22.5 mt-10 -161.56 88.41 0.71 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.998 -1.001 . . . . 0.0 108.643 173.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 778' ' ' TYR . . . . . 0.744 ' HB3' HD11 ' A' ' 745' ' ' LEU . 50.2 t80 -130.88 132.41 45.13 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.644 -169.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 779' ' ' VAL . . . . . 0.669 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 20.1 t -87.07 113.78 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 CA-C-O 121.209 0.528 . . . . 0.0 110.396 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 780' ' ' ILE . . . . . . . . . . . . . 66.0 mt -82.79 143.41 12.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.577 -178.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.73 110.55 17.97 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 176.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 782' ' ' THR . . . . . 0.643 ' O ' ' HB2' ' A' ' 738' ' ' HIS . 29.8 p -77.56 142.07 66.02 Favored Pre-proline 0 C--N 1.317 -0.834 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 783' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 782' ' ' THR . 38.0 Cg_exo -57.46 166.02 5.2 Favored 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 123.364 2.709 . . . . 0.0 112.229 -179.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 784' ' ' VAL . . . . . . . . . . . . . 14.1 p -67.53 135.26 28.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.291 0.567 . . . . 0.0 111.065 -175.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 785' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -104.77 103.64 13.29 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.539 178.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 82.3 p -86.21 18.54 3.09 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.463 -172.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 29.9 m -158.11 121.77 4.01 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.66 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 788' ' ' GLY . . . . . 0.572 ' HA2' HG12 ' A' ' 817' ' ' VAL . . . -48.85 118.22 4.77 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.888 -0.596 . . . . 0.0 112.791 171.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 789' ' ' GLY . . . . . 0.545 ' H ' ' HB ' ' A' ' 817' ' ' VAL . . . -174.88 168.39 40.99 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -97.32 135.93 38.52 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 118.066 0.933 . . . . 0.0 110.692 -178.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 791' ' ' TYR . . . . . 0.667 ' CE2' ' HB3' ' A' ' 759' ' ' GLU . 70.3 m-85 -123.18 150.21 43.63 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.671 176.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 792' ' ' ILE . . . . . 0.615 ' O ' HG13 ' A' ' 758' ' ' ILE . 11.3 mt -128.7 110.38 21.0 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 793' ' ' LEU . . . . . 0.567 HD23 HG11 ' A' ' 741' ' ' VAL . 1.1 tp -84.2 111.75 19.65 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 794' ' ' SER . . . . . 0.517 ' N ' HD12 ' A' ' 793' ' ' LEU . 40.5 t -122.48 161.07 24.26 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.322 -1.308 . . . . 0.0 108.875 -175.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 795' ' ' LEU . . . . . . . . . . . . . 39.9 mt -88.71 142.67 27.48 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.658 -0.247 . . . . 0.0 110.738 -176.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 796' ' ' VAL . . . . . . . . . . . . . 73.4 t -102.73 -55.18 6.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.186 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 797' ' ' SER . . . . . 0.511 ' HA ' HD13 ' A' ' 808' ' ' LEU . 7.4 t -178.03 177.78 1.0 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.475 -173.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 798' ' ' ILE . . . . . 0.634 ' HA ' ' O ' ' A' ' 752' ' ' THR . 9.2 tt -150.15 163.12 3.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 799' ' ' LYS . . . . . 0.768 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 9.6 tmtt? -138.71 119.53 14.22 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.895 0.379 . . . . 0.0 111.0 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 800' ' ' ASP . . . . . 0.595 ' HB3' ' HB3' ' A' ' 804' ' ' CYS . 14.1 t70 -64.12 155.72 30.62 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.729 174.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 3.5 m -60.01 -17.22 37.15 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 124.071 0.857 . . . . 0.0 112.596 -173.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 802' ' ' THR . . . . . 0.423 HG22 ' OD1' ' A' ' 800' ' ' ASP . 13.0 t -89.86 -0.55 57.63 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 121.836 0.827 . . . . 0.0 109.636 177.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 803' ' ' GLY . . . . . 0.454 ' HA2' ' HE2' ' A' ' 799' ' ' LYS . . . 86.68 38.23 8.24 Favored Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.846 -178.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 804' ' ' CYS . . . . . 0.595 ' HB3' ' HB3' ' A' ' 800' ' ' ASP . 46.5 t -99.73 105.15 16.92 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 805' ' ' VAL . . . . . . . . . . . . . 5.9 t -85.51 122.87 38.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.246 0.546 . . . . 0.0 110.143 -176.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 806' ' ' VAL . . . . . 0.746 HG11 ' HD2' ' A' ' 721' ' ' PRO . 32.4 t -114.43 136.99 49.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.552 -174.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -81.89 110.31 3.16 Favored Glycine 0 C--N 1.322 -0.207 0 C-N-CA 120.76 -0.733 . . . . 0.0 113.279 -176.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 808' ' ' LEU . . . . . 0.511 HD13 ' HA ' ' A' ' 797' ' ' SER . 10.9 mp -81.36 123.58 28.66 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 178.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 9.7 t -141.91 86.78 2.0 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 168.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 810' ' ' GLN . . . . . 0.459 ' HB3' ' O ' ' A' ' 723' ' ' ALA . 0.9 OUTLIER -146.07 176.07 2.4 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.879 -171.238 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 811' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_exo -41.61 142.91 1.11 Allowed 'Trans proline' 0 C--N 1.362 1.258 0 C-N-CA 123.559 2.839 . . . . 0.0 115.495 -171.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -125.37 167.57 14.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.348 -1.296 . . . . 0.0 110.577 -176.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 813' ' ' ALA . . . . . 0.547 ' HB1' HD23 ' A' ' 727' ' ' LEU . . . -122.31 158.56 29.29 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.714 178.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 814' ' ' LYS . . . . . 0.527 ' O ' ' HA ' ' A' ' 730' ' ' ASP . 21.5 ttpp -123.55 111.42 16.25 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.381 0.61 . . . . 0.0 110.521 175.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 815' ' ' ILE . . . . . 0.53 ' HA ' ' HB2' ' A' ' 731' ' ' LEU . 5.4 mp -92.54 113.67 28.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 115.364 -0.834 . . . . 0.0 108.837 177.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 816' ' ' GLN . . . . . 0.53 HE22 ' HB2' ' A' ' 818' ' ' ARG . 1.1 tm0? -99.55 108.38 20.78 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.258 0.551 . . . . 0.0 110.119 -177.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 817' ' ' VAL . . . . . 0.572 HG12 ' HA2' ' A' ' 788' ' ' GLY . 42.0 t -99.08 143.66 13.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.81 -179.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 818' ' ' ARG . . . . . 0.53 ' HB2' HE22 ' A' ' 816' ' ' GLN . 30.1 tpt180 . . . . . 0 C--N 1.318 -0.761 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 720' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp . . . . . 0 N--CA 1.447 -0.585 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 721' ' ' PRO . . . . . 0.455 ' HB2' HD13 ' A' ' 798' ' ' ILE . 59.5 Cg_endo -84.79 146.65 10.55 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 122.106 1.871 . . . . 0.0 112.042 -172.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 722' ' ' SER . . . . . 0.542 ' HA ' HD22 ' A' ' 808' ' ' LEU . 22.7 t -177.39 -157.29 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.597 -171.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 723' ' ' ALA . . . . . 0.643 ' HB1' HG21 ' A' ' 743' ' ' VAL . . . -148.97 142.07 24.91 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 176.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 724' ' ' SER . . . . . 0.436 ' HB2' ' OE1' ' A' ' 810' ' ' GLN . 23.0 t -130.98 105.04 7.48 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -178.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 725' ' ' LEU . . . . . 0.495 ' CD2' ' HB ' ' A' ' 743' ' ' VAL . 14.0 mt -65.31 149.17 50.42 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-O 121.854 0.835 . . . . 0.0 112.31 -173.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 726' ' ' LYS . . . . . 0.403 ' HB2' ' HB2' ' A' ' 742' ' ' PRO . 40.0 mtpt -100.32 -17.05 17.46 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 114.072 -1.422 . . . . 0.0 109.547 -177.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 727' ' ' LEU . . . . . 0.58 HD23 ' HB1' ' A' ' 813' ' ' ALA . 23.6 tp -66.13 117.24 8.16 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.845 177.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 9.8 t-80 -111.85 33.34 4.85 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -170.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -172.62 168.73 5.2 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.543 0.211 . . . . 0.0 110.546 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 730' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -73.25 126.63 30.53 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.479 0.657 . . . . 0.0 110.042 176.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 731' ' ' LEU . . . . . 0.682 HD23 ' HB2' ' A' ' 739' ' ' SER . 16.2 tp -85.94 101.29 12.76 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.01 -0.995 . . . . 0.0 111.473 -173.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 732' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -77.72 115.79 17.75 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.876 -177.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 733' ' ' LEU . . . . . 0.568 HD21 ' HG ' ' A' ' 731' ' ' LEU . 23.9 mt -118.77 165.41 14.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.414 -178.036 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 734' ' ' CYS . . . . . . . . . . . . . 69.4 m -106.18 -176.79 3.18 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.413 174.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 735' ' ' LEU . . . . . 0.511 HD23 ' N ' ' A' ' 736' ' ' GLY . 2.4 tt -63.75 130.49 44.42 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.425 -175.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 736' ' ' GLY . . . . . 0.511 ' N ' HD23 ' A' ' 735' ' ' LEU . . . 72.05 15.76 76.53 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.212 175.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 737' ' ' ASP . . . . . 0.499 ' HB3' ' HB3' ' A' ' 733' ' ' LEU . 20.6 t0 -80.59 161.4 24.75 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.18 0.514 . . . . 0.0 110.102 178.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 50.3 p-80 -120.72 153.18 37.3 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 173.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 739' ' ' SER . . . . . 0.682 ' HB2' HD23 ' A' ' 731' ' ' LEU . 1.4 p -101.56 160.64 14.27 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 118.954 -1.099 . . . . 0.0 111.383 -171.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 740' ' ' SER . . . . . 0.431 ' H ' HD21 ' A' ' 731' ' ' LEU . 39.3 t -132.73 100.41 4.92 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.703 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 741' ' ' VAL . . . . . 0.588 HG11 HD13 ' A' ' 793' ' ' LEU . 1.3 p -120.05 108.59 38.32 Favored Pre-proline 0 C--N 1.316 -0.883 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.884 -177.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 742' ' ' PRO . . . . . 0.687 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 2.5 Cg_endo -74.36 137.26 23.03 Favored 'Trans proline' 0 N--CA 1.448 -1.179 0 C-N-CA 122.316 2.011 . . . . 0.0 110.895 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 743' ' ' VAL . . . . . 0.643 HG21 ' HB1' ' A' ' 723' ' ' ALA . 1.6 p -135.64 120.38 27.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.49 0.662 . . . . 0.0 112.267 177.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 744' ' ' ALA . . . . . 0.49 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -83.4 100.91 10.99 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 168.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 745' ' ' LEU . . . . . 0.917 HD13 HD13 ' A' ' 773' ' ' ILE . 0.2 OUTLIER -82.47 168.64 17.23 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 113.936 -1.483 . . . . 0.0 111.073 -167.222 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -123.39 146.19 48.17 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.675 -175.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 747' ' ' GLY . . . . . . . . . . . . . . . 101.86 123.38 5.21 Favored Glycine 0 C--N 1.312 -0.782 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.869 -178.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -103.6 120.81 41.63 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.793 0.33 . . . . 0.0 110.851 -174.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 127.31 179.83 16.01 Favored Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.74 -178.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -70.56 93.53 0.59 Allowed 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.339 2.026 . . . . 0.0 111.936 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 751' ' ' PHE . . . . . 0.503 ' CE2' ' HA ' ' A' ' 800' ' ' ASP . 82.9 m-85 -112.19 142.09 45.08 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.901 179.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 752' ' ' THR . . . . . 0.733 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 85.0 m -92.18 106.01 18.11 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 177.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 753' ' ' LEU . . . . . 0.504 ' CD2' HD22 ' A' ' 745' ' ' LEU . 59.2 tp -94.6 114.69 26.69 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.924 -172.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 754' ' ' THR . . . . . 0.491 HG23 ' HB2' ' A' ' 769' ' ' GLU . 1.5 m -113.92 134.59 54.72 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.683 179.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 755' ' ' TYR . . . . . 0.636 ' CE1' ' HB3' ' A' ' 768' ' ' PHE . 25.6 p90 -143.2 156.79 44.84 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.088 0.471 . . . . 0.0 111.177 178.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 756' ' ' ASP . . . . . 0.541 ' HB2' HG23 ' A' ' 758' ' ' ILE . 2.2 p30 -106.41 125.76 51.41 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.211 -178.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 757' ' ' ILE . . . . . 0.446 ' HB ' ' HB3' ' A' ' 766' ' ' LYS . 3.5 mp -94.47 93.23 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 163.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 758' ' ' ILE . . . . . 0.552 HG22 ' HD3' ' A' ' 765' ' ' ARG . 2.3 pp -95.12 143.46 11.81 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-O 121.12 0.486 . . . . 0.0 111.6 -170.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -91.16 101.46 14.19 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.226 -176.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 760' ' ' THR . . . . . 0.462 HG23 ' CB ' ' A' ' 790' ' ' ASP . 0.5 OUTLIER . . . . . 0 C--N 1.317 -0.823 0 CA-C-O 121.869 0.842 . . . . 0.0 108.939 -178.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 765' ' ' ARG . . . . . 0.552 ' HD3' HG22 ' A' ' 758' ' ' ILE . 21.6 ttp180 . . . . . 0 N--CA 1.439 -0.983 0 CA-C-O 121.004 0.431 . . . . 0.0 111.001 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 766' ' ' LYS . . . . . 0.667 ' HD3' ' N ' ' A' ' 767' ' ' THR . 8.4 tmtm? -118.2 146.36 44.29 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 175.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 767' ' ' THR . . . . . 0.667 ' N ' ' HD3' ' A' ' 766' ' ' LYS . 32.3 m -124.41 125.19 43.88 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 110.048 -0.352 . . . . 0.0 110.048 178.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 768' ' ' PHE . . . . . 0.636 ' HB3' ' CE1' ' A' ' 755' ' ' TYR . 3.4 t80 -122.5 137.73 54.79 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 769' ' ' GLU . . . . . 0.491 ' HB2' HG23 ' A' ' 754' ' ' THR . 38.3 tt0 -133.23 130.37 38.96 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.397 -175.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 770' ' ' ILE . . . . . 0.579 HG22 HG22 ' A' ' 773' ' ' ILE . 3.7 mt -121.91 110.61 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 177.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 771' ' ' LYS . . . . . 0.626 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 11.4 mtpt -83.87 150.79 25.5 Favored 'General case' 0 N--CA 1.436 -1.175 0 CA-C-O 121.243 0.544 . . . . 0.0 110.889 -175.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 772' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 55.53 50.82 13.78 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.39 -1.277 . . . . 0.0 111.998 177.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 773' ' ' ILE . . . . . 0.917 HD13 HD13 ' A' ' 745' ' ' LEU . 0.5 OUTLIER -77.86 116.88 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 173.377 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 70.0 mttt -117.61 29.5 7.82 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -177.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 775' ' ' THR . . . . . 0.7 ' H ' HD12 ' A' ' 773' ' ' ILE . 1.8 m -97.2 -72.58 0.64 Allowed 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 114.748 -1.115 . . . . 0.0 112.868 -172.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 776' ' ' ASN . . . . . 0.62 ' HB2' ' O ' ' A' ' 775' ' ' THR . 0.9 OUTLIER 87.26 6.18 0.27 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.512 1.125 . . . . 0.0 109.915 -178.074 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 777' ' ' GLU . . . . . 0.49 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 1.4 tm-20 -161.91 86.16 0.63 Allowed 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 114.846 -1.07 . . . . 0.0 108.333 179.001 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 778' ' ' TYR . . . . . 0.812 ' HB3' HD11 ' A' ' 745' ' ' LEU . 87.3 t80 -137.28 134.36 36.03 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.686 -170.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 779' ' ' VAL . . . . . 0.687 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 23.5 t -89.94 117.96 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 CA-C-O 121.022 0.439 . . . . 0.0 110.529 177.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 780' ' ' ILE . . . . . 0.418 ' HB ' HG13 ' A' ' 741' ' ' VAL . 68.3 mt -88.47 143.26 11.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.782 -178.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 781' ' ' LYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 739' ' ' SER . 3.8 mppt? -124.21 109.39 13.36 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 175.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 782' ' ' THR . . . . . . . . . . . . . 42.9 p -78.06 144.92 68.45 Favored Pre-proline 0 C--N 1.321 -0.653 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -177.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 783' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -51.32 158.33 3.82 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 123.465 2.777 . . . . 0.0 113.193 -178.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 784' ' ' VAL . . . . . 0.508 HG12 HG23 ' A' ' 786' ' ' THR . 53.4 t -58.81 126.71 16.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.066 -0.97 . . . . 0.0 112.208 -176.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 785' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -103.85 98.2 8.08 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.883 176.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 786' ' ' THR . . . . . 0.508 HG23 HG12 ' A' ' 784' ' ' VAL . 37.1 p -87.22 32.48 0.69 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.704 0.764 . . . . 0.0 110.989 -178.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.45 110.97 3.51 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.533 -1.212 . . . . 0.0 110.59 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 788' ' ' GLY . . . . . . . . . . . . . . . -53.1 112.62 2.35 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.253 171.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 789' ' ' GLY . . . . . 0.485 ' H ' ' HB ' ' A' ' 817' ' ' VAL . . . -154.5 -151.55 5.84 Favored Glycine 0 N--CA 1.443 -0.893 0 N-CA-C 110.806 -0.917 . . . . 0.0 110.806 -178.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 790' ' ' ASP . . . . . 0.462 ' CB ' HG23 ' A' ' 760' ' ' THR . 4.3 m-20 -137.57 124.01 20.77 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 791' ' ' TYR . . . . . 0.488 ' HA ' ' O ' ' A' ' 758' ' ' ILE . 80.9 m-85 -124.64 152.91 43.05 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.294 -0.412 . . . . 0.0 109.99 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 792' ' ' ILE . . . . . 0.48 ' O ' HG13 ' A' ' 758' ' ' ILE . 14.4 mt -133.39 122.84 45.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 171.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 793' ' ' LEU . . . . . 0.588 HD13 HG11 ' A' ' 741' ' ' VAL . 10.4 tt -87.71 108.01 18.91 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 794' ' ' SER . . . . . 0.449 ' HB3' ' OD2' ' A' ' 756' ' ' ASP . 31.3 t -121.54 146.06 47.33 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.166 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 795' ' ' LEU . . . . . 0.515 ' H ' HD22 ' A' ' 795' ' ' LEU . 1.4 mm? -72.98 135.15 44.94 Favored 'General case' 0 N--CA 1.448 -0.569 0 O-C-N 122.062 -0.399 . . . . 0.0 111.481 -179.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 796' ' ' VAL . . . . . . . . . . . . . 66.7 t -95.91 -57.46 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.207 -177.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 797' ' ' SER . . . . . 0.588 ' HA ' ' HG ' ' A' ' 808' ' ' LEU . 35.7 m -171.38 157.02 4.77 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.719 -173.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 798' ' ' ILE . . . . . 0.558 ' HA ' ' O ' ' A' ' 752' ' ' THR . 13.2 tt -132.22 162.07 40.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 177.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 799' ' ' LYS . . . . . 0.733 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 22.1 tttt -129.83 118.19 21.37 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 120.967 0.413 . . . . 0.0 110.993 -174.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 800' ' ' ASP . . . . . 0.507 ' HB3' ' HB2' ' A' ' 804' ' ' CYS . 21.6 t70 -65.3 152.89 42.65 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.259 -0.882 . . . . 0.0 108.854 173.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 4.4 m -62.62 -8.56 6.71 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 123.768 0.667 . . . . 0.0 112.503 -171.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 40.1 p -96.67 5.62 50.32 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.426 0.631 . . . . 0.0 110.191 176.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 803' ' ' GLY . . . . . 0.53 ' HA2' ' HE2' ' A' ' 799' ' ' LYS . . . 77.98 42.25 16.6 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.029 -177.014 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 804' ' ' CYS . . . . . 0.507 ' HB2' ' HB3' ' A' ' 800' ' ' ASP . 69.4 m -110.24 106.87 16.45 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 176.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 805' ' ' VAL . . . . . 0.52 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 3.5 t -86.24 112.36 22.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.279 0.561 . . . . 0.0 111.071 -173.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 806' ' ' VAL . . . . . 0.452 ' HB ' HG22 ' A' ' 798' ' ' ILE . 73.4 t -90.0 135.14 27.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.152 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -73.7 120.57 6.95 Favored Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 111.601 -0.599 . . . . 0.0 111.601 178.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 808' ' ' LEU . . . . . 0.588 ' HG ' ' HA ' ' A' ' 797' ' ' SER . 45.4 mt -88.71 132.96 34.37 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -175.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 44.7 m -149.86 87.2 1.47 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.023 -0.989 . . . . 0.0 109.633 172.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 810' ' ' GLN . . . . . 0.516 HE21 ' CB ' ' A' ' 722' ' ' SER . 11.3 mt-30 -135.34 171.84 8.23 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.336 174.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 811' ' ' PRO . . . . . 0.464 ' HD2' ' HB3' ' A' ' 810' ' ' GLN . 97.0 Cg_exo -45.81 137.82 12.18 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 122.999 2.466 . . . . 0.0 114.328 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -109.1 167.29 10.21 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.217 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 813' ' ' ALA . . . . . 0.58 ' HB1' HD23 ' A' ' 727' ' ' LEU . . . -126.7 141.17 51.92 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.571 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 814' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -100.24 129.56 46.26 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.143 0.497 . . . . 0.0 110.555 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 815' ' ' ILE . . . . . 0.541 ' HA ' ' HB3' ' A' ' 731' ' ' LEU . 5.3 mp -112.55 109.75 29.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 176.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 816' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -106.08 109.05 20.86 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.061 0.457 . . . . 0.0 109.991 -175.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 817' ' ' VAL . . . . . 0.485 ' HB ' ' H ' ' A' ' 789' ' ' GLY . 4.7 t -99.74 141.27 17.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.513 -174.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 818' ' ' ARG . . . . . . . . . . . . . 39.9 mmt180 . . . . . 0 C--N 1.319 -0.724 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 177.521 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 720' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt . . . . . 0 N--CA 1.442 -0.828 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 721' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -86.46 140.34 6.26 Favored 'Trans proline' 0 N--CA 1.445 -1.353 0 C-N-CA 122.233 1.955 . . . . 0.0 111.204 178.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 722' ' ' SER . . . . . 0.454 ' HA ' ' CD2' ' A' ' 808' ' ' LEU . 50.2 m -167.42 -157.19 0.23 Allowed 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -172.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 723' ' ' ALA . . . . . 0.752 ' HB1' HG21 ' A' ' 743' ' ' VAL . . . -145.77 142.62 29.08 Favored 'General case' 0 N--CA 1.449 -0.521 0 O-C-N 122.093 -0.38 . . . . 0.0 110.27 175.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -129.72 100.4 5.49 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 725' ' ' LEU . . . . . 0.494 ' CD2' ' HB ' ' A' ' 743' ' ' VAL . 13.2 mt -62.65 144.09 56.65 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 121.765 0.793 . . . . 0.0 111.869 -173.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 33.4 mtpt -95.22 -18.92 20.47 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.544 -1.207 . . . . 0.0 109.366 -178.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 727' ' ' LEU . . . . . 0.544 ' HB2' ' HD2' ' A' ' 742' ' ' PRO . 0.7 OUTLIER -76.67 109.97 10.87 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 177.304 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 33.4 m80 -115.83 46.19 1.58 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.02 0.438 . . . . 0.0 110.532 -176.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -148.31 174.33 12.13 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.92 -176.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 730' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -100.5 108.78 20.82 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 175.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 731' ' ' LEU . . . . . 0.59 ' HB2' ' HA ' ' A' ' 815' ' ' ILE . 53.9 mt -72.03 100.82 2.58 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.984 -173.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 732' ' ' LYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 816' ' ' GLN . 32.2 mmtp -79.43 121.6 25.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.681 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 733' ' ' LEU . . . . . 0.721 ' HB2' ' HB ' ' A' ' 817' ' ' VAL . 25.6 mt -126.41 169.52 12.9 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.372 0.606 . . . . 0.0 111.835 -174.154 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 734' ' ' CYS . . . . . 0.467 ' HA ' ' O ' ' A' ' 818' ' ' ARG . 13.2 p -105.39 -176.97 3.23 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.107 176.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 735' ' ' LEU . . . . . . . . . . . . . 36.2 tp -71.41 122.54 20.56 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.569 -178.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 79.94 16.46 76.92 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.191 -1.004 . . . . 0.0 112.317 178.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 737' ' ' ASP . . . . . 0.568 ' HB3' ' HB3' ' A' ' 733' ' ' LEU . 25.3 t0 -86.22 157.63 19.91 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.769 0.318 . . . . 0.0 110.713 174.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 27.1 p-80 -117.16 -177.86 3.31 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 174.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 739' ' ' SER . . . . . 0.574 ' HB2' ' OG1' ' A' ' 782' ' ' THR . 29.8 m -142.22 169.43 17.6 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 119.777 -0.769 . . . . 0.0 112.894 179.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 740' ' ' SER . . . . . 0.412 ' HA ' ' O ' ' A' ' 780' ' ' ILE . 5.7 p -138.07 109.66 7.04 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 114.433 -1.258 . . . . 0.0 109.4 177.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 741' ' ' VAL . . . . . 0.592 HG11 HD13 ' A' ' 793' ' ' LEU . 0.6 OUTLIER -113.1 112.44 49.86 Favored Pre-proline 0 C--N 1.316 -0.877 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.226 -177.912 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 742' ' ' PRO . . . . . 0.649 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 4.1 Cg_endo -75.48 135.38 18.15 Favored 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 122.422 2.081 . . . . 0.0 111.652 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 743' ' ' VAL . . . . . 0.752 HG21 ' HB1' ' A' ' 723' ' ' ALA . 1.7 p -131.05 119.31 44.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.564 0.697 . . . . 0.0 111.981 176.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 744' ' ' ALA . . . . . 0.464 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -83.89 101.47 11.69 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 169.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 745' ' ' LEU . . . . . 0.978 HD13 HD13 ' A' ' 773' ' ' ILE . 0.3 OUTLIER -80.4 161.37 25.0 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 114.26 -1.336 . . . . 0.0 111.2 -166.752 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -110.91 146.31 36.79 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.628 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 747' ' ' GLY . . . . . . . . . . . . . . . 98.87 122.92 4.79 Favored Glycine 0 C--N 1.305 -1.168 0 N-CA-C 110.54 -1.024 . . . . 0.0 110.54 -176.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.95 128.68 53.96 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.321 0.581 . . . . 0.0 111.811 -169.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 109.44 -178.7 20.64 Favored Glycine 0 C--O 1.22 -0.724 0 CA-C-N 114.902 -1.044 . . . . 0.0 111.044 -175.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 750' ' ' PRO . . . . . 0.525 ' HB3' ' HE2' ' A' ' 774' ' ' LYS . 73.3 Cg_endo -65.51 100.96 0.42 Allowed 'Trans proline' 0 C--O 1.235 0.363 0 C-N-CA 123.37 2.714 . . . . 0.0 113.821 -178.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 751' ' ' PHE . . . . . 0.601 ' CE2' ' HA ' ' A' ' 800' ' ' ASP . 75.6 m-85 -117.0 146.86 42.78 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.743 176.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 752' ' ' THR . . . . . 0.713 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 33.4 m -89.64 106.64 18.59 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 176.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 753' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -96.72 111.26 23.49 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.338 -172.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 754' ' ' THR . . . . . 0.487 HG23 ' HB2' ' A' ' 769' ' ' GLU . 1.6 m -108.81 137.26 47.03 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.558 -0.747 . . . . 0.0 111.269 -178.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 755' ' ' TYR . . . . . . . . . . . . . 29.9 p90 -148.16 156.89 43.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.88 0.371 . . . . 0.0 110.953 176.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 756' ' ' ASP . . . . . 0.587 ' OD2' HG21 ' A' ' 796' ' ' VAL . 0.7 OUTLIER -125.18 121.76 35.11 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.513 178.667 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 757' ' ' ILE . . . . . 0.412 ' N ' HD12 ' A' ' 757' ' ' ILE . 4.2 mp -83.72 96.59 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 172.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 758' ' ' ILE . . . . . 0.659 HG22 ' HD2' ' A' ' 765' ' ' ARG . 2.4 pp -93.92 148.25 5.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.248 -167.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 759' ' ' GLU . . . . . 0.638 ' HG2' ' CE2' ' A' ' 791' ' ' TYR . 23.9 mt-10 -88.68 117.82 27.92 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.921 176.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 760' ' ' THR . . . . . . . . . . . . . 1.2 t . . . . . 0 C--N 1.313 -1.016 0 CA-C-O 121.512 0.672 . . . . 0.0 109.227 176.501 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 765' ' ' ARG . . . . . 0.659 ' HD2' HG22 ' A' ' 758' ' ' ILE . 19.0 ttt180 . . . . . 0 N--CA 1.453 -0.29 0 CA-C-O 120.952 0.406 . . . . 0.0 110.8 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 766' ' ' LYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 756' ' ' ASP . 9.7 tmtm? -106.78 140.47 39.57 Favored 'General case' 0 C--O 1.216 -0.674 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.794 -175.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 767' ' ' THR . . . . . . . . . . . . . 21.1 m -111.39 134.83 52.69 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.016 -176.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 768' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -140.46 137.89 34.26 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.01 0.433 . . . . 0.0 110.742 173.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 769' ' ' GLU . . . . . 0.487 ' HB2' HG23 ' A' ' 754' ' ' THR . 27.7 tt0 -131.86 123.17 26.97 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.558 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 770' ' ' ILE . . . . . 0.553 HG22 HG22 ' A' ' 773' ' ' ILE . 6.5 mt -114.45 112.23 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 771' ' ' LYS . . . . . 0.581 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 9.7 mtpt -85.88 154.64 21.38 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.52 -173.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 772' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 54.6 44.06 29.25 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.388 -1.278 . . . . 0.0 111.984 175.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 773' ' ' ILE . . . . . 0.978 HD13 HD13 ' A' ' 745' ' ' LEU . 0.5 OUTLIER -73.95 116.21 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 172.142 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 774' ' ' LYS . . . . . 0.525 ' HE2' ' HB3' ' A' ' 750' ' ' PRO . 58.0 mttt -111.88 26.36 10.69 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -178.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 775' ' ' THR . . . . . 0.683 ' H ' HD12 ' A' ' 773' ' ' ILE . 0.2 OUTLIER -96.22 -75.86 0.52 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 114.767 -1.106 . . . . 0.0 113.676 -166.333 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 776' ' ' ASN . . . . . 0.672 ' HB2' ' O ' ' A' ' 775' ' ' THR . 0.8 OUTLIER 89.98 2.52 0.19 Allowed 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.892 1.277 . . . . 0.0 110.565 -172.897 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 777' ' ' GLU . . . . . 0.464 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 9.4 mp0 -154.6 90.65 1.33 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 175.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 778' ' ' TYR . . . . . 0.703 ' HB3' HD11 ' A' ' 745' ' ' LEU . 81.7 t80 -132.12 128.8 38.89 Favored 'General case' 0 C--N 1.315 -0.932 0 C-N-CA 120.249 -0.58 . . . . 0.0 111.212 -172.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 779' ' ' VAL . . . . . 0.649 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 17.3 t -89.18 112.82 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-O 121.308 0.575 . . . . 0.0 110.4 178.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 780' ' ' ILE . . . . . 0.457 ' HB ' HG13 ' A' ' 741' ' ' VAL . 77.8 mt -81.29 147.05 6.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.549 -178.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -120.1 108.23 14.01 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 175.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 782' ' ' THR . . . . . 0.574 ' OG1' ' HB2' ' A' ' 739' ' ' SER . 54.6 p -77.51 141.41 65.35 Favored Pre-proline 0 C--N 1.319 -0.758 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.359 -178.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 783' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 782' ' ' THR . 52.3 Cg_exo -53.91 158.57 8.54 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 123.758 2.972 . . . . 0.0 112.515 -175.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 784' ' ' VAL . . . . . . . . . . . . . 12.9 p -65.7 128.93 29.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.33 0.586 . . . . 0.0 109.974 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 785' ' ' PHE . . . . . 0.414 ' CG ' HG11 ' A' ' 817' ' ' VAL . 89.8 m-85 -97.48 96.61 8.45 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.321 -176.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 69.8 p -84.32 18.63 2.13 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.395 0.616 . . . . 0.0 111.473 -174.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 3.0 m -155.72 124.22 5.93 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.629 177.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 788' ' ' GLY . . . . . 0.694 ' HA2' HG22 ' A' ' 817' ' ' VAL . . . -50.89 123.69 17.8 Favored Glycine 0 CA--C 1.524 0.645 0 O-C-N 123.522 0.513 . . . . 0.0 112.336 172.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 789' ' ' GLY . . . . . . . . . . . . . . . -164.03 -165.76 21.77 Favored Glycine 0 N--CA 1.442 -0.964 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -133.41 124.18 26.66 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 791' ' ' TYR . . . . . 0.638 ' CE2' ' HG2' ' A' ' 759' ' ' GLU . 81.5 m-85 -124.78 148.68 48.0 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.106 0.479 . . . . 0.0 111.286 -173.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 792' ' ' ILE . . . . . 0.547 ' O ' HG13 ' A' ' 758' ' ' ILE . 13.2 mt -126.07 116.36 45.56 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.656 175.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 793' ' ' LEU . . . . . 0.592 HD13 HG11 ' A' ' 741' ' ' VAL . 9.3 tt -84.25 111.23 19.2 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 794' ' ' SER . . . . . . . . . . . . . 17.8 m -120.65 139.66 52.69 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.389 -178.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 795' ' ' LEU . . . . . 0.672 ' HG ' ' HB3' ' A' ' 723' ' ' ALA . 1.6 mm? -69.25 132.07 45.9 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.619 176.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 796' ' ' VAL . . . . . 0.587 HG21 ' OD2' ' A' ' 756' ' ' ASP . 53.4 t -97.61 -51.71 10.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-O 120.993 0.425 . . . . 0.0 111.272 -178.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 797' ' ' SER . . . . . 0.569 ' HA ' ' HG ' ' A' ' 808' ' ' LEU . 81.1 p -168.42 155.62 7.75 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.391 -172.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 798' ' ' ILE . . . . . 0.63 ' HA ' ' O ' ' A' ' 752' ' ' THR . 8.7 tt -130.15 167.2 25.88 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 177.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 799' ' ' LYS . . . . . 0.713 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 2.7 ttmp? -135.74 118.32 15.93 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.626 -176.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 800' ' ' ASP . . . . . 0.601 ' HA ' ' CE2' ' A' ' 751' ' ' PHE . 12.0 m-20 -58.88 154.91 14.15 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.805 171.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 801' ' ' SER . . . . . 0.404 ' OG ' ' HG2' ' A' ' 750' ' ' PRO . 5.8 m -62.06 -10.21 9.43 Favored 'General case' 0 C--N 1.326 -0.415 0 O-C-N 124.14 0.9 . . . . 0.0 112.505 -172.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 14.0 t -96.24 4.99 51.98 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.559 0.695 . . . . 0.0 109.636 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 803' ' ' GLY . . . . . . . . . . . . . . . 81.19 43.36 8.73 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 115.316 -0.857 . . . . 0.0 112.135 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 804' ' ' CYS . . . . . 0.418 ' HB3' ' HB2' ' A' ' 800' ' ' ASP . 46.4 t -114.71 119.75 37.74 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 178.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 805' ' ' VAL . . . . . 0.535 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 3.0 t -94.22 124.79 46.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.327 0.584 . . . . 0.0 111.562 -172.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 806' ' ' VAL . . . . . . . . . . . . . 39.5 t -104.72 135.64 41.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.299 177.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -74.16 127.91 10.41 Favored Glycine 0 C--N 1.323 -0.177 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.47 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 808' ' ' LEU . . . . . 0.569 ' HG ' ' HA ' ' A' ' 797' ' ' SER . 64.2 mt -98.05 136.96 37.55 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -172.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 43.0 m -148.71 86.39 1.52 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.822 -1.081 . . . . 0.0 109.173 170.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 810' ' ' GLN . . . . . 0.428 ' HG2' ' HD2' ' A' ' 811' ' ' PRO . 0.7 OUTLIER -139.79 172.92 5.65 Favored Pre-proline 0 CA--C 1.539 0.539 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.132 179.373 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 811' ' ' PRO . . . . . 0.428 ' HD2' ' HG2' ' A' ' 810' ' ' GLN . 92.7 Cg_exo -44.4 138.77 7.21 Favored 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 123.059 2.506 . . . . 0.0 115.159 -173.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -104.47 167.46 9.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.541 -1.209 . . . . 0.0 110.327 178.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 813' ' ' ALA . . . . . . . . . . . . . . . -123.88 152.01 42.84 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.437 175.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 814' ' ' LYS . . . . . 0.531 ' HG2' HG12 ' A' ' 792' ' ' ILE . 48.8 mttp -118.18 127.7 54.0 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.718 0.771 . . . . 0.0 111.241 -178.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 815' ' ' ILE . . . . . 0.59 ' HA ' ' HB2' ' A' ' 731' ' ' LEU . 5.3 mp -116.44 107.29 22.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 114.552 -1.204 . . . . 0.0 108.797 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 816' ' ' GLN . . . . . 0.405 ' O ' ' HA ' ' A' ' 732' ' ' LYS . 0.9 OUTLIER -108.68 107.24 17.62 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.313 0.578 . . . . 0.0 110.024 -177.179 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 817' ' ' VAL . . . . . 0.721 ' HB ' ' HB2' ' A' ' 733' ' ' LEU . 1.9 m -102.21 147.46 8.87 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -178.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 818' ' ' ARG . . . . . 0.467 ' O ' ' HA ' ' A' ' 734' ' ' CYS . 16.1 tpt180 . . . . . 0 C--N 1.313 -1.019 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -172.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 720' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm . . . . . 0 N--CA 1.45 -0.45 0 CA-C-O 120.926 0.393 . . . . 0.0 111.119 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 721' ' ' PRO . . . . . 0.519 ' HD2' HG11 ' A' ' 806' ' ' VAL . 74.1 Cg_endo -88.35 148.3 6.44 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 123.279 2.653 . . . . 0.0 111.249 177.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 722' ' ' SER . . . . . 0.727 ' HA ' HD22 ' A' ' 808' ' ' LEU . 11.6 p 179.44 -158.25 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.802 -171.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 723' ' ' ALA . . . . . 0.723 ' HB1' HG21 ' A' ' 743' ' ' VAL . . . -144.15 142.03 30.32 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 177.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 11.7 m -129.31 99.0 5.05 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -178.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 725' ' ' LEU . . . . . 0.496 HD22 ' HB ' ' A' ' 743' ' ' VAL . 8.3 mt -64.22 143.63 57.74 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-O 121.811 0.815 . . . . 0.0 112.366 -172.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 29.1 mtpt -93.67 -18.91 21.62 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.216 -1.356 . . . . 0.0 108.583 177.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 727' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -60.43 119.2 7.55 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.569 173.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -88.93 -48.26 7.57 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -170.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 8.8 p80 -136.11 -175.7 4.07 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.224 -177.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 730' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' A' ' 814' ' ' LYS . 9.1 p-10 -40.65 133.98 1.9 Allowed 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.66 0.743 . . . . 0.0 112.098 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 731' ' ' LEU . . . . . 0.574 ' HB3' ' HA ' ' A' ' 815' ' ' ILE . 22.1 tp -104.26 104.68 14.62 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.258 -177.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 732' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -74.19 112.74 10.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.481 -171.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 733' ' ' LEU . . . . . 0.619 ' HG ' ' HB3' ' A' ' 737' ' ' ASP . 9.2 mp -120.01 164.97 15.31 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.73 173.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 734' ' ' CYS . . . . . 0.451 ' HA ' ' O ' ' A' ' 818' ' ' ARG . 2.1 p -124.4 -173.62 2.82 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.486 173.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 735' ' ' LEU . . . . . . . . . . . . . 2.6 tt -53.64 115.65 2.08 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.088 0.471 . . . . 0.0 111.284 -174.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 87.88 3.27 80.27 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.592 -0.814 . . . . 0.0 112.965 173.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 737' ' ' ASP . . . . . 0.619 ' HB3' ' HG ' ' A' ' 733' ' ' LEU . 0.3 OUTLIER -76.99 148.98 35.95 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.253 0.549 . . . . 0.0 111.684 178.076 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 738' ' ' HIS . . . . . 0.494 ' HB2' ' O ' ' A' ' 782' ' ' THR . 36.1 p-80 -113.1 151.05 31.26 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 170.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 739' ' ' SER . . . . . 0.533 ' O ' ' HA ' ' A' ' 781' ' ' LYS . 17.3 p -108.6 167.56 9.96 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 119.219 -0.992 . . . . 0.0 111.803 -170.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 740' ' ' SER . . . . . 0.428 ' HA ' ' O ' ' A' ' 780' ' ' ILE . 12.9 p -132.7 99.62 4.68 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 114.924 -1.035 . . . . 0.0 109.301 175.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 741' ' ' VAL . . . . . 0.62 HG11 HD13 ' A' ' 793' ' ' LEU . 0.5 OUTLIER -104.98 105.04 49.85 Favored Pre-proline 0 C--N 1.316 -0.877 0 CA-C-N 115.037 -0.983 . . . . 0.0 108.799 179.02 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 742' ' ' PRO . . . . . 0.778 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 2.1 Cg_endo -74.97 131.91 14.85 Favored 'Trans proline' 0 N--CA 1.441 -1.589 0 C-N-CA 122.097 1.865 . . . . 0.0 110.777 -177.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 743' ' ' VAL . . . . . 0.723 HG21 ' HB1' ' A' ' 723' ' ' ALA . 1.4 p -131.99 120.88 45.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.769 0.795 . . . . 0.0 112.788 177.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 744' ' ' ALA . . . . . 0.518 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -81.02 99.88 8.68 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 168.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 745' ' ' LEU . . . . . 0.905 HD13 HD13 ' A' ' 773' ' ' ILE . 0.2 OUTLIER -83.59 165.33 19.13 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 114.536 -1.211 . . . . 0.0 111.28 -167.475 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 34.9 tptt -114.51 165.0 13.21 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.699 -178.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 747' ' ' GLY . . . . . . . . . . . . . . . 90.16 129.61 4.04 Favored Glycine 0 C--N 1.306 -1.089 0 CA-C-N 115.276 -0.874 . . . . 0.0 111.538 -175.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 748' ' ' GLN . . . . . 0.419 ' C ' ' HE1' ' A' ' 751' ' ' PHE . 0.0 OUTLIER -112.34 113.82 26.23 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.201 0.524 . . . . 0.0 111.636 -173.89 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 123.77 -174.88 16.81 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.371 -0.832 . . . . 0.0 111.045 -177.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 750' ' ' PRO . . . . . 0.402 ' HD2' ' OG ' ' A' ' 801' ' ' SER . 14.0 Cg_exo -69.69 93.89 0.52 Allowed 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.552 2.168 . . . . 0.0 112.317 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 751' ' ' PHE . . . . . 0.564 ' HA ' ' O ' ' A' ' 799' ' ' LYS . 75.6 m-85 -109.84 139.97 44.31 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.45 177.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 752' ' ' THR . . . . . 0.701 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 92.6 m -91.04 108.22 19.72 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 176.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 753' ' ' LEU . . . . . 0.553 ' CD1' HD22 ' A' ' 745' ' ' LEU . 3.7 tt -100.46 118.41 36.61 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.094 -171.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 754' ' ' THR . . . . . 0.47 HG23 ' HB2' ' A' ' 769' ' ' GLU . 1.6 m -114.66 138.25 50.92 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.967 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 755' ' ' TYR . . . . . 0.643 ' CE1' ' HB3' ' A' ' 768' ' ' PHE . 28.9 p90 -146.47 153.91 40.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.998 0.428 . . . . 0.0 111.392 178.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 756' ' ' ASP . . . . . 0.435 ' CG ' ' HD2' ' A' ' 765' ' ' ARG . 39.3 m-20 -112.04 120.85 43.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.818 -178.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 757' ' ' ILE . . . . . . . . . . . . . 3.3 mp -88.02 95.77 5.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 168.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 758' ' ' ILE . . . . . 0.638 HG22 ' HD3' ' A' ' 765' ' ' ARG . 2.3 pp -96.09 140.58 16.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-O 121.595 0.712 . . . . 0.0 112.056 -170.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 759' ' ' GLU . . . . . 0.414 ' HG2' ' CD2' ' A' ' 791' ' ' TYR . 13.4 mt-10 -95.64 103.32 15.19 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.336 -176.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 760' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.315 -0.918 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.132 -168.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 765' ' ' ARG . . . . . 0.638 ' HD3' HG22 ' A' ' 758' ' ' ILE . 5.4 ttp180 . . . . . 0 N--CA 1.443 -0.788 0 CA-C-O 120.958 0.408 . . . . 0.0 111.531 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 766' ' ' LYS . . . . . 0.461 ' HD3' ' N ' ' A' ' 767' ' ' THR . 9.6 tmtm? -117.91 146.42 43.96 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 177.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 767' ' ' THR . . . . . 0.461 ' N ' ' HD3' ' A' ' 766' ' ' LYS . 90.0 m -121.09 133.9 55.24 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 116.629 -0.26 . . . . 0.0 110.473 178.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 768' ' ' PHE . . . . . 0.643 ' HB3' ' CE1' ' A' ' 755' ' ' TYR . 1.2 t80 -134.74 135.93 42.29 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 177.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 769' ' ' GLU . . . . . 0.47 ' HB2' HG23 ' A' ' 754' ' ' THR . 42.8 tt0 -131.94 135.25 46.46 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.054 -178.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 770' ' ' ILE . . . . . 0.554 HG22 HG22 ' A' ' 773' ' ' ILE . 3.8 mt -126.81 112.0 27.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 176.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 771' ' ' LYS . . . . . 0.635 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 11.3 mtpt -83.49 154.96 23.62 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-O 121.035 0.445 . . . . 0.0 110.897 -177.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 772' ' ' GLU . . . . . 0.416 ' O ' ' HG3' ' A' ' 774' ' ' LYS . 5.2 mt-10 53.58 48.45 21.65 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.674 -1.148 . . . . 0.0 111.932 177.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 773' ' ' ILE . . . . . 0.905 HD13 HD13 ' A' ' 745' ' ' LEU . 0.5 OUTLIER -74.77 115.34 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 174.278 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 774' ' ' LYS . . . . . 0.416 ' HG3' ' O ' ' A' ' 772' ' ' GLU . 72.0 mttt -116.33 32.28 6.22 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 -178.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 775' ' ' THR . . . . . 0.679 ' H ' HD12 ' A' ' 773' ' ' ILE . 0.2 OUTLIER -96.56 -72.37 0.64 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.212 -1.358 . . . . 0.0 112.522 -171.598 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 776' ' ' ASN . . . . . 0.416 ' O ' ' HG3' ' A' ' 777' ' ' GLU . 11.5 m120 79.36 5.35 2.15 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.035 0.934 . . . . 0.0 110.506 -176.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 777' ' ' GLU . . . . . 0.518 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 21.8 mt-10 -160.36 79.45 0.66 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.7 -1.136 . . . . 0.0 108.826 176.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 778' ' ' TYR . . . . . 0.79 ' HB3' HD11 ' A' ' 745' ' ' LEU . 91.4 t80 -132.61 130.72 40.59 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.964 -171.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 779' ' ' VAL . . . . . 0.778 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 2.0 m -95.73 126.16 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 CA-C-O 122.331 1.062 . . . . 0.0 110.575 176.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 780' ' ' ILE . . . . . 0.443 ' HB ' HG13 ' A' ' 741' ' ' VAL . 79.6 mt -89.04 145.57 7.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 113.542 -1.663 . . . . 0.0 110.465 -174.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 781' ' ' LYS . . . . . 0.533 ' HA ' ' O ' ' A' ' 739' ' ' SER . 3.9 mppt? -118.07 111.91 19.53 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 177.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 782' ' ' THR . . . . . 0.494 ' O ' ' HB2' ' A' ' 738' ' ' HIS . 30.8 p -74.75 142.87 77.58 Favored Pre-proline 0 C--N 1.319 -0.727 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 177.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 783' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_exo -52.03 161.52 2.39 Favored 'Trans proline' 0 N--CA 1.472 0.22 0 C-N-CA 123.681 2.921 . . . . 0.0 113.171 -177.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 784' ' ' VAL . . . . . . . . . . . . . 51.1 t -63.4 113.7 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.046 177.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 785' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -104.16 102.3 12.03 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.351 178.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 77.2 p -85.94 26.64 0.97 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.781 0.8 . . . . 0.0 111.058 -176.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 92.4 m -144.74 111.47 5.77 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.173 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 788' ' ' GLY . . . . . 0.741 ' HA2' HG12 ' A' ' 817' ' ' VAL . . . -49.65 121.4 9.11 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.971 -0.633 . . . . 0.0 113.201 171.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 789' ' ' GLY . . . . . 0.52 ' H ' ' HB ' ' A' ' 817' ' ' VAL . . . -175.19 173.94 46.51 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 178.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -100.19 133.98 43.79 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 117.819 0.809 . . . . 0.0 109.606 -179.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 791' ' ' TYR . . . . . 0.452 ' HA ' ' O ' ' A' ' 758' ' ' ILE . 68.1 m-85 -129.63 118.62 22.26 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.063 0.459 . . . . 0.0 110.702 -177.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 792' ' ' ILE . . . . . 0.578 HG12 ' HG2' ' A' ' 814' ' ' LYS . 17.8 mt -97.01 116.09 38.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.066 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 793' ' ' LEU . . . . . 0.62 HD13 HG11 ' A' ' 741' ' ' VAL . 10.1 tt -84.45 106.49 16.07 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 175.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 794' ' ' SER . . . . . . . . . . . . . 23.0 t -115.88 148.42 40.0 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.397 -177.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 795' ' ' LEU . . . . . . . . . . . . . 44.9 mt -82.39 134.23 35.24 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.829 0.347 . . . . 0.0 110.681 -176.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 796' ' ' VAL . . . . . . . . . . . . . 77.6 t -95.79 -55.9 5.69 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.46 -177.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 797' ' ' SER . . . . . 0.544 ' HA ' ' HG ' ' A' ' 808' ' ' LEU . 92.0 p -177.74 162.61 1.77 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.373 -172.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 798' ' ' ILE . . . . . 0.656 ' HA ' ' O ' ' A' ' 752' ' ' THR . 9.4 tt -135.28 168.44 23.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 178.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 799' ' ' LYS . . . . . 0.701 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 19.9 tttt -133.5 114.83 14.05 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.732 0.301 . . . . 0.0 111.274 -177.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 800' ' ' ASP . . . . . 0.562 ' HA ' ' CE2' ' A' ' 751' ' ' PHE . 1.6 m-20 -58.27 153.09 15.97 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.594 170.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 801' ' ' SER . . . . . 0.402 ' OG ' ' HD2' ' A' ' 750' ' ' PRO . 6.6 m -66.56 -4.72 9.2 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.141 -172.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 21.6 p -95.06 6.4 49.18 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.585 0.707 . . . . 0.0 109.889 175.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 803' ' ' GLY . . . . . 0.533 ' HA2' ' HE2' ' A' ' 799' ' ' LYS . . . 74.95 41.28 33.28 Favored Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.716 -178.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 804' ' ' CYS . . . . . 0.419 ' HB3' ' HB2' ' A' ' 800' ' ' ASP . 51.9 t -114.83 120.23 39.3 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 805' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 10.2 p -84.9 133.77 28.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 121.523 0.678 . . . . 0.0 110.684 -175.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 806' ' ' VAL . . . . . 0.519 HG11 ' HD2' ' A' ' 721' ' ' PRO . 24.8 t -117.03 135.45 57.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.995 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -74.91 122.59 7.07 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.865 -178.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 808' ' ' LEU . . . . . 0.727 HD22 ' HA ' ' A' ' 722' ' ' SER . 50.9 mt -89.11 127.56 35.72 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.059 0.456 . . . . 0.0 112.145 -177.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 20.1 m -144.27 85.58 1.8 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.882 172.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 810' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -145.82 170.85 7.26 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.251 177.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 811' ' ' PRO . . . . . . . . . . . . . 99.7 Cg_exo -42.98 139.84 3.37 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 123.204 2.603 . . . . 0.0 115.3 -170.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -103.38 167.35 9.87 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 114.475 -1.239 . . . . 0.0 110.207 178.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 813' ' ' ALA . . . . . 0.478 ' HB3' ' HB3' ' A' ' 793' ' ' LEU . . . -116.58 150.15 38.49 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.381 178.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 814' ' ' LYS . . . . . 0.578 ' HG2' HG12 ' A' ' 792' ' ' ILE . 47.3 mttp -123.27 96.86 5.16 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 122.048 0.928 . . . . 0.0 111.106 176.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 815' ' ' ILE . . . . . 0.574 ' HA ' ' HB3' ' A' ' 731' ' ' LEU . 5.4 mp -87.71 110.82 21.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 CA-C-N 113.97 -1.468 . . . . 0.0 108.987 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 816' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -100.48 107.85 19.68 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.223 0.535 . . . . 0.0 110.226 -175.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 817' ' ' VAL . . . . . 0.741 HG12 ' HA2' ' A' ' 788' ' ' GLY . 57.3 t -93.84 146.04 7.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.241 177.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 818' ' ' ARG . . . . . 0.451 ' O ' ' HA ' ' A' ' 734' ' ' CYS . 30.6 tpt180 . . . . . 0 C--N 1.317 -0.812 0 CA-C-O 121.09 0.471 . . . . 0.0 110.619 178.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 720' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? . . . . . 0 N--CA 1.441 -0.91 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 721' ' ' PRO . . . . . 0.506 ' HD2' HG21 ' A' ' 806' ' ' VAL . 57.4 Cg_endo -84.92 148.12 10.68 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 122.632 2.221 . . . . 0.0 111.268 -173.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 722' ' ' SER . . . . . 0.666 ' HA ' HD22 ' A' ' 808' ' ' LEU . 57.0 m -166.78 -161.83 0.47 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.857 -171.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 723' ' ' ALA . . . . . 0.627 ' HB1' HG21 ' A' ' 743' ' ' VAL . . . -149.03 140.56 23.39 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.336 173.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 724' ' ' SER . . . . . 0.416 ' C ' HG23 ' A' ' 743' ' ' VAL . 19.0 m -126.7 104.96 8.36 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -177.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 725' ' ' LEU . . . . . 0.556 ' CD2' ' HB ' ' A' ' 743' ' ' VAL . 14.8 mt -63.39 137.42 58.16 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-O 121.331 0.586 . . . . 0.0 110.839 -176.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 726' ' ' LYS . . . . . 0.439 ' HD2' ' HB2' ' A' ' 744' ' ' ALA . 33.9 mtpt -89.76 -18.3 26.6 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.886 -175.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 727' ' ' LEU . . . . . 0.422 ' HB2' ' HD2' ' A' ' 742' ' ' PRO . 25.5 tp -68.15 109.59 3.61 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.248 175.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 11.6 t-80 -110.83 25.22 12.01 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.266 0.555 . . . . 0.0 111.534 -173.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 6.2 p80 -155.81 162.08 40.53 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.092 179.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 730' ' ' ASP . . . . . 0.541 ' OD1' ' HB2' ' A' ' 816' ' ' GLN . 16.5 t70 -72.25 131.41 42.69 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.807 0.813 . . . . 0.0 111.301 -176.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 731' ' ' LEU . . . . . 0.597 ' HG ' HD21 ' A' ' 733' ' ' LEU . 25.9 tp -87.17 110.13 19.94 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 114.114 -1.403 . . . . 0.0 110.671 -174.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 732' ' ' LYS . . . . . . . . . . . . . 26.5 mmmt -86.74 107.4 18.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.389 -172.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 733' ' ' LEU . . . . . 0.723 HD12 HG22 ' A' ' 817' ' ' VAL . 16.8 mt -119.32 163.92 16.45 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.848 0.356 . . . . 0.0 111.088 -179.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 734' ' ' CYS . . . . . 0.562 ' O ' ' HB2' ' A' ' 737' ' ' ASP . 15.5 t -116.97 -173.75 2.45 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 174.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 735' ' ' LEU . . . . . . . . . . . . . 18.6 tp -73.23 133.83 44.1 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.447 0.642 . . . . 0.0 111.724 -172.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 81.49 10.11 84.9 Favored Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 114.674 -1.148 . . . . 0.0 111.423 -178.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 737' ' ' ASP . . . . . 0.562 ' HB2' ' O ' ' A' ' 734' ' ' CYS . 0.9 OUTLIER -88.14 149.7 23.76 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.918 0.389 . . . . 0.0 111.315 175.99 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 25.6 p-80 -109.52 167.27 10.26 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 170.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 739' ' ' SER . . . . . 0.429 ' HB3' HD23 ' A' ' 731' ' ' LEU . 0.3 OUTLIER -121.25 164.59 16.73 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 119.855 -0.738 . . . . 0.0 111.74 -173.206 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 62.8 m -143.35 128.15 18.28 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.126 -0.943 . . . . 0.0 108.941 178.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 741' ' ' VAL . . . . . 0.722 HG11 HD23 ' A' ' 793' ' ' LEU . 0.8 OUTLIER -138.06 114.85 9.24 Favored Pre-proline 0 C--N 1.312 -1.048 0 CA-C-O 121.337 0.589 . . . . 0.0 110.326 -177.866 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 742' ' ' PRO . . . . . 0.659 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 6.5 Cg_endo -76.66 136.35 17.05 Favored 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 122.389 2.059 . . . . 0.0 111.396 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 743' ' ' VAL . . . . . 0.627 HG21 ' HB1' ' A' ' 723' ' ' ALA . 1.6 p -131.64 119.44 42.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.253 0.549 . . . . 0.0 111.915 176.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 744' ' ' ALA . . . . . 0.439 ' HB2' ' HD2' ' A' ' 726' ' ' LYS . . . -84.0 111.65 19.48 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 168.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 745' ' ' LEU . . . . . 0.908 HD13 HD13 ' A' ' 773' ' ' ILE . 0.2 OUTLIER -94.11 154.78 17.42 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.645 -1.161 . . . . 0.0 110.9 -166.359 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -107.01 149.85 27.12 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.161 -178.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 747' ' ' GLY . . . . . 0.489 ' HA3' ' HB3' ' A' ' 721' ' ' PRO . . . 96.2 118.62 3.48 Favored Glycine 0 C--N 1.316 -0.559 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -174.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 27.4 mp0 -99.77 122.47 42.79 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.192 0.52 . . . . 0.0 112.115 -169.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 116.24 -170.75 13.46 Favored Glycine 0 C--O 1.218 -0.845 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.439 -179.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 750' ' ' PRO . . . . . 0.497 ' HB3' ' HE2' ' A' ' 774' ' ' LYS . 88.8 Cg_endo -69.94 96.6 0.61 Allowed 'Trans proline' 0 CA--C 1.533 0.445 0 C-N-CA 123.506 2.804 . . . . 0.0 113.893 -178.291 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 751' ' ' PHE . . . . . 0.597 ' CD2' ' HA ' ' A' ' 800' ' ' ASP . 80.7 m-85 -115.19 148.14 39.44 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.176 178.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 752' ' ' THR . . . . . 0.761 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 98.2 m -90.56 104.16 16.77 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.231 0.538 . . . . 0.0 109.684 178.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 753' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.14 113.7 25.3 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.186 -170.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 754' ' ' THR . . . . . 0.474 HG23 ' HB2' ' A' ' 769' ' ' GLU . 1.6 m -109.89 134.42 52.09 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.455 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 755' ' ' TYR . . . . . 0.616 ' CE1' ' HB2' ' A' ' 768' ' ' PHE . 24.9 p90 -143.97 152.89 41.66 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.021 0.439 . . . . 0.0 112.133 179.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 756' ' ' ASP . . . . . 0.468 ' HB2' HG23 ' A' ' 758' ' ' ILE . 2.9 p30 -113.31 121.14 43.5 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.513 -178.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 757' ' ' ILE . . . . . 0.532 ' CD1' HD13 ' A' ' 793' ' ' LEU . 4.0 mp -93.89 96.16 5.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 165.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 758' ' ' ILE . . . . . 0.535 HG13 ' O ' ' A' ' 792' ' ' ILE . 2.2 pp -100.39 150.16 5.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.749 -170.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -92.96 115.85 28.51 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.764 -177.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 760' ' ' THR . . . . . 0.473 HG23 ' HB2' ' A' ' 790' ' ' ASP . 0.2 OUTLIER . . . . . 0 C--N 1.317 -0.824 0 CA-C-O 121.389 0.614 . . . . 0.0 109.781 178.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 765' ' ' ARG . . . . . 0.527 ' HD3' HG22 ' A' ' 758' ' ' ILE . 6.7 ttp180 . . . . . 0 N--CA 1.444 -0.749 0 CA-C-O 120.653 0.263 . . . . 0.0 110.506 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 766' ' ' LYS . . . . . 0.658 ' HD3' ' N ' ' A' ' 767' ' ' THR . 7.8 tmtm? -115.48 146.24 41.85 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 177.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 767' ' ' THR . . . . . 0.658 ' N ' ' HD3' ' A' ' 766' ' ' LYS . 90.7 m -132.49 135.83 46.27 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.42 -177.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 768' ' ' PHE . . . . . 0.616 ' HB2' ' CE1' ' A' ' 755' ' ' TYR . 20.8 m-85 -123.26 134.57 54.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.38 174.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 769' ' ' GLU . . . . . 0.474 ' HB2' HG23 ' A' ' 754' ' ' THR . 40.5 tt0 -126.9 104.83 8.24 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.591 177.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 770' ' ' ILE . . . . . 0.402 HG22 HG22 ' A' ' 773' ' ' ILE . 22.1 mt -105.22 117.55 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.422 -178.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 771' ' ' LYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 17.7 mmtt -77.74 159.11 29.29 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.451 0.643 . . . . 0.0 111.006 -179.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 772' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 48.02 45.96 19.22 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 113.863 -1.517 . . . . 0.0 112.83 172.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 773' ' ' ILE . . . . . 0.908 HD13 HD13 ' A' ' 745' ' ' LEU . 0.5 OUTLIER -75.72 109.85 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 172.149 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 774' ' ' LYS . . . . . 0.497 ' HE2' ' HB3' ' A' ' 750' ' ' PRO . 59.6 mttt -105.65 28.83 7.1 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 -177.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 775' ' ' THR . . . . . 0.687 ' H ' HD12 ' A' ' 773' ' ' ILE . 0.6 OUTLIER -95.32 -74.61 0.55 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.95 -1.023 . . . . 0.0 113.122 -166.726 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 776' ' ' ASN . . . . . 0.461 ' HA ' ' HB2' ' A' ' 745' ' ' LEU . 11.8 m120 84.48 1.86 0.83 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.76 1.224 . . . . 0.0 110.893 -176.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 777' ' ' GLU . . . . . 0.424 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 5.2 mp0 -156.05 83.17 1.0 Allowed 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 177.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 778' ' ' TYR . . . . . 0.645 ' HB3' HD11 ' A' ' 745' ' ' LEU . 67.1 t80 -125.97 127.68 46.31 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.582 -170.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 779' ' ' VAL . . . . . 0.659 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 15.5 t -88.55 108.6 18.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.285 0.564 . . . . 0.0 110.216 177.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 780' ' ' ILE . . . . . . . . . . . . . 79.4 mt -76.41 143.56 12.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.63 -178.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.73 106.6 11.08 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 175.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 782' ' ' THR . . . . . 0.423 ' HA ' ' HD3' ' A' ' 783' ' ' PRO . 39.5 p -83.51 144.02 45.35 Favored Pre-proline 0 C--N 1.315 -0.9 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.356 -177.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 783' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 782' ' ' THR . 60.3 Cg_exo -52.75 160.46 3.91 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 123.775 2.983 . . . . 0.0 112.798 -177.291 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 784' ' ' VAL . . . . . . . . . . . . . 14.9 p -66.34 135.2 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.495 -177.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 785' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -102.54 99.43 9.44 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.561 0.696 . . . . 0.0 110.028 179.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 66.3 p -86.09 24.66 1.28 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.861 0.839 . . . . 0.0 110.295 -178.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 5.5 m -160.58 110.65 1.77 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.459 -1.246 . . . . 0.0 110.032 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 788' ' ' GLY . . . . . . . . . . . . . . . -49.91 147.73 6.88 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 121.241 -0.504 . . . . 0.0 113.718 173.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 789' ' ' GLY . . . . . . . . . . . . . . . 167.34 177.43 38.9 Favored Glycine 0 N--CA 1.443 -0.873 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 -177.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 790' ' ' ASP . . . . . 0.473 ' HB2' HG23 ' A' ' 760' ' ' THR . 5.3 m-20 -109.03 128.8 55.28 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -179.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 791' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -129.87 145.36 51.6 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -177.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 792' ' ' ILE . . . . . 0.535 ' O ' HG13 ' A' ' 758' ' ' ILE . 20.3 mt -123.47 122.26 64.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 177.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 793' ' ' LEU . . . . . 0.722 HD23 HG11 ' A' ' 741' ' ' VAL . 0.7 OUTLIER -89.42 115.21 26.69 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 176.859 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 794' ' ' SER . . . . . 0.546 ' N ' HD12 ' A' ' 793' ' ' LEU . 34.5 t -128.06 149.93 50.17 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.344 -176.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 795' ' ' LEU . . . . . 0.506 ' H ' HD22 ' A' ' 795' ' ' LEU . 1.3 mm? -78.85 130.35 35.57 Favored 'General case' 0 C--N 1.323 -0.579 0 O-C-N 122.158 -0.339 . . . . 0.0 111.383 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 796' ' ' VAL . . . . . . . . . . . . . 94.2 t -89.91 -56.77 4.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.05 0.452 . . . . 0.0 111.035 -177.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 797' ' ' SER . . . . . 0.636 ' HA ' ' HG ' ' A' ' 808' ' ' LEU . 30.0 m -171.83 160.75 5.67 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.657 -173.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 798' ' ' ILE . . . . . 0.61 ' HA ' ' O ' ' A' ' 752' ' ' THR . 11.7 tt -134.58 160.18 41.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 176.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 799' ' ' LYS . . . . . 0.761 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 7.7 tmtt? -131.77 122.22 25.47 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.206 0.527 . . . . 0.0 110.595 179.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 800' ' ' ASP . . . . . 0.597 ' HA ' ' CD2' ' A' ' 751' ' ' PHE . 7.3 t70 -68.29 156.84 36.86 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.671 -1.149 . . . . 0.0 109.844 176.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 17.3 t -60.03 -14.22 15.34 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 124.093 0.87 . . . . 0.0 112.812 -172.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 802' ' ' THR . . . . . 0.495 HG22 ' OD2' ' A' ' 800' ' ' ASP . 13.9 t -90.33 -0.46 57.65 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.48 0.657 . . . . 0.0 109.733 176.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 803' ' ' GLY . . . . . . . . . . . . . . . 85.44 39.21 8.44 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.9 -178.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 804' ' ' CYS . . . . . . . . . . . . . 48.8 t -110.51 115.19 29.19 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 -178.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 805' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 7.6 p -86.34 134.24 27.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.215 0.531 . . . . 0.0 111.079 -176.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 806' ' ' VAL . . . . . 0.506 HG21 ' HD2' ' A' ' 721' ' ' PRO . 71.4 t -118.56 131.22 71.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.12 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -69.78 116.47 6.9 Favored Glycine 0 N--CA 1.453 -0.178 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.907 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 808' ' ' LEU . . . . . 0.666 HD22 ' HA ' ' A' ' 722' ' ' SER . 32.2 mt -84.87 131.13 34.55 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -174.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 36.4 m -147.42 86.25 1.61 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.62 173.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 810' ' ' GLN . . . . . 0.562 ' HB3' ' HD2' ' A' ' 811' ' ' PRO . 89.1 mt-30 -139.18 169.53 12.2 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.261 177.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 811' ' ' PRO . . . . . 0.562 ' HD2' ' HB3' ' A' ' 810' ' ' GLN . 89.3 Cg_exo -45.68 135.84 12.91 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 122.847 2.364 . . . . 0.0 114.611 -175.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -107.13 167.36 9.96 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.343 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 813' ' ' ALA . . . . . 0.528 ' N ' HD12 ' A' ' 725' ' ' LEU . . . -119.67 152.79 36.56 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.404 -178.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 814' ' ' LYS . . . . . . . . . . . . . 16.9 ttpp -118.23 126.45 52.21 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 121.341 0.591 . . . . 0.0 110.562 178.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 815' ' ' ILE . . . . . 0.594 ' HA ' ' HB3' ' A' ' 731' ' ' LEU . 5.2 mp -112.71 119.28 60.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 114.946 -1.025 . . . . 0.0 109.08 178.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 816' ' ' GLN . . . . . 0.674 HE22 ' HG2' ' A' ' 818' ' ' ARG . 0.0 OUTLIER -107.32 115.04 29.46 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.68 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 817' ' ' VAL . . . . . 0.723 HG22 HD12 ' A' ' 733' ' ' LEU . 3.9 t -106.43 145.71 13.86 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 177.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 818' ' ' ARG . . . . . 0.674 ' HG2' HE22 ' A' ' 816' ' ' GLN . 20.9 mmt85 . . . . . 0 C--N 1.319 -0.723 0 C-N-CA 120.524 -0.47 . . . . 0.0 111.621 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 720' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp . . . . . 0 N--CA 1.45 -0.456 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 721' ' ' PRO . . . . . 0.541 ' HB2' HD13 ' A' ' 798' ' ' ILE . 95.3 Cg_endo -86.03 148.7 9.37 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 122.869 2.379 . . . . 0.0 112.35 -172.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 722' ' ' SER . . . . . 0.466 ' HB3' ' NE2' ' A' ' 810' ' ' GLN . 22.6 t -179.22 -154.05 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.362 -174.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 723' ' ' ALA . . . . . 0.542 ' HB3' ' HG ' ' A' ' 795' ' ' LEU . . . -144.77 144.82 31.37 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 176.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 7.8 m -128.97 98.96 5.1 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 -175.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 725' ' ' LEU . . . . . 0.577 HD22 ' CG2' ' A' ' 743' ' ' VAL . 1.7 mt -63.74 145.32 55.98 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-O 121.216 0.531 . . . . 0.0 110.96 -171.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 31.2 mtpt -101.23 -14.56 17.64 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.358 -177.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 727' ' ' LEU . . . . . 0.475 ' HB2' HG23 ' A' ' 741' ' ' VAL . 0.6 OUTLIER -74.17 123.31 24.23 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 177.132 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 61.3 m-70 -87.7 -38.0 16.21 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -171.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 729' ' ' HIS . . . . . 0.422 ' O ' HD22 ' A' ' 727' ' ' LEU . 3.1 p80 -126.61 -176.63 3.74 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.991 -172.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 730' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -61.52 145.5 51.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.711 0.767 . . . . 0.0 111.427 178.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 731' ' ' LEU . . . . . 0.559 HD23 ' HB2' ' A' ' 739' ' ' SER . 16.2 tp -105.37 108.62 20.23 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.927 -177.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 732' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -76.93 122.1 24.38 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.9 -175.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 733' ' ' LEU . . . . . 0.495 HD11 ' HB3' ' A' ' 739' ' ' SER . 85.3 mt -132.71 164.09 27.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.773 176.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 734' ' ' CYS . . . . . 0.535 ' O ' ' HB2' ' A' ' 737' ' ' ASP . 26.8 p -115.93 -174.06 2.47 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 172.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 735' ' ' LEU . . . . . . . . . . . . . 6.1 tp -66.61 135.48 54.17 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.778 0.799 . . . . 0.0 112.322 -175.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 81.97 4.72 90.19 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 114.357 -1.292 . . . . 0.0 111.767 178.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 737' ' ' ASP . . . . . 0.535 ' HB2' ' O ' ' A' ' 734' ' ' CYS . 6.8 m-20 -82.15 150.54 27.38 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.329 0.585 . . . . 0.0 112.422 -179.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 738' ' ' HIS . . . . . 0.497 ' HB2' ' O ' ' A' ' 782' ' ' THR . 42.6 p-80 -113.39 160.32 18.53 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 169.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 739' ' ' SER . . . . . 0.559 ' HB2' HD23 ' A' ' 731' ' ' LEU . 1.5 p -117.25 170.03 9.01 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 119.556 -0.857 . . . . 0.0 111.827 -172.05 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 740' ' ' SER . . . . . 0.486 ' HA ' ' O ' ' A' ' 780' ' ' ILE . 50.5 m -143.08 101.52 3.84 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.146 177.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 741' ' ' VAL . . . . . 0.547 HG11 HD13 ' A' ' 793' ' ' LEU . 1.2 p -108.74 109.46 61.22 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.546 178.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 742' ' ' PRO . . . . . 0.806 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 5.9 Cg_exo -72.41 128.89 14.13 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 122.252 1.968 . . . . 0.0 111.51 -177.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 743' ' ' VAL . . . . . 0.577 ' CG2' HD22 ' A' ' 725' ' ' LEU . 43.5 t -130.41 119.2 45.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -178.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 744' ' ' ALA . . . . . 0.572 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -84.27 117.97 23.89 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 170.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 745' ' ' LEU . . . . . 0.926 HD13 HD13 ' A' ' 773' ' ' ILE . 0.4 OUTLIER -95.45 150.67 20.04 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.931 -165.222 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -105.92 146.76 29.57 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.483 -177.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 747' ' ' GLY . . . . . . . . . . . . . . . 110.27 135.29 6.99 Favored Glycine 0 C--N 1.311 -0.842 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 -173.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -114.16 106.33 14.25 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 117.053 0.426 . . . . 0.0 111.37 -171.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 129.17 -175.48 18.85 Favored Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 -178.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -68.01 93.46 0.39 Allowed 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.506 2.137 . . . . 0.0 112.119 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 751' ' ' PHE . . . . . 0.496 ' CE2' ' HA ' ' A' ' 800' ' ' ASP . 57.7 m-85 -109.66 140.42 43.53 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.119 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 752' ' ' THR . . . . . 0.759 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 53.8 m -90.24 102.73 15.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.358 0.599 . . . . 0.0 109.837 176.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 753' ' ' LEU . . . . . 0.428 HD22 ' N ' ' A' ' 754' ' ' THR . 0.4 OUTLIER -94.06 123.09 37.21 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.662 -169.695 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 754' ' ' THR . . . . . 0.428 ' N ' HD22 ' A' ' 753' ' ' LEU . 0.8 OUTLIER -119.49 139.88 51.37 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.281 -177.878 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 755' ' ' TYR . . . . . 0.636 ' CE1' ' HB3' ' A' ' 768' ' ' PHE . 23.8 p90 -146.41 155.82 42.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.938 0.399 . . . . 0.0 111.528 177.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 756' ' ' ASP . . . . . 0.465 ' HB3' HG23 ' A' ' 758' ' ' ILE . 5.2 m-20 -113.54 120.27 40.4 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.317 -178.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 757' ' ' ILE . . . . . 0.453 HG13 HD12 ' A' ' 793' ' ' LEU . 4.2 mp -89.14 95.41 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 169.358 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 758' ' ' ILE . . . . . 0.549 HG13 ' O ' ' A' ' 792' ' ' ILE . 1.6 pp -101.19 148.2 7.41 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.56 -174.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 759' ' ' GLU . . . . . 0.796 ' HB3' ' CE2' ' A' ' 791' ' ' TYR . 7.0 pt-20 -106.17 122.15 45.62 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.075 173.021 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 760' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.311 -1.069 0 CA-C-N 114.683 -1.144 . . . . 0.0 108.618 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 765' ' ' ARG . . . . . 0.474 ' CG ' HG22 ' A' ' 758' ' ' ILE . 23.0 ttp180 . . . . . 0 N--CA 1.446 -0.65 0 CA-C-O 120.879 0.371 . . . . 0.0 111.045 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 766' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -126.54 140.82 52.15 Favored 'General case' 0 C--O 1.215 -0.738 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.847 -178.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 767' ' ' THR . . . . . . . . . . . . . 43.0 m -112.06 129.78 56.1 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.498 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 768' ' ' PHE . . . . . 0.636 ' HB3' ' CE1' ' A' ' 755' ' ' TYR . 2.5 t80 -126.1 135.83 52.19 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.334 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 769' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -132.42 127.98 36.53 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.933 -175.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 770' ' ' ILE . . . . . 0.596 HG22 HG22 ' A' ' 773' ' ' ILE . 4.6 mt -121.52 114.14 41.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 177.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 771' ' ' LYS . . . . . 0.595 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 0.1 OUTLIER -87.46 153.88 21.08 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 121.256 0.55 . . . . 0.0 111.842 -174.643 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 772' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 52.35 47.93 23.69 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.363 -1.29 . . . . 0.0 112.009 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 773' ' ' ILE . . . . . 0.926 HD13 HD13 ' A' ' 745' ' ' LEU . 0.5 OUTLIER -75.17 114.79 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 174.771 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 72.1 mttt -114.3 30.95 6.93 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 775' ' ' THR . . . . . 0.706 ' H ' HD12 ' A' ' 773' ' ' ILE . 2.5 m -97.01 -71.82 0.66 Allowed 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 113.488 -1.687 . . . . 0.0 112.415 -169.128 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 776' ' ' ASN . . . . . 0.452 ' HB2' ' O ' ' A' ' 775' ' ' THR . 11.5 m120 83.17 7.99 0.69 Allowed 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.198 0.999 . . . . 0.0 110.138 -177.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 777' ' ' GLU . . . . . 0.572 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 22.5 tt0 -161.55 94.39 0.96 Allowed 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.725 175.445 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 778' ' ' TYR . . . . . 0.901 ' HB3' HD11 ' A' ' 745' ' ' LEU . 67.9 t80 -141.91 120.52 12.53 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.553 -172.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 779' ' ' VAL . . . . . 0.806 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 1.4 m -88.07 129.38 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 CA-C-O 122.035 0.921 . . . . 0.0 109.733 179.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 780' ' ' ILE . . . . . 0.486 ' O ' ' HA ' ' A' ' 740' ' ' SER . 89.7 mt -91.23 138.3 19.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 113.959 -1.473 . . . . 0.0 110.971 -172.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 781' ' ' LYS . . . . . 0.453 ' HD3' ' N ' ' A' ' 781' ' ' LYS . 0.0 OUTLIER -115.86 106.73 14.15 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.33 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 782' ' ' THR . . . . . 0.497 ' O ' ' HB2' ' A' ' 738' ' ' HIS . 32.5 p -78.22 143.26 64.72 Favored Pre-proline 0 C--N 1.32 -0.706 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.102 -178.124 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 783' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -55.79 161.65 7.86 Favored 'Trans proline' 0 CA--C 1.529 0.252 0 C-N-CA 123.513 2.809 . . . . 0.0 113.109 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 784' ' ' VAL . . . . . 0.467 HG12 HG23 ' A' ' 786' ' ' THR . 55.3 t -59.02 121.71 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.312 -177.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 785' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -97.52 98.22 9.74 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.906 177.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 786' ' ' THR . . . . . 0.467 HG23 HG12 ' A' ' 784' ' ' VAL . 35.3 p -87.28 33.7 0.69 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 122.051 0.929 . . . . 0.0 110.092 178.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 28.7 m -153.52 104.98 2.78 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.38 -1.282 . . . . 0.0 110.223 -179.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 788' ' ' GLY . . . . . . . . . . . . . . . -49.59 113.37 1.76 Allowed Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.277 168.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 789' ' ' GLY . . . . . 0.403 ' H ' ' HB ' ' A' ' 817' ' ' VAL . . . -160.49 -166.07 18.56 Favored Glycine 0 N--CA 1.441 -0.97 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 -179.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -123.62 122.74 38.91 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 117.621 0.711 . . . . 0.0 109.319 -178.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 791' ' ' TYR . . . . . 0.796 ' CE2' ' HB3' ' A' ' 759' ' ' GLU . 88.8 m-85 -117.44 150.86 38.2 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.413 0.625 . . . . 0.0 111.407 -177.017 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 792' ' ' ILE . . . . . 0.549 ' O ' HG13 ' A' ' 758' ' ' ILE . 17.0 mt -131.53 113.04 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.338 175.115 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 793' ' ' LEU . . . . . 0.547 HD13 HG11 ' A' ' 741' ' ' VAL . 7.9 tt -85.03 110.26 18.79 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 794' ' ' SER . . . . . . . . . . . . . 13.6 t -123.45 142.2 51.23 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.968 -177.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 795' ' ' LEU . . . . . 0.578 ' H ' HD22 ' A' ' 795' ' ' LEU . 1.2 mm? -67.91 140.22 56.47 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 120.904 0.383 . . . . 0.0 111.454 -178.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 796' ' ' VAL . . . . . . . . . . . . . 69.7 t -99.82 -55.28 6.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.015 -178.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 797' ' ' SER . . . . . 0.568 ' HA ' HD13 ' A' ' 808' ' ' LEU . 89.5 p -173.66 176.94 2.62 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.345 -173.018 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 798' ' ' ILE . . . . . 0.621 ' HA ' ' O ' ' A' ' 752' ' ' THR . 11.0 tt -151.22 161.43 3.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 799' ' ' LYS . . . . . 0.759 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 5.2 tttt -132.24 113.89 13.79 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 120.836 0.35 . . . . 0.0 110.521 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 800' ' ' ASP . . . . . 0.577 ' HB3' ' HB3' ' A' ' 804' ' ' CYS . 16.9 t70 -57.91 152.27 16.47 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.263 171.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 3.4 p -65.59 -7.51 15.3 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -171.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 35.5 p -93.6 1.7 56.59 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.659 0.743 . . . . 0.0 110.04 176.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 803' ' ' GLY . . . . . 0.512 ' HA2' ' HE2' ' A' ' 799' ' ' LYS . . . 82.76 44.73 7.09 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.873 -177.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 804' ' ' CYS . . . . . 0.577 ' HB3' ' HB3' ' A' ' 800' ' ' ASP . 45.1 t -111.68 106.93 15.87 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 177.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 805' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 3.9 t -86.06 119.32 34.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.38 0.609 . . . . 0.0 110.08 -176.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 806' ' ' VAL . . . . . 0.541 HG11 ' HD2' ' A' ' 721' ' ' PRO . 37.3 t -108.01 139.17 31.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.498 -176.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -80.06 110.3 3.07 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.557 -179.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 808' ' ' LEU . . . . . 0.568 HD13 ' HA ' ' A' ' 797' ' ' SER . 10.8 mp -77.61 134.19 38.26 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 177.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 19.9 m -149.5 85.76 1.45 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.166 -0.924 . . . . 0.0 109.175 169.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 810' ' ' GLN . . . . . 0.466 ' NE2' ' HB3' ' A' ' 722' ' ' SER . 4.6 mt-30 -132.26 170.8 10.41 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.009 177.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 811' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -45.3 144.08 4.78 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 123.038 2.492 . . . . 0.0 114.588 -176.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -111.15 166.21 11.26 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.656 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 813' ' ' ALA . . . . . 0.42 ' O ' ' HA ' ' A' ' 792' ' ' ILE . . . -117.87 147.57 42.96 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.257 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 814' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -108.8 125.44 51.96 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.513 0.673 . . . . 0.0 110.92 178.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 815' ' ' ILE . . . . . 0.544 ' HA ' ' HB3' ' A' ' 731' ' ' LEU . 5.1 mp -110.81 109.06 27.09 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-N 114.818 -1.083 . . . . 0.0 108.651 177.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 816' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -99.4 109.27 21.88 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.184 0.516 . . . . 0.0 110.15 -175.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 817' ' ' VAL . . . . . 0.403 ' HB ' ' H ' ' A' ' 789' ' ' GLY . 2.6 t -105.71 146.18 12.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.356 -177.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 818' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 . . . . . 0 C--N 1.324 -0.525 0 CA-C-O 121.245 0.545 . . . . 0.0 111.887 -179.11 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 720' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt . . . . . 0 N--CA 1.447 -0.599 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 721' ' ' PRO . . . . . 0.422 ' O ' HG21 ' A' ' 798' ' ' ILE . 37.6 Cg_endo -83.1 145.36 12.27 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 C-N-CA 122.424 2.083 . . . . 0.0 111.436 -175.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 722' ' ' SER . . . . . 0.497 ' OG ' HD22 ' A' ' 808' ' ' LEU . 25.6 t 177.42 -153.08 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -171.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 723' ' ' ALA . . . . . 0.737 ' HB1' HG21 ' A' ' 743' ' ' VAL . . . -150.21 143.48 25.02 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.482 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 23.1 t -129.95 103.84 7.02 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 725' ' ' LEU . . . . . 0.465 ' CD2' ' HB ' ' A' ' 743' ' ' VAL . 13.2 mt -64.35 149.26 48.61 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 121.616 0.722 . . . . 0.0 111.839 -175.264 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 726' ' ' LYS . . . . . 0.543 ' HD2' ' HB2' ' A' ' 744' ' ' ALA . 20.2 mtpp -106.8 -10.09 16.18 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.46 -175.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 727' ' ' LEU . . . . . 0.465 ' HB2' ' HD2' ' A' ' 742' ' ' PRO . 0.3 OUTLIER -81.31 111.22 17.49 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 176.364 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 40.9 m80 -103.68 37.37 2.05 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -168.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 9.7 p80 -174.08 -177.05 1.25 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.662 0.268 . . . . 0.0 110.776 177.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 730' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -81.04 139.65 35.6 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.297 177.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 731' ' ' LEU . . . . . 0.559 ' HB2' ' HA ' ' A' ' 815' ' ' ILE . 36.4 mt -87.61 117.06 26.16 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.263 -178.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 732' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -84.09 113.01 20.73 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.333 -178.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 733' ' ' LEU . . . . . 0.522 HD11 ' HB3' ' A' ' 739' ' ' SER . 43.5 mt -131.67 159.6 37.86 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 121.267 0.556 . . . . 0.0 111.9 -175.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 734' ' ' CYS . . . . . 0.624 ' HA ' ' O ' ' A' ' 818' ' ' ARG . 78.4 m -104.12 -173.75 2.38 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.131 176.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 735' ' ' LEU . . . . . . . . . . . . . 19.9 tp -73.79 134.71 43.44 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.174 0.511 . . . . 0.0 111.342 -178.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 74.72 11.56 83.16 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.439 -0.886 . . . . 0.0 111.285 -176.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 737' ' ' ASP . . . . . 0.603 ' HB2' ' O ' ' A' ' 734' ' ' CYS . 0.2 OUTLIER -84.77 150.11 25.29 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.119 0.485 . . . . 0.0 111.231 176.55 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 27.9 p-80 -114.25 175.27 5.55 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 168.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 739' ' ' SER . . . . . 0.522 ' HB3' HD11 ' A' ' 733' ' ' LEU . 0.0 OUTLIER -140.0 166.66 24.04 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 120.083 -0.647 . . . . 0.0 111.999 -178.615 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 19.7 m -136.75 112.97 9.82 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.6 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 741' ' ' VAL . . . . . 0.664 HG11 HD23 ' A' ' 793' ' ' LEU . 0.9 OUTLIER -111.05 112.95 55.1 Favored Pre-proline 0 C--N 1.318 -0.799 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.746 -179.621 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 742' ' ' PRO . . . . . 0.678 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 1.6 Cg_endo -73.43 134.97 21.52 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 122.517 2.145 . . . . 0.0 111.284 -179.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 743' ' ' VAL . . . . . 0.737 HG21 ' HB1' ' A' ' 723' ' ' ALA . 2.0 p -131.91 116.44 30.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.376 0.608 . . . . 0.0 112.032 176.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 744' ' ' ALA . . . . . 0.574 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -81.22 98.99 8.34 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 169.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 745' ' ' LEU . . . . . 0.968 HD13 HD13 ' A' ' 773' ' ' ILE . 0.3 OUTLIER -79.36 165.33 23.24 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.675 -167.385 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 17.3 ttmm -114.44 165.33 12.84 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.679 -179.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 747' ' ' GLY . . . . . . . . . . . . . . . 94.45 128.45 5.25 Favored Glycine 0 C--N 1.31 -0.863 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 -175.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 748' ' ' GLN . . . . . 0.522 ' C ' ' HE1' ' A' ' 751' ' ' PHE . 48.3 mm-40 -110.85 98.62 7.71 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.749 -0.38 . . . . 0.0 111.061 -173.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 133.91 -159.23 23.66 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.549 -177.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -78.88 94.99 1.06 Allowed 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 122.944 2.43 . . . . 0.0 112.516 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 751' ' ' PHE . . . . . 0.717 ' CE2' ' HA ' ' A' ' 800' ' ' ASP . 94.6 m-85 -118.41 140.66 49.51 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.799 -178.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 752' ' ' THR . . . . . 0.701 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 92.3 m -95.31 106.7 18.77 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.623 0.725 . . . . 0.0 109.536 179.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 753' ' ' LEU . . . . . 0.485 HD23 HG12 ' A' ' 798' ' ' ILE . 0.4 OUTLIER -97.19 117.78 32.17 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.538 -1.21 . . . . 0.0 109.783 -170.354 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 754' ' ' THR . . . . . 0.486 HG23 ' HB2' ' A' ' 769' ' ' GLU . 1.2 m -116.71 137.04 52.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.897 -177.074 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 755' ' ' TYR . . . . . 0.681 ' CE1' ' HB2' ' A' ' 768' ' ' PHE . 24.3 p90 -144.64 155.38 43.58 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -179.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 756' ' ' ASP . . . . . 0.413 ' OD2' ' HB2' ' A' ' 794' ' ' SER . 4.9 p-10 -116.94 119.94 36.88 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.551 -177.295 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 757' ' ' ILE . . . . . 0.536 ' CD1' HD13 ' A' ' 793' ' ' LEU . 4.0 mp -91.87 96.49 6.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 167.376 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 758' ' ' ILE . . . . . 0.659 HG22 ' HD2' ' A' ' 765' ' ' ARG . 2.4 pp -100.57 149.56 6.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.25 -170.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 759' ' ' GLU . . . . . 0.503 ' HG2' ' CE2' ' A' ' 791' ' ' TYR . 12.5 mt-10 -86.38 118.59 25.92 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 120.921 0.391 . . . . 0.0 111.13 -179.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 760' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.315 -0.9 0 CA-C-O 121.56 0.695 . . . . 0.0 109.533 174.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 765' ' ' ARG . . . . . 0.659 ' HD2' HG22 ' A' ' 758' ' ' ILE . 12.0 ttt180 . . . . . 0 N--CA 1.44 -0.948 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 766' ' ' LYS . . . . . 0.614 ' HD3' ' N ' ' A' ' 767' ' ' THR . 2.0 tmtp? -120.48 146.32 46.38 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 767' ' ' THR . . . . . 0.614 ' N ' ' HD3' ' A' ' 766' ' ' LYS . 96.6 m -131.74 132.36 43.78 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 120.962 0.411 . . . . 0.0 111.751 -176.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 768' ' ' PHE . . . . . 0.681 ' HB2' ' CE1' ' A' ' 755' ' ' TYR . 42.9 m-85 -120.07 141.21 49.98 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.214 174.105 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 769' ' ' GLU . . . . . 0.486 ' HB2' HG23 ' A' ' 754' ' ' THR . 46.0 tt0 -131.27 109.37 10.34 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.383 178.073 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 770' ' ' ILE . . . . . 0.564 HG22 HG22 ' A' ' 773' ' ' ILE . 21.2 mt -105.97 120.37 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 771' ' ' LYS . . . . . 0.577 ' HD2' ' N ' ' A' ' 771' ' ' LYS . 0.1 OUTLIER -85.55 164.62 17.67 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.067 0.46 . . . . 0.0 111.144 -175.192 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 772' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 36.36 50.44 0.75 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 113.853 -1.521 . . . . 0.0 112.64 177.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 773' ' ' ILE . . . . . 0.968 HD13 HD13 ' A' ' 745' ' ' LEU . 0.5 OUTLIER -76.71 111.98 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 175.67 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 75.7 mttt -113.04 33.62 4.95 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 -179.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 775' ' ' THR . . . . . 0.691 ' H ' HD12 ' A' ' 773' ' ' ILE . 1.2 m -95.12 -71.64 0.66 Allowed 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 113.836 -1.529 . . . . 0.0 111.769 -169.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 776' ' ' ASN . . . . . 0.417 ' HB2' ' O ' ' A' ' 775' ' ' THR . 11.5 m120 81.92 4.11 1.28 Allowed 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.129 0.971 . . . . 0.0 110.79 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 777' ' ' GLU . . . . . 0.574 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 18.4 mt-10 -160.2 84.66 0.72 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.197 176.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 778' ' ' TYR . . . . . 0.808 ' HB3' HD11 ' A' ' 745' ' ' LEU . 79.4 t80 -128.89 129.08 45.05 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.843 0.354 . . . . 0.0 110.863 -172.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 779' ' ' VAL . . . . . 0.678 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 21.1 t -87.95 112.81 24.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 121.281 0.562 . . . . 0.0 110.515 178.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 780' ' ' ILE . . . . . . . . . . . . . 74.0 mt -80.2 141.48 15.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.603 -178.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -114.93 107.85 15.94 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 177.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 782' ' ' THR . . . . . 0.403 ' HA ' ' HD3' ' A' ' 783' ' ' PRO . 68.7 p -78.15 135.33 62.37 Favored Pre-proline 0 N--CA 1.441 -0.895 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 783' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 782' ' ' THR . 46.3 Cg_exo -57.05 158.32 18.0 Favored 'Trans proline' 0 CA--C 1.518 -0.278 0 C-N-CA 123.523 2.815 . . . . 0.0 112.401 -173.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 784' ' ' VAL . . . . . . . . . . . . . 12.8 p -60.47 136.43 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.697 -177.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 785' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -110.08 97.15 6.7 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.617 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 82.1 p -83.77 25.16 0.81 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.725 0.774 . . . . 0.0 110.822 -176.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 36.7 m -156.47 120.97 4.51 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.446 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 788' ' ' GLY . . . . . 0.673 ' HA2' HG12 ' A' ' 817' ' ' VAL . . . -51.74 110.64 1.14 Allowed Glycine 0 N--CA 1.448 -0.554 0 O-C-N 123.669 0.605 . . . . 0.0 113.335 174.232 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 789' ' ' GLY . . . . . 0.415 ' H ' ' HB ' ' A' ' 817' ' ' VAL . . . -157.28 166.37 33.63 Favored Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 110.571 -1.012 . . . . 0.0 110.571 177.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -107.97 132.29 53.67 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 117.305 0.552 . . . . 0.0 109.763 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 791' ' ' TYR . . . . . 0.503 ' CE2' ' HG2' ' A' ' 759' ' ' GLU . 89.4 m-85 -124.61 158.52 32.88 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.951 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 792' ' ' ILE . . . . . 0.609 ' O ' HG13 ' A' ' 758' ' ' ILE . 6.2 mt -134.21 117.71 25.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 171.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 793' ' ' LEU . . . . . 0.664 HD23 HG11 ' A' ' 741' ' ' VAL . 1.0 OUTLIER -84.91 112.21 20.36 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.408 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 794' ' ' SER . . . . . 0.516 ' N ' HD12 ' A' ' 793' ' ' LEU . 13.6 m -118.39 177.3 4.87 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 114.81 -1.086 . . . . 0.0 108.744 -177.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 795' ' ' LEU . . . . . 0.423 HD11 ' O ' ' A' ' 723' ' ' ALA . 42.9 mt -103.79 132.3 50.17 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.784 0.326 . . . . 0.0 110.644 -179.005 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 796' ' ' VAL . . . . . . . . . . . . . 64.1 t -89.27 -56.72 4.88 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.661 -177.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 797' ' ' SER . . . . . 0.44 ' HA ' ' HG ' ' A' ' 808' ' ' LEU . 26.6 m -173.36 172.83 3.66 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.855 -173.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 798' ' ' ILE . . . . . 0.725 ' HB ' HD21 ' A' ' 808' ' ' LEU . 0.5 OUTLIER -146.34 166.76 7.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -173.529 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 799' ' ' LYS . . . . . 0.701 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 34.5 tttt -135.29 117.4 15.42 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.281 -179.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 800' ' ' ASP . . . . . 0.717 ' HA ' ' CE2' ' A' ' 751' ' ' PHE . 8.0 t70 -68.65 153.02 44.56 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.192 173.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 24.2 p -62.44 -8.12 5.62 Favored 'General case' 0 C--N 1.33 -0.255 0 O-C-N 123.867 0.73 . . . . 0.0 112.375 -173.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 35.4 p -94.8 9.79 37.69 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.536 0.684 . . . . 0.0 109.673 176.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 803' ' ' GLY . . . . . 0.554 ' HA2' ' HE2' ' A' ' 799' ' ' LYS . . . 72.45 40.83 53.66 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 114.871 -1.059 . . . . 0.0 112.389 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 804' ' ' CYS . . . . . . . . . . . . . 59.6 m -114.09 116.32 28.95 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 805' ' ' VAL . . . . . 0.658 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 6.1 p -84.92 113.43 23.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.895 0.855 . . . . 0.0 110.821 -177.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 806' ' ' VAL . . . . . 0.671 ' HB ' HG22 ' A' ' 798' ' ' ILE . 41.0 t -96.05 138.42 21.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.604 -178.043 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -70.53 122.03 10.34 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.733 179.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 808' ' ' LEU . . . . . 0.725 HD21 ' HB ' ' A' ' 798' ' ' ILE . 24.1 mt -89.63 132.88 34.91 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -175.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 14.9 t -149.71 87.04 1.47 Allowed 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.452 -0.794 . . . . 0.0 109.62 172.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 810' ' ' GLN . . . . . 0.438 ' HB3' ' HD2' ' A' ' 811' ' ' PRO . 13.1 mt-30 -136.17 170.44 10.96 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.591 -0.732 . . . . 0.0 109.779 173.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 811' ' ' PRO . . . . . 0.438 ' HD2' ' HB3' ' A' ' 810' ' ' GLN . 89.2 Cg_exo -44.93 139.11 8.24 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 122.973 2.449 . . . . 0.0 114.192 -177.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -110.4 166.07 11.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.599 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 813' ' ' ALA . . . . . . . . . . . . . . . -114.57 154.62 27.98 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.257 -177.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 814' ' ' LYS . . . . . . . . . . . . . 50.6 tttp -115.0 130.05 56.85 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-O 121.129 0.49 . . . . 0.0 110.143 176.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 815' ' ' ILE . . . . . 0.559 ' HA ' ' HB2' ' A' ' 731' ' ' LEU . 4.8 mp -113.42 118.24 57.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 816' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -109.05 114.25 27.83 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.846 0.355 . . . . 0.0 110.81 -179.088 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 817' ' ' VAL . . . . . 0.673 HG12 ' HA2' ' A' ' 788' ' ' GLY . 92.5 t -110.07 124.55 66.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 176.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 818' ' ' ARG . . . . . 0.624 ' O ' ' HA ' ' A' ' 734' ' ' CYS . 15.0 mmt180 . . . . . 0 C--N 1.32 -0.685 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 176.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 720' ' ' LYS . . . . . 0.456 ' HA ' ' HD3' ' A' ' 721' ' ' PRO . 12.9 mmmm . . . . . 0 N--CA 1.443 -0.793 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 721' ' ' PRO . . . . . 0.545 ' HD2' HG21 ' A' ' 806' ' ' VAL . 5.9 Cg_endo -78.12 138.47 16.23 Favored 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 122.471 2.114 . . . . 0.0 110.174 -179.071 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 722' ' ' SER . . . . . 0.881 ' HB2' ' OE1' ' A' ' 810' ' ' GLN . 7.3 p -175.21 -153.05 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.347 -166.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 723' ' ' ALA . . . . . 0.605 ' HA ' ' HA ' ' A' ' 745' ' ' LEU . . . -157.73 151.27 23.75 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-N 118.518 0.599 . . . . 0.0 110.659 177.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 41.6 m -140.03 99.1 3.6 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 121.624 -0.672 . . . . 0.0 110.027 179.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 725' ' ' LEU . . . . . 0.938 ' HG ' HG22 ' A' ' 743' ' ' VAL . 5.2 mp -57.3 143.3 40.23 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-O 122.516 1.15 . . . . 0.0 112.661 -175.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 36.5 mtpt -96.82 -13.98 22.21 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 112.851 -1.977 . . . . 0.0 110.279 -177.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 727' ' ' LEU . . . . . 0.518 ' HB2' HG23 ' A' ' 741' ' ' VAL . 3.1 tm? -50.4 128.91 20.93 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.387 -1.278 . . . . 0.0 109.966 176.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 35.4 m170 -89.9 -52.48 4.95 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -171.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -145.65 -177.0 5.35 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.535 -0.466 . . . . 0.0 111.513 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 730' ' ' ASP . . . . . 0.406 ' HA ' ' O ' ' A' ' 814' ' ' LYS . 9.5 p-10 -48.06 133.12 15.26 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 124.019 0.824 . . . . 0.0 111.523 178.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 731' ' ' LEU . . . . . 0.575 ' CD2' ' HB2' ' A' ' 739' ' ' SER . 27.2 tp -99.53 111.49 23.83 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.526 -175.088 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 732' ' ' LYS . . . . . . . . . . . . . 40.5 mmtm -72.76 121.32 19.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.552 -179.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 733' ' ' LEU . . . . . 0.49 HD12 ' CG2' ' A' ' 815' ' ' ILE . 94.4 mt -138.26 160.54 39.2 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.445 178.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 734' ' ' CYS . . . . . . . . . . . . . 63.8 m -109.96 -174.06 2.4 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.001 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 735' ' ' LEU . . . . . . . . . . . . . 38.4 tp -65.24 125.85 26.3 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.902 0.382 . . . . 0.0 111.36 -172.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 736' ' ' GLY . . . . . 0.508 ' O ' HG13 ' A' ' 784' ' ' VAL . . . 81.4 7.91 87.74 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.455 -0.879 . . . . 0.0 112.622 177.383 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 737' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -78.58 150.37 32.79 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.024 0.44 . . . . 0.0 111.452 176.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 738' ' ' HIS . . . . . 0.622 ' HB2' ' O ' ' A' ' 782' ' ' THR . 39.8 p-80 -116.83 166.11 12.53 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 172.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 739' ' ' SER . . . . . 0.575 ' HB2' ' CD2' ' A' ' 731' ' ' LEU . 13.5 p -124.98 163.37 22.47 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 118.956 -1.098 . . . . 0.0 112.27 -172.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 740' ' ' SER . . . . . 0.497 ' HA ' ' O ' ' A' ' 780' ' ' ILE . 46.0 m -130.44 99.94 5.18 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.089 174.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 741' ' ' VAL . . . . . 0.541 HG11 HD23 ' A' ' 793' ' ' LEU . 0.1 OUTLIER -100.42 112.73 64.87 Favored Pre-proline 0 C--N 1.318 -0.79 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.338 179.449 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 742' ' ' PRO . . . . . 0.753 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 6.3 Cg_exo -75.54 129.8 12.19 Favored 'Trans proline' 0 N--CA 1.445 -1.356 0 C-N-CA 122.215 1.944 . . . . 0.0 110.96 -176.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 743' ' ' VAL . . . . . 0.938 HG22 ' HG ' ' A' ' 725' ' ' LEU . 20.1 t -127.95 121.34 56.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.128 0.489 . . . . 0.0 112.247 178.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 744' ' ' ALA . . . . . 0.661 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -83.33 99.38 9.98 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 122.326 1.06 . . . . 0.0 108.275 169.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 745' ' ' LEU . . . . . 0.877 HD11 ' HB3' ' A' ' 778' ' ' TYR . 3.5 mt -77.39 164.9 25.07 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 113.52 -1.673 . . . . 0.0 110.742 -169.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 746' ' ' LYS . . . . . 0.469 ' HB3' ' OG ' ' A' ' 722' ' ' SER . 14.4 tppt? -123.46 161.31 25.08 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.079 0.466 . . . . 0.0 110.457 -176.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 747' ' ' GLY . . . . . . . . . . . . . . . 91.3 121.69 2.6 Favored Glycine 0 C--N 1.312 -0.783 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 -175.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -95.34 117.97 31.26 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.28 0.562 . . . . 0.0 111.98 -172.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 116.65 -175.91 16.01 Favored Glycine 0 CA--C 1.499 -0.934 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.506 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 750' ' ' PRO . . . . . 0.488 ' HB3' ' HE2' ' A' ' 774' ' ' LYS . 86.8 Cg_endo -69.07 94.88 0.48 Allowed 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 123.359 2.706 . . . . 0.0 113.187 -177.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 751' ' ' PHE . . . . . 0.583 ' CD2' ' HA ' ' A' ' 800' ' ' ASP . 64.0 m-85 -112.13 144.87 40.78 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.067 179.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 752' ' ' THR . . . . . 0.766 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 89.0 m -91.85 102.76 15.35 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.277 0.56 . . . . 0.0 109.921 179.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 753' ' ' LEU . . . . . 0.71 ' CD2' HD22 ' A' ' 745' ' ' LEU . 46.9 tp -97.0 121.52 38.97 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.298 -171.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 754' ' ' THR . . . . . 0.481 ' HB ' ' HB ' ' A' ' 796' ' ' VAL . 1.0 OUTLIER -109.66 135.98 49.75 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.131 -177.592 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 755' ' ' TYR . . . . . 0.628 ' CE1' ' HB3' ' A' ' 768' ' ' PHE . 29.6 p90 -143.1 152.43 41.84 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 120.977 0.418 . . . . 0.0 111.843 178.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 756' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -117.7 118.47 32.16 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.694 -179.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 757' ' ' ILE . . . . . 0.611 ' CD1' HD13 ' A' ' 793' ' ' LEU . 3.5 mp -87.7 96.56 5.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 168.206 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 758' ' ' ILE . . . . . 0.624 HG22 ' HD3' ' A' ' 765' ' ' ARG . 2.3 pp -94.53 149.89 4.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 121.322 0.582 . . . . 0.0 111.962 -171.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 759' ' ' GLU . . . . . 0.503 ' HG2' ' CE2' ' A' ' 791' ' ' TYR . 16.1 mt-10 -90.86 115.13 27.67 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.832 175.041 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 760' ' ' THR . . . . . . . . . . . . . 2.5 t . . . . . 0 C--N 1.312 -1.023 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 172.789 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 765' ' ' ARG . . . . . 0.624 ' HD3' HG22 ' A' ' 758' ' ' ILE . 6.1 ttp180 . . . . . 0 N--CA 1.451 -0.411 0 CA-C-O 120.552 0.215 . . . . 0.0 110.903 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 766' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -123.7 134.38 53.72 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 120.922 0.391 . . . . 0.0 110.449 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 767' ' ' THR . . . . . . . . . . . . . 47.3 m -107.58 131.39 54.41 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.46 -177.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 768' ' ' PHE . . . . . 0.628 ' HB3' ' CE1' ' A' ' 755' ' ' TYR . 0.2 OUTLIER -137.16 135.84 37.7 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.203 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 769' ' ' GLU . . . . . 0.46 ' HB2' HG23 ' A' ' 754' ' ' THR . 39.3 tt0 -129.54 124.01 32.82 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.118 0.485 . . . . 0.0 111.692 -175.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 4.6 mm -102.38 110.66 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.759 -179.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 771' ' ' LYS . . . . . 0.616 ' HD2' ' N ' ' A' ' 771' ' ' LYS . 0.0 OUTLIER -80.41 157.4 26.27 Favored 'General case' 0 C--N 1.312 -1.028 0 C-N-CA 120.104 -0.639 . . . . 0.0 109.983 179.293 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 772' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 41.77 50.33 3.98 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 113.871 -1.513 . . . . 0.0 113.515 178.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 773' ' ' ILE . . . . . 0.843 HD12 ' H ' ' A' ' 775' ' ' THR . 0.5 OUTLIER -75.35 111.37 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 171.135 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 774' ' ' LYS . . . . . 0.488 ' HE2' ' HB3' ' A' ' 750' ' ' PRO . 58.7 mttt -107.26 24.35 12.99 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -178.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 775' ' ' THR . . . . . 0.843 ' H ' HD12 ' A' ' 773' ' ' ILE . 0.2 OUTLIER -95.38 -74.27 0.56 Allowed 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -165.763 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 776' ' ' ASN . . . . . 0.637 ' HB2' ' O ' ' A' ' 775' ' ' THR . 0.9 OUTLIER 91.07 4.13 0.1 Allowed 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.5 1.12 . . . . 0.0 110.596 -177.605 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 777' ' ' GLU . . . . . 0.661 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 13.9 tt0 -162.94 101.59 0.99 Allowed 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.133 174.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 778' ' ' TYR . . . . . 0.877 ' HB3' HD11 ' A' ' 745' ' ' LEU . 90.7 t80 -153.69 129.7 10.29 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.633 -171.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 779' ' ' VAL . . . . . 0.753 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 1.9 m -91.68 129.54 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 CA-C-O 122.15 0.976 . . . . 0.0 110.823 178.061 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 780' ' ' ILE . . . . . 0.497 ' O ' ' HA ' ' A' ' 740' ' ' SER . 88.2 mt -90.13 139.79 16.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 113.59 -1.641 . . . . 0.0 110.811 -174.028 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 781' ' ' LYS . . . . . 0.45 ' HD3' ' N ' ' A' ' 781' ' ' LYS . 0.1 OUTLIER -111.81 107.62 16.74 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.928 0.394 . . . . 0.0 110.323 179.623 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 782' ' ' THR . . . . . 0.622 ' O ' ' HB2' ' A' ' 738' ' ' HIS . 25.2 p -77.8 142.91 66.03 Favored Pre-proline 0 C--N 1.318 -0.761 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.827 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 783' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 782' ' ' THR . 53.0 Cg_exo -56.32 160.72 10.44 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 123.53 2.82 . . . . 0.0 113.2 -178.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 784' ' ' VAL . . . . . 0.508 HG13 ' O ' ' A' ' 736' ' ' GLY . 40.5 t -58.55 122.62 8.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.952 178.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 785' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -100.67 97.27 7.96 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.187 178.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 786' ' ' THR . . . . . 0.45 HG23 HG12 ' A' ' 784' ' ' VAL . 44.1 p -84.37 34.23 0.52 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.677 0.751 . . . . 0.0 111.165 -178.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 12.7 m -154.69 112.72 3.48 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.045 -0.979 . . . . 0.0 111.006 178.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 788' ' ' GLY . . . . . 0.689 ' HA2' HG12 ' A' ' 817' ' ' VAL . . . -50.13 112.49 1.52 Allowed Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.521 169.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 789' ' ' GLY . . . . . . . . . . . . . . . -157.51 -148.15 5.03 Favored Glycine 0 N--CA 1.443 -0.843 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -144.86 124.77 13.47 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 179.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 791' ' ' TYR . . . . . 0.503 ' CE2' ' HG2' ' A' ' 759' ' ' GLU . 90.9 m-85 -118.99 145.14 46.07 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.998 -176.174 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 792' ' ' ILE . . . . . 0.576 ' O ' HG13 ' A' ' 758' ' ' ILE . 16.5 mt -123.56 110.41 25.92 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.508 173.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 793' ' ' LEU . . . . . 0.848 ' HB3' ' HB3' ' A' ' 813' ' ' ALA . 4.0 tp -84.75 109.55 18.14 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.428 0.632 . . . . 0.0 109.448 179.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 794' ' ' SER . . . . . . . . . . . . . 19.1 m -112.31 156.52 22.3 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.062 -174.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 795' ' ' LEU . . . . . 0.485 HD13 ' HB3' ' A' ' 723' ' ' ALA . 74.9 mt -91.13 130.5 37.02 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.903 0.382 . . . . 0.0 110.372 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 796' ' ' VAL . . . . . 0.481 ' HB ' ' HB ' ' A' ' 754' ' ' THR . 76.6 t -91.52 -55.53 6.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.159 -175.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 797' ' ' SER . . . . . 0.608 ' HA ' HD13 ' A' ' 808' ' ' LEU . 88.9 p -179.43 179.12 0.64 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.503 -172.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 798' ' ' ILE . . . . . 0.62 ' HA ' ' O ' ' A' ' 752' ' ' THR . 10.3 tt -148.53 161.94 5.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 178.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 799' ' ' LYS . . . . . 0.766 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 7.6 tmtt? -133.31 122.02 23.25 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.037 0.446 . . . . 0.0 110.787 -178.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 800' ' ' ASP . . . . . 0.583 ' HA ' ' CD2' ' A' ' 751' ' ' PHE . 9.0 t70 -66.45 154.87 39.09 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.971 174.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 38.2 t -59.15 -14.18 9.56 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 124.236 0.96 . . . . 0.0 112.719 -172.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 61.8 p -96.25 5.57 50.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.554 0.692 . . . . 0.0 110.189 178.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 803' ' ' GLY . . . . . . . . . . . . . . . 82.23 40.19 10.48 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.07 -0.968 . . . . 0.0 112.148 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 804' ' ' CYS . . . . . 0.464 ' HB2' ' HB3' ' A' ' 800' ' ' ASP . 63.4 m -110.94 114.62 28.08 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 179.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 805' ' ' VAL . . . . . . . . . . . . . 11.4 p -85.75 137.54 20.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.487 0.66 . . . . 0.0 111.464 -173.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 806' ' ' VAL . . . . . 0.582 ' HB ' HG22 ' A' ' 798' ' ' ILE . 97.0 t -118.03 137.65 51.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.176 176.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -87.6 110.63 3.61 Favored Glycine 0 C--N 1.321 -0.277 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.481 -178.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 808' ' ' LEU . . . . . 0.608 HD13 ' HA ' ' A' ' 797' ' ' SER . 11.1 mp -79.78 129.69 34.7 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 178.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 8.8 t -138.6 87.01 2.19 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 168.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 810' ' ' GLN . . . . . 0.881 ' OE1' ' HB2' ' A' ' 722' ' ' SER . 25.2 mt-30 -139.48 174.57 3.97 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.295 -170.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 811' ' ' PRO . . . . . 0.499 ' HD2' ' HB3' ' A' ' 810' ' ' GLN . 75.5 Cg_exo -44.69 146.68 2.12 Favored 'Trans proline' 0 C--N 1.36 1.14 0 C-N-CA 123.395 2.73 . . . . 0.0 114.376 -178.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -119.99 166.93 12.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.147 -177.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 813' ' ' ALA . . . . . 0.848 ' HB3' ' HB3' ' A' ' 793' ' ' LEU . . . -105.19 146.18 29.6 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.212 178.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 814' ' ' LYS . . . . . 0.479 ' HG2' HG12 ' A' ' 792' ' ' ILE . 6.7 mtmp? -122.85 112.72 18.21 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.839 0.828 . . . . 0.0 110.605 172.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 815' ' ' ILE . . . . . 0.544 ' HA ' ' HB3' ' A' ' 731' ' ' LEU . 4.5 mp -109.89 109.07 27.06 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 114.088 -1.415 . . . . 0.0 109.25 -176.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 816' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -98.98 108.58 21.29 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.262 0.553 . . . . 0.0 110.263 -176.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 817' ' ' VAL . . . . . 0.689 HG12 ' HA2' ' A' ' 788' ' ' GLY . 96.1 t -98.46 145.56 9.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.599 -179.171 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 818' ' ' ARG . . . . . . . . . . . . . 20.0 tpt180 . . . . . 0 C--N 1.313 -0.992 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -178.556 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 720' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt . . . . . 0 N--CA 1.446 -0.649 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 721' ' ' PRO . . . . . 0.488 ' HB3' ' HA3' ' A' ' 747' ' ' GLY . 36.3 Cg_endo -86.75 148.89 8.48 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 122.564 2.176 . . . . 0.0 110.801 177.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 722' ' ' SER . . . . . 0.578 ' HA ' HD22 ' A' ' 808' ' ' LEU . 8.4 t -178.78 -154.6 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -171.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 723' ' ' ALA . . . . . 0.696 ' O ' HD11 ' A' ' 795' ' ' LEU . . . -150.99 140.17 21.21 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.902 0.382 . . . . 0.0 110.799 176.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 43.4 t -128.52 99.43 5.38 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -174.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 725' ' ' LEU . . . . . 0.55 ' HG ' ' O ' ' A' ' 811' ' ' PRO . 1.1 mt -65.02 146.25 55.26 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.604 -172.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 726' ' ' LYS . . . . . 0.41 ' HD2' ' HB2' ' A' ' 744' ' ' ALA . 34.3 mtpt -103.88 -10.58 18.08 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.464 -174.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 727' ' ' LEU . . . . . 0.475 ' HB2' HG23 ' A' ' 741' ' ' VAL . 0.8 OUTLIER -74.46 109.67 8.14 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 175.751 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 41.6 m80 -105.43 38.06 2.06 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -169.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -169.51 -176.99 2.62 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.719 0.295 . . . . 0.0 111.104 179.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 730' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -66.21 137.1 56.74 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.953 173.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 731' ' ' LEU . . . . . 0.598 ' HB3' ' HA ' ' A' ' 815' ' ' ILE . 40.4 tp -103.23 100.17 10.06 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.973 178.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 732' ' ' LYS . . . . . 0.48 ' HD3' ' HB3' ' A' ' 816' ' ' GLN . 32.6 mmtp -78.63 124.26 27.99 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.454 0.645 . . . . 0.0 112.09 -175.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 733' ' ' LEU . . . . . 0.638 ' HG ' ' HB3' ' A' ' 737' ' ' ASP . 7.9 mp -120.4 165.13 15.32 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.671 -1.15 . . . . 0.0 109.705 177.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 734' ' ' CYS . . . . . 0.5 ' O ' ' HB2' ' A' ' 737' ' ' ASP . 31.2 p -120.16 -179.27 3.89 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.702 171.008 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 735' ' ' LEU . . . . . . . . . . . . . 2.8 tt -57.88 116.5 3.52 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.938 0.399 . . . . 0.0 110.34 -179.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 736' ' ' GLY . . . . . 0.515 ' HA2' HG22 ' A' ' 786' ' ' THR . . . 91.64 3.39 68.82 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.458 176.137 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 737' ' ' ASP . . . . . 0.638 ' HB3' ' HG ' ' A' ' 733' ' ' LEU . 0.3 OUTLIER -72.47 158.21 36.15 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.973 0.416 . . . . 0.0 111.146 177.957 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 37.0 p-80 -116.66 153.68 31.89 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 171.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 739' ' ' SER . . . . . 0.728 ' HB2' ' OG1' ' A' ' 782' ' ' THR . 10.8 m -98.15 159.0 15.22 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 119.126 -1.03 . . . . 0.0 111.235 -174.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 740' ' ' SER . . . . . 0.539 ' H ' HD21 ' A' ' 731' ' ' LEU . 10.5 t -143.37 101.09 3.73 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.915 -1.038 . . . . 0.0 108.657 -174.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 741' ' ' VAL . . . . . 0.475 HG23 ' HB2' ' A' ' 727' ' ' LEU . 2.1 p -121.26 112.51 32.98 Favored Pre-proline 0 C--N 1.316 -0.864 0 CA-C-O 121.283 0.563 . . . . 0.0 110.266 -177.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 742' ' ' PRO . . . . . 0.662 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 4.5 Cg_exo -71.33 125.93 11.8 Favored 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 122.294 1.996 . . . . 0.0 109.863 178.141 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 743' ' ' VAL . . . . . 0.514 ' CG2' HD22 ' A' ' 725' ' ' LEU . 24.0 t -129.31 114.77 32.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -178.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 744' ' ' ALA . . . . . 0.49 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -81.59 101.6 10.1 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 171.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 745' ' ' LEU . . . . . 0.962 HD11 ' HB3' ' A' ' 778' ' ' TYR . 0.2 OUTLIER -83.94 168.2 16.25 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.258 -167.814 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 44.1 tptt -122.24 156.18 34.33 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.405 -177.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 747' ' ' GLY . . . . . 0.488 ' HA3' ' HB3' ' A' ' 721' ' ' PRO . . . 93.66 123.62 3.65 Favored Glycine 0 C--N 1.311 -0.827 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.378 -177.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 25.7 mp0 -106.69 114.45 28.56 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.119 0.485 . . . . 0.0 111.283 -173.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 130.69 -175.98 19.13 Favored Glycine 0 N--CA 1.446 -0.7 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 -177.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -70.57 95.07 0.61 Allowed 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.658 2.238 . . . . 0.0 112.392 178.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 751' ' ' PHE . . . . . 0.502 ' CE2' ' HA ' ' A' ' 800' ' ' ASP . 77.5 m-85 -113.34 140.88 47.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.522 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 752' ' ' THR . . . . . 0.752 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 86.6 m -91.05 104.61 17.17 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.344 0.592 . . . . 0.0 109.763 177.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 753' ' ' LEU . . . . . 0.564 ' CD1' HD22 ' A' ' 745' ' ' LEU . 1.8 tt -95.95 116.34 28.78 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.608 -171.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 754' ' ' THR . . . . . 0.458 HG23 ' HB2' ' A' ' 769' ' ' GLU . 1.0 OUTLIER -114.44 137.7 51.5 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.989 -179.1 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 755' ' ' TYR . . . . . 0.505 ' CD1' HD11 ' A' ' 793' ' ' LEU . 24.5 p90 -145.37 162.93 36.09 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 120.961 0.41 . . . . 0.0 111.541 178.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 756' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -128.73 121.13 27.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.677 -178.222 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 757' ' ' ILE . . . . . 0.521 HG13 HD13 ' A' ' 793' ' ' LEU . 3.5 mp -87.01 96.47 5.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 169.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 758' ' ' ILE . . . . . 0.715 HG22 ' HD3' ' A' ' 765' ' ' ARG . 2.3 pp -95.21 149.65 4.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 116.116 -0.493 . . . . 0.0 112.218 -169.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 759' ' ' GLU . . . . . 0.647 ' HG2' ' CE2' ' A' ' 791' ' ' TYR . 24.6 mt-10 -89.75 119.94 30.58 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.394 179.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 760' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.313 -0.995 0 CA-C-O 121.346 0.593 . . . . 0.0 109.564 175.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 765' ' ' ARG . . . . . 0.715 ' HD3' HG22 ' A' ' 758' ' ' ILE . 7.9 ttp180 . . . . . 0 CA--C 1.535 0.385 0 CA-C-O 120.87 0.367 . . . . 0.0 111.523 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 766' ' ' LYS . . . . . . . . . . . . . 9.7 tmtm? -115.98 135.45 53.95 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-O 121.088 0.47 . . . . 0.0 110.409 -177.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 767' ' ' THR . . . . . . . . . . . . . 27.7 m -109.04 137.03 47.59 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.833 -174.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 768' ' ' PHE . . . . . 0.495 ' HB3' ' CE1' ' A' ' 755' ' ' TYR . 3.2 t80 -139.72 139.74 36.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.96 0.41 . . . . 0.0 110.643 175.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 769' ' ' GLU . . . . . 0.458 ' HB2' HG23 ' A' ' 754' ' ' THR . 35.5 tt0 -129.76 129.98 44.81 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.848 -179.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 770' ' ' ILE . . . . . 0.531 HG22 HG22 ' A' ' 773' ' ' ILE . 5.0 mt -122.82 111.87 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 176.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 771' ' ' LYS . . . . . 0.637 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 9.5 mtpt -85.1 152.04 23.69 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-O 121.492 0.663 . . . . 0.0 111.328 -174.01 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 772' ' ' GLU . . . . . 0.415 ' O ' ' HG3' ' A' ' 774' ' ' LYS . 5.4 mt-10 54.7 47.11 23.24 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.211 -1.359 . . . . 0.0 112.532 177.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 773' ' ' ILE . . . . . 0.931 HD13 HD13 ' A' ' 745' ' ' LEU . 0.5 OUTLIER -73.8 119.89 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 173.835 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 774' ' ' LYS . . . . . 0.415 ' HG3' ' O ' ' A' ' 772' ' ' GLU . 73.0 mttt -118.21 30.66 7.11 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -177.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 775' ' ' THR . . . . . 0.686 ' H ' HD12 ' A' ' 773' ' ' ILE . 0.6 OUTLIER -95.88 -72.24 0.64 Allowed 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 114.957 -1.019 . . . . 0.0 113.381 -171.394 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 776' ' ' ASN . . . . . 0.595 ' HB2' ' O ' ' A' ' 775' ' ' THR . 0.9 OUTLIER 83.82 4.67 0.78 Allowed 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.045 0.938 . . . . 0.0 110.389 -175.601 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 777' ' ' GLU . . . . . 0.49 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 6.9 tp10 -161.69 78.3 0.54 Allowed 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 -179.47 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 778' ' ' TYR . . . . . 0.962 ' HB3' HD11 ' A' ' 745' ' ' LEU . 82.4 t80 -132.86 125.65 30.44 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.115 0.483 . . . . 0.0 111.69 -169.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 779' ' ' VAL . . . . . 0.662 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 21.6 t -84.16 115.97 27.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.051 176.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 780' ' ' ILE . . . . . 0.479 HD12 HG21 ' A' ' 743' ' ' VAL . 77.2 mt -89.84 135.92 25.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.724 -176.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 781' ' ' LYS . . . . . 0.415 ' HD3' ' C ' ' A' ' 780' ' ' ILE . 0.0 OUTLIER -118.89 109.12 15.63 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 177.682 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 782' ' ' THR . . . . . 0.728 ' OG1' ' HB2' ' A' ' 739' ' ' SER . 82.6 p -82.6 148.62 58.75 Favored Pre-proline 0 C--O 1.244 0.811 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.862 -176.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 783' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -49.27 157.0 2.17 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 124.09 3.193 . . . . 0.0 113.447 -178.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 784' ' ' VAL . . . . . 0.533 HG12 HG23 ' A' ' 786' ' ' THR . 70.1 t -61.19 131.24 26.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.086 -0.961 . . . . 0.0 112.803 -174.176 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 785' ' ' PHE . . . . . 0.415 ' C ' ' H ' ' A' ' 787' ' ' THR . 80.0 m-85 -103.68 88.96 3.19 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.01 177.164 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 786' ' ' THR . . . . . 0.533 HG23 HG12 ' A' ' 784' ' ' VAL . 32.5 p -83.47 29.42 0.51 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 122.077 0.941 . . . . 0.0 110.284 178.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 787' ' ' THR . . . . . 0.415 ' H ' ' C ' ' A' ' 785' ' ' PHE . 2.1 m -159.65 105.46 1.63 Allowed 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.941 -175.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 788' ' ' GLY . . . . . 0.825 ' HA2' HG22 ' A' ' 817' ' ' VAL . . . -49.46 137.76 19.55 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.75 -0.659 . . . . 0.0 113.648 172.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 789' ' ' GLY . . . . . 0.514 ' H ' HG13 ' A' ' 817' ' ' VAL . . . -176.84 -178.01 46.24 Favored Glycine 0 N--CA 1.44 -1.062 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -178.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -118.5 119.66 35.19 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 117.851 0.826 . . . . 0.0 109.029 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 791' ' ' TYR . . . . . 0.647 ' CE2' ' HG2' ' A' ' 759' ' ' GLU . 92.6 m-85 -122.24 148.88 44.44 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.582 -175.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 792' ' ' ILE . . . . . 0.586 ' O ' HG13 ' A' ' 758' ' ' ILE . 19.9 mt -124.64 114.33 40.21 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.065 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 172.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 793' ' ' LEU . . . . . 0.524 HD12 ' N ' ' A' ' 794' ' ' SER . 0.5 OUTLIER -84.39 115.73 22.67 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.893 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 794' ' ' SER . . . . . 0.524 ' N ' HD12 ' A' ' 793' ' ' LEU . 23.1 m -130.51 161.42 31.5 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 114.701 -1.136 . . . . 0.0 109.084 -174.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 795' ' ' LEU . . . . . 0.696 HD11 ' O ' ' A' ' 723' ' ' ALA . 27.6 mt -87.3 148.07 25.24 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 120.813 0.34 . . . . 0.0 110.897 -177.022 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 796' ' ' VAL . . . . . . . . . . . . . 69.7 t -105.17 -56.03 5.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.004 178.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 797' ' ' SER . . . . . 0.593 ' HA ' ' HG ' ' A' ' 808' ' ' LEU . 95.9 p -176.47 154.14 1.25 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.202 -172.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 798' ' ' ILE . . . . . 0.615 ' HA ' ' O ' ' A' ' 752' ' ' THR . 12.4 tt -127.51 164.04 29.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 177.149 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 799' ' ' LYS . . . . . 0.752 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 28.0 tttt -131.19 120.17 22.91 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 120.668 0.271 . . . . 0.0 111.058 -176.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 800' ' ' ASP . . . . . 0.502 ' HA ' ' CE2' ' A' ' 751' ' ' PHE . 19.8 t70 -69.18 154.63 41.74 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.312 173.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 9.0 m -59.32 -13.77 9.26 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 124.042 0.839 . . . . 0.0 112.994 -170.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 52.1 p -93.47 -0.87 56.24 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.466 0.651 . . . . 0.0 110.136 179.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 803' ' ' GLY . . . . . 0.519 ' HA2' ' HE2' ' A' ' 799' ' ' LYS . . . 85.74 46.87 5.29 Favored Glycine 0 N--CA 1.444 -0.807 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.702 -176.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 804' ' ' CYS . . . . . 0.435 ' HB2' ' HB3' ' A' ' 800' ' ' ASP . 61.3 m -116.71 110.76 18.88 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 177.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 805' ' ' VAL . . . . . 0.56 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 9.8 p -85.47 133.61 29.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.301 0.572 . . . . 0.0 111.006 -175.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 806' ' ' VAL . . . . . 0.511 ' HB ' HG22 ' A' ' 798' ' ' ILE . 84.5 t -112.02 133.76 56.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.009 178.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -70.49 113.19 4.71 Favored Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 177.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 808' ' ' LEU . . . . . 0.593 ' HG ' ' HA ' ' A' ' 797' ' ' SER . 40.0 mt -81.65 130.04 34.91 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.264 0.554 . . . . 0.0 112.462 -172.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 39.8 m -148.53 86.27 1.53 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.082 173.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 810' ' ' GLN . . . . . 0.616 ' HB3' ' HD2' ' A' ' 811' ' ' PRO . 75.1 mt-30 -135.54 173.27 5.89 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 174.229 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 811' ' ' PRO . . . . . 0.616 ' HD2' ' HB3' ' A' ' 810' ' ' GLN . 86.6 Cg_exo -45.28 139.44 9.01 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 122.654 2.236 . . . . 0.0 114.68 -177.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -111.42 166.15 11.37 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.301 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 813' ' ' ALA . . . . . . . . . . . . . . . -116.42 154.14 30.83 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.357 -178.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 814' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -120.22 108.7 14.52 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.18 0.514 . . . . 0.0 110.498 177.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 815' ' ' ILE . . . . . 0.598 ' HA ' ' HB3' ' A' ' 731' ' ' LEU . 4.8 mp -97.5 123.71 50.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.481 -179.085 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 816' ' ' GLN . . . . . 0.48 ' HB3' ' HD3' ' A' ' 732' ' ' LYS . 0.1 OUTLIER -118.39 106.31 12.6 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -179.873 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 817' ' ' VAL . . . . . 0.825 HG22 ' HA2' ' A' ' 788' ' ' GLY . 0.5 OUTLIER -100.61 143.61 13.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -179.879 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 818' ' ' ARG . . . . . . . . . . . . . 20.9 tpt180 . . . . . 0 C--N 1.311 -1.105 0 CA-C-O 121.086 0.47 . . . . 0.0 110.683 -176.036 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 720' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt . . . . . 0 N--CA 1.448 -0.537 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 721' ' ' PRO . . . . . 0.463 ' HB2' HD13 ' A' ' 798' ' ' ILE . 56.4 Cg_endo -88.04 144.91 6.25 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 123.381 2.721 . . . . 0.0 112.426 -174.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 722' ' ' SER . . . . . 0.609 ' HA ' HD22 ' A' ' 808' ' ' LEU . 61.8 m -169.27 -156.52 0.15 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -172.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 723' ' ' ALA . . . . . 0.676 ' HB1' HG21 ' A' ' 743' ' ' VAL . . . -152.2 143.51 23.31 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 122.273 -0.267 . . . . 0.0 110.845 179.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 724' ' ' SER . . . . . 0.429 ' HB2' ' OE1' ' A' ' 810' ' ' GLN . 26.0 t -132.58 99.5 4.66 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 725' ' ' LEU . . . . . 0.576 HD21 HD22 ' A' ' 793' ' ' LEU . 4.9 mp -62.42 143.4 57.1 Favored 'General case' 0 N--CA 1.426 -1.632 0 CA-C-O 122.428 1.109 . . . . 0.0 112.407 -176.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 30.8 mtpt -94.49 -16.47 23.31 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 113.26 -1.791 . . . . 0.0 110.417 -176.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 727' ' ' LEU . . . . . 0.501 ' HB2' ' HD2' ' A' ' 742' ' ' PRO . 1.5 tt -76.04 109.29 9.57 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 177.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 35.9 m80 -110.47 48.84 0.88 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -171.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -177.86 177.78 1.04 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.13 176.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 730' ' ' ASP . . . . . 0.428 ' HA ' ' O ' ' A' ' 814' ' ' LYS . 1.4 m-20 -67.01 134.94 52.94 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.967 0.413 . . . . 0.0 110.131 175.244 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 731' ' ' LEU . . . . . 0.58 ' HB3' ' HA ' ' A' ' 815' ' ' ILE . 28.2 tp -93.08 105.95 17.98 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.516 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 732' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -76.98 104.62 7.57 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.656 -174.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 733' ' ' LEU . . . . . 0.455 HD11 ' CB ' ' A' ' 739' ' ' SER . 85.2 mt -116.77 155.57 28.7 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.498 177.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 734' ' ' CYS . . . . . 0.473 ' O ' ' HB2' ' A' ' 737' ' ' ASP . 36.5 m -105.34 -173.38 2.29 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.84 179.101 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 735' ' ' LEU . . . . . . . . . . . . . 24.5 tp -67.05 135.8 54.25 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 178.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 736' ' ' GLY . . . . . 0.485 ' HA2' ' HA ' ' A' ' 786' ' ' THR . . . 80.02 7.84 88.17 Favored Glycine 0 C--N 1.321 -0.298 0 C-N-CA 120.339 -0.934 . . . . 0.0 112.673 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 737' ' ' ASP . . . . . 0.473 ' HB2' ' O ' ' A' ' 734' ' ' CYS . 0.7 OUTLIER -87.47 148.77 24.8 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.51 0.671 . . . . 0.0 112.628 179.078 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 738' ' ' HIS . . . . . 0.444 ' HB2' ' O ' ' A' ' 782' ' ' THR . 40.3 p-80 -110.93 164.98 12.24 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 166.19 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 739' ' ' SER . . . . . 0.578 ' HB2' HD23 ' A' ' 731' ' ' LEU . 4.5 p -109.99 162.7 14.27 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 119.277 -0.969 . . . . 0.0 112.0 -171.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 23.4 t -138.88 100.91 4.17 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 114.961 -1.018 . . . . 0.0 108.783 177.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 741' ' ' VAL . . . . . 0.529 HG11 HD13 ' A' ' 793' ' ' LEU . 1.5 p -117.1 111.45 40.54 Favored Pre-proline 0 C--N 1.318 -0.785 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.115 -179.015 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 742' ' ' PRO . . . . . 0.661 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 4.6 Cg_endo -76.63 134.07 14.82 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 122.578 2.185 . . . . 0.0 111.58 -179.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 743' ' ' VAL . . . . . 0.676 HG21 ' HB1' ' A' ' 723' ' ' ALA . 1.6 p -131.32 120.91 47.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.51 0.671 . . . . 0.0 112.249 176.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 744' ' ' ALA . . . . . 0.475 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -83.22 103.25 12.48 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 169.072 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 745' ' ' LEU . . . . . 0.934 HD13 HD13 ' A' ' 773' ' ' ILE . 0.3 OUTLIER -85.36 166.26 16.58 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.622 -1.172 . . . . 0.0 111.538 -167.092 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -120.14 148.95 43.0 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.914 -176.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 747' ' ' GLY . . . . . 0.431 ' HA3' ' HB3' ' A' ' 721' ' ' PRO . . . 100.28 127.2 5.96 Favored Glycine 0 C--N 1.316 -0.546 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 -173.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -102.08 124.59 47.94 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.327 0.584 . . . . 0.0 112.279 -170.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 108.06 -174.11 18.79 Favored Glycine 0 CA--C 1.501 -0.815 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.542 178.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 750' ' ' PRO . . . . . 0.547 ' HB3' ' HE2' ' A' ' 774' ' ' LYS . 72.8 Cg_endo -65.93 100.62 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.384 0 C-N-CA 123.317 2.678 . . . . 0.0 113.619 -177.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 751' ' ' PHE . . . . . 0.69 ' CE2' ' HA ' ' A' ' 800' ' ' ASP . 62.1 m-85 -113.99 144.18 43.51 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.701 177.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 752' ' ' THR . . . . . 0.731 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 96.1 m -89.21 103.17 15.81 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 177.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 753' ' ' LEU . . . . . 0.436 HD22 HD22 ' A' ' 745' ' ' LEU . 24.9 tp -91.28 122.65 34.09 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.407 -1.27 . . . . 0.0 110.093 -171.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 754' ' ' THR . . . . . 0.441 HG23 ' HB2' ' A' ' 769' ' ' GLU . 0.6 OUTLIER -122.57 131.37 53.8 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.555 0.217 . . . . 0.0 110.748 179.795 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 755' ' ' TYR . . . . . 0.663 ' CE1' ' HB3' ' A' ' 768' ' ' PHE . 24.2 p90 -140.23 154.09 46.77 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.076 0.465 . . . . 0.0 111.453 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 756' ' ' ASP . . . . . 0.485 ' O ' ' HA ' ' A' ' 793' ' ' LEU . 2.3 p30 -107.97 134.45 50.86 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.789 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 757' ' ' ILE . . . . . 0.561 HG21 ' HZ ' ' A' ' 785' ' ' PHE . 4.5 mp -103.73 94.97 3.47 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 167.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 758' ' ' ILE . . . . . 0.599 HG22 ' HD3' ' A' ' 765' ' ' ARG . 2.5 pp -100.77 145.99 10.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.769 -169.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -83.82 128.18 34.35 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.152 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 760' ' ' THR . . . . . 0.463 HG23 ' OD2' ' A' ' 790' ' ' ASP . 0.1 OUTLIER . . . . . 0 C--N 1.315 -0.921 0 CA-C-O 121.229 0.538 . . . . 0.0 110.055 175.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 765' ' ' ARG . . . . . 0.599 ' HD3' HG22 ' A' ' 758' ' ' ILE . 10.9 ttp180 . . . . . 0 N--CA 1.452 -0.373 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 766' ' ' LYS . . . . . 0.471 ' HD3' ' N ' ' A' ' 767' ' ' THR . 9.6 tmtm? -119.73 146.55 45.53 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 114.935 -1.03 . . . . 0.0 108.688 177.26 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 767' ' ' THR . . . . . 0.471 ' N ' ' HD3' ' A' ' 766' ' ' LYS . 89.1 m -123.31 131.36 53.64 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 120.62 0.248 . . . . 0.0 110.508 177.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 768' ' ' PHE . . . . . 0.663 ' HB3' ' CE1' ' A' ' 755' ' ' TYR . 1.8 t80 -127.78 135.06 49.58 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 178.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 769' ' ' GLU . . . . . 0.441 ' HB2' HG23 ' A' ' 754' ' ' THR . 34.5 tt0 -128.7 128.65 44.5 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.666 -177.244 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 770' ' ' ILE . . . . . 0.522 HG22 HG22 ' A' ' 773' ' ' ILE . 4.7 mt -123.12 113.33 37.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 109.182 -0.674 . . . . 0.0 109.182 177.117 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 771' ' ' LYS . . . . . 0.584 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 0.1 OUTLIER -84.3 155.76 22.25 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 121.181 0.515 . . . . 0.0 111.506 -175.914 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 772' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 53.72 44.57 29.46 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.316 -1.311 . . . . 0.0 112.318 176.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 773' ' ' ILE . . . . . 0.934 HD13 HD13 ' A' ' 745' ' ' LEU . 0.5 OUTLIER -73.44 112.1 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 172.644 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 774' ' ' LYS . . . . . 0.547 ' HE2' ' HB3' ' A' ' 750' ' ' PRO . 71.3 mttt -107.8 26.37 10.41 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -178.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 775' ' ' THR . . . . . 0.645 ' H ' HD12 ' A' ' 773' ' ' ILE . 0.4 OUTLIER -95.91 -74.8 0.54 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.067 -0.969 . . . . 0.0 113.488 -165.71 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 776' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' A' ' 775' ' ' THR . 10.6 m120 83.53 7.86 0.65 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.344 1.057 . . . . 0.0 111.13 -175.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 777' ' ' GLU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 21.8 mt-10 -159.64 83.48 0.75 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.023 -0.99 . . . . 0.0 108.331 174.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 778' ' ' TYR . . . . . 0.773 ' HB3' HD11 ' A' ' 745' ' ' LEU . 83.2 t80 -129.61 129.39 44.3 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.911 -169.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 779' ' ' VAL . . . . . 0.661 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 14.1 t -89.42 111.26 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 CA-C-O 121.157 0.503 . . . . 0.0 110.213 178.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 780' ' ' ILE . . . . . 0.444 ' HB ' HG13 ' A' ' 741' ' ' VAL . 72.9 mt -79.15 145.12 9.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.273 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 781' ' ' LYS . . . . . 0.432 ' HA ' ' O ' ' A' ' 739' ' ' SER . 3.7 mppt? -130.3 108.8 10.28 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 174.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 782' ' ' THR . . . . . 0.444 ' O ' ' HB2' ' A' ' 738' ' ' HIS . 30.9 p -77.19 141.37 66.78 Favored Pre-proline 0 N--CA 1.444 -0.748 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 -178.28 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 783' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -55.9 150.02 48.47 Favored 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 122.918 2.412 . . . . 0.0 111.274 -177.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 784' ' ' VAL . . . . . . . . . . . . . 14.9 p -61.81 133.03 27.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.433 0.635 . . . . 0.0 110.812 -172.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 785' ' ' PHE . . . . . 0.561 ' HZ ' HG21 ' A' ' 757' ' ' ILE . 88.9 m-85 -90.24 -37.47 14.09 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.834 -173.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 786' ' ' THR . . . . . 0.485 ' HA ' ' HA2' ' A' ' 736' ' ' GLY . 28.3 p 57.97 3.39 0.22 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.507 0.723 . . . . 0.0 111.744 -178.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 787' ' ' THR . . . . . 0.436 ' H ' ' C ' ' A' ' 785' ' ' PHE . 42.8 m -134.37 118.53 17.56 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.868 -179.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 788' ' ' GLY . . . . . 0.645 ' HA2' HG12 ' A' ' 817' ' ' VAL . . . -54.4 108.66 0.94 Allowed Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.523 -0.762 . . . . 0.0 113.224 174.349 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 789' ' ' GLY . . . . . 0.501 ' H ' ' HB ' ' A' ' 817' ' ' VAL . . . -155.56 167.16 33.0 Favored Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 174.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 790' ' ' ASP . . . . . 0.463 ' OD2' HG23 ' A' ' 760' ' ' THR . 0.2 OUTLIER -109.3 129.39 55.52 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 117.567 0.684 . . . . 0.0 109.906 179.335 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 791' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -130.0 156.17 44.91 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.213 -174.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 792' ' ' ILE . . . . . 0.519 ' O ' HG13 ' A' ' 758' ' ' ILE . 14.5 mt -128.45 119.07 49.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 109.354 -0.609 . . . . 0.0 109.354 174.241 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 793' ' ' LEU . . . . . 0.576 HD22 HD21 ' A' ' 725' ' ' LEU . 10.1 tt -84.51 107.36 16.71 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 794' ' ' SER . . . . . . . . . . . . . 3.7 m -116.23 170.87 8.2 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.14 -179.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 795' ' ' LEU . . . . . . . . . . . . . 22.8 mt -97.68 129.6 44.73 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.603 0.239 . . . . 0.0 110.977 -175.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 796' ' ' VAL . . . . . . . . . . . . . 75.0 t -88.94 -56.1 5.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.812 -179.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 797' ' ' SER . . . . . 0.511 ' HA ' ' HG ' ' A' ' 808' ' ' LEU . 24.4 m -173.39 164.15 4.59 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.128 -173.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 798' ' ' ILE . . . . . 0.587 ' O ' ' HA ' ' A' ' 805' ' ' VAL . 11.5 tt -136.15 167.55 24.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 176.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 799' ' ' LYS . . . . . 0.731 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 83.6 tttt -136.04 120.56 18.18 Favored 'General case' 0 C--N 1.315 -0.932 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.248 -176.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 800' ' ' ASP . . . . . 0.69 ' HA ' ' CE2' ' A' ' 751' ' ' PHE . 6.2 m-20 -63.12 156.46 24.98 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.279 174.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 4.0 m -64.81 -5.22 5.47 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 124.151 0.907 . . . . 0.0 112.212 -174.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 8.9 t -104.98 12.63 32.11 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.757 0.789 . . . . 0.0 109.617 175.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 803' ' ' GLY . . . . . 0.49 ' HA2' ' CE ' ' A' ' 799' ' ' LYS . . . 74.71 46.85 16.7 Favored Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.121 -0.945 . . . . 0.0 112.831 -179.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 804' ' ' CYS . . . . . 0.597 ' HB3' ' HB2' ' A' ' 800' ' ' ASP . 53.7 t -109.87 106.23 15.73 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 177.181 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 805' ' ' VAL . . . . . 0.587 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 2.6 t -86.69 104.95 14.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.591 0.71 . . . . 0.0 110.704 -175.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 806' ' ' VAL . . . . . . . . . . . . . 39.5 t -90.13 138.54 19.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.065 -178.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -74.96 113.21 3.91 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.662 178.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 808' ' ' LEU . . . . . 0.609 HD22 ' HA ' ' A' ' 722' ' ' SER . 30.8 mt -80.17 132.02 35.82 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 -174.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 20.4 m -143.97 85.65 1.82 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.52 171.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 810' ' ' GLN . . . . . 0.494 ' HB3' ' O ' ' A' ' 723' ' ' ALA . 1.0 OUTLIER -146.69 173.91 3.83 Favored Pre-proline 0 CA--C 1.542 0.645 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.363 177.501 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 811' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -44.0 154.47 0.26 Allowed 'Trans proline' 0 C--N 1.359 1.08 0 C-N-CA 123.782 2.988 . . . . 0.0 116.294 -173.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -131.35 167.83 18.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 113.797 -1.547 . . . . 0.0 109.613 -178.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 813' ' ' ALA . . . . . . . . . . . . . . . -127.69 148.65 50.4 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.748 0.308 . . . . 0.0 110.505 178.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 814' ' ' LYS . . . . . 0.428 ' O ' ' HA ' ' A' ' 730' ' ' ASP . 50.3 tttm -110.17 112.79 24.99 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.14 0.495 . . . . 0.0 110.704 -176.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 815' ' ' ILE . . . . . 0.58 ' HA ' ' HB3' ' A' ' 731' ' ' LEU . 5.3 mp -98.21 127.66 50.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.855 -178.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 816' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -114.42 110.6 20.13 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.742 0.306 . . . . 0.0 110.842 -178.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 817' ' ' VAL . . . . . 0.645 HG12 ' HA2' ' A' ' 788' ' ' GLY . 61.3 t -105.66 127.66 60.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 175.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 818' ' ' ARG . . . . . . . . . . . . . 25.4 mmt180 . . . . . 0 C--N 1.327 -0.394 0 O-C-N 121.849 -0.532 . . . . 0.0 111.319 177.33 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 720' ' ' LYS . . . . . . . . . . . . . 27.7 mtpp . . . . . 0 N--CA 1.451 -0.398 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 721' ' ' PRO . . . . . 0.523 ' O ' HG21 ' A' ' 798' ' ' ILE . 46.3 Cg_endo -88.25 140.76 4.76 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 123.08 2.52 . . . . 0.0 112.115 -173.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 25.2 m -174.83 -151.44 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -170.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 723' ' ' ALA . . . . . 0.562 ' HA ' ' HA ' ' A' ' 745' ' ' LEU . . . -146.65 149.0 32.63 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 174.054 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 28.5 t -131.66 98.38 4.47 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 725' ' ' LEU . . . . . 0.563 HD21 HD21 ' A' ' 795' ' ' LEU . 2.0 mt -66.79 143.69 56.75 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-O 121.441 0.638 . . . . 0.0 110.984 -171.053 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 35.6 mtpt -94.45 -19.61 20.42 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.869 -1.06 . . . . 0.0 111.079 -174.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 727' ' ' LEU . . . . . 0.686 HD23 ' HB1' ' A' ' 813' ' ' ALA . 25.9 tp -56.67 129.54 41.5 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.04 178.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 8.3 t-160 -117.82 16.28 14.37 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.943 -173.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -169.84 -178.8 3.05 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 122.311 -0.243 . . . . 0.0 110.886 177.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 730' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.32 132.25 52.03 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.159 0.504 . . . . 0.0 110.726 175.048 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 731' ' ' LEU . . . . . 0.637 HD21 ' H ' ' A' ' 740' ' ' SER . 49.3 tp -91.56 102.1 14.75 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.07 177.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 732' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -77.51 122.57 25.42 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.647 -174.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 733' ' ' LEU . . . . . 0.633 ' HG ' ' HB3' ' A' ' 737' ' ' ASP . 7.8 mp -120.79 164.22 16.94 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.708 178.242 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 734' ' ' CYS . . . . . 0.564 ' O ' ' HB2' ' A' ' 737' ' ' ASP . 66.1 m -116.49 -178.27 3.38 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.089 173.001 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 735' ' ' LEU . . . . . . . . . . . . . 31.0 tp -63.42 122.92 17.44 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.894 0.378 . . . . 0.0 111.236 -176.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 82.43 7.64 87.3 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.438 -0.887 . . . . 0.0 112.384 178.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 737' ' ' ASP . . . . . 0.633 ' HB3' ' HG ' ' A' ' 733' ' ' LEU . 0.2 OUTLIER -72.2 154.04 41.26 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.909 0.385 . . . . 0.0 110.953 176.076 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 37.9 p-80 -112.85 148.49 34.79 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 171.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 739' ' ' SER . . . . . 0.481 ' HB3' HD23 ' A' ' 731' ' ' LEU . 4.6 m -94.93 158.09 15.63 Favored 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 119.966 -0.694 . . . . 0.0 110.927 -172.322 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 740' ' ' SER . . . . . 0.637 ' H ' HD21 ' A' ' 731' ' ' LEU . 12.5 p -144.19 100.85 3.62 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.213 -178.543 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 741' ' ' VAL . . . . . 0.479 HG11 HD13 ' A' ' 793' ' ' LEU . 0.4 OUTLIER -117.51 119.12 34.68 Favored Pre-proline 0 C--N 1.314 -0.968 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.459 179.973 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 742' ' ' PRO . . . . . 0.717 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 10.1 Cg_endo -80.86 134.12 9.42 Favored 'Trans proline' 0 N--CA 1.435 -1.93 0 C-N-CA 121.712 1.608 . . . . 0.0 110.649 -179.482 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 743' ' ' VAL . . . . . 0.519 ' CG2' HD22 ' A' ' 725' ' ' LEU . 49.0 t -132.77 119.64 38.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 121.336 0.588 . . . . 0.0 111.913 -178.507 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 744' ' ' ALA . . . . . 0.618 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -81.77 95.33 7.24 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 122.129 0.966 . . . . 0.0 108.653 170.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 745' ' ' LEU . . . . . 0.83 HD11 ' HB3' ' A' ' 778' ' ' TYR . 1.9 mt -77.84 159.86 28.69 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.045 -1.434 . . . . 0.0 111.384 -168.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 8.5 tptp -111.58 166.47 11.12 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.626 -178.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 747' ' ' GLY . . . . . . . . . . . . . . . 96.1 124.87 4.64 Favored Glycine 0 C--N 1.312 -0.756 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.714 -173.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 748' ' ' GLN . . . . . 0.442 ' C ' ' HE1' ' A' ' 751' ' ' PHE . 26.6 mm-40 -103.57 95.51 6.11 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 122.676 -0.308 . . . . 0.0 111.026 -176.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 134.48 -164.73 24.59 Favored Glycine 0 C--O 1.223 -0.589 0 N-CA-C 111.269 -0.732 . . . . 0.0 111.269 -178.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -74.25 94.35 0.9 Allowed 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.719 2.279 . . . . 0.0 112.084 179.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 751' ' ' PHE . . . . . 0.73 ' CE2' ' HA ' ' A' ' 800' ' ' ASP . 81.2 m-85 -115.71 141.67 47.77 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.585 -179.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 752' ' ' THR . . . . . 0.737 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 73.5 m -97.63 105.73 17.92 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-O 121.709 0.766 . . . . 0.0 109.352 -179.319 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 753' ' ' LEU . . . . . 0.694 HD13 HD22 ' A' ' 745' ' ' LEU . 3.9 tt -105.11 114.1 28.09 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 114.47 -1.241 . . . . 0.0 110.015 -168.206 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 754' ' ' THR . . . . . 0.459 HG23 ' HB2' ' A' ' 769' ' ' GLU . 1.5 m -107.9 136.3 47.84 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.769 -176.186 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 755' ' ' TYR . . . . . 0.404 ' CE1' ' HB3' ' A' ' 768' ' ' PHE . 26.2 p90 -135.6 159.6 41.11 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.036 0.446 . . . . 0.0 111.694 179.146 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 756' ' ' ASP . . . . . 0.588 ' OD2' ' HB3' ' A' ' 794' ' ' SER . 3.1 p30 -118.53 128.33 54.47 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.447 -178.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 757' ' ' ILE . . . . . 0.526 HG13 HD12 ' A' ' 793' ' ' LEU . 4.2 mp -98.18 94.04 3.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 167.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 758' ' ' ILE . . . . . 0.541 HG13 ' O ' ' A' ' 792' ' ' ILE . 2.6 pp -99.38 142.45 15.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-O 121.552 0.692 . . . . 0.0 112.033 -169.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 759' ' ' GLU . . . . . 0.559 ' HG2' ' CD2' ' A' ' 791' ' ' TYR . 24.8 mt-10 -96.54 101.14 12.72 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.145 -171.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 760' ' ' THR . . . . . 0.461 HG23 ' HB2' ' A' ' 790' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.32 -0.683 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.382 -169.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 765' ' ' ARG . . . . . 0.494 ' HD3' HG22 ' A' ' 758' ' ' ILE . 16.4 ttp180 . . . . . 0 N--CA 1.443 -0.793 0 CA-C-O 120.974 0.416 . . . . 0.0 111.666 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 766' ' ' LYS . . . . . 0.676 ' HD3' ' N ' ' A' ' 767' ' ' THR . 10.4 tmtt? -123.48 147.59 47.04 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 178.168 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 767' ' ' THR . . . . . 0.676 ' N ' ' HD3' ' A' ' 766' ' ' LYS . 62.0 m -132.31 141.92 49.15 Favored 'General case' 0 C--N 1.314 -0.975 0 O-C-N 122.301 -0.25 . . . . 0.0 111.618 -176.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 768' ' ' PHE . . . . . 0.404 ' HB3' ' CE1' ' A' ' 755' ' ' TYR . 2.9 t80 -145.49 144.35 30.52 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.724 0.297 . . . . 0.0 110.536 176.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 769' ' ' GLU . . . . . 0.459 ' HB2' HG23 ' A' ' 754' ' ' THR . 41.2 tt0 -127.06 126.05 42.4 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.498 -175.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 5.2 mm -107.22 103.39 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 178.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 771' ' ' LYS . . . . . 0.486 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 12.3 mtpt -83.22 149.93 26.51 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.648 -179.053 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 772' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 50.96 50.46 19.06 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.488 -1.233 . . . . 0.0 112.205 -179.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 773' ' ' ILE . . . . . 0.77 HD12 ' H ' ' A' ' 775' ' ' THR . 0.5 OUTLIER -76.12 117.92 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 173.416 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 78.4 mttt -118.15 28.09 8.59 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -178.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 775' ' ' THR . . . . . 0.77 ' H ' HD12 ' A' ' 773' ' ' ILE . 0.9 OUTLIER -95.18 -72.19 0.64 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.572 -1.195 . . . . 0.0 112.429 -171.538 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 776' ' ' ASN . . . . . 0.451 ' HB2' ' O ' ' A' ' 775' ' ' THR . 10.8 m120 87.7 4.39 0.31 Allowed 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.703 1.201 . . . . 0.0 110.031 -178.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 777' ' ' GLU . . . . . 0.618 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 21.7 tt0 -162.69 96.28 0.93 Allowed 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.143 172.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 778' ' ' TYR . . . . . 0.83 ' HB3' HD11 ' A' ' 745' ' ' LEU . 83.3 t80 -139.63 128.83 23.88 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.081 -170.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 779' ' ' VAL . . . . . 0.717 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 7.6 t -84.73 105.91 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.196 -179.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 780' ' ' ILE . . . . . . . . . . . . . 70.1 mt -77.06 132.59 32.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.697 -178.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -117.18 109.58 17.08 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.385 0.612 . . . . 0.0 110.262 179.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 782' ' ' THR . . . . . 0.468 ' CG2' ' HB2' ' A' ' 739' ' ' SER . 1.1 p -80.82 149.22 66.88 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.526 -176.516 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 783' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -51.7 161.38 2.14 Favored 'Trans proline' 0 N--CA 1.473 0.292 0 C-N-CA 123.737 2.958 . . . . 0.0 113.34 -178.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 784' ' ' VAL . . . . . 0.497 HG12 HG23 ' A' ' 786' ' ' THR . 55.1 t -62.69 122.13 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.309 177.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 785' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -103.31 96.09 6.53 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.557 178.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 786' ' ' THR . . . . . 0.497 HG23 HG12 ' A' ' 784' ' ' VAL . 46.0 p -85.12 36.98 0.65 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.926 0.87 . . . . 0.0 110.369 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 58.4 m -159.48 110.26 1.98 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.336 -1.302 . . . . 0.0 110.191 179.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 788' ' ' GLY . . . . . 1.034 ' HA2' HG22 ' A' ' 817' ' ' VAL . . . -54.39 134.56 45.59 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.919 -0.658 . . . . 0.0 113.241 173.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 789' ' ' GLY . . . . . 0.65 ' H ' HG13 ' A' ' 817' ' ' VAL . . . -178.35 -170.43 40.46 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 179.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 790' ' ' ASP . . . . . 0.485 ' OD2' ' HG2' ' A' ' 816' ' ' GLN . 6.6 m-20 -114.16 130.6 56.6 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 174.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 791' ' ' TYR . . . . . 0.559 ' CD2' ' HG2' ' A' ' 759' ' ' GLU . 60.2 m-85 -131.27 123.85 29.25 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -179.119 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 792' ' ' ILE . . . . . 0.541 ' O ' HG13 ' A' ' 758' ' ' ILE . 19.8 mt -103.88 116.52 47.81 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 C-N-CA 120.445 -0.502 . . . . 0.0 109.778 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 793' ' ' LEU . . . . . 0.562 ' HB3' ' HB3' ' A' ' 813' ' ' ALA . 3.6 tt -83.87 106.28 15.43 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 177.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 794' ' ' SER . . . . . 0.588 ' HB3' ' OD2' ' A' ' 756' ' ' ASP . 15.2 t -117.77 179.46 4.07 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.852 -1.067 . . . . 0.0 108.765 -177.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 795' ' ' LEU . . . . . 0.563 HD21 HD21 ' A' ' 725' ' ' LEU . 58.2 mt -106.38 130.62 54.17 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 120.681 0.277 . . . . 0.0 111.01 -175.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 796' ' ' VAL . . . . . . . . . . . . . 51.4 t -88.89 -56.86 4.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.202 -177.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 797' ' ' SER . . . . . . . . . . . . . 24.4 m -173.45 168.89 4.49 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.012 -173.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 798' ' ' ILE . . . . . 0.7 HG22 ' HB ' ' A' ' 806' ' ' VAL . 0.4 OUTLIER -141.01 166.4 18.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 -173.906 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 799' ' ' LYS . . . . . 0.737 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 26.0 tttm -140.31 118.42 11.94 Favored 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 120.4 -0.52 . . . . 0.0 111.533 -177.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 800' ' ' ASP . . . . . 0.73 ' HA ' ' CE2' ' A' ' 751' ' ' PHE . 12.4 t70 -70.6 156.93 38.79 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.114 174.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 12.8 t -67.28 -5.22 13.13 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 123.652 0.595 . . . . 0.0 111.287 -172.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 18.5 p -95.87 7.72 45.55 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.459 0.647 . . . . 0.0 109.919 174.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 803' ' ' GLY . . . . . . . . . . . . . . . 74.9 32.37 56.95 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.969 -177.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 804' ' ' CYS . . . . . 0.557 ' HB3' ' HB3' ' A' ' 800' ' ' ASP . 37.1 t -99.16 108.03 20.54 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 -179.132 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 805' ' ' VAL . . . . . 0.547 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 3.3 t -85.05 106.54 15.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.194 0.521 . . . . 0.0 110.303 -174.231 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 806' ' ' VAL . . . . . 0.7 ' HB ' HG22 ' A' ' 798' ' ' ILE . 22.9 t -92.88 136.84 23.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.021 -178.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -74.94 134.27 16.8 Favored Glycine 0 N--CA 1.451 -0.311 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.465 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 808' ' ' LEU . . . . . 0.585 HD21 ' HB ' ' A' ' 798' ' ' ILE . 46.3 mt -99.06 130.81 45.42 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -173.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 6.1 t -145.83 85.65 1.7 Allowed 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.219 -0.901 . . . . 0.0 109.232 171.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 810' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -138.22 174.96 3.72 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-O 118.798 -0.62 . . . . 0.0 109.735 178.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 811' ' ' PRO . . . . . 0.447 ' O ' ' HG ' ' A' ' 725' ' ' LEU . 83.2 Cg_exo -43.79 152.86 0.3 Allowed 'Trans proline' 0 C--N 1.361 1.225 0 C-N-CA 123.347 2.698 . . . . 0.0 114.68 -177.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 812' ' ' ASP . . . . . 0.476 ' C ' HD12 ' A' ' 725' ' ' LEU . 7.9 p-10 -122.73 165.51 16.44 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.273 -176.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 813' ' ' ALA . . . . . 0.686 ' HB1' HD23 ' A' ' 727' ' ' LEU . . . -120.98 113.04 19.51 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.193 -175.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 814' ' ' LYS . . . . . . . . . . . . . 41.6 tttm -93.4 112.15 23.99 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.436 0.636 . . . . 0.0 111.488 -177.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 815' ' ' ILE . . . . . 0.607 ' HA ' ' HB3' ' A' ' 731' ' ' LEU . 4.7 mp -93.25 135.54 27.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.254 175.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 816' ' ' GLN . . . . . 0.485 ' HG2' ' OD2' ' A' ' 790' ' ' ASP . 0.5 OUTLIER -128.87 106.95 9.26 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.943 0.401 . . . . 0.0 109.982 178.525 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 817' ' ' VAL . . . . . 1.034 HG22 ' HA2' ' A' ' 788' ' ' GLY . 0.2 OUTLIER -103.19 142.53 16.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-O 121.324 0.583 . . . . 0.0 110.577 179.052 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 818' ' ' ARG . . . . . 0.466 ' HG2' HE22 ' A' ' 816' ' ' GLN . 35.6 mmt180 . . . . . 0 C--N 1.308 -1.212 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 175.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 720' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm . . . . . 0 N--CA 1.452 -0.333 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 721' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -86.91 152.2 8.49 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 122.46 2.107 . . . . 0.0 111.791 -176.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 722' ' ' SER . . . . . 0.541 ' HB3' ' NE2' ' A' ' 810' ' ' GLN . 21.6 t 177.53 -151.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -172.314 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 723' ' ' ALA . . . . . 0.76 ' HB1' HG21 ' A' ' 743' ' ' VAL . . . -150.67 143.09 24.34 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 121.238 -0.185 . . . . 0.0 111.114 178.138 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 37.1 t -127.72 102.51 6.84 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -179.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 725' ' ' LEU . . . . . 0.494 ' CD2' ' HB ' ' A' ' 743' ' ' VAL . 12.5 mt -63.88 147.08 52.78 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-O 121.641 0.734 . . . . 0.0 111.455 -175.215 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 34.2 mtpt -99.84 -15.85 18.26 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.042 -176.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 727' ' ' LEU . . . . . 0.521 HD21 ' HG ' ' A' ' 731' ' ' LEU . 48.3 tp -64.58 132.34 49.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.248 178.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -103.76 -26.26 12.8 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.095 0.405 . . . . 0.0 112.095 -173.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -122.98 173.12 8.01 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.807 -173.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 730' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -74.38 140.66 44.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.403 177.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 731' ' ' LEU . . . . . 0.69 HD12 HG13 ' A' ' 815' ' ' ILE . 73.5 mt -84.39 100.02 11.02 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.326 -179.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 732' ' ' LYS . . . . . 0.491 ' HE3' ' OE1' ' A' ' 816' ' ' GLN . 14.1 mmmm -76.97 112.87 14.05 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.637 -179.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 733' ' ' LEU . . . . . 0.774 HD12 HG22 ' A' ' 817' ' ' VAL . 58.2 mt -123.34 158.58 30.72 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.108 -178.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 734' ' ' CYS . . . . . 0.517 ' O ' ' HB2' ' A' ' 737' ' ' ASP . 21.2 p -107.68 -173.36 2.27 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 167.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 735' ' ' LEU . . . . . 0.525 ' CD1' ' H ' ' A' ' 788' ' ' GLY . 1.4 tp -71.95 148.92 45.52 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 120.055 -0.658 . . . . 0.0 111.032 -171.01 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 736' ' ' GLY . . . . . 0.5 ' HA2' ' HA ' ' A' ' 786' ' ' THR . . . 76.22 10.02 85.49 Favored Glycine 0 C--N 1.321 -0.258 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.54 -179.587 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 737' ' ' ASP . . . . . 0.517 ' HB2' ' O ' ' A' ' 734' ' ' CYS . 0.7 OUTLIER -93.68 155.24 17.37 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -177.719 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 738' ' ' HIS . . . . . 0.508 ' HB2' ' O ' ' A' ' 782' ' ' THR . 37.4 p-80 -121.86 -175.57 3.13 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 168.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 739' ' ' SER . . . . . 0.65 ' HB3' HD13 ' A' ' 731' ' ' LEU . 67.9 m -145.85 176.37 9.72 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.128 -0.629 . . . . 0.0 112.502 178.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 740' ' ' SER . . . . . 0.48 ' HA ' ' O ' ' A' ' 780' ' ' ILE . 9.7 p -142.43 109.7 5.62 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.144 176.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 741' ' ' VAL . . . . . 0.51 HG11 HD13 ' A' ' 793' ' ' LEU . 2.3 p -105.04 116.01 61.39 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.708 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 742' ' ' PRO . . . . . 0.657 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 3.7 Cg_exo -75.13 131.15 13.82 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 122.244 1.963 . . . . 0.0 111.03 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 743' ' ' VAL . . . . . 0.76 HG21 ' HB1' ' A' ' 723' ' ' ALA . 1.8 p -131.47 120.07 44.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.656 0.741 . . . . 0.0 112.72 178.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 744' ' ' ALA . . . . . 0.565 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -82.41 109.9 17.06 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 168.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 745' ' ' LEU . . . . . 0.914 HD13 HD13 ' A' ' 773' ' ' ILE . 0.4 OUTLIER -93.23 157.94 16.01 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.828 -1.078 . . . . 0.0 111.599 -164.652 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 37.9 tptt -105.06 157.69 17.07 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.235 178.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 747' ' ' GLY . . . . . . . . . . . . . . . 93.42 120.76 3.06 Favored Glycine 0 C--N 1.305 -1.186 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -175.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -96.37 115.4 27.38 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.04 0.448 . . . . 0.0 112.081 -170.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 749' ' ' GLY . . . . . 0.41 ' O ' ' HD1' ' A' ' 751' ' ' PHE . . . 109.88 -167.66 12.86 Favored Glycine 0 CA--C 1.5 -0.853 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.531 179.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 750' ' ' PRO . . . . . 0.502 ' HB3' ' HE2' ' A' ' 774' ' ' LYS . 85.5 Cg_endo -66.24 95.08 0.31 Allowed 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 123.73 2.953 . . . . 0.0 113.617 -175.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 751' ' ' PHE . . . . . 0.498 ' CE2' ' HA ' ' A' ' 800' ' ' ASP . 56.7 m-85 -112.43 142.68 44.68 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.68 177.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 752' ' ' THR . . . . . 0.758 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 96.4 m -88.93 106.14 18.22 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 753' ' ' LEU . . . . . 0.623 HD22 HD22 ' A' ' 745' ' ' LEU . 12.3 tp -100.2 110.11 22.37 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.052 -0.977 . . . . 0.0 111.091 -172.167 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 754' ' ' THR . . . . . 0.463 HG23 ' HB2' ' A' ' 769' ' ' GLU . 1.2 m -99.43 135.24 41.13 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.442 177.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 755' ' ' TYR . . . . . . . . . . . . . 39.3 p90 -136.29 148.34 47.93 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 121.147 0.499 . . . . 0.0 111.638 179.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 756' ' ' ASP . . . . . 0.591 ' O ' ' HA ' ' A' ' 793' ' ' LEU . 2.5 p30 -110.22 137.96 47.25 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.789 178.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 757' ' ' ILE . . . . . . . . . . . . . 4.3 mp -107.66 94.79 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.087 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 166.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 758' ' ' ILE . . . . . 0.595 HG22 ' HD3' ' A' ' 765' ' ' ARG . 2.6 pp -99.84 150.36 5.38 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.92 -169.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 759' ' ' GLU . . . . . 0.632 ' HG2' ' CE2' ' A' ' 791' ' ' TYR . 9.4 mt-10 -88.16 120.92 29.98 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.174 -179.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 760' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.312 -1.052 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 169.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 765' ' ' ARG . . . . . 0.595 ' HD3' HG22 ' A' ' 758' ' ' ILE . 12.3 ttp180 . . . . . 0 N--CA 1.452 -0.327 0 CA-C-O 121.193 0.521 . . . . 0.0 111.477 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 766' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -120.5 146.54 46.18 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -178.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 767' ' ' THR . . . . . . . . . . . . . 90.0 m -128.48 136.22 50.52 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 120.573 0.225 . . . . 0.0 110.836 -179.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 768' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -141.09 145.07 35.32 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 177.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 769' ' ' GLU . . . . . 0.463 ' HB2' HG23 ' A' ' 754' ' ' THR . 32.9 tt0 -128.17 132.0 48.89 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.985 0.421 . . . . 0.0 111.447 -176.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 11.1 mm -111.73 100.57 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 771' ' ' LYS . . . . . 0.494 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 12.6 mtpt -79.98 150.54 30.42 Favored 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 120.044 -0.662 . . . . 0.0 111.04 -177.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 772' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 53.7 48.16 22.14 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.04 -1.437 . . . . 0.0 112.521 177.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 773' ' ' ILE . . . . . 0.914 HD13 HD13 ' A' ' 745' ' ' LEU . 0.5 OUTLIER -73.34 117.6 17.33 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.578 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 171.538 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 774' ' ' LYS . . . . . 0.502 ' HE2' ' HB3' ' A' ' 750' ' ' PRO . 59.5 mttt -112.08 28.04 9.12 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 -179.248 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 775' ' ' THR . . . . . 0.691 ' H ' HD12 ' A' ' 773' ' ' ILE . 0.2 OUTLIER -95.69 -76.7 0.49 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.862 -1.063 . . . . 0.0 113.5 -167.874 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 776' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 775' ' ' THR . 12.2 m120 88.48 3.91 0.25 Allowed 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.943 1.297 . . . . 0.0 111.054 -175.144 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 777' ' ' GLU . . . . . 0.565 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 9.9 mt-10 -161.07 88.29 0.75 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.025 172.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 778' ' ' TYR . . . . . 0.676 ' HB3' HD11 ' A' ' 745' ' ' LEU . 63.9 t80 -133.51 136.68 45.21 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.611 -170.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 779' ' ' VAL . . . . . 0.657 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 21.5 t -91.25 115.77 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 CA-C-O 121.337 0.589 . . . . 0.0 110.309 178.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 780' ' ' ILE . . . . . 0.48 ' O ' ' HA ' ' A' ' 740' ' ' SER . 61.7 mt -82.74 142.22 13.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.309 -179.125 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 781' ' ' LYS . . . . . 0.4 ' HD3' ' C ' ' A' ' 780' ' ' ILE . 0.0 OUTLIER -113.13 110.77 20.98 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.153 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 782' ' ' THR . . . . . 0.508 ' O ' ' HB2' ' A' ' 738' ' ' HIS . 70.3 p -77.01 133.35 69.38 Favored Pre-proline 0 N--CA 1.441 -0.899 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.567 178.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 783' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 782' ' ' THR . 23.7 Cg_exo -62.88 151.32 84.96 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 122.942 2.428 . . . . 0.0 111.548 -175.444 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 784' ' ' VAL . . . . . . . . . . . . . 13.8 p -59.59 130.73 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-O 121.406 0.622 . . . . 0.0 110.477 -174.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 785' ' ' PHE . . . . . 0.478 ' C ' ' H ' ' A' ' 787' ' ' THR . 86.3 m-85 -87.21 -31.84 20.1 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.598 -171.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 786' ' ' THR . . . . . 0.5 ' HA ' ' HA2' ' A' ' 736' ' ' GLY . 30.9 p 58.05 -5.4 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.911 0.885 . . . . 0.0 112.94 176.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 787' ' ' THR . . . . . 0.478 ' H ' ' C ' ' A' ' 785' ' ' PHE . 1.3 m -145.76 124.65 12.7 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.752 0.311 . . . . 0.0 110.543 -176.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 788' ' ' GLY . . . . . 0.525 ' H ' ' CD1' ' A' ' 735' ' ' LEU . . . -50.28 125.9 22.1 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.354 -0.839 . . . . 0.0 113.353 173.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 789' ' ' GLY . . . . . . . . . . . . . . . -174.51 -179.88 45.4 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 179.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -119.46 128.02 53.61 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 117.773 0.786 . . . . 0.0 109.758 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 791' ' ' TYR . . . . . 0.632 ' CE2' ' HG2' ' A' ' 759' ' ' GLU . 84.0 m-85 -127.65 153.38 46.52 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.595 -176.022 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 792' ' ' ILE . . . . . 0.567 ' O ' HG13 ' A' ' 758' ' ' ILE . 13.0 mt -129.92 120.36 49.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 172.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 793' ' ' LEU . . . . . 0.591 ' HA ' ' O ' ' A' ' 756' ' ' ASP . 8.1 tt -85.28 110.34 19.0 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 178.28 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 794' ' ' SER . . . . . . . . . . . . . 3.7 m -119.45 148.89 42.72 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.023 -178.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 795' ' ' LEU . . . . . 0.64 ' HG ' ' HB3' ' A' ' 723' ' ' ALA . 1.5 mm? -73.36 124.75 26.35 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-O 120.715 0.293 . . . . 0.0 111.028 177.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 796' ' ' VAL . . . . . 0.423 ' HB ' ' HB ' ' A' ' 754' ' ' THR . 53.7 t -85.67 -54.78 7.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.213 -177.207 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 797' ' ' SER . . . . . 0.589 ' HA ' ' HG ' ' A' ' 808' ' ' LEU . 87.9 p -172.42 152.66 2.73 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.202 -172.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 798' ' ' ILE . . . . . 0.636 ' HA ' ' O ' ' A' ' 752' ' ' THR . 5.9 tt -127.5 164.6 28.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 176.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 799' ' ' LYS . . . . . 0.758 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 8.0 tmtt? -139.51 118.86 12.84 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.14 -177.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 800' ' ' ASP . . . . . 0.532 ' HB2' ' HB3' ' A' ' 804' ' ' CYS . 14.1 m-20 -58.59 155.37 12.53 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.504 173.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 6.3 p -61.62 -11.86 13.39 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 124.021 0.826 . . . . 0.0 112.56 -174.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 8.9 t -91.06 -6.38 53.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.666 0.745 . . . . 0.0 109.836 178.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 803' ' ' GLY . . . . . 0.485 ' HA2' ' HE2' ' A' ' 799' ' ' LYS . . . 92.12 42.69 4.58 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.771 -177.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 804' ' ' CYS . . . . . 0.532 ' HB3' ' HB2' ' A' ' 800' ' ' ASP . 41.7 t -110.55 106.53 15.84 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 805' ' ' VAL . . . . . 0.549 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 15.7 t -88.27 110.78 21.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.285 0.564 . . . . 0.0 111.279 -175.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 806' ' ' VAL . . . . . 0.434 ' HB ' HG22 ' A' ' 798' ' ' ILE . 88.2 t -90.55 137.76 20.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.995 177.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -76.07 120.53 5.94 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 111.099 -0.8 . . . . 0.0 111.099 177.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 808' ' ' LEU . . . . . 0.589 ' HG ' ' HA ' ' A' ' 797' ' ' SER . 40.1 mt -88.81 133.7 34.17 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -173.007 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 31.8 t -149.67 86.73 1.47 Allowed 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.019 -0.992 . . . . 0.0 108.991 172.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 810' ' ' GLN . . . . . 0.541 ' NE2' ' HB3' ' A' ' 722' ' ' SER . 1.6 mt-30 -139.25 174.39 4.18 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.388 -0.823 . . . . 0.0 108.93 176.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 811' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_exo -44.0 139.17 6.0 Favored 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 123.049 2.499 . . . . 0.0 114.644 -175.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -115.67 165.76 12.68 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.204 -179.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 813' ' ' ALA . . . . . 0.501 ' HB1' HD23 ' A' ' 727' ' ' LEU . . . -115.06 155.63 26.66 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.492 -177.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 814' ' ' LYS . . . . . 0.457 ' HG3' HG12 ' A' ' 792' ' ' ILE . 2.7 mptm? -112.45 137.83 50.08 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.499 0.666 . . . . 0.0 110.647 175.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 815' ' ' ILE . . . . . 0.69 HG13 HD12 ' A' ' 731' ' ' LEU . 5.3 mp -124.27 111.85 30.2 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-N 114.792 -1.094 . . . . 0.0 108.155 177.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 816' ' ' GLN . . . . . 0.714 ' NE2' ' HG2' ' A' ' 818' ' ' ARG . 0.9 OUTLIER -108.72 109.16 20.26 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.023 0.44 . . . . 0.0 110.671 -177.22 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 817' ' ' VAL . . . . . 0.774 HG22 HD12 ' A' ' 733' ' ' LEU . 2.3 t -104.85 142.58 17.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 -179.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 818' ' ' ARG . . . . . 0.714 ' HG2' ' NE2' ' A' ' 816' ' ' GLN . 73.6 mmt-85 . . . . . 0 C--N 1.321 -0.654 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 175.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 720' ' ' LYS . . . . . . . . . . . . . 52.6 mtpt . . . . . 0 N--CA 1.441 -0.887 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 721' ' ' PRO . . . . . 0.453 ' HD2' HG21 ' A' ' 806' ' ' VAL . 72.0 Cg_endo -88.75 151.35 6.11 Favored 'Trans proline' 0 N--CA 1.446 -1.298 0 C-N-CA 122.431 2.087 . . . . 0.0 111.488 -178.4 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 722' ' ' SER . . . . . 0.782 ' HB2' ' OE1' ' A' ' 810' ' ' GLN . 8.6 p -179.18 -159.32 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -175.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 723' ' ' ALA . . . . . 0.595 ' HB3' ' HG ' ' A' ' 795' ' ' LEU . . . -151.67 140.74 21.19 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 118.807 0.73 . . . . 0.0 110.931 176.068 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 35.1 m -132.89 105.63 7.23 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 -177.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 725' ' ' LEU . . . . . 0.51 ' CD2' ' HB ' ' A' ' 743' ' ' VAL . 16.7 mt -62.22 144.92 54.87 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-O 121.478 0.656 . . . . 0.0 111.507 -176.087 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 29.3 mtpt -97.62 -14.41 20.99 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.856 -1.065 . . . . 0.0 109.638 -177.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 727' ' ' LEU . . . . . 0.591 HD23 ' HB1' ' A' ' 813' ' ' ALA . 38.7 tp -69.21 114.24 7.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.713 175.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 9.6 t-80 -115.71 43.5 2.08 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.816 0.341 . . . . 0.0 111.214 -174.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 9.5 p80 -175.24 -177.67 1.07 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.629 177.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 730' ' ' ASP . . . . . 0.515 ' HA ' ' O ' ' A' ' 814' ' ' LYS . 1.2 m-20 -76.53 148.22 37.24 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.564 177.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 731' ' ' LEU . . . . . 0.601 HD13 ' HB2' ' A' ' 739' ' ' SER . 12.0 mt -101.93 104.45 15.15 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.555 173.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 732' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -81.23 93.24 6.46 Favored 'General case' 0 C--N 1.323 -0.56 0 O-C-N 123.712 0.632 . . . . 0.0 111.26 -172.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 733' ' ' LEU . . . . . 0.438 ' HB3' ' CB ' ' A' ' 737' ' ' ASP . 0.2 OUTLIER -107.38 163.69 12.83 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.107 0.48 . . . . 0.0 111.487 -178.415 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 734' ' ' CYS . . . . . 0.699 ' HA ' ' O ' ' A' ' 818' ' ' ARG . 69.2 m -113.14 -173.38 2.24 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.352 177.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 735' ' ' LEU . . . . . 0.449 HD23 ' N ' ' A' ' 736' ' ' GLY . 3.5 tt -62.56 128.1 34.39 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.925 -179.289 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 736' ' ' GLY . . . . . 0.48 ' HA2' ' HA ' ' A' ' 786' ' ' THR . . . 86.37 4.96 83.05 Favored Glycine 0 C--N 1.322 -0.199 0 C-N-CA 120.22 -0.991 . . . . 0.0 112.735 177.116 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 737' ' ' ASP . . . . . 0.501 ' HB2' ' O ' ' A' ' 734' ' ' CYS . 0.3 OUTLIER -84.26 153.3 23.66 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.364 0.602 . . . . 0.0 112.448 179.281 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 738' ' ' HIS . . . . . 0.486 ' HB2' ' O ' ' A' ' 782' ' ' THR . 47.0 p-80 -118.88 173.28 6.97 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 167.106 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 739' ' ' SER . . . . . 0.601 ' HB2' HD13 ' A' ' 731' ' ' LEU . 51.5 p -128.08 173.75 9.8 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 118.236 -1.385 . . . . 0.0 112.791 -173.043 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 10.4 p -144.98 103.93 3.93 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.861 -172.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 741' ' ' VAL . . . . . 0.813 HG11 HD23 ' A' ' 793' ' ' LEU . 0.4 OUTLIER -120.87 116.63 31.4 Favored Pre-proline 0 C--N 1.314 -0.963 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.282 -177.804 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 742' ' ' PRO . . . . . 0.643 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 9.8 Cg_endo -77.66 137.32 16.12 Favored 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 122.252 1.968 . . . . 0.0 111.545 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 743' ' ' VAL . . . . . 0.51 HG21 ' HB1' ' A' ' 723' ' ' ALA . 2.2 p -130.33 119.54 46.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.452 0.644 . . . . 0.0 112.231 177.33 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 744' ' ' ALA . . . . . 0.578 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -78.81 95.01 5.26 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 122.237 1.017 . . . . 0.0 109.03 168.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 745' ' ' LEU . . . . . 0.823 HD11 ' HB3' ' A' ' 778' ' ' TYR . 1.7 mt -76.41 142.54 41.06 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 113.706 -1.588 . . . . 0.0 110.485 -173.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -100.01 163.14 12.56 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.442 0.639 . . . . 0.0 110.571 -176.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 747' ' ' GLY . . . . . . . . . . . . . . . 91.36 139.11 8.23 Favored Glycine 0 C--N 1.309 -0.928 0 CA-C-N 114.855 -1.066 . . . . 0.0 111.64 -175.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 748' ' ' GLN . . . . . 0.45 ' C ' ' HE1' ' A' ' 751' ' ' PHE . 20.9 mp0 -114.22 111.2 21.16 Favored 'General case' 0 C--N 1.32 -0.679 0 O-C-N 122.469 -0.43 . . . . 0.0 111.081 -175.137 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 132.75 -170.7 21.95 Favored Glycine 0 N--CA 1.445 -0.764 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.034 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -73.5 93.84 0.84 Allowed 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.564 2.176 . . . . 0.0 111.676 -179.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 751' ' ' PHE . . . . . 0.607 ' CE2' ' HA ' ' A' ' 800' ' ' ASP . 80.0 m-85 -113.92 141.1 47.78 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.237 -178.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 752' ' ' THR . . . . . 0.695 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 86.7 m -91.66 105.28 17.62 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 177.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 753' ' ' LEU . . . . . 0.474 HD23 HD12 ' A' ' 798' ' ' ILE . 0.5 OUTLIER -98.79 123.0 42.74 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.362 -172.168 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 754' ' ' THR . . . . . 0.476 HG23 ' HB2' ' A' ' 769' ' ' GLU . 0.7 OUTLIER -117.89 136.29 53.56 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.659 -178.197 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 755' ' ' TYR . . . . . 0.4 ' CE1' ' HB3' ' A' ' 768' ' ' PHE . 17.2 p90 -143.29 153.95 43.29 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 178.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 756' ' ' ASP . . . . . 0.419 ' HB2' HG23 ' A' ' 758' ' ' ILE . 14.9 p-10 -118.91 118.86 32.68 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.341 0.591 . . . . 0.0 111.86 -178.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 757' ' ' ILE . . . . . 0.503 HG13 HD13 ' A' ' 793' ' ' LEU . 4.0 mp -89.74 96.34 6.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 167.369 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 758' ' ' ILE . . . . . 0.64 HG13 ' O ' ' A' ' 792' ' ' ILE . 2.5 pp -103.89 149.72 7.57 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -168.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 759' ' ' GLU . . . . . 0.536 ' HG2' ' CE2' ' A' ' 791' ' ' TYR . 19.8 mt-10 -87.48 123.99 32.98 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.164 178.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 760' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.313 -0.98 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.309 175.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 66.5 mtm180 . . . . . 0 C--O 1.234 0.247 0 CA-C-O 121.221 0.534 . . . . 0.0 111.88 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 766' ' ' LYS . . . . . 0.66 ' HD3' ' N ' ' A' ' 767' ' ' THR . 9.0 tmtt? -124.84 145.51 49.74 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 175.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 767' ' ' THR . . . . . 0.66 ' N ' ' HD3' ' A' ' 766' ' ' LYS . 91.7 m -133.16 141.7 48.26 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.295 -179.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 768' ' ' PHE . . . . . 0.4 ' HB3' ' CE1' ' A' ' 755' ' ' TYR . 4.1 t80 -136.21 141.74 44.02 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.05 0.452 . . . . 0.0 110.656 177.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 769' ' ' GLU . . . . . 0.476 ' HB2' HG23 ' A' ' 754' ' ' THR . 40.0 tt0 -126.41 121.08 31.45 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.487 -179.255 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 770' ' ' ILE . . . . . 0.645 HG22 HG22 ' A' ' 773' ' ' ILE . 9.4 mt -115.57 111.27 34.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 771' ' ' LYS . . . . . 0.619 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 7.8 mtpt -83.97 148.4 26.92 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.624 0.726 . . . . 0.0 111.521 -176.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 772' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 57.71 47.45 15.62 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 113.514 -1.675 . . . . 0.0 112.479 175.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 773' ' ' ILE . . . . . 0.74 HD12 ' H ' ' A' ' 775' ' ' THR . 0.5 OUTLIER -75.64 119.29 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 175.426 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 79.7 mttt -117.88 33.26 5.72 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 775' ' ' THR . . . . . 0.74 ' H ' HD12 ' A' ' 773' ' ' ILE . 1.1 m -95.4 -72.32 0.63 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 113.939 -1.482 . . . . 0.0 112.289 -172.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 776' ' ' ASN . . . . . 0.465 ' HA ' ' O ' ' A' ' 745' ' ' LEU . 12.2 m120 85.96 3.63 0.53 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.599 1.159 . . . . 0.0 110.934 -179.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 777' ' ' GLU . . . . . 0.578 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 12.3 mt-10 -161.84 88.7 0.7 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.171 -0.922 . . . . 0.0 108.799 172.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 778' ' ' TYR . . . . . 0.823 ' HB3' HD11 ' A' ' 745' ' ' LEU . 49.4 t80 -123.59 127.65 48.59 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 120.881 0.372 . . . . 0.0 110.778 -171.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 779' ' ' VAL . . . . . 0.643 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 15.1 t -85.52 105.42 14.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.206 0.527 . . . . 0.0 110.382 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 780' ' ' ILE . . . . . 0.429 ' HB ' ' O ' ' A' ' 741' ' ' VAL . 83.1 mt -75.44 142.31 14.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.703 -178.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.08 103.6 8.91 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 174.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 782' ' ' THR . . . . . 0.486 ' O ' ' HB2' ' A' ' 738' ' ' HIS . 2.9 p -75.36 143.6 76.65 Favored Pre-proline 0 C--N 1.319 -0.738 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.985 -175.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 783' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.69 157.76 9.38 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 123.378 2.719 . . . . 0.0 111.963 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 784' ' ' VAL . . . . . 0.45 ' HA ' ' HB3' ' A' ' 738' ' ' HIS . 11.6 p -68.47 130.89 33.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.45 0.643 . . . . 0.0 110.283 -175.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 785' ' ' PHE . . . . . 0.473 ' C ' ' H ' ' A' ' 787' ' ' THR . 62.3 m-85 -85.87 -40.17 16.24 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.42 -175.008 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 786' ' ' THR . . . . . 0.48 ' HA ' ' HA2' ' A' ' 736' ' ' GLY . 27.3 p 60.26 -4.92 0.1 Allowed 'General case' 0 N--CA 1.469 0.495 0 O-C-N 124.451 1.094 . . . . 0.0 112.053 -178.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 787' ' ' THR . . . . . 0.473 ' H ' ' C ' ' A' ' 785' ' ' PHE . 43.1 m -130.94 116.12 17.43 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.879 -173.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 788' ' ' GLY . . . . . . . . . . . . . . . -52.59 118.56 7.95 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.963 171.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 789' ' ' GLY . . . . . 0.453 ' H ' ' HB ' ' A' ' 817' ' ' VAL . . . -175.86 -174.97 42.86 Favored Glycine 0 N--CA 1.448 -0.546 0 N-CA-C 110.041 -1.223 . . . . 0.0 110.041 179.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -115.41 130.11 56.79 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 118.267 1.033 . . . . 0.0 110.254 178.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 791' ' ' TYR . . . . . 0.536 ' CE2' ' HG2' ' A' ' 759' ' ' GLU . 69.2 m-85 -121.3 143.98 48.88 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.473 179.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 792' ' ' ILE . . . . . 0.64 ' O ' HG13 ' A' ' 758' ' ' ILE . 21.2 mt -120.84 113.68 40.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 177.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 793' ' ' LEU . . . . . 0.813 HD23 HG11 ' A' ' 741' ' ' VAL . 0.7 OUTLIER -86.55 114.53 23.36 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.084 179.279 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 794' ' ' SER . . . . . 0.511 ' N ' HD12 ' A' ' 793' ' ' LEU . 23.1 t -123.86 159.68 29.1 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.763 -174.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 795' ' ' LEU . . . . . 0.595 ' HG ' ' HB3' ' A' ' 723' ' ' ALA . 1.2 mm? -87.51 135.31 33.4 Favored 'General case' 0 N--CA 1.44 -0.948 0 O-C-N 121.997 -0.44 . . . . 0.0 110.837 176.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 796' ' ' VAL . . . . . 0.405 ' HB ' ' HB ' ' A' ' 754' ' ' THR . 73.3 t -92.64 -55.36 6.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.95 -178.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 797' ' ' SER . . . . . 0.415 ' HA ' HD23 ' A' ' 808' ' ' LEU . 58.7 m -169.18 168.35 9.91 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.091 -173.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 798' ' ' ILE . . . . . 0.616 ' HA ' ' O ' ' A' ' 752' ' ' THR . 9.1 tt -141.06 165.39 19.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 172.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 799' ' ' LYS . . . . . 0.695 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 85.3 tttt -136.96 121.67 18.58 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.887 0.375 . . . . 0.0 111.333 -174.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 800' ' ' ASP . . . . . 0.607 ' HA ' ' CE2' ' A' ' 751' ' ' PHE . 7.9 t70 -65.49 153.62 40.88 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.21 175.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 5.4 p -58.83 -13.97 7.64 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 124.199 0.937 . . . . 0.0 112.948 -174.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 52.2 p -89.68 -5.83 56.7 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.511 0.672 . . . . 0.0 109.847 177.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 803' ' ' GLY . . . . . 0.529 ' HA2' ' CE ' ' A' ' 799' ' ' LYS . . . 89.81 40.31 5.95 Favored Glycine 0 N--CA 1.44 -1.071 0 CA-C-N 114.934 -1.03 . . . . 0.0 111.601 -177.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 804' ' ' CYS . . . . . 0.518 ' HB3' ' HB3' ' A' ' 800' ' ' ASP . 42.0 t -111.69 113.8 26.4 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 110.056 -0.349 . . . . 0.0 110.056 -178.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 805' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 11.0 p -85.01 132.85 30.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.396 0.617 . . . . 0.0 110.948 -174.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 806' ' ' VAL . . . . . 0.492 ' HB ' HG22 ' A' ' 798' ' ' ILE . 85.0 t -109.29 138.34 37.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.769 178.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -76.28 111.24 3.24 Favored Glycine 0 N--CA 1.452 -0.28 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.785 -178.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 808' ' ' LEU . . . . . 0.439 HD12 ' CB ' ' A' ' 795' ' ' LEU . 2.6 mm? -76.07 127.31 32.69 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 10.8 p -149.93 86.75 1.45 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.509 170.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 810' ' ' GLN . . . . . 0.782 ' OE1' ' HB2' ' A' ' 722' ' ' SER . 35.1 mt-30 -137.8 171.91 7.64 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.743 -176.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 811' ' ' PRO . . . . . 0.421 ' HD2' ' HB3' ' A' ' 810' ' ' GLN . 81.3 Cg_exo -47.78 140.32 17.78 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.798 2.332 . . . . 0.0 113.563 178.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -114.67 165.67 12.55 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.798 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 813' ' ' ALA . . . . . 0.591 ' HB1' HD23 ' A' ' 727' ' ' LEU . . . -111.33 151.37 28.49 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.278 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 814' ' ' LYS . . . . . 0.515 ' O ' ' HA ' ' A' ' 730' ' ' ASP . 19.5 ttpp -120.25 107.78 13.4 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.849 0.833 . . . . 0.0 110.827 178.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 815' ' ' ILE . . . . . 0.53 ' HA ' ' HB2' ' A' ' 731' ' ' LEU . 5.1 mp -86.65 116.94 30.12 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-N 114.539 -1.209 . . . . 0.0 108.68 177.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 816' ' ' GLN . . . . . 0.469 HE22 ' HB2' ' A' ' 818' ' ' ARG . 1.0 OUTLIER -107.88 106.57 16.9 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.686 0.755 . . . . 0.0 110.339 -177.041 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 817' ' ' VAL . . . . . 0.453 ' HB ' ' H ' ' A' ' 789' ' ' GLY . 1.9 t -101.43 146.43 9.79 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -177.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 818' ' ' ARG . . . . . 0.699 ' O ' ' HA ' ' A' ' 734' ' ' CYS . 17.2 tpt180 . . . . . 0 C--N 1.317 -0.833 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 178.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 720' ' ' LYS . . . . . 0.416 ' HG2' ' O ' ' A' ' 720' ' ' LYS . 19.1 ttpt . . . . . 0 N--CA 1.416 -2.139 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 721' ' ' PRO . . . . . 0.465 ' HG3' ' CE2' ' A' ' 751' ' ' PHE . 56.5 Cg_endo -87.91 155.41 7.26 Favored 'Trans proline' 0 N--CA 1.449 -1.121 0 C-N-CA 123.348 2.699 . . . . 0.0 112.092 -176.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 722' ' ' SER . . . . . 0.744 ' HA ' ' CD2' ' A' ' 808' ' ' LEU . 7.5 t -174.25 -159.84 0.1 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -174.019 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 723' ' ' ALA . . . . . 0.63 ' O ' ' HB2' ' A' ' 810' ' ' GLN . . . -156.77 140.67 16.2 Favored 'General case' 0 C--O 1.218 -0.562 0 C-N-CA 121.383 -0.127 . . . . 0.0 110.741 177.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 22.6 t -136.06 101.25 4.66 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 -176.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 725' ' ' LEU . . . . . 0.584 ' HA ' ' HA ' ' A' ' 743' ' ' VAL . 5.6 mp -60.7 139.41 57.88 Favored 'General case' 0 N--CA 1.425 -1.688 0 CA-C-O 122.396 1.093 . . . . 0.0 112.427 -175.117 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 33.4 mtpt -87.43 -18.12 30.67 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 113.002 -1.908 . . . . 0.0 109.356 -178.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 727' ' ' LEU . . . . . 0.528 ' HB2' ' HD2' ' A' ' 742' ' ' PRO . 21.2 tp -71.3 110.22 5.8 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 173.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 9.1 t60 -95.19 -48.4 5.94 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.528 -172.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -101.21 177.71 4.86 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.871 -177.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 730' ' ' ASP . . . . . 0.449 ' HA ' ' O ' ' A' ' 814' ' ' LYS . 7.7 p-10 -68.73 145.67 53.62 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.568 0.699 . . . . 0.0 110.933 -178.047 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 731' ' ' LEU . . . . . 0.537 ' HB3' ' HA ' ' A' ' 815' ' ' ILE . 36.4 tp -104.44 111.71 24.48 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.372 -175.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 732' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -70.35 127.47 32.88 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.884 -177.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 733' ' ' LEU . . . . . 0.485 HD11 ' OG ' ' A' ' 739' ' ' SER . 55.4 mt -136.59 163.72 29.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.195 0.522 . . . . 0.0 111.144 177.101 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 734' ' ' CYS . . . . . 0.472 ' O ' ' HB2' ' A' ' 737' ' ' ASP . 72.1 m -108.58 -176.18 2.97 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.036 175.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 735' ' ' LEU . . . . . . . . . . . . . 24.7 tp -63.95 131.57 48.06 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.022 0.439 . . . . 0.0 111.068 -177.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 736' ' ' GLY . . . . . 0.476 ' O ' HG13 ' A' ' 784' ' ' VAL . . . 70.27 13.48 70.47 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.619 177.058 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 737' ' ' ASP . . . . . 0.472 ' HB2' ' O ' ' A' ' 734' ' ' CYS . 0.3 OUTLIER -77.7 150.76 34.43 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.792 0.329 . . . . 0.0 110.711 178.763 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 16.1 p-80 -111.9 163.06 14.64 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 171.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 739' ' ' SER . . . . . 0.485 ' OG ' HD11 ' A' ' 733' ' ' LEU . 0.0 OUTLIER -131.36 174.08 10.42 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 119.526 -0.869 . . . . 0.0 112.732 -173.325 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 5.6 p -131.36 115.51 16.34 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.282 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 741' ' ' VAL . . . . . 0.412 ' HB ' ' HB ' ' A' ' 780' ' ' ILE . 3.6 t -113.6 98.98 48.7 Favored Pre-proline 0 C--N 1.318 -0.768 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.411 -175.356 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 742' ' ' PRO . . . . . 0.762 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 2.2 Cg_endo -75.88 121.65 6.36 Favored 'Trans proline' 0 N--CA 1.441 -1.579 0 C-N-CA 122.912 2.408 . . . . 0.0 110.712 -175.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 743' ' ' VAL . . . . . 0.584 ' HA ' ' HA ' ' A' ' 725' ' ' LEU . 1.4 p -125.67 121.52 60.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 121.662 0.744 . . . . 0.0 112.671 178.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 744' ' ' ALA . . . . . 0.586 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -83.42 111.67 19.24 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 169.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 745' ' ' LEU . . . . . 0.886 HD13 HD13 ' A' ' 773' ' ' ILE . 0.3 OUTLIER -95.11 168.99 10.42 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.705 -1.134 . . . . 0.0 111.251 -165.861 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 1.1 tppm? -122.9 147.59 46.41 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.287 -176.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 747' ' ' GLY . . . . . 0.45 ' HA3' ' HB3' ' A' ' 721' ' ' PRO . . . 100.73 129.97 6.87 Favored Glycine 0 C--N 1.311 -0.833 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.451 -177.268 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 748' ' ' GLN . . . . . 0.428 ' C ' ' HE1' ' A' ' 751' ' ' PHE . 2.1 mp0 -108.76 115.71 30.6 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.917 0.389 . . . . 0.0 111.059 -175.054 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 134.52 -176.31 19.97 Favored Glycine 0 N--CA 1.444 -0.773 0 N-CA-C 111.501 -0.64 . . . . 0.0 111.501 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_exo -71.89 93.89 0.71 Allowed 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.545 2.163 . . . . 0.0 111.839 179.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 751' ' ' PHE . . . . . 0.501 ' CD2' ' HA ' ' A' ' 800' ' ' ASP . 78.2 m-85 -110.2 141.95 42.42 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.41 -178.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 752' ' ' THR . . . . . 0.771 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 94.7 m -90.85 102.66 15.42 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.725 0.774 . . . . 0.0 109.471 178.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 753' ' ' LEU . . . . . 0.456 HD22 HD22 ' A' ' 745' ' ' LEU . 24.3 tp -91.82 116.85 29.25 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 114.448 -1.251 . . . . 0.0 110.461 -171.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 754' ' ' THR . . . . . 0.448 HG23 ' HB2' ' A' ' 769' ' ' GLU . 1.3 m -115.1 130.11 56.85 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.028 179.363 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 755' ' ' TYR . . . . . 0.557 ' CE1' ' HB2' ' A' ' 768' ' ' PHE . 22.2 p90 -141.31 156.73 45.82 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.856 0.36 . . . . 0.0 111.338 178.405 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 756' ' ' ASP . . . . . 0.442 ' HB3' HG23 ' A' ' 758' ' ' ILE . 0.2 OUTLIER -121.07 118.95 31.08 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.37 -176.628 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 757' ' ' ILE . . . . . 0.512 HG13 HD13 ' A' ' 793' ' ' LEU . 3.7 mp -87.98 96.24 5.72 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 168.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 758' ' ' ILE . . . . . 0.625 HG13 ' O ' ' A' ' 792' ' ' ILE . 2.5 pp -94.78 149.98 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.215 -173.363 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -105.13 125.65 51.21 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 120.173 -0.611 . . . . 0.0 110.562 178.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 760' ' ' THR . . . . . 0.462 HG23 ' OD2' ' A' ' 790' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.319 -0.746 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 177.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 765' ' ' ARG . . . . . 0.418 HH11 ' HD2' ' A' ' 765' ' ' ARG . 47.2 mtm105 . . . . . 0 C--O 1.233 0.21 0 CA-C-O 120.985 0.421 . . . . 0.0 111.569 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 766' ' ' LYS . . . . . 0.665 ' HD3' ' N ' ' A' ' 767' ' ' THR . 7.5 tmtm? -124.5 144.8 49.91 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 176.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 767' ' ' THR . . . . . 0.665 ' N ' ' HD3' ' A' ' 766' ' ' LYS . 91.4 m -125.05 137.84 54.21 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 120.879 0.371 . . . . 0.0 111.742 -176.34 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 768' ' ' PHE . . . . . 0.557 ' HB2' ' CE1' ' A' ' 755' ' ' TYR . 2.1 m-85 -131.89 130.25 41.38 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.047 171.074 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 769' ' ' GLU . . . . . 0.448 ' HB2' HG23 ' A' ' 754' ' ' THR . 37.1 tt0 -124.6 108.07 11.68 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.294 179.307 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 770' ' ' ILE . . . . . 0.429 ' N ' HD12 ' A' ' 770' ' ' ILE . 4.3 mp -106.76 113.23 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.196 -178.171 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 771' ' ' LYS . . . . . 0.612 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 1.7 mtpt -81.88 149.57 28.2 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.252 0.548 . . . . 0.0 111.125 -177.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 772' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 57.32 50.19 11.93 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.36 -1.291 . . . . 0.0 112.652 177.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 773' ' ' ILE . . . . . 0.886 HD13 HD13 ' A' ' 745' ' ' LEU . 0.5 OUTLIER -78.88 119.64 28.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 170.692 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 72.3 mttt -118.49 29.72 7.6 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 -177.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 775' ' ' THR . . . . . 0.659 ' H ' HD12 ' A' ' 773' ' ' ILE . 0.2 OUTLIER -94.08 -71.27 0.67 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.469 -1.241 . . . . 0.0 113.266 -167.753 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 776' ' ' ASN . . . . . 0.594 ' HB2' ' O ' ' A' ' 775' ' ' THR . 0.9 OUTLIER 84.8 2.86 0.73 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.326 1.05 . . . . 0.0 110.273 -176.739 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 777' ' ' GLU . . . . . 0.586 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 7.5 mt-10 -162.31 86.18 0.59 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.314 174.062 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 778' ' ' TYR . . . . . 0.685 ' HB3' HD11 ' A' ' 745' ' ' LEU . 69.9 t80 -132.38 131.1 41.52 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -173.53 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 779' ' ' VAL . . . . . 0.762 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 1.5 m -96.93 132.46 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 CA-C-O 122.684 1.231 . . . . 0.0 110.337 176.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 780' ' ' ILE . . . . . 0.412 ' HB ' ' HB ' ' A' ' 741' ' ' VAL . 88.8 mt -89.21 147.76 4.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-N 112.88 -1.964 . . . . 0.0 110.143 -170.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -112.09 110.55 20.9 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 120.271 -0.572 . . . . 0.0 109.575 175.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 782' ' ' THR . . . . . 0.497 HG22 HG12 ' A' ' 757' ' ' ILE . 11.5 p -85.66 142.43 37.12 Favored Pre-proline 0 C--N 1.312 -1.065 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.076 -177.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 783' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 782' ' ' THR . 32.2 Cg_exo -59.68 160.2 21.81 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 123.614 2.876 . . . . 0.0 113.233 -174.087 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 784' ' ' VAL . . . . . 0.531 HG12 HG23 ' A' ' 786' ' ' THR . 52.5 t -59.51 115.38 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.316 177.18 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 785' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -94.88 95.4 8.63 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.242 -179.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 786' ' ' THR . . . . . 0.531 HG23 HG12 ' A' ' 784' ' ' VAL . 33.4 p -86.67 35.23 0.67 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 122.026 0.917 . . . . 0.0 110.648 -178.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 44.3 m -152.79 109.31 3.42 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.457 -1.247 . . . . 0.0 110.902 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 788' ' ' GLY . . . . . 0.706 ' HA2' HG12 ' A' ' 817' ' ' VAL . . . -52.42 109.14 0.82 Allowed Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.16 169.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 789' ' ' GLY . . . . . 0.433 ' H ' ' HB ' ' A' ' 817' ' ' VAL . . . -169.91 176.58 43.66 Favored Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -179.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 790' ' ' ASP . . . . . 0.462 ' OD2' HG23 ' A' ' 760' ' ' THR . 0.4 OUTLIER -103.12 133.12 48.75 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.384 0.612 . . . . 0.0 110.58 -178.563 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 791' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -123.66 148.41 46.51 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.342 -0.844 . . . . 0.0 109.697 -179.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 792' ' ' ILE . . . . . 0.625 ' O ' HG13 ' A' ' 758' ' ' ILE . 14.1 mt -128.62 114.28 32.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 177.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 793' ' ' LEU . . . . . 0.536 HD12 ' N ' ' A' ' 794' ' ' SER . 0.7 OUTLIER -84.62 113.44 21.27 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.122 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 794' ' ' SER . . . . . 0.536 ' N ' HD12 ' A' ' 793' ' ' LEU . 13.7 p -124.68 164.34 20.1 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.344 -1.298 . . . . 0.0 109.315 -174.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 795' ' ' LEU . . . . . 0.619 HD11 ' O ' ' A' ' 723' ' ' ALA . 36.7 mt -89.4 144.85 25.74 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.688 -0.233 . . . . 0.0 110.942 -176.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 796' ' ' VAL . . . . . . . . . . . . . 68.8 t -104.88 -57.68 4.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.159 177.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 797' ' ' SER . . . . . 0.504 ' HA ' ' HG ' ' A' ' 808' ' ' LEU . 10.4 m -176.95 161.53 1.96 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.978 -175.283 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 798' ' ' ILE . . . . . 0.557 ' HA ' ' O ' ' A' ' 752' ' ' THR . 11.7 tt -132.07 162.11 40.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 176.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 799' ' ' LYS . . . . . 0.771 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 5.2 tmtt? -137.4 119.84 15.91 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.097 0.475 . . . . 0.0 111.024 -178.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 800' ' ' ASP . . . . . 0.501 ' HA ' ' CD2' ' A' ' 751' ' ' PHE . 11.7 t70 -64.23 153.0 39.36 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.256 -0.884 . . . . 0.0 108.982 174.046 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 3.5 p -68.02 0.92 3.08 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -173.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 24.3 p -92.95 -0.46 57.21 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.657 0.741 . . . . 0.0 109.511 172.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 803' ' ' GLY . . . . . 0.45 ' HA2' ' HE2' ' A' ' 799' ' ' LYS . . . 81.05 41.92 9.97 Favored Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.8 -177.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 804' ' ' CYS . . . . . . . . . . . . . 63.4 m -113.78 114.22 26.02 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 805' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 8.3 p -86.52 134.25 27.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.313 0.578 . . . . 0.0 110.831 -177.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 806' ' ' VAL . . . . . . . . . . . . . 53.2 t -123.04 134.84 64.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.717 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.365 178.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -66.24 127.29 29.5 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 114.816 -1.084 . . . . 0.0 111.939 -179.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 808' ' ' LEU . . . . . 0.744 ' CD2' ' HA ' ' A' ' 722' ' ' SER . 45.6 mt -90.81 126.62 36.08 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -177.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 5.6 p -149.47 85.95 1.46 Allowed 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 121.522 0.677 . . . . 0.0 110.97 173.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 810' ' ' GLN . . . . . 0.63 ' HB2' ' O ' ' A' ' 723' ' ' ALA . 90.8 mt-30 -140.5 168.02 15.93 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 172.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 811' ' ' PRO . . . . . 0.524 ' HD2' ' HB3' ' A' ' 810' ' ' GLN . 86.6 Cg_exo -45.34 137.33 10.88 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 123.098 2.532 . . . . 0.0 115.228 -173.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -103.25 166.72 10.26 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.303 177.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 813' ' ' ALA . . . . . . . . . . . . . . . -119.68 161.11 21.24 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.245 -177.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 814' ' ' LYS . . . . . 0.449 ' O ' ' HA ' ' A' ' 730' ' ' ASP . 73.9 tttt -123.98 125.2 44.16 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 121.163 0.506 . . . . 0.0 110.834 177.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 815' ' ' ILE . . . . . 0.537 ' HA ' ' HB3' ' A' ' 731' ' ' LEU . 5.3 mp -109.39 119.24 58.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 176.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 816' ' ' GLN . . . . . 0.702 ' NE2' ' HG2' ' A' ' 818' ' ' ARG . 0.8 OUTLIER -108.95 114.51 28.33 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.217 0.532 . . . . 0.0 111.062 -174.748 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 817' ' ' VAL . . . . . 0.706 HG12 ' HA2' ' A' ' 788' ' ' GLY . 84.4 t -103.97 140.52 21.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.316 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 818' ' ' ARG . . . . . 0.702 ' HG2' ' NE2' ' A' ' 816' ' ' GLN . 34.1 mmt180 . . . . . 0 C--N 1.322 -0.594 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 172.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 720' ' ' LYS . . . . . . . . . . . . . 16.7 mtpp . . . . . 0 N--CA 1.444 -0.746 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 721' ' ' PRO . . . . . 0.427 ' HG3' ' CE2' ' A' ' 751' ' ' PHE . 60.6 Cg_endo -88.5 154.93 6.48 Favored 'Trans proline' 0 N--CA 1.447 -1.217 0 C-N-CA 122.713 2.275 . . . . 0.0 112.472 -174.209 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 722' ' ' SER . . . . . 0.51 ' HA ' ' CD2' ' A' ' 808' ' ' LEU . 11.4 t 178.49 -152.4 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.871 -176.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 723' ' ' ALA . . . . . 0.639 ' HA ' ' HA ' ' A' ' 745' ' ' LEU . . . -152.53 153.65 33.87 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 178.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 49.7 m -144.45 98.67 3.24 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.213 0.53 . . . . 0.0 109.634 175.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 725' ' ' LEU . . . . . 0.535 ' HA ' ' HA ' ' A' ' 743' ' ' VAL . 4.9 mp -62.38 141.45 58.32 Favored 'General case' 0 N--CA 1.424 -1.747 0 CA-C-O 122.4 1.095 . . . . 0.0 111.808 -175.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 726' ' ' LYS . . . . . 0.522 ' HD2' ' HB2' ' A' ' 744' ' ' ALA . 19.2 mtpp -94.79 -13.02 26.02 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 112.887 -1.96 . . . . 0.0 110.288 -173.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 727' ' ' LEU . . . . . 0.554 ' HB2' ' HD2' ' A' ' 742' ' ' PRO . 0.9 OUTLIER -82.3 112.38 19.24 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 176.096 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 51.5 m-70 -114.67 54.25 0.78 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.713 0.635 . . . . 0.0 112.713 -172.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 7.6 p80 -178.15 -178.08 0.63 Allowed 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.762 -0.199 . . . . 0.0 110.492 176.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 730' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -81.58 125.84 31.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.303 176.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 731' ' ' LEU . . . . . 0.6 ' HB2' ' HA ' ' A' ' 815' ' ' ILE . 21.2 mt -79.95 113.14 17.89 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.215 177.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 732' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -76.61 109.94 10.78 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.092 -176.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 733' ' ' LEU . . . . . 0.815 HD12 HG22 ' A' ' 817' ' ' VAL . 64.3 mt -122.94 164.21 18.92 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.16 0.505 . . . . 0.0 110.864 177.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 734' ' ' CYS . . . . . 0.517 ' O ' ' HB2' ' A' ' 737' ' ' ASP . 76.3 m -113.75 -174.28 2.44 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.023 170.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 735' ' ' LEU . . . . . . . . . . . . . 8.6 tp -68.37 135.24 51.5 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 121.448 0.642 . . . . 0.0 111.898 -176.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 81.37 8.74 86.77 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 114.854 -1.066 . . . . 0.0 111.996 -178.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 737' ' ' ASP . . . . . 0.517 ' HB2' ' O ' ' A' ' 734' ' ' CYS . 4.1 m-20 -89.67 151.48 21.85 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 179.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 738' ' ' HIS . . . . . 0.444 ' HB2' ' O ' ' A' ' 782' ' ' THR . 45.4 p-80 -114.2 -175.53 2.7 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 169.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 739' ' ' SER . . . . . 0.594 ' OG ' HD11 ' A' ' 733' ' ' LEU . 9.2 m -141.55 174.39 10.61 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.567 0.698 . . . . 0.0 112.471 178.021 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 740' ' ' SER . . . . . 0.415 ' HA ' ' O ' ' A' ' 780' ' ' ILE . 14.1 t -141.67 103.04 4.3 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.489 178.251 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 741' ' ' VAL . . . . . 0.692 HG11 HD23 ' A' ' 793' ' ' LEU . 1.7 p -107.57 114.65 60.36 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.642 -175.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 742' ' ' PRO . . . . . 0.651 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 1.0 OUTLIER -73.64 129.19 13.34 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 122.488 2.126 . . . . 0.0 111.286 179.403 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 743' ' ' VAL . . . . . 0.535 ' HA ' ' HA ' ' A' ' 725' ' ' LEU . 1.5 p -128.53 119.92 51.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.308 0.575 . . . . 0.0 111.759 175.014 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 744' ' ' ALA . . . . . 0.583 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -85.1 105.51 15.88 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 169.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 745' ' ' LEU . . . . . 0.817 HD13 HD13 ' A' ' 773' ' ' ILE . 0.4 OUTLIER -85.23 168.0 15.15 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.156 -167.403 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 12.3 tttp -121.23 155.43 34.63 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.678 0.752 . . . . 0.0 110.724 -177.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 747' ' ' GLY . . . . . . . . . . . . . . . 97.66 135.92 8.92 Favored Glycine 0 C--N 1.306 -1.121 0 CA-C-N 114.441 -1.254 . . . . 0.0 111.229 -178.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 60.9 mm-40 -106.46 116.74 32.46 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.858 -173.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 130.28 164.77 11.42 Favored Glycine 0 CA--C 1.496 -1.114 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.518 -175.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 750' ' ' PRO . . . . . 0.573 ' HB3' ' HE2' ' A' ' 774' ' ' LYS . 46.2 Cg_endo -60.31 94.08 0.1 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 123.388 2.725 . . . . 0.0 111.768 172.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 751' ' ' PHE . . . . . 0.467 ' CE2' ' HA ' ' A' ' 800' ' ' ASP . 44.0 m-85 -105.0 143.34 33.32 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.103 -177.149 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 752' ' ' THR . . . . . 0.783 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 93.0 m -88.44 102.97 15.42 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 121.563 0.697 . . . . 0.0 109.137 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 753' ' ' LEU . . . . . 0.438 HD22 HD22 ' A' ' 745' ' ' LEU . 23.6 tp -93.3 117.81 30.52 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.844 -169.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 754' ' ' THR . . . . . 0.501 HG23 ' HB2' ' A' ' 769' ' ' GLU . 1.4 m -117.99 132.11 56.42 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.707 0.289 . . . . 0.0 110.642 179.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 755' ' ' TYR . . . . . 0.551 ' CE1' ' HB3' ' A' ' 768' ' ' PHE . 24.1 p90 -142.45 156.94 45.22 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.89 0.376 . . . . 0.0 111.438 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 756' ' ' ASP . . . . . 0.526 ' HB3' HG23 ' A' ' 758' ' ' ILE . 0.1 OUTLIER -119.76 118.83 31.89 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.526 -179.282 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 757' ' ' ILE . . . . . 0.567 ' CD1' HD13 ' A' ' 793' ' ' LEU . 3.6 mp -87.22 96.39 5.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 167.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 758' ' ' ILE . . . . . 0.526 HG23 ' HB3' ' A' ' 756' ' ' ASP . 2.4 pp -96.08 144.33 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.562 -171.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 759' ' ' GLU . . . . . 0.458 ' O ' ' HG3' ' A' ' 759' ' ' GLU . 5.6 pt-20 -95.64 124.37 39.63 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 119.47 -0.892 . . . . 0.0 109.988 177.138 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 760' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.314 -0.975 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 177.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 765' ' ' ARG . . . . . 0.449 ' HA ' ' HA ' ' A' ' 758' ' ' ILE . 42.4 mtm180 . . . . . 0 C--O 1.235 0.329 0 CA-C-O 120.916 0.389 . . . . 0.0 111.443 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 766' ' ' LYS . . . . . 0.478 ' O ' ' HA ' ' A' ' 756' ' ' ASP . 1.0 OUTLIER -121.44 136.05 55.0 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.018 -179.037 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 767' ' ' THR . . . . . . . . . . . . . 60.7 m -115.38 136.73 52.79 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.89 -175.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 768' ' ' PHE . . . . . 0.551 ' HB3' ' CE1' ' A' ' 755' ' ' TYR . 2.8 t80 -138.33 135.68 35.65 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 175.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 769' ' ' GLU . . . . . 0.501 ' HB2' HG23 ' A' ' 754' ' ' THR . 33.2 tt0 -127.17 133.15 50.36 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.117 -179.277 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 770' ' ' ILE . . . . . 0.413 HG22 HG22 ' A' ' 773' ' ' ILE . 4.1 mt -123.9 109.04 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 175.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 771' ' ' LYS . . . . . 0.609 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 9.6 mtpt -80.12 151.59 29.73 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-O 121.35 0.595 . . . . 0.0 111.035 -176.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 772' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 55.35 50.66 14.41 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.312 -1.313 . . . . 0.0 112.393 176.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 773' ' ' ILE . . . . . 0.817 HD13 HD13 ' A' ' 745' ' ' LEU . 0.5 OUTLIER -74.99 122.07 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 170.989 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 774' ' ' LYS . . . . . 0.573 ' HE2' ' HB3' ' A' ' 750' ' ' PRO . 65.5 mttt -115.38 25.42 10.84 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.364 -0.835 . . . . 0.0 108.818 -176.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 775' ' ' THR . . . . . 0.692 ' H ' HD12 ' A' ' 773' ' ' ILE . 0.7 OUTLIER -96.33 -73.36 0.6 Allowed 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -169.551 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 776' ' ' ASN . . . . . 0.629 ' HB2' ' O ' ' A' ' 775' ' ' THR . 0.7 OUTLIER 85.97 3.65 0.53 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.548 1.139 . . . . 0.0 111.242 -173.345 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 777' ' ' GLU . . . . . 0.583 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 30.0 mt-10 -161.27 84.64 0.65 Allowed 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 177.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 778' ' ' TYR . . . . . 0.686 ' HB3' HD11 ' A' ' 745' ' ' LEU . 89.9 t80 -132.72 133.01 42.94 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.897 -169.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 779' ' ' VAL . . . . . 0.651 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 12.2 t -93.5 114.36 30.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.465 0.65 . . . . 0.0 110.555 179.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 780' ' ' ILE . . . . . 0.548 ' HB ' HG13 ' A' ' 741' ' ' VAL . 70.6 mt -79.4 147.52 6.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.606 -177.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 781' ' ' LYS . . . . . 0.43 ' HD3' ' C ' ' A' ' 780' ' ' ILE . 0.0 OUTLIER -117.89 100.67 7.73 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 175.222 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 782' ' ' THR . . . . . 0.493 ' OG1' ' HB2' ' A' ' 739' ' ' SER . 62.1 p -70.16 135.19 87.08 Favored Pre-proline 0 N--CA 1.441 -0.884 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.633 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 783' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 782' ' ' THR . 25.5 Cg_exo -62.66 156.21 54.28 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.793 2.329 . . . . 0.0 111.303 -175.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 784' ' ' VAL . . . . . . . . . . . . . 14.6 p -58.64 127.87 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 CA-C-O 121.489 0.661 . . . . 0.0 109.974 -177.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 785' ' ' PHE . . . . . 0.454 ' C ' ' H ' ' A' ' 787' ' ' THR . 94.7 m-85 -81.88 -31.83 31.33 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.419 -172.122 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 43.1 p 56.64 2.49 0.1 Allowed 'General case' 0 N--CA 1.471 0.59 0 O-C-N 124.065 0.853 . . . . 0.0 112.233 178.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 787' ' ' THR . . . . . 0.454 ' H ' ' C ' ' A' ' 785' ' ' PHE . 14.8 m -139.93 122.91 16.68 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.05 -179.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 788' ' ' GLY . . . . . . . . . . . . . . . -58.76 111.23 3.11 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.304 168.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 789' ' ' GLY . . . . . 0.459 ' H ' ' HB ' ' A' ' 817' ' ' VAL . . . -166.89 167.21 39.58 Favored Glycine 0 N--CA 1.442 -0.916 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 178.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -99.11 130.98 45.47 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 117.674 0.737 . . . . 0.0 109.72 -179.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 791' ' ' TYR . . . . . 0.438 ' CE2' ' HB3' ' A' ' 759' ' ' GLU . 86.9 m-85 -124.3 153.48 41.68 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.29 0.567 . . . . 0.0 110.885 -178.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 792' ' ' ILE . . . . . 0.484 ' O ' HG13 ' A' ' 758' ' ' ILE . 7.2 mt -130.72 113.97 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 CA-C-N 115.283 -0.871 . . . . 0.0 108.944 176.113 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 793' ' ' LEU . . . . . 0.692 HD23 HG11 ' A' ' 741' ' ' VAL . 1.3 tp -84.74 110.68 18.97 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 176.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 794' ' ' SER . . . . . 0.492 ' N ' HD12 ' A' ' 793' ' ' LEU . 6.1 p -124.7 157.5 35.49 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.53 -1.214 . . . . 0.0 109.729 -173.472 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 795' ' ' LEU . . . . . 0.509 ' CD2' ' HB3' ' A' ' 723' ' ' ALA . 51.4 mt -85.29 133.39 34.16 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.57 -0.287 . . . . 0.0 111.147 -174.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 796' ' ' VAL . . . . . . . . . . . . . 79.2 t -95.62 -55.06 6.45 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.715 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 797' ' ' SER . . . . . 0.566 ' HA ' ' HG ' ' A' ' 808' ' ' LEU . 97.5 p -176.7 158.55 1.71 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.988 -173.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 798' ' ' ILE . . . . . 0.503 ' HA ' ' O ' ' A' ' 752' ' ' THR . 8.0 tt -131.01 163.88 35.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 176.182 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 799' ' ' LYS . . . . . 0.783 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 16.5 ttmt -140.91 125.82 18.2 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.06 0.457 . . . . 0.0 111.503 -177.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 800' ' ' ASP . . . . . 0.467 ' HA ' ' CE2' ' A' ' 751' ' ' PHE . 28.2 t70 -65.98 155.77 35.61 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.517 174.024 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 801' ' ' SER . . . . . 0.458 ' HB3' ' HG2' ' A' ' 750' ' ' PRO . 18.2 p -59.03 -10.05 2.33 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -171.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 36.1 p -96.76 8.83 43.39 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.37 0.605 . . . . 0.0 110.324 179.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 803' ' ' GLY . . . . . . . . . . . . . . . 76.17 41.37 26.83 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.038 -178.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 804' ' ' CYS . . . . . 0.429 ' HB2' ' HB3' ' A' ' 800' ' ' ASP . 76.7 m -109.72 111.74 23.38 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 178.247 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 805' ' ' VAL . . . . . 0.438 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 14.4 p -86.25 139.46 17.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.422 0.63 . . . . 0.0 111.702 -174.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 806' ' ' VAL . . . . . 0.494 ' HB ' HG22 ' A' ' 798' ' ' ILE . 52.0 t -119.21 131.99 70.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.551 177.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -72.99 114.07 4.62 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.791 179.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 808' ' ' LEU . . . . . 0.566 ' HG ' ' HA ' ' A' ' 797' ' ' SER . 36.0 mt -84.9 124.46 31.66 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -173.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 19.1 t -138.98 86.51 2.14 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.241 171.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 810' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -146.91 173.55 4.11 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.873 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 811' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_exo -43.53 144.36 2.12 Favored 'Trans proline' 0 C--N 1.357 1.019 0 C-N-CA 123.618 2.879 . . . . 0.0 115.812 -173.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -116.22 169.1 9.54 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 114.554 -1.203 . . . . 0.0 110.546 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 813' ' ' ALA . . . . . . . . . . . . . . . -120.68 160.15 23.87 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.994 175.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 814' ' ' LYS . . . . . 0.468 ' HG2' ' CG1' ' A' ' 792' ' ' ILE . 48.3 mttp -123.62 134.31 53.81 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.451 0.643 . . . . 0.0 110.648 177.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 815' ' ' ILE . . . . . 0.6 ' HA ' ' HB2' ' A' ' 731' ' ' LEU . 5.3 mp -121.16 108.48 22.66 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 CA-C-N 115.055 -0.975 . . . . 0.0 108.898 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 816' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -100.87 108.01 19.68 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.257 0.551 . . . . 0.0 110.441 -176.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 817' ' ' VAL . . . . . 0.815 HG22 HD12 ' A' ' 733' ' ' LEU . 2.9 t -101.91 146.86 9.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -179.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 818' ' ' ARG . . . . . . . . . . . . . 20.7 tpt180 . . . . . 0 C--N 1.323 -0.587 0 CA-C-O 121.467 0.651 . . . . 0.0 112.175 -178.396 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 718' ' ' ARG . . . . . . . . . . . . . 1.1 tpm_? . . . . . 0 CA--C 1.509 -0.617 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 719' ' ' VAL . . . . . 0.543 ' O ' ' HD3' ' A' ' 721' ' ' PRO . 1.9 m -133.62 149.72 31.22 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.569 -178.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 720' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -96.46 98.83 4.64 Favored Pre-proline 0 C--N 1.304 -1.41 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.373 175.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 721' ' ' PRO . . . . . 0.543 ' HD3' ' O ' ' A' ' 719' ' ' VAL . 62.7 Cg_endo -87.62 155.97 7.67 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 122.948 2.432 . . . . 0.0 112.071 -174.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 722' ' ' SER . . . . . 0.588 ' HA ' HD22 ' A' ' 808' ' ' LEU . 12.7 t -176.77 -146.42 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -174.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 723' ' ' ALA . . . . . 0.521 ' HA ' ' HA ' ' A' ' 745' ' ' LEU . . . -153.24 149.31 27.82 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.658 0.266 . . . . 0.0 110.621 177.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 70.6 m -135.11 98.42 3.99 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 725' ' ' LEU . . . . . 0.578 HD22 ' CG2' ' A' ' 743' ' ' VAL . 2.3 mt -64.67 141.91 58.61 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.571 -171.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 33.3 mtpt -93.47 -22.51 18.83 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.043 -176.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 727' ' ' LEU . . . . . 0.491 ' HB2' ' HD2' ' A' ' 742' ' ' PRO . 0.2 OUTLIER -70.24 108.7 4.29 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 173.771 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 34.2 m170 -104.78 42.93 1.15 Allowed 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -169.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 729' ' ' HIS . . . . . 0.403 ' O ' HD12 ' A' ' 727' ' ' LEU . 6.7 p80 -179.45 -177.21 0.42 Allowed 'General case' 0 C--N 1.327 -0.402 0 O-C-N 123.238 0.336 . . . . 0.0 110.279 176.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 730' ' ' ASP . . . . . 0.492 ' HB3' ' HE2' ' A' ' 814' ' ' LYS . 5.0 p-10 -78.47 153.96 30.96 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.075 0.464 . . . . 0.0 110.86 179.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 731' ' ' LEU . . . . . 0.565 ' HB2' ' HA ' ' A' ' 815' ' ' ILE . 49.1 mt -102.53 137.35 40.88 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.672 178.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 732' ' ' LYS . . . . . . . . . . . . . 35.2 mmtm -104.12 103.83 13.67 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.155 0.503 . . . . 0.0 110.901 177.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 733' ' ' LEU . . . . . 0.585 HD22 HG23 ' A' ' 815' ' ' ILE . 0.8 OUTLIER -112.01 164.17 13.44 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.725 -178.972 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 734' ' ' CYS . . . . . 0.632 ' O ' ' HB2' ' A' ' 737' ' ' ASP . 56.6 m -104.65 -176.8 3.18 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 171.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 735' ' ' LEU . . . . . 0.578 HD13 ' HD2' ' A' ' 819' ' ' ARG . 10.3 tt -84.28 137.23 33.57 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 119.767 -0.773 . . . . 0.0 109.639 -175.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 82.97 8.02 86.36 Favored Glycine 0 N--CA 1.441 -0.989 0 CA-C-N 114.947 -1.024 . . . . 0.0 110.845 -171.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 737' ' ' ASP . . . . . 0.632 ' HB2' ' O ' ' A' ' 734' ' ' CYS . 0.5 OUTLIER -93.27 145.9 24.1 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.13 0.49 . . . . 0.0 111.546 177.262 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 738' ' ' HIS . . . . . 0.532 ' HB2' ' O ' ' A' ' 782' ' ' THR . 40.8 p-80 -110.76 175.82 5.28 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 170.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 739' ' ' SER . . . . . 0.409 ' CB ' HD21 ' A' ' 733' ' ' LEU . 0.0 OUTLIER -132.19 173.02 11.68 Favored 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 120.019 -0.672 . . . . 0.0 111.883 -177.344 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 36.8 m -143.03 106.82 4.65 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.032 -0.986 . . . . 0.0 109.702 178.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 741' ' ' VAL . . . . . 0.604 HG11 HD23 ' A' ' 793' ' ' LEU . 0.8 OUTLIER -110.32 111.92 57.41 Favored Pre-proline 0 C--N 1.318 -0.771 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.177 -176.871 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 742' ' ' PRO . . . . . 0.792 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 4.0 Cg_exo -72.16 131.29 17.69 Favored 'Trans proline' 0 N--CA 1.449 -1.111 0 C-N-CA 122.434 2.089 . . . . 0.0 111.249 -179.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 743' ' ' VAL . . . . . 0.578 ' CG2' HD22 ' A' ' 725' ' ' LEU . 41.2 t -131.3 118.05 38.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.503 0.668 . . . . 0.0 112.742 -179.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 744' ' ' ALA . . . . . 0.614 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -82.75 97.42 8.57 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 122.009 0.909 . . . . 0.0 108.621 170.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 745' ' ' LEU . . . . . 0.739 HD11 ' HB3' ' A' ' 778' ' ' TYR . 2.5 mt -76.72 159.72 29.93 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 113.972 -1.467 . . . . 0.0 111.86 -168.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 16.9 tppt? -111.61 146.78 36.8 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.08 -178.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 747' ' ' GLY . . . . . 0.435 ' HA3' ' HB3' ' A' ' 721' ' ' PRO . . . 103.24 119.87 4.68 Favored Glycine 0 C--N 1.304 -1.204 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.622 -178.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 748' ' ' GLN . . . . . 0.429 ' C ' ' HE1' ' A' ' 751' ' ' PHE . 0.0 OUTLIER -105.43 110.01 22.2 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.138 0.494 . . . . 0.0 111.2 -173.415 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 136.23 -175.68 20.76 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.877 -176.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -71.04 94.1 0.64 Allowed 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.397 2.064 . . . . 0.0 111.865 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 751' ' ' PHE . . . . . 0.574 ' HA ' ' O ' ' A' ' 799' ' ' LYS . 88.1 m-85 -113.2 140.46 47.92 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.368 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 752' ' ' THR . . . . . 0.682 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 98.0 m -89.92 104.99 17.5 Favored 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 121.556 0.693 . . . . 0.0 109.243 178.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 753' ' ' LEU . . . . . . . . . . . . . 21.3 tp -92.24 116.96 29.41 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 114.374 -1.285 . . . . 0.0 110.532 -172.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 754' ' ' THR . . . . . 0.453 HG23 ' HB2' ' A' ' 769' ' ' GLU . 0.9 OUTLIER -117.88 130.18 56.09 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.21 179.241 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 755' ' ' TYR . . . . . 0.565 ' CE1' ' HB3' ' A' ' 768' ' ' PHE . 20.8 p90 -139.43 153.8 47.66 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 120.741 -0.384 . . . . 0.0 111.582 -179.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 756' ' ' ASP . . . . . 0.488 ' HB2' HG23 ' A' ' 758' ' ' ILE . 7.6 p-10 -114.93 118.85 34.62 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.823 -176.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 757' ' ' ILE . . . . . 0.513 HG13 HD13 ' A' ' 793' ' ' LEU . 3.6 mp -91.68 95.36 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.747 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 167.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 758' ' ' ILE . . . . . 0.527 HG13 ' O ' ' A' ' 792' ' ' ILE . 2.3 pp -103.93 149.67 7.62 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.061 -170.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 759' ' ' GLU . . . . . 0.599 ' CG ' ' H ' ' A' ' 764' ' ' LYS . 8.3 pt-20 -96.89 135.28 39.1 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.364 177.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 760' ' ' THR . . . . . 0.48 ' OG1' ' HB3' ' A' ' 790' ' ' ASP . 38.7 p -81.42 -4.11 54.84 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-O 121.904 0.859 . . . . 0.0 108.684 174.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 761' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -73.51 -35.7 65.63 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-N 114.139 -1.391 . . . . 0.0 110.534 -176.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 762' ' ' SER . . . . . . . . . . . . . 16.2 t -169.05 -80.75 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 176.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 763' ' ' SER . . . . . . . . . . . . . 23.5 t -166.86 27.04 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 112.716 0.635 . . . . 0.0 112.716 -173.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 764' ' ' LYS . . . . . 0.599 ' H ' ' CG ' ' A' ' 759' ' ' GLU . 40.0 mttp -84.03 52.54 2.33 Favored 'General case' 0 N--CA 1.467 0.401 0 O-C-N 121.651 -0.656 . . . . 0.0 110.039 176.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 765' ' ' ARG . . . . . 0.473 ' CG ' HG22 ' A' ' 758' ' ' ILE . 15.2 ttp180 -62.32 120.62 11.36 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.071 -0.968 . . . . 0.0 111.88 -178.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 766' ' ' LYS . . . . . 0.584 ' HD3' ' N ' ' A' ' 767' ' ' THR . 9.3 tmtm? -97.99 144.11 27.85 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 177.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 767' ' ' THR . . . . . 0.584 ' N ' ' HD3' ' A' ' 766' ' ' LYS . 60.0 m -132.3 132.61 43.16 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.603 -178.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 768' ' ' PHE . . . . . 0.565 ' HB3' ' CE1' ' A' ' 755' ' ' TYR . 1.7 t80 -130.83 136.25 48.49 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 769' ' ' GLU . . . . . 0.453 ' HB2' HG23 ' A' ' 754' ' ' THR . 35.1 tt0 -128.83 118.71 23.19 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.954 -177.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 770' ' ' ILE . . . . . 0.437 HG22 HG22 ' A' ' 773' ' ' ILE . 7.7 mt -115.68 112.26 39.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 178.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 771' ' ' LYS . . . . . 0.635 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 3.1 mtpt -82.25 150.61 27.21 Favored 'General case' 0 N--CA 1.443 -0.792 0 CA-C-O 121.431 0.634 . . . . 0.0 111.528 -176.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 772' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 56.21 48.32 17.6 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 113.985 -1.462 . . . . 0.0 112.549 176.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 773' ' ' ILE . . . . . 0.668 HD12 ' H ' ' A' ' 775' ' ' THR . 0.5 OUTLIER -74.58 119.09 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 173.215 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 76.2 mttt -117.91 31.32 6.76 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -178.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 775' ' ' THR . . . . . 0.668 ' H ' HD12 ' A' ' 773' ' ' ILE . 2.1 m -95.74 -69.99 0.73 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.388 -1.278 . . . . 0.0 112.55 -172.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 776' ' ' ASN . . . . . 0.579 ' HB2' ' O ' ' A' ' 775' ' ' THR . 0.9 OUTLIER 82.78 4.43 1.0 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.825 0.85 . . . . 0.0 110.547 -177.092 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 777' ' ' GLU . . . . . 0.614 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 9.4 mt-10 -160.88 85.8 0.7 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.046 -0.979 . . . . 0.0 109.344 175.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 778' ' ' TYR . . . . . 0.739 ' HB3' HD11 ' A' ' 745' ' ' LEU . 75.6 t80 -136.26 126.97 27.24 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.258 -172.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 779' ' ' VAL . . . . . 0.792 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 1.6 m -91.52 126.4 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 CA-C-O 122.435 1.112 . . . . 0.0 110.612 179.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 780' ' ' ILE . . . . . . . . . . . . . 71.0 mt -89.22 145.32 7.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 113.543 -1.662 . . . . 0.0 110.954 -172.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? -112.75 115.45 28.54 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 175.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 782' ' ' THR . . . . . 0.532 ' O ' ' HB2' ' A' ' 738' ' ' HIS . 22.9 p -89.43 140.48 28.45 Favored Pre-proline 0 C--N 1.309 -1.158 0 CA-C-N 115.252 -0.886 . . . . 0.0 110.674 -178.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 783' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.02 156.56 28.5 Favored 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.641 2.894 . . . . 0.0 112.655 -174.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 784' ' ' VAL . . . . . . . . . . . . . 15.0 p -62.9 135.31 27.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.126 -176.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 785' ' ' PHE . . . . . 0.401 ' CB ' HG21 ' A' ' 817' ' ' VAL . 69.1 m-85 -105.04 102.72 12.21 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.744 179.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 81.4 p -84.54 19.35 1.99 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.386 -174.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -159.42 119.05 2.98 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.211 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 788' ' ' GLY . . . . . 0.785 ' HA2' HG12 ' A' ' 817' ' ' VAL . . . -46.08 116.29 2.11 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.431 -0.804 . . . . 0.0 113.571 170.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 789' ' ' GLY . . . . . 0.511 ' H ' ' HB ' ' A' ' 817' ' ' VAL . . . -156.8 -162.31 11.4 Favored Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 177.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 790' ' ' ASP . . . . . 0.48 ' HB3' ' OG1' ' A' ' 760' ' ' THR . 16.5 t70 -130.54 122.09 26.92 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 791' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -127.55 153.39 46.42 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.379 -174.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 792' ' ' ILE . . . . . 0.527 ' O ' HG13 ' A' ' 758' ' ' ILE . 19.2 mt -127.85 124.74 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 176.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 793' ' ' LEU . . . . . 0.604 HD23 HG11 ' A' ' 741' ' ' VAL . 1.2 tp -90.67 112.25 23.92 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 173.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 794' ' ' SER . . . . . 0.518 ' N ' HD12 ' A' ' 793' ' ' LEU . 9.4 t -118.79 175.16 5.88 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 114.451 -1.25 . . . . 0.0 108.492 -176.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 795' ' ' LEU . . . . . 0.545 HD21 HD21 ' A' ' 725' ' ' LEU . 21.5 mt -103.74 127.88 51.16 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 -178.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 796' ' ' VAL . . . . . . . . . . . . . 55.6 t -86.71 -57.6 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 CA-C-O 120.865 0.364 . . . . 0.0 110.773 -177.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 797' ' ' SER . . . . . 0.586 ' HA ' ' HG ' ' A' ' 808' ' ' LEU . 27.3 m -174.64 156.23 2.33 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.61 -173.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 798' ' ' ILE . . . . . 0.574 ' HA ' ' O ' ' A' ' 752' ' ' THR . 11.8 tt -128.8 168.06 22.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 176.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 799' ' ' LYS . . . . . 0.682 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 42.9 tttp -139.62 121.89 15.95 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 120.739 -0.384 . . . . 0.0 111.312 -174.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 800' ' ' ASP . . . . . 0.546 ' HA ' ' CD2' ' A' ' 751' ' ' PHE . 12.6 t70 -69.22 156.94 37.9 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.236 176.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 27.4 t -64.6 -10.9 29.7 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 123.759 0.662 . . . . 0.0 112.208 -174.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 13.9 t -90.95 2.26 56.39 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.991 0.9 . . . . 0.0 109.137 175.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 803' ' ' GLY . . . . . 0.452 ' HA2' ' HE3' ' A' ' 799' ' ' LYS . . . 81.71 46.79 6.6 Favored Glycine 0 N--CA 1.44 -1.061 0 CA-C-N 114.764 -1.107 . . . . 0.0 111.781 -178.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 804' ' ' CYS . . . . . 0.459 ' HB3' ' HB3' ' A' ' 800' ' ' ASP . 42.7 t -114.12 113.23 24.42 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.39 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 805' ' ' VAL . . . . . 0.525 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 8.4 p -85.03 129.93 36.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.346 0.593 . . . . 0.0 110.549 -177.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 806' ' ' VAL . . . . . 0.485 ' HB ' HG22 ' A' ' 798' ' ' ILE . 74.0 t -112.97 133.61 58.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.022 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -69.87 113.34 4.94 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.755 178.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 808' ' ' LEU . . . . . 0.588 HD22 ' HA ' ' A' ' 722' ' ' SER . 38.0 mt -84.55 125.05 32.08 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 -175.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 23.2 t -144.51 87.14 1.85 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.169 172.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 810' ' ' GLN . . . . . 0.494 ' HB3' ' HD2' ' A' ' 811' ' ' PRO . 10.6 mt-30 -143.88 171.22 7.11 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.132 178.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 811' ' ' PRO . . . . . 0.523 ' O ' ' HG ' ' A' ' 725' ' ' LEU . 79.2 Cg_exo -42.73 139.68 3.16 Favored 'Trans proline' 0 C--N 1.356 0.925 0 C-N-CA 123.045 2.497 . . . . 0.0 114.826 -171.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -112.19 167.71 10.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.642 -177.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 813' ' ' ALA . . . . . 0.414 ' N ' HD12 ' A' ' 725' ' ' LEU . . . -118.19 155.85 29.78 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.604 179.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 814' ' ' LYS . . . . . 0.492 ' HE2' ' HB3' ' A' ' 730' ' ' ASP . 12.0 ttpt -121.24 134.42 55.18 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.137 -0.625 . . . . 0.0 110.528 176.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 815' ' ' ILE . . . . . 0.585 HG23 HD22 ' A' ' 733' ' ' LEU . 4.6 mp -116.38 108.15 24.35 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-N 115.21 -0.905 . . . . 0.0 108.68 177.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 816' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -103.05 108.43 19.6 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.545 0.688 . . . . 0.0 109.629 -178.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 817' ' ' VAL . . . . . 0.785 HG12 ' HA2' ' A' ' 788' ' ' GLY . 90.4 t -98.36 139.5 20.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.168 -177.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 818' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 -126.83 175.83 7.73 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 178.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 819' ' ' ARG . . . . . 0.578 ' HD2' HD13 ' A' ' 735' ' ' LEU . 46.6 ttt180 -114.74 114.15 25.23 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.123 0.487 . . . . 0.0 110.948 -179.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 820' ' ' ASP . . . . . 0.477 ' OD1' ' HB3' ' A' ' 734' ' ' CYS . 11.9 p-10 . . . . . 0 C--N 1.321 -0.643 0 CA-C-N 115.568 -0.742 . . . . 99.989999999999995 110.011 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 718' ' ' ARG . . . . . . . . . . . . . 25.6 tpt180 . . . . . 0 N--CA 1.447 -0.601 0 CA-C-O 121.656 0.741 . . . . 0.0 109.979 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 719' ' ' VAL . . . . . 0.42 ' O ' ' HD3' ' A' ' 721' ' ' PRO . 4.4 p -141.73 150.15 19.57 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.22 0 CA-C-N 114.728 -1.124 . . . . 0.0 108.824 -177.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 720' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -81.18 104.94 3.3 Favored Pre-proline 0 C--N 1.308 -1.231 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.545 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 721' ' ' PRO . . . . . 0.467 ' HD2' HG21 ' A' ' 806' ' ' VAL . 63.3 Cg_endo -87.62 152.41 7.57 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 122.977 2.451 . . . . 0.0 112.401 -172.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 722' ' ' SER . . . . . 0.458 ' OG ' ' HG ' ' A' ' 808' ' ' LEU . 15.0 t -176.66 -148.5 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -174.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 723' ' ' ALA . . . . . 0.58 ' HA ' ' HA ' ' A' ' 745' ' ' LEU . . . -157.18 155.41 30.88 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 20.8 p -147.47 107.53 4.02 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.969 0.414 . . . . 0.0 109.894 174.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 725' ' ' LEU . . . . . 0.589 ' CD2' ' HB ' ' A' ' 743' ' ' VAL . 14.6 mt -62.96 145.62 54.91 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 121.591 0.71 . . . . 0.0 111.683 -175.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 726' ' ' LYS . . . . . 0.448 ' HB3' ' HE2' ' A' ' 726' ' ' LYS . 29.9 mtpt -95.85 -17.63 20.98 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.13 -177.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 727' ' ' LEU . . . . . 0.582 HD23 ' HB1' ' A' ' 813' ' ' ALA . 37.1 tp -67.15 115.14 6.5 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.213 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 34.5 m80 -109.48 30.02 7.02 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.968 0.413 . . . . 0.0 111.742 -176.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 6.4 p80 -162.23 179.9 7.54 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 175.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 730' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -91.72 143.47 26.51 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.023 0.439 . . . . 0.0 110.315 -178.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 731' ' ' LEU . . . . . 0.588 ' HB2' ' HA ' ' A' ' 815' ' ' ILE . 16.0 mt -78.48 108.44 11.85 Favored 'General case' 0 C--O 1.217 -0.629 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.771 -177.254 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 732' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -77.5 103.91 7.72 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.718 0.294 . . . . 0.0 111.022 178.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 733' ' ' LEU . . . . . 0.647 ' HB2' ' HB ' ' A' ' 817' ' ' VAL . 30.9 mt -118.06 164.78 14.6 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.183 0.516 . . . . 0.0 111.794 -177.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 734' ' ' CYS . . . . . 0.515 ' SG ' ' HA ' ' A' ' 820' ' ' ASP . 11.2 t -120.77 -174.41 2.81 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.039 179.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 735' ' ' LEU . . . . . 0.509 ' CD1' ' HG3' ' A' ' 819' ' ' ARG . 0.4 OUTLIER -72.39 119.29 16.39 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.064 0.459 . . . . 0.0 110.858 -171.507 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 86.66 10.93 72.09 Favored Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.893 -179.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 737' ' ' ASP . . . . . 0.535 ' HB3' ' HB3' ' A' ' 733' ' ' LEU . 5.8 t0 -75.43 168.78 19.36 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.084 0.469 . . . . 0.0 110.417 177.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 47.7 p-80 -126.21 153.72 44.29 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 175.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 739' ' ' SER . . . . . 0.581 ' HB2' ' OG1' ' A' ' 782' ' ' THR . 1.4 m -101.96 152.69 20.64 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 119.817 -0.753 . . . . 0.0 111.07 -173.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 740' ' ' SER . . . . . 0.456 ' HA ' ' O ' ' A' ' 780' ' ' ILE . 54.6 p -140.97 104.91 4.76 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.494 0.664 . . . . 0.0 110.055 179.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 741' ' ' VAL . . . . . 0.561 HG11 HD13 ' A' ' 793' ' ' LEU . 1.5 p -118.67 114.94 35.6 Favored Pre-proline 0 C--N 1.317 -0.838 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.918 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 742' ' ' PRO . . . . . 0.658 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 1.8 Cg_endo -75.86 130.37 12.37 Favored 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 122.431 2.087 . . . . 0.0 111.082 179.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 743' ' ' VAL . . . . . 0.589 ' HB ' ' CD2' ' A' ' 725' ' ' LEU . 1.6 p -126.7 121.29 58.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.547 0.689 . . . . 0.0 112.61 175.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 744' ' ' ALA . . . . . 0.495 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -82.67 102.23 11.35 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 168.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 745' ' ' LEU . . . . . 0.922 HD13 HD13 ' A' ' 773' ' ' ILE . 1.0 OUTLIER -81.11 168.63 18.39 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 114.282 -1.327 . . . . 0.0 111.258 -168.569 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 746' ' ' LYS . . . . . 0.408 ' HE3' ' HB2' ' A' ' 746' ' ' LYS . 28.0 ttmt -123.02 154.82 37.97 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.307 0.575 . . . . 0.0 110.717 -177.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 747' ' ' GLY . . . . . 0.404 ' HA3' ' HB3' ' A' ' 721' ' ' PRO . . . 92.05 133.11 5.98 Favored Glycine 0 C--N 1.309 -0.926 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.001 -174.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 748' ' ' GLN . . . . . 0.411 ' C ' ' HE1' ' A' ' 751' ' ' PHE . 65.7 mm-40 -101.89 123.03 45.13 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -170.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 107.98 -169.54 14.53 Favored Glycine 0 C--O 1.219 -0.815 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.896 179.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -67.23 99.86 0.51 Allowed 'Trans proline' 0 CA--C 1.531 0.356 0 C-N-CA 123.561 2.84 . . . . 0.0 113.542 -178.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 751' ' ' PHE . . . . . 0.634 ' CE2' ' HA ' ' A' ' 800' ' ' ASP . 60.9 m-85 -115.29 142.8 46.18 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.384 178.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 752' ' ' THR . . . . . 0.76 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 91.0 m -87.91 102.84 15.1 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.575 0.702 . . . . 0.0 109.867 178.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 753' ' ' LEU . . . . . 0.461 HD22 HD22 ' A' ' 745' ' ' LEU . 17.4 tp -92.08 130.71 37.75 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.537 -1.211 . . . . 0.0 110.538 -170.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 754' ' ' THR . . . . . 0.45 HG23 ' HB2' ' A' ' 769' ' ' GLU . 0.6 OUTLIER -125.98 134.84 51.37 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.607 0.241 . . . . 0.0 111.327 179.813 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 755' ' ' TYR . . . . . 0.422 ' CE1' ' HB3' ' A' ' 768' ' ' PHE . 26.1 p90 -145.93 154.66 42.18 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.14 177.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 756' ' ' ASP . . . . . 0.475 ' OD2' ' HD2' ' A' ' 765' ' ' ARG . 49.8 m-20 -116.9 122.76 45.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.868 -179.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 757' ' ' ILE . . . . . . . . . . . . . 4.2 mp -89.88 97.31 6.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 170.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 758' ' ' ILE . . . . . 0.555 HG22 ' HD3' ' A' ' 765' ' ' ARG . 2.1 pp -96.5 149.62 4.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.042 -169.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 759' ' ' GLU . . . . . 0.596 ' CD ' ' HB2' ' A' ' 764' ' ' LYS . 12.2 mt-10 -93.79 112.52 24.39 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.839 -176.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 760' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.32 -9.76 32.08 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.843 0.83 . . . . 0.0 109.252 179.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 761' ' ' PHE . . . . . 0.553 ' HB2' ' H ' ' A' ' 790' ' ' ASP . 90.5 t80 -87.59 -24.37 24.01 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.199 177.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 762' ' ' SER . . . . . . . . . . . . . 15.7 m -124.81 -87.03 0.62 Allowed 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.108 -179.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 763' ' ' SER . . . . . . . . . . . . . 32.2 t 177.04 -12.75 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 120.828 0.347 . . . . 0.0 110.981 -177.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 764' ' ' LYS . . . . . 0.596 ' HB2' ' CD ' ' A' ' 759' ' ' GLU . 98.7 mttt -77.82 -175.92 4.18 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.377 0.608 . . . . 0.0 111.318 -175.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 765' ' ' ARG . . . . . 0.555 ' HD3' HG22 ' A' ' 758' ' ' ILE . 3.8 ttp180 -162.93 134.54 5.08 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.317 -0.856 . . . . 0.0 110.341 -177.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 766' ' ' LYS . . . . . 0.466 ' HD3' ' N ' ' A' ' 767' ' ' THR . 1.3 tmtp? -109.78 146.12 35.51 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 767' ' ' THR . . . . . 0.466 ' N ' ' HD3' ' A' ' 766' ' ' LYS . 77.6 m -121.05 134.14 55.27 Favored 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.244 -176.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 768' ' ' PHE . . . . . 0.422 ' HB3' ' CE1' ' A' ' 755' ' ' TYR . 0.7 OUTLIER -133.66 131.48 39.58 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.995 0.426 . . . . 0.0 110.498 175.101 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 769' ' ' GLU . . . . . 0.45 ' HB2' HG23 ' A' ' 754' ' ' THR . 36.5 tt0 -127.25 117.23 21.89 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.681 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 770' ' ' ILE . . . . . 0.43 HG22 HG22 ' A' ' 773' ' ' ILE . 12.1 mt -111.43 112.02 38.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 179.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 771' ' ' LYS . . . . . 0.625 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 12.4 mtpt -83.79 153.03 24.32 Favored 'General case' 0 N--CA 1.435 -1.217 0 CA-C-O 121.496 0.665 . . . . 0.0 111.609 -175.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 772' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 56.64 46.16 20.79 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 113.979 -1.464 . . . . 0.0 112.558 177.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 773' ' ' ILE . . . . . 0.922 HD13 HD13 ' A' ' 745' ' ' LEU . 0.6 OUTLIER -74.29 113.84 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 171.949 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 53.6 mttt -107.31 29.65 6.95 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -177.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 775' ' ' THR . . . . . 0.705 ' H ' HD12 ' A' ' 773' ' ' ILE . 0.2 OUTLIER -95.85 -82.32 0.39 Allowed 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -167.785 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 776' ' ' ASN . . . . . 0.657 ' HB2' ' O ' ' A' ' 775' ' ' THR . 0.8 OUTLIER 89.08 3.64 0.21 Allowed 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 124.521 1.129 . . . . 0.0 111.281 -171.741 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 777' ' ' GLU . . . . . 0.495 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 12.5 mt-10 -160.88 82.94 0.66 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 175.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 778' ' ' TYR . . . . . 0.832 ' HB3' HD11 ' A' ' 745' ' ' LEU . 87.9 t80 -127.33 127.68 44.68 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.128 -171.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 779' ' ' VAL . . . . . 0.658 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 20.8 t -87.25 116.44 29.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.111 0.481 . . . . 0.0 110.4 177.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 780' ' ' ILE . . . . . 0.456 ' O ' ' HA ' ' A' ' 740' ' ' SER . 75.9 mt -86.35 139.6 17.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.405 -178.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 781' ' ' LYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 739' ' ' SER . 3.6 mppt? -125.33 104.11 8.29 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 176.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 782' ' ' THR . . . . . 0.581 ' OG1' ' HB2' ' A' ' 739' ' ' SER . 44.3 p -77.42 145.5 72.18 Favored Pre-proline 0 N--CA 1.443 -0.79 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -177.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 783' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_exo -50.69 158.92 2.55 Favored 'Trans proline' 0 CA--C 1.529 0.271 0 C-N-CA 123.711 2.94 . . . . 0.0 113.57 -177.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 784' ' ' VAL . . . . . 0.423 HG12 HG23 ' A' ' 786' ' ' THR . 54.7 t -58.65 127.26 17.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.308 -177.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 785' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -102.45 103.25 13.63 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.294 177.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 786' ' ' THR . . . . . 0.423 HG23 HG12 ' A' ' 784' ' ' VAL . 38.9 p -90.59 30.65 1.13 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.939 0.876 . . . . 0.0 110.846 -178.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 27.6 m -152.34 107.42 3.25 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.709 -1.132 . . . . 0.0 110.347 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 788' ' ' GLY . . . . . 0.771 ' HA2' HG22 ' A' ' 817' ' ' VAL . . . -51.24 107.96 0.49 Allowed Glycine 0 CA--C 1.525 0.676 0 C-N-CA 121.065 -0.588 . . . . 0.0 113.128 174.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 789' ' ' GLY . . . . . 0.538 ' H ' HG22 ' A' ' 817' ' ' VAL . . . -152.22 -173.33 21.7 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 -179.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 790' ' ' ASP . . . . . 0.553 ' H ' ' HB2' ' A' ' 761' ' ' PHE . 2.6 m-20 -121.5 129.95 53.25 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -177.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 791' ' ' TYR . . . . . 0.416 ' HA ' ' O ' ' A' ' 758' ' ' ILE . 61.6 m-85 -134.12 161.31 35.22 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.077 -176.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 792' ' ' ILE . . . . . . . . . . . . . 9.9 mt -137.94 121.64 21.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 CA-C-O 120.845 0.355 . . . . 0.0 110.087 176.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 793' ' ' LEU . . . . . 0.561 HD13 HG11 ' A' ' 741' ' ' VAL . 9.6 tt -84.76 107.77 17.11 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 794' ' ' SER . . . . . . . . . . . . . 21.7 m -112.6 150.63 31.12 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.297 -178.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 795' ' ' LEU . . . . . 0.481 HD22 ' HB3' ' A' ' 723' ' ' ALA . 34.6 mt -83.55 132.42 34.92 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.359 -178.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 796' ' ' VAL . . . . . . . . . . . . . 71.7 t -99.39 -57.88 4.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.926 -0.309 . . . . 0.0 111.794 -175.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 797' ' ' SER . . . . . 0.508 ' HA ' HD13 ' A' ' 808' ' ' LEU . 22.9 m -172.32 177.28 3.14 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.379 -173.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 798' ' ' ILE . . . . . 0.641 ' HA ' ' O ' ' A' ' 752' ' ' THR . 8.4 tt -150.92 156.73 6.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 799' ' ' LYS . . . . . 0.76 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 8.9 tmtt? -124.81 119.25 28.33 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 177.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 800' ' ' ASP . . . . . 0.634 ' HA ' ' CE2' ' A' ' 751' ' ' PHE . 11.4 t70 -63.88 154.1 34.77 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.487 175.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 10.6 t -60.95 -12.04 9.98 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 123.94 0.775 . . . . 0.0 112.171 -171.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 39.9 p -91.35 1.0 57.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.485 0.66 . . . . 0.0 110.45 177.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 803' ' ' GLY . . . . . 0.456 ' HA2' ' HE2' ' A' ' 799' ' ' LYS . . . 81.5 39.01 12.92 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.713 -176.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 804' ' ' CYS . . . . . 0.452 ' HB3' ' HB3' ' A' ' 800' ' ' ASP . 49.4 t -111.77 110.71 21.21 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 805' ' ' VAL . . . . . . . . . . . . . 7.5 p -86.25 127.49 40.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.671 0.748 . . . . 0.0 111.377 -173.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 806' ' ' VAL . . . . . 0.467 HG21 ' HD2' ' A' ' 721' ' ' PRO . 81.1 t -112.42 139.0 39.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.851 -178.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -83.96 109.53 3.21 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.756 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 808' ' ' LEU . . . . . 0.508 HD13 ' HA ' ' A' ' 797' ' ' SER . 10.4 mp -74.58 133.43 42.22 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 178.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 38.3 m -148.28 85.64 1.53 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.911 -1.04 . . . . 0.0 109.166 170.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 810' ' ' GLN . . . . . 0.507 ' HB3' ' HD2' ' A' ' 811' ' ' PRO . 12.0 mt-30 -138.86 173.66 4.99 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.527 178.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 811' ' ' PRO . . . . . 0.507 ' HD2' ' HB3' ' A' ' 810' ' ' GLN . 86.9 Cg_exo -44.39 140.76 5.67 Favored 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 123.153 2.568 . . . . 0.0 115.273 -175.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -113.25 166.61 11.29 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 114.474 -1.239 . . . . 0.0 109.727 176.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 813' ' ' ALA . . . . . 0.582 ' HB1' HD23 ' A' ' 727' ' ' LEU . . . -124.45 143.79 50.44 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.909 -177.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 814' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -97.53 130.18 44.62 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.589 0.709 . . . . 0.0 110.952 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 815' ' ' ILE . . . . . 0.588 ' HA ' ' HB2' ' A' ' 731' ' ' LEU . 5.0 mp -107.28 119.64 57.24 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 CA-C-N 114.833 -1.076 . . . . 0.0 108.824 176.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 816' ' ' GLN . . . . . 0.745 ' NE2' ' HG2' ' A' ' 818' ' ' ARG . 0.9 OUTLIER -117.02 106.66 13.63 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.272 0.558 . . . . 0.0 110.648 -177.842 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 817' ' ' VAL . . . . . 0.771 HG22 ' HA2' ' A' ' 788' ' ' GLY . 0.7 OUTLIER -111.29 143.97 20.1 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-O 121.113 0.482 . . . . 0.0 110.201 -179.167 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 818' ' ' ARG . . . . . 0.745 ' HG2' ' NE2' ' A' ' 816' ' ' GLN . 29.1 mmt180 -130.94 177.37 7.48 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.502 -179.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 819' ' ' ARG . . . . . 0.509 ' HG3' ' CD1' ' A' ' 735' ' ' LEU . 5.0 mpt_? -83.32 158.45 22.19 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.838 171.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 820' ' ' ASP . . . . . 0.515 ' HA ' ' SG ' ' A' ' 734' ' ' CYS . 9.1 p-10 . . . . . 0 C--N 1.324 -0.523 0 N-CA-C 110.015 -0.365 . . . . 99.989999999999995 110.015 177.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 718' ' ' ARG . . . . . . . . . . . . . 5.1 tpp180 . . . . . 0 N--CA 1.448 -0.562 0 CA-C-O 122.107 0.956 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 719' ' ' VAL . . . . . 0.547 ' O ' ' HD3' ' A' ' 721' ' ' PRO . 3.4 p -152.71 150.45 12.77 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 CA-C-N 113.674 -1.603 . . . . 0.0 108.065 177.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 720' ' ' LYS . . . . . . . . . . . . . 49.5 mtpt -78.75 107.84 6.8 Favored Pre-proline 0 C--N 1.314 -0.948 0 O-C-N 123.533 0.52 . . . . 0.0 110.557 -178.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 721' ' ' PRO . . . . . 0.547 ' HD3' ' O ' ' A' ' 719' ' ' VAL . 38.7 Cg_endo -87.47 164.18 8.06 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.826 2.351 . . . . 0.0 111.291 179.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 722' ' ' SER . . . . . 0.6 ' HA ' ' CD2' ' A' ' 808' ' ' LEU . 8.8 t -174.76 -154.37 0.05 Allowed 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 120.892 0.377 . . . . 0.0 110.521 -173.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 723' ' ' ALA . . . . . 0.65 ' HB1' HG21 ' A' ' 743' ' ' VAL . . . -151.73 143.03 23.38 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 178.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 14.9 t -134.57 98.97 4.21 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 725' ' ' LEU . . . . . 0.629 ' HA ' ' HA ' ' A' ' 743' ' ' VAL . 5.7 mp -59.7 144.28 48.47 Favored 'General case' 0 N--CA 1.427 -1.589 0 CA-C-O 122.476 1.131 . . . . 0.0 112.752 -175.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 32.4 mtpt -93.23 -19.66 21.2 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 113.038 -1.892 . . . . 0.0 109.461 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 727' ' ' LEU . . . . . 0.486 ' HB2' ' HD2' ' A' ' 742' ' ' PRO . 0.6 OUTLIER -72.0 108.64 5.33 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 177.588 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 31.2 t-80 -115.56 52.32 0.89 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.705 0.288 . . . . 0.0 111.401 -172.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 7.8 p80 -175.92 -177.91 0.98 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.49 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 730' ' ' ASP . . . . . 0.427 ' HB2' ' HE3' ' A' ' 732' ' ' LYS . 12.3 m-20 -77.78 131.76 37.76 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 173.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 731' ' ' LEU . . . . . 0.574 ' HB3' ' HA ' ' A' ' 815' ' ' ILE . 9.8 tp -96.35 100.81 12.39 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 120.979 0.419 . . . . 0.0 110.053 -176.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 732' ' ' LYS . . . . . 0.427 ' HE3' ' HB2' ' A' ' 730' ' ' ASP . 33.4 mmtp -80.52 112.36 17.8 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.749 -0.659 . . . . 0.0 112.087 -171.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 733' ' ' LEU . . . . . 0.607 ' HG ' ' HB3' ' A' ' 737' ' ' ASP . 7.3 mp -113.58 163.26 15.18 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.88 177.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 734' ' ' CYS . . . . . 0.575 ' O ' ' HB2' ' A' ' 737' ' ' ASP . 51.6 t -104.69 -174.96 2.66 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.501 173.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 735' ' ' LEU . . . . . 0.478 ' N ' ' SG ' ' A' ' 734' ' ' CYS . 40.0 tp -72.47 130.14 39.96 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 121.195 0.522 . . . . 0.0 111.293 -178.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 78.92 4.17 88.36 Favored Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.608 -177.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 737' ' ' ASP . . . . . 0.607 ' HB3' ' HG ' ' A' ' 733' ' ' LEU . 0.3 OUTLIER -77.87 151.71 33.72 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.096 0.474 . . . . 0.0 111.687 179.327 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 738' ' ' HIS . . . . . 0.445 ' HB2' ' O ' ' A' ' 782' ' ' THR . 34.6 p-80 -114.95 161.7 17.94 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 170.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 739' ' ' SER . . . . . 0.444 ' HB3' HD21 ' A' ' 733' ' ' LEU . 8.0 p -120.36 171.78 8.27 Favored 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 119.159 -1.016 . . . . 0.0 111.522 -173.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 7.0 p -137.85 100.74 4.26 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.649 177.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 741' ' ' VAL . . . . . 0.579 HG11 HD13 ' A' ' 793' ' ' LEU . 0.7 OUTLIER -109.86 107.74 59.11 Favored Pre-proline 0 C--N 1.318 -0.775 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.618 -179.119 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 742' ' ' PRO . . . . . 0.665 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 3.1 Cg_endo -76.84 137.83 18.15 Favored 'Trans proline' 0 N--CA 1.448 -1.183 0 C-N-CA 122.478 2.119 . . . . 0.0 111.545 -177.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 743' ' ' VAL . . . . . 0.65 HG21 ' HB1' ' A' ' 723' ' ' ALA . 1.7 p -131.01 118.58 42.06 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.697 0.76 . . . . 0.0 112.121 175.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 744' ' ' ALA . . . . . 0.606 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -80.62 95.61 6.6 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 169.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 745' ' ' LEU . . . . . 1.018 HD13 HD13 ' A' ' 773' ' ' ILE . 0.7 OUTLIER -73.31 159.23 33.68 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 113.901 -1.499 . . . . 0.0 111.472 -168.545 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -114.39 147.67 38.86 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.025 -174.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 747' ' ' GLY . . . . . . . . . . . . . . . 92.81 127.84 4.52 Favored Glycine 0 N--CA 1.442 -0.935 0 C-N-CA 120.166 -1.016 . . . . 0.0 110.625 -174.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 25.0 mp0 -101.68 127.07 48.6 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-O 121.194 0.521 . . . . 0.0 112.036 -171.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 112.88 -177.12 18.09 Favored Glycine 0 CA--C 1.5 -0.853 0 CA-C-N 115.169 -0.923 . . . . 0.0 111.936 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 750' ' ' PRO . . . . . 0.501 ' HB3' ' HE2' ' A' ' 774' ' ' LYS . 74.4 Cg_endo -65.87 94.91 0.28 Allowed 'Trans proline' 0 C--O 1.234 0.315 0 C-N-CA 123.838 3.025 . . . . 0.0 113.71 -177.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 751' ' ' PHE . . . . . 0.53 ' CE2' ' HA ' ' A' ' 800' ' ' ASP . 68.6 m-85 -113.91 144.06 43.67 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.997 178.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 752' ' ' THR . . . . . 0.749 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 63.8 m -89.41 107.93 19.35 Favored 'General case' 0 CA--C 1.512 -0.489 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 177.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 753' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.73 112.16 24.32 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.285 -171.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 754' ' ' THR . . . . . 0.491 HG23 ' HB2' ' A' ' 769' ' ' GLU . 2.2 m -109.74 135.32 50.85 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.41 -179.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 755' ' ' TYR . . . . . 0.532 ' CE1' ' HB3' ' A' ' 768' ' ' PHE . 29.2 p90 -143.43 157.01 44.8 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 120.968 0.413 . . . . 0.0 111.208 177.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 756' ' ' ASP . . . . . 0.425 ' OD2' ' HD2' ' A' ' 765' ' ' ARG . 41.2 m-20 -115.57 120.29 38.98 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.694 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 757' ' ' ILE . . . . . 0.403 ' HB ' ' HB3' ' A' ' 766' ' ' LYS . 3.3 mp -84.71 94.73 3.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 167.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 758' ' ' ILE . . . . . 0.56 HG22 ' HD3' ' A' ' 765' ' ' ARG . 2.2 pp -91.75 140.7 15.66 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 C-N-CA 120.258 -0.577 . . . . 0.0 111.429 -171.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 759' ' ' GLU . . . . . 0.409 ' HB2' ' HB2' ' A' ' 764' ' ' LYS . 6.8 mt-10 -93.19 99.88 12.36 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.06 -174.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 760' ' ' THR . . . . . 0.412 HG22 ' H ' ' A' ' 760' ' ' THR . 0.9 OUTLIER -88.75 -2.04 58.39 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.819 0.819 . . . . 0.0 109.358 -175.754 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 761' ' ' PHE . . . . . 0.548 ' HB2' ' H ' ' A' ' 790' ' ' ASP . 58.0 t80 -62.65 -32.94 74.09 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.388 174.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 762' ' ' SER . . . . . . . . . . . . . 49.8 m -146.8 -96.1 0.09 Allowed 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.191 178.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 763' ' ' SER . . . . . . . . . . . . . 50.4 m -156.06 55.73 0.59 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.025 0.44 . . . . 0.0 110.843 178.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 764' ' ' LYS . . . . . 0.409 ' HB2' ' HB2' ' A' ' 759' ' ' GLU . 87.7 mttt -127.88 175.54 8.27 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.003 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 765' ' ' ARG . . . . . 0.56 ' HD3' HG22 ' A' ' 758' ' ' ILE . 6.7 ttp180 -164.48 140.07 5.87 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 121.247 0.546 . . . . 0.0 111.417 -178.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 766' ' ' LYS . . . . . 0.521 ' HD3' ' N ' ' A' ' 767' ' ' THR . 9.8 tmtm? -111.89 146.02 38.48 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 178.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 767' ' ' THR . . . . . 0.521 ' N ' ' HD3' ' A' ' 766' ' ' LYS . 88.4 m -123.76 135.14 53.65 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.9 -178.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 768' ' ' PHE . . . . . 0.532 ' HB3' ' CE1' ' A' ' 755' ' ' TYR . 3.0 t80 -139.73 137.53 35.2 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 177.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 769' ' ' GLU . . . . . 0.491 ' HB2' HG23 ' A' ' 754' ' ' THR . 31.8 tt0 -131.2 132.8 44.95 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.003 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 770' ' ' ILE . . . . . 0.575 HG22 HG22 ' A' ' 773' ' ' ILE . 4.1 mt -121.99 111.57 31.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 177.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 771' ' ' LYS . . . . . 0.559 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 5.2 mtpt -85.15 157.31 20.7 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.176 0.512 . . . . 0.0 111.349 -175.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 772' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 53.71 44.29 29.88 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.546 -1.206 . . . . 0.0 112.19 177.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 773' ' ' ILE . . . . . 1.018 HD13 HD13 ' A' ' 745' ' ' LEU . 0.5 OUTLIER -75.15 111.36 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 173.342 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 774' ' ' LYS . . . . . 0.501 ' HE2' ' HB3' ' A' ' 750' ' ' PRO . 56.9 mttt -108.36 29.87 6.96 Favored 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 775' ' ' THR . . . . . 0.678 ' H ' HD12 ' A' ' 773' ' ' ILE . 2.1 m -96.11 -81.39 0.41 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.913 -1.039 . . . . 0.0 113.392 -166.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 776' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' A' ' 775' ' ' THR . 10.3 m120 93.79 4.18 0.05 OUTLIER 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 125.268 1.427 . . . . 0.0 110.971 -176.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 777' ' ' GLU . . . . . 0.606 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 4.9 mt-10 -161.11 87.96 0.73 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.364 171.041 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 778' ' ' TYR . . . . . 0.817 ' HB3' HD11 ' A' ' 745' ' ' LEU . 73.7 t80 -125.92 128.29 47.31 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.418 -172.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 779' ' ' VAL . . . . . 0.665 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 21.2 t -86.33 113.27 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 CA-C-O 121.14 0.495 . . . . 0.0 110.46 179.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 780' ' ' ILE . . . . . 0.434 ' HB ' HG13 ' A' ' 741' ' ' VAL . 76.2 mt -82.39 143.69 11.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.958 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -123.8 112.77 17.7 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 175.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 782' ' ' THR . . . . . 0.445 ' O ' ' HB2' ' A' ' 738' ' ' HIS . 44.2 p -77.01 142.19 68.69 Favored Pre-proline 0 C--N 1.318 -0.77 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.75 -179.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 783' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 782' ' ' THR . 51.2 Cg_exo -55.3 161.5 7.03 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 123.509 2.806 . . . . 0.0 112.899 -178.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 784' ' ' VAL . . . . . 0.443 HG12 HG23 ' A' ' 786' ' ' THR . 46.5 t -58.39 124.21 11.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.423 -0.808 . . . . 0.0 112.094 -179.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 785' ' ' PHE . . . . . 0.432 ' HE1' ' OG1' ' A' ' 782' ' ' THR . 99.5 m-85 -99.44 95.53 7.08 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.741 178.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 786' ' ' THR . . . . . 0.443 HG23 HG12 ' A' ' 784' ' ' VAL . 59.9 p -84.71 28.97 0.64 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.526 0.679 . . . . 0.0 110.912 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.05 108.92 3.68 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.56 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 788' ' ' GLY . . . . . 0.656 ' HA2' HG12 ' A' ' 817' ' ' VAL . . . -52.44 107.46 0.51 Allowed Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.465 171.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 789' ' ' GLY . . . . . 0.53 ' H ' ' HB ' ' A' ' 817' ' ' VAL . . . -152.22 -151.58 5.69 Favored Glycine 0 N--CA 1.444 -0.803 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 -179.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 790' ' ' ASP . . . . . 0.548 ' H ' ' HB2' ' A' ' 761' ' ' PHE . 11.3 t70 -141.07 133.16 27.85 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 791' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -135.0 149.06 50.12 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.382 -174.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 792' ' ' ILE . . . . . 0.418 ' O ' HG13 ' A' ' 758' ' ' ILE . 13.8 mt -127.61 116.32 42.96 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-O 121.091 0.472 . . . . 0.0 110.046 178.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 793' ' ' LEU . . . . . 0.579 HD13 HG11 ' A' ' 741' ' ' VAL . 10.3 tt -84.15 106.79 16.06 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 178.007 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 794' ' ' SER . . . . . . . . . . . . . 19.3 m -116.33 150.92 36.89 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.861 -177.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 795' ' ' LEU . . . . . 0.459 HD21 HD11 ' A' ' 725' ' ' LEU . 52.9 mt -83.0 136.55 34.47 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.861 -178.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 796' ' ' VAL . . . . . . . . . . . . . 77.2 t -100.35 -57.44 4.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.642 -176.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 797' ' ' SER . . . . . 0.56 ' HA ' ' HG ' ' A' ' 808' ' ' LEU . 25.9 m -170.86 153.54 3.97 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.305 -173.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 798' ' ' ILE . . . . . 0.607 ' HA ' ' O ' ' A' ' 752' ' ' THR . 9.1 tt -125.41 166.45 21.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 176.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 799' ' ' LYS . . . . . 0.749 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 87.7 tttt -137.53 123.09 19.71 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.407 -173.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 800' ' ' ASP . . . . . 0.623 ' HB3' ' HB3' ' A' ' 804' ' ' CYS . 13.4 t70 -70.93 157.64 37.83 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.469 175.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 10.4 p -60.68 -9.62 4.17 Favored 'General case' 0 CA--C 1.532 0.251 0 O-C-N 124.007 0.817 . . . . 0.0 112.799 -174.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 42.8 p -97.38 7.38 46.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.577 0.703 . . . . 0.0 110.308 176.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 803' ' ' GLY . . . . . 0.514 ' HA2' ' CE ' ' A' ' 799' ' ' LYS . . . 76.68 31.41 54.02 Favored Glycine 0 N--CA 1.444 -0.826 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.841 -176.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 804' ' ' CYS . . . . . 0.623 ' HB3' ' HB3' ' A' ' 800' ' ' ASP . 35.5 t -96.41 103.43 15.34 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 -179.089 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 805' ' ' VAL . . . . . 0.484 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 3.2 t -86.17 119.9 35.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.165 0.507 . . . . 0.0 110.889 -173.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 806' ' ' VAL . . . . . 0.455 HG21 ' HD2' ' A' ' 721' ' ' PRO . 73.0 t -103.56 133.6 47.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.245 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -67.14 134.09 31.35 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 121.077 -0.582 . . . . 0.0 111.664 178.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 808' ' ' LEU . . . . . 0.6 ' CD2' ' HA ' ' A' ' 722' ' ' SER . 69.2 mt -100.73 132.82 45.93 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -176.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 22.0 t -146.77 87.18 1.68 Allowed 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.921 171.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 810' ' ' GLN . . . . . 0.472 ' HB3' ' HD2' ' A' ' 811' ' ' PRO . 8.7 mt-30 -139.83 173.76 4.74 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.678 173.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 811' ' ' PRO . . . . . 0.472 ' HD2' ' HB3' ' A' ' 810' ' ' GLN . 78.9 Cg_exo -44.58 141.1 5.77 Favored 'Trans proline' 0 C--N 1.355 0.884 0 C-N-CA 122.971 2.447 . . . . 0.0 115.209 -176.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -108.36 168.05 9.59 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.285 -1.325 . . . . 0.0 109.495 176.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 813' ' ' ALA . . . . . . . . . . . . . . . -126.03 137.26 53.63 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.36 176.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 814' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -103.14 114.83 29.44 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 120.911 0.386 . . . . 0.0 110.441 -177.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 815' ' ' ILE . . . . . 0.574 ' HA ' ' HB3' ' A' ' 731' ' ' LEU . 5.2 mp -97.81 109.39 23.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.493 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 816' ' ' GLN . . . . . 0.703 ' NE2' ' HG2' ' A' ' 818' ' ' ARG . 0.8 OUTLIER -95.32 124.17 39.22 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.871 -178.592 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 817' ' ' VAL . . . . . 0.656 HG12 ' HA2' ' A' ' 788' ' ' GLY . 59.7 t -117.09 135.17 58.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 -177.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 818' ' ' ARG . . . . . 0.703 ' HG2' ' NE2' ' A' ' 816' ' ' GLN . 35.2 mmt180 -142.14 145.53 34.32 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 121.841 -0.537 . . . . 0.0 111.372 176.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 819' ' ' ARG . . . . . 0.456 ' HB3' ' HB2' ' A' ' 735' ' ' LEU . 0.0 OUTLIER -94.03 117.72 30.5 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.508 171.102 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 820' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 . . . . . 0 C--N 1.319 -0.731 0 CA-C-N 116.571 -0.286 . . . . 99.989999999999995 110.252 -179.992 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 718' ' ' ARG . . . . . . . . . . . . . 9.2 tpp180 . . . . . 0 CA--C 1.507 -0.69 0 CA-C-O 122.037 0.923 . . . . 0.0 110.663 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 719' ' ' VAL . . . . . 0.463 ' O ' ' HD3' ' A' ' 721' ' ' PRO . 1.2 m -143.99 159.46 15.92 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-N 113.533 -1.667 . . . . 0.0 108.418 178.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 720' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -84.25 108.87 15.82 Favored Pre-proline 0 C--N 1.31 -1.111 0 O-C-N 123.605 0.566 . . . . 0.0 109.601 175.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 721' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 719' ' ' VAL . 57.1 Cg_endo -87.48 150.03 7.66 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 122.82 2.346 . . . . 0.0 111.869 -177.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 722' ' ' SER . . . . . 0.41 ' HA ' ' HG ' ' A' ' 808' ' ' LEU . 16.1 t -176.71 -150.15 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -172.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 723' ' ' ALA . . . . . 0.593 ' HB1' HG21 ' A' ' 743' ' ' VAL . . . -153.95 143.41 21.56 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 110.449 -0.204 . . . . 0.0 110.449 178.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 4.2 p -134.36 105.44 6.6 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 178.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 725' ' ' LEU . . . . . 0.507 ' CD2' ' HB ' ' A' ' 743' ' ' VAL . 14.4 mt -65.4 148.95 50.83 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.728 -173.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 32.1 mtpt -105.75 -0.45 25.4 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.471 -1.241 . . . . 0.0 109.408 -177.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 727' ' ' LEU . . . . . 0.441 ' HB2' ' HD2' ' A' ' 742' ' ' PRO . 2.6 tm? -81.78 124.74 29.9 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.818 -1.083 . . . . 0.0 108.953 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 48.6 m80 -86.08 -85.14 0.16 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -173.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 10.7 p80 -92.56 174.83 7.07 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 120.587 -0.445 . . . . 0.0 111.235 -176.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 730' ' ' ASP . . . . . 0.405 ' HA ' ' O ' ' A' ' 814' ' ' LYS . 4.0 p30 -53.11 144.3 15.81 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.638 0.732 . . . . 0.0 111.898 -177.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 731' ' ' LEU . . . . . 0.558 ' HB2' ' HA ' ' A' ' 815' ' ' ILE . 15.8 mt -83.27 118.85 23.93 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.972 -1.013 . . . . 0.0 111.272 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 732' ' ' LYS . . . . . 0.42 ' C ' ' HG ' ' A' ' 733' ' ' LEU . 14.4 mmmm -85.18 117.94 24.43 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.457 179.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 733' ' ' LEU . . . . . 0.466 HD13 ' OD2' ' A' ' 737' ' ' ASP . 4.6 mt -142.48 164.64 29.57 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.913 0.387 . . . . 0.0 111.488 -173.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 734' ' ' CYS . . . . . 0.694 ' HA ' ' O ' ' A' ' 818' ' ' ARG . 18.5 p -117.78 -174.15 2.58 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.129 -177.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 735' ' ' LEU . . . . . 0.414 ' HB2' ' HA ' ' A' ' 819' ' ' ARG . 1.4 tt -61.0 127.84 33.54 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.552 -177.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 78.52 16.48 79.29 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.377 -0.916 . . . . 0.0 112.033 174.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 737' ' ' ASP . . . . . 0.466 ' OD2' HD13 ' A' ' 733' ' ' LEU . 0.9 OUTLIER -64.99 165.72 10.47 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.377 0.608 . . . . 0.0 111.096 176.995 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 22.0 p-80 -137.52 129.33 28.7 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 162.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 739' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -97.86 171.76 8.09 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 119.674 -0.81 . . . . 0.0 111.165 -165.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 740' ' ' SER . . . . . 0.421 ' HA ' ' O ' ' A' ' 780' ' ' ILE . 50.2 m -142.45 107.68 4.99 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.16 -178.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 741' ' ' VAL . . . . . 0.636 HG11 HD13 ' A' ' 793' ' ' LEU . 1.0 OUTLIER -114.51 105.67 53.39 Favored Pre-proline 0 C--N 1.315 -0.924 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.075 179.672 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 742' ' ' PRO . . . . . 0.81 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 5.9 Cg_exo -73.76 135.5 21.72 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 122.248 1.965 . . . . 0.0 111.441 -176.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 743' ' ' VAL . . . . . 0.593 HG21 ' HB1' ' A' ' 723' ' ' ALA . 2.1 p -133.54 122.76 44.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 178.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 744' ' ' ALA . . . . . 0.574 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -82.77 98.6 9.19 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 167.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 745' ' ' LEU . . . . . 0.726 HD11 ' HB3' ' A' ' 778' ' ' TYR . 1.8 mt -77.53 157.69 30.26 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.262 -1.335 . . . . 0.0 111.471 -170.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 22.2 ttmm -112.56 155.48 24.28 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.284 -176.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 747' ' ' GLY . . . . . 0.441 ' HA3' ' HB3' ' A' ' 721' ' ' PRO . . . 100.19 120.43 4.52 Favored Glycine 0 C--N 1.305 -1.161 0 CA-C-N 115.131 -0.941 . . . . 0.0 111.62 -175.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 20.2 mm-40 -100.34 106.35 17.95 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.003 -174.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 136.14 -174.52 21.4 Favored Glycine 0 N--CA 1.448 -0.546 0 N-CA-C 111.64 -0.584 . . . . 0.0 111.64 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -68.47 94.41 0.43 Allowed 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 122.642 2.228 . . . . 0.0 111.983 178.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 751' ' ' PHE . . . . . 0.564 ' CE2' ' HA ' ' A' ' 800' ' ' ASP . 73.8 m-85 -113.35 136.53 52.67 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.391 -179.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 752' ' ' THR . . . . . 0.807 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 59.8 m -90.44 102.46 15.19 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 121.961 0.886 . . . . 0.0 109.287 178.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 753' ' ' LEU . . . . . 0.419 HD22 HD22 ' A' ' 745' ' ' LEU . 16.4 tp -89.0 131.71 35.06 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 113.803 -1.544 . . . . 0.0 110.48 -170.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 754' ' ' THR . . . . . 0.449 HG23 ' HB2' ' A' ' 769' ' ' GLU . 1.2 m -131.61 132.89 44.41 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.17 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 755' ' ' TYR . . . . . 0.452 ' CE1' ' HB3' ' A' ' 768' ' ' PHE . 22.4 p90 -141.52 153.93 45.18 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.072 0.463 . . . . 0.0 111.758 179.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 756' ' ' ASP . . . . . 0.44 ' CG ' ' HD2' ' A' ' 765' ' ' ARG . 5.5 m-20 -115.13 119.63 37.07 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.451 -179.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 757' ' ' ILE . . . . . 0.401 HG12 HG22 ' A' ' 782' ' ' THR . 4.8 mp -90.88 95.56 5.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 168.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 758' ' ' ILE . . . . . 0.673 HG22 ' HD3' ' A' ' 765' ' ' ARG . 2.2 pp -90.21 140.06 16.54 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-O 121.413 0.625 . . . . 0.0 111.188 -170.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -92.73 98.72 11.59 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.724 -174.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 760' ' ' THR . . . . . 0.402 HG22 ' H ' ' A' ' 760' ' ' THR . 1.4 t -87.83 -10.92 49.38 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.663 -172.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 761' ' ' PHE . . . . . 0.639 ' HB2' ' H ' ' A' ' 790' ' ' ASP . 51.6 t80 -65.18 -34.67 78.94 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.276 175.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 762' ' ' SER . . . . . . . . . . . . . 34.4 p -126.06 -102.09 0.36 Allowed 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.798 178.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 763' ' ' SER . . . . . . . . . . . . . 19.3 m -156.24 15.44 0.33 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.027 0.441 . . . . 0.0 110.525 178.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 764' ' ' LYS . . . . . . . . . . . . . 47.8 mtpt -90.66 -179.05 5.45 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.055 -176.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 765' ' ' ARG . . . . . 0.673 ' HD3' HG22 ' A' ' 758' ' ' ILE . 16.7 ttp180 -166.8 144.53 4.99 Favored 'General case' 0 N--CA 1.445 -0.715 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.155 -179.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 766' ' ' LYS . . . . . 0.587 ' HD3' ' N ' ' A' ' 767' ' ' THR . 10.3 tmtt? -120.89 146.5 46.54 Favored 'General case' 0 C--O 1.218 -0.579 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -179.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 767' ' ' THR . . . . . 0.587 ' N ' ' HD3' ' A' ' 766' ' ' LYS . 31.1 m -123.67 143.24 50.38 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 116.725 -0.216 . . . . 0.0 111.13 -176.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 768' ' ' PHE . . . . . 0.452 ' HB3' ' CE1' ' A' ' 755' ' ' TYR . 4.5 t80 -142.34 137.32 30.46 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-O 120.995 0.426 . . . . 0.0 110.485 172.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 769' ' ' GLU . . . . . 0.449 ' HB2' HG23 ' A' ' 754' ' ' THR . 26.5 tt0 -128.33 123.67 34.55 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.951 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 770' ' ' ILE . . . . . 0.485 HG22 HG22 ' A' ' 773' ' ' ILE . 7.4 mt -116.56 112.69 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 771' ' ' LYS . . . . . 0.594 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 4.1 mtpt -84.61 150.39 25.21 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.31 0.576 . . . . 0.0 111.777 -173.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 772' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 51.69 52.89 13.67 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.315 -1.311 . . . . 0.0 111.943 178.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 773' ' ' ILE . . . . . 0.687 HD12 ' H ' ' A' ' 775' ' ' THR . 0.5 OUTLIER -76.81 117.82 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 173.437 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 73.3 mttt -116.29 30.62 7.23 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -178.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 775' ' ' THR . . . . . 0.687 ' H ' HD12 ' A' ' 773' ' ' ILE . 1.6 m -96.62 -72.25 0.64 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 113.76 -1.563 . . . . 0.0 112.215 -171.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 776' ' ' ASN . . . . . 0.426 ' HB2' ' O ' ' A' ' 775' ' ' THR . 11.7 m120 85.43 6.37 0.45 Allowed 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 124.349 1.06 . . . . 0.0 110.238 178.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 777' ' ' GLU . . . . . 0.574 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 2.3 tm-20 -162.1 93.46 0.88 Allowed 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 114.374 -1.285 . . . . 0.0 107.702 176.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 778' ' ' TYR . . . . . 0.726 ' HB3' HD11 ' A' ' 745' ' ' LEU . 52.8 t80 -144.57 128.68 17.62 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.666 -169.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 779' ' ' VAL . . . . . 0.81 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 1.3 m -94.52 129.09 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.082 0 C-N-CA 118.861 -1.136 . . . . 0.0 110.506 179.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 780' ' ' ILE . . . . . 0.421 ' O ' ' HA ' ' A' ' 740' ' ' SER . 83.0 mt -89.43 142.94 12.18 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-N 114.072 -1.422 . . . . 0.0 110.828 -174.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -118.38 107.52 13.95 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.942 178.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 782' ' ' THR . . . . . 0.457 ' HA ' ' HD3' ' A' ' 783' ' ' PRO . 25.1 p -76.91 141.13 67.61 Favored Pre-proline 0 C--N 1.315 -0.902 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.376 -177.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 783' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 782' ' ' THR . 50.2 Cg_exo -55.07 161.4 6.7 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.719 2.946 . . . . 0.0 112.837 -174.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 784' ' ' VAL . . . . . 0.509 HG22 HG23 ' A' ' 786' ' ' THR . 7.4 p -58.83 131.46 23.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.107 -178.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 785' ' ' PHE . . . . . 0.409 ' C ' ' H ' ' A' ' 787' ' ' THR . 32.0 m-85 -112.14 88.59 2.85 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.716 177.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 786' ' ' THR . . . . . 0.509 HG23 HG22 ' A' ' 784' ' ' VAL . 44.8 p -82.23 31.71 0.39 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.796 0.808 . . . . 0.0 110.918 -178.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 787' ' ' THR . . . . . 0.409 ' H ' ' C ' ' A' ' 785' ' ' PHE . 12.4 m -157.38 107.46 2.22 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.282 -179.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 788' ' ' GLY . . . . . 0.723 ' HA2' HG12 ' A' ' 817' ' ' VAL . . . -45.66 124.39 6.9 Favored Glycine 0 C--N 1.334 0.471 0 CA-C-N 116.174 -0.466 . . . . 0.0 113.243 174.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 789' ' ' GLY . . . . . 0.557 ' H ' ' HB ' ' A' ' 817' ' ' VAL . . . -165.88 -151.24 6.62 Favored Glycine 0 N--CA 1.443 -0.861 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 179.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 790' ' ' ASP . . . . . 0.639 ' H ' ' HB2' ' A' ' 761' ' ' PHE . 6.4 t70 -147.15 133.43 19.5 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -178.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 791' ' ' TYR . . . . . 0.421 ' HB2' ' HB ' ' A' ' 815' ' ' ILE . 41.8 m-85 -132.73 154.66 49.99 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.777 -174.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 792' ' ' ILE . . . . . 0.437 ' CG1' ' HG3' ' A' ' 814' ' ' LYS . 12.6 mt -131.2 116.79 34.35 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 176.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 793' ' ' LEU . . . . . 0.636 HD13 HG11 ' A' ' 741' ' ' VAL . 10.1 tt -84.72 107.29 16.84 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 178.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 794' ' ' SER . . . . . . . . . . . . . 19.3 m -114.18 164.96 13.17 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.319 179.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 795' ' ' LEU . . . . . . . . . . . . . 48.9 mt -94.89 132.61 39.52 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 120.71 0.29 . . . . 0.0 110.905 -175.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 796' ' ' VAL . . . . . . . . . . . . . 85.4 t -88.95 -56.99 4.58 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.386 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.705 -178.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 797' ' ' SER . . . . . 0.515 ' HA ' HD13 ' A' ' 808' ' ' LEU . 7.1 m 178.46 177.26 0.45 Allowed 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.013 0.821 . . . . 0.0 109.583 -175.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 798' ' ' ILE . . . . . 0.523 ' O ' ' HA ' ' A' ' 805' ' ' VAL . 11.4 tt -146.31 164.67 9.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 177.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 799' ' ' LYS . . . . . 0.807 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 7.4 tttm -135.08 120.02 18.58 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.045 0.45 . . . . 0.0 111.142 -176.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 800' ' ' ASP . . . . . 0.564 ' HA ' ' CE2' ' A' ' 751' ' ' PHE . 19.3 t70 -63.65 159.36 19.18 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.877 176.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 24.9 t -61.19 -20.91 63.3 Favored 'General case' 0 N--CA 1.453 -0.307 0 O-C-N 123.902 0.751 . . . . 0.0 111.422 -175.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 39.7 p -83.8 -5.29 59.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.698 0.761 . . . . 0.0 109.676 178.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 803' ' ' GLY . . . . . . . . . . . . . . . 87.88 43.86 5.59 Favored Glycine 0 N--CA 1.439 -1.14 0 CA-C-N 114.435 -1.257 . . . . 0.0 111.258 -177.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 804' ' ' CYS . . . . . 0.528 ' HB3' ' HB3' ' A' ' 800' ' ' ASP . 30.6 t -107.99 108.69 19.92 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 -179.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 805' ' ' VAL . . . . . 0.523 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 4.8 t -85.75 110.53 19.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 121.178 0.514 . . . . 0.0 110.616 -175.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 806' ' ' VAL . . . . . 0.418 HG21 ' HD2' ' A' ' 721' ' ' PRO . 94.1 t -94.69 141.12 15.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.233 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -80.89 109.83 3.03 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.146 178.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 808' ' ' LEU . . . . . 0.515 HD13 ' HA ' ' A' ' 797' ' ' SER . 10.5 mp -73.61 126.85 31.21 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 178.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 20.5 m -141.59 85.7 1.96 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.171 170.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 810' ' ' GLN . . . . . 0.488 ' HB3' ' HD2' ' A' ' 811' ' ' PRO . 11.0 mt-30 -145.56 169.36 9.89 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.303 -179.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 811' ' ' PRO . . . . . 0.488 ' HD2' ' HB3' ' A' ' 810' ' ' GLN . 88.1 Cg_exo -43.94 139.19 5.86 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 123.336 2.69 . . . . 0.0 115.714 -171.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -107.78 167.94 9.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 114.355 -1.293 . . . . 0.0 109.763 175.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 813' ' ' ALA . . . . . . . . . . . . . . . -127.36 151.9 48.19 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.304 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 814' ' ' LYS . . . . . 0.437 ' HG3' ' CG1' ' A' ' 792' ' ' ILE . 13.9 ttpp -113.54 127.86 56.23 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 121.709 0.766 . . . . 0.0 111.265 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 815' ' ' ILE . . . . . 0.558 ' HA ' ' HB2' ' A' ' 731' ' ' LEU . 4.3 mp -106.01 125.09 61.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 114.712 -1.131 . . . . 0.0 109.386 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 816' ' ' GLN . . . . . 0.659 ' NE2' ' HG2' ' A' ' 818' ' ' ARG . 0.8 OUTLIER -115.19 116.65 28.71 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.275 0.56 . . . . 0.0 111.027 -178.291 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 817' ' ' VAL . . . . . 0.723 HG12 ' HA2' ' A' ' 788' ' ' GLY . 58.7 t -109.94 133.22 55.97 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.882 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 818' ' ' ARG . . . . . 0.694 ' O ' ' HA ' ' A' ' 734' ' ' CYS . 85.4 mmt-85 -137.32 130.94 31.48 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.914 0.388 . . . . 0.0 110.395 175.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 819' ' ' ARG . . . . . 0.496 ' HG2' ' H ' ' A' ' 788' ' ' GLY . 18.1 mtm180 -68.1 131.61 45.73 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.822 -177.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 820' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 . . . . . 0 C--N 1.319 -0.729 0 CA-C-N 116.102 -0.499 . . . . 99.989999999999995 110.099 179.124 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 718' ' ' ARG . . . . . 0.406 ' HD2' ' N ' ' A' ' 718' ' ' ARG . 3.6 mpt_? . . . . . 0 CA--C 1.509 -0.611 0 CA-C-O 121.609 0.719 . . . . 0.0 110.598 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 719' ' ' VAL . . . . . 0.501 ' O ' ' HD3' ' A' ' 721' ' ' PRO . 3.5 m -129.53 -167.98 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 CA-C-N 114.435 -1.257 . . . . 0.0 108.618 -176.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 720' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -97.95 104.89 24.24 Favored Pre-proline 0 C--N 1.304 -1.395 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.402 174.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 721' ' ' PRO . . . . . 0.513 ' HB2' HD13 ' A' ' 798' ' ' ILE . 60.7 Cg_endo -88.6 145.16 5.71 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 122.897 2.398 . . . . 0.0 111.429 177.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 722' ' ' SER . . . . . 0.643 ' HA ' HD22 ' A' ' 808' ' ' LEU . 10.7 t -175.9 -153.04 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.82 0.343 . . . . 0.0 110.524 -175.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 723' ' ' ALA . . . . . 0.536 ' HA ' ' HA ' ' A' ' 745' ' ' LEU . . . -149.49 143.19 25.49 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.361 -0.381 . . . . 0.0 109.99 179.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 9.4 m -131.37 98.61 4.58 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 725' ' ' LEU . . . . . 0.471 ' CD2' ' HB ' ' A' ' 743' ' ' VAL . 12.7 mt -64.42 143.49 57.87 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-O 121.695 0.759 . . . . 0.0 111.557 -175.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 34.2 mtpt -96.77 -18.75 19.4 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 114.6 -1.182 . . . . 0.0 109.866 -176.276 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 727' ' ' LEU . . . . . 0.533 HD21 ' HB2' ' A' ' 731' ' ' LEU . 33.7 tp -69.66 112.67 6.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.854 175.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 31.3 t-80 -112.78 45.83 1.28 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.695 0.283 . . . . 0.0 111.573 -174.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -177.77 -177.91 0.68 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.698 -0.228 . . . . 0.0 110.643 177.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 730' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -76.42 137.6 39.83 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.194 0.521 . . . . 0.0 109.71 175.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 731' ' ' LEU . . . . . 0.556 HD23 ' HB2' ' A' ' 739' ' ' SER . 25.9 tp -100.42 113.05 25.5 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.865 -176.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 732' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt -78.29 110.8 13.63 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.047 -173.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 733' ' ' LEU . . . . . 0.634 ' HG ' ' HB3' ' A' ' 737' ' ' ASP . 8.5 mp -117.5 163.75 15.94 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.489 175.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 734' ' ' CYS . . . . . 0.538 ' HA ' ' O ' ' A' ' 818' ' ' ARG . 74.5 m -115.82 -173.85 2.42 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.826 175.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 735' ' ' LEU . . . . . 0.625 ' HB2' ' HA ' ' A' ' 819' ' ' ARG . 16.7 tp -65.92 123.71 20.54 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.794 0.33 . . . . 0.0 110.531 -177.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 79.64 13.29 82.65 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.472 -0.87 . . . . 0.0 112.312 179.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 737' ' ' ASP . . . . . 0.634 ' HB3' ' HG ' ' A' ' 733' ' ' LEU . 0.3 OUTLIER -80.72 151.99 28.59 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.03 0.443 . . . . 0.0 111.057 175.987 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 738' ' ' HIS . . . . . 0.485 ' HB2' ' O ' ' A' ' 782' ' ' THR . 38.6 p-80 -117.08 149.22 40.67 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 170.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 739' ' ' SER . . . . . 0.556 ' HB2' HD23 ' A' ' 731' ' ' LEU . 5.3 p -103.95 167.63 9.65 Favored 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 119.387 -0.925 . . . . 0.0 111.549 -169.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 740' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 780' ' ' ILE . 40.4 m -139.07 100.41 4.02 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.327 176.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 741' ' ' VAL . . . . . 0.614 HG11 HD23 ' A' ' 793' ' ' LEU . 0.9 OUTLIER -111.86 113.87 52.22 Favored Pre-proline 0 C--N 1.317 -0.831 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.873 -179.434 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 742' ' ' PRO . . . . . 0.691 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 1.0 OUTLIER -74.98 132.95 16.03 Favored 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 122.278 1.985 . . . . 0.0 111.454 -179.093 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 743' ' ' VAL . . . . . 0.514 HG21 ' HB1' ' A' ' 723' ' ' ALA . 2.0 p -130.21 120.35 48.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.405 0.622 . . . . 0.0 112.316 175.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 744' ' ' ALA . . . . . 0.643 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -80.72 95.26 6.56 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 122.098 0.951 . . . . 0.0 108.697 168.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 745' ' ' LEU . . . . . 0.603 HD11 ' HB3' ' A' ' 778' ' ' TYR . 3.0 mt -74.92 151.62 38.89 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.165 -1.38 . . . . 0.0 111.477 -170.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 19.8 ttmm -106.36 162.26 13.84 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.001 -178.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 747' ' ' GLY . . . . . . . . . . . . . . . 99.74 129.87 6.76 Favored Glycine 0 C--N 1.308 -0.975 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.458 -175.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 40.1 mm-40 -107.43 107.8 18.85 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.895 -0.322 . . . . 0.0 110.856 -174.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 125.89 -171.43 17.72 Favored Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.848 -0.691 . . . . 0.0 111.927 -179.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -70.2 95.11 0.58 Allowed 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.953 2.435 . . . . 0.0 112.177 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 751' ' ' PHE . . . . . 0.539 ' HA ' ' O ' ' A' ' 799' ' ' LYS . 76.2 m-85 -117.25 135.39 53.85 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.239 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 752' ' ' THR . . . . . 0.751 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 89.8 m -85.95 107.65 17.83 Favored 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 753' ' ' LEU . . . . . 0.497 ' HG ' HD22 ' A' ' 745' ' ' LEU . 0.6 OUTLIER -97.93 117.73 32.9 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.322 -171.944 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 754' ' ' THR . . . . . 0.447 HG23 ' HB2' ' A' ' 769' ' ' GLU . 1.0 OUTLIER -118.17 139.28 51.5 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.056 -177.002 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 755' ' ' TYR . . . . . 0.7 ' CE1' ' HB3' ' A' ' 768' ' ' PHE . 22.5 p90 -147.1 158.81 44.06 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 756' ' ' ASP . . . . . 0.467 ' HB3' HG23 ' A' ' 758' ' ' ILE . 0.4 OUTLIER -122.77 120.5 33.76 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.833 -178.262 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 757' ' ' ILE . . . . . 0.554 ' CD1' HD13 ' A' ' 793' ' ' LEU . 3.8 mp -89.3 96.51 6.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 170.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 758' ' ' ILE . . . . . 0.55 HG13 ' O ' ' A' ' 792' ' ' ILE . 2.5 pp -98.65 152.01 4.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 121.52 0.676 . . . . 0.0 112.593 -168.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 759' ' ' GLU . . . . . 0.649 ' OE2' ' HB2' ' A' ' 762' ' ' SER . 2.6 mt-10 -91.15 120.08 31.8 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.422 -179.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 760' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -96.5 -4.65 41.09 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.725 172.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 761' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -102.44 -33.65 9.46 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.196 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 762' ' ' SER . . . . . 0.649 ' HB2' ' OE2' ' A' ' 759' ' ' GLU . 32.6 m -141.19 -96.69 0.14 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -178.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 763' ' ' SER . . . . . . . . . . . . . 26.5 t -167.62 0.68 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.608 0.595 . . . . 0.0 112.608 -174.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 764' ' ' LYS . . . . . 0.537 ' HZ2' ' CD ' ' A' ' 759' ' ' GLU . 9.4 mtmp? -82.78 60.41 5.3 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.998 0.428 . . . . 0.0 111.816 -174.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 765' ' ' ARG . . . . . 0.525 ' HD2' HG22 ' A' ' 758' ' ' ILE . 68.8 mtm180 -61.42 160.33 11.14 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.907 172.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 766' ' ' LYS . . . . . 0.628 ' HD3' ' N ' ' A' ' 767' ' ' THR . 8.1 tmtt? -145.11 136.93 25.57 Favored 'General case' 0 C--O 1.216 -0.686 0 CA-C-O 120.971 0.415 . . . . 0.0 110.423 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 767' ' ' THR . . . . . 0.628 ' N ' ' HD3' ' A' ' 766' ' ' LYS . 84.8 m -114.0 128.14 56.26 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.544 -176.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 768' ' ' PHE . . . . . 0.7 ' HB3' ' CE1' ' A' ' 755' ' ' TYR . 2.9 t80 -128.62 137.24 51.57 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 769' ' ' GLU . . . . . 0.447 ' HB2' HG23 ' A' ' 754' ' ' THR . 34.7 tt0 -130.58 122.38 27.4 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.706 -175.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 770' ' ' ILE . . . . . 0.621 HG22 HG22 ' A' ' 773' ' ' ILE . 6.0 mt -117.14 111.15 33.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 177.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 771' ' ' LYS . . . . . 0.633 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 13.4 mtpt -85.03 150.2 25.05 Favored 'General case' 0 N--CA 1.441 -0.923 0 CA-C-O 121.547 0.689 . . . . 0.0 112.065 -173.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 772' ' ' GLU . . . . . 0.425 ' O ' ' HG3' ' A' ' 774' ' ' LYS . 3.6 mt-10 52.1 49.63 20.22 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 113.897 -1.501 . . . . 0.0 111.865 177.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 773' ' ' ILE . . . . . 0.718 HD12 ' H ' ' A' ' 775' ' ' THR . 0.5 OUTLIER -73.75 118.6 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 176.266 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 774' ' ' LYS . . . . . 0.425 ' HG3' ' O ' ' A' ' 772' ' ' GLU . 73.9 mttt -116.23 30.16 7.51 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 -178.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 775' ' ' THR . . . . . 0.718 ' H ' HD12 ' A' ' 773' ' ' ILE . 1.6 m -95.9 -73.25 0.6 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 113.79 -1.55 . . . . 0.0 112.238 -171.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 776' ' ' ASN . . . . . 0.472 ' HB2' ' O ' ' A' ' 775' ' ' THR . 11.6 m120 88.14 5.59 0.23 Allowed 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 124.622 1.169 . . . . 0.0 110.62 179.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 777' ' ' GLU . . . . . 0.643 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 30.7 tt0 -161.94 100.47 1.12 Allowed 'General case' 0 N--CA 1.441 -0.904 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.875 171.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 778' ' ' TYR . . . . . 0.603 ' HB3' HD11 ' A' ' 745' ' ' LEU . 81.8 t80 -141.92 129.98 22.02 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.63 -170.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 779' ' ' VAL . . . . . 0.691 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 14.4 t -89.22 114.11 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 CA-C-O 121.259 0.552 . . . . 0.0 110.094 -179.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 780' ' ' ILE . . . . . 0.472 ' O ' ' HA ' ' A' ' 740' ' ' SER . 77.7 mt -81.17 141.72 14.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.604 -178.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 781' ' ' LYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 739' ' ' SER . 0.0 OUTLIER -121.54 109.4 14.77 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 176.288 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 782' ' ' THR . . . . . 0.485 ' O ' ' HB2' ' A' ' 738' ' ' HIS . 38.7 p -79.08 143.51 61.33 Favored Pre-proline 0 C--N 1.32 -0.705 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -178.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 783' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 782' ' ' THR . 52.4 Cg_exo -53.17 158.19 7.41 Favored 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 123.546 2.83 . . . . 0.0 113.179 -177.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 784' ' ' VAL . . . . . 0.472 HG12 HG23 ' A' ' 786' ' ' THR . 53.5 t -58.93 118.69 2.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.157 -179.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 785' ' ' PHE . . . . . . . . . . . . . 24.9 m-85 -98.43 97.19 8.56 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.913 178.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 786' ' ' THR . . . . . 0.472 HG23 HG12 ' A' ' 784' ' ' VAL . 38.4 p -84.71 31.49 0.53 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.711 0.767 . . . . 0.0 111.201 -178.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 77.6 m -152.27 112.59 4.08 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.847 -1.07 . . . . 0.0 110.829 179.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 788' ' ' GLY . . . . . 0.628 ' HA2' HG12 ' A' ' 817' ' ' VAL . . . -51.57 114.13 2.84 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.648 171.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 789' ' ' GLY . . . . . 0.573 ' H ' ' HB ' ' A' ' 817' ' ' VAL . . . -158.52 -167.26 19.08 Favored Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 110.391 -1.083 . . . . 0.0 110.391 -178.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -128.3 124.75 37.3 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 117.629 0.715 . . . . 0.0 109.864 -178.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 791' ' ' TYR . . . . . 0.609 ' CE2' ' HG2' ' A' ' 759' ' ' GLU . 97.7 m-85 -120.67 149.48 42.43 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.32 -176.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 792' ' ' ILE . . . . . 0.55 ' O ' HG13 ' A' ' 758' ' ' ILE . 12.5 mt -126.88 116.46 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 171.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 793' ' ' LEU . . . . . 0.614 HD23 HG11 ' A' ' 741' ' ' VAL . 0.9 OUTLIER -84.95 113.14 21.19 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.211 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 794' ' ' SER . . . . . 0.527 ' N ' HD12 ' A' ' 793' ' ' LEU . 21.6 t -122.76 164.6 18.03 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.997 -176.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 795' ' ' LEU . . . . . 0.432 HD13 ' HB3' ' A' ' 723' ' ' ALA . 21.6 mt -94.49 134.11 37.37 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.992 -173.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 796' ' ' VAL . . . . . . . . . . . . . 67.8 t -95.51 -55.79 5.79 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.767 -176.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 797' ' ' SER . . . . . 0.583 ' HA ' ' HG ' ' A' ' 808' ' ' LEU . 87.5 p -177.33 160.22 1.65 Allowed 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.755 -174.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 798' ' ' ILE . . . . . 0.685 ' HA ' ' O ' ' A' ' 752' ' ' THR . 9.4 tt -131.35 166.95 27.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 177.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 799' ' ' LYS . . . . . 0.751 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 15.6 tttm -136.62 117.25 13.91 Favored 'General case' 0 C--N 1.322 -0.623 0 O-C-N 122.26 -0.275 . . . . 0.0 111.65 -174.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 800' ' ' ASP . . . . . 0.489 ' HB3' ' HB3' ' A' ' 804' ' ' CYS . 24.2 t70 -69.9 157.14 37.98 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 170.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 58.0 p -63.09 -8.92 8.67 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -170.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 26.6 p -89.0 -1.75 58.26 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.636 0.731 . . . . 0.0 109.875 176.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 803' ' ' GLY . . . . . . . . . . . . . . . 84.59 27.14 36.39 Favored Glycine 0 N--CA 1.439 -1.111 0 CA-C-N 114.907 -1.042 . . . . 0.0 111.028 -176.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 804' ' ' CYS . . . . . 0.489 ' HB3' ' HB3' ' A' ' 800' ' ' ASP . 46.1 t -94.43 108.94 20.84 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 -178.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 805' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 4.2 p -85.58 119.6 34.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.875 0.845 . . . . 0.0 110.626 -176.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 806' ' ' VAL . . . . . 0.464 HG11 ' HD2' ' A' ' 721' ' ' PRO . 21.4 t -102.03 135.36 39.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.106 -178.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -73.12 125.24 9.5 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.997 -177.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 808' ' ' LEU . . . . . 0.643 HD22 ' HA ' ' A' ' 722' ' ' SER . 49.3 mt -89.91 123.36 33.78 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.162 0.506 . . . . 0.0 112.225 -177.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 22.5 m -142.12 86.61 1.98 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.101 175.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 810' ' ' GLN . . . . . 0.45 ' HB3' ' HD2' ' A' ' 811' ' ' PRO . 8.1 mt-30 -144.54 173.58 4.24 Favored Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.23 175.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 811' ' ' PRO . . . . . 0.45 ' HD2' ' HB3' ' A' ' 810' ' ' GLN . 82.5 Cg_exo -45.0 140.86 6.75 Favored 'Trans proline' 0 C--N 1.358 1.05 0 C-N-CA 123.102 2.534 . . . . 0.0 114.716 -177.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -109.09 167.21 10.27 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.653 -1.158 . . . . 0.0 110.418 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 813' ' ' ALA . . . . . 0.503 ' HB1' HD23 ' A' ' 727' ' ' LEU . . . -116.25 156.82 25.92 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.687 -179.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 814' ' ' LYS . . . . . 0.456 ' HG2' HG12 ' A' ' 792' ' ' ILE . 49.2 mttp -118.76 125.04 48.74 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.121 0.486 . . . . 0.0 110.821 177.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 815' ' ' ILE . . . . . 0.538 ' HA ' ' HB3' ' A' ' 731' ' ' LEU . 5.3 mp -113.02 117.4 55.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 115.311 -0.859 . . . . 0.0 108.888 178.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 816' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -103.71 113.36 26.82 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.195 -177.243 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 817' ' ' VAL . . . . . 0.628 HG12 ' HA2' ' A' ' 788' ' ' GLY . 43.8 t -106.02 137.28 36.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 818' ' ' ARG . . . . . 0.538 ' O ' ' HA ' ' A' ' 734' ' ' CYS . 22.4 tpt180 -148.79 140.22 23.37 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -178.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 819' ' ' ARG . . . . . 0.625 ' HA ' ' HB2' ' A' ' 735' ' ' LEU . 0.0 OUTLIER -78.83 125.39 29.31 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.5 0.667 . . . . 0.0 111.557 -179.717 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 820' ' ' ASP . . . . . . . . . . . . . 10.3 p-10 . . . . . 0 C--N 1.318 -0.767 0 CA-C-N 114.691 -1.141 . . . . 99.989999999999995 110.335 179.891 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 718' ' ' ARG . . . . . . . . . . . . . 21.2 mmm180 . . . . . 0 CA--C 1.503 -0.841 0 CA-C-O 121.8 0.809 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 719' ' ' VAL . . . . . . . . . . . . . 3.2 m -139.72 -173.63 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 CA-C-N 113.986 -1.461 . . . . 0.0 109.057 -177.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 720' ' ' LYS . . . . . . . . . . . . . 56.8 mtpt -102.16 115.49 64.52 Favored Pre-proline 0 C--N 1.303 -1.427 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.17 179.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 721' ' ' PRO . . . . . 0.746 ' HD2' HG11 ' A' ' 806' ' ' VAL . 36.4 Cg_endo -83.95 137.92 7.75 Favored 'Trans proline' 0 N--CA 1.447 -1.227 0 C-N-CA 122.597 2.198 . . . . 0.0 110.601 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 32.4 p -176.25 -150.58 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.205 -167.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 723' ' ' ALA . . . . . 0.602 ' HA ' ' HA ' ' A' ' 745' ' ' LEU . . . -155.09 149.4 26.08 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 110.428 -0.212 . . . . 0.0 110.428 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 15.9 m -139.89 98.78 3.54 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 725' ' ' LEU . . . . . 0.578 ' HA ' ' HA ' ' A' ' 743' ' ' VAL . 6.2 mp -59.84 142.19 53.95 Favored 'General case' 0 N--CA 1.43 -1.466 0 CA-C-O 122.328 1.061 . . . . 0.0 112.551 -175.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 36.9 mtpt -91.41 -16.7 26.96 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 113.269 -1.787 . . . . 0.0 110.309 -176.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 727' ' ' LEU . . . . . 0.547 HD23 ' HB1' ' A' ' 813' ' ' ALA . 51.1 tp -70.24 126.93 31.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.016 178.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -119.26 29.93 7.39 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.427 0.529 . . . . 0.0 112.427 -174.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 9.7 p80 -166.94 170.78 11.81 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.73 0.3 . . . . 0.0 110.434 177.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 730' ' ' ASP . . . . . 0.527 ' HA ' ' O ' ' A' ' 814' ' ' LYS . 10.3 p-10 -79.44 138.57 37.64 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.69 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 731' ' ' LEU . . . . . 0.591 HD13 ' HB2' ' A' ' 739' ' ' SER . 35.1 mt -87.23 107.76 18.63 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.485 -177.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 732' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt -81.59 96.71 7.56 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.013 -176.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 733' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.95 163.97 14.01 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.328 0.585 . . . . 0.0 111.904 -178.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 734' ' ' CYS . . . . . 0.588 ' O ' ' HB2' ' A' ' 737' ' ' ASP . 72.5 m -105.39 -172.98 2.19 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.032 -0.986 . . . . 0.0 109.66 176.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 735' ' ' LEU . . . . . 0.576 ' HB2' ' HA ' ' A' ' 819' ' ' ARG . 13.4 tp -73.83 138.68 44.59 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.444 0.64 . . . . 0.0 112.03 -172.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 74.38 14.8 80.59 Favored Glycine 0 N--CA 1.443 -0.899 0 CA-C-N 114.756 -1.111 . . . . 0.0 111.286 -177.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 737' ' ' ASP . . . . . 0.588 ' HB2' ' O ' ' A' ' 734' ' ' CYS . 1.0 OUTLIER -89.34 147.09 24.27 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.394 0.616 . . . . 0.0 112.036 177.61 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 738' ' ' HIS . . . . . 0.643 ' HB2' ' O ' ' A' ' 782' ' ' THR . 46.5 p-80 -110.31 177.49 4.68 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 167.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 739' ' ' SER . . . . . 0.591 ' HB2' HD13 ' A' ' 731' ' ' LEU . 16.5 p -138.36 171.08 14.9 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 118.519 -1.272 . . . . 0.0 112.503 -174.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 12.4 p -133.44 110.86 10.28 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.314 -179.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 741' ' ' VAL . . . . . 0.567 HG11 HD23 ' A' ' 793' ' ' LEU . 1.5 p -119.31 113.9 35.04 Favored Pre-proline 0 C--N 1.319 -0.745 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.031 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 742' ' ' PRO . . . . . 0.669 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 2.2 Cg_endo -77.9 136.35 14.86 Favored 'Trans proline' 0 N--CA 1.449 -1.133 0 C-N-CA 122.389 2.059 . . . . 0.0 111.641 -178.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 743' ' ' VAL . . . . . 0.578 ' HA ' ' HA ' ' A' ' 725' ' ' LEU . 2.1 p -132.45 121.52 45.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.602 0.715 . . . . 0.0 112.466 177.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 744' ' ' ALA . . . . . 0.619 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -79.46 95.69 5.87 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 122.17 0.985 . . . . 0.0 108.769 168.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 745' ' ' LEU . . . . . 0.744 HD11 ' HB3' ' A' ' 778' ' ' TYR . 2.0 mt -77.68 160.18 28.65 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 114.074 -1.421 . . . . 0.0 111.137 -172.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 31.8 ttmt -116.29 167.15 11.27 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.793 -178.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 747' ' ' GLY . . . . . . . . . . . . . . . 93.78 125.0 3.99 Favored Glycine 0 C--N 1.309 -0.921 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.384 -173.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 67.0 mm-40 -100.24 114.29 27.61 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 120.877 0.37 . . . . 0.0 111.532 -175.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 119.98 -175.92 16.02 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.923 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -67.95 94.39 0.4 Allowed 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.929 2.419 . . . . 0.0 112.259 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 751' ' ' PHE . . . . . 0.415 ' HB3' HG12 ' A' ' 798' ' ' ILE . 53.7 m-85 -108.98 141.62 40.81 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.313 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 752' ' ' THR . . . . . 0.768 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 99.2 m -88.39 101.77 14.22 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 121.737 0.779 . . . . 0.0 109.645 177.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 753' ' ' LEU . . . . . . . . . . . . . 16.9 tp -90.19 125.2 35.39 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 114.409 -1.269 . . . . 0.0 110.511 -171.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 754' ' ' THR . . . . . 0.449 HG23 ' HB2' ' A' ' 769' ' ' GLU . 0.6 OUTLIER -123.48 131.24 53.58 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.159 -179.866 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 755' ' ' TYR . . . . . 0.587 ' CE1' ' HB3' ' A' ' 768' ' ' PHE . 22.3 p90 -141.39 157.34 45.31 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.801 0.334 . . . . 0.0 111.207 178.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 756' ' ' ASP . . . . . 0.463 ' HB3' HG23 ' A' ' 758' ' ' ILE . 0.5 OUTLIER -119.82 118.48 30.92 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.256 -176.386 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 757' ' ' ILE . . . . . 0.509 HG13 HD13 ' A' ' 793' ' ' LEU . 3.5 mp -87.93 95.91 5.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 168.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 758' ' ' ILE . . . . . 0.615 HG13 ' O ' ' A' ' 792' ' ' ILE . 2.3 pp -94.68 149.62 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.931 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.256 -173.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 759' ' ' GLU . . . . . 0.667 ' HB3' ' CE2' ' A' ' 791' ' ' TYR . 8.7 pt-20 -107.09 129.36 54.83 Favored 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 120.148 -0.621 . . . . 0.0 111.132 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 760' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -92.38 -5.26 52.47 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 176.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 761' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -68.36 -35.66 78.05 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.537 175.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 762' ' ' SER . . . . . 0.534 ' HB2' ' OE1' ' A' ' 759' ' ' GLU . 14.8 m -150.43 -97.87 0.07 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.06 175.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 763' ' ' SER . . . . . . . . . . . . . 62.5 m -167.15 31.01 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -174.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 764' ' ' LYS . . . . . 0.567 ' H ' ' CG ' ' A' ' 759' ' ' GLU . 66.9 mttm -105.06 73.35 1.05 Allowed 'General case' 0 C--N 1.328 -0.366 0 O-C-N 121.776 -0.578 . . . . 0.0 110.335 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 765' ' ' ARG . . . . . 0.45 ' HA ' ' HA ' ' A' ' 758' ' ' ILE . 48.7 mtm180 -63.13 142.98 58.18 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.707 177.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 766' ' ' LYS . . . . . 0.46 ' O ' ' HA ' ' A' ' 756' ' ' ASP . 0.7 OUTLIER -120.5 143.12 48.72 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 -179.887 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 767' ' ' THR . . . . . . . . . . . . . 87.6 m -119.32 130.71 55.51 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.949 -176.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 768' ' ' PHE . . . . . 0.587 ' HB3' ' CE1' ' A' ' 755' ' ' TYR . 1.8 t80 -127.09 128.67 46.61 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 174.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 769' ' ' GLU . . . . . 0.449 ' HB2' HG23 ' A' ' 754' ' ' THR . 40.0 tt0 -126.22 118.27 24.82 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.782 -175.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 9.0 mt -116.12 113.29 42.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.021 -0.536 . . . . 0.0 109.557 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 771' ' ' LYS . . . . . 0.647 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 6.1 mtpt -82.56 151.98 26.17 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-O 121.394 0.616 . . . . 0.0 111.079 -178.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 772' ' ' GLU . . . . . 0.42 ' O ' ' HG3' ' A' ' 774' ' ' LYS . 8.0 mt-10 57.75 46.92 16.38 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.169 -1.378 . . . . 0.0 112.28 176.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 773' ' ' ILE . . . . . 0.637 HD12 ' H ' ' A' ' 775' ' ' THR . 0.5 OUTLIER -73.85 119.46 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 172.969 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 774' ' ' LYS . . . . . 0.42 ' HG3' ' O ' ' A' ' 772' ' ' GLU . 74.0 mttt -118.21 30.53 7.18 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -177.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 775' ' ' THR . . . . . 0.637 ' H ' HD12 ' A' ' 773' ' ' ILE . 0.2 OUTLIER -96.06 -73.57 0.59 Allowed 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 113.988 -1.46 . . . . 0.0 112.498 -171.43 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 776' ' ' ASN . . . . . 0.439 ' HB2' ' O ' ' A' ' 775' ' ' THR . 11.7 m120 83.48 4.3 0.86 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.504 1.121 . . . . 0.0 110.431 -176.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 777' ' ' GLU . . . . . 0.619 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 22.5 mt-10 -161.56 88.41 0.71 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.998 -1.001 . . . . 0.0 108.643 173.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 778' ' ' TYR . . . . . 0.744 ' HB3' HD11 ' A' ' 745' ' ' LEU . 50.2 t80 -130.88 132.41 45.13 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.644 -169.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 779' ' ' VAL . . . . . 0.669 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 20.1 t -87.07 113.78 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.678 0 CA-C-O 121.209 0.528 . . . . 0.0 110.396 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 780' ' ' ILE . . . . . . . . . . . . . 66.0 mt -82.79 143.41 12.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.577 -178.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.73 110.55 17.97 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 176.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 782' ' ' THR . . . . . 0.643 ' O ' ' HB2' ' A' ' 738' ' ' HIS . 29.8 p -77.56 142.07 66.02 Favored Pre-proline 0 C--N 1.317 -0.834 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 783' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 782' ' ' THR . 38.0 Cg_exo -57.46 166.02 5.2 Favored 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 123.364 2.709 . . . . 0.0 112.229 -179.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 784' ' ' VAL . . . . . . . . . . . . . 14.1 p -67.53 135.26 28.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.291 0.567 . . . . 0.0 111.065 -175.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 785' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -104.77 103.64 13.29 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.539 178.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 82.3 p -86.21 18.54 3.09 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.463 -172.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 29.9 m -158.11 121.77 4.01 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.66 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 788' ' ' GLY . . . . . 0.572 ' HA2' HG12 ' A' ' 817' ' ' VAL . . . -48.85 118.22 4.77 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.888 -0.596 . . . . 0.0 112.791 171.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 789' ' ' GLY . . . . . 0.545 ' H ' ' HB ' ' A' ' 817' ' ' VAL . . . -174.88 168.39 40.99 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -97.32 135.93 38.52 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 118.066 0.933 . . . . 0.0 110.692 -178.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 791' ' ' TYR . . . . . 0.667 ' CE2' ' HB3' ' A' ' 759' ' ' GLU . 70.3 m-85 -123.18 150.21 43.63 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.671 176.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 792' ' ' ILE . . . . . 0.615 ' O ' HG13 ' A' ' 758' ' ' ILE . 11.3 mt -128.7 110.38 21.0 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 177.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 793' ' ' LEU . . . . . 0.567 HD23 HG11 ' A' ' 741' ' ' VAL . 1.1 tp -84.2 111.75 19.65 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 794' ' ' SER . . . . . 0.517 ' N ' HD12 ' A' ' 793' ' ' LEU . 40.5 t -122.48 161.07 24.26 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.322 -1.308 . . . . 0.0 108.875 -175.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 795' ' ' LEU . . . . . . . . . . . . . 39.9 mt -88.71 142.67 27.48 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.658 -0.247 . . . . 0.0 110.738 -176.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 796' ' ' VAL . . . . . . . . . . . . . 73.4 t -102.73 -55.18 6.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.186 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 797' ' ' SER . . . . . 0.511 ' HA ' HD13 ' A' ' 808' ' ' LEU . 7.4 t -178.03 177.78 1.0 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.475 -173.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 798' ' ' ILE . . . . . 0.634 ' HA ' ' O ' ' A' ' 752' ' ' THR . 9.2 tt -150.15 163.12 3.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 799' ' ' LYS . . . . . 0.768 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 9.6 tmtt? -138.71 119.53 14.22 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 120.895 0.379 . . . . 0.0 111.0 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 800' ' ' ASP . . . . . 0.595 ' HB3' ' HB3' ' A' ' 804' ' ' CYS . 14.1 t70 -64.12 155.72 30.62 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.729 174.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 3.5 m -60.01 -17.22 37.15 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 124.071 0.857 . . . . 0.0 112.596 -173.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 802' ' ' THR . . . . . 0.423 HG22 ' OD1' ' A' ' 800' ' ' ASP . 13.0 t -89.86 -0.55 57.63 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 121.836 0.827 . . . . 0.0 109.636 177.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 803' ' ' GLY . . . . . 0.454 ' HA2' ' HE2' ' A' ' 799' ' ' LYS . . . 86.68 38.23 8.24 Favored Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.846 -178.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 804' ' ' CYS . . . . . 0.595 ' HB3' ' HB3' ' A' ' 800' ' ' ASP . 46.5 t -99.73 105.15 16.92 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 805' ' ' VAL . . . . . . . . . . . . . 5.9 t -85.51 122.87 38.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.246 0.546 . . . . 0.0 110.143 -176.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 806' ' ' VAL . . . . . 0.746 HG11 ' HD2' ' A' ' 721' ' ' PRO . 32.4 t -114.43 136.99 49.23 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.154 -0.93 . . . . 0.0 110.552 -174.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -81.89 110.31 3.16 Favored Glycine 0 C--N 1.322 -0.207 0 C-N-CA 120.76 -0.733 . . . . 0.0 113.279 -176.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 808' ' ' LEU . . . . . 0.511 HD13 ' HA ' ' A' ' 797' ' ' SER . 10.9 mp -81.36 123.58 28.66 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 178.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 9.7 t -141.91 86.78 2.0 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 168.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 810' ' ' GLN . . . . . 0.459 ' HB3' ' O ' ' A' ' 723' ' ' ALA . 0.9 OUTLIER -146.07 176.07 2.4 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.879 -171.238 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 811' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_exo -41.61 142.91 1.11 Allowed 'Trans proline' 0 C--N 1.362 1.258 0 C-N-CA 123.559 2.839 . . . . 0.0 115.495 -171.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -125.37 167.57 14.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.348 -1.296 . . . . 0.0 110.577 -176.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 813' ' ' ALA . . . . . 0.547 ' HB1' HD23 ' A' ' 727' ' ' LEU . . . -122.31 158.56 29.29 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.714 178.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 814' ' ' LYS . . . . . 0.527 ' O ' ' HA ' ' A' ' 730' ' ' ASP . 21.5 ttpp -123.55 111.42 16.25 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.381 0.61 . . . . 0.0 110.521 175.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 815' ' ' ILE . . . . . 0.53 ' HA ' ' HB2' ' A' ' 731' ' ' LEU . 5.4 mp -92.54 113.67 28.07 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 115.364 -0.834 . . . . 0.0 108.837 177.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 816' ' ' GLN . . . . . 0.53 HE22 ' HB2' ' A' ' 818' ' ' ARG . 1.1 tm0? -99.55 108.38 20.78 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.258 0.551 . . . . 0.0 110.119 -177.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 817' ' ' VAL . . . . . 0.572 HG12 ' HA2' ' A' ' 788' ' ' GLY . 42.0 t -99.08 143.66 13.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.81 -179.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 818' ' ' ARG . . . . . 0.53 ' HB2' HE22 ' A' ' 816' ' ' GLN . 30.1 tpt180 -142.12 175.6 9.62 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 819' ' ' ARG . . . . . 0.576 ' HA ' ' HB2' ' A' ' 735' ' ' LEU . 10.8 mmm180 -71.77 155.64 40.22 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 110.117 -0.327 . . . . 0.0 110.117 172.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 820' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 . . . . . 0 C--N 1.323 -0.565 0 N-CA-C 109.577 -0.527 . . . . 99.989999999999995 109.577 177.948 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 718' ' ' ARG . . . . . . . . . . . . . 23.8 mmm180 . . . . . 0 CA--C 1.499 -1.004 0 CA-C-O 122.0 0.905 . . . . 0.0 111.039 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 719' ' ' VAL . . . . . 0.515 ' O ' ' HD3' ' A' ' 721' ' ' PRO . 2.3 m -142.55 157.61 18.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-N 113.45 -1.705 . . . . 0.0 109.816 -175.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 720' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -96.11 97.08 2.81 Favored Pre-proline 0 C--N 1.306 -1.315 0 CA-C-N 115.154 -0.93 . . . . 0.0 108.609 173.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 721' ' ' PRO . . . . . 0.515 ' HD3' ' O ' ' A' ' 719' ' ' VAL . 59.5 Cg_endo -84.79 146.65 10.55 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 122.106 1.871 . . . . 0.0 112.042 -172.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 722' ' ' SER . . . . . 0.542 ' HA ' HD22 ' A' ' 808' ' ' LEU . 22.7 t -177.39 -157.29 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.597 -171.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 723' ' ' ALA . . . . . 0.643 ' HB1' HG21 ' A' ' 743' ' ' VAL . . . -148.97 142.07 24.91 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 176.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 724' ' ' SER . . . . . 0.436 ' HB2' ' OE1' ' A' ' 810' ' ' GLN . 23.0 t -130.98 105.04 7.48 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -178.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 725' ' ' LEU . . . . . 0.495 ' CD2' ' HB ' ' A' ' 743' ' ' VAL . 14.0 mt -65.31 149.17 50.42 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-O 121.854 0.835 . . . . 0.0 112.31 -173.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 726' ' ' LYS . . . . . 0.403 ' HB2' ' HB2' ' A' ' 742' ' ' PRO . 40.0 mtpt -100.32 -17.05 17.46 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 114.072 -1.422 . . . . 0.0 109.547 -177.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 727' ' ' LEU . . . . . 0.58 HD23 ' HB1' ' A' ' 813' ' ' ALA . 23.6 tp -66.13 117.24 8.16 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.845 177.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 9.8 t-80 -111.85 33.34 4.85 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -170.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -172.62 168.73 5.2 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.543 0.211 . . . . 0.0 110.546 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 730' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -73.25 126.63 30.53 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.479 0.657 . . . . 0.0 110.042 176.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 731' ' ' LEU . . . . . 0.682 HD23 ' HB2' ' A' ' 739' ' ' SER . 16.2 tp -85.94 101.29 12.76 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.01 -0.995 . . . . 0.0 111.473 -173.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 732' ' ' LYS . . . . . . . . . . . . . 28.4 mmmt -77.72 115.79 17.75 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.876 -177.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 733' ' ' LEU . . . . . 0.568 HD21 ' HG ' ' A' ' 731' ' ' LEU . 23.9 mt -118.77 165.41 14.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.414 -178.036 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 734' ' ' CYS . . . . . . . . . . . . . 69.4 m -106.18 -176.79 3.18 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.413 174.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 735' ' ' LEU . . . . . 0.511 HD23 ' N ' ' A' ' 736' ' ' GLY . 2.4 tt -63.75 130.49 44.42 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.425 -175.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 736' ' ' GLY . . . . . 0.511 ' N ' HD23 ' A' ' 735' ' ' LEU . . . 72.05 15.76 76.53 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.212 175.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 737' ' ' ASP . . . . . 0.499 ' HB3' ' HB3' ' A' ' 733' ' ' LEU . 20.6 t0 -80.59 161.4 24.75 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.18 0.514 . . . . 0.0 110.102 178.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 50.3 p-80 -120.72 153.18 37.3 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 173.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 739' ' ' SER . . . . . 0.682 ' HB2' HD23 ' A' ' 731' ' ' LEU . 1.4 p -101.56 160.64 14.27 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 118.954 -1.099 . . . . 0.0 111.383 -171.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 740' ' ' SER . . . . . 0.431 ' H ' HD21 ' A' ' 731' ' ' LEU . 39.3 t -132.73 100.41 4.92 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.703 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 741' ' ' VAL . . . . . 0.588 HG11 HD13 ' A' ' 793' ' ' LEU . 1.3 p -120.05 108.59 38.32 Favored Pre-proline 0 C--N 1.316 -0.883 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.884 -177.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 742' ' ' PRO . . . . . 0.687 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 2.5 Cg_endo -74.36 137.26 23.03 Favored 'Trans proline' 0 N--CA 1.448 -1.179 0 C-N-CA 122.316 2.011 . . . . 0.0 110.895 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 743' ' ' VAL . . . . . 0.643 HG21 ' HB1' ' A' ' 723' ' ' ALA . 1.6 p -135.64 120.38 27.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.49 0.662 . . . . 0.0 112.267 177.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 744' ' ' ALA . . . . . 0.49 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -83.4 100.91 10.99 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 168.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 745' ' ' LEU . . . . . 0.917 HD13 HD13 ' A' ' 773' ' ' ILE . 0.2 OUTLIER -82.47 168.64 17.23 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 113.936 -1.483 . . . . 0.0 111.073 -167.222 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -123.39 146.19 48.17 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.675 -175.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 747' ' ' GLY . . . . . . . . . . . . . . . 101.86 123.38 5.21 Favored Glycine 0 C--N 1.312 -0.782 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.869 -178.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -103.6 120.81 41.63 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.793 0.33 . . . . 0.0 110.851 -174.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 127.31 179.83 16.01 Favored Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.74 -178.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -70.56 93.53 0.59 Allowed 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.339 2.026 . . . . 0.0 111.936 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 751' ' ' PHE . . . . . 0.503 ' CE2' ' HA ' ' A' ' 800' ' ' ASP . 82.9 m-85 -112.19 142.09 45.08 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.901 179.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 752' ' ' THR . . . . . 0.733 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 85.0 m -92.18 106.01 18.11 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 177.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 753' ' ' LEU . . . . . 0.504 ' CD2' HD22 ' A' ' 745' ' ' LEU . 59.2 tp -94.6 114.69 26.69 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.924 -172.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 754' ' ' THR . . . . . 0.491 HG23 ' HB2' ' A' ' 769' ' ' GLU . 1.5 m -113.92 134.59 54.72 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.683 179.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 755' ' ' TYR . . . . . 0.636 ' CE1' ' HB3' ' A' ' 768' ' ' PHE . 25.6 p90 -143.2 156.79 44.84 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.088 0.471 . . . . 0.0 111.177 178.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 756' ' ' ASP . . . . . 0.541 ' HB2' HG23 ' A' ' 758' ' ' ILE . 2.2 p30 -106.41 125.76 51.41 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.211 -178.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 757' ' ' ILE . . . . . 0.446 ' HB ' ' HB3' ' A' ' 766' ' ' LYS . 3.5 mp -94.47 93.23 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 163.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 758' ' ' ILE . . . . . 0.552 HG22 ' HD3' ' A' ' 765' ' ' ARG . 2.3 pp -95.12 143.46 11.81 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-O 121.12 0.486 . . . . 0.0 111.6 -170.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 759' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -91.16 101.46 14.19 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.226 -176.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 760' ' ' THR . . . . . 0.462 HG23 ' CB ' ' A' ' 790' ' ' ASP . 0.5 OUTLIER -84.42 -7.28 59.34 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 121.869 0.842 . . . . 0.0 108.939 -178.872 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 761' ' ' PHE . . . . . 0.571 ' HB2' ' H ' ' A' ' 790' ' ' ASP . 67.4 t80 -62.86 -34.05 76.55 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.805 174.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 762' ' ' SER . . . . . . . . . . . . . 16.1 p -140.0 -93.17 0.16 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.383 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 763' ' ' SER . . . . . . . . . . . . . 18.8 p -161.68 14.99 0.09 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.891 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 764' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -88.68 174.96 7.73 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.557 -178.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 765' ' ' ARG . . . . . 0.552 ' HD3' HG22 ' A' ' 758' ' ' ILE . 21.6 ttp180 -162.05 144.31 11.33 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-O 121.004 0.431 . . . . 0.0 111.001 -175.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 766' ' ' LYS . . . . . 0.667 ' HD3' ' N ' ' A' ' 767' ' ' THR . 8.4 tmtm? -118.2 146.36 44.29 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 175.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 767' ' ' THR . . . . . 0.667 ' N ' ' HD3' ' A' ' 766' ' ' LYS . 32.3 m -124.41 125.19 43.88 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 110.048 -0.352 . . . . 0.0 110.048 178.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 768' ' ' PHE . . . . . 0.636 ' HB3' ' CE1' ' A' ' 755' ' ' TYR . 3.4 t80 -122.5 137.73 54.79 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 769' ' ' GLU . . . . . 0.491 ' HB2' HG23 ' A' ' 754' ' ' THR . 38.3 tt0 -133.23 130.37 38.96 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.397 -175.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 770' ' ' ILE . . . . . 0.579 HG22 HG22 ' A' ' 773' ' ' ILE . 3.7 mt -121.91 110.61 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.638 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 177.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 771' ' ' LYS . . . . . 0.626 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 11.4 mtpt -83.87 150.79 25.5 Favored 'General case' 0 N--CA 1.436 -1.175 0 CA-C-O 121.243 0.544 . . . . 0.0 110.889 -175.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 772' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 55.53 50.82 13.78 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.39 -1.277 . . . . 0.0 111.998 177.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 773' ' ' ILE . . . . . 0.917 HD13 HD13 ' A' ' 745' ' ' LEU . 0.5 OUTLIER -77.86 116.88 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 173.377 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 70.0 mttt -117.61 29.5 7.82 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -177.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 775' ' ' THR . . . . . 0.7 ' H ' HD12 ' A' ' 773' ' ' ILE . 1.8 m -97.2 -72.58 0.64 Allowed 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 114.748 -1.115 . . . . 0.0 112.868 -172.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 776' ' ' ASN . . . . . 0.62 ' HB2' ' O ' ' A' ' 775' ' ' THR . 0.9 OUTLIER 87.26 6.18 0.27 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.512 1.125 . . . . 0.0 109.915 -178.074 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 777' ' ' GLU . . . . . 0.49 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 1.4 tm-20 -161.91 86.16 0.63 Allowed 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 114.846 -1.07 . . . . 0.0 108.333 179.001 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 778' ' ' TYR . . . . . 0.812 ' HB3' HD11 ' A' ' 745' ' ' LEU . 87.3 t80 -137.28 134.36 36.03 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.686 -170.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 779' ' ' VAL . . . . . 0.687 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 23.5 t -89.94 117.96 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 CA-C-O 121.022 0.439 . . . . 0.0 110.529 177.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 780' ' ' ILE . . . . . 0.418 ' HB ' HG13 ' A' ' 741' ' ' VAL . 68.3 mt -88.47 143.26 11.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.782 -178.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 781' ' ' LYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 739' ' ' SER . 3.8 mppt? -124.21 109.39 13.36 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 175.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 782' ' ' THR . . . . . . . . . . . . . 42.9 p -78.06 144.92 68.45 Favored Pre-proline 0 C--N 1.321 -0.653 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -177.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 783' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -51.32 158.33 3.82 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 123.465 2.777 . . . . 0.0 113.193 -178.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 784' ' ' VAL . . . . . 0.508 HG12 HG23 ' A' ' 786' ' ' THR . 53.4 t -58.81 126.71 16.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.066 -0.97 . . . . 0.0 112.208 -176.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 785' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -103.85 98.2 8.08 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.883 176.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 786' ' ' THR . . . . . 0.508 HG23 HG12 ' A' ' 784' ' ' VAL . 37.1 p -87.22 32.48 0.69 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.704 0.764 . . . . 0.0 110.989 -178.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.45 110.97 3.51 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.533 -1.212 . . . . 0.0 110.59 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 788' ' ' GLY . . . . . . . . . . . . . . . -53.1 112.62 2.35 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.623 -0.799 . . . . 0.0 112.253 171.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 789' ' ' GLY . . . . . 0.485 ' H ' ' HB ' ' A' ' 817' ' ' VAL . . . -154.5 -151.55 5.84 Favored Glycine 0 N--CA 1.443 -0.893 0 N-CA-C 110.806 -0.917 . . . . 0.0 110.806 -178.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 790' ' ' ASP . . . . . 0.571 ' H ' ' HB2' ' A' ' 761' ' ' PHE . 4.3 m-20 -137.57 124.01 20.77 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 791' ' ' TYR . . . . . 0.488 ' HA ' ' O ' ' A' ' 758' ' ' ILE . 80.9 m-85 -124.64 152.91 43.05 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.294 -0.412 . . . . 0.0 109.99 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 792' ' ' ILE . . . . . 0.48 ' O ' HG13 ' A' ' 758' ' ' ILE . 14.4 mt -133.39 122.84 45.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 171.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 793' ' ' LEU . . . . . 0.588 HD13 HG11 ' A' ' 741' ' ' VAL . 10.4 tt -87.71 108.01 18.91 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 794' ' ' SER . . . . . 0.449 ' HB3' ' OD2' ' A' ' 756' ' ' ASP . 31.3 t -121.54 146.06 47.33 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.166 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 795' ' ' LEU . . . . . 0.515 ' H ' HD22 ' A' ' 795' ' ' LEU . 1.4 mm? -72.98 135.15 44.94 Favored 'General case' 0 N--CA 1.448 -0.569 0 O-C-N 122.062 -0.399 . . . . 0.0 111.481 -179.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 796' ' ' VAL . . . . . . . . . . . . . 66.7 t -95.91 -57.46 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.207 -177.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 797' ' ' SER . . . . . 0.588 ' HA ' ' HG ' ' A' ' 808' ' ' LEU . 35.7 m -171.38 157.02 4.77 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.719 -173.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 798' ' ' ILE . . . . . 0.558 ' HA ' ' O ' ' A' ' 752' ' ' THR . 13.2 tt -132.22 162.07 40.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 177.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 799' ' ' LYS . . . . . 0.733 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 22.1 tttt -129.83 118.19 21.37 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 120.967 0.413 . . . . 0.0 110.993 -174.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 800' ' ' ASP . . . . . 0.507 ' HB3' ' HB2' ' A' ' 804' ' ' CYS . 21.6 t70 -65.3 152.89 42.65 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.259 -0.882 . . . . 0.0 108.854 173.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 4.4 m -62.62 -8.56 6.71 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 123.768 0.667 . . . . 0.0 112.503 -171.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 40.1 p -96.67 5.62 50.32 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.426 0.631 . . . . 0.0 110.191 176.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 803' ' ' GLY . . . . . 0.53 ' HA2' ' HE2' ' A' ' 799' ' ' LYS . . . 77.98 42.25 16.6 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.029 -177.014 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 804' ' ' CYS . . . . . 0.507 ' HB2' ' HB3' ' A' ' 800' ' ' ASP . 69.4 m -110.24 106.87 16.45 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 176.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 805' ' ' VAL . . . . . 0.52 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 3.5 t -86.24 112.36 22.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.279 0.561 . . . . 0.0 111.071 -173.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 806' ' ' VAL . . . . . 0.452 ' HB ' HG22 ' A' ' 798' ' ' ILE . 73.4 t -90.0 135.14 27.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.152 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -73.7 120.57 6.95 Favored Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 111.601 -0.599 . . . . 0.0 111.601 178.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 808' ' ' LEU . . . . . 0.588 ' HG ' ' HA ' ' A' ' 797' ' ' SER . 45.4 mt -88.71 132.96 34.37 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -175.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 44.7 m -149.86 87.2 1.47 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.023 -0.989 . . . . 0.0 109.633 172.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 810' ' ' GLN . . . . . 0.516 HE21 ' CB ' ' A' ' 722' ' ' SER . 11.3 mt-30 -135.34 171.84 8.23 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.336 174.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 811' ' ' PRO . . . . . 0.464 ' HD2' ' HB3' ' A' ' 810' ' ' GLN . 97.0 Cg_exo -45.81 137.82 12.18 Favored 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 122.999 2.466 . . . . 0.0 114.328 -179.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -109.1 167.29 10.21 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.217 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 813' ' ' ALA . . . . . 0.58 ' HB1' HD23 ' A' ' 727' ' ' LEU . . . -126.7 141.17 51.92 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.571 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 814' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -100.24 129.56 46.26 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.143 0.497 . . . . 0.0 110.555 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 815' ' ' ILE . . . . . 0.541 ' HA ' ' HB3' ' A' ' 731' ' ' LEU . 5.3 mp -112.55 109.75 29.69 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 176.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 816' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -106.08 109.05 20.86 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.061 0.457 . . . . 0.0 109.991 -175.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 817' ' ' VAL . . . . . 0.485 ' HB ' ' H ' ' A' ' 789' ' ' GLY . 4.7 t -99.74 141.27 17.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.513 -174.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 818' ' ' ARG . . . . . . . . . . . . . 39.9 mmt180 -127.69 177.01 7.09 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 177.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 819' ' ' ARG . . . . . 0.44 ' HA ' ' HB2' ' A' ' 735' ' ' LEU . 26.1 mtm180 -118.21 130.95 56.38 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 120.951 0.405 . . . . 0.0 110.69 177.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 820' ' ' ASP . . . . . . . . . . . . . 14.2 p-10 . . . . . 0 C--N 1.322 -0.615 0 CA-C-N 115.985 -0.552 . . . . 99.989999999999995 110.399 179.861 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 718' ' ' ARG . . . . . . . . . . . . . 14.6 tpp180 . . . . . 0 CA--C 1.509 -0.62 0 CA-C-O 122.092 0.948 . . . . 0.0 110.721 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 719' ' ' VAL . . . . . . . . . . . . . 4.7 m -125.66 -171.62 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 CA-C-N 113.637 -1.619 . . . . 0.0 108.808 177.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 720' ' ' LYS . . . . . . . . . . . . . 53.8 mtpt -116.88 90.71 33.28 Favored Pre-proline 0 C--N 1.306 -1.325 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.652 178.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 721' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -86.46 140.34 6.26 Favored 'Trans proline' 0 N--CA 1.445 -1.353 0 C-N-CA 122.233 1.955 . . . . 0.0 111.204 178.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 722' ' ' SER . . . . . 0.454 ' HA ' ' CD2' ' A' ' 808' ' ' LEU . 50.2 m -167.42 -157.19 0.23 Allowed 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -172.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 723' ' ' ALA . . . . . 0.752 ' HB1' HG21 ' A' ' 743' ' ' VAL . . . -145.77 142.62 29.08 Favored 'General case' 0 N--CA 1.449 -0.521 0 O-C-N 122.093 -0.38 . . . . 0.0 110.27 175.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -129.72 100.4 5.49 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 725' ' ' LEU . . . . . 0.494 ' CD2' ' HB ' ' A' ' 743' ' ' VAL . 13.2 mt -62.65 144.09 56.65 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 121.765 0.793 . . . . 0.0 111.869 -173.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 33.4 mtpt -95.22 -18.92 20.47 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.544 -1.207 . . . . 0.0 109.366 -178.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 727' ' ' LEU . . . . . 0.544 ' HB2' ' HD2' ' A' ' 742' ' ' PRO . 0.7 OUTLIER -76.67 109.97 10.87 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 177.304 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 33.4 m80 -115.83 46.19 1.58 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.02 0.438 . . . . 0.0 110.532 -176.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -148.31 174.33 12.13 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.92 -176.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 730' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -100.5 108.78 20.82 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 175.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 731' ' ' LEU . . . . . 0.59 ' HB2' ' HA ' ' A' ' 815' ' ' ILE . 53.9 mt -72.03 100.82 2.58 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.984 -173.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 732' ' ' LYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 816' ' ' GLN . 32.2 mmtp -79.43 121.6 25.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.681 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 733' ' ' LEU . . . . . 0.721 ' HB2' ' HB ' ' A' ' 817' ' ' VAL . 25.6 mt -126.41 169.52 12.9 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.372 0.606 . . . . 0.0 111.835 -174.154 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 734' ' ' CYS . . . . . 0.467 ' HA ' ' O ' ' A' ' 818' ' ' ARG . 13.2 p -105.39 -176.97 3.23 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.107 176.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 735' ' ' LEU . . . . . 0.436 HD13 ' HD3' ' A' ' 819' ' ' ARG . 36.2 tp -71.41 122.54 20.56 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.569 -178.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 79.94 16.46 76.92 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.191 -1.004 . . . . 0.0 112.317 178.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 737' ' ' ASP . . . . . 0.568 ' HB3' ' HB3' ' A' ' 733' ' ' LEU . 25.3 t0 -86.22 157.63 19.91 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.769 0.318 . . . . 0.0 110.713 174.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 27.1 p-80 -117.16 -177.86 3.31 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 174.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 739' ' ' SER . . . . . 0.574 ' HB2' ' OG1' ' A' ' 782' ' ' THR . 29.8 m -142.22 169.43 17.6 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 119.777 -0.769 . . . . 0.0 112.894 179.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 740' ' ' SER . . . . . 0.412 ' HA ' ' O ' ' A' ' 780' ' ' ILE . 5.7 p -138.07 109.66 7.04 Favored 'General case' 0 N--CA 1.444 -0.771 0 CA-C-N 114.433 -1.258 . . . . 0.0 109.4 177.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 741' ' ' VAL . . . . . 0.592 HG11 HD13 ' A' ' 793' ' ' LEU . 0.6 OUTLIER -113.1 112.44 49.86 Favored Pre-proline 0 C--N 1.316 -0.877 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.226 -177.912 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 742' ' ' PRO . . . . . 0.649 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 4.1 Cg_endo -75.48 135.38 18.15 Favored 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 122.422 2.081 . . . . 0.0 111.652 -179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 743' ' ' VAL . . . . . 0.752 HG21 ' HB1' ' A' ' 723' ' ' ALA . 1.7 p -131.05 119.31 44.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.564 0.697 . . . . 0.0 111.981 176.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 744' ' ' ALA . . . . . 0.464 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -83.89 101.47 11.69 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 169.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 745' ' ' LEU . . . . . 0.978 HD13 HD13 ' A' ' 773' ' ' ILE . 0.3 OUTLIER -80.4 161.37 25.0 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 114.26 -1.336 . . . . 0.0 111.2 -166.752 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -110.91 146.31 36.79 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.628 179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 747' ' ' GLY . . . . . . . . . . . . . . . 98.87 122.92 4.79 Favored Glycine 0 C--N 1.305 -1.168 0 N-CA-C 110.54 -1.024 . . . . 0.0 110.54 -176.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.95 128.68 53.96 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.321 0.581 . . . . 0.0 111.811 -169.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 109.44 -178.7 20.64 Favored Glycine 0 C--O 1.22 -0.724 0 CA-C-N 114.902 -1.044 . . . . 0.0 111.044 -175.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 750' ' ' PRO . . . . . 0.525 ' HB3' ' HE2' ' A' ' 774' ' ' LYS . 73.3 Cg_endo -65.51 100.96 0.42 Allowed 'Trans proline' 0 C--O 1.235 0.363 0 C-N-CA 123.37 2.714 . . . . 0.0 113.821 -178.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 751' ' ' PHE . . . . . 0.601 ' CE2' ' HA ' ' A' ' 800' ' ' ASP . 75.6 m-85 -117.0 146.86 42.78 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.743 176.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 752' ' ' THR . . . . . 0.713 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 33.4 m -89.64 106.64 18.59 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 176.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 753' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -96.72 111.26 23.49 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.338 -172.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 754' ' ' THR . . . . . 0.487 HG23 ' HB2' ' A' ' 769' ' ' GLU . 1.6 m -108.81 137.26 47.03 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.558 -0.747 . . . . 0.0 111.269 -178.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 755' ' ' TYR . . . . . . . . . . . . . 29.9 p90 -148.16 156.89 43.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.88 0.371 . . . . 0.0 110.953 176.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 756' ' ' ASP . . . . . 0.587 ' OD2' HG21 ' A' ' 796' ' ' VAL . 0.7 OUTLIER -125.18 121.76 35.11 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.513 178.667 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 757' ' ' ILE . . . . . 0.412 ' N ' HD12 ' A' ' 757' ' ' ILE . 4.2 mp -83.72 96.59 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 172.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 758' ' ' ILE . . . . . 0.659 HG22 ' HD2' ' A' ' 765' ' ' ARG . 2.4 pp -93.92 148.25 5.0 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.248 -167.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 759' ' ' GLU . . . . . 0.669 ' OE2' ' HB3' ' A' ' 762' ' ' SER . 23.9 mt-10 -88.68 117.82 27.92 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.921 176.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 760' ' ' THR . . . . . . . . . . . . . 1.2 t -94.51 -4.18 48.53 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 121.512 0.672 . . . . 0.0 109.227 176.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 761' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -103.83 -24.09 13.33 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.781 178.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 762' ' ' SER . . . . . 0.669 ' HB3' ' OE2' ' A' ' 759' ' ' GLU . 9.2 t -137.53 -101.8 0.19 Allowed 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 119.884 -0.726 . . . . 0.0 111.302 178.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 763' ' ' SER . . . . . . . . . . . . . 69.3 m -164.57 -5.31 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -173.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 764' ' ' LYS . . . . . 0.511 ' C ' ' HG3' ' A' ' 759' ' ' GLU . 8.6 mtpm? -87.22 54.29 3.11 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.329 0.585 . . . . 0.0 112.043 -171.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 765' ' ' ARG . . . . . 0.659 ' HD2' HG22 ' A' ' 758' ' ' ILE . 19.0 ttt180 -55.21 129.77 39.58 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.8 172.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 766' ' ' LYS . . . . . 0.404 ' O ' ' HA ' ' A' ' 756' ' ' ASP . 9.7 tmtm? -106.78 140.47 39.57 Favored 'General case' 0 C--O 1.216 -0.674 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.794 -175.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 767' ' ' THR . . . . . . . . . . . . . 21.1 m -111.39 134.83 52.69 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.016 -176.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 768' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -140.46 137.89 34.26 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.01 0.433 . . . . 0.0 110.742 173.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 769' ' ' GLU . . . . . 0.487 ' HB2' HG23 ' A' ' 754' ' ' THR . 27.7 tt0 -131.86 123.17 26.97 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.558 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 770' ' ' ILE . . . . . 0.553 HG22 HG22 ' A' ' 773' ' ' ILE . 6.5 mt -114.45 112.23 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 771' ' ' LYS . . . . . 0.581 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 9.7 mtpt -85.88 154.64 21.38 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.52 -173.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 772' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 54.6 44.06 29.25 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.388 -1.278 . . . . 0.0 111.984 175.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 773' ' ' ILE . . . . . 0.978 HD13 HD13 ' A' ' 745' ' ' LEU . 0.5 OUTLIER -73.95 116.21 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 172.142 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 774' ' ' LYS . . . . . 0.525 ' HE2' ' HB3' ' A' ' 750' ' ' PRO . 58.0 mttt -111.88 26.36 10.69 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -178.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 775' ' ' THR . . . . . 0.683 ' H ' HD12 ' A' ' 773' ' ' ILE . 0.2 OUTLIER -96.22 -75.86 0.52 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 114.767 -1.106 . . . . 0.0 113.676 -166.333 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 776' ' ' ASN . . . . . 0.672 ' HB2' ' O ' ' A' ' 775' ' ' THR . 0.8 OUTLIER 89.98 2.52 0.19 Allowed 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.892 1.277 . . . . 0.0 110.565 -172.897 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 777' ' ' GLU . . . . . 0.464 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 9.4 mp0 -154.6 90.65 1.33 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 175.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 778' ' ' TYR . . . . . 0.703 ' HB3' HD11 ' A' ' 745' ' ' LEU . 81.7 t80 -132.12 128.8 38.89 Favored 'General case' 0 C--N 1.315 -0.932 0 C-N-CA 120.249 -0.58 . . . . 0.0 111.212 -172.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 779' ' ' VAL . . . . . 0.649 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 17.3 t -89.18 112.82 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-O 121.308 0.575 . . . . 0.0 110.4 178.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 780' ' ' ILE . . . . . 0.457 ' HB ' HG13 ' A' ' 741' ' ' VAL . 77.8 mt -81.29 147.05 6.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.549 -178.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -120.1 108.23 14.01 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 175.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 782' ' ' THR . . . . . 0.574 ' OG1' ' HB2' ' A' ' 739' ' ' SER . 54.6 p -77.51 141.41 65.35 Favored Pre-proline 0 C--N 1.319 -0.758 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.359 -178.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 783' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 782' ' ' THR . 52.3 Cg_exo -53.91 158.57 8.54 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 123.758 2.972 . . . . 0.0 112.515 -175.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 784' ' ' VAL . . . . . . . . . . . . . 12.9 p -65.7 128.93 29.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.33 0.586 . . . . 0.0 109.974 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 785' ' ' PHE . . . . . 0.414 ' CG ' HG11 ' A' ' 817' ' ' VAL . 89.8 m-85 -97.48 96.61 8.45 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.321 -176.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 69.8 p -84.32 18.63 2.13 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.395 0.616 . . . . 0.0 111.473 -174.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 3.0 m -155.72 124.22 5.93 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.629 177.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 788' ' ' GLY . . . . . 0.694 ' HA2' HG22 ' A' ' 817' ' ' VAL . . . -50.89 123.69 17.8 Favored Glycine 0 CA--C 1.524 0.645 0 O-C-N 123.522 0.513 . . . . 0.0 112.336 172.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 789' ' ' GLY . . . . . . . . . . . . . . . -164.03 -165.76 21.77 Favored Glycine 0 N--CA 1.442 -0.964 0 N-CA-C 110.981 -0.848 . . . . 0.0 110.981 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -133.41 124.18 26.66 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 791' ' ' TYR . . . . . 0.638 ' CE2' ' HG2' ' A' ' 759' ' ' GLU . 81.5 m-85 -124.78 148.68 48.0 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.106 0.479 . . . . 0.0 111.286 -173.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 792' ' ' ILE . . . . . 0.547 ' O ' HG13 ' A' ' 758' ' ' ILE . 13.2 mt -126.07 116.36 45.56 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.656 175.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 793' ' ' LEU . . . . . 0.592 HD13 HG11 ' A' ' 741' ' ' VAL . 9.3 tt -84.25 111.23 19.2 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 178.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 794' ' ' SER . . . . . . . . . . . . . 17.8 m -120.65 139.66 52.69 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.389 -178.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 795' ' ' LEU . . . . . 0.672 ' HG ' ' HB3' ' A' ' 723' ' ' ALA . 1.6 mm? -69.25 132.07 45.9 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.619 176.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 796' ' ' VAL . . . . . 0.587 HG21 ' OD2' ' A' ' 756' ' ' ASP . 53.4 t -97.61 -51.71 10.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-O 120.993 0.425 . . . . 0.0 111.272 -178.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 797' ' ' SER . . . . . 0.569 ' HA ' ' HG ' ' A' ' 808' ' ' LEU . 81.1 p -168.42 155.62 7.75 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.391 -172.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 798' ' ' ILE . . . . . 0.63 ' HA ' ' O ' ' A' ' 752' ' ' THR . 8.7 tt -130.15 167.2 25.88 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 177.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 799' ' ' LYS . . . . . 0.713 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 2.7 ttmp? -135.74 118.32 15.93 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.626 -176.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 800' ' ' ASP . . . . . 0.601 ' HA ' ' CE2' ' A' ' 751' ' ' PHE . 12.0 m-20 -58.88 154.91 14.15 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.805 171.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 801' ' ' SER . . . . . 0.404 ' OG ' ' HG2' ' A' ' 750' ' ' PRO . 5.8 m -62.06 -10.21 9.43 Favored 'General case' 0 C--N 1.326 -0.415 0 O-C-N 124.14 0.9 . . . . 0.0 112.505 -172.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 14.0 t -96.24 4.99 51.98 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.559 0.695 . . . . 0.0 109.636 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 803' ' ' GLY . . . . . . . . . . . . . . . 81.19 43.36 8.73 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 115.316 -0.857 . . . . 0.0 112.135 -179.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 804' ' ' CYS . . . . . 0.418 ' HB3' ' HB2' ' A' ' 800' ' ' ASP . 46.4 t -114.71 119.75 37.74 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 178.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 805' ' ' VAL . . . . . 0.535 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 3.0 t -94.22 124.79 46.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.327 0.584 . . . . 0.0 111.562 -172.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 806' ' ' VAL . . . . . . . . . . . . . 39.5 t -104.72 135.64 41.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.299 177.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -74.16 127.91 10.41 Favored Glycine 0 C--N 1.323 -0.177 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.47 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 808' ' ' LEU . . . . . 0.569 ' HG ' ' HA ' ' A' ' 797' ' ' SER . 64.2 mt -98.05 136.96 37.55 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -172.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 43.0 m -148.71 86.39 1.52 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.822 -1.081 . . . . 0.0 109.173 170.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 810' ' ' GLN . . . . . 0.428 ' HG2' ' HD2' ' A' ' 811' ' ' PRO . 0.7 OUTLIER -139.79 172.92 5.65 Favored Pre-proline 0 CA--C 1.539 0.539 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.132 179.373 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 811' ' ' PRO . . . . . 0.428 ' HD2' ' HG2' ' A' ' 810' ' ' GLN . 92.7 Cg_exo -44.4 138.77 7.21 Favored 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 123.059 2.506 . . . . 0.0 115.159 -173.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -104.47 167.46 9.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.541 -1.209 . . . . 0.0 110.327 178.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 813' ' ' ALA . . . . . . . . . . . . . . . -123.88 152.01 42.84 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.437 175.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 814' ' ' LYS . . . . . 0.531 ' HG2' HG12 ' A' ' 792' ' ' ILE . 48.8 mttp -118.18 127.7 54.0 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.718 0.771 . . . . 0.0 111.241 -178.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 815' ' ' ILE . . . . . 0.59 ' HA ' ' HB2' ' A' ' 731' ' ' LEU . 5.3 mp -116.44 107.29 22.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 114.552 -1.204 . . . . 0.0 108.797 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 816' ' ' GLN . . . . . 0.405 ' O ' ' HA ' ' A' ' 732' ' ' LYS . 0.9 OUTLIER -108.68 107.24 17.62 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.313 0.578 . . . . 0.0 110.024 -177.179 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 817' ' ' VAL . . . . . 0.721 ' HB ' ' HB2' ' A' ' 733' ' ' LEU . 1.9 m -102.21 147.46 8.87 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -178.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 818' ' ' ARG . . . . . 0.467 ' O ' ' HA ' ' A' ' 734' ' ' CYS . 16.1 tpt180 -147.07 154.76 41.55 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -172.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 819' ' ' ARG . . . . . 0.436 ' HD3' HD13 ' A' ' 735' ' ' LEU . 18.6 mmt180 -68.6 132.98 47.82 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 820' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 . . . . . 0 C--N 1.321 -0.654 0 N-CA-C 110.163 -0.31 . . . . 99.989999999999995 110.163 178.865 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 718' ' ' ARG . . . . . . . . . . . . . 7.6 mpt_? . . . . . 0 C--O 1.234 0.28 0 CA-C-O 121.63 0.729 . . . . 0.0 111.053 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 719' ' ' VAL . . . . . 0.652 ' O ' ' HD3' ' A' ' 721' ' ' PRO . 4.7 p -148.75 152.01 12.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.005 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 720' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -84.49 105.14 5.48 Favored Pre-proline 0 C--N 1.312 -1.026 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.119 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 721' ' ' PRO . . . . . 0.652 ' HD3' ' O ' ' A' ' 719' ' ' VAL . 74.1 Cg_endo -88.35 148.3 6.44 Favored 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 123.279 2.653 . . . . 0.0 111.249 177.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 722' ' ' SER . . . . . 0.727 ' HA ' HD22 ' A' ' 808' ' ' LEU . 11.6 p 179.44 -158.25 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.802 -171.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 723' ' ' ALA . . . . . 0.723 ' HB1' HG21 ' A' ' 743' ' ' VAL . . . -144.15 142.03 30.32 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 110.168 -0.308 . . . . 0.0 110.168 177.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 11.7 m -129.31 99.0 5.05 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -178.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 725' ' ' LEU . . . . . 0.496 HD22 ' HB ' ' A' ' 743' ' ' VAL . 8.3 mt -64.22 143.63 57.74 Favored 'General case' 0 N--CA 1.438 -1.027 0 CA-C-O 121.811 0.815 . . . . 0.0 112.366 -172.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 29.1 mtpt -93.67 -18.91 21.62 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.216 -1.356 . . . . 0.0 108.583 177.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 727' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -60.43 119.2 7.55 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.569 173.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -88.93 -48.26 7.57 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -170.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 8.8 p80 -136.11 -175.7 4.07 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.224 -177.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 730' ' ' ASP . . . . . 0.46 ' HA ' ' O ' ' A' ' 814' ' ' LYS . 9.1 p-10 -40.65 133.98 1.9 Allowed 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.66 0.743 . . . . 0.0 112.098 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 731' ' ' LEU . . . . . 0.574 ' HB3' ' HA ' ' A' ' 815' ' ' ILE . 22.1 tp -104.26 104.68 14.62 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.258 -177.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 732' ' ' LYS . . . . . . . . . . . . . 30.1 mmmt -74.19 112.74 10.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.481 -171.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 733' ' ' LEU . . . . . 0.619 ' HG ' ' HB3' ' A' ' 737' ' ' ASP . 9.2 mp -120.01 164.97 15.31 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.73 173.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 734' ' ' CYS . . . . . 0.451 ' HA ' ' O ' ' A' ' 818' ' ' ARG . 2.1 p -124.4 -173.62 2.82 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.486 173.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 735' ' ' LEU . . . . . 0.549 HD12 ' HG3' ' A' ' 819' ' ' ARG . 2.6 tt -53.64 115.65 2.08 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.088 0.471 . . . . 0.0 111.284 -174.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 87.88 3.27 80.27 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.592 -0.814 . . . . 0.0 112.965 173.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 737' ' ' ASP . . . . . 0.619 ' HB3' ' HG ' ' A' ' 733' ' ' LEU . 0.3 OUTLIER -76.99 148.98 35.95 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.253 0.549 . . . . 0.0 111.684 178.076 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 738' ' ' HIS . . . . . 0.494 ' HB2' ' O ' ' A' ' 782' ' ' THR . 36.1 p-80 -113.1 151.05 31.26 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 170.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 739' ' ' SER . . . . . 0.533 ' O ' ' HA ' ' A' ' 781' ' ' LYS . 17.3 p -108.6 167.56 9.96 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 119.219 -0.992 . . . . 0.0 111.803 -170.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 740' ' ' SER . . . . . 0.428 ' HA ' ' O ' ' A' ' 780' ' ' ILE . 12.9 p -132.7 99.62 4.68 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 114.924 -1.035 . . . . 0.0 109.301 175.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 741' ' ' VAL . . . . . 0.62 HG11 HD13 ' A' ' 793' ' ' LEU . 0.5 OUTLIER -104.98 105.04 49.85 Favored Pre-proline 0 C--N 1.316 -0.877 0 CA-C-N 115.037 -0.983 . . . . 0.0 108.799 179.02 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 742' ' ' PRO . . . . . 0.778 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 2.1 Cg_endo -74.97 131.91 14.85 Favored 'Trans proline' 0 N--CA 1.441 -1.589 0 C-N-CA 122.097 1.865 . . . . 0.0 110.777 -177.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 743' ' ' VAL . . . . . 0.723 HG21 ' HB1' ' A' ' 723' ' ' ALA . 1.4 p -131.99 120.88 45.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.769 0.795 . . . . 0.0 112.788 177.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 744' ' ' ALA . . . . . 0.518 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -81.02 99.88 8.68 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 168.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 745' ' ' LEU . . . . . 0.905 HD13 HD13 ' A' ' 773' ' ' ILE . 0.2 OUTLIER -83.59 165.33 19.13 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 114.536 -1.211 . . . . 0.0 111.28 -167.475 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 34.9 tptt -114.51 165.0 13.21 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.699 -178.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 747' ' ' GLY . . . . . . . . . . . . . . . 90.16 129.61 4.04 Favored Glycine 0 C--N 1.306 -1.089 0 CA-C-N 115.276 -0.874 . . . . 0.0 111.538 -175.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 748' ' ' GLN . . . . . 0.467 ' NE2' HG21 ' A' ' 719' ' ' VAL . 0.0 OUTLIER -112.34 113.82 26.23 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.201 0.524 . . . . 0.0 111.636 -173.89 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 123.77 -174.88 16.81 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.371 -0.832 . . . . 0.0 111.045 -177.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 750' ' ' PRO . . . . . 0.402 ' HD2' ' OG ' ' A' ' 801' ' ' SER . 14.0 Cg_exo -69.69 93.89 0.52 Allowed 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.552 2.168 . . . . 0.0 112.317 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 751' ' ' PHE . . . . . 0.564 ' HA ' ' O ' ' A' ' 799' ' ' LYS . 75.6 m-85 -109.84 139.97 44.31 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.45 177.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 752' ' ' THR . . . . . 0.701 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 92.6 m -91.04 108.22 19.72 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 176.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 753' ' ' LEU . . . . . 0.553 ' CD1' HD22 ' A' ' 745' ' ' LEU . 3.7 tt -100.46 118.41 36.61 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.094 -171.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 754' ' ' THR . . . . . 0.47 HG23 ' HB2' ' A' ' 769' ' ' GLU . 1.6 m -114.66 138.25 50.92 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.967 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 755' ' ' TYR . . . . . 0.643 ' CE1' ' HB3' ' A' ' 768' ' ' PHE . 28.9 p90 -146.47 153.91 40.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.998 0.428 . . . . 0.0 111.392 178.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 756' ' ' ASP . . . . . 0.435 ' CG ' ' HD2' ' A' ' 765' ' ' ARG . 39.3 m-20 -112.04 120.85 43.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.818 -178.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 757' ' ' ILE . . . . . . . . . . . . . 3.3 mp -88.02 95.77 5.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 168.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 758' ' ' ILE . . . . . 0.638 HG22 ' HD3' ' A' ' 765' ' ' ARG . 2.3 pp -96.09 140.58 16.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 CA-C-O 121.595 0.712 . . . . 0.0 112.056 -170.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 759' ' ' GLU . . . . . 0.457 ' CD ' ' HB2' ' A' ' 764' ' ' LYS . 13.4 mt-10 -95.64 103.32 15.19 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.336 -176.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 760' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -80.71 -11.47 59.62 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.132 -168.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 761' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -94.22 -29.2 15.22 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.169 -178.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 762' ' ' SER . . . . . 0.513 ' O ' ' HB2' ' A' ' 763' ' ' SER . 3.2 p -111.11 -5.15 14.81 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -175.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 763' ' ' SER . . . . . 0.513 ' HB2' ' O ' ' A' ' 762' ' ' SER . 64.6 m 73.29 4.02 4.76 Favored 'General case' 0 C--O 1.234 0.277 0 O-C-N 123.62 0.575 . . . . 0.0 111.006 -177.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 764' ' ' LYS . . . . . 0.457 ' HB2' ' CD ' ' A' ' 759' ' ' GLU . 6.6 mtpm? -86.23 177.26 7.56 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.932 179.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 765' ' ' ARG . . . . . 0.638 ' HD3' HG22 ' A' ' 758' ' ' ILE . 5.4 ttp180 -163.32 146.82 10.56 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-O 120.958 0.408 . . . . 0.0 111.531 -175.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 766' ' ' LYS . . . . . 0.461 ' HD3' ' N ' ' A' ' 767' ' ' THR . 9.6 tmtm? -117.91 146.42 43.96 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 177.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 767' ' ' THR . . . . . 0.461 ' N ' ' HD3' ' A' ' 766' ' ' LYS . 90.0 m -121.09 133.9 55.24 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-N 116.629 -0.26 . . . . 0.0 110.473 178.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 768' ' ' PHE . . . . . 0.643 ' HB3' ' CE1' ' A' ' 755' ' ' TYR . 1.2 t80 -134.74 135.93 42.29 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 177.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 769' ' ' GLU . . . . . 0.47 ' HB2' HG23 ' A' ' 754' ' ' THR . 42.8 tt0 -131.94 135.25 46.46 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.054 -178.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 770' ' ' ILE . . . . . 0.554 HG22 HG22 ' A' ' 773' ' ' ILE . 3.8 mt -126.81 112.0 27.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 176.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 771' ' ' LYS . . . . . 0.635 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 11.3 mtpt -83.49 154.96 23.62 Favored 'General case' 0 N--CA 1.441 -0.924 0 CA-C-O 121.035 0.445 . . . . 0.0 110.897 -177.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 772' ' ' GLU . . . . . 0.416 ' O ' ' HG3' ' A' ' 774' ' ' LYS . 5.2 mt-10 53.58 48.45 21.65 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.674 -1.148 . . . . 0.0 111.932 177.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 773' ' ' ILE . . . . . 0.905 HD13 HD13 ' A' ' 745' ' ' LEU . 0.5 OUTLIER -74.77 115.34 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 174.278 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 774' ' ' LYS . . . . . 0.416 ' HG3' ' O ' ' A' ' 772' ' ' GLU . 72.0 mttt -116.33 32.28 6.22 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 -178.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 775' ' ' THR . . . . . 0.679 ' H ' HD12 ' A' ' 773' ' ' ILE . 0.2 OUTLIER -96.56 -72.37 0.64 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.212 -1.358 . . . . 0.0 112.522 -171.598 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 776' ' ' ASN . . . . . 0.416 ' O ' ' HG3' ' A' ' 777' ' ' GLU . 11.5 m120 79.36 5.35 2.15 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.035 0.934 . . . . 0.0 110.506 -176.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 777' ' ' GLU . . . . . 0.518 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 21.8 mt-10 -160.36 79.45 0.66 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.7 -1.136 . . . . 0.0 108.826 176.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 778' ' ' TYR . . . . . 0.79 ' HB3' HD11 ' A' ' 745' ' ' LEU . 91.4 t80 -132.61 130.72 40.59 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.964 -171.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 779' ' ' VAL . . . . . 0.778 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 2.0 m -95.73 126.16 48.34 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 CA-C-O 122.331 1.062 . . . . 0.0 110.575 176.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 780' ' ' ILE . . . . . 0.443 ' HB ' HG13 ' A' ' 741' ' ' VAL . 79.6 mt -89.04 145.57 7.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 113.542 -1.663 . . . . 0.0 110.465 -174.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 781' ' ' LYS . . . . . 0.533 ' HA ' ' O ' ' A' ' 739' ' ' SER . 3.9 mppt? -118.07 111.91 19.53 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 177.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 782' ' ' THR . . . . . 0.494 ' O ' ' HB2' ' A' ' 738' ' ' HIS . 30.8 p -74.75 142.87 77.58 Favored Pre-proline 0 C--N 1.319 -0.727 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 177.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 783' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_exo -52.03 161.52 2.39 Favored 'Trans proline' 0 N--CA 1.472 0.22 0 C-N-CA 123.681 2.921 . . . . 0.0 113.171 -177.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 784' ' ' VAL . . . . . . . . . . . . . 51.1 t -63.4 113.7 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.046 177.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 785' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -104.16 102.3 12.03 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.351 178.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 77.2 p -85.94 26.64 0.97 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.781 0.8 . . . . 0.0 111.058 -176.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 92.4 m -144.74 111.47 5.77 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.173 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 788' ' ' GLY . . . . . 0.741 ' HA2' HG12 ' A' ' 817' ' ' VAL . . . -49.65 121.4 9.11 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.971 -0.633 . . . . 0.0 113.201 171.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 789' ' ' GLY . . . . . 0.52 ' H ' ' HB ' ' A' ' 817' ' ' VAL . . . -175.19 173.94 46.51 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 178.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -100.19 133.98 43.79 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 117.819 0.809 . . . . 0.0 109.606 -179.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 791' ' ' TYR . . . . . 0.452 ' HA ' ' O ' ' A' ' 758' ' ' ILE . 68.1 m-85 -129.63 118.62 22.26 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.063 0.459 . . . . 0.0 110.702 -177.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 792' ' ' ILE . . . . . 0.578 HG12 ' HG2' ' A' ' 814' ' ' LYS . 17.8 mt -97.01 116.09 38.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.066 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 793' ' ' LEU . . . . . 0.62 HD13 HG11 ' A' ' 741' ' ' VAL . 10.1 tt -84.45 106.49 16.07 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 175.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 794' ' ' SER . . . . . . . . . . . . . 23.0 t -115.88 148.42 40.0 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.397 -177.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 795' ' ' LEU . . . . . . . . . . . . . 44.9 mt -82.39 134.23 35.24 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.829 0.347 . . . . 0.0 110.681 -176.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 796' ' ' VAL . . . . . . . . . . . . . 77.6 t -95.79 -55.9 5.69 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.46 -177.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 797' ' ' SER . . . . . 0.544 ' HA ' ' HG ' ' A' ' 808' ' ' LEU . 92.0 p -177.74 162.61 1.77 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.373 -172.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 798' ' ' ILE . . . . . 0.656 ' HA ' ' O ' ' A' ' 752' ' ' THR . 9.4 tt -135.28 168.44 23.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 178.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 799' ' ' LYS . . . . . 0.701 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 19.9 tttt -133.5 114.83 14.05 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.732 0.301 . . . . 0.0 111.274 -177.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 800' ' ' ASP . . . . . 0.562 ' HA ' ' CE2' ' A' ' 751' ' ' PHE . 1.6 m-20 -58.27 153.09 15.97 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.594 170.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 801' ' ' SER . . . . . 0.402 ' OG ' ' HD2' ' A' ' 750' ' ' PRO . 6.6 m -66.56 -4.72 9.2 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.141 -172.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 21.6 p -95.06 6.4 49.18 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.585 0.707 . . . . 0.0 109.889 175.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 803' ' ' GLY . . . . . 0.533 ' HA2' ' HE2' ' A' ' 799' ' ' LYS . . . 74.95 41.28 33.28 Favored Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.716 -178.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 804' ' ' CYS . . . . . 0.419 ' HB3' ' HB2' ' A' ' 800' ' ' ASP . 51.9 t -114.83 120.23 39.3 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 805' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 10.2 p -84.9 133.77 28.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 121.523 0.678 . . . . 0.0 110.684 -175.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 806' ' ' VAL . . . . . 0.519 HG11 ' HD2' ' A' ' 721' ' ' PRO . 24.8 t -117.03 135.45 57.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.995 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -74.91 122.59 7.07 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.274 -0.875 . . . . 0.0 111.865 -178.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 808' ' ' LEU . . . . . 0.727 HD22 ' HA ' ' A' ' 722' ' ' SER . 50.9 mt -89.11 127.56 35.72 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.059 0.456 . . . . 0.0 112.145 -177.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 20.1 m -144.27 85.58 1.8 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.882 172.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 810' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -145.82 170.85 7.26 Favored Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.251 177.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 811' ' ' PRO . . . . . . . . . . . . . 99.7 Cg_exo -42.98 139.84 3.37 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 123.204 2.603 . . . . 0.0 115.3 -170.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -103.38 167.35 9.87 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 114.475 -1.239 . . . . 0.0 110.207 178.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 813' ' ' ALA . . . . . 0.478 ' HB3' ' HB3' ' A' ' 793' ' ' LEU . . . -116.58 150.15 38.49 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.381 178.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 814' ' ' LYS . . . . . 0.578 ' HG2' HG12 ' A' ' 792' ' ' ILE . 47.3 mttp -123.27 96.86 5.16 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 122.048 0.928 . . . . 0.0 111.106 176.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 815' ' ' ILE . . . . . 0.574 ' HA ' ' HB3' ' A' ' 731' ' ' LEU . 5.4 mp -87.71 110.82 21.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 CA-C-N 113.97 -1.468 . . . . 0.0 108.987 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 816' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -100.48 107.85 19.68 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.223 0.535 . . . . 0.0 110.226 -175.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 817' ' ' VAL . . . . . 0.741 HG12 ' HA2' ' A' ' 788' ' ' GLY . 57.3 t -93.84 146.04 7.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.241 177.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 818' ' ' ARG . . . . . 0.451 ' O ' ' HA ' ' A' ' 734' ' ' CYS . 30.6 tpt180 -137.11 124.22 21.64 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.09 0.471 . . . . 0.0 110.619 178.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 819' ' ' ARG . . . . . 0.549 ' HG3' HD12 ' A' ' 735' ' ' LEU . 9.3 ttp180 -79.39 113.12 17.27 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.105 -179.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 820' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 . . . . . 0 C--N 1.318 -0.771 0 CA-C-N 115.172 -0.922 . . . . 99.989999999999995 110.161 -178.725 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 718' ' ' ARG . . . . . . . . . . . . . 17.2 tpp180 . . . . . 0 CA--C 1.511 -0.537 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 719' ' ' VAL . . . . . 0.587 ' O ' ' HD3' ' A' ' 721' ' ' PRO . 2.1 t -113.63 164.51 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.201 0 N-CA-C 107.124 -1.435 . . . . 0.0 107.124 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 720' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -94.89 96.26 1.88 Allowed Pre-proline 0 C--N 1.299 -1.596 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 168.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 721' ' ' PRO . . . . . 0.587 ' HD3' ' O ' ' A' ' 719' ' ' VAL . 57.4 Cg_endo -84.92 148.12 10.68 Favored 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 122.632 2.221 . . . . 0.0 111.268 -173.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 722' ' ' SER . . . . . 0.666 ' HA ' HD22 ' A' ' 808' ' ' LEU . 57.0 m -166.78 -161.83 0.47 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.857 -171.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 723' ' ' ALA . . . . . 0.627 ' HB1' HG21 ' A' ' 743' ' ' VAL . . . -149.03 140.56 23.39 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.336 173.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 724' ' ' SER . . . . . 0.416 ' C ' HG23 ' A' ' 743' ' ' VAL . 19.0 m -126.7 104.96 8.36 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 -177.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 725' ' ' LEU . . . . . 0.556 ' CD2' ' HB ' ' A' ' 743' ' ' VAL . 14.8 mt -63.39 137.42 58.16 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-O 121.331 0.586 . . . . 0.0 110.839 -176.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 726' ' ' LYS . . . . . 0.439 ' HD2' ' HB2' ' A' ' 744' ' ' ALA . 33.9 mtpt -89.76 -18.3 26.6 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.886 -175.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 727' ' ' LEU . . . . . 0.422 ' HB2' ' HD2' ' A' ' 742' ' ' PRO . 25.5 tp -68.15 109.59 3.61 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.248 175.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 11.6 t-80 -110.83 25.22 12.01 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.266 0.555 . . . . 0.0 111.534 -173.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 6.2 p80 -155.81 162.08 40.53 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.092 179.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 730' ' ' ASP . . . . . 0.541 ' OD1' ' HB2' ' A' ' 816' ' ' GLN . 16.5 t70 -72.25 131.41 42.69 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.807 0.813 . . . . 0.0 111.301 -176.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 731' ' ' LEU . . . . . 0.597 ' HG ' HD21 ' A' ' 733' ' ' LEU . 25.9 tp -87.17 110.13 19.94 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 114.114 -1.403 . . . . 0.0 110.671 -174.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 732' ' ' LYS . . . . . . . . . . . . . 26.5 mmmt -86.74 107.4 18.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.389 -172.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 733' ' ' LEU . . . . . 0.723 HD12 HG22 ' A' ' 817' ' ' VAL . 16.8 mt -119.32 163.92 16.45 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.848 0.356 . . . . 0.0 111.088 -179.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 734' ' ' CYS . . . . . 0.562 ' O ' ' HB2' ' A' ' 737' ' ' ASP . 15.5 t -116.97 -173.75 2.45 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 174.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 735' ' ' LEU . . . . . 0.495 ' HB2' ' HA ' ' A' ' 819' ' ' ARG . 18.6 tp -73.23 133.83 44.1 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.447 0.642 . . . . 0.0 111.724 -172.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 81.49 10.11 84.9 Favored Glycine 0 N--CA 1.442 -0.944 0 CA-C-N 114.674 -1.148 . . . . 0.0 111.423 -178.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 737' ' ' ASP . . . . . 0.562 ' HB2' ' O ' ' A' ' 734' ' ' CYS . 0.9 OUTLIER -88.14 149.7 23.76 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.918 0.389 . . . . 0.0 111.315 175.99 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 25.6 p-80 -109.52 167.27 10.26 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 170.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 739' ' ' SER . . . . . 0.429 ' HB3' HD23 ' A' ' 731' ' ' LEU . 0.3 OUTLIER -121.25 164.59 16.73 Favored 'General case' 0 C--N 1.312 -1.042 0 C-N-CA 119.855 -0.738 . . . . 0.0 111.74 -173.206 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 62.8 m -143.35 128.15 18.28 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.126 -0.943 . . . . 0.0 108.941 178.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 741' ' ' VAL . . . . . 0.722 HG11 HD23 ' A' ' 793' ' ' LEU . 0.8 OUTLIER -138.06 114.85 9.24 Favored Pre-proline 0 C--N 1.312 -1.048 0 CA-C-O 121.337 0.589 . . . . 0.0 110.326 -177.866 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 742' ' ' PRO . . . . . 0.659 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 6.5 Cg_endo -76.66 136.35 17.05 Favored 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 122.389 2.059 . . . . 0.0 111.396 -179.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 743' ' ' VAL . . . . . 0.627 HG21 ' HB1' ' A' ' 723' ' ' ALA . 1.6 p -131.64 119.44 42.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.253 0.549 . . . . 0.0 111.915 176.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 744' ' ' ALA . . . . . 0.439 ' HB2' ' HD2' ' A' ' 726' ' ' LYS . . . -84.0 111.65 19.48 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 168.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 745' ' ' LEU . . . . . 0.908 HD13 HD13 ' A' ' 773' ' ' ILE . 0.2 OUTLIER -94.11 154.78 17.42 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.645 -1.161 . . . . 0.0 110.9 -166.359 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -107.01 149.85 27.12 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.161 -178.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 747' ' ' GLY . . . . . 0.489 ' HA3' ' HB3' ' A' ' 721' ' ' PRO . . . 96.2 118.62 3.48 Favored Glycine 0 C--N 1.316 -0.559 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -174.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 27.4 mp0 -99.77 122.47 42.79 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.192 0.52 . . . . 0.0 112.115 -169.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 116.24 -170.75 13.46 Favored Glycine 0 C--O 1.218 -0.845 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.439 -179.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 750' ' ' PRO . . . . . 0.497 ' HB3' ' HE2' ' A' ' 774' ' ' LYS . 88.8 Cg_endo -69.94 96.6 0.61 Allowed 'Trans proline' 0 CA--C 1.533 0.445 0 C-N-CA 123.506 2.804 . . . . 0.0 113.893 -178.291 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 751' ' ' PHE . . . . . 0.597 ' CD2' ' HA ' ' A' ' 800' ' ' ASP . 80.7 m-85 -115.19 148.14 39.44 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.176 178.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 752' ' ' THR . . . . . 0.761 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 98.2 m -90.56 104.16 16.77 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.231 0.538 . . . . 0.0 109.684 178.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 753' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.14 113.7 25.3 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.186 -170.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 754' ' ' THR . . . . . 0.474 HG23 ' HB2' ' A' ' 769' ' ' GLU . 1.6 m -109.89 134.42 52.09 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.455 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 755' ' ' TYR . . . . . 0.616 ' CE1' ' HB2' ' A' ' 768' ' ' PHE . 24.9 p90 -143.97 152.89 41.66 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.021 0.439 . . . . 0.0 112.133 179.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 756' ' ' ASP . . . . . 0.468 ' HB2' HG23 ' A' ' 758' ' ' ILE . 2.9 p30 -113.31 121.14 43.5 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.513 -178.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 757' ' ' ILE . . . . . 0.532 ' CD1' HD13 ' A' ' 793' ' ' LEU . 4.0 mp -93.89 96.16 5.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 165.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 758' ' ' ILE . . . . . 0.535 HG13 ' O ' ' A' ' 792' ' ' ILE . 2.2 pp -100.39 150.16 5.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.749 -170.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 759' ' ' GLU . . . . . 0.559 ' CD ' ' HB2' ' A' ' 764' ' ' LYS . 10.2 mt-10 -92.96 115.85 28.51 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.764 -177.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 760' ' ' THR . . . . . 0.473 HG23 ' HB2' ' A' ' 790' ' ' ASP . 0.2 OUTLIER -96.4 -5.68 39.23 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.389 0.614 . . . . 0.0 109.781 178.169 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 761' ' ' PHE . . . . . 0.559 ' CB ' ' H ' ' A' ' 790' ' ' ASP . 91.3 t80 -95.34 -28.12 15.12 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.747 178.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 762' ' ' SER . . . . . . . . . . . . . 49.1 m -120.62 -102.67 0.41 Allowed 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.153 177.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 763' ' ' SER . . . . . . . . . . . . . 28.7 p -167.54 5.73 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -175.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 764' ' ' LYS . . . . . 0.559 ' HB2' ' CD ' ' A' ' 759' ' ' GLU . 9.2 mtmp? -95.75 -178.35 4.35 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.484 -0.486 . . . . 0.0 111.039 -178.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 765' ' ' ARG . . . . . 0.527 ' HD3' HG22 ' A' ' 758' ' ' ILE . 6.7 ttp180 -163.43 137.0 5.71 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.506 -175.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 766' ' ' LYS . . . . . 0.658 ' HD3' ' N ' ' A' ' 767' ' ' THR . 7.8 tmtm? -115.48 146.24 41.85 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 177.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 767' ' ' THR . . . . . 0.658 ' N ' ' HD3' ' A' ' 766' ' ' LYS . 90.7 m -132.49 135.83 46.27 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.42 -177.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 768' ' ' PHE . . . . . 0.616 ' HB2' ' CE1' ' A' ' 755' ' ' TYR . 20.8 m-85 -123.26 134.57 54.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.38 174.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 769' ' ' GLU . . . . . 0.474 ' HB2' HG23 ' A' ' 754' ' ' THR . 40.5 tt0 -126.9 104.83 8.24 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.591 177.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 770' ' ' ILE . . . . . 0.402 HG22 HG22 ' A' ' 773' ' ' ILE . 22.1 mt -105.22 117.55 51.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.422 -178.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 771' ' ' LYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 17.7 mmtt -77.74 159.11 29.29 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.451 0.643 . . . . 0.0 111.006 -179.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 772' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 48.02 45.96 19.22 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 113.863 -1.517 . . . . 0.0 112.83 172.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 773' ' ' ILE . . . . . 0.908 HD13 HD13 ' A' ' 745' ' ' LEU . 0.5 OUTLIER -75.72 109.85 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 172.149 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 774' ' ' LYS . . . . . 0.497 ' HE2' ' HB3' ' A' ' 750' ' ' PRO . 59.6 mttt -105.65 28.83 7.1 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 -177.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 775' ' ' THR . . . . . 0.687 ' H ' HD12 ' A' ' 773' ' ' ILE . 0.6 OUTLIER -95.32 -74.61 0.55 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.95 -1.023 . . . . 0.0 113.122 -166.726 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 776' ' ' ASN . . . . . 0.461 ' HA ' ' HB2' ' A' ' 745' ' ' LEU . 11.8 m120 84.48 1.86 0.83 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.76 1.224 . . . . 0.0 110.893 -176.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 777' ' ' GLU . . . . . 0.424 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 5.2 mp0 -156.05 83.17 1.0 Allowed 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 177.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 778' ' ' TYR . . . . . 0.645 ' HB3' HD11 ' A' ' 745' ' ' LEU . 67.1 t80 -125.97 127.68 46.31 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.516 -0.474 . . . . 0.0 111.582 -170.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 779' ' ' VAL . . . . . 0.659 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 15.5 t -88.55 108.6 18.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.285 0.564 . . . . 0.0 110.216 177.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 780' ' ' ILE . . . . . . . . . . . . . 79.4 mt -76.41 143.56 12.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.63 -178.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.73 106.6 11.08 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 175.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 782' ' ' THR . . . . . 0.423 ' HA ' ' HD3' ' A' ' 783' ' ' PRO . 39.5 p -83.51 144.02 45.35 Favored Pre-proline 0 C--N 1.315 -0.9 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.356 -177.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 783' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 782' ' ' THR . 60.3 Cg_exo -52.75 160.46 3.91 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 123.775 2.983 . . . . 0.0 112.798 -177.291 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 784' ' ' VAL . . . . . . . . . . . . . 14.9 p -66.34 135.2 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.495 -177.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 785' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -102.54 99.43 9.44 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.561 0.696 . . . . 0.0 110.028 179.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 66.3 p -86.09 24.66 1.28 Allowed 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.861 0.839 . . . . 0.0 110.295 -178.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 5.5 m -160.58 110.65 1.77 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 114.459 -1.246 . . . . 0.0 110.032 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 788' ' ' GLY . . . . . . . . . . . . . . . -49.91 147.73 6.88 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 121.241 -0.504 . . . . 0.0 113.718 173.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 789' ' ' GLY . . . . . . . . . . . . . . . 167.34 177.43 38.9 Favored Glycine 0 N--CA 1.443 -0.873 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 -177.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 790' ' ' ASP . . . . . 0.559 ' H ' ' CB ' ' A' ' 761' ' ' PHE . 5.3 m-20 -109.03 128.8 55.28 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -179.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 791' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -129.87 145.36 51.6 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -177.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 792' ' ' ILE . . . . . 0.535 ' O ' HG13 ' A' ' 758' ' ' ILE . 20.3 mt -123.47 122.26 64.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 177.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 793' ' ' LEU . . . . . 0.722 HD23 HG11 ' A' ' 741' ' ' VAL . 0.7 OUTLIER -89.42 115.21 26.69 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 176.859 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 794' ' ' SER . . . . . 0.546 ' N ' HD12 ' A' ' 793' ' ' LEU . 34.5 t -128.06 149.93 50.17 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.344 -176.031 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 795' ' ' LEU . . . . . 0.506 ' H ' HD22 ' A' ' 795' ' ' LEU . 1.3 mm? -78.85 130.35 35.57 Favored 'General case' 0 C--N 1.323 -0.579 0 O-C-N 122.158 -0.339 . . . . 0.0 111.383 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 796' ' ' VAL . . . . . . . . . . . . . 94.2 t -89.91 -56.77 4.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.05 0.452 . . . . 0.0 111.035 -177.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 797' ' ' SER . . . . . 0.636 ' HA ' ' HG ' ' A' ' 808' ' ' LEU . 30.0 m -171.83 160.75 5.67 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.657 -173.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 798' ' ' ILE . . . . . 0.61 ' HA ' ' O ' ' A' ' 752' ' ' THR . 11.7 tt -134.58 160.18 41.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 176.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 799' ' ' LYS . . . . . 0.761 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 7.7 tmtt? -131.77 122.22 25.47 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.206 0.527 . . . . 0.0 110.595 179.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 800' ' ' ASP . . . . . 0.597 ' HA ' ' CD2' ' A' ' 751' ' ' PHE . 7.3 t70 -68.29 156.84 36.86 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.671 -1.149 . . . . 0.0 109.844 176.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 17.3 t -60.03 -14.22 15.34 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 124.093 0.87 . . . . 0.0 112.812 -172.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 802' ' ' THR . . . . . 0.495 HG22 ' OD2' ' A' ' 800' ' ' ASP . 13.9 t -90.33 -0.46 57.65 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-O 121.48 0.657 . . . . 0.0 109.733 176.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 803' ' ' GLY . . . . . . . . . . . . . . . 85.44 39.21 8.44 Favored Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.9 -178.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 804' ' ' CYS . . . . . . . . . . . . . 48.8 t -110.51 115.19 29.19 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 -178.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 805' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 7.6 p -86.34 134.24 27.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.215 0.531 . . . . 0.0 111.079 -176.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 806' ' ' VAL . . . . . 0.506 HG21 ' HD2' ' A' ' 721' ' ' PRO . 71.4 t -118.56 131.22 71.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.12 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -69.78 116.47 6.9 Favored Glycine 0 N--CA 1.453 -0.178 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.907 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 808' ' ' LEU . . . . . 0.666 HD22 ' HA ' ' A' ' 722' ' ' SER . 32.2 mt -84.87 131.13 34.55 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -174.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 36.4 m -147.42 86.25 1.61 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.62 173.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 810' ' ' GLN . . . . . 0.562 ' HB3' ' HD2' ' A' ' 811' ' ' PRO . 89.1 mt-30 -139.18 169.53 12.2 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.261 177.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 811' ' ' PRO . . . . . 0.562 ' HD2' ' HB3' ' A' ' 810' ' ' GLN . 89.3 Cg_exo -45.68 135.84 12.91 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 122.847 2.364 . . . . 0.0 114.611 -175.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -107.13 167.36 9.96 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.729 -1.123 . . . . 0.0 110.343 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 813' ' ' ALA . . . . . 0.528 ' N ' HD12 ' A' ' 725' ' ' LEU . . . -119.67 152.79 36.56 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.404 -178.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 814' ' ' LYS . . . . . . . . . . . . . 16.9 ttpp -118.23 126.45 52.21 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 121.341 0.591 . . . . 0.0 110.562 178.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 815' ' ' ILE . . . . . 0.594 ' HA ' ' HB3' ' A' ' 731' ' ' LEU . 5.2 mp -112.71 119.28 60.02 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 114.946 -1.025 . . . . 0.0 109.08 178.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 816' ' ' GLN . . . . . 0.674 HE22 ' HG2' ' A' ' 818' ' ' ARG . 0.0 OUTLIER -107.32 115.04 29.46 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.68 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 817' ' ' VAL . . . . . 0.723 HG22 HD12 ' A' ' 733' ' ' LEU . 3.9 t -106.43 145.71 13.86 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 177.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 818' ' ' ARG . . . . . 0.674 ' HG2' HE22 ' A' ' 816' ' ' GLN . 20.9 mmt85 -129.43 174.19 9.86 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 120.524 -0.47 . . . . 0.0 111.621 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 819' ' ' ARG . . . . . 0.495 ' HA ' ' HB2' ' A' ' 735' ' ' LEU . 45.5 ttt180 -124.75 124.54 42.36 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.75 174.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 820' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 . . . . . 0 C--N 1.32 -0.694 0 CA-C-N 116.328 -0.397 . . . . 99.989999999999995 110.77 -177.437 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 718' ' ' ARG . . . . . . . . . . . . . 22.7 tpt180 . . . . . 0 CA--C 1.506 -0.714 0 CA-C-O 121.533 0.682 . . . . 0.0 109.683 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 719' ' ' VAL . . . . . 0.655 ' O ' ' HD3' ' A' ' 721' ' ' PRO . 2.3 m -142.77 168.24 13.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 114.506 -1.225 . . . . 0.0 108.785 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 720' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -94.06 96.06 1.58 Allowed Pre-proline 0 C--N 1.307 -1.241 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.107 174.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 721' ' ' PRO . . . . . 0.655 ' HD3' ' O ' ' A' ' 719' ' ' VAL . 95.3 Cg_endo -86.03 148.7 9.37 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 122.869 2.379 . . . . 0.0 112.35 -172.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 722' ' ' SER . . . . . 0.466 ' HB3' ' NE2' ' A' ' 810' ' ' GLN . 22.6 t -179.22 -154.05 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.362 -174.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 723' ' ' ALA . . . . . 0.542 ' HB3' ' HG ' ' A' ' 795' ' ' LEU . . . -144.77 144.82 31.37 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 176.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 7.8 m -128.97 98.96 5.1 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 -175.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 725' ' ' LEU . . . . . 0.577 HD22 ' CG2' ' A' ' 743' ' ' VAL . 1.7 mt -63.74 145.32 55.98 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-O 121.216 0.531 . . . . 0.0 110.96 -171.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 31.2 mtpt -101.23 -14.56 17.64 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.358 -177.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 727' ' ' LEU . . . . . 0.475 ' HB2' HG23 ' A' ' 741' ' ' VAL . 0.6 OUTLIER -74.17 123.31 24.23 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 177.132 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 61.3 m-70 -87.7 -38.0 16.21 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -171.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 729' ' ' HIS . . . . . 0.422 ' O ' HD22 ' A' ' 727' ' ' LEU . 3.1 p80 -126.61 -176.63 3.74 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.715 -0.394 . . . . 0.0 111.991 -172.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 730' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -61.52 145.5 51.71 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.711 0.767 . . . . 0.0 111.427 178.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 731' ' ' LEU . . . . . 0.559 HD23 ' HB2' ' A' ' 739' ' ' SER . 16.2 tp -105.37 108.62 20.23 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.927 -177.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 732' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -76.93 122.1 24.38 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.9 -175.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 733' ' ' LEU . . . . . 0.495 HD11 ' HB3' ' A' ' 739' ' ' SER . 85.3 mt -132.71 164.09 27.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.773 176.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 734' ' ' CYS . . . . . 0.535 ' O ' ' HB2' ' A' ' 737' ' ' ASP . 26.8 p -115.93 -174.06 2.47 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 172.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 735' ' ' LEU . . . . . . . . . . . . . 6.1 tp -66.61 135.48 54.17 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.778 0.799 . . . . 0.0 112.322 -175.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 81.97 4.72 90.19 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 114.357 -1.292 . . . . 0.0 111.767 178.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 737' ' ' ASP . . . . . 0.535 ' HB2' ' O ' ' A' ' 734' ' ' CYS . 6.8 m-20 -82.15 150.54 27.38 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.329 0.585 . . . . 0.0 112.422 -179.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 738' ' ' HIS . . . . . 0.497 ' HB2' ' O ' ' A' ' 782' ' ' THR . 42.6 p-80 -113.39 160.32 18.53 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 169.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 739' ' ' SER . . . . . 0.559 ' HB2' HD23 ' A' ' 731' ' ' LEU . 1.5 p -117.25 170.03 9.01 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 119.556 -0.857 . . . . 0.0 111.827 -172.05 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 740' ' ' SER . . . . . 0.486 ' HA ' ' O ' ' A' ' 780' ' ' ILE . 50.5 m -143.08 101.52 3.84 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.146 177.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 741' ' ' VAL . . . . . 0.547 HG11 HD13 ' A' ' 793' ' ' LEU . 1.2 p -108.74 109.46 61.22 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.546 178.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 742' ' ' PRO . . . . . 0.806 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 5.9 Cg_exo -72.41 128.89 14.13 Favored 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 122.252 1.968 . . . . 0.0 111.51 -177.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 743' ' ' VAL . . . . . 0.577 ' CG2' HD22 ' A' ' 725' ' ' LEU . 43.5 t -130.41 119.2 45.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -178.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 744' ' ' ALA . . . . . 0.572 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -84.27 117.97 23.89 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 170.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 745' ' ' LEU . . . . . 0.926 HD13 HD13 ' A' ' 773' ' ' ILE . 0.4 OUTLIER -95.45 150.67 20.04 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.931 -165.222 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -105.92 146.76 29.57 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.483 -177.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 747' ' ' GLY . . . . . . . . . . . . . . . 110.27 135.29 6.99 Favored Glycine 0 C--N 1.311 -0.842 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 -173.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -114.16 106.33 14.25 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 117.053 0.426 . . . . 0.0 111.37 -171.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 129.17 -175.48 18.85 Favored Glycine 0 N--CA 1.448 -0.504 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 -178.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -68.01 93.46 0.39 Allowed 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.506 2.137 . . . . 0.0 112.119 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 751' ' ' PHE . . . . . 0.496 ' CE2' ' HA ' ' A' ' 800' ' ' ASP . 57.7 m-85 -109.66 140.42 43.53 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.119 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 752' ' ' THR . . . . . 0.759 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 53.8 m -90.24 102.73 15.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.358 0.599 . . . . 0.0 109.837 176.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 753' ' ' LEU . . . . . 0.428 HD22 ' N ' ' A' ' 754' ' ' THR . 0.4 OUTLIER -94.06 123.09 37.21 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.662 -169.695 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 754' ' ' THR . . . . . 0.428 ' N ' HD22 ' A' ' 753' ' ' LEU . 0.8 OUTLIER -119.49 139.88 51.37 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.281 -177.878 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 755' ' ' TYR . . . . . 0.636 ' CE1' ' HB3' ' A' ' 768' ' ' PHE . 23.8 p90 -146.41 155.82 42.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.938 0.399 . . . . 0.0 111.528 177.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 756' ' ' ASP . . . . . 0.465 ' HB3' HG23 ' A' ' 758' ' ' ILE . 5.2 m-20 -113.54 120.27 40.4 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.317 -178.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 757' ' ' ILE . . . . . 0.453 HG13 HD12 ' A' ' 793' ' ' LEU . 4.2 mp -89.14 95.41 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.153 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 169.358 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 758' ' ' ILE . . . . . 0.549 HG13 ' O ' ' A' ' 792' ' ' ILE . 1.6 pp -101.19 148.2 7.41 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.56 -174.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 759' ' ' GLU . . . . . 0.796 ' HB3' ' CE2' ' A' ' 791' ' ' TYR . 7.0 pt-20 -106.17 122.15 45.62 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.075 173.021 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 760' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -84.12 -9.06 58.89 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.683 -1.144 . . . . 0.0 108.618 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 761' ' ' PHE . . . . . 0.513 ' HB2' ' H ' ' A' ' 790' ' ' ASP . 38.5 t80 -70.54 -35.65 73.24 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 114.618 -1.174 . . . . 0.0 110.782 177.03 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 762' ' ' SER . . . . . 0.62 ' HB2' ' OE2' ' A' ' 759' ' ' GLU . 20.1 m -151.71 -99.29 0.06 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.666 175.386 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 763' ' ' SER . . . . . . . . . . . . . 64.2 m -164.14 44.83 0.1 Allowed 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -170.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 764' ' ' LYS . . . . . 0.698 ' H ' ' CG ' ' A' ' 759' ' ' GLU . 39.0 mttp -113.03 66.02 0.65 Allowed 'General case' 0 C--N 1.327 -0.38 0 O-C-N 121.976 -0.453 . . . . 0.0 110.306 175.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 765' ' ' ARG . . . . . 0.474 ' CG ' HG22 ' A' ' 758' ' ' ILE . 23.0 ttp180 -72.9 139.71 47.02 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.045 177.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 766' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -126.54 140.82 52.15 Favored 'General case' 0 C--O 1.215 -0.738 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.847 -178.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 767' ' ' THR . . . . . . . . . . . . . 43.0 m -112.06 129.78 56.1 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.498 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 768' ' ' PHE . . . . . 0.636 ' HB3' ' CE1' ' A' ' 755' ' ' TYR . 2.5 t80 -126.1 135.83 52.19 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.334 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 769' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -132.42 127.98 36.53 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.933 -175.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 770' ' ' ILE . . . . . 0.596 HG22 HG22 ' A' ' 773' ' ' ILE . 4.6 mt -121.52 114.14 41.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 177.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 771' ' ' LYS . . . . . 0.595 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 0.1 OUTLIER -87.46 153.88 21.08 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 121.256 0.55 . . . . 0.0 111.842 -174.643 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 772' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 52.35 47.93 23.69 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.363 -1.29 . . . . 0.0 112.009 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 773' ' ' ILE . . . . . 0.926 HD13 HD13 ' A' ' 745' ' ' LEU . 0.5 OUTLIER -75.17 114.79 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.675 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 174.771 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 72.1 mttt -114.3 30.95 6.93 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 -179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 775' ' ' THR . . . . . 0.706 ' H ' HD12 ' A' ' 773' ' ' ILE . 2.5 m -97.01 -71.82 0.66 Allowed 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 113.488 -1.687 . . . . 0.0 112.415 -169.128 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 776' ' ' ASN . . . . . 0.452 ' HB2' ' O ' ' A' ' 775' ' ' THR . 11.5 m120 83.17 7.99 0.69 Allowed 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.198 0.999 . . . . 0.0 110.138 -177.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 777' ' ' GLU . . . . . 0.572 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 22.5 tt0 -161.55 94.39 0.96 Allowed 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.725 175.445 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 778' ' ' TYR . . . . . 0.901 ' HB3' HD11 ' A' ' 745' ' ' LEU . 67.9 t80 -141.91 120.52 12.53 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.553 -172.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 779' ' ' VAL . . . . . 0.806 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 1.4 m -88.07 129.38 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 CA-C-O 122.035 0.921 . . . . 0.0 109.733 179.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 780' ' ' ILE . . . . . 0.486 ' O ' ' HA ' ' A' ' 740' ' ' SER . 89.7 mt -91.23 138.3 19.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 113.959 -1.473 . . . . 0.0 110.971 -172.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 781' ' ' LYS . . . . . 0.453 ' HD3' ' N ' ' A' ' 781' ' ' LYS . 0.0 OUTLIER -115.86 106.73 14.15 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.33 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 782' ' ' THR . . . . . 0.497 ' O ' ' HB2' ' A' ' 738' ' ' HIS . 32.5 p -78.22 143.26 64.72 Favored Pre-proline 0 C--N 1.32 -0.706 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.102 -178.124 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 783' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -55.79 161.65 7.86 Favored 'Trans proline' 0 CA--C 1.529 0.252 0 C-N-CA 123.513 2.809 . . . . 0.0 113.109 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 784' ' ' VAL . . . . . 0.467 HG12 HG23 ' A' ' 786' ' ' THR . 55.3 t -59.02 121.71 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 CA-C-N 115.185 -0.916 . . . . 0.0 112.312 -177.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 785' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -97.52 98.22 9.74 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.906 177.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 786' ' ' THR . . . . . 0.467 HG23 HG12 ' A' ' 784' ' ' VAL . 35.3 p -87.28 33.7 0.69 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 122.051 0.929 . . . . 0.0 110.092 178.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 28.7 m -153.52 104.98 2.78 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.38 -1.282 . . . . 0.0 110.223 -179.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 788' ' ' GLY . . . . . 0.44 ' H ' ' HB2' ' A' ' 819' ' ' ARG . . . -49.59 113.37 1.76 Allowed Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.277 168.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 789' ' ' GLY . . . . . 0.403 ' H ' ' HB ' ' A' ' 817' ' ' VAL . . . -160.49 -166.07 18.56 Favored Glycine 0 N--CA 1.441 -0.97 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 -179.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 790' ' ' ASP . . . . . 0.513 ' H ' ' HB2' ' A' ' 761' ' ' PHE . 19.3 m-20 -123.62 122.74 38.91 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 117.621 0.711 . . . . 0.0 109.319 -178.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 791' ' ' TYR . . . . . 0.796 ' CE2' ' HB3' ' A' ' 759' ' ' GLU . 88.8 m-85 -117.44 150.86 38.2 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.413 0.625 . . . . 0.0 111.407 -177.017 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 792' ' ' ILE . . . . . 0.549 ' O ' HG13 ' A' ' 758' ' ' ILE . 17.0 mt -131.53 113.04 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.338 175.115 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 793' ' ' LEU . . . . . 0.547 HD13 HG11 ' A' ' 741' ' ' VAL . 7.9 tt -85.03 110.26 18.79 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 178.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 794' ' ' SER . . . . . . . . . . . . . 13.6 t -123.45 142.2 51.23 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.968 -177.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 795' ' ' LEU . . . . . 0.578 ' H ' HD22 ' A' ' 795' ' ' LEU . 1.2 mm? -67.91 140.22 56.47 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 120.904 0.383 . . . . 0.0 111.454 -178.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 796' ' ' VAL . . . . . . . . . . . . . 69.7 t -99.82 -55.28 6.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.015 -178.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 797' ' ' SER . . . . . 0.568 ' HA ' HD13 ' A' ' 808' ' ' LEU . 89.5 p -173.66 176.94 2.62 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.345 -173.018 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 798' ' ' ILE . . . . . 0.621 ' HA ' ' O ' ' A' ' 752' ' ' THR . 11.0 tt -151.22 161.43 3.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 799' ' ' LYS . . . . . 0.759 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 5.2 tttt -132.24 113.89 13.79 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 120.836 0.35 . . . . 0.0 110.521 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 800' ' ' ASP . . . . . 0.577 ' HB3' ' HB3' ' A' ' 804' ' ' CYS . 16.9 t70 -57.91 152.27 16.47 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.263 171.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 3.4 p -65.59 -7.51 15.3 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -171.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 35.5 p -93.6 1.7 56.59 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.659 0.743 . . . . 0.0 110.04 176.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 803' ' ' GLY . . . . . 0.512 ' HA2' ' HE2' ' A' ' 799' ' ' LYS . . . 82.76 44.73 7.09 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.873 -177.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 804' ' ' CYS . . . . . 0.577 ' HB3' ' HB3' ' A' ' 800' ' ' ASP . 45.1 t -111.68 106.93 15.87 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 177.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 805' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 3.9 t -86.06 119.32 34.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.38 0.609 . . . . 0.0 110.08 -176.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 806' ' ' VAL . . . . . 0.541 HG11 ' HD2' ' A' ' 721' ' ' PRO . 37.3 t -108.01 139.17 31.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.498 -176.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -80.06 110.3 3.07 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.557 -179.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 808' ' ' LEU . . . . . 0.568 HD13 ' HA ' ' A' ' 797' ' ' SER . 10.8 mp -77.61 134.19 38.26 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 177.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 19.9 m -149.5 85.76 1.45 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.166 -0.924 . . . . 0.0 109.175 169.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 810' ' ' GLN . . . . . 0.466 ' NE2' ' HB3' ' A' ' 722' ' ' SER . 4.6 mt-30 -132.26 170.8 10.41 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.009 177.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 811' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -45.3 144.08 4.78 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 123.038 2.492 . . . . 0.0 114.588 -176.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -111.15 166.21 11.26 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.656 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 813' ' ' ALA . . . . . 0.42 ' O ' ' HA ' ' A' ' 792' ' ' ILE . . . -117.87 147.57 42.96 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.257 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 814' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -108.8 125.44 51.96 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.513 0.673 . . . . 0.0 110.92 178.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 815' ' ' ILE . . . . . 0.544 ' HA ' ' HB3' ' A' ' 731' ' ' LEU . 5.1 mp -110.81 109.06 27.09 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-N 114.818 -1.083 . . . . 0.0 108.651 177.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 816' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -99.4 109.27 21.88 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.184 0.516 . . . . 0.0 110.15 -175.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 817' ' ' VAL . . . . . 0.403 ' HB ' ' H ' ' A' ' 789' ' ' GLY . 2.6 t -105.71 146.18 12.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.356 -177.355 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 818' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -136.67 133.42 36.18 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.245 0.545 . . . . 0.0 111.887 -179.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 819' ' ' ARG . . . . . 0.44 ' HB2' ' H ' ' A' ' 788' ' ' GLY . 31.5 ttt180 -103.52 118.12 36.0 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.107 174.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 820' ' ' ASP . . . . . . . . . . . . . 36.4 t70 . . . . . 0 C--N 1.328 -0.353 0 O-C-N 123.599 0.562 . . . . 99.989999999999995 110.844 -177.447 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 718' ' ' ARG . . . . . . . . . . . . . 7.5 tpp180 . . . . . 0 CA--C 1.508 -0.657 0 CA-C-O 121.686 0.755 . . . . 0.0 110.241 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 719' ' ' VAL . . . . . . . . . . . . . 3.3 m -134.55 -170.79 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 CA-C-N 114.298 -1.319 . . . . 0.0 109.175 -178.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 720' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -117.85 85.19 22.12 Favored Pre-proline 0 C--N 1.307 -1.274 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.22 175.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 721' ' ' PRO . . . . . 0.422 ' O ' HG21 ' A' ' 798' ' ' ILE . 37.6 Cg_endo -83.1 145.36 12.27 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 C-N-CA 122.424 2.083 . . . . 0.0 111.436 -175.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 722' ' ' SER . . . . . 0.497 ' OG ' HD22 ' A' ' 808' ' ' LEU . 25.6 t 177.42 -153.08 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -171.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 723' ' ' ALA . . . . . 0.737 ' HB1' HG21 ' A' ' 743' ' ' VAL . . . -150.21 143.48 25.02 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.482 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 23.1 t -129.95 103.84 7.02 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 725' ' ' LEU . . . . . 0.465 ' CD2' ' HB ' ' A' ' 743' ' ' VAL . 13.2 mt -64.35 149.26 48.61 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 121.616 0.722 . . . . 0.0 111.839 -175.264 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 726' ' ' LYS . . . . . 0.543 ' HD2' ' HB2' ' A' ' 744' ' ' ALA . 20.2 mtpp -106.8 -10.09 16.18 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.46 -175.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 727' ' ' LEU . . . . . 0.465 ' HB2' ' HD2' ' A' ' 742' ' ' PRO . 0.3 OUTLIER -81.31 111.22 17.49 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 176.364 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 40.9 m80 -103.68 37.37 2.05 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.774 0.657 . . . . 0.0 112.774 -168.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 9.7 p80 -174.08 -177.05 1.25 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.662 0.268 . . . . 0.0 110.776 177.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 730' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -81.04 139.65 35.6 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.297 177.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 731' ' ' LEU . . . . . 0.559 ' HB2' ' HA ' ' A' ' 815' ' ' ILE . 36.4 mt -87.61 117.06 26.16 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.263 -178.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 732' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -84.09 113.01 20.73 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.333 -178.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 733' ' ' LEU . . . . . 0.522 HD11 ' HB3' ' A' ' 739' ' ' SER . 43.5 mt -131.67 159.6 37.86 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-O 121.267 0.556 . . . . 0.0 111.9 -175.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 734' ' ' CYS . . . . . 0.624 ' HA ' ' O ' ' A' ' 818' ' ' ARG . 78.4 m -104.12 -173.75 2.38 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.131 176.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 735' ' ' LEU . . . . . 0.587 ' HB2' ' HA ' ' A' ' 819' ' ' ARG . 19.9 tp -73.79 134.71 43.44 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.174 0.511 . . . . 0.0 111.342 -178.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 74.72 11.56 83.16 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.439 -0.886 . . . . 0.0 111.285 -176.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 737' ' ' ASP . . . . . 0.603 ' HB2' ' O ' ' A' ' 734' ' ' CYS . 0.2 OUTLIER -84.77 150.11 25.29 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.119 0.485 . . . . 0.0 111.231 176.55 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 27.9 p-80 -114.25 175.27 5.55 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 168.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 739' ' ' SER . . . . . 0.522 ' HB3' HD11 ' A' ' 733' ' ' LEU . 0.0 OUTLIER -140.0 166.66 24.04 Favored 'General case' 0 C--N 1.313 -0.993 0 C-N-CA 120.083 -0.647 . . . . 0.0 111.999 -178.615 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 19.7 m -136.75 112.97 9.82 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.6 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 741' ' ' VAL . . . . . 0.664 HG11 HD23 ' A' ' 793' ' ' LEU . 0.9 OUTLIER -111.05 112.95 55.1 Favored Pre-proline 0 C--N 1.318 -0.799 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.746 -179.621 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 742' ' ' PRO . . . . . 0.678 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 1.6 Cg_endo -73.43 134.97 21.52 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 122.517 2.145 . . . . 0.0 111.284 -179.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 743' ' ' VAL . . . . . 0.737 HG21 ' HB1' ' A' ' 723' ' ' ALA . 2.0 p -131.91 116.44 30.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.376 0.608 . . . . 0.0 112.032 176.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 744' ' ' ALA . . . . . 0.574 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -81.22 98.99 8.34 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 169.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 745' ' ' LEU . . . . . 0.968 HD13 HD13 ' A' ' 773' ' ' ILE . 0.3 OUTLIER -79.36 165.33 23.24 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 114.309 -1.314 . . . . 0.0 111.675 -167.385 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 17.3 ttmm -114.44 165.33 12.84 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.679 -179.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 747' ' ' GLY . . . . . . . . . . . . . . . 94.45 128.45 5.25 Favored Glycine 0 C--N 1.31 -0.863 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 -175.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 748' ' ' GLN . . . . . 0.522 ' C ' ' HE1' ' A' ' 751' ' ' PHE . 48.3 mm-40 -110.85 98.62 7.71 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 120.749 -0.38 . . . . 0.0 111.061 -173.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 133.91 -159.23 23.66 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.549 -177.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -78.88 94.99 1.06 Allowed 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 122.944 2.43 . . . . 0.0 112.516 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 751' ' ' PHE . . . . . 0.717 ' CE2' ' HA ' ' A' ' 800' ' ' ASP . 94.6 m-85 -118.41 140.66 49.51 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.799 -178.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 752' ' ' THR . . . . . 0.701 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 92.3 m -95.31 106.7 18.77 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.623 0.725 . . . . 0.0 109.536 179.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 753' ' ' LEU . . . . . 0.485 HD23 HG12 ' A' ' 798' ' ' ILE . 0.4 OUTLIER -97.19 117.78 32.17 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.538 -1.21 . . . . 0.0 109.783 -170.354 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 754' ' ' THR . . . . . 0.486 HG23 ' HB2' ' A' ' 769' ' ' GLU . 1.2 m -116.71 137.04 52.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.897 -177.074 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 755' ' ' TYR . . . . . 0.681 ' CE1' ' HB2' ' A' ' 768' ' ' PHE . 24.3 p90 -144.64 155.38 43.58 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.465 0.543 . . . . 0.0 112.465 -179.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 756' ' ' ASP . . . . . 0.413 ' OD2' ' HB2' ' A' ' 794' ' ' SER . 4.9 p-10 -116.94 119.94 36.88 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.551 -177.295 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 757' ' ' ILE . . . . . 0.536 ' CD1' HD13 ' A' ' 793' ' ' LEU . 4.0 mp -91.87 96.49 6.32 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 167.376 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 758' ' ' ILE . . . . . 0.659 HG22 ' HD2' ' A' ' 765' ' ' ARG . 2.4 pp -100.57 149.56 6.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.25 -170.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 759' ' ' GLU . . . . . 0.638 ' OE2' ' HB2' ' A' ' 762' ' ' SER . 12.5 mt-10 -86.38 118.59 25.92 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 120.921 0.391 . . . . 0.0 111.13 -179.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 760' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -97.42 -6.32 34.22 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.56 0.695 . . . . 0.0 109.533 174.11 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 761' ' ' PHE . . . . . 0.579 ' CB ' ' H ' ' A' ' 790' ' ' ASP . 85.3 t80 -96.44 -34.17 11.61 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.928 178.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 762' ' ' SER . . . . . 0.638 ' HB2' ' OE2' ' A' ' 759' ' ' GLU . 16.5 m -118.25 -99.12 0.45 Allowed 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 120.251 -0.58 . . . . 0.0 111.49 -177.251 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 763' ' ' SER . . . . . . . . . . . . . 70.8 p -166.88 -4.84 0.02 OUTLIER 'General case' 0 C--O 1.232 0.164 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -176.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 764' ' ' LYS . . . . . 0.497 ' C ' ' HG3' ' A' ' 759' ' ' GLU . 62.0 mttp -89.5 -173.55 4.01 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.54 0.686 . . . . 0.0 111.569 -175.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 765' ' ' ARG . . . . . 0.659 ' HD2' HG22 ' A' ' 758' ' ' ILE . 12.0 ttt180 -168.88 140.8 2.61 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-N 114.741 -1.118 . . . . 0.0 109.875 -175.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 766' ' ' LYS . . . . . 0.614 ' HD3' ' N ' ' A' ' 767' ' ' THR . 2.0 tmtp? -120.48 146.32 46.38 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 767' ' ' THR . . . . . 0.614 ' N ' ' HD3' ' A' ' 766' ' ' LYS . 96.6 m -131.74 132.36 43.78 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 120.962 0.411 . . . . 0.0 111.751 -176.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 768' ' ' PHE . . . . . 0.681 ' HB2' ' CE1' ' A' ' 755' ' ' TYR . 42.9 m-85 -120.07 141.21 49.98 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.214 174.105 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 769' ' ' GLU . . . . . 0.486 ' HB2' HG23 ' A' ' 754' ' ' THR . 46.0 tt0 -131.27 109.37 10.34 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.383 178.073 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 770' ' ' ILE . . . . . 0.564 HG22 HG22 ' A' ' 773' ' ' ILE . 21.2 mt -105.97 120.37 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 -179.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 771' ' ' LYS . . . . . 0.577 ' HD2' ' N ' ' A' ' 771' ' ' LYS . 0.1 OUTLIER -85.55 164.62 17.67 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.067 0.46 . . . . 0.0 111.144 -175.192 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 772' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 36.36 50.44 0.75 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 113.853 -1.521 . . . . 0.0 112.64 177.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 773' ' ' ILE . . . . . 0.968 HD13 HD13 ' A' ' 745' ' ' LEU . 0.5 OUTLIER -76.71 111.98 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 175.67 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 75.7 mttt -113.04 33.62 4.95 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 -179.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 775' ' ' THR . . . . . 0.691 ' H ' HD12 ' A' ' 773' ' ' ILE . 1.2 m -95.12 -71.64 0.66 Allowed 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 113.836 -1.529 . . . . 0.0 111.769 -169.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 776' ' ' ASN . . . . . 0.417 ' HB2' ' O ' ' A' ' 775' ' ' THR . 11.5 m120 81.92 4.11 1.28 Allowed 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.129 0.971 . . . . 0.0 110.79 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 777' ' ' GLU . . . . . 0.574 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 18.4 mt-10 -160.2 84.66 0.72 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.197 176.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 778' ' ' TYR . . . . . 0.808 ' HB3' HD11 ' A' ' 745' ' ' LEU . 79.4 t80 -128.89 129.08 45.05 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.843 0.354 . . . . 0.0 110.863 -172.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 779' ' ' VAL . . . . . 0.678 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 21.1 t -87.95 112.81 24.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 121.281 0.562 . . . . 0.0 110.515 178.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 780' ' ' ILE . . . . . . . . . . . . . 74.0 mt -80.2 141.48 15.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.603 -178.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -114.93 107.85 15.94 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 177.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 782' ' ' THR . . . . . 0.403 ' HA ' ' HD3' ' A' ' 783' ' ' PRO . 68.7 p -78.15 135.33 62.37 Favored Pre-proline 0 N--CA 1.441 -0.895 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 783' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 782' ' ' THR . 46.3 Cg_exo -57.05 158.32 18.0 Favored 'Trans proline' 0 CA--C 1.518 -0.278 0 C-N-CA 123.523 2.815 . . . . 0.0 112.401 -173.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 784' ' ' VAL . . . . . . . . . . . . . 12.8 p -60.47 136.43 24.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.697 -177.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 785' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -110.08 97.15 6.7 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.617 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 82.1 p -83.77 25.16 0.81 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.725 0.774 . . . . 0.0 110.822 -176.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 36.7 m -156.47 120.97 4.51 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.446 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 788' ' ' GLY . . . . . 0.673 ' HA2' HG12 ' A' ' 817' ' ' VAL . . . -51.74 110.64 1.14 Allowed Glycine 0 N--CA 1.448 -0.554 0 O-C-N 123.669 0.605 . . . . 0.0 113.335 174.232 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 789' ' ' GLY . . . . . 0.415 ' H ' ' HB ' ' A' ' 817' ' ' VAL . . . -157.28 166.37 33.63 Favored Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 110.571 -1.012 . . . . 0.0 110.571 177.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 790' ' ' ASP . . . . . 0.579 ' H ' ' CB ' ' A' ' 761' ' ' PHE . 2.7 m-20 -107.97 132.29 53.67 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 117.305 0.552 . . . . 0.0 109.763 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 791' ' ' TYR . . . . . 0.503 ' CE2' ' HG2' ' A' ' 759' ' ' GLU . 89.4 m-85 -124.61 158.52 32.88 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.951 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 792' ' ' ILE . . . . . 0.609 ' O ' HG13 ' A' ' 758' ' ' ILE . 6.2 mt -134.21 117.71 25.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 171.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 793' ' ' LEU . . . . . 0.664 HD23 HG11 ' A' ' 741' ' ' VAL . 1.0 OUTLIER -84.91 112.21 20.36 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.408 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 794' ' ' SER . . . . . 0.516 ' N ' HD12 ' A' ' 793' ' ' LEU . 13.6 m -118.39 177.3 4.87 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 114.81 -1.086 . . . . 0.0 108.744 -177.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 795' ' ' LEU . . . . . 0.423 HD11 ' O ' ' A' ' 723' ' ' ALA . 42.9 mt -103.79 132.3 50.17 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.784 0.326 . . . . 0.0 110.644 -179.005 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 796' ' ' VAL . . . . . . . . . . . . . 64.1 t -89.27 -56.72 4.88 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.348 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.661 -177.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 797' ' ' SER . . . . . 0.44 ' HA ' ' HG ' ' A' ' 808' ' ' LEU . 26.6 m -173.36 172.83 3.66 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.855 -173.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 798' ' ' ILE . . . . . 0.725 ' HB ' HD21 ' A' ' 808' ' ' LEU . 0.5 OUTLIER -146.34 166.76 7.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -173.529 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 799' ' ' LYS . . . . . 0.701 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 34.5 tttt -135.29 117.4 15.42 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 120.33 -0.548 . . . . 0.0 111.281 -179.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 800' ' ' ASP . . . . . 0.717 ' HA ' ' CE2' ' A' ' 751' ' ' PHE . 8.0 t70 -68.65 153.02 44.56 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.192 173.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 24.2 p -62.44 -8.12 5.62 Favored 'General case' 0 C--N 1.33 -0.255 0 O-C-N 123.867 0.73 . . . . 0.0 112.375 -173.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 35.4 p -94.8 9.79 37.69 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.536 0.684 . . . . 0.0 109.673 176.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 803' ' ' GLY . . . . . 0.554 ' HA2' ' HE2' ' A' ' 799' ' ' LYS . . . 72.45 40.83 53.66 Favored Glycine 0 N--CA 1.446 -0.643 0 CA-C-N 114.871 -1.059 . . . . 0.0 112.389 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 804' ' ' CYS . . . . . . . . . . . . . 59.6 m -114.09 116.32 28.95 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 805' ' ' VAL . . . . . 0.658 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 6.1 p -84.92 113.43 23.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.895 0.855 . . . . 0.0 110.821 -177.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 806' ' ' VAL . . . . . 0.671 ' HB ' HG22 ' A' ' 798' ' ' ILE . 41.0 t -96.05 138.42 21.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.604 -178.043 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -70.53 122.03 10.34 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.733 179.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 808' ' ' LEU . . . . . 0.725 HD21 ' HB ' ' A' ' 798' ' ' ILE . 24.1 mt -89.63 132.88 34.91 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -175.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 14.9 t -149.71 87.04 1.47 Allowed 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 115.452 -0.794 . . . . 0.0 109.62 172.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 810' ' ' GLN . . . . . 0.438 ' HB3' ' HD2' ' A' ' 811' ' ' PRO . 13.1 mt-30 -136.17 170.44 10.96 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.591 -0.732 . . . . 0.0 109.779 173.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 811' ' ' PRO . . . . . 0.438 ' HD2' ' HB3' ' A' ' 810' ' ' GLN . 89.2 Cg_exo -44.93 139.11 8.24 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 122.973 2.449 . . . . 0.0 114.192 -177.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -110.4 166.07 11.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.599 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 813' ' ' ALA . . . . . . . . . . . . . . . -114.57 154.62 27.98 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.257 -177.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 814' ' ' LYS . . . . . . . . . . . . . 50.6 tttp -115.0 130.05 56.85 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-O 121.129 0.49 . . . . 0.0 110.143 176.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 815' ' ' ILE . . . . . 0.559 ' HA ' ' HB2' ' A' ' 731' ' ' LEU . 4.8 mp -113.42 118.24 57.62 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 816' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -109.05 114.25 27.83 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.846 0.355 . . . . 0.0 110.81 -179.088 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 817' ' ' VAL . . . . . 0.673 HG12 ' HA2' ' A' ' 788' ' ' GLY . 92.5 t -110.07 124.55 66.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 176.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 818' ' ' ARG . . . . . 0.624 ' O ' ' HA ' ' A' ' 734' ' ' CYS . 15.0 mmt180 -142.17 144.96 33.67 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 176.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 819' ' ' ARG . . . . . 0.587 ' HA ' ' HB2' ' A' ' 735' ' ' LEU . 27.0 mtm180 -67.26 132.95 48.76 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.998 -174.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 820' ' ' ASP . . . . . . . . . . . . . 32.3 t70 . . . . . 0 C--N 1.323 -0.568 0 CA-C-N 115.795 -0.638 . . . . 99.989999999999995 110.497 -176.802 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 718' ' ' ARG . . . . . . . . . . . . . 18.4 tpt180 . . . . . 0 CA--C 1.511 -0.545 0 CA-C-O 121.358 0.599 . . . . 0.0 110.438 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 719' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -150.35 -168.95 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 114.649 -1.16 . . . . 0.0 108.375 178.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 720' ' ' LYS . . . . . 0.456 ' HA ' ' HD3' ' A' ' 721' ' ' PRO . 12.9 mmmm -80.06 119.45 76.63 Favored Pre-proline 0 C--N 1.305 -1.365 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.856 176.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 721' ' ' PRO . . . . . 0.545 ' HD2' HG21 ' A' ' 806' ' ' VAL . 5.9 Cg_endo -78.12 138.47 16.23 Favored 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 122.471 2.114 . . . . 0.0 110.174 -179.071 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 722' ' ' SER . . . . . 0.881 ' HB2' ' OE1' ' A' ' 810' ' ' GLN . 7.3 p -175.21 -153.05 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.347 -166.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 723' ' ' ALA . . . . . 0.605 ' HA ' ' HA ' ' A' ' 745' ' ' LEU . . . -157.73 151.27 23.75 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-N 118.518 0.599 . . . . 0.0 110.659 177.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 41.6 m -140.03 99.1 3.6 Favored 'General case' 0 C--N 1.321 -0.636 0 O-C-N 121.624 -0.672 . . . . 0.0 110.027 179.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 725' ' ' LEU . . . . . 0.938 ' HG ' HG22 ' A' ' 743' ' ' VAL . 5.2 mp -57.3 143.3 40.23 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-O 122.516 1.15 . . . . 0.0 112.661 -175.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 36.5 mtpt -96.82 -13.98 22.21 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 112.851 -1.977 . . . . 0.0 110.279 -177.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 727' ' ' LEU . . . . . 0.518 ' HB2' HG23 ' A' ' 741' ' ' VAL . 3.1 tm? -50.4 128.91 20.93 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.387 -1.278 . . . . 0.0 109.966 176.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 35.4 m170 -89.9 -52.48 4.95 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -171.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -145.65 -177.0 5.35 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.535 -0.466 . . . . 0.0 111.513 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 730' ' ' ASP . . . . . 0.406 ' HA ' ' O ' ' A' ' 814' ' ' LYS . 9.5 p-10 -48.06 133.12 15.26 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 124.019 0.824 . . . . 0.0 111.523 178.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 731' ' ' LEU . . . . . 0.575 ' CD2' ' HB2' ' A' ' 739' ' ' SER . 27.2 tp -99.53 111.49 23.83 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.526 -175.088 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 732' ' ' LYS . . . . . . . . . . . . . 40.5 mmtm -72.76 121.32 19.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.552 -179.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 733' ' ' LEU . . . . . 0.49 HD12 ' CG2' ' A' ' 815' ' ' ILE . 94.4 mt -138.26 160.54 39.2 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.445 178.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 734' ' ' CYS . . . . . . . . . . . . . 63.8 m -109.96 -174.06 2.4 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.001 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 735' ' ' LEU . . . . . 0.415 ' HB2' ' HA ' ' A' ' 819' ' ' ARG . 38.4 tp -65.24 125.85 26.3 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.902 0.382 . . . . 0.0 111.36 -172.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 736' ' ' GLY . . . . . 0.508 ' O ' HG13 ' A' ' 784' ' ' VAL . . . 81.4 7.91 87.74 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.455 -0.879 . . . . 0.0 112.622 177.383 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 737' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -78.58 150.37 32.79 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.024 0.44 . . . . 0.0 111.452 176.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 738' ' ' HIS . . . . . 0.622 ' HB2' ' O ' ' A' ' 782' ' ' THR . 39.8 p-80 -116.83 166.11 12.53 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 172.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 739' ' ' SER . . . . . 0.575 ' HB2' ' CD2' ' A' ' 731' ' ' LEU . 13.5 p -124.98 163.37 22.47 Favored 'General case' 0 C--N 1.316 -0.875 0 C-N-CA 118.956 -1.098 . . . . 0.0 112.27 -172.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 740' ' ' SER . . . . . 0.497 ' HA ' ' O ' ' A' ' 780' ' ' ILE . 46.0 m -130.44 99.94 5.18 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.089 174.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 741' ' ' VAL . . . . . 0.541 HG11 HD23 ' A' ' 793' ' ' LEU . 0.1 OUTLIER -100.42 112.73 64.87 Favored Pre-proline 0 C--N 1.318 -0.79 0 CA-C-N 115.485 -0.779 . . . . 0.0 109.338 179.449 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 742' ' ' PRO . . . . . 0.753 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 6.3 Cg_exo -75.54 129.8 12.19 Favored 'Trans proline' 0 N--CA 1.445 -1.356 0 C-N-CA 122.215 1.944 . . . . 0.0 110.96 -176.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 743' ' ' VAL . . . . . 0.938 HG22 ' HG ' ' A' ' 725' ' ' LEU . 20.1 t -127.95 121.34 56.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.128 0.489 . . . . 0.0 112.247 178.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 744' ' ' ALA . . . . . 0.661 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -83.33 99.38 9.98 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 122.326 1.06 . . . . 0.0 108.275 169.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 745' ' ' LEU . . . . . 0.877 HD11 ' HB3' ' A' ' 778' ' ' TYR . 3.5 mt -77.39 164.9 25.07 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 113.52 -1.673 . . . . 0.0 110.742 -169.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 746' ' ' LYS . . . . . 0.469 ' HB3' ' OG ' ' A' ' 722' ' ' SER . 14.4 tppt? -123.46 161.31 25.08 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.079 0.466 . . . . 0.0 110.457 -176.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 747' ' ' GLY . . . . . . . . . . . . . . . 91.3 121.69 2.6 Favored Glycine 0 C--N 1.312 -0.783 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 -175.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -95.34 117.97 31.26 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.28 0.562 . . . . 0.0 111.98 -172.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 116.65 -175.91 16.01 Favored Glycine 0 CA--C 1.499 -0.934 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.506 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 750' ' ' PRO . . . . . 0.488 ' HB3' ' HE2' ' A' ' 774' ' ' LYS . 86.8 Cg_endo -69.07 94.88 0.48 Allowed 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 123.359 2.706 . . . . 0.0 113.187 -177.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 751' ' ' PHE . . . . . 0.583 ' CD2' ' HA ' ' A' ' 800' ' ' ASP . 64.0 m-85 -112.13 144.87 40.78 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.067 179.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 752' ' ' THR . . . . . 0.766 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 89.0 m -91.85 102.76 15.35 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.277 0.56 . . . . 0.0 109.921 179.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 753' ' ' LEU . . . . . 0.71 ' CD2' HD22 ' A' ' 745' ' ' LEU . 46.9 tp -97.0 121.52 38.97 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.298 -171.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 754' ' ' THR . . . . . 0.481 ' HB ' ' HB ' ' A' ' 796' ' ' VAL . 1.0 OUTLIER -109.66 135.98 49.75 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.131 -177.592 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 755' ' ' TYR . . . . . 0.628 ' CE1' ' HB3' ' A' ' 768' ' ' PHE . 29.6 p90 -143.1 152.43 41.84 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 120.977 0.418 . . . . 0.0 111.843 178.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 756' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -117.7 118.47 32.16 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.694 -179.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 757' ' ' ILE . . . . . 0.611 ' CD1' HD13 ' A' ' 793' ' ' LEU . 3.5 mp -87.7 96.56 5.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 168.206 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 758' ' ' ILE . . . . . 0.624 HG22 ' HD3' ' A' ' 765' ' ' ARG . 2.3 pp -94.53 149.89 4.26 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 121.322 0.582 . . . . 0.0 111.962 -171.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 759' ' ' GLU . . . . . 0.513 ' HG3' ' C ' ' A' ' 764' ' ' LYS . 16.1 mt-10 -90.86 115.13 27.67 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.832 175.041 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 760' ' ' THR . . . . . . . . . . . . . 2.5 t -95.04 -0.17 53.92 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 172.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 761' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -94.08 -34.48 12.97 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.45 176.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 762' ' ' SER . . . . . 0.49 ' HB2' ' OE2' ' A' ' 759' ' ' GLU . 65.6 m -141.11 -93.55 0.14 Allowed 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 120.959 -0.297 . . . . 0.0 111.74 177.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 763' ' ' SER . . . . . . . . . . . . . 34.4 p -170.56 -0.91 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -174.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 764' ' ' LYS . . . . . 0.513 ' C ' ' HG3' ' A' ' 759' ' ' GLU . 9.7 mtpm? -82.9 55.66 3.15 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.164 0.507 . . . . 0.0 112.072 -174.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 765' ' ' ARG . . . . . 0.624 ' HD3' HG22 ' A' ' 758' ' ' ILE . 6.1 ttp180 -55.19 141.37 35.38 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.903 172.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 766' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -123.7 134.38 53.72 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 120.922 0.391 . . . . 0.0 110.449 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 767' ' ' THR . . . . . . . . . . . . . 47.3 m -107.58 131.39 54.41 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.46 -177.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 768' ' ' PHE . . . . . 0.628 ' HB3' ' CE1' ' A' ' 755' ' ' TYR . 0.2 OUTLIER -137.16 135.84 37.7 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.203 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 769' ' ' GLU . . . . . 0.46 ' HB2' HG23 ' A' ' 754' ' ' THR . 39.3 tt0 -129.54 124.01 32.82 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.118 0.485 . . . . 0.0 111.692 -175.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 4.6 mm -102.38 110.66 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.759 -179.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 771' ' ' LYS . . . . . 0.616 ' HD2' ' N ' ' A' ' 771' ' ' LYS . 0.0 OUTLIER -80.41 157.4 26.27 Favored 'General case' 0 C--N 1.312 -1.028 0 C-N-CA 120.104 -0.639 . . . . 0.0 109.983 179.293 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 772' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 41.77 50.33 3.98 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 113.871 -1.513 . . . . 0.0 113.515 178.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 773' ' ' ILE . . . . . 0.843 HD12 ' H ' ' A' ' 775' ' ' THR . 0.5 OUTLIER -75.35 111.37 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 171.135 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 774' ' ' LYS . . . . . 0.488 ' HE2' ' HB3' ' A' ' 750' ' ' PRO . 58.7 mttt -107.26 24.35 12.99 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 -178.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 775' ' ' THR . . . . . 0.843 ' H ' HD12 ' A' ' 773' ' ' ILE . 0.2 OUTLIER -95.38 -74.27 0.56 Allowed 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 -165.763 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 776' ' ' ASN . . . . . 0.637 ' HB2' ' O ' ' A' ' 775' ' ' THR . 0.9 OUTLIER 91.07 4.13 0.1 Allowed 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.5 1.12 . . . . 0.0 110.596 -177.605 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 777' ' ' GLU . . . . . 0.661 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 13.9 tt0 -162.94 101.59 0.99 Allowed 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.133 174.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 778' ' ' TYR . . . . . 0.877 ' HB3' HD11 ' A' ' 745' ' ' LEU . 90.7 t80 -153.69 129.7 10.29 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.633 -171.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 779' ' ' VAL . . . . . 0.753 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 1.9 m -91.68 129.54 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 CA-C-O 122.15 0.976 . . . . 0.0 110.823 178.061 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 780' ' ' ILE . . . . . 0.497 ' O ' ' HA ' ' A' ' 740' ' ' SER . 88.2 mt -90.13 139.79 16.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 113.59 -1.641 . . . . 0.0 110.811 -174.028 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 781' ' ' LYS . . . . . 0.45 ' HD3' ' N ' ' A' ' 781' ' ' LYS . 0.1 OUTLIER -111.81 107.62 16.74 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.928 0.394 . . . . 0.0 110.323 179.623 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 782' ' ' THR . . . . . 0.622 ' O ' ' HB2' ' A' ' 738' ' ' HIS . 25.2 p -77.8 142.91 66.03 Favored Pre-proline 0 C--N 1.318 -0.761 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.827 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 783' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 782' ' ' THR . 53.0 Cg_exo -56.32 160.72 10.44 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 123.53 2.82 . . . . 0.0 113.2 -178.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 784' ' ' VAL . . . . . 0.508 HG13 ' O ' ' A' ' 736' ' ' GLY . 40.5 t -58.55 122.62 8.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.952 178.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 785' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -100.67 97.27 7.96 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.187 178.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 786' ' ' THR . . . . . 0.45 HG23 HG12 ' A' ' 784' ' ' VAL . 44.1 p -84.37 34.23 0.52 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.677 0.751 . . . . 0.0 111.165 -178.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 12.7 m -154.69 112.72 3.48 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.045 -0.979 . . . . 0.0 111.006 178.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 788' ' ' GLY . . . . . 0.689 ' HA2' HG12 ' A' ' 817' ' ' VAL . . . -50.13 112.49 1.52 Allowed Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 121.027 -0.606 . . . . 0.0 112.521 169.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 789' ' ' GLY . . . . . . . . . . . . . . . -157.51 -148.15 5.03 Favored Glycine 0 N--CA 1.443 -0.843 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -144.86 124.77 13.47 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 179.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 791' ' ' TYR . . . . . 0.503 ' CE2' ' HG2' ' A' ' 759' ' ' GLU . 90.9 m-85 -118.99 145.14 46.07 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.998 -176.174 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 792' ' ' ILE . . . . . 0.576 ' O ' HG13 ' A' ' 758' ' ' ILE . 16.5 mt -123.56 110.41 25.92 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.508 173.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 793' ' ' LEU . . . . . 0.848 ' HB3' ' HB3' ' A' ' 813' ' ' ALA . 4.0 tp -84.75 109.55 18.14 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.428 0.632 . . . . 0.0 109.448 179.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 794' ' ' SER . . . . . . . . . . . . . 19.1 m -112.31 156.52 22.3 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.062 -174.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 795' ' ' LEU . . . . . 0.485 HD13 ' HB3' ' A' ' 723' ' ' ALA . 74.9 mt -91.13 130.5 37.02 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.903 0.382 . . . . 0.0 110.372 -179.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 796' ' ' VAL . . . . . 0.481 ' HB ' ' HB ' ' A' ' 754' ' ' THR . 76.6 t -91.52 -55.53 6.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.159 -175.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 797' ' ' SER . . . . . 0.608 ' HA ' HD13 ' A' ' 808' ' ' LEU . 88.9 p -179.43 179.12 0.64 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.503 -172.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 798' ' ' ILE . . . . . 0.62 ' HA ' ' O ' ' A' ' 752' ' ' THR . 10.3 tt -148.53 161.94 5.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 178.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 799' ' ' LYS . . . . . 0.766 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 7.6 tmtt? -133.31 122.02 23.25 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.037 0.446 . . . . 0.0 110.787 -178.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 800' ' ' ASP . . . . . 0.583 ' HA ' ' CD2' ' A' ' 751' ' ' PHE . 9.0 t70 -66.45 154.87 39.09 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.971 174.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 38.2 t -59.15 -14.18 9.56 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 124.236 0.96 . . . . 0.0 112.719 -172.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 61.8 p -96.25 5.57 50.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.554 0.692 . . . . 0.0 110.189 178.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 803' ' ' GLY . . . . . . . . . . . . . . . 82.23 40.19 10.48 Favored Glycine 0 N--CA 1.446 -0.691 0 CA-C-N 115.07 -0.968 . . . . 0.0 112.148 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 804' ' ' CYS . . . . . 0.464 ' HB2' ' HB3' ' A' ' 800' ' ' ASP . 63.4 m -110.94 114.62 28.08 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 179.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 805' ' ' VAL . . . . . . . . . . . . . 11.4 p -85.75 137.54 20.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.487 0.66 . . . . 0.0 111.464 -173.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 806' ' ' VAL . . . . . 0.582 ' HB ' HG22 ' A' ' 798' ' ' ILE . 97.0 t -118.03 137.65 51.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.176 176.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -87.6 110.63 3.61 Favored Glycine 0 C--N 1.321 -0.277 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.481 -178.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 808' ' ' LEU . . . . . 0.608 HD13 ' HA ' ' A' ' 797' ' ' SER . 11.1 mp -79.78 129.69 34.7 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 178.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 8.8 t -138.6 87.01 2.19 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 168.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 810' ' ' GLN . . . . . 0.881 ' OE1' ' HB2' ' A' ' 722' ' ' SER . 25.2 mt-30 -139.48 174.57 3.97 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.081 -0.963 . . . . 0.0 111.295 -170.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 811' ' ' PRO . . . . . 0.499 ' HD2' ' HB3' ' A' ' 810' ' ' GLN . 75.5 Cg_exo -44.69 146.68 2.12 Favored 'Trans proline' 0 C--N 1.36 1.14 0 C-N-CA 123.395 2.73 . . . . 0.0 114.376 -178.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -119.99 166.93 12.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.147 -177.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 813' ' ' ALA . . . . . 0.848 ' HB3' ' HB3' ' A' ' 793' ' ' LEU . . . -105.19 146.18 29.6 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.212 178.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 814' ' ' LYS . . . . . 0.479 ' HG2' HG12 ' A' ' 792' ' ' ILE . 6.7 mtmp? -122.85 112.72 18.21 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.839 0.828 . . . . 0.0 110.605 172.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 815' ' ' ILE . . . . . 0.544 ' HA ' ' HB3' ' A' ' 731' ' ' LEU . 4.5 mp -109.89 109.07 27.06 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 114.088 -1.415 . . . . 0.0 109.25 -176.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 816' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -98.98 108.58 21.29 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.262 0.553 . . . . 0.0 110.263 -176.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 817' ' ' VAL . . . . . 0.689 HG12 ' HA2' ' A' ' 788' ' ' GLY . 96.1 t -98.46 145.56 9.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.599 -179.171 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 818' ' ' ARG . . . . . 0.424 ' HG3' ' H ' ' A' ' 819' ' ' ARG . 20.0 tpt180 -138.36 176.39 8.74 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -178.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 819' ' ' ARG . . . . . 0.424 ' H ' ' HG3' ' A' ' 818' ' ' ARG . 13.6 mmm180 -76.91 155.48 32.79 Favored 'General case' 0 C--N 1.316 -0.878 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.112 175.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 820' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 . . . . . 0 C--N 1.322 -0.593 0 N-CA-C 109.468 -0.567 . . . . 99.989999999999995 109.468 178.026 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 718' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.517 -0.299 0 CA-C-O 121.6 0.714 . . . . 0.0 110.671 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 719' ' ' VAL . . . . . 0.445 ' O ' ' HD3' ' A' ' 721' ' ' PRO . 7.8 p -141.9 161.18 20.69 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-N 115.201 -0.909 . . . . 0.0 108.7 -179.213 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 720' ' ' LYS . . . . . . . . . . . . . 53.0 mtpt -89.91 110.06 37.15 Favored Pre-proline 0 C--N 1.305 -1.341 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.985 176.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 721' ' ' PRO . . . . . 0.488 ' HB3' ' HA3' ' A' ' 747' ' ' GLY . 36.3 Cg_endo -86.75 148.89 8.48 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 122.564 2.176 . . . . 0.0 110.801 177.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 722' ' ' SER . . . . . 0.578 ' HA ' HD22 ' A' ' 808' ' ' LEU . 8.4 t -178.78 -154.6 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -171.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 723' ' ' ALA . . . . . 0.696 ' O ' HD11 ' A' ' 795' ' ' LEU . . . -150.99 140.17 21.21 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.902 0.382 . . . . 0.0 110.799 176.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 43.4 t -128.52 99.43 5.38 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -174.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 725' ' ' LEU . . . . . 0.55 ' HG ' ' O ' ' A' ' 811' ' ' PRO . 1.1 mt -65.02 146.25 55.26 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.604 -172.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 726' ' ' LYS . . . . . 0.41 ' HD2' ' HB2' ' A' ' 744' ' ' ALA . 34.3 mtpt -103.88 -10.58 18.08 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.464 -174.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 727' ' ' LEU . . . . . 0.475 ' HB2' HG23 ' A' ' 741' ' ' VAL . 0.8 OUTLIER -74.46 109.67 8.14 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 175.751 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 41.6 m80 -105.43 38.06 2.06 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -169.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -169.51 -176.99 2.62 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.719 0.295 . . . . 0.0 111.104 179.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 730' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -66.21 137.1 56.74 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.953 173.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 731' ' ' LEU . . . . . 0.598 ' HB3' ' HA ' ' A' ' 815' ' ' ILE . 40.4 tp -103.23 100.17 10.06 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.973 178.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 732' ' ' LYS . . . . . 0.48 ' HD3' ' HB3' ' A' ' 816' ' ' GLN . 32.6 mmtp -78.63 124.26 27.99 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.454 0.645 . . . . 0.0 112.09 -175.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 733' ' ' LEU . . . . . 0.638 ' HG ' ' HB3' ' A' ' 737' ' ' ASP . 7.9 mp -120.4 165.13 15.32 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.671 -1.15 . . . . 0.0 109.705 177.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 734' ' ' CYS . . . . . 0.5 ' O ' ' HB2' ' A' ' 737' ' ' ASP . 31.2 p -120.16 -179.27 3.89 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.702 171.008 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 735' ' ' LEU . . . . . 0.494 HD12 ' HG3' ' A' ' 819' ' ' ARG . 2.8 tt -57.88 116.5 3.52 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.938 0.399 . . . . 0.0 110.34 -179.161 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 736' ' ' GLY . . . . . 0.515 ' HA2' HG22 ' A' ' 786' ' ' THR . . . 91.64 3.39 68.82 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.458 176.137 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 737' ' ' ASP . . . . . 0.638 ' HB3' ' HG ' ' A' ' 733' ' ' LEU . 0.3 OUTLIER -72.47 158.21 36.15 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.973 0.416 . . . . 0.0 111.146 177.957 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 37.0 p-80 -116.66 153.68 31.89 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 171.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 739' ' ' SER . . . . . 0.728 ' HB2' ' OG1' ' A' ' 782' ' ' THR . 10.8 m -98.15 159.0 15.22 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 119.126 -1.03 . . . . 0.0 111.235 -174.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 740' ' ' SER . . . . . 0.539 ' H ' HD21 ' A' ' 731' ' ' LEU . 10.5 t -143.37 101.09 3.73 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.915 -1.038 . . . . 0.0 108.657 -174.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 741' ' ' VAL . . . . . 0.475 HG23 ' HB2' ' A' ' 727' ' ' LEU . 2.1 p -121.26 112.51 32.98 Favored Pre-proline 0 C--N 1.316 -0.864 0 CA-C-O 121.283 0.563 . . . . 0.0 110.266 -177.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 742' ' ' PRO . . . . . 0.662 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 4.5 Cg_exo -71.33 125.93 11.8 Favored 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 122.294 1.996 . . . . 0.0 109.863 178.141 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 743' ' ' VAL . . . . . 0.514 ' CG2' HD22 ' A' ' 725' ' ' LEU . 24.0 t -129.31 114.77 32.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -178.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 744' ' ' ALA . . . . . 0.49 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -81.59 101.6 10.1 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 171.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 745' ' ' LEU . . . . . 0.962 HD11 ' HB3' ' A' ' 778' ' ' TYR . 0.2 OUTLIER -83.94 168.2 16.25 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.258 -167.814 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 44.1 tptt -122.24 156.18 34.33 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.405 -177.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 747' ' ' GLY . . . . . 0.488 ' HA3' ' HB3' ' A' ' 721' ' ' PRO . . . 93.66 123.62 3.65 Favored Glycine 0 C--N 1.311 -0.827 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.378 -177.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 25.7 mp0 -106.69 114.45 28.56 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.119 0.485 . . . . 0.0 111.283 -173.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 130.69 -175.98 19.13 Favored Glycine 0 N--CA 1.446 -0.7 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 -177.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -70.57 95.07 0.61 Allowed 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.658 2.238 . . . . 0.0 112.392 178.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 751' ' ' PHE . . . . . 0.502 ' CE2' ' HA ' ' A' ' 800' ' ' ASP . 77.5 m-85 -113.34 140.88 47.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.522 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 752' ' ' THR . . . . . 0.752 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 86.6 m -91.05 104.61 17.17 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-O 121.344 0.592 . . . . 0.0 109.763 177.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 753' ' ' LEU . . . . . 0.564 ' CD1' HD22 ' A' ' 745' ' ' LEU . 1.8 tt -95.95 116.34 28.78 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.608 -171.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 754' ' ' THR . . . . . 0.458 HG23 ' HB2' ' A' ' 769' ' ' GLU . 1.0 OUTLIER -114.44 137.7 51.5 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.989 -179.1 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 755' ' ' TYR . . . . . 0.505 ' CD1' HD11 ' A' ' 793' ' ' LEU . 24.5 p90 -145.37 162.93 36.09 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 120.961 0.41 . . . . 0.0 111.541 178.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 756' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -128.73 121.13 27.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.677 -178.222 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 757' ' ' ILE . . . . . 0.521 HG13 HD13 ' A' ' 793' ' ' LEU . 3.5 mp -87.01 96.47 5.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 169.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 758' ' ' ILE . . . . . 0.715 HG22 ' HD3' ' A' ' 765' ' ' ARG . 2.3 pp -95.21 149.65 4.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 116.116 -0.493 . . . . 0.0 112.218 -169.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 759' ' ' GLU . . . . . 0.647 ' HG2' ' CE2' ' A' ' 791' ' ' TYR . 24.6 mt-10 -89.75 119.94 30.58 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.394 179.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 760' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -96.55 -3.1 43.68 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.346 0.593 . . . . 0.0 109.564 175.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 761' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -103.46 -21.74 13.74 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.245 178.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 762' ' ' SER . . . . . 0.593 ' HB2' ' OE1' ' A' ' 759' ' ' GLU . 69.7 m -140.64 -97.01 0.14 Allowed 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 120.557 -0.457 . . . . 0.0 111.569 174.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 763' ' ' SER . . . . . . . . . . . . . 50.5 p -174.17 -1.16 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.207 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -175.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 764' ' ' LYS . . . . . 0.457 ' C ' ' HG3' ' A' ' 759' ' ' GLU . 59.6 mtpt -85.73 56.84 4.14 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.616 0.722 . . . . 0.0 111.65 -173.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 765' ' ' ARG . . . . . 0.715 ' HD3' HG22 ' A' ' 758' ' ' ILE . 7.9 ttp180 -52.64 138.48 28.34 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 114.552 -1.204 . . . . 0.0 111.523 174.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 766' ' ' LYS . . . . . . . . . . . . . 9.7 tmtm? -115.98 135.45 53.95 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-O 121.088 0.47 . . . . 0.0 110.409 -177.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 767' ' ' THR . . . . . . . . . . . . . 27.7 m -109.04 137.03 47.59 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.833 -174.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 768' ' ' PHE . . . . . 0.495 ' HB3' ' CE1' ' A' ' 755' ' ' TYR . 3.2 t80 -139.72 139.74 36.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.96 0.41 . . . . 0.0 110.643 175.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 769' ' ' GLU . . . . . 0.458 ' HB2' HG23 ' A' ' 754' ' ' THR . 35.5 tt0 -129.76 129.98 44.81 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.848 -179.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 770' ' ' ILE . . . . . 0.531 HG22 HG22 ' A' ' 773' ' ' ILE . 5.0 mt -122.82 111.87 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 176.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 771' ' ' LYS . . . . . 0.637 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 9.5 mtpt -85.1 152.04 23.69 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-O 121.492 0.663 . . . . 0.0 111.328 -174.01 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 772' ' ' GLU . . . . . 0.415 ' O ' ' HG3' ' A' ' 774' ' ' LYS . 5.4 mt-10 54.7 47.11 23.24 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.211 -1.359 . . . . 0.0 112.532 177.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 773' ' ' ILE . . . . . 0.931 HD13 HD13 ' A' ' 745' ' ' LEU . 0.5 OUTLIER -73.8 119.89 21.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 173.835 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 774' ' ' LYS . . . . . 0.415 ' HG3' ' O ' ' A' ' 772' ' ' GLU . 73.0 mttt -118.21 30.66 7.11 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -177.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 775' ' ' THR . . . . . 0.686 ' H ' HD12 ' A' ' 773' ' ' ILE . 0.6 OUTLIER -95.88 -72.24 0.64 Allowed 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 114.957 -1.019 . . . . 0.0 113.381 -171.394 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 776' ' ' ASN . . . . . 0.595 ' HB2' ' O ' ' A' ' 775' ' ' THR . 0.9 OUTLIER 83.82 4.67 0.78 Allowed 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.045 0.938 . . . . 0.0 110.389 -175.601 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 777' ' ' GLU . . . . . 0.49 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 6.9 tp10 -161.69 78.3 0.54 Allowed 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 -179.47 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 778' ' ' TYR . . . . . 0.962 ' HB3' HD11 ' A' ' 745' ' ' LEU . 82.4 t80 -132.86 125.65 30.44 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.115 0.483 . . . . 0.0 111.69 -169.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 779' ' ' VAL . . . . . 0.662 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 21.6 t -84.16 115.97 27.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.051 176.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 780' ' ' ILE . . . . . 0.479 HD12 HG21 ' A' ' 743' ' ' VAL . 77.2 mt -89.84 135.92 25.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.173 -0.921 . . . . 0.0 110.724 -176.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 781' ' ' LYS . . . . . 0.415 ' HD3' ' C ' ' A' ' 780' ' ' ILE . 0.0 OUTLIER -118.89 109.12 15.63 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 177.682 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 782' ' ' THR . . . . . 0.728 ' OG1' ' HB2' ' A' ' 739' ' ' SER . 82.6 p -82.6 148.62 58.75 Favored Pre-proline 0 C--O 1.244 0.811 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.862 -176.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 783' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -49.27 157.0 2.17 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 124.09 3.193 . . . . 0.0 113.447 -178.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 784' ' ' VAL . . . . . 0.533 HG12 HG23 ' A' ' 786' ' ' THR . 70.1 t -61.19 131.24 26.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.086 -0.961 . . . . 0.0 112.803 -174.176 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 785' ' ' PHE . . . . . 0.415 ' C ' ' H ' ' A' ' 787' ' ' THR . 80.0 m-85 -103.68 88.96 3.19 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.01 177.164 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 786' ' ' THR . . . . . 0.533 HG23 HG12 ' A' ' 784' ' ' VAL . 32.5 p -83.47 29.42 0.51 Allowed 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 122.077 0.941 . . . . 0.0 110.284 178.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 787' ' ' THR . . . . . 0.415 ' H ' ' C ' ' A' ' 785' ' ' PHE . 2.1 m -159.65 105.46 1.63 Allowed 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.941 -175.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 788' ' ' GLY . . . . . 0.825 ' HA2' HG22 ' A' ' 817' ' ' VAL . . . -49.46 137.76 19.55 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.75 -0.659 . . . . 0.0 113.648 172.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 789' ' ' GLY . . . . . 0.514 ' H ' HG13 ' A' ' 817' ' ' VAL . . . -176.84 -178.01 46.24 Favored Glycine 0 N--CA 1.44 -1.062 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -178.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -118.5 119.66 35.19 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 117.851 0.826 . . . . 0.0 109.029 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 791' ' ' TYR . . . . . 0.647 ' CE2' ' HG2' ' A' ' 759' ' ' GLU . 92.6 m-85 -122.24 148.88 44.44 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.582 -175.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 792' ' ' ILE . . . . . 0.586 ' O ' HG13 ' A' ' 758' ' ' ILE . 19.9 mt -124.64 114.33 40.21 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.065 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 172.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 793' ' ' LEU . . . . . 0.524 HD12 ' N ' ' A' ' 794' ' ' SER . 0.5 OUTLIER -84.39 115.73 22.67 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.893 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 794' ' ' SER . . . . . 0.524 ' N ' HD12 ' A' ' 793' ' ' LEU . 23.1 m -130.51 161.42 31.5 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 114.701 -1.136 . . . . 0.0 109.084 -174.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 795' ' ' LEU . . . . . 0.696 HD11 ' O ' ' A' ' 723' ' ' ALA . 27.6 mt -87.3 148.07 25.24 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 120.813 0.34 . . . . 0.0 110.897 -177.022 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 796' ' ' VAL . . . . . . . . . . . . . 69.7 t -105.17 -56.03 5.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.004 178.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 797' ' ' SER . . . . . 0.593 ' HA ' ' HG ' ' A' ' 808' ' ' LEU . 95.9 p -176.47 154.14 1.25 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.202 -172.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 798' ' ' ILE . . . . . 0.615 ' HA ' ' O ' ' A' ' 752' ' ' THR . 12.4 tt -127.51 164.04 29.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 177.149 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 799' ' ' LYS . . . . . 0.752 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 28.0 tttt -131.19 120.17 22.91 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 120.668 0.271 . . . . 0.0 111.058 -176.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 800' ' ' ASP . . . . . 0.502 ' HA ' ' CE2' ' A' ' 751' ' ' PHE . 19.8 t70 -69.18 154.63 41.74 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.312 173.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 9.0 m -59.32 -13.77 9.26 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 124.042 0.839 . . . . 0.0 112.994 -170.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 52.1 p -93.47 -0.87 56.24 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.466 0.651 . . . . 0.0 110.136 179.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 803' ' ' GLY . . . . . 0.519 ' HA2' ' HE2' ' A' ' 799' ' ' LYS . . . 85.74 46.87 5.29 Favored Glycine 0 N--CA 1.444 -0.807 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.702 -176.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 804' ' ' CYS . . . . . 0.435 ' HB2' ' HB3' ' A' ' 800' ' ' ASP . 61.3 m -116.71 110.76 18.88 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 177.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 805' ' ' VAL . . . . . 0.56 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 9.8 p -85.47 133.61 29.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.301 0.572 . . . . 0.0 111.006 -175.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 806' ' ' VAL . . . . . 0.511 ' HB ' HG22 ' A' ' 798' ' ' ILE . 84.5 t -112.02 133.76 56.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.009 178.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -70.49 113.19 4.71 Favored Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 177.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 808' ' ' LEU . . . . . 0.593 ' HG ' ' HA ' ' A' ' 797' ' ' SER . 40.0 mt -81.65 130.04 34.91 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.264 0.554 . . . . 0.0 112.462 -172.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 39.8 m -148.53 86.27 1.53 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.082 173.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 810' ' ' GLN . . . . . 0.616 ' HB3' ' HD2' ' A' ' 811' ' ' PRO . 75.1 mt-30 -135.54 173.27 5.89 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 174.229 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 811' ' ' PRO . . . . . 0.616 ' HD2' ' HB3' ' A' ' 810' ' ' GLN . 86.6 Cg_exo -45.28 139.44 9.01 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 122.654 2.236 . . . . 0.0 114.68 -177.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -111.42 166.15 11.37 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.301 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 813' ' ' ALA . . . . . . . . . . . . . . . -116.42 154.14 30.83 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.357 -178.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 814' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -120.22 108.7 14.52 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.18 0.514 . . . . 0.0 110.498 177.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 815' ' ' ILE . . . . . 0.598 ' HA ' ' HB3' ' A' ' 731' ' ' LEU . 4.8 mp -97.5 123.71 50.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.481 -179.085 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 816' ' ' GLN . . . . . 0.48 ' HB3' ' HD3' ' A' ' 732' ' ' LYS . 0.1 OUTLIER -118.39 106.31 12.6 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -179.873 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 817' ' ' VAL . . . . . 0.825 HG22 ' HA2' ' A' ' 788' ' ' GLY . 0.5 OUTLIER -100.61 143.61 13.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -179.879 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 818' ' ' ARG . . . . . . . . . . . . . 20.9 tpt180 -124.3 123.55 40.47 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 121.086 0.47 . . . . 0.0 110.683 -176.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 819' ' ' ARG . . . . . 0.617 ' HB2' ' H ' ' A' ' 788' ' ' GLY . 11.2 ttt180 -90.35 114.28 26.33 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.254 179.031 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 820' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 . . . . . 0 C--N 1.32 -0.705 0 CA-C-N 115.687 -0.688 . . . . 99.989999999999995 110.353 178.561 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 718' ' ' ARG . . . . . 0.487 ' HA ' ' NE ' ' A' ' 718' ' ' ARG . 4.1 mmp_? . . . . . 0 CA--C 1.502 -0.873 0 CA-C-O 122.114 0.959 . . . . 0.0 111.463 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 719' ' ' VAL . . . . . 0.629 HG22 ' H ' ' A' ' 720' ' ' LYS . 6.0 p -132.39 179.68 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.392 0 CA-C-N 113.735 -1.575 . . . . 0.0 107.477 -177.342 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 720' ' ' LYS . . . . . 0.629 ' H ' HG22 ' A' ' 719' ' ' VAL . 55.6 mtpt -109.19 88.2 5.59 Favored Pre-proline 0 C--N 1.301 -1.503 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 177.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 721' ' ' PRO . . . . . 0.578 ' HD3' ' O ' ' A' ' 719' ' ' VAL . 56.4 Cg_endo -88.04 144.91 6.25 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 123.381 2.721 . . . . 0.0 112.426 -174.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 722' ' ' SER . . . . . 0.609 ' HA ' HD22 ' A' ' 808' ' ' LEU . 61.8 m -169.27 -156.52 0.15 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -172.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 723' ' ' ALA . . . . . 0.676 ' HB1' HG21 ' A' ' 743' ' ' VAL . . . -152.2 143.51 23.31 Favored 'General case' 0 N--CA 1.45 -0.469 0 O-C-N 122.273 -0.267 . . . . 0.0 110.845 179.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 724' ' ' SER . . . . . 0.429 ' HB2' ' OE1' ' A' ' 810' ' ' GLN . 26.0 t -132.58 99.5 4.66 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 725' ' ' LEU . . . . . 0.576 HD21 HD22 ' A' ' 793' ' ' LEU . 4.9 mp -62.42 143.4 57.1 Favored 'General case' 0 N--CA 1.426 -1.632 0 CA-C-O 122.428 1.109 . . . . 0.0 112.407 -176.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 30.8 mtpt -94.49 -16.47 23.31 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 113.26 -1.791 . . . . 0.0 110.417 -176.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 727' ' ' LEU . . . . . 0.501 ' HB2' ' HD2' ' A' ' 742' ' ' PRO . 1.5 tt -76.04 109.29 9.57 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 177.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 35.9 m80 -110.47 48.84 0.88 Allowed 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -171.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -177.86 177.78 1.04 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.13 176.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 730' ' ' ASP . . . . . 0.428 ' HA ' ' O ' ' A' ' 814' ' ' LYS . 1.4 m-20 -67.01 134.94 52.94 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.967 0.413 . . . . 0.0 110.131 175.244 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 731' ' ' LEU . . . . . 0.58 ' HB3' ' HA ' ' A' ' 815' ' ' ILE . 28.2 tp -93.08 105.95 17.98 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.516 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 732' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -76.98 104.62 7.57 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.656 -174.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 733' ' ' LEU . . . . . 0.455 HD11 ' CB ' ' A' ' 739' ' ' SER . 85.2 mt -116.77 155.57 28.7 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.498 177.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 734' ' ' CYS . . . . . 0.473 ' O ' ' HB2' ' A' ' 737' ' ' ASP . 36.5 m -105.34 -173.38 2.29 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.84 179.101 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 735' ' ' LEU . . . . . 0.476 HD22 ' HB3' ' A' ' 819' ' ' ARG . 24.5 tp -67.05 135.8 54.25 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 178.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 736' ' ' GLY . . . . . 0.485 ' HA2' ' HA ' ' A' ' 786' ' ' THR . . . 80.02 7.84 88.17 Favored Glycine 0 C--N 1.321 -0.298 0 C-N-CA 120.339 -0.934 . . . . 0.0 112.673 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 737' ' ' ASP . . . . . 0.473 ' HB2' ' O ' ' A' ' 734' ' ' CYS . 0.7 OUTLIER -87.47 148.77 24.8 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.51 0.671 . . . . 0.0 112.628 179.078 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 738' ' ' HIS . . . . . 0.444 ' HB2' ' O ' ' A' ' 782' ' ' THR . 40.3 p-80 -110.93 164.98 12.24 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 106.642 -1.614 . . . . 0.0 106.642 166.19 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 739' ' ' SER . . . . . 0.578 ' HB2' HD23 ' A' ' 731' ' ' LEU . 4.5 p -109.99 162.7 14.27 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 119.277 -0.969 . . . . 0.0 112.0 -171.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 23.4 t -138.88 100.91 4.17 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 114.961 -1.018 . . . . 0.0 108.783 177.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 741' ' ' VAL . . . . . 0.529 HG11 HD13 ' A' ' 793' ' ' LEU . 1.5 p -117.1 111.45 40.54 Favored Pre-proline 0 C--N 1.318 -0.785 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.115 -179.015 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 742' ' ' PRO . . . . . 0.661 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 4.6 Cg_endo -76.63 134.07 14.82 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 122.578 2.185 . . . . 0.0 111.58 -179.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 743' ' ' VAL . . . . . 0.676 HG21 ' HB1' ' A' ' 723' ' ' ALA . 1.6 p -131.32 120.91 47.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 121.51 0.671 . . . . 0.0 112.249 176.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 744' ' ' ALA . . . . . 0.475 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -83.22 103.25 12.48 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 169.072 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 745' ' ' LEU . . . . . 0.934 HD13 HD13 ' A' ' 773' ' ' ILE . 0.3 OUTLIER -85.36 166.26 16.58 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 114.622 -1.172 . . . . 0.0 111.538 -167.092 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -120.14 148.95 43.0 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.914 -176.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 747' ' ' GLY . . . . . 0.431 ' HA3' ' HB3' ' A' ' 721' ' ' PRO . . . 100.28 127.2 5.96 Favored Glycine 0 C--N 1.316 -0.546 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 -173.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -102.08 124.59 47.94 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.327 0.584 . . . . 0.0 112.279 -170.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 108.06 -174.11 18.79 Favored Glycine 0 CA--C 1.501 -0.815 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.542 178.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 750' ' ' PRO . . . . . 0.547 ' HB3' ' HE2' ' A' ' 774' ' ' LYS . 72.8 Cg_endo -65.93 100.62 0.44 Allowed 'Trans proline' 0 C--O 1.236 0.384 0 C-N-CA 123.317 2.678 . . . . 0.0 113.619 -177.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 751' ' ' PHE . . . . . 0.69 ' CE2' ' HA ' ' A' ' 800' ' ' ASP . 62.1 m-85 -113.99 144.18 43.51 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.701 177.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 752' ' ' THR . . . . . 0.731 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 96.1 m -89.21 103.17 15.81 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 177.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 753' ' ' LEU . . . . . 0.436 HD22 HD22 ' A' ' 745' ' ' LEU . 24.9 tp -91.28 122.65 34.09 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.407 -1.27 . . . . 0.0 110.093 -171.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 754' ' ' THR . . . . . 0.441 HG23 ' HB2' ' A' ' 769' ' ' GLU . 0.6 OUTLIER -122.57 131.37 53.8 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.555 0.217 . . . . 0.0 110.748 179.795 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 755' ' ' TYR . . . . . 0.663 ' CE1' ' HB3' ' A' ' 768' ' ' PHE . 24.2 p90 -140.23 154.09 46.77 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.076 0.465 . . . . 0.0 111.453 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 756' ' ' ASP . . . . . 0.485 ' O ' ' HA ' ' A' ' 793' ' ' LEU . 2.3 p30 -107.97 134.45 50.86 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.789 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 757' ' ' ILE . . . . . 0.561 HG21 ' HZ ' ' A' ' 785' ' ' PHE . 4.5 mp -103.73 94.97 3.47 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 167.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 758' ' ' ILE . . . . . 0.599 HG22 ' HD3' ' A' ' 765' ' ' ARG . 2.5 pp -100.77 145.99 10.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.769 -169.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 759' ' ' GLU . . . . . 0.431 ' OE1' ' HB2' ' A' ' 762' ' ' SER . 13.0 mt-10 -83.82 128.18 34.35 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.152 -179.643 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 760' ' ' THR . . . . . 0.463 HG23 ' OD2' ' A' ' 790' ' ' ASP . 0.1 OUTLIER -95.7 -2.93 46.96 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.229 0.538 . . . . 0.0 110.055 175.586 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 761' ' ' PHE . . . . . . . . . . . . . 35.9 p90 -100.87 -28.81 12.57 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.152 176.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 762' ' ' SER . . . . . 0.431 ' HB2' ' OE1' ' A' ' 759' ' ' GLU . 66.3 m -135.05 -103.12 0.22 Allowed 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 120.38 -0.528 . . . . 0.0 111.829 178.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 763' ' ' SER . . . . . . . . . . . . . 35.4 p -173.17 4.64 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -173.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 764' ' ' LYS . . . . . 0.408 ' HB2' ' CD ' ' A' ' 759' ' ' GLU . 10.0 mtmp? -86.85 58.65 5.19 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.738 0.78 . . . . 0.0 111.25 -174.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 765' ' ' ARG . . . . . 0.599 ' HD3' HG22 ' A' ' 758' ' ' ILE . 10.9 ttp180 -49.84 147.24 3.9 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 114.124 -1.398 . . . . 0.0 112.869 176.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 766' ' ' LYS . . . . . 0.471 ' HD3' ' N ' ' A' ' 767' ' ' THR . 9.6 tmtm? -119.73 146.55 45.53 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 114.935 -1.03 . . . . 0.0 108.688 177.26 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 767' ' ' THR . . . . . 0.471 ' N ' ' HD3' ' A' ' 766' ' ' LYS . 89.1 m -123.31 131.36 53.64 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-O 120.62 0.248 . . . . 0.0 110.508 177.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 768' ' ' PHE . . . . . 0.663 ' HB3' ' CE1' ' A' ' 755' ' ' TYR . 1.8 t80 -127.78 135.06 49.58 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 178.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 769' ' ' GLU . . . . . 0.441 ' HB2' HG23 ' A' ' 754' ' ' THR . 34.5 tt0 -128.7 128.65 44.5 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.666 -177.244 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 770' ' ' ILE . . . . . 0.522 HG22 HG22 ' A' ' 773' ' ' ILE . 4.7 mt -123.12 113.33 37.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 109.182 -0.674 . . . . 0.0 109.182 177.117 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 771' ' ' LYS . . . . . 0.584 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 0.1 OUTLIER -84.3 155.76 22.25 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-O 121.181 0.515 . . . . 0.0 111.506 -175.914 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 772' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 53.72 44.57 29.46 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.316 -1.311 . . . . 0.0 112.318 176.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 773' ' ' ILE . . . . . 0.934 HD13 HD13 ' A' ' 745' ' ' LEU . 0.5 OUTLIER -73.44 112.1 9.33 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 172.644 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 774' ' ' LYS . . . . . 0.547 ' HE2' ' HB3' ' A' ' 750' ' ' PRO . 71.3 mttt -107.8 26.37 10.41 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -178.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 775' ' ' THR . . . . . 0.645 ' H ' HD12 ' A' ' 773' ' ' ILE . 0.4 OUTLIER -95.91 -74.8 0.54 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.067 -0.969 . . . . 0.0 113.488 -165.71 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 776' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' A' ' 775' ' ' THR . 10.6 m120 83.53 7.86 0.65 Allowed 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.344 1.057 . . . . 0.0 111.13 -175.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 777' ' ' GLU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 21.8 mt-10 -159.64 83.48 0.75 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.023 -0.99 . . . . 0.0 108.331 174.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 778' ' ' TYR . . . . . 0.773 ' HB3' HD11 ' A' ' 745' ' ' LEU . 83.2 t80 -129.61 129.39 44.3 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.911 -169.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 779' ' ' VAL . . . . . 0.661 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 14.1 t -89.42 111.26 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.88 0 CA-C-O 121.157 0.503 . . . . 0.0 110.213 178.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 780' ' ' ILE . . . . . 0.444 ' HB ' HG13 ' A' ' 741' ' ' VAL . 72.9 mt -79.15 145.12 9.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.273 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 781' ' ' LYS . . . . . 0.432 ' HA ' ' O ' ' A' ' 739' ' ' SER . 3.7 mppt? -130.3 108.8 10.28 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 174.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 782' ' ' THR . . . . . 0.444 ' O ' ' HB2' ' A' ' 738' ' ' HIS . 30.9 p -77.19 141.37 66.78 Favored Pre-proline 0 N--CA 1.444 -0.748 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 -178.28 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 783' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -55.9 150.02 48.47 Favored 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 122.918 2.412 . . . . 0.0 111.274 -177.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 784' ' ' VAL . . . . . . . . . . . . . 14.9 p -61.81 133.03 27.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.433 0.635 . . . . 0.0 110.812 -172.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 785' ' ' PHE . . . . . 0.561 ' HZ ' HG21 ' A' ' 757' ' ' ILE . 88.9 m-85 -90.24 -37.47 14.09 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.834 -173.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 786' ' ' THR . . . . . 0.485 ' HA ' ' HA2' ' A' ' 736' ' ' GLY . 28.3 p 57.97 3.39 0.22 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.507 0.723 . . . . 0.0 111.744 -178.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 787' ' ' THR . . . . . 0.436 ' H ' ' C ' ' A' ' 785' ' ' PHE . 42.8 m -134.37 118.53 17.56 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.868 -179.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 788' ' ' GLY . . . . . 0.645 ' HA2' HG12 ' A' ' 817' ' ' VAL . . . -54.4 108.66 0.94 Allowed Glycine 0 N--CA 1.447 -0.568 0 CA-C-N 115.523 -0.762 . . . . 0.0 113.224 174.349 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 789' ' ' GLY . . . . . 0.501 ' H ' ' HB ' ' A' ' 817' ' ' VAL . . . -155.56 167.16 33.0 Favored Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 174.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 790' ' ' ASP . . . . . 0.463 ' OD2' HG23 ' A' ' 760' ' ' THR . 0.2 OUTLIER -109.3 129.39 55.52 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 117.567 0.684 . . . . 0.0 109.906 179.335 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 791' ' ' TYR . . . . . . . . . . . . . 48.7 m-85 -130.0 156.17 44.91 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.33 -0.85 . . . . 0.0 110.213 -174.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 792' ' ' ILE . . . . . 0.519 ' O ' HG13 ' A' ' 758' ' ' ILE . 14.5 mt -128.45 119.07 49.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 109.354 -0.609 . . . . 0.0 109.354 174.241 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 793' ' ' LEU . . . . . 0.576 HD22 HD21 ' A' ' 725' ' ' LEU . 10.1 tt -84.51 107.36 16.71 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 794' ' ' SER . . . . . . . . . . . . . 3.7 m -116.23 170.87 8.2 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.14 -179.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 795' ' ' LEU . . . . . . . . . . . . . 22.8 mt -97.68 129.6 44.73 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.603 0.239 . . . . 0.0 110.977 -175.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 796' ' ' VAL . . . . . . . . . . . . . 75.0 t -88.94 -56.1 5.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.812 -179.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 797' ' ' SER . . . . . 0.511 ' HA ' ' HG ' ' A' ' 808' ' ' LEU . 24.4 m -173.39 164.15 4.59 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.128 -173.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 798' ' ' ILE . . . . . 0.587 ' O ' ' HA ' ' A' ' 805' ' ' VAL . 11.5 tt -136.15 167.55 24.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 176.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 799' ' ' LYS . . . . . 0.731 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 83.6 tttt -136.04 120.56 18.18 Favored 'General case' 0 C--N 1.315 -0.932 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.248 -176.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 800' ' ' ASP . . . . . 0.69 ' HA ' ' CE2' ' A' ' 751' ' ' PHE . 6.2 m-20 -63.12 156.46 24.98 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.279 174.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 4.0 m -64.81 -5.22 5.47 Favored 'General case' 0 CA--C 1.535 0.397 0 O-C-N 124.151 0.907 . . . . 0.0 112.212 -174.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 8.9 t -104.98 12.63 32.11 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 121.757 0.789 . . . . 0.0 109.617 175.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 803' ' ' GLY . . . . . 0.49 ' HA2' ' CE ' ' A' ' 799' ' ' LYS . . . 74.71 46.85 16.7 Favored Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.121 -0.945 . . . . 0.0 112.831 -179.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 804' ' ' CYS . . . . . 0.597 ' HB3' ' HB2' ' A' ' 800' ' ' ASP . 53.7 t -109.87 106.23 15.73 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 177.181 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 805' ' ' VAL . . . . . 0.587 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 2.6 t -86.69 104.95 14.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.591 0.71 . . . . 0.0 110.704 -175.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 806' ' ' VAL . . . . . . . . . . . . . 39.5 t -90.13 138.54 19.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.065 -178.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -74.96 113.21 3.91 Favored Glycine 0 N--CA 1.45 -0.431 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.662 178.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 808' ' ' LEU . . . . . 0.609 HD22 ' HA ' ' A' ' 722' ' ' SER . 30.8 mt -80.17 132.02 35.82 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.662 0.615 . . . . 0.0 112.662 -174.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 20.4 m -143.97 85.65 1.82 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.52 171.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 810' ' ' GLN . . . . . 0.494 ' HB3' ' O ' ' A' ' 723' ' ' ALA . 1.0 OUTLIER -146.69 173.91 3.83 Favored Pre-proline 0 CA--C 1.542 0.645 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.363 177.501 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 811' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -44.0 154.47 0.26 Allowed 'Trans proline' 0 C--N 1.359 1.08 0 C-N-CA 123.782 2.988 . . . . 0.0 116.294 -173.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -131.35 167.83 18.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 113.797 -1.547 . . . . 0.0 109.613 -178.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 813' ' ' ALA . . . . . . . . . . . . . . . -127.69 148.65 50.4 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.748 0.308 . . . . 0.0 110.505 178.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 814' ' ' LYS . . . . . 0.428 ' O ' ' HA ' ' A' ' 730' ' ' ASP . 50.3 tttm -110.17 112.79 24.99 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.14 0.495 . . . . 0.0 110.704 -176.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 815' ' ' ILE . . . . . 0.58 ' HA ' ' HB3' ' A' ' 731' ' ' LEU . 5.3 mp -98.21 127.66 50.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.855 -178.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 816' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -114.42 110.6 20.13 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.742 0.306 . . . . 0.0 110.842 -178.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 817' ' ' VAL . . . . . 0.645 HG12 ' HA2' ' A' ' 788' ' ' GLY . 61.3 t -105.66 127.66 60.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 175.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 818' ' ' ARG . . . . . . . . . . . . . 25.4 mmt180 -148.25 144.51 27.71 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 121.849 -0.532 . . . . 0.0 111.319 177.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 819' ' ' ARG . . . . . 0.476 ' HB3' HD22 ' A' ' 735' ' ' LEU . 0.0 OUTLIER -91.96 147.24 23.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.408 177.401 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 820' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 . . . . . 0 C--N 1.32 -0.68 0 CA-C-N 116.235 -0.438 . . . . 99.989999999999995 109.983 178.916 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 718' ' ' ARG . . . . . . . . . . . . . 13.8 tpp180 . . . . . 0 CA--C 1.51 -0.558 0 CA-C-O 121.401 0.62 . . . . 0.0 110.399 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 719' ' ' VAL . . . . . 0.669 HG22 ' H ' ' A' ' 720' ' ' LYS . 5.0 p -143.42 -176.56 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 -178.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 720' ' ' LYS . . . . . 0.669 ' H ' HG22 ' A' ' 719' ' ' VAL . 27.7 mtpp -110.28 85.62 4.6 Favored Pre-proline 0 C--N 1.308 -1.224 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 177.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 721' ' ' PRO . . . . . 0.583 ' HD3' ' O ' ' A' ' 719' ' ' VAL . 46.3 Cg_endo -88.25 140.76 4.76 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 123.08 2.52 . . . . 0.0 112.115 -173.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 25.2 m -174.83 -151.44 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -170.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 723' ' ' ALA . . . . . 0.562 ' HA ' ' HA ' ' A' ' 745' ' ' LEU . . . -146.65 149.0 32.63 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 174.054 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 28.5 t -131.66 98.38 4.47 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 725' ' ' LEU . . . . . 0.563 HD21 HD21 ' A' ' 795' ' ' LEU . 2.0 mt -66.79 143.69 56.75 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-O 121.441 0.638 . . . . 0.0 110.984 -171.053 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 35.6 mtpt -94.45 -19.61 20.42 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.869 -1.06 . . . . 0.0 111.079 -174.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 727' ' ' LEU . . . . . 0.686 HD23 ' HB1' ' A' ' 813' ' ' ALA . 25.9 tp -56.67 129.54 41.5 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.04 178.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 8.3 t-160 -117.82 16.28 14.37 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.943 -173.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 8.7 p80 -169.84 -178.8 3.05 Favored 'General case' 0 N--CA 1.465 0.309 0 O-C-N 122.311 -0.243 . . . . 0.0 110.886 177.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 730' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.32 132.25 52.03 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.159 0.504 . . . . 0.0 110.726 175.048 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 731' ' ' LEU . . . . . 0.637 HD21 ' H ' ' A' ' 740' ' ' SER . 49.3 tp -91.56 102.1 14.75 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.07 177.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 732' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -77.51 122.57 25.42 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.647 -174.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 733' ' ' LEU . . . . . 0.633 ' HG ' ' HB3' ' A' ' 737' ' ' ASP . 7.8 mp -120.79 164.22 16.94 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.708 178.242 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 734' ' ' CYS . . . . . 0.564 ' O ' ' HB2' ' A' ' 737' ' ' ASP . 66.1 m -116.49 -178.27 3.38 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.089 173.001 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 735' ' ' LEU . . . . . 0.475 ' HB2' ' HA ' ' A' ' 819' ' ' ARG . 31.0 tp -63.42 122.92 17.44 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.894 0.378 . . . . 0.0 111.236 -176.11 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 82.43 7.64 87.3 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.438 -0.887 . . . . 0.0 112.384 178.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 737' ' ' ASP . . . . . 0.633 ' HB3' ' HG ' ' A' ' 733' ' ' LEU . 0.2 OUTLIER -72.2 154.04 41.26 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.909 0.385 . . . . 0.0 110.953 176.076 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 37.9 p-80 -112.85 148.49 34.79 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 171.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 739' ' ' SER . . . . . 0.481 ' HB3' HD23 ' A' ' 731' ' ' LEU . 4.6 m -94.93 158.09 15.63 Favored 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 119.966 -0.694 . . . . 0.0 110.927 -172.322 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 740' ' ' SER . . . . . 0.637 ' H ' HD21 ' A' ' 731' ' ' LEU . 12.5 p -144.19 100.85 3.62 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.213 -178.543 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 741' ' ' VAL . . . . . 0.479 HG11 HD13 ' A' ' 793' ' ' LEU . 0.4 OUTLIER -117.51 119.12 34.68 Favored Pre-proline 0 C--N 1.314 -0.968 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.459 179.973 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 742' ' ' PRO . . . . . 0.717 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 10.1 Cg_endo -80.86 134.12 9.42 Favored 'Trans proline' 0 N--CA 1.435 -1.93 0 C-N-CA 121.712 1.608 . . . . 0.0 110.649 -179.482 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 743' ' ' VAL . . . . . 0.519 ' CG2' HD22 ' A' ' 725' ' ' LEU . 49.0 t -132.77 119.64 38.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 121.336 0.588 . . . . 0.0 111.913 -178.507 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 744' ' ' ALA . . . . . 0.618 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -81.77 95.33 7.24 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 122.129 0.966 . . . . 0.0 108.653 170.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 745' ' ' LEU . . . . . 0.83 HD11 ' HB3' ' A' ' 778' ' ' TYR . 1.9 mt -77.84 159.86 28.69 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.045 -1.434 . . . . 0.0 111.384 -168.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 8.5 tptp -111.58 166.47 11.12 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.626 -178.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 747' ' ' GLY . . . . . . . . . . . . . . . 96.1 124.87 4.64 Favored Glycine 0 C--N 1.312 -0.756 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.714 -173.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 748' ' ' GLN . . . . . 0.442 ' C ' ' HE1' ' A' ' 751' ' ' PHE . 26.6 mm-40 -103.57 95.51 6.11 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 122.676 -0.308 . . . . 0.0 111.026 -176.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 134.48 -164.73 24.59 Favored Glycine 0 C--O 1.223 -0.589 0 N-CA-C 111.269 -0.732 . . . . 0.0 111.269 -178.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -74.25 94.35 0.9 Allowed 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.719 2.279 . . . . 0.0 112.084 179.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 751' ' ' PHE . . . . . 0.73 ' CE2' ' HA ' ' A' ' 800' ' ' ASP . 81.2 m-85 -115.71 141.67 47.77 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.585 -179.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 752' ' ' THR . . . . . 0.737 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 73.5 m -97.63 105.73 17.92 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-O 121.709 0.766 . . . . 0.0 109.352 -179.319 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 753' ' ' LEU . . . . . 0.694 HD13 HD22 ' A' ' 745' ' ' LEU . 3.9 tt -105.11 114.1 28.09 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 114.47 -1.241 . . . . 0.0 110.015 -168.206 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 754' ' ' THR . . . . . 0.459 HG23 ' HB2' ' A' ' 769' ' ' GLU . 1.5 m -107.9 136.3 47.84 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.769 -176.186 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 755' ' ' TYR . . . . . 0.404 ' CE1' ' HB3' ' A' ' 768' ' ' PHE . 26.2 p90 -135.6 159.6 41.11 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.036 0.446 . . . . 0.0 111.694 179.146 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 756' ' ' ASP . . . . . 0.588 ' OD2' ' HB3' ' A' ' 794' ' ' SER . 3.1 p30 -118.53 128.33 54.47 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.447 -178.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 757' ' ' ILE . . . . . 0.526 HG13 HD12 ' A' ' 793' ' ' LEU . 4.2 mp -98.18 94.04 3.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 167.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 758' ' ' ILE . . . . . 0.541 HG13 ' O ' ' A' ' 792' ' ' ILE . 2.6 pp -99.38 142.45 15.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-O 121.552 0.692 . . . . 0.0 112.033 -169.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 759' ' ' GLU . . . . . 0.559 ' HG2' ' CD2' ' A' ' 791' ' ' TYR . 24.8 mt-10 -96.54 101.14 12.72 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.999 -1.0 . . . . 0.0 110.145 -171.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 760' ' ' THR . . . . . 0.461 HG23 ' HB2' ' A' ' 790' ' ' ASP . 0.0 OUTLIER -87.91 0.81 55.38 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.382 -169.742 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 761' ' ' PHE . . . . . 0.424 ' CE1' ' HB3' ' A' ' 759' ' ' GLU . 46.2 p90 -85.43 -10.05 56.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.703 177.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 762' ' ' SER . . . . . . . . . . . . . 18.9 p -144.83 -98.57 0.1 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.802 175.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 763' ' ' SER . . . . . . . . . . . . . 73.8 p -160.87 16.73 0.12 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.251 0.548 . . . . 0.0 110.325 179.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 764' ' ' LYS . . . . . 0.445 ' HZ2' ' CD ' ' A' ' 759' ' ' GLU . 7.4 mtpm? -90.16 174.29 7.7 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.47 -175.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 765' ' ' ARG . . . . . 0.494 ' HD3' HG22 ' A' ' 758' ' ' ILE . 16.4 ttp180 -165.68 146.79 7.03 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-O 120.974 0.416 . . . . 0.0 111.666 -173.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 766' ' ' LYS . . . . . 0.676 ' HD3' ' N ' ' A' ' 767' ' ' THR . 10.4 tmtt? -123.48 147.59 47.04 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 178.168 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 767' ' ' THR . . . . . 0.676 ' N ' ' HD3' ' A' ' 766' ' ' LYS . 62.0 m -132.31 141.92 49.15 Favored 'General case' 0 C--N 1.314 -0.975 0 O-C-N 122.301 -0.25 . . . . 0.0 111.618 -176.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 768' ' ' PHE . . . . . 0.404 ' HB3' ' CE1' ' A' ' 755' ' ' TYR . 2.9 t80 -145.49 144.35 30.52 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.724 0.297 . . . . 0.0 110.536 176.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 769' ' ' GLU . . . . . 0.459 ' HB2' HG23 ' A' ' 754' ' ' THR . 41.2 tt0 -127.06 126.05 42.4 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.498 -175.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 5.2 mm -107.22 103.39 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 178.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 771' ' ' LYS . . . . . 0.486 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 12.3 mtpt -83.22 149.93 26.51 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 120.289 -0.564 . . . . 0.0 110.648 -179.053 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 772' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 50.96 50.46 19.06 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.488 -1.233 . . . . 0.0 112.205 -179.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 773' ' ' ILE . . . . . 0.77 HD12 ' H ' ' A' ' 775' ' ' THR . 0.5 OUTLIER -76.12 117.92 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 173.416 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 78.4 mttt -118.15 28.09 8.59 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -178.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 775' ' ' THR . . . . . 0.77 ' H ' HD12 ' A' ' 773' ' ' ILE . 0.9 OUTLIER -95.18 -72.19 0.64 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.572 -1.195 . . . . 0.0 112.429 -171.538 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 776' ' ' ASN . . . . . 0.451 ' HB2' ' O ' ' A' ' 775' ' ' THR . 10.8 m120 87.7 4.39 0.31 Allowed 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 124.703 1.201 . . . . 0.0 110.031 -178.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 777' ' ' GLU . . . . . 0.618 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 21.7 tt0 -162.69 96.28 0.93 Allowed 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.143 172.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 778' ' ' TYR . . . . . 0.83 ' HB3' HD11 ' A' ' 745' ' ' LEU . 83.3 t80 -139.63 128.83 23.88 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.081 -170.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 779' ' ' VAL . . . . . 0.717 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 7.6 t -84.73 105.91 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.196 -179.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 780' ' ' ILE . . . . . . . . . . . . . 70.1 mt -77.06 132.59 32.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.697 -178.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -117.18 109.58 17.08 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.385 0.612 . . . . 0.0 110.262 179.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 782' ' ' THR . . . . . 0.468 ' CG2' ' HB2' ' A' ' 739' ' ' SER . 1.1 p -80.82 149.22 66.88 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.526 -176.516 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 783' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -51.7 161.38 2.14 Favored 'Trans proline' 0 N--CA 1.473 0.292 0 C-N-CA 123.737 2.958 . . . . 0.0 113.34 -178.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 784' ' ' VAL . . . . . 0.497 HG12 HG23 ' A' ' 786' ' ' THR . 55.1 t -62.69 122.13 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.309 177.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 785' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -103.31 96.09 6.53 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.557 178.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 786' ' ' THR . . . . . 0.497 HG23 HG12 ' A' ' 784' ' ' VAL . 46.0 p -85.12 36.98 0.65 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.926 0.87 . . . . 0.0 110.369 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 58.4 m -159.48 110.26 1.98 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.336 -1.302 . . . . 0.0 110.191 179.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 788' ' ' GLY . . . . . 1.034 ' HA2' HG22 ' A' ' 817' ' ' VAL . . . -54.39 134.56 45.59 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.919 -0.658 . . . . 0.0 113.241 173.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 789' ' ' GLY . . . . . 0.65 ' H ' HG13 ' A' ' 817' ' ' VAL . . . -178.35 -170.43 40.46 Favored Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 179.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 790' ' ' ASP . . . . . 0.485 ' OD2' ' HG2' ' A' ' 816' ' ' GLN . 6.6 m-20 -114.16 130.6 56.6 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 174.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 791' ' ' TYR . . . . . 0.559 ' CD2' ' HG2' ' A' ' 759' ' ' GLU . 60.2 m-85 -131.27 123.85 29.25 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -179.119 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 792' ' ' ILE . . . . . 0.541 ' O ' HG13 ' A' ' 758' ' ' ILE . 19.8 mt -103.88 116.52 47.81 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 C-N-CA 120.445 -0.502 . . . . 0.0 109.778 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 793' ' ' LEU . . . . . 0.562 ' HB3' ' HB3' ' A' ' 813' ' ' ALA . 3.6 tt -83.87 106.28 15.43 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 177.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 794' ' ' SER . . . . . 0.588 ' HB3' ' OD2' ' A' ' 756' ' ' ASP . 15.2 t -117.77 179.46 4.07 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 114.852 -1.067 . . . . 0.0 108.765 -177.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 795' ' ' LEU . . . . . 0.563 HD21 HD21 ' A' ' 725' ' ' LEU . 58.2 mt -106.38 130.62 54.17 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 120.681 0.277 . . . . 0.0 111.01 -175.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 796' ' ' VAL . . . . . . . . . . . . . 51.4 t -88.89 -56.86 4.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.202 -177.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 797' ' ' SER . . . . . . . . . . . . . 24.4 m -173.45 168.89 4.49 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.012 -173.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 798' ' ' ILE . . . . . 0.7 HG22 ' HB ' ' A' ' 806' ' ' VAL . 0.4 OUTLIER -141.01 166.4 18.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 -173.906 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 799' ' ' LYS . . . . . 0.737 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 26.0 tttm -140.31 118.42 11.94 Favored 'General case' 0 C--N 1.312 -1.023 0 C-N-CA 120.4 -0.52 . . . . 0.0 111.533 -177.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 800' ' ' ASP . . . . . 0.73 ' HA ' ' CE2' ' A' ' 751' ' ' PHE . 12.4 t70 -70.6 156.93 38.79 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.884 -1.053 . . . . 0.0 109.114 174.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 12.8 t -67.28 -5.22 13.13 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 123.652 0.595 . . . . 0.0 111.287 -172.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 18.5 p -95.87 7.72 45.55 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.459 0.647 . . . . 0.0 109.919 174.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 803' ' ' GLY . . . . . . . . . . . . . . . 74.9 32.37 56.95 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.969 -177.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 804' ' ' CYS . . . . . 0.557 ' HB3' ' HB3' ' A' ' 800' ' ' ASP . 37.1 t -99.16 108.03 20.54 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 -179.132 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 805' ' ' VAL . . . . . 0.547 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 3.3 t -85.05 106.54 15.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.194 0.521 . . . . 0.0 110.303 -174.231 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 806' ' ' VAL . . . . . 0.7 ' HB ' HG22 ' A' ' 798' ' ' ILE . 22.9 t -92.88 136.84 23.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.021 -178.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -74.94 134.27 16.8 Favored Glycine 0 N--CA 1.451 -0.311 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.465 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 808' ' ' LEU . . . . . 0.585 HD21 ' HB ' ' A' ' 798' ' ' ILE . 46.3 mt -99.06 130.81 45.42 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 113.239 0.829 . . . . 0.0 113.239 -173.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 6.1 t -145.83 85.65 1.7 Allowed 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.219 -0.901 . . . . 0.0 109.232 171.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 810' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -138.22 174.96 3.72 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-O 118.798 -0.62 . . . . 0.0 109.735 178.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 811' ' ' PRO . . . . . 0.447 ' O ' ' HG ' ' A' ' 725' ' ' LEU . 83.2 Cg_exo -43.79 152.86 0.3 Allowed 'Trans proline' 0 C--N 1.361 1.225 0 C-N-CA 123.347 2.698 . . . . 0.0 114.68 -177.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 812' ' ' ASP . . . . . 0.476 ' C ' HD12 ' A' ' 725' ' ' LEU . 7.9 p-10 -122.73 165.51 16.44 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.273 -176.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 813' ' ' ALA . . . . . 0.686 ' HB1' HD23 ' A' ' 727' ' ' LEU . . . -120.98 113.04 19.51 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.193 -175.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 814' ' ' LYS . . . . . . . . . . . . . 41.6 tttm -93.4 112.15 23.99 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.436 0.636 . . . . 0.0 111.488 -177.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 815' ' ' ILE . . . . . 0.607 ' HA ' ' HB3' ' A' ' 731' ' ' LEU . 4.7 mp -93.25 135.54 27.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.254 175.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 816' ' ' GLN . . . . . 0.485 ' HG2' ' OD2' ' A' ' 790' ' ' ASP . 0.5 OUTLIER -128.87 106.95 9.26 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.943 0.401 . . . . 0.0 109.982 178.525 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 817' ' ' VAL . . . . . 1.034 HG22 ' HA2' ' A' ' 788' ' ' GLY . 0.2 OUTLIER -103.19 142.53 16.9 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-O 121.324 0.583 . . . . 0.0 110.577 179.052 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 818' ' ' ARG . . . . . 0.466 ' HG2' HE22 ' A' ' 816' ' ' GLN . 35.6 mmt180 -133.31 175.56 9.29 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 175.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 819' ' ' ARG . . . . . 0.475 ' HA ' ' HB2' ' A' ' 735' ' ' LEU . 0.3 OUTLIER -74.88 153.19 38.76 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 173.409 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 820' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 . . . . . 0 C--N 1.321 -0.636 0 N-CA-C 110.011 -0.366 . . . . 99.989999999999995 110.011 -178.733 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 718' ' ' ARG . . . . . . . . . . . . . 25.2 mmm180 . . . . . 0 CA--C 1.5 -0.965 0 CA-C-O 122.133 0.968 . . . . 0.0 111.048 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 719' ' ' VAL . . . . . 0.499 ' O ' ' HD3' ' A' ' 721' ' ' PRO . 7.5 p -164.23 157.68 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 CA-C-N 113.222 -1.808 . . . . 0.0 108.578 -175.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 720' ' ' LYS . . . . . . . . . . . . . 12.7 mmmm -80.74 104.69 2.91 Favored Pre-proline 0 C--N 1.31 -1.14 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.735 178.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 721' ' ' PRO . . . . . 0.499 ' HD3' ' O ' ' A' ' 719' ' ' VAL . 51.9 Cg_endo -86.91 152.2 8.49 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 122.46 2.107 . . . . 0.0 111.791 -176.281 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 722' ' ' SER . . . . . 0.541 ' HB3' ' NE2' ' A' ' 810' ' ' GLN . 21.6 t 177.53 -151.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -172.314 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 723' ' ' ALA . . . . . 0.76 ' HB1' HG21 ' A' ' 743' ' ' VAL . . . -150.67 143.09 24.34 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 121.238 -0.185 . . . . 0.0 111.114 178.138 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 37.1 t -127.72 102.51 6.84 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -179.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 725' ' ' LEU . . . . . 0.494 ' CD2' ' HB ' ' A' ' 743' ' ' VAL . 12.5 mt -63.88 147.08 52.78 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-O 121.641 0.734 . . . . 0.0 111.455 -175.215 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 34.2 mtpt -99.84 -15.85 18.26 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.042 -176.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 727' ' ' LEU . . . . . 0.521 HD21 ' HG ' ' A' ' 731' ' ' LEU . 48.3 tp -64.58 132.34 49.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.248 178.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -103.76 -26.26 12.8 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.095 0.405 . . . . 0.0 112.095 -173.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -122.98 173.12 8.01 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.807 -173.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 730' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -74.38 140.66 44.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.403 177.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 731' ' ' LEU . . . . . 0.69 HD12 HG13 ' A' ' 815' ' ' ILE . 73.5 mt -84.39 100.02 11.02 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.326 -179.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 732' ' ' LYS . . . . . 0.491 ' HE3' ' OE1' ' A' ' 816' ' ' GLN . 14.1 mmmm -76.97 112.87 14.05 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.637 -179.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 733' ' ' LEU . . . . . 0.774 HD12 HG22 ' A' ' 817' ' ' VAL . 58.2 mt -123.34 158.58 30.72 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.108 -178.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 734' ' ' CYS . . . . . 0.517 ' O ' ' HB2' ' A' ' 737' ' ' ASP . 21.2 p -107.68 -173.36 2.27 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 167.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 735' ' ' LEU . . . . . 0.525 ' CD1' ' H ' ' A' ' 788' ' ' GLY . 1.4 tp -71.95 148.92 45.52 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 120.055 -0.658 . . . . 0.0 111.032 -171.01 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 736' ' ' GLY . . . . . 0.5 ' HA2' ' HA ' ' A' ' 786' ' ' THR . . . 76.22 10.02 85.49 Favored Glycine 0 C--N 1.321 -0.258 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.54 -179.587 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 737' ' ' ASP . . . . . 0.517 ' HB2' ' O ' ' A' ' 734' ' ' CYS . 0.7 OUTLIER -93.68 155.24 17.37 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -177.719 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 738' ' ' HIS . . . . . 0.508 ' HB2' ' O ' ' A' ' 782' ' ' THR . 37.4 p-80 -121.86 -175.57 3.13 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 168.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 739' ' ' SER . . . . . 0.65 ' HB3' HD13 ' A' ' 731' ' ' LEU . 67.9 m -145.85 176.37 9.72 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.128 -0.629 . . . . 0.0 112.502 178.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 740' ' ' SER . . . . . 0.48 ' HA ' ' O ' ' A' ' 780' ' ' ILE . 9.7 p -142.43 109.7 5.62 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.085 -0.961 . . . . 0.0 110.144 176.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 741' ' ' VAL . . . . . 0.51 HG11 HD13 ' A' ' 793' ' ' LEU . 2.3 p -105.04 116.01 61.39 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.708 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 742' ' ' PRO . . . . . 0.657 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 3.7 Cg_exo -75.13 131.15 13.82 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 122.244 1.963 . . . . 0.0 111.03 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 743' ' ' VAL . . . . . 0.76 HG21 ' HB1' ' A' ' 723' ' ' ALA . 1.8 p -131.47 120.07 44.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.656 0.741 . . . . 0.0 112.72 178.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 744' ' ' ALA . . . . . 0.565 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -82.41 109.9 17.06 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 168.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 745' ' ' LEU . . . . . 0.914 HD13 HD13 ' A' ' 773' ' ' ILE . 0.4 OUTLIER -93.23 157.94 16.01 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-N 114.828 -1.078 . . . . 0.0 111.599 -164.652 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 37.9 tptt -105.06 157.69 17.07 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.235 178.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 747' ' ' GLY . . . . . . . . . . . . . . . 93.42 120.76 3.06 Favored Glycine 0 C--N 1.305 -1.186 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 -175.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -96.37 115.4 27.38 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.04 0.448 . . . . 0.0 112.081 -170.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 749' ' ' GLY . . . . . 0.41 ' O ' ' HD1' ' A' ' 751' ' ' PHE . . . 109.88 -167.66 12.86 Favored Glycine 0 CA--C 1.5 -0.853 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.531 179.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 750' ' ' PRO . . . . . 0.502 ' HB3' ' HE2' ' A' ' 774' ' ' LYS . 85.5 Cg_endo -66.24 95.08 0.31 Allowed 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 123.73 2.953 . . . . 0.0 113.617 -175.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 751' ' ' PHE . . . . . 0.498 ' CE2' ' HA ' ' A' ' 800' ' ' ASP . 56.7 m-85 -112.43 142.68 44.68 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.68 177.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 752' ' ' THR . . . . . 0.758 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 96.4 m -88.93 106.14 18.22 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 753' ' ' LEU . . . . . 0.623 HD22 HD22 ' A' ' 745' ' ' LEU . 12.3 tp -100.2 110.11 22.37 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.052 -0.977 . . . . 0.0 111.091 -172.167 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 754' ' ' THR . . . . . 0.463 HG23 ' HB2' ' A' ' 769' ' ' GLU . 1.2 m -99.43 135.24 41.13 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.442 177.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 755' ' ' TYR . . . . . . . . . . . . . 39.3 p90 -136.29 148.34 47.93 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 121.147 0.499 . . . . 0.0 111.638 179.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 756' ' ' ASP . . . . . 0.591 ' O ' ' HA ' ' A' ' 793' ' ' LEU . 2.5 p30 -110.22 137.96 47.25 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.789 178.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 757' ' ' ILE . . . . . . . . . . . . . 4.3 mp -107.66 94.79 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.087 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 166.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 758' ' ' ILE . . . . . 0.595 HG22 ' HD3' ' A' ' 765' ' ' ARG . 2.6 pp -99.84 150.36 5.38 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.92 -169.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 759' ' ' GLU . . . . . 0.69 ' OE1' ' HB2' ' A' ' 762' ' ' SER . 9.4 mt-10 -88.16 120.92 29.98 Favored 'General case' 0 N--CA 1.442 -0.862 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.174 -179.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 760' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.17 -5.28 44.35 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 169.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 761' ' ' PHE . . . . . 0.537 ' HB2' ' H ' ' A' ' 790' ' ' ASP . 77.4 t80 -94.44 -32.05 13.71 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 114.468 -1.242 . . . . 0.0 110.972 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 762' ' ' SER . . . . . 0.69 ' HB2' ' OE1' ' A' ' 759' ' ' GLU . 22.2 m -146.62 -93.88 0.09 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 120.594 -0.443 . . . . 0.0 112.066 179.384 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 763' ' ' SER . . . . . . . . . . . . . 21.5 t -172.37 0.86 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -174.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 764' ' ' LYS . . . . . 0.451 ' C ' ' HG3' ' A' ' 759' ' ' GLU . 51.8 mtmt -82.36 55.5 2.92 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.435 0.636 . . . . 0.0 111.315 -176.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 765' ' ' ARG . . . . . 0.595 ' HD3' HG22 ' A' ' 758' ' ' ILE . 12.3 ttp180 -56.06 140.33 43.99 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.477 175.034 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 766' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -120.5 146.54 46.18 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -178.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 767' ' ' THR . . . . . . . . . . . . . 90.0 m -128.48 136.22 50.52 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 120.573 0.225 . . . . 0.0 110.836 -179.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 768' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -141.09 145.07 35.32 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 177.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 769' ' ' GLU . . . . . 0.463 ' HB2' HG23 ' A' ' 754' ' ' THR . 32.9 tt0 -128.17 132.0 48.89 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.985 0.421 . . . . 0.0 111.447 -176.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 770' ' ' ILE . . . . . . . . . . . . . 11.1 mm -111.73 100.57 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 771' ' ' LYS . . . . . 0.494 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 12.6 mtpt -79.98 150.54 30.42 Favored 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 120.044 -0.662 . . . . 0.0 111.04 -177.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 772' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 53.7 48.16 22.14 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.04 -1.437 . . . . 0.0 112.521 177.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 773' ' ' ILE . . . . . 0.914 HD13 HD13 ' A' ' 745' ' ' LEU . 0.5 OUTLIER -73.34 117.6 17.33 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.578 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 171.538 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 774' ' ' LYS . . . . . 0.502 ' HE2' ' HB3' ' A' ' 750' ' ' PRO . 59.5 mttt -112.08 28.04 9.12 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 -179.248 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 775' ' ' THR . . . . . 0.691 ' H ' HD12 ' A' ' 773' ' ' ILE . 0.2 OUTLIER -95.69 -76.7 0.49 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.862 -1.063 . . . . 0.0 113.5 -167.874 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 776' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 775' ' ' THR . 12.2 m120 88.48 3.91 0.25 Allowed 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.943 1.297 . . . . 0.0 111.054 -175.144 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 777' ' ' GLU . . . . . 0.565 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 9.9 mt-10 -161.07 88.29 0.75 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.025 172.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 778' ' ' TYR . . . . . 0.676 ' HB3' HD11 ' A' ' 745' ' ' LEU . 63.9 t80 -133.51 136.68 45.21 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.611 -170.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 779' ' ' VAL . . . . . 0.657 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 21.5 t -91.25 115.77 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 CA-C-O 121.337 0.589 . . . . 0.0 110.309 178.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 780' ' ' ILE . . . . . 0.48 ' O ' ' HA ' ' A' ' 740' ' ' SER . 61.7 mt -82.74 142.22 13.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.309 -179.125 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 781' ' ' LYS . . . . . 0.4 ' HD3' ' C ' ' A' ' 780' ' ' ILE . 0.0 OUTLIER -113.13 110.77 20.98 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.153 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 782' ' ' THR . . . . . 0.508 ' O ' ' HB2' ' A' ' 738' ' ' HIS . 70.3 p -77.01 133.35 69.38 Favored Pre-proline 0 N--CA 1.441 -0.899 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.567 178.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 783' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 782' ' ' THR . 23.7 Cg_exo -62.88 151.32 84.96 Favored 'Trans proline' 0 C--O 1.234 0.298 0 C-N-CA 122.942 2.428 . . . . 0.0 111.548 -175.444 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 784' ' ' VAL . . . . . . . . . . . . . 13.8 p -59.59 130.73 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-O 121.406 0.622 . . . . 0.0 110.477 -174.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 785' ' ' PHE . . . . . 0.478 ' C ' ' H ' ' A' ' 787' ' ' THR . 86.3 m-85 -87.21 -31.84 20.1 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.598 -171.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 786' ' ' THR . . . . . 0.5 ' HA ' ' HA2' ' A' ' 736' ' ' GLY . 30.9 p 58.05 -5.4 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.911 0.885 . . . . 0.0 112.94 176.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 787' ' ' THR . . . . . 0.478 ' H ' ' C ' ' A' ' 785' ' ' PHE . 1.3 m -145.76 124.65 12.7 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.752 0.311 . . . . 0.0 110.543 -176.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 788' ' ' GLY . . . . . 0.525 ' H ' ' CD1' ' A' ' 735' ' ' LEU . . . -50.28 125.9 22.1 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.354 -0.839 . . . . 0.0 113.353 173.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 789' ' ' GLY . . . . . . . . . . . . . . . -174.51 -179.88 45.4 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 110.141 -1.184 . . . . 0.0 110.141 179.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 790' ' ' ASP . . . . . 0.537 ' H ' ' HB2' ' A' ' 761' ' ' PHE . 3.3 m-20 -119.46 128.02 53.61 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 117.773 0.786 . . . . 0.0 109.758 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 791' ' ' TYR . . . . . 0.632 ' CE2' ' HG2' ' A' ' 759' ' ' GLU . 84.0 m-85 -127.65 153.38 46.52 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.595 -176.022 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 792' ' ' ILE . . . . . 0.567 ' O ' HG13 ' A' ' 758' ' ' ILE . 13.0 mt -129.92 120.36 49.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 172.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 793' ' ' LEU . . . . . 0.591 ' HA ' ' O ' ' A' ' 756' ' ' ASP . 8.1 tt -85.28 110.34 19.0 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 178.28 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 794' ' ' SER . . . . . . . . . . . . . 3.7 m -119.45 148.89 42.72 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.023 -178.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 795' ' ' LEU . . . . . 0.64 ' HG ' ' HB3' ' A' ' 723' ' ' ALA . 1.5 mm? -73.36 124.75 26.35 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-O 120.715 0.293 . . . . 0.0 111.028 177.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 796' ' ' VAL . . . . . 0.423 ' HB ' ' HB ' ' A' ' 754' ' ' THR . 53.7 t -85.67 -54.78 7.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.213 -177.207 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 797' ' ' SER . . . . . 0.589 ' HA ' ' HG ' ' A' ' 808' ' ' LEU . 87.9 p -172.42 152.66 2.73 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.202 -172.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 798' ' ' ILE . . . . . 0.636 ' HA ' ' O ' ' A' ' 752' ' ' THR . 5.9 tt -127.5 164.6 28.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 176.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 799' ' ' LYS . . . . . 0.758 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 8.0 tmtt? -139.51 118.86 12.84 Favored 'General case' 0 C--N 1.313 -1.007 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.14 -177.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 800' ' ' ASP . . . . . 0.532 ' HB2' ' HB3' ' A' ' 804' ' ' CYS . 14.1 m-20 -58.59 155.37 12.53 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.504 173.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 6.3 p -61.62 -11.86 13.39 Favored 'General case' 0 C--N 1.327 -0.4 0 O-C-N 124.021 0.826 . . . . 0.0 112.56 -174.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 8.9 t -91.06 -6.38 53.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.666 0.745 . . . . 0.0 109.836 178.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 803' ' ' GLY . . . . . 0.485 ' HA2' ' HE2' ' A' ' 799' ' ' LYS . . . 92.12 42.69 4.58 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.771 -177.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 804' ' ' CYS . . . . . 0.532 ' HB3' ' HB2' ' A' ' 800' ' ' ASP . 41.7 t -110.55 106.53 15.84 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 805' ' ' VAL . . . . . 0.549 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 15.7 t -88.27 110.78 21.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.285 0.564 . . . . 0.0 111.279 -175.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 806' ' ' VAL . . . . . 0.434 ' HB ' HG22 ' A' ' 798' ' ' ILE . 88.2 t -90.55 137.76 20.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.995 177.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -76.07 120.53 5.94 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 111.099 -0.8 . . . . 0.0 111.099 177.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 808' ' ' LEU . . . . . 0.589 ' HG ' ' HA ' ' A' ' 797' ' ' SER . 40.1 mt -88.81 133.7 34.17 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -173.007 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 31.8 t -149.67 86.73 1.47 Allowed 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.019 -0.992 . . . . 0.0 108.991 172.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 810' ' ' GLN . . . . . 0.541 ' NE2' ' HB3' ' A' ' 722' ' ' SER . 1.6 mt-30 -139.25 174.39 4.18 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.388 -0.823 . . . . 0.0 108.93 176.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 811' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_exo -44.0 139.17 6.0 Favored 'Trans proline' 0 C--N 1.356 0.948 0 C-N-CA 123.049 2.499 . . . . 0.0 114.644 -175.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -115.67 165.76 12.68 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.694 -1.139 . . . . 0.0 110.204 -179.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 813' ' ' ALA . . . . . 0.501 ' HB1' HD23 ' A' ' 727' ' ' LEU . . . -115.06 155.63 26.66 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.492 -177.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 814' ' ' LYS . . . . . 0.457 ' HG3' HG12 ' A' ' 792' ' ' ILE . 2.7 mptm? -112.45 137.83 50.08 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.499 0.666 . . . . 0.0 110.647 175.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 815' ' ' ILE . . . . . 0.69 HG13 HD12 ' A' ' 731' ' ' LEU . 5.3 mp -124.27 111.85 30.2 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-N 114.792 -1.094 . . . . 0.0 108.155 177.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 816' ' ' GLN . . . . . 0.714 ' NE2' ' HG2' ' A' ' 818' ' ' ARG . 0.9 OUTLIER -108.72 109.16 20.26 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.023 0.44 . . . . 0.0 110.671 -177.22 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 817' ' ' VAL . . . . . 0.774 HG22 HD12 ' A' ' 733' ' ' LEU . 2.3 t -104.85 142.58 17.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 -179.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 818' ' ' ARG . . . . . 0.714 ' HG2' ' NE2' ' A' ' 816' ' ' GLN . 73.6 mmt-85 -137.48 174.43 10.61 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 175.016 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 819' ' ' ARG . . . . . 0.427 ' HA ' ' HB2' ' A' ' 735' ' ' LEU . 33.9 ttt180 -107.96 115.16 29.63 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.14 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 820' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 . . . . . 0 C--N 1.32 -0.686 0 CA-C-N 115.806 -0.634 . . . . 99.989999999999995 110.469 -176.023 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 718' ' ' ARG . . . . . 0.409 ' HD3' ' N ' ' A' ' 718' ' ' ARG . 0.5 OUTLIER . . . . . 0 N--CA 1.453 -0.278 0 CA-C-O 120.784 0.326 . . . . 0.0 110.23 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 719' ' ' VAL . . . . . 0.671 HG13 ' H ' ' A' ' 720' ' ' LYS . 2.5 p -101.42 -99.07 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 177.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 720' ' ' LYS . . . . . 0.671 ' H ' HG13 ' A' ' 719' ' ' VAL . 52.6 mtpt -128.44 117.49 20.0 Favored Pre-proline 0 C--N 1.314 -0.95 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 170.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 721' ' ' PRO . . . . . 0.453 ' HD2' HG21 ' A' ' 806' ' ' VAL . 72.0 Cg_endo -88.75 151.35 6.11 Favored 'Trans proline' 0 N--CA 1.446 -1.298 0 C-N-CA 122.431 2.087 . . . . 0.0 111.488 -178.4 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 722' ' ' SER . . . . . 0.782 ' HB2' ' OE1' ' A' ' 810' ' ' GLN . 8.6 p -179.18 -159.32 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -175.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 723' ' ' ALA . . . . . 0.595 ' HB3' ' HG ' ' A' ' 795' ' ' LEU . . . -151.67 140.74 21.19 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 118.807 0.73 . . . . 0.0 110.931 176.068 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 35.1 m -132.89 105.63 7.23 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 -177.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 725' ' ' LEU . . . . . 0.51 ' CD2' ' HB ' ' A' ' 743' ' ' VAL . 16.7 mt -62.22 144.92 54.87 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-O 121.478 0.656 . . . . 0.0 111.507 -176.087 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 29.3 mtpt -97.62 -14.41 20.99 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.856 -1.065 . . . . 0.0 109.638 -177.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 727' ' ' LEU . . . . . 0.591 HD23 ' HB1' ' A' ' 813' ' ' ALA . 38.7 tp -69.21 114.24 7.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.713 175.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 9.6 t-80 -115.71 43.5 2.08 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.816 0.341 . . . . 0.0 111.214 -174.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 9.5 p80 -175.24 -177.67 1.07 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.629 177.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 730' ' ' ASP . . . . . 0.515 ' HA ' ' O ' ' A' ' 814' ' ' LYS . 1.2 m-20 -76.53 148.22 37.24 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.564 177.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 731' ' ' LEU . . . . . 0.601 HD13 ' HB2' ' A' ' 739' ' ' SER . 12.0 mt -101.93 104.45 15.15 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.555 173.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 732' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -81.23 93.24 6.46 Favored 'General case' 0 C--N 1.323 -0.56 0 O-C-N 123.712 0.632 . . . . 0.0 111.26 -172.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 733' ' ' LEU . . . . . 0.438 ' HB3' ' CB ' ' A' ' 737' ' ' ASP . 0.2 OUTLIER -107.38 163.69 12.83 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.107 0.48 . . . . 0.0 111.487 -178.415 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 734' ' ' CYS . . . . . 0.699 ' HA ' ' O ' ' A' ' 818' ' ' ARG . 69.2 m -113.14 -173.38 2.24 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.352 177.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 735' ' ' LEU . . . . . 0.473 ' HG ' ' HD3' ' A' ' 819' ' ' ARG . 3.5 tt -62.56 128.1 34.39 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.925 -179.289 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 736' ' ' GLY . . . . . 0.48 ' HA2' ' HA ' ' A' ' 786' ' ' THR . . . 86.37 4.96 83.05 Favored Glycine 0 C--N 1.322 -0.199 0 C-N-CA 120.22 -0.991 . . . . 0.0 112.735 177.116 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 737' ' ' ASP . . . . . 0.501 ' HB2' ' O ' ' A' ' 734' ' ' CYS . 0.3 OUTLIER -84.26 153.3 23.66 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.364 0.602 . . . . 0.0 112.448 179.281 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 738' ' ' HIS . . . . . 0.486 ' HB2' ' O ' ' A' ' 782' ' ' THR . 47.0 p-80 -118.88 173.28 6.97 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 167.106 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 739' ' ' SER . . . . . 0.601 ' HB2' HD13 ' A' ' 731' ' ' LEU . 51.5 p -128.08 173.75 9.8 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 118.236 -1.385 . . . . 0.0 112.791 -173.043 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 10.4 p -144.98 103.93 3.93 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.861 -172.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 741' ' ' VAL . . . . . 0.813 HG11 HD23 ' A' ' 793' ' ' LEU . 0.4 OUTLIER -120.87 116.63 31.4 Favored Pre-proline 0 C--N 1.314 -0.963 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.282 -177.804 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 742' ' ' PRO . . . . . 0.643 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 9.8 Cg_endo -77.66 137.32 16.12 Favored 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 122.252 1.968 . . . . 0.0 111.545 179.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 743' ' ' VAL . . . . . 0.51 HG21 ' HB1' ' A' ' 723' ' ' ALA . 2.2 p -130.33 119.54 46.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.452 0.644 . . . . 0.0 112.231 177.33 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 744' ' ' ALA . . . . . 0.578 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -78.81 95.01 5.26 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 122.237 1.017 . . . . 0.0 109.03 168.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 745' ' ' LEU . . . . . 0.823 HD11 ' HB3' ' A' ' 778' ' ' TYR . 1.7 mt -76.41 142.54 41.06 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 113.706 -1.588 . . . . 0.0 110.485 -173.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 31.6 ttmt -100.01 163.14 12.56 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.442 0.639 . . . . 0.0 110.571 -176.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 747' ' ' GLY . . . . . . . . . . . . . . . 91.36 139.11 8.23 Favored Glycine 0 C--N 1.309 -0.928 0 CA-C-N 114.855 -1.066 . . . . 0.0 111.64 -175.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 748' ' ' GLN . . . . . 0.45 ' C ' ' HE1' ' A' ' 751' ' ' PHE . 20.9 mp0 -114.22 111.2 21.16 Favored 'General case' 0 C--N 1.32 -0.679 0 O-C-N 122.469 -0.43 . . . . 0.0 111.081 -175.137 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 132.75 -170.7 21.95 Favored Glycine 0 N--CA 1.445 -0.764 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.034 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -73.5 93.84 0.84 Allowed 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.564 2.176 . . . . 0.0 111.676 -179.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 751' ' ' PHE . . . . . 0.607 ' CE2' ' HA ' ' A' ' 800' ' ' ASP . 80.0 m-85 -113.92 141.1 47.78 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.237 -178.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 752' ' ' THR . . . . . 0.695 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 86.7 m -91.66 105.28 17.62 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 177.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 753' ' ' LEU . . . . . 0.474 HD23 HD12 ' A' ' 798' ' ' ILE . 0.5 OUTLIER -98.79 123.0 42.74 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.362 -172.168 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 754' ' ' THR . . . . . 0.476 HG23 ' HB2' ' A' ' 769' ' ' GLU . 0.7 OUTLIER -117.89 136.29 53.56 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.659 -178.197 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 755' ' ' TYR . . . . . 0.4 ' CE1' ' HB3' ' A' ' 768' ' ' PHE . 17.2 p90 -143.29 153.95 43.29 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 111.922 0.341 . . . . 0.0 111.922 178.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 756' ' ' ASP . . . . . 0.419 ' HB2' HG23 ' A' ' 758' ' ' ILE . 14.9 p-10 -118.91 118.86 32.68 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.341 0.591 . . . . 0.0 111.86 -178.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 757' ' ' ILE . . . . . 0.503 HG13 HD13 ' A' ' 793' ' ' LEU . 4.0 mp -89.74 96.34 6.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 167.369 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 758' ' ' ILE . . . . . 0.64 HG13 ' O ' ' A' ' 792' ' ' ILE . 2.5 pp -103.89 149.72 7.57 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 N-CA-C 112.412 0.523 . . . . 0.0 112.412 -168.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 759' ' ' GLU . . . . . 0.721 ' OE1' ' HB3' ' A' ' 762' ' ' SER . 19.8 mt-10 -87.48 123.99 32.98 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.164 178.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 760' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.38 -4.85 41.13 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 120.426 -0.51 . . . . 0.0 110.309 175.583 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 761' ' ' PHE . . . . . . . . . . . . . 19.8 p90 -103.41 -29.02 11.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.798 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 762' ' ' SER . . . . . 0.721 ' HB3' ' OE1' ' A' ' 759' ' ' GLU . 18.5 t -128.57 -95.86 0.41 Allowed 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 120.215 -0.594 . . . . 0.0 110.848 -178.022 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 763' ' ' SER . . . . . . . . . . . . . 9.3 t -179.79 -1.93 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 120.939 -0.304 . . . . 0.0 111.811 -177.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 764' ' ' LYS . . . . . 0.482 ' HB2' ' CD ' ' A' ' 759' ' ' GLU . 49.7 mtpt -82.72 54.76 2.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.492 0.663 . . . . 0.0 111.54 -173.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 765' ' ' ARG . . . . . . . . . . . . . 66.5 mtm180 -52.04 147.54 7.19 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.692 -1.14 . . . . 0.0 111.88 176.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 766' ' ' LYS . . . . . 0.66 ' HD3' ' N ' ' A' ' 767' ' ' THR . 9.0 tmtt? -124.84 145.51 49.74 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 175.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 767' ' ' THR . . . . . 0.66 ' N ' ' HD3' ' A' ' 766' ' ' LYS . 91.7 m -133.16 141.7 48.26 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.295 -179.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 768' ' ' PHE . . . . . 0.4 ' HB3' ' CE1' ' A' ' 755' ' ' TYR . 4.1 t80 -136.21 141.74 44.02 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.05 0.452 . . . . 0.0 110.656 177.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 769' ' ' GLU . . . . . 0.476 ' HB2' HG23 ' A' ' 754' ' ' THR . 40.0 tt0 -126.41 121.08 31.45 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.487 -179.255 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 770' ' ' ILE . . . . . 0.645 HG22 HG22 ' A' ' 773' ' ' ILE . 9.4 mt -115.57 111.27 34.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 771' ' ' LYS . . . . . 0.619 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 7.8 mtpt -83.97 148.4 26.92 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.624 0.726 . . . . 0.0 111.521 -176.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 772' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 57.71 47.45 15.62 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 113.514 -1.675 . . . . 0.0 112.479 175.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 773' ' ' ILE . . . . . 0.74 HD12 ' H ' ' A' ' 775' ' ' THR . 0.5 OUTLIER -75.64 119.29 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 175.426 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 79.7 mttt -117.88 33.26 5.72 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 775' ' ' THR . . . . . 0.74 ' H ' HD12 ' A' ' 773' ' ' ILE . 1.1 m -95.4 -72.32 0.63 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 113.939 -1.482 . . . . 0.0 112.289 -172.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 776' ' ' ASN . . . . . 0.465 ' HA ' ' O ' ' A' ' 745' ' ' LEU . 12.2 m120 85.96 3.63 0.53 Allowed 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.599 1.159 . . . . 0.0 110.934 -179.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 777' ' ' GLU . . . . . 0.578 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 12.3 mt-10 -161.84 88.7 0.7 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.171 -0.922 . . . . 0.0 108.799 172.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 778' ' ' TYR . . . . . 0.823 ' HB3' HD11 ' A' ' 745' ' ' LEU . 49.4 t80 -123.59 127.65 48.59 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 120.881 0.372 . . . . 0.0 110.778 -171.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 779' ' ' VAL . . . . . 0.643 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 15.1 t -85.52 105.42 14.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.206 0.527 . . . . 0.0 110.382 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 780' ' ' ILE . . . . . 0.429 ' HB ' ' O ' ' A' ' 741' ' ' VAL . 83.1 mt -75.44 142.31 14.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.703 -178.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.08 103.6 8.91 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 174.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 782' ' ' THR . . . . . 0.486 ' O ' ' HB2' ' A' ' 738' ' ' HIS . 2.9 p -75.36 143.6 76.65 Favored Pre-proline 0 C--N 1.319 -0.738 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.985 -175.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 783' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.69 157.76 9.38 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 123.378 2.719 . . . . 0.0 111.963 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 784' ' ' VAL . . . . . 0.45 ' HA ' ' HB3' ' A' ' 738' ' ' HIS . 11.6 p -68.47 130.89 33.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.45 0.643 . . . . 0.0 110.283 -175.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 785' ' ' PHE . . . . . 0.473 ' C ' ' H ' ' A' ' 787' ' ' THR . 62.3 m-85 -85.87 -40.17 16.24 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.42 -175.008 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 786' ' ' THR . . . . . 0.48 ' HA ' ' HA2' ' A' ' 736' ' ' GLY . 27.3 p 60.26 -4.92 0.1 Allowed 'General case' 0 N--CA 1.469 0.495 0 O-C-N 124.451 1.094 . . . . 0.0 112.053 -178.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 787' ' ' THR . . . . . 0.473 ' H ' ' C ' ' A' ' 785' ' ' PHE . 43.1 m -130.94 116.12 17.43 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.879 -173.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 788' ' ' GLY . . . . . . . . . . . . . . . -52.59 118.56 7.95 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.963 171.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 789' ' ' GLY . . . . . 0.453 ' H ' ' HB ' ' A' ' 817' ' ' VAL . . . -175.86 -174.97 42.86 Favored Glycine 0 N--CA 1.448 -0.546 0 N-CA-C 110.041 -1.223 . . . . 0.0 110.041 179.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -115.41 130.11 56.79 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 118.267 1.033 . . . . 0.0 110.254 178.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 791' ' ' TYR . . . . . 0.536 ' CE2' ' HG2' ' A' ' 759' ' ' GLU . 69.2 m-85 -121.3 143.98 48.88 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.473 179.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 792' ' ' ILE . . . . . 0.64 ' O ' HG13 ' A' ' 758' ' ' ILE . 21.2 mt -120.84 113.68 40.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 177.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 793' ' ' LEU . . . . . 0.813 HD23 HG11 ' A' ' 741' ' ' VAL . 0.7 OUTLIER -86.55 114.53 23.36 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.084 179.279 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 794' ' ' SER . . . . . 0.511 ' N ' HD12 ' A' ' 793' ' ' LEU . 23.1 t -123.86 159.68 29.1 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.763 -174.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 795' ' ' LEU . . . . . 0.595 ' HG ' ' HB3' ' A' ' 723' ' ' ALA . 1.2 mm? -87.51 135.31 33.4 Favored 'General case' 0 N--CA 1.44 -0.948 0 O-C-N 121.997 -0.44 . . . . 0.0 110.837 176.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 796' ' ' VAL . . . . . 0.405 ' HB ' ' HB ' ' A' ' 754' ' ' THR . 73.3 t -92.64 -55.36 6.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.95 -178.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 797' ' ' SER . . . . . 0.415 ' HA ' HD23 ' A' ' 808' ' ' LEU . 58.7 m -169.18 168.35 9.91 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.091 -173.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 798' ' ' ILE . . . . . 0.616 ' HA ' ' O ' ' A' ' 752' ' ' THR . 9.1 tt -141.06 165.39 19.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 172.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 799' ' ' LYS . . . . . 0.695 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 85.3 tttt -136.96 121.67 18.58 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.887 0.375 . . . . 0.0 111.333 -174.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 800' ' ' ASP . . . . . 0.607 ' HA ' ' CE2' ' A' ' 751' ' ' PHE . 7.9 t70 -65.49 153.62 40.88 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.21 175.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 5.4 p -58.83 -13.97 7.64 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 124.199 0.937 . . . . 0.0 112.948 -174.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 52.2 p -89.68 -5.83 56.7 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.511 0.672 . . . . 0.0 109.847 177.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 803' ' ' GLY . . . . . 0.529 ' HA2' ' CE ' ' A' ' 799' ' ' LYS . . . 89.81 40.31 5.95 Favored Glycine 0 N--CA 1.44 -1.071 0 CA-C-N 114.934 -1.03 . . . . 0.0 111.601 -177.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 804' ' ' CYS . . . . . 0.518 ' HB3' ' HB3' ' A' ' 800' ' ' ASP . 42.0 t -111.69 113.8 26.4 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 110.056 -0.349 . . . . 0.0 110.056 -178.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 805' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 11.0 p -85.01 132.85 30.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.396 0.617 . . . . 0.0 110.948 -174.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 806' ' ' VAL . . . . . 0.492 ' HB ' HG22 ' A' ' 798' ' ' ILE . 85.0 t -109.29 138.34 37.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.296 -0.866 . . . . 0.0 109.769 178.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -76.28 111.24 3.24 Favored Glycine 0 N--CA 1.452 -0.28 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.785 -178.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 808' ' ' LEU . . . . . 0.439 HD12 ' CB ' ' A' ' 795' ' ' LEU . 2.6 mm? -76.07 127.31 32.69 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 10.8 p -149.93 86.75 1.45 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.509 170.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 810' ' ' GLN . . . . . 0.782 ' OE1' ' HB2' ' A' ' 722' ' ' SER . 35.1 mt-30 -137.8 171.91 7.64 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.743 -176.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 811' ' ' PRO . . . . . 0.421 ' HD2' ' HB3' ' A' ' 810' ' ' GLN . 81.3 Cg_exo -47.78 140.32 17.78 Favored 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 122.798 2.332 . . . . 0.0 113.563 178.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -114.67 165.67 12.55 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.798 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 813' ' ' ALA . . . . . 0.591 ' HB1' HD23 ' A' ' 727' ' ' LEU . . . -111.33 151.37 28.49 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.278 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 814' ' ' LYS . . . . . 0.515 ' O ' ' HA ' ' A' ' 730' ' ' ASP . 19.5 ttpp -120.25 107.78 13.4 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.849 0.833 . . . . 0.0 110.827 178.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 815' ' ' ILE . . . . . 0.53 ' HA ' ' HB2' ' A' ' 731' ' ' LEU . 5.1 mp -86.65 116.94 30.12 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-N 114.539 -1.209 . . . . 0.0 108.68 177.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 816' ' ' GLN . . . . . 0.469 HE22 ' HB2' ' A' ' 818' ' ' ARG . 1.0 OUTLIER -107.88 106.57 16.9 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.686 0.755 . . . . 0.0 110.339 -177.041 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 817' ' ' VAL . . . . . 0.453 ' HB ' ' H ' ' A' ' 789' ' ' GLY . 1.9 t -101.43 146.43 9.79 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 -177.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 818' ' ' ARG . . . . . 0.699 ' O ' ' HA ' ' A' ' 734' ' ' CYS . 17.2 tpt180 -150.53 136.63 18.52 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 178.412 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 819' ' ' ARG . . . . . 0.473 ' HD3' ' HG ' ' A' ' 735' ' ' LEU . 21.2 mmt180 -62.88 124.14 20.3 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 176.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 820' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 . . . . . 0 C--N 1.321 -0.655 0 N-CA-C 109.693 -0.484 . . . . 99.989999999999995 109.693 178.514 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 718' ' ' ARG . . . . . . . . . . . . . 1.8 tmt_? . . . . . 0 CA--C 1.512 -0.504 0 CA-C-O 121.928 0.87 . . . . 0.0 109.621 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 719' ' ' VAL . . . . . 0.544 ' O ' ' HD3' ' A' ' 721' ' ' PRO . 11.5 p -139.27 166.71 21.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 CA-C-N 114.625 -1.17 . . . . 0.0 108.413 -176.452 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 720' ' ' LYS . . . . . 0.443 ' N ' HG22 ' A' ' 719' ' ' VAL . 19.1 ttpt -109.68 91.97 11.4 Favored Pre-proline 0 N--CA 1.416 -2.139 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 721' ' ' PRO . . . . . 0.544 ' HD3' ' O ' ' A' ' 719' ' ' VAL . 56.5 Cg_endo -87.91 155.41 7.26 Favored 'Trans proline' 0 N--CA 1.449 -1.121 0 C-N-CA 123.348 2.699 . . . . 0.0 112.092 -176.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 722' ' ' SER . . . . . 0.744 ' HA ' ' CD2' ' A' ' 808' ' ' LEU . 7.5 t -174.25 -159.84 0.1 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 -174.019 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 723' ' ' ALA . . . . . 0.63 ' O ' ' HB2' ' A' ' 810' ' ' GLN . . . -156.77 140.67 16.2 Favored 'General case' 0 C--O 1.218 -0.562 0 C-N-CA 121.383 -0.127 . . . . 0.0 110.741 177.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 22.6 t -136.06 101.25 4.66 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 -176.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 725' ' ' LEU . . . . . 0.584 ' HA ' ' HA ' ' A' ' 743' ' ' VAL . 5.6 mp -60.7 139.41 57.88 Favored 'General case' 0 N--CA 1.425 -1.688 0 CA-C-O 122.396 1.093 . . . . 0.0 112.427 -175.117 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 726' ' ' LYS . . . . . . . . . . . . . 33.4 mtpt -87.43 -18.12 30.67 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 113.002 -1.908 . . . . 0.0 109.356 -178.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 727' ' ' LEU . . . . . 0.528 ' HB2' ' HD2' ' A' ' 742' ' ' PRO . 21.2 tp -71.3 110.22 5.8 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 173.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 9.1 t60 -95.19 -48.4 5.94 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.528 -172.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -101.21 177.71 4.86 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.878 -0.329 . . . . 0.0 110.871 -177.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 730' ' ' ASP . . . . . 0.449 ' HA ' ' O ' ' A' ' 814' ' ' LYS . 7.7 p-10 -68.73 145.67 53.62 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.568 0.699 . . . . 0.0 110.933 -178.047 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 731' ' ' LEU . . . . . 0.537 ' HB3' ' HA ' ' A' ' 815' ' ' ILE . 36.4 tp -104.44 111.71 24.48 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.372 -175.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 732' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -70.35 127.47 32.88 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.884 -177.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 733' ' ' LEU . . . . . 0.485 HD11 ' OG ' ' A' ' 739' ' ' SER . 55.4 mt -136.59 163.72 29.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.195 0.522 . . . . 0.0 111.144 177.101 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 734' ' ' CYS . . . . . 0.492 ' HB3' ' OD2' ' A' ' 820' ' ' ASP . 72.1 m -108.58 -176.18 2.97 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.036 175.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 735' ' ' LEU . . . . . 0.479 HD13 ' HD2' ' A' ' 819' ' ' ARG . 24.7 tp -63.95 131.57 48.06 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.022 0.439 . . . . 0.0 111.068 -177.285 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 736' ' ' GLY . . . . . 0.476 ' O ' HG13 ' A' ' 784' ' ' VAL . . . 70.27 13.48 70.47 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.619 177.058 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 737' ' ' ASP . . . . . 0.472 ' HB2' ' O ' ' A' ' 734' ' ' CYS . 0.3 OUTLIER -77.7 150.76 34.43 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.792 0.329 . . . . 0.0 110.711 178.763 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 738' ' ' HIS . . . . . . . . . . . . . 16.1 p-80 -111.9 163.06 14.64 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 171.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 739' ' ' SER . . . . . 0.485 ' OG ' HD11 ' A' ' 733' ' ' LEU . 0.0 OUTLIER -131.36 174.08 10.42 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 119.526 -0.869 . . . . 0.0 112.732 -173.325 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 740' ' ' SER . . . . . . . . . . . . . 5.6 p -131.36 115.51 16.34 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.282 -179.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 741' ' ' VAL . . . . . 0.412 ' HB ' ' HB ' ' A' ' 780' ' ' ILE . 3.6 t -113.6 98.98 48.7 Favored Pre-proline 0 C--N 1.318 -0.768 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.411 -175.356 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 742' ' ' PRO . . . . . 0.762 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 2.2 Cg_endo -75.88 121.65 6.36 Favored 'Trans proline' 0 N--CA 1.441 -1.579 0 C-N-CA 122.912 2.408 . . . . 0.0 110.712 -175.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 743' ' ' VAL . . . . . 0.584 ' HA ' ' HA ' ' A' ' 725' ' ' LEU . 1.4 p -125.67 121.52 60.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-O 121.662 0.744 . . . . 0.0 112.671 178.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 744' ' ' ALA . . . . . 0.586 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -83.42 111.67 19.24 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 169.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 745' ' ' LEU . . . . . 0.886 HD13 HD13 ' A' ' 773' ' ' ILE . 0.3 OUTLIER -95.11 168.99 10.42 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 114.705 -1.134 . . . . 0.0 111.251 -165.861 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 1.1 tppm? -122.9 147.59 46.41 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.287 -176.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 747' ' ' GLY . . . . . 0.45 ' HA3' ' HB3' ' A' ' 721' ' ' PRO . . . 100.73 129.97 6.87 Favored Glycine 0 C--N 1.311 -0.833 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.451 -177.268 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 748' ' ' GLN . . . . . 0.428 ' C ' ' HE1' ' A' ' 751' ' ' PHE . 2.1 mp0 -108.76 115.71 30.6 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.917 0.389 . . . . 0.0 111.059 -175.054 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 134.52 -176.31 19.97 Favored Glycine 0 N--CA 1.444 -0.773 0 N-CA-C 111.501 -0.64 . . . . 0.0 111.501 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 750' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_exo -71.89 93.89 0.71 Allowed 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.545 2.163 . . . . 0.0 111.839 179.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 751' ' ' PHE . . . . . 0.501 ' CD2' ' HA ' ' A' ' 800' ' ' ASP . 78.2 m-85 -110.2 141.95 42.42 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.41 -178.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 752' ' ' THR . . . . . 0.771 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 94.7 m -90.85 102.66 15.42 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.725 0.774 . . . . 0.0 109.471 178.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 753' ' ' LEU . . . . . 0.456 HD22 HD22 ' A' ' 745' ' ' LEU . 24.3 tp -91.82 116.85 29.25 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 114.448 -1.251 . . . . 0.0 110.461 -171.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 754' ' ' THR . . . . . 0.448 HG23 ' HB2' ' A' ' 769' ' ' GLU . 1.3 m -115.1 130.11 56.85 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.028 179.363 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 755' ' ' TYR . . . . . 0.557 ' CE1' ' HB2' ' A' ' 768' ' ' PHE . 22.2 p90 -141.31 156.73 45.82 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.856 0.36 . . . . 0.0 111.338 178.405 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 756' ' ' ASP . . . . . 0.442 ' HB3' HG23 ' A' ' 758' ' ' ILE . 0.2 OUTLIER -121.07 118.95 31.08 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.37 -176.628 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 757' ' ' ILE . . . . . 0.512 HG13 HD13 ' A' ' 793' ' ' LEU . 3.7 mp -87.98 96.24 5.72 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 168.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 758' ' ' ILE . . . . . 0.625 HG13 ' O ' ' A' ' 792' ' ' ILE . 2.5 pp -94.78 149.98 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.215 -173.363 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 759' ' ' GLU . . . . . 0.582 ' OE2' ' HB2' ' A' ' 762' ' ' SER . 8.2 pt-20 -105.13 125.65 51.21 Favored 'General case' 0 C--N 1.307 -1.253 0 C-N-CA 120.173 -0.611 . . . . 0.0 110.562 178.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 760' ' ' THR . . . . . 0.462 HG23 ' OD2' ' A' ' 790' ' ' ASP . 0.0 OUTLIER -89.94 -3.16 58.19 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 177.444 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 761' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -69.74 -36.18 75.62 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 114.712 -1.131 . . . . 0.0 110.971 175.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 762' ' ' SER . . . . . 0.582 ' HB2' ' OE2' ' A' ' 759' ' ' GLU . 66.9 m -150.76 -88.8 0.07 Allowed 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 177.321 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 763' ' ' SER . . . . . . . . . . . . . 26.3 p -176.2 26.14 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 -175.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 764' ' ' LYS . . . . . 0.575 ' H ' ' CD ' ' A' ' 759' ' ' GLU . 10.5 mtmp? -105.46 75.89 1.18 Allowed 'General case' 0 C--N 1.327 -0.377 0 O-C-N 121.623 -0.673 . . . . 0.0 110.408 -178.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 765' ' ' ARG . . . . . 0.418 HH11 ' HD2' ' A' ' 765' ' ' ARG . 47.2 mtm105 -62.49 152.88 33.3 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.569 179.247 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 766' ' ' LYS . . . . . 0.665 ' HD3' ' N ' ' A' ' 767' ' ' THR . 7.5 tmtm? -124.5 144.8 49.91 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 176.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 767' ' ' THR . . . . . 0.665 ' N ' ' HD3' ' A' ' 766' ' ' LYS . 91.4 m -125.05 137.84 54.21 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 120.879 0.371 . . . . 0.0 111.742 -176.34 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 768' ' ' PHE . . . . . 0.557 ' HB2' ' CE1' ' A' ' 755' ' ' TYR . 2.1 m-85 -131.89 130.25 41.38 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.047 171.074 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 769' ' ' GLU . . . . . 0.448 ' HB2' HG23 ' A' ' 754' ' ' THR . 37.1 tt0 -124.6 108.07 11.68 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.294 179.307 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 770' ' ' ILE . . . . . 0.429 ' N ' HD12 ' A' ' 770' ' ' ILE . 4.3 mp -106.76 113.23 42.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.196 -178.171 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 771' ' ' LYS . . . . . 0.612 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 1.7 mtpt -81.88 149.57 28.2 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.252 0.548 . . . . 0.0 111.125 -177.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 772' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 57.32 50.19 11.93 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.36 -1.291 . . . . 0.0 112.652 177.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 773' ' ' ILE . . . . . 0.886 HD13 HD13 ' A' ' 745' ' ' LEU . 0.5 OUTLIER -78.88 119.64 28.46 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 170.692 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 774' ' ' LYS . . . . . . . . . . . . . 72.3 mttt -118.49 29.72 7.6 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 -177.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 775' ' ' THR . . . . . 0.659 ' H ' HD12 ' A' ' 773' ' ' ILE . 0.2 OUTLIER -94.08 -71.27 0.67 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.469 -1.241 . . . . 0.0 113.266 -167.753 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 776' ' ' ASN . . . . . 0.594 ' HB2' ' O ' ' A' ' 775' ' ' THR . 0.9 OUTLIER 84.8 2.86 0.73 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.326 1.05 . . . . 0.0 110.273 -176.739 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 777' ' ' GLU . . . . . 0.586 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 7.5 mt-10 -162.31 86.18 0.59 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.314 174.062 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 778' ' ' TYR . . . . . 0.685 ' HB3' HD11 ' A' ' 745' ' ' LEU . 69.9 t80 -132.38 131.1 41.52 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -173.53 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 779' ' ' VAL . . . . . 0.762 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 1.5 m -96.93 132.46 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.166 0 CA-C-O 122.684 1.231 . . . . 0.0 110.337 176.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 780' ' ' ILE . . . . . 0.412 ' HB ' ' HB ' ' A' ' 741' ' ' VAL . 88.8 mt -89.21 147.76 4.98 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-N 112.88 -1.964 . . . . 0.0 110.143 -170.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 781' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -112.09 110.55 20.9 Favored 'General case' 0 C--N 1.314 -0.947 0 C-N-CA 120.271 -0.572 . . . . 0.0 109.575 175.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 782' ' ' THR . . . . . 0.497 HG22 HG12 ' A' ' 757' ' ' ILE . 11.5 p -85.66 142.43 37.12 Favored Pre-proline 0 C--N 1.312 -1.065 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.076 -177.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 783' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 782' ' ' THR . 32.2 Cg_exo -59.68 160.2 21.81 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 123.614 2.876 . . . . 0.0 113.233 -174.087 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 784' ' ' VAL . . . . . 0.531 HG12 HG23 ' A' ' 786' ' ' THR . 52.5 t -59.51 115.38 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.316 177.18 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 785' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -94.88 95.4 8.63 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.242 -179.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 786' ' ' THR . . . . . 0.531 HG23 HG12 ' A' ' 784' ' ' VAL . 33.4 p -86.67 35.23 0.67 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 122.026 0.917 . . . . 0.0 110.648 -178.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 787' ' ' THR . . . . . . . . . . . . . 44.3 m -152.79 109.31 3.42 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 114.457 -1.247 . . . . 0.0 110.902 179.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 788' ' ' GLY . . . . . 0.706 ' HA2' HG12 ' A' ' 817' ' ' VAL . . . -52.42 109.14 0.82 Allowed Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.16 169.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 789' ' ' GLY . . . . . 0.433 ' H ' ' HB ' ' A' ' 817' ' ' VAL . . . -169.91 176.58 43.66 Favored Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 110.82 -0.912 . . . . 0.0 110.82 -179.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 790' ' ' ASP . . . . . 0.462 ' OD2' HG23 ' A' ' 760' ' ' THR . 0.4 OUTLIER -103.12 133.12 48.75 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.384 0.612 . . . . 0.0 110.58 -178.563 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 791' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -123.66 148.41 46.51 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.342 -0.844 . . . . 0.0 109.697 -179.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 792' ' ' ILE . . . . . 0.625 ' O ' HG13 ' A' ' 758' ' ' ILE . 14.1 mt -128.62 114.28 32.84 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 177.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 793' ' ' LEU . . . . . 0.536 HD12 ' N ' ' A' ' 794' ' ' SER . 0.7 OUTLIER -84.62 113.44 21.27 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.122 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 794' ' ' SER . . . . . 0.536 ' N ' HD12 ' A' ' 793' ' ' LEU . 13.7 p -124.68 164.34 20.1 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.344 -1.298 . . . . 0.0 109.315 -174.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 795' ' ' LEU . . . . . 0.619 HD11 ' O ' ' A' ' 723' ' ' ALA . 36.7 mt -89.4 144.85 25.74 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.688 -0.233 . . . . 0.0 110.942 -176.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 796' ' ' VAL . . . . . . . . . . . . . 68.8 t -104.88 -57.68 4.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.159 177.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 797' ' ' SER . . . . . 0.504 ' HA ' ' HG ' ' A' ' 808' ' ' LEU . 10.4 m -176.95 161.53 1.96 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.978 -175.283 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 798' ' ' ILE . . . . . 0.557 ' HA ' ' O ' ' A' ' 752' ' ' THR . 11.7 tt -132.07 162.11 40.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 108.679 -0.859 . . . . 0.0 108.679 176.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 799' ' ' LYS . . . . . 0.771 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 5.2 tmtt? -137.4 119.84 15.91 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.097 0.475 . . . . 0.0 111.024 -178.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 800' ' ' ASP . . . . . 0.501 ' HA ' ' CD2' ' A' ' 751' ' ' PHE . 11.7 t70 -64.23 153.0 39.36 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.256 -0.884 . . . . 0.0 108.982 174.046 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 801' ' ' SER . . . . . . . . . . . . . 3.5 p -68.02 0.92 3.08 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -173.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 24.3 p -92.95 -0.46 57.21 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.657 0.741 . . . . 0.0 109.511 172.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 803' ' ' GLY . . . . . 0.45 ' HA2' ' HE2' ' A' ' 799' ' ' LYS . . . 81.05 41.92 9.97 Favored Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.8 -177.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 804' ' ' CYS . . . . . . . . . . . . . 63.4 m -113.78 114.22 26.02 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 805' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 8.3 p -86.52 134.25 27.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.313 0.578 . . . . 0.0 110.831 -177.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 806' ' ' VAL . . . . . . . . . . . . . 53.2 t -123.04 134.84 64.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.717 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.365 178.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -66.24 127.29 29.5 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 114.816 -1.084 . . . . 0.0 111.939 -179.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 808' ' ' LEU . . . . . 0.744 ' CD2' ' HA ' ' A' ' 722' ' ' SER . 45.6 mt -90.81 126.62 36.08 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -177.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 5.6 p -149.47 85.95 1.46 Allowed 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 121.522 0.677 . . . . 0.0 110.97 173.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 810' ' ' GLN . . . . . 0.63 ' HB2' ' O ' ' A' ' 723' ' ' ALA . 90.8 mt-30 -140.5 168.02 15.93 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 172.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 811' ' ' PRO . . . . . 0.524 ' HD2' ' HB3' ' A' ' 810' ' ' GLN . 86.6 Cg_exo -45.34 137.33 10.88 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 123.098 2.532 . . . . 0.0 115.228 -173.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -103.25 166.72 10.26 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.303 177.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 813' ' ' ALA . . . . . . . . . . . . . . . -119.68 161.11 21.24 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.245 -177.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 814' ' ' LYS . . . . . 0.449 ' O ' ' HA ' ' A' ' 730' ' ' ASP . 73.9 tttt -123.98 125.2 44.16 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 121.163 0.506 . . . . 0.0 110.834 177.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 815' ' ' ILE . . . . . 0.537 ' HA ' ' HB3' ' A' ' 731' ' ' LEU . 5.3 mp -109.39 119.24 58.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 176.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 816' ' ' GLN . . . . . 0.702 ' NE2' ' HG2' ' A' ' 818' ' ' ARG . 0.8 OUTLIER -108.95 114.51 28.33 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.217 0.532 . . . . 0.0 111.062 -174.748 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 817' ' ' VAL . . . . . 0.706 HG12 ' HA2' ' A' ' 788' ' ' GLY . 84.4 t -103.97 140.52 21.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.316 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 818' ' ' ARG . . . . . 0.702 ' HG2' ' NE2' ' A' ' 816' ' ' GLN . 34.1 mmt180 -141.85 154.95 45.52 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 172.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 819' ' ' ARG . . . . . 0.479 ' HD2' HD13 ' A' ' 735' ' ' LEU . 9.1 mtm180 -85.91 140.0 30.74 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.724 -174.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 820' ' ' ASP . . . . . 0.492 ' OD2' ' HB3' ' A' ' 734' ' ' CYS . 11.3 p-10 . . . . . 0 C--N 1.317 -0.812 0 CA-C-N 115.785 -0.643 . . . . 99.989999999999995 109.766 178.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 718' ' ' ARG . . . . . . . . . . . . . 18.9 tpt180 . . . . . 0 CA--C 1.513 -0.453 0 CA-C-O 121.983 0.897 . . . . 0.0 110.361 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 719' ' ' VAL . . . . . . . . . . . . . 2.5 m -133.16 155.78 41.3 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 CA-C-N 114.744 -1.116 . . . . 0.0 109.463 -175.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 720' ' ' LYS . . . . . . . . . . . . . 16.7 mtpp -87.27 110.65 35.35 Favored Pre-proline 0 C--N 1.307 -1.277 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.64 -178.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 721' ' ' PRO . . . . . 0.427 ' HG3' ' CE2' ' A' ' 751' ' ' PHE . 60.6 Cg_endo -88.5 154.93 6.48 Favored 'Trans proline' 0 N--CA 1.447 -1.217 0 C-N-CA 122.713 2.275 . . . . 0.0 112.472 -174.209 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 722' ' ' SER . . . . . 0.51 ' HA ' ' CD2' ' A' ' 808' ' ' LEU . 11.4 t 178.49 -152.4 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.871 -176.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 723' ' ' ALA . . . . . 0.639 ' HA ' ' HA ' ' A' ' 745' ' ' LEU . . . -152.53 153.65 33.87 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 178.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 724' ' ' SER . . . . . . . . . . . . . 49.7 m -144.45 98.67 3.24 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.213 0.53 . . . . 0.0 109.634 175.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 725' ' ' LEU . . . . . 0.535 ' HA ' ' HA ' ' A' ' 743' ' ' VAL . 4.9 mp -62.38 141.45 58.32 Favored 'General case' 0 N--CA 1.424 -1.747 0 CA-C-O 122.4 1.095 . . . . 0.0 111.808 -175.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 726' ' ' LYS . . . . . 0.522 ' HD2' ' HB2' ' A' ' 744' ' ' ALA . 19.2 mtpp -94.79 -13.02 26.02 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 112.887 -1.96 . . . . 0.0 110.288 -173.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 727' ' ' LEU . . . . . 0.554 ' HB2' ' HD2' ' A' ' 742' ' ' PRO . 0.9 OUTLIER -82.3 112.38 19.24 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 176.096 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 51.5 m-70 -114.67 54.25 0.78 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.713 0.635 . . . . 0.0 112.713 -172.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 729' ' ' HIS . . . . . . . . . . . . . 7.6 p80 -178.15 -178.08 0.63 Allowed 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.762 -0.199 . . . . 0.0 110.492 176.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 730' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -81.58 125.84 31.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.303 176.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 731' ' ' LEU . . . . . 0.6 ' HB2' ' HA ' ' A' ' 815' ' ' ILE . 21.2 mt -79.95 113.14 17.89 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.215 177.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 732' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -76.61 109.94 10.78 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.092 -176.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 733' ' ' LEU . . . . . 0.815 HD12 HG22 ' A' ' 817' ' ' VAL . 64.3 mt -122.94 164.21 18.92 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.16 0.505 . . . . 0.0 110.864 177.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 734' ' ' CYS . . . . . 0.517 ' O ' ' HB2' ' A' ' 737' ' ' ASP . 76.3 m -113.75 -174.28 2.44 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.023 170.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 735' ' ' LEU . . . . . . . . . . . . . 8.6 tp -68.37 135.24 51.5 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 121.448 0.642 . . . . 0.0 111.898 -176.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 81.37 8.74 86.77 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 114.854 -1.066 . . . . 0.0 111.996 -178.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 737' ' ' ASP . . . . . 0.517 ' HB2' ' O ' ' A' ' 734' ' ' CYS . 4.1 m-20 -89.67 151.48 21.85 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 179.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 738' ' ' HIS . . . . . 0.444 ' HB2' ' O ' ' A' ' 782' ' ' THR . 45.4 p-80 -114.2 -175.53 2.7 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 169.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 739' ' ' SER . . . . . 0.594 ' OG ' HD11 ' A' ' 733' ' ' LEU . 9.2 m -141.55 174.39 10.61 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.567 0.698 . . . . 0.0 112.471 178.021 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 740' ' ' SER . . . . . 0.415 ' HA ' ' O ' ' A' ' 780' ' ' ILE . 14.1 t -141.67 103.04 4.3 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.489 178.251 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 741' ' ' VAL . . . . . 0.692 HG11 HD23 ' A' ' 793' ' ' LEU . 1.7 p -107.57 114.65 60.36 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.642 -175.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 742' ' ' PRO . . . . . 0.651 ' HA ' ' HA ' ' A' ' 779' ' ' VAL . 1.0 OUTLIER -73.64 129.19 13.34 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 122.488 2.126 . . . . 0.0 111.286 179.403 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 743' ' ' VAL . . . . . 0.535 ' HA ' ' HA ' ' A' ' 725' ' ' LEU . 1.5 p -128.53 119.92 51.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.308 0.575 . . . . 0.0 111.759 175.014 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 744' ' ' ALA . . . . . 0.583 ' HA ' ' HA ' ' A' ' 777' ' ' GLU . . . -85.1 105.51 15.88 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 169.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 745' ' ' LEU . . . . . 0.817 HD13 HD13 ' A' ' 773' ' ' ILE . 0.4 OUTLIER -85.23 168.0 15.15 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.156 -167.403 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 746' ' ' LYS . . . . . . . . . . . . . 12.3 tttp -121.23 155.43 34.63 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.678 0.752 . . . . 0.0 110.724 -177.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 747' ' ' GLY . . . . . . . . . . . . . . . 97.66 135.92 8.92 Favored Glycine 0 C--N 1.306 -1.121 0 CA-C-N 114.441 -1.254 . . . . 0.0 111.229 -178.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 60.9 mm-40 -106.46 116.74 32.46 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.858 -173.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 749' ' ' GLY . . . . . . . . . . . . . . . 130.28 164.77 11.42 Favored Glycine 0 CA--C 1.496 -1.114 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.518 -175.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 750' ' ' PRO . . . . . 0.573 ' HB3' ' HE2' ' A' ' 774' ' ' LYS . 46.2 Cg_endo -60.31 94.08 0.1 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 123.388 2.725 . . . . 0.0 111.768 172.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 751' ' ' PHE . . . . . 0.467 ' CE2' ' HA ' ' A' ' 800' ' ' ASP . 44.0 m-85 -105.0 143.34 33.32 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.103 -177.149 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 752' ' ' THR . . . . . 0.783 ' HB ' ' HB3' ' A' ' 799' ' ' LYS . 93.0 m -88.44 102.97 15.42 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 121.563 0.697 . . . . 0.0 109.137 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 753' ' ' LEU . . . . . 0.438 HD22 HD22 ' A' ' 745' ' ' LEU . 23.6 tp -93.3 117.81 30.52 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.379 -1.282 . . . . 0.0 110.844 -169.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 754' ' ' THR . . . . . 0.501 HG23 ' HB2' ' A' ' 769' ' ' GLU . 1.4 m -117.99 132.11 56.42 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.707 0.289 . . . . 0.0 110.642 179.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 755' ' ' TYR . . . . . 0.551 ' CE1' ' HB3' ' A' ' 768' ' ' PHE . 24.1 p90 -142.45 156.94 45.22 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.89 0.376 . . . . 0.0 111.438 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 756' ' ' ASP . . . . . 0.526 ' HB3' HG23 ' A' ' 758' ' ' ILE . 0.1 OUTLIER -119.76 118.83 31.89 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.526 -179.282 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 757' ' ' ILE . . . . . 0.567 ' CD1' HD13 ' A' ' 793' ' ' LEU . 3.6 mp -87.22 96.39 5.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 167.348 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 758' ' ' ILE . . . . . 0.526 HG23 ' HB3' ' A' ' 756' ' ' ASP . 2.4 pp -96.08 144.33 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.562 -171.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 759' ' ' GLU . . . . . 0.539 ' CG ' ' H ' ' A' ' 764' ' ' LYS . 5.6 pt-20 -95.64 124.37 39.63 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 119.47 -0.892 . . . . 0.0 109.988 177.138 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 760' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -90.19 -0.24 57.52 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 177.44 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 761' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -69.01 -36.3 77.63 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 114.596 -1.183 . . . . 0.0 109.996 175.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 762' ' ' SER . . . . . 0.451 ' HB2' ' OE1' ' A' ' 759' ' ' GLU . 1.2 m -148.6 -81.51 0.12 Allowed 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.464 174.276 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 763' ' ' SER . . . . . . . . . . . . . 81.1 p -174.35 10.99 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -176.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 764' ' ' LYS . . . . . 0.539 ' H ' ' CG ' ' A' ' 759' ' ' GLU . 96.7 mttt -83.56 73.81 10.18 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.262 0.553 . . . . 0.0 110.414 -173.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 765' ' ' ARG . . . . . 0.449 ' HA ' ' HA ' ' A' ' 758' ' ' ILE . 42.4 mtm180 -65.96 141.99 58.01 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.443 -179.084 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 766' ' ' LYS . . . . . 0.478 ' O ' ' HA ' ' A' ' 756' ' ' ASP . 1.0 OUTLIER -121.44 136.05 55.0 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.018 -179.037 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 767' ' ' THR . . . . . . . . . . . . . 60.7 m -115.38 136.73 52.79 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.89 -175.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 768' ' ' PHE . . . . . 0.551 ' HB3' ' CE1' ' A' ' 755' ' ' TYR . 2.8 t80 -138.33 135.68 35.65 Favored 'General case' 0 N--CA 1.443 -0.801 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 175.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 769' ' ' GLU . . . . . 0.501 ' HB2' HG23 ' A' ' 754' ' ' THR . 33.2 tt0 -127.17 133.15 50.36 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.117 -179.277 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 770' ' ' ILE . . . . . 0.413 HG22 HG22 ' A' ' 773' ' ' ILE . 4.1 mt -123.9 109.04 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.625 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 175.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 771' ' ' LYS . . . . . 0.609 ' HA ' ' HA ' ' A' ' 752' ' ' THR . 9.6 mtpt -80.12 151.59 29.73 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-O 121.35 0.595 . . . . 0.0 111.035 -176.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 772' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 55.35 50.66 14.41 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 114.312 -1.313 . . . . 0.0 112.393 176.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 773' ' ' ILE . . . . . 0.817 HD13 HD13 ' A' ' 745' ' ' LEU . 0.5 OUTLIER -74.99 122.07 27.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 170.989 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 774' ' ' LYS . . . . . 0.573 ' HE2' ' HB3' ' A' ' 750' ' ' PRO . 65.5 mttt -115.38 25.42 10.84 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.364 -0.835 . . . . 0.0 108.818 -176.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 775' ' ' THR . . . . . 0.692 ' H ' HD12 ' A' ' 773' ' ' ILE . 0.7 OUTLIER -96.33 -73.36 0.6 Allowed 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -169.551 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 776' ' ' ASN . . . . . 0.629 ' HB2' ' O ' ' A' ' 775' ' ' THR . 0.7 OUTLIER 85.97 3.65 0.53 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.548 1.139 . . . . 0.0 111.242 -173.345 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 777' ' ' GLU . . . . . 0.583 ' HA ' ' HA ' ' A' ' 744' ' ' ALA . 30.0 mt-10 -161.27 84.64 0.65 Allowed 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 177.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 778' ' ' TYR . . . . . 0.686 ' HB3' HD11 ' A' ' 745' ' ' LEU . 89.9 t80 -132.72 133.01 42.94 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.897 -169.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 779' ' ' VAL . . . . . 0.651 ' HA ' ' HA ' ' A' ' 742' ' ' PRO . 12.2 t -93.5 114.36 30.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.465 0.65 . . . . 0.0 110.555 179.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 780' ' ' ILE . . . . . 0.548 ' HB ' HG13 ' A' ' 741' ' ' VAL . 70.6 mt -79.4 147.52 6.62 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.606 -177.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 781' ' ' LYS . . . . . 0.43 ' HD3' ' C ' ' A' ' 780' ' ' ILE . 0.0 OUTLIER -117.89 100.67 7.73 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 175.222 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 782' ' ' THR . . . . . 0.493 ' OG1' ' HB2' ' A' ' 739' ' ' SER . 62.1 p -70.16 135.19 87.08 Favored Pre-proline 0 N--CA 1.441 -0.884 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.633 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 783' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 782' ' ' THR . 25.5 Cg_exo -62.66 156.21 54.28 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.793 2.329 . . . . 0.0 111.303 -175.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 784' ' ' VAL . . . . . . . . . . . . . 14.6 p -58.64 127.87 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.639 0 CA-C-O 121.489 0.661 . . . . 0.0 109.974 -177.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 785' ' ' PHE . . . . . 0.454 ' C ' ' H ' ' A' ' 787' ' ' THR . 94.7 m-85 -81.88 -31.83 31.33 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.419 -172.122 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 786' ' ' THR . . . . . . . . . . . . . 43.1 p 56.64 2.49 0.1 Allowed 'General case' 0 N--CA 1.471 0.59 0 O-C-N 124.065 0.853 . . . . 0.0 112.233 178.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 787' ' ' THR . . . . . 0.454 ' H ' ' C ' ' A' ' 785' ' ' PHE . 14.8 m -139.93 122.91 16.68 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.05 -179.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 788' ' ' GLY . . . . . . . . . . . . . . . -58.76 111.23 3.11 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.304 168.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 789' ' ' GLY . . . . . 0.459 ' H ' ' HB ' ' A' ' 817' ' ' VAL . . . -166.89 167.21 39.58 Favored Glycine 0 N--CA 1.442 -0.916 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 178.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 790' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -99.11 130.98 45.47 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 117.674 0.737 . . . . 0.0 109.72 -179.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 791' ' ' TYR . . . . . 0.438 ' CE2' ' HB3' ' A' ' 759' ' ' GLU . 86.9 m-85 -124.3 153.48 41.68 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.29 0.567 . . . . 0.0 110.885 -178.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 792' ' ' ILE . . . . . 0.484 ' O ' HG13 ' A' ' 758' ' ' ILE . 7.2 mt -130.72 113.97 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 CA-C-N 115.283 -0.871 . . . . 0.0 108.944 176.113 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 793' ' ' LEU . . . . . 0.692 HD23 HG11 ' A' ' 741' ' ' VAL . 1.3 tp -84.74 110.68 18.97 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 176.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 794' ' ' SER . . . . . 0.492 ' N ' HD12 ' A' ' 793' ' ' LEU . 6.1 p -124.7 157.5 35.49 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.53 -1.214 . . . . 0.0 109.729 -173.472 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 795' ' ' LEU . . . . . 0.509 ' CD2' ' HB3' ' A' ' 723' ' ' ALA . 51.4 mt -85.29 133.39 34.16 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.57 -0.287 . . . . 0.0 111.147 -174.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 796' ' ' VAL . . . . . . . . . . . . . 79.2 t -95.62 -55.06 6.45 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.715 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 797' ' ' SER . . . . . 0.566 ' HA ' ' HG ' ' A' ' 808' ' ' LEU . 97.5 p -176.7 158.55 1.71 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.988 -173.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 798' ' ' ILE . . . . . 0.503 ' HA ' ' O ' ' A' ' 752' ' ' THR . 8.0 tt -131.01 163.88 35.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 176.182 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 799' ' ' LYS . . . . . 0.783 ' HB3' ' HB ' ' A' ' 752' ' ' THR . 16.5 ttmt -140.91 125.82 18.2 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.06 0.457 . . . . 0.0 111.503 -177.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 800' ' ' ASP . . . . . 0.467 ' HA ' ' CE2' ' A' ' 751' ' ' PHE . 28.2 t70 -65.98 155.77 35.61 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.517 174.024 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 801' ' ' SER . . . . . 0.458 ' HB3' ' HG2' ' A' ' 750' ' ' PRO . 18.2 p -59.03 -10.05 2.33 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 -171.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 802' ' ' THR . . . . . . . . . . . . . 36.1 p -96.76 8.83 43.39 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.37 0.605 . . . . 0.0 110.324 179.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 803' ' ' GLY . . . . . . . . . . . . . . . 76.17 41.37 26.83 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.038 -178.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 804' ' ' CYS . . . . . 0.429 ' HB2' ' HB3' ' A' ' 800' ' ' ASP . 76.7 m -109.72 111.74 23.38 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 178.247 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 805' ' ' VAL . . . . . 0.438 ' HA ' ' O ' ' A' ' 798' ' ' ILE . 14.4 p -86.25 139.46 17.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.422 0.63 . . . . 0.0 111.702 -174.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 806' ' ' VAL . . . . . 0.494 ' HB ' HG22 ' A' ' 798' ' ' ILE . 52.0 t -119.21 131.99 70.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.551 177.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 807' ' ' GLY . . . . . . . . . . . . . . . -72.99 114.07 4.62 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.798 -0.715 . . . . 0.0 111.791 179.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 808' ' ' LEU . . . . . 0.566 ' HG ' ' HA ' ' A' ' 797' ' ' SER . 36.0 mt -84.9 124.46 31.66 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -173.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 809' ' ' SER . . . . . . . . . . . . . 19.1 t -138.98 86.51 2.14 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.241 171.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 810' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -146.91 173.55 4.11 Favored Pre-proline 0 CA--C 1.54 0.594 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.873 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 811' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_exo -43.53 144.36 2.12 Favored 'Trans proline' 0 C--N 1.357 1.019 0 C-N-CA 123.618 2.879 . . . . 0.0 115.812 -173.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 812' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -116.22 169.1 9.54 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 114.554 -1.203 . . . . 0.0 110.546 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 813' ' ' ALA . . . . . . . . . . . . . . . -120.68 160.15 23.87 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.994 175.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 814' ' ' LYS . . . . . 0.468 ' HG2' ' CG1' ' A' ' 792' ' ' ILE . 48.3 mttp -123.62 134.31 53.81 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.451 0.643 . . . . 0.0 110.648 177.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 815' ' ' ILE . . . . . 0.6 ' HA ' ' HB2' ' A' ' 731' ' ' LEU . 5.3 mp -121.16 108.48 22.66 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.99 0 CA-C-N 115.055 -0.975 . . . . 0.0 108.898 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 816' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -100.87 108.01 19.68 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.257 0.551 . . . . 0.0 110.441 -176.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 817' ' ' VAL . . . . . 0.815 HG22 HD12 ' A' ' 733' ' ' LEU . 2.9 t -101.91 146.86 9.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 -179.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 818' ' ' ARG . . . . . . . . . . . . . 20.7 tpt180 -140.79 131.63 25.91 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.467 0.651 . . . . 0.0 112.175 -178.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 819' ' ' ARG . . . . . . . . . . . . . 20.9 ttt180 -99.09 117.73 34.23 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.274 173.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 820' ' ' ASP . . . . . . . . . . . . . 38.6 t70 . . . . . 0 C--N 1.328 -0.327 0 O-C-N 123.494 0.496 . . . . 99.989999999999995 110.798 -176.55 . . . . . . . . 0 0 . 1 stop_ save_